{
  "hum0429.v1": {
    "ja": {
      "NBDC Research ID": "hum0429.v1",
      "データ": {
        "JGAS000643": {
          "データID": "JGAS000643",
          "内容": "NGS（WGS、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/11/13"
        }
      },
      "研究内容の概要": {
        "目的": "KRAS G12C阻害剤は、KRAS G12C変異を保有する非小細胞肺がん（NSCLC）およびその他の固形悪性腫瘍患者において臨床活性を示すものの、複数の耐性機序によって奏効が制限される。KRAS G12C阻害剤（JDQ443）は、SHP2阻害剤（TNO155）と併用することで抗腫瘍活性が増強されことが示唆されているが、この併用療法は現在臨床評価中である。ある種の耐性を克服または予防する合理的な薬剤併用戦略を立てるために、KRAS G12C変異を保有するNSCLC株由来の異種移植モデル（Xenograftマウス）の腫瘍細胞において、JDQ443±TNO155の投与またはPI3Kα阻害剤（アルペリシブ）および／またはCDK4/6阻害剤（リボシクリブ）との併用投与に対する腫瘍の奏効期間を評価し、KRAS G12C/SHP2併用阻害に対する奏効消失に関連する遺伝的機序を検討した。",
        "方法": "Low-pass whole-genome sequencing（lp-WGS）、RNA-seq",
        "対象": "ヒト肺非小細胞がん細胞株（LU99）を移植し、樹立したXenograftマウスの腫瘍組織に対して薬剤の組み合わせによる処理を施した細胞"
      },
      "分子データ": {
        "WGS": {
          "対象": "ヒト肺がん（ICD10：C349）細胞株LU99を移植したマウスの腫瘍組織：計16検体\r\n     Xenograftマウスの腫瘍細胞に対して、薬剤（JDQ443＋TNO155＋alpelisib＋ribociclib）もしくは溶媒（対照）を投与し、3時間後および24時間後に採取した細胞：各4検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "https://cellbank.brc.riken.jp/cell_bank/CellInfo/?cellNo=RCB1900",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra II DNA PCR-free Library Prep Kit for Illumina",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "51 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000773",
          "総データ量": "85.9 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "ヒト肺がん（ICD10：C349）細胞株LU99を移植したマウスの腫瘍組織：計16検体\r\n     Xenograftマウスの腫瘍細胞に対して、薬剤（JDQ443＋TNO155＋alpelisib＋ribociclib）もしくは溶媒（対照）を投与し、3時間後および24時間後に採取した細胞：各4検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "https://cellbank.brc.riken.jp/cell_bank/CellInfo/?cellNo=RCB1900",
          "ライブラリ作製方法（キット名）": "Illumina Stranded Total RNA Prep, Ligation with Ribo-Zero Plus",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000773",
          "総データ量": "85.9 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "Saskia Brachmann",
        "所 属 機 関": "Novartis Institutes for BioMedical Research",
        "プロジェクト/研究グループ名": "Oncology",
        "科研費/助成金（Research Project Number）": {
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer",
          "DOI": "doi: 10.1158/0008-5472.CAN-23-1127",
          "データID": "JGAD000773"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0429.v1": {
          "Research ID": "hum0429.v1",
          "公開日": "2023/11/13",
          "内容": "NGS（WGS、RNA-seq）",
          "description": "ヒト肺非小細胞がん細胞株（LU99）を移植し、樹立したXenograftマウスの腫瘍組織を対象に、薬剤投与の有無による処理を施した細胞より抽出したDNA/RNAを用いたWGS、RNA-seq解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0429.v1",
      "DATA": {
        "JGAS000643": {
          "Data Set ID": "JGAS000643",
          "Type of Data": "NGS（WGS, RNA-seq）",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/11/13"
        }
      },
      "SUMMARY": {
        "Aims": "Although KRAS G12C inhibitors show clinical activity in patients with KRAS G12C mutated Non-Small Cell Lung Cancer (NSCLC) and other solid tumor malignancies, the response is limited by multiple mechanisms of resistance. The KRAS G12C inhibitor JDQ443 shows enhanced preclinical antitumor activity combined with the SHP2 inhibitor TNO155, and the combination is currently under clinical evaluation. To identify rational combination strategies that could help overcome or prevent some types of resistance, we evaluated the duration of tumor responses to JDQ443 ± TNO155, alone or combined with the PI3Kα inhibitor alpelisib and/or the CDK4/6 inhibitor ribociclib, in xenograft models derived from a KRAS G12C-mutant NSCLC cell-line and investigated the genetic mechanisms associated with loss of response to combined KRAS G12C/SHP2 inhibition.",
        "Methods": "Low-pass whole-genome sequencing (lp-WGS), RNA-seq",
        "Participants/Materials": "LU99 tumor-bearing mice treated with either vehicle or quadruple combination regiment (JDQ443 + TNO155 + alpelisib + ribociclib)"
      },
      "MOLECULAR DATA": {
        "WGS": {
          "Participants/Materials": "tumor tissue collected from LU99 tumor-bearing mice: total 16 samples\r\n    tumor tissue collected from mice with treatment (JDQ443 + TNO155 + alpelisib + ribociclib) / vehicle condition at 3 hours / 24 hours after the last dose: 4 samples each",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor tissues",
          "Cell Lines": "https://cellbank.brc.riken.jp/cell_bank/CellInfo/?cellNo=RCB1900",
          "Library Construction (kit name)": "NEBNext Ultra II DNA PCR-free Library Prep Kit for Illumina",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "51 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000773",
          "Total Data Volume": "85.9 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "tumor tissue collected from LU99 tumor-bearing mice: total 16 samples\r\n    tumor tissue collected from mice with treatment (JDQ443 + TNO155 + alpelisib + ribociclib) / vehicle condition at 3 hours / 24 hours after the last dose: 4 samples each",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from tumor tissues",
          "Cell Lines": "https://cellbank.brc.riken.jp/cell_bank/CellInfo/?cellNo=RCB1900",
          "Library Construction (kit name)": "Illumina Stranded Total RNA Prep, Ligation with Ribo-Zero Plus",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000773",
          "Total Data Volume": "85.9 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Saskia Brachmann",
        "Affiliation": "Novartis Institutes for BioMedical Research",
        "Project / Group Name": "Oncology",
        "Funds / Grants (Research Project Number)": {
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer",
          "DOI": "doi: 10.1158/0008-5472.CAN-23-1127",
          "Data Set ID": "JGAD000773"
        },
        "": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0429.v1": {
          "Research ID": "hum0429.v1",
          "Release Date": "2023/11/13",
          "Type of Data": "NGS (WGS, RNA-seq)",
          "description": "DNAs/RNAs extracted from tumor tissues collected from LU99 tumor-bearing mice with treatment / vehicle condition were used for the WGS and RNA-seq analyses. Fastq files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0427.v1": {
    "ja": {
      "NBDC Research ID": "hum0427.v1",
      "データ": {
        "JGAS000645": {
          "データID": "JGAS000645",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/11/02"
        }
      },
      "研究内容の概要": {
        "目的": "悪性腫瘍の研究において、多くの研究者が細胞バンクの細胞株を利用しているが、細胞バンクから入手可能な頭頚部悪性腫瘍の細胞株は部位、組織型ともに限られており、特に希少がんの細胞株入手は困難である。本研究では、頭頸部悪性腫瘍の細胞株を樹立後免疫不全動物へ移植し、生着・増殖の可否を検討する。また、樹立した細胞株は細胞バンクへ寄託・譲渡し、多くの研究者が利用可能なものとすることで、頭頚部悪性腫瘍、特に希少がんについて病態の解明や治療法確立に向けての研究を推進することを目的とする。",
        "方法": "末梢血単核細胞、原発腫瘍組織、原発巣腫瘍組織から樹立した細胞株、それぞれから抽出したDNAを用いた全エクソーム配列決定",
        "対象": "外耳道扁平上皮がん患者1名から採取した末梢血単核細胞、腫瘍原発巣組織、および腫瘍原発巣組織から樹立した細胞株（計3検体）。細胞株は細胞株（SCEACono2）として理化学研究所バイオリソース研究センターに寄託済（https://cellbank.brc.riken.jp/cell_bank/CellInfo/?cellNo=RCB5515&lang=En）。"
      },
      "分子データ": {
        "JGAS000645": {
          "対象": "外耳道扁平上皮がん（ICD10：C44.2）：1症例（3検体）\r\n    非腫瘍組織（末梢血単核細胞）、腫瘍原発巣組織、腫瘍原発巣組織から樹立した細胞株：各1検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "MGI [DNBSEQ-G400]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織、ならびに細胞株から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6 Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000775",
          "総データ量": "29.6 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 尚志",
        "所 属 機 関": "九州大学大学院医学研究院 耳鼻咽喉科学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（B）",
            "タイトル": "側頭骨扁平上皮癌の悪性度を決定するエピジェネティックな腫瘍制御機構の解明",
            "研究課題番号": "22H03236"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinoma",
          "DOI": "doi: 10.1002/2211-5463.13225",
          "データID": "JGAD000775"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0427.v1": {
          "Research ID": "hum0427.v1",
          "公開日": "2023/11/02",
          "内容": "NGS（Exome）",
          "description": "外耳道扁平上皮がん1症例の末梢血単核細胞、原発腫瘍組織、原発腫瘍組織から樹立した細胞株、それぞれから抽出したDNAを用いたwhole exome sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0427.v1",
      "DATA": {
        "JGAS000645": {
          "Data Set ID": "JGAS000645",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/11/02"
        }
      },
      "SUMMARY": {
        "Aims": "In the field of oncology, many researchers generally use cell lines obtained from cell banks. However, cell lines for head and neck malignancies available from cell banks are limited especially for rare-type cancers, resulting in difficulties in elucidation of biological characterization of such malignancies and establishment of therapeutic strategies. This study aimed to establish cell lines of head and neck malignancies and to examine their tumorigenic abilities in immune-deficient animals. The established cell lines will be deposited to cell banks.",
        "Methods": "Genomic DNAs extracted from peripheral blood mononuclear cells (PBMC), the primary tumor tissues, and the cell line were used for whole exome sequencing analysis.",
        "Participants/Materials": "PBMC and the primary tumor tissues were collected from a patient with external auditory canal squamous cell carcinoma, and a cell line was established from the primary tumor tissues. The cell line was deposited as SCEACono2 in RIKEN BioResource Research Center (https://cellbank.brc.riken.jp/cell_bank/CellInfo/?cellNo=RCB5515&lang=En)."
      },
      "MOLECULAR DATA": {
        "JGAS000645": {
          "Participants/Materials": "external auditory canal squamous cell carcinoma (ICD10: C44.2): 1 case (3 samples)\r\n    non-tumor tissue (PBMC), primary tumor tissue, cell line established from the primary tumor tissue: 1 sample each",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "MGI [DNBSEQ-G400]",
          "Library Source": "DNAs extracted from PBMC, the primary tumor tissues, and the cell line",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6 Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000775",
          "Total Data Volume": "29.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takashi Nakagawa",
        "Affiliation": "Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Elucidation of epigenetic tumor control mechanisms that determine the malignancy of squamous cell carcinoma of the temporal bone",
            "Project Number": "22H03236"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinoma",
          "DOI": "doi: 10.1002/2211-5463.13225",
          "Data Set ID": "JGAD000775"
        },
        "": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0427.v1": {
          "Research ID": "hum0427.v1",
          "Release Date": "2023/11/02",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from PBMC, the primary tumor tissues, and the cell line of tumor tissues from a patient with external auditory canal squamous cell carcinoma were used for the whole exome sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0416.v1": {
    "ja": {
      "NBDC Research ID": "hum0416.v1",
      "データ": {
        "E-GEAD-635": {
          "データID": "E-GEAD-635",
          "内容": "NGS（CITE-seq）",
          "制限": "非制限公開",
          "公開日": "2023/08/10"
        }
      },
      "研究内容の概要": {
        "目的": "免疫反応が関与する疾病（自己免疫及び難治性免疫疾患や、線維化を伴う疾患、がんなど）について、体内の生体反応や病態をより詳細に把握するため、血液及び組織標本を用いた経時的な変化と推移を追う。これにより、患者毎の多種多様なバックグラウンドや反応個体差に捉われずに、病態推移や薬剤副作用と深く関連するメカニズムや細胞などを見出せると期待する。本研究では、何らかの機能既知の分子に着目した測定や解析から始めるのではなく、網羅的なパラメータの取得によりプロファイリングすることで病態や治療と関連する因子を探索する。その後、見出された分子の変動確認や機能探索などを通じ、病態理解と治療法の開発に繋げる。",
        "方法": "single call CITE-seq（Cellular indexing of transcriptomes and epitopes）",
        "対象": "顕微鏡的多発血管炎（microscopic polyangiitis：MPA）8症例および健常者7名の血液検体から取得したPBMC（Peripheral blood mononuclear cell）"
      },
      "分子データ": {
        "E-GEAD-635": {
          "対象": "顕微鏡的多発血管炎（ICD10：M31.7）：8症例\r\n   　 内、3症例は2時点採取、5症例は1時点採取\r\n健常者：7名",
          "規模": "CITE-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500、NovaSeq 6000]",
          "ライブラリソース": "末梢血よりPBMCを取得し、単細胞へ分離した上で抽出したmRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Single Cell 5' Reagent Kits v2",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "91 bp",
          "解析ソフトウェア": "CellRanger（version 6.0.6）",
          "リファレンス配列": "GRCh38",
          "フィルタリング（QC）方法": "Cell Ranger Metrics",
          "Genomic Expression Archive ID": "E-GEAD-635",
          "総データ量": "311 MB（発現マトリクスデータ、HDF5）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "北沢 剛久",
        "所 属 機 関": "中外製薬株式会社 研究本部",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis",
          "DOI": "doi: 10.1038/s41467-023-41328-0",
          "データID": "E-GEAD-635"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0416.v1": {
          "Research ID": "hum0416.v1",
          "公開日": "2023/08/10",
          "内容": "NGS（CITE-seq）",
          "description": "顕微鏡的多発血管炎8症例および健常者7名の末梢血から取得したPBMCを単細胞へ分離した上でmRNAを抽出し、CITE-seq解析を実施した。発現マトリクスデータを提供する（HDF5）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0416.v1",
      "DATA": {
        "E-GEAD-635": {
          "Data Set ID": "E-GEAD-635",
          "Type of Data": "NGS (CITE-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/08/10"
        }
      },
      "SUMMARY": {
        "Aims": "In order to grasp the biological reactions and pathological conditions occurring in the body in more detail for diseases involving immune reactions, blood and tissue samples were used and analyzed by following the changes and changes over time for each patient. The present research will acquire and profile comprehensive parameters for each patient and explore factors related to disease conditions and treatments. Then, it will be linked to the understanding of pathology and the development of therapeutic methods through the confirmation of changes in the found molecules and the search for functions.",
        "Methods": "single-cell CITE-seq (Cellular indexing of transcriptomes and epitopes)",
        "Participants/Materials": "Peripheral blood mononuclear cells (PBMCs) were obtained from blood samples of 8 patients with microscopic polyangiitis (MPA) and 7 healthy donors."
      },
      "MOLECULAR DATA": {
        "E-GEAD-635": {
          "Participants/Materials": "microscopic polyangiitis (ICD10: M31.7): 8 cases\r\n    blood samples were collected from 3 patients twice and 5 patients once\r\n7 healthy donors",
          "Targets": "CITE-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500, NovaSeq 6000]",
          "Library Source": "RNAs extracted from a single cell isolated from PBMCs",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Single Cell 5' Reagent Kits v2",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "91 bp",
          "Software": "CellRanger (version 6.0.6)",
          "Reference Genome Sequence": "GRCh38",
          "QC Methods": "Cell Ranger Metrics",
          "Genomic Expression Archive ID": "E-GEAD-635",
          "Total Data Volume": "311 MB (expression matrix, HDF5)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takehisa Kitazawa",
        "Affiliation": "Research Division, Chugai Pharmaceutical Co., Ltd.",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis",
          "DOI": "doi: 10.1038/s41467-023-41328-0",
          "Data Set ID": "E-GEAD-635"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0416.v1": {
          "Research ID": "hum0416.v1",
          "Release Date": "2023/08/10",
          "Type of Data": "NGS (CITE-seq)",
          "description": "RNA extracted from PBMCs collected from 8 patients with microscopic polyangiitis and 7 healthy donors were used for CITE-seq analysis. The resulting expression matrix data are provided (HDF5).\nNote：\n"
        }
      }
    }
  },
  "hum0414.v1": {
    "ja": {
      "NBDC Research ID": "hum0414.v1",
      "データ": {
        "DRA016800": {
          "データID": "DRA016800",
          "内容": "NGS（WGS）",
          "制限": "非制限公開",
          "公開日": "2023/07/25"
        }
      },
      "研究内容の概要": {
        "目的": "ヒト肺がん細胞における変異・欠失・増幅・過メチル化等、体細胞レベルで生じたゲノム異常と遺伝子発現変動を解析し、それらを臨床病理学的情報と対比検討することで肺がんの発生・進展の分子機構及び特性を遺伝子レベルで明らかにすること。",
        "方法": "ヒト小気道上皮細胞（SAEC）は、hTERT・CDK4変異体・サイクリンD1の発現により不死化されている。KRAS G12Vを発現するSAEC（Control-ER-KRAS-G12V）を最大35日間2次元培養すると、限定的ではあるが有意な足場非依存性増殖を示す。これらのクローンをピックアップし、複製ストレス耐性細胞と名付けた（RSTC-2、RSTC-5、RSTC-7）。これらの細胞株に対して、全ゲノムシークエンスを実施した。",
        "対象": "SAEC、Control-ER-KRAS-G12V、RSTC-2、RSTC-5、RSTC-7（計5株）",
        "URL": "https://www.ncc.go.jp/jp/ri/division/genome_stress_signaling/index.html"
      },
      "分子データ": {
        "DRA016800": {
          "対象": "SAECとその派生細胞株：5株\r\n    （SAEC、Control-ER-KRAS-G12V、RSTC-2、RSTC-5、RSTC-7）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "細胞株から抽出したDNA",
          "検体情報（購入の場合）": "SAEC（Lonza, Cat# CC-2547）",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free Library Prep Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150bp",
          "DDBJ Sequence Read Archive ID": "DRA016800",
          "総データ量": "900 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "塩谷 文章",
        "所 属 機 関": "国立がん研究センター研究所",
        "プロジェクト/研究グループ名": "ゲノムストレス応答学ユニット",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "国立研究開発法人科学技術振興機構（JST） AIPチャレンジPRISM加速支援（AIP-PRISM）",
            "タイトル": "人工知能技術を活用した革新的ながん創薬システムの開発",
            "研究課題番号": "JPMJCR18Y4"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress. Nature Communications.",
          "DOI": "doi: 10.1038/s41467-023-40578-2",
          "データID": "DRA016800"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0414.v1": {
          "Research ID": "hum0414.v1",
          "公開日": "2023/07/25",
          "内容": "NGS（WGS）",
          "description": "小気道上皮細胞株（SAEC）とその派生細胞株から抽出したDNAを用いたwhole genome sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0414.v1",
      "DATA": {
        "DRA016800": {
          "Data Set ID": "DRA016800",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/07/25"
        }
      },
      "SUMMARY": {
        "Aims": "To analyze genomic aberrations and gene expression changes such as mutations, deletions, amplifications, and hypermethylation in human lung cancer cells at the somatic cell level, and to contrast these with clinicopathological information to elucidate the molecular mechanisms and characteristics of lung cancer development and progression at the genetic level.",
        "Methods": "Human small airway epithelial cells (SAEC) were immortalized via the expression of hTERT, a CDK4 mutant, and cyclin D1. After up to 35 days of 2D culture, SAECs expressing KRAS G12V (Control-ER-KRAS-G12V) showed a limited but significant anchorage-independent growth. These individual clones were named replication stress-tolerant cells (RSTC-2, RSTC-5, and RSTC-7). In this study, whole genome sequencing was performed on these five cell lines.",
        "Participants/Materials": "SAEC and its derived cell lines",
        "URL": "https://www.ncc.go.jp/en/ri/division/genome_stress_signaling/index.html"
      },
      "MOLECULAR DATA": {
        "DRA016800": {
          "Participants/Materials": "SAEC and its derived cell lines: 5 samples\r\n    (SAEC, Control-ER-KRAS-G12V, RSTC-2, RSTC-5, RSTC-7)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNA extracted from cell lines",
          "Cell Lines": "SAEC (Lonza, Cat# CC-2547)",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "DDBJ Sequence Read Archive ID": "DRA016800",
          "Total Data Volume": "900 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Bunsyo Shiotani",
        "Affiliation": "National Cancer Center Research Institute",
        "Project / Group Name": "Laboratory of Genome Stress Signaling",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "AIP Challenge PRISM Acceleration Support Program (AIP-PRISM), Japan Science and Technology Agency (JST)",
            "Title": "Development of the innovative drug discovery system using artificial intelligence",
            "Project Number": "JPMJCR18Y4"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress.",
          "DOI": "doi: 10.1038/s41467-023-40578-2",
          "Data Set ID": "DRA016800"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0414.v1": {
          "Research ID": "hum0414.v1",
          "Release Date": "2023/07/25",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from SAEC and its derived cell lines were used for whole genome sequencing analysis. Fastq file are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0413.v1": {
    "ja": {
      "NBDC Research ID": "hum0413.v1",
      "データ": {
        "JGAS000628": {
          "データID": "JGAS000628",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/07/20"
        }
      },
      "研究内容の概要": {
        "目的": "膨大なデータを蓄積・解析することで、発症予測・予防・治療法の選択など、医療戦略に貢献することを目的とする。アレルギー疾患をモデルとして計算科学分野を中核に、異分野の研究を融合させた新たな研究分野の創成を目指し、知識基盤として疾患ビッグデータ解析技術の開発と疾患メカニズム研究を行う。",
        "方法": "RNA-seq解析",
        "対象": "アトピー性皮膚炎 161症例（皮膚組織：260検体、末梢血単核細胞［PBMC］：461検体）"
      },
      "分子データ": {
        "JGAS000628": {
          "対象": "アトピー性皮膚炎（ICD10：L20.9）：161症例\r\n      皮膚：260検体、PBMC：461検体\r\n健常者：41名\r\n      皮膚：55検体、PBMC：41検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500/2500]",
          "ライブラリソース": "皮膚検体およびPBMC検体から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "皮膚：NEBNext Ultra RNA Library Prep Kit for Illumina\r\nPBMC：SureSelect Strand-Specific RNA Library Prep Kit",
          "断片化の方法": "高温条件下での2価陽イオンによる断片化",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000757",
          "総データ量": "506.3 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "古関 明彦",
        "所 属 機 関": "理化学研究所 生命医科学研究センター 免疫器官形成研究チーム",
        "プロジェクト/研究グループ名": "アトピー性皮膚炎患者の網羅的データ解析研究",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "科学技術振興機構（JST） イノベーションハブ構築支援事業",
            "タイトル": "高精度の予測に基づく予防医療の実現に向けた疾患ビッグデータ主導型イノベーションハブ",
            "研究課題番号": "JPMJIH1504"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Multifaceted analysis of cross-tissue transcriptomes reveals phenotype–endotype associations in atopic dermatitis.",
          "DOI": "doi: 10.1038/s41467-023-41857-8",
          "データID": "JGAD000757"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0413.v1": {
          "Research ID": "hum0413.v1",
          "公開日": "2023/07/20",
          "内容": "NGS（RNA-seq）",
          "description": "アトピー性皮膚炎161症例と健常者41名の皮膚組織および末梢血単核細胞から抽出したRNAを用いたRNA-seq解析データをfastqファイルにて提供する\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0413.v1",
      "DATA": {
        "JGAS000628": {
          "Data Set ID": "JGAS000628",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/07/20"
        }
      },
      "SUMMARY": {
        "Aims": "To contribute to medical strategies involving disease prediction, prevention, and treatment selection through collecting and analyzing human omics data. We strive to create a novel research field that integrates interdisciplinary studies, with a focus on computational science, using allergy disorders as a model.",
        "Methods": "RNA-seq analysis",
        "Participants/Materials": ""
      },
      "MOLECULAR DATA": {
        "JGAS000628": {
          "Participants/Materials": "Atopic dermatitis (ICD10: L20.9): 161 cases\r\n   skin tissue: 260 samples, PBMC: 461 samples\r\n41 Healthy controls\r\n   skin tissue: 55 samples, PBMC: 41 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500/2500]",
          "Library Source": "RNAs extracted from skin tissues or PBMC",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra RNA Library Prep Kit for Illumina for skin\r\nSureSelect Strand-Specific RNA Library Prep Kit for PBMC",
          "Fragmentation Methods": "Exposure to divalent cations at elevated temperatures",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000757",
          "Total Data Volume": "506.3 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Haruhiko Koseki",
        "Affiliation": "Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "Comprehensive analysis on medical and omics data from patients with atopic dermatitis.",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Project for Development of Innovation Hub, Japan Science and Technology Agency (JST)",
            "Title": "Hub for Predictive and Preventative Precision Medicine Driven by Big Data",
            "Project Number": "JPMJIH1504"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Multifaceted analysis of cross-tissue transcriptomes reveals phenotype–endotype associations in atopic dermatitis.",
          "DOI": "doi: 10.1038/s41467-023-41857-8",
          "Data Set ID": "JGAD000757"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0413.v1": {
          "Research ID": "hum0413.v1",
          "Release Date": "2023/07/20",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from skin tissues and PBMCs from 161 atopic dermatitis cases and 41 healthy controls were used for RNA-sequencing analysis. Fastq files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0411.v1": {
    "ja": {
      "NBDC Research ID": "hum0411.v1",
      "データ": {
        "JGAS000625": {
          "データID": "JGAS000625",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/07/18"
        }
      },
      "研究内容の概要": {
        "目的": "Fructose-1,6-bisphosphatase（FBPase）欠損症の病態解明",
        "方法": "末梢血から抽出したDNAを用いた全エクソーム解析",
        "対象": "小児期より原因不明の乳酸アシドーシスを伴う低血糖を繰り返していたFBPase欠損症１症例とその家族（父、母、妹）"
      },
      "分子データ": {
        "JGAS000625": {
          "対象": "FBPase欠損症症例（ICD10：E74.1）：1症例\r\n    家族：3名（父、母、妹）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "126 bp",
          "マッピング方法": "bwa",
          "マッピングクオリティ": "mapping quality > 20",
          "マッピングの際のリファレンス配列": "hg19（GRCh37）",
          "平均カバー率（Depth）": "139",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000754",
          "総データ量": "37.4 GB （bam）",
          "コメント（利用にあたっての制限事項）": "Familial policy"
        }
      },
      "提供者情報": {
        "研究代表者": "田中 知明",
        "所 属 機 関": "千葉大学大学院医学研究院 分子病態解析学",
        "プロジェクト/研究グループ名": "FBPase欠損症の分子病態解明/田中知明研究室",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費補助金 挑戦的研究（開拓）",
            "タイトル": "一細胞解析と空間的トランスクリプトームによる肝臓糖代謝―免疫連関機構の解明",
            "研究課題番号": "23K17429"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Identification of genotype–biochemical phenotype correlations associated with fructose1,6-bisphosphatase deficiency",
          "DOI": "doi: 10.1038/s42003-023-05160-y",
          "データID": "JGAD000754"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0411.v1": {
          "Research ID": "hum0411.v1",
          "公開日": "2023/07/18",
          "内容": "NGS（Exome）",
          "description": "FBPase欠損症1症例とその家族の末梢血から抽出したDNAを用いたwhole exome sequencing解析データをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0411.v1",
      "DATA": {
        "JGAS000625": {
          "Data Set ID": "JGAS000625",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/07/18"
        }
      },
      "SUMMARY": {
        "Aims": "Elucidation of the molecular mechanism of fructose-1,6-bisphosphatase (FBPase) deficiency",
        "Methods": "Whole exome analysis using DNAs extracted from the peripheral blood cells",
        "Participants/Materials": "FBPase deficiency patient and its family member (father, mother, sister)"
      },
      "MOLECULAR DATA": {
        "JGAS000625": {
          "Participants/Materials": "FBPase deficiency (ICD10: E74.1): 1 case\r\n    3 family members (father, mother, sister)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "126 bp",
          "Mapping Methods": "bwa",
          "Mapping Quality": "mapping quality > 20",
          "Reference Genome Sequence": "hg19 (GRCh37)",
          "Coverage (Depth)": "139",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000754",
          "Total Data Volume": "37.4 GB (bam)",
          "Comments (Policies)": "Familial policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tomoaki Tanaka",
        "Affiliation": "Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University",
        "Project / Group Name": "Molecular Pathophysiology of FBPase Deficiency / Tomoaki Tanaka Laboratory",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Challenging Research (Pioneering)",
            "Title": "Elucidation of the mechanism of liver glucose metabolism-immune linkage by single cell analysis and spatial transcriptomics",
            "Project Number": "23K17429"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Identification of genotype–biochemical phenotype correlations associated with fructose1,6-bisphosphatase deficiency",
          "DOI": "doi: 10.1038/s42003-023-05160-y",
          "Data Set ID": "JGAD000754"
        },
        "": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0411.v1": {
          "Research ID": "hum0411.v1",
          "Release Date": "2023/07/18",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from peripheral blood cells from an FBPase deficiency patient and its family  (father, mother, sister) were used for whole exome sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0409.v1": {
    "ja": {
      "NBDC Research ID": "hum0409.v1",
      "データ": {
        "JGAS000619": {
          "データID": "JGAS000619",
          "内容": "NGS（Exome）\r\nNGS（RNA-seq）\r\nNGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/06/27"
        }
      },
      "研究内容の概要": {
        "目的": "VEGF受容体阻害薬、マルチキナーゼ阻害薬、細胞傷害性抗がん剤などによるがん薬物療法において、Exceptional Responseの原因となる遺伝子異常を同定する。これらの情報をもとに、早期治験参加、適応外使用によるProof of Concept（POC）取得、医師主導・企業治験への展開を狙う。",
        "方法": "Whole exome sequencing、RNA sequencing、cfDNA target sequencing",
        "対象": "MDM2増幅内膜肉腫11症例のFFPE腫瘍組織から抽出したDNA（13検体）とRNA（12検体）、対照正常血液細胞から抽出したDNA（11検体）、ならびに、血中セルフリーDNA（cfDNA）（26検体）",
        "URL": "https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000019319"
      },
      "分子データ": {
        "Exome": {
          "対象": "MDM2増幅内膜肉腫 （ICD-O-3：9137/3）：11症例\r\n    FFPE腫瘍組織：13検体\r\n    対照正常血液細胞：11検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "腫瘍組織および正常血液細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V7、SureSelect XT Reagent Kit、KAPA Hyper Prep Kit",
          "断片化の方法": "超音波断片化 （Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000748",
          "総データ量": "263 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および Cancer Research Use Only"
        },
        "RNA-seq": {
          "対象": "MDM2増幅内膜肉腫 （ICD-O-3：9137/3）：10症例\r\n    FFPE腫瘍組織：12検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "FFPE腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V7、SureSelect XT HS2 RNA Reagent Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "145 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD00748",
          "総データ量": "110 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および Cancer Research Use Only"
        },
        "Target Capture": {
          "対象": "MDM2増幅内膜肉腫 （ICD-O-3：9137/3）：10症例\r\n    血液試料中のセルフリーDNA（cfDNA）：26検体\r\n    対照正常血液細胞：10検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "737遺伝子",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "血中cfDNAおよび正常血液細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Twist Library Preparation EF Kit",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "BWA",
          "マッピングクオリティ": "0以上",
          "マッピングの際のリファレンス配列": "hg38",
          "平均カバー率（Depth）": "438×～2221×",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000748",
          "総データ量": "100 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および Cancer Research Use Only"
        }
      },
      "提供者情報": {
        "研究代表者": "小山 隆文",
        "所 属 機 関": "国立がん研究センター中央病院 先端医療科",
        "プロジェクト/研究グループ名": "NCCH1806",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "国立がん研究センター研究開発費",
            "タイトル": "リキッドバイオプシーの開発と稼動性・臨床的有用性の検証研究",
            "研究課題番号": "2022-A-02"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification",
          "DOI": "doi: 10.1158/2159-8290.CD-23-0419",
          "データID": "JGAD000748"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0409.v1": {
          "Research ID": "hum0409.v1",
          "公開日": "2023/06/27",
          "内容": "NGS（Exome、RNA-seq、Target Capture）",
          "description": "MDM2増幅内膜肉腫 11症例のFFPE腫瘍組織および正常血液細胞より抽出したDNA/RNAを用いたWhole exome sequencingおよびRNA sequencing、ならびに、血中セルフリーDNA 26検体を用いたTarget Capture Sequencing解析データをfastqおよびbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0409.v1",
      "DATA": {
        "JGAS000619": {
          "Data Set ID": "JGAS000619",
          "Type of Data": "NGS (Exome)\r\nNGS (RNA-seq)\r\nNGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/06/27"
        }
      },
      "SUMMARY": {
        "Aims": "To identify genetic abnormalities that cause Exceptional Response in cancer drug therapy with VEGFR inhibitors, multi-kinase inhibitors, cytotoxic anticancer drugs, and others. Based on this information, we aim for early participation in clinical trials, acquisition of POC through off-label use, and development into investigator-initiated and corporate clinical trials.",
        "Methods": "Whole exome sequencing, Exome RNA sequencing, cfDNA target sequencing",
        "Participants/Materials": "FFPE tumor tissue DNA (13 samples) and RNA (12 samples), control normal blood cell DNA (11 samples), cell-free DNA (cfDNA) in blood (26 samples) from 11 cases of intimal sarcoma with MDM2 amplification",
        "URL": "https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019319"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "intimal sarcoma with MDM2 amplification (ICD-O-3: 9137/3): 11 cases\r\n    FFPE tumor tissue: 13 samples\r\n    control normal blood cell: 11 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "DNAs extracted from FFPE tumor tissues and normal blood cells of patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V7, SureSelect XT Reagent Kit, KAPA Hyper Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000748",
          "Total Data Volume": "263 GB (fastq)",
          "Comments (Policies)": "NBDC policy & Cancer Research Use Only"
        },
        "RNA-seq": {
          "Participants/Materials": "intimal sarcoma with MDM2 amplification (ICD-O-3: 9137/3): 10 cases\r\n    FFPE tumor tissue: 12 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "RNAs extracted from FFPE tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V7, SureSelect XT HS2 RNA Reagent Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "145 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000748",
          "Total Data Volume": "110 GB (fastq)",
          "Comments (Policies)": "NBDC policy & Cancer Research Use Only"
        },
        "Target Capture": {
          "Participants/Materials": "intimal sarcoma with MDM2 amplification (ICD-O-3: 9137/3): 10 cases\r\n     cell-free DNA (cfDNA) in blood: 26 samples\r\n     control normal blood cell: 10 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "737 genes",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "cfDNA in blood and DNAs extracted from normal blood cells of patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Twist Library Preparation EF Kit",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "BWA",
          "Mapping Quality": "0≦",
          "Reference Genome Sequence": "hg38",
          "Coverage (Depth)": "438x~2221x",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000748",
          "Total Data Volume": "100 GB (bam)",
          "Comments (Policies)": "NBDC policy & Cancer Research Use Only"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takafumi Koyama",
        "Affiliation": "Department of Experimental Therapeutics, National Cancer Center Hospital",
        "Project / Group Name": "NCCH1806",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "The National Cancer Center Research and Development Fund",
            "Title": "Development of the precision liquid biopsy and evaluation of its feasibility and clinical utility",
            "Project Number": "2022-A-02"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification",
          "DOI": "doi: 10.1158/2159-8290.CD-23-0419",
          "Data Set ID": "JGAD000748"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0409.v1": {
          "Research ID": "hum0409.v1",
          "Release Date": "2023/06/27",
          "Type of Data": "NGS (Exome, RNA-seq, Target Capture)",
          "description": "- DNAs/RNAs were extracted from FFPE tumor tissues and normal blood cells from 11 patients with intimal sarcoma with MDM2 amplification. WES and RNA-seq analyses were performed. Fastq files are provided.\n- Cell-free DNA (cfDNA) in blood from 10 patients were used for the target capture sequencing analysis. Bam files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0406.v1": {
    "ja": {
      "NBDC Research ID": "hum0406.v1",
      "データ": {
        "JGAS000617": {
          "データID": "JGAS000617",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/08/29"
        },
        "E-GEAD-623": {
          "データID": "E-GEAD-623",
          "内容": "NGS（RNA-seq）",
          "制限": "非制限公開",
          "公開日": "2023/08/29"
        }
      },
      "研究内容の概要": {
        "目的": "病態メカニズムの解明には患者の疾患部位を研究することが最も理想的だが、検体採取のために患者に大きな負担がかかるリスクや、技術的に不可能な場合があり、また採取できる量も限られていることから、繰り返し実験が行えないなどの問題があった。人工多能性幹細胞は、体を構成するさまざまな組織に分化することができる強力な技術であり、本研究計画では患者およびその家族の体細胞からiPS細胞を作り、臨床情報と合わせて病気の原因を調べたり、有効な治療法を見つけ出すことを目的としている。",
        "方法": "フローサイトメトリーにより、誘導型2型肺胞上皮（iAT2）細胞（EpCAM+CPM+）と線維芽細胞（EpCAM-CPM-）を分離し、抽出したtotal RNAを用いたRNA-seq解析を実施した。",
        "対象": "Surfactant protein C遺伝子（SFTPC）バリアントにおける家族性間質性肺炎 1症例"
      },
      "分子データ": {
        "JGAS000617 / E-GEAD-623": {
          "対象": "SFTPCバリアントにおける家族性間質性肺炎（ICD10：J84.9）：1症例\r\n    1: 患者血液から樹立したiPS細胞由来肺胞オルガノイドのEpCAM+CPM+細胞 ：3検体\r\n    2: 患者血液から樹立したiPS細胞由来肺胞オルガノイドのEpCAM-CPM-細胞 ：3検体\r\n    3: 患者血液から樹立した修復iPS細胞由来肺胞オルガノイドのEpCAM+CPM+細胞 ：3検体\r\n    4: 患者血液から樹立した修復iPS細胞由来肺胞オルガノイドのEpCAM-CPM-細胞 ：3検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 2000]",
          "ソース": "フローサイトメトリーにより分離した誘導型2型肺胞上皮（iAT2）細胞（EpCAM+CPM+）および線維芽細胞（EpCAM-CPM-）より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Stranded Total RNA Prep, Ligation with Ribo-Zero Plus kit",
          "断片化の方法": "高温条件下での2価陽イオンによる断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "59 bp x 2",
          "マッピング方法": "STAR 2.7.10b",
          "リファレンス配列": "GRCh38",
          "リードカウント決定アルゴリズム（ソフトウェア）": "HTSeq package",
          "フィルタリング（QC）方法": "RSeQC package",
          "遺伝子数": "36,602遺伝子",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000746",
          "Genomic Expression Archive ID": "E-GEAD-623",
          "総データ量": "JGAD000746：27.7 GB（fastq）\r\nE-GEAD-623：2.16 MB（csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "後藤 慎平",
        "所 属 機 関": "京都大学 iPS細胞研究所 臨床応用研究部門",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 再生医療実現拠点ネットワークプログラム",
            "タイトル": "ヒトiPS細胞を用いた呼吸器難病の病態機序の解明と新規創薬基盤の確立",
            "研究課題番号": "JP17bm0804007"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC",
          "DOI": "doi: 10.1016/j.isci.2023.107731",
          "データID": "JGAD000746E-GEAD-623"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0406.v1": {
          "Research ID": "hum0406.v1",
          "公開日": "2023/08/29",
          "内容": "NGS（RNA-seq）",
          "description": "SFTPCバリアントにおける家族性間質性肺炎1症例の患者血液から樹立したiPS細胞由来肺胞オルガノイドおよび修復iPS細胞由来肺胞オルガノイドより単離した誘導型2型肺胞上皮（iAT2）細胞（EpCAM+CPM+）と線維芽細胞（EpCAM-CPM-）より抽出したRNAを用いたRNA-seq解析結果をfastq、csvファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0406.v1",
      "DATA": {
        "JGAS000617": {
          "Data Set ID": "JGAS000617",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/08/29"
        },
        "E-GEAD-623": {
          "Data Set ID": "E-GEAD-623",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/08/29"
        }
      },
      "SUMMARY": {
        "Aims": "The ideal way of studying the disease is to use an affected part (tissue) of the patient's body. However, the use of the affected tissue involves many issues; for example, sampling of the affected tissue may impose a severe burden on the patient or is sometimes technically impossible. Therefore, iPS cells are a powerful technology that can differentiate into the various tissues that make up our bodies. The aim of this study is to generate iPS cells from patients’ and/or their family members’ somatic cells and to use them together with clinical information to discover more about the cause of the diseases and to develop new effective treatments.",
        "Methods": "Patient iPSC-derived type 2 alveolar epithelial (iAT2) cells (EpCAM+CPM+) and fibroblasts (EpCAM-CPM-) were isolated by fluorescence-activated cell sorting. Total RNA was extracted from the cells and sequenced."
      },
      "MOLECULAR DATA": {
        "JGAS000617 / E-GEAD-623": {
          "Participants/Materials": "Familial interstitial pneumonia with SFTPC variant (ICD10: J84.9): 1 case\r\n- EpCAM+CPM+ or EpCAM-CPM- cells of alveolar organoids derived from iPSCs established from PBMCs of the patient with Y104H variant of SFTPC: 3 samples each\r\n- EpCAM+CPM+ or EpCAM-CPM- cells of Y104H-KO iPSC-derived alveolar organoids established from PBMCs of the patient with Y104H variant of SFTPC: 3 samples each",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 2000]",
          "Source": "RNAs extracted from EpCAM+CPM+ or EpCAM-CPM- cells derived from iPSCs established from PBMCs of a patient with Y104H variant of SFTPC",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Stranded Total RNA Prep, Ligation with Ribo-Zero Plus kit",
          "Fragmentation Methods": "Exposure to divalent cations at elevated temperatures",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "59 bp x 2",
          "Mapping Methods": "STAR 2.7.10b",
          "Reference Genome Sequence": "GRCh38",
          "Detecting method for read count (software)": "HTSeq package",
          "QC Methods": "RSeQC package",
          "Gene Number": "36,602 genes",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000746",
          "Genomic Expression Archive ID": "E-GEAD-623",
          "Total Data Volume": "JGAD000746: 27.7 GB (fastq)\r\nE-GEAD-623: 2.16 MB (csv)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shimpei Gotoh",
        "Affiliation": "Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Research Center Network for Realization of Regenerative Medicine, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Application of human iPS cells for disclosing the pathogenic mechanisms of intractable respiratory diseases and finding novel therapeutic agents",
            "Project Number": "JP17bm0804007"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC",
          "DOI": "doi: 10.1016/j.isci.2023.107731",
          "Data Set ID": "JGAD000746E-GEAD-623"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0406.v1": {
          "Research ID": "hum0406.v1",
          "Release Date": "2023/08/29",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from EpCAM+CPM+ (iAT cells) or EpCAM-CPM- (fibroblast cells) derived from iPSCs established from PBMCs of a patient with Y104H variant of SFTPC were used for RNA-seq analysis. Sequencing data and analyzed data (fastq and csv files) are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0403.v1": {
    "ja": {
      "NBDC Research ID": "hum0403.v1",
      "データ": {
        "JGAS000622": {
          "データID": "JGAS000622",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/07/27"
        }
      },
      "研究内容の概要": {
        "目的": "泌尿器がん症例から採取された腫瘍組織と遊離核酸を用い、遺伝子変異およびmicro RNA発現を評価し、新たなバイオマーカーの同定を前向き研究として行うこと。",
        "方法": "抽出した血漿のセルフリーDNAの濃度は、Qubit fluorometer（Thermo Fisher Scientific, Waltham, MA, USA）を用いて評し、AVENIO ctDNA Expanded Kit（Roche Diagnostics, Basel, Switzerland）を用いて循環腫瘍DNA解析を行った。",
        "対象": "転移性尿路上皮がん16症例から採取した免疫チェックポイント阻害剤投与前の血漿16検体と投与後の血漿9検体（計25検体）"
      },
      "分子データ": {
        "JGAS000622": {
          "対象": "転移性尿路上皮がん（ICD10：C65、C66、C67.9）：16症例\r\n     免疫チェックポイント阻害剤投与前の血漿：16検体\r\n     免疫チェックポイント阻害剤投与後の血漿：9検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "77遺伝子",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "血漿のセルフリーDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "AVENIO ctDNA Expanded Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151bp x 2",
          "マッピング方法": "AVENIO ctDNA Analysis Software Version 2.0.0",
          "マッピングクオリティ": "99.99997595",
          "マッピングの際のリファレンス配列": "hg38",
          "平均カバー率（Depth）": "7243",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000751",
          "総データ量": "40.8 GB （bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "濱田 和希",
        "所 属 機 関": "筑波大学附属病院 腎泌尿器外科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "泌尿器癌における全血RNAを用いた免疫細胞の多様性の理解と治療効果予測への応用",
            "研究課題番号": "21K09365"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma.",
          "DOI": "doi: 10.3892/ol.2023.13975",
          "データID": "JGAD000751"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0403.v1": {
          "Research ID": "hum0403.v1",
          "公開日": "2023/07/27",
          "内容": "NGS（Target Capture）",
          "description": "転移性尿路上皮がん症例の免疫チェックポイント阻害剤投与前後の血漿中セルフリーDNAを用いた77遺伝子のTarget Capture Sequencing解析データをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0403.v1",
      "DATA": {
        "JGAS000622": {
          "Data Set ID": "JGAS000622",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/07/27"
        }
      },
      "SUMMARY": {
        "Aims": "To prospectively identify new biomarkers by evaluating gene mutations and microRNA expression using tumor tissues and free nucleic acids collected from patients with urologic cancer.",
        "Methods": " Cell-free DNAs extracted from plasma samples were subjected to a circulating tumor DNA analysis using the AVENIO ctDNA Expanded Kit (Roche Diagnostics, Basel, Switzerland). DNA concentration was assessed using a Qubit fluorometer (Thermo Fisher Scientific, Waltham, MA, USA).",
        "Participants/Materials": "16 plasma samples were collected before immune checkpoint inhibitor treatment and 9 plasma samples were collected after immune checkpoint inhibitor treatment from 16 metastatic urothelial carcinoma patients."
      },
      "MOLECULAR DATA": {
        "JGAS000622": {
          "Participants/Materials": "metastatic urothelial carcinoma (ICD10: C65, C66, C67.9): 16 cases\r\n       16 plasma samples collected before immune checkpoint inhibitor treatment\r\n       9 plasma samples collected after immune checkpoint inhibitor treatment",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "77 genes",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "cell-free DNA in plasma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "AVENIO ctDNA Expanded Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp x 2",
          "Mapping Methods": "AVENIO ctDNA Analysis Software Version 2.0.0",
          "Mapping Quality": "99.99997595",
          "Reference Genome Sequence": "hg38",
          "Coverage (Depth)": "7243",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000751",
          "Total Data Volume": "40.8 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kazuki Hamada",
        "Affiliation": "Department of Urology, University of Tsukuba Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Application of whole blood RNA in urological cancer to understand immune cell diversity and predict therapeutic effect",
            "Project Number": "21K09365"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma.",
          "DOI": "doi: 10.3892/ol.2023.13975",
          "Data Set ID": "JGAD000751"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0403.v1": {
          "Research ID": "hum0403.v1",
          "Release Date": "2023/07/27",
          "Type of Data": "NGS (Target Capture)",
          "description": "Cell-free DNAs extracted from plasma samples collected before and/or after immune checkpoint inhibitor treatment from metastatic urothelial carcinoma patients were used for the target capture sequencing analysis. Bam files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0401.v1": {
    "ja": {
      "NBDC Research ID": "hum0401.v1",
      "データ": {
        "JGAS000618": {
          "データID": "JGAS000618",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/06/29"
        }
      },
      "研究内容の概要": {
        "目的": "骨軟部腫瘍は、がん腫に比べ発症頻度が低く手術以外に有効な治療法がない希少難治がんに分類される疾患群で、新規治療法の開発が著しく遅れている。適切な動物モデルは皆無で薬剤開発へ向けた研究材料となる生物資源に乏しい。本研究は、再現性・利便性・経済性に秀でた質の高い肉腫生物資源の整備を目的とし、臨床材料から種々の骨軟部肉腫細胞株の樹立および実験動物モデルの構築を行い、その整備作業を通じて、肉腫がん化機構の解明および新規の創薬に取り組んでいる。",
        "方法": "悪性骨巨細胞腫腫瘍組織および同患者正常筋組織よりRNA、DNAを採取しRNA-seq、Whole Exome Sequencing（WES）解析を次世代シークエンサーにて実施した。",
        "対象": "悪性骨巨細胞腫1症例",
        "URL": "https://oici.jp/hospital/department/gansenmoni/seikei/"
      },
      "分子データ": {
        "Exome": {
          "対象": "悪性骨巨細胞腫（ICD10：C419）：1症例\r\n    腫瘍組織（2回目手術検体）：1検体\r\n    腫瘍組織（3回目手術検体）：1検体\r\n    腫瘍組織のオルガノイドを移植したxenograftの腫瘍組織：1検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6",
          "断片化の方法": "超音波断片化 （Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000747",
          "総データ量": "69.2 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "悪性骨巨細胞腫（ICD10：C419）：1症例\r\n    非腫瘍組織（筋肉組織）：1検体\r\n    腫瘍組織（2回目手術検体）：1検体\r\n    腫瘍組織（3回目手術検体）：1検体\r\n    腫瘍組織から作製したオルガノイド：2検体\r\n    腫瘍組織のオルガノイドを移植したxenograftの腫瘍組織：3検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "MGI [DNBSEQ-G400]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "MGIEasy RNA Directional Library Prep Set",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000747",
          "総データ量": "69.2 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "若松 透",
        "所 属 機 関": "大阪国際がんセンター 整形外科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 若手研究",
            "タイトル": "新規治療開発を目指した肉腫由来オルガノイドパネルの構築",
            "研究課題番号": "20K18048"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genetic characterization of a novel organoid from human malignant giant-cell tumor",
          "DOI": "doi: 10.1016/j.jbo.2023.100486",
          "データID": "JGAD000747"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0401.v1": {
          "Research ID": "hum0401.v1",
          "公開日": "2023/06/29",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "悪性骨巨細胞腫1症例の腫瘍組織および正常筋組織より抽出したDNA/RNAを用いたWES/RNA-seq解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0401.v1",
      "DATA": {
        "JGAS000618": {
          "Data Set ID": "JGAS000618",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/06/29"
        }
      },
      "SUMMARY": {
        "Aims": "Sarcomas are classified as rare cancers, that is, cancers with an incidence of 6/100000 patients per year. The prognosis of rare cancers, including sarcomas, is poorer than that of common cancers because of the lack of effective treatment. One of the reasons is that the biological resources of sarcomas are not sufficient for advanced research. Therefore, we are establishing several types of sarcomas recapitulating biological characteristics of them including cell lines, organoids, and mouse models in order to develop effective novel treatment against sarcomas.",
        "Methods": "In RNAseq, raw data were generated using DNBSEQ-G400. In WES, raw sequence data were generated using Illumina NovaSeq 6000 sequencers.",
        "Participants/Materials": "giant cell tumor of bone: 1 case",
        "URL": "https://oici.jp.e.abv.hp.transer.com/hospital/department/gansenmoni/seikei/"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "giant cell tumor of bone (ICD10: C419): 1 case\r\n    tumor tissue (2nd operation): 1 sample\r\n    tumor tissue (3rd operation): 1 sample\r\n    organoid derived xenograft tumor: 1 sample",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000747",
          "Total Data Volume": "69.2 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "giant cell tumor of bone (ICD10: C419): 1 case\r\n    normal muscle tissue: 1 sample\r\n    tumor tissue (2nd operation): 1 sample\r\n    tumor tissue (3rd operation): 1 sample\r\n    patient derived organoid: 2 samples\r\n    organoid derived xenograft tumor: 3 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "MGI [DNBSEQ-G400]",
          "Library Source": "RNAs extracted from normal and tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "MGIEasy RNA Directional Library Prep Set",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000747",
          "Total Data Volume": "69.2 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toru Wakamatsu",
        "Affiliation": "Department of Musculoskeletal Oncology Service, Osaka International Cancer Institute",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Early-Career Scientists",
            "Title": "Development of sarcoma organoid panel for novel treatment",
            "Project Number": "20K18048"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genetic characterization of a novel organoid from human malignant giant-cell tumor",
          "DOI": "doi: 10.1016/j.jbo.2023.100486",
          "Data Set ID": "JGAD000747"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0401.v1": {
          "Research ID": "hum0401.v1",
          "Release Date": "2023/06/29",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNA/RNAs extracted from normal and tumor tissues of giant cell tumor were used for the whole exome sequencing and RNA sequencing analyses. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0390.v1": {
    "ja": {
      "NBDC Research ID": "hum0390.v1",
      "データ": {
        "JGAS000621": {
          "データID": "JGAS000621",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/06/30"
        }
      },
      "研究内容の概要": {
        "目的": "妊娠の成立と維持に必要な組織および細胞の網羅的なゲノム・エピゲノム解析を行い、生殖と発生に関わる成育疾患の研究基盤となる知見を確立する。",
        "方法": "子宮内膜組織片から抽出したRNAを用いたRNAシーケンス解析",
        "対象": "慢性子宮内膜炎症例とコントロール（非慢性子宮内膜炎症例）から採取した子宮内膜組織片"
      },
      "分子データ": {
        "JGAS000621": {
          "対象": "慢性子宮内膜炎（ICD10：N71.1）：24症例\r\n非慢性子宮内膜炎：33症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "子宮内膜組織片から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra II Directional RNA Library Prep Kit",
          "断片化の方法": "アルカリ条件での加熱処理によるRNA加水分解",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000750",
          "総データ量": "100 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "黒田 恵司",
        "所 属 機 関": "杉山産婦人科丸の内 生殖医療科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Gene expression signatures associated with chronic endometritis revealed by RNA sequencing",
          "DOI": "doi: 10.3389/fmed.2023.1185284",
          "データID": "JGAD000750"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0390.v1": {
          "Research ID": "hum0390.v1",
          "公開日": "2023/06/30",
          "内容": "NGS（RNA-seq）",
          "description": "慢性子宮内膜炎24症例と非慢性子宮内膜炎33症例の子宮内膜組織片から抽出したRNAを用いたRNA-seq解析データをfastqファイルにて提供する\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0390.v1",
      "DATA": {
        "JGAS000621": {
          "Data Set ID": "JGAS000621",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/06/30"
        }
      },
      "SUMMARY": {
        "Aims": "To establish a knowledge basis for human reproduction and development by conducting genomic and epigenomic analyses on the cells and tissues of organs essential for pregnancy.",
        "Methods": "Total RNA samples from endometrial tissues were subjected to RNA sequencing analysis.",
        "Participants/Materials": "Endometrial tissues from chronic endometritis cases and control cases"
      },
      "MOLECULAR DATA": {
        "JGAS000621": {
          "Participants/Materials": "chronic endometritis (ICD10: N71.1): 24 cases\r\n33 control cases (without chronic endometritis)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "RNAs extracted from endometrial tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra II Directional RNA Library Prep Kit",
          "Fragmentation Methods": "Alkaline hydrolysis of RNA",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000750",
          "Total Data Volume": "100 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Keiji Kuroda",
        "Affiliation": "Center for Reproductive Medicine and Endoscopy, Sugiyama Clinic Marunouchi",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Gene expression signatures associated with chronic endometritis revealed by RNA sequencing",
          "DOI": "doi: 10.3389/fmed.2023.1185284",
          "Data Set ID": "JGAD000750"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0390.v1": {
          "Research ID": "hum0390.v1",
          "Release Date": "2023/06/30",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from endometrial tissues of 24 chronic endometritis cases and 33 controls were used for RNA-sequencing analysis. Fastq files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0389.v1": {
    "ja": {
      "NBDC Research ID": "hum0389.v1",
      "データ": {
        "JGAS000605": {
          "データID": "JGAS000605",
          "内容": "NGS（Capture Methyl-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/04/04"
        }
      },
      "研究内容の概要": {
        "目的": "児と付属物（胎盤）の発生・発育異常を呈する症例において、関連が疑われる遺伝子・ゲノム領域を解析し、発症に関与する因子の解明と適切な周産期管理法の開発を目指す",
        "方法": "キャプチャーメチルシーケンス法（アジレント社SureSelect XT Methyl-Seq法）",
        "対象": "健常女性4名の末梢血由来ゲノムDNAに対して取得したキャプチャーメチルシーケンスデータ",
        "URL": "https://www.raddarj.org/registry/精緻エピゲノム解析技術開発とirud未解明症例への/"
      },
      "分子データ": {
        "JGAS000605": {
          "対象": "健常女性：4名（疾患罹患児の母、もしくは正常分娩妊婦）",
          "規模": "Capture Methyl-seq",
          "対象領域（Target Captureの場合）": "Agilent SureSelect XT Methyl-Seqキャプチャーベイトが標的とする3,156,463箇所のCGサイト",
          "Platform": "Illumina [HiSeq X]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT Methyl-Seq",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000734",
          "総データ量": "17.4 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中林 一彦",
        "所 属 機 関": "国立成育医療研究センター 周産期病態研究部",
        "プロジェクト/研究グループ名": "精緻エピゲノム解析技術開発とIRUD未解明症例への応用",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A capture methyl-seq protocol with improved efficiency and cost-effectiveness using pre-pooling and enzymatic conversion",
          "DOI": "doi: 10.1186/s13148-019-0712-3",
          "データID": "JGAD000734"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0389.v1": {
          "Research ID": "hum0389.v1",
          "公開日": "2023/04/04",
          "内容": "NGS（Capture Methyl-seq）",
          "description": "健常女性4名の末梢血から抽出したDNAを用いたキャプチャーメチルシーケンス解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0389.v1",
      "DATA": {
        "JGAS000605": {
          "Data Set ID": "JGAS000605",
          "Type of Data": "NGS (Capture Methyl-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/04/04"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate genetic etiologies of abnormal development and growth observed in fetuses and placentas through genomic and epigenomic analyses, and to apply knowledge from new discoveries to improve perinatal management.",
        "Methods": "Capture methyl-seq (Agilent SureSelect XT Methyl-Seq)",
        "Participants/Materials": "Capture methyl-seq data for four genomic DNA samples from peripheral blood cells of healthy women"
      },
      "MOLECULAR DATA": {
        "JGAS000605": {
          "Participants/Materials": "4 healthy women (mother of an affected infant or healthy pregnant women)",
          "Targets": "Capture Methyl-seq",
          "Target Loci for Capture Methods": "3,156,463 individual CpG dinucleotide sequences (Agilent SureSelect XT Methyl-Seq)",
          "Platform": "Illumina [HiSeq X]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT Methyl-Seq",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000734",
          "Total Data Volume": "17.4 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kazuhiko Nakabayashi",
        "Affiliation": "Division of Developmental Genomics, Department of Maternal-Fetal Biology, Research Institute, National Center for Child Health and Development",
        "Project / Group Name": "Diagnosis of rare diseases and elucidation of molecular pathological states by using epigenetic information",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A capture methyl-seq protocol with improved efficiency and cost-effectiveness using pre-pooling and enzymatic conversion",
          "DOI": "doi: 10.1186/s13148-019-0712-3",
          "Data Set ID": "JGAD000734"
        },
        "": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0389.v1": {
          "Research ID": "hum0389.v1",
          "Release Date": "2023/04/04",
          "Type of Data": "NGS (Capture Methyl-seq)",
          "description": "DNAs extracted from peripheral blood cells of 4 healthy women were used for the capture methyl-seq analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0386.v1": {
    "ja": {
      "NBDC Research ID": "hum0386.v1",
      "データ": {
        "DRA015813": {
          "データID": "DRA015813",
          "内容": "NGS（WGS）",
          "制限": "非制限公開",
          "公開日": "2023/04/11"
        }
      },
      "研究内容の概要": {
        "目的": "長鎖シークエンスデータはエラー率が高く、取り扱いが確立していない。そのため有用な情報解析手法の確立が重要である。マッピングに基づく解析や全ゲノムアセンブリに基づく変異検出には、反復配列によるエラーや塩基配列情報の欠如など問題がある。また、欠失などに比べ、挿入は多くが反復配列に由来することや配列情報が得にくいことから解析が困難であった。本研究では、ヒトの挿入配列の全容と挿入メカニズムの解明を目的として、長鎖リードに対応した新規解析手法を開発し、さらにそれを適用し、2サンプルの全ゲノム解析を行なった。",
        "方法": "NA18943の細胞株から抽出したDNAを、Oxford Nanoporeシークエンサーを用いてシークエンスし、231.6 Gbp（77× coverage）のデータを得た。",
        "対象": "NA18943はHapMap計画で用いられた健常者の細胞株由来のDNAサンプルである。本研究において、申請者らはOxford Nanoporeシークエンサーを用いてNA18943の全ゲノムシークエンスを行った。",
        "URL": "http://www.humgenet.m.u-tokyo.ac.jp"
      },
      "分子データ": {
        "DRA015813": {
          "対象": "NA18943（HapMap検体）：1検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Nanopore [MinION]",
          "ライブラリソース": "HapMap DNA検体",
          "検体情報（購入の場合）": "https://www.coriell.org/0/Sections/Search/Sample_Detail.aspx?Ref=NA18943&Product=DNA",
          "ライブラリ作製方法（キット名）": "1D Ligation Sequencing Kit（Cat#SQK-LSK108）",
          "断片化の方法": "g-TUBE（Covaris）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均5.1 kbp（最短3.3 kbp - 最長11.1 kbp）",
          "DDBJ Sequence Read Archive ID": "DRA015813",
          "総データ量": "470 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "藤本 明洋",
        "所 属 機 関": "東京大学 医学系研究科",
        "プロジェクト/研究グループ名": "人類遺伝学分野",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究（研究領域提案型）",
            "タイトル": "ヤポネシア人の人口推定を中心とした巨大データ解析",
            "研究課題番号": "18H05511"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Localized assembly for long reads enables genome-wide analysis of repetitive regions at single-base resolution in human genomes",
          "DOI": "doi: 10.1186/s40246-023-00467-7",
          "データID": "DRA015813"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0386.v1": {
          "Research ID": "hum0386.v1",
          "公開日": "2023/04/11",
          "内容": "NGS（WGS）",
          "description": "HapMap日本人検体（NA18943）を対象とし、長鎖シークエンサー（nanopore）による全ゲノムシークエンスを行った。fastqファイルを提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0386.v1",
      "DATA": {
        "DRA015813": {
          "Data Set ID": "DRA015813",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/04/11"
        }
      },
      "SUMMARY": {
        "Aims": "Long-read sequencing data has a high error rate, and its handling has not been established. Therefore, it is important to establish useful bioinformatics analysis methods. Mapping-based analysis and whole-genome-assembly-based variant detection have problems such as errors due to repetitive sequences and lack of nucleotide sequence information. Compared to deletions, insertions are difficult to analyze because many of them are derived from repetitive sequences and sequence information is difficult to obtain. In this study, we developed a novel analysis method for long reads and applied it to whole genome analysis of two samples to elucidate the entire human insertion sequence and insertion mechanism.",
        "Methods": "We sequenced the genomic DNA of NA18943 from a B cell line using a single platform, MinION. The sequencing data totaled 231.6 Gbp (77× coverage).",
        "Participants/Materials": "NA18943 is a healthy sample used in the HapMap project. We performed whole genome sequencing of NA18943 using Oxford Nanopore sequencer.",
        "URL": "http://www.humgenet.m.u-tokyo.ac.jp/index.en.html"
      },
      "MOLECULAR DATA": {
        "DRA015813": {
          "Participants/Materials": "NA18943 (HapMap): 1 sample",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Nanopore [MinION]",
          "Library Source": "HapMap DNA sample",
          "Cell Lines": "https://www.coriell.org/0/Sections/Search/Sample_Detail.aspx?Ref=NA18943&Product=DNA",
          "Library Construction (kit name)": "1D Ligation Sequencing Kit (Cat#SQK-LSK108)",
          "Fragmentation Methods": "g-TUBE (Covaris)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "3.3-11.1 kbp (5.1 kbp on average)",
          "DDBJ Sequence Read Archive ID": "DRA015813",
          "Total Data Volume": "470 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Akihiro Fujimoto",
        "Affiliation": "Graduate School of Medicine,The University of Tokyo",
        "Project / Group Name": "Department of Human Genetics",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)",
            "Title": "Deciphering Origin and Establishment of Japonesians mainly based on genome sequence data",
            "Project Number": "18H05511"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Localized assembly for long reads enables genome-wide analysis of repetitive regions at single-base resolution in human genomes",
          "DOI": "doi: 10.1186/s40246-023-00467-7",
          "Data Set ID": "DRA015813"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0386.v1": {
          "Research ID": "hum0386.v1",
          "Release Date": "2023/04/11",
          "Type of Data": "NGS (WGS)",
          "description": "A HapMap DNA sample (NA18943) was used for whole genome sequencing with Nanopore sequencer. A fastq file is provided.\nNote：\n"
        }
      }
    }
  },
  "hum0385.v1": {
    "ja": {
      "NBDC Research ID": "hum0385.v1",
      "データ": {
        "JGAS000597": {
          "データID": "JGAS000597",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/12/14"
        }
      },
      "研究内容の概要": {
        "目的": "混合型肝がん・細胆管細胞がん・Cytokeratin（CK）19陽性肝がん・SOX9陽性肝がんの遺伝子変異を調査し、臨床病理学的特徴との関係性を明らかにする",
        "方法": "細胆管細胞がんの手術検体（非腫瘍組織および腫瘍組織）から抽出したDNAを用いた全エクソン解析",
        "対象": "細胆管細胞がん",
        "URL": "https://hbptsurgery.kuhp.kyoto-u.ac.jp/study/liver-regeneration-research/"
      },
      "分子データ": {
        "JGAS000597": {
          "対象": "細胆管細胞がん（ICD10：C221）：8症例\r\n    腫瘍組織：8検体、非腫瘍組織：8検体、再発巣：2検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織、非腫瘍組織、および再発巣から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6",
          "断片化の方法": "超音波断片化（Covaris LE220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000726",
          "総データ量": "157.1 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "石井 隆道",
        "所 属 機 関": "京都大学大学院医学研究科 肝胆膵・移植外科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "癌幹細胞の観点から見た肝癌におけるゲノム不均一性の解明",
            "研究課題番号": "19K09145"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency.",
          "DOI": "",
          "データID": "JGAD000726"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0385.v1": {
          "Research ID": "hum0385.v1",
          "公開日": "2023/12/14",
          "内容": "NGS（Exome）",
          "description": "細胆管細胞がんの腫瘍組織ならびに非腫瘍組織から抽出したDNAを用いたwhole exome sequencing解析データをfastqファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0385.v1",
      "DATA": {
        "JGAS000597": {
          "Data Set ID": "JGAS000597",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/12/14"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate genetic mutations of Combined hepatocellular-cholangiocarcinoma, Cholangiolocarcinoma, Keratin 19-expressing hepatocellular carcinoma, and SOX9-expressing hepatocellular carcinoma and to clarify their association with clinicopathological features",
        "Methods": "We obtained non-tumor and tumor tissues from surgical specimens of cholangiolocarcinoma and extracted DNA from tissues, then performed whole-exome sequencing analysis.",
        "Participants/Materials": "Cholangiolocarcinoma patients"
      },
      "MOLECULAR DATA": {
        "JGAS000597": {
          "Participants/Materials": "cholangiolocarcinoma (ICD10: C221): 8 cases\r\n    tumor tissue: 8 samples, non-tumor tissue: 8 samples, recurrent tumor tissue: 2 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris LE220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000726",
          "Total Data Volume": "157.1 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takamichi Ishii",
        "Affiliation": "Department of Surgery, Graduate School of Medicine, Kyoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Elucidation of Genomic Heterogeneity in Hepatocellular Carcinoma from the Perspective of Cancer Stem Cells",
            "Project Number": "19K09145"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency.",
          "DOI": "",
          "Data Set ID": "JGAD000726"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0385.v1": {
          "Research ID": "hum0385.v1",
          "Release Date": "2023/12/14",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor and non-tumor tissues from patients with cholangiolocarcinoma were used for whole exome sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0383.v1": {
    "ja": {
      "NBDC Research ID": "hum0383.v1",
      "データ": {
        "JGAS000602": {
          "データID": "JGAS000602",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/03/28"
        }
      },
      "研究内容の概要": {
        "目的": "関節リウマチの治療においてT細胞の共刺激を阻害するCTLA4-Igであるアバタセプトの作用点及び予後予測因子の解明",
        "方法": "関節リウマチ症例に対するアバタセプト治療前後の末梢血由来の免疫細胞18画分を分取し（CD16p_Mono, CL_Mono, DN_B, Fr_II_eTreg, mDC, Mem_CD4, Naive_B, Naive_CD4, Neu, NK, pDC, Plasmablast, SM_B, Tfh, Th1, Th17, Th2, USM_B）、各画分のRNA-seqを実施した。",
        "対象": "関節リウマチ5症例",
        "URL": "http://ryumachi.umin.jp/"
      },
      "分子データ": {
        "JGAS000602": {
          "対象": "関節リウマチ（ICD10：M0690）：5症例\r\n（アバタセプト投与前後）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血免疫細胞18画分（CD16p_Mono, CL_Mono, DN_B, Fr_II_eTreg, mDC, Mem_CD4, Naive_B, Naive_CD4, Neu, NK, pDC, Plasmablast, SM_B, Tfh, Th1, Th17, Th2, USM_B）より抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-seq v4 Ultra Low Input RNA Kit",
          "断片化の方法": "SMART-seq v4 Ultra Low Input RNA Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "STAR（hg38）",
          "フィルタリング（QC）方法": "アダプター配列及び3’の低クオリティー塩基をトリムした（Phred quality score < 20）。50塩基未満のリード、及び低クオリティーの塩基を多く含むリード（20%を超える塩基で、Phred quality score < 20）を除去した。ユニークマップ率が80%未満、もしくはユニークマップリード数が5.00 x 106未満のサンプルは除去した。同一サブセット内の遺伝子発現の相関係数（Di）を計算した。Diが平均-2標準偏差未満のサンプルは除去した。",
          "遺伝子数": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000731",
          "総データ量": "17.8 MB（各遺伝子にマップされたリードのカウントデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "藤尾 圭志",
        "所 属 機 関": "東京大学大学院 医学系研究科 アレルギー・リウマチ学",
        "プロジェクト/研究グループ名": "生物学的製剤投与前後のリンパ球の遺伝子発現修飾の解析",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance",
          "DOI": "doi: 10.1136/ard-2022-223645",
          "データID": "JGAD000731\r\nJGAD000727"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0383.v1": {
          "Research ID": "hum0383.v1",
          "公開日": "2023/03/28",
          "内容": "NGS（RNA-seq）",
          "description": "関節リウマチ5症例の末梢血免疫細胞18画分を分取し、各画分サンプルを用いたRNA-seqを実施した。サンプルのフィルタリングの上で各遺伝子にマップされたリード数を提供する（txt）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0383.v1",
      "DATA": {
        "JGAS000602": {
          "Data Set ID": "JGAS000602",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/03/28"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the mechanism and predictors of abatacept, a CTLA4 agonist that regulates T cell co-stimulation, in rheumatoid arthritis (RA) treatment.",
        "Methods": "Various peripheral blood immune cell subsets from 5 RA patients were collected (CD16p_Mono, CL_Mono, DN_B, Fr_II_eTreg, mDC, Mem_CD4, Naive_B, Naive_CD4, Neu, NK, pDC, Plasmablast, SM_B, Tfh, Th1, Th17, Th2, USM_B). The patients were analyzed again longitudinally after abatacept treatment. RNA-seq was performed with each immune cell subset sample.",
        "Participants/Materials": "5 RA patients",
        "URL": "https://www.h.u-tokyo.ac.jp/english/centers-services/clinical-divisions/allergy-and-rheumatology/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000602": {
          "Participants/Materials": "RA (ICD10: M0690): 5 cases\r\n(before/after abatacept treatment)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "Total RNAs extracted from 18 immune cell subsets (CD16p_Mono, CL_Mono, DN_B, Fr_II_eTreg, mDC, Mem_CD4, Naive_B, Naive_CD4, Neu, NK, pDC, Plasmablast, SM_B, Tfh, Th1, Th17, Th2, USM_B)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Fragmentation Methods": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "STAR (hg38)",
          "QC Methods": "The adaptor sequences and 3’ low-quality bases (Phred quality score < 20) were trimmed. Short reads (< 50bp) and reads containing many low-quality bases (Phred quality score < 20 in > 20% of the bases) were removed. If the uniquely mapped rate was less than 80%, or the number of uniquely mapped reads was 5.00 x 106 reads, the sample was removed before further analysis. The correlation coefficient of the expression data between two samples belonging to the same cell subset and calculated the average of the correlation coefficient (Di). Samples for which Di was less than the mean – 2SD were removed.",
          "Gene Number": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000731",
          "Total Data Volume": "17.8 MB (count data, txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Keishi Fujio",
        "Affiliation": "Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "Analysis of the effect of abatacept for the transcriptome of multiple lymphoid subsets",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance",
          "DOI": "doi: 10.1136/ard-2022-223645",
          "Data Set ID": "JGAD000731\r\nJGAD000727"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0383.v1": {
          "Research ID": "hum0383.v1",
          "Release Date": "2023/03/28",
          "Type of Data": "NGS (RNA-seq)",
          "description": "18 immune cell subsets from 5 rheumatoid arthritis patients were collected. RNA-seq was performed with each immune cell subset sample. After filtering of the gene expression data, read count data mapped to each gene are provided as txt files.\nNote：\n"
        }
      }
    }
  },
  "hum0382.v1": {
    "ja": {
      "NBDC Research ID": "hum0382.v1",
      "データ": {
        "JGAS000587": {
          "データID": "JGAS000587",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/01/19"
        }
      },
      "研究内容の概要": {
        "目的": "造血器疾患患者より採取した腫瘍細胞を用いたゲノム解析を通して検出された遺伝子異常やエピジェネティクス異常と、細胞生物学的実験や臨床情報とを統合して解析することで、疾患の発症・進展・維持のメカニズムや予後との関連性を探索する。具体的にはどのような遺伝子異常・エピジェネティック異常が折り重なって造血器疾患を発症するのか、どのような細胞が造血器疾患の発生母地なのか、どのような異常があると造血器疾患が進行するのか、またどういう異常が臨床的予後に影響するのか、といった点について明らかにする。",
        "方法": "骨髄単核細胞（ficoll-paqueにより精製）および頬粘膜細胞より抽出したDNAを用いた全ゲノムシーケンス解析",
        "対象": "FUS-ERGを伴う骨髄異形成症候群（myelodysplastic syndrome：MDS）と診断され、後にFUS-ERGを伴う急性骨髄性白血病（acute myeloid leukemia: AML）として再発した１症例"
      },
      "分子データ": {
        "JGAS000587": {
          "対象": "FUS-ERGを伴うAML（ICD10：C92.0）：1症例3検体\r\n    1. 初診時（MDS）の骨髄細胞：1検体\r\n    2. AML発症時（再発時）の骨髄細胞：1検体\r\n    3. 口腔内スワブ：1検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "骨髄細胞および口腔内スワブから抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Nano DNA Library Prep Kit",
          "断片化の方法": "超音波断片化 （Covaris S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "DRAGEN DNA Pipeline",
          "マッピングクオリティ": "1. マップされたリード：83.26％、ユニークリード：77.34％\r\n2. マップされたリード：94.94％、ユニークリード：89.15％\r\n3. マップされたリード：95.09％、ユニークリード：85.93％",
          "マッピングの際のリファレンス配列": "hg19",
          "平均カバー率（Depth）": "1. 27.96（Pct > 0.2*mean：97.61）\r\n2. 54.68（Pct > 0.2*mean：97.66）\r\n3. 65.07（Pct > 0.2*mean：97.62）",
          "変異検出方法": "DRAGEN DNA Pipeline（Somatic Mode [tumor-normal pipeline]）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000714",
          "総データ量": "488.1 GB（fastq、bam、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "河原 真大",
        "所 属 機 関": "滋賀医科大学 血液内科",
        "プロジェクト/研究グループ名": "造血器疾患における遺伝子異常・エピジェネティクス異常の解析",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "MSD株式会社",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "FUS-ERG induces late-onset azacitidine resistance in acute myeloid leukaemia cells",
          "DOI": "doi: 10.1038/s41598-023-41230-1",
          "データID": "JGAD000714"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0382.v1": {
          "Research ID": "hum0382.v1",
          "公開日": "2023/01/19",
          "内容": "NGS（WGS）",
          "description": "FUS-ERGを伴う急性骨髄性白血病1症例の骨髄細胞および口腔内スワブから抽出したDNAを用いたwhole genome sequencing解析データをfastq、bam、txtファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0382.v1",
      "DATA": {
        "JGAS000587": {
          "Data Set ID": "JGAS000587",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/01/19"
        }
      },
      "SUMMARY": {
        "Aims": "We collect tumor cells from patients with hematopoietic diseases, analyze genetic abnormalities and epigenetic abnormalities through genomic analyses, and integrate them with cell biological experiments and clinical information to understand the onset, progression, and maintenance of the disease. Specifically, what kind of genetic and epigenetic abnormalities stack up to cause hematopoietic diseases, what kind of cells are the origin of hematopoietic diseases, what kind of abnormalities lead to hematopoietic diseases, and what abnormalities influence clinical prognosis?",
        "Methods": "DNAs extracted from bone marrow mononuclear cells purified by ficoll-paque (GE HealthCare, Chicago, IL) and oral mucosa cells were used for whole-genome sequencing analysis.",
        "Participants/Materials": "A patient who was initially diagnosed with myelodysplastic syndrome (MDS) and had a fusion FUS gene with ERG (FUS-ERG), and relapsed acute myeloid leukemia (AML) with FUS-ERG"
      },
      "MOLECULAR DATA": {
        "JGAS000587": {
          "Participants/Materials": "AML with FUS-ERG (ICD10: C92.0): 1 case\r\n    1. bone marrow cells at the first visit for MDS: 1 sample\r\n    2. bone marrow cells at that time for AML (relapse): 1 sample\r\n    3. oral swab specimen: 1 sample",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from bone marrow mononuclear cells and oral mucosa cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Nano DNA Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "DRAGEN DNA Pipeline",
          "Mapping Quality": "1. Mapped reads: 83.26%, Unique reads: 77.34%\r\n2. Mapped reads: 94.94%, Unique reads: 89.15%\r\n3. Mapped reads: 95.09%, Unique reads: 85.93%",
          "Reference Genome Sequence": "hg19",
          "Coverage (Depth)": "1. Mean depth: 27.96 (Pct > 0.2*mean: 97.61)\r\n2. Mean depth: 54.68 (Pct > 0.2*mean: 97.66)\r\n3. Mean depth: 65.07 (Pct > 0.2*mean: 97.62)",
          "Detecting Methods for Variation": "DRAGEN DNA Pipeline (Somatic Mode [tumor-normal pipeline])",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000714",
          "Total Data Volume": "488.1 GB (fastq, bam, txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masahiro Kawahara",
        "Affiliation": "Department of Hematology, Shiga University of Medical Science",
        "Project / Group Name": "Analysis of genetic and epigenetic abnormalities in hematopoietic diseases",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "MSD K.K.",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "FUS-ERG induces late-onset azacitidine resistance in acute myeloid leukaemia cells",
          "DOI": "doi: 10.1038/s41598-023-41230-1",
          "Data Set ID": "JGAD000714"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0382.v1": {
          "Research ID": "hum0382.v1",
          "Release Date": "2023/01/19",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from bone marrow mononuclear cells and oral mucosa cells of a patient with acute myeloid leukemia with the fusion of FUS gene with ERG were used for the whole genome sequencing analyses. Fastq, bam, and txt files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0381.v1": {
    "ja": {
      "NBDC Research ID": "hum0381.v1",
      "データ": {
        "JGAS000588": {
          "データID": "JGAS000588",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/01/05"
        }
      },
      "研究内容の概要": {
        "目的": "血液、腫瘍組織標本を用いて、病理学的評価、薬物動態・分子イメージング解析、ゲノム解析、免疫モニタリングを行い、多角的な解析を行うことで、切除不能または再発胸腺がん患者における、ニボルマブの有効性と安全性に関するバイオマーカーの探索を行う。",
        "方法": "末梢血血球成分を用いて、Immuno-PGxパネルによる免疫関連遺伝子（SNV、inDelの解析と機能予測、コピー数変異解析など）の解析を行う。",
        "対象": "NCCH1505試験へ参加している胸腺がん患者のうち、Immuno-pharmacogenomics（Immuno-PGx）を行った15症例"
      },
      "分子データ": {
        "JGAS000588": {
          "対象": "胸腺がん（ICD10：C37）：15症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "Immuno-PGxパネル",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Sure Select XT Library Prep Kit",
          "断片化の方法": "超音波断片化 （Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000715",
          "総データ量": "17.1 GB（fasq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "堀之内 秀仁",
        "所 属 機 関": "国立がん研究センター中央病院 呼吸器内科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma",
          "DOI": "doi: 10.3389/fonc.2022.966527",
          "データID": "JGAD000715"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0381.v1": {
          "Research ID": "hum0381.v1",
          "公開日": "2023/01/05",
          "内容": "NGS（Target Capture）",
          "description": "胸腺がん15症例の末梢血から抽出したDNAを用いた、Immuno-PGxパネルによるTarget Capture Sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0381.v1",
      "DATA": {
        "JGAS000588": {
          "Data Set ID": "JGAS000588",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/01/05"
        }
      },
      "SUMMARY": {
        "Aims": "We explore biomarkers of nivolumab efficacy and safety in patients with unresectable or recurrent thymic carcinoma. In order to perform multifaceted analysis using blood and tumor tissue specimens, pathological evaluation, pharmacokinetic, and molecular imaging analysis, genomic analysis, and immunomonitoring were performed.",
        "Methods": "We analyze immune-related genes (SNV, indel analysis and function prediction, copy number mutation analysis, etc.) by Immuno-PGx panel with peripheral blood cell components.",
        "Participants/Materials": "15 patients with thymic carcinoma participating in the NCCH1505 study"
      },
      "MOLECULAR DATA": {
        "JGAS000588": {
          "Participants/Materials": "thymic carcinoma (ICD10: C37) : 15 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "Immuno-PGx panel",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Sure Select XT Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000715",
          "Total Data Volume": "17.1 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hidehito Horinouchi",
        "Affiliation": "Department of Thoracic Oncology, Nantional Cancer Center Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma",
          "DOI": "doi: 10.3389/fonc.2022.966527",
          "Data Set ID": "JGAD000715"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0381.v1": {
          "Research ID": "hum0381.v1",
          "Release Date": "2023/01/05",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from peripheral blood cells of 15 patients with thymic carcinoma were used for the target capture sequencing analysis (Immuno-PGx panel). Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0379.v1": {
    "ja": {
      "NBDC Research ID": "hum0379.v1",
      "データ": {
        "JGAS000578": {
          "データID": "JGAS000578",
          "内容": "NGS（scRNA-seq、scVDJ-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/11/20"
        }
      },
      "研究内容の概要": {
        "目的": "自己免疫疾患における免疫担当細胞の解析",
        "方法": "single-cell RNA-seqおよびsingle-cell VDJ-seq",
        "対象": "重症筋無力症（myasthenia gravis：MG） 2症例、多発性硬化症（multiple sclerosis：MS）4症例、全身性エリテマトーデス（systemic lupus erythematosus：SLE）3症例、健常者3名"
      },
      "分子データ": {
        "JGAS000578": {
          "対象": "MG （ICD10：G70.0）：2症例（CD4+T細胞・B細胞の2検体ずつ）\r\nMS（ICD10：G35）：4症例（CD4+T細胞・B細胞の2検体ずつ3症例、CD4+T細胞とB細胞の混合1検体）\r\nSLE（ICD10：M32.9）：3症例（CD4+T細胞・B細胞の2検体ずつ2症例、CD4+T細胞1検体）\r\n健常者：3名（CD4+T細胞・B細胞の2検体ずつ）",
          "規模": "scRNA-seqおよびscVDJ-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血のCD4+T細胞およびB細胞より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "scRNA-seq：Chromium Next GEM Single Cell 5’ Kit v2\r\nscVDJ-seq：Chromium Single Cell Human BCR Amplification Kit もしくは Chromium Single Cell Human TCR Amplification Kit",
          "断片化の方法": "上記キットに準拠",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000704",
          "総データ量": "511 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "坂口 志文",
        "所 属 機 関": "大阪大学 免疫学フロンティア研究センター 実験免疫学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的先端研究開発支援事業 インキュベートタイプ（LEAP）",
            "タイトル": "制御性T細胞を標的とした免疫応答制御技術に関する研究開発",
            "研究課題番号": "JP18gm0010005"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0379.v1": {
          "Research ID": "hum0379.v1",
          "公開日": "2023/11/20",
          "内容": "NGS（scRNA-seq、scVDJ-seq）",
          "description": "重症筋無力症2症例、多発性硬化症4症例、全身性エリテマトーデス3症例、健常者3名の末梢血由来CD4+T細胞およびB細胞から抽出したRNAを用いたscRNA-seq解析ならびにscVDJ-seq解析の結果をfastqファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0379.v1",
      "DATA": {
        "JGAS000578": {
          "Data Set ID": "JGAS000578",
          "Type of Data": "NGS (scRNA-seq, scVDJ-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/11/20"
        }
      },
      "SUMMARY": {
        "Aims": "Analysis of immune cells in autoimmune diseases",
        "Methods": "single-cell RNA+VDJ-seq",
        "Participants/Materials": "myasthenia gravis (MG) 2 cases, multiple sclerosis (MS) 4 cases, systemic lupus erythematosus (SLE) 3 cases, 3 healthy cases"
      },
      "MOLECULAR DATA": {
        "JGAS000578": {
          "Participants/Materials": "MG (ICD10: G70.0): 2 cases (CD4+ T cell and B cell specimens each)\r\nMS (ICD10: G35): 4 cases (3 cases of CD4+ T cell and B cell specimens each + 1 mixed CD4+ T cell and B cell specimen)\r\nSLE (ICD10: M32.9): 3 cases (3 cases of CD4+ T cell and B cell specimens each + 1 CD4+ T cell pecimen)\r\n3 healthy cases (CD4+ T cell and B cell specimens each)",
          "Targets": "scRNA-seq and scVDJ-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from CD4+ T cell and B cell isolated from peripheral blood",
          "Cell Lines": "-",
          "Library Construction (kit name)": "scRNA-seq: Chromium Next GEM Single Cell 5’ Kit v2\r\nscVDJ-seq: Chromium Single Cell Human BCR Amplification Kit or Chromium Single Cell Human TCR Amplification Kit",
          "Fragmentation Methods": "included in the above library construction kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000704",
          "Total Data Volume": "511 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shimon Sakaguchi",
        "Affiliation": "Experimental Immunology, IFReC, Osaka University",
        "Project / Group Name": "　-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Leading Advanced Projects for medical innovation (LEAP), Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Study of Immunoregulatory technology targeting regulatory T cells",
            "Project Number": "JP18gm0010005"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0379.v1": {
          "Research ID": "hum0379.v1",
          "Release Date": "2023/11/20",
          "Type of Data": "NGS (scRNA-seq, scVDJ-seq)",
          "description": "RNAs extracted from CD4+ T cell and B cell isolated from peripheral blood of 2 myasthenia gravis patients, 4 multiple sclerosis patients, 3 systemic lupus erythematosus patients and 3 healthy cases were used for the single-cell RNA sequencing and single-cell VDJ sequencing analyses. Fastq files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0377.v1": {
    "ja": {
      "NBDC Research ID": "hum0377.v1",
      "データ": {
        "JGAS000579": {
          "データID": "JGAS000579",
          "内容": "NGS（Amplicon-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/12/13"
        }
      },
      "研究内容の概要": {
        "目的": "家族性致死性不整脈の中には、一見健康な個人を突然死に陥れるものがある。これらの疾患を心電図などの臨床検査のみから発症前診断することは必ずしも容易ではない。本研究の目的は、致死的不整脈の原因またはその感受性を左右する遺伝的要因を同定し、機能異常を評価することで、早期診断や有効な治療法の選択が可能になり、適切な突然死予防策をとることができるようになることである。",
        "方法": "QT延長症候群（Long QT syndrome：LQTS）と診断された症例から採取した末梢血からDNAを抽出し、LQTSの原因遺伝子として報告されている15遺伝子および候補遺伝子85遺伝子領域に対し、シーケンシング解析を実施した。",
        "対象": "日本人LQTS 556症例",
        "URL": "https://www.tmd.ac.jp/grad/hgdd/"
      },
      "分子データ": {
        "JGAS000579": {
          "対象": "LQTS（ICD10：I45.81）：556症例",
          "規模": "Amplicon-seq",
          "対象領域（Target Captureの場合）": "LQTSの原因遺伝子として報告されている15遺伝子および候補遺伝子85遺伝子領域*1",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Library Kit for Chef DL8",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均 119 bp",
          "マッピング方法": "Ion Torrent Variant Caller",
          "マッピングクオリティ": "Mapped reads：2,485,134\r\nOn target region：98.21%",
          "マッピングの際のリファレンス配列": "GRCh37",
          "平均カバー率（Depth）": "473.5",
          "変異検出方法": "Ion Torrent Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000705",
          "総データ量": "169.5 MB（vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "田中 敏博",
        "所 属 機 関": "東京医科歯科大学大学院 疾患バイオリソースセンター",
        "プロジェクト/研究グループ名": "疾患多様性遺伝学分野",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Targeted deep sequencing analyses of long QT syndrome in a Japanese population.",
          "DOI": "doi: 10.1371/journal.pone.0277242",
          "データID": "JGAD000705"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0377.v1": {
          "Research ID": "hum0377.v1",
          "公開日": "2022/12/13",
          "内容": "NGS（Amplicon-seq）",
          "description": "QT延長症候群（LQTS）556症例の末梢血から抽出したDNAを用いた、LQTSの原因遺伝子として報告されている15遺伝子および候補遺伝子85遺伝子領域のAmplicon Sequencing解析データをvcfファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0377.v1",
      "DATA": {
        "JGAS000579": {
          "Data Set ID": "JGAS000579",
          "Type of Data": "NGS (Amplicon-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/12/13"
        }
      },
      "SUMMARY": {
        "Aims": "Some of the fatal familial arrhythmias cause sudden death in seemingly healthy individuals. It is not easy to make a pre-symptomatic diagnosis of these diseases using only clinical examinations such as an electrocardiogram. The purpose of this study is to elucidate the cause of lethal arrhythmia and/or the genetic factors that influence its susceptibility, thereby enabling early diagnosis and selection of effective treatment methods, and preventing sudden death. If a genetic abnormality is found, it is expected that the functional abnormality can be evaluated and appropriate measures to prevent sudden death can be taken.",
        "Methods": "Peripheral blood cells were collected from the patients with LQTS and genomic DNAs were extracted. Fifteen causative and 85 candidate genetic loci of LQTS were targeted for the sequence analysis.",
        "Participants/Materials": "Japanese 556 LQTS patients",
        "URL": "https://www.tmd.ac.jp/english/dept/medicine/brc/"
      },
      "MOLECULAR DATA": {
        "JGAS000579": {
          "Participants/Materials": "LQTS (ICD10: I45.81) : 556 cases",
          "Targets": "Amplicon-seq",
          "Target Loci for Capture Methods": "LQTS causative 15 genes and LQTS related 85 genes*1",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Library Kit for Chef DL8",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "119 bp (mean)",
          "Mapping Methods": "Ion Torrent Variant Caller",
          "Mapping Quality": "Mapped reads: 2,485,134\r\nOn target region: 98.21%",
          "Reference Genome Sequence": "GRCh37",
          "Coverage (Depth)": "473.5 (mean)",
          "Detecting Methods for Variation": "Ion Torrent Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000705",
          "Total Data Volume": "169.5 MB (vcf)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshihiro Tanaka",
        "Affiliation": "BioResource Research Center, Tokyo Medical and Dental University",
        "Project / Group Name": "Human Genetics and Disease Diversity",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Targeted deep sequencing analyses of long QT syndrome in a Japanese population.",
          "DOI": "doi: 10.1371/journal.pone.0277242",
          "Data Set ID": "JGAD000705"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0377.v1": {
          "Research ID": "hum0377.v1",
          "Release Date": "2022/11/30",
          "Type of Data": "NGS (Amplicon-seq)",
          "description": "DNAs extracted from peripheral blood cells of 556 LQTS patients were used for the amplicon sequencing analysis. Vcf files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0376.v2": {
    "ja": {
      "NBDC Research ID": "hum0376.v2",
      "データ": {
        "JGAS000585": {
          "データID": "JGAS000585",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/12/27"
        },
        "JGAS000585（データ追加）": {
          "データID": "JGAS000585（データ追加）",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/03/28"
        }
      },
      "研究内容の概要": {
        "目的": "治療法の開発に資する研究リソースとして、臨床検体からゼノグラフト株・培養細胞株を樹立すること。ならびに、樹立方法を開発すること。",
        "方法": "子宮内膜がん症例の腫瘍細胞および腫瘍細胞から樹立したゼノグラフト株から抽出したDNAを用いたNCCオンコパネル v4を用いて114遺伝子の変異および12遺伝子の増幅と融合の有無を解析した。",
        "対象": "子宮内膜がん2＋4症例の腫瘍組織とゼノグラフト株から各1検体ずつ",
        "URL": "https://www.ncc.go.jp/jp/ri/department/cancer_model_development/index.html"
      },
      "分子データ": {
        "JGAS000585": {
          "対象": "子宮内膜がん（ICD10：C54.1）：2＋4症例\r\n    腫瘍組織：各1検体\r\n    腫瘍組織を用いて樹立したゼノグラフト株：各1検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "NCC Oncopanel v4\r\nhttps://www.ncc.go.jp/jp/information/pr_release/2019/0529/index.html",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "腫瘍組織および腫瘍組織から樹立したゼノグラフト株から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT Reagents＋KAPA Hyper Prep Kit",
          "断片化の方法": "超音波断片化 （Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "WA-MEM",
          "マッピングクオリティ": "0以上",
          "マッピングの際のリファレンス配列": "hg19",
          "平均カバー率（Depth）": "1240.7（UXE009T-Fr2）、1119.6（UXE009T2P8-Fr2）、1496.7（UXE010T-Fr2）、1225.0（UXE010T3P8-Fr2）、2039.1（UXE001T-Fr1）、1952.7（UXE001P8-Fr1）、2180.5（UXE004T-Fr1）、2518.6（UXE004P8-Fr1）、2141.6（UXE005T-Fr1）、1830.4（UXE005P8-Fr1）、2337.9（UXE008T-Fr1）、2155.6（UXE008P8-Fr1）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000712",
          "総データ量": "4.5＋16.9 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "今井 俊夫",
        "所 属 機 関": "国立がん研究センター研究所 がんモデル開発部門",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Alteration in molecular properties during establishment and passages in endometrial carcinoma patient-derived xenografts.",
          "DOI": "doi: 10.1038/s41598-023-35703-6",
          "データID": "JGAD000712"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0376.v2": {
          "Research ID": "hum0376.v2",
          "公開日": "2023/03/28",
          "内容": "NGS（Target Capture）",
          "description": "子宮内膜がん4症例の腫瘍組織および腫瘍組織から樹立したゼノグラフト株から抽出したDNAを用いたTarget Capture Sequencing解析データ（NCC Oncopanel v4）をbamファイルにて提供する。\n"
        },
        "hum0376.v1": {
          "Research ID": "hum0376.v1",
          "公開日": "2022/12/27",
          "内容": "NGS（Target Capture）",
          "description": "子宮内膜がん2症例の腫瘍組織および腫瘍組織から樹立したゼノグラフト株から抽出したDNAを用いたTarget Capture Sequencing解析データ（NCC Oncopanel v4）をbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0376.v2",
      "DATA": {
        "JGAS000585": {
          "Data Set ID": "JGAS000585",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/12/27"
        },
        "JGAS000585 (Data addition)": {
          "Data Set ID": "JGAS000585 (Data addition)",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/03/28"
        }
      },
      "SUMMARY": {
        "Aims": "To establish xenografts and cultured cell lines from clinical samples, as a bioresource for the development of a method of treatment, and to investigate their establishment methods.",
        "Methods": "A targeted sequencing analysis was performed using the NCC Oncopanel v4 test, which can analyze mutations of 114 genes and amplifications and fusions of 12 genes.",
        "Participants/Materials": "Endometrial cancer samples and their xenografts. Samples of one parent tissue and one xenograft each from two + four cases.",
        "URL": "https://www.ncc.go.jp/en/ri/department/cancer_model_development/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000585": {
          "Participants/Materials": "endometrial cancer (ICD10: C54.1) : 2 + 4 cases\r\n    tumor tissue: 1 sample each\r\n    patient-derived xenograft: 1 sample each",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "NCC Oncopanel v4\r\nhttps://www.ncc.go.jp/en/information/press_release/20190717/20190717152024.html",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "DNAs extracted from tumor tissues and xenograft samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT Reagents + KAPA Hyper Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "WA-MEM",
          "Mapping Quality": "≥0",
          "Reference Genome Sequence": "hg19",
          "Coverage (Depth)": "1240.7 (UXE009T-Fr2), 1119.6 (UXE009T2P8-Fr2), 1496.7 (UXE010T-Fr2), 1225.0 (UXE010T3P8-Fr2), 2039.1 (UXE001T-Fr1), 1952.7 (UXE001P8-Fr1), 2180.5 (UXE004T-Fr1), 2518.6 (UXE004P8-Fr1), 2141.6 (UXE005T-Fr1), 1830.4 (UXE005P8-Fr1), 2337.9 (UXE008T-Fr1), 2155.6 (UXE008P8-Fr1)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000712",
          "Total Data Volume": "4.5 + 16.9 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshio Imai",
        "Affiliation": "Department of Cancer Model Development, National Cancer Center Research Institute",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Alteration in molecular properties during establishment and passages in endometrial carcinoma patient-derived xenografts.",
          "DOI": "doi: 10.1038/s41598-023-35703-6",
          "Data Set ID": "JGAD000712"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0376.v2": {
          "Research ID": "hum0376.v2",
          "Release Date": "2023/03/28",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from tumor tissues from patients with endometrial cancer and patient-derived xenograft samples were used for the target capture sequencing analysis (NCC Oncopanel v4). Bam files are provided.\n"
        },
        "hum0376.v1": {
          "Research ID": "hum0376.v1",
          "Release Date": "2022/12/27",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from tumor tissues from patients with endometrial cancer and patient-derived xenograft samples were used for the target capture sequencing analysis (NCC Oncopanel v4). Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0372.v1": {
    "ja": {
      "NBDC Research ID": "hum0372.v1",
      "データ": {
        "JGAS000572": {
          "データID": "JGAS000572",
          "内容": "364代謝物の存在量",
          "制限": "制限公開（Type I）",
          "公開日": "2022/11/22"
        },
        "MTBKS213、MTBKS214": {
          "データID": "MTBKS213、MTBKS214",
          "内容": "364代謝物の要約統計量",
          "制限": "非制限公開",
          "公開日": "2022/11/22"
        }
      },
      "研究内容の概要": {
        "目的": "日本人における、糖尿病等メタボリック・シンドローム関連疾患の遺伝素因や、糖尿病治療薬などの反応性・副作用の遺伝素因を解明することで、糖尿病の発症予防や個別化医療への応用を図り、メタボリック・シンドローム関連疾患患者やその合併症の増加抑制に寄与することを目的とする。",
        "方法": "2型糖尿病症例の血清代謝物を、質量分析により包括的なノンターゲットメタボロミクスアプローチにて測定した。複数の合併症がある2型糖尿病症例（n = 141）および、合併症がない2型糖尿病症例（n = 159）間において364の血清代謝物の存在量を比較し、要約統計量を算出した。",
        "対象": "2型糖尿病"
      },
      "分子データ": {
        "JGAS000572 / MTBKS213 / MTBKS214": {
          "対象": "2型糖尿病・合併症なし（ICD10：E11）：159症例\r\n糖尿病性腎臓病と糖尿病性網膜症の両方を合併する2型糖尿病（ICD10：E11）：141症例",
          "規模": "メタボローム",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Agilent Technologies [Agilent CE system equipped with an Agilent 6210 TOFMS, Agilent 1100 isocratic HPLC pump]\r\nAgilent Technologies [Agilent LC System equipped with an Agilent 6230 TOFMS]",
          "ソース": "血清サンプル",
          "検体情報（購入の場合）": "-",
          "測定方法": "Agilent Technologies [Agilent CE system equipped with an Agilent 6210 TOFMS, Agilent 1100 isocratic HPLC pump]\r\nAgilent Technologies [Agilent LC System equipped with an Agilent 6230 TOFMS]",
          "測定パラメータ": "-",
          "ノイズの低減方法・補正方法": "-",
          "アノテーション方法": "-",
          "定量アルゴリズム": "-",
          "定量対象領域": "364代謝物",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000698",
          "MetaboBank Accession ID": "CE-MS：MTBKS213\r\nLC-MS：MTBKS214",
          "総データ量": "JGAD000698：2.1 MB（txt）\r\nMTBKS213 / MTBKS214：39 KB（tsv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山内 敏正 1 / 門脇 孝 1,2 / 岡田 随象 3",
        "所 属 機 関": "1. 東京大学医学部附属病院 糖尿病・代謝内科",
        "プロジェクト/研究グループ名": "糖尿病の遺伝・環境因子の包括的解析から日本発次世代型精密医療を社会実装するプロジェクト",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） ゲノム医療実現推進プラットフォーム事業",
            "タイトル": "糖尿病の遺伝・環境因子の包括的解析から日本発次世代型精密医療を社会実装するプロジェクト",
            "研究課題番号": "JP21tm0424218"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Identification of serum metabolome signatures associated with retinal and renal complications of type 2 diabetes",
          "DOI": "doi: 10.1038/s43856-022-00231-3",
          "データID": "JGAD000698MTBKS213MTBKS214"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0372.v1": {
          "Research ID": "hum0372.v1",
          "公開日": "2022/11/22",
          "内容": "364血清代謝物の存在量、要約統計量",
          "description": "合併症がない2型糖尿病159症例、および、糖尿病性腎臓病と糖尿病性網膜症を合併する2型糖尿病141症例の血清代謝物を、質量分析による包括的なノンターゲットメタボロミクスアプローチ法により測定した。364血清代謝物の存在量および要約統計量をテキストファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0372.v1",
      "DATA": {
        "JGAS000572": {
          "Data Set ID": "JGAS000572",
          "Type of Data": "the abundance of the 364 serum metabolites",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/11/22"
        },
        "MTBKS213, MTBKS214": {
          "Data Set ID": "MTBKS213, MTBKS214",
          "Type of Data": "the summary statistics",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/11/22"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the genetic predisposition to metabolic syndrome-related diseases such as diabetes and the genetic predisposition to reactivity and side effects of diabetes drugs in Japanese people, and to apply this to the prevention of diabetes and personalized medicine.",
        "Methods": "We profiled serum metabolites of persons with type 2 diabetes (T2D) with or without diabetic complications using a comprehensive non-targeted metabolomics approach with mass spectrometry. The abundance of the 364 serum metabolites was compared between the T2D patients with multiple complications (N = 141) and those without any complications (N = 159), then calculated the summary statistics.",
        "Participants/Materials": "T2D"
      },
      "MOLECULAR DATA": {
        "JGAS000572 / MTBKS213 / MTBKS214": {
          "Participants/Materials": "T2D without diabetic complications (ICD10: E11): 159 cases\r\nT2D with both diabetic kidney disease and diabetic retinopathy (ICD10: E11): 141 cases",
          "Targets": "metabolome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Agilent Technologies [Agilent CE system equipped with an Agilent 6210 TOFMS, Agilent 1100 isocratic HPLC pump]\r\nAgilent Technologies [Agilent LC System equipped with an Agilent 6230 TOFMS]",
          "Source": "Serum",
          "Cell Lines": "-",
          "Measurement Method": "Agilent Technologies [Agilent CE system equipped with an Agilent 6210 TOFMS, Agilent 1100 isocratic HPLC pump]\r\nAgilent Technologies [Agilent LC System equipped with an Agilent 6230 TOFMS]",
          "Measurement Conditions (Parameters)": "-",
          "Noise reduction & Data correction": "-",
          "Annotation": "-",
          "Quantification Methods (software)": "-",
          "Metabolic biomarkers": "364 serum metabolites",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000698",
          "MetaboBank Accession ID": "CE-MS: MTBKS213\r\nLC-MS: MTBKS214",
          "Total Data Volume": "JGAD000698: 2.1 MB (txt)\r\nMTBKS213 / MTBKS214: 39 KB (tsv)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshimasa Yamauchi 1 / Takashi Kadowaki 1,2 / Yukinori Okada 3",
        "Affiliation": "1. Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "Social implementation of next-generation precision medicine from Japan based on comprehensive analysis of genetic and environmental factors of diabetes",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Platform Program for Promotion of Genome Medicine, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Social implementation of next-generation precision medicine from Japan based on comprehensive analysis of genetic and environmental factors of diabetes",
            "Project Number": "JP21tm0424218"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Identification of serum metabolome signatures associated with retinal and renal complications of type 2 diabetes",
          "DOI": "doi: 10.1038/s43856-022-00231-3",
          "Data Set ID": "JGAD000698MTBKS213MTBK214"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0372.v1": {
          "Research ID": "hum0372.v1",
          "Release Date": "2022/11/22",
          "Type of Data": "the abundance of the 364 serum metabolites and the summary statistics",
          "description": "A comprehensive non-targeted metabolomics analysis with mass spectrometry was performed to profile serum metabolites of patients with type 2 diabetes with or without diabetic complications. The abundance of the 364 serum metabolites and the summary statistics are provided as text files.\nNote：\n"
        }
      }
    }
  },
  "hum0371.v1": {
    "ja": {
      "NBDC Research ID": "hum0371.v1",
      "データ": {
        "JGAS000574": {
          "データID": "JGAS000574",
          "内容": "メタゲノム",
          "制限": "制限公開（Type I）",
          "公開日": "2022/12/22"
        }
      },
      "研究内容の概要": {
        "目的": "慢性肝炎、肝硬変、肝癌など肝臓病は国民の健康に多大な影響を与えている。我が国の肝臓病の大半はB型肝炎ウイルス、C型肝炎ウイルス等の肝炎ウイルス感染症で、ウイルス遺伝子の違いによって肝炎の病態が異なり、抗ウイルス療法の治療効果にもウイルス遺伝子が影響する。一方、宿主の遺伝子やその発現も病態に関与している。ポストゲノム時代の現在ではゲノム解析、トランスクリプトーム解析が行われる一方、質量分析によるプロテオーム研究も重要になっている。また、慢性肝炎や脂肪肝の病態と腸内細菌の関連が明らかになり、薬剤奏効性との関連性も示唆されている。本研究の目的は、これらのDNA、RNA、蛋白質に関する網羅的・包括的解析の手法を用い、ウイルス側、宿主側の両面から、肝臓疾患の診断と病態把握に役立つ遺伝子関連情報を得て日常診療に役立てる、更には疾患の早期発見、治療後の予後予測に結び付けられる方法を開発することである。",
        "方法": "16Sメタゲノミクス解析",
        "対象": "糖尿病を併発する非アルコール性脂肪性肝炎（マッテオーニ分類3もしくは4と病理診断された）20症例"
      },
      "分子データ": {
        "JGAS000574": {
          "対象": "糖尿病を併発する非アルコール性脂肪性肝炎（ICD10: K75.81）：20症例\r\n    マッテオーニ分類3もしくは4と病理診断された症例",
          "規模": "メタゲノム",
          "対象領域（Target Captureの場合）": "16S rDNA",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "糞便より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina 16S Metagenomic Sequencing Library Preparation protocol、Nextera XT Index Kit v2 Set A",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "301 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000700",
          "総データ量": "845 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "建石 良介",
        "所 属 機 関": "東京大学医学部附属病院 消化器内科",
        "プロジェクト/研究グループ名": "肝臓疾患に関与する遺伝子とタンパク質の探索に関する研究",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis",
          "DOI": "doi: 10.1038/s41467-023-42334-y",
          "データID": "JGAD000700"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0371.v1": {
          "Research ID": "hum0371.v1",
          "公開日": "2022/12/22",
          "内容": "メタゲノム",
          "description": "非アルコール性脂肪性肝炎20症例の糞便から抽出したDNAを用いた16Sメタゲノム解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0371.v1",
      "DATA": {
        "JGAS000574": {
          "Data Set ID": "JGAS000574",
          "Type of Data": "Metagenome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/12/22"
        }
      },
      "SUMMARY": {
        "Aims": "Liver diseases, including chronic hepatitis, cirrhosis, and liver cancer, are prevalent in Japan, which are often caused by hepatitis viral infections. The pathogenesis of hepatitis and the selection of antiviral therapies varies depending on the genotypes or sequences of the viruses. Genes and gene expression levels of the host are also involved in the pathogenesis. Recently, along with genomics and transcriptomics, proteomics and metagenomics are also available which have revealed that gut flora is also associated with the pathogenesis and therapeutic efficacy of drugs in chronic hepatitis. The aim of this study is to establish a comprehensive genetic diagnosis system for chronic liver diseases by investigating genes and proteins associated with chronic liver diseases from both the viral and host side.",
        "Methods": "16S metagenomic analysis was performed on stool DNA samples collected from 27 patients who experienced liver biopsy according to the following criteria or clinically diagnosed severe non-B non-C cirrhosis at the University of Tokyo Hospital. After excluding patients who had never been diagnosed with diabetes (6 cases) and patients who were categorized to Matteoni classification class 2 or 1 (1 case), 20 patients with diabetes who were diagnosed NASH as Matteoni classification class 4 or clinically diagnosed liver cirrhosis were analyzed. The 16S metagenomic data from 5 patients who were under insulin treatment were compared with those of the remaining 15 patients.",
        "Participants/Materials": "20 patients with nonalcoholic steatohepatitis (NASH)"
      },
      "MOLECULAR DATA": {
        "JGAS000574": {
          "Participants/Materials:": "NASH (ICD10: K75.81): 20 cases\r\n    patients with diabetes who were also diagnosed NASH as Matteoni classification class 3 or 4",
          "Targets": "Metagenome",
          "Target Loci for Capture Methods": "16S rDNA",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNA extracted from stool samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina 16S Metagenomic Sequencing Library Preparation protocol, Nextera XT Index Kit v2 Set A",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "301 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000700",
          "Total Data Volume": "845 MB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Ryosuke Tateishi",
        "Affiliation": "Gastroenterology, The University of Tokyo Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis",
          "DOI": "doi: 10.1038/s41467-023-42334-y",
          "Data Set ID": "JGAD000700"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0371.v1": {
          "Research ID": "hum0371.v1",
          "Release Date": "2022/12/22",
          "Type of Data": "Metagenome",
          "description": "DNAs extracted from the stool samples collected from 20 patients with nonalcoholic steatohepatitis (NASH) were used for 16S metagenomic analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0369.v1": {
    "ja": {
      "NBDC Research ID": "hum0369.v1",
      "データ": {
        "JGAS000562": {
          "データID": "JGAS000562",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/28"
        }
      },
      "研究内容の概要": {
        "目的": "茨城県においても、複数の病院において医療従事者の院内感染と思われる事例が発生した。感染した医療従事者については、感染者との濃厚接触により発症したものと想定されるが、明らかに感染した医療従事者よりも濃厚接触したにもかかわらず、感染に至らない医療従事者が多数いることを確認した。そこで、新型コロナウィルス感染症に対して罹患しにくい個人の内的要因、ならびにストレス耐性を明らかにすることで、医療従事者の適正配置に加え、今後の本症の対応に対し、より安全に対処可能な体制作りの実現を目的とした。",
        "方法": "末梢血より抽出したゲノムDNAを用いたアンプリコンシーケンス解析",
        "対象": "新型コロナウイルス感染者に濃厚接触したものの、罹患しなかった健常者：139名",
        "URL": "https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047878"
      },
      "分子データ": {
        "JGAS000562": {
          "対象": "健常者：139名",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "TMPRSS2、MxA、ACE2、IFNL3、IFNL4",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "PCRアンプリコンシーケンス（QIAseq Targeted DNA Custom Panel）",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000684",
          "総データ量": "7.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "川口 敦史",
        "所 属 機 関": "筑波大学 医学医療系 ウイルス学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0369.v1": {
          "Research ID": "hum0369.v1",
          "公開日": "2022/09/28",
          "内容": "NGS（Target Capture）",
          "description": "新型コロナウイルス感染者に濃厚接触したものの、新型コロナウイルスに罹患しなかった健常者139名の末梢血から抽出したDNAを用いた5遺伝子（TMPRSS2、MxA、ACE2、IFNL3、IFNL4）のTarget Capture Sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0369.v1",
      "DATA": {
        "JGAS000562": {
          "Data Set ID": "JGAS000562",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/28"
        }
      },
      "SUMMARY": {
        "Aims": "There have been cases of what appear to be nosocomial infections among healthcare workers at several hospitals. The infected healthcare workers were assumed to have contracted the disease through close contact with infected patients. However, we confirmed at each hospital that there were many healthcare workers who had apparently had closer contact with infected patients than the infected healthcare workers but had not contracted the disease. The purpose of this study was to clarify the internal factors that make individuals less susceptible to novel coronavirus infection and their stress tolerance and to establish a system that contributes to the appropriate allocation of healthcare workers and the creation of a system that can more safely deal with this disease in the future.",
        "Methods": "Amplicon sequencing was performed using genomic DNA purified from peripheral blood.",
        "Participants/Materials": "139 healthy individuals who had contacted patients infected with novel coronavirus but did not contract novel coronavirus",
        "URL": "https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047878"
      },
      "MOLECULAR DATA": {
        "JGAS000562": {
          "Participants/Materials": "139 healthy individuals",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "TMPRSS2, MxA, ACE2, IFNL3, and IFNL4",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "PCR amplicon sequencing (QIAseq Targeted DNA Custom Panel)",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000684",
          "Total Data Volume": "7.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Atsushi Kawaguchi",
        "Affiliation": "Division of Molecular Virology, Faculty of Medicine, University of Tsukuba",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Health, Labour and Welfare Sciences Research Grants for Special Research",
            "Title": "Study to establish protective measures for health care workers treating COVID-19 infections",
            "Project Number": "20CA2055"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0369.v1": {
          "Research ID": "hum0369.v1",
          "Release Date": "2022/09/28",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from peripheral blood cells of 139 healthy individuals who had contacted a person infected with novel coronavirus but who did not contract novel coronavirus were used for the target capture sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0368.v1": {
    "ja": {
      "NBDC Research ID": "hum0368.v1",
      "データ": {
        "JGAS000559": {
          "データID": "JGAS000559",
          "内容": "NGS（PBAT-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/11/29"
        }
      },
      "研究内容の概要": {
        "目的": "ICF（immunodeficiency, centromeric instability, facial anomaly）症候群は免疫不全、DNAの低メチル化を伴う染色体の不安定性、顔貌異常を特徴とする稀な先天性の常染色体潜性遺伝病である。これまでの研究により、ICF患者は原因遺伝子（DNMT3B、ZBTB24、CDCA７、もしくはHELLS）によって4つのsubtypeに分けられることが明らかにされている。しかしながら、依然、原因遺伝子が不明の患者が少数存在する。本研究ではそのような患者のうち１名の原因遺伝子がUHRF1であることを突き止め、この患者の末梢血細胞から抽出したDNAの全ゲノムメチル化解析を行い、当該患者に特徴的なDNAの低メチル化パターンを明らかにした。",
        "方法": "末梢血細胞からDNAを抽出し、Post-bisulfite adaptor-tagging（PBAT）法にてライブラリーを調整後、全ゲノム配列決定を行なうことで全シトシンのメチル化状態を決定した。",
        "対象": "ICF症候群1症例",
        "URL": "https://www.bioreg.kyushu-u.ac.jp/labo/epigenome/hitogenome.html"
      },
      "分子データ": {
        "JGAS000559": {
          "対象": "ICF症候群（ICD10：D800）：1症例",
          "規模": "PBAT-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血細胞から抽出したDNA（増幅なし）",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Post-Bisulfite Adaptor-Tagging（PBAT）法*1",
          "断片化の方法": "バイサルファイト処理",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000681",
          "総データ量": "46.4 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "鵜木 元香",
        "所 属 機 関": "九州大学生体防御医学研究所 エピゲノム制御学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "山田科学振興財団　研究援助",
            "タイトル": "セントロメア・ペリセントロメア反復配列の新たなDNAメチル化維持機構",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Novel compound heterozygous mutations in UHRF1 are associated with atypical immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome with distinctive genome-wide DNA hypomethylation.",
          "DOI": "doi: 10.1093/hmg/ddac291",
          "データID": "JGAD000681"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0368.v1": {
          "Research ID": "hum0368.v1",
          "公開日": "2022/11/29",
          "内容": "NGS（PBAT-seq）",
          "description": "ICF症候群1症例の末梢血から抽出したDNAを用いた全ゲノムバイサルファイトシークエンス解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0368.v1",
      "DATA": {
        "JGAS000559": {
          "Data Set ID": "JGAS000559",
          "Type of Data": "NGS (PBAT-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/11/29"
        }
      },
      "SUMMARY": {
        "Aims": "ICF (immunodeficiency, centromeric instability, facial anomaly) syndrome is a rare congenital autosomal recessive genetic disorder characterized by immunodeficiency, chromosomal instability with DNA hypomethylation, and facial anomalies. Previous studies have revealed that ICF patients can be divided into four subtypes according to their causative genes (DNMT3B, ZBTB24, CDCA7, or HELLS). However, there are still a few patients whose causative genes are unknown. In this study, we identified UHRF1 as a novel causative gene in one such patient and performed whole-genome bisulfite sequencing analysis of DNA extracted from peripheral blood cells of this patient to identify a DNA hypomethylation pattern characteristic of this patient.",
        "Methods": "DNA was extracted from peripheral blood cells, and prepared libraries by the post-bisulfite adaptor-tagging (PBAT) method. Then whole genome sequencing was performed and determined the methylation status of all cytosines.",
        "Participants/Materials": "ICF syndrome"
      },
      "MOLECULAR DATA": {
        "JGAS000559": {
          "Participants/Materials": "ICF syndrome (ICD10: D800) : 1 case",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from peripheral blood cells (Amplification-free)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Post-Bisulfite Adaptor-Tagging (PBAT)*1",
          "Fragmentation Methods": "Bisulfite Treatment",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000681",
          "Total Data Volume": "46.4 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Motoko Unoki",
        "Affiliation": "Division of Epigenomics and Development, Medical Institute of Bioregulation, Kyushu University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Yamada Science Foundation",
            "Title": "Novel DNA methylation maintenance mechanism for centromeric and pericentromeric repeats",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Novel compound heterozygous mutations in UHRF1 are associated with atypical immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome with distinctive genome-wide DNA hypomethylation.",
          "DOI": "doi: 10.1093/hmg/ddac291",
          "Data Set ID": "JGAD000681"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0368.v1": {
          "Research ID": "hum0368.v1",
          "Release Date": "2022/11/29",
          "Type of Data": "NGS (PBAT-seq)",
          "description": "DNAs extracted from peripheral blood cells of a patient with ICF syndrome were used for the whole genome bisulfite sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0367.v1": {
    "ja": {
      "NBDC Research ID": "hum0367.v1",
      "データ": {
        "JGAS000558": {
          "データID": "JGAS000558",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/21"
        }
      },
      "研究内容の概要": {
        "目的": "白血病に代表される造血器腫瘍は、未分化血液細胞にゲノムならびにエピゲノムの構造的・機能的異常が集積した結果発症する。しかしこれらの発生機序や発症に至る過程の詳細には未解明な点が多く、発症メカニズムに根ざした根本的治療法は確立されていない。そこで本研究では、血液疾患の病態形成に関わるゲノムならびにエピゲノムの異常を網羅的ゲノム解析の手法を用いて明らかにするとともに、その結果にもとづいて血液疾患の正確な診断、創薬に繋がる鍵分子を探索する事を目的とする。",
        "方法": "診断時に採取した骨髄検体（BM）およびリンパ節検体（LN）から抽出したDNAを対象に、Human Myeloid Neoplasms QIAseq Targeted DNA Panelを使用した骨髄性造血器腫瘍に関連する遺伝子変異の有無の検討。",
        "対象": "ランゲルハンス細胞組織球症（Langerhans cell histiocytosis：LCH）1症例"
      },
      "分子データ": {
        "JGAS000558": {
          "対象": "LCH（ICD10：C96.6）：1症例\r\n    骨髄、リンパ節：各1検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "Human Myeloid Neoplasms QIAseq Targeted DNA Panel",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "BMおよびLNから抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "PCRアンプリコンシーケンス（Human Myeloid Neoplasms QIAseq Targeted DNA Panel）",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "250 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000680",
          "総データ量": "736.7 MB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "東條 有伸",
        "所 属 機 関": "東京大学 医科学研究所附属病院 血液腫瘍内科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Case report: Common clonal origin of concurrent Langerhans cell histiocytosis and acute myeloid leukemia",
          "DOI": "doi: 10.3389/fonc.2022.974307",
          "データID": "JGAD000680"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0367.v1": {
          "Research ID": "hum0367.v1",
          "公開日": "2021/09/21",
          "内容": "NGS（Target Capture）",
          "description": "ランゲルハンス細胞組織球症1症例の骨髄およびリンパ節から抽出したDNAを対象に、Human Myeloid Neoplasms QIAseq Targeted DNA Panelを使用したTarget Capture Sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0367.v1",
      "DATA": {
        "JGAS000558": {
          "Data Set ID": "JGAS000558",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/09/21"
        }
      },
      "SUMMARY": {
        "Aims": "Hematopoietic malignancies such as leukemia develop as a result of the accumulation of structural and functional abnormalities in the genome and epigenome in the originating undifferentiated hematopoietic stem and progenitor cells. However, the details of the pathogenesis and the processes leading to the onset of these disorders remain unresolved, and fundamental treatments based on the pathogenic mechanisms have not been established. In this study, we aim to clarify the genomic and epigenomic abnormalities involved in the pathogenesis of hematological diseases using comprehensive genomic analysis and to search for key molecules that will lead to accurate diagnosis and drug discovery for hematological diseases based on the mechanisms.",
        "Methods": "DNAs extracted from bone marrow (BM) and lymph node (LN) samples at the time of diagnosis were subjected to a target capture sequencing analysis by using the Human Myeloid Neoplasms QIAseq Targeted DNA Panel.",
        "Participants/Materials": "Langerhans cell histiocytosis (LCH)"
      },
      "MOLECULAR DATA": {
        "JGAS000558": {
          "Participants/Materials": "LCH (ICD10: C96.6): 1 case\r\n    BM and LN: 1 sample each",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "Human Myeloid Neoplasms QIAseq Targeted DNA Panel",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNAs extracted from BM and LN",
          "Cell Lines": "-",
          "Library Construction (kit name)": "PCR amplicon sequencing (Human Myeloid Neoplasms QIAseq Targeted DNA Panel)",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "250 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000680",
          "Total Data Volume": "736.7 MB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Arinobu Tojo",
        "Affiliation": "Department of Hematology/Oncology, Institute of Medical Science, University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia",
          "DOI": "doi: 10.3389/fonc.2022.974307",
          "Data Set ID": "JGAD000680"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0367.v1": {
          "Research ID": "hum0367.v1",
          "Release Date": "2021/09/21",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from bone marrow and lymph node of a patient with Langerhans cell histiocytosis were used for the target capture sequencing analysis (Human Myeloid Neoplasms QIAseq Targeted DNA Panel). Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0366.v1": {
    "ja": {
      "NBDC Research ID": "hum0366.v1",
      "データ": {
        "E-GEAD-551": {
          "データID": "E-GEAD-551",
          "内容": "NGS（scRNA-seq）",
          "制限": "非制限公開",
          "公開日": "2023/03/16"
        },
        "E-GEAD-552": {
          "データID": "E-GEAD-552",
          "内容": "NGS（RNA-seq）\r\nNGS（ATAC-seq）",
          "制限": "非制限公開",
          "公開日": "2023/03/16"
        }
      },
      "研究内容の概要": {
        "目的": "新型コロナウイルス感染症（COVID-19）の病態生理及びコロナワクチン接種後の免疫動態を解析し、臨床分野での応用を目指す。",
        "方法": "single cell RNA-seq：COVID-19患者16症例（ARDS合併；8症例、ARDS非合併；8症例）と対照健常者5名の末梢血単核球をシングルセルRNA sequenceで解析。",
        "対象": "single cell RNA-seq: COVID-19患者: 16症例（ARDS合併；8例、ADRS非合併；8例）、対照健常者: 5名"
      },
      "分子データ": {
        "scRNA-seq": {
          "対象": "COVID-19患者 （ICD10：U07.1）：16症例\r\n    ARDS合併：8症例\r\n    ARDS非合併：8症例\r\n対照健常者：5名",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血単核細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Next GEM Single Cell 5′ Library & Gel Bead Kit v1.1、Chromium Next GEM Chip G Single Cell Kit、Single Index Kit T Set A",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "Read1：26 bp\r\nRead2：91 bp",
          "マッピング方法": "STAR",
          "リファレンス配列": "GRCh38",
          "リードカウント決定アルゴリズム（ソフトウェア）": "dropEst",
          "フィルタリング（QC）方法": "UMI値が1,000未満または20,000以上の細胞、およびミトコンドリア遺伝子またはヘモグロビン遺伝子からのリードが10%以上含まれる細胞はlow qualityと判断し、解析から除外した。また、各サンプル毎にScrubletを用いて、推定ダブレットを除去した。",
          "遺伝子数": "24,541 genes",
          "Genomic Expression Archive ID": "E-GEAD-551",
          "総データ量": "2.3495 GB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "健常者：4名（各4検体）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血単核細胞由来の単球から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Nextera XT DNA Library Preparation Kit",
          "断片化の方法": "Tagmentation（Nextera XT DNA Library Preparation Kit）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "マッピング方法": "HISAT2",
          "リファレンス配列": "hg38",
          "リードカウント決定アルゴリズム（ソフトウェア）": "featureCounts（version 1.6.3）",
          "フィルタリング（QC）方法": "Trimmomatic software（version 0.38）を用いて、Low-quality（<20）塩基とアダプター配列を除去した。（設定パラメータは以下の通り: ILLUMINACLIP: path/to/adapter.fa:2:30:10 LEADING:20 TRAILING:20 SLIDINGWINDOW:4:15 MINLEN:36）",
          "遺伝子数": "31,706 genes",
          "Genomic Expression Archive ID": "E-GEAD-552",
          "総データ量": "2.3495 GB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ATAC-seq": {
          "対象": "健常者：5名（各4検体ないしは5検体）",
          "規模": "ATAC-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血単核細胞由来の単球から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "ATAC-Seq Kit",
          "断片化の方法": "Tagmentation（ATAC-Seq Kit）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "Bowtie2",
          "リファレンス配列": "hg38",
          "オープンクロマチン領域決定アルゴリズム（ソフトウェア）": "featureCounts（version 1.6.3）",
          "フィルタリング（QC）方法": "Trimmomatic software（version 0.38）を用いて、Low-quality（<20）塩基とアダプター配列を除去した。（設定パラメータは以下の通り: ILLUMINACLIP: path/to/adapter.fa:2:30:10 LEADING:20 TRAILING:20 SLIDINGWINDOW:4:15 MINLEN:36）",
          "peak数": "33548 peaks",
          "Genomic Expression Archive ID": "E-GEAD-552",
          "総データ量": "2.3495 GB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "加藤 保宏",
        "所 属 機 関": "大阪大学大学院医学系研究科 呼吸器・免疫内科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells",
          "DOI": "doi: 10.1172/jci.insight.163347",
          "データID": "E-GEAD-551E-GEAD-552"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0366.v1": {
          "Research ID": "hum0366.v1",
          "公開日": "2023/03/16",
          "内容": "NGS（scRNA-seq、RNA-seq、ATAC-seq）",
          "description": "mRNAワクチンを接種した健常者ならびにCOVID-19感染者の末梢血単核球から抽出したDNA/RNAを用いたscRNA-seq、RNA-seq、ATAC-seq解析のリードカウントデータおよびオープンクロマチン領域データを提供する（txt）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0366.v1",
      "DATA": {
        "E-GEAD-551": {
          "Data Set ID": "E-GEAD-551",
          "Type of Data": "NGS (scRNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/03/16"
        },
        "E-GEAD-552": {
          "Data Set ID": "E-GEAD-552",
          "Type of Data": "NGS (RNA-seq)\r\nNGS (ATAC-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/03/16"
        }
      },
      "SUMMARY": {
        "Aims": "To analyze the immune response to the mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and pathophysiology of the coronavirus disease 2019 (COVID-19) and to provide insights into the clinical development.",
        "Methods": "single cell RNA-seq: Peripheral blood mononuclear cells from COVID-19 patients (with ARDS, n=8; without ARDS, n=8) and healthy controls (n=5) were analyzed by single cell RNA sequence.",
        "Participants/Materials": "single cell RNA-seq: patients with COVID-19 (with ARDS, n=8; without ADRS, n=8), healthy subjects (n=5)"
      },
      "MOLECULAR DATA": {
        "scRNA-seq": {
          "Participants/Materials": "COVID-19 (ICD10: U07.1): 16 cases\r\n    patients with ARDS: 8 cases\r\n    patients without ARDS: 8 cases\r\nhealthy subjects : 5 individuals",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from a single cell isolated from PBMCs",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Next GEM Single Cell 5′ Library & Gel Bead Kit v1.1, Chromium Next GEM Chip G Single Cell Kit, Single Index Kit T Set A",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "Read1: 26 bp\r\nRead2: 91 bp",
          "Mapping Methods": "STAR",
          "Reference Genome Sequence": "GRCh38",
          "Detecting method for read count (software)": "dropEst",
          "QC Methods": "Cells with less than 1,000 UMIs or more than 20,000 UMIs, and cells containing more than 10% reads from mitochondrial or hemoglobin genes, were filtered. Furthermore, for each sample, doublets identified by Scrublet were removed.",
          "Gene Number": "24,541 genes",
          "Genomic Expression Archive ID": "E-GEAD-551",
          "Total Data Volume": "2.3495 GB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "healthy subjects : 4 individuals (4 samples each)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "Total RNA extracted from monocytes derived from PBMCs",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Nextera XT DNA Library Preparation Kit",
          "Fragmentation Methods": "Tagmentation (Nextera XT DNA Library Preparation Kit)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Mapping Methods": "HISAT2",
          "Reference Genome Sequence": "hg38",
          "Detecting method for read count (software)": "featureCounts (version 1.6.3)",
          "QC Methods": "Low-quality (<20) bases and adaptor sequences were trimmed with Trimmomatic software (version 0.38) with the following parameters: ILLUMINACLIP: path/to/adapter.fa:2:30:10 LEADING:20 TRAILING:20 SLIDINGWINDOW:4:15 MINLEN:36.",
          "Gene Number": "31,706 genes",
          "Genomic Expression Archive ID": "E-GEAD-552",
          "Total Data Volume": "2.3495 GB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "ATAC-seq": {
          "Participants/Materials": "healthy subjects : 5 individuals (4 or 5 samples each)",
          "Targets": "ATAC-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNA extracted from monocytes derived from PBMCs",
          "Cell Lines": "-",
          "Library Construction (kit name)": "ATAC-Seq Kit",
          "Fragmentation Methods": "Tagmentation (ATAC-Seq Kit)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "Bowtie2",
          "Reference Genome Sequence": "hg38",
          "Detecting method for open chromatin region (software)": "featureCounts (version 1.6.3)",
          "QC Methods": "Low-quality (<20) bases and adaptor sequences were trimmed with Trimmomatic software (version 0.38) with the following parameters: ILLUMINACLIP: path/to/adapter.fa:2:30:10 LEADING:20 TRAILING:20 SLIDINGWINDOW:4:15 MINLEN:36.",
          "Peak Number": "33548 peaks",
          "Genomic Expression Archive ID": "E-GEAD-552",
          "Total Data Volume": "2.3495 GB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yasuhiro Kato",
        "Affiliation": "Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells",
          "DOI": "doi: 10.1172/jci.insight.163347",
          "Data Set ID": "E-GEAD-551E-GEAD-552"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0366.v1": {
          "Research ID": "hum0366.v1",
          "Release Date": "2023/03/16",
          "Type of Data": "NGS (scRNA-seq, RNA-seq, ATAC-seq)",
          "description": "DNA/RNA extracted from PBMCs of COVID-19 patients and healthy subjects vaccinated with mRNA vaccine were used for scRNA-seq, RNA-seq, and ATAC-seq analyses. The read count data and open chromatin region data (text file) are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0365.v1": {
    "ja": {
      "NBDC Research ID": "hum0365.v1",
      "データ": {
        "JGAS000569": {
          "データID": "JGAS000569",
          "内容": "NGS（CAGE-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/06/09"
        }
      },
      "研究内容の概要": {
        "目的": "糖尿病は高齢者における主要な疾患であり、心筋梗塞・脳卒中のリスクが増大することにより日本人の健康寿命を短縮する原因となっている。最近、肥満や2型糖尿病といった生活習慣病と腸内細菌との関連が動物やヒトで報告されている。そこで本研究では、東京大学検診センターの受診者から血液、便、唾液を採取し、次世代シーケンサーによりメタゲノム解析を行い、腸内細菌叢やその遺伝子構成の特徴を明らかにする。更に、メタボローム解析や血液を用いたトランスクリプトーム解析を行い、宿主代謝物や遺伝子発現の変化を明らかにする。これら包括的オミクス解析から得られた宿主および細菌由来情報と、検診項目に含まれる代謝パラメーターを比較することで、腸内細菌が肥満・2型糖尿病・メタボリックシンドロームといった生活習慣病の予測因子になりうるかについて検討する。",
        "方法": "東京大学検診センター人間ドックの受診者の末梢血単核細胞を分離後、抽出したRNAを用いたCAGE-seq解析",
        "対象": "東京大学検診センター人間ドックの受診者298名（健常者103名、肥満者98名、耐糖能異常者97名）"
      },
      "分子データ": {
        "JGAS000569": {
          "対象": "健常者：103名\r\n肥満症（ICD10：E669）：98症例\r\n耐糖能異常（ICD10：E11、R730）：97症例",
          "規模": "CAGE-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Hiseq 2500]",
          "ライブラリソース": "末梢血単核球より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "dual index nanoCAGE protocolに従い作製（Salimulla et al. 2011, Cold Spring Harbor Protocols）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "マッピング方法": "BWA version 0.5.9",
          "マッピングクオリティ": "rDNAと低クオリティリードはMOIRAI pipelineを用いて除去（Hasegawa et al., BMC Bioinformatics 2014）",
          "マッピングの際のリファレンス配列": "hg38",
          "平均カバー率（Depth）": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000695",
          "総データ量": "457.2 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "大野 博司",
        "所 属 機 関": "理化学研究所 生命医科学研究センター 粘膜システム研究チーム",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "小野医学研究財団研究奨励助成",
            "タイトル": "2型糖尿病の肝臓におけるpathogenic paradoxの解明 -肝臓特異的IRS-1･IRS-2欠損マウスを用いて-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Gut microbial carbohydrate metabolism contributes to insulin resistance",
          "DOI": "doi: 10.1038/s41586-023-06466-x",
          "データID": "JGAD000695"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0365.v1": {
          "Research ID": "hum0365.v1",
          "公開日": "2023/06/09",
          "内容": "NGS（CAGE-seq）",
          "description": "東京大学検診センター人間ドックの受診者298名（健常者103名、肥満者98名、耐糖能異常者97名）の末梢血単核球より抽出したRNAを用いたCAGE-seqデータをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0365.v1",
      "DATA": {
        "JGAS000569": {
          "Data Set ID": "JGAS000569",
          "Type of Data": "NGS (CAGE-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/06/09"
        }
      },
      "SUMMARY": {
        "Aims": "Diabetes is a major disease in the elderly and is responsible for an increased risk of myocardial infarction and stroke. Recently, the relationship between microbiota and diabetes has been reported in animals and humans. In this study, blood, stool, and saliva samples were collected from examinees at the University of Tokyo Health Screening Center, and 16S rRNA and metagenomic analyses were performed to determine the variation of microbiota. Furthermore, metabolome and transcriptome analyses using blood were performed to reveal changes in host metabolites and gene expression. By comparing the host- and bacteria-derived information with the metabolic parameters, we analyzed whether microbiota can be a predictor of metabolic diseases.",
        "Methods": "RNAs were extracted from peripheral blood mononuclear cells and used for CAGE-seq analysis.",
        "Participants/Materials": "298 individuals (including 103, 98, and 97 individuals from normoglycemic lean, obese, and prediabetic groups, respectively) underwent their annual health check-up at the University of Tokyo Hospital."
      },
      "MOLECULAR DATA": {
        "JGAS000569": {
          "Participants/Materials": "normoglycemic individuals: 103 cases\r\nobese (ICD10: E669): 98 cases\r\npre-diabetes (ICD10: E11, R730): 97 cases",
          "Targets": "CAGE-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Hiseq 2500]",
          "Library Source": "RNAs extracted from peripheral blood mononuclear cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "dual index nanoCAGE protocol (Salimulla et al. 2011, Cold Spring Harbor Protocols)",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "Mapping Methods": "BWA version 0.5.9",
          "Mapping Quality": "rDNA and low quality read filtering with MOIRAI pipeline (Hasegawa et al., BMC Bioinformatics 2014)",
          "Reference Genome Sequence": "hg38",
          "Coverage (Depth)": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000695",
          "Total Data Volume": "457.2 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroshi Ohno",
        "Affiliation": "Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "ONO Medical Research Foundation",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Gut microbial carbohydrate metabolism contributes to insulin resistance",
          "DOI": "doi: 10.1038/s41586-023-06466-x",
          "Data Set ID": "JGAD000695"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0365.v1": {
          "Research ID": "hum0365.v1",
          "Release Date": "2023/06/09",
          "Type of Data": "NGS (CAGE-seq)",
          "description": "RNAs were extracted from peripheral blood mononuclear cells of 298 individuals (including 103, 98, and 97 individuals from normoglycemic lean, obese, and prediabetic groups, respectively) and were used for CAGE-seq analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0364.v1": {
    "ja": {
      "NBDC Research ID": "hum0364.v1",
      "データ": {
        "hum0364.v1.wgs-ms.v1": {
          "データID": "hum0364.v1.wgs-ms.v1",
          "内容": "NGS（WGS）",
          "制限": "非制限公開",
          "公開日": "2022/08/29"
        }
      },
      "研究内容の概要": {
        "目的": "次世代シークエンス技術（NGS）により全ゲノムシーケンス（WGS）解析が可能になり、一塩基変異、挿入・欠失、コピー数変異、構造変異などの遺伝子変異を同定できるようになった。 しかし、リード長が短く、リピート領域でのシーケンスエラー率が高いため、マイクロサテライト（MS）領域の変異や多型の同定は困難であった。本研究では、ヒトのMS多型の全容を明らかにするため、公開されている2つの大規模なヒトゲノムシーケンスデータセット（Simons Genome Diversity Project [SGDP]、Human Genome Diversity Project [HGDP]）および縄文人の全ゲノムデータについて、以前開発したMS検出法（MIVcall法）を用いて約900万個のMS領域の解析を行った。",
        "方法": "MIVcall法を用いたMS多型の検出",
        "対象": "非制限公開されているWGS解析データをダウンロードし、データの質の評価をクリアしたSGDP 276サンプル、 HGDP 693サンプル、縄文人 1サンプル（全て健常者由来）",
        "URL": "http://www.humgenet.m.u-tokyo.ac.jp"
      },
      "分子データ": {
        "hum0364.v1.wgs-ms.v1": {
          "対象": "非制限公開されているヒトのWGS解析データ（健常者）\r\n  SGDP：276名\r\n  HGDP：693名\r\n  縄文人：１名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "-",
          "ソース": "非制限公開されているSGDP、HGDP、縄文人のWGS解析データ（NGS）",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "-",
          "断片化の方法": "-",
          "ライブラリ構築方法": "-",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "-",
          "クオリティコントロール方法": "10本未満のリードで覆われているMSは深度不足とした。全MSのうち深度不足が4%以上のサンプルは解析から除いた。",
          "重複するリードの除去": "SGDPやHGDPにより行われた。本研究では公開されているbamファイルを用いた。",
          "リアライメントおよびベースクオリティのキャリブレーション": "SGDPやHGDPにより行われた。本研究では公開されているbamファイルを用いた。",
          "マッピング方法": "SGDPやHGDPにより行われた。本研究では公開されているbamファイルを用いた。",
          "マッピングクオリティ": "20以上のリードを用いた。",
          "マッピングの際のリファレンス配列": "GRCh37",
          "平均カバー率（Depth）": "MSをカバーしていたリード数の平均　31.7 （HGDPおよびSGDP）、30.4 （Funadomari）",
          "変異検出方法": "MIVcall法",
          "MS数（QC後）": "733900（常染色体）",
          "NBDC Dataset ID": "hum0364.v1.wgs-ms.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nREADME",
          "総データ量": "9.37 GB（vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "藤本 明洋",
        "所 属 機 関": "​東京大学大学院 医学系研究科 人類遺伝学教室",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "国立研究開発法人日本医療研究開発機構（AMED）　ゲノム医療実現推進プラットフォーム事業",
            "タイトル": "先進的シークエンス情報解析技術基盤の開発",
            "研究課題番号": "JP20km0405207"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0364.v1": {
          "Research ID": "hum0364.v1",
          "公開日": "2022/08/29",
          "内容": "WGSのMS解析",
          "description": "非制限公開されているSimons Genome Diversity Project（SGDP）276サンプル、Human Genome Diversity Project（HGDP）693サンプル、縄文人1サンプル（F23）のWGS解析データについて、MIVcall法を用いて検出した733900個のマイクロサテライト（MS）多型情報をvcfファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0364.v1",
      "DATA": {
        "hum0364.v1.wgs-ms.v1": {
          "Data Set ID": "hum0364.v1.wgs-ms.v1",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/08/29"
        }
      },
      "SUMMARY": {
        "Aims": "Next generation sequencing technologies (NGS) enable whole genome sequencing (WGS) analysis. In the past decade, applications of NGS and the development of algorithms for the analysis have successfully identified various types of genetic variations. However, due to the short read length and the high sequencing error rate in repeat regions, the identification of mutations and polymorphisms in microsatellite (MS) regions has been difficult. In this study, we analyzed approximately nine million MS regions using a previously developed MS caller (MIVcall) for three large publicly available human genome sequencing data sets: Simons Genome Diversity Project (SGDP), and Human Genome Diversity Project (HGDP).",
        "Methods": "MS regions were detected by MIVcall method",
        "Participants/Materials": "Publicly available whole genome sequencing data of healthy individuals were downloaded and used for MS analysis. After evaluating the quality of the data, we analyzed 276 samples from SGDP, 693 from HGDP, and one Jomon Individual (F23).",
        "URL": "http://www.humgenet.m.u-tokyo.ac.jp/index.en.html"
      },
      "MOLECULAR DATA": {
        "hum0364.v1.wgs-ms.v1": {
          "Participants/Materials": "Publicly available WGS data of healthy individuals\r\n   SGDP: 276 samples\r\n   HGDP: 693 samples\r\n   Jomon people: 1 sample",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "-",
          "Library Source": "Publicly available WGS data: SGDP, HGDP, Jomon",
          "Cell Lines": "-",
          "Library Construction (kit name)": "-",
          "Fragmentation Methods": "-",
          "Spot Type": "-",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "-",
          "QC/Filtering Methods": "MS covered by less than ten reads were considered insufficient depth, and we excluded samples if more than 4% had insufficient depth of MS.",
          "Deduplication": "Bam files generated by SGDP and HGDP project were used in this study.",
          "Mapping Methods": "Bam files generated by SGDP and HGDP project were used in this study.",
          "Reference Genome Sequence": "GRCh37",
          "Coverage (Depth)": "The average numbers of reads of MS were 31.7 in HGDP and SGDP combined, and 27.1 in F23.",
          "Detecting Methods for Variation": "MIVcall method",
          "Detecting Methods for Structural Variation": "-",
          "SNV Numbers (after QC)": "-",
          "SV Numbers (after QC)": "733900 (Polymorphic MS in the autosome)",
          "NBDC Dataset ID": "hum0364.v1.wgs-ms.v1\r\n(Click the Dataset ID to download the file)\r\nREADME",
          "Total Data Volume": "9.37 GB (vcf)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Akihiro Fujimoto",
        "Affiliation": "School of Integrated Health Sciences, Faculty of Medicine, The University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Platform Program for Promotion of Genome Medicine, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Development of advanced data analysis methods for genome sequencing",
            "Project Number": "JP20km0405207"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0364.v1": {
          "Research ID": "hum0364.v1",
          "Release Date": "2022/08/29",
          "Type of Data": "WGS",
          "description": "Whole genome sequencing data (Simons Genome Diversity Project [SGDP], Human Genome Diversity Project [HGDP], Jomon Individual) were downloaded and used for MS analysis by using of MIVcall method. Individual MS data are provided as a vcf file.\nNote：\n"
        }
      }
    }
  },
  "hum0360.v1": {
    "ja": {
      "NBDC Research ID": "hum0360.v1",
      "データ": {
        "JGAS000546": {
          "データID": "JGAS000546",
          "内容": "NGS（scRNA-seq、scVDJ-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/12/21"
        }
      },
      "研究内容の概要": {
        "目的": "日本国内でのCOVID-19罹患者から得られた検体を用いた研究により、その病態をシングルセルレベルで明らかにすること",
        "方法": "COVID-19罹患者の血液試料から分離されたPBMCを用いた、シングルセル解析",
        "対象": "COVID-19罹患者から採取した末梢血"
      },
      "分子データ": {
        "JGAS000546": {
          "対象": "COVID-19罹患者 （ICD10：U07.1）：6症例（8検体）\r\n    4症例：入院日あるいは翌日に採血\r\n    2症例：入院日あるいは翌日＋退院後に採血",
          "規模": "scRNA-seqおよびscVDJ-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血単核球（PBMC）より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Next GEM Single Cell V(D)J Reagent Kits",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "scRNA-seq：91 bp\r\nscVDJ-seq：91 bp、90 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000665",
          "総データ量": "342.2 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "立川 愛",
        "所 属 機 関": "国立感染症研究所 エイズ研究センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 新興・再興感染症に対する革新的医薬品等開発推進研究事業",
            "タイトル": "病理学的アプローチによる先天性感染症・原因不明感染症診断法の開発",
            "研究課題番号": "JP19fk0108104"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan",
          "DOI": "doi: 10.1038/s41598-023-28696-9",
          "データID": "JGAD000665"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0360.v1": {
          "Research ID": "hum0360.v1",
          "公開日": "2022/12/21",
          "内容": "NGS（scRNA-seq、scVDJ-seq）",
          "description": "COVID-19罹患者6名の末梢血単核球（PBMC）から抽出したRNAを用いたscRNA-seq解析ならびにscVDJ-seq解析の結果をfastqファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0360.v1",
      "DATA": {
        "JGAS000546": {
          "Data Set ID": "JGAS000546",
          "Type of Data": "NGS (scRNA-seq, scVDJ-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/12/21"
        }
      },
      "SUMMARY": {
        "Aims": "To understand the mechanism of the pathogenesis of COVID-19 at the single-cell level",
        "Methods": "Single-cell analyses were performed using PBMCs from COVID-19 patients.",
        "Participants/Materials": "Blood samples from COVID-19 patients"
      },
      "MOLECULAR DATA": {
        "JGAS000546": {
          "Participants/Materials": "COVID-19 (ICD10: U07.1): 6 cases (8 samples)\r\n    4 cases: blood samples collected on the day or the next day of admission\r\n    2 cases: blood samples collected on the day or the next day of admission + after discharge",
          "Targets": "scRNA-seq and scVDJ-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from PBMCs",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Next GEM Single Cell V(D)J Reagent Kits",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "scRNA-seq: 91 bp\r\nscVDJ-seq: 91 bp, 90 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000665",
          "Total Data Volume": "342.2 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Ai Tachikawa",
        "Affiliation": "AIDS Research Center, National Institute of Infectious Diseases",
        "Project / Group Name": "　-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Research Program on Emerging and Re-emerging Infectious Diseases, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Development of pathological diagnostic methods for congenital infections and unexplained illness of possible infectious etiology",
            "Project Number": "JP19fk0108104"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan",
          "DOI": "doi: 10.1038/s41598-023-28696-9",
          "Data Set ID": "JGAD000665"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0360.v1": {
          "Research ID": "hum0360.v1",
          "Release Date": "2022/12/21",
          "Type of Data": "NGS (scRNA-seq, scVDJ-seq)",
          "description": "RNAs extracted from PBMCs from COVID-19 patients were used for the single-cell RNA sequencing and single-cell VDJ sequencing analyses. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0359.v1": {
    "ja": {
      "NBDC Research ID": "hum0359.v1",
      "データ": {
        "JGAS000548": {
          "データID": "JGAS000548",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/08/01"
        }
      },
      "研究内容の概要": {
        "目的": "T/NK細胞リンパ腫の病態は不均一かつ複雑であり、比較的稀な疾患であることから、最適な治療が確立されていない。T/NK細胞リンパ腫に生じるゲノム異常、エピゲノム異常、遺伝子発現異常を包括的に解析することで、その病態を明らかにするだけでなく、特徴ある疾患単位、新たな分子標的、予後予測因子を同定できる可能性がある。本研究では、T/NK細胞リンパ腫のゲノム、エピゲノム、遺伝子発現を包括的に解析し、病理組織像、病型、予後などとの関連を検討することで、その分子病態を明らかにする。",
        "方法": "腫瘍（リンパ腫）組織のTargeted DNA sequencing解析",
        "対象": "節外性NK/T細胞リンパ腫（鼻型）症例"
      },
      "分子データ": {
        "JGAS000548": {
          "対象": "節外性NK/T細胞リンパ腫・鼻型（ICD10：C86.0）：67症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "ARID1A、ASXL3、BCOR、CDKN2A、DDX3X、DNMT3A、ECSIT、EP300、FAT4、HDAC9、 IDH1、IDH2、 JAK1、JAK2、JAK3、KMT2C、KMT2D、MGA、MSN、NRAS、STAT1、 STAT3、STAT5A、STAT5B、 STAT6、TET1、TET2、TET3、TP53",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "xGen Prism DNA Library Prep Kit",
          "断片化の方法": "超音波断片化 （Covaris M220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "142 bp",
          "マッピング方法": "CLC Genomics Workbench version 21",
          "マッピングクオリティ": "-",
          "マッピングの際のリファレンス配列": "hg19",
          "平均カバー率（Depth）": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000668",
          "総データ量": "10.6 GB （bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "大石 直輝",
        "所 属 機 関": "山梨大学 大学院総合研究部医学域人体病理学講座",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "黒住医学研究振興財団・研究助成金",
            "タイトル": "節外性NK/T細胞リンパ腫の予後を効率よく層別化できる病理学的スキームの開発",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genetic and immunohistochemical profiling of NK/T-cell Lymphomas reveals prognostically relevant BCOR-MYC association",
          "DOI": "doi: 10.1182/bloodadvances.2022007541",
          "データID": "JGAD000668"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0359.v1": {
          "Research ID": "hum0359.v1",
          "公開日": "2022/08/01",
          "内容": "NGS（Target Capture）",
          "description": "節外性NK/T細胞リンパ腫（鼻型）症例の腫瘍組織より抽出したDNAを用いた29遺伝子のTarget Capture Sequencing解析データをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0359.v1",
      "DATA": {
        "JGAS000548": {
          "Data Set ID": "JGAS000548",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/07/01"
        }
      },
      "SUMMARY": {
        "Aims": "The pathogenesis of T/NK cell lymphoma is heterogeneous and complex, and optimal treatment has not been established, partly because the disease is relatively rare. Comprehensive analysis of genomic, epigenomic, and gene expression abnormalities occurring in T/NK cell lymphomas may not only clarify the pathogenesis of the disease, but also identify distinctive disease units, new molecular targets, and prognostic factors. In this study, we will comprehensively analyze the genome, epigenome, and gene expression of T/NK cell lymphoma, and clarify the molecular pathogenesis of the disease by examining the relationship with histopathology, disease type, and prognosis.",
        "Methods": "Targeted DNA sequencing of tumor (lymphoma) tissues",
        "Participants/Materials": "Extranodal NK/T-cell lymphoma, nasal type"
      },
      "MOLECULAR DATA": {
        "JGAS000548": {
          "Participants/Materials": "Extranodal NK/T-cell lymphoma, nasal type (ICD10: C86.0): 67 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "ARID1A, ASXL3, BCOR, CDKN2A, DDX3X, DNMT3A, ECSIT, EP300, FAT4, HDAC9, IDH1, IDH2, JAK1, JAK2, JAK3, KMT2C, KMT2D, MGA, MSN, NRAS, STAT1, STAT3, STAT5A, STAT5B, STAT6, TET1, TET2, TET3, TP53",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "xGen Prism DNA Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris M220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "142 bp",
          "Mapping Methods": "CLC Genomics Workbench version 21",
          "Mapping Quality": "-",
          "Reference Genome Sequence": "hg19",
          "Coverage (Depth)": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000668",
          "Total Data Volume": "10.6 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Naoki Oishi",
        "Affiliation": "Department of Pathology, University of Yamanashi",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Kurozumi Medical Foundation",
            "Title": "Development of Molecular-based Pathologic Prognostic Stratification for Extranodal NK/T cell lymphoma, Nasal Type",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genetic and immunohistochemical profiling of NK/T-cell Lymphomas reveals prognostically relevant BCOR-MYC association",
          "DOI": "doi: 10.1182/bloodadvances.2022007541",
          "Data Set ID": "JGAD000668"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0359.v1": {
          "Research ID": "hum0359.v1",
          "Release Date": "2022/08/01",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from tumor tissues of patients with extranodal NK/T-cell lymphoma (nasal type) were used for the target capture sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0358.v2": {
    "ja": {
      "NBDC Research ID": "hum0358.v2",
      "データ": {
        "JGAS000582\r\nJGAS000586": {
          "データID": "JGAS000582\r\nJGAS000586",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/12/20"
        },
        "JGAS000640": {
          "データID": "JGAS000640",
          "内容": "NGS（RNA-seq、scRNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/10/19"
        }
      },
      "研究内容の概要": {
        "目的": "現在、子宮頸部腺がんのような治療抵抗性の悪性腫瘍の発生及び予後決定に関わる明確な因子は同定されていない。本研究において、子宮頸部腺がんの分子生物学的特徴を、その他の子宮頸がん（扁平上皮がん）や腟・ 外陰部がんの発がんの分子生物学的特徴と対比した上で、子宮頸部腺がんの発生や予後決定に関わる分子マーカーを同定する。子宮頸部扁平上皮がんの中には若年発症かつ予後不良のがんも存在し、子宮頸部小細胞がんも進行が速く予後不良であることから、診断法・治療法の確立は急務である。",
        "方法": "全エクソン解析、RNAシークエンス解析、シングルセルRNAシークエンス解析",
        "対象": "子宮頸がん19＋4症例、NIKS18細胞株"
      },
      "分子データ": {
        "Exome": {
          "対象": "子宮頸がん（ICD10：C539）\r\n   【JGAS000582】4症例：腫瘍組織（8検体）・末梢血もしくは腫瘍近傍の正常組織（4検体）\r\n   【JGAS000586】1症例：腫瘍組織・腫瘍組織由来オルガノイド・末梢血の3検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織、腫瘍組織由来オルガノイド、末梢血もしくは腫瘍周辺正常組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Twist Comprehenive exome",
          "断片化の方法": "超音波断片化 （Covaris S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "bwa、bowtie2",
          "マッピングクオリティ": "30以上",
          "マッピングの際のリファレンス配列": "hg38",
          "平均カバー率（Depth）": "168x（39x - 318x）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000708\r\nJGAD000713",
          "総データ量": "JGAD000708：76 GB（bam）\r\nJGAD000713：25.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "子宮頸がん（ICD10：C539）\r\n   【JGAS000582】5症例：同一腫瘍内複数検体（77検体）\r\n   【JGAS000586】1症例：腫瘍組織・腫瘍由来オルガノイドの2検体\r\n   【JGAS000586】13症例：腫瘍組織（13検体）\r\n   【JGAS000640】3症例：正常子宮頸部由来オルガノイド（各1検体ずつ計3検体）\r\n   【JGAS000640】1症例：正常子宮頸部マイクロダイセクションで取得した非腫瘍組織（4検体）\r\n \r\nNIKS18細胞株\r\n   【JGAS000640】 siRNAで NPM3をノックダウン（siNPM3）：2検体\r\n   【JGAS000640】 siRNAのnegative controlでノックダウン（siNC）：3検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "腫瘍組織、非腫瘍組織、腫瘍組織および正常子宮頸部由来オルガノイド、ならびに細胞株由来検体から抽出したRNA",
          "検体情報（購入の場合）": "NIKS18:ヒトケラチノサイト細胞株NIKS（ATCC CRL-12191）にHPV18エピゾームを導入した細胞株",
          "ライブラリ作製方法（キット名）": "Nextera XT DNA Library Preparation Kit",
          "断片化の方法": "Nextera XT transposome",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000708\r\nJGAD000713\r\nJGAD000770",
          "総データ量": "JGAD000708：76 GB（bam）\r\nJGAD000713：25.5 GB（fastq）\r\nJGAD000770：19.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "scRNA-seq": {
          "対象": "子宮頸がん（ICD10：C539）：1症例\r\n 　正常子宮頸部由来オルガノイド由来の細胞：50個",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "正常子宮頸部由来オルガノイド由来の細胞より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Nextera XT DNA Library Preparation Kit",
          "断片化の方法": "Nextera XT transposome",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000770",
          "総データ量": "19.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "曾根 献文",
        "所 属 機 関": "東京大学医学部附属病院 女性診療科・産科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 創薬等ライフサイエンス研究支援基盤事業 創薬等先端技術支援基盤プラットフォーム（BINDS）",
            "タイトル": "1細胞/微小組織マルチオミックスのオールインワン解析による生命科学研究の支援",
            "研究課題番号": "JP22ama121055"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Cells with stem-like properties are associated with the development of HPV18-positive cervical cancer",
          "DOI": "doi: 10.1111/cas.15664",
          "データID": "JGAD000708"
        },
        "2": {
          "タイトル": "Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine",
          "DOI": "doi: 10.1002/cam4.5588",
          "データID": "JGAD000713"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0358.v2": {
          "Research ID": "hum0358.v2",
          "公開日": "2023/10/19",
          "内容": "NGS（RNA-seq、scRNA-seq）",
          "description": "正常子宮頸部をもつ症例の正常子宮頸部組織由来オルガノイド、正常子宮頸部マイクロダイセクションで取得した組織、および、ヒト細胞株にsiRNA knockdownを行った検体から抽出したRNAを用いたsingle cell RNA-seqならびにRNA-seq解析データをfastqファイル形式で提供する。\n"
        },
        "hum0358.v1": {
          "Research ID": "hum0358.v1",
          "公開日": "2022/12/20",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "子宮頸部腺がんの腫瘍組織、腫瘍組織由来オルガノイド、および、非腫瘍組織（末梢血、腫瘍近傍の正常組織）から抽出したDNA/RNAを用いたwhole exome sequencingならびにRNA-seq解析データをfastq、bamファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0358.v2",
      "DATA": {
        "JGAS000582\r\nJGAS000586": {
          "Data Set ID": "JGAS000582\r\nJGAS000586",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/12/20"
        },
        "JGAS000640": {
          "Data Set ID": "JGAS000640",
          "Type of Data": "NGS (RNA-seq, scRNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/10/19"
        }
      },
      "SUMMARY": {
        "Aims": "To identify molecular markers involved in the development and prognosis of cervical adenocarcinoma, we would like to elucidate the molecular biological characteristics of cervical adenocarcinoma in relation to the carcinogenesis of other cervical cancers (squamous cell carcinoma), vaginal and vulvar cancers.　In addition, some squamous cell carcinomas of the cervix develop at a young age and have a poor prognosis. Furthermore, small cell carcinoma of the uterine cervix also progresses rapidly and has a poor prognosis, making the establishment of diagnostic and therapeutic methods an urgent task.",
        "Methods": "Whole exome sequencing, RNA-seq, single-cell RNA sequencing",
        "Participants/Materials": "cervical cancer total of 19 + 4 cases, NIKS18 cell line"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "cervical cancer (ICD10: C539)\r\n      [JGAS000582] 4 cases: 8 tumor samples, 2 peripheral blood samples, 2 normal areas near the tumor\r\n      [JGAS000586] 1 case: 3 samples of tumor/tumor-derived organoids/peripheral blood",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumors, tumor-derived organoids, peripheral blood cells, or normal areas near the tumor",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Twist Comprehenive exome",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "bwa, bowtie2",
          "Mapping Quality": "≧30",
          "Reference Genome Sequence": "hg38",
          "Coverage (Depth)": "168x (39x-318x)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000708\r\nJGAD000713",
          "Total Data Volume": "JGAD000708: 76 GB (bam)\r\nJGAD000713: 25.5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "cervical cancer (ICD10: C539)\r\n      [JGAS000582] 5 cases: multiple sampling each from within the same tumor for a total of 77 samples\r\n      [JGAS000586] 1 case: 2 samples of tumor/tumor-derived organoids\r\n      [JGAS000586] 13 cases: 13 samples of tumors\r\n      [JGAS000640] 3 cases: 3 samples of normal cervical tissue-derived organoids\r\n      [JGAS000640] 1 case: 4 samples of normal cervical tissue\r\n \r\nsiRNA-mediated knockdown samples of NIKS18 cell line\r\n      [JGAS000640] siNPM3: 2 samples, siNC: 3 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "RNAs extracted from tumor tissues, non-tumor tissues, patient-derived organoids, or siRNA-mediated knockdown samples of NIKS18",
          "Cell Lines": "NIKS18 is NIKS, which is a human keratinocyte cell line (ATCC CRL-12191), contain HPV18 genome as episomes",
          "Library Construction (kit name)": "Nextera XT DNA Library Preparation Kit",
          "Fragmentation Methods": "Nextera XT transposome",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000708\r\nJGAD000713\r\nJGAD000770",
          "Total Data Volume": "JGAD000708: 76 GB (bam)\r\nJGAD000713: 25.5 GB (fastq)\r\nJGAD000770: 19.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "scRNA-seq": {
          "Participants/Materials": "cervical cancer (ICD10: C539)\r\n   1 case: 50 cells of normal cervical tissue-derived organoids",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "RNAs extracted from cells of normal cervical tissue-derived organoids",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Nextera XT DNA Library Preparation Kit",
          "Fragmentation Methods": "Nextera XT transposome",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000770",
          "Total Data Volume": "19.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kenbun Sone",
        "Affiliation": "Department of obstetrics and gynecology, The university of Tokyo Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Support of life science studies by all-in-one single cell/micro tissue multi-omics analysis",
            "Project Number": "JP22ama121055"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Cells with stem-like properties are associated with the development of HPV18-positive cervical cancer",
          "DOI": "doi: 10.1111/cas.15664",
          "Data Set ID": "JGAD000708"
        },
        "2": {
          "Title": "Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine",
          "DOI": "doi: 10.1002/cam4.5588",
          "Data Set ID": "JGAD000713"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0358.v2": {
          "Research ID": "hum0358.v2",
          "Release Date": "2023/10/19",
          "Type of Data": "NGS (RNA-seq, scRNA-seq)",
          "description": "RNAs extracted from patient-derived organoids or micro-dissected tissues of normal uterine cervix, or siRNA-mediated knockdown samples of NIKS18 were used for the single-cell RNA sequencing and RNA sequencing analyses. Fastq files are provided.\n"
        },
        "hum0358.v1": {
          "Research ID": "hum0358.v1",
          "Release Date": "2022/12/20",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs/RNAs extracted from tumors, tumor-derived organoids, peripheral blood cells, or normal areas near the tumor of cervical cancer patients were used for the whole exome sequencing and RNA sequencing analyses. Fastq and bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0357.v4": {
    "ja": {
      "NBDC Research ID": "hum0357.v4",
      "データ": {
        "JGAS000557": {
          "データID": "JGAS000557",
          "内容": "NGS（WGS）\r\nNGS（Exome）\r\nNGS（RNA-seq）\r\nNGS（ATAC-seq）\r\nメチル化アレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/11/30"
        },
        "JGAS000557（データ削除）": {
          "データID": "JGAS000557（データ削除）",
          "内容": "NGS（WGS）\r\nNGS（RNA-seq）\r\nNGS（ATAC-seq）\r\nメチル化アレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2023/01/11"
        },
        "JGAS000557（データ追加）": {
          "データID": "JGAS000557（データ追加）",
          "内容": "NGS（WGS）\r\nNGS（RNA-seq）\r\nNGS（ATAC-seq）\r\nメチル化アレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2023/02/15"
        },
        "JGAS000609": {
          "データID": "JGAS000609",
          "内容": "NGS（Exome）\r\nNGS（RNA-seq）\r\nNGS（ATAC-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/08/09"
        },
        "JGAS000610": {
          "データID": "JGAS000610",
          "内容": "NGS（Exome）\r\nNGS（RNA-seq）\r\nNGS（ATAC-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/08/09"
        }
      },
      "研究内容の概要": {
        "目的": "呼吸器疾患症例の肺組織を用いたマルチオミックス解析による新規治療方法の解明",
        "方法": "肺がん症例の腫瘍組織（胸水、喀痰、末梢血、摘出組織、生検）から樹立したオルガノイドから抽出したDNA/RNAを用いたWhole Genome Sequencing（WGS）、Whole Exome Sequencing（WES）、RNA-seq、ATAC-seq、Methylation解析",
        "対象": "肺がん92症例",
        "URL": "http://www.keio-med.jp/pulmonary/clinical/case.html"
      },
      "分子データ": {
        "WGS": {
          "対象": "肺がん （ICD10：C349）：22症例",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織から樹立したオルガノイドより抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6 kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000678",
          "総データ量": "3 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Exome": {
          "対象": "肺がん （ICD10：C349）：21＋30＋31症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "腫瘍組織から樹立したオルガノイドより抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6 kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000678\r\nJGAD000738\r\nJGAD000739",
          "総データ量": "JGAD000678：3 TB（fastq）\r\nJGAD000738：384.8 GB（fastq）\r\nJGAD000739：471.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "肺がん （ICD10：C349）：43＋37＋31症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織から樹立したオルガノイドより抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Library Prep Kit v2",
          "断片化の方法": "TruSeq RNA Library Prep Kit v2",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000678\r\nJGAD000738\r\nJGAD000739",
          "総データ量": "JGAD000678：3 TB（fastq）\r\nJGAD000738：384.8 GB（fastq）\r\nJGAD000739：471.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ATAC-seq": {
          "対象": "肺がん （ICD10：C349）：42＋14＋28症例",
          "規模": "ATAC-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "腫瘍組織から樹立したオルガノイドより抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Nextera XT DNA Library Preparation Kit",
          "断片化の方法": "Tn5 transposase",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000678\r\nJGAD000738\r\nJGAD000739",
          "総データ量": "JGAD000678：3 TB（fastq）\r\nJGAD000738：384.8 GB（fastq）\r\nJGAD000739：471.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "メチル化アレイ": {
          "対象": "肺がん （ICD10：C349）：42症例",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium MethylationEPIC BeadChip]",
          "ソース": "腫瘍組織から樹立したオルガノイドより抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium MethylationEPIC microarray",
          "プローブ数": "850,000",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000678",
          "総データ量": "3 TB（idat）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "安田 浩之",
        "所 属 機 関": "慶應義塾大学 医学部 呼吸器内科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "小細胞肺癌オルガノイドを用いた小細胞肺癌発癌過程の理解",
            "研究課題番号": "22K08290"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma",
          "DOI": "doi: 10.1016/j.celrep.2023.112212",
          "データID": "JGAD000678"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0357.v4": {
          "Research ID": "hum0357.v4",
          "公開日": "2023/08/09",
          "内容": "NGS（Exome、RNA-seq、ATAC-seq）",
          "description": "肺がん68症例の腫瘍組織から樹立したオルガノイドより抽出したDNA/RNAを用いたWES、RNA-seq、ATAC-seqデータをfastqファイルにて提供する。\n"
        },
        "hum0357.v3": {
          "Research ID": "hum0357.v3",
          "公開日": "2023/02/15",
          "内容": "NGS（WGS、RNA-seq、ATAC-seq）、メチル化アレイ",
          "description": "肺がん2症例のWGS、RNA-seq、ATAC-seq、メチル化アレイ解析データを追加した。\n"
        },
        "hum0357.v2": {
          "Research ID": "hum0357.v2",
          "公開日": "2023/01/11",
          "内容": "NGS（WGS、RNA-seq、ATAC-seq）、メチル化アレイ",
          "description": "肺がん2症例のWGS、RNA-seq、ATAC-seq、メチル化アレイ解析データを削除した。\n"
        },
        "hum0357.v1": {
          "Research ID": "hum0357.v1",
          "公開日": "2022/11/30",
          "内容": "NGS（WGS、Exome、RNA-seq、ATAC-seq）、メチル化アレイ",
          "description": "肺がん43症例の腫瘍組織から樹立したオルガノイドより抽出したDNA/RNAを用いたWGS、WES、RNA-seq、ATAC-seq、メチル化アレイ解析データをfastqおよびidatファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0357.v4",
      "DATA": {
        "JGAS000557": {
          "Data Set ID": "JGAS000557",
          "Type of Data": "NGS (WGS)\r\nNGS (Exome)\r\nNGS (RNA-seq)\r\nNGS (ATAC-seq)\r\nMethylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/11/30"
        },
        "JGAS000557 (data deleted)": {
          "Data Set ID": "JGAS000557 (data deleted)",
          "Type of Data": "NGS (WGS)\r\nNGS (RNA-seq)\r\nNGS (ATAC-seq)\r\nMethylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/01/11"
        },
        "JGAS000557 (data added)": {
          "Data Set ID": "JGAS000557 (data added)",
          "Type of Data": "NGS (WGS)\r\nNGS (RNA-seq)\r\nNGS (ATAC-seq)\r\nMethylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/02/15"
        },
        "JGAS000609": {
          "Data Set ID": "JGAS000609",
          "Type of Data": "NGS (Exome)\r\nNGS (RNA-seq)\r\nNGS (ATAC-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/08/09"
        },
        "JGAS000610": {
          "Data Set ID": "JGAS000610",
          "Type of Data": "NGS (Exome)\r\nNGS (RNA-seq)\r\nNGS (ATAC-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/08/09"
        }
      },
      "SUMMARY": {
        "Aims": "To develop new treatments for pulmonary diseases by using NGS analyses data ",
        "Methods": "Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), ATAC-seq, and methylation array analyses with DNA harvested from lung cancer organoids established from surgery, biopsy, pleural effusion, sputum, and peripheral blood samples of patients. RNA-seq analysis with RNA harvested from lung cancer organoids established from surgery, biopsy, pleural effusion, sputum, and peripheral blood samples of patients.",
        "Participants/Materials": "Lung cancer"
      },
      "MOLECULAR DATA": {
        "WGS": {
          "Participants/Materials": "lung cancer (ICD10: C349): 22 cases",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from organoids established from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6 kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD00678",
          "Total Data Volume": "3 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Exome": {
          "Participants/Materials": "lung cancer (ICD10: C349): 21 + 30 + 31 cases",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from organoids established from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6 kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000678\r\nJGAD000738\r\nJGAD000739",
          "Total Data Volume": "JGAD000678: 3 TB (fastq)\r\nJGAD000738: 384.8 GB (fastq)\r\nJGAD000739: 471.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "lung cancer (ICD10: C349): 43 + 37 + 31 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from organoids established from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Library Prep Kit v2",
          "Fragmentation Methods": "TruSeq RNA Library Prep Kit v2",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000678\r\nJGAD000738\r\nJGAD000739",
          "Total Data Volume": "JGAD000678: 3 TB (fastq)\r\nJGAD000738: 384.8 GB (fastq)\r\nJGAD000739: 471.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "ATAC-seq": {
          "Participants/Materials": "lung cancer (ICD10: C349): 42 + 14 + 28 cases",
          "Targets": "ATAC-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "DNAs extracted from organoids established from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Nextera XT DNA Library Preparation Kit",
          "Fragmentation Methods": "Tn5 transposase",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000678\r\nJGAD000738\r\nJGAD000739",
          "Total Data Volume": "JGAD000678: 3 TB (fastq)\r\nJGAD000738: 384.8 GB (fastq)\r\nJGAD000739: 471.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation array": {
          "Participants/Materials": "lung cancer (ICD10: C349): 42 cases",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium MethylationEPIC BeadChip]",
          "Source": "DNAs extracted from organoids established from tumor tissues",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Infinium MethylationEPIC microarray",
          "Probe Number": "850,000",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD00678",
          "Total Data Volume": "3 TB (idat)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Yasuda",
        "Affiliation": "Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Clarification of carcinogenesis process of small cell lung cancer using patient-derived organoid library",
            "Project Number": "22K08290"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma",
          "DOI": "doi: 10.1016/j.celrep.2023.112212",
          "Data Set ID": "JGAD000678"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0357.v4": {
          "Research ID": "hum0357.v4",
          "Release Date": "2023/08/09",
          "Type of Data": "NGS (Exome, RNA-seq, ATAC-seq)",
          "description": "DNAs/RNAs were extracted from organoids established from tumor tissues of 68 patients with lung cancer. WES, RNA-seq, and ATAC-seq analyses were performed. Fastq files are provided.\n"
        },
        "hum0357.v3": {
          "Research ID": "hum0357.v3",
          "Release Date": "2023/02/15",
          "Type of Data": "NGS (WGS, RNA-seq, ATAC-seq), Methylation array",
          "description": "WGS, RNA-seq, ATAC-seq, and methylation array analyses data of 2 patients with lung cancer were added.\n"
        },
        "hum0357.v2": {
          "Research ID": "hum0357.v2",
          "Release Date": "2023/01/11",
          "Type of Data": "NGS (WGS, RNA-seq, ATAC-seq), Methylation array",
          "description": "WGS, RNA-seq, ATAC-seq, and methylation array analyses data of 2 patients with lung cancer were deleted.\n"
        },
        "hum0357.v1": {
          "Research ID": "hum0357.v1",
          "Release Date": "2022/11/30",
          "Type of Data": "NGS (WGS, Exome, RNA-seq, ATAC-seq), Methylation array",
          "description": "DNAs/RNAs were extracted from organoids established from tumor tissues of 43 patients with lung cancer. WGS, WES, RNA-seq, ATAC-seq, and methylation array analyses were performed. Fastq and idat files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0356.v1": {
    "ja": {
      "NBDC Research ID": "hum0356.v1",
      "データ": {
        "DRA015288\r\nE-GEAD-579": {
          "データID": "DRA015288\r\nE-GEAD-579",
          "内容": "NGS（Visium Spatial Gene Expression）、病理画像",
          "制限": "非制限公開",
          "公開日": "2022/12/20"
        }
      },
      "研究内容の概要": {
        "目的": "これまで、adenocarcinoma sequenceを背景とする大腸がんのがん細胞と間質細胞における細胞間コミュニケーションについて、single cell RNA sequencing解析が行われてきたため、空間的な視点が欠落していた。今回はパブリックなシングルセル解析データと空間トランスクリプトーム解析データの統合解析により、大腸がんの浸潤先進部における細胞間コミュニケーションを明らかにし、大腸がん細胞が免疫から逃避するメカニズムを明らかにする事によって新たな治療標的分子を探索する。",
        "方法": "手術による摘出検体を液体窒素にて凍結させた。その後、キャプチャ領域に合わせて切断し、クライオスタットを用いて10μmの切片に切り出した。この標本をVisium Spatialスライドに載せ、使用するまで-80 ℃で保存した。組織を透過酵素（10x Genomics: 2000214）で50分間透過処理し、0.1×SSCバッファー（Sigma-Aldrich）で洗浄し、画像化した。全ての工程は、製造元のプロトコール（CG000240 Rev D、CG000160 Rev A）に従って行った。",
        "対象": "denocarcinoma sequenceを背景とした大腸がん症例",
        "URL": "https://www.beppu.kyushu-u.ac.jp/geka/labo/reseach/"
      },
      "分子データ": {
        "DRA015288 / E-GEAD-579": {
          "対象": "adenocarcinoma sequenceを背景とした大腸がん（ICD10：D01.0）：1症例\r\n     腫瘍組織切片：4検体",
          "規模": "Visium Spatial Gene Expression、病理画像",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "切除した凍結腫瘍組織から切り出した厚さ10μmの切片より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Visium Spatial Gene Expression Reagent Kits",
          "断片化の方法": "上記キットに準拠（酵素反応）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "118 bp",
          "解析ソフトウェア": "spaceranger-1.2.1",
          "リファレンス": "GRCh38",
          "組織画像": "HE染色",
          "DDBJ Sequence Read Archive ID": "DRA015288",
          "Genomic Expression Archive ID": "E-GEAD-579",
          "総データ量": "142.6 GB（fastq、tif、 png、json、csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "三森 功士",
        "所 属 機 関": "九州大学病院別府病院 外科",
        "プロジェクト/研究グループ名": "大腸発がんにおける遺伝子変化の解明と間質の臨床的意義の確立",
        "科研費/助成金（Research Project Number）": {
          "10": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的がん医療実用化研究事業",
            "タイトル": "大腸がん細胞の多段階悪性化が制御する微小環境形成ネットワーク機構の解明と新規予防治療戦略の確立",
            "研究課題番号": "JP19ck0106259"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "spatial and single-cell transcriptomics to decipher the cellular society containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer",
          "DOI": "doi: 10.1016/j.celrep.2022.111929",
          "データID": "DRA015288E-GEAD-579"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0356.v1": {
          "Research ID": "hum0356.v1",
          "公開日": "2022/12/20",
          "内容": "NGS（Visium Spatial Gene Expression）、病理画像",
          "description": "adenocarcinoma sequence（良性のポリープである腺腫が少しずつ悪性化し、ついには大腸がんになる説）を背景とした大腸がん症例の腫瘍組織に対して実施した空間トランスクリプトーム解析データをfastq、tif、png、csvファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0356.v1",
      "DATA": {
        "DRA015288\r\nE-GEAD-579": {
          "Data Set ID": "DRA015288\r\nE-GEAD-579",
          "Type of Data": "NGS (Visium Spatial Gene Expression), histological image",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/12/20"
        }
      },
      "SUMMARY": {
        "Aims": "Several single-cell RNA sequencing analyses have been used to analyze intercellular communication between colon cancer cells and stromal cells in colorectal cancer patients with an adenocarcinoma sequence background; the analyses lacked a spatial perspective. In this study, we combined public single-cell and spatial-transcriptome analyses to elucidate cell-to-cell communication in the advanced invasive zone of colorectal cancer cells. This analysis was aimed at identifying the mechanism by which colon cancer cells evade immunity, and thereby searching for new therapeutic target molecules.",
        "Methods": "Surgical specimens were frozen in liquid nitrogen. Specimens were cut according to the capture area and sectioned into 10-μm sections using a cryostat. The specimens were placed on Visium Spatial slides and stored at -80 °C until use. Tissues were permeabilized with permeabilization enzyme (10x Genomics: 2000214) for 50 min, washed with 0.1 x SSC buffer (Sigma-Aldrich), and imaged. All steps were performed according to the manufacturer's protocol (CG000240 Rev D, CG000160 Rev A).",
        "Participants/Materials": "A patient with colorectal cancer with a background of adenocarcinoma sequence"
      },
      "MOLECULAR DATA": {
        "DRA015288 / E-GEAD-579": {
          "Participants/Materials": "colon cancer (ICD10: D01.0): 1 case\r\n      fragment tumor tissue section: 4 samples",
          "Targets": "Visium Spatial Gene Expression, histological image",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from sample tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Visium Spatial Gene Expression Reagent Kits",
          "Fragmentation Methods": "included in the above library construction kit (enzymatic fragmentation)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "118 bp",
          "Software": "spaceranger-1.2.1",
          "Reference": "GRCh38",
          "Tissue Image": "hematoxylin-eosin staining",
          "DDBJ Sequence Read Archive ID": "DRA015288",
          "Genomic Expression Archive ID": "E-GEAD-579",
          "Total Data Volume": "142.6 GB (fastq, tif, png, json, csv)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koshi Mimori",
        "Affiliation": "Department of Surgery, Kyushu University Beppu Hospital",
        "Project / Group Name": "Elucidation of genetic alterations in colorectal carcinogenesis and establishment of clinical significance of interstitial",
        "Funds / Grants (Research Project Number)": {
          "10": {
            "Name": "Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Elucidation of microenvironmental network mechanisms regulating multistep malignant transformation of colorectal cancer cells and establishment of novel preventive therapeutic strategies",
            "Project Number": "JP19ck0106259"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "spatial and single-cell transcriptomics to decipher the cellular society containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer",
          "DOI": "doi: 10.1016/j.celrep.2022.111929",
          "Data Set ID": "DRA015288E-GEAD-579"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0356.v1": {
          "Research ID": "hum0356.v1",
          "Release Date": "2022/12/20",
          "Type of Data": "NGS (Visium Spatial Gene Expression), histological image",
          "description": "RNAs extracted from specimens sectioned into 10-μm sections were used for Visium Spatial Gene Expression Assay. Fastq files, tif files (histological image for Visium Spatial Gene Expression Assay), and a tsv file are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0355.v1": {
    "ja": {
      "NBDC Research ID": "hum0355.v1",
      "データ": {
        "JGAS000544": {
          "データID": "JGAS000544",
          "内容": "NGS（WGS、Exome、RNA-seq）\r\nnCounterデジタルカウント",
          "制限": "制限公開（Type I）",
          "公開日": "2023/06/19"
        }
      },
      "研究内容の概要": {
        "目的": "泌尿器科腫瘍（副腎腫瘍、腎がん、腎盂がん、後腹膜腫瘍、尿管がん、尿膜管がん、膀胱がん、前立腺がん、尿道がん、陰茎がん、精巣腫瘍など）の遺伝子異常（変異・コピー数異常・構造異常など）およびエピジェネティック異常、トランスクリプトーム異常の検索を行うことで、泌尿器科腫瘍において各疾患単位の遺伝子異常プロファイルを明らかにする。同時に、患者背景・治療成績・予後などについて既存の資料を用いて検討することにより、各遺伝子異常プロファイル治療反応性や分子病態との関連について明らかにすることを目指す。",
        "方法": "全ゲノムシーケンス解析、全エキソームシーケンス解析、RNAシーケンス解析、nCounterデジタルカウント解析（nCounter Human Immunology V2 panel使用）",
        "対象": "Von Hippel-Lindau（VHL）病に伴う遺伝性淡明細胞型腎細胞がん：10症例",
        "URL": "https://www.ncc.go.jp/jp/ri/division/molecular_oncology/index.html"
      },
      "分子データ": {
        "WGS": {
          "対象": "VHL病（ICD10：Q858）に伴う遺伝性淡明細胞型腎細胞がん（ICD10：C64）：1症例\r\n      末梢血（生殖細胞系列の解析として）：1検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Nano DNA Library Prep Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "bwa",
          "マッピングクオリティ": "10x coverage 99%",
          "マッピングの際のリファレンス配列": "hs37d5",
          "平均カバー率（Depth）": "34×",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000663",
          "総データ量": "1.1 TB （bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Exome": {
          "対象": "VHL病（ICD10：Q858）に伴う遺伝性淡明細胞型腎細胞がん（ICD10：C64）：10症例 98検体\r\n      原発巣：10症例 81検体\r\n      転移巣：1症例 7検体（肺1検体、胸膜3検体、リンパ節3検体）\r\n      末梢血（生殖系列コントロール）：10症例 10検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 500、NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織および末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6、SureSelectXT HS Target Enrichment System、SureSelectXT Target Enrichment System",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "bwa",
          "マッピングクオリティ": "Median 30x coverage 97%",
          "マッピングの際のリファレンス配列": "hs37d5",
          "平均カバー率（Depth）": "166×",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000663",
          "総データ量": "1.1 TB （bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "VHL病（ICD10：Q858）に伴う遺伝性淡明細胞型腎細胞がん（ICD10：C64）：7症例 49検体\r\n      原発巣：7症例 49検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "腫瘍組織より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra II RNA Library Prep Kit for Illumina",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "bwa",
          "マッピングクオリティ": "Median mapped reads 9,639,928",
          "マッピングの際のリファレンス配列": "hs37d5",
          "遺伝子数": "26,718",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000663",
          "総データ量": "1.1 TB （bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "nCounterデジタルカウント解析": {
          "対象": "VHL病（ICD10：Q858）に伴う遺伝性淡明細胞型腎細胞がん（ICD10：C64）：9症例 82検体\r\n      原発巣：9症例 76検体\r\n      正常腎皮質：6症例 6検体",
          "規模": "ダイレクトデジタルカウント",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "チップ：nCounter Human Immunology V2 panel（免疫に関連した594遺伝子）\r\nスキャナー：NanoString Technologies [nCounter Digital Analyzer]",
          "ソース": "腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "nCounter Human Immunology V2 Panel CodeSet",
          "解析ソフトウェア": "nSolver analysis software v4.0.70",
          "フィルタリング（ノーマライズ、QC方法）": "nSolver analysis software v4.0.70",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000663",
          "総データ量": "1.1 TB （txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "片岡 圭亮",
        "所 属 機 関": "国立がん研究センター研究所 分子腫瘍学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん医療加速化研究事業（P-PROMOTE）",
            "タイトル": "患者間・腫瘍間・腫瘍内における遺伝学的・免疫学的不均一性の統合的理解",
            "研究課題番号": "JP23ama221510"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinoma",
          "DOI": "doi: 10.1016/j.celrep.2023.112736",
          "データID": "JGAD000663"
        }
      },
      "制限公開データの利用者一覧": {
        "Maher Eamonn": {
          "研究代表者": "Maher Eamonn",
          "所属機関": "University of Cambridge",
          "研究題目": "イギリス",
          "利用データID": "Molecular Pathology of Human Genetic Disease",
          "利用期間": "JGAD000663"
        }
      },
      "リリース情報": {
        "hum0355.v1": {
          "Research ID": "hum0355.v1",
          "公開日": "2023/06/19",
          "内容": "NGS（WGS、Exome、RNA-seq）、nCounterデジタルカウント",
          "description": "VHL病に伴う遺伝性淡明細胞型腎細胞がん10症例の腫瘍組織、非腫瘍組織および末梢血から抽出したDNA/RNAを用いた全ゲノムシーケンス解析、全エキソームシーケンス解析、RNAシーケンス解析、ならびにnCounterデジタルカウント解析データをbam、textファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0355.v1",
      "DATA": {
        "JGAS000544": {
          "Data Set ID": "JGAS000544",
          "Type of Data": "NGS (WGS, Exome, RNA-seq)\r\nDigital multiplexed gene expression analysis",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/06/19"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate genetic (variants, copy number alterations, structural abnormalities, etc.), epigenetic, and transcriptomic profiles of genitourinary tumors (adrenal, kidney, renal pelvis, retroperitoneal, ureter, ureteric duct, bladder, prostate, urethra, penis, testis, etc.). At the same time, by combining the profiles with clinical data (patient's background, treatment outcome, and prognosis), we clarify the relationship between the profiles and therapeutic efficacy, and molecular pathogenesis.",
        "Methods": "whole-genome sequencing (NGS), whole-exome sequencing (NGS), RNA-sequence (NGS), and digital multiplexed gene expression analysis using the NanoString nCounter system",
        "Participants/Materials": "Ten patients with hereditary clear cell renal cell carcinoma (ccRCC) associated with Von Hippel-Lindau (VHL) disease",
        "URL": "https://www.ncc.go.jp/en/ri/division/molecular_oncology/index.html"
      },
      "MOLECULAR DATA": {
        "WGS": {
          "Participants/Materials": "hereditary ccRCC (ICD10: C64) with VHL (ICD10: Q858): 1 case\r\n    peripheral blood: 1 sample (for germline VHL gene alteration testing)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Nano DNA Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "bwa",
          "Mapping Quality": "10x coverage width: 99%",
          "Reference Genome Sequence": "hs37d5",
          "Coverage (Depth)": "34X",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000663",
          "Total Data Volume": "1.1 TB (bam)",
          "Comments (Policies)": "NBDC policy"
        },
        "Exome": {
          "Participants/Materials": "hereditary ccRCC (ICD10: C64) with VHL (ICD10: Q858): 10 cases (98 samples)\r\n    primary tumor: 10 cases (81 samples)\r\n    metastatic tumor: 1 case (7 samples [1 lung, 3pleura, and 3 lymph nodes])\r\n    peripheral blood: 10 cases (10 samples)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 500, NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor tissues and peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6, SureSelectXT HS Target Enrichment System, SureSelectXT Target Enrichment System",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "bwa",
          "Mapping Quality": "Median 30x coverage width: 97%",
          "Reference Genome Sequence": "hs37d5",
          "Coverage (Depth)": "166X",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000663",
          "Total Data Volume": "1.1 TB (bam)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "hereditary ccRCC (ICD10: C64) with VHL (ICD10: Q858): 7 cases (49 samples)\r\n    primary tumor: 7 cases (49 samples)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "RNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra II RNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "bwa",
          "Mapping Quality": "Median mapped reads 9,639,928",
          "Reference Genome Sequence": "hs37d5",
          "Gene number": "26,718",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000663",
          "Total Data Volume": "1.1 TB (bam)",
          "Comments (Policies)": "NBDC policy"
        },
        "Digital multiplexed gene expression analysis": {
          "Participants/Materials": "hereditary ccRCC (ICD10: C64) with VHL (ICD10: Q858): 9 cases (82 samples)\r\n    primary tumor: 9 cases (76 samples)\r\n    normal renal cortex: 6 cases (6 samples)",
          "Targets": "Direct Digital Count",
          "Target Loci for Capture Methods": "594 genes",
          "Platform": "Chip: nCounter Human Immunology V2 panel\r\nScanner: NanoString Technologies [nCounter Digital Analyzer]",
          "Source": "RNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "nCounter Human Immunology V2 Panel CodeSet",
          "Software": "nSolver analysis software v4.0.70",
          "Filtering Methods (normalization, QC)": "nSolver analysis software v4.0.70",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000663",
          "Total Data Volume": "1.1 TB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Keisuke Kataoka",
        "Affiliation": "Division of Molecular Oncology, National Cancer Center Research Institute",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Project for Promotion of Cancer Research and Therapeutic Evolution (P-PROMOTE), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Elucidation of inter-patient, inter-tumor, and intra-tumor heterogeneity of genetic and immune status",
            "Project Number": "JP23ama221510"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinoma",
          "DOI": "doi: 10.1016/j.celrep.2023.112736",
          "Data Set ID": "JGAD000663"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Maher Eamonn": {
          "Principal Investigator": "Maher Eamonn",
          "Affiliation": "University of Cambridge",
          "Research Title": "United Kingdom of Great Britain and Northern Ireland",
          "Data in Use (Dataset ID)": "Molecular Pathology of Human Genetic Disease",
          "Period of Data Use": "JGAD000663"
        }
      },
      "Release Note": {
        "hum0355.v1": {
          "Research ID": "hum0355.v1",
          "Release Date": "2023/06/19",
          "Type of Data": "NGS (WGS, Exome, RNA-seq), Digital multiplexed gene expression analysis",
          "description": "DNAs/RNAs extracted from tumor tissues, non-tumor tissues, and peripheral blood cells of patients with hereditary clear cell renal cell carcinoma (ccRCC) associated with Von Hippel-Lindau (VHL) disease were used for several analyses (whole genome sequencing, whole exome sequencing, RNA-sequence, and digital multiplexed gene expression). Bam and text files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0354.v2": {
    "ja": {
      "NBDC Research ID": "hum0354.v2",
      "データ": {
        "hum0354.v1.qRT-PCR.v1": {
          "データID": "hum0354.v1.qRT-PCR.v1",
          "内容": "qRT-PCR",
          "制限": "非制限公開",
          "公開日": "2022/06/30"
        },
        "hum0354.v2.qRT-PCR.v1": {
          "データID": "hum0354.v2.qRT-PCR.v1",
          "内容": "qRT-PCR",
          "制限": "非制限公開",
          "公開日": "2023/04/18"
        }
      },
      "研究内容の概要": {
        "目的": "近年、固形腫瘍の診断、転移、再発、予後予測に有用な方法として、末梢循環腫瘍細胞（Circulating Tumor Cells：CTC）の検出、計測が注目されている。従来の腫瘍マーカーと異なり、がん細胞そのものを患者の末梢血から採取する事で、信頼度の高い診断を可能とする手段である。また、その手法は非侵襲性で時系列的に解析ができるというメリットがある。本研究では、進行泌尿器がん、とくに進行転移性去勢抵抗性前立腺がん（castration-resistant prostate cancer：CRPC）症例のCTCの分子発現異常を解析し、治療効果判定や予後予測の腫瘍マーカーとして確立することを目的とする。",
        "方法": "エンザルタミド（enzalutamide）、ドセタキセル（docetaxel）、もしくは、カバジダキセル（cabazitaxel）を使用されている急性転移性CRPC症例からCTCを採取し、アンドロゲン受容体発現とスプライシングバリアント7（AR-V7）の有無を解析する。",
        "対象": "薬剤加療中の進行転移性CRPC症例"
      },
      "分子データ": {
        "hum0354.v1.qRT-PCR.v1 / hum0354.v2.qRT-PCR.v1": {
          "対象": "進行転移性CRPC（ICD-10：C61）：127症例\r\n    1. cabazitaxel使用の48症例（CTC 150検体）\r\n    2. enzalutamide使用の90症例（CTC 46検体）",
          "規模": "qRT-PCR ",
          "対象領域（Target Captureの場合）": "アンドロゲン受容体、スプライシングバリアント７（AR-V7）",
          "Platform": "qPCRキット：Adns Test Prostate Cancer Panel AR-V7（Qiagen）\r\nqPCR装置：BioRad T100 Thermal cycler",
          "ソース": "CTCから抽出したmRNA",
          "検体情報（購入の場合）": "-",
          "発現量解析ソフトウェア": "Experion Software Version 3.0",
          "NBDC Dataset ID": "1. hum0354.v1.qRT-PCR.v1\r\n2. hum0354.v2.qRT-PCR.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary File",
          "総データ量": "1. 23 KB （xlsx）\r\n2. 20 KB （xlsx）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "永田 政義",
        "所 属 機 関": "​順天堂大学大学院 医学研究科 泌尿器外科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer",
          "DOI": "doi: 10.1371/journal.pone.0226219",
          "データID": "hum0354.v1.qRT-PCR.v1"
        },
        "2": {
          "タイトル": "Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer",
          "DOI": "doi: 10.1038/s41598-022-22854-1",
          "データID": "hum0354.v1.qRT-PCR.v1"
        },
        "3": {
          "タイトル": "Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases",
          "DOI": "doi: 10.1038/s41598-023-35790-5",
          "データID": "hum0354.v2.qRT-PCR.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0354.v2": {
          "Research ID": "hum0354.v2",
          "公開日": "2023/04/18",
          "内容": "進行転移性去勢抵抗性前立腺がん症例のCTC由来ｍRNAを用いたqRT-PCR（enzalutamide）",
          "description": "薬剤（enzalutamide）加療中の進行転移性去勢抵抗性前立腺がん46症例の末梢血内末梢循環腫瘍細胞（circulation tumor cells：CTC）から抽出したmRNAを用いたqRT-PCRによるアンドロゲン受容体発現およびスプライシングバリアント7（AR-V7）の有無の解析結果をエクセル形式にて提供する。\n"
        },
        "hum0354.v1": {
          "Research ID": "hum0354.v1",
          "公開日": "2022/06/30",
          "内容": "進行転移性去勢抵抗性前立腺がん症例のCTC由来ｍRNAを用いたqRT-PCR（cabazitaxel）",
          "description": "薬剤（cabazitaxel）加療中の進行転移性去勢抵抗性前立腺がん48症例の末梢血内末梢循環腫瘍細胞（circulation tumor cells：CTC）から抽出したmRNAを用いたqRT-PCRによるアンドロゲン受容体発現およびスプライシングバリアント7（AR-V7）の有無の解析結果をエクセル形式にて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0354.v2",
      "DATA": {
        "hum0354.v1.qRT-PCR.v1": {
          "Data Set ID": "hum0354.v1.qRT-PCR.v1",
          "Type of Data": "qRT-PCR",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/06/30"
        },
        "hum0354.v2.qRT-PCR.v1": {
          "Data Set ID": "hum0354.v2.qRT-PCR.v1",
          "Type of Data": "qRT-PCR",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/04/18"
        }
      },
      "SUMMARY": {
        "Aims": "In recent years, the detection and measurement of peripheral circulating tumor cells (CTC) has attracted attention as a useful method for diagnosing solid tumors, metastasis, recurrence, and prognosis. Unlike conventional tumor markers, cancer cells themselves are collected from the patient's peripheral blood, which is a means that enables a highly reliable diagnosis. In addition, the method has the advantage of being non-invasive and capable of time-series analyses. The purpose of this study is to collect CTCs from patients with advanced urogenital cancer, especially metastatic castration-resistant prostate cancer (CRPC), and analyze molecular expression abnormalities, and establish them as tumor markers for therapeutic effect determination and prognosis prediction.",
        "Methods": "CTCs are collected from CRPC patients receiving enzalutamide, docetaxel, or cabazitaxel.",
        "Participants/Materials": "Patients with advanced metastatic CRPC undergoing drug treatment at Juntendo University Hospital"
      },
      "MOLECULAR DATA": {
        "hum0354.v1.qRT-PCR.v1 / hum0354.v2.qRT-PCR.v1": {
          "Participants/Materials": "CRPC (ICD10: C61): 127 cases\r\n    1. patients receiving cabazitaxel: 48 cases (150 CTC samples)\r\n    2. patients receiving enzalutamide: 90 cases (46 CTC samples)",
          "Targets": "qRT-PCR",
          "Target Loci for Capture Methods": "androgen receptor expression, splicing variant 7 (AR-V7)",
          "Platform": "qPCR kit: Adns Test Prostate Cancer Panel AR-V7（Qiagen）\r\nqPCR instrument: BioRad T100 Thermal cycler",
          "Source": "mRNAs extracted from CTC",
          "Cell Lines": "-",
          "Software for analyzing the quantitative expression": "Experion Software Version 3.0",
          "NBDC Dataset ID": "1. hum0354.v1.qRT-PCR.v1\r\n2. hum0354.v2.qRT-PCR.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary File",
          "Total Data Volume": "1. 23 KB (xlsx)\r\n2. 20 KB (xlsx)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masayoshi Nagata",
        "Affiliation": "Urology, Graduate School of Medicine, Juntendo University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer",
          "DOI": "doi: 10.1371/journal.pone.0226219",
          "Data Set ID": "hum0354.v1.qRT-PCR.v1"
        },
        "2": {
          "Title": "Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer",
          "DOI": "doi: 10.1038/s41598-022-22854-1",
          "Data Set ID": "hum0354.v1.qRT-PCR.v1"
        },
        "3": {
          "Title": "Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases",
          "DOI": "doi: 10.1038/s41598-023-35790-5",
          "Data Set ID": "hum0354.v2.qRT-PCR.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0354.v2": {
          "Research ID": "hum0354.v2",
          "Release Date": "2023/04/18",
          "Type of Data": "qRT-PCR using mRNA derived from CTC of patients with advanced metastatic castration-resistant prostate cancer undergoing drug treatment (enzalutamide)",
          "description": "mRNAs extracted from circulating tumor cells (CTC) in peripheral blood samples of 46 patients with advanced metastatic castration-resistant prostate cancer undergoing drug treatment (enzalutamide) were performed qRT-PCR. The intensity of androgen receptor expression in CTC and the presence or absence of splicing variant 7 (AR-V7) were analyzed (xlsx files).\n"
        },
        "hum0354.v1": {
          "Research ID": "hum0354.v1",
          "Release Date": "2022/06/30",
          "Type of Data": "qRT-PCR using mRNA derived from CTC of patients with advanced metastatic castration-resistant prostate cancer undergoing drug treatment (cabazitaxel)",
          "description": "mRNAs extracted from circulating tumor cells (CTC) in peripheral blood samples of 48 patients with advanced metastatic castration-resistant prostate cancer undergoing drug treatment (cabazitaxel) were performed qRT-PCR. The intensity of androgen receptor expression in CTC and the presence or absence of splicing variant 7 (AR-V7) were analyzed (xlsx files).\nNote：\n"
        }
      }
    }
  },
  "hum0352.v1": {
    "ja": {
      "NBDC Research ID": "hum0352.v1",
      "データ": {
        "JGAS000545": {
          "データID": "JGAS000545",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/20"
        }
      },
      "研究内容の概要": {
        "目的": "肺がんへの放射線治療における治療効果および有害事象の発現に関与する、DNA修復タンパクの機能、RNA発現を明らかにすること。特に放射線治療による治療効果予測と、有害事象に関与している可能性が高いタンパク、およびその発現に関わるRNAを同定する。",
        "方法": "本研究について同意を得られた対象者の末梢血から抽出したRNAを用いたRNA-seq解析",
        "対象": "2019年から2020年にかけて当院にて放射線治療を行った原発性肺がん症例。その内、治療前後での治療効果判定および有害事象の評価が可能であり、放射線治療前、治療終了時、治療後2-4週間後の3点において採血可能な症例。"
      },
      "分子データ": {
        "JGAS000545": {
          "対象": "原発性肺がん（ICD10：C340）：5症例\r\n放射線治療前、治療終了時、治療後2-4週間後の3点、計15検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "断片化の方法": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000664",
          "総データ量": "189.0 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "染谷 正則",
        "所 属 機 関": "札幌医科大学医学部 放射線医学講座",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "リキッドバイオプシーを用いた個別化放射線治療の実践",
            "研究課題番号": "21K07680"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Combined chemoradiotherapy and programmed cell death-ligand 1 blockade leads to changes in the circulating T-cell receptor repertoire of patients with non-small-cell lung cancer",
          "DOI": "doi: 10.1111/cas.15566",
          "データID": "JGAD000664"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0352.v1": {
          "Research ID": "hum0352.v1",
          "公開日": "2022/09/20",
          "内容": "NGS（RNA-seq）",
          "description": "原発性肺がんに対し放射線治療を行った5症例15検体（放射線治療前、治療終了時、治療後2-4週間後の3点）の末梢血から抽出したRNAを用いたRNA-seq解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0352.v1",
      "DATA": {
        "JGAS000545": {
          "Data Set ID": "JGAS000545",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/20"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the functions of DNA repair proteins and RNA expression that are involved in the therapeutic efficacy and adverse events of radiotherapy for lung cancer. In particular, this is an exploratory study to identify proteins and RNAs involved in the expression of proteins that are likely to be involved in the prediction of radiotherapy response and adverse events.",
        "Methods": "Peripheral blood samples were collected from the patients with lung cancer who gave consent for this study. RNA-sequencing analysis was performed with the RNAs extracted from the blood samples.",
        "Participants/Materials": "Patients who have undergone radiotherapy for primary lung cancer at our hospital between 2019 and 2020 will be considered. Among them, we will include cases in which it is possible to determine the effect of treatment and evaluate adverse events before and, and whose blood can be drawn at 3 points: before radiotherapy, at the end of treatment, and 2-4 weeks after treatment."
      },
      "MOLECULAR DATA": {
        "JGAS000545": {
          "Participants/Materials": "primary lung cancer (ICD10: C340): 5 cases\r\nblood obtained before radiotherapy, at the end of treatment, and 2-4 weeks after treatment, 15 samples in total",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "Fragmentation Methods": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000664",
          "Total Data Volume": "189.0 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masanori Someya",
        "Affiliation": "Department of Radiology, Sapporo Medical University, School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Practical application of individualized radiotherapy using liquid biopsy",
            "Project Number": "21K07680"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Combined chemoradiotherapy and programmed cell death-ligand 1 blockade leads to changes in the circulating T-cell receptor repertoire of patients with non-small-cell lung cancer",
          "DOI": "doi: 10.1111/cas.15566",
          "Data Set ID": "JGAD000664"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0352.v1": {
          "Research ID": "hum0352.v1",
          "Release Date": "2022/09/20",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from peripheral blood cells of primary lung cancer patients who have undergone radiotherapy were used for RNA-sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0351.v1": {
    "ja": {
      "NBDC Research ID": "hum0351.v1",
      "データ": {
        "JGAS000540": {
          "データID": "JGAS000540",
          "内容": "メタゲノム",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/08"
        }
      },
      "研究内容の概要": {
        "目的": "もやもや病のリスク遺伝子であるRNF213以外に、もやもや病の発症や病態に関連する遺伝因子を特定すると共に、傍脳室側副血行路・血管の屈曲度・狭窄の範囲や程度などの画像評価に関わる遺伝因子を探索する。また、病態には遺伝因子以外の要因も考えられるため、腸内環境や尿、髄液といった体内環境との関連についても検討し、総合的にもやもや病を理解する。",
        "方法": "採取した便からNucleoSpin DNA Stool Kitを用いてDNAを抽出し、PCR（Ex Taq HS）により対象領域（V3-V4領域）を増幅後、Fragment Analyzer and dsDNA915 Reagent Kitにより質を確認し、MiSeq （Reagent Kit v3）によりシークエンスを行った。",
        "対象": "もやもや病、非もやもや脳血管障害、対照健常者から採取した便"
      },
      "分子データ": {
        "JGAS000540": {
          "対象": "もやもや病（ICD10: I675）：27症例\r\n非もやもや脳血管障害：7症例\r\n対照健常者：15名",
          "規模": "メタゲノム（16S rRNA）",
          "対象領域（Target Captureの場合）": "V3-V4",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "便より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "2-step tailed PCR（Ex Taq HS）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "クオリティコントロール方法": "・FASTXToolkitでプライマーの除去\r\n・sickleで低品質の除去",
          "腸内細菌叢のバクテリア同定方法": "Greengene （ver.13_8）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000659",
          "総データ量": "1.3 GB（fastq、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "峰晴 陽平",
        "所 属 機 関": "京都大学 健康医療AI講座 脳神経外科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0351.v1": {
          "Research ID": "hum0351.v1",
          "公開日": "2022/09/08",
          "内容": "メタゲノム",
          "description": "もやもや病27症例、非もやもや脳血管障害7症例、対照者15名の便検体から抽出したDNAを用いたメタゲノム解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0351.v1",
      "DATA": {
        "JGAS000540": {
          "Data Set ID": "JGAS000540",
          "Type of Data": "Metagenome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/08"
        }
      },
      "SUMMARY": {
        "Aims": "To unravel the genetic and environmental background of moyamoya disease and to understand the pathophysiology of the disease by utilizing radiological evaluations. We will identify susceptibility genes other than RNF213. We also assess whether genetics affects radiological characteristics including collateral development, tortuosity of the main trunk of the arteries, and the extent of stenosis.",
        "Methods": "DNAs were extracted from the fecal samples obtained from participants using NucleoSpin DNA Stool Kit. DNAs was amplified using the 2-step tailed PCR to target the V3-V4 regions of bacterial 16S rRNA. The PCR amplicons were pooled to construct the sequencing library and the quality of the library was confirmed using Fragment Analyzer and dsDNA915 Reagent Kit. Sequencing was performed using the MiSeq Reagent Kit v3.",
        "Participants/Materials": "Fecal samples were collected from 27 patients with moyamoya disease, 7 patients with non-moyamoya intracranial large artery disease, and 15 control individuals."
      },
      "MOLECULAR DATA": {
        "JGAS000540": {
          "Participants/Materials:": "27 patients with moyamoya disease (ICD10: I675)\r\n7 patients with non-moyamoya intracranial large artery disease\r\n15 control individuals",
          "Targets": "Metagenome (16S rRNA)",
          "Target Loci for Capture Methods": "V3-V4",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNA extracted from fecal samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "2-step tailed PCR (Ex Taq HS)",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "QC": "- Removal of primers by FASTXToolkit\r\n- Removal of low quality by sickle",
          "Bacteria Identification Methods": "Greengene (ver.13_8)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000659",
          "Total Data Volume": "1.3 GB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yohei Mineharu",
        "Affiliation": "Department of Artificial Intelligence in Healthcare and Medicine, Kyoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0351.v1": {
          "Research ID": "hum0351.v1",
          "Release Date": "2022/09/08",
          "Type of Data": "Metagenome",
          "description": "DNAs extracted from the fecal samples collected from 27 patients with moyamoya disease, 7 patients with non-moyamoya intracranial large artery disease and 15 control individuals were used for metagenome analysis (fastq files).\nNote：\n"
        }
      }
    }
  },
  "hum0348.v1": {
    "ja": {
      "NBDC Research ID": "hum0348.v1",
      "データ": {
        "JGAS000537": {
          "データID": "JGAS000537",
          "内容": "NGS（Exome）\r\nアレイCGH",
          "制限": "制限公開（Type I）",
          "公開日": "2023/05/15"
        }
      },
      "研究内容の概要": {
        "目的": "CD30陽性HTLV-1感染細胞の全ゲノムにわたる染色体構造とエキソーム領域の遺伝子配列を解析し、この細胞集団が高いゲノム不安定性を持つか、さらに、CD30リガンドを介したCD30刺激が染色体構造変異および遺伝子異常を促進するか評価することで、成人T細胞白血病（adult T-cell leukemia-lymphoma：ATL）の発症に関連するバイオマーカーの同定および病態進行のメカニズムの解明を目指す。",
        "方法": "FACS AriaIIIを用いてCD30発現ATL細胞、CD30非発現ATL細胞、HTLV-1非感染リンパ球を分画後、各分画からDNAを抽出し、whole exome sequencing解析を実施した。併せて、アレイCGH解析により網羅的なDNAコピー数の変化をプロファイリングした。",
        "対象": "成人T細胞白血病（ATL）：8症例"
      },
      "分子データ": {
        "Exome": {
          "対象": "ATL（ICD10：C91.5）：8症例\r\n    CD30発現ATL細胞：8検体\r\n    CD30非発現ATL細胞：8検体\r\n    HTLV-1非感染リンパ球：8検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "PBMCの各分画から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6 Kit",
          "断片化の方法": "超音波断片化 （Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "Trimmomatic（v.0.38）、DRAGEN Bio-IT Platform（v.3.7.5）",
          "マッピングクオリティ": "-",
          "マッピングの際のリファレンス配列": "hg38",
          "平均カバー率（Depth）": "83.6",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000656",
          "総データ量": "118.1 GB （bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "アレイCGH": {
          "対象": "ATL（ICD10：C91.5）：8症例",
          "規模": "アレイCGH",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Agilent Technologies [GenetiSure Cancer Research CGH+SNP Microarray 2 x 400K]",
          "ソース": "PBMCの各分画から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "SureTag Complete DNA Labeling Kit",
          "コピー数変化領域決定アルゴリズム（ソフトウェア）": "Cytogenomics v5.0",
          "フィルタリング": "ADM-2 algorithm、Threshokd value：5.5",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000656",
          "総データ量": "118.1 GB （txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中島 誠",
        "所 属 機 関": "東京大学大学院新領域創成科学研究科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 若手研究",
            "タイトル": "CD30によるROS-DSBを介したゲノム不安定性とATL病態進展機構の解析",
            "研究課題番号": "22K15420"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma",
          "DOI": "doi: 10.1111/cas.15706",
          "データID": "JGAD000656"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0348.v1": {
          "Research ID": "hum0348.v1",
          "公開日": "2023/05/15",
          "内容": "NGS（Exome）、アレイCGH",
          "description": "成人T細胞白血病（ATL）8症例のCD30発現ATL細胞、CD30非発現ATL細胞、HTLV-1非感染リンパ球の各分画から抽出したDNAを用いたwhole exome sequencing解析データをbamファイルにて提供する。\n成人T細胞白血病（ATL）8症例を対象としたアレイCGH解析データをtxtファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0348.v1",
      "DATA": {
        "JGAS000537": {
          "Data Set ID": "JGAS000537",
          "Type of Data": "NGS (Exome)\r\narray-CGH",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/05/15"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the mechanism of the tumorigenic process involving genomic aberrations by CD30 signaling in HTLV-1–infected T-cells",
        "Methods": "CD30+ATL cells, CD30-ATL cells, and HTLV-1 uninfected lymphocytes were sorted by FACS AriaIII. DNA was extracted from each sorted cell and used for whole exome sequencing analysis and array-CGH analysis. ",
        "Participants/Materials": "Adult T-cell leukemia/lymphoma (ATL): 8 cases"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "ATL (ICD10: C91.5): 8 cases\r\n    CD30+ATL cells: 8 samples\r\n    CD30-ATL cells: 8 samples\r\n    HTLV-1 uninfected lymphocytes: 8 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from sorted cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6 Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "Trimmomatic (v.0.38), DRAGEN Bio-IT Platform (v.3.7.5)",
          "Mapping Quality": "-",
          "Reference Genome Sequence": "hg38",
          "Coverage (Depth)": "83.6",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000656",
          "Total Data Volume": "118.1 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        },
        "Array CGH": {
          "Participants/Materials": "ATL (ICD10: C91.5): 8 cases",
          "Targets": "array-CGH",
          "Target Loci for Capture Methods": "-",
          "Platform": "Agilent Technologies [GenetiSure Cancer Research CGH+SNP Microarray 2 x 400K]",
          "Source": "DNAs extracted from sorted cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "SureTag Complete DNA Labeling Kit",
          "Genotype Call Methods (software)": "Cytogenomics v5.0",
          "Filtering": "ADM-2 algorithm, Threshokd value: 5.5",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000656",
          "Total Data Volume": "118.1 GB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Makoto Nakashima",
        "Affiliation": "Graduate School of Frontier Sciences, The University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Early-Career Scientists",
            "Title": "The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma",
            "Project Number": "22K15420"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma",
          "DOI": "doi: 10.1111/cas.15706",
          "Data Set ID": "JGAD000656"
        },
        "": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0348.v1": {
          "Research ID": "hum0348.v1",
          "Release Date": "2023/05/15",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from CD30+ATL cells, CD30-ATL cells, and HTLV-1 uninfected lymphocytes from 8 patients with ATL were used for the whole exome sequencing analysis. Bam files are provided.\nDNAs extracted from 8 patients with ATL were used for the Array CGH analysis. Text files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0347.v2": {
    "ja": {
      "NBDC Research ID": "hum0347.v2",
      "データ": {
        "hum0347.v1.freq.v1": {
          "データID": "hum0347.v1.freq.v1",
          "内容": "AESD症例のrs16944（IL1B）のgenotype",
          "制限": "非制限公開",
          "公開日": "2022/05/23"
        },
        "hum0347.v2.gwas.v1": {
          "データID": "hum0347.v2.gwas.v1",
          "内容": "AESD症例のGWAS統計情報",
          "制限": "非制限公開",
          "公開日": "2022/07/15"
        }
      },
      "研究内容の概要": {
        "目的": "急性脳症に関連があると考えられる候補遺伝子解析と全ゲノム解析を通して、急性脳症の疾患感受性遺伝子を探索すること。また、関連が検出された遺伝子の機能解析により、急性脳症の病態機序を明らかにすることで、治療法・予防法の確立も目指す。",
        "方法": "末梢血から抽出したDNAを用いたサンガー法による塩基配列決定およびゲノムワイド関連解析",
        "対象": "塩基配列決定：けいれん重積型急性脳症（acute encephalopathy with biphasic seizures and late reduced diffusion：AESD） 283症例",
        "URL": "https://encephalopathy.jp"
      },
      "分子データ": {
        "hum0347.v1.freq.v1": {
          "対象": "けいれん重積型急性脳症 （ICD-10：G934）：283症例",
          "規模": "rs16944（IL1B）",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "310 Genetic Analyzer、3100 Genetic Analyzer、3130xl Genetic Analyzer （Life Technologies）",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "AmpliTaq PCR kits、the Big Dye Terminator FS ready-reaction kit （Applied Biosystems）\r\nPCR product presequencing kit （Amersham Biosciences）",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Applied Biosystems™ Sequence Scanner Software v2.0",
          "NBDC Dataset ID": "hum0347.v1.freq.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）",
          "総データ量": "18 KB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0347.v2.gwas.v1": {
          "対象": "けいれん重積型急性脳症 （ICD-10：G934）：254症例\r\n対照健常者：799名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Japonica Array Ⓡ v2]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Axiom 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Affymetrix Power Tools ver. 1.18.2",
          "フィルタリング": "以下の条件のものを除外：\r\nサンプルQC：\r\n（１） Sample Call rate < 0.97\r\n（２） 血縁関係者（PI_HAT > 0.1875）\r\n（３） サンプル集団中主成分分析により、見かけ上外れ値となったサンプル\r\nSNP QC：\r\n（１） SNP call rate < 0.99\r\n（２） HWE P < 0.0001\r\n（３） MAF < 0.05\r\n（４） 性染色体とミトコンドリア上に位置しているSNP",
          "マーカー数（QC後）": "常染色体：445,917 SNPs（ref：hg19）",
          "解析手法（ソフトウェア）": "PLINK（v1.9）",
          "NBDC Dataset ID": "hum0347.v2.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "35 MB（csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "水口 雅",
        "所 属 機 関": "東京大学大学院 医学系研究科 発達医科学分野",
        "プロジェクト/研究グループ名": "急性脳症の包括的遺伝子解析",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Association of IL-1B rs16944 polymorphism with acute encephalopathy with biphasic seizures and late reduced diffusion is opposite to that with febrile seizures.",
          "DOI": "doi: 10.3389/fneur.2022.891721",
          "データID": "hum0347.v1.freq.v1"
        },
        "2": {
          "タイトル": "GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion",
          "DOI": "doi: 10.1038/s41598-021-04576-y",
          "データID": "hum0347.v2.gwas.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0347.v2": {
          "Research ID": "hum0347.v2",
          "公開日": "2022/07/15",
          "内容": "AESD症例のGWAS",
          "description": "AESD254症例および対照者799名の末梢血から抽出したDNAを用いて遺伝子型を決定し、GWASを実施した結果（統計情報）をcsvファイルにて提供する。\n"
        },
        "hum0347.v1": {
          "Research ID": "hum0347.v1",
          "公開日": "2022/05/16",
          "内容": "AESD症例のrs16944のgenotype",
          "description": "AESD283症例の末梢血から抽出したDNAを用いたrs16944（IL1B）のgenotypeをテキスト形式にて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0347.v2",
      "DATA": {
        "hum0347.v1.freq.v1": {
          "Data Set ID": "hum0347.v1.freq.v1",
          "Type of Data": "rs16944 genotype of AESD patients",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/05/23"
        },
        "hum0347.v2.gwas.v1": {
          "Data Set ID": "hum0347.v2.gwas.v1",
          "Type of Data": "GWAS for AESD",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/07/15"
        }
      },
      "SUMMARY": {
        "Aims": "The objective of our study is that explore susceptibility genes for acute encephalopathy (AE). The ultimate purpose of our research is to elucidate the pathology of AE and to establish early diagnosis and specific treatment.",
        "Methods": "Peripheral blood samples were collected from the AE with biphasic seizures and late reduced diffusion (AESD) patients. DNA extraction and PCR were conducted, then PCR amplicons were subjected to the sequencing analysis by the Sanger method or performed a genome-wide association study using genotyping data obtained from SNP chip.",
        "Participants/Materials": "Sequencing analysis: 283 AESD patients"
      },
      "MOLECULAR DATA": {
        "hum0347.v1.freq.v1": {
          "Participants/Materials": "AESD (ICD-10: G934) : 283 cases",
          "Targets": "rs16944 (IL1B)",
          "Target Loci for Capture Methods": "-",
          "Platform": "310 Genetic Analyzer, 3100 Genetic Analyzer, 3130xl Genetic Analyzer (Life Technologies)",
          "Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "AmpliTaq PCR kits, the Big Dye Terminator FS ready-reaction kit (Applied Biosystems)\r\nPCR product presequencing kit (Amersham Biosciences)",
          "Genotype Call Methods (software)": "Applied Biosystems™ Sequence Scanner Software v2.0",
          "NBDC Dataset ID": "hum0347.v1.freq.v1\r\n(Click the Dataset ID to download the file)",
          "Total Data Volume": "18 KB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0347.v2.gwas.v1": {
          "Participants/Materials": "AESD (ICD-10: G934): 254 cases\r\nhealthy adult controls: 799 individuals",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Japonica Array v.2]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Axiom 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "Affymetrix Power Tools ver. 1.18.2",
          "Filtering": "Exclude the following conditions:\r\nSample QCs:\r\n(1) overall call rates < 0.97\r\n(2) relatives (PI_HAT > 0.1875)\r\n(3) outliers from Japanese cluster by principal component analysis\r\nSNP QCs:\r\n(1) SNP call rate < 0.99\r\n(2) HWE P < 0.0001\r\n(3) MAF < 0.05\r\n(4) located in sex chromosomes or mitochondria",
          "Marker Number (after QC)": "445,917 SNPs (ref: hg19)",
          "Analysis Method (software)": "PLINK (v1.9)",
          "NBDC Dataset ID": "hum0347.v2.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "35 MB (csv)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masashi Mizuguchi",
        "Affiliation": "Graduate School of Medicine, Department of Developmental Medical Sciences, The University of Tokyo",
        "Project / Group Name": "Comprehensive genetic analysis of acute encephalopathy",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Association of IL-1B rs16944 polymorphism with acute encephalopathy with biphasic seizures and late reduced diffusion is opposite to that with febrile seizures.",
          "DOI": "doi: 10.3389/fneur.2022.891721",
          "Data Set ID": "hum0347.v1.freq.v1"
        },
        "2": {
          "Title": "GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion",
          "DOI": "doi: 10.1038/s41598-021-04576-y",
          "Data Set ID": "hum0347.v2.gwas.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0347.v2": {
          "Research ID": "hum0347.v2",
          "Release Date": "2022/07/15",
          "Type of Data": "GWAS for AESD patients",
          "description": "DNAs extracted from peripheral blood cells of 254 AESD patients and 799 healthy adult controls were genotyped and a genome-wide association study was performed. Statistical analysis data is provided as a csv file.\n"
        },
        "hum0347.v1": {
          "Research ID": "hum0347.v1",
          "Release Date": "2022/05/16",
          "Type of Data": "rs16944 genotype of AESD patients",
          "description": "DNAs extracted from peripheral blood cells of 283 AESD patients were genotyped by using of 310 Genetic Analyzer, 3100 Genetic Analyzer or 3130xl Genetic Analyzer (txt files).\nNote：\n"
        }
      }
    }
  },
  "hum0345.v1": {
    "ja": {
      "NBDC Research ID": "hum0345.v1",
      "データ": {
        "JGAS000528\r\nJGAS000551": {
          "データID": "JGAS000528\r\nJGAS000551",
          "内容": "NGS（scRNA-seq）\r\nNGS（ATAC-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/08/05"
        }
      },
      "研究内容の概要": {
        "目的": "リンパ球系および樹状細胞の分化経路およびそのメカニズムをヒト臍帯血を用いて解明する",
        "方法": "臍帯血中のCD34陽性細胞、あるいは、CD34陽性細胞中のリンパ球系分画をソート後にストローマ細胞と共培養し、抽出したRNA/DNAを用いたsingle cell RNA-seqおよびATAC sequence解析。",
        "対象": "健常者の正常分娩後、臍帯より臍帯血 30～50 ml を採取し、２日以内にCD34 陽性細胞を分離・保存する。"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "scRNA-seq": {
          "対象": "健常者：30名（１．についてはATAC-seqも実施）",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "以下の臍帯血から分取したCD34 陽性細胞およびリンパ系分画から抽出したRNA\r\n　　１．健常者2名の臍帯血を混合し単離したCD34陽性細胞\r\n　　２．健常者30名の臍帯血を混合し単離したCD10SP細胞",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "　　１．Chromium Next GEM Single Cell Multiome ATAC ＋ Gene Expression（10x Genomics）\r\n　　２．10X Genomics Chromium",
          "断片化の方法": "　　酵素処理",
          "ライブラリ構築方法": "　　Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "　　１．118 bp\r\n　　２．300-500 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "　　１．JGAD000647\r\n　　２．JGAD000671",
          "総データ量": "　　１．76.6 GB（fastq）\r\n　　２．41.9 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ATAC-seq": {
          "対象": "健常者：2名（scRNA-seqも実施）",
          "規模": "ATAC-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "健常者2名の臍帯血を混合し単離したCD34陽性細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Next GEM Single Cell Multiome ATAC ＋ Gene Expression（10x Genomics）",
          "断片化の方法": "酵素処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "99 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000647",
          "総データ量": "76.6 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "大石 晃嗣",
        "所 属 機 関": "三重大学医学部附属病院 輸血・細胞治療部",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "先進ゲノム解析研究推進プラットフォーム",
            "研究課題番号": "16H06279"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0345.v1": {
          "Research ID": "hum0345.v1",
          "公開日": "2022/08/05",
          "内容": "NGS（scRNA-seq、ATAC-seq）",
          "description": "健常人2名の臍帯血より分取したCD34陽性細胞から抽出したRNA/DNAを対象としたscRNA-seqならびにATAC-seqを行った結果、および健常人30名の臍帯血より分取したCD10SP分画から抽出したRNAを対象としたscRNA-seqを行った結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0345.v1",
      "DATA": {
        "JGAS000528\r\nJGAS000551": {
          "Data Set ID": "JGAS000528\r\nJGAS000551",
          "Type of Data": "NGS (scRNA-seq)\r\nNGS (ATAC-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/08/05"
        }
      },
      "SUMMARY": {
        "Aims": " To clarify the differentiation pathway and mechanism of human lymphoid and dendritic cells from hematopoietic stem cells",
        "Methods": " CD34+ cells or target cells in CD34+ cells were sorted and assessed for scRNA-seq and ATAC-seq analyses. Obtained findings were evaluated by culture on a co-culture system.",
        "Participants/Materials": ""
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000525 (scRNA-seq)": {
          "Participants/Materials:": "30 healthy volunteers (ATAC-seq were also performed for 1. samples)",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from CD34+ cells or lymphoid fractions from mixed cord blood of healthy volunteers\r\n　　1. CD34+ cells from 2 volunteers' cord blood\r\n　　2. CD10SP fraction from 30 volunteers' cord blood",
          "Cell Lines": "-",
          "Library Construction (kit name)": "　　1. Chromium Next GEM Single Cell Multiome ATAC + Gene Expression (10x Genomics)\r\n　　2. 10X Genomics Chromium",
          "Fragmentation Methods": "　　Enzymatic fragmentation",
          "Spot Type": "　　Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "　　1. 118 bp\r\n　　2. 300-500 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "　　1. JGAD000647\r\n　　2. JGAD000671",
          "Total Data Volume": "　　1. 76.6 GB (fastq)\r\n　　2. 41.9 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000525 (ATAC-seq)": {
          "Participants/Materials:": "2 healthy volunteers",
          "Targets": "ATAC-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from CD34+ cells from 2 healthy volunteers' cord blood",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Next GEM Single Cell Multiome ATAC + Gene Expression (10x Genomics)",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "99 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000647",
          "Total Data Volume": "76.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kohshi Ohishi",
        "Affiliation": "Transfusion Medicine and Cell Therapy, Mie University Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "Platform for Advanced Genome Science",
            "Project Number": "16H06279"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0345.v1": {
          "Research ID": "hum0345.v1",
          "Release Date": "2022/08/05",
          "Type of Data": "NGS (scRNA-seq, ATAC-seq)",
          "description": "RNA/DNA extracted from CD34+ cells or lymphoid cells (CD10SP) from volunteers' cord blood were used for scRNA-seq and ATAC-seq analyses. Fastq files were provided.\nNote：\n"
        }
      }
    }
  },
  "hum0344.v2": {
    "ja": {
      "NBDC Research ID": "hum0344.v2",
      "データ": {
        "JGAS000533": {
          "データID": "JGAS000533",
          "内容": "NGS（WGS）\r\nNGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/08/04"
        },
        "JGAS000611": {
          "データID": "JGAS000611",
          "内容": "NGS（Amplicon-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/05/16"
        }
      },
      "研究内容の概要": {
        "目的": "日本人の腎臓がんにおけるゲノム変異を探索する",
        "方法": "全ゲノムシークエンス、トランスクリプトームシークエンス、ミトコンドリアDNAのアンプリコンシークエンス",
        "対象": "透析患者の腎臓がん、慢性腎臓病症例、および、HEK293細胞株"
      },
      "分子データ": {
        "WGS": {
          "対象": "終末期の腎臓がん （ICD10：C64）：38症例\r\n   腫瘍組織：38検体\r\n   非腫瘍組織もしくは末梢血：37検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "MGI Tech [MGISEQ-2000RS]",
          "ライブラリソース": "終末期の腎臓がんの腫瘍組織ならびに非腫瘍組織もしくは末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra II FS DNA Module and MGIEasy DNA library prep kit",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp または 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000652",
          "総データ量": "9.1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "終末期の腎臓がん （ICD10：C64）：26症例（WGSも実施）\r\n   腫瘍組織：26検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "終末期の腎臓がんの腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000652",
          "総データ量": "9.1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Amplicon-seq": {
          "対象": "慢性腎臓病ステージG1、G2、G4、G5 （ICD10：N18.1、N18.2、N18.4、N18.5）：77症例（78検体）\r\nHEK293細胞株：1検体",
          "規模": "Amplicon-seq",
          "対象領域（Target Captureの場合）": "ミトコンドリアゲノム",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "慢性腎臓病症例の非腫瘍組織およびHEK293細胞株から抽出したミトコンドリアDNA",
          "検体情報（購入の場合）": "293 [HEK-293] （American Type Culture Collection、CRL-1573™）",
          "ライブラリ作製方法（キット名）": "KAPA Hyper Prep Kit\r\nIllumina Adapter Index（TruSeq DNA CD Indexes、TruSeq DNA Single Indexes）",
          "断片化の方法": "超音波断片化 (Covaris)",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000740",
          "総データ量": "54 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 英刀",
        "所 属 機 関": "理化学研究所 生命医科学研究センター がん免疫基盤研究部門 がんゲノム研究チーム",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis",
          "DOI": "doi: 10.1093/hmg/ddac180",
          "データID": "JGAD000652"
        },
        "2": {
          "タイトル": "Mitochondrial DNA Mutations at Low-level Heteroplasmy in Chronic Kidney Disease",
          "DOI": "",
          "データID": "JGAD000740"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0344.v2": {
          "Research ID": "hum0344.v2",
          "公開日": "2023/05/16",
          "内容": "NGS（Amplicon-seq）",
          "description": "CKDステージG1、G2、G4、G5の慢性腎臓病77症例の非腫瘍組織およびHEK293細胞株1検体から抽出したミトコンドリアDNAを用いたAmplicon-seq解析データをfastqファイルにて提供する。\n"
        },
        "hum0344.v1": {
          "Research ID": "hum0344.v1",
          "公開日": "2022/08/04",
          "内容": "NGS（WGS、RNA-seq）",
          "description": "終末期の腎臓がん38症例の腫瘍組織ならびに37症例の非腫瘍組織もしくは末梢血より抽出したDNAを用いたWGS解析データ、ならびに、26症例の腫瘍組織より抽出したRNAを用いたRNA-seq解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0344.v2",
      "DATA": {
        "JGAS000535": {
          "Data Set ID": "JGAS000535",
          "Type of Data": "NGS (WGS)\r\nNGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/08/04"
        },
        "JGAS000611": {
          "Data Set ID": "JGAS000611",
          "Type of Data": "NGS (Amplicon-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/05/16"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate genomic alterations of Japanese biliary tract cancer",
        "Methods": "Whole genome sequencing analysis, transcriptome sequencing analysis, and amplicon sequencing analysis",
        "Participants/Materials": "Kidney cancer in endo-stage kidney disease, chronic kidney diseases, and HEK293 cell line",
        "URL": "https://www.riken.jp/en/research/labs/ims/genome_seq_anl/index.html"
      },
      "MOLECULAR DATA": {
        "WGS": {
          "Participants/Materials": "Kidney cancer (ICD10: C64) in endo-stage kidney disease: 38 cases (of these, 26 cases also underwent RNA-seq analysis)\r\n      tumor tissues: 38 samples\r\n      non-tumor tissues/peripheral blood cells: 37 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "MGI Tech [MGISEQ-2000RS]",
          "Library Source": "DNAs extracted from tumor tissues and non-tumor tissues/peripheral blood cells from kidney cancer in endo-stage kidney disease",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra II FS DNA Module and MGIEasy DNA library prep kit",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp or 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000652",
          "Total Data Volume": "9.1 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials:": "Kidney cancer (ICD10: C64) in endo-stage kidney disease: 26 cases (These were also undergone WGS analysis)\r\n      tumor tissues: 26 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor tissues from kidney cancer in endo-stage kidney disease",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000652",
          "Total Data Volume": "9.1 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Amplicon-seq": {
          "Participants/Materials": "Chronic kidney disease, CKD stage G1, G2, G4, G5 (ICD10: N18.1, N18.2, N18.4, N18.5): 77 cases (78 samples)\r\nHEK293 cell line: 1 sample",
          "Targets": "Amplicon-seq",
          "Target Loci for Capture Methods": "mitochondrial genome",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "mitochondrial DNAs extracted from non-tumor tissues from chronic kidney disease patients and HEK293 cell line",
          "Cell Lines": "293 [HEK-293] (American Type Culture Collection, CRL-1573™)",
          "Library Construction (kit name)": "KAPA Hyper Prep Kit\r\nIllumina Adapter Indexes (TruSeq DNA CD Indexes, TruSeq DNA Single Indexes)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000740",
          "Total Data Volume": "54 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hidewaki Nakagawa",
        "Affiliation": "Laboratory of Genome Sequencing Analysis, RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "Laboratory for Cancer Genomics",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis",
          "DOI": "doi: 10.1093/hmg/ddac180",
          "Data Set ID": "JGAD000652"
        },
        "2": {
          "Title": "Mitochondrial DNA Mutations at Low-level Heteroplasmy in Chronic Kidney Disease",
          "DOI": "",
          "Data Set ID": "JGAD000740"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0344.v2": {
          "Research ID": "hum0344.v2",
          "Release Date": "2023/05/16",
          "Type of Data": "NGS (Amplicon-seq)",
          "description": "Mitochondrial DNAs extracted from non-tumor tissues from chronic kidney disease patients and HEK293 cell line were used for Amplicon-seq analysis. Fastq files are provided.\n"
        },
        "hum0344.v1": {
          "Research ID": "hum0344.v1",
          "Release Date": "2022/08/04",
          "Type of Data": "NGS (WGS, RNA-seq)",
          "description": "DNAs and RNAs extracted from tumor tissues and non-tumor tissue/peripheral blood cells in kidney cancer in endo-stage kidney disease were used for WGS and RNA-seq analyses. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0343.v2": {
    "ja": {
      "NBDC Research ID": "hum0343.v2",
      "データ": {
        "hum0343.v1.covid19.v1": {
          "データID": "hum0343.v1.covid19.v1",
          "内容": "COVID19感染者のGWAS集計情報",
          "制限": "非制限公開",
          "公開日": "2022/05/26"
        },
        "hum0343.v1.count.v1": {
          "データID": "hum0343.v1.count.v1",
          "内容": "COVID19感染者末梢血のNGS（RNA-seq）から得られたリードカウントデータ",
          "制限": "非制限公開",
          "公開日": "2022/05/26"
        },
        "hum0343.v2.qtl.v1": {
          "データID": "hum0343.v2.qtl.v1",
          "内容": "COVID19感染者末梢血のRNA-seq解析データ・SNPアレイデータより算出したeQTL/sQTLサマリーデータ",
          "制限": "非制限公開",
          "公開日": "2022/06/14"
        }
      },
      "研究内容の概要": {
        "目的": "新型コロナウイルス感染症患者、無症候性感染者及び新型コロナウイルス感染症が疑われる患者の全ゲノムシーケンス、RNAシーケンス、超高精度HLA解析などを通して、重症化予測法システムの構築を行うことを目的とする。また、匿名化データを使用しCOVID-19の重症度予測などを数理モデルで解析する。",
        "方法": "ゲノムワイド関連解析、RNA-seq、eQTL/sQTL解析",
        "対象": "ゲノムワイド関連解析：日本人5682名 （COVID-19感染症患者：2393名、対照者：3289名）"
      },
      "分子データ": {
        "GWAS": {
          "対象": "[GWAS-1]\r\n　　COVID-19感染者 （ICD-10：U071）：2393症例、対照者：3289名\r\n[GWAS-2]\r\n　　[GWAS-1]のCOVID-19感染者の内、重症者：990症例、対照者：3289名\r\n[GWAS-3]\r\n　　[GWAS-1] の対象者の内65歳未満の者（COVID-19感染者：1484症例、対照者：2377名）\r\n[GWAS-4]\r\n　　[GWAS-3]の65歳未満のCOVID19感染者の内、重症者：440症例、対照者：2377名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium Asian Screening Array]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium Asian Screening Array",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "genotyping： GenomeStudio\r\nhaplotype phasing： SHAPEIT4（autosome）、SHAPEIT2（X-chromosome）\r\nimputation： Minimac4",
          "関連解析（ソフトウェア）": "PLINK2",
          "フィルタリング": "SampleのQC： We excluded samples with\r\n      (1) sample call rate < 0.97\r\n      (2) excess heterozygosity of genotypes > mean + 3SD\r\n      (3) related samples with PI_HAT > 0.175\r\n      (4) outlier samples from East Asian clusters in principal component analysis with 1000 Genomes Project samples.\r\nGenotypingのQC： We excluded variants with \r\n      (1) variant call rate < 0.99\r\n      (2) significant call rate differences between cases and controls with P < 5.0×10-8\r\n      (3) deviation from Hardy-Weinberg equilibrium with P < 1.0×10-6\r\n      (4) minor allele count < 5\r\nImputation後のQC： MAF ≥ 0.1% and imputation score (Rsq) > 0.5",
          "マーカー数(QC後)": "[GWAS-1] 13,484,569バリアント\r\n[GWAS-2] 13,199,053バリアント\r\n[GWAS-3] 13,241,602バリアント\r\n[GWAS-4] 12,764,136バリアント",
          "NBDC Dataset ID": "hum0343.v1.covid19.v1\r\n[GWAS-1][GWAS-2][GWAS-3][GWAS-4]\r\n（データのダウンロードは各GWAS番号をクリックしてください）\r\nDictionary file",
          "総データ量": "[GWAS-1] 361 MB\r\n[GWAS-2] 354 MB\r\n[GWAS-3] 354 MB\r\n[GWAS-4] 343 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "COVID-19感染者（ICD-10：U071）：473症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq6000]",
          "ライブラリソース": "末梢血より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext® Poly(A) mRNA Magnetic Isolation Module、NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina",
          "断片化の方法": "Mg2+含有バッファー中94°C 15分間にて加熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "マッピング方法": "Adapter removal： Trimmomatic (v0.39)\r\nAlignment： STAR (v2.7.9a)\r\nAnnotation： GENCODE v30",
          "リファレンス配列": "GRCh38/hg38",
          "リードカウント決定アルゴリズム（ソフトウェア）": "Gene level quantification and normalization： RSEM (v1.3.3)",
          "フィルタリング（QC）方法": "median transcripts per kilobase million (TPM) > 10",
          "遺伝子数": "5991",
          "NBDC Dataset ID": "hum0343.v1.count.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nサンプル情報",
          "総データ量": "6 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "eQTL/sQTL解析": {
          "対象": "COVID-19感染者（ICD-10：U071）：465症例 （重症者 359名、軽症者 106名）",
          "規模": "eQTL/sQTL要約統計量",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "RNA-seq：Illumina [NovaSeq6000]\r\nSNPアレイデータ：Illumina [Infinium Asian Screening Array]",
          "ライブラリソース": "RNA-seqで得られたfastqデータ、およびGWASで用いられたSNPアレイデータ",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "RNA-seq：RNA-seqを参照\r\nSNPアレイデータ：GWASを参照",
          "リードカウント決定アルゴリズム（ソフトウェア）": "Gene level quantification and normalization： RSEM (v1.3.3)\r\nIntron cluster quantification： LeafCutter（ v0.2.7）",
          "フィルタリング（QC）方法": "GTEx パイプライン （https://github.com/broadinstitute/gtex-pipeline/）に準拠",
          "eQTL（cis）検出方法": "各遺伝子転写開始点に関して、+-1Mb以内に存在する（= cis）変異（頻度>1%）のeQTL効果をfastQTLを用い検定した。 \r\np値が0.05以下である変異-遺伝子組の、変異頻度、p値、効果量、原因変異確率の推定値（=PIP）をsummary dataとした。",
          "eQTL（trans）検出方法": "各遺伝子転写開始点に関してtrans-eQTL効果はtensorQTLを用い検定した。 \r\np値が5.0*10^8以下である変異-遺伝子組の、変異頻度、p値、効果量をsummary dataとした。",
          "sQTL検出方法": "各イントロン分岐点に関して、+-1Mb以内に存在する変異（頻度>1%）のsQTL効果をfastQTLを用い検定した。\r\np値が0.05以下である変異-イントロン領域組の、変異頻度、p値、効果量、PIPをsummary dataとした。",
          "NBDC Dataset ID": "hum0343.v2.qtl.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "714 MB （tsv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "福永 興壱",
        "所 属 機 関": "慶應義塾大学医学部 呼吸器内科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "6": {
            "科研費・助成金名": "科学研究費補助金 基盤研究（Ａ）",
            "タイトル": "横断的オミクス解析と全ゲノムシークエンスを駆使した疾患病態と組織特異性 の解明",
            "研究課題番号": "19H01021"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "DOCK2 is involved in the host genetics and biology of severe COVID-19",
          "DOI": "doi: 10.1038/s41586-022-05163-5",
          "データID": "hum0343.v1.covid19.v1hum0343.v1.count.v1hum0343.v2.qtl.v1"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0343.v2": {
          "Research ID": "hum0343.v2",
          "公開日": "2022/06/14",
          "内容": "COVID19感染者のRNA-seq解析データ・SNPアレイデータを使用し、算出したeQTL/sQTLサマリーデータ",
          "description": "COVID19感染者473症例の末梢血から抽出したRNAを用いたRNA-seq解析データおよびDNAを用いたSNPアレイデータを使用し、算出したeQTL/sQTLサマリーデータをテキスト形式にて提供する。\n"
        },
        "hum0343.v1": {
          "Research ID": "hum0343.v1",
          "公開日": "2022/05/26",
          "内容": "COVID19感染者のGWAS統計データ、NGS（RNA-seq）リードカウントデータ",
          "description": "COVID19感染者2393名および対照者3289名の末梢血から抽出したDNAを用いたSNPアレイデータによるGenotypingデータのGWAS統計データ、並びに、473症例の末梢血から抽出したRNAを用いたRNA-seq解析データのリードカウントデータをテキスト形式にて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0343.v2",
      "DATA": {
        "hum0343.v1.covid19.v1": {
          "Data Set ID": "hum0343.v1.covid19.v1",
          "Type of Data": "GWAS for COVID-19",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/05/26"
        },
        "hum0343.v1.count.v1": {
          "Data Set ID": "hum0343.v1.count.v1",
          "Type of Data": "NGS (RNA-seq) for COVID-19",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/05/26"
        },
        "hum0343.v2.qtl.v1": {
          "Data Set ID": "hum0343.v2.qtl.v1",
          "Type of Data": "eQTL/sQTL summary statistics for COVID-19",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/06/14"
        }
      },
      "SUMMARY": {
        "Aims": "To construct a prediction system for severe disease through whole genome sequencing, RNA sequencing, and ultra-high-precision HLA analysis of patients with COVID-19, asymptomatic infected patients, and patients suspected of having novel coronavirus infection. In addition, we will use anonymized data to analyze the prediction of severity of COVID-19 using mathematical models.",
        "Methods": "Genome-wide association study (GWAS), RNA-seq, eQTL/sQTL study",
        "Participants/Materials": "GWAS: 5682 Japanese individuals (2393 COVID-19 infected patients and 3289 controls)　"
      },
      "MOLECULAR DATA": {
        "GWAS": {
          "Participants/Materials": "[GWAS-1]\r\n   COVID-19 (ICD-10: U071): 2393 cases, Healthy controls: 3289 individuals\r\n[GWAS-2]\r\n   Severe COVID-19: 990 cases and 3289 healthy controls from [GWAS-1]\r\n[GWAS-3]\r\n   COVID-19 under age 65: 1,484 cases and 2,377 healthy controls under age 65 from [GWAS-1]\r\n[GWAS-4]\r\n   Severe COVID-19 under age 65: 440 cases and 2,377 healthy controls under age 65 from [GWAS-3]",
          "Targets": "Genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium Asian Screening Array]",
          "Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Infinium Asian Screening Array",
          "Genotype Call Methods (software)": "genotyping: GenomeStudio\r\nhaplotype phasing: SHAPEIT4 (autosome), SHAPEIT2 (X-chromosome)\r\nimputation: Minimac4",
          "Association Analysis (software)": "PLINK2",
          "Filtering Methods": "Sample QC: We excluded samples with\r\n      (1) sample call rate < 0.97\r\n      (2) excess heterozygosity of genotypes > mean + 3SD\r\n      (3) related samples with PI_HAT > 0.175\r\n      (4) outlier samples from East Asian clusters in principal component analysis with 1000 Genomes Project samples.\r\nGenotyping QC: We excluded variants with \r\n      (1) variant call rate < 0.99\r\n      (2) significant call rate differences between cases and controls with P < 5.0×10-8\r\n      (3) deviation from Hardy-Weinberg equilibrium with P < 1.0×10-6\r\n      (4) minor allele count < 5\r\nImputation QC: MAF ≥ 0.1% and imputation score (Rsq) > 0.5",
          "Marker Number (after QC)": "[GWAS-1] 13,484,569 variants \r\n[GWAS-2] 13,199,053 variants \r\n[GWAS-3] 13,241,602 variants\r\n[GWAS-4] 12,764,136 variants",
          "NBDC Dataset ID": "hum0343.v1.covid19.v1\r\n[GWAS-1][GWAS-2][GWAS-3][GWAS-4]\r\n(Click the gwas number to download files)\r\nDictionary file",
          "Total Data Volume": "[GWAS-1] 361 MB\r\n[GWAS-2] 354 MB\r\n[GWAS-3] 354 MB\r\n[GWAS-4] 343 MB",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "COVID-19 (ICD-10: U071): 473 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq6000]",
          "Library Source": "RNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext® Poly(A) mRNA Magnetic Isolation Module and NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "Incubation in the buffer containing Mg2+ at 94°C for 15 minutes",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Mapping Methods": "Adapter removal: Trimmomatic (v0.39)\r\nAlignment: STAR (v2.7.9a)\r\nAnnotation: GENCODE v30",
          "Reference Genome Sequence": "GRCh38/hg38",
          "Detecting method for read count (software)": "Gene level quantification and normalization: RSEM (v1.3.3)",
          "QC": "median transcripts per kilobase million (TPM) > 10",
          "Gene Number": "5991",
          "NBDC Dataset ID": "hum0343.v1.count.v1\r\n(Click the Dataset ID to download the file)\r\nSample Information",
          "Total Data Volume": "6 MB",
          "Comments (Policies)": "NBDC policy"
        },
        "eQTL/sQTL study": {
          "Participants/Materials": "COVID-19 (ICD-10: U071): 473 cases",
          "Targets": "eQTL/sQTL summary statistics",
          "Target Loci for Capture Methods": "-",
          "Platform": "RNA-seq: Illumina [NovaSeq6000]\r\nSNP array data: Illumina [Infinium Asian Screening Array]",
          "Library Source": "read count data of RNA-seq and SNP array data of GWAS",
          "Cell Lines": "-",
          "Library Construction (kit name)": "RNA-seq: See RNA-seq\r\nSNP array data: See GWAS",
          "Detecting method for read count (software)": "Gene level quantification and normalization: RSEM (v1.3.3)\r\nIntron cluster quantification: LeafCutter (v0.2.7)",
          "QC": "Following GTEx pipeline (https://github.com/broadinstitute/gtex-pipeline/)",
          "Detection method of eQTL (cis)": "The eQTL effects of common (>1%) variants in cis (<+-1Mb) window of transcription sites were tested using fastQTL. Variant-gene pairs with cis-eQTL p-value<0.05, annotated with allele frequency (AF), p-value, effect size (beta) and posterior inclusion probability (PIP) were summarized.",
          "Detection method of eQTL (trans)": "Trans-eQTL effects were tested using tensorQTL. Variant-gene pairs with trans-eQTL p-value <5*10^-8, annotated with AF, p-value and beta were summarized.",
          "Detection method of sQTL": "The sQTL effects of common (>1%) variants in cis (<+-1Mb) window of intron cluster start sites were tested using fastQTL. Variant-intron cluster pairs with cis-sQTL p-value<0.05, annotated with AF, p-value, beta and PIP were summarized.",
          "NBDC Dataset ID": "hum0343.v2.qtl.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "714 MB (tsv)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koichi Fukunaga",
        "Affiliation": "Department of Medicine, Pulmonary Division, Keio University School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "6": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (A)",
            "Title": "Elucidation of tissue-specificity of disease biology using trans-layer omics analysis and whole-genome sequencing",
            "Project Number": "19H01021"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "DOCK2 is involved in the host genetics and biology of severe COVID-19",
          "DOI": "doi: 10.1038/s41586-022-05163-5",
          "Data Set ID": "hum0343.v1.covid19.v1hum0343.v1.count.v1hum0343.v2.qtl.v1"
        },
        "": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0343.v2": {
          "Research ID": "hum0343.v2",
          "Release Date": "2022/06/14",
          "Type of Data": "eQTL/sQTL summary statistics for COVID-19",
          "description": "RNAs and DNAs extracted from peripheral blood cells of 473 COVID-19 infected patients were used for RNA sequencing and SNP array analyses. eQTL/sQTL summary statistics (text file) are provided.\n"
        },
        "hum0343.v1": {
          "Research ID": "hum0343.v1",
          "Release Date": "2022/05/26",
          "Type of Data": "GWAS and NGS (RNA-seq) for COVID-19",
          "description": "GWAS\nDNAs extracted from peripheral blood cells of 2393 COVID-19 infected patients and 3289 controls were genotyped by using of Illumina Infinium Asian Screening Array and genome-wide association studies were performed (txt files).\nRNA-seq\nRNAs extracted from peripheral blood cells of 473 COVID-19 infected patients were used for RNA sequencing analysis. The read count data (text file) is provided.\nNote：\n"
        }
      }
    }
  },
  "hum0342.v1": {
    "ja": {
      "NBDC Research ID": "hum0342.v1",
      "データ": {
        "JGAS000538": {
          "データID": "JGAS000538",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/06/27"
        }
      },
      "研究内容の概要": {
        "目的": "主に消化器腫瘍を対象として遺伝子変異・発現および蛋白発現の統合的な解析を行うことで、それらの所見と病理組織所見、および臨床病理学的所見との相関を明らかにし、組織病理診断や分子病理学診断に応用可能な新たな組織型特異的マーカー・予後因子の探索を行う。",
        "方法": "RSPO融合陽性大腸癌症例に対してwhole exome sequencing解析を実施した。",
        "対象": "大腸がん"
      },
      "分子データ": {
        "JGAS000538": {
          "対象": "大腸がん（ICD10：C18）：29症例\r\n   腫瘍組織：29検体、非腫瘍組織：29検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6",
          "断片化の方法": "超音波断片化 （Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "2 × 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000657",
          "総データ量": "512.8 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "関根 茂樹",
        "所 属 機 関": "国立研究開発法人国立がん研究センター中央病院 病理診断科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "黒住医学研究振興財団研究助成",
            "タイトル": "RNA in situ hybridization法を用いた大腸癌および胃癌におけるRSPO遺伝子融合/過剰発現の効率的な検出法の開発",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer",
          "DOI": "doi: 10.1038/s41416-022-01880-w",
          "データID": "JGAD000657"
        },
        "": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0342.v1": {
          "Research ID": "hum0342.v1",
          "公開日": "2022/06/27",
          "内容": "NGS（Exome）",
          "description": "RSPO融合陽性大腸がん29症例の腫瘍組織ならびに非腫瘍組織より抽出したDNAを用いたwhole exome sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0342.v1",
      "DATA": {
        "JGAS000538": {
          "Data Set ID": "JGAS000538",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/06/27"
        }
      },
      "SUMMARY": {
        "Aims": "We will conduct an integrated analysis of somatic mutations/expression and protein expression, mainly in gastrointestinal tumors. By correlating these findings with histopathological and clinicopathological findings, we will search for new tissue-specific markers and prognostic factors that can be applied to histopathological and molecular pathological diagnosis.",
        "Methods": "Whole exome sequencing (WES) was conducted using tumor and non-tumor tissues obtained from RSPO fusion-positive cases.",
        "Participants/Materials": "colorectal cancer"
      },
      "MOLECULAR DATA": {
        "JGAS000538": {
          "Participants/Materials": "Colorectal cancer (ICD10: C18): 29 cases\r\n   tumor tissues: 29 samples, non-tumor tissues: 29 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "2ｘ150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000657",
          "Total Data Volume": "512.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shigeki Sekine",
        "Affiliation": "Department of Diagnostic Pathology, National Cancer Center Hospital",
        "Project / Group Name": " -",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Kurozumi Medical Foundation",
            "Title": "Efficient detection of RSPO gene fusion/overexpression in colorectal and gastric cancers using RNA in situ hybridization",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer",
          "DOI": "doi: 10.1038/s41416-022-01880-w",
          "Data Set ID": "JGAD000657"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0342.v1": {
          "Research ID": "hum0342.v1",
          "Release Date": "2022/06/27",
          "Type of Data": "NGS (Exome)",
          "description": "DNA extracted from tumor tissues and non-tumor tissues obtained from 29 RSPO fusion-positive cases were used for whole exome sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0340.v1": {
    "ja": {
      "NBDC Research ID": "hum0340.v1",
      "データ": {
        "JGAS000520": {
          "データID": "JGAS000520",
          "内容": "NGS （WGS、Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/08/04"
        }
      },
      "研究内容の概要": {
        "目的": "成人がんと比べて小児がんは患者数が極端に少なく、疾患も多岐に渡るため、小児がん特有の遺伝子異常やエピジェネティックな異常については十分に解明されていないのが現状である。我々の施設は全国15施設ある小児がん拠点病院の1つに認定されており、九州圏内から小児がん患者が集約されている。治療抵抗性の再発・難治症例、標準治療が確立していない希少がん症例も多数経験しており、各症例の詳細な臨床情報も保存されている。今回、私達は当院で経験した本研究に同意を得た小児固形腫瘍患者の腫瘍組織、正常組織および生殖細胞組織を用いた網羅的ゲノム解析を行い、臨床情報と照らし合わせ、病態の解明ならびに標的治療薬の可能性を検討する。また、成人がん症例のゲノム情報と比較し、小児がん特有の異常を解明する。",
        "方法": "ホルマリン固定パラフィン包埋（FFPE）組織を対象として異なる方法によりDNA抽出・ライブラリ調整を行い、whole genome sequencing（WGS）解析ならびにTarget Capture sequencing（TCS）解析データを比較する。"
      },
      "分子データ": {
        "WGS": {
          "対象": "成人大腸がん（ICD10：C189） ： 24症例\r\n     FFPEの非腫瘍組織：24 検体\r\n     上記24検体とは異なるライブラリ調整法：4検体\r\n小児網膜芽腫（ICD10：C692）：1症例\r\n     FFPE腫瘍組織：3検体（2つの方法でライブラリ調整、片方は2回実施）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Hiseq X Ten]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Thru PLEX DNA-Seq Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100-200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000640",
          "総データ量": "175.1 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture": {
          "対象": "成人膠芽腫（ICD10：C719）：2症例\r\n     血液：2検体\r\n　 凍結腫瘍組織：2検体（それぞれの症例から1検体ずつ）\r\n　 FFPE腫瘍組織：8検体（2回ずつ条件変更をして2つの方法でライブラリ調整）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "12種のがんに共通して変異が観察される127遺伝子（xGen® Pan-Cancer Panel v1.5）",
          "Platform": "Illumina [Hiseq X Ten]",
          "ライブラリソース": "腫瘍組織および末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Thru PLEX DNA-Seq Kit",
          "断片化の方法": "超音波断片化（Covaris S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000640",
          "総データ量": "175.1 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "大場 詩子",
        "所 属 機 関": "九州大学大学院 医学研究院 成長発達医学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "An efficient procedure for the recovery of DNA from formalin-fixed paraffin-embedded tissue sections",
          "DOI": "doi: 10.1093/biomethods/bpac014",
          "データID": "JGAD000640"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0340.v1": {
          "Research ID": "hum0340.v1",
          "公開日": "2022/08/04",
          "内容": "NGS （WGS、Target Capture）",
          "description": "成人大腸がん24症例のホルマリン固定パラフィン包埋（FFPE）非腫瘍組織28検体および小児網膜芽腫1症例のFFPE腫瘍組織から抽出したDNAを用いたwhole genome sequencing解析データ、ならびに、成人膠芽腫2症例（血液2検体、凍結腫瘍組織2検体、FFPE腫瘍組織8検体）から抽出したDNAを用いたTarget Capture Sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0340.v1",
      "DATA": {
        "JGAS000520": {
          "Data Set ID": "JGAS000520",
          "Type of Data": "NGS（WGS, Target Capture）",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/08/04"
        }
      },
      "SUMMARY": {
        "Aims": "Compared to adult cancer, pediatric cancer has an extremely small number of patients and a wide range of diseases, so the genetic and epigenetic abnormalities have not been fully elucidated. Our hospital is one of the 15 pediatric cancer base hospitals nationwide. We have experienced a large number of relapsed / refractory cancer cases, and detailed clinical information on each case is also preserved. We conducted a comprehensive genomic analysis using tumor tissue, non-tumor tissue, and germline tissue of pediatric solid tumor patients which we experienced at our hospital. In addition, we will clarify the abnormalities peculiar to pediatric cancer by comparing them with the genomic information of adult cancer cases.",
        "Methods": "We developed more efficient DNA extraction methods using FFPE tissues of pediatric and adult cancer patients and compared the data from whole genome sequencing (WGS) analysis and target capture sequencing (TCS) analysis."
      },
      "MOLECULAR DATA": {
        "WGS": {
          "Participants/Materials": "Adult colorectal cancer (ICD10: C189)：24 cases\r\n     FFPE non-tumor tissues: 28 samples\r\nChild retinoblastoma (ICD10: C692)：1 case\r\n     FFPE tumor tissues: 3 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Hiseq X Ten]",
          "Library Source": "DNAs extracted from FFPE normal tissues and FFPE tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Thru PLEX DNA-Seq Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100-200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000640",
          "Total Data Volume": "175.1 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture": {
          "Participants/Materials": "Adult glioblastoma (ICD10 : C719)：2 cases\r\n      blood cells: 2 samples\r\n      fresh frozen tumor tissues: 2 samples\r\n      FFPE tumor tissues: 8 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "127 mutated genes implicated across 12 tumor tissue types (xGen® Pan-Cancer Panel v1.5)",
          "Platform": "Illumina [Hiseq X Ten]",
          "Library Source": "DNAs extracted from peripheral blood cells, fresh frozen tumor tissues, and FFPE tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Thru PLEX DNA-Seq Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000640",
          "Total Data Volume": "175.1 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Utako Oba",
        "Affiliation": "Department of Pediatrics, Kyusyu University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "An efficient procedure for the recovery of DNA from formalin-fixed paraffin-embedded tissue sections",
          "DOI": "doi: 10.1093/biomethods/bpac014",
          "Data Set ID": "JGAD000640"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0340.v1": {
          "Research ID": "hum0340.v1",
          "Release Date": "2022/08/04",
          "Type of Data": "NGS (WGS, Target Capture）",
          "description": "DNAs extracted from FFPE non-tumor tissues of 24 adult patients with colorectal cancer and FFPE tumor tissues of 1 child patient with retinoblastoma were used for whole genome sequencing analysis. Fastq files are provided.\nDNAs extracted from blood samples, fresh frozen tumor tissues, and FFPE tumor tissues obtained from 2 adult patients with glioblastoma were used for the target capture sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0338.v1": {
    "ja": {
      "NBDC Research ID": "hum0338.v1",
      "データ": {
        "JGAS000575": {
          "データID": "JGAS000575",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/11/22"
        }
      },
      "研究内容の概要": {
        "目的": "2014年がんゲノムアトラス（The Cancer Genome Atlas：TCGA）を皮切りに、アジアがん研究グループ（Asian Cancer Research Group：ACRG）や東アジアの研究グループより全ゲノムシーケンスを含む複数の進行胃がんに関する報告があり、網羅的・包括的なゲノム解析データが集積・公開され、利用可能な状態になっている。ピロリ菌感染と付随する炎症は加齢と並んで胃がんの重要なリスク因子であり、ほとんどの胃がん患者でピロリ感染の痕跡が見られる。しかし、若年性でピロリ陰性の胃がんも少数存在し、そのような患者のゲノムプロファイルの詳細は不明である。本研究は、加齢やピロリ感染といった通常の胃がんの発がんに強く関与する因子を持たない患者集団に絞り、新たな発がん及びがんの進展の本質をなす分子異常の解明と新規治療標的の探索を行うことを目的とする。さらに、治療標的候補が同定された際には、in vitro, vivoで機能解析や生物学的意義を検証する。",
        "方法": "Whole Exome Sequencing解析",
        "対象": "ピロリ菌未感染胃がん：27症例、ピロリ菌感染胃がん：36症例"
      },
      "分子データ": {
        "JGAS000575": {
          "対象": "ピロリ菌未感染胃がん（ICD10：C169）：27症例\r\n    腫瘍組織：27検体、非腫瘍組織：27検体\r\nピロリ菌感染胃がん（ICD10：C169）：36症例\r\n    腫瘍組織：36検体、非腫瘍組織：36検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V4 + lincRNA、SureSelect Human All Exon V5 + lincRNA",
          "断片化の方法": "超音波断片化（Covaris E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000701",
          "総データ量": "3.8 TB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "森 誠一",
        "所 属 機 関": "がん研究会 がんプレシジョン医療研究センター 次世代がん研究シーズ育成プロジェクト",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genomic features of Helicobacter pylori-naïve diffuse-type gastric cancer",
          "DOI": "doi: 10.1002/path.6000",
          "データID": "JGAD000701"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0338.v1": {
          "Research ID": "hum0338.v1",
          "公開日": "2022/11/22",
          "内容": "NGS（Exome）",
          "description": "ピロリ菌未感染胃がん27症例、および、ピロリ菌感染胃がん36症例の腫瘍組織および非腫瘍組織から抽出したDNAを用いたwhole exome sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0338.v1",
      "DATA": {
        "JGAS000575": {
          "Data Set ID": "JGAS000575",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/11/22"
        }
      },
      "SUMMARY": {
        "Aims": "Comprehensive genome data for advanced gastric cancer have already been accumulated, widely published, and available including the Cancer Genome Atlas (TCGA) published in 2014 and the Asian Cancer Research Group (ACRG) in 2015. Aging and inflammation associated with H. pylori (HP) is an important risk factor for gastric cancer. HP shows evidence of infection in most gastric cancer patients. However, there are also a small number of juvenile and HP-negative gastric cancers, and the details of their genomic profile are unknown. This study narrows down to a patient population without factors such as aging and HP infection to elucidate the molecular abnormalities essential to new carcinogenesis and cancer progression, search for new therapeutic targets and to analyze the function of them to verify their biological significance in vitro and in vivo.",
        "Methods": "Whole Exome Sequencing Analysis",
        "Participants/Materials": "H. Pylori uninfected gastric cancer: 27 patients, H. Pylori infected gastric cancer: 36 patients"
      },
      "MOLECULAR DATA": {
        "JGAS000575": {
          "Participants/Materials": "H. Pylori uninfected gastric cancer (ICD10: C169): 27 cases\r\n    tumor tissue: 27 samples, non-tumor tissue: 27 samples\r\nH. Pylori infected gastric cancer (ICD10: C169): 36 cases\r\n    tumor tissue: 36 samples, non-tumor tissue: 36 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V4 + lincRNA, SureSelect Human All Exon V5 + lincRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000701",
          "Total Data Volume": "3 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Seiichi Mori",
        "Affiliation": "Cancer Precision Medicine Center, Japanese Foundation for Cancer Research",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genomic features of Helicobacter pylori-naïve diffuse-type gastric cancer",
          "DOI": "doi: 10.1002/path.6000",
          "Data Set ID": "JGAD000701"
        },
        "": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0338.v1": {
          "Research ID": "hum0338.v1",
          "Release Date": "2022/11/22",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor and non-tumor tissues of H. Pylori uninfected gastric cancer patients and H. Pylori infected gastric cancer patients were used for the whole exome sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0335.v1": {
    "ja": {
      "NBDC Research ID": "hum0335.v1",
      "データ": {
        "DRA014819": {
          "データID": "DRA014819",
          "内容": "NGS（Target Capture）",
          "制限": "非制限公開",
          "公開日": "2022/09/14"
        }
      },
      "研究内容の概要": {
        "目的": "急性リンパ性白血病、悪性リンパ腫、慢性リンパ性白血病、多発性骨髄腫などを含むリンパ増殖性疾患は、典型例を除きその診断は病理学的にも困難なことは稀ではなく、染色体分析や免疫形質、遺伝子異常を加味した診断が以前から行われている。近年の遺伝子異常に関する網羅的解析や免疫学的研究の進歩から、診断に結びつく新たな異常や特徴が続々と報告されているが、実臨床における診断はそうした変化に追いついていないのが現状である。現在リンパ増殖性疾患の診断は、2017年に発表されたWHO分類に基づいて行われているが、その中にもすでに実臨床の中に取り入れることができていない遺伝子検査や免疫形質の検査が多く盛り込まれている。そこで通常診療で行われていない遺伝子変異を網羅的に解析し、免疫形質の分析を行うことで得られた新たな診断と現状の病理診断における生命予後を含めた臨床像を比較検討する。",
        "方法": "ARID1A、NOTCH2、CXCR4、MYD88、PRDM1、CD274、PDCD1LG2、RAG2、KMT2D、MYBBP1A、TP53、CD79B のコーディング領域をカバーするプライマーを作成し、次世代シーケンサー（NextSeq 500）を使用したターゲットシーケンスを行った。GRCh37/hg19に基づいてアノテーションを行った後、以下の条件に該当する変異を除外した。Read Depth<500、Alt Variant Freq<5%（MYD88 L265Pは<1%）、global freq>1%または1000 Genomes ProjectにおいてEast Asian pop freq>1%、synonymous mutations、inflame mutations、SIFTが“tolerated”またはPolyPhenが“benign”のmissense mutations",
        "対象": "原発性マクログロブリン血症（Waldenström macroglobulinemia：WM）10症例およびnon IgM-typeリンパ形質細胞性リンパ腫 （lymphoplasmacytic lymphoma：LPL）10症例の各種検体から抽出したDNA"
      },
      "分子データ": {
        "DRA014819": {
          "対象": "WM （ICD10: C880）：10症例\r\n   骨髄単核球：5検体、末梢血単核球：1検体、骨髄ホルマリン固定パラフィン包埋（FFPE）検体：2検体、リンパ節FFPE検体：2検体\r\nnon IgM-type LPL （ICD10: C830）：10症例\r\n   骨髄単核球：3検体、末梢血単核球：3検体、骨髄FFPE検体：4検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "ARID1A、NOTCH2、CXCR4、MYD88、PRDM1、CD274、PDCD1LG2、RAG2、KMT2D、MYBBP1A、TP53、CD79B",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "骨髄単核球、末梢血単核球、骨髄FFPE検体およびリンパ節FFPE検体から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "AmpliSeq Custom DNA Panel for Illumina",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151 bp",
          "DDBJ Sequence Read Archive ID": "DRA014819",
          "総データ量": "9.9 GB（bam [ref：GRCh37/hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "横濱 章彦",
        "所 属 機 関": "群馬大学医学部附属病院 輸血部",
        "プロジェクト/研究グループ名": "「Waldenström macroglobulinemia and non-IgM-type lymphoplasmacytic lymphoma are genetically similar」",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "悪性リンパ腫におけるアミノ酸トランスポーターの解析と治療への応用",
            "研究課題番号": "16K10342"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0335.v1": {
          "Research ID": "hum0335.v1",
          "公開日": "2022/09/14",
          "内容": "NGS（Target Capture）",
          "description": "原発性マクログロブリン血症10症例およびnon IgM-type リンパ形質細胞性リンパ腫10症例の骨髄単核球、末梢血単核球、骨髄FFPE検体およびリンパ節FFPE検体から抽出したDNAを用いた12遺伝子領域のTarget Capture seq解析データをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0335.v1",
      "DATA": {
        "DRA014819": {
          "Data Set ID": "DRA014819",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/09/14"
        }
      },
      "SUMMARY": {
        "Aims": "Diagnosis of lymphoproliferative diseases, except for typical cases, is often pathologically difficult, and diagnosis has long been based on chromosome analysis, immunological traits, and genetic abnormalities. Recent advances in the comprehensive analysis of genetic abnormalities and immunological studies have led to a number of reports of new abnormalities and features that can lead to diagnosis, but diagnosis in clinical practice has not kept pace with these changes. In this study, we compared the clinical picture, including prognosis, of the current pathological diagnosis with that of a new diagnosis based on comprehensive analysis of genetic mutations and immunological traits that have not yet been incorporated into conventional clinical practice.",
        "Methods": "We created primers covering the coding regions of ARID1A, NOTCH2, CXCR4, MYD88, PRDM1, CD274, PDCD1LG2, RAG2, KMT2D, MYBBP1A, TP53, and CD79B and performed targeted sequencing using the NextSeq 500 next-generation sequencer. After annotation based on GRCh37/hg19, mutations that met the following criteria were filtered out: Read Depth < 500, Alt Variant Freq < 5% (< 1% on MYD88 L265P), global frequency > 1% or East Asian pop frequency > 1% based on 1000 Genomes Project, synonymous mutations, inflame mutations, and missense mutations scored “tolerated” by SIFT or “benign” by PolyPhen.",
        "Participants/Materials": "DNAs extracted from specimens from 10 cases of Waldenström macroglobulinemia and 10 cases of non IgM-type lymphoplasmacytic lymphoma (LPL)"
      },
      "MOLECULAR DATA": {
        "DRA014819": {
          "Participants/Materials": "Waldenström macroglobulinemia (ICD10: C880): 10 cases\r\n     5 bone marrow mononuclear cells\r\n     1 peripheral blood mononuclear cell\r\n     2 bone marrow formalin-fixed paraffin-embedded (FFPE) specimens\r\n     2 lymph node FFPE specimens\r\nnon IgM-type LPL (ICD10: C830): 10 cases\r\n     3 bone marrow mononuclear cells\r\n     3 peripheral blood mononuclear cells\r\n     4 bone marrow FFPE specimens",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "ARID1A, NOTCH2, CXCR4, MYD88, PRDM1, CD274, PDCD1LG2, RAG2, KMT2D, MYBBP1A, TP53, CD79B",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "DNAs extracted from bone marrow mononuclear cells, peripheral blood mononuclear cells, bone marrow FFPE specimens or lymph node FFPE specimens",
          "Cell Lines": "-",
          "Library Construction (kit name)": "AmpliSeq Custom DNA Panel for Illumina",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "151 bp",
          "DDBJ Sequence Read Archive ID": "DRA014819",
          "Total Data Volume": "9.9 GB (bam [ref：GRCh37/hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Akihiko Yokohama",
        "Affiliation": "Division of Blood Transfusion Service, Gunma University",
        "Project / Group Name": "\"Waldenström macroglobulinemia and non-IgM-type lymphoplasmacytic lymphoma are genetically similar\"",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Amino acid transporter in malignant lymphoma; its analysis and clinical application",
            "Project Number": "16K10342"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0335.v1": {
          "Research ID": "hum0335.v1",
          "Release Date": "2022/09/14",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from 10 cases of Waldenström macroglobulinemia and 10 cases of non IgM-type LPL were used for the target capture sequencing analysis using the NextSeq 500 next generation sequencer. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0332.v1": {
    "ja": {
      "NBDC Research ID": "hum0332.v1",
      "データ": {
        "JGAS000510": {
          "データID": "JGAS000510",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/05/30"
        }
      },
      "研究内容の概要": {
        "目的": "尿路性器がんの治療効果予測バイオマーカーの探索",
        "方法": "Whole Exome Sequencing解析（WES）",
        "対象": " 去勢抵抗性前立腺がん（castration-resistant prostate cancer: CRPC）症例から採取した腫瘍組織ならびに末梢血白血球"
      },
      "分子データ": {
        "JGAS000510": {
          "対象": "去勢抵抗性前立腺がん（ICD10：C61）：1症例　\r\n腫瘍組織 1検体、末梢血 1検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "CRPC1症例の腫瘍組織並びに末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelectXT Library Prep Kit",
          "断片化の方法": "超音波断片化 （Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000628",
          "総データ量": "13.4 GB （fastq、tab）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "赤松 秀輔",
        "所 属 機 関": "京都大学大学院医学研究科 泌尿器科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本学術振興会科学研究費補助金",
            "タイトル": "血中遊離DNA解析を応用した前立腺癌のDNA修復遺伝子異常の生物学的特性の解明",
            "研究課題番号": "20H03814"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A case of microsatellite instability-high clinically advanced castration-resistant prostate cancer showing a remarkable response to pembrolizumab sustained over at least 18 months",
          "DOI": "doi: 10.1101/mcs.a006194",
          "データID": "JGAD000628"
        },
        "": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0332.v1": {
          "Research ID": "hum0332.v1",
          "公開日": "2022/05/30",
          "内容": "NGS（Exome）",
          "description": "去勢抵抗性前立腺がん1症例の腫瘍組織、並びに、末梢血白血球から抽出したDNAを用いたWES解析データを提供する（fastq）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0332.v1",
      "DATA": {
        "JGAS000510": {
          "Data Set ID": "JGAS000510",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/05/30"
        }
      },
      "SUMMARY": {
        "Aims": "To detect predictive biomarkers for genitourinary cancer treatment.",
        "Methods": " Whole exome sequencing analysis",
        "Participants/Materials": " Genomic DNAs extracted from tumor tissues and leukocytes that were obtained from one castration-resistant prostate cancer (CRPC) patient."
      },
      "MOLECULAR DATA": {
        "JGAS000510": {
          "Participants/Materials": "CRPC (ICD10: C61):  1 case\r\n     tumor tissues, leukocytes: 1 sample each",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Nova Seq 6000]",
          "Library Source": "DNAs extracted from tumor tissues and leukocytes",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelectXT Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000628",
          "Total Data Volume": "13.4 GB (fastq, tab)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shusuke Akamatsu",
        "Affiliation": "Kyoto University Graduate School of Medicine Department of Urology",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Understanding the biological mechanisms of defective DNA damage repair in prostate cancer using cell-free DNA analysis",
            "Project Number": "20H03814"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A case of microsatellite instability-high clinically advanced castration-resistant prostate cancer showing a remarkable response to pembrolizumab sustained over at least 18 months",
          "DOI": "doi: 10.1101/mcs.a006194",
          "Data Set ID": "JGAD000628"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0332.v1": {
          "Research ID": "hum0332.v1",
          "Release Date": "2022/05/30",
          "Type of Data": "NGS (Exome)",
          "description": "Genomic DNAs extracted from tumor tissues and leukocytes that were obtained from one castration-resistant prostate cancer (CRPC) patient were used for WES analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0331.v1": {
    "ja": {
      "NBDC Research ID": "hum0331.v1",
      "データ": {
        "hum0331.v1.freq.v1": {
          "データID": "hum0331.v1.freq.v1",
          "内容": "NGS（WGS）",
          "制限": "非制限公開",
          "公開日": "2023/02/01"
        }
      },
      "研究内容の概要": {
        "目的": "難病やがんを対象としたゲノム医療の推進のため、全ゲノムシークエンス解析が進められている。疾患ゲノム解析の遂行には、疾患群の対照となる健常人コントロール群の全ゲノム解析データも必要である。国内の６つの国立高度専門医療研究センター（ナショナルセンター[National Centers: NC]）のバイオバンクにおいて収集し、地域性を考慮した検体から難病やがんに対するコントロール群を選定の上、全ゲノム解析を実施することで、コントロール群のゲノムデータベースを構築する。",
        "方法": "本研究の目的に適したDNAサンプルを各バイオバンクから選定し、受託解析機関で全ゲノムシークエンス（Whole genome sequencing：WGS）解析を実施する。WGS解析はPCRフリープロトコルによりライブラリを調整し、NovaSeq 6000シークエンサーにてリードを取得することで、最低90Gbの出力を得る。解析で得られたfastq形式のリードデータは研究代表機関（国立国際医療研究センター）において情報解析（マッピング・バリアントコール）を行い、バリアント情報を含むデータをデータベース化する。",
        "対象": "難病やがん研究のコントロール群として利用可能な健常者（難病やがんを罹患していない生活習慣病を持つ人を含む） 9850名の内、QCにより除外された560名を除く9290名",
        "URL": "https://ncbiobank.org/"
      },
      "分子データ": {
        "hum0331.v1.freq.v1": {
          "対象": "健常者（難病やがんを罹患していない生活習慣病を持つ人を含む）（ICD10：Z006）：9290名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ソース": "各バイオバンクから選定した健常者の末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free HT Library Prep Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "クオリティコントロール方法": "以下の条件で全ゲノムシークエンス解析を実施\r\n- ライブラリサイズが400bp-750bpであることを確認\r\n- QV30以上の塩基の割合が75%以上\r\n- FASTQCによる重複リード除去後の総塩基数が900億塩基以上\r\n \r\nアライメントとバリアントコール後に以下のサンプルを解析から除外した\r\n- Depthおよびマップ率が異常値を示すサンプル\r\n- 性染色体のDepthが臨床情報の性別と矛盾するサンプル\r\n- KINGプログラムで２親等以内と判定されたサンプルのいずれか\r\n \r\nバリアントコールの結果は以下のフィルタリングを実行した\r\n- GQ<20またはDP<11またはDP>64またはヘテロ接合体コールにおいてマイナーアリルの割合が25%未満のジェノタイプはno callに設定\r\n- VQSRの結果をVCFのFILTERフィールドにセット\r\n- コール率95%未満のバリアントにはFILTERにLowCRをセット\r\n- Hardy-Weinberg平衡検定のP値が10-6未満のバリアントにはFILTERにHWEをセット",
          "重複するリードの除去方法": "MarkDuplicates（GATK4.1.0）互換アルゴリズム（Parabricks 3.1.0 fq2bam）",
          "リアライメントおよびベースクオリティのキャリブレーション": "-",
          "マッピング方法": "bwa mem（v0.7.15）互換アルゴリズム（Parabricks 3.1.0 fq2bam）",
          "マッピングクオリティ": "MQによるハードフィルタリングは未実施",
          "マッピングの際のリファレンス配列": "GRCh38（+HLA+decoy）",
          "平均カバー率（Depth）": "34.0（常染色体）",
          "変異検出方法": "HaplotypeCaller（GATK4.1.0）互換アルゴリズム（Parabricks 3.1.0 haplotypecaller）",
          "SNV数（QC後）": "153,554,029（常染色体）\r\n6,325,046（X染色体）",
          "INDEL数（QC後）": "18,899,392（常染色体）\r\n836,126（X染色体）",
          "NBDC Dataset ID": "hum0331.v1.freq.v1\r\nhum0331.v1.freq-index.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nREADME",
          "総データ量": "69.24 GB（vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": " 徳永 勝士",
        "所 属 機 関": "国立国際医療研究センター ゲノム医科学プロジェクト",
        "プロジェクト/研究グループ名": "ナショナルセンターバイオバンクネットワーク",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0331.v1": {
          "Research ID": "hum0331.v1",
          "公開日": "2023/02/01",
          "内容": "がんや難病の研究のコントロールとして利用可能な健常者（難病やがんを罹患していない生活習慣病を持つ人を含む）群におけるWGS解析データより得られた頻度情報",
          "description": "がんや難病の研究のコントロールとして利用可能なNCBNのバイオバンクの登録者（難病やがんを罹患していない生活習慣病を持つ人を含む） 9850名のDNA検体をWGS解析した。国際1000人ゲノムプロジェクトが公開している高深度WGS解析の結果と合わせてJoint Callを行い、集団内頻度情報をvcfファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0331.v1",
      "DATA": {
        "hum0331.v1.freq.v1": {
          "Data Set ID": "hum0331.v1.freq.v1",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/02/01"
        }
      },
      "SUMMARY": {
        "Aims": "Whole genome sequencing is being promoted for better medical care of rare diseases and cancers. For these disease genome analyses, whole genome sequencing (WGS) analysis data of the healthy control group is necessary. We conducted WGS analysis of healthy individuals for cancers and rare diseases from biobank specimens held by six National Centers (NCs) Biobanks in Japan, taking regional variations into consideration, and construct a genome database of healthy individuals and disease control groups.",
        "Methods": "DNA samples that meet the criteria for the study will be shipped from the biobank and subjected to WGS analysis at a contract analysis laboratory. WGS analysis will be performed on a Novaseq6000 sequencer using a PCR-free protocol to obtain a minimum output of 90 Gb. The read data in fastq format obtained from the analysis will be subjected to data analysis (mapping and variant calling) at the principal institute (National Center for Global Health and Medicine), and the data including variant information will be made into a database.",
        "Participants/Materials": "A total of 9850 DNA samples from healthy individuals (including people with common complex diseases who do not have rare diseases or cancers) that can be utilized as controls for cancers and rare diseases studies. 560 were excluded after QC.",
        "URL": "https://ncbiobank.org/en/"
      },
      "MOLECULAR DATA": {
        "hum0331.v1.freq.v1": {
          "Participants/Materials": "Healthy individuals without any cancers or rare diseases (ICD10: Z006): 9850 individuals",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free HT Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "QC": "Whole genome sequencing analysis was performed under the following conditions.\r\n- Confirm library size is 400bp-750bp.\r\n- At least 75% of the bases are QV30 or better.\r\n- Total number of bases after removal of duplicate reads by FASTQC is more than 90 GBase. \r\n \r\nAfter alignment and variant calling, the following samples were excluded from the analysis. \r\n- Samples with abnormal values for depth and mapping rate.\r\n- Samples where the depth of the sex chromosome is inconsistent with the clinical information.\r\n- Any of the samples determined to be within the second degree of kinship in the KING program.\r\n \r\nVariant call results were filtered for the following\r\n- Genotypes with GQ64 or with less than 25% minor alleles in heterozygous calls are set to no call\r\n- Set VQSR results to FILTER field in VCF\r\n- Set LowCR in FILTER field for variants with less than 95% call rate\r\n- Variants with a Hardy-Weinberg equilibrium test P-value less than 10-6 have HWE set in FILTER field",
          "Deduplication": "MarkDuplicates (GATK4.1.0) compatible algorithm (Parabricks 3.1.0 fq2bam)",
          "Calibration for re-alignment and base quality": "-",
          "Mapping Methods": "bwa mem (v0.7.15) compatible algorithm (Parabricks 3.1.0 fq2bam)",
          "Mapping Quality": "No hard filtering was performaed by mapping quality.",
          "Reference Genome Sequence": "GRCh38 (+HLA+decoy)",
          "Detecting Methods for Variations": "34.0 (autosome)",
          "INDEL Numbers (after QC)": "HaplotypeCaller (GATK4.1.0) compatible algorithm (Parabricks 3.1.0 haplotypecaller)",
          "SNV Numbers (after QC)": "153,554,029 (autosomes)\r\n6,325,046 (chromosome X)",
          "Coverage (Depth)": "18,899,392 (autosomes)\r\n836,126 (chromosome X)",
          "NBDC Dataset ID": "hum0331.v1.freq.v1\r\nhum0331.v1.freq-index.v1\r\n(Click the Dataset ID to download the file)\r\nREADME",
          "Total Data Volume": "69.24 GB (vcf)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Katsushi Tokunaga",
        "Affiliation": " National Center for Global Health and Medicine Genome Medical Science",
        "Project / Group Name": " National Center Biobank Network",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0331.v1": {
          "Research ID": "hum0331.v1",
          "Release Date": "2023/02/01",
          "Type of Data": "Frequencies of variant information obtained from whole genome sequencing (WGS) analysis of 9850 participants without cancers or rare diseases",
          "description": " WGS analysis of DNA samples from 9850 individuals registered in the NCBN biobank, which is available as a control for cancer and rare disease studies. Joint Call was performed together with the results of high coverage WGS analysis published by the International 1000 Genomes Project, and the allele frequency information for each population is provided in VCF.\nNote：\n"
        }
      }
    }
  },
  "hum0328.v1": {
    "ja": {
      "NBDC Research ID": "hum0328.v1",
      "データ": {
        "JGAS000509": {
          "データID": "JGAS000509",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/05/11"
        }
      },
      "研究内容の概要": {
        "目的": "日本人進行前立腺がん患者における生殖細胞系列でのDNA修復関連遺伝子異常の頻度について調べる",
        "方法": "診断時に転移を有する、もしくは、治療中に去勢抵抗性を獲得した前立腺がん患者の血球DNAを収集した。これらの検体について27遺伝子の全エクソン領域を対象としたmultiple PCR-based target sequencingを実施した。",
        "対象": "診断時に転移を有する、もしくは治療中に去勢抵抗性を獲得した前立腺がん患者の内、データ公開について同意を受けている129症例"
      },
      "分子データ": {
        "JGAS000509": {
          "対象": "前立腺がん（ICD10：C61）：129症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "DNA修復に関わる27遺伝子（APC, ATM, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, MUTYH, NBN, NF1, PALB2, PMS2, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53）",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "multiplex PCR（対象遺伝子領域の抽出）：2x Platinum Multiplex PCR Master Mix\r\n2nd PCR（バーコード配列およびアダプター配列の付加）：KAPA HiFi DNA Polymerase",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000627",
          "総データ量": "7.3 GB（fasq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "赤松 秀輔",
        "所 属 機 関": "京都大学大学院医学研究科 泌尿器科学講座",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer",
          "DOI": "doi: 10.1038/s41416-022-01915-2",
          "データID": "JGAD000627"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0328.v1": {
          "Research ID": "hum0328.v1",
          "公開日": "2023/05/11",
          "内容": "NGS（Target Capture）",
          "description": "診断時に転移を有する、もしくは治療中に去勢抵抗性を獲得した前立腺がん129症例の末梢血から抽出したDNAを用いた、DNA修復に関わる27遺伝子の全エクソン領域のTarget Capture Sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0328.v1",
      "DATA": {
        "JGAS000509": {
          "Data Set ID": "JGAS000509",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/05/11"
        }
      },
      "SUMMARY": {
        "Aims": "To examine the frequency of germline variants in DNA repair-associated genes among advanced Japanese prostate cancer patients",
        "Methods": "Leukocyte DNA from patients with metastatic prostate cancer at diagnosis or those who developed castration resistance during treatment were collected from multiple institutions in Japan. Multiple PCR-based target sequences of entire exon regions of the 27 genes were conducted.",
        "Participants/Materials": "129 prostate cancer patients who were with metastasis at initial diagnosis or who developed castration-resistant prostate cancer during treatment and accepted data publication "
      },
      "MOLECULAR DATA": {
        "JGAS000509": {
          "Participants/Materials": "prostate cancer (ICD10: C61) : 129 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "27 DNA repair-associated genes (APC, ATM, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, MUTYH, NBN, NF1, PALB2, PMS2, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53)",
          "Platform": "Illumina [HiSeq2500]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "multiplex PCR: 2xPlatinum Multiplex PCR Master Mix\r\n2nd PCR: KAPA HiFi DNA Polymerase",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000627",
          "Total Data Volume": "7.3 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shusuke Akamatsu",
        "Affiliation": "Department of Urology, Graduate School of Medicine, Kyoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer",
          "DOI": "doi: 10.1038/s41416-022-01915-2",
          "Data Set ID": "JGAD000627"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0328.v1": {
          "Research ID": "hum0328.v1",
          "Release Date": "2023/05/11",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from peripheral blood cells of 129 prostate cancer patients who are with metstasis at intial diagnosis or who developed castration resistant prostate cancer during treatment were used for the target capture sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0327.v1": {
    "ja": {
      "NBDC Research ID": "hum0327.v1",
      "データ": {
        "JGAS000507": {
          "データID": "JGAS000507",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/02/25"
        }
      },
      "研究内容の概要": {
        "目的": "肝胆膵領域のがんは患者数が多いだけでなく、根治することが難しいがんである。 近年、遺伝子変異により新しく生じた変異ペプチドが、ネオアンチゲンとして免疫系に認識されることが報告され、それらを標的とした免疫療法の開発が国内外で進められている。腫瘍内に浸潤しているＴ細胞の中には、このような遺伝子変異に由来するペプチドを認識し、活性化、浸潤した細胞分画が含まれていると考えられる。腫瘍内に浸潤しているＴ細胞が多様なネオアンチゲンを認識排除できるならば、それらを応用することで、がんの持つ不均一性に対応できるがん免疫治療法と成り得る可能性がある。本研究では、肝胆膵領域のがんに有効な免疫療法を開発し、がんの新しい治療法として提案するため、患者間で異なるがんの遺伝子変異や抗原を同定し、それらを認識する多様なＴ細胞集団を用いた免疫治療法の実用性の検証を行う。",
        "方法": "外科的に切除された肝細胞がんおよび転移性肝がんから新鮮な正常組織と腫瘍組織を収集。それぞれの組織サンプル（直径2~5mm）からDNA/RNAを単離し、NextSeq 550（イルミナ）による全エキソームシーケンスまたはRNAシーケンスに用いた。",
        "対象": "2017年から2020年において、国立がん研究センター東病院で外科的切除術を受けた肝がん症例",
        "URL": "https://www.ncc.go.jp/jp/epoc/division/immunotherapy/kashiwa/030/020/20170728190117.html"
      },
      "分子データ": {
        "Exome": {
          "対象": "肝細胞がん（ICD10：C22.0）：28症例\r\n転移性肝がん（ICD10：C22.7）：18症例\r\n    （腫瘍組織および非腫瘍組織のペア）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 550]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT library preparation kit",
          "断片化の方法": "超音波断片化（Covaris S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000624",
          "総データ量": "1.0 TB（fastq、vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "肝細胞がん（ICD10：C22.0）：28症例\r\n転移性肝がん（ICD10：C22.7）：18症例\r\n    （腫瘍組織および非腫瘍組織のペア）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 550]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Library prep kit、SureSelect strand specific RNA",
          "断片化の方法": "超音波断片化（Covaris S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000624",
          "総データ量": "1.0 TB（fastq、tpmリスト）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "鈴木 利宙",
        "所 属 機 関": "国立がん研究センター 先端医療開発センター 免疫療法開発分野",
        "プロジェクト/研究グループ名": "がん個別化がんワクチン療法の開発",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "ブライトパス・バイオ株式会社との共同研究費",
            "タイトル": "完全個別化ネオアンチゲンワクチン療法の手法の開発",
            "研究課題番号": "C2017-054"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Development of antigen-prediction algorithm for personalized neoantigens vaccine using human leukocyte antigen transgenic mouse.",
          "DOI": "doi: 10.1111/cas.15291",
          "データID": "JGAD000624"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000624"
        }
      },
      "リリース情報": {
        "hum0327.v1": {
          "Research ID": "hum0327.v1",
          "公開日": "2022/02/25",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "肝細胞がんおよび転移性肝がんの腫瘍組織および非腫瘍組織から抽出したDNA/RNAを用いたwhole exome sequencingならびにRNA-seq解析データをfastq、vcf、tpmファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0327.v1",
      "DATA": {
        "JGAS000507": {
          "Data Set ID": "JGAS000507",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/02/25"
        }
      },
      "SUMMARY": {
        "Aims": "Cancers in the hepatobiliary and pancreatic regions are not only common but also difficult to cure. Recently, it has been reported that mutant peptides newly generated by genetic mutations are recognized by the immune system as neoantigens, and the development of immunotherapy targeting these peptides has been promoted. In this study, in order to develop effective immunotherapy for hepatobiliary and pancreatic cancers and to propose it as a new cancer therapy, we will first identify different genetic mutations and antigens in each patient with these cancers, and then verify the practicality of immunotherapy using a diverse population of T cells that recognize them.",
        "Methods": "Paired fresh normal and tumor tissues were collected from surgically resected HCC and mCRC. RNA and genomic DNA were extracted from tumor/normal tissues (2–5 mm in diameter) and used for whole exome sequencing or RNA sequencing with NextSeq 550 (Illumina).",
        "Participants/Materials": "Tumor tissues were collected from liver cancer patients, who were received surgical resection at the National Cancer Center Hospital East (NCCE) between 2017 and 2020.",
        "URL": "https://www.ncc.go.jp/en/epoc/division/immunotherapy/kashiwa/030/020/20170728190117.html"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "hepatocellular carcinoma (ICD10: C22.0): 28 cases\r\nmetastatic colorectal carcinoma (ICD10: C22.7): 18 cases\r\n    tumor and paired non-tumor tissues",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 550]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT library preparation kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000624",
          "Total Data Volume": "1.0 TB (fastq, vcf)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "hepatocellular carcinoma (ICD10: C22.0): 28 cases\r\nmetastatic colorectal carcinoma (ICD10: C22.7): 18 cases\r\n    tumor and paired non-tumor tissues",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 550]",
          "Library Source": "RNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Library prep kit, SureSelect strand specific RNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000624",
          "Total Data Volume": "1.0 TB (fastq, tpm)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshihiro Suzuki",
        "Affiliation": "Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center",
        "Project / Group Name": "Development of personalize neoantigen vaccine",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Collaboration funding from BrightPath Biotherapeutics Co., Ltd.",
            "Title": "Development of the methodology for individualized neoantigen vaccine therapy",
            "Project Number": "C2017-054"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Development of antigen-prediction algorithm for personalized neoantigens vaccine using human leukocyte antigen transgenic mouse.",
          "DOI": "doi: 10.1111/cas.15291",
          "Data Set ID": "JGAD000624"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000624"
        }
      },
      "Release Note": {
        "hum0327.v1": {
          "Research ID": "hum0327.v1",
          "Release Date": "2022/02/25",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs/RNAs extracted from tumor and paired non-tumor tissues of hepatocellular carcinoma or metastatic colorectal carcinoma patients were used for the whole exome sequencing and RNA sequencing analyses. Fastq, vcf, and tpm files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0324.v1": {
    "ja": {
      "NBDC Research ID": "hum0324.v1",
      "データ": {
        "JGAS000515": {
          "データID": "JGAS000515",
          "内容": "NGS（WGBS）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/04/11"
        }
      },
      "研究内容の概要": {
        "目的": "神経筋疾患についてゲノム解析を行い（一部の症例に対して網羅的な解析を行う）、診断の向上・病態の解明・新しい治療法の確立を行うことを目標とする。",
        "方法": "事前に同意が得られた神経筋疾患罹患者および健常者の末梢血血漿からcell-free DNAを抽出し、バイサルファイトシークエンスによるメチル化解析を行った。",
        "対象": "AQP4抗体陽性の視神経脊髄炎（Neuromyelitis Optica Spectrum Disorders：NMOSD）および対照健常者"
      },
      "分子データ": {
        "JGAS000515": {
          "対象": "AQP4抗体陽性NMOSD（ICD10：G360）：10症例\r\n対照健常者：8名",
          "規模": "WGBS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq6000]",
          "ライブラリソース": "血漿から抽出したcell-free DNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Accel-NGS™ Methyl-Seq DNA library Kit、Methyl-Seq Set A Indexing Kit （Swift Biosciences™）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000634",
          "総データ量": "66.2 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "奥野 龍禎",
        "所 属 機 関": "大阪大学医学部附属病院 神経内科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Cell-Free DNA Derived From Neutrophils Triggers Type 1 Interferon Signature in Neuromyelitis Optica Spectrum Disorder",
          "DOI": "doi: 10.1212/NXI.0000000000001149",
          "データID": "JGAD000634"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0324.v1": {
          "Research ID": "hum0324.v1",
          "公開日": "2022/04/11",
          "内容": "NGS（WGBS）",
          "description": "AQP4抗体陽性の視神経脊髄炎（NMOSD）症例および対照健常者の血漿から抽出したcell-free DNAを用いたWGBS解析の結果をfastqファイルにて提供する。Accel-NGS™ Methyl-Seq DNA library Kit および Methyl-Seq Set A Indexing Kit（Swift Biosciences™）によるライブラリ作製後、NovaSeq 6000（Illumina）によりシークエンシングを行った。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0324.v1",
      "DATA": {
        "JGAS000515": {
          "Data Set ID": "JGAS000515",
          "Type of Data": "NGS (WGBS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/04/11"
        }
      },
      "SUMMARY": {
        "Aims": "To perform genomic analysis of neuromuscular diseases in order to improve diagnosis, elucidate pathogenesis, and establish new therapeutic strategies. In particular, we aim to elucidate the pathogenesis of the disease by performing comprehensive analysis using DNA sequencers.",
        "Methods": "Cell-free DNA was extracted from plasma and analyzed by whole genome bisulfite sequencing technology in NMOSD patients and healthy controls who had given prior consent.",
        "Participants/Materials": "neuromyelitis optica (NMOSD) positive for AQP4 antibody and 8 healthy controls",
        "URL": "-"
      },
      "MOLECULAR DATA": {
        "JGAS000515": {
          "Participants/Materials:": "NMOSD (ICD10: G360) positive for AQP4 antibody: 10 cases\r\nhealthy controls: 8 individuals",
          "Targets": "WGBS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "Cell-free DNAs extracted from plasma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Accel-NGS™ Methyl-Seq DNA library Kit, Methyl-Seq Set A Indexing Kit (Swift Biosciences™)",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000634",
          "Total Data Volume": "66.2 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tatsusada Okuno",
        "Affiliation": "Department of Neurology, Osaka University Graduate School of Medicine",
        "Project / Group Name": "Gene expression analysis of systemic sclerosis patients.",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Cell-Free DNA Derived From Neutrophils Triggers Type 1 Interferon Signature in Neuromyelitis Optica Spectrum Disorder",
          "DOI": "doi: 10.1212/NXI.0000000000001149",
          "Data Set ID": "JGAD000634"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0324.v1": {
          "Research ID": "hum0324.v1",
          "Release Date": "2022/04/11",
          "Type of Data": "NGS (WGBS)",
          "description": "Cell-free DNAs extracted from plasma obtained from 10 neuromyelitis optica (NMOSD) positive for AQP4 antibody and 8 healthy controls were used for whole genome bisulfite sequencing analysis (fastq format files). Libraries were prepared using Accel-NGS™ Methyl-Seq DNA library Kit and Methyl-Seq Set A Indexing Kit (Swift Biosciences™) and sequenced using NovaSeq 6000 (Illumina).\nNote：\n"
        }
      }
    }
  },
  "hum0323.v1": {
    "ja": {
      "NBDC Research ID": "hum0323.v1",
      "データ": {
        "JGAS000489": {
          "データID": "JGAS000489",
          "内容": "NGS（CAGE-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/01/24"
        }
      },
      "研究内容の概要": {
        "目的": "血液検査によって迅速かつ低侵襲で高精度に大腸がんの早期発見が可能なマーカーや、予後や悪性度を判定可能なマーカー等を新規に探索すること、ならびに、治療法への応用を目指したがん患者特異的遺伝子・蛋白質情報を取得すること。",
        "方法": "大腸がん手術摘出検体の腫瘍組織より抽出したRNAを用いたCAGE法",
        "対象": "大腸がん症例"
      },
      "分子データ": {
        "JGAS000489": {
          "対象": "大腸がん（ICD10：C18.9）：45症例",
          "規模": "CAGE-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "手術摘出組織の腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "CAGE assay（※論文Method参照）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000606",
          "総データ量": "19.2 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "向後 泰司",
        "所 属 機 関": "理化学研究所 科技ハブ産連本部",
        "プロジェクト/研究グループ名": "大腸癌の診断マーカーの探索研究（順天堂大学 坂本 一博, 杉本 起一、理化学研究所 予防医療・診断技術開発プログラム 林崎 良英）",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "理化学研究所 予防医療・診断技術開発プログラム 運営費交付金",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0323.v1": {
          "Research ID": "hum0323.v1",
          "公開日": "2022/01/24",
          "内容": "NGS（CAGE-seq）",
          "description": "大腸がん45症例の手術摘出検体の腫瘍組織から抽出したRNAを用いたCAGE-seqデータをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0323.v1",
      "DATA": {
        "JGAS000489": {
          "Data Set ID": "JGAS000489",
          "Type of Data": "NGS (CAGE-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/01/24"
        }
      },
      "SUMMARY": {
        "Aims": "Exploration of biomarkers for early diagnosis and prognosis of colon cancer.",
        "Methods": "RNA extracts of colon cancer tissues dissected by surgery are subjected to CAGE profiling.",
        "Participants/Materials": "45 colon cancers"
      },
      "MOLECULAR DATA": {
        "JGAS000489": {
          "Participants/Materials": "colon cancer (ICD10: C18.9): 45 cases",
          "Targets": "CAGE-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNA extracted from surgically dissected tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "CAGE assay (*References)",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000606",
          "Total Data Volume": "19.2 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yasushi Kogo",
        "Affiliation": "RIKEN Cluster for Science, Technology and Innovation Hub",
        "Project / Group Name": "Genome-wide exploration for diagnostic biomarkers in colon cancer by using CAGE (Kazuhiro Sakamoto, Kiichi Sugimoto at Juntendo University; Yoshihide Hayashizaki at RIKEN Preventive Medicine & Diagnosis Innovation Program)",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Research Grant to RIKEN Preventive Medicine and Diagnosis Innovation Program from MEXT",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0323.v1": {
          "Research ID": "hum0323.v1",
          "Release Date": "2022/01/24",
          "Type of Data": "NGS (CAGE-seq)",
          "description": "RNAs extracted from surgically dissected tumor tissues of 45 colon cancer patients were used for CAGE-seq analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0321.v1": {
    "ja": {
      "NBDC Research ID": "hum0321.v1",
      "データ": {
        "JGAS000482": {
          "データID": "JGAS000482",
          "内容": "NGS（scRNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/06/17"
        }
      },
      "研究内容の概要": {
        "目的": "正常胸腺および自己免疫性疾患との関連が強く示唆されている胸腺腫・胸腺過形成組織における 胸腺上皮細胞・胸腺内免疫細胞の解析を行うとともに、自己免疫疾患罹患者の末梢血免疫細胞の特性解析、末梢血中および髄液中自己抗体産生解析を行うことで胸腺免疫システムの破綻と自己免疫疾患発症機序を解明する。本解析では通常の FACS 解析および single cell 解析も含む。免疫担当細胞の発生・分化および機能について、遺伝子発現の観点から胸腺制御による免疫細胞の応答について解析も試みる。本研究の成果としては、様々な自己免疫疾患における発症機序としての胸腺での免疫制御の鍵分子同定が可能となり、新規薬剤ターゲットの開発起点となることが期待できる。",
        "方法": "血液および胸腺組織からRNAを抽出し、次世代シークエンサーによるsingle cell RNA-seq解析を行った。",
        "対象": "重症筋無力症症例の末梢血または治療の際に切除された胸腺を解析対象とする。",
        "URL": "https://www.med.osaka-u.ac.jp/pub/neurol/myweb6/group03.html"
      },
      "分子データ": {
        "JGAS000482": {
          "対象": "重症筋無力症（ICD10：G70.01）：4症例\r\n末梢血：2検体、胸腺腫手術摘出検体：4検体",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血および胸腺腫手術摘出検体から単離した細胞より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "（3' プロファイリング）\r\nChromium Next GEM Single Cell 3’ GEM, Library & Gel Bead Kit v3.1 もしくは Chromium Next GEM Single Cell 3’ Kit v3.1 （10x Genomics）\r\n（5'+VDJ プロファイリング）\r\nChromium Next GEM Single Cell 5’ Kit v2 および Chromium Single Cell Human BCR Amplification Kit もしくは Chromium Single Cell Human TCR Amplification Kit （10x Genomics）",
          "断片化の方法": "サプライヤー提供プロトコルに準拠",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000599",
          "総データ量": "235.1 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "奥野 龍禎",
        "所 属 機 関": "大阪大学大学院 医学系研究科 神経内科学",
        "プロジェクト/研究グループ名": "神経免疫グループ",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的先端研究開発支援事業",
            "タイトル": "制御性T細胞を標的とした免疫応答制御技術に関する研究開発",
            "研究課題番号": "JP20gm0010005"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma",
          "DOI": "doi: 10.1038/s41467-022-31951-8",
          "データID": "JGAD000599"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0321.v1": {
          "Research ID": "hum0321.v1",
          "公開日": "2022/06/17",
          "内容": "NGS（scRNA-seq）",
          "description": "重症筋無力症４症例の末梢血（2症例2検体）および生体組織（胸腺腫手術摘出検体4症例4検体）から抽出したRNAを用いたsingle cell RNA-seq解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0321.v1",
      "DATA": {
        "JGAS000482": {
          "Data Set ID": "JGAS000482",
          "Type of Data": "NGS (scRNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/06/17"
        }
      },
      "SUMMARY": {
        "Aims": "We analyze thymic epithelial cells and intrathymic immune cells in the normal thymus and in thymoma and thymic hyperplasia tissues, which have been strongly implicated in autoimmune diseases. These analyses include conventional FACS analysis and single-cell analysis. The development, differentiation, and function of immunocompetent cells will also be analyzed from the perspective of gene expression as well as thymic regulation of immune cell responses. The results of this research will enable the identification of key molecules in thymic immune regulation as a pathogenic mechanism in various autoimmune diseases and will serve as a starting point for the development of new drug targets.",
        "Methods": "Blood cells and thymus tissues were collected and subjected to single-cell RNA sequencing using a next-generation sequencer.",
        "Participants/Materials": "Peripheral blood samples from patients with myasthenia gravis, or thymus glands from the patients resected at the time of surgery were used for the analysis.",
        "URL": "https://singlecell.broadinstitute.org/single_cell/study/SCP1532/thymoma-and-pbmc-of-myasthenia-gravis-patients#study-summary"
      },
      "MOLECULAR DATA": {
        "JGAS000482": {
          "Participants/Materials": "myasthenia gravis (ICD10: G70.01): 4 cases\r\nperipheral blood: 2 samples, thymoma surgery: 4 samples",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from peripheral blood cells or thymoma surgery samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "(3' profiling)\r\nChromium Next GEM Single Cell 3’ GEM, Library & Gel Bead Kit v3.1 or Chromium Next GEM Single Cell 3’ Kit v3.1 (10x Genomics)\r\n(5'+VDJ profiling)\r\nChromium Next GEM Single Cell 5’ Kit v2 and Chromium Single Cell Human BCR Amplification Kit or Chromium Single Cell Human TCR Amplification Kit (10x Genomics)",
          "Fragmentation Methods": "manufacturer’s protocol",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000599",
          "Total Data Volume": "235.1 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tatsusada Okuno",
        "Affiliation": "Department of Neurology, Osaka University Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Innovation and Clinical Research Center Project, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Study of Immunoregulatory technology targeting regulatory T cells",
            "Project Number": "JP21gm0010005"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma",
          "DOI": "doi: 10.1038/s41467-022-31951-8",
          "Data Set ID": "JGAD000599"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0321.v1": {
          "Research ID": "hum0321.v1",
          "Release Date": "2022/06/17",
          "Type of Data": "NGS (scRNA-seq)",
          "description": "RNAs extracted from peripheral blood cells or thymoma surgery of 4 myasthenia gravis patients were used for single-cell RNA-sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0320.v1": {
    "ja": {
      "NBDC Research ID": "hum0320.v1",
      "データ": {
        "JGAS000480": {
          "データID": "JGAS000480",
          "内容": "NGS（scRNA-seq、TCR-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/01/25"
        }
      },
      "研究内容の概要": {
        "目的": "悪性腫瘍を有する患者における末梢血や腫瘍組織等での種々の免疫担当細胞や免疫担当因子などを解析し、その免疫学的状態を明らかにする。副次的に免疫状態と臨床病理学的特徴、分子生物学的特徴、治療効果や予後との関連について検討する。",
        "方法": "免疫担当細胞（CD4/CD8T細胞、抗原提示細胞、制御性T細胞、 MDSC、自然リンパ球など）におけるCD4, CD8, FoxP3, CD25, CD45RA, CTLA-4, PD-1, ICOS, BTLA, Tim-3, LAG3, CCR7などの分子発現について、シングルセルシークエンスを用いた免疫フェノタイプ解析を実施した。併せて、免疫細胞のT-cell receptor（TCR）の解析を実施した。",
        "対象": "肺腺がん2症例および頭頸部がん3症例（腫瘍組織1検体、リンパ節1検体、末梢血1検体、計15検体）"
      },
      "分子データ": {
        "scRNA-seq": {
          "対象": "肺腺がん（ICD10：C349）：2症例\r\n頭頸部がん（ICD10：C760）：3症例\r\n    腫瘍組織、リンパ節、末梢血：各1検体",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "MGI [DNBSEQ-G400]",
          "ライブラリソース": "腫瘍組織、リンパ節、末梢血から単離したT細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Next GEM Single Cell 5' Reagent Kits v2",
          "断片化の方法": "Hybrid Selection",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均 100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000597",
          "総データ量": "719.9 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "TCR-seq": {
          "対象": "肺腺がん（ICD10：C349）：2症例\r\n頭頸部がん（ICD10：C760）：3症例\r\n    腫瘍組織、リンパ節、末梢血：各1検体",
          "規模": "TCR-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "MGI [DNBSEQ-G400]",
          "ライブラリソース": "腫瘍組織、リンパ節および末梢血から単離したT細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Next GEM Single Cell 5' Reagent Kits v2",
          "断片化の方法": "Hybrid Selection",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均 100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000597",
          "総データ量": "719.9 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "冨樫 庸介",
        "所 属 機 関": "千葉県がんセンター研究所",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん医療創生研究事業（P-CREATE）",
            "タイトル": "T細胞受容体認識エピトープによる腫瘍浸潤Tリンパ球の次世代解析方法の開発",
            "研究課題番号": "JP18cm0106340"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes",
          "DOI": "doi: 10.1016/j.celrep.2022.110331",
          "データID": "JGAD000597"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Ansuman Satpathy": {
          "研究代表者": "Ansuman Satpathy",
          "所属機関": "Department of Pathology, Stanford University",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Epigenetics of Inflammatory Skin Disorders",
          "利用期間": "JGAD000597"
        }
      },
      "リリース情報": {
        "hum0320.v1": {
          "Research ID": "hum0320.v1",
          "公開日": "2022/01/25",
          "内容": "NGS（scRNA-seq、TCR-seq）",
          "description": "肺腺がん2症例、頭頸部がん3症例の腫瘍組織、リンパ節、および末梢血から単離したT細胞から抽出したRNAを用いたscRNA-seqならびにTCR-seq解析の結果をfastqファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0320.v1",
      "DATA": {
        "JGAS000480": {
          "Data Set ID": "JGAS000480",
          "Type of Data": "NGS (scRNA-seq, TCR-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/01/25"
        }
      },
      "SUMMARY": {
        "Aims": "Various immunocompetent cells and factors in the peripheral blood cells and tumor tissues of patients with malignant tumors were analyzed. The immunological status of patients with malignant tumors will be clarified by analyzing various immune cells and factors in peripheral blood cells and tumor tissues. The relationship between immune status and clinicopathological characteristics, molecular biological characteristics, therapeutic effects, and prognosis will be evaluated as well.",
        "Methods": "Expressions of CD4, CD8, FoxP3, CD25, CD45RA, CTLA-4, PD-1, ICOS, BTLA, Tim-3, LAG3, CCR7, and other molecules on immunocompetent cells (CD4/CD8 T cells, antigen-presenting cells, regulatory T cells, MDSCs, spontaneous lymphocytes, etc.) were analyzed by single-cell sequencing technology. The T-cell receptor (TCR) of immune cells was also analyzed in the same technology.",
        "Participants/Materials": "pulmonary gland cancer: 2 cases, head and neck part cancer: 3 cases"
      },
      "MOLECULAR DATA": {
        "scRNA-seq": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 2 cases\r\nhead and neck cancer (ICD10: C760): 3 cases\r\n    tumor tissue: 1 sample each\r\n    lymph node: 1 sample each\r\n    peripheral blood; 1 sample each\r\n     (Total 15 samples)",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "MGI [DNBSEQ-G400]",
          "Library Source": "RNAs extracted from a single T cell isolated from tumor tissues, lymph node,s and peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Next GEM Single Cell 5' Reagent Kits v2",
          "Fragmentation Methods": "Hybrid Selection",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "average 100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000597",
          "Total Data Volume": "719.9 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "TCR-seq": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 2 cases\r\nhead and neck cancer (ICD10: C760): 3 cases\r\n    tumor tissue: 1 sample, lymph node: 1 sample, peripheral blood; 1 sample, Total 15 samples",
          "Targets": "TCR-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "MGI [DNBSEQ-G400]",
          "Library Source": "RNAs extracted from a single T cell isolated from tumor tissue, lymph node and peripheral blood",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Next GEM Single Cell 5' Reagent Kits v2",
          "Fragmentation Methods": "Hybrid Selection",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "average 100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000597",
          "Total Data Volume": "719.9 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yosuke Togashi",
        "Affiliation": "Chiba Cancer Center Research Institute",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Novel tumor-infiltrating T cell analysis according to antigen epitope",
            "Project Number": "JP18cm0106340"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes",
          "DOI": "doi: 10.1016/j.celrep.2022.110331",
          "Data Set ID": "JGAD000597"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Ansuman Satpathy": {
          "Principal Investigator": "Ansuman Satpathy",
          "Affiliation": "Department of Pathology, Stanford University",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Epigenetics of Inflammatory Skin Disorders",
          "Period of Data Use": "JGAD000597"
        }
      },
      "Release Note": {
        "hum0320.v1": {
          "Research ID": "hum0320.v1",
          "Release Date": "2022/01/25",
          "Type of Data": "NGS (scRNA-seq, TCR-seq)",
          "description": "RNAs extracted from a single T cell isolated from tumor tissues, lymph nodes, and peripheral blood cells of lung adenocarcinoma and head and neck cancer patients were used for the single-cell RNA sequencing and TCR sequencing analyses. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0319.v1": {
    "ja": {
      "NBDC Research ID": "hum0319.v1",
      "データ": {
        "JGAS000487": {
          "データID": "JGAS000487",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/01/21"
        }
      },
      "研究内容の概要": {
        "目的": "血清中の前立腺特異抗原（prostate-specific antigen：PSA）高値や直腸診での異常等を認め、前立腺がんの確定診断のために前立腺生検を行う患者の血液を用いて、複数の遺伝子多型を組み合わせた前立腺がんリスク予測モデルを前向きに評価し、前立腺がん診断マーカーとしての性能を評価すること。また、前立腺がんのレアバリアントの検索を行うことで日本人の前立腺がん発症に関わるレアバリアントを同定すること。",
        "方法": "末梢血より抽出したDNAを用いた、マルチプレックスPCR法によるターゲットシーケンス。ターゲットは、日本人の前立腺がんと関連が報告されている55 SNPs（既存のリスクモデルで用いられた16 SNPsおよび追加の39 SNPs）、ならびに、前立腺がん発症との関連が報告されてる8遺伝子（ATM, BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, NBN, PALB2）の全エクソン領域。",
        "対象": "前立腺がんが疑われ前立腺生検を予定された1,336名"
      },
      "分子データ": {
        "JGAS000487": {
          "対象": "前立腺がん（ICD10：C61）の確定診断のために前立腺生検を行う患者：1,336症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "日本人の前立腺がんと関連が報告されている55 SNPsおよび、前立腺がん発症との関連が報告されてる8遺伝子（ATM, BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, NBN, PALB2）の全エクソン領域",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "2X Platinum Multiplex PCR Master Mix（Thermo Fisher Scientific）を用いたmultiplex PCRで対象遺伝子領域を抽出し、2nd PCRにより、KAPA HiFi DNA Polymeraseを用いてHiSeqに必要なバーコード配列およびアダプター配列を付加",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000604",
          "総データ量": "83.9 GB（fasq、vcf [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "赤松 秀輔",
        "所 属 機 関": "京都大学大学院医学研究科 泌尿器科学",
        "プロジェクト/研究グループ名": "Prostate Cancer Susceptibility Single Nucleotide Polymorphism (PCSSNP) study",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "アストラゼネカ　Externally Sponsored Research",
            "タイトル": "Prevalence of germline and somatic DNA repair gene mutations in Japanese prostate cancer patients.",
            "研究課題番号": "NCR-17-13159"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy",
          "DOI": "doi: 10.1093/jncics/pkac001",
          "データID": "JGAD000604"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0319.v1": {
          "Research ID": "hum0319.v1",
          "公開日": "2022/01/21",
          "内容": "NGS（Target Capture）",
          "description": "前立腺がんの確定診断のために前立腺生検を行う1,336症例の末梢血から抽出したDNAを用いた、日本人の前立腺がんと関連が報告されている55 SNPsおよび、前立腺がん発症との関連が報告されてる8遺伝子の全エクソン領域のTarget Capture Sequencing解析データをfastqおよびvcfファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0319.v1",
      "DATA": {
        "JGAS000487": {
          "Data Set ID": "JGAS000487",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/01/21"
        }
      },
      "SUMMARY": {
        "Aims": "To prospectively evaluate a prostate cancer risk prediction model combining multiple genetic polymorphisms using blood samples from patients who have high serum prostate-specific antigen (PSA) or abnormalities on rectal examination and undergo prostate biopsy for the definitive diagnosis of prostate cancer, and to evaluate its performance as a diagnostic marker for prostate cancer. In addition, to identify rare variants involved in the development of prostate cancer in Japanese by searching for rare variants.",
        "Methods": "DNA was extracted from peripheral blood samples taken prior to prostate biopsy. Targeted sequencing using multiplex PCR was performed to genotype 55 SNPs (16 SNPs used in the existing risk model and 39 additional SNPs) that have been reported to be associated with prostate cancer in Japan. We also performed targeted sequencing of all exonic regions of 8 genes (ATM, BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, NBN, and PALB2) that have been reported to be associated with prostate cancer development.",
        "Participants/Materials": "1,336 men with suspected prostate cancer scheduled for prostate biopsy"
      },
      "MOLECULAR DATA": {
        "JGAS000487": {
          "Participants/Materials": "1,336 men with suspected prostate cancer (ICD10: C61) scheduled for prostate biopsy",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "55 SNPs and all exonic regions of 8 genes (ATM, BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, NBN, and PALB2)",
          "Platform": "Illumina [HiSeq2500]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Target gene region was amplified by multiplex PCR using 2X Platinum Multiplex PCR Master Mix (Thermo Fisher Scientific), and 2nd PCR was conducted to attach barcode and adaptor sequences necessary for sequencing by HiSeq using KAPA HiFi DNA Polymerase.",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000604",
          "Total Data Volume": "83.9 GB (fastq, vcf [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shusuke Akamatsu",
        "Affiliation": "Department of Urology, Graduate School of Medicine, Kyoto University",
        "Project / Group Name": "Prostate Cancer Susceptibility Single Nucleotide Polymorphism (PCSSNP) study",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Externally Sponsored Research by AstraZeneca",
            "Title": "Prevalence of germline and somatic DNA repair gene mutations in Japanese prostate cancer patients.",
            "Project Number": "NCR-17-13159"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy",
          "DOI": "doi: 10.1093/jncics/pkac001",
          "Data Set ID": "JGAD000604"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0319.v1": {
          "Research ID": "hum0319.v1",
          "Release Date": "2022/01/21",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from peripheral blood cells of 1,336 men with suspected prostate cancer scheduled for prostate biopsy were used for the target capture sequencing analysis. Fastq and vcf files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0318.v1": {
    "ja": {
      "NBDC Research ID": "hum0318.v1",
      "データ": {
        "JGAS000483": {
          "データID": "JGAS000483",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/03/09"
        }
      },
      "研究内容の概要": {
        "目的": "白血病に代表される造血器腫瘍は、未分化血液細胞にゲノムならびにエピゲノムの構造的・機能的異常が集積した結果発症する。しかしこれらの発生機序や発症に至る過程の詳細には未解明な点が多く、発症メカニズムに根ざした根本的治療法は確立されていない。そこで本研究では、血液疾患の病態形成に関わるゲノムならびにエピゲノムの異常を網羅的ゲノム解析の手法を用いて明らかにするとともに、その結果にもとづいて血液疾患の正確な診断、創薬に繋がる鍵分子を探索する事を目的とする。",
        "方法": "臨床経過中の3つの異なる時点で収集された患者の骨髄検体からDNAを抽出し、TruSight MyeloidPanelを使用した骨髄性造血器腫瘍に関連する遺伝子変異の有無を検討した。生殖細胞系列コントロールとして口腔粘膜上皮細胞も併せて解析した。",
        "対象": "B細胞性急性リンパ芽球性白血病（B-ALL）1症例"
      },
      "分子データ": {
        "JGAS000483": {
          "対象": "B-ALL（ICD10：C91.0）：1症例\r\n      骨髄：3検体\r\n      口腔粘膜：1検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "TruSight Myeloid Sequencing Panel （遺伝子リスト）",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "骨髄検体の骨髄および口腔粘膜細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "oligonucleotide-based target capture followed by PCR amplicon sequencing (TruSight ™ Myeloid Sequencing Panel)",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "250 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000600",
          "総データ量": "5.1 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "東條 有伸",
        "所 属 機 関": "東京大学医科学研究所附属病院 血液腫瘍内科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review",
          "DOI": "doi: 10.3389/fonc.2022.799982",
          "データID": "JGAD000600"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0318.v1": {
          "Research ID": "hum0318.v1",
          "公開日": "2022/03/09",
          "内容": "Target Capture",
          "description": "臨床経過中の異なる3点で収集したB細胞性急性リンパ芽球性白血病（B-ALL）1症例の骨髄（3検体）および口腔粘膜（1検体）より抽出したDNAを用いたTarget Capture Sequencing解析データ（fastq）を提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0318.v1",
      "DATA": {
        "JGAS000487": {
          "Data Set ID": "JGAS000487",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/03/09"
        }
      },
      "SUMMARY": {
        "Aims": " Hematopoietic malignancies such as leukemia develop as a result of the accumulation of structural and functional abnormalities in the genome and epigenome in the originating undifferentiated hematopoietic stem and progenitor cells. However, the details of the pathogenesis and the processes leading to the onset of these disorders remain unresolved, and fundamental treatments based on the pathogenic mechanisms have not been established. In this study, we aim to clarify the genomic and epigenomic abnormalities involved in the pathogenesis of hematological diseases using a comprehensive genomic analysis, and to search for key molecules that will lead to accurate diagnosis and drug discovery for hematological diseases based on the mechanisms.",
        "Methods": " The patient’s bone marrow (BM) samples were collected at three different time points during the clinical course. NGS was performed using extracted DNA from each BM sample via the TruSight Myeloid Panel on the MiSeq platform (Illumina). Oral epithelial cells were collected from buccal swabs served as a germline control.",
        "Participants/Materials": "Bone marrow and oral mucosa samples from one B-cell acute lymphoblastic leukemia (B-ALL) patient"
      },
      "MOLECULAR DATA": {
        "JGAS000487": {
          "Participants/Materials": "B-ALL (ICD10：C91.0): 1 patient\r\n      bone marrow: 3 samples\r\n      oral mucosa: 1 sample",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "TruSight Myeloid Sequencing Panel (Gene List)",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNAs extracted from BM and oral mucosa samples from a B-ALL patient",
          "Cell Lines": "-",
          "Library Construction (kit name)": "oligonucleotide-based target capture followed by PCR amplicon sequencing (TruSight ™ Myeloid Sequencing Panel)",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "250 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000604",
          "Total Data Volume": "5.1GB  (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Arinobu Tojo",
        "Affiliation": "Department of Hematology/Oncology, Institute of Medical Science, University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Repeated Lineage Switches in an Elderly Case of Refractory B-Cell Acute Lymphoblastic Leukemia With MLL Gene Amplification: A Case Report and Literature Review",
          "DOI": "doi: 10.3389/fonc.2022.799982",
          "Data Set ID": "JGAD000600"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0318.v1": {
          "Research ID": "hum0318.v1",
          "Release Date": "2022/03/09",
          "Type of Data": "Target Capture",
          "description": "DNAs extracted from bone marrow and oral mucosa samples of a B-ALL patient were used for the target capture sequencing analysis. Fastq and vcf files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0317.v1": {
    "ja": {
      "NBDC Research ID": "hum0317.v1",
      "データ": {
        "JGAS000413": {
          "データID": "JGAS000413",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/12/06"
        }
      },
      "研究内容の概要": {
        "目的": "外科的切除、放射線治療、抗がん剤治療を検討している、またはすでに開始しているがん患者を対象に、患者検体を用いたPatient-Derived Xenograft（PDX）モデルを作製し、ヒト生体組織に近似した形での抗悪性腫瘍薬の薬物動態・治療効果解析研究を行う。",
        "方法": "患者腫瘍およびPDX腫瘍からDNA・RNAを抽出し、whole exome sequencing解析ならびにRNA-seq解析を実施した。",
        "対象": "ドライバー遺伝子異常を持つ非小細胞肺がん4症例（計33検体）",
        "URL": "https://www.ncc.go.jp/jp/ri/division/molecular_pharmacology/project/040/20170918202513.html"
      },
      "分子データ": {
        "Exome": {
          "対象": "非小細胞肺がん（ICD10：C349）\r\n    患者生殖細胞系列細胞：3症例3検体\r\n    患者腫瘍組織：4症例4検体\r\n    PDX腫瘍組織：4症例12検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "患者生殖細胞系列細胞、患者腫瘍およびPDX腫瘍から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Twist Comprehensive Exome Kit",
          "断片化の方法": "酵素処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000530",
          "総データ量": "228 GB（bam [ref: hg38/mm10]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "非小細胞肺がん（ICD10：C349）\r\n    患者腫瘍組織：2症例2検体\r\n    PDX腫瘍組織：4症例12検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "患者腫瘍およびPDX腫瘍から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra Directional RNA Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000530",
          "総データ量": "53 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "濱田 哲暢",
        "所 属 機 関": "国立がん研究センター研究所 分子薬理研究分野",
        "プロジェクト/研究グループ名": "J-PDXライブラリープロジェクト",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "科学研究費助成事業 若手研究",
            "タイトル": "遺伝子変異を有する非小細胞肺がんのPDXモデル樹立と新薬開発の基盤研究",
            "研究課題番号": "18K15296"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Comparative study on the efficacy and exposure of molecular target agents in non-small cell lung cancer PDX models with driver genetic alterations",
          "DOI": "doi: 10.1158/1535-7163.MCT-21-0371",
          "データID": "JGAD000530"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000530"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000530"
        }
      },
      "リリース情報": {
        "hum0317.v1": {
          "Research ID": "hum0317.v1",
          "公開日": "2021/12/06",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "非小細胞肺がん症例の生殖細胞系列細胞、腫瘍組織およびPDX腫瘍から抽出したDNA、RNAを用いたwhole exome sequencing解析ならびにRNA-seq解析の結果をbamおよびfastqファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0317.v1",
      "DATA": {
        "JGAS000413": {
          "Data Set ID": "JGAS000413",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/12/06"
        }
      },
      "SUMMARY": {
        "Aims": "To analyze the pharmacokinetics and therapeutic effects of anticancer drugs in patients with cancer who are undergoing or have already begun surgical resection, radiotherapy, or anticancer drug therapy by creating a patient-derived xenograft (PDX) model using patient specimens to approximate human biological tissues. This is to create a PDX model using patient specimens to analyze the pharmacokinetics and therapeutic effects of anticancer drugs in a manner that approximates human tissues.",
        "Methods": "Whole-exome sequencing and RNA-sequencing analyses",
        "Participants/Materials": "Non-small cell lung cancer with driver gene abnormalities 4 cases, 33 samples",
        "URL": "https://www.ncc.go.jp/en/ri/department/pharmacology_therapeutics/index.html"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "Non-small cell lung cancer (ICD10: C349)\r\n    - germline tissues: 3 cases, 3 samples\r\n    - tumor tissues: 4 cases, 4 samples\r\n    - tumor tissues from PDX: 4 cases, 12 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from germline tissues, tumor tissues, and tumor tissues from PDX",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Twist Comprehensive Exome Kit",
          "Fragmentation Methods": "Enzymatic Fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000530",
          "Total Data Volume": "228 GB (bam [ref: hg38/mm10])",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Non-small cell lung cancer (ICD10: C349)\r\n    - tumor tissues: 2 cases, 2 samples, \r\n    - tumor tissues from PDX: 4 cases, 12 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from tumor tissues and tumor tissues from PDX",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra Directional RNA Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000530",
          "Total Data Volume": "53 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Akinobu Hamada",
        "Affiliation": "Division of Molecular Pharmacology, National Cancer Center Research Institute",
        "Project / Group Name": "J-PDX library project",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "KAKENHI Grant-in-Aid for Early-Career Scientists",
            "Title": "Establishment of PDX model for non-small cell lung cancer with genetic alteration and basic research for new drug development",
            "Project Number": "18K15296"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Comparative study on the efficacy and exposure of molecular target agents in non-small cell lung cancer PDX models with driver genetic alterations",
          "DOI": "doi: 10.1158/1535-7163.MCT-21-0371",
          "Data Set ID": "JGAD000530"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000530"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000530"
        }
      },
      "Release Note": {
        "hum0317.v1": {
          "Research ID": "hum0317.v1",
          "Release Date": "2021/12/06",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs/RNAs extracted from germline tissues and tumor tissues from patients with non-small cell lung cancer and tumor tissues from PDX using patient specimens were used for the whole exome sequencing and RNA sequencing analyses. Bam and fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0316.v1": {
    "ja": {
      "NBDC Research ID": "hum0316.v1",
      "データ": {
        "JGAS000535": {
          "データID": "JGAS000535",
          "内容": "NGS（WGS）\r\nNGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/05/26"
        }
      },
      "研究内容の概要": {
        "目的": "日本人の食道扁平上皮がんにおけるゲノム変異を探索する",
        "方法": "食道扁平上皮がん切除切片における非腫瘍組織（正常組織）および腫瘍組織より抽出したDNAを用いたWhole Genome Sequencing解析、ならびに、腫瘍組織より抽出したRNAを用いたRNA-seq解析。",
        "対象": "食道扁平上皮がん症例の腫瘍組織および非腫瘍組織"
      },
      "分子データ": {
        "NGS（WGS）": {
          "対象": "食道扁平上皮がん （ICD10：C15.9）：81症例（内、71症例はRNA-seqも実施）\r\n腫瘍組織：81検体、非腫瘍組織：81検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "食道扁平上皮がん切除切片における腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA Sample Prep kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000654",
          "総データ量": "812.3 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "NGS（RNA-seq）": {
          "対象": "食道扁平上皮がん （ICD10：C15.9）：100 症例（うち71症例はWGSも実施）\r\n　　腫瘍組織：100 検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "食道扁平上皮がん切除切片における腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Library Preparation kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "127 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000654",
          "総データ量": "812.3 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 英刀",
        "所 属 機 関": "理化学研究所 生命医科学研究センター がんゲノム研究チーム",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん医療創生研究事業（P-CREATE）",
            "タイトル": "がんゲノム解析による新規免疫療法および複合免疫療法開発のためのシーズ探索",
            "研究課題番号": "JP20cm0106552"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Immuno-genomic Profiling of Biopsy Specimens Predicts Neoadjuvant Chemotherapy Response in Esophageal Squamous Cell Carcinoma",
          "DOI": "doi: 10.1016/j.xcrm.2022.100705",
          "データID": "JGAD000654"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000654"
        },
        "杉田 静紀": {
          "研究代表者": "杉田 静紀",
          "所属機関": "名古屋大学医学部附属病院 ゲノム医療センター",
          "研究題目": "日本",
          "利用データID": "全ゲノム解析による食道癌の周術期補助療法と早期再発に関する研究",
          "利用期間": "JGAD000654"
        }
      },
      "リリース情報": {
        "hum0316.v1": {
          "Research ID": "hum0316.v1",
          "公開日": "2022/05/26",
          "内容": "NGS（WGS、RNA-seq）",
          "description": "食道扁平上皮がん症例の腫瘍組織および非腫瘍組織より抽出したDNAを用いたWGS解析データ、ならびに、腫瘍組織より抽出したRNAを用いたRNA-seq解析データをFastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0316.v1",
      "DATA": {
        "JGAS000535": {
          "Data Set ID": "JGAS000535",
          "Type of Data": "NGS (WGS)\r\nNGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/05/26"
        }
      },
      "SUMMARY": {
        "Aims": "Search for genomic mutations in esophageal squamous cell carcinoma in Japanese.",
        "Methods": "NGS libraries using DNA extracted from non-tumor tissues (normal tissues) and tumor tissues and NGS libraries using RNA extracted from tumor tissues in resected sections of esophageal squamous cell carcinoma are prepared and sequenced using Illumina HiSeq 2000/2500.",
        "Participants/Materials": "tumor tissues and non-tumor tissues of esophageal squamous cell carcinoma cases"
      },
      "MOLECULAR DATA": {
        "NGS (WGS)": {
          "Participants/Materials": "esophageal squamous cell carcinoma (ICD10: C15.9): 81 cases (Of these, 71 cases also underwent RNA-seq analysis)\r\n      tumor tissues: 81 samples\r\n      non-tumor tissues: 81 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "DNAs extracted from tumor tissues and non-tumor tissues from esophageal squamous cell carcinoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA Sample Prep kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000654",
          "Total Data Volume": "812.3 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "NGS (RNA-seq)": {
          "Participants/Materials:": "esophageal squamous cell carcinoma (ICD10: C15.9): 100 cases (Of these, 71 cases also underwent WGS analysis)\r\n      tumor tissues: 100 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "RNAs extracted from tumor tissues from esophageal squamous cell carcinoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Sample Prep kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "127 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000654",
          "Total Data Volume": "812.3 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hidewaki Nakagawa",
        "Affiliation": "RIKEN Center for Integrative Medical Sciences Laboratory of Genome Sequencing Analysis",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Search for seeds for the development of novel immunotherapies and combined immunotherapies by cancer genome analysis",
            "Project Number": "JP20cm0106552"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Immuno-genomic Profiling of Biopsy Specimens Predicts Neoadjuvant Chemotherapy Response in Esophageal Squamous Cell Carcinoma",
          "DOI": "doi: 10.1016/j.xcrm.2022.100705",
          "Data Set ID": "JGAD000654"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000654"
        },
        "Shizuki Sugita": {
          "Principal Investigator": "Shizuki Sugita",
          "Affiliation": "Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Elucidation of the impact of neoadjuvant therapy on tumor microenvironment and the factor of early recurrence in esophageal cancer patients by whole genome sequencing",
          "Period of Data Use": "JGAD000654"
        }
      },
      "Release Note": {
        "hum0316.v1": {
          "Research ID": "hum0316.v1",
          "Release Date": "2022/05/26",
          "Type of Data": "NGS (WGS, RNA-seq)",
          "description": "DNAs and RNAs extracted from tumor tissues and non-tumor tissue (normal tissue) in resected sections of esophageal squamous cell carcinoma patients were used for WGS and RNA-seq analyses. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0315.v2": {
    "ja": {
      "NBDC Research ID": "hum0315.v2",
      "データ": {
        "JGAS000385": {
          "データID": "JGAS000385",
          "内容": "NGS（Exome）\r\nNGS（RNA-seq）\r\nNGS（scRNA-seq）\r\nNGS（ChIP-seq）\r\nメチル化アレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/01/14"
        },
        "JGAS000385追加": {
          "データID": "JGAS000385追加",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/07/28"
        }
      },
      "研究内容の概要": {
        "目的": "次世代シーケンサーを用いた種々の遺伝子解析技術により、KMT2A遺伝子再構成陽性乳児急性リンパ性白血病の発症の原因となる遺伝子異常をゲノムワイドに解析する。",
        "方法": "患者の白血病細胞から抽出したDNA/RNAを用いたRNAシーケンス解析・メチル化アレイ解析・エクソームシーケンス解析・シングルセルRNAシーケンス解析、Target Capture シーケンス解析、ならびに、患者由来細胞株検体から抽出したDNA/RNAを用いたChIPシーケンス解析・RNAシーケンス解析を実施。それぞれの解析により得られたデータを統合的に解析した。",
        "対象": "乳児期発症のKMT2A遺伝子再構成陽性急性リンパ性白血病 84症例、および乳児KMT2A遺伝子再構成陽性急性リンパ性白血病由来細胞株 3検体（84症例とは異なる症例の白血病細胞から樹立）"
      },
      "分子データ": {
        "Exome": {
          "対象": "乳児期発症のKMT2A遺伝子再構成陽性急性リンパ性白血病 （ICD10：C91.0）：31症例\r\n    白血病細胞（腫瘍細胞）と正常血液細胞のペア：計62検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "患者白血病細胞および正常血液細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT Human All Exon V5+lncRNA",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "総データ量": "1.2 TB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "乳児期発症のKMT2A遺伝子再構成陽性急性リンパ性白血病 （ICD10：C91.0）：61症例\r\n乳児KMT2A遺伝子再構成陽性急性リンパ性白血病由来細胞株：3検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "患者白血病細胞および患者由来細胞株から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina TruSeq RNA Library Prep Kit\r\nNEB NEBNext Ultra RNA Library Prep Kit for Illumina",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100-150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "総データ量": "1.2 TB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "scRNA-seq": {
          "対象": "乳児期発症のKMT2A遺伝子再構成陽性急性リンパ性白血病 （ICD10：C91.0）：2症例",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "患者白血病細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "BD Rhapsody WTA Amplification Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "-",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "総データ量": "1.2 TB（csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ChIP-seq": {
          "対象": "乳児KMT2A遺伝子再構成陽性急性リンパ性白血病由来細胞株：3検体",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "患者由来細胞株から抽出したDNAに対し、抗ヒストン抗体（H3K27ac、H3K4me3）、抗RNAPII抗体、抗KMT2A抗体を用いた免疫沈降",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina TruSeq ChIP Sample Prep Kit",
          "断片化の方法": "酵素反応（MNase）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "総データ量": "1.2 TB（bam [ref: hg19]、bw）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "メチル化アレイ": {
          "対象": "乳児期発症のKMT2A遺伝子再構成陽性急性リンパ性白血病 （ICD10：C91.0）：84症例\r\n    EPIC：25症例\r\n    450K：59症例",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium MethylationEPIC BeadChip、Infinium Human Methylation 450K BeadChip]",
          "ソース": "患者白血病細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "EPIC：Infinium MethylationEPIC BeadChip Kit\r\n450K：Infinium HumanMethylation450 BeadChip Kit",
          "プローブ数": "EPIC：866,836 プローブ\r\n450K：485,577 プローブ",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "総データ量": "1.2 TB（idat）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture": {
          "対象": "乳児期発症のKMT2A遺伝子再構成陽性急性リンパ性白血病 （ICD10：C91.0）：72症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "ARHGAP32、CDKN2A、CDKN2B、CHD4、CHD7、COL24A1、DDX10、DNHD1、FGF5、FLT3、IGSF9、 JAG1、KRAS、MED12、NEB、NF1、NRAS、PAX5、PCDH19、PDGFRB、PICALM、PIK3CA、PIK3R1、 PLXNA2、PTPN11、TP53、TTLL4、TUBGCP6、XBP1、XPO1",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "患者白血病細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect-XT Low Input Reagent Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "総データ量": "48.5 GB（bam [ref: GRCh37]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "滝田 順子",
        "所 属 機 関": "京都大学 小児科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（A）",
            "タイトル": "小児がんにおける遺伝学的高発がん感受性の機序とクローン進化の統合的解析",
            "研究課題番号": "20H00528"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia",
          "DOI": "doi: 10.1038/s41467-022-32266-4",
          "データID": "JGAD000500"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000500"
        }
      },
      "リリース情報": {
        "hum0315.v2": {
          "Research ID": "hum0315.v2",
          "公開日": "2022/07/28",
          "内容": "NGS（Target Capture）",
          "description": "乳児期発症のKMT2A遺伝子再構成陽性急性リンパ性白血病 72症例の白血病細胞より抽出したDNAを用いたTarget Capture Srquencing解析データをbamファイルにて提供する。\n"
        },
        "hum0315.v1": {
          "Research ID": "hum0315.v1",
          "公開日": "2022/01/14",
          "内容": "NGS（Exome、RNA-seq、scRNA-seq、ChIP-seq）、メチル化アレイ",
          "description": "乳児期発症のKMT2A遺伝子再構成陽性急性リンパ性白血病 84症例の白血病細胞および正常血液細胞より抽出したDNA/RNAを用いたWES、RNA-seq、scRNA-seq、メチル化アレイ解析データ、ならびに、乳児KMT2A遺伝子再構成陽性急性リンパ性白血病由来細胞株 3検体より抽出したDNA/RNAを用いたRNA-seq、ChIP-seq解析データをbam、idat、bw、csvファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0315.v2",
      "DATA": {
        "JGAS000385": {
          "Data Set ID": "JGAS000385",
          "Type of Data": "NGS (Exome)\r\nNGS (RNA-seq)\r\nNGS (scRNA-seq)\r\nNGS (ChIP-seq)\r\nMethylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/01/14"
        },
        "JGAS000385 (Data addition)": {
          "Data Set ID": "JGAS000385 (Data addition)",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/07/28"
        }
      },
      "SUMMARY": {
        "Aims": "To explore genetic alteratoins in KMT2A-rearranged infant acute lymphoblastic leukemia, we performed genome wide analyses using next generation sequencing technologies.",
        "Methods": "A total of 84 infants with KMT2A-r ALL were characterized by RNA sequencing, methylation array, and whole exome and targeted deep sequencing. Single-cell RNA sequencing analysis was performed in two cases. ChIP-seq and RNA sequencing were performed in three cell lines derived from infants with KMT2A-r ALL.",
        "Participants/Materials": "84 infants with KMT2A-rearranged acute lymphoblastic leukemia, and 3 cell lines derived from infants with KMT2A-rearranged acute lymphoblastic leukemia"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "infants with KMT2A-rearranged acute lymphoblastic leukemia (ICD10: C91.0): 31 cases\r\n    leukemia cells and matched normal blood cells: total 62 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from leukemia cells and normal blood cells of patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT Human All Exon V5+lncRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "Total Data Volume": "1.2 TB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "infants with KMT2A-rearranged acute lymphoblastic leukemia (ICD10: C91.0): 61 cases\r\ncell lines derived from infants with KMT2A-rearranged acute lymphoblastic leukemia: 3 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from leukemia cells of patients and cell lines",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina TruSeq RNA Library Prep Kit\r\nNEB NEBNext Ultra RNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "restriction enzyme reaction",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100-150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "Total Data Volume": "1.2 TB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "scRNA-seq": {
          "Participants/Materials": "infants with KMT2A-rearranged acute lymphoblastic leukemia (ICD10: C91.0): 2 cases",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "RNAs extracted from leukemia cells of patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "BD Rhapsody WTA Amplification Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "-",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "Total Data Volume": "1.2 TB (csv)",
          "Comments (Policies)": "NBDC policy"
        },
        "ChIP-seq": {
          "Participants/Materials": "cell lines derived from infants with KMT2A-rearranged acute lymphoblastic leukemia: 3 samples",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from cell lines, immunoprecipitated with an anti-histone antibody (H3K27Ac or H3K4me3) or anti-RNA Polymerase II antibody or anti-KMT2A antibody",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina TruSeq ChIP Sample Prep Kit",
          "Fragmentation Methods": "Enzymatic reaction (MNase)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "Total Data Volume": "1.2 TB (bam [ref: hg19], bw)",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation array": {
          "Participants/Materials": "infants with KMT2A-rearranged acute lymphoblastic leukemia (ICD10: C91.0): 84 cases\r\n    EPIC: 25 cases\r\n    450K: 59 cases",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium MethylationEPIC BeadChip, Infinium Human Methylation 450K BeadChip]",
          "Library Source": "DNAs extracted from leukemia cells of patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "EPIC: Infinium MethylationEPIC BeadChip Kit\r\n450K: Infinium HumanMethylation450 BeadChip Kit",
          "Probe Number": "EPIC: 866,836 probes\r\n450K: 485,577 probes",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "Total Data Volume": "1.2 TB (idat)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture": {
          "Participants/Materials": "infants with KMT2A-rearranged acute lymphoblastic leukemia (ICD10: C91.0): 72 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "ARHGAP32, CDKN2A, CDKN2B, CHD4, CHD7, COL24A1, DDX10, DNHD1, FGF5, FLT3, IGSF9, JAG1, KRAS, MED12, NEB, NF1, NRAS, PAX5, PCDH19, PDGFRB, PICALM, PIK3CA, PIK3R1, PLXNA2, PTPN11, TP53, TTLL4, TUBGCP6, XBP1, XPO1",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "DNAs extracted from leukemia cells of patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect-XT Low Input Reagent Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000500",
          "Total Data Volume": "48.5 GB (bam [ref: GRCh37])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Junko Takita",
        "Affiliation": "Department of Pediatrics, Graduate School of Medicine, Kyoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (A)",
            "Title": "Integrated analysis of mechanisms of genetic susceptibility and clonal evolution in pediatric cancers",
            "Project Number": "20H00528"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia",
          "DOI": "doi: 10.1038/s41467-022-32266-4",
          "Data Set ID": "JGAD000500"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000500"
        }
      },
      "Release Note": {
        "hum0315.v2": {
          "Research ID": "hum0315.v2",
          "Release Date": "2022/07/28",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from leukemia cells from a total of 72 infants with KMT2A-rearranged acute lymphoblastic leukemia were used for the target capture sequencing analysis. Bam files are provided. \n"
        },
        "hum0315.v1": {
          "Research ID": "hum0315.v1",
          "Release Date": "2022/01/14",
          "Type of Data": "NGS (Exome, RNA-seq, scRNA-seq, ChIP-seq), Methylation array",
          "description": "DNAs/RNAs were extracted from leukemia cells and normal blood cells from total 84 infants with KMT2A-rearranged acute lymphoblastic leukemia, and 3 cell lines derived from infants with KMT2A-rearranged acute lymphoblastic leukemia. WES, RNA-seq, scRNA-seq, ChIP-seq and methylation array analysis were performed. Bam, idat, bw and csv files are provided. \nNote：\n"
        }
      }
    }
  },
  "hum0314.v1": {
    "ja": {
      "NBDC Research ID": "hum0314.v1",
      "データ": {
        "JGAS000383": {
          "データID": "JGAS000383",
          "内容": "SNPアレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/19"
        }
      },
      "研究内容の概要": {
        "目的": "アルツハイマー病（Alzheimer's disease: AD）の病態は未解明で、対症療法としての薬物介入やリハビリ・介護サービスで患者の生活の質を保つといった治療アプローチに限られる。孤発性AD発症には遺伝的背景が大きく関与していることが示されており、ADの病態解明および治療薬開発のためにiPS細胞技術と遺伝的背景の理解が有用である。患者細胞に付随する匿名化された情報およびジェノタイプ情報を比較することで病態を探索する。",
        "方法": "Infinium OmniExpressExome-8 v1.4 BeadChip（イルミナ社）を用いて、既存試料ゲノムDNAからジェノタイプデータを取得した。",
        "対象": "102名分の孤発性アルツハイマー病患者",
        "URL": "https://inoue.cira.kyoto-u.ac.jp"
      },
      "分子データ": {
        "JGAS000383": {
          "対象": "孤発性アルツハイマー病（ICD10：G309、F009）：102症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium OmniExpressExome-8 v1.4 BeadChip]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium OmniExpressExome-8 v1.4 BeadChip Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "マーカー数": "962,215 SNVs（reference：1,000 Genomes Project Phase 3）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000498",
          "総データ量": "4 GB（csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "井上 治久",
        "所 属 機 関": "京都大学 iPS細胞研究所",
        "プロジェクト/研究グループ名": "幹細胞医学",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "理化学研究所　革新知能統合研究センター　運営費交付金",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Dissection of the polygenic architecture of neuronal Aβ production in Alzheimer’s disease using induced neurons from patient iPSCs",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0314.v1": {
          "Research ID": "hum0314.v1",
          "公開日": "2021/11/19",
          "内容": "SNPアレイ",
          "description": "孤発性アルツハイマー病102症例の末梢血より抽出したDNAを用いたSNPアレイ解析データをcsvファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0314.v1",
      "DATA": {
        "JGAS000383": {
          "Data Set ID": "JGAS000383",
          "Type of Data": "SNP array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/19"
        }
      },
      "SUMMARY": {
        "Aims": "The pathophysiology of Alzheimer's disease (AD) remains unclear and is limited to therapeutic approaches such as symptomatic drug intervention and rehabilitation / long-term care services to maintain the patient's quality of life. It has been shown that the genetic background is significantly involved in the development of sporadic AD. Pseudonymized information of the patient's cells and genotypes of them were compared with each other.",
        "Methods": "Genotyped with Infinium OmniExpressExome-8 v1.4 BeadChip according to manufacturer instructions",
        "Participants/Materials": "102 patients with sporadic Alzheimer's disease",
        "URL": "https://inoue.cira.kyoto-u.ac.jp/en/"
      },
      "MOLECULAR DATA": {
        "JGAS000383": {
          "Participants/Materials": "sporadic Alzheimer's disease (ICD10: G309, F009): 102 cases",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium OmniExpressExome-8 v1.4 BeadChip]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Infinium OmniExpressExome-8 v1.4 BeadChip Kit",
          "Genotype Call Methods (software)": "GenCall software (GenomeStudio)",
          "Marker Number": "962,215 SNVs (reference: 1,000 Genomes Project Phase 3）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000498",
          "Total Data Volume": "4 GB (csv)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Haruhisa Inoue",
        "Affiliation": "Center for iPS Cell Research and Applicatio (CiRA), Kyoto university",
        "Project / Group Name": "Laboratory of Stem Cell Medicine",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Center for Advanced Intelligence Project (AIP), RIKEN　 Management Expenses Grants",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Dissection of the polygenic architecture of neuronal Aβ production in Alzheimer’s disease using induced neurons from patient iPSCs",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0314.v1": {
          "Research ID": "hum0314.v1",
          "Release Date": "2021/11/19",
          "Type of Data": "SNP array",
          "description": "DNAs extracted from peripheral blood cells from 102 patients with sporadic Alzheimer's disease were genotyped with Infinium OmniExpressExome-8 v1.4 BeadChip. Csv files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0311.v5": {
    "ja": {
      "NBDC Research ID": "hum0311.v5",
      "データ": {
        "JGAS000412": {
          "データID": "JGAS000412",
          "内容": "BBJ第一コホート11,716名、BBJ第二コホート42,689名のGenotypeデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/30"
        },
        "JGAS000541": {
          "データID": "JGAS000541",
          "内容": "BBJ第一コホート180,882名を男女別に7つのバッチに分けて実施したImputationデータならびにindexデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/07/28"
        },
        "JGAS000561": {
          "データID": "JGAS000561",
          "内容": "BBJ第一コホート1,285名の血清サンプルを対象としたNMRによるメタボロームデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/08"
        },
        "JGAS000561（データ追加）": {
          "データID": "JGAS000561（データ追加）",
          "内容": "BBJ第一コホート2,570名の血清サンプルを対象としたNMRによるメタボロームデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2023/04/24"
        },
        "hum0311.v5.gwas.v1": {
          "データID": "hum0311.v5.gwas.v1",
          "内容": "消化性潰瘍のGWAS",
          "制限": "非制限公開",
          "公開日": "2023/07/27"
        }
      },
      "研究内容の概要": {
        "目的": "バイオバンク・ジャパン（BBJ）は、東京大学医科学研究所内に設置された臨床情報と生体試料（DNA・血清）のバイオバンクで、平成15（2003）年に委託事業として出発した「オーダーメイド医療実現化プロジェクト」により国内12協力医療機関と協力して収集された47疾患・約20万人（第一コホート）、並びに平成25（2013）年度に開始した「オーダーメイド医療の実現プログラム」により同様の方法で収集された38疾患・約6.7万人（第二コホート）からなる我が国の重要な研究基盤である。 本研究ではBBJが管理する試料・臨床情報及びゲノム情報のさらなる利活用を目指して、試料・情報の保管、管理、提供を継続して実施するとともに、生体試料やゲノム情報、臨床情報を用いて疾患のリスクや予後、薬剤感受性に関わるバイオマーカーを同定し、個別化医療に貢献する。",
        "方法": "Asian Screening Array （ASA-24v1-0_A2）による塩基配列決定",
        "対象": "BBJ第一コホート（11,716＋180,882＋1,285＋2,570名）、BBJ第二コホート（42,689名）、ToMMo（49,621名）、UKバイオバンク（456,327名）、FinnGen（230,635名）",
        "URL": "https://biobankjp.org/"
      },
      "分子データ": {
        "JGAS000412": {
          "対象": "BBJ第一コホート（47疾患）：11,716名\r\nBBJ第二コホート（38疾患）：42,689名\r\nICD10：C34, C15, C16, C18-C21, C22, C25, C23, C24, C61, C50, C53, C54, C56, C81-C86, C90-C93, I63, G45.9, I67.1, G40, J45, A15-A19, J44.9, J84.1-9, I21.0-9, I20.0, I20.1, I20.8, I20.9, R00, I44.0-3, I45.5-6, I47-I49, I50, I70.9, B18.1, B18.2, K74.6, N04, N20-N23, M80-M81, E10, E11, E88.8, E78.0-5, E78.8-9, E05.0, M05-M06, J30.1, L91.0, L20, L51.1-2, L27.0, D25, N80, R56.0, H40, H25-H26, K05, G12.2, I61, C64",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Asian Screening Array (ASA-24v1-0_A2)]",
          "ソース": "末梢血（一部唾液）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium Asian Screening Array-24 v1.0 BeadChip Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenomeStudio",
          "マーカー数（QC後）": "657,060 SNVs（GRCh38）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000529",
          "総データ量": "1,020 GB（idat、csv、plink binary）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000541": {
          "対象": "BBJ第一コホート（47疾患）：180,882名\r\nICD10：A15-A16、B16-B17.0、B18.0-B18.1、B17.1、B18.2、C15、C16、C18、C22、C23-C24、C25、C33-C34、C50、C53、C54、C56、C61、C81、D25、E05、E10、E78.0-E78.5、G12、G40-G41、H25-H26、H40-H42、I20、I21-I22、I44-I49、I50、I60、I69.0、I63、I69.3、I70、J30、J41-J44、J45-J46、J80-J84、K05、K74.3-K74.6、L00-L99、L20、M05-M06、M80-M82、N04、N20-N23、N80、R00-R9",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpressExome、HumanOmniExpress、HumanExome]",
          "ソース": "末梢血（一部唾液）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpressExome-8、HumanOmniExpress-12、HumanExome-12 kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenomeStudio Software\r\nEagle software （v2.4.1） without a reference panel\r\nMinimac4 software (v1.0.2) ",
          "リファレンス配列": "TOPMed reference panel (Version R2 on GRC38)",
          "フィルタリング": "imputation前のQC：\r\nBefore imputation, we excluded SNPs using the following criteria:\r\n    - Heterozygosity count for each chip < 5 \r\n    - P-value for Hardy–Weinberg equilibrium (HWE) for each chip < 1.0 x 10^-6 *\r\n    - Genotype concordance rate with whole-genome sequencing (WGS) for 939 samples < 99.5% and its non-reference discordance rate >= 0.5%\r\n    - Lower call rate SNPs if the position was the same when merging datasets\r\n    - Call rate < 99%\r\n   * P-values for chrX SNPs were calculated by using female samples\r\n We also excluded samples using the following criteria ：\r\n    - Call Rate < 98%\r\n    - Samples whose inferred sex was not matched with the clinical information\r\n    - Lower call rate samples for duplicated or monozygotic twin in the dataset\r\n    - Outliers from East Asian clusters from principal component analysis with 1KGp3v5 samples.",
          "マーカー数(QC後)": "常染色体：515,587 SNVs（GRCh38）\r\nX染色体：11,140 SNVs（GRCh38）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000660",
          "総データ量": "11.1 TB （vcf、tbi）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000561": {
          "対象": "BBJ第一コホート（47疾患）：1,285名 （1,286検体）＋2,570名（2,573検体）  累計：3,841名 （3,859検体）\r\nICD10：R00、I44.0-3、I45.5-6、I47-I49、I70.9、L20、J45、I67.1、I63、G45.9、C50、I50、I21.0-9、H25-H26、C53、B18.1、B18.2、C18-C21、J44.9、L51.1-2、L27.0、E10、E11、E88.8、N80、G40、C15、D25、C23、C24、H40、E05.0、K05、R56.0、C81-C86、C90-C93、C22、J30.1、E78.0-5、E78.8-9、J84.1-9、L91.0、K74.6、C34、N04、M80-M81、C56、C25、A15-A19、C61、M05-M06、I20.1、I20.8、I20.9、C16、N20-N23、I20.0、C54",
          "規模": "メタボローム（NMR）",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Bruker [AVANCE III HD]",
          "ソース": "血清サンプル",
          "検体情報（購入の場合）": "-",
          "測定パラメータ": "Nightingale Healthの内製ソフトウェア（quantification library 2020）",
          "ノイズの低減方法・補正方法": "Nightingale Healthの内製ソフトウェア（quantification library 2020）",
          "アノテーション方法": "Nightingale Healthの内製ソフトウェア（quantification library 2020）",
          "定量アルゴリズム（ソフトウェア）": "Nightingale Healthの内製ソフトウェア（quantification library 2020）",
          "定量対象領域": "250代謝物 （代謝物リスト）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000683",
          "総データ量": "7.1＋15.3 MB（xlsx）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0311.v5.gwas.v1": {
          "対象": "消化性潰瘍（ICD10：K27.9）、十二指腸潰瘍（ICD10：K26.9）、胃潰瘍（ICD10：K25.9）\r\n　　- BBJ1-180K：潰瘍（19,713名）、対照（153,178名）\r\n　　- BBJ1-12K：潰瘍（1,001名）、対照（8,617名）\r\n　　- BBJ2-42K：潰瘍（3,637名）、対照（3,4647名）\r\n　　- EAS meta-analysis：潰瘍（29,739名）、対照（240,675名）\r\n　　　（BBJ180K、BBJ1-12K、BBJ2-42K、TMM-50K）\r\n　　- Cross-ancestry meta-analysis：潰瘍（52,032名）、対照（905,344名）\r\n　　　（BBJ180K、BBJ1-12K、BBJ2-42K、TMM-50K、FinnGen、UKB）\r\n※詳細はこちら",
          "規模": "genome wide variants",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "BBJ1-180K：Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]\r\nBBJ1-12K、BBJ2-42K：Illumina [Infinium Asian Screening Array BeadChip] \r\nToMMo：Thermo Fisher [Axiom Japonica Array JPAv2]\r\nUK Biobank：Applied Biosystems [UK BiLEVE Axiom Array、UK Biobank Axiom Array] \r\nFinnGen：Thermo Fisher Scientific [FinnGen1 ThermoFisher Arrayなど]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "BBJ：HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit、Infinium Asian Screening Array BeadChip kit\r\nToMMo：Axiom 2.0 Reagent kit\r\nUK Biobank：UK BiLEVE Axiom Array、UK Biobank Axiom Array\r\nFinnGen：FinnGen1 ThermoFisher Arrayなど",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Genotype Call：GenomeStudio\r\nPhasing：eagle2\r\nImputation：minimac4 [reference：1KGP p3v5 ALL]",
          "関連解析（ソフトウェア）": "SAIGE（v0.44）",
          "フィルタリング": "Rsq < 0.3 および MAC < 20 のバリアントを除外\r\n※Sample QC、Variant QCの詳細はDictionary fileをご参照ください。",
          "メタ解析（ソフトウェア）": "METAL",
          "マーカー数（QC後）": "BBJ1-180K GWAS：~12,013,066 variants\r\nBBJ1-12K GWAS：~10,836,527 variants\r\nBBJ2-42K GWAS:：~11,504,022 variants\r\nEAS-specific meta-analysis：~13,846,852 variants\r\nCross-ancestry meta-analysis：~19,078,654 variants\r\n※詳細はこちら",
          "NBDC Dataset ID": "hum0311.v5.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックし、遷移先のサイトのファイルダウンロードリンクをクリックしてください）\r\nDictionary file",
          "総データ量": "9.7 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "松田 浩一",
        "所 属 機 関": "東京大学大学院 新領域創成科学研究科",
        "プロジェクト/研究グループ名": "利活用を目的とした日本疾患バイオバンクの運営・管理",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） ゲノム医療実現推進プラットフォーム事業",
            "タイトル": "TOPMED panelを用いた高密度Imputationによる、バイオバンクジャパン18万症例のphenotype横断的解析",
            "研究課題番号": "JP21km0405215"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "小川 誠司": {
          "研究代表者": "小川 誠司",
          "所属機関": "京都大学大学院医学研究科 腫瘍生物学講座",
          "研究題目": "日本",
          "利用データID": "クローン性造血と新型コロナウイルス感染症の関連性についての解析",
          "利用期間": "JGAD000529"
        },
        "岡田 随象": {
          "研究代表者": "岡田 随象",
          "所属機関": "大阪大学大学院医学系研究科　遺伝統計学",
          "研究題目": "日本",
          "利用データID": "日本人由来B細胞株DNAのゲノムデータを用いた遺伝統計解析手法の研究",
          "利用期間": "JGAD000529JGAD000660"
        },
        "加藤　正樹": {
          "研究代表者": "加藤　正樹",
          "所属機関": "関西医科大学",
          "研究題目": "日本",
          "利用データID": "精神疾患個別化治療アルゴリズムの構築を目的とする生物学的反応因子の探索・検証試験",
          "利用期間": "JGAD000529"
        },
        "福永 航也": {
          "研究代表者": "福永 航也",
          "所属機関": "国立医薬品食品衛生研究所 医薬安全科学部",
          "研究題目": "日本",
          "利用データID": "重篤な皮膚有害事象の診断・治療と遺伝子マーカーに関する研究",
          "利用期間": "JGAD000529JGAD000660"
        },
        "上辻󠄀 茂男": {
          "研究代表者": "上辻󠄀 茂男",
          "所属機関": "株式会社スタージェン 統計解析事業部",
          "研究題目": "日本",
          "利用データID": "斜視の遺伝的要因の検証のためのゲノムワイド関連研究",
          "利用期間": "JGAD000529"
        },
        "高地 雄太": {
          "研究代表者": "高地 雄太",
          "所属機関": "東京医科歯科大学 難治疾患研究所 ゲノム機能多様性分野",
          "研究題目": "日本",
          "利用データID": "機能性遺伝子多型の網羅的解析を介した多因子疾患の病態解明",
          "利用期間": "JGAD000660"
        },
        "木村 大樹": {
          "研究代表者": "木村 大樹",
          "所属機関": "名古屋大学大学院医学系研究科",
          "研究題目": "日本",
          "利用データID": "遺伝子解析による脳とこころの病気に対するかかりやすさ（発症脆弱性）や薬の効きめや副作用（治療反応性）等の解明に関する研究",
          "利用期間": "JGAD000529"
        },
        "寺尾 知可史": {
          "研究代表者": "寺尾 知可史",
          "所属機関": "理化学研究所生命医学研究センター",
          "研究題目": "日本",
          "利用データID": "ゲノミクス情報を基盤とした個別化医療の研究",
          "利用期間": "JGAD000529"
        },
        "朝野 仁裕": {
          "研究代表者": "朝野 仁裕",
          "所属機関": "国立循環器病研究センター",
          "研究題目": "日本",
          "利用データID": "循環器疾患におけるゲノム医療推進のための全国規模プラットフォームの構築",
          "利用期間": "JGAD000529"
        }
      },
      "リリース情報": {
        "hum0311.v5": {
          "Research ID": "hum0311.v5",
          "公開日": "2023/07/27",
          "内容": "消化性潰瘍のゲノムワイド関連解析",
          "description": "BBJ第一コホートおよび第二コホートならびに多人種集団の末梢血より抽出したDNAを用いた、消化性潰瘍のゲノムワイド関連解析データ（メタ解析データ）を提供する（txt）。\n"
        },
        "hum0311.v4": {
          "Research ID": "hum0311.v4",
          "公開日": "2023/04/24",
          "内容": "BBJ第一コホート2,570名の血清サンプルを対象としたNMRによるメタボロームデータ（250代謝物）",
          "description": "BBJ第一コホート2,570名の血清サンプル2,573検体について、500MHz NMR装置（Bruker AVANCE III HD）を用いて測定したNMRスペクトラムをNightingale Healthの内製ソフトウェア（quantification library 2020）で定量した250代謝物のメタボロームデータをxlsxファイルにて提供する。\n"
        },
        "hum0311.v3": {
          "Research ID": "hum0311.v3",
          "公開日": "2022/09/08",
          "内容": "BBJ第一コホート1,285名の血清サンプルを対象としたNMRによるメタボロームデータ（250代謝物）",
          "description": "BBJ第一コホート1,285名の血清サンプル1,286検体について、500MHz NMR装置（Bruker AVANCE IIIHD）を用いて測定したNMRスペクトラムをNightingale Healthの内製ソフトウェア（quantification library 2020）で定量した250代謝物のメタボロームデータをxlsxファイルにて提供する。\n"
        },
        "hum0311.v2": {
          "Research ID": "hum0311.v2",
          "公開日": "2022/07/28",
          "内容": "BBJ第一コホート180,882名を男女別に7つのバッチに分けて実施したImputationデータならびにindexデータ",
          "description": "BBJ第一コホート180,882名の末梢血（一部唾液）より抽出したDNAを用い、SNPアレイ解析（Illumina [HumanOmniExpressExome、HumanOmniExpress、HumanExome]）によりGenotypeを決定後、GenomeStudio Software、Eagle software（without a reference panel）および Minimac4 softwareにて男女別に7つのバッチに分けてimputation （reference: GRCh38）を実施した。Imputationデータおよびindexデータをvcfファイルにて提供する。\n"
        },
        "hum0311.v1": {
          "Research ID": "hum0311.v1",
          "公開日": "2021/11/30",
          "内容": "BBJ第一コホート11,716名、BBJ第二コホート42,689名のGenotypeデータ",
          "description": "BBJ第一コホート11,716名、BBJ第二コホート42,689名の末梢血（一部唾液）より抽出したDNAを用いたSNPアレイ解析（Asian Screening Array）で得られた657,060バリアントのGenotypeデータをidat、csv、plink binaryファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0311.v5",
      "DATA": {
        "JGAS000412": {
          "Data Set ID": "JGAS000412",
          "Type of Data": "Genotype data for 11,716 patients from BBJ 1st cohort and 42,689 patients from BBJ 2nd cohort",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/30"
        },
        "JGAS000541": {
          "Data Set ID": "JGAS000541",
          "Type of Data": "Imputation data and index data for 180,882 patients from BBJ 1st cohort",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/07/28"
        },
        "JGAS000561": {
          "Data Set ID": "JGAS000561",
          "Type of Data": "NMR metabolic biomarkers for 1,285 patients from BBJ 1st cohort",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/08"
        },
        "JGAS000561 (Data addition)": {
          "Data Set ID": "JGAS000561 (Data addition)",
          "Type of Data": "NMR metabolic biomarkers for 2,570 patients from BBJ 1st cohort",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/04/24"
        },
        "hum0311.v5.gwas.v1": {
          "Data Set ID": "hum0311.v5.gwas.v1",
          "Type of Data": "GWAS for peptic ulcers",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/07/27"
        }
      },
      "SUMMARY": {
        "Aims": "The BioBank Japan (BBJ) is a biobank established in the Institute of Medical Science, the University of Tokyo to collect clinical information and biological materials (DNA and serum samples). It collected about 200 thousand participants of 47 diseases started in 2003 (BBJ 1st cohort), and 67 thousand participants of 38 diseases started in 2013 (BBJ 2nd cohort), both in collaboration with 12 medical centers.\" This project is aiming at further utilization of the materials, and clinical and genomic information managed by BBJ to contribute to precision medicine by storing, managing, and providing the materials and data, as well as identifying biomarkers associated with disease risk, prognosis, and drug sensitivity.",
        "Methods": "Asian Screening Array (ASA-24v1-0_A2)",
        "Participants/Materials": "BBJ 1st cohort (n = 11,716 + 180,882 + 1,285 + 2,570), BBJ 2nd cohort (n = 42,689), ToMMo (n = 49,621), UK biobank (n = 456,327), and FinnGen (n = 230,635)",
        "URL": "https://biobankjp.org/en/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000412": {
          "Participants/Materials": "11,716 patients from BBJ 1st cohort and 42,689 patients from BBJ 2nd cohort\r\nICD10: C34, C15, C16, C18-C21, C22, C25, C23, C24, C61, C50, C53, C54, C56, C81-C86, C90-C93, I63, G45.9, I67.1, G40, J45, A15-A19, J44.9, J84.1-9, I21.0-9, I20.0, I20.1, I20.8, I20.9, R00, I44.0-3, I45.5-6, I47-I49, I50, I70.9, B18.1, B18.2, K74.6, N04, N20-N23, M80-M81, E10, E11, E88.8, E78.0-5, E78.8-9, E05.0, M05-M06, J30.1, L91.0, L20, L51.1-2, L27.0, D25, N80, R56.0, H40, H25-H26, K05, G12.2, I61, C64",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Asian Screening Array (ASA-24v1-0_A2)]",
          "Library Source": "DNAs extracted from peripheral blood cells or saliva",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Infinium Asian Screening Array-24 v1.0 BeadChip Kit",
          "Genotype Call Methods (software)": "GenomeStudio",
          "Marker Number (after QC)": "657,060 SNVs (GRCh38)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000529",
          "Total Data Volume": "1,020 GB (idat, csv, plink binary)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000541": {
          "Participants/Materials": "180,882 patients from BBJ 1st cohort\r\nICD10: A15-A16, B16-B17.0, B18.0-B18.1, B17.1, B18.2, C15, C16, C18, C22, C23-C24, C25, C33-C34, C50, C53, C54, C56, C61, C81, D25, E05, E10, E78.0-E78.5, G12, G40-G41, H25-H26, H40-H42, I20, I21-I22, I44-I49, I50, I60, I69.0, I63, I69.3, I70, J30, J41-J44, J45-J46, J80-J84, K05, K74.3-K74.6, L00-L99, L20, M05-M06, M80-M82, N04, N20-N23, N80, R00-R9",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpressExome, HumanOmniExpress, HumanExome]",
          "Library Source": "DNAs extracted from peripheral blood cells or saliva",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpressExome-8, HumanOmniExpress-12, HumanExome-12 kit",
          "Genotype Call Methods (software)": "GenomeStudio Software\r\nEagle software (v2.4.1) without a reference panel\r\nMinimac4 software (v1.0.2)",
          "Reference Genome Sequence": "TOPMed reference panel (Version R2 on GRC38)",
          "Filtering Methods": "Before imputation, we excluded SNPs using the following criteria:\r\n    - Heterozygosity count for each chip < 5\r\n    - P-value for Hardy–Weinberg equilibrium (HWE) for each chip < 1.0 x 10^-6 *\r\n    - Genotype concordance rate with whole-genome sequencing (WGS) for 939 samples < 99.5% and its non-reference discordance rate >= 0.5%\r\n    - Lower call rate SNPs if the position was the same when merging datasets\r\n    - Call rate < 99%\r\n   * P-values for chrX SNPs were calculated by using female samples\r\nWe also excluded samples using the following criteria ：\r\n   - Call Rate < 98%\r\n   - Samples whose inferred sex was not matched with the clinical information\r\n   - Lower call rate samples for duplicated or monozygotic twin in the dataset\r\n   - Outliers from East Asian clusters from principal component analysis with 1KGp3v5 samples.",
          "Marker Number (after QC)": "autosomes: 515,587 SNVs (GRCh38)\r\nX-chromosome: 11,140 SNVs (GRCh38)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000660",
          "Total Data Volume": "11.1 TB (vcf, tbi)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000561": {
          "Participants/Materials": "1,285 + 2,570 patients from BBJ 1st cohort: 1,286 + 2,573 samples      Total: 3,841 patients (3,859 samples)\r\nICD10: R00, I44.0-3, I45.5-6, I47-I49, I70.9, L20, J45, I67.1, I63, G45.9, C50, I50, I21.0-9, H25-H26, C53, B18.1, B18.2, C18-C21, J44.9, L51.1-2, L27.0, E10, E11, E88.8, N80, G40, C15, D25, C23, C24, H40, E05.0, K05, R56.0, C81-C86, C90-C93, C22, J30.1, E78.0-5, E78.8-9, J84.1-9, L91.0, K74.6, C34, N04, M80-M81, C56, C25, A15-A19, C61, M05-M06, I20.1, I20.8, I20.9, C16, N20-N23, I20.0, C54",
          "Targets": "metabolome (NMR)",
          "Target Loci for Capture Methods": "-",
          "Platform": "Bruker [AVANCE III HD]",
          "Source": "serum samples",
          "Cell Lines": "-",
          "Parameters": "Nightingale Health's proprietary software (quantification library 2020)",
          "Noise reduction & Data correction": "Nightingale Health's proprietary software (quantification library 2020)",
          "Annotation": "Nightingale Health's proprietary software (quantification library 2020)",
          "Quantification Methods (software)": "Nightingale Health's proprietary software (quantification library 2020)",
          "Metabolic biomarkers ": "250 metabolites (List)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000683",
          "Total Data Volume": "7.1 + 15.3 MB (xlsx)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0311.v5.gwas.v1": {
          "Participants/Materials": "peptic ulcer (ICD10: K27.9), duodenal ulcer (ICD10: K26.9), gastric ulcer (ICD10: K25.9)\r\n    - BBJ1-180K: ulcers (n = 19,713), control (n = 153,178)\r\n    - BBJ1-12K: ulcers (n = 1,001), control (n = 8,617)\r\n    - BBJ2-42K: ulcers (n = 3,637), control (n = 34,647)\r\n    - EAS meta-analysis: ulcers (n = 29,739), control (n = 240,675)\r\n      (BBJ180K, BBJ1-12K, BBJ2-42k, and TMM-50K)\r\n    - Cross-ancestry meta-analysis (EAS and EUR): ulcers (n = 52,032), control (n = 905,344)\r\n      (BBJ180K, BBJ1-12K, BBJ2-42k, TMM-50K, FinnGen, and UKB)\r\n* Detailed information on participants",
          "Targets": "genome wide variants",
          "Target Loci for Capture Methods": "-",
          "Platform": "BBJ1-180K: Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]\r\nBBJ1-12K and BBJ2-42K: Illumina [Infinium Asian Screening Array BeadChip]\r\nToMMo: Thermo Fisher Scientific [Axiom Japonica Array JPAv2]\r\nUK Biobank: Applied Biosystems [UK BiLEVE Axiom Array、UK Biobank Axiom Array]\r\nFinnGen: Thermo Fisher Scientific [FinnGen1 ThermoFisher Array or other genotyping arrays]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "BBJ: HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit, Infinium Asian Screening Array BeadChip kit\r\nToMMo: Axiom 2.0 Reagent kit\r\nUK Biobank: UK BiLEVE Axiom Array、UK Biobank Axiom Array\r\nFinnGen: FinnGen1 ThermoFisher Array or other genotyping arrays",
          "Genotype Call Methods (software)": "Genotype Call: GenomeStudio\r\nPre-phasing: eagle2\r\nImputation: minimac4 [reference: 1KGP p3v5 ALL]",
          "Association Analysis (software)": "SAIGE (v0.44)",
          "Filtering Methods": "Variants with imputation quality (Rsq) < 0.3 or MAC < 20 were excluded \r\n*Sample QC and Variant QC were described in the Dictionary file",
          "Meta-analysis (software)": "METAL",
          "Marker Number (after QC)": "BBJ1-180K GWAS: ~12,013,066 variants\r\nBBJ1-12K GWAS: ~10,836,527 variants\r\nBBJ2-42K GWAS: ~11,504,022 variants\r\nEAS-specific meta-analysis : ~13,846,852 variants\r\nCross-ancestry meta-analysis : ~19,078,654 variants\r\n* Detailed information on marker number",
          "NBDC Dataset ID": "hum0311.v5.gwas.v1\r\n(Click the Dataset ID to download the files)\r\nDictionary file",
          "Total Data Volume": "9.7 GB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koichi Matsuda",
        "Affiliation": "Graduate school of Frontier Science, The University of Tokyo",
        "Project / Group Name": "Management of disease-oriented biobank in Japan for utilization",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Platform Program for Promotion of Genome Medicine, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Phenotype-wide association study of 180,000 Biobank Japan samples using high density imputation of TOPMED reference panel",
            "Project Number": "JP21km0405215"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Seishi Ogawa": {
          "Principal Investigator": "Seishi Ogawa",
          "Affiliation": "Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Analysis on the relationship between clonal hematopoiesis and COVID-19 infection.",
          "Period of Data Use": "JGAD000529"
        },
        "Yukinori Okada": {
          "Principal Investigator": "Yukinori Okada",
          "Affiliation": "Department of Statistical Genetics, Osaka University Graduate School of Medicine",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Development of statistical genetic analysis methods using the whole-genome data from B cell lines of Japanese individuals",
          "Period of Data Use": "JGAD000529, JGAD000660"
        },
        "Masaki Kato": {
          "Principal Investigator": "Masaki Kato",
          "Affiliation": "kansai medical university",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Exploratory and validation study of genetic and biological factors for the development of precision medicine algorithms for psychiatric disorders",
          "Period of Data Use": "JGAD000529"
        },
        "Koya Fukunaga": {
          "Principal Investigator": "Koya Fukunaga",
          "Affiliation": "Division of Medical Safety Science, National Institute of Health Sciences",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Research on the diagnosis, treatment, and biomarkers for severe cutaneous adverse reactions",
          "Period of Data Use": "JGAD000529JGAD000660"
        },
        "Shigeo Kamitsuji": {
          "Principal Investigator": "Shigeo Kamitsuji",
          "Affiliation": "Statistical Analysis Division, StaGen Co., Ltd.",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genome-Wide Association Study to identify genetic factors for strabismus in Japanese population",
          "Period of Data Use": "JGAD000529"
        },
        "Yuta Kochi": {
          "Principal Investigator": "Yuta Kochi",
          "Affiliation": "Department of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic study of complex diseases through comprehensive analysis of functional genetic variations",
          "Period of Data Use": "JGAD000660"
        },
        "Hiroki Kimura": {
          "Principal Investigator": "Hiroki Kimura",
          "Affiliation": "Department of Psychiatry, Nagoya University Graduate school of medicine",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Research on elucidation of susceptibility to brain and mental illness (vulnerability to disease onset) and efficacy and side effects of drugs (treatment responsiveness) through genetic analysis",
          "Period of Data Use": "JGAD000529"
        },
        "Chikashi Terao": {
          "Principal Investigator": "Chikashi Terao",
          "Affiliation": "Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Research on personalized medicine based on genomics information",
          "Period of Data Use": "JGAD000529"
        },
        "Yoshihiro Asano": {
          "Principal Investigator": "Yoshihiro Asano",
          "Affiliation": "National Cerebral and Cardiovascular Center",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Nationwide Platform for the Promotion of Genomic Medicine in Cardiovascular Diseases",
          "Period of Data Use": "JGAD000529"
        }
      },
      "Release Note": {
        "hum0311.v5": {
          "Research ID": "hum0311.v5",
          "Release Date": "2023/07/27",
          "Type of Data": "GWAS for peptic ulcers",
          "description": "DNAs extracted from the Japanese and trans-ethnic populations were genotyped, imputed, and performed genome-wide association studies and meta-analyses for peptic ulcer disease (text file).\n"
        },
        "hum0311.v4": {
          "Research ID": "hum0311.v4",
          "Release Date": "2023/04/24",
          "Type of Data": "NMR metabolic biomarkers in 2,570 patients (2,573 samples) from BBJ 1st cohort",
          "description": "Metabolome data was obtained from serum samples of 2,570 patients from BBJ 1st cohort, measured by 500 MHz NMR spectrometers (Bruker AVANCE III HD), and quantified by Nightingale Health's proprietary software (quantification library 2020). These data were provided in xlsx files.\n"
        },
        "hum0311.v3": {
          "Research ID": "hum0311.v3",
          "Release Date": "2022/09/08",
          "Type of Data": "NMR metabolic biomarkers in 1,285 patients (1,286 samples) from BBJ 1st cohort",
          "description": "Metabolome data was obtained from serum samples, measured by 500 MHz NMR spectrometers (Bruker AVANCE IIIHD), and quantified by Nightingale Health's proprietary software (quantification library 2020). These data were provided in xlsx files.\n"
        },
        "hum0311.v2": {
          "Research ID": "hum0311.v2",
          "Release Date": "2022/07/28",
          "Type of Data": "Imputation data and index data for 180,882 patients from BBJ 1st cohort",
          "description": "DNAs extracted from peripheral blood cells or saliva of 180,882 patients from BBJ 1st cohort were genotyped by using of Illumina (HumanOmniExpressExome, HumanOmniExpress, HumanExome). Genotype imputation divided into 7 batches was carried out using GenomeStudio Software, Eagle software without a reference panel and Minimac4 software with TOPMed reference panel (Version R2 on GRC38) as a reference. Imputation data and index data were provided in vcf files.\n"
        },
        "hum0311.v1": {
          "Research ID": "hum0311.v1",
          "Release Date": "2021/11/30",
          "Type of Data": "Genotype data for 11,716 patients from BBJ 1st cohort and 42,689 patients from BBJ 2nd cohort",
          "description": "DNAs extracted from peripheral blood cells or saliva of 11,716 patients from BBJ 1st cohort and 42,689 patients from BBJ 2nd cohort were genotyped using Asian Screening Array. Genotyping data of 657,060 variants were provided (idat, csv, plink binary files).\nNote:\n"
        }
      }
    }
  },
  "hum0309.v1": {
    "ja": {
      "NBDC Research ID": "hum0309.v1",
      "データ": {
        "JGAS000418": {
          "データID": "JGAS000418",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/03/11"
        }
      },
      "研究内容の概要": {
        "目的": "皮脂と角層中のRNA発現量の特徴の解明",
        "方法": "皮脂および角層のRNA発現量のAmpliSeq Transcriptomeを用いたRNA-seq解析",
        "対象": "健常男性10名の顔面の皮脂10サンプル、角層10サンプル"
      },
      "分子データ": {
        "JGAS000418": {
          "対象": "健常男性：10名\r\n皮脂10サンプル、角層10サンプル",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "ライブラリソース": "健常男性の顔面の皮脂および角層から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Transcriptome Human Gene Expression Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "110 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000535",
          "総データ量": "67.4 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "井上 高良",
        "所 属 機 関": "花王株式会社 生物科学研究所",
        "プロジェクト/研究グループ名": "皮脂RNAプロジェクト",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Non-invasive human skin transcriptome analysis using mRNA in skin surface lipids",
          "DOI": "doi: 10.1038/s42003-022-03154-w",
          "データID": "JGAD000535"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000535"
        }
      },
      "リリース情報": {
        "hum0309.v1": {
          "Research ID": "hum0309.v1",
          "公開日": "2022/03/11",
          "内容": "NGS（RNA-seq）",
          "description": "健常男性10名の皮脂および角層から抽出したRNAを用いたRNA-seq解析データをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0309.v1",
      "DATA": {
        "JGAS000418": {
          "Data Set ID": "JGAS000418",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/03/11"
        }
      },
      "SUMMARY": {
        "Aims": "Evaluation of properties between sebum and stratum corneum RNA",
        "Methods": "AmpliSeq Transcriptome analysis was performed to analyze human mRNA expressions in sebum or stratum corneum RNA",
        "Participants/Materials": "ten males (facial sebum 10 samples and facial stratum corneum 10 samples)"
      },
      "MOLECULAR DATA": {
        "JGAS000418": {
          "Participants/Materials": "10 healthy males\r\nfacial sebum 10 samples and facial stratum corneum 10 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "Library Source": "RNAs extracted from sebum and stratum corneum",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Transcriptome Human Gene Expression Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "110 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000535",
          "Total Data Volume": "67.4 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takayoshi Inoue",
        "Affiliation": "Biological Science Laboratories, Kao Corporation",
        "Project / Group Name": "Sebum RNA project",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Non-invasive human skin transcriptome analysis using mRNA in skin surface lipids",
          "DOI": "doi: 10.1038/s42003-022-03154-w",
          "Data Set ID": "JGAD000535"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000535"
        }
      },
      "Release Note": {
        "hum0309.v1": {
          "Research ID": "hum0309.v1",
          "Release Date": "2022/03/11",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from facial sebum and facial stratum corneum of 10 healthy males were used for RNA-sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0308.v1": {
    "ja": {
      "NBDC Research ID": "hum0308.v1",
      "データ": {
        "JGAS000417": {
          "データID": "JGAS000417",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/03/11"
        }
      },
      "研究内容の概要": {
        "目的": "顔と頭皮の皮脂RNAの部位差の解明",
        "方法": "皮脂中のRNA発現量をAmpliSeq Transcriptomeを用いたRNA-seq解析",
        "対象": "健常女性10名の顔面皮脂10サンプル、頭皮皮脂10サンプル"
      },
      "分子データ": {
        "JGAS000417": {
          "対象": "健常女性：10名\r\n顔面皮脂10サンプル、頭皮皮脂10サンプル",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "ライブラリソース": "健常女性の顔面および頭皮の皮脂から抽出したｍRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Transcriptome Human Gene Expression Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "110 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000534",
          "総データ量": "73.1 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "井上 高良",
        "所 属 機 関": "花王株式会社 生物科学研究所",
        "プロジェクト/研究グループ名": "皮脂RNAプロジェクト",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Non-invasive human skin transcriptome analysis using mRNA in skin surface lipids",
          "DOI": "doi: 10.1038/s42003-022-03154-w",
          "データID": "JGAD000534"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000534"
        }
      },
      "リリース情報": {
        "hum0308.v1": {
          "Research ID": "hum0308.v1",
          "公開日": "2022/03/11",
          "内容": "NGS（RNA-seq）",
          "description": "健常女性10名の顔面および頭皮の皮脂から抽出したmRNAを用いたRNA-seq解析データをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0308.v1",
      "DATA": {
        "JGAS000417": {
          "Data Set ID": "JGAS000417",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/03/11"
        }
      },
      "SUMMARY": {
        "Aims": " Evaluate the site differentiation of scalp and facial skin of sebum RNA",
        "Methods": "AmpliSeq Transcriptome analysis was performed to analyze human mRNA expressions in sebum RNA",
        "Participants/Materials": "ten females (facial sebum 10 samples and scalp sebum 10 samples)"
      },
      "MOLECULAR DATA": {
        "JGAS000417": {
          "Participants/Materials": "10 healthy females\r\nfacial sebum 10 samples and scalp sebum 10 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "Library Source": "RNAs extracted from sebum",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Transcriptome Human Gene Expression Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "110 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000534",
          "Total Data Volume": "73.1 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takayoshi Inoue",
        "Affiliation": "Biological Science Laboratories, Kao Corporation",
        "Project / Group Name": "Sebum RNA project",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Non-invasive human skin transcriptome analysis using mRNA in skin surface lipids",
          "DOI": "doi: 10.1038/s42003-022-03154-w",
          "Data Set ID": "JGAD000534"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000534"
        }
      },
      "Release Note": {
        "hum0308.v1": {
          "Research ID": "hum0308.v1",
          "Release Date": "2022/03/11",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from sebum of 10 healthy females were used for RNA-sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0307.v1": {
    "ja": {
      "NBDC Research ID": "hum0307.v1",
      "データ": {
        "JGAS000416": {
          "データID": "JGAS000416",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/03/11"
        }
      },
      "研究内容の概要": {
        "目的": "試験１「健常者における皮膚物性および皮膚成分の解析」および試験２「アトピー性皮膚炎患者における皮膚成分の解析」において実施したRNA発現量を解析し、健常者とAD患者間の皮脂RNAの違いを解明すること。",
        "方法": "皮脂中のRNA発現量のAmpliSeq Transcriptomeを用いたRNA-seq解析",
        "対象": "健常男性29名、および、アトピー性皮膚炎男性患者30症例"
      },
      "分子データ": {
        "JGAS000416": {
          "対象": "健常男性：29名\r\n男性のアトピー性皮膚炎（ICD10：L20）：30症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "ライブラリソース": "顔面の皮脂から抽出したmRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Transcriptome Human Gene Expression Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "110 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000533",
          "総データ量": "261 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "井上 高良",
        "所 属 機 関": "花王株式会社 生物科学研究所",
        "プロジェクト/研究グループ名": "皮脂RNAプロジェクト",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Non-invasive human skin transcriptome analysis using mRNA in skin surface lipids",
          "DOI": "doi: 10.1038/s42003-022-03154-w",
          "データID": "JGAD000533"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000533"
        }
      },
      "リリース情報": {
        "hum0307.v1": {
          "Research ID": "hum0307.v1",
          "公開日": "2022/03/11",
          "内容": "NGS（RNA-seq）",
          "description": "健常男性29名およびアトピー性皮膚炎男性患者30名の顔面皮脂から抽出したRNAを用いたRNA-seq解析データをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0307.v1",
      "DATA": {
        "JGAS000416": {
          "Data Set ID": "JGAS000416",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/03/11"
        }
      },
      "SUMMARY": {
        "Aims": "Evaluate the differences of sebum RNA between healthy males and male patients with atopic dermatitis using the data of study 1 (Analysis for skin molecules and properties in healthy subjects) and study 2 (Analysis for skin molecules in patients with atopic dermatitis).",
        "Methods": "AmpliSeq Transcriptome analysis was performed to analyze human mRNA expressions in sebum RNA",
        "Participants/Materials": "Healthy males: 29, Male patients with atopic dermatitis: 30"
      },
      "MOLECULAR DATA": {
        "JGAS000416": {
          "Participants/Materials": "healthy control: 29 males\r\natopic dermatitis (ICD10: L20): 30 males",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "Library Source": "mRNAs extracted from sebum",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Transcriptome Human Gene Expression Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "110 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000533",
          "Total Data Volume": "261 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takayoshi Inoue",
        "Affiliation": "Biological Science Laboratories, Kao Corporation",
        "Project / Group Name": "Sebum RNA project",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Non-invasive human skin transcriptome analysis using mRNA in skin surface lipids",
          "DOI": "doi: 10.1038/s42003-022-03154-w",
          "Data Set ID": "JGAD000533"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000533"
        }
      },
      "Release Note": {
        "hum0307.v1": {
          "Research ID": "hum0307.v1",
          "Release Date": "2022/03/11",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from sebum of 29 healthy males and 30 male patients with atopic dermatitis were used for RNA-sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0306.v1": {
    "ja": {
      "NBDC Research ID": "hum0306.v1",
      "データ": {
        "JGAS000361": {
          "データID": "JGAS000361",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/10/15"
        }
      },
      "研究内容の概要": {
        "目的": "がん患者から採取した腫瘍や組織の網羅的ゲノム解析を行い、そのデータを国際連携（ICGC）の場にて解析し、がんゲノムカタログを作成する。",
        "方法": "長鎖一分子シークエンサー（nanopore）による全ゲノムシークエンス",
        "対象": "国際がんゲノムコンソーシアム（ICGC）の際に収集した日本人肝臓がん9症例（hum0158においてshort read sequencerを用いた解析を実施している肝臓がん症例）の腫瘍組織由来DNA"
      },
      "分子データ": {
        "JGAS000361": {
          "対象": "肝臓がん（ICD10：C220）：9 症例",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Nanopore [MinION]",
          "ライブラリソース": "腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SQK-LSK109",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均7875 bp（最短4715 bp - 最長12070 bp）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000475",
          "総データ量": "201.3 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 英刀",
        "所 属 機 関": "理化学研究所 生命医科学研究センター がん免疫基盤研究部門 がんゲノム研究チーム",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture",
          "DOI": "doi: 10.1038/s41467-021-26805-8",
          "データID": "JGAD000475"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0306.v1": {
          "Research ID": "hum0306.v1",
          "公開日": "2021/10/15",
          "内容": "NGS（WGS）",
          "description": "肝臓がん9症例の腫瘍組織から抽出したDNAを用いたロングリードWGS解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0306.v1",
      "DATA": {
        "JGAS000361": {
          "Data Set ID": "JGAS000361",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/10/15"
        }
      },
      "SUMMARY": {
        "Aims": "Cancer genome sequencing and analysis in international cancer genome collaboration ICGC for establishment of cancer genome catalogue",
        "Methods": "Whole genome sequencing with Nanopore sequencer",
        "Participants/Materials": "DNA extracted from tumor tissues of 9 liver cancer patients (also analyzed in hum0158 with short-read sequencer)"
      },
      "MOLECULAR DATA": {
        "JGAS000361": {
          "Participants/Materials": "liver cancer (ICD10：C220): 9 cases",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Nanopore [MinION]",
          "Library Source": "DNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SQK-LSK109",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "4715-12070 bp (7875 bp on average)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000475",
          "Total Data Volume": "201.3 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hidewaki Nakagawa",
        "Affiliation": "Laboratory of Genome Sequencing Analysis, RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (A)",
            "Title": "Multi-omics analysis for hepato-biliary-pancreatic cancers",
            "Project Number": "18H04049"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture",
          "DOI": "doi: 10.1038/s41467-021-26805-8",
          "Data Set ID": "JGAD000475"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0306.v1": {
          "Research ID": "hum0306.v1",
          "Release Date": "2021/10/15",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from tumor tissues obtained from liver cancer patients were used for the long-read whole-genome sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0305.v1": {
    "ja": {
      "NBDC Research ID": "hum0305.v1",
      "データ": {
        "JGAS000377": {
          "データID": "JGAS000377",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/29"
        }
      },
      "研究内容の概要": {
        "目的": "造血細胞移植後2次固形がんは、通常のがんと比較して、固有のゲノム異常プロファイルを有した腫瘍である可能性がある。2次固形がんと通常のがんの検体を対象とした全エクソン配列決定解析を行うことにより、我々の仮説を検証する。",
        "方法": "ゲノムDNAは、凍結新鮮検体はQIAamp Fast DNA Tissue kit、FFPE検体はGeneRead DNA FFPE kitを用いて調整した。全エクソームシークエンス（Whole Exome Sequence：WES）解析用のライブラリはTwist社のTwist library preparation kitを用いて作製した。作製したライブラリはIllumina社 Novaseq 6000またはMGI社DNBSEQ-G400でシークエンス解析を行った。",
        "対象": "固形がん14症例の腫瘍組織凍結検体14検体、および、ホルマリン固定パラフィン包埋（FFPE）14検体"
      },
      "分子データ": {
        "JGAS000377": {
          "対象": "固形がん（舌がん [ICD10：C02.9]、大腸がん [ICD10：C18.9]）：14症例\r\n　　28検体 （腫瘍組織の凍結検体とFFPE検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]\r\nMGI [DNBSEQ-G400]",
          "ライブラリソース": "腫瘍組織の凍結検体とFFPE検体から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Twist library preparation kit",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000491",
          "総データ量": "288.4 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および 民間企業における利用禁止"
        }
      },
      "提供者情報": {
        "研究代表者": "稲本 賢弘",
        "所 属 機 関": "国立がん研究センター中央病院 造血幹細胞移植科",
        "プロジェクト/研究グループ名": "造血細胞移植後2次固形がんのゲノム解析",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的がん医療実用化研究事業",
            "タイトル": "ゲノム解析に基づいた造血細胞移植後2次固形がん最適個別化医療の実現",
            "研究課題番号": "JP20ck0106539"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples",
          "DOI": "doi: 10.1038/s42003-021-02930-4",
          "データID": "JGAD000491"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0305.v1": {
          "Research ID": "hum0305.v1",
          "公開日": "2021/11/29",
          "内容": "NGS（Exome）",
          "description": "固形がん（舌がん、大腸がん）の腫瘍組織の凍結検体とFFPE検体から抽出したDNAを用いた全エクソームシークエンス解析の結果をbamファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0305.v1",
      "DATA": {
        "JGAS000377": {
          "Data Set ID": "JGAS000377",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/29"
        }
      },
      "SUMMARY": {
        "Aims": "Subsequent solid cancers after allogenic hematopoietic cell transplantation may have unique genomic profiles compared with de novo cancers. In order to identify such profiles, we applied whole exome sequencing (WES) of subsequent solid cancers after allogeneic hematopoietic cell transplantation as well as de novo cancers.",
        "Methods": "Genomic DNA was extracted using a QIAamp Fast DNA Tissue kit, GeneRead DNA FFPE kit or QIAamp DNA Mini kit. Libraries for WES were prepared using the Twist library preparation kit. The libraries were sequenced using a Novaseq 6000 or DNBSEQ G400 with the paired-end option.",
        "Participants/Materials": "14 fresh-frozen tumor tissues and 14 formalin-fixed-paraffin-embedded (FFPE) tumor tissues of 14 de novo cancer patients"
      },
      "MOLECULAR DATA": {
        "JGAS000377": {
          "Participants/Materials": "de novo cancer (tongue cancer [ICD10: C02.9], colon cancer [ICD10: C18.9]): 14 cases\r\n    fresh-frozen tumor tissue: 14 samples,\r\n    FFPE tumor tissue: 14 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]\r\nMGI [DNBSEQ-G400]",
          "Library Source": "DNAs extracted from fresh-frozen and FFPE tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Twist library preparation kit",
          "Fragmentation Methods": "Enzymatic Fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000491",
          "Total Data Volume": "288.4 GB (bam)",
          "Comments (Policies)": "NBDC policy and Company User Limit"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yoshihiro Inamoto",
        "Affiliation": "Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital",
        "Project / Group Name": "Comprehensive molecular profiling of subsequent solid cancers after allogenic hematopoietic cell transplantation",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Establishment of personalized medicine for secondary solid tumors after hematopoietic cell transplantation based on genomic characterization",
            "Project Number": "JP20ck0106539"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples",
          "DOI": "doi: 10.1038/s42003-021-02930-4",
          "Data Set ID": "JGAD000491"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0305.v1": {
          "Research ID": "hum0305.v1",
          "Release Date": "2021/11/29",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from fresh-frozen and FFPE tumor tissues from 14 de novo cancer patients were used for the whole exome sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0304.v1": {
    "ja": {
      "NBDC Research ID": "hum0304.v1",
      "データ": {
        "JGAS000370": {
          "データID": "JGAS000370",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/04/08"
        }
      },
      "研究内容の概要": {
        "目的": "タキサン系抗がん剤は乳がん治療におけるキードラッグの一つであり、乳がん治療における初期および再発治療を含むすべての段階で重要な役割を担う薬剤である。しかし、タキサン系抗がん剤の投与により腫瘍が増大傾向を示す乳がんがまれながら経験され、ひとつの臨床的課題となっている。本研究は、タキサン系抗がん剤投与により腫瘍が増大傾向を示した症例を選別し、網羅的にwhole exome sequencing解析を実施することで共通する体細胞変異を見出し、その機能解析を通してタキサン作用メカニズムの解明と薬剤不応の克服を目指す。",
        "方法": "タキサン系抗がん剤投与により腫瘍が増大傾向を示した症例を選別し、乳がん組織ならびに血液組織から抽出したDNAを対象に網羅的にwhole exome sequencing解析を行い、腫瘍組織に特異的な変異を検出する。",
        "対象": "タキサン系抗がん剤投与により腫瘍が増大傾向を示した乳がん症例"
      },
      "分子データ": {
        "JGAS000370": {
          "対象": "タキサン系抗がん剤投与により腫瘍が増大傾向を示した乳がん（ICD10：C50）：6症例\r\n    腫瘍組織：6検体\r\n    非腫瘍組織（末梢血）：3検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "腫瘍組織：Illumina [HiSeq 2000]\r\n末梢血：Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織および末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human ALL Exon V5 Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000484",
          "総データ量": "41.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "鰐渕 友美",
        "所 属 機 関": "名古屋市立大学大学院 医学研究科 乳腺外科学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Discovering novel mechanisms of taxane resistance in human breast cancer by whole-exome sequencing",
          "DOI": "doi: 10.3892/ol.2021.13178",
          "データID": "JGAD000484"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0304.v1": {
          "Research ID": "hum0304.v1",
          "公開日": "2022/04/08",
          "内容": "NGS（Exome）",
          "description": "タキサン系抗がん剤投与により腫瘍が増大傾向を示した乳がん症例の腫瘍組織および末梢血から抽出したDNAを用いたwhole exome sequencing解析データの結果をfastqファイルにて提供する。SureSelect Human ALL Exon V5 KitによりDNAライブラリを作成し、Illumina HiSeq 2000/2500にて平均長200塩基を解読した（paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0304.v1",
      "DATA": {
        "JGAS000370": {
          "Data Set ID": "JGAS000370",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/04/08"
        }
      },
      "SUMMARY": {
        "Aims": "Taxanes are key drugs in the treatment of breast cancer, but some breast cancers are resistant to taxanes. We used whole exome-sequencing (WES) technology to investigate mechanisms of taxane resistance in human breast cancer.",
        "Methods": "DNAs extracted from tumor tissues and peripheral blood cells of patients with breast cancer whose tumors responded well to anthracycline treatment but grew rapidly during neoadjuvant taxane-based chemotherapy were used for WES analysis and somatic mutations in the candidate genes were identified.",
        "Participants/Materials": "Six patients with breast cancer whose tumors grew rapidly during neoadjuvant taxane-based chemotherapy"
      },
      "MOLECULAR DATA": {
        "JGAS000370": {
          "Participants/Materials": "breast cancer (ICD10: C50): 6 cases\r\n    tumor tissue: 6 samples\r\n    peripheral blood cells: 3 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "tumor tissue: Illumina [HiSeq 2000]\r\nperipheral blood: Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor tissue and peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ultrasonic fragmentation",
          "Fragmentation Methods": "SureSelect Human ALL Exon V5 Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000484",
          "Total Data Volume": "41.5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yumi Wanifuchi-Endo",
        "Affiliation": "Department of Breast Surgery, Graduate School of Medical Sciences, Nagoya City University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Exome sequencing analysis in human breast cancer tissues showing resistance for taxanes.",
            "Project Number": "16K10469"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Discovering novel mechanisms of taxane resistance in human breast cancer by whole-exome sequencing",
          "DOI": "doi: 10.3892/ol.2021.13178",
          "Data Set ID": "JGAD000484"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0304.v1": {
          "Research ID": "hum0304.v1",
          "Release Date": "2022/04/08",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor tissue and peripheral blood cells of 6 patients with breast cancer whose tumors grew rapidly during neoadjuvant taxane-based chemotherapy were used for the whole exome sequencing analysis. DNA libraries were established with SureSelect Human ALL Exon V5 Kit and sequenced by Illumina HiSeq 2000/2500 (paired-end; 200 bp). Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0302.v1": {
    "ja": {
      "NBDC Research ID": "hum0302.v1",
      "データ": {
        "JGAS000382": {
          "データID": "JGAS000382",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/05"
        }
      },
      "研究内容の概要": {
        "目的": "iPS細胞株（健常人及び疾患特異的iPS細胞株）を使用し、分化能解析（疾患原因細胞や関与細胞への分化能の評価）、疾患原因遺伝子の解析、全ゲノム解析等の高次特性解析を実施する。また、ゲノム編集技術等を利用して（１）疾患原因遺伝子を正常遺伝子に置換した疾患特異的iPS細胞株（isogenic control cell）、疾患特異的iPS細胞における疾患原因遺伝子を正常遺伝子に置換した細胞（isogenic control cell）、（２）正常遺伝子を疾患原因遺伝子に置換した細胞株（人工作製疾患特異的iPS細胞株）、（３）組織特異的及び／又は分化段階特異的にマーカー（蛍光マーカー等）を発現する加工iPS細胞株を作製する。",
        "方法": "ヒトiPS細胞から肝細胞を分化誘導し、19日目に回収。RNAを抽出後PolyA選択法により作製したストランド特異的ライブラリーのシークエンシング解析をNovaseq6000にて行った（サンプルあたり約6Gb [約2000万ペアリード相当]のデータ出力）。",
        "対象": "ウイルソン病（指定難病171）患者由来iPS細胞株、ならびに、健常人由来iPS細胞株",
        "URL": "https://acd.brc.riken.jp/ja/"
      },
      "分子データ": {
        "JGAS000382": {
          "対象": "ウィルソン病（ICD10：E830）患者由来iPS細胞から分化誘導させた肝細胞サンプル：5検体\r\nウイルソン病患者由来iPS細胞をゲノム編集し、ATP7B変異を修復した肝細胞サンプル：1検体\r\n健常人由来iPS細胞から分化誘導させた肝細胞サンプル：5検体\r\n健常人由来iPS細胞をゲノム編集し、ATP7B変異を導入した肝細胞サンプル：1検体 \r\n計12検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "iPS細胞から分化誘導させた肝細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "GeneWiz社のプロトコルに準拠",
          "断片化の方法": "GeneWiz社のプロトコルに準拠",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000497",
          "総データ量": "45.6 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "林 洋平",
        "所 属 機 関": "理化学研究所 バイオリソース研究センター",
        "プロジェクト/研究グループ名": " iPS細胞高次特性解析開発チーム",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Retinoids rescue ceruloplasmin secretion and alleviate oxidative stress in Wilson's disease-specific hepatocytes.",
          "DOI": "doi: 10.1093/hmg/ddac080",
          "データID": "JGAD000497"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0302.v1": {
          "Research ID": "hum0302.v1",
          "公開日": "2022/09/05",
          "内容": "NGS（RNA-seq）",
          "description": "ウイルソン病患者由来iPS細胞および健常人由来iPS細胞から分化誘導させた肝細胞サンプルから抽出したRNAを用いたRNA-seq解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0302.v1",
      "DATA": {
        "JGAS000382": {
          "Data Set ID": "JGAS000382",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/05"
        }
      },
      "SUMMARY": {
        "Aims": "To characterize iPS cell lines (healthy-donor iPS cell lines and disease-specific iPS cell lines), differentiation potential analysis (evaluation of differentiation potential into disease-causing cells and involved cells), disease-causing gene analysis, and whole genome analysis were performed.",
        "Methods": "Hepatocytes were induced to differentiate from human iPS cells and collected on day 19. RNA was collected and strand-specific library preparation was performed by a PolyA selection method. The prepared library was sequenced by Novaseq6000. Sequencing was performed in a 2x150 bp PE configuration with a data output of about 6 Gb per sample (equivalent to about 20 million paired reads).",
        "Participants/Materials": "iPS cells derived from patients with Wilson's disease and iPS cells derived from healthy donors",
        "URL": "https://acd.brc.riken.jp/en/"
      },
      "MOLECULAR DATA": {
        "JGAS000382": {
          "Participants/Materials": "Five samples of hepatocytes differentiated from iPS cells derived from patients with Wilson's disease (ICD10: E830)\r\nOne hepatocyte sample from a patient with Wilson's disease in which the ATP7B mutation was corrected by genome editing of iPS cells\r\nFive samples of hepatocytes differentiated from healthy human-derived iPS cells\r\nOne hepatocyte sample in which the ATP7B mutation was introduced by genome editing of healthy donor-derived iPS cells\r\n  [Total: 12 samples]",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from hepatocytes differentiated from iPS cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "GeneWiz inc.'s protocol",
          "Fragmentation Methods": "GeneWiz inc.'s protocol",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000497",
          "Total Data Volume": "45.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yohei Hayashi",
        "Affiliation": "RIKEN BioResource Research Center",
        "Project / Group Name": "iPS Cell Advanced Characterization and Development Team",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Retinoids rescue ceruloplasmin secretion and alleviate oxidative stress in Wilson's disease-specific hepatocytes.",
          "DOI": "doi: 10.1093/hmg/ddac080",
          "Data Set ID": "JGAD000497"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0302.v1": {
          "Research ID": "hum0302.v1",
          "Release Date": "2022/09/05",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from hepatocytes differentiated from iPS cells derived from patients with Wilson's disease and iPS cells derived from healthy donors were used for RNA-sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0301.v1": {
    "ja": {
      "NBDC Research ID": "hum0301.v1",
      "データ": {
        "JGAS000368": {
          "データID": "JGAS000368",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/29"
        }
      },
      "研究内容の概要": {
        "目的": "日常診療で得られた検体の残余腫瘍及び正常乳腺検体及び研究用血液検体を用いて、腫瘍及び正常乳腺組織の遺伝子変異腫瘍局所及び末梢血の種々の免疫担当細胞や免疫担当因子を解析し、がん患者及び高リスク者におけるゲノム異常と免疫状態との関係性を明らかにする。腫瘍及び正常乳腺ゲノム異常と免疫常態の関係性をエンドポイントとし、副次的に免疫状態と臨床病理学的特徴、分子生物学的な特徴や治療効果や予後との関連について検討する。免疫学的なプロファイルの変化・違いについてはゲノム異常の有無さらには臨床的な背景でも患者を分けたうえで免疫細胞数や、免疫細胞表面マーカーの発現の違いなどをt検定やWilcoxon検定、Welch検定、Mann-Whitney検定、Log-rank検定などで解析する。",
        "方法": "ゲノムDNAをはQIAamp DNA Mini Kit / QIAamp Fast DNA Tissue Kit（新鮮凍結検体）あるいはGeneRead DNA FFPE Kit（FFPE検体）を用いて抽出したDNAを用いたTarget Capture Sequencing解析",
        "対象": "乳がん26症例の腫瘍組織ならびに正常乳腺組織（新鮮凍結検体、FFPE検体）"
      },
      "分子データ": {
        "JGAS000368": {
          "対象": "乳がん（ICD10：C50.9）：26症例（計329検体）\r\n    腫瘍組織 凍結検体：9症例（23検体）\r\n    腫瘍組織 FFPE検体：19症例（37検体）\r\n    正常組織 凍結検体：14症例（57検体）\r\n    正常組織 FFPE検体：22症例（212検体）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "464遺伝子（Todai OncoPanel）",
          "Platform": "Illumina [HiSeq 2500、NovaSeq 6000]\r\nMGI Technologies社 [DNBSEQ-G400]",
          "ライブラリソース": "腫瘍組織および正常組織（凍結検体、FFPE）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina：SureSelectXT Custom kitあるいはTwist Custom Panels（Todai OncoPanel）\r\nMGI：Illumina用ライブラリをMGIEasy Universal Library Conversion Kitを用いて変換",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "124–151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000482",
          "総データ量": "814.2 GB（bam [ref：hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "間野 博行",
        "所 属 機 関": "国立がん研究センター研究所 細胞情報学分野",
        "プロジェクト/研究グループ名": "Immuno-Genome Atlas Project (iGAP)",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的がん医療実用化研究事業",
            "タイトル": "革新的がん遺伝子機能解析法によるプレシジョンメディシンの実現",
            "研究課題番号": "JP19ck0106252"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples",
          "DOI": "doi: 10.1038/s42003-021-02930-4",
          "データID": "JGAD000482"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0301.v1": {
          "Research ID": "hum0301.v1",
          "公開日": "2021/11/29",
          "内容": "NGS（Target Capture）",
          "description": "乳がん26症例の腫瘍組織および正常組織（凍結検体、FFPE）から抽出したDNAを用いた464遺伝子のTarget Capture Sequencing解析データをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0301.v1",
      "DATA": {
        "JGAS000368": {
          "Data Set ID": "JGAS000368",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/29"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify the relationship between genomic abnormalities and immune status in cancer patients and high-risk individuals, we analyzed various immunocompetent cells/factors (immunological profile) in tumor tissues, normal mammary tissue, and peripheral blood cells for genetic mutations. The relationship between immune status and clinicopathological/biological features, treatment response, and prognosis were examined as a secondary endpoint.",
        "Methods": "For target sequence, genomic DNA was extracted using QIAamp DNA Mini Kits or QIAamp Fast DNA Tissue Kit for fresh-frozen samples and GeneRead DNA FFPE Kit for formalin-fixed-paraffin-embedded (FFPE) samples.",
        "Participants/Materials": "Tumor tissues and normal breast tissues from 26 patients with breast cancer (fresh frozen samples and FFPE samples)"
      },
      "MOLECULAR DATA": {
        "JGAS000368": {
          "Participants/Materials": "breast cancer (ICD10: C50.9): 26 cases (Total: 329 samples)\r\n    fresh-frozen tumor tissue: 9 cases, 23 samples\r\n    FFPE tumor tissue: 19 cases, 37 samples\r\n    fresh-frozen normal breast tissue: 14 cases, 57 samples\r\n    FFPE normal breast tissue: 22 cases, 212 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "464 genes (Todai OncoPanel, a custom target-capturing panel)",
          "Platform": "Illumina [HiSeq 2500, NovaSeq 6000]\r\nMGI Technologies [DNBSEQ-G400]",
          "Library Source": "DNAs extracted from tumor tissues and normal breast tissues (fresh-frozen and FFPE samples)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina: SureSelectXT Custom kits [Agilent Technologies] or Twist Custom Panels [Twist Bioscience]\r\nMGI: DNA libraries for Illumina sequencer were converted to single-stranded circular DNA libraries for MGI sequencer with the MGIEasy Universal Library Conversion Kit [MGI Technologies]",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "124–151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000482",
          "Total Data Volume": "814.2 GB (bam [ref: hg38])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Mano",
        "Affiliation": "Division of Cellular Signaling, National Cancer Center Research Institute",
        "Project / Group Name": "Immuno-Genome Atlas Project (iGAP)",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Implementation of precision medicine by the application of an innovative method for functional evaluation of oncogenes.",
            "Project Number": "JP19ck0106252"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples",
          "DOI": "doi: 10.1038/s42003-021-02930-4",
          "Data Set ID": "JGAD000482"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0301.v1": {
          "Research ID": "hum0301.v1",
          "Release Date": "2021/11/29",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from tumor tissues and normal breast tissues (fresh-frozen and FFPE samples) of 26 patients with breast cancer were used for the target capture sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0300.v1": {
    "ja": {
      "NBDC Research ID": "hum0300.v1",
      "データ": {
        "JGAS000367": {
          "データID": "JGAS000367",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/12"
        }
      },
      "研究内容の概要": {
        "目的": "次世代シーケンサーを始めとする種々のゲノム解析手法により同定されるゲノム・エピゲノム異常やCopy number variant（CNV）の異常、遺伝子発現異常などを併せた統合的Omics解析によって、がんの原因遺伝子や主要シグナル伝達経路を明らかにし、がん病態を包括的に理解するとともに画期的ながん分子診断法の開発ならびに治療標的分子の同定を行うこと。",
        "方法": "全エクソンシーケンスおよびRNA-seq",
        "対象": "全エクソン解析：食道扁平上皮がん88症例、RNA-seq解析：食道扁平上皮がん57症例（56症例に対して両解析を実施）"
      },
      "分子データ": {
        "Exome": {
          "対象": "食道扁平上皮がん（ICD10：C15）：88症例\r\n    （腫瘍組織および非腫瘍組織ペア）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT Human All Exon",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000481",
          "総データ量": "6 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "食道扁平上皮がん（ICD10：C15）：57症例\r\n    （腫瘍組織および非腫瘍組織ペア）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ribo-Zero Magnetic Gold Kit、TruSeq Stranded mRNA Sample Prep Kit",
          "断片化の方法": "TruSeq Stranded mRNA Sample Prep Kitを使用",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000481",
          "総データ量": "6 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "稲澤 譲治",
        "所 属 機 関": "東京医科歯科大学 難治疾患研究所 分子細胞遺伝",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "東京医科歯科大学　難治疾患共同研究拠点",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma",
          "DOI": "doi: 10.1111/cas.15063",
          "データID": "JGAD000481"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000481"
        }
      },
      "リリース情報": {
        "hum0300.v1": {
          "Research ID": "hum0300.v1",
          "公開日": "2021/11/12",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "食道扁平上皮がんの腫瘍組織および非腫瘍組織から抽出したDNA/RNAを用いたExome、RNA-seq解析の結果をfastqファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0300.v1",
      "DATA": {
        "JGAS000367": {
          "Data Set ID": "JGAS000367",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/12"
        }
      },
      "SUMMARY": {
        "Aims": "We perform integrative genome-wide analyses such as whole-exome sequencing, epigenome analysis, copy number variant (CNV) analysis, and gene expression analysis using next-generation sequencing and other methods to elucidate driver genes and signaling pathways causing tumorigenesis and cancer progression, leading novel molecular diagnostics and molecular therapies.",
        "Methods": "Whole-exome sequencing, RNA-sequencing",
        "Participants/Materials": "Whole-exome sequencing, Esophageal squamous cell carcinoma, tumor and paired non-tumor, 88 pairs; RNA-sequencing, Esophageal squamous cell carcinoma, tumor and paired non-tumor, 57 pairs"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "Esophageal squamous cell carcinoma (ICD10: C15): 88 cases\r\n    tumor and paired non-tumor tissue",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT Human All Exon",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000481",
          "Total Data Volume": "6 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Esophageal squamous cell carcinoma (ICD10: C15): 57 cases (56 cases are also used for Exome)\r\n    tumor and paired non-tumor tissue",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ribo-Zero Magnetic Gold Kit, TruSeq Stranded mRNA Sample Prep Kit",
          "Fragmentation Methods": "TruSeq Stranded mRNA Sample Prep Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000481",
          "Total Data Volume": "6 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Johji Inazawa",
        "Affiliation": "Department of molecular cytogenetics, Medical Research Institute, Tokyo Medical and Dental University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Tokyo Medical and Dental University, Nanken-Kyoten",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma",
          "DOI": "doi: 10.1111/cas.15063",
          "Data Set ID": "JGAD000481"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000481"
        }
      },
      "Release Note": {
        "hum0300.v1": {
          "Research ID": "hum0300.v1",
          "Release Date": "2021/11/12",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs/RNAs extracted from tumor and paired non-tumor tissues of esophageal squamous cell carcinoma patients were used for the whole exome sequencing and RNA sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0299.v1": {
    "ja": {
      "NBDC Research ID": "hum0299.v1",
      "データ": {
        "DRA012759": {
          "データID": "DRA012759",
          "内容": "NGS（WGS）",
          "制限": "非制限公開",
          "公開日": "2022/09/15"
        }
      },
      "研究内容の概要": {
        "目的": "ナノポアシークエンサーPromethIONの新たなプラットフォームQ20を用いた全ゲノムシークエンスによるハプロタイプフェージング解析の精度への影響を調べる",
        "方法": "ナノポアシークエンサーPromethIONの新たなプラットフォームQ20を用いた全ゲノムシークエンス",
        "対象": "健常白人由来B細胞株HG002（NA24385）",
        "URL": "https://www.k.u-tokyo.ac.jp/information/category/press/9567.html"
      },
      "分子データ": {
        "DRA012759": {
          "対象": "健常白人由来B細胞株HG002 (NA24385) :1検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Nanopore [PromethION]",
          "ライブラリソース": "B細胞株 HG002(NA24835) から抽出したDNA",
          "検体情報（購入の場合）": "HG002（NA24385, Coriell Institute）",
          "ライブラリ作製方法（キット名）": "SQK-Q20EA",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "11,990 bp",
          "DDBJ Sequence Read Archive ID": "DRA012759",
          "総データ量": "5.7 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "鈴木 穣",
        "所 属 機 関": "東京大学大学院 新領域創成科学研究科 メディカル情報生命専攻 生命システム観測分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん医療創生研究事業（P-CREATE）",
            "タイトル": "受動喫煙により惹起される肺がんゲノム変異の多様性の理解と治療方針の策定",
            "研究課題番号": "JP21cm0106577"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Phasing analysis of lung cancer genomes using a long read sequencer",
          "DOI": "doi: 10.1038/s41467-022-31133-6",
          "データID": "DRA012759"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0299.v1": {
          "Research ID": "hum0299.v1",
          "公開日": "2022/09/15",
          "内容": "NGS（WGS）",
          "description": "健常白人由来B細胞株HG002（NA24385）より抽出したDNAを対象とし、ナノポアシークエンサーPromethIONの新たなプラットフォームQ20を用いた全ゲノムシークエンス解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0299.v1",
      "DATA": {
        "DRA012759": {
          "Data Set ID": "DRA012759",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/09/15"
        }
      },
      "SUMMARY": {
        "Aims": "Whole genome sequencing using the newly available PromethION Q20 platform (Nanopore) to validate haplotype phasing analysis",
        "Methods": "Whole genome sequencing using the PromethION Q20 platform (Nanopore)",
        "Participants/Materials": "Healthy white B-Lymphocyte cell line HG002 (NA24385)"
      },
      "MOLECULAR DATA": {
        "DRA012759": {
          "Participants/Materials": "Healthy white B-Lymphocyte cell line HG002 (NA24385): 1 sample",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Nanopore [PromethION]",
          "Library Source": "DNAs extracted from healthy white B-Lymphocyte cell line HG002 (NA24385)",
          "Cell Lines": "HG002 (NA24385, Coriell Institute)",
          "Library Construction (kit name)": "SQK-Q20EA",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "11,990 bp",
          "DDBJ Sequence Read Archive ID": "DRA012759",
          "Total Data Volume": "5.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yutaka Suzuki",
        "Affiliation": "Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Understanding the diversity of lung cancer genomic mutations induced by passive smoking and formulating therapeutic strategies",
            "Project Number": "JP21cm0106577"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Phasing analysis of lung cancer genomes using a long read sequencer",
          "DOI": "doi: 10.1038/s41467-022-31133-6",
          "Data Set ID": "DRA012759"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0299.v1": {
          "Research ID": "hum0299.v1",
          "Release Date": "2022/09/15",
          "Type of Data": "NGS (WGS)",
          "description": "DNA extracted from Healthy white B-Lymphocyte cell line HG002 (NA24385) was used for whole-genome sequencing analysis by using of Q20 platform (PromethION, Nanopore). Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0297.v1": {
    "ja": {
      "NBDC Research ID": "hum0297.v1",
      "データ": {
        "JGAS000348": {
          "データID": "JGAS000348",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/15"
        }
      },
      "研究内容の概要": {
        "目的": "ヒトの色覚多様性が、どのような遺伝的基盤・神経基盤・経験や社会的影響を受けてもたらされているかについて、遺伝子から認知までの様々なレベルのアプローチにより総合的に明らかにすること",
        "方法": "唾液から抽出したDNAを用いて色覚に関連するオプシン遺伝子群やその周辺領域の多型解析を行う",
        "対象": "健常者：１名"
      },
      "分子データ": {
        "JGAS000348": {
          "対象": "健常者：1名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]\r\nNanopore [PromethION]",
          "ライブラリソース": "唾液から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina：TruSeq DNA Nano\r\nNanopore：SQK-LSK109",
          "断片化の方法": "Illumina：超音波断片化（Covaris）\r\nNanopore：-",
          "ライブラリ構築方法": "Illumina：Paired-end\r\nNanopore：Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "Illumina：300 bp\r\nNanopore：平均 8248 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000462",
          "総データ量": "249.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "平松 千尋",
        "所 属 機 関": "九州大学 芸術工学研究院",
        "プロジェクト/研究グループ名": "感性多様性研究室",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0297.v1": {
          "Research ID": "hum0297.v1",
          "公開日": "2022/09/15",
          "内容": "NGS（WGS）",
          "description": "健常者1名の唾液から抽出したDNAを用いたIllumina NovaSeq 6000によるショートリード、ならびに、Nanopore PromethIONによるロングリードによるWhole Genome Sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0297.v1",
      "DATA": {
        "JGAS000348": {
          "Data Set ID": "JGAS000348",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/15"
        }
      },
      "SUMMARY": {
        "Aims": "To comprehensively clarify the genetic, neural, experiential and social influences that contribute to the diversity of color vision in humans, using approaches at various levels from genes to cognition.",
        "Methods": "Polymorphism analysis of a group of opsin genes related to color vision and their surrounding regions was performed using DNA extracted from saliva.",
        "Participants/Materials": "1 healthy donor"
      },
      "MOLECULAR DATA": {
        "JGAS000348": {
          "Participants/Materials": "1 healthy donor",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]\r\nNanopore [PromethION]",
          "Library Source": "DNAs extracted from saliva of healthy donor",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina: TruSeq DNA Nano\r\nNanopore: SQK-LSK109",
          "Fragmentation Methods": "Illumina: Ultrasonic fragmentation (Covaris)\r\nNanopore: -",
          "Spot Type": "Illumina: Paired-end\r\nNanopore: Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "Illumina: 300 bp\r\nNanopore: 8248 bp on average",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000462",
          "Total Data Volume": "249.5 GB（fastq）",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Chihiro Hiramatsu",
        "Affiliation": "Sensory Diversity Laboratory Department of Human Science Faculty of Design, Kyushu University",
        "Project / Group Name": "Laboratory of Sensory Diversity",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0297.v1": {
          "Research ID": "hum0297.v1",
          "Release Date": "2022/09/15",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from saliva of 1 healthy donor were used for whole genome sequencing analysis (short read and long read). Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0293.v1": {
    "ja": {
      "NBDC Research ID": "hum0293.v1",
      "データ": {
        "JGAS000320": {
          "データID": "JGAS000320",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/07/25"
        }
      },
      "研究内容の概要": {
        "目的": "造血器腫瘍の分子病態・治療感受性を規定する遺伝学的因子の探索",
        "方法": "1. 成人T細胞性白血病リンパ腫（adult T-cell leukemia/lymphoma：ATL）症例の末梢血より腫瘍細胞を含む単核球を分離後、抽出したDNAを用いたwhole genome sequencing解析",
        "対象": "ATL症例、ならびに、遺伝子改変操作を行ったATL細胞株"
      },
      "分子データ": {
        "JGAS000320": {
          "対象": "ATL（ICD10：C91.5）：7症例\r\nATL細胞株（TL-om1細胞株）：1検体\r\n12種の遺伝子改変操作を実施",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeqX10]\r\nBGI [BGISEQ-500]",
          "ライブラリソース": "末梢血より分離した腫瘍細胞を含む単核球および遺伝子改変操作を行ったATL細胞株より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "BGI's standard protocol に準拠",
          "断片化の方法": "BGI's standard protocol に準拠",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000431",
          "総データ量": "1.1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "三田 貴臣",
        "所 属 機 関": "名古屋市立大学医学部 血液腫瘍内科学／シンガポール国立大学 癌科学研究所",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0293.v1": {
          "Research ID": "hum0293.v1",
          "公開日": "2022/07/25",
          "内容": "NGS（WGS）",
          "description": "成人T細胞性白血病リンパ腫7症例の末梢血単核球より抽出したDNAを用いたWGS解析データ、ならびに、12の実験条件（遺伝子改変操作）を行ったATL細胞株（TL-om1）より抽出したDNAを用いたWGS解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0293.v1",
      "DATA": {
        "JGAS000320": {
          "Data Set ID": "JGAS000320",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/07/25"
        }
      },
      "SUMMARY": {
        "Aims": "Exploration of genetic factors that contribute to molecular pathogenesis and therapeutic sensitivity of hematopoietic malignancies",
        "Methods": "1. Genomic DNA was extracted from peripheral blood mononuclear cells of primary adult T-cell leukemia/lymphoma (ATL) patients. Library construction and whole-genome sequencing analysis were performed.",
        "Participants/Materials": "ATL  patients and  ATL cell line"
      },
      "MOLECULAR DATA": {
        "JGAS000320": {
          "Participants/Materials": "ATL (ICD10: C91.5): 7 cases\r\nATL cell line (TL-om1 cell): 1 sample (12 genetic modifications)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeqX10]\r\nBGI [BGISEQ-500]",
          "Library Source": "DNAs extracted from peripheral blood mononuclear cells of primary ATL patients or genetic modified ATL cell line (TL-om1 cell)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "BGI's standard protocol",
          "Fragmentation Methods": "BGI's standard protocol",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000431",
          "Total Data Volume": "1.1 TB（fastq）",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takaomi Sanda",
        "Affiliation": "Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences / Cancer Science Institute of Singapore, National University of Singapore",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0293.v1": {
          "Research ID": "hum0293.v1",
          "Release Date": "2022/07/25",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from peripheral blood mononuclear cells of primary ATL patients or an ATL cell line with 12 genetic modifications were used for whole genome sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0292.v1": {
    "ja": {
      "NBDC Research ID": "hum0292.v1",
      "データ": {
        "JGAS000330": {
          "データID": "JGAS000330",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/09/24"
        }
      },
      "研究内容の概要": {
        "目的": "血中遊離DNA（cell free DNA：cfDNA）および血中循環腫瘍細胞（circulating tumor cells：CTC）のゲノム解析に基づく、去勢抵抗性前立腺がん（castration-resistant prostate cancer：CRPC）に対する各種薬剤（アビラテロン、エンザルタミド、ドセタキセル、カバジタキセル）効果予測システムの開発",
        "方法": "アビラテロンまたはエンザルタミド投与前のCRPC患者100名を国内17施設で集積。薬剤投与前採血より、cfDNAと白血球からDNAを抽出。DNA断片に分子バーコードを付加した上でシークエンスライブラリを作成し、Illumina NovaSeqを用いてターゲットシークエンス（88遺伝子のエクソン領域を対象）を行った。",
        "対象": "アビラテロンまたはエンザルタミド投与前の去勢抵抗性前立腺がん患者100名"
      },
      "分子データ": {
        "JGAS000330": {
          "対象": "アビラテロンまたはエンザルタミド投与前の去勢抵抗性前立腺がん（ICD10：C61）：100症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "88遺伝子",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血から抽出したcfDNAおよび白血球DNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "ThruPLEX tag-seq、KAPA HyperChoice Probes",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000441",
          "総データ量": "1.8 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "赤松 秀輔",
        "所 属 機 関": "京都大学大学院医学研究科 泌尿器科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "アステラス 研究助成金",
            "タイトル": "去勢抵抗性前立腺癌生検組織を用いたエンザルタミド治療効果予測因子の検討",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer",
          "DOI": "doi: 10.1158/1078-0432.CCR-21-2328",
          "データID": "JGAD000441"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0292.v1": {
          "Research ID": "hum0292.v1",
          "公開日": "2021/09/24",
          "内容": "NGS（Target Capture）",
          "description": "アビラテロンまたはエンザルタミド投与前の去勢抵抗性前立腺がん100症例の末梢血から抽出したcfDNAおよび白血球DNAを用いた88遺伝子のTarget Capture Sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0292.v1",
      "DATA": {
        "JGAS000330": {
          "Data Set ID": "JGAS000330",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/09/24"
        }
      },
      "SUMMARY": {
        "Aims": "To develop predictive biomarkers for the treatment of castration-resistant prostate cancer (CRPC) such as abiraterone, enzalutamide, docetaxel, and cabazitaxel based on genomic analyses of cell-free DNA (cfDNA) and circulating tumor cells (CTC).",
        "Methods": "One hundred CRPC patients eligible for treatment with either abiraterone or enzalutamide were prospectively enrolled at 17 institutions in Japan. cfDNA and paired lymphocyte DNA per patient were used for sequencing library preparation, and unique molecular identifiers were added. Targeted sequencing was performed using Illumina NovaSeq (Our custom gene panel captures the exonic regions of 88 genes).",
        "Participants/Materials": "100 CRPC patients eligible for abiraterone or enzalutamide"
      },
      "MOLECULAR DATA": {
        "JGAS000330": {
          "Participants/Materials": "CRPC patients eligible for abiraterone or enzalutamide (ICD10: C61): 100 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "88 genes",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "cfDNA and paired lymphocyte DNA extracted from peripheral blood",
          "Cell Lines": "-",
          "Library Construction (kit name)": "ThruPLEX tag-seq, KAPA HyperChoice Probes",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000441",
          "Total Data Volume": "1.8 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shusuke Akamatsu",
        "Affiliation": "Department of Urology, Graduate School of Medicine, Kyoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Astellas Research Grant",
            "Title": "Identification of factors predicting response to enzalutamide using tissues of castration-resistant prostate cancer",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer",
          "DOI": "doi: 10.1158/1078-0432.CCR-21-2328",
          "Data Set ID": "JGAD000441"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0292.v1": {
          "Research ID": "hum0292.v1",
          "Release Date": "2021/09/24",
          "Type of Data": "NGS (Target Capture)",
          "description": "cfDNA and paired lymphocyte DNA extracted from peripheral blood of 100 patients with castration-resistant prostate cancer were used for the target capture sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0291.v2": {
    "ja": {
      "NBDC Research ID": "hum0291.v2",
      "データ": {
        "JGAS000359": {
          "データID": "JGAS000359",
          "内容": "NGS（WGS、Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/12/10"
        },
        "JGAS000359（データ追加）": {
          "データID": "JGAS000359（データ追加）",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/09/08"
        }
      },
      "研究内容の概要": {
        "目的": "膵腫瘍、十二指腸腫瘍、胆道腫瘍の網羅的ゲノムプロファイリングによる疾患の病態解明",
        "方法": "全ゲノム解析には凍結サンプルからQIAamp DNA Mini Kitを用いて、また、全エクソーム解析にはFFPEサンプルからQIAamp DNA FFPE Tissue Kitを用いてDNAを抽出した。断片化したDNA（1〜2 µg）に対し、全ゲノム解析ではTruSeq DNA PCR-Free Library Prep Kitを、全エクソーム解析ではTruSeq Exome Library Prep Kit用いてライブラリを調製し、HiSeq 2000/2500にて塩基配列の読み取りを行った。RNAシーケンシングについては、凍結サンプルからIllustra RNAspin Mini RNA Isolation Kitを用いてtotal RNAを抽出した。TruSeq RNA Access Library Prep Kitを用いてライブラリを調製し、HiSeq2500にて塩基配列の読み取りを行った。",
        "対象": "膵腫瘍 57＋6 症例、十二指腸腫瘍 6＋1 症例、胆道腫瘍 11 症例",
        "URL": "http://www.cgi.med.osaka-u.ac.jp/"
      },
      "分子データ": {
        "WGS": {
          "対象": "膵腫瘍（ICD10：C25）：33症例\r\n十二指腸腫瘍（ICD10：C170）：2症例\r\n胆道腫瘍（ICD10：C240）：1症例",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "凍結検体（腫瘍組織および非腫瘍組織のペア）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free Library Prep Kit",
          "断片化の方法": "超音波断片化（Covaris S2 or E220ev）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000473",
          "総データ量": "12.8 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Exome": {
          "対象": "膵腫瘍（ICD10：C25）：24症例\r\n十二指腸腫瘍（ICD10：C170）：4症例\r\n胆道腫瘍（ICD10：C240）：10症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "FFPE検体（腫瘍組織および非腫瘍組織のペア）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Exome Library Prep Kit",
          "断片化の方法": "超音波断片化（Covaris S2 or E220ev）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000473",
          "総データ量": "12.8 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "膵腫瘍（ICD10：C25）：43症例\r\n      腫瘍組織 43検体、非腫瘍組織 3検体\r\n十二指腸腫瘍（ICD10：C170）：4症例\r\n      腫瘍組織 5検体、非腫瘍組織 1検体\r\n胆道腫瘍（ICD10：C240）：1症例\r\n      腫瘍組織 1検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織もしくは非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Access Library Prep Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000473",
          "総データ量": "361.7 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "谷内田 真一",
        "所 属 機 関": "大阪大学大学院 医学系研究科 医学専攻 ゲノム生物学講座・がんゲノム情報学",
        "プロジェクト/研究グループ名": "Elucidation of molecular mechanisms of tumorigenesis and development of diagnoses and treatments based on comprehensive genomic analyses in pancreatic tumors, duodenal tumors and biliary tumors",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System",
          "DOI": "doi: 10.1158/2159-8290.CD-21-0669",
          "データID": "JGAD000473"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "谷本 梓": {
          "研究代表者": "谷本 梓",
          "所属機関": "金沢大学 腫瘍内科",
          "研究題目": "",
          "利用データID": "肺大細胞神経内分泌がん （LCNEC） に対する遺伝子プロファイルに基づいた治療戦略の確立",
          "利用期間": "JGAD000473"
        }
      },
      "リリース情報": {
        "hum0291.v2": {
          "Research ID": "hum0291.v2",
          "公開日": "2023/09/08",
          "内容": "NGS（RNA-seq）",
          "description": "膵腫瘍、十二指腸腫瘍、胆道腫瘍の腫瘍組織ならびに非腫瘍組織から抽出したRNAを用いたRNAシーケンシング解析データをfastqファイルにて提供する。\n"
        },
        "hum0291.v1": {
          "Research ID": "hum0291.v1",
          "公開日": "2021/12/10",
          "内容": "NGS（WGS、Exome）",
          "description": "膵腫瘍、十二指腸腫瘍、胆道腫瘍の腫瘍組織ならびに非腫瘍組織のペアから抽出したDNAを用いたWGS解析データおよびWES解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0291.v2",
      "DATA": {
        "JGAS000359": {
          "Data Set ID": "JGAS000359",
          "Type of Data": "NGS (WGS, Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/12/10"
        },
        "JGAS000359 (data addition)": {
          "Data Set ID": "JGAS000359 (data addition)",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/09/08"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate the molecular mechanisms of tumorigenesis based on the comprehensive genome profiling in pancreatic tumors, duodenal tumors, and biliary tumors",
        "Methods": "Genomic DNA was extracted from frozen tissues using QIAamp DNA Mini Kit for whole-genome sequencing (WGS) or from FFPE tissues using QIAamp DNA FFPE Tissue Kit for whole-exome sequencing (WES). For WGS, short-fragment libraries (insert size 350 bp) were prepared with 1-2 μg aliquots of genomic DNA from tumor and matched non-neoplastic tissues using a TruSeq DNA PCR-Free Library Prep Kit according to the manufacturer’s instructions. Paired-end sequencing of the libraries was performed using a HiSeq 2000/2500 sequencer. Whole-exome capture libraries were prepared from tumor and matched non-tumor DNAs using a TruSeq Exome Library Prep Kit, according to the manufacturer’s instructions. DNA libraries were sequenced in a paired-end mode with 100-bp reads, using HiSeq 2000/2500 sequencer. Total RNA was extracted from frozen tissues using Illustra RNAspin Mini RNA Isolation Kit. Whole-transcriptome sequencing libraries were prepared using the TruSeq RNA Access Library Prep Kit. Sequencing was performed on HiSeq 2500 sequencer.",
        "Participants/Materials": "Pancreatic tumor, Duodenal tumor, Biliary tumors",
        "URL": "https://resou.osaka-u.ac.jp/en/research/2021/20211209_1"
      },
      "MOLECULAR DATA": {
        "WGS": {
          "Participants/Materials": "Pancreatic tumor (ICD10: C25): 33 cases\r\nDuodenal tumor (ICD10: C170): 2 cases\r\nBiliary tumors (ICD10: C240): 1 case",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "DNAs extracted from frozen samples (tumor and matched non-tumor tissues)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S2 or E220ev)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000473",
          "Total Data Volume": "12.8 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Exome": {
          "Participants/Materials": "Pancreatic tumor (ICD10: C25): 24 cases\r\nDuodenal tumor (ICD10: C170): 4 cases\r\nBiliary tumors (ICD10: C240): 10 cases",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "DNAs extracted from FFPE samples (tumor and matched non-tumor tissues)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Exome Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S2 or E220ev)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000473",
          "Total Data Volume": "12.8 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Pancreatic tumor (ICD10: C25): 43 cases\r\n   tumor tissue: 43 samples, non-tumor tissue: 3 samples\r\nDuodenal tumor (ICD10: C170): 4 cases\r\n   tumor tissue: 5 samples, non-tumor tissue: 1 sample\r\nBiliary tumors (ICD10: C240): 1 case\r\n   tumor tissue: 1 sample",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor or non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Access Library Prep Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000473",
          "Total Data Volume": "361.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shinichi Yachida",
        "Affiliation": "Cancer Genome Informatics, Department of Genome Biology, Graduate School of Medicine/Faculty of Medicine, Osaka University",
        "Project / Group Name": "Elucidation of molecular mechanisms of tumorigenesis and development of diagnoses and treatments based on comprehensive genomic analyses in pancreatic tumors, duodenal tumors and biliary tumors",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System",
          "DOI": "doi: 10.1158/2159-8290.CD-21-0669",
          "Data Set ID": "JGAD000473"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Auzsa Tanimoto": {
          "Principal Investigator": "Auzsa Tanimoto",
          "Affiliation": "Division of Medical Oncology, Cancer Research Institute, Kanazawa University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Strategy for large cell neuroendocrine carcinoma based on gene and molecular subtypes",
          "Period of Data Use": "JGAD000473"
        }
      },
      "Release Note": {
        "hum0291.v2": {
          "Research ID": "hum0291.v2",
          "Release Date": "2023/09/08",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from tumor and non-tumor tissues of patients with pancreatic tumors, duodenal tumors, or biliary tumors were used for the RNA sequencing analysis. Fastq files are provided.\n"
        },
        "hum0291.v1": {
          "Research ID": "hum0291.v1",
          "Release Date": "2021/12/10",
          "Type of Data": "NGS (WGS, Exome)",
          "description": "DNAs extracted from tumor and matched non-tumor tissues of patients with pancreatic tumors, duodenal tumors, and biliary tumors were used for the whole genome and whole exome sequencing analyses. Fastq files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0290.v1": {
    "ja": {
      "NBDC Research ID": "hum0290.v1",
      "データ": {
        "JGAS000321": {
          "データID": "JGAS000321",
          "内容": "NGS（WGS）\r\nNGS（scRNA-seq）\r\nNGS（TCR-seq）\r\nNGS（BCR-seq）\r\nCyTOF",
          "制限": "制限公開（Type I）",
          "公開日": "2022/03/07"
        }
      },
      "研究内容の概要": {
        "目的": "柏の葉地域に在勤・在住の健常者を対象としたゲノムコホート研究を通じ、より安心で快適な生活環境の実現、創薬研究・個別化医療の発展に向けた基盤構築",
        "方法": "血液試料を用いたwhole genome aequencing解析、scRNA-seq解析、TCR-seq解析、BCR-seq解析、CyTOF解析",
        "対象": "柏の葉地域に在勤・在住の18歳以上の健常者",
        "URL": "-"
      },
      "分子データ": {
        "WGS": {
          "対象": "健常者：2名（2検体）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]\r\nNanopore [PromethION]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina：TruSeq DNA Nano kit\r\nNanopore：SQK-LSK109 Kit",
          "断片化の方法": "Illumina：超音波断片化 （Covaris）\r\nNanopore：-",
          "ライブラリ構築方法": "Illumina：Paired-end\r\nNanopore：Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "Illumina: 300 bp\r\nNanopore: -",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000432",
          "総データ量": "2.2 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "scRNA-seq": {
          "対象": "健常者：7名（57検体）",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "ライブラリソース": "末梢血より単離した細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Next GEM Single Cell V(D)J Reagent Kits v1.1 （10x Genomics）",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000432",
          "総データ量": "2.2 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "TCR-seq": {
          "対象": "健常者：7名（57検体）",
          "規模": "TCR-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "ライブラリソース": "末梢血より単離した細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Next GEM Single Cell V(D)J Reagent Kits v1.1 （10x Genomics）",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000432",
          "総データ量": "2.2 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "BCR-seq": {
          "対象": "健常者：7名（35検体）",
          "規模": "BCR-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "ライブラリソース": "末梢血より単離した細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Next GEM Single Cell V(D)J Reagent Kits v1.1 （10x Genomics）",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000432",
          "総データ量": "2.2 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "CyTOF": {
          "対象": "健常者：6名（30検体）",
          "規模": "CyTOF® Mass Cytometry",
          "対象領域": "免疫応答に関する30蛋白質",
          "Platform（ハードウェア）": "Helios a CyTOF system [Fluidigm]",
          "ソース": "末梢血から単離した細胞",
          "検体情報（購入の場合）": "-",
          "試薬": "Maxper Direct Immune Profiling Assay, 30 Marker - 25 test （Cat. #201325）",
          "パラメータ": "30",
          "検出・定量解析ソフトウェア": "Maxpar Pathsetter （Cat. #401018）",
          "実験期間": "2020/11/1 - 2021/7/31",
          "実験変数": "個別変異、ワクチン接種後、ワクチンの種類（インフルエンザ、SARS-CoV-2）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000432",
          "総データ量": "2.2 TB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "鈴木 穣",
        "所 属 機 関": "東京大学大学院 新領域創成科学研究科 メディカル情報生命専攻 生命システム観測分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "JST Moonshot R&D – MILLENNIA Program",
            "タイトル": "ウイルス-人体相互作用ネットワークの理解と制御",
            "研究課題番号": "JPMJMS2025"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Intensive Single Cell Analysis Reveals Immune Cell Diversity among Healthy Individuals",
          "DOI": "doi: 10.26508/lsa.202201398",
          "データID": "JGAD000432"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0290.v1": {
          "Research ID": "hum0290.v1",
          "公開日": "2022/03/07",
          "内容": "NGS（WGS、scRNA-seq、TCR-seq、BCR-seq、CyTOF）",
          "description": "柏の葉地域に在勤・在住の18歳以上の健常者より採取した血液試料を用いた、WGS、10x scRNA、10x TCR、10x BCR、CyTOF解析の結果をfastqおよびtxtファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0290.v1",
      "DATA": {
        "JGAS000321": {
          "Data Set ID": "JGAS000321",
          "Type of Data": "NGS (WGS)\r\nNGS (scRNA-seq)\r\nNGS (TCR-seq)\r\nNGS (BCR-seq)\r\nCyTOF",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/03/07"
        }
      },
      "SUMMARY": {
        "Aims": "Through genome cohort studies targeting healthy volunteers who work or live in the Kashiwa-no-ha area, we aim to realize a safer and more comfortable living environment and build a foundation for drug discovery research and the development of personalized medicine.",
        "Methods": "WGS, 10x scRNA, 10x TCR, 10x BCR, CyTOF analyses were performed using blood samples collected from healthy volunteers aged 18 years or older who worked or lived in the Kashiwa-no-ha area.",
        "Participants/Materials": "7 healthy volunteers aged 18 years or older who worked or lived in the Kashiwa-no-ha area",
        "URL": "-"
      },
      "MOLECULAR DATA": {
        "WGS": {
          "Participants/Materials": "2 healthy volunteers (2 samples)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]\r\nNanopore [PromethION]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina: TruSeq DNA Nano kit\r\nNanopore: SQK-LSK109 Kit",
          "Fragmentation Methods": "Illumina: Ultrasonic fragmentation (Covaris)\r\nNanopore: -",
          "Spot Type": "Illumina: Paired-end\r\nNanopore: Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "Illumina: 300 bp\r\nNanopore: -",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000432",
          "Total Data Volume": "2.2 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "scRNA-seq": {
          "Participants/Materials": "7 healthy volunteers (57 samples)",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "Library Source": "RNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Next GEM Single Cell V(D)J Reagent Kits v1.1 (10x Genomics)",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000432",
          "Total Data Volume": "2.2 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "TCR-seq": {
          "Participants/Materials": "7 healthy volunteers (57 samples)",
          "Targets": "TCR-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "Library Source": "RNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Next GEM Single Cell V(D)J Reagent Kits v1.1 (10x Genomics)",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000432",
          "Total Data Volume": "2.2 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "BCR-seq": {
          "Participants/Materials": "7 healthy volunteers (35 samples)",
          "Targets": "BCR-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "Library Source": "RNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Next GEM Single Cell V(D)J Reagent Kits v1.1 (10x Genomics)",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000432",
          "Total Data Volume": "2.2 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "CyTOF": {
          "Participants/Materials": "6 healthy volunteers (30 samples)",
          "Targets": "CyTOF@ Mass cytometry",
          "Target Loci for Capture Methods": "30 proteins related to immune response",
          "Platform": "Helios a CyTOF system [Fluidigm]",
          "Source": "peripheral blood cells",
          "Cell Lines": "-",
          "Reagents": "Maxper Direct Immune Profiling Assay, 30 Marker - 25 test (Cat. #201325)",
          "Parameter": "30",
          "Acquire/analyze data software": "Maxpar Pathsetter (Cat. #401018)",
          "Experiment date": "2020/11/1 - 2021/7/31",
          "Experiment variables": "individual variation, timepoint post-vaccination, vaccination type (influenza, SARS-CoV-2)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000432",
          "Total Data Volume": "2.2 TB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yutaka Suzuki",
        "Affiliation": "Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "JST Moonshot R&D – MILLENNIA Program",
            "Title": "Understanding and Control of Virus-Human Interaction Networks",
            "Project Number": "JPMJMS2025"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Intensive Single Cell Analysis Reveals Immune Cell Diversity among Healthy Individuals",
          "DOI": "doi: 10.26508/lsa.202201398",
          "Data Set ID": "JGAD000432"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0290.v1": {
          "Research ID": "hum0290.v1",
          "Release Date": "2022/03/07",
          "Type of Data": "NGS (WGS, scRNA-seq, TCR-seq, BCR-seq, CyTOF)",
          "description": "WGS, 10x scRNA, 10x TCR, 10x BCR, CyTOF analyses were performed using blood samples collected from healthy volunteers aged 18 years or older who worked or lived in the Kashiwa-no-ha area. Fastq and txt files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0289.v1": {
    "ja": {
      "NBDC Research ID": "hum0289.v1",
      "データ": {
        "JGAS000317": {
          "データID": "JGAS000317",
          "内容": "NGS（RNA-seq）\r\nNGS（Exome）\r\nメチル化アレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/09"
        }
      },
      "研究内容の概要": {
        "目的": "次世代シーケンサーなどを使用した網羅的な解析を行うことで、慢性骨髄単球性白血病（CMML）症例における同種造血幹細胞移植後再発メカニズムの同定を行う。",
        "方法": "移植時および再発時の末梢血サンプルより分離した腫瘍由来のCD14+/CD16-単球から抽出したDNA/RNAを用いたRNAシークエンス、エクソンシークエンス、メチル化アレイ解析",
        "対象": "慢性骨髄単球性白血病（CMML）1症例、同種造血幹細胞移植前と移植後再発時の末梢血サンプル（1症例2サンプル）"
      },
      "分子データ": {
        "RNA-seq": {
          "対象": "慢性骨髄単球性白血病（CMML）（ICD10：C93.1）：1症例\r\n    同種造血幹細胞移植前と移植後再発時の末梢血：各1検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血より単離したCD14+/CD16-単球から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-seq Stranded kit",
          "断片化の方法": "SMART-seq Stranded kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "クオリティコントロール方法": "NovaSeq Control Software v1.6.0\r\nReal Time Analysis (RTA) v3.4.4\r\nbcl2fastq2 v2.20",
          "マッピング方法": "Genedata Profiler Genome 13.0.11\r\nSTAR 2.6.0c",
          "平均カバー率（Depth）": "76.3-84.1%",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000428",
          "総データ量": "23.9 GB（bam [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Exome": {
          "対象": "慢性骨髄単球性白血病（CMML）（ICD10：C93.1）：1症例\r\n    同種造血幹細胞移植前と移植後再発時の末梢血：各1検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血より単離したCD14+/CD16-単球から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelectXT Reagent kit、SureSelectXT Human All Exon kit V6 （Agilent Technology）",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "クオリティコントロール方法": "NovaSeq Control Software v1.6.0\r\nReal Time Analysis (RTA) v3.4.4\r\nbcl2fastq2 v2.20",
          "マッピング方法": "DRAGEN Bio-IT Platform 3.5.7\r\nSnpEff v4.2\r\nVCFtools 0.1.9",
          "平均カバー率（Depth）": ">99%",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000428",
          "総データ量": "23.9 GB（bam [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "メチル化アレイ": {
          "対象": "慢性骨髄単球性白血病（CMML）（ICD10：C93.1）：1症例\r\n    同種造血幹細胞移植前と移植後再発時の末梢血：各1検体",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium MethylationEPIC BeadChip]",
          "ソース": "末梢血より単離したCD14+/CD16-単球から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium MethylationEPIC BeadChip",
          "メチル化率決定アルゴリズム（ソフトウェア）": "iScan システム 309171 Rev B\r\niScan Control Software 3.4.8",
          "フィルタリング": "GenomeStudio Software V2011.1\r\nMethylation Module 1.9.0",
          "マイクロアレイ標準化方法": "GenomeStudio Software V2011.1\r\nMethylation Module 1.9.0",
          "プローブ数": "85万プローブ （Infinium MethylationEPIC BeadChip）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000428",
          "総データ量": "23.9 GB（bpm）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "赤星 佑",
        "所 属 機 関": "自治医科大学附属さいたま医療センター 血液科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT",
          "DOI": "doi: 10.1007/s12185-021-03284-7",
          "データID": "JGAD000428"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0289.v1": {
          "Research ID": "hum0289.v1",
          "公開日": "2022/09/09",
          "内容": "NGS（RNA-seq、Exome）、メチル化アレイ",
          "description": "慢性骨髄単球性白血病（CMML）1症例の 同種造血幹細胞移植前と移植後再発時の末梢血より単離したCD14+･CD16-単球から抽出したDNA/RNAを用いたRNA-seq、Exome、メチル化アレイ解析の結果をbam、bpmファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0289.v1",
      "DATA": {
        "JGAS000317": {
          "Data Set ID": "JGAS000317",
          "Type of Data": "NGS (RNA-seq)\r\nNGS (Exome)\r\nMethylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/09"
        }
      },
      "SUMMARY": {
        "Aims": "Disease relapse is a major cause of treatment failure after allogeneic hematopoietic cell transplantation (HCT), and mechanisms on relapse still remain to be elucidated. We experienced a patient with chronic myelomonocytic leukemia (CMML) who underwent haploidentical HCT from his daughter and developed relapse. To understand the mechanisms on relapse after HCT, we analyze blood samples at HCT and at relapse.",
        "Methods": "We analyzed peripheral blood samples that had been collected at HCT and relapse. CD14+/CD16- monocytes that accumulate typically in CMML were isolated by flow cytometry. Whole-exome sequencing, RNA sequencing, and methylation array were performed to determine the mechanism of relapse.",
        "Participants/Materials": "chronic myelomonocytic leukemia (CMML): 1 case; peripheral blood samples that had been collected at allogeneic hematopoietic cell transplantation and relapse (2 samples)"
      },
      "MOLECULAR DATA": {
        "RNA-seq": {
          "Participants/Materials": "chronic myelomonocytic leukemia (CMML) (ICD10: C93.1): 1 case (2 samples)\r\n    peripheral blood samples collected at HCT and relapse",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from CD14+/CD16- monocytes isolated from peripheral blood samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-seq Stranded kit",
          "Fragmentation Methods": "SMART-seq Stranded kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "QC": "NovaSeq Control Software v1.6.0\r\nReal Time Analysis (RTA) v3.4.4\r\nbcl2fastq2 v2.20",
          "Mapping Methods": "Genedata Profiler Genome 13.0.11\r\nSTAR 2.6.0c",
          "Coverage (Depth)": "76.3-84.1%",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000428",
          "Total Data Volume": "23.9 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "Exome": {
          "Participants/Materials": "chronic myelomonocytic leukemia (CMML) (ICD10: C93.1): 1 case (2 samples)\r\n    peripheral blood samples collected at HCT and relapse",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from CD14+/CD16- monocytes isolated from peripheral blood samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelectXT Reagent kit, SureSelectXT Human All Exon kit V6 (Agilent Technology)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "QC": "NovaSeq Control Software v1.6.0\r\nReal Time Analysis (RTA) v3.4.4\r\nbcl2fastq2 v2.20",
          "Mapping Methods": "DRAGEN Bio-IT Platform 3.5.7\r\nSnpEff v4.2\r\nVCFtools 0.1.9",
          "Coverage (Depth)": ">99%",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000428",
          "Total Data Volume": "23.9 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation array": {
          "Participants/Materials": "chronic myelomonocytic leukemia (CMML) (ICD10: C93.1): 1 case (2 samples)\r\n    peripheral blood samples collected at HCT and relapse",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium MethylationEPIC BeadChip Kit]",
          "Library Source": "DNAs extracted from CD14+/CD16- monocytes isolated from peripheral blood samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Infinium MethylationEPIC BeadChip",
          "Algorithms for Calculating Methylation-rate (software)": "iScan System 309171 Rev B\r\niScan Control Software 3.4.8",
          "Filtering Methods": "GenomeStudio Software V2011.1\r\nMethylation Module 1.9.0",
          "Normalization of microarray": "GenomeStudio Software V2011.1\r\nMethylation Module 1.9.0",
          "Probe Number": "850,000 probes (Infinium MethylationEPIC BeadChip)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000428",
          "Total Data Volume": "23.9 GB (bpm)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yu Akahoshi",
        "Affiliation": "Saitama Medical Center, Jichi Medical University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT",
          "DOI": "doi: 10.1007/s12185-021-03284-7",
          "Data Set ID": "JGAD000428"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0289.v1": {
          "Research ID": "hum0289.v1",
          "Release Date": "2022/09/09",
          "Type of Data": "NGS (RNA-seq, Exome), Methylation array",
          "description": "RNA-seq, Exome and DNA methylation array in a patient with chronic myelomonocytic leukemia (CMML) were performed using DNA/RNAs extracted from CD14+/CD16- monocytes isolated from peripheral blood samples collected at HCT and relapse. The data are provided as bam and bpm format files.\nNote：\n"
        }
      }
    }
  },
  "hum0287.v2": {
    "ja": {
      "NBDC Research ID": "hum0287.v2",
      "データ": {
        "JGAS000310": {
          "データID": "JGAS000310",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/02"
        },
        "JGAS000573": {
          "データID": "JGAS000573",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/03/29"
        }
      },
      "研究内容の概要": {
        "目的": "ヒトiPS細胞株のゲノム配列比較",
        "方法": "ヒトiPS細胞株からゲノムDNAを抽出し、全ゲノム配列解析を行った。",
        "対象": "ヒトiPS細胞株5株"
      },
      "分子データ": {
        "JGAS000310": {
          "対象": "ヒトiPS細胞株：5株",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X]",
          "ライブラリソース": "iPS細胞から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR Free（350）",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000421",
          "総データ量": "343 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000573": {
          "対象": "ヒトiPS細胞株：1株\r\n    AGVTノックイン株（AG: TFAP2C-EGFP; VT: hVASA-tdTomato knock-ins）*1, *2",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Nanopore [PromethION]",
          "ライブラリソース": "iPS細胞から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ligation Sequencing Kit（SQK-LSK110）（run1）\r\nUltra-Long Sequencing Kit（SQK-ULK001）（run2）",
          "断片化の方法": "トランスポゼースを用いた断片化",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "N50 = 6.7 kb（run1）、110 kb（run2）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000699",
          "総データ量": "89.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "横林 しほり",
        "所 属 機 関": "京都大学 iPS細胞研究所 / 医学研究科 機能微細形態学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（B）",
            "タイトル": "哺乳類始原生殖細胞におけるクロマチン高次構造と核内動態変化の分子的理解",
            "研究課題番号": "18H02613"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Inherent genomic properties underlie the epigenomic heterogeneity of human induced pluripotent stem cells",
          "DOI": "doi: 10.1016/j.celrep.2021.109909",
          "データID": "JGAD000421"
        },
        "2": {
          "タイトル": "Induction of fetal meiotic oocytes from embryonic stem cells in cynomolgus monkeys",
          "DOI": "doi: 10.15252/embj.2022112962",
          "データID": "JGAD000699"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0287.v2": {
          "Research ID": "hum0287.v2",
          "公開日": "2023/03/29",
          "内容": "NGS（WGS）",
          "description": "ヒトiPS細胞株1株（AGVTノックイン株）から抽出したgDNAを用いたwhole genome sequence解析データをfastqファイルにて提供する。\n"
        },
        "hum0287.v1": {
          "Research ID": "hum0287.v1",
          "公開日": "2021/11/02",
          "内容": "NGS（WGS）",
          "description": "ヒトiPS細胞株5株から抽出したgDNAを用いたwhole genome sequence解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0287.v2",
      "DATA": {
        "JGAS000310": {
          "Data Set ID": "JGAS000310",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/02"
        },
        "JGAS000573": {
          "Data Set ID": "JGAS000573",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/03/29"
        }
      },
      "SUMMARY": {
        "Aims": "Genome sequence comparison of human iPS cell lines",
        "Methods": "Genomic DNA was extracted from human iPS cell lines and whole genome sequence analysis was performed.",
        "Participants/Materials": "Human iPS cell lines"
      },
      "MOLECULAR DATA": {
        "JGAS000310": {
          "Participants/Materials": "Human iPS cell line: 5 lines",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X]",
          "Library Source": "gDNAs extracted from iPS cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR Free (350)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000421",
          "Total Data Volume": "343 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000573": {
          "Participants/Materials": "Human iPS cell line: 1 line\r\n    AGVT cell line (AG: TFAP2C-EGFP; VT: hVASA-tdTomato knock-ins)*1, *2",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Nanopore [PromethION]",
          "Library Source": "gDNAs extracted from iPS cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ligation Sequencing Kit (SQK-LSK110) (run1)\r\nUltra-Long DNA Sequencing Kit (SQK-ULK001) (run2)",
          "Fragmentation Methods": "transposase chemistry",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "N50 = 6.7 kb (run1) or 110 kb (run2)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000699",
          "Total Data Volume": "89.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shihori Yokobayashi",
        "Affiliation": "Center for iPS Cell Research and Application, Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Chromatin dynamics during primordial germ cell development in mammals",
            "Project Number": "18H02613"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Inherent genomic properties underlie the epigenomic heterogeneity of human induced pluripotent stem cells",
          "DOI": "doi: 10.1016/j.celrep.2021.109909",
          "Data Set ID": "JGAD000421"
        },
        "2": {
          "Title": "Induction of fetal meiotic oocytes from embryonic stem cells in cynomolgus monkeys",
          "DOI": "doi: 10.15252/embj.2022112962",
          "Data Set ID": "JGAD000699"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0287.v2": {
          "Research ID": "hum0287.v2",
          "Release Date": "2023/03/29",
          "Type of Data": "NGS (WGS)",
          "description": "gDNA extracted from 1 human iPS cell line (AGVT cell line) was used for the whole genome sequence analysis. Fastq files are provided.\n"
        },
        "hum0287.v1": {
          "Research ID": "hum0287.v1",
          "Release Date": "2021/11/02",
          "Type of Data": "NGS (WGS)",
          "description": "gDNAs extracted from 5 human iPS cell lines were used for the whole genome sequence analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0286.v2": {
    "ja": {
      "NBDC Research ID": "hum0286.v2",
      "データ": {
        "JGAS000311": {
          "データID": "JGAS000311",
          "内容": "NGS（Visium Spatial Gene Expression）、病理画像",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/12"
        },
        "JGAS000523": {
          "データID": "JGAS000523",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/11/15"
        }
      },
      "研究内容の概要": {
        "目的": "非ウイルス性肝細胞がんの腫瘍免疫微小環境におけるがん細胞と免疫細胞の相互作用を解明すること",
        "方法": "Visium空間的遺伝子発現解析、Target Capture Sequencing解析",
        "対象": "Visium空間的遺伝子発現解析：脂肪を含む肝細胞がん（hepatocellular carcinoma：HCC）検体#1、脂肪を含むHCCの非腫瘍組織#2、脂肪を含むHCCの腫瘍検体#3、脂肪を含まないHCCの腫瘍組織#4。＃１と＃２は同一症例由来の検体。",
        "URL": "https://www.med.osaka-u.ac.jp/activities/results/2022year/takehara2022-5-16"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000311": {
          "対象": "肝細胞がん（ICD10：C220）：3症例\r\n     脂肪を含むHCC：2検体\r\n     脂肪を含むHCCの非腫瘍組織：1検体\r\n     脂肪を含まないHCC：1検体",
          "規模": "Visium Spatial Gene Expression、病理画像",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "HCCおよび非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Visium Spatial Gene Expression Reagent Kits （10X Genomics）",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "118 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000422",
          "総データ量": "131.7 GB（fastq、tif、tsv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000523": {
          "対象": "肝細胞がん（ICD10：C220）：55症例\r\n　　腫瘍組織：55検体、非腫瘍組織：55検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "TERT遺伝子プロモータ領域＋69遺伝子のエクソン領域",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Library Kit Plus、Ion AmpliSeq Kit for Chef DL8",
          "断片化の方法": "PCR",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "220 bp",
          "マッピング方法": "BWA",
          "マッピングクオリティ": "Qscore >=20",
          "マッピングの際のリファレンス配列": "GRCh38",
          "平均カバー率（Depth）": "腫瘍組織：2000、非腫瘍組織：1000",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000642",
          "総データ量": "109.4 GB （bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "小玉 尚宏",
        "所 属 機 関": "大阪大学大学院医学系研究科消化器内科学教室",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma",
          "DOI": "doi: 10.1002/hep.32573",
          "データID": "JGAD000422"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0286.v2": {
          "Research ID": "hum0286.v2",
          "公開日": "2022/11/15",
          "内容": "NGS（Target Capture）",
          "description": "肝細胞がん55症例の腫瘍組織ならびに非腫瘍組織より抽出したDNAを用いたTERT遺伝子プロモータ領域＋69遺伝子のエクソン領域を対象としたTarget Capture Sequencing解析の結果をbamファイルにて提供する。\n"
        },
        "hum0286.v1": {
          "Research ID": "hum0286.v1",
          "公開日": "2022/09/12",
          "内容": "NGS（Visium Spatial Gene Expression）、病理画像",
          "description": "非アルコール性脂肪性肝疾患3症例の肝細胞がん組織および非腫瘍組織から抽出したRNAを用いた空間トランスクリプトーム解析の結果を病理画像とともに提供する（fastqファイル、tifファイル [病理画像]、tsvファイル [位置情報]）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0286.v2",
      "DATA": {
        "JGAS000311": {
          "Data Set ID": "JGAS000311",
          "Type of Data": "NGS (Visium Spatial Gene Expression), Histological image",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/12"
        },
        "JGAS000523": {
          "Data Set ID": "JGAS000523",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/11/15"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the interaction between cancer cells and immune cells in the tumor immune microenvironment of non-viral hepatocellular carcinoma",
        "Methods": "Visium Spatial Gene Expression Assay, Target Capture Sequencing Analysis",
        "Participants/Materials": "",
        "URL": "https://www.med.osaka-u.ac.jp/eng/activities/results/2022year/takehara2022-5-16"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000311": {
          "Participants/Materials": "hepatocellular carcinoma (ICD10: C220): 3 cases\r\n      fat-containing HCC: 2 sample\r\n      non-tumor tissue of fat-containing HCC: 1 sample\r\n      fat-not containing HCC: 1 sample",
          "Targets": "Visium Spatial Gene Expression",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from sample tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Visium Spatial Gene Expression Reagent Kits (10X Genomics)",
          "Fragmentation Methods": "enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "118 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000422",
          "Total Data Volume": "131.7 GB (fastq, tif, tsv)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000523": {
          "Participants/Materials": "hepatocellular carcinoma (ICD10: C220): 55 cases \r\n    tumor tissue: 55 samples, non-tumor tissue: 55samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "promoter region of TERT gene + exonic regions of 69 genes",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Library Kit Plus, Ion AmpliSeq Kit for Chef DL8",
          "Fragmentation Methods": "PCR",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "220 bp",
          "Mapping Methods": "BWA",
          "Mapping Quality": "Qscore >=20",
          "Reference Genome Sequence": "GRCh38",
          "Coverage (Depth)": "tumor tissue: 2000, non-tumor tissue: 1000",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000642",
          "Total Data Volume": "109.4 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takahiro Kodama",
        "Affiliation": "Dept. Gastroenterology and Hepatology, Graduate School of Medicine, Osaka University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma",
          "DOI": "doi: 10.1002/hep.32573",
          "Data Set ID": "JGAD000422"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0286.v2": {
          "Research ID": "hum0286.v2",
          "Release Date": "2022/11/15",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from tumor tissues and non-tumor tissues of hepatocellular carcinoma patients were used for a target capture sequencing analysis. Bam files are provided.\n"
        },
        "hum0286.v1": {
          "Research ID": "hum0286.v1",
          "Release Date": "2022/09/12",
          "Type of Data": "NGS (Visium Spatial Gene Expression), Histological image",
          "description": "RNAs extracted from tumor tissues and non-tumor tissues of hepatocellular carcinoma patients were used for Visium Spatial Gene Expression Assay. Fastq files, tif files (histological image), and a tsv file (position information) are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0284.v1": {
    "ja": {
      "NBDC Research ID": "hum0284.v1",
      "データ": {
        "JGAS000309": {
          "データID": "JGAS000309",
          "内容": "NGS（scRNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/01/19"
        }
      },
      "研究内容の概要": {
        "目的": "乳がん臨床検体の1細胞解析を通して、前がん病変から発がん悪性化に至る遺伝子発現領域の変化を明らかにする",
        "方法": "外科的切除された腫瘍組織から細胞を単離し、10xChromiumを用いてシングルセルライブラリを構築する。作製したライブラリに対して次世代シーケンサーを用いた1細胞遺伝子発現解析を行う。",
        "対象": "乳がん症例より採取した原発腫瘍組織"
      },
      "分子データ": {
        "JGAS000309": {
          "対象": "乳がん（ICD10：C50）：4症例\r\n   原発腫瘍組織：4検体",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "外科的切除された腫瘍組織から単離した細胞より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Next GEM Single Cell 3' Reagent Kits v3.1",
          "断片化の方法": "Chromium Next GEM Single Cell 3' Reagent Kits v3.1",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000420",
          "総データ量": "134.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中山 淳",
        "所 属 機 関": "国立がん研究センター 研究所細胞情報学分野",
        "プロジェクト/研究グループ名": "病態情報学ユニット",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ",
          "DOI": "doi: 10.1158/0008-5472.CAN-22-0090",
          "データID": "JGAD000420"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0284.v1": {
          "Research ID": "hum0284.v1",
          "公開日": "2023/01/19",
          "内容": "NGS（scRNA-seq）",
          "description": "乳がん症例より採取した原発腫瘍組織から単離した細胞より抽出したRNAを用いてsingle cell RNA-seq解析したデータをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0284.v1",
      "DATA": {
        "JGAS000309": {
          "Data Set ID": "JGAS000309",
          "Type of Data": "NGS (scRNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/01/19"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify expressional changes from precancerous to malignancy by single-cell RNA-seq analysis of breast cancer clinical specimens",
        "Methods": "Cells were isolated from the surgically resected tumor tissue. Single-cell sequence library was constructed using 10xChromium kit. Single-cell gene expression analysis was performed by a next-generation sequencer.",
        "Participants/Materials": "Primary tumor samples collected from breast cancer patients"
      },
      "MOLECULAR DATA": {
        "JGAS000309": {
          "Participants/Materials": "breast invasive carcinoma (ICD10: C50): 4 cases\r\n   surgically resected tumor tissue: 4 samples",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from isolated cells abteined from surgically resected tumor tissues.",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Next GEM Single Cell 3' Reagent Kits v3.1",
          "Fragmentation Methods": "Chromium Next GEM Single Cell 3' Reagent Kits v3.1",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000420",
          "Total Data Volume": "134.5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Jun Nakayama",
        "Affiliation": "Division of Cellular Signaling, National Cancer Center Research Institute",
        "Project / Group Name": "Laboratory of Integrative Oncology",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ",
          "DOI": "doi: 10.1158/0008-5472.CAN-22-0090",
          "Data Set ID": "JGAD000420"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0284.v1": {
          "Research ID": "hum0284.v1",
          "Release Date": "2023/01/19",
          "Type of Data": "NGS (scRNA-seq)",
          "description": "RNAs extracted from surgically resected tumor tissues of breast invasive carcinoma patients were used for single-cell RNA-sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0280.v1": {
    "ja": {
      "NBDC Research ID": "hum0280.v1",
      "データ": {
        "DRA012560": {
          "データID": "DRA012560",
          "内容": "NGS（RNA-seq）",
          "制限": "非制限公開",
          "公開日": "2022/01/07"
        }
      },
      "研究内容の概要": {
        "目的": "肺がんにおける患者毎の標的抗原とがん微小環境を明らかにし、それに基づいた最適な複合的免疫療法を開発すること。",
        "方法": "RNA-seq解析データから、Molecular Signatures Database（MSigDB）の遺伝子セットに基づきsingle sample Gene Set Enrichment analysis（ssGSEA）を行い、腫瘍（T-score: Glycolysis, Mitotic spindle）、宿主免疫応答（I-score: T cells, B cells, MHC-complex）、免疫応答抑制（S-score: angiogenesis, hypoxia, epithelial mesenchymal transition, cytokine production suppression）の3因子に分類し、スコアを算出した。",
        "対象": "2019年8月から2020年6月の間に根治切除を行った原発性肺がん症例の内、新鮮腫瘍検体が採取できた113症例。"
      },
      "分子データ": {
        "DRA012560": {
          "対象": "原発肺がん（ICD10：C34）：113症例\r\n    腫瘍組織：113検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "DDBJ Sequence Read Archive ID": "DRA012560",
          "総データ量": "2.5 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "松下 博和",
        "所 属 機 関": "愛知県がんセンター 腫瘍免疫制御TR分野",
        "プロジェクト/研究グループ名": "肺癌患者における標的抗原の同定とがん微小環境の解析",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "呼吸器財団",
            "タイトル": "肺癌免疫療法における細胞傷害性CD4陽性T細胞に関する探索的研究：新たな免疫療法治療ターゲットの可能性",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0280.v1": {
          "Research ID": "hum0280.v1",
          "公開日": "2022/01/07",
          "内容": "NGS（RNA-seq）",
          "description": "原発肺がん113症例の腫瘍組織より抽出したRNAを用いたRNA sequencing解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0280.v1",
      "DATA": {
        "DRA012560": {
          "Data Set ID": "DRA012560",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/01/07"
        }
      },
      "SUMMARY": {
        "Aims": "To evaluate the tumor immune microenvironment (TIME) of lung cancer to develop a new immune based therapy.",
        "Methods": "We carried out RNA sequencing (RNA-seq) on 113 tumor tissues from patients with lung cancer. To evaluate the tumor immune microenviroment (TIME), we calculated the score (T-score; Glycolysis, Mitotic spindle, I-score; T cells, B cells, MHC-complex, S-score; angiogenesis, hypoxia, epithelial mesenchymal transition, cytokine production suppression) using single sample Gene Set Enrichment Analysis (ssGSEA).",
        "Participants/Materials": "We enrolled a total of 113 patients with lung cancer who underwent lung resection from August 2019 to June 2021 and obtained the fresh tumor samples."
      },
      "MOLECULAR DATA": {
        "DRA012560": {
          "Participants/Materials": "lung cancer (ICD10: C34): 113 cases\r\n    tumor tissue: 113 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "DDBJ Sequence Read Archive ID": "DRA012560",
          "Total Data Volume": "2.5 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hirokazu Matsushita",
        "Affiliation": "Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute",
        "Project / Group Name": "Identification of target antigens and analysis of cancer microenvironments in lung cancer patients",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Japanese Respiratory Foundation",
            "Title": "The identification of CD4 positive cytotoxic T cell as a new target for immune-based therapy",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0280.v1": {
          "Research ID": "hum0280.v1",
          "Release Date": "2022/01/07",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from tumor tissues of 113 lung cancer patients were used for the RNA sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0279.v1": {
    "ja": {
      "NBDC Research ID": "hum0279.v1",
      "データ": {
        "JGAS000307": {
          "データID": "JGAS000307",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/05"
        }
      },
      "研究内容の概要": {
        "目的": "びまん性大細胞型B細胞リンパ腫（Diffuse large B-cell lymphoma：DLBCL）は高頻度かつ高悪性度の悪性リンパ腫である。抗CD20抗体併用化学療法の導入により長期生存は60%前後まで改善したものの、いまだ予後不良群も存在する。次世代シーケンサーの普及によって、遺伝子変異の網羅的解析結果を用いたDLBCLの新たな層別化が報告されているが、その手法は煩雑であり、実臨床への応用が容易でない。また、先行研究では、アジア人における解析が充分でないため、アジア人特異的な予後不良因子の層別化における影響は未検討のままである。そこで本研究では、DLBCLのホルマリン固定パラフィン包埋（FFPE）検体について、既存の大規模研究より選択した144遺伝子についてターゲットシーケンスで遺伝子変異の有無を検討し、日本人コホートにおいて分子遺伝学的サブタイプ分類の有用性を検証することを目的とした。",
        "方法": "ホルマリン固定パラフィン包埋標本177例及び対応する19例の凍結保存検体から抽出したDNAを用いて、ターゲットシークエンスによる遺伝子変異解析を行う。",
        "対象": "びまん性大細胞型B細胞リンパ腫177例",
        "URL": "https://www.m.chiba-u.ac.jp/dept/hematology/research/clinical/"
      },
      "分子データ": {
        "JGAS000307": {
          "対象": "びまん性大細胞型B細胞リンパ腫（ICD10：C833）：177症例\r\n      腫瘍組織：196検体（FFPE検体：177検体、対応する凍結検体：19検体）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "144遺伝子",
          "Platform": "Illumina [NextSeq 550]",
          "ライブラリソース": "腫瘍組織（FFPEおよび凍結検体）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra II DNA Library Prep Kit",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000418",
          "総データ量": "41.8 GB（bam [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "堺田 恵美子",
        "所 属 機 関": "千葉大学医学部附属病院 血液内科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort",
          "DOI": "doi: 10.1111/bjh.17765",
          "データID": "JGAD000418"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0279.v1": {
          "Research ID": "hum0279.v1",
          "公開日": "2022/09/05",
          "内容": "NGS（Target Capture）",
          "description": "びまん性大細胞型B細胞リンパ腫177症例のFFPE検体および凍結検体（腫瘍組織）から抽出したDNAを用いた144遺伝子のTarget Capture Sequencing解析データをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0279.v1",
      "DATA": {
        "JGAS000307": {
          "Data Set ID": "JGAS000307",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/05"
        }
      },
      "SUMMARY": {
        "Aims": "Diffuse large B-cell lymphoma (DLBCL) is a common hematological malignancy. Treatment with standard chemotherapy results in long-term remission in approximately 60% of patients. Whole-exome sequencing studies of large DLBCL cohorts revealed the biological diversity of tumors and facilitated the identification of genetic subtypes based on genetic alterations. Despite the progress facilitated by NGS, genetic classification is difficult to apply in clinical practice because of the complexity of the clustering algorithm. Furthermore, only a few reports included large Asian cohorts. Thus, a genetic overview of Japanese patients with DLBCL is still needed. Thus, in this study, we aimed to establish the clinical application of our simplified genetic classification algorithm in Japanese DLBCL.",
        "Methods": "Gene mutation analysis by a targeted DNA sequencing was performed using DNA extracted from 177 formalin-fixed paraffin-embedded specimens and 19 matched frozen specimens.",
        "Participants/Materials": "177 patients of diffuse large B-cell lymphoma"
      },
      "MOLECULAR DATA": {
        "JGAS000307": {
          "Participants/Materials": "Diffuse large B-cell lymphoma (ICD10: C833): 177 cases\r\n      tumor tissues: 196 samples (FFPE: 177 samples, matched frozen specimens: 19 samples)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "144 genes",
          "Platform": "Illumina [NextSeq 550]",
          "Library Source": "DNAs extracted from tumor tissues (FFPE and frozen specimens)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra II DNA Library Prep Kit",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000418",
          "Total Data Volume": "41.8 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Emiko Sakaida",
        "Affiliation": "Department of Hematology, Chiba University Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Young Scientists (B)",
            "Title": "Profiling of EBV positive DLBCL by DNA methylation epigenotype",
            "Project Number": "17K17637"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort",
          "DOI": "doi: 10.1111/bjh.17765",
          "Data Set ID": "JGAD000418"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0279.v1": {
          "Research ID": "hum0279.v1",
          "Release Date": "2022/09/05",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from tumor tissues of 177 patients with diffuse large B-cell lymphoma were used for the target capture sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0278.v1": {
    "ja": {
      "NBDC Research ID": "hum0278.v1",
      "データ": {
        "JGAS000304": {
          "データID": "JGAS000304",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/07/07"
        },
        "JGAS000305": {
          "データID": "JGAS000305",
          "内容": "NGS（scRNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/07/07"
        }
      },
      "研究内容の概要": {
        "目的": "乳がん幹細胞のゲノム解析およびシングルセル解析を用いた乳がんにおける不均一変異の解明",
        "方法": "乳がん症例の腫瘍組織や、当該腫瘍組織を免疫不全マウスに移植したPatient-derived xenograft（PDX）モデルにおいて増殖した腫瘍組織からDNA/RNAを抽出し、whole exome sequencing（Exome）/ RNA-seq解析を実施",
        "対象": "乳がん 5症例（scRNA-seq：4症例11検体、Exome：5症例12検体）",
        "URL": "http://bunshibyotai.w3.kanazawa-u.ac.jp"
      },
      "分子データ": {
        "JGAS000304": {
          "対象": "乳がん（ICD10：C509）：5症例\r\n    腫瘍組織：12検体 （乳がん幹細胞、乳がん非幹細胞）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Hiseq 3000/NovaSeq 6000]",
          "ライブラリソース": "乳がん幹細胞マーカーにより分画した乳がん幹細胞および乳がん非幹細胞のそれぞれから抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT HS V5 （Agilent Technologies）",
          "断片化の方法": "超音波断片化 （Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200bp（100PE）：HiSeq\r\n300bp（150PE）：NovaSeq",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000415",
          "総データ量": "198.7 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000305": {
          "対象": "乳がん（ICD10：C509）：4症例\r\n    腫瘍組織：11検体 （乳がん幹細胞）",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Hiseq 3000]",
          "ライブラリソース": "乳がん幹細胞マーカーにより分画した乳がん幹細胞から１細胞ごとに抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Nextera XT DNA Sample Preparation Kit （Illumina）",
          "断片化の方法": "Tagmentation （Nextera XT DNA Sample Preparation Kit）",
          "ライブラリ構築方法": "Single-end／Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50bp （50SR）／200bp （100PE）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000416",
          "総データ量": "332.7 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "後藤 典子",
        "所 属 機 関": "金沢大学がん進展制御研究所 分子病態研究分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "先進ゲノム解析研究推進プラットフォーム",
            "研究課題番号": "16H06279"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.",
          "DOI": "doi: 10.1038/onc.2016.293",
          "データID": "-"
        },
        "2": {
          "タイトル": "Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.",
          "DOI": "doi: 10.1073/pnas.1806851116",
          "データID": "-"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0278.v1": {
          "Research ID": "hum0278.v1",
          "公開日": "2022/07/07",
          "内容": "NGS（Exome、scRNA-seq）",
          "description": "乳がん臨床検体から得られたがん細胞をがん幹細胞と非がん幹細胞に分画し、各分画細胞から抽出したDNAを用いたWES解析データ、および、単一がん幹細胞から抽出したRNAを用いたsingle cell RNA-seq解析データをfastqファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0278.v1",
      "DATA": {
        "JGAS000304": {
          "Data Set ID": "JGAS000304",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/07/07"
        },
        "JGAS000305": {
          "Data Set ID": "JGAS000305",
          "Type of Data": "NGS (scRNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/07/07"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of heterogeneity of breast cancer stem cells using genomic and single cell analyses.",
        "Methods": "Whole exome sequence analysis by using breast cancer cells sorted into cancer stem cells and non-cancer stem cells. Single cell RNA sequence of sorted breast cancer stem cells exploiting C1 system.",
        "Participants/Materials": "Breast cancer: 5 cases (scRNA: 4 cases, 11 samples; exome: 5 cases, 12 samples)"
      },
      "MOLECULAR DATA": {
        "JGAS000304": {
          "Participants/Materials": "Breast cancer (ICD10: C509): 5 cases\r\n    cancer stem cells and non-cancer stem cells: 12 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Hiseq 3000/NovaSeq 6000]",
          "Library Source": "DNAs extracted from breast cancer cells sorted into cancer stem cells and non-cancer stem cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT HS V5 (Agilent Technologies)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200bp (100PE): HiSeq\r\n300bp (150PE): NovaSeq",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000415",
          "Total Data Volume": "198.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000305": {
          "Participants/Materials": "Breast cancer (ICD10: C509): 4 cases\r\n    cancer stem cells: 11 samples\r\n    (cancer stem cells)",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Hiseq3000]",
          "Library Source": "RNAs extracted from sorted breast cancer stem cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Nextera XT DNA Sample Preparation Kit (Illumina)",
          "Fragmentation Methods": "Tagmentation (Nextera XT DNA Sample Preparation Kit)",
          "Spot Type": "Single-end/Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50bp (50SR)/200bp (100PE)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000416",
          "Total Data Volume": "332.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Noriko Gotoh",
        "Affiliation": "Division of Cancer Cell Biology, Cancer Research Institute, Kanazawa University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Grant-in-Aid for Scientific Research on Innovative Areas - Platforms for Advanced Technologies and Research Resources",
            "Title": "Platform for Advaced Genomic Science",
            "Project Number": "16H06279"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.",
          "DOI": "doi: 10.1038/onc.2016.293",
          "Data Set ID": "-"
        },
        "2": {
          "Title": "Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.",
          "DOI": "doi: 10.1073/pnas.1806851116",
          "Data Set ID": "-"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0278.v1": {
          "Research ID": "hum0278.v1",
          "Release Date": "2022/07/07",
          "Type of Data": "NGS (Exome, scRNA-seq)",
          "description": "- DNAs extracted from breast cancer stem cells and those extracted from breast non-cancer stem cells were used for whole exome sequencing analysis. Fastq files are provided.\n- RNAs extracted from each of breast cancer stem cells were used for single cell RNA sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0277.v3": {
    "ja": {
      "NBDC Research ID": "hum0277.v3",
      "データ": {
        "JGAS000303": {
          "データID": "JGAS000303",
          "内容": "NGS（scRNA-seq、Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/09"
        },
        "JGAS000564": {
          "データID": "JGAS000564",
          "内容": "NGS（WGS、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/04/18"
        },
        "JGAS000564（データ追加）": {
          "データID": "JGAS000564（データ追加）",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/05/10"
        }
      },
      "研究内容の概要": {
        "目的": "継続的に収集している腫瘍臨床検体を用いた網羅的なゲノム・エピゲノム解析を行うことで、泌尿器系の腫瘍の発症・進展・治療効果に寄与する分子メカニズムを明らかにし、発症機構や治療機構を解明する。",
        "方法": "single cell RNA-seq（scRNA-seq）、Whole exome sequencing（WES）、RNA-seq、Whole genome sequencing（WGS）を実施。",
        "対象": "Birt-Hogg-Dubé（BHD）関連腎がん19症例、hereditary leiomyomatosis and renal cell cancer（HLRCC）関連腎がん1症例、Von Hippel-Lindau（VHL）関連腎がん2症例、散発性淡明細胞型腎がん2症例、散発性嫌色素性腎がん21症例、腎オンコサイトーマ7症例"
      },
      "分子データ": {
        "scRNA-seq": {
          "対象": "腎がん（ICD10：C64）：7症例 （WESと同じ症例)\r\n      BHD（ICD10：Q878）関連腎がん：2症例 2検体\r\n      HLRCC（MedGen ID：353771）関連腎がん：1症例 2検体\r\n      VHL（ICD10：Q858）関連腎がん：2症例 2検体\r\n      散発性淡明細胞型腎がん：2症例 6検体\r\n        　  （腫瘍組織 4検体、非腫瘍組織 2検体）",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000/NextSeq 500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織に対して１細胞処理を実施後、抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium single cell 3’ kit （10XGenomics）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "index 8 bp、 read1 28 bp、 read2 91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000414",
          "総データ量": "316.9 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Exome": {
          "対象": "腎がん（ICD10：C64）：7症例 （scRNA-seqと同じ症例)\r\n      BHD（ICD10：Q878）関連腎がん：2症例 4検体\r\n          （腫瘍組織 2検体、非腫瘍組織 2検体）\r\n      HLRCC（MedGen ID：353771）関連腎がん：1症例 3検体\r\n　　　（腫瘍組織 2検体、非腫瘍組織 1検体）\r\n      VHL（ICD10：Q858）関連腎がん：2症例 4検体\r\n　　　（腫瘍組織 2検体、非腫瘍組織 2検体）\r\n      散発性淡明細胞型腎がん：2症例 6検体\r\n          （腫瘍組織 4検体、非腫瘍組織 2検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000/PE150]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6 （Agilent Technologies）",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "read1 150 bp、 read2 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000414",
          "総データ量": "316.9 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq （JGAS000303、JGAS000564）": {
          "対象": "BHD（ICD10：Q878）関連腎がん（ICD10：C64）：10症例 21検体\r\n      （腫瘍組織 16検体、非腫瘍組織 5検体）\r\n散発性嫌色素性腎がん（ICD10：C64）：21症例 21検体\r\n      （腫瘍組織 21検体）\r\n腎オンコサイトーマ（ICD10：C64）：7症例 7検体\r\n      （腫瘍組織 7検体）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Library Prep Kit、TruSeq RNA CD Index Kit（Dual Index）",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "read1 126 bp、 read2 126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "BHD関連腎がん：JGAD000414\r\n散発性嫌色素性腎がん、腎オンコサイトーマ：JGAD000686",
          "総データ量": "JGAD000414：316.9 GB（fastq）\r\nJGAD000686：1.4 TB＋20 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGS": {
          "対象": "BHD（ICD10：Q878）関連腎がん（ICD10：C64）：9症例 25検体\r\n       （腫瘍組織 16検体、非腫瘍組織 9検体）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Nano DNA Library Prep Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "read1 150 bp、 read2 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000686",
          "総データ量": "1.4 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "蓮見 壽史",
        "所 属 機 関": "横浜市立大学 泌尿器科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "文部科学省「特色ある共同利用・共同研究拠点事業」",
            "タイトル": "横浜市立大学先端医科学研究センター「マルチオミックスによる遺伝子発現制御の先端的医学共同研究拠点」",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers",
          "DOI": "doi: 10.1016/j.isci.2022.104463",
          "データID": "JGAD000414"
        },
        "2": {
          "タイトル": "Comparative analyses define differences between BHD-associated renal tumor and sporadic chromophobe renal cell carcinoma",
          "DOI": "doi: 10.1016/j.ebiom.2023.104596",
          "データID": "JGAD000686"
        }
      },
      "制限公開データの利用者一覧": {
        "Antonio Finelli": {
          "研究代表者": "Antonio Finelli",
          "所属機関": "University Health Network/Princess Margaret Cancer Center",
          "研究題目": "カナダ",
          "利用データID": "Identifying novel immune evasion tumor immune networks as targets for ccRCC immunotherapy",
          "利用期間": "JGAD000414, JGAD000686"
        }
      },
      "リリース情報": {
        "hum0277.v3": {
          "Research ID": "hum0277.v3",
          "公開日": "2023/05/10",
          "内容": "NGS（RNA-seq）",
          "description": "腎オンコサイトーマの腫瘍組織から抽出したRNAを用いたRNA-seq解析データをfastqファイル形式で提供する。\n"
        },
        "hum0277.v2": {
          "Research ID": "hum0277.v2",
          "公開日": "2023/04/18",
          "内容": "NGS（WGS、RNA-seq）",
          "description": "BHD関連腎がんの腫瘍組織および非腫瘍組織から抽出したDNAを用いたwhole genome sequencing解析データ、ならびに散発性嫌色素性腎がんの腫瘍組織より抽出したRNAを用いたRNA-seq解析データをfastqファイル形式で提供する。\n"
        },
        "hum0277.v1": {
          "Research ID": "hum0277.v1",
          "公開日": "2022/09/09",
          "内容": "NGS（scRNA-seq、Exome、RNA-seq）",
          "description": "BHD関連腎がん、HLRCC関連腎がん、VHL関連腎がん、ならびに散発性淡明細胞型腎がんの腫瘍組織および非腫瘍組織から抽出したDNA/RNAを用いたsingle cell RNA-seq、whole exome sequencing、RNA-seq解析データをfastqファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0277.v3",
      "DATA": {
        "JGAS000303": {
          "Data Set ID": "JGAS000303",
          "Type of Data": "NGS (scRNA-seq, Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/09"
        },
        "JGAS000564": {
          "Data Set ID": "JGAS000564",
          "Type of Data": "NGS (WGS, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/04/18"
        },
        "JGAS000564 (Data addition)": {
          "Data Set ID": "JGAS000564 (Data addition)",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/05/10"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify the oncogenesis and the progression mechanism of urological tumors, we continuously collect tumor samples of our patients with high quality. Then we used them to comprehensive analyses such as genome sequencing or epi-genome sequencing. Through these analyses, we aim for elucidating the oncogenesis or for developing newly treatment strategies of each cancer.",
        "Methods": "single-cell RNA sequencing (scRNA-seq), whole exome sequencing (WES), RNA-seq, and Whole genome sequencing (WGS)",
        "Participants/Materials": "19 patients with Birt-Hogg-Dubé (BHD) associated renal cell carcinoma (RCC), 1 patient with hereditary leiomyomatosis and renal cell cancer (HLRCC) associated RCC, 2 patients with Von Hippel-Lindau (VHL) associated RCC, 2 patients with sporadic clear cell RCC (ccRCC), 21 patients with sporadic chromophobe RCC (chRCC), and 7 patients with sporadic oncocytoma"
      },
      "MOLECULAR DATA": {
        "scRNA-seq": {
          "Participants/Materials": "RCC (ICD10: C64): 7 cases\r\n      BHD (ICD10: Q878) -associated RCC: 2 cases (2 samples)\r\n      HLRCC (MedGen ID: 353771) -associated RCC: 1 case (2 samples)\r\n      VHL (ICD10: Q858) -associated RCC: 2 cases (2 samples)\r\n      ccRCC: 2 cases (4 tumor samples and 2 normal kidney tissues)",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000/NextSeq 500]",
          "Library Source": "RNAs extracted from single cells of tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium single cell 3’ kit (10XGenomics)",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "index 8 bp, read1 28 bp, read2 91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000414",
          "Total Data Volume": "316.9 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Exome": {
          "Participants/Materials": "RCC (ICD10: C64): 7 cases\r\n      BHD (ICD10: Q878) -associated RCC: 2 cases\r\n            (tumor: 2 samples, normal kidney: 2 samples)\r\n      HLRCC (MedGen ID: 353771) -associated RCC: 1 case\r\n            (tumor: 2 samples, normal kidney: 1 sample)\r\n      VHL (ICD10: Q858) -associated RCC: 2 cases\r\n            (tumor: 2 samples, normal kidney: 2 samples)\r\n      ccRCC: 2 cases\r\n            (tumor: 4 samples, normal kidney: 2 samples)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000/PE150]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6 (Agilent Technologies)",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "read1 150 bp, read2 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000414",
          "Total Data Volume": "316.9 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq (JGAS000303, JGAS000564)": {
          "Participants/Materials": "BHD (ICD10: Q878) -associated RCC (ICD10: C64): 10 cases\r\n      (tumor: 16 samples, normal kidney: 5 samples)\r\nchRCC (ICD10: C64): 21 cases\r\n      (tumor: 21 samples)\r\nsporadic oncocytoma (ICD10: C64): 7 cases\r\n      (tumor: 7 samples)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Library Prep Kit, TruSeq RNA CD Index Kit (Dual Index)",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "read1 126 bp, read2 126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "BHD-associated RCC: JGAD000414\r\nchRCC and sporadic oncocytoma: JGAD000686",
          "Total Data Volume": "JGAD000414: 316.9 GB (fastq)\r\nJGAD000686: 1.4 TB + 20 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGS": {
          "Participants/Materials": "BHD (ICD10: Q878) -associated RCC (ICD10: C64): 9 cases\r\n          (tumor: 16 samples, normal kidney: 9 samples)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Nano DNA Library Prep Kit (Illumina)",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "read1 150 bp, read2 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000686",
          "Total Data Volume": "1.4 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hisashi Hasumi",
        "Affiliation": "Department of Urology, Yokohama City University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "the MEXT Joint Usage/Research Center Program",
            "Title": "The Advanced Medical Research Center of Yokohama City University \"Center for Advanced Medical Research Collaboration in Multi-omics Gene Expression Regulation\"",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers",
          "DOI": "doi: 10.1016/j.isci.2022.104463",
          "Data Set ID": "JGAD000414"
        },
        "2": {
          "Title": "Comparative analyses define differences between BHD-associated renal tumor and sporadic chromophobe renal cell carcinoma",
          "DOI": "doi: 10.1016/j.ebiom.2023.104596",
          "Data Set ID": "JGAD000686"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Antonio Finelli": {
          "Principal Investigator": "Antonio Finelli",
          "Affiliation": "University Health Network/Princess Margaret Cancer Center",
          "Research Title": "Canada",
          "Data in Use (Dataset ID)": "Identifying novel immune evasion tumor immune networks as targets for ccRCC immunotherapy",
          "Period of Data Use": "JGAD000414, JGAD000686"
        }
      },
      "Release Note": {
        "hum0277.v3": {
          "Research ID": "hum0277.v3",
          "Release Date": "2023/05/10",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from tumor tissues of sporadic oncocytoma patients were used for the RNA sequencing analysis. Fastq files are provided.\n"
        },
        "hum0277.v2": {
          "Research ID": "hum0277.v2",
          "Release Date": "2023/04/18",
          "Type of Data": "NGS (WGS, RNA-seq)",
          "description": "DNAs extracted from tumor and paired non-tumor tissues of BHD-associated RCC patients were used for whole genome sequencing analysis, and RNAs extracted from tumor tissues of sporadic chromophobe RCC patients were used for the RNA sequencing analysis. Fastq files are provided.\n"
        },
        "hum0277.v1": {
          "Research ID": "hum0277.v1",
          "Release Date": "2022/09/09",
          "Type of Data": "NGS (scRNA-seq, Exome, RNA-seq)",
          "description": "DNAs/RNAs extracted from tumor and paired non-tumor tissues of renal cell carcinoma (RCC) patients were used for the single-cell RNA sequencing, whole exome sequencing, and RNA sequencing analyses. Fastq files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0276.v1": {
    "ja": {
      "NBDC Research ID": "hum0276.v1",
      "データ": {
        "JGAS000308": {
          "データID": "JGAS000308",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/10/01"
        }
      },
      "研究内容の概要": {
        "目的": "Gorlin症候群の特徴は、顎骨に多発する歯原性角化嚢胞や皮膚に生じる基底細胞癌であり、本疾患の原因遺伝子はPTCH1である。本疾患は根本的な治療薬が無く、各症状で発症年齢に違いがあるため、経時的な診察により早期診断と治療が求められる。以上の点から、本疾患の病態解明を行うとともにGorlin症候群に対する汎用型遺伝子診断パネルを作製し、以下の内容を検証する。①Gorlin症候群の責任遺伝子となりうる4遺伝子（PTCH1、PTCH2、SMO、SUFU）におけるゲノム変異検出可能な汎用型遺伝子診断パネル検査の有用性の検証。②血液、口腔組織、嚢胞から採取した検体からゲノムDNAを抽出し、次世代シークエンサーでの解析を行うことで、病理検体採取よりも侵襲度の低い血液検体を対象とした遺伝子診断パネルの有用性の検証、並びに、組織由来DNAと同様の結果が血液より得られるかの検証。",
        "方法": "本研究への参加に同意されたGorlin症候群患者のうち、2014年10月から2025年3月の期間に手術摘出組織の一部、口腔組織、および血液からDNAを抽出する。同様に、本研究への参加に同意されたGorlin症候群患者の血縁者が、他の疾患の診断を目的とした場合や全身麻酔の術前検査で必要となった場合の採取の残血からDNAを抽出する。抽出したDNAのライブラリー調整後に次世代シークエンサー解析にかけ、解析結果から本疾患の原因となりうる4遺伝子（PTCH1、PTCH2、SMO、SUFU）の変異解析を行う。",
        "対象": "研究対象者は東京歯科大学千葉歯科医療センター、水道橋病院、市川総合病院で治療を行っているGorlin症候群患者で本研究に参加同意された方と未診断の患者の血縁者。",
        "URL": "http://www.tdc.ac.jp/college/activity/tabid/526/Default.aspx"
      },
      "分子データ": {
        "JGAS000308": {
          "対象": "Gorlin症候群（ICD10：Q859）：12症例\r\n    （病変組織：嚢胞7検体、正常組織：歯肉12検体、血液5検体）\r\n患者の血縁者：3名\r\n    （血液3検体）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "PTCH1、PTCH2、SMO、SUFU",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "患者の病変組織（嚢胞）および正常組織（歯肉、血液）、並びに、血縁者の血液から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "AmpliSeq Library PLUS for illumina",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "375 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000419",
          "総データ量": "1.4 GB（fastq、bam [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "東 俊文",
        "所 属 機 関": "東京歯科大学 生化学講座",
        "プロジェクト/研究グループ名": "私立大学研究ブランディング事業 顎骨疾患プロジェクト",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "東京歯科大学研究ブランディング事業大学院研究助成",
            "タイトル": "リキッドバイオプシーで応用可能なGorlin症候群診断遺伝子パネルの開発",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0276.v1": {
          "Research ID": "hum0276.v1",
          "公開日": "2021/10/01",
          "内容": "NGS（Target Capture）",
          "description": "Gorlin症候群患者の病変組織（嚢胞）および正常組織（歯肉、血液）、並びに、血縁者の血液から抽出したgDNAを用いた4遺伝子（PTCH1、PTCH2、SMO、SUFU）のTarget Capture Sequencing解析データをfastqおよびbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0276.v1",
      "DATA": {
        "JGAS000308": {
          "Data Set ID": "JGAS000308",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/10/01"
        }
      },
      "SUMMARY": {
        "Aims": "The responsible gene for Gorlin syndrome is PTCH1. Early diagnosis by genetic testing is necessary. In this study, we will create a generic genetic diagnostic panel for Gorlin syndrome. The following points will be verified. (1) To validate the usefulness of a general-purpose genetic diagnostic panel test that can detect genomic mutations in the four genes (PTCH1, PTCH2, SMO, and SUFU) that are thought to cause Gorlin syndrome. (2) Extract genomic DNA from peripheral blood samples, oral tissues, and cysts and analyze them with a next-generation sequencer to verify the usefulness of a genetic diagnostic panel test from blood samples, which is less invasive than pathological specimen collection, and whether the same results can be obtained from blood-derived DNA as from tissue-derived DNA.",
        "Methods": "Genomic DNA is extracted from a portion of tissues, oral tissues, and blood samples removed during surgery between October 2014 and March 2025 from patients with Gorlin syndrome who have given consent for this study. Similarly, genomic DNA is extracted from leftover blood samples taken by blood relatives of patients with Gorlin syndrome who have consented to participate in this study, when needed for the purpose of diagnosing other diseases or for preoperative testing for general anesthesia. Libraries are prepared from the extracted DNAs and they are subjected to the next-generation sequencing analysis. Four genes (PTCH1, PTCH2, SMO, and SUFU) that may cause the disease are targeted and mutation analysis was performed.",
        "Participants/Materials": "The research subjects are patients with Gorlin syndrome treated at the Chiba Dental Center of the Tokyo Dental University, Suidobashi Hospital, and Ichikawa General Hospital who have consented to participate in this study, and undiagnosed blood relatives."
      },
      "MOLECULAR DATA": {
        "JGAS000308": {
          "Participants/Materials": "Gorlin syndrome (ICD10: Q859): 12 cases\r\n     (7 cyst samples, 12 gingival samples, and 5 blood samples)\r\n3 blood relatives\r\n     (3 blood samples)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "PTCH1, PTCH2, SMO, SUFU",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "gDNA extracted from cysts, gingival, and blood samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "AmpliSeq Library PLUS for illumina",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "375 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000419",
          "Total Data Volume": "1.4 GB (fastq, bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshifumi Azuma",
        "Affiliation": "Department of Biochemistry, Tokyo Dental College",
        "Project / Group Name": "Tokyo dental College Research Branding Project",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Tokyo dental College Research Branding Project",
            "Title": "Development of a diagnostic gene panel for Gorlin syndrome that can be applied in liquid biopsy",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0276.v1": {
          "Research ID": "hum0276.v1",
          "Release Date": "2021/10/01",
          "Type of Data": "NGS (Target Capture)",
          "description": "gDNA extracted from cysts, gingival, and blood samples of 12 patients with Gorlin syndrome, and blood samples of 3 blood relatives were used for the target capture sequencing analysis. Fastq and bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0275.v1": {
    "ja": {
      "NBDC Research ID": "hum0275.v1",
      "データ": {
        "JGAS000313": {
          "データID": "JGAS000313",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/08/16"
        }
      },
      "研究内容の概要": {
        "目的": "全エクソンシーケンスを含む網羅的ゲノム解析により固形腫瘍の遺伝学的背景を明らかにする",
        "方法": "通常診療において何らかの病変に対する上部消化管内視鏡検査が予定され、事前に同意が得られた患者さんの、生検時に採取された正常胃粘膜から胃腺管を抽出し、全エクソン解析を行った。",
        "対象": "胃がん既往の無いヘリコバクターピロリ未感染者",
        "URL": "http://plaza.umin.ac.jp/kyoto_tumorpatho/"
      },
      "分子データ": {
        "JGAS000313": {
          "対象": "胃がん既往の無いヘリコバクターピロリ未感染者：9名、45検体\r\n    正常胃粘膜検体：36検体（2か所より採取した検体を2つに分けた各4検体）\r\n    末梢血：9検体（各1検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "胃粘膜および末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "IDT Lotus DNA Library Prep Kit",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000424",
          "総データ量": "156.4 GB（bam [ref: GRCh38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "小川 誠司",
        "所 属 機 関": "京都大学 大学院医学研究科",
        "プロジェクト/研究グループ名": "固形腫瘍における遺伝子異常の網羅的解析 / 腫瘍生物学講座",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業（AMED-CREST）",
            "タイトル": "加齢や炎症に伴う組織の再構築と機能低下",
            "研究課題番号": "JP20gm1110011"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Indolent feature of Helicobacter pylori‑uninfected intramucosal signet ring cell carcinomas with CDH1 mutations",
          "DOI": "doi: 10.1007/s10120-021-01191-8",
          "データID": "JGAD000424"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0275.v1": {
          "Research ID": "hum0275.v1",
          "公開日": "2021/08/16",
          "内容": "NGS（Exome）",
          "description": "胃がん既往の無いヘリコバクターピロリ未感染者9名の正常胃粘膜生検検体および末梢血から抽出したDNAを用いたExome解析の結果をbamファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0275.v1",
      "DATA": {
        "JGAS000313": {
          "Data Set ID": "JGAS000313",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/08/16"
        }
      },
      "SUMMARY": {
        "Aims": "Through an integrated genetic study involving whole exome sequencing analysis, we delineate the landscape of genetic alterations in solid tumors.",
        "Methods": "We collected additional biopsied gastric tissues from nine subjects who underwent diagnostic endoscopy and biopsy for upper gastrointestinal symptoms. Genomic DNA isolated from each gland was subjected to whole exome sequencing.",
        "Participants/Materials": "Nine subjects without Helicobacter pylori (Hp) infection or gastric cancer were included as the healthy population. Two biopsies of normal gastric mucosa were obtained from each subject."
      },
      "MOLECULAR DATA": {
        "JGAS000313": {
          "Participants/Materials": "Nine subjects without Hp infection or gastric cancer (healthy population)\r\n     normal gastric mucosa: 36 samples (4 samples/subject)\r\n    peripheral blood: 9 samples (1 sample/subject)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from gastric mucosa and peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "IDT Lotus DNA Library Prep Kit",
          "Fragmentation Methods": "Enzymatic Fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000424",
          "Total Data Volume": "156.4 GB (bam [ref: GRCh38])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Seishi Ogawa",
        "Affiliation": "Kyoto University Graduate School of Medicine",
        "Project / Group Name": "Comprehensive analysis of genetic abnormalities in solid tumors / Department of Pathology and Tumor Biology",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)",
            "Title": "Tissue remodeling and functional deterioration associated with aging and inflammation",
            "Project Number": "JP20gm1110011"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Indolent feature of Helicobacter pylori‑uninfected intramucosal signet ring cell carcinomas with CDH1 mutations",
          "DOI": "doi: 10.1007/s10120-021-01191-8",
          "Data Set ID": "JGAD000424"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0275.v1": {
          "Research ID": "hum0275.v1",
          "Release Date": "2021/08/16",
          "Type of Data": "NGS (Exome)",
          "description": "Exome sequencing analysis in nine subjects without Hp infection or gastric cancer (healthy population) was performed using DNAs extracted from gastric mucosa and peripheral blood cells. The data are provided as bam format files.\nNote：\n"
        }
      }
    }
  },
  "hum0274.v1": {
    "ja": {
      "NBDC Research ID": "hum0274.v1",
      "データ": {
        "JGAS000294": {
          "データID": "JGAS000294",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/04/22"
        }
      },
      "研究内容の概要": {
        "目的": "mRNAの核外輸送はmRNA輸送体によって担われており、ヒトにおいてはNXF1とCRM1がmRNAの輸送に機能する。しかし両者が異なるmRNA群を輸送するか明らかではない。本研究は、NXF1とCRM1が輸送するmRNA群をゲノムワイドに同定し、NXF1とCRM1によるmRNA輸送の分子機構を明らかにする。",
        "方法": "目的遺伝子をノックダウン（knockdown：KD）したHeLa細胞を核と細胞質に分画した後RNAを抽出し、RNA-seq解析を実施した。",
        "対象": "目的遺伝子KD後のHeLa細胞"
      },
      "分子データ": {
        "JGAS000294": {
          "対象": "目的遺伝子KD後のHeLa細胞：20検体\r\n      Control KD＋LeptomycinB（LMB：CRM1阻害剤）処理有無の核と細胞質（duplicate）計8検体\r\n      NXF1 KDの核と細胞質（duplicate）計4検体\r\n      MTR4 KD＋LMB処理有無の核と細胞質（duplicate）計8検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "目的遺伝子KD後のHeLa細胞を核と細胞質に分画し、抽出したRNA",
          "検体情報（購入の場合）": "HeLa （ATCCより購入）",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Library Prep Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000401",
          "総データ量": "307.2 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "藤田 賢一",
        "所 属 機 関": "藤田医科大学 総合医科学研究所",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "-",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000401"
        }
      },
      "リリース情報": {
        "hum0274.v1": {
          "Research ID": "hum0274.v1",
          "公開日": "2022/04/22",
          "内容": "NGS（RNA-seq）",
          "description": "control KD、NXF1 KD、MTR4 KDそれぞれを実施したHeLa細胞に対し、LMB（CRM1阻害剤）処理の有無により培養し、核と細胞質へ分画後に抽出したRNAを用いたRNA-seq解析データ（fastqファイル形式）を提供する。\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0274.v1",
      "DATA": {
        "JGAS000294": {
          "Data Set ID": "JGAS000294",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/04/22"
        }
      },
      "SUMMARY": {
        "Aims": "mRNA exporters, NXF1 and CRM1, are known to function in mRNA export. However, since each target mRNA has not been identified genome-widely, it is not clear whether they export exclusive mRNA subsets. To reveal this point, we prepared the nuclear and the cytoplasmic RNAs under either exporter inhibited condition and carried out RNA-seq.",
        "Methods": "Knockdown of a target gene was performed in cultured human cells (HeLa), and RNA was extracted after fractionation into the nucleus and cytoplasm.",
        "Participants/Materials": "HeLa cells with knockdown of the target gene"
      },
      "MOLECULAR DATA": {
        "JGAS000294": {
          "Participants/Materials:": "HeLa cells with knockdown (KD) of a target gene: 20 samples\r\n      control KD cultured with/without LeptomycinB (LMB: CRM1 inhibitor), nucleus and cytoplasm (duplicate): total 8 samples\r\n     NXF1 KD, nucleus and cytoplasm (duplicate): total 4 samples\r\n     MTR4 KD cultured with/without LMB, nucleus and cytoplasm (duplicate): total 8 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from the nucleus or cytoplasm fractions obtained from HeLa cells with knockdown of a target gene",
          "Cell Lines": "HeLa (ATCC)",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Library Prep Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000401",
          "Total Data Volume": "307.2 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": " Kenichi Fujita",
        "Affiliation": "Division of Gene Expression Mechanism, Fujita Healthy University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "-": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000401"
        }
      },
      "Release Note": {
        "hum0274.v1": {
          "Research ID": "hum0274.v1",
          "Release Date": "2022/04/22",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from nucleus or cytoplasm fractions obtained from HeLa cells which were knockdown of each target gene and cultured with/without LMB were used for RNA-sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0273.v1": {
    "ja": {
      "NBDC Research ID": "hum0273.v1",
      "データ": {
        "JGAS000300": {
          "データID": "JGAS000300",
          "内容": "NGS（Amplicon-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/08/27"
        }
      },
      "研究内容の概要": {
        "目的": "乳がんは多様な形態を示し、特に変異や遺伝子発現プロファイルが異なる様々な細胞型を持つことを特徴としている。管腔がんと小葉がんの両方の表現型からなる腫瘍におけるがん細胞のクローン関係を明らかにする。",
        "方法": "サンプルDNAを製造業者のプロトコルに従って、Ion Torrentプラットフォーム（Thermo Fisher SCIENTIFIC）上のIon AmpliSeq Comprehensive Cancer Panelを用いて、アンプリコン配列決定に使用した。このパネルは、409個のがん関連遺伝子のすべてのエクソンをカバーする約16,000個のプライマー対から構成されている。DNA（120 ng）を使用して、IonXpressバーコードされたアダプターを用いてライブラリーを調製し、イオンチップを用いたシーケンシングには、イオンプロトンシーケンサー（Thermo Fisher SCIENTIFIC）を用いた。",
        "対象": "小葉がんおよび乳管がん併存2症例の腫瘍組織ならびに周辺の非腫瘍組織からレーザーマイクロダイセクションにより採取した合計9検体"
      },
      "分子データ": {
        "JGAS000300": {
          "対象": "小葉がんおよび乳管がん併存（ICD10：C509）：2症例\r\n    腫瘍組織：6検体、非腫瘍組織：3検体",
          "規模": "Amplicon-seq",
          "対象領域（Target Captureの場合）": "409遺伝子（Ion Ampliseq Comprehensive Cancer Panel）",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion Xpress Barcode Adapters",
          "断片化の方法": "PCRによる増幅",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100-300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000411",
          "総データ量": "7.1 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "増田 しのぶ",
        "所 属 機 関": "日本大学医学部 病態病理学系 腫瘍病理学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Phylogenetic analysis of combined lobular and ductal carcinoma of the breast",
          "DOI": "doi: 10.3892/mmr.2021.12357",
          "データID": "JGAD000411"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0273.v1": {
          "Research ID": "hum0273.v1",
          "公開日": "2021/08/27",
          "内容": "NGS（Amplicon-seq）",
          "description": "小葉がんおよび乳管がん併存2症例の腫瘍組織ならびに非腫瘍組織からDNAを抽出し、Ion AmpliSeq Comprehensive Cancer Panel（がん関連409遺伝子）を用いてAmplicon Sequencingを行った結果をbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0273.v1",
      "DATA": {
        "JGAS000300": {
          "Data Set ID": "JGAS000300",
          "Type of Data": "NGS (Amplicon-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/08/27"
        }
      },
      "SUMMARY": {
        "Aims": "Breast cancer manifests in diverse forms, with particular reference to various cell types harboring different mutations and gene expression profiles. To elucidate the clonal relationship between cancer cells in tumors composed of both ductal and lobular phenotypes, we analyzed two combined lobular and ductal carcinoma cases by next generation sequencing.",
        "Methods": "DNA from samples were used for amplicon sequencing by an Ion AmpliSeq Comprehensive Cancer Panel on an Ion Torrent platform (Thermo Fisher SCIENTIFIC). The panel consists of approximately 16,000 primer pairs covering all exons of 409 cancer-associated genes (1.6 megabases of target sequences). DNA (120 ng) was used to prepare the libraries with IonXpress barcoded adapters. An Ion Proton Sequencer (Thermo Fisher SCIENTIFIC) was used for sequencing with the ion chip.",
        "Participants/Materials": "A total of 9 DNAs collected by laser microdissection from 2 cases of lobular carcinoma in situ with ductal carcinoma in situ."
      },
      "MOLECULAR DATA": {
        "JGAS000300": {
          "Participants/Materials": "lobular carcinoma in situ with ductal carcinoma in situ (ICD10: C509): 2 cases\r\n    tumor tissues: 6 samples, non-tumor tissues: 3 samples",
          "Targets": "Amplicon-seq",
          "Target Loci for Capture Methods": "409 genes (Ion Ampliseq Comprehensive Cancer Panel)",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from tumor tissues and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion Xpress Barcode Adapters",
          "Fragmentation Methods": "PCR amplification",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100-300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000411",
          "Total Data Volume": "7.1 GB（bam）",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shinobu Masuda",
        "Affiliation": "Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Phylogenetic analysis of combined lobular and ductal carcinoma of the breast",
          "DOI": "doi: 10.3892/mmr.2021.12357",
          "Data Set ID": "JGAD000411"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0273.v1": {
          "Research ID": "hum0273.v1",
          "Release Date": "2021/08/27",
          "Type of Data": "NGS (Amplicon-seq)",
          "description": "DNAs extracted from tumor tissues and and non-tumor tissues of 2 patients of lobular carcinoma in situ with ductal carcinoma in situ were used for an amplicon sequencing analysis of 409 cancer-related genes. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0272.v2": {
    "ja": {
      "NBDC Research ID": "hum0272.v2",
      "データ": {
        "JGAS000285": {
          "データID": "JGAS000285",
          "内容": "NGS（Exome）\r\nNGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/12/20"
        },
        "JGAS000285（データ追加）": {
          "データID": "JGAS000285（データ追加）",
          "内容": "NGS（Exome）\r\nNGS（scRNA-seq）\r\nNGS（scTCR-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/02/07"
        }
      },
      "研究内容の概要": {
        "目的": "メラノーマなどの皮膚腫瘍検体を用いた、がん細胞や免疫細胞などの遺伝子発現、体細胞遺伝子変異の解析",
        "方法": "whole exome sequencing解析、RNA sequencing解析、scRNA sequencing解析、scTCR sequencing解析",
        "対象": "メラノーマ患者 4例",
        "URL": "http://www.m.chiba-u.ac.jp/dept/dermatology/research/res/"
      },
      "分子データ": {
        "Exome": {
          "対象": "メラノーマ（ICD10：C439）：4症例\r\n    腫瘍組織から樹立した培養細胞：4症例 4＋1検体\r\n    リンパ節：1症例 2検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織から樹立した培養細胞および患者リンパ節から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Hybrid Selection",
          "断片化の方法": "Captured / Adaptor ligation",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均 92 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000391",
          "総データ量": "99.6＋628.8 GB（bam [ref：hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "メラノーマ（ICD10：C439）：4症例\r\n    腫瘍組織から樹立した培養細胞：4症例 4検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織から樹立した培養細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Hybrid Selection",
          "断片化の方法": "Captured / Adaptor ligation",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均 100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000391",
          "総データ量": "99.6 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "scRNA-seq / scTCR-seq": {
          "対象": "メラノーマ（ICD10：C439）：3症例\r\n    腫瘍浸潤リンパ球（TIL）：2症例 3検体\r\n    末梢血リンパ球（PBL）：2症例 2検体\r\n    リンパ節の腫瘍浸潤リンパ球（LN-TIL）：1症例 2検体",
          "規模": "scRNA-seq / scTCR-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍浸潤リンパ球、末梢血リンパ球およびリンパ節の腫瘍浸潤リンパ球から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Single Cell Immune Profiling Solution Kit",
          "断片化の方法": "Hybrid Selection",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均 100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000391",
          "総データ量": "628.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "猪爪 隆史",
        "所 属 機 関": "千葉大学医学部 皮膚科",
        "プロジェクト/研究グループ名": "皮膚がんに対するより効果的な免疫療法の開発",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業　基盤研究（C）",
            "タイトル": "抗PD-1抗体治療の効果を示す直接的バイオマーカーの検索",
            "研究課題番号": "19K08744"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment",
          "DOI": "doi: 10.1136/jitc-2021-003134",
          "データID": "JGAD000391"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000391"
        }
      },
      "リリース情報": {
        "hum0272.v2": {
          "Research ID": "hum0272.v2",
          "公開日": "2022/02/07",
          "内容": "NGS（Exome、scRNA-seq、scTCR-seq）",
          "description": "メラノーマ3症例の腫瘍組織から樹立した培養細胞、患者リンパ節、腫瘍浸潤リンパ球、末梢血リンパ球およびリンパ節の腫瘍浸潤リンパ球から抽出したDNA/RNAを用いたExome、scRNA-seq、scTCR-seq解析の結果を追加した。fastqおよびbamファイル形式で提供する。\n"
        },
        "hum0272.v1": {
          "Research ID": "hum0272.v1",
          "公開日": "2021/12/20",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "メラノーマ4症例の腫瘍組織から樹立した培養細胞から抽出したDNA/RNAを用いたExome、RNA-seq解析の結果をfastqおよびbamファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0272.v2",
      "DATA": {
        "JGAS000285": {
          "Data Set ID": "JGAS000285",
          "Type of Data": "NGS (Exome)\r\nNGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/12/20"
        },
        "JGAS000285 (Data addition)": {
          "Data Set ID": "JGAS000285 (Data addition)",
          "Type of Data": "NGS (Exome)\r\nNGS (scRNA-seq)\r\nNGS (scTCR-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/02/07"
        }
      },
      "SUMMARY": {
        "Aims": "Analysis of gene expression and somatic gene mutation in tumor cells and immune cells using skin tumor samples such as melanoma",
        "Methods": "whole exome sequencing analysis, RNA sequencing analysis, scRNA sequencing analyses, scTCR sequencing analyses",
        "Participants/Materials": "melanoma patients: 4 cases"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "melanoma (ICD10: C439): 4 cases\r\n    cultured tumor cells established from melanoma patients: 4 cases, 4 + 1 samples\r\n    lymph node metastatic lesions: 1 case, 2 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from cultured tumor cells and lymph nodes",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Hybrid Selection",
          "Fragmentation Methods": "Captured / Adaptor ligation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "92 bp (mean)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000391",
          "Total Data Volume": "99.6 + 628.8 GB (bam [ref: hg38])",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "melanoma (ICD10: C439): 4 cases\r\n    cultured tumor cells established from melanoma patients: 4 cases, 4 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from cultured tumor cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Hybrid Selection",
          "Fragmentation Methods": "Captured / Adaptor ligation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp (mean)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000391",
          "Total Data Volume": "99.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "scRNA-seq / scTCR-seq": {
          "Participants/Materials": "melanoma (ICD10: C439): 3 cases\r\n    tumor-infiltrating lymphocyte (TIL): 2 cases, 3 samples\r\n    peripheral blood lymphocyte (PBL): 2 cases, 2 samples\r\n    lymph node tumor-infiltrating lymphocyte (LN-TIL): 1 case, 2 samples",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from TIL, PBL and LN-TIL",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Single Cell Immune Profiling Solution Kit",
          "Fragmentation Methods": "Hybrid Selection",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp (mean)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000391",
          "Total Data Volume": "628.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takashi Inozume",
        "Affiliation": "Department of Dermatology, Chiba University",
        "Project / Group Name": "Development of more effective immunotherapy for skin cancer",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Identification of essential biomarkers for efficacy of anti-PD-1 therapy",
            "Project Number": "19K08744"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment",
          "DOI": "doi: 10.1136/jitc-2021-003134",
          "Data Set ID": "JGAD000391"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000391"
        }
      },
      "Release Note": {
        "hum0272.v2": {
          "Research ID": "hum0272.v2",
          "Release Date": "2022/02/07",
          "Type of Data": "NGS (Exome, scRNA-seq, scTCR-seq)",
          "description": "DNAs/RNAs extracted from cultured tumor cells from a melanoma patient, lymph nodes metastatic lesions of a melanoma case and TIL, PBL and LN-TIL of 3 melanoma cases were used for the whole exome sequencing, scRNA sequencing, and scTCR sequencing analyses. Fastq and bam files are provided.\n"
        },
        "hum0272.v1": {
          "Research ID": "hum0272.v1",
          "Release Date": "2021/12/20",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs/RNAs extracted from cultured tumor cells from 4 melanoma patients were used for the whole exome sequencing and RNA sequencing. Fastq and bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0271.v1": {
    "ja": {
      "NBDC Research ID": "hum0271.v1",
      "データ": {
        "JGAS000288": {
          "データID": "JGAS000288",
          "内容": "NGS（Target Capture、Target RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/05/11"
        }
      },
      "研究内容の概要": {
        "目的": "神経線維腫症1型の表現型の発現とその重症度に関与する分子遺伝学的要因の解析",
        "方法": "患者由来末梢血を用いて、NF1遺伝子の全ゲノム領域DNA配列決定、またNF1のmRNAバリアント解析を行い、疾患重症度に関与している変異、多型を抽出する。",
        "対象": "神経線維腫症1型症例",
        "URL": "http://mri-genome-medicine.kanazawa-med.labos.ac/one/"
      },
      "分子データ": {
        "Target Capture": {
          "対象": "神経線維腫症1型（ICD10：Q85.0）：20症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "NF1遺伝子",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Nextera DNA Flex Library Prep",
          "断片化の方法": "Nextera DNA Flex Library Prep",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "400 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000394",
          "総データ量": "1.7 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target RNA-seq": {
          "対象": "神経線維腫症1型（ICD10：Q85.0）：20症例",
          "規模": "Target RNA-seq",
          "対象領域（Target Captureの場合）": "NF1遺伝子",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "末梢血から抽出したmRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-Seq HT Kit（Takara Bio）にて逆転写後、NF1遺伝子領域をPCRで増幅し、Nextera DNA Flex Library Prepにてライブラリ作製",
          "断片化の方法": "Nextera DNA Flex Library Prep",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "400 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000394",
          "総データ量": "1.7 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "新井田 要",
        "所 属 機 関": "金沢医科大学 総合医学研究所 先端医療研究領域 ゲノム疾患研究分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Optimization and Validation of Multimodular, Long-Range PCR-Based Next-Generation Sequencing Assays for Comprehensive Detection of Mutation in Tuberous Sclerosis Complex",
          "DOI": "doi: 10.1016/j.jmoldx.2020.12.009",
          "データID": "JGAD000394"
        },
        "2": {
          "タイトル": "Application of Combined Long Amplicon Sequencing (CoLAS) for Genetic Analysis of Neurofibromatosis Type 1: A Pilot Study",
          "DOI": "doi: 10.3390/cimb43020057",
          "データID": "JGAD000394"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0271.v1": {
          "Research ID": "hum0271.v1",
          "公開日": "2021/05/11",
          "内容": "NGS（Target Capture、Target RNA-seq）",
          "description": "神経線維腫症1型20症例の末梢血から抽出したDNAとmRNAを用いたNF1遺伝子領域のTarget Capture Resequencing（Long PCR based）ならびにmRNAバリアント解析（Long PCR based RNA-seq）結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0271.v1",
      "DATA": {
        "JGAS000288": {
          "Data Set ID": "JGAS000288",
          "Type of Data": "NGS (Target Capture, Target RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/05/11"
        }
      },
      "SUMMARY": {
        "Aims": "Analyze the genetic factors involved in the expression and severity of the neurofibromatosis type 1 phenotype",
        "Methods": "Using patient-derived peripheral blood, whole regional DNA sequencing and mRNA variant analysis of NF1 are performed to extract mutations and polymorphisms involved in disease severity.",
        "Participants/Materials": "Patients with neurofibromatosis type 1",
        "URL": "http://mri-genome-medicine.kanazawa-med.labos.ac/one/en/"
      },
      "MOLECULAR DATA": {
        "Target Capture": {
          "Participants/Materials": "Neurofibromatosis type 1 (ICD10: Q85.0): 20 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "NF1 gene",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Nextera DNA Flex Library Prep",
          "Fragmentation Methods": "Nextera DNA Flex Library Prep",
          "Spot Type": "Paired-end or Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "400 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000394",
          "Total Data Volume": "1.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target RNA-seq": {
          "Participants/Materials": "Neurofibromatosis type 1 (ICD10: Q85.0): 20 cases",
          "Targets": "Target RNA-seq",
          "Target Loci for Capture Methods": "NF1 gene",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "mRNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Reverse-transcribed by using of SMART-Seq HT Kit (Takara Bio) and amplified NF1 gene region, then library was constructed by using of Nextera DNA Flex Library Prep kit",
          "Fragmentation Methods": "Nextera DNA Flex Library Prep",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "400 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000394",
          "Total Data Volume": "1.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yo Niida",
        "Affiliation": "Division of Genomic Medicine, Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Optimization and Validation of Multimodular, Long-Range PCR-Based Next-Generation Sequencing Assays for Comprehensive Detection of Mutation in Tuberous Sclerosis Complex",
          "DOI": "doi: 10.1016/j.jmoldx.2020.12.009",
          "Data Set ID": "JGAD000394"
        },
        "2": {
          "Title": "Application of Combined Long Amplicon Sequencing (CoLAS) for Genetic Analysis of Neurofibromatosis Type 1: A Pilot Study",
          "DOI": "doi: 10.3390/cimb43020057",
          "Data Set ID": "JGAD000394"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0271.v1": {
          "Research ID": "hum0271.v1",
          "Release Date": "2021/05/11",
          "Type of Data": "NGS (Target Capture, Target RNA-seq)",
          "description": "DNAs and mRNAs extracted from peripheral blood cells of neurofibromatosis type 1 patients were used for the target capture sequencing and target RNA sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0270.v1": {
    "ja": {
      "NBDC Research ID": "hum0270.v1",
      "データ": {
        "JGAS000282": {
          "データID": "JGAS000282",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/05/19"
        }
      },
      "研究内容の概要": {
        "目的": "小児骨肉腫に特徴的なゲノム異常の同定",
        "方法": "腫瘍及び正常組織から抽出したゲノムDNAを用いたcomprehensive cancer panelによるターゲットエクソンシークエンス解析（Ion Torrent Proton）",
        "対象": "小児骨肉腫患者16症例"
      },
      "分子データ": {
        "JGAS000282": {
          "対象": "小児骨肉腫（ICD10：C41.9）：16症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "409遺伝子（Ion Ampliseq Comprehensive Cancer Panel）",
          "Platform": "Thermo Fisher Scientific [Ion Torrent Proton]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織（もしくは末梢血）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq™ Library Kit 2.0",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均155 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000388",
          "総データ量": "131.3 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "米本 司",
        "所 属 機 関": "千葉県がんセンター 整形外科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "厚生労働科学研究費補助金（第3次対がん総合戦略研究事業）",
            "タイトル": "ゲノム・遺伝子発現情報からみた小児がんの臨床的特性の解明と治療への応用",
            "研究課題番号": "H22-3 次がん-一 般-011"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma",
          "DOI": "doi: 10.3892/or.2021.8086",
          "データID": "JGAD000388"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0270.v1": {
          "Research ID": "hum0270.v1",
          "公開日": "2022/05/19",
          "内容": "NGS（Target Capture）",
          "description": "小児骨肉腫16症例の腫瘍組織および非腫瘍組織（もしくは末梢血）から抽出したDNAを用いた409遺伝子のTarget Capture Sequencing解析結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0270.v1",
      "DATA": {
        "JGAS000282": {
          "Data Set ID": "JGAS000282",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/05/19"
        }
      },
      "SUMMARY": {
        "Aims": "To identify prognosis-related genomic alterations in pediatric Osteosarcoma patients using NGS technique.",
        "Methods": "By using a comprehensive cancer panel which amplifies coding exons of cancer-related 409 genes, candidate mutations occurred in OS were surveyed.",
        "Participants/Materials": "Pediatric Osteosarcoma: 16 patients"
      },
      "MOLECULAR DATA": {
        "JGAS000282": {
          "Participants/Materials": "Pediatric Osteosarcoma (ICD10: C41.9): 16 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "409 genes (Ion Ampliseq Comprehensive Cancer Panel)",
          "Platform": "Thermo Fisher Scientific [Ion Torrent Proton]",
          "Library Source": "DNAs extracted from tumor tissues and non-tumor tissues (or peripheral blood cells)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq™ Library Kit 2.0",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "155 bp on average",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000388",
          "Total Data Volume": "131.3 GB（fastq）",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tsukasa Yonemoto",
        "Affiliation": "Division of Orthopedic Surgery, Chiba Cancer Center",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Grants-in-Aid by the Ministry of Health, Labor and Welfare of Japan for the Third Term Comprehensive 10-year Strategy for Cancer Control",
            "Title": "Genomic and gene expression profiling of pediatric solid tumors",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma",
          "DOI": "doi: 10.3892/or.2021.8086",
          "Data Set ID": "JGAD000388"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0270.v1": {
          "Research ID": "hum0270.v1",
          "Release Date": "2022/05/19",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from tumor tissues and non-tumor tissues or peripheral blood cells of pediatric Osteosarcoma patiets were used for Target Capture sequencing of 409 cancer-related genes. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0269.v1": {
    "ja": {
      "NBDC Research ID": "hum0269.v1",
      "データ": {
        "JGAS000295": {
          "データID": "JGAS000295",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/05/25"
        }
      },
      "研究内容の概要": {
        "目的": "遺伝性心血管疾患の病態解明",
        "方法": "遺伝性心血管疾患10症例の末梢血から抽出したDNAを用いた全エクソーム解析、ならびに、遺伝性心血管疾患3症例の心筋サンプルから抽出したRNAを用いたRNAseq解析",
        "対象": "遺伝性心血管疾患症例",
        "URL": "http://www.cardiology.med.osaka-u.ac.jp/?page_id=34297"
      },
      "分子データ": {
        "Exome": {
          "対象": "遺伝性心血管疾患（ICD10：I42）：10症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 3000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000402",
          "総データ量": "80.7 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および 民間企業における利用禁止"
        },
        "RNA-seq": {
          "対象": "遺伝性心血管疾患（ICD10：I42）：3症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500/3000]",
          "ライブラリソース": "心臓移植時の心筋サンプルから抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000402",
          "総データ量": "80.7 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および 民間企業における利用禁止"
        }
      },
      "提供者情報": {
        "研究代表者": "朝野 仁裕",
        "所 属 機 関": "大阪大学 大学院医学系研究科循環器内科学",
        "プロジェクト/研究グループ名": "病態分子探索グループ",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000402"
        }
      },
      "リリース情報": {
        "hum0269.v1": {
          "Research ID": "hum0269.v1",
          "公開日": "2021/05/25",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "遺伝性心血管疾患10症例の末梢血から抽出したDNAを用いたWhole Exome Sequencing解析データ、ならびに3症例の心臓移植時の心筋サンプルから抽出したRNAを用いたRNA-seq解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0269.v1",
      "DATA": {
        "JGAS000295": {
          "Data Set ID": "JGAS000295",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/05/25"
        }
      },
      "SUMMARY": {
        "Aims": "Elucidation of the pathophysiology of patients with hereditary cardiovascular disease",
        "Methods": " Whole exome sequencing analysis and RNA-seq analysis",
        "Participants/Materials": " hereditary cardiovascular disease",
        "URL": "http://www.cardiology.med.osaka-u.ac.jp/?page_id=34297"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "hereditary cardiovascular disease (ICD10: I42): 10 cases",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 3000]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000402",
          "Total Data Volume": "80.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy & Company User Limit"
        },
        "RNA-seq": {
          "Participants/Materials": "hereditary cardiovascular disease (ICD10: I42): 3 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500/3000]",
          "Library Source": "RNAs extracted from myocardial samples at the time of heart transplantation",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end or Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000402",
          "Total Data Volume": "80.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy & Company User Limit"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yoshihiro Asano",
        "Affiliation": "Department of Cardiovascular Medicine, Graduate School of Medicine, Osaka University",
        "Project / Group Name": "Molecular Genetics and Drug Discovery Group",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Identification of de novo molecular targets and drug discovery by genome analysis and trans-omics analysis of hereditary cardiomyopathy",
            "Project Number": "19H03652"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000402"
        }
      },
      "Release Note": {
        "hum0269.v1": {
          "Research ID": "hum0269.v1",
          "Release Date": "2021/05/25",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "A whole exome sequencing analysis was performed on 10 patients with hereditary cardiovascular disease using DNAs extracted from peripheral blood cells. An RNAseq was performed on 3 patients with hereditary cardiovascular disease using RNAs extracted from myocardial samples at the time of heart transplantation. Fastq format files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0268.v1": {
    "ja": {
      "NBDC Research ID": "hum0268.v1",
      "データ": {
        "JGAS000280": {
          "データID": "JGAS000280",
          "内容": "NGS（Iso-seq、CAGE-seq、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/04/09"
        }
      },
      "研究内容の概要": {
        "目的": "大腸がん組織のプロテオゲノミクスHLAリガンドーム解析による新規タイプがん抗原の探索",
        "方法": "RNA-seq、CAGE-seq、ならびにIso-seq解析を実施し、組織解析で同定済みの非コード領域由来新規がん抗原をコードする転写産物バリアントを探索した。",
        "対象": "ヒト大腸がん細胞株：1種類、大腸がん6症例"
      },
      "分子データ": {
        "Iso-seq": {
          "対象": "ヒト大腸がん細胞株（ICD10：C18）：1検体",
          "規模": "Iso-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "PacBio [Sequel]",
          "ライブラリソース": "細胞から抽出したRNA",
          "検体情報（購入の場合）": "ATCCより購入したヒト大腸がん細胞株（CCL-220）",
          "ライブラリ作製方法（キット名）": "SMRTbell Template Prep Kit 2.0",
          "断片化の方法": "SMRTbell Template Prep Kit 2.0",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000386",
          "総データ量": "16.1 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "CAGE-seq": {
          "対象": "ヒト大腸がん細胞株（ICD10：C18）：1検体",
          "規模": "CAGE-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq]",
          "ライブラリソース": "細胞から抽出したRNA",
          "検体情報（購入の場合）": "ATCCより購入したヒト大腸がん細胞株（CCL-220）",
          "ライブラリ作製方法（キット名）": "-",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000386",
          "総データ量": "16.1 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "ヒト大腸がん細胞株（ICD10：C18）：1検体\r\n大腸がん：6症例（腫瘍組織：6検体、非腫瘍組織：5検体）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織、非腫瘍組織、ならびに培養細胞から抽出したRNA",
          "検体情報（購入の場合）": "ATCCより購入したヒト大腸がん細胞株（CCL-220）",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "断片化の方法": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000386",
          "総データ量": "153.2 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "金関 貴幸",
        "所 属 機 関": "札幌医科大学 病理学第一講座",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん医療創生研究事業（P-CREATE）",
            "タイトル": "プロテオゲノミクスによるlncRNAがん抗原を標的とした革新的免疫治療の開発",
            "研究課題番号": "JP20cm0106352"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000386"
        }
      },
      "リリース情報": {
        "hum0268.v1": {
          "Research ID": "hum0268.v1",
          "公開日": "2021/04/09",
          "内容": "NGS（Iso-seq、CAGE-seq、RNA-seq）",
          "description": "ヒト大腸がん細胞株から抽出したRNAを用いたIso-seq、CAGE-seq、RNA-seqデータ、ならびに大腸がん6症例の腫瘍組織・非腫瘍組織から抽出したRNAを用いたRNA-seqデータをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0268.v1",
      "DATA": {
        "JGAS000280": {
          "Data Set ID": "JGAS000280",
          "Type of Data": "NGS (Iso-seq, CAGE-seq, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/04/09"
        }
      },
      "SUMMARY": {
        "Aims": "Proteogenomic discovery of a novel class of cancer antigens by HLA ligandome analysis of colon cancer tissues",
        "Methods": "RNA-seq, CAGE-seq and Iso-seq data were used to analyze the transcript variants coding an identified non-coding RNA-derived antigen.",
        "Participants/Materials": "Human colon cancer cell line: 1, colon cancer: 6 "
      },
      "MOLECULAR DATA": {
        "Iso-seq": {
          "Participants/Materials": "Human colon cancer cell line (ICD10: C18): 1 sample",
          "Targets": "Iso-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "PacBio [Sequel]",
          "Library Source": "RNAs extracted from cells",
          "Cell Lines": "ATCC (CCL-220)",
          "Library Construction (kit name)": "SMRTbell Template Prep Kit 2.0",
          "Fragmentation Methods": "SMRTbell Template Prep Kit 2.0",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000386",
          "Total Data Volume": "16.1 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "CAGE-seq": {
          "Participants/Materials": "Human colon cancer cell line (ICD10: C18): 1 sample",
          "Targets": "CAGE-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq]",
          "Library Source": "RNAs extracted from cells",
          "Cell Lines": "ATCC (CCL-220)",
          "Library Construction (kit name)": "-",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000386",
          "Total Data Volume": "16.1 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Human colon cancer cell line (ICD10: C18): 1 sample\r\nColon cancer: 6 patients \r\n(6 tumor tissues and 5 non-tumor tissues)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from cells",
          "Cell Lines": "ATCC (CCL-220)",
          "Library Construction (kit name)": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "Fragmentation Methods": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000386",
          "Total Data Volume": "153.2 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takayuki Kanaseki",
        "Affiliation": "Department of Pathology, Sapporo Medical University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Proteogenomic discovery of HLA presented tumor antigens that arise from non-coding RNAs",
            "Project Number": "JP20cm0106352"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000386"
        }
      },
      "Release Note": {
        "hum0268.v1": {
          "Research ID": "hum0268.v1",
          "Release Date": "2021/04/09",
          "Type of Data": "NGS (Iso-seq, CAGE-seq, RNA-seq)",
          "description": "RNAs extracted from human colon cancer cell line were used for Iso-seq, CAGE-seq and RNA-seq analyses. RNAs extracted from tumor tissues and non-tumor tissues from colon cancer patients were used for RNA-seq analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0266.v1": {
    "ja": {
      "NBDC Research ID": "hum0266.v1",
      "データ": {
        "JGAS000281": {
          "データID": "JGAS000281",
          "内容": "NGS（scRNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/12/27"
        }
      },
      "研究内容の概要": {
        "目的": "自己免疫性皮膚疾患である天疱瘡では自己抗原であるデスモグレインに対する自己抗体が産生することで発症する。臨床的にはB細胞を標的とする治療が効果的であることがわかっており、デスモグレイン特異的B細胞が病態に重要な役割を担っていると考えられる。本研究では、標識をつけたデスモグレイン蛋白を使って患者末梢血中のデスモグレイン特異的B細胞を単離し、網羅的遺伝子解析をすることでその特性や治療による遺伝子発現変化を解析し、病勢マーカーや治療に結びつけることを目的としている。",
        "方法": "標識したデスモグレイン蛋白またはインフルエンザHA抗原を用いてPBMCから抗原特異的B細胞をFACS ARIA3でシングルセルソートを実施し、SMART-seqでライブラリを作成し、Novaseqにてシークエンスを行った。",
        "対象": "3例の天疱瘡患者からデスモグレイン特異的B細胞ならびに非デスモグレイン特異的B細胞。内1例は治療開始後のデスモグレイン特異的B細胞と非デスモグレイン特異的B細胞。"
      },
      "分子データ": {
        "JGAS000281": {
          "対象": "天疱瘡（ICD10：L10.0/L10.2）：3症例（細胞数）\r\n    治療開始前デスモグレイン特異的B細胞（37、30、36）\r\n    治療開始前非デスモグレイン特異的B細胞（44、40、44）\r\n    内１例は治療開始後のデスモグレイン特異的B細胞と非デスモグレイン特異的B細胞（31、96）も含む\r\n健常人：3名（細胞数）\r\n    インフルエンザHA特異的B細胞（48、36、36）\r\n    非インフルエンザHA特異的B細胞（48、48、48）",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "抗原特異的B細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-Seq HT Kit",
          "断片化の方法": "Nextera XT DNA Library Prep Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000387",
          "総データ量": "200 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "江上 将平",
        "所 属 機 関": "慶應義塾大学医学部 皮膚科学教室",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "厚生労働科学研究費補助金 難治性疾患政策研究事業",
            "タイトル": "稀少難治性皮膚疾患に関する調査研究",
            "研究課題番号": "20FC1052"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0266.v1": {
          "Research ID": "hum0266.v1",
          "公開日": "2022/12/27",
          "内容": "NGS（scRNA-seq）",
          "description": "天疱瘡3症例のデスモグレイン特異的B細胞と非デスモグレイン特異的B細胞、並びに健常人3名のインフルエンザHA特異的B細胞と非インフルエンザHA特異的B細胞から抽出したRNAを用いたsingle cell RNA-seq解析データをfastqファイルにて提供する。SMART-seqでライブラリを作成し、Novaseqにてシークエンスを行った。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0266.v1",
      "DATA": {
        "JGAS000281": {
          "Data Set ID": "JGAS000281",
          "Type of Data": "NGS (scRNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/12/27"
        }
      },
      "SUMMARY": {
        "Aims": "Pemphigus, an autoimmune skin disease, is caused by the production of autoantibodies against desmoglein, an autoantigen. Clinically, treatment targeting B cells has been shown to be effective, and desmoglein-specific B cells may play an important role in the pathogenesis. The purpose of this research is to isolate desmoglein-specific B cells in the peripheral blood of patients using labeled desmoglein protein, and to analyze their characteristics and changes in gene expression due to treatment by comprehensive genetic analysis, and to link them to disease markers and treatments.",
        "Methods": "Antigen-specific B cells from PBMCs were single-cell sorted with FACS ARIA3 using labeled desmoglein protein or influenza HA antigen, libraries were prepared with SMART-seq, and sequenced with Novaseq.",
        "Participants/Materials": "Desmoglein-specific B cells and non-desmoglein-specific B cells from 3 patients with pemphigus"
      },
      "MOLECULAR DATA": {
        "JGAS000281": {
          "Participants/Materials": "Pemphigus (ICD10: L10.0/L10.2): 3 cases (number of single cells)\r\n    Desmoglein-specific B cell (37 , 30 , 36)\r\n    non-desmoglein-specific B cell (44 , 40 , 44)\r\n    One of the patients, desmoglein-specific B cells and non-desmoglein-specific B cells (31 , 96) after PSL treatment are also included.\r\n3 healthy controls (number of single cells)\r\n    Influenza HA specific B cell (48 , 36 , 36)\r\n    non-influenza HA specific B cell (48 , 48 , 48)",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from antigen-specific B cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-Seq HT Kit",
          "Fragmentation Methods": "Nextera XT DNA Library Prep Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000387",
          "Total Data Volume": "200 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shohei Egami",
        "Affiliation": "Department of Dermatology, Keio University School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Health and Labor Sciences Research Grants for Research on Rare and Intractable Diseases",
            "Title": "Research on rare intractable skin diseases",
            "Project Number": "20FC1052"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0266.v1": {
          "Research ID": "hum0266.v1",
          "Release Date": "2022/12/27",
          "Type of Data": "NGS (scRNA-seq)",
          "description": "RNAs extracted from desmoglein-specific B cells and non-desmoglein-specific B cells from 3 patients with pemphigus, and influenza HA specific B cells and non-influenza HA specific B cells from 3 healthy controls were used for the single cell RNA-seq analyses. Libraries were prepared with SMART-seq, and sequenced with Novaseq. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0264.v2": {
    "ja": {
      "NBDC Research ID": "hum0264.v2",
      "データ": {
        "hum0264.v1.gwas.v1": {
          "データID": "hum0264.v1.gwas.v1",
          "内容": "特発性過眠症のGWAS",
          "制限": "非制限公開",
          "公開日": "2022/02/07"
        },
        "JGAS000508": {
          "データID": "JGAS000508",
          "内容": "特発性過眠症のSNPアレイデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/02/28"
        }
      },
      "研究内容の概要": {
        "目的": "ナルコレプシータイプ1は遺伝要因との強い関連が知られており、睡眠発作、情動脱力発作等を主症状とする代表的な中枢性過眠症である。さらに遺伝要因が関わる中枢性過眠症として、特発性過眠症及び真性過眠症（ナルコレプシータイプ2）等が知られている。特発性過眠症は長時間にわたる睡眠エピソードが出現し、日中に強い眠気を感じ、1日の総睡眠時間が11時間以上となる特に重症な過眠症である。真性過眠症は睡眠発作を主症状とするが情動脱力発作は認められない。中枢性過眠症は稀な疾患であり、精神疾患、身体疾患等で説明できない。その病態及び原因が解明されていないため、治療法が確立しておらず、さらに対症療法に用いられる薬剤は副作用が多いことが問題となっている。そこで、中枢性過眠症を対象としたゲノムワイド関連解析やシークエンス解析等により、疾患感受性遺伝子を同定することで、その病態及び原因を解明することを研究目的としている。",
        "方法": "SNPチップにより得られた遺伝子型情報を用いて、ゲノムワイド関連解析を実施した。",
        "対象": "特発性過眠症（オレキシン変異陽性13例、オレキシン変異陰性116例）",
        "URL": "https://www.igakuken.or.jp/sleep/"
      },
      "分子データ": {
        "hum0264.v1.gwas.v1/JGAS000508": {
          "対象": "特発性過眠症（ICD10：G47.11）：129症例\r\n（オレキシン変異陽性13例、オレキシン変異陰性116例）",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GeneChip Operating Software (GCOS)、Genotyping Console 4.0",
          "フィルタリング": "SNP call rate < 0.97、HWE P < 0.001、MAF < 0.05、non-autosomal chromosomes",
          "マーカー数（QC後）": "487,321 SNPs（ref：GRCh37.p13）",
          "解析手法（ソフトウェア）": "PLINK、R",
          "NBDC Dataset ID": "hum0264.v1.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000626\r\n（オレキシン変異陽性11例、オレキシン変異陰性85例）",
          "総データ量": "hum0264.v1.gwas.v1：30 MB（xlsx）\r\nJGAD000626：6.6 GB（CEL）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "本多 真",
        "所 属 機 関": "東京都医学総合研究所 精神行動医学研究分野",
        "プロジェクト/研究グループ名": "睡眠プロジェクト",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genome-wide association study of idiopathic hypersomnia in a Japanese population",
          "DOI": "doi: 10.1007/s41105-021-00349-2",
          "データID": "JGAD000626"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0264.v2": {
          "Research ID": "hum0264.v2",
          "公開日": "2022/02/28",
          "内容": "特発性過眠症のSNPアレイデータ",
          "description": "特発性過眠症96症例の個人毎のSNPアレイデータをCELファイルにて提供する。\n"
        },
        "hum0264.v1": {
          "Research ID": "hum0264.v1",
          "公開日": "2022/02/07",
          "内容": "特発性過眠症のゲノムワイド関連解析",
          "description": "特発性過眠症129症例の末梢血から抽出したDNAを用いて遺伝子型を決定し、GWASを実施した結果（統計情報）をエクセルファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0264.v2",
      "DATA": {
        "hum0264.v1.gwas.v1": {
          "Data Set ID": "hum0264.v1.gwas.v1",
          "Type of Data": "GWAS for Idiopathic hypersomnia",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/02/07"
        },
        "JGAS000508": {
          "Data Set ID": "JGAS000508",
          "Type of Data": "SNP array data for Idiopathic hypersomnia",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/02/28"
        }
      },
      "SUMMARY": {
        "Aims": "Central disorders of hypersomnolence are lifelong disorders characterized by recurrent episodes of excessive daytime sleepiness. Central disorders of hypersomnolence include narcolepsy (type 1 and type 2) and idiopathic hypersomnia. The pathogenesis of central disorders of hypersomnolence is poorly understood. No effective treatment for the disorders has been established. We expect that genetic researches will provide important contributions to understand the genetic basis and pathogenesis of the disorders. To identify susceptibility genes associated with central disorders of hypersomnolence, we will perform genome-wide association analyses, sequencing analyses and so on for the disorders.",
        "Methods": "We performed a genome-wide association study using genotyping data obtained from SNP chip.",
        "Participants/Materials": "Idiopathic hypersomnia (13 orexin mutation-positive patients, 116 orexin mutation-negative patients)",
        "URL": "https://www.igakuken.or.jp/english/project/detail/sleep1.html"
      },
      "MOLECULAR DATA": {
        "hum0264.v1.gwas.v1 / JGAS000508": {
          "Participants/Materials": "Idiopathic hypersomnia (ICD10: G47.11): 129 patients\r\n (13 orexin mutation-positive patients, 116 orexin mutation-negative patients)",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "Genotype Call Methods (software)": "GeneChip Operating Software (GCOS), Genotyping Console 4.0",
          "Filtering": "SNP call rate < 0.97, HWE P < 0.001, MAF < 0.05, non-autosomal chromosomes",
          "Marker Number (after QC)": "487,321 SNPs (ref: GRCh37.p13)",
          "Analysis Method (software)": "PLINK, R",
          "NBDC Dataset ID": "hum0264.v1.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000626\r\n(11 orexin mutation-positive patients, 85 orexin mutation-negative patients)",
          "Total Data Volume": "hum0264.v1.gwas.v1: 30 MB (xlsx)\r\nJGAD000626: 6.6 GB (CEL)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Makoto Honda",
        "Affiliation": "Psychiatry and Behavioral Science, Tokyo Metropolitan Institute of Medical Science",
        "Project / Group Name": "Sleep Disorders Project",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Elucidation of the pathogenesis of narcolepsy by metabolome/genome analysis and its application to personalized medicine",
            "Project Number": "19H03588"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genome-wide association study of idiopathic hypersomnia in a Japanese population",
          "DOI": "doi: 10.1007/s41105-021-00349-2",
          "Data Set ID": "JGAD000626"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0264.v2": {
          "Research ID": "hum0264.v2",
          "Release Date": "2022/02/28",
          "Type of Data": "SNP array data for Idiopathic hypersomnia",
          "description": "Individual SNP array data for 96 patients with idiopathic hypersomnia are provided as CEL files.\n"
        },
        "hum0264.v1": {
          "Research ID": "hum0264.v1",
          "Release Date": "2022/02/07",
          "Type of Data": "GWAS for Idiopathic hypersomnia",
          "description": "DNAs extracted from peripheral blood cells of 129 patiants with idiopathic hypersomnia were genotyped and a genome-wide association study was performed. Statistical analyses data is provided as xlsx files.\nNote：\n"
        }
      }
    }
  },
  "hum0263.v1": {
    "ja": {
      "NBDC Research ID": "hum0263.v1",
      "データ": {
        "JGAS000292": {
          "データID": "JGAS000292",
          "内容": "NGS（DREAM-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/07/24"
        }
      },
      "研究内容の概要": {
        "目的": "若年性骨髄単球性白血病のリスク層別化のための、Infinium® HumanMethylation450 BeadChip（Illumina）に代わる、簡便かつ堅牢性の保持された解析手法の開発",
        "方法": "NGSを用いた全ゲノムメチル化解析の方法であるDREAM法を用いて、 若年性骨髄単球性白血病のメチル化解析を行った",
        "対象": "若年性骨髄単球性白血病"
      },
      "分子データ": {
        "JGAS000292": {
          "対象": "若年性骨髄単球性白血病（ICD10：C933）：149症例（167検体）\r\n    16症例については複数回解析を実施（34検体）",
          "規模": "DREAM-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra II DNA Library Prep Kit for Illumina",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000398",
          "総データ量": "513.6 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "髙橋 義行",
        "所 属 機 関": "名古屋大学大学院医学系研究科 小児科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia",
          "DOI": "doi: 10.1182/bloodadvances.2021005080",
          "データID": "JGAD000398"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0263.v1": {
          "Research ID": "hum0263.v1",
          "公開日": "2023/07/24",
          "内容": "NGS（DREAM-seq）",
          "description": "若年性骨髄単球性白血病149症例の腫瘍組織から抽出したDNAを用いた網羅的メチル化解析（DREAM-seq）の結果をfastqファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0263.v1",
      "DATA": {
        "JGAS000292": {
          "Data Set ID": "JGAS000292",
          "Type of Data": "NGS (DREAM-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/07/24"
        }
      },
      "SUMMARY": {
        "Aims": "To develop a simple and robust methylation analysis method for risk stratification of patients with juvenile myelomonocytic Leukemia.",
        "Methods": "the DREAM method; a method for whole genome methylation analysis using NGS",
        "Participants/Materials": "Juvenile myelomonocytic Leukemia"
      },
      "MOLECULAR DATA": {
        "JGAS000292": {
          "Participants/Materials": "Juvenile myelomonocytic Leukemia (ICD10: C933): 149 cases (167 samples)\r\n    16 cases (34 samples) were repeatedly examined",
          "Targets": "DREAM-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Library Construction (kit name)": "NEBNext Ultra II DNA Library Prep Kit for Illumina",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000398",
          "Total Data Volume": "513.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yoshiyuki Takahashi",
        "Affiliation": "Department of Pediatrics, Nagoya University Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia",
          "DOI": "doi: 10.1182/bloodadvances.2021005080",
          "Data Set ID": "JGAD000398"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0263.v1": {
          "Research ID": "hum0263.v1",
          "Release Date": "2023/07/24",
          "Type of Data": "NGS (DREAM-seq)",
          "description": "DREAM-seq (a method for whole genome methylation analysis) in 149 cases of juvenile myelomonocytic leukemia were performed using DNAs extracted from tumor tissues of the patients. The data are provided as fastq format files.\nNote:\n"
        }
      }
    }
  },
  "hum0262.v1": {
    "ja": {
      "NBDC Research ID": "hum0262.v1",
      "データ": {
        "JGAS000267": {
          "データID": "JGAS000267",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/05/11"
        }
      },
      "研究内容の概要": {
        "目的": "発現モジュール解析に基づいた肺腺癌における微小管阻害剤効果予測マーカーの探索",
        "方法": "RNAシークエンス",
        "対象": "肺腺がん24症例"
      },
      "分子データ": {
        "JGAS000267": {
          "対象": "肺腺がん（ICD10：C349）：24症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500/2500]",
          "ライブラリソース": "腫瘍組織（FFPE）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Access Library Prep Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "202 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000370",
          "総データ量": "751.7 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "土原 一哉",
        "所 属 機 関": "国立がん研究センター 先端医療開発センター トランスレーショナルインフォマティクス分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究（研究領域提案型）",
            "タイトル": "次世代トランスクリプトーム解析技術の開発と応用",
            "研究課題番号": "17H06306"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000370"
        }
      },
      "リリース情報": {
        "hum0262.v1": {
          "Research ID": "hum0262.v1",
          "公開日": "2021/05/11",
          "内容": "NGS（RNA-seq）",
          "description": "肺腺がん24症例の腫瘍組織から抽出したRNAを用いたRNA-seqデータをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0262.v1",
      "DATA": {
        "JGAS000267": {
          "Data Set ID": "JGAS000267",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/05/11"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of predictive markers based on transcriptome modules for microtubule inhibitors of lung adenocarcinoma patients",
        "Methods": "RNA sequencing",
        "Participants/Materials": "Lung Adenocarcinoma, 24 cases"
      },
      "MOLECULAR DATA": {
        "JGAS000267": {
          "Participants/Materials": "Lung Adenocarcinoma (ICD10: C349): 24 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500/2500]",
          "Library Source": "RNAs extracted from tumor tissues (FFPE)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Access Library Prep Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "202 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000370",
          "Total Data Volume": "751.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Katsuya Tsuchihara",
        "Affiliation": "Division of Tranaslational Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Priority Areas (Research in a proposed research area)",
            "Title": "Development of the next generation transcriptome analysis and its application",
            "Project Number": "17H06306"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000370"
        }
      },
      "Release Note": {
        "hum0262.v1": {
          "Research ID": "hum0262.v1",
          "Release Date": "2021/05/11",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from tumor tissues of 24 patients with lung adenocarcinoma were used for the RNA-sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0261.v2": {
    "ja": {
      "NBDC Research ID": "hum0261.v2",
      "データ": {
        "hum0261.v1.rhm.v1": {
          "データID": "hum0261.v1.rhm.v1",
          "内容": "PBC1,953症例および健常対照者3,690名のRHM",
          "制限": "非制限公開",
          "公開日": "2021/01/08"
        },
        "hum0261.v1.gwas.v1": {
          "データID": "hum0261.v1.gwas.v1",
          "内容": "PBC1,953症例および健常対照者3,690名のGWAS",
          "制限": "非制限公開",
          "公開日": "2021/01/08"
        },
        "hum0261.v2.gwas.v1": {
          "データID": "hum0261.v2.gwas.v1",
          "内容": "PBC1,920症例および健常対照者1,770名のGWAS",
          "制限": "非制限公開",
          "公開日": "2021/01/19"
        }
      },
      "研究内容の概要": {
        "目的": "日本人原発性胆汁性胆管炎（Primary Biliary Cholangitis：PBC）の発症に関わる遺伝因子の網羅的解析",
        "方法": "領域内遺伝率推定法（Regional Heritability Mapping：RHM）、ゲノムワイド関連解析（Genome-Wide Association Study：GWAS）",
        "対象": "PBC 1,953症例、健常対照者 3,690名"
      },
      "分子データ": {
        "hum0261.v1.rhm.v1 / hum0261.v1.gwas.v1": {
          "対象": "PBC（ICD10：K743）：1,953症例\r\n健常対照者：3,690名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array、Japonica Array v1]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Axiom 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "ASI：Genotyping Console ver. 4.2.0.26\r\nJaponica：Affymetrix Power Tools ver. 1.18.2\r\nIMPUTE4（with 2KJPN reference panel）",
          "フィルタリング": "HWE: P≥10^-6、Imputation info score: ≥ 0.5\r\nIndividuals call rate ≥ 98%, SNPs call rate ≥ 98%, MAF ≥ 1%",
          "マーカー数（QC後）": "1,022,237 SNVs",
          "解析手法（ソフトウェア）": "RHM：GCTA\r\nGWAS：PLINK",
          "NBDC Dataset ID": "RHM：hum0261.v1.rhm.v1\r\nGWAS：hum0261.v1.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nRHM：Dictionary file\r\nGWAS：Dictionary file",
          "総データ量": "17 MB（csv.zip）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0261.v2.gwas.v1": {
          "対象": "PBC（ICD10：K743）：1,920症例\r\n健常対照者：1,770名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array、Japonica Array v1]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Axiom 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "ASI：Genotyping Console ver. 4.2.0.26\r\nJaponica：Affymetrix Power Tools ver. 1.18.2\r\nEagle v2.3.2 for haplotype phasing\r\nIMPUTE4 v1.0 for genotype imputation with 2KJPN reference panel",
          "フィルタリング": "Sample QCs: sample call rate < 0.97, closely related samples by PRIMUS (PI_HAT > 0.09375), outlier from Japanese cluster by PCA (Smirnov‐Grubbs test with a Bonferroni corrected P < 0.05)\r\nSNP QCs: SNP call rate < 0.99, HWE P < 0.0001, MAF < 0.05",
          "マーカー数（QC後）": "4,902,084 SNPs（hg19）",
          "解析手法（ソフトウェア）": "PLINK（v1.9）",
          "NBDC Dataset ID": "hum0261.v2.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "81.6 MB（tsv.zip）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中村 稔",
        "所 属 機 関": "国立病院機構長崎医療センター＆長崎大学大学院医歯薬学総合研究科 新興感染症病態制御学系専攻肝臓病学講座",
        "プロジェクト/研究グループ名": "PBC Consortium in Japan（PBCCJP）",
        "科研費/助成金（Research Project Number）": {
          "6": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（B）",
            "タイトル": "原発性胆汁性胆管炎の発症と重症化機構解明のためのGWASを基盤とした統合解析",
            "研究課題番号": "17H04169"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrated GWAS and mRNA Microarray Analysis Identified IFNG and CD40L as the Central Upstream Regulators in Primary Biliary Cholangitis.",
          "DOI": "doi: 10.1002/hep4.1497",
          "データID": "hum0261.v2.gwas.v1"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0261.v2": {
          "Research ID": "hum0261.v2",
          "公開日": "2021/01/19",
          "内容": "原発性胆汁性胆管炎1,920症例および健常対照者1,770名のゲノムワイド関連解析",
          "description": "原発性胆汁性胆管炎1,920症例および健常対照者1,770名の末梢血より抽出したDNAを対象とし、SNPアレイによりGenotypeを決定し、GWAS解析を行った結果をtsv fileにて提供する。\n"
        },
        "hum0261.v1": {
          "Research ID": "hum0261.v1",
          "公開日": "2021/01/08",
          "内容": "原発性胆汁性胆管炎1,953症例および健常対照者3,690名の領域内遺伝率推定法解析およびゲノムワイド関連解析",
          "description": "原発性胆汁性胆管炎1,953症例および健常対照者3,690名の末梢血より抽出したDNAを対象とし、SNPアレイによりGenotypeを決定し、領域内遺伝率推定法解析およびGWAS解析を行った結果をcsv fileにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0261.v2",
      "DATA": {
        "hum0261.v1.rhm.v1": {
          "Data Set ID": "hum0261.v1.rhm.v1",
          "Type of Data": "RHM for 1,953 PBCs and 3,690 healthy controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/01/08"
        },
        "hum0261.v1.gwas.v1": {
          "Data Set ID": "hum0261.v1.gwas.v1",
          "Type of Data": "GWAS for 1,953 PBCs and 3,690 healthy controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/01/08"
        },
        "hum0261.v2.gwas.v1": {
          "Data Set ID": "hum0261.v2.gwas.v1",
          "Type of Data": "GWAS for 1,920 PBCs and 1,770 healthy controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/01/19"
        }
      },
      "SUMMARY": {
        "Aims": "Genome-wide search for susceptibility genes for primary biliary cholangitis (PBC)",
        "Methods": "Regional Heritability Mapping (RHM) and Genome-wide Association Study (GWAS)",
        "Participants/Materials": "1,953 PBCs and 3,690 healthy controls"
      },
      "MOLECULAR DATA": {
        "hum0261.v1.rhm.v1 / hum0261.v1.gwas.v1": {
          "Participants/Materials": "1,953 PBCs (ICD10: K743) and 3,690 healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array, Japonica Array v1]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Axiom 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "ASI: Genotyping Console ver. 4.2.0.26\r\nJaponica: Affymetrix Power Tools ver. 1.18.2\r\nIMPUTE4 (with 2KJPN reference panel)",
          "Filtering Methods": "HWE: P≥10^-6、Imputation info score: ≥ 0.5\r\nIndividuals call rate ≥ 98%, SNPs call rate ≥ 98%, MAF ≥ 1%",
          "Marker Number (after QC)": "1,022,237 SNPs",
          "Analysis Method (software)": "RHM: GCTA\r\nGWAS: PLINK",
          "NBDC Dataset ID": "RHM: hum0261.v1.rhm.v1\r\nGWAS: hum0261.v1.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nRHM: Dictionary file\r\nGWAS: Dictionary file",
          "Total Data Volume": "17 MB (csv.zip)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0261.v2.gwas.v1": {
          "Participants/Materials": "1,920 PBCs (ICD10: K743) and 1,770 healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array, Japonica Array v1]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Axiom 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "ASI: Genotyping Console ver. 4.2.0.26\r\nJaponica: Affymetrix Power Tools ver. 1.18.2\r\nEagle v2.3.2 for haplotype phasing\r\nIMPUTE4 v1.0 for genotype imputation with 2KJPN reference panel",
          "Filtering Methods": "Sample QCs: sample call rate < 0.97, closely related samples by PRIMUS (PI_HAT > 0.09375), outlier from Japanese cluster by PCA (Smirnov‐Grubbs test with a Bonferroni corrected P < 0.05)\r\nSNP QCs: SNP call rate < 0.99, HWE P < 0.0001, MAF < 0.05",
          "Marker Number (after QC)": "4,902,084 SNPs (hg19)",
          "Analysis Method (software)": "PLINK (v1.9)",
          "NBDC Dataset ID": "hum0261.v2.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "81.6 MB (tsv.zip)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Minoru Nakamura",
        "Affiliation": "NHO Nagasaki Medical Center & Nagasaki University Graduate School of Biomedical Sciences Division of Advanced Research, Department of Hepatology",
        "Project / Group Name": "PBC Consortium in Japan (PBCCJP)",
        "Funds / Grants (Research Project Number)": {
          "6": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "GWAS-based integrated analysis of PBC to dissect the mechanism of development and progression of primary biliary cholangitis",
            "Project Number": "17H04169"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrated GWAS and mRNA Microarray Analysis Identified IFNG and CD40L as the Central Upstream Regulators in Primary Biliary Cholangitis.",
          "DOI": "doi: 10.1002/hep4.1497",
          "Data Set ID": "hum0261.v2.gwas.v1"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0261.v2": {
          "Research ID": "hum0261.v2",
          "Release Date": "2021/01/19",
          "Type of Data": "GWAS for 1,920 PBCs and 1,770 healthy controls",
          "description": "DNAs extracted from 1,920 PBCs and 1,770 healthy controls were genotyped by using of Affymetrix Axiom Genome-Wide ASI 1 Array and Japonica Array v1 and genome-wide association study was performed (tsv file).\n"
        },
        "hum0261.v1": {
          "Research ID": "hum0261.v1",
          "Release Date": "2021/01/08",
          "Type of Data": "RHM and GWAS for 1,953 PBCs and 3,690 healthy controls",
          "description": "DNAs extracted from 1,953 PBCs and 3,690 healthy controls were genotyped by using of Affymetrix Axiom Genome-Wide ASI 1 Array and Japonica Array v1 and regional heritability mapping and genome-wide association study was performed (csv file).\nNote：\n"
        }
      }
    }
  },
  "hum0257.v2": {
    "ja": {
      "NBDC Research ID": "hum0257.v2",
      "データ": {
        "JGAS000263": {
          "データID": "JGAS000263",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/12/24"
        },
        "E-GEAD-414": {
          "データID": "E-GEAD-414",
          "内容": "NGS（RNA-seq）",
          "制限": "非制限公開",
          "公開日": "2021/12/24"
        },
        "JGAS000264": {
          "データID": "JGAS000264",
          "内容": "NGS（ATAC-seq、ChIP-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/12/24"
        },
        "E-GEAD-416": {
          "データID": "E-GEAD-416",
          "内容": "NGS（ATAC-seq）",
          "制限": "非制限公開",
          "公開日": "2021/12/24"
        },
        "E-GEAD-417": {
          "データID": "E-GEAD-417",
          "内容": "NGS（ChIP-seq）",
          "制限": "非制限公開",
          "公開日": "2021/12/24"
        },
        "JGAS000262": {
          "データID": "JGAS000262",
          "内容": "NGS（Hi-C）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/12/24"
        },
        "E-GEAD-415": {
          "データID": "E-GEAD-415",
          "内容": "NGS（Hi-C）",
          "制限": "非制限公開",
          "公開日": "2021/12/24"
        },
        "JGAS000514": {
          "データID": "JGAS000514",
          "内容": "NGS（RNA-seq、ChIP-seq、Hi-C）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/01/10"
        },
        "GSE202023": {
          "データID": "GSE202023",
          "内容": "NGS（ChIP-seq）",
          "制限": "非制限公開",
          "公開日": "2023/01/10"
        }
      },
      "研究内容の概要": {
        "目的": "ヒト膵腫瘍サブタイプの包括的解析",
        "方法": "膵腫瘍組織から樹立したオルガノイドのWhole Exome sequencing、RNA sequencing、ATAC sequencing、ChIP sequencing、およびHi-C解析",
        "対象": "膵管がん、膵管内乳頭粘液性腫瘍（IPMN）"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "Exome": {
          "対象": "膵管がん（ICD10：C25.3）：10症例\r\n  - 腫瘍組織由来オルガノイド：10検体\r\n膵管内乳頭粘液性腫瘍（ICD10：D13.6）：3症例\r\n  - 腫瘍組織由来オルガノイド：3検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "膵腫瘍組織から樹立したオルガノイドより抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6 Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp、150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000366",
          "総データ量": "121 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "膵管がん（ICD10：C25.3）：10症例\r\n  【JGAD000366/E-GEAD-414】腫瘍組織由来オルガノイド：22検体\r\n  【JGAD000633】1症例の腫瘍組織由来オルガノイド：4検体（HNF1B過剰発現2検体、コントロール2検体）\r\n膵管内乳頭粘液性腫瘍（ICD10：D13.6）：5症例\r\n  【JGAD000366/E-GEAD-414】腫瘍組織由来オルガノイド：4検体、傍腫瘍組織由来オルガノイド1検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500、NovaSeq 6000]",
          "ライブラリソース": "膵腫瘍組織から樹立したオルガノイドより抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA sample Preparation KitV2、TruSeq Stranded mRNA LT Sample Prep Kit、TruSeq Stranded mRNA Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp、150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000366\r\nJGAD000633",
          "Genomic Expression Archive ID": "E-GEAD-414",
          "総データ量": "JGAD000366/E-GEAD-414：121 GB（fastq）\r\nJGAD000633：15 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ATAC-seq": {
          "対象": "膵管がん（ICD10：C25.3）：17症例\r\n  - 腫瘍組織由来オルガノイド：20検体\r\n膵管内乳頭粘液性腫瘍（ICD10：D13.6）：6症例\r\n  - 腫瘍組織由来オルガノイド：4検体、傍腫瘍組織由来オルガノイド：2検体",
          "規模": "ATAC-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "膵腫瘍組織から樹立したオルガノイドより抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina Tagment DNA TDE1 Enzyme and Buffer Kits",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp＋25 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000367",
          "Genomic Expression Archive ID": "E-GEAD-416",
          "総データ量": "117 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ChIP-seq": {
          "対象": "膵管がん（ICD10：C25.3）：2症例\r\n  【JGAD000367/E-GEAD-417】腫瘍組織由来オルガノイド：4検体（ChIP2検体＋Input2検体）\r\n  【JGAD000633/GSE202023】腫瘍組織由来オルガノイド：6検体（HNF1B過剰発現有無、抗CTCF抗体、抗H3K27Ac抗体、もしくは抗HNF1B抗体による免疫沈降）",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "膵腫瘍組織から樹立したオルガノイドより抽出したクロマチン免疫沈降DNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina Tagment DNA TDE1 Enzyme and Buffer Kits",
          "断片化の方法": "超音波断片化（Bioruptor UCD-250）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000367\r\nJGAD000633",
          "Genomic Expression Archive ID": "E-GEAD-417",
          "Gene Expression Omnibus ID": "GSE202023",
          "総データ量": "JGAD000367/E-GEAD-417：117 GB（fastq）\r\nJGAD000633/GSE202023：10 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Hi-C": {
          "対象": "膵管がん（ICD10：C25.3）：2症例\r\n  【JGAD000365】腫瘍組織由来オルガノイド：2検体\r\n  【JGAD000633】各条件につきduplicate：8検体\r\n    - 1症例の腫瘍組織由来オルガノイド：HNF1B過剰発現有無\r\n    - IPMN由来膵管がん1症例のオルガノイド：HNF1Bノックダウン有無",
          "規模": "Hi-C",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "膵腫瘍組織から樹立したオルガノイドより抽出したクロスリンク済みDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Arima Hi-C kit",
          "断片化の方法": "制限酵素処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000365\r\nJGAD000633",
          "Genomic Expression Archive ID": "E-GEAD-415",
          "総データ量": "JGAD000365：159 GB（fastq）\r\nJGAD000633：493 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "立石 敬介",
        "所 属 機 関": "東京大学医学部 消化器内科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "MNX1-HNF1B axis is indispensable for intraductal papillary mucinous neoplasm lineages",
          "DOI": "doi: 10.1053/j.gastro.2021.12.254",
          "データID": "JGAD000365JGAD000366JGAD000367E-GEAD-414E-GEAD-415E-GEAD-416E-GEAD-417"
        },
        "2": {
          "タイトル": "HNF1B-driven three-dimensional chromatin structure for molecular classification in pancreatic cancers",
          "DOI": "doi: 10.1111/cas.15690",
          "データID": "JGAD000633GSE202023"
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000366"
        }
      },
      "リリース情報": {
        "hum0257.v2": {
          "Research ID": "hum0257.v2",
          "公開日": "2023/01/10",
          "内容": "NGS（RNA-seq、ChIP-seq、Hi-C）",
          "description": "膵管がんおよび膵管内乳頭粘液性腫瘍由来膵管がんの腫瘍組織由来オルガノイド検体から抽出したDNA/RNAを用いたRNA sequencing、ChIP sequencing、およびHi-C解析データをfastqファイルにて提供する。\n"
        },
        "hum0257.v1": {
          "Research ID": "hum0257.v1",
          "公開日": "2021/12/24",
          "内容": "NGS（Exome、RNA-seq、ATAC-seq、ChIP-seq、Hi-C）",
          "description": "膵管がんと膵管内乳頭粘液性腫瘍症例の腫瘍組織（RNA-seqとATAC-seqは腫瘍組織に加えて傍腫瘍組織）由来オルガノイド検体から抽出したDNA/RNAを用いたWhole Exome sequencing、RNA sequencing、ATAC sequencing、ChIP sequencing、およびHi-C解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0257.v2",
      "DATA": {
        "JGAS000263": {
          "Data Set ID": "JGAS000263",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/12/24"
        },
        "E-GEAD-414": {
          "Data Set ID": "E-GEAD-414",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/12/24"
        },
        "JGAS000264": {
          "Data Set ID": "JGAS000264",
          "Type of Data": "NGS (ATAC-seq, ChIP-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/12/24"
        },
        "E-GEAD-416": {
          "Data Set ID": "E-GEAD-416",
          "Type of Data": "NGS (ATAC-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/12/24"
        },
        "E-GEAD-417": {
          "Data Set ID": "E-GEAD-417",
          "Type of Data": "NGS (ChIP-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/12/24"
        },
        "JGAS000262": {
          "Data Set ID": "JGAS000262",
          "Type of Data": "NGS (Hi-C)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/12/24"
        },
        "E-GEAD-415": {
          "Data Set ID": "E-GEAD-415",
          "Type of Data": "NGS (Hi-C)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/12/24"
        },
        "JGAS000514": {
          "Data Set ID": "JGAS000514",
          "Type of Data": "NGS (RNA-seq, ChIP-seq, Hi-C)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/01/10"
        },
        "GSE202023": {
          "Data Set ID": "GSE202023",
          "Type of Data": "NGS (ChIP-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/01/10"
        }
      },
      "SUMMARY": {
        "Aims": "Comprehensive analysis of human pancreatic tumor subtypes.",
        "Methods": "Whole Exome sequencing, RNA sequencing, ATAC sequencing, ChIP sequencing, and Hi-C analysis using organoids established from pancreatic tumors.",
        "Participants/Materials": "Pancreatic ductal adenocarcinoma, Intraductal papillary mucinous neoplasm"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by \"Genome Science\". \"Genome Science\" is a part of the \"Support Programs for Three Fields in Life Sciences (cancer, genome, and brain sciences)\" established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "Exome": {
          "Participants/Materials": "Pancreatic ductal adenocarcinoma (ICD10: C25.3): 10 cases\r\n  - organoids derived from tumor tissues: 10 samples\r\nIntraductal papillary mucinous neoplasm (ICD10: D13.6): 3 cases\r\n  - organoids derived from tumor tissues: 3 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from organoids established from pancreatic tumors",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6 Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp, 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000366",
          "Total Data Volume": "121 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Pancreatic ductal adenocarcinoma (ICD10: C25.3): 10 cases\r\n  [JGAD000366/E-GEAD-414] organoids derived from tumor tissues: 22 samples\r\n  [JGAD000633] One case of organoid from tumor tissues with HNF1B overexpression (2 samples) and its control (2 samples)\r\nIntraductal papillary mucinous neoplasm (ICD10: D13.6): 5 cases\r\n  [JGAD000366/E-GEAD-414] organoids derived from tumor tissues: 4 samples, organoids derived from tumor-adjacent tissues: 1 sample",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500, NovaSeq 6000]",
          "Library Source": "RNAs extracted from organoids established from pancreatic tumors",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA sample Preparation KitV2, TruSeq Stranded mRNA LT Sample Prep Kit, TruSeq Stranded mRNA Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp, 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000366\r\nJGAD000633",
          "Genomic Expression Archive ID": "E-GEAD-414",
          "Total Data Volume": "JGAD000366/E-GEAD-414: 121 GB (fastq)\r\nJGAD000633: 15 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "ATAC-seq": {
          "Participants/Materials": "Pancreatic ductal adenocarcinoma (ICD10: C25.3): 17 cases\r\n  - organoids derived from tumor tissues: 20 samples\r\nIntraductal papillary mucinous neoplasm (ICD10: D13.6): 6 cases\r\n  - organoids derived from tumor tissues: 4 samples, organoids derived from tumor-adjacent tissues: 2 samples",
          "Targets": "ATAC-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "DNAs extracted from organoids established from pancreatic tumors",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina Tagment DNA TDE1 Enzyme and Buffer Kits",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp + 25 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000367",
          "Genomic Expression Archive ID": "E-GEAD-416",
          "Total Data Volume": "117 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "ChIP-seq": {
          "Participants/Materials": "Pancreatic ductal adenocarcinoma (ICD10: C25.3): 2 cases\r\n  [JGAD000367/E-GEAD-417] organoids derived from tumor tissues: 4 samples (2 ChIP experiments and 2 input experiments)\r\n  [JGAD000633/GSE202023] organoids derived from tumor tissues: 6 samples (with/without HNF1B overexpression with anti-CTCF antibody, anti-H3K27Ac antibody or anti-HNF1B antibody)",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "Chromatin immunoprecipitated DNAs extracted from organoids established from pancreatic tumors",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina Tagment DNA TDE1 Enzyme and Buffer Kits",
          "Fragmentation Methods": "Ultrasonic fragmentation (Bioruptor UCD-250)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000367\r\nJGAD000633",
          "Genomic Expression Archive ID": "E-GEAD-417",
          "Gene Expression Omnibus ID": "GSE202023",
          "Total Data Volume": "JGAD000367/E-GEAD-417: 117 GB (fastq)\r\nJGAD000633/GSE202023: 10 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Hi-C": {
          "Participants/Materials": "Pancreatic ductal adenocarcinoma (ICD10: C25.3): 2 cases\r\n  [JGAD000365] organoids derived from tumor tissues: 2 samples\r\n  [JGAD000633] duplicate for each condition: 8 samples\r\n    - One case of organoid from tumor tissues: with/without HNF1B overexpression\r\n    - One case of organoid from tumor tissues of pancreatic ductal adenocarcinoma derived from intraductal papillary mucinous neoplasm: with/without HNF1B knockdown",
          "Targets": "Hi-C",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "Cross-linked DNAs extracted from organoids established from pancreatic tumors",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Arima Hi-C kit",
          "Fragmentation Methods": "Restriction enzyme treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000365\r\nJGAD000633",
          "Genomic Expression Archive ID": "E-GEAD-415",
          "Total Data Volume": "JGAD000365: 159 GB (fastq)\r\nJGAD000633: 493 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Keisuke Tateishi",
        "Affiliation": "Department of Gastroenterology, The University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "MNX1-HNF1B axis is indispensable for intraductal papillary mucinous neoplasm lineages",
          "DOI": "doi: 10.1053/j.gastro.2021.12.254",
          "Data Set ID": "JGAD000365JGAD000366JGAD000367E-GEAD-414E-GEAD-415E-GEAD-416E-GEAD-417"
        },
        "2": {
          "Title": "HNF1B-driven three-dimensional chromatin structure for molecular classification in pancreatic cancers",
          "DOI": "doi: 10.1111/cas.15690",
          "Data Set ID": "JGAD000633GSE202023"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000366"
        }
      },
      "Release Note": {
        "hum0257.v2": {
          "Research ID": "hum0257.v2",
          "Release Date": "2023/01/10",
          "Type of Data": "NGS (RNA-seq, ChIP-seq, Hi-C)",
          "description": "DNAs/RNAs extracted from organoids established from pancreatic tumors were used for the RNA sequencing, ChIP sequencing and Hi-C analyses. Fastq files are provided.\n"
        },
        "hum0257.v1": {
          "Research ID": "hum0257.v1",
          "Release Date": "2021/12/24",
          "Type of Data": "NGS (Exome, RNA-seq, ATAC-seq, ChIP-seq, Hi-C)",
          "description": "DNAs/RNAs extracted from organoids established from pancreatic tumors were used for the Whole Exome sequencing, RNA sequencing, ATAC sequencing, ChIP sequencing and Hi-C analyses. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0254.v1": {
    "ja": {
      "NBDC Research ID": "hum0254.v1",
      "データ": {
        "JGAS000257": {
          "データID": "JGAS000257",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/09/24"
        }
      },
      "研究内容の概要": {
        "目的": "新たに開発したアダプター連結反応を用いてセルフリーDNA（cell-free DNA：cfDNA）からライブラリー調製を実施するための条件検討",
        "方法": "新規技術で調製したcfDNAライブラリを用いて配列決定し、cfDNAの特性について解析を行う",
        "対象": "健常人のヒト血漿由来cfDNA"
      },
      "分子データ": {
        "JGAS000257": {
          "対象": "健常人：5名8検体\r\n（1名：前処理条件が異なる4検体、その他4名：1検体ずつ計4検体）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Miseq、HiSeq X Ten]",
          "ライブラリソース": "末梢血血漿由来cfDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TACS-T4",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75-190 bp（平均119 bp）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000360",
          "総データ量": "378.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "三浦 史仁",
        "所 属 機 関": "九州大学 大学院医学研究院 医化学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "公益財団法人臨床研究奨励基金（2020年） 研究助成金",
            "タイトル": "血漿セルフリーＤＮＡの構造と修飾の網羅的解析",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Short single-stranded DNAs with putative non-canonical structures comprise a new class of plasma cell-free DNA.",
          "DOI": "doi: 10.1186/s12915-021-01160-8",
          "データID": "JGAD000360"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0254.v1": {
          "Research ID": "hum0254.v1",
          "公開日": "2021/09/24",
          "内容": "NGS（WGS）",
          "description": "新たに開発した方法により、血漿中セルフリーDNAから効率よくライブラリを調製し、実施したwhole genome sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0254.v1",
      "DATA": {
        "JGAS000257": {
          "Data Set ID": "JGAS000257",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/09/24"
        }
      },
      "SUMMARY": {
        "Aims": "Investigation of the conditions for library preparation from cell-free DNAs (cfDNAs) using the newly developed adapter linkage reaction.",
        "Methods": "The cfDNA library prepared by the new technology was sequenced and analyzed for the properties of cfDNA.",
        "Participants/Materials": "cfDNA from healthy human plasma"
      },
      "MOLECULAR DATA": {
        "JGAS000257": {
          "Participants/Materials": "5 healthy individuals (8 samples)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Miseq, HiSeq X Ten]",
          "Library Source": "cfDNA in plasma of peripheral blood",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TACS-T4",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75-190 bp (119 bp on average)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000360",
          "Total Data Volume": "378.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Fumihito Miura",
        "Affiliation": "Department of Biochemistry, Kyushu University Graduate School of Medical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Grant of The Clinical Research Promotion Foundation (2020)",
            "Title": "Comprehensive analysis of structure and modifications of plasma cell-free DNA",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Short single-stranded DNAs with putative non-canonical structures comprise a new class of plasma cell-free DNA.",
          "DOI": "doi: 10.1186/s12915-021-01160-8",
          "Data Set ID": "JGAD000360"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0254.v1": {
          "Research ID": "hum0254.v1",
          "Release Date": "2021/09/24",
          "Type of Data": "NGS (WGS)",
          "description": "The cfDNA library prepared by the new technology is sequenced. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0252.v2": {
    "ja": {
      "NBDC Research ID": "hum0252.v2",
      "データ": {
        "JGAS000301": {
          "データID": "JGAS000301",
          "内容": "NGS（Target Capture、RNA-seq、scRNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/12"
        },
        "JGAS000553": {
          "データID": "JGAS000553",
          "内容": "NGS（Target Capture、WGS、scRNA-seq、scATAC-seq、ChIP-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/12/06"
        }
      },
      "研究内容の概要": {
        "目的": "成人T 細胞白血病（ATL）の遺伝子変異と遺伝子発現の解析を通じてATLのリスクバイオマーカーと発症メカニズムを明らかにする。Target capture sequencingを用いて成人T細胞白血病（ATL）の遺伝子変異とクローン構造を解析し、さらにRNA sequencingによって遺伝子変異の生物学的意義を検討する。",
        "方法": "Target capture sequencing、RNA sequencing（RNA-seq）、single cell RNA sequencing（scRNA-seq）、Whole genome sequencing（WGS）、scATAC-seq、ChIP-seq",
        "対象": "ATL6＋4症例、及びHTLV-1感染者10症例の感染細胞分画及び非感染細胞分画、並びに健常者3＋1名のCD4+T細胞（Lonzaからの購入検体）"
      },
      "分子データ": {
        "Target Capture（JGAS000301/JGAS000553）": {
          "対象": "【JGAS000301/JGAD000412】\r\n  ATL（ICD10：C915）：6症例\r\n    （感染細胞分画：19検体、非感染細胞分画：7検体）\r\n  HTLV-1感染者：10症例（2症例はATL発症後の検体を含む）\r\n    （感染細胞分画：20検体、非感染細胞分画：10検体）\r\n【JGAS000553/JGAD000674】\r\n  ATL（ICD10：C915）：4症例（計30検体）\r\n    （正常細胞：4検体、投薬前の腫瘍細胞：4検体、投薬後の腫瘍細胞：22検体）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "ATLリスク50遺伝子を含む280遺伝子",
          "Platform": "Illumina [HiSeq 3000、NovaSeq 6000]",
          "ライブラリソース": "ATL患者及びHTLV-1感染者末梢血の感染細胞分画及び非感染細胞分画ならびに正常細胞および腫瘍細胞から抽出したDNA（CD4+ T細胞、PBMC）",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Target Enrichment System",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000412\r\nJGAD000674",
          "総データ量": "JGAD000412：585.8 GB（fastq）\r\nJGAD000674：3.7 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGS": {
          "対象": "ATL（ICD10：C915）：3症例（計9検体）\r\n  （正常細胞：3検体、投薬前の腫瘍細胞：3検体、投薬後の腫瘍細胞：3検体）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "MGI [DNBSEQ-G400]",
          "ライブラリソース": "ATL患者の正常細胞および腫瘍細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "MGIEasy PCR-Free DNA Library Prep Set",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000674",
          "総データ量": "3.7 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "ATL（ICD10：C915）：4症例\r\n  （感染細胞分画：6検体、非感染細胞分画：2検体）\r\n健常者：3名（セルライン）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "ATL患者末梢血の感染細胞分画、及び、非感染細胞分画、並びに健常者のCD4+T細胞から抽出したRNA",
          "検体情報（購入の場合）": "ヒト末梢血CD4+T細胞（Lonza Catalog #: 2W-200）",
          "ライブラリ作製方法（キット名）": "NEBNext UltraTM RNA Library Prep Kit for Illumina",
          "断片化の方法": "上記キットに準拠（化学反応[Mg2+、熱処理]）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000412",
          "総データ量": "585.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "scRNA-seq（JGAS000301/JGAS000553）": {
          "対象": "【JGAS000301/JGAD000412】\r\n  ATL（ICD10：C915）：1症例（2点）\r\n    （感染細胞分画：4検体、非感染細胞分画：2検体）\r\n【JGAS000553/JGAD000674】\r\n  ATL（ICD10：C915）：3症例（計10検体）\r\n    （末梢血リンパ球　投薬前：3検体、投薬後：7検体）",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500/3000、NovaSeq 6000]",
          "ライブラリソース": "ATL患者末梢血の感染細胞分画、非感染細胞分画のCD4+T細胞（シングルセル）および末梢血リンパ球から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Single Cell 3’ Library v2 kit",
          "断片化の方法": "上記キットに準拠（酵素反応）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "124 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000412\r\nJGAD000674",
          "総データ量": "JGAD000412：585.8 GB（fastq）\r\nJGAD000674：3.7 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "scATAC-seq": {
          "対象": "ATL（ICD10：C915）：3症例（計10検体）\r\n  （末梢血リンパ球　投薬前：3検体、投薬後：7検体）",
          "規模": "scATAC-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "ATL患者のリンパ球から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium NextGEM Single Cell ATAC Reagent Kits v1.1",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000674",
          "総データ量": "3.7 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ChIP-seq": {
          "対象": "ATL（ICD10：C915）：1症例\r\n健常者：1名（セルライン）",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "ATL患者腫瘍細胞および健常者のCD4+T細胞より抽出したDNAについて免疫沈降（H3K27me3、H3K27ac）を実施\r\n   ・ATL患者腫瘍細胞\r\n            投薬前：コントロール 1検体、免疫沈降 2検体\r\n            投薬後：免疫沈降 2検体\r\n   ・健常者：コントロール 1検体、免疫沈降 2検体",
          "検体情報（購入の場合）": "ヒト末梢血CD4+T細胞（Lonza Catalog #: 2W-200）",
          "ライブラリ作製方法（キット名）": "Standard consecutive enzymatic steps of end-polishing, dA-addition, and adaptor ligation",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000674",
          "総データ量": "3.7 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山岸 誠",
        "所 属 機 関": "東京大学大学院 新領域創成科学研究科",
        "プロジェクト/研究グループ名": "",
        "科研費/助成金（Research Project Number）": {
          "6": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "ゲノム異常とエピゲノム異常によるATLの協奏的クローン進化メカニズムの解明",
            "研究課題番号": "21K08386"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "松岡 雅雄": {
          "研究代表者": "松岡 雅雄",
          "所属機関": "熊本大学大学院生命科学研究部",
          "研究題目": "日本",
          "利用データID": "悪性リンパ腫、成人T細胞白血病・リンパ腫の遺伝・病理学的検討を用いた特性および経過・治療に関する後方視的観察研究",
          "利用期間": "JGAD000412"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000412"
        }
      },
      "リリース情報": {
        "hum0252.v2": {
          "Research ID": "hum0252.v2",
          "公開日": "2023/12/06",
          "内容": "NGS（Target Capture、WGS、scRNA-seq、scATAC-seq、ChIP-seq）",
          "description": "ATL4症例の正常細胞、投薬前および投薬後の腫瘍細胞と末梢血リンパ球、並びに健常者1名のCD4+T細胞から抽出したDNA/RNAを用いたTarget Capture Sequencing、Whole genome sequencing、single cell RNA-seq、single cell ATAC-seq、ChIP-seq解析データをfastqファイルにて提供する。\n"
        },
        "hum0252.v1": {
          "Research ID": "hum0252.v1",
          "公開日": "2021/07/12",
          "内容": "NGS（Target Capture、RNA-seq、scRNA-seq）",
          "description": "ATL6症例及びHTLV-1感染者10例の感染細胞分画及び非感染細胞分画、並びに健常者3名のCD4+T細胞から抽出したDNA/RNAを用いたTarget Capture Sequencing、RNA-seq、single cell RNA-seq解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0252.v2",
      "DATA": {
        "JGAS000301": {
          "Data Set ID": "JGAS000301",
          "Type of Data": "NGS (Target Capture, RNA-seq, scRNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/12"
        },
        "JGAS000553": {
          "Data Set ID": "JGAS000553",
          "Type of Data": "NGS（Target Capture, WGS, scRNA-seq, scATAC-seq, ChIP-seq）",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/12/06"
        }
      },
      "SUMMARY": {
        "Aims": "Study for molecular characteristics of adult T-cell leukemia-lymphoma and HTLV-1-associated diseases",
        "Methods": "Target capture sequencing, RNA-seq, single cell RNA-seq (scRNA-seq), Whole genome sequencing (WGS), scATAC-seq, ChIP-seq",
        "Participants/Materials": "ATL 6 + 4 cases, HTLV-1 infected carrier 10 cases (infected cells and unifected cells), and 3 + 1 healthy donors"
      },
      "MOLECULAR DATA": {
        "Target Capture (JGAS000301/JGAS000553)": {
          "Participants/Materials": "[JGAS000301/JGAD000412]\r\nATL (ICD10: C915): 6 cases\r\n   infected cells: 19 samples, uninfected cells: 7 samples\r\nHTLV-1 infected carriers: 10 cases (including post-ATL specimens for 2 cases)\r\n   infected cells: 20 samples, uninfected cells: 10 samples\r\n[JGAS000553/JGAD000674]\r\nATL (ICD10: C915): 4 cases (total 30 samples)\r\n   non-tumor cells: 4 samples\r\n   tumor cells: before treatment: 4 samples, after treatment: 22 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "280 genes including 50 candidate genes for ATL",
          "Platform": "Illumina [HiSeq 3000, NovaSeq 6000]",
          "Library Source": "DNAs extracted from infected cells, uninfected cells, non-tumor and tumor cells of ATL and HTLV-1 carriers",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Target Enrichment System",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000412\r\nJGAD000674",
          "Total Data Volume": "JGAD000412: 585.8 GB (fastq)\r\nJGAD000674: 3.7 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGS": {
          "Participants/Materials": "ATL (ICD10: C915): 3 cases (total 9 samples)\r\n   non-tumor cells: 3 samples\r\n   tumor cells: before treatment: 3 samples, after treatment: 3 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "MGI [DNBSEQ-G400]",
          "Library Source": "DNAs extracted from normal cells and tumor cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "MGIEasy PCR-Free DNA Library Prep Set",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000674",
          "Total Data Volume": "3.7 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "ATL (ICD10: C915): 4 cases\r\n      CD4+ T cells from infected cells: 6 samples, uninfected cells: 2 samples\r\nCD4+ T cells from 3 cell lines",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from with/ without infected CD4+ T cells of ATL and CD4+ T cells of healthy donors",
          "Cell Lines": "Human Peripheral Blood CD4+ T cells (Lonza Catalog #: 2W-200)",
          "Library Construction (kit name)": "NEBNext UltraTM RNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "included in the above library construction kit (chemical reaction [Mg2+, heat treatment])",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000412",
          "Total Data Volume": "585.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "scRNA-seq (JGAS000301/JGAS000553)": {
          "Participants/Materials": "[JGAS000301/JGAD000412]\r\nATL (ICD10: C915): 1 case (2 points)\r\n      CD4+ T cells of infected cells: 4 samples, uninfected cells: 2 samples\r\n[JGAS000553/JGAD000674]\r\nATL (ICD10: C915): 3 cases (total 10 samples)\r\n      peripheral blood lymphocytes: before treatment: 3 samples, after treatment: 7 samples",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500/3000, NovaSeq 6000]",
          "Library Source": "RNAs extracted from single CD4+ T cells with/without infection of ATL or peripheral blood lymphocytes of ATL cases before and after treatment",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Single Cell 3’ Library v2 kit",
          "Fragmentation Methods": "included in the above library construction kit (enzymatic fragmentation)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "124 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000412\r\nJGAD000674",
          "Total Data Volume": "JGAD000412: 585.8 GB (fastq)\r\nJGAD000674: 3.7 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "scATAC-seq": {
          "Participants/Materials": "ATL (ICD10: C915): 3 cases (total 10 samples)\r\n      Peripheral blood lymphocytes: before treatment: 3 samples, after treatment: 7 samples",
          "Targets": "scATAC-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from peripheral blood lymphocytes of ATL cases before and after treatment",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium NextGEM Single Cell ATAC Reagent Kits v1.1",
          "Fragmentation Methods": "enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000674",
          "Total Data Volume": "3.7 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "ChIP-seq": {
          "Participants/Materials": "ATL (ICD10: C915): 1 case\r\nCD4+ T cells from 1 cell line",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "DNAs extracted from CD4+ T cells and tumor cells and immunoprecipitated with anti-histone antibodies (H3K27me3, H3K27ac)\r\n      ATL tumor cells before treatment: control 1 sample, ChIP 2 samples\r\n      ATL tumor cells after treatment: ChIP 2 samples\r\n      CD4+ T cells: control 1 sample, ChIP 2 samples",
          "Cell Lines": "Human Peripheral Blood CD4+ T cells (Lonza Catalog #: 2W-200)",
          "Library Construction (kit name)": "Standard consecutive enzymatic steps of end-polishing, dA-addition, and adaptor ligation",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000674",
          "Total Data Volume": "3.7 TB（fastq）",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Makoto Yamagishi",
        "Affiliation": "Graduate School of Frontier Sciences, The University of Tokyo",
        "Project / Group Name": "",
        "Funds / Grants (Research Project Number)": {
          "6": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Mechanisms of cooperative clonal evolution of ATL by genomic and epigenomic abnormalities",
            "Project Number": "21K08386"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Masao Matsuoka": {
          "Principal Investigator": "Masao Matsuoka",
          "Affiliation": "Kumamoto University School of Medicine Hematology, Rheumatology and Infectious Diseases",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Retrospective observational study of characteristics, clinical course and treatment of malignant lymphoma and adult T-cell leukemia/lymphoma with genetic and pathological evaluations",
          "Period of Data Use": "JGAD000412"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000412"
        }
      },
      "Release Note": {
        "hum0252.v2": {
          "Research ID": "hum0252.v2",
          "Release Date": "2023/12/06",
          "Type of Data": "NGS (Target Capture, WGS, scRNA-seq, scATAC-seq, ChIP-seq)",
          "description": "DNAs/RNAs extracted from non-tumor and tumor cells, or peripheral blood lymphocytes before and after treatment from 4 ATL cases and CD4+ T cells from healthy donors were used for the target capture sequencing, whole genome sequencing, single cell RNA-seq, single cell ATAC-seq, and ChIP-seq analyses. Fastq files are provided.\n"
        },
        "hum0252.v1": {
          "Research ID": "hum0252.v1",
          "Release Date": "2021/07/12",
          "Type of Data": "NGS (Target Capture, RNA-seq, scRNA-seq)",
          "description": "DNAs/RNAs extracted from infected cells and unifected cells of ATL and HTLV-1 carriers and CD4+ T cells from healthy donors were used for the target capture sequencing, RNA-seq, and single cell RNA-seq analyses. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0251.v1": {
    "ja": {
      "NBDC Research ID": "hum0251.v1",
      "データ": {
        "JGAS000278": {
          "データID": "JGAS000278",
          "内容": "NGS（RNA-seq、Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/10/25"
        }
      },
      "研究内容の概要": {
        "目的": "B細胞性急性リンパ性白血病に対するゲノム解析による分子病態の解明",
        "方法": "RNA Sequencing、Target Capture Sequencing",
        "対象": "フィラデルフィア染色体陰性B細胞性急性リンパ性白血病（B-ALL）153症例"
      },
      "分子データ": {
        "RNA-seq": {
          "対象": "フィラデルフィア染色体陰性B-ALL（ICD10：C91.0）：122症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "白血病細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra Directional RNA Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000384",
          "総データ量": "681.6 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture": {
          "対象": "フィラデルフィア染色体陰性B-ALL（ICD10：C91.0）：148症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "110遺伝子",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "白血病細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT Low Input",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "マッピング方法": "bwa",
          "マッピングクオリティ": "> 20",
          "マッピングの際のリファレンス配列": "hg19",
          "平均カバー率（Depth）": "570",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000384",
          "総データ量": "681.6 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "八田 善弘",
        "所 属 機 関": "日本大学 医学部 内科学系血液膠原病内科学分野",
        "プロジェクト/研究グループ名": "JALSG Ph(-)B-ALL213",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations",
          "DOI": "doi: 10.1182/blood.2021011921",
          "データID": "JGAD000384"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0251.v1": {
          "Research ID": "hum0251.v1",
          "公開日": "2022/10/25",
          "内容": "NGS（RNA-seq、Target Capture）",
          "description": "フィラデルフィア染色体陰性B細胞性急性リンパ性白血病153症例の白血病細胞から抽出したDNA/RNAを対象としたRNA SequencingおよびTarget Capture Sequencing解析データをfastqおよびbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0251.v1",
      "DATA": {
        "JGAS000278": {
          "Data Set ID": "JGAS000278",
          "Type of Data": "NGS (RNA-seq, Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/10/25"
        }
      },
      "SUMMARY": {
        "Aims": "Elucidation of molecular pathology for B-cell acute lymphocytic leukemia (B-ALL) by genomic analysis",
        "Methods": "RNA Sequencing and target capture sequencing analyses",
        "Participants/Materials": "Philadelphia chromosome-negative (Ph-negative) B-ALL"
      },
      "MOLECULAR DATA": {
        "RNA-seq": {
          "Participants/Materials": "Ph-negative B-ALL (ICD10: C91.0): 122 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNA extracted from leukemia cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra Directional RNA Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000384",
          "Total Data Volume": "681.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture": {
          "Participants/Materials": "Ph-negative B-ALL (ICD10: C91.0): 148 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "110 genes",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA extracted from leukemia cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT Low Input",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "Mapping Methods": "bwa",
          "Mapping Quality": "> 20",
          "Reference Genome Sequence": "hg19",
          "Coverage (Depth)": "570",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000384",
          "Total Data Volume": "681.6 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yoshihiro Hatta",
        "Affiliation": "Division of Hematology and Rheumatology, Nihon University School of Medicine",
        "Project / Group Name": "JALSG Ph(-)B-ALL213",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations",
          "DOI": "doi: 10.1182/blood.2021011921",
          "Data Set ID": "JGAD000384"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0251.v1": {
          "Research ID": "hum0251.v1",
          "Release Date": "2022/10/25",
          "Type of Data": "NGS (RNA-seq, Target Capture)",
          "description": "DNA/RNA extracted from leukemia cells of 153 patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia were used for RNA Sequencing and Target Capture Sequencing analyses. Fastq and bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0250.v1": {
    "ja": {
      "NBDC Research ID": "hum0250.v1",
      "データ": {
        "JGAS000277": {
          "データID": "JGAS000277",
          "内容": "神経心理検査、MRI検査（3T）、PET検査（Amyloid [11C-PiB]）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/29"
        }
      },
      "研究内容の概要": {
        "目的": "機能的MRI データとアミロイドPET画像・認知機能データとの対比解析により、超早期アルツハイマー病（AD）病態変化を検出する",
        "方法": "構造的MRI, 安静時機能的MRI（fMRI）、拡散テンソル画像法（DTI）、動脈スピンラベル法（ASL）などのMRI画像データを取得する",
        "対象": "認知機能障害を認めない健常高齢者28名、記憶障害などが顕在化しているが認知症に至っていない経度認知障害（MCI）患者（ICD10：F00）11名",
        "URL": "https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000020292"
      },
      "分子データ": {
      },
      "提供者情報": {
        "研究代表者": "岩坪 威",
        "所 属 機 関": "東京大学大学院医学系研究科 神経病理学分野",
        "プロジェクト/研究グループ名": "革新的技術による脳機能ネットワークの全容解明（革新脳）",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的技術による脳機能ネットワークの全容解明プロジェクト",
            "タイトル": "超早期アルツハイマー病における画像診断を用いた鍵神経回路の同定と、タウ病理進展機構の解明",
            "研究課題番号": "JP18dm0207014"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "安田 実樹大": {
          "研究代表者": "安田 実樹大",
          "所属機関": "関西学院大学",
          "研究題目": "日本",
          "利用データID": "fMRIデータに基づく脳内ネットワークの分析手法の構築",
          "利用期間": "JGAD000383"
        }
      },
      "リリース情報": {
        "hum0250.v1": {
          "Research ID": "hum0250.v1",
          "公開日": "2021/03/29",
          "内容": "MRIおよびPET画像データ、神経心理検査データ",
          "description": "認知機能障害を認めない健常高齢者28名、およびMCI患者11名のMRIおよびPET画像データ、神経心理検査データを公開した。\n"
        },
        "GE MEDICAL SYSTEMS": {
          "MRI SCANNER_VENDOR": "GE MEDICAL SYSTEMS",
          "MRI SCANNER_MODEL": "DISCOVERY MR750w(3T MRI)"
        },
        "Siemens": {
          "PET SCANNER_VENDOR": "Siemens",
          "PETSCANNER_MODEL": "Siemens Biograph 16 Truepoint"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0250.v1",
      "DATA": {
        "JGAS000277": {
          "Data Set ID": "JGAS000277",
          "Type of Data": "Psychometric Tests, MRI Scan (3T), PET Scan (Amyloid [11C-PiB])",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/29"
        }
      },
      "SUMMARY": {
        "Aims": "Compare the functional MRI data with amyloid PET images and cognitive data and establish a methodologies for the very early stage of Alzheimer disease (AD).",
        "Methods": "Structural MRI, resting state functional MRI, diffusion tensor imaging, and arterial spin labeling will be acquired",
        "Participants/Materials": "Mild cognitive impairment (MCI) and preclinical AD individuals (ICD10: F00)",
        "URL": "https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020292"
      },
      "MOLECULAR DATA": {
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takeshi Iwatsubo",
        "Affiliation": "Department of Neuropathology, Graduate School of Medicine, the University of Tokyo",
        "Project / Group Name": " Brain Mapping by Integrated Neurotechnologies for Disease Studies",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Identification of damaged neuronal circuits in very early Alzheimer disease patients and elucidation of molecular mechanism of tau pathology spreading",
            "Project Number": "JP18dm0207014"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Mikihiro Yasuda": {
          "Principal Investigator": "Mikihiro Yasuda",
          "Affiliation": "Kwansei Gakuin University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of a method for analyzing brain networks based on fMRI data",
          "Period of Data Use": "JGAD000383"
        }
      },
      "Release Note": {
        "hum0250.v1": {
          "Research ID": "hum0250.v1",
          "Release Date": "2021/03/29",
          "Type of Data": "MRI and PET images, psychometric tests",
          "description": "MRI and PET images and psychometric data obtained from participants (healthly elderly controls: 28, MCI: 11) were released.\n"
        },
        "GE MEDICAL SYSTEMS": {
          "MRI SCANNER_VENDOR": "GE MEDICAL SYSTEMS",
          "MRI SCANNER_MODEL": "DISCOVERY MR750w(3T MRI)"
        },
        "Siemens": {
          "PET SCANNER_VENDOR": "Siemens",
          "PETSCANNER_MODEL": "Siemens Biograph 16 Truepoint"
        }
      }
    }
  },
  "hum0249.v1": {
    "ja": {
      "NBDC Research ID": "hum0249.v1",
      "データ": {
        "JGAS000248": {
          "データID": "JGAS000248",
          "内容": "NGS（CAGE-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/09/01"
        }
      },
      "研究内容の概要": {
        "目的": "硬組織・結合組織関連疾患患者由来iPS細胞を用いた疾患メカニズムの解明および治療法開発",
        "方法": "疾患iPS細胞を用いたCap Analysis of Gene Expression（CAGE）-seq",
        "対象": "鎖骨頭蓋骨異形成症",
        "URL": "http://www.tdc.ac.jp/college/activity/branding/tabid/659/Default.aspx"
      },
      "分子データ": {
        "JGAS000248": {
          "対象": "鎖骨頭蓋骨異形成症（ICD10：Q870）：3症例\r\n    頬粘膜線維芽細胞から樹立したiPS細胞から分化させた骨芽細胞：2症例（2検体）\r\n    頬粘膜線維芽細胞から樹立したiPS細胞に対して遺伝子編集により変異を正常化させたiPS細胞から分化させた骨芽細胞：1症例（1検体）",
          "規模": "CAGE-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "iPS細胞から分化させた骨芽細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "nAnT-iCAGE プロトコル",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000348",
          "総データ量": "39 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "東 俊文",
        "所 属 機 関": "東京歯科大学 生化学講座",
        "プロジェクト/研究グループ名": "顎骨疾患プロジェクト",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "東京歯科大学顎骨疾患プロジェクト研究助成",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "CAGE-seq analysis of osteoblast derived from cleidocranial dysplasia human induced pluripotent stem cells",
          "DOI": "doi: 10.1016/j.bone.2020.115582",
          "データID": "JGAD000348"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0249.v1": {
          "Research ID": "hum0249.v1",
          "公開日": "2020/09/01",
          "内容": "NGS（CAGE-seq）",
          "description": "鎖骨頭蓋骨異形成症2症例の頬粘膜線維芽細胞から樹立したiPS細胞から分化させた骨芽細胞、並びに、1症例の頬粘膜線維芽細胞から樹立したiPS細胞に対して遺伝子編集により変異を正常化させたiPS細胞から分化させた骨芽細胞、それぞれから抽出したRNAを用いたCAGE-seqデータをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0249.v1",
      "DATA": {
        "JGAS000248": {
          "Data Set ID": "JGAS000248",
          "Type of Data": "NGS (CAGE-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/09/01"
        }
      },
      "SUMMARY": {
        "Aims": "Elucidation of pathological conditions and development of therapeutic methods using iPS cells derived from patients with hard tissue/connective tissue related diseases",
        "Methods": "Cap Analysis of Gene Expression (CAGE)-seq",
        "Participants/Materials": "iPS cells derived from patients with hard tissue/connective tissue related diseases"
      },
      "MOLECULAR DATA": {
        "JGAS000248": {
          "Participants/Materials": "hard tissue/connective tissue related diseases (ICD10: Q870): 3 cases\r\n    osteoblast differentiated from iPS cells established from oral mucosa fibroblast: 2 cases (2 samples)\r\n    osteoblast differentiated from iPS cells established from oral mucosa fibroblast (mutation-corrected iPS cells by gene editing): 1 case (1 sample)",
          "Targets": "CAGE-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "RNA extracted from osteoblast differentiated from iPS cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "nAnT-iCAGE protocol",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000348",
          "Total Data Volume": "39 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshifumi Azuma",
        "Affiliation": "Tokyo Dental College / Biochemistry",
        "Project / Group Name": "Tokyo Dental College Research Branding Project",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Tokyo Dental College Research Branding Project",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "CAGE-seq analysis of osteoblast derived from cleidocranial dysplasia human induced pluripotent stem cells",
          "DOI": "doi: 10.1016/j.bone.2020.115582",
          "Data Set ID": "JGAD000348"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0249.v1": {
          "Research ID": "hum0249.v1",
          "Release Date": "2020/09/01",
          "Type of Data": "NGS (CAGE-seq)",
          "description": "RNAs extracted from osteoblast differentiated from iPS cells derived from patients with hard tissue/connective tissue related diseases were used for CAGE-seq analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0248.v2": {
    "ja": {
      "NBDC Research ID": "hum0248.v2",
      "データ": {
      },
      "研究内容の概要": {
        "目的": "日本人基準ゲノム配列の構築",
        "方法": " 日本人健常男性3名それぞれから、PacBio、Bionano、Illumina HiSeq法にて配列を取得し、デノボアセンブリを実施後メタアセンブリにより三者の配列を統合した。さらに三者間において塩基が異なる部位では多数派アレルを採用した。遺伝地図・放射線ハイブリッド地図のマーカーによりアンカリングし、擬似染色体配列セットとして統合した。",
        "対象": "日本人健常男性3名",
        "URL": "jMorp: https://jmorp.megabank.tohoku.ac.jp/"
      },
      "分子データ": {
        "AP023461-AP024084 / JGAS000259": {
          "対象": "日本人健常男性：3名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "PacBio [RS II]\r\nBionano [Irys、Saphyr]\r\nIllumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "PacBio：DNA template prep kit 2.0\r\nBionano：ゲルプラグによるDNA単離、Proteinase KとRNase処理、GELaseによるプラグの可溶化を行なった。jg1aについてはNt.BspQIとNb.BssSIによるニックラベル修復法、またはjg1bとjg1cについては直接標識、により蛍光ラベル付加を行った。\r\nIllumina：TruSeq DNA PCR-Free HT sample prep kit",
          "断片化方法": "Illumina：超音波断片化（Covaris）",
          "ライブラリ構築方法": "Illumina：Paired-end、Mate pair",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "PacBio：10 kb\r\n    - jg1a：10,589 bp（mean）\r\n    - jg1b：10,066 bp（mean）\r\n    - jg1c：9,226 bp（mean）\r\nBionano：>146 kb\r\n    - jg1a.BspQI：318,216 bp（mean）\r\n    - jg1a.BssSI：228,101 bp（mean）\r\n    - jg1b.DLS：169,138 bp（mean）\r\n    - jg1c.DLS：146,026 bp（mean）\r\nIllumina：162 or 259 bp",
          "クオリティコントロール方法": "PacBio：Falconソフトウェア内でのQC（length_cutoff = 9000, length_cutoff_pr = 15000）\r\nBionano：BionanoSolveソフトウェア内でのQC (default config)\r\nIllumina：特になし",
          "ゲノム配列構築方法": "① デノボアセンブリ（リードによる全ゲノム塩基配列の決定）\r\n　①－１ 長鎖リード解読技術によるコンティグ作成：Pacific Bioscience社の一分子リアルタイムシークエンシング技術（SMRTシークエンシング技術）と、Falconソフトウェアによるデノボアセンブリ。\r\n　①ー２ 解読したゲノム配列間の結合：Bionano Genomics社のオプティカルマッピング技術とBionanoSolveソフトウェアによるデノボアセンブリ\r\n② ①－１と①ー２を用いてハイブリッドスキャフォールドの作成（BionanoSolveソフトウェアによる）\r\n③ エラー除去：IlluminaのPair-end配列情報を用いたエラー修正（Pilonソフトウェア）\r\n④ 位置・配向情報の取得：Illuminaリードによるメイトペアライブラリー技術（Bowtie2ソフトウェア）\r\n⑤ ②に③と④の情報を加えることで、１名ずつのドラフト配列の決定、ならびに、３者間で解読できなかった領域の補完（Metassembler）\r\n⑥ 配列スキャフォールドと染色体との対応付け（アンカリング）：観測された組み換えの頻度から遺伝子やマーカーの並び順と距離を示す遺伝地図（連鎖地図）、放射線ハイブリッド地図、（gPCRソフトウェアによる）",
          "平均カバー率（Depth）": "PacBio：>122×\r\n    - jg1a：122×\r\n    - jg1b：123×\r\n    - jg1c：128×\r\nBionano：>123×\r\n    - jg1a.BspQI：123×\r\n    - jg1a.BssSI：140×\r\n    - jg1b：160×\r\n    - jg1c：175×\r\nIllumina paired end：>26×\r\n    - jg1a.162PE：29×\r\n    - jg1a.259PE：26×\r\n    - jg1b.162PE：31×\r\n    - jg1b.259PE：28×\r\n    - jg1c.162PE：31×\r\n    - jg1c.259PE：26×\r\nIllumina mate-pair：>12×\r\n    - jg1a：13×\r\n    - jg1b：12×\r\n    - jg1c：12×",
          "変異決定方法": "hs37d5とJG1の常染色体およびX染色体における比較；minimap2, paftools",
          "一塩基変異数": "2,501,575 SNVs",
          "構造変異検出方法": "GRCh38 and JG1間の比較; minimap2, paftools",
          "構造多型数": "8,697 insertions and 6,190 deletions >50 bp in length",
          "Mass Submission System ID": "AP023461-AP024084",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000362",
          "総データ量": "AP023461-AP024084：821 MB（fasta）\r\nJGAD000362：2.4 TB（fasta、fastq、bnx）",
          "コメント（利用にあたっての制限事項）": "AP023461-AP024084：NBDC policy\r\nJGAD000362：NBDC policy および hum0184 policy\r\n東北メディカル・メガバンク機構のスパコンに関するお問い合わせ先：emailProtector.addCloakedMailto(\"ep_d8cae513\", 0);"
        }
      },
      "提供者情報": {
        "研究代表者": " 山本 雅之",
        "所 属 機 関": "東北大学大学院 医学系研究科 兼）東北メディカル・メガバンク機構",
        "プロジェクト/研究グループ名": "JRGA (Japanese Reference Genome Assembly)",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "深層学習による大規模ゲノムコホートの次世代シークエンス解析",
            "研究課題番号": "JP19K06625"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Construction and Integration of Three De Novo Japanese Human Genome Assemblies toward a Population-Specific Reference",
          "DOI": "doi:10.1101/861658",
          "データID": "AP023461-AP024084\r\nJGAD000362"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0248.v2": {
          "Research ID": "hum0248.v2",
          "公開日": "2020/11/06",
          "内容": "日本人基準ゲノム配列",
          "description": "日本人健常男性3名それぞれから、PacBio, Bionano, Illumina HiSeq法にて配列を取得した際のfastqファイルならびにオプティカルマップデータを提供する。\n"
        },
        "hum0248.v1": {
          "Research ID": "hum0248.v1",
          "公開日": "2020/10/30",
          "内容": "日本人基準ゲノム配列",
          "description": "日本人健常男性3名それぞれから、PacBio、Bionano、Illumina HiSeq法にて配列を取得し、デノボアセンブリ後、メタアセンブリにより三者を統合した。さらに塩基配列の異なる部位について、三者の多数派塩基を採用した。遺伝地図・放射線ハイブリッド地図のマーカーによりアンカリングし、擬似染色体配列セットとして統合した。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0248.v2",
      "DATA": {
      },
      "SUMMARY": {
        "Aims": "To construct a Japanese reference genome sequence",
        "Methods": "Sequence data were obtained from each of three healthy Japanese males by the PacBio, Bionano, and Illumina HiSeq platforms. De novo assembly was performed for each individual, and then the three assemblies were integrated by meta-assembly. In addition, the majority variant was adopted by majority vote for the polymorphic sites among the three assemblies. Finally, the meta-scaffolds were anchored by markers from genetic and radiation hybrid maps and integrated as a pseudo-chromosome sequence set.",
        "Participants/Materials": "three Japanese male individuals",
        "URL": "jMorp: https://jmorp.megabank.tohoku.ac.jp/"
      },
      "MOLECULAR DATA": {
        "AP023461-AP024084 / JGAS000259": {
          "Participants/Materials": "3 Japanese male individuals",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "PacBio [RS II]\r\nBionano [Irys, Saphyr]\r\nIllumina [HiSeq 2500]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "PacBio: DNA template prep kit 2.0\r\nBionano: DNA isolation in gel plug, treated with Proteinase K and RNase, solubilized plug with GELase, nick-label-repair with Nt.BspQI and Nb.BssSI for jg1a, or with direct labeling and staining for jg1b and jg1c.\r\nIllumina: TruSeq DNA PCR-Free HT sample prep kit",
          "Fragmentation Methods": "Illumina: Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Illumina: Paired-end, Mate pair",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "PacBio: 10 kb\r\n    - jg1a: 10,589 bp (mean)\r\n    - jg1b: 10,066 bp (mean)\r\n    - jg1c: 9,226 bp (mean)\r\nBionano: >146 kb\r\n    - jg1a.BspQI: 318,216 bp (mean)\r\n    - jg1a.BssSI: 228,101 bp (mean)\r\n    - jg1b.DLS: 169,138 bp (mean)\r\n    - jg1c.DLS: 146,026 bp (mean)\r\nIllumina: 162 or 259 bp",
          "QC Methods": "PacBio: QC with Falcon software with length_cutoff = 9000, length_cutoff_pr = 15000\r\nBionano: QC with BionanoSolve software with default settings\r\nIllumina: NA",
          "Genome Sequence Construction Methods": "1. highly contiguous de novo assembly: \r\n  1) PacBio long reads were de novo assembled to yield primary contigs\r\n  2) Bionano raw data were also de novo assembled (independent of the PacBio assembly) to yield genome maps\r\n  3) the PacBio-derived contigs were scaffolded by the Bionano genome maps\r\n2. Polishing the hybrid scaffolds with Illumina short reads (paired-end)\r\n3. Integrating and filling the gaps of the hybrid scaffolds of each individual with an aid of mate pair Illumina short reads\r\n4. meta-assembly with Metassembler software\r\n5. Anchoring scaffolds to chromosomes with genetic and radiation hybrid maps",
          "Coverage（Depth）": "PacBio: >122×\r\n    - jg1a: 122×\r\n    - jg1b: 123×\r\n    - jg1c: 128×\r\nBionano: >123×\r\n    - jg1a.BspQI: 123×\r\n    - jg1a.BssSI: 140×\r\n    - jg1b: 160×\r\n    - jg1c: 175×\r\nIllumina paired end: >26×\r\n    - jg1a.162PE: 29×\r\n    - jg1a.259PE: 26×\r\n    - jg1b.162PE: 31×\r\n    - jg1b.259PE: 28×\r\n    - jg1c.162PE: 31×\r\n    - jg1c.259PE: 26×\r\nIllumina mate-pair: >12×\r\n    - jg1a: 13×\r\n    - jg1b: 12×\r\n    - jg1c: 12×",
          "Variation Detection Methods": "SNVs between hs37d5 and JG1 in the autosomes and X chromosome were called using minimap2 and paftools software",
          "Single Nucleotide Variants Number": "2,501,575 SNVs",
          "Structural Variants Detection Methods": "genome-by-genome alignement with minimap2 and paftools software between GRCh38 and JG1",
          "Structural Varinats Number": "8,697 insertions and 6,190 deletions >50 bp in length.",
          "Mass Submission System ID": "AP023461-AP024084",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000362",
          "Total Data Volume": "AP023461-AP024084: 821 MB (fasta)\r\nJGAD000362: 2.4 TB (fasta, fastq, bnx)",
          "Comments (Policies)": "AP023461-AP024084: NBDC policy\r\nJGAD000362: NBDC policy & hum0184 policy\r\nContact Information of ToMMo Supercomputer: emailProtector.addCloakedMailto(\"ep_7a822e4a\", 0);"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masayuki Yamamoto",
        "Affiliation": "Tohoku University School of Medicine, Tohoku Medical Megabank Organization",
        "Project / Group Name": "JRGA (Japanese Reference Genome Assembly)",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "NGS analysis of a large genome cohort by deep learning Research Project",
            "Project Number": "JP19K06625"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Construction and Integration of Three De Novo Japanese Human Genome Assemblies toward a Population-Specific Reference",
          "DOI": "doi:10.1101/861658",
          "Data Set ID": "AP023461-AP024084\r\nJGAD000362"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0248.v2": {
          "Research ID": "hum0248.v2",
          "Release Date": "2020/11/06",
          "Type of Data": "Japanese reference genome sequence",
          "description": "Sequence data and optical maps obtained from each of three healthy Japanese males by PacBio, Bionano, and Illumina HiSeq platforms are provided.\n"
        },
        "hum0248.v1": {
          "Research ID": "hum0248.v1",
          "Release Date": "2020/10/30",
          "Type of Data": "Japanese reference genome sequence",
          "description": "Sequence data were obtained from each of three healthy Japanese males by the PacBio, Bionano, and Illumina HiSeq platforms. De novo assembly was performed for each individual, and then the three assemblies were integrated by meta-assembly. In addition, the majority variant was adopted by majority vote for the polymorphic sites among the three assemblies. Finally, the meta-scaffolds were anchored by markers from genetic and radiation hybrid maps and integrated as a pseudo-chromosome sequence set.\nNote：\n"
        }
      }
    }
  },
  "hum0247.v1": {
    "ja": {
      "NBDC Research ID": "hum0247.v1",
      "データ": {
        "JGAS000249": {
          "データID": "JGAS000249",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/01/04"
        },
        "DRA010773": {
          "データID": "DRA010773",
          "内容": "NGS（Exome）",
          "制限": "非制限公開",
          "公開日": "2021/01/04"
        }
      },
      "研究内容の概要": {
        "目的": "ヒトメラノーマ細胞より樹立したtumor infiltrating lymphocyte（TIL）を用いた細胞治療法の確立",
        "方法": "TILのもとになったメラノーマ腫瘍細胞および末梢血peripheral blood mononuclear cells（PBMC）のエクソームシークエンス",
        "対象": "悪性黒色腫の腫瘍組織と非腫瘍組織"
      },
      "分子データ": {
        "JGAS000249 / DRA010773": {
          "対象": "悪性黒色腫（ICD10：C43.3、C43.7）：3症例\r\n    腫瘍組織：3検体\r\n    非腫瘍組織（PBMC）：3検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "ライブラリソース": "悪性黒色腫の腫瘍組織およびPBMCから抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon Kit V6",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID / DDBJ Sequence Read Archive ID": "非腫瘍組織：JGAD000349\r\n腫瘍組織：DRA010773",
          "総データ量": "非腫瘍組織：25 GB（fastq）\r\n腫瘍組織：15 GB（bam [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "岩田 卓",
        "所 属 機 関": "慶應義塾大学医学部 産婦人科学教室",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Pilot study of adoptive cell therapy using cultured tumor infiltrating lymphocytes for Japanese melanoma patients refractory to immune-checkpoint inhibitors",
          "DOI": "doi: 10.1111/cas.15009",
          "データID": "JGAD000349\r\nDRA010773"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0247.v1": {
          "Research ID": "hum0247.v1",
          "公開日": "2021/01/04",
          "内容": "NGS（Exome）",
          "description": "悪性黒色腫3症例の腫瘍組織および非腫瘍組織（末梢血PBMC）から抽出したDNAを用いたWhole Exome Sequencingデータの解析結果をbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0247.v1",
      "DATA": {
        "JGAS000249": {
          "Data Set ID": "JGAS000249",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/01/04"
        },
        "DRA010773": {
          "Data Set ID": "DRA010773",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/01/04"
        }
      },
      "SUMMARY": {
        "Aims": "Establishment of a tumor infiltrating lymphocytes (TIL) therapy for malignant melanoma",
        "Methods": "Exome sequencing of melanoma tissues for TIL production and paired peripheral blood mononuclear cells (PBMC)",
        "Participants/Materials": "human melanoma and paired PBMC"
      },
      "MOLECULAR DATA": {
        "JGAS000249 / DRA010773": {
          "Participants/Materials": "melanoma (ICD10: C43.3, C43.7): 3 cases\r\n    tumor tissue: 3 samples\r\n    non-tumor tissue (PBMC): 3 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "Library Source": "DNAs extracted from tumor tissues and PBMCs of melanoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon Kit V6",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID / DDBJ Sequence Read Archive ID": "non-tumor tissues: JGAD000349\r\ntumor tissues: DRA010773",
          "Total Data Volume": "non-tumor tissues: 25 GB (fastq)\r\ntumor tissues: 15 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takashi Iwata",
        "Affiliation": "Department of Obsterics and Gynecology, Keio University School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Pilot study of adoptive cell therapy using cultured tumor infiltrating lymphocytes for Japanese melanoma patients refractory to immune-checkpoint inhibitors",
          "DOI": "doi: 10.1111/cas.15009",
          "Data Set ID": "JGAD000349\r\nDRA010773"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0247.v1": {
          "Research ID": "hum0247.v1",
          "Release Date": "2021/01/04",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor tissues and PBMCs of malignant melanoma patients were used for the whole exome sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0245.v1": {
    "ja": {
      "NBDC Research ID": "hum0245.v1",
      "データ": {
        "JGAS000276": {
          "データID": "JGAS000276",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/10/25"
        }
      },
      "研究内容の概要": {
        "目的": "急性リンパ性白血病（Acute Lymphoblastic Leukemia: ALL）のゲノム解析による分子病態の解明",
        "方法": "Target Capture Sequencing解析",
        "対象": "フィラデルフィア染色体陰性ALL"
      },
      "分子データ": {
        "JGAS000276": {
          "対象": "フィラデルフィア染色体陰性ALL（ICD10：C91.0）：46症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "110遺伝子",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "白血病細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT Low Input",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "マッピング方法": "bwa",
          "マッピングクオリティ": "> 20",
          "マッピングの際のリファレンス配列": "hg19",
          "平均カバー率（Depth）": "570",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000382",
          "総データ量": "116.1 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy",
          "関連データセット": "JGAD000047"
        }
      },
      "提供者情報": {
        "研究代表者": "早川 文彦",
        "所 属 機 関": "名古屋大学大学院 医学系研究科 病態解析学講座",
        "プロジェクト/研究グループ名": "JALSG ALL202-U",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations",
          "DOI": "doi: 10.1182/blood.2021011921",
          "データID": "JGAD000382"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0245.v1": {
          "Research ID": "hum0245.v1",
          "公開日": "2022/10/25",
          "内容": "NGS（Target Capture）",
          "description": "フィラデルフィア染色体陰性急性リンパ性白血病46症例の白血病細胞から抽出したDNAを対象とした110遺伝子のTarget Capture Sequencing解析データをbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0245.v1",
      "DATA": {
        "JGAS000276": {
          "Data Set ID": "JGAS000276",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/10/25"
        }
      },
      "SUMMARY": {
        "Aims": "Elucidation of molecular pathology for acute lymphocytic leukemia (ALL) by genomic analysis",
        "Methods": "Target Capture Sequencing Analysis",
        "Participants/Materials": "Philadelphia chromosome-negative (Ph-negative) ALL"
      },
      "MOLECULAR DATA": {
        "JGAS000276": {
          "Participants/Materials": "Ph-negative ALL (ICD10: C91.0): 46 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "110 genes",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA extracted from leukemia cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT Low Input",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "Mapping Methods": "bwa",
          "Mapping Quality": "> 20",
          "Reference Genome Sequence": "hg19",
          "Coverage (Depth)": "570",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000382",
          "Total Data Volume": "116.1 GB (bam)",
          "Comments (Policies)": "NBDC policy",
          "Related Datasets": "JGAD000047"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Fumihiko Hayakawa",
        "Affiliation": "Pathophysiological Laboratory Sciences, Nagoya University School of Medicine",
        "Project / Group Name": "JALSG ALL202-U",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations",
          "DOI": "doi: 10.1182/blood.2021011921",
          "Data Set ID": "JGAD000382"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0245.v1": {
          "Research ID": "hum0245.v1",
          "Release Date": "2022/10/25",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNA extracted from leukemia cells of 46 patients with Philadelphia chromosome-negative acute lymphoblastic leukemia were used for target capture sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0243.v1": {
    "ja": {
      "NBDC Research ID": "hum0243.v1",
      "データ": {
        "JGAS000253": {
          "データID": "JGAS000253",
          "内容": "NGS（RNA-seq、CAGE-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/11/20"
        }
      },
      "研究内容の概要": {
        "目的": "ヒト免疫系を構築したヒト化マウスを用いた免疫細胞の機能の検証",
        "方法": "RNA sequencingやCap Analysis Gene Expression（CAGE）sequencingによる遺伝子発現解析",
        "対象": "ヒト急性骨髄性白血病116症例の患者末梢血もしくは骨髄液、患者検体を移植し白血病を発症したマウスの骨髄液もしくは脾臓細胞から得られたヒト白血病細胞（193サンプル）（RNA-seqは114症例166サンプル、CAGE-seqは27症例27サンプル、25症例が重複）、ならびに、臍帯血バンクに登録されている24検体から得られた細胞（44サンプル）",
        "URL": "http://www.riken.jp/research/labs/ims/hum_dis_model/"
      },
      "分子データ": {
        "RNA-seq": {
          "対象": "ヒト急性骨髄性白血病（ICD10：C920）：114症例166検体\r\n臍帯血24検体から得られた細胞：44検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "ヒト急性骨髄性白血病の患者末梢血もしくは骨髄液、患者検体を移植し白血病を発症したマウスの骨髄液もしくは脾臓細胞から得られたヒト白血病細胞、および臍帯血から得られた細胞から抽出したRNA",
          "検体情報（購入の場合）": "https://www.bs.jrc.or.jp/ktks/bbc/special/m6_03_00_index.html\r\nhttps://www.chubu-cbb.org",
          "ライブラリ作製方法（キット名）": "NEXT Ultra DNA Library Prep kit for Illumina",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000356",
          "総データ量": "152 GB（fastq、bed [ref：GRCh38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "CAGE-seq": {
          "対象": "ヒト急性骨髄性白血病（ICD10：C920）：27症例27検体（25症例はRNA-seqと重複）",
          "規模": "CAGE-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "ヒト急性骨髄性白血病の患者末梢血もしくは骨髄液、患者検体を移植し白血病を発症したマウスの骨髄液もしくは脾臓細胞からえられたヒト白血病細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Low Quantity single strand CAGE protocol *1（See also: https://www.protocols.io/view/low-quantity-single-strand-cage-protocol-10bbwkipcw）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000356",
          "総データ量": "152 GB（fastq、bed [ref：GRCh38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "石川 文彦",
        "所 属 機 関": "理化学研究所統合生命医科学センター・ヒト疾患モデル研究チーム",
        "プロジェクト/研究グループ名": "白血病再発克服プロジェクト",
        "科研費/助成金（Research Project Number）": {
        }
      },
      "関連論文": {
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Jinyan Huang": {
          "研究代表者": "Jinyan Huang",
          "所属機関": "Zhejiang University School of Medicine",
          "研究題目": "",
          "利用データID": "Comprehensive analysis of alternative splicing in malignant tumors",
          "利用期間": "JGAD000356"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000356"
        }
      },
      "リリース情報": {
        "hum0243.v1": {
          "Research ID": "hum0243.v1",
          "公開日": "2020/11/20",
          "内容": "NGS（RNA-seq、CAGE-seq）",
          "description": "ヒト急性骨髄性白血病の患者末梢血もしくは骨髄液、患者検体を移植し白血病を発症したマウスの骨髄液もしくは脾臓細胞から得られたヒト白血病細胞、および臍帯血から得られた細胞から抽出したRNAを用いたRNA-seqまたはCAGE-seqデータをfastqおよびbedファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0243.v1",
      "DATA": {
        "JGAS000253": {
          "Data Set ID": "JGAS000253",
          "Type of Data": "NGS (RNA-seq, CAGE-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/11/20"
        }
      },
      "SUMMARY": {
        "Aims": "Evaluation of function of immue cells using humanized mice",
        "Methods": "RNA-seq or CAGE-seq",
        "Participants/Materials": "RNAs extracted from cells derived from cord blood, and leukemia cells harvested from bone marrow aspirates or spleen cells of humanized mice generated from peripheral blood, bone marrow aspirates or samples from patients with Acute Myeloid Leukemia",
        "URL": "http://www.riken.jp/en/research/labs/ims/hum_dis_model/"
      },
      "MOLECULAR DATA": {
        "RNA-seq": {
          "Participants/Materials": "Acute Myeloid Leukemia (ICD10: C920): 114 cases (166 samples)\r\nCells derived from cord blood: 44 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from cells derived from cord blood, and leukemia cells harvested from bone marrow aspirates or spleen cells of humanized mice generated from peripheral blood, bone marrow aspirates or samples from patients with Acute Myeloid Leukemia",
          "Cell Lines": "https://www.bs.jrc.or.jp/ktks/bbc/special/m6_03_00_index.html\r\nhttps://www.chubu-cbb.org",
          "Library Construction (kit name)": "NEXT Ultra DNA Library Prep kit for Illumina",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000356",
          "Total Data Volume": "152 GB (fastq, bed [ref: GRCh38])",
          "Comments (Policies)": "NBDC policy"
        },
        "CAGE-seq": {
          "Participants/Materials": "Acute Myeloid Leukemia (ICD10: C920): 27 cases (27 samples, 25 are also used in RNA-seq analysis)",
          "Targets": "CAGE-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from leukemia cells harvested from bone marrow aspirates or spleen cells of humanized mice generated from peripheral blood, bone marrow aspirates or samples from patients with Acute Myeloid Leukemia",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Low Quantity single strand CAGE protocol *1 (See also: https://www.protocols.io/view/low-quantity-single-strand-cage-protocol-10bbwkipcw)",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000356",
          "Total Data Volume": "152 GB (fastq, bed [ref: GRCh38])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Fumihiko Ishikawa",
        "Affiliation": "Laboratory for Human Disease Models, Riken Center for Integrative Medical Sciences",
        "Project / Group Name": "Target AML project",
        "Funds / Grants (Research Project Number)": {
        }
      },
      "PUBLICATIONS": {
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Jinyan Huang": {
          "Principal Investigator": "Jinyan Huang",
          "Affiliation": "School of Medicine, Zhejiang University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of alternative splicing in malignant tumors",
          "Period of Data Use": "JGAD000356"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000356"
        }
      },
      "Release Note": {
        "hum0243.v1": {
          "Research ID": "hum0243.v1",
          "Release Date": "2020/11/20",
          "Type of Data": "NGS (RNA-seq, CAGE-sq)",
          "description": "RNAs extracted from cells derived from cord blood, and leukemia cells harvested from bone marrow aspirates or spleem cells of humanized mice generated from peripheral blood, bone marrow aspirates or samples from patients with Acute Myeloid Leukemia were used for RNA-seq or CAGE-seq analyses (fastq and bed files). \nNote：\n"
        }
      }
    }
  },
  "hum0242.v1": {
    "ja": {
      "NBDC Research ID": "hum0242.v1",
      "データ": {
        "JGAS000243": {
          "データID": "JGAS000243",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/01/05"
        }
      },
      "研究内容の概要": {
        "目的": "大腸がん組織から同定された遺伝子変異を腫瘍由来血漿中循環DNA（ctDNA）としてモニタリングし、個別化腫瘍マーカーとしてのctDNAの臨床的妥当性を検証する",
        "方法": "12症例（内、2症例には2つの大腸がんが観察された）から術前および術後の血漿、原発腫瘍、末梢血単核細胞（PBMC）を採取した。 原発腫瘍標本は手術直後に3箇所から採取し、すべての標本の細胞密度が顕微鏡で30％以上であることを確認した。42の原発腫瘍組織および12のPBMCからDNAを抽出し、HiSeq 2000 System（Illumina）を使用して、がん関連の151遺伝子についてtarget sequenceを実施した。",
        "対象": "大腸がんで術前診断がStage III以上と診断された症例のうち書面での同意が得られた症例",
        "URL": "https://nishizukalab.org/"
      },
      "分子データ": {
        "JGAS000243": {
          "対象": "大腸がん（ICD10：C189）：12症例\r\n　　原発腫瘍組織：計42検体（3か所、36検体 [内2症例は2組織ずつ6か所]）\r\n　　PBMC：12検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "がん関連の151遺伝子\r\nClearSeq SS Comprehensive Cancer kits",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "原発腫瘍組織およびPBMCから抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "ClearSeq SS Comprehensive Cancer kits",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000343",
          "総データ量": "119 GB（fastq、bam [ref: GRCh37]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "西塚 哲",
        "所 属 機 関": "岩手医科大学 医歯薬総合研究所 医療開発研究部門",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "9": {
            "科研費・助成金名": "岩手県地域新成長産業創出促進事業費補助金",
            "タイトル": "進行がん治療の定量評価へ向けた高感度個別化腫瘍マーカーの開発",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0242.v1": {
          "Research ID": "hum0242.v1",
          "公開日": "2021/01/05",
          "内容": "NGS（Target Capture）",
          "description": "大腸がんStage III以上と診断された12症例の原発腫瘍組織およびPBMCから抽出したDNAを用いたTarget Capture解析結果をfastqおよびbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0242.v1",
      "DATA": {
        "JGAS000243": {
          "Data Set ID": "JGAS000243",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/01/05"
        }
      },
      "SUMMARY": {
        "Aims": "To evaluate clinical validity of circulating tumor DNA (ctDNA) of tumor-unique mutations identified from colorectal cancer tissues, as a personalized tumor marker.",
        "Methods": "Pre- and post-operational plasma, primary tumor, and peripheral blood mononuclear cells (PBMCs) were collected from 12 enrolled patients. Among these patients, two patients had two separate colorectal tumors. The primary tumor specimens were taken from three regions immediately after the operation, and the cellularity of all specimens was microscopically confirmed to be >30%. DNA was extracted from 42 primary tumor specimens and 12 PBMCs, and target sequencing using a HiSeq 2000 System (Illumina) conducted for 151 genes that have been implicated in a wide range of cancers was performed.",
        "Participants/Materials": "Colorectal cancer patients with preoperative diagnosis of Stage III or higher. Individual written consent was obtained from each participant.",
        "URL": "https://nishizukalab.org/en/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000243": {
          "Participants/Materials": "Colorectal cancer (ICD10: C189): 12 cases\r\n    primary tumor tissue: 42 samples\r\n    PBMC: 12 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "Coding regions of the 151 disease-associated genes\r\nClearSeq SS Comprehensive Cancer kits",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from primary tumor tissues and PBMC",
          "Cell Lines": "-",
          "Library Construction (kit name)": "ClearSeq SS Comprehensive Cancer kits",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000343",
          "Total Data Volume": "119 GB (fastq, bam [ref: GRCh37])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Satsoshi Nishizuka",
        "Affiliation": "Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "9": {
            "Name": "Iwate Prefectural Regional Innovation Grant",
            "Title": "Development of high-sensitive individualized tumor markers for quantitative evaluation of advanced cancer",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0242.v1": {
          "Research ID": "hum0242.v1",
          "Release Date": "2021/01/05",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from primary tumor tissues and PBMC of 12 patients with colorectal cancer (Stage III or higher) were used for the target capture sequencing analysis (fastq and bam files).\nNote：\n"
        }
      }
    }
  },
  "hum0240.v1": {
    "ja": {
      "NBDC Research ID": "hum0240.v1",
      "データ": {
        "JGAS000258": {
          "データID": "JGAS000258",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/10/30"
        }
      },
      "研究内容の概要": {
        "目的": "中枢神経原発悪性リンパ腫の診断マーカーならびに治療標的の探索研究",
        "方法": "原発腫瘍組織と末梢血から抽出したgenomic DNAを用いたTarget Capture Sequencing解析",
        "対象": "中枢神経原発悪性リンパ腫"
      },
      "分子データ": {
        "JGAS000258": {
          "対象": "中枢神経原発悪性リンパ腫（ICD10：C859）：28症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "409遺伝子（Ion Ampliseq Comprehensive Cancer Panel）",
          "Platform": "Thermo Fisher Scientific [Ion Torrent]",
          "ライブラリソース": "原発腫瘍組織および末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq™ Library Kit 2.0",
          "断片化の方法": "FuPa Reagent（Thermo Fisher Scientific）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000361",
          "総データ量": "26 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山中 龍也",
        "所 属 機 関": "京都府立医科大学 腫瘍分子標的治療学",
        "プロジェクト/研究グループ名": "Genome-wide analysis in patients with primary central nervous system lymphomas.",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（B）",
            "タイトル": "脳悪性リンパ腫の全エクソンシーケンスを応用したゲノム創薬・バイオマーカー研究",
            "研究課題番号": "24390347"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma",
          "DOI": "doi: 10.18632/oncotarget.25463",
          "データID": "JGAD000361"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0240.v1": {
          "Research ID": "hum0240.v1",
          "公開日": "2020/10/30",
          "内容": "NGS（Target Capture）",
          "description": "中枢神経原発悪性リンパ腫28症例の原発腫瘍組織および末梢血から抽出したDNAを用いたTarget Capture Sequencing解析結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0240.v1",
      "DATA": {
        "JGAS000258": {
          "Data Set ID": "JGAS000258",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/10/30"
        }
      },
      "SUMMARY": {
        "Aims": "To explore molecular targets of primary central nervous system lymphoma (PCNSL)",
        "Methods": "Target amplicon sequencing analysis was performed using Target Capture technology (NGS) on Cancer Panel",
        "Participants/Materials": "PCNSL patients"
      },
      "MOLECULAR DATA": {
        "JGAS000258": {
          "Participants/Materials": "PCNSL (ICD10: C859): 28 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "409 genes (Ion Ampliseq Comprehensive Cancer Panel)",
          "Platform": "Thermo Fisher Scientific [Ion Torrent]",
          "Library Source": "DNAs extracted from primary tumor tissues and peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq™ Library Kit 2.0",
          "Fragmentation Methods": "FuPa Reagent (Thermo Fisher Scientific)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000361",
          "Total Data Volume": "26 GB（fastq）",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Ryuya Yamanaka",
        "Affiliation": "Laboratory of Molecular Targeted Therapy for Cancer, Kyoto Prefectural University of Medicine",
        "Project / Group Name": "Genome-wide analysis in patients with primary central nervous system lymphomas.",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Development of molecular targeted therapy for primary central nervous system lymphomas.",
            "Project Number": "24390347"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma",
          "DOI": "doi: 10.18632/oncotarget.25463",
          "Data Set ID": "JGAD000361"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0240.v1": {
          "Research ID": "hum0240.v1",
          "Release Date": "2020/10/30",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from primary tumor tissues and peripheral blood cells of 28 patients with PCNSL were used for a target capture sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0239.v1": {
    "ja": {
      "NBDC Research ID": "hum0239.v1",
      "データ": {
        "JGAS000241": {
          "データID": "JGAS000241",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/07/27"
        }
      },
      "研究内容の概要": {
        "目的": "膀胱がん患者におけるがん組織のゲノムプロファイルの解明",
        "方法": "multiplex PCRで増幅した対象領域を次世代シークエンス技術により解読し、がん組織で生じている体細胞変異を解明する",
        "対象": "膀胱がん患者の腫瘍組織",
        "URL": "https://www.ych.pref.yamanashi.jp/department02/3639/"
      },
      "分子データ": {
        "JGAS000241": {
          "対象": "膀胱がん（ICD10：C67）：19症例（腫瘍組織：19検体）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "泌尿器に関連する71遺伝子のエクソン領域\r\n ",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "IonAmpliSeq Plus Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000341",
          "総データ量": "74 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および 民間企業における利用禁止"
        }
      },
      "提供者情報": {
        "研究代表者": "弘津 陽介",
        "所 属 機 関": "山梨県立中央病院 ゲノム解析センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genomic Profiling Identified ERCC2 E606Q Mutation in Helicase Domain Respond to Platinum-Based Neoadjuvant Therapy in Urothelial Bladder Cancer",
          "DOI": "doi: 10.3389/fonc.2020.01643",
          "データID": "JGAD000341"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0239.v1": {
          "Research ID": "hum0239.v1",
          "公開日": "2020/07/27",
          "内容": "NGS（Target Capture）",
          "description": "膀胱がん19症例の腫瘍組織から抽出したDNAを用いたTarget Capture Sequencing解析結果をbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0239.v1",
      "DATA": {
        "JGAS000241": {
          "Data Set ID": "JGAS000241",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/07/27"
        }
      },
      "SUMMARY": {
        "Aims": "To reveal the genome profiles in urothelial bladder cancer",
        "Methods": "Amplicon Target Sequencing Analysis",
        "Participants/Materials": "Patients with urothelial bladder cancer"
      },
      "MOLECULAR DATA": {
        "JGAS000241": {
          "Participants/Materials": "Urothelial bladder cancer (ICD10: C67): 19 cases (19 tumor tissues)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "exon regions of 71 urothelial bladder cancer-associated genes\r\n ",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "IonAmpliSeq Plus Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000341",
          "Total Data Volume": "74 GB (bam)",
          "Comments (Policies)": "NBDC policy & Company User Limit"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yosuke Hirotsu",
        "Affiliation": "Genome Analysis Center, Yamanashi Central Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genomic Profiling Identified ERCC2 E606Q Mutation in Helicase Domain Respond to Platinum-Based Neoadjuvant Therapy in Urothelial Bladder Cancer",
          "DOI": "doi: 10.3389/fonc.2020.01643",
          "Data Set ID": "JGAD000341"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0239.v1": {
          "Research ID": "hum0239.v1",
          "Release Date": "2020/07/27",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from tumor tissues of 19 patients with urothelial bladder cancer were used for a target capture sequencing analysis. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0238.v1": {
    "ja": {
      "NBDC Research ID": "hum0238.v1",
      "データ": {
        "JGAS000240": {
          "データID": "JGAS000240",
          "内容": "NGS（WGS）に内在するHHV-6配列",
          "制限": "制限公開（Type I）",
          "公開日": "2020/07/28"
        }
      },
      "研究内容の概要": {
        "目的": "ヒトDNA塩基配列に確認された内在性ヒトヘルペスウイルス６（HHV-6）配列の同定",
        "方法": "全ゲノムシーケンスデータの内、ヒト参照配列にマップしなかったリード配列より再構築を行った",
        "対象": "HHV-6のゲノム挿入が確認された検体",
        "URL": "https://www.riken.jp/research/labs/ims/genom_immunobiol_riken_hakubi/index.html"
      },
      "分子データ": {
        "JGAS000240": {
          "対象": "JGAD000220 / AGDD_000005に含まれる全ゲノムシーケンスデータの内、HHV-6のゲノム挿入が確認された検体：10検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Nano DNA Library Preparation Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "160 bp",
          "ヒト配列排除方法": "ヒトゲノムのリファレンスゲノム（hg19）にマッピングされないリードを使用し、HHV-6リファレンスに再度アライメントを行った。\r\nHHV-6カバレッジ高く、ヒトゲノムにおける内在化が疑われる10サンプルを選択した。",
          "HHV-6配列構築方法": "BWA-MEMを使用して、日本人のNA18999（GenBankアクセッション番号：KY316047.1）から得られたiciHHV-6Aゲノムに対してHHV-6リードをアライメントした。\r\nアラインメントに基づいて、freebayes（バージョン：v1.2.0-2-g29c4002）を使用してバリアントコールを行った（パラメーターploidy = 1およびmin-alternate-fraction = 0.8）。\r\nその後、Genome Analysis Toolkit（GATK）v3.7のFastaAlternateReferenceMakerツールを使用して、結果として得られたバリアントをKY316047.1リファレンスゲノムにパッチすることにより、個人サンプルのiciHHV-6ウイルス配列を生成した。",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000340",
          "総データ量": "1 MB（chromosome_fasta）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "桃沢 幸秀／Nicholas Parrish",
        "所 属 機 関": "理化学研究所 生命医科学研究センター 基盤技術開発研究チーム／ゲノム免疫生物学理研白眉研究チーム",
        "科研費/助成金（Research Project Number）": {
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Endogenization and excision of human herpesvirus 6 in human genomes",
          "DOI": "doi: 10.1101/2019.12.19.882522",
          "データID": "JGAD000340"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0238.v1": {
          "Research ID": "hum0238.v1",
          "公開日": "2020/07/28",
          "内容": "NGS（WGS）に内在するHHV-6配列",
          "description": "オーダーメイド医療の実現プログラムにおいて実施した全ゲノムシーケンスデータの内、HHV-6のゲノム挿入が確認された10サンプルにおいて、ヒト参照配列にマップしなかったリードから再構築したHHV-6のゲノム挿入配列をchromosome_fastaファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0238.v1",
      "DATA": {
        "JGAS000240": {
          "Data Set ID": "JGAS000240",
          "Type of Data": "NGS (HHV-6 sequences in WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/07/28"
        }
      },
      "SUMMARY": {
        "Aims": "To determine human herpesvirus 6 (HHV-6) sequences in human genome sequences",
        "Methods": "Reconstruction of integrated HHV-6 sequences from whole genome sequencing data of BioBank Japan (BBJ) participants using unmapped reads",
        "Participants/Materials": "BBJ participants whose DNA sequences contain germline integration of HHV-6 sequences",
        "URL": "https://www.riken.jp/en/research/labs/ims/genom_immunobiol_riken_hakubi/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000240": {
          "Participants/Materials": "BBJ participants (WGS are included in JGAD000220 / AGDD_000005) whose DNA sequences contain germline integration of HHV-6 sequences: 10 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Nano DNA Library Preparation Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "160 bp",
          "Human Sequence Exclusion Method": "We used reads that are unmappable to the human reference genome (hg19) and realign such reads against a HHV-6 reference.\r\nTen subjects with high depth of coverage of HHV-6 were selected.",
          "HHV-6 sequence construction method": "We aligned HHV-6 reads against the integrated HHV-6A genome derived from a Japanese individual NA18999 (GenBank Accession number: KY316047.1) using BWA-MEM.\r\nBased on the alignment, variant calling was performed using freebayes (version: v1.2.0-2-g29c4002) with parameters ploidy = 1 and min-alternate-fraction = 0.8.\r\nWe generated subject-specific iciHHV-6 viral sequences by applying the resulting variants to the KY316047.1 reference genome using the FastaAlternateReferenceMaker function in the Genome Analysis Toolkit (GATK) v3.7.",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000340",
          "Total Data Volume": "1 MB (chromosome_fasta)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yukihide Momozawa / Nicholas Parrish",
        "Affiliation": "Laboratory for Genotyping Development / Genome Immunobiology RIKEN Hakubi Research Team, RIKEN Center for Integrative Medical Sciences",
        "Funds / Grants (Research Project Number)": {
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Endogenization and excision of human herpesvirus 6 in human genomes",
          "DOI": "doi: 10.1101/2019.12.19.882522",
          "Data Set ID": "JGAD000340"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0238.v1": {
          "Research ID": "hum0238.v1",
          "Release Date": "2020/07/28",
          "Type of Data": "NGS (HHV-6 sequences in WGS)",
          "description": "Integrated HHV-6 sequences were reconstructed from whole-genome sequening data of 10 BioBank Japan participants using unmapped reads. Chromosome_fasta files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0237.v1": {
    "ja": {
      "NBDC Research ID": "hum0237.v1",
      "データ": {
        "hum0237.v1.gwas.v1": {
          "データID": "hum0237.v1.gwas.v1",
          "内容": "アルツハイマー病のGWAS",
          "制限": "非制限公開",
          "公開日": "2021/03/05"
        }
      },
      "研究内容の概要": {
        "目的": "アルツハイマー病の関連遺伝子群を同定し予知診断、治療に応用する",
        "方法": "ジェノタイピングアレイデータを用いたアルツハイマー病のゲノムワイド関連解析（GWAS）",
        "対象": "アルツハイマー病3,962症例、非アルツハイマー病4,074名",
        "URL": "https://www.ncgg.go.jp/mgc/index.html"
      },
      "分子データ": {
        "hum0237.v1.gwas.v1": {
          "対象": "アルツハイマー病（ICD10：F00）：3,962症例\r\n非アルツハイマー病：4,074名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Japonica Array、GeneChip 6.0 microarrays]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Axiom 2.0 Reagent kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Axiom Analysis suite 1.1.1.66",
          "Imputation方法": "IMPUTE2 with 3.5KJPN (ToMMo)\r\nIMPUTE2 with 1000 Genomes Project reference panel（1000 Genomes Phase 3）",
          "フィルタリング": "サンプルQCs：\r\n（１）性情報とX染色体近交係数から予測される性の不一致\r\n（２）近交係数：ヘテロ接合度 < 0.1\r\n（３）サンプル内genotypeコール率 < 0.95\r\n（４）血縁係数 > 0.2\r\n（５）主成分分析によって東アジア集団（1000 Genomes Phase 3）クラスターから外れた検体\r\nマーカー (SNPs・Indels) QCs：\r\n（１）マーカー内genotypingコール率 < 0.95\r\n（２）マイナーアリル頻度（MAF） < 0.001\r\n（３）HWE P < 0.001",
          "マーカー数（QC後）": "4,852,957 SNVs",
          "解析手法（ソフトウェア）": "PLINK",
          "NBDC Dataset ID": "hum0237.v1.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "520 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "尾崎 浩一",
        "所 属 機 関": "国立長寿医療研究センター メディカルゲノムセンター 臨床ゲノム解析推進部",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 臨床ゲノム情報統合データベース整備事業",
            "タイトル": "認知症臨床ゲノム情報データベース構築に関する開発研究",
            "研究課題番号": "JP18kk0205009"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Alzheimer’s disease risk in Japanese",
          "DOI": "doi: 10.1038/s41398-021-01272-3",
          "データID": "hum0237.v1.gwas.v1"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0237.v1": {
          "Research ID": "hum0237.v1",
          "公開日": "2021/03/05",
          "内容": "アルツハイマー病のゲノムワイド関連解析",
          "description": "アルツハイマー病3962症例、非アルツハイマー病4074名の末梢血から抽出したDNAを用いて遺伝子型を決定し、GWASを実施した結果（統計情報）をテキストファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0237.v1",
      "DATA": {
        "hum0237.v1.gwas.v1": {
          "Data Set ID": "hum0237.v1.gwas.v1",
          "Type of Data": "GWAS for Alzheimer's disease",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/03/05"
        }
      },
      "SUMMARY": {
        "Aims": "Application to future medicine by analyzing Alzheimer's disease associated genes",
        "Methods": "Genome wide association study",
        "Participants/Materials": "Alzheimer's disease"
      },
      "MOLECULAR DATA": {
        "hum0237.v1.gwas.v1": {
          "Participants/Materials": "Alzheimer's disease (ICD10: F00): 3,962 cases\r\n4,074 controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Japonica Array, GeneChip 6.0 microarrays]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Axiom 2.0 Reagent kit",
          "Genotype Call Methods (software)": "Axiom Analysis suite 1.1.1.66",
          "Imputation方法": "IMPUTE2 with 3.5K Japanese reference panel\r\nIMPUTE2 with 1000 Genomes Project reference panel (1000 Genomes Phase 3)",
          "フィルタリング": "Sample QCs: (1) sex inconsistencies (--check-sex), (2) inbreeding coefficient (--het 0.1), (3) genotype missingness (--missing 0.05), (4) kinship coefficient (--genome 0.2) and (5) exclusion of outliers from the clusters of East Asian populations in principal component analysis that was conducted together with 1000 Genomes Phase 3 data.\r\nMarker (SNPs and Indels) QCs: (1) genotyping efficiency or call rate (--geno 0.95), (2) minor allele frequency (--freq 0.001), (3) Hardy-Weinberg equilibrium (--hwe 0.001).",
          "Marker Number (after QC)": "4,852,957 SNVs",
          "Analysis Method (software)": "PLINK",
          "NBDC Dataset ID": "hum0237.v1.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "520 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kouichi Ozaki",
        "Affiliation": "Division for Genomic medicine, Medical Genome Center, National Center for Geriatrics and Gerontology",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Program for Integrated Database of Clinical and Genomic Information, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Genome wide association study and data storage of dementia in a large Japanese population",
            "Project Number": "JP18kk0205009"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Alzheimer’s disease risk in Japanese",
          "DOI": "doi: 10.1038/s41398-021-01272-3",
          "Data Set ID": "hum0237.v1.gwas.v1"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0237.v1": {
          "Research ID": "hum0237.v1",
          "Release Date": "2021/03/05",
          "Type of Data": "GWAS for Alzheimer's disease",
          "description": "DNAs extracted from peripheral blood cells of 3,962 patiants with Alzheimer's disease and 4,074 controls were genotyped and a genome-wide association study was performed. Statistical analyses data is provided as txt files.\nNote：\n"
        }
      }
    }
  },
  "hum0236.v1": {
    "ja": {
      "NBDC Research ID": "hum0236.v1",
      "データ": {
        "JGAS000245": {
          "データID": "JGAS000245",
          "内容": "NGS（Exome）\r\nNGS（RNA-seq [MinION]）\r\nNGS（RNA-seq [HiSeq 2500]）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/12/14"
        }
      },
      "研究内容の概要": {
        "目的": "非小細胞肺がんにおける異常スプライシングアイソフォームとネオ抗原候補の同定",
        "方法": "ロングリードシークエンサー（MinION）により、がんに発現する転写産物の全長を同定した。また、ショートリードシークエンサーによるRNA sequence、whole exome sequenceデータと組み合わせ、異常転写産物から生じるネオ抗原候補を同定した。",
        "対象": "非小細胞肺癌臨床検体（7例、非腫瘍組織と腫瘍組織のペア）",
        "URL": "http://kero.hgc.jp/"
      },
      "分子データ": {
        "Exome": {
          "対象": "非小細胞肺がん（ICD10：C349）：7症例\r\n      腫瘍組織：7検体\r\n      非腫瘍組織：7検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "手術切除切片の腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V5",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000345",
          "総データ量": "249 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq（MinION）": {
          "対象": "非小細胞肺がん（ICD10：C349）：7症例\r\n      腫瘍組織：7検体\r\n      非腫瘍組織：7検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Nanopore［MinION］",
          "ライブラリソース": "手術切除切片の腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SQK-LSK308",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "cDNA全長（全サンプルの平均リード長：1614 bp）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000345",
          "総データ量": "249 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq（HiSeq 2500）": {
          "対象": "非小細胞肺がん（ICD10：C349）：7症例\r\n      腫瘍組織：7検体\r\n      非腫瘍組織：7検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "手術切除切片の腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000345",
          "総データ量": "249 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中面 哲也",
        "所 属 機 関": "国立がん研究センター 先端医療開発センター 免疫療法開発分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "科学研究費助成事業 若手研究",
            "タイトル": "長鎖シークエンサーによる全長RNA解読が可能にするがんの新規ネオ抗原評価法の開発",
            "研究課題番号": "19K16792"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "河野 隆志": {
          "研究代表者": "河野 隆志",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "AYA （Adolescence and Young Adult） 世代がんの個別化予防に資する遺伝要因の同定を目指す研究",
          "利用期間": "JGAD000345"
        },
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000345"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000345"
        }
      },
      "リリース情報": {
        "hum0236.v1": {
          "Research ID": "hum0236.v1",
          "公開日": "2020/12/14",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "非小細胞肺がん7症例の腫瘍組織とペア非腫瘍組織から抽出したDNA/RNAを用いたWhole Exome Sequencing解析並びにロングリード（MinION）とショートリード（HiSeq 2500）によるRNA-seq解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0236.v1",
      "DATA": {
        "JGAS000245": {
          "Data Set ID": "JGAS000245",
          "Type of Data": "NGS (Exome)\r\nNGS (RNA-seq [MinION])\r\nNGS (RNA-seq [HiSeq 2500])",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/12/14"
        }
      },
      "SUMMARY": {
        "Aims": "Identifying aberrant splicing isoforms and potential neoantigens in non-small cell lung cancer",
        "Methods": "Full-length cDNA sequencing using a long-read sequencer MinION, short-read RNA sequencing, and whole-exome sequencing were performed to detect aberrant splicing isoforms and neoantigens expressed in non-small cell lung cancer specimens.",
        "Participants/Materials": "Seven non-small cell lung cancer specimens (tumor and matched-non tumor pair)",
        "URL": "http://kero.hgc.jp/"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "non-small cell lung cancer (ICD10: C349): 7 cases\r\n      tumor tissues: 7 samples\r\n      non-tumor tissues: 7 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from clinical specimens (tumor tissues and matched non-tumor tissues)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V5",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000345",
          "Total Data Volume": "249 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq (MinION)": {
          "Participants/Materials": "non-small cell lung cancer (ICD10: C349): 7 cases\r\n      tumor tissues: 7 samples\r\n      non-tumor tissues: 7 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Nanopore［MinION］",
          "Library Source": "RNAs extracted from clinical specimens (tumor tissues and matched non-tumor tissues)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SQK-LSK308",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "full-length cDNA (1614 bp on average)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000345",
          "Total Data Volume": "249 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq (HiSeq 2500)": {
          "Participants/Materials": "non-small cell lung cancer (ICD10: C349): 7 cases\r\n      tumor tissues: 7 samples\r\n      non-tumor tissues: 7 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from clinical specimens (tumor tissues and matched non-tumor tissues)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000345",
          "Total Data Volume": "249 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tetsuya Nakatsura",
        "Affiliation": "Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Grant-in-Aid for Early-Career Scientists",
            "Title": "Development of novel methods for detection of neoantigens in cancers by full-length transcriptome sequencing using nanopore sequencers",
            "Project Number": "19K16792"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Takashi Kohno": {
          "Principal Investigator": "Takashi Kohno",
          "Affiliation": "Division of Genome Biology, National Cancer Center Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Identification of genetic risk factors in AYA (Adolescence and Young Adult) cancer",
          "Period of Data Use": "JGAD000345"
        },
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000345"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000345"
        }
      },
      "Release Note": {
        "hum0236.v1": {
          "Research ID": "hum0236.v1",
          "Release Date": "2020/12/14",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs and RNAs extracted from clinical specimens (tumor and non-tumor tissues) of seven non-small cell lung cancer patients were used for the whole exome sequencing and RNA-seq (MinION/HiSeq 2500) analyses (fastq files).\nNote：\n"
        }
      }
    }
  },
  "hum0235.v1": {
    "ja": {
      "NBDC Research ID": "hum0235.v1",
      "データ": {
      },
      "研究内容の概要": {
        "目的": "プレクリニカルアルツハイマー病（AD）患者において、心理検査、MRIやPET画像、血液髄液などを採取し、プレクリニカル期ADにおける客観的画像診断および評価法の確立を目指す",
        "方法": "健常高齢者にアミロイドPETを施行し、アミロイド蓄積が認められるプレクリニカルAD群を抽出する。蓄積の認められない被験者は健常対象者として登録。その他に心理検査でMCIと診断された被験者を登録した。それらの対象者に、詳細な心理検査、MRI、FDG-PET、血液、髄液検査を施行し、6ヶ月から36ヶ月経過観察した。",
        "URL": "https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000022596"
      },
      "分子データ": {
      },
      "提供者情報": {
        "研究代表者": "嶋田 裕之",
        "所 属 機 関": "大阪市立大学大学院医学研究科 放射線診断学・IVR学",
        "プロジェクト/研究グループ名": "AMED Preclinical AD study group（研究参加施設一覧、引用する際の記載要領 [UMIN登録情報の「その他関連情報/Other related information」の欄参照]）",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 認知症研究開発事業",
            "タイトル": "プレクリニカル期におけるアルツハイマー病に対する客観的画像診断・評価法の確立を目指す臨床研究",
            "研究課題番号": "JP19dk0207020"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer’s Disease",
          "DOI": "doi: 10.14283/jpad.2021.37",
          "データID": "JGAD000378"
        }
      },
      "制限公開データの利用者一覧": {
        "井狩 彌彦": {
          "研究代表者": "井狩 彌彦",
          "所属機関": "神戸市立医療センター中央市民病院 臨床研究推進センター",
          "研究題目": "",
          "利用データID": "認知症臨床研究データベースを利用した認知症に対する画像バイオマーカーの確立に関する研究",
          "利用期間": "JGAD000378"
        }
      },
      "リリース情報": {
        "hum0235.v1": {
          "Research ID": "hum0235.v1",
          "公開日": "2021/04/06",
          "内容": "構造MRI画像, 機能的MRI画像, 拡散テンソル画像, ASL 画像\r\nFDG, Amyloid (PIB, florbetapir, flutemetamol), Tau(flortaucipir) PET 画像\r\nUS-ADNI互換の臨床/神経心理検査データ\r\nApoE遺伝子型、血液・脳脊髄液サンプルデータ",
          "description": "このバージョンでは、アミロイド蓄積が認められなかった健常高齢者25名、プレクリニカルAD3名、早期MCI（軽度認知症）7症例、後期MCI5症例のデータを公開した。追跡期間は、半年～3年間。\n"
        },
        "GE MEDICAL SYSTEMS": {
          "MRI SCANNER_VENDOR": "GE MEDICAL SYSTEMS",
          "MRI SCANNER_MODEL": "SIGNA Architect"
        },
        "Philips Healthcare": {
          "MRI SCANNER_VENDOR": "Philips Healthcare",
          "MRI SCANNER_MODEL": "Ingenia"
        },
        "Philips Medical Systems": {
          "MRI SCANNER_VENDOR": "Philips Medical Systems",
          "MRI SCANNER_MODEL": "Achieva"
        },
        "SIEMENS": {
          "PET SCANNER_VENDOR": "SIEMENS",
          "PETSCANNER_MODEL": "Biograph mCT-Flow"
        },
        "SIEMENS & FUJITSU LTD.": {
          "MRI SCANNER_VENDOR": "SIEMENS & FUJITSU LTD.",
          "MRI SCANNER_MODEL": "Skyra"
        },
        "Canon": {
          "PET SCANNER_VENDOR": "Canon",
          "PETSCANNER_MODEL": "Celesteion"
        },
        "GE": {
          "PET SCANNER_VENDOR": "GE",
          "PETSCANNER_MODEL": "DiscoveryST-Elite"
        },
        "Shimadzu": {
          "PET SCANNER_VENDOR": "Shimadzu",
          "PETSCANNER_MODEL": "SET3000-GX"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0235.v1",
      "DATA": {
      },
      "SUMMARY": {
        "Aims": "A study aiming to establish objective imaging and evaluation methods in preclinical Alzheimer's disease by collecting biochemical data such as psychological tests, MRI and PET images, and blood cerebrospinal fluid over time in patients with preclinical AD",
        "Methods": "We performed amyloid PET in healthy elderly and enrolled subjects with amyloid accumulation in the preclinical AD group. Subjects without amyloid accumulation were enrolled as healthy subjects. In addition, subjects who were diagnosed with MCI by psychological examination were enrolled. Those subjects underwent detailed psychological examination, MRI, FDG-PET, blood, and cerebrospinal fluid examination, and were followed up for 6 to 36 months.",
        "Participants/Materials": "",
        "URL": "https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022596"
      },
      "MOLECULAR DATA": {
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Shimada",
        "Affiliation": "Department of Diagnostic and Interventional Radiology, Osaka City University Graduate School of Medicine",
        "Project / Group Name": " AMED Preclinical AD study group (Clinical Sites, Citation Information [see 'Other related information'])",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Research and Development Grants for Dementia, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Evaluation and imaging study of the preclinical stage of Alzheimer's disease in Japan",
            "Project Number": "JP19dk0207020"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer’s Disease",
          "DOI": "doi: 10.14283/jpad.2021.37",
          "Data Set ID": "JGAD000378"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Yasuhiko Ikari": {
          "Principal Investigator": "Yasuhiko Ikari",
          "Affiliation": "Molecular Imaging Center for Clinical Research and Innovation, Kobe City Medical Center General Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Development of imaging biomarkers on clinical study image database for Alzheimers disease.",
          "Period of Data Use": "JGAD000378"
        }
      },
      "Release Note": {
        "hum0235.v1": {
          "Research ID": "hum0235.v1",
          "Release Date": "2021/04/06",
          "Type of Data": "structural MRI imaging, funcational MRI imaging, DTI, ASL\r\nFDG, Amyloid (PIB, florbetapir, flutemetamol), Tau(flortaucipir) PET imaging\r\nUS-ADNI compatible clinical and psychometric tests\r\nPeripheral Blood, Cerebrospinal Fluid (CSF) and ApoE genotype",
          "description": "Data obtained from participants enrolled in a longitudinal study (healthly elderly controls: 25, preclinical AD: 3, early MCI: 7, late MCI: 5) was released. The follow-up span of the study was 6 to 36 months.\n"
        },
        "GE MEDICAL SYSTEMS": {
          "MRI SCANNER_VENDOR": "GE MEDICAL SYSTEMS",
          "MRI SCANNER_MODEL": "SIGNA Architect"
        },
        "Philips Healthcare": {
          "MRI SCANNER_VENDOR": "Philips Healthcare",
          "MRI SCANNER_MODEL": "Ingenia"
        },
        "Philips Medical Systems": {
          "MRI SCANNER_VENDOR": "Philips Medical Systems",
          "MRI SCANNER_MODEL": "Achieva"
        },
        "SIEMENS": {
          "PET SCANNER_VENDOR": "SIEMENS",
          "PETSCANNER_MODEL": "Biograph mCT-Flow"
        },
        "SIEMENS & FUJITSU LTD.": {
          "MRI SCANNER_VENDOR": "SIEMENS & FUJITSU LTD.",
          "MRI SCANNER_MODEL": "Skyra"
        },
        "Canon": {
          "PET SCANNER_VENDOR": "Canon",
          "PETSCANNER_MODEL": "Celesteion"
        },
        "GE": {
          "PET SCANNER_VENDOR": "GE",
          "PETSCANNER_MODEL": "DiscoveryST-Elite"
        },
        "Shimadzu": {
          "PET SCANNER_VENDOR": "Shimadzu",
          "PETSCANNER_MODEL": "SET3000-GX"
        }
      }
    }
  },
  "hum0233.v1": {
    "ja": {
      "NBDC Research ID": "hum0233.v1",
      "データ": {
        "JGAS000236": {
          "データID": "JGAS000236",
          "内容": "NGS（Exome）\r\nNGS（RNA-seq）\r\nSNPアレイ\r\nメチル化アレイ\r\nNGS（WGBS）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/05/31"
        }
      },
      "研究内容の概要": {
        "目的": "本試験では、肝芽腫に加えて、小児肝細胞がんの腫瘍特性の解析を目的とし、悪性度に関与するゲノム解析および分子細胞生物学的情報を解析し、臨床経過と生物学的情報の両者を解析することで、腫瘍の生物学的性質に応じたより優れた治療戦略開発につなげることを目的としている。",
        "方法": "Exome (NGS)、RNA-seq (NGS)、SNPアレイ、メチル化アレイ、WGBS (NGS)",
        "対象": "小児肝腫瘍（肝芽腫または肝細胞がん）165例",
        "URL": "https://home.hiroshima-u.ac.jp/eiso/"
      },
      "分子データ": {
        "Exome": {
          "対象": "小児肝腫瘍（ICD10：C22.0、C22.2）：112症例\r\n    腫瘍組織：112検体\r\n    非腫瘍組織：112検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT Exome V5 Custom kit",
          "断片化の方法": "超音波断片化（Covaris S2）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "クオリティコントロール方法": "-",
          "マッピング方法": "BWA, Karkinos（in-house mapper）",
          "平均カバー率（Depth）": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000334",
          "総データ量": "2 TB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "小児肝腫瘍（ICD10：C22.0、C22.2）：113症例\r\n    腫瘍組織：111検体\r\n    非腫瘍組織：28検体\r\n    （腫瘍組織・非腫瘍組織ペア26症例、腫瘍組織のみ85症例、非腫瘍組織のみ2症例）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA LT Sample Prep Kit",
          "断片化の方法": "上記キットに準拠",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "クオリティコントロール方法": "-",
          "マッピング方法": "BWA, Finemap（in-house mapper）",
          "平均カバー率（Depth）": "-",
          "総リード数 / ユニークにマップされたリード数": "-",
          "対象遺伝子数": "86,817",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000334",
          "総データ量": "2 TB（bam [ref: hg19]、FPKM値 [txt]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "SNPアレイ": {
          "対象": "小児肝腫瘍（ICD10：C22.0、C22.2）：112症例\r\n    腫瘍組織：112検体\r\n    非腫瘍組織：112検体",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Assay Kit 6.0",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000334",
          "総データ量": "2 TB（CEL）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "メチル化アレイ": {
          "対象": "小児肝腫瘍（ICD10：C22.0、C22.2）：146症例\r\n    腫瘍組織：146検体\r\n    非腫瘍組織：32検体\r\n    （腫瘍組織・非腫瘍組織ペア32症例、腫瘍組織のみ114症例、非腫瘍組織のみ0症例）",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium Human Methylation 450K BeadChip]",
          "ソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium HumanMethylation450 BeadChip",
          "メチル化率決定アルゴリズム（ソフトウェア）": "Genome Studio",
          "フィルタリング": "-",
          "マイクロアレイ標準化方法": "following the standard protocol of Genome Studio",
          "プローブ数": "485,577",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000334",
          "総データ量": "2 TB（beta value [txt、ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGBS": {
          "対象": "小児肝腫瘍（ICD10：C22.0、C22.2）：21症例\r\n    腫瘍組織：20検体\r\n    非腫瘍組織：3検体\r\n    （腫瘍組織・非腫瘍組織ペア2症例、腫瘍組織のみ18症例、非腫瘍組織のみ1症例）",
          "規模": "WGBS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "EZ DNA Methylation-Gold",
          "断片化の方法": "Bisulfite変換に伴うDNA切断",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "クオリティコントロール方法": "high mapping efficiency（58.3%）",
          "マッピング方法": "Bowtie2 v2.2.5（Bismark v0.14.3）",
          "平均カバー率（Depth）": "19.7X",
          "総リード数 / ユニークにマップされたリード数": "Total reads: 627,297,250（mean） / Uniquely mapped reads: 364,372,627（mean）",
          "メチル化コール・メチル化率算出方法": "Bismark（v0.14.3）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000334",
          "総データ量": "2 TB（bigwig [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "檜山 英三",
        "所 属 機 関": "広島大学自然科学研究支援開発センター",
        "プロジェクト/研究グループ名": "JPLT-2 project / Japanese study group for Pediatric Liver Tumor (JPLT)",
        "科研費/助成金（Research Project Number）": {
          "7": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（A）",
            "タイトル": "一生細胞解析による小児腫瘍における次世代Cancer Liquid Biopsy",
            "研究課題番号": "19H01056"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Jinyan Huang": {
          "研究代表者": "Jinyan Huang",
          "所属機関": "Zhejiang University School of Medicine",
          "研究題目": "",
          "利用データID": "Comprehensive analysis of alternative splicing in malignant tumors",
          "利用期間": "JGAD000334"
        },
        "Tianzhong Yang": {
          "研究代表者": "Tianzhong Yang",
          "所属機関": "Childhood Cancer Genomic Group, Division of Biostatistics, University of Minnesota",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Evaluating germline genetic risk factors of hepatoblastoma onset and survival",
          "利用期間": "JGAD000334"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000334"
        },
        "Yujie Tang": {
          "研究代表者": "Yujie Tang",
          "所属機関": "Department of Histoembryology, Genetics and Developmental Biology, College of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine",
          "研究題目": "中華人民共和国",
          "利用データID": "The key molecular mechanisms underlying the oncogenesis and progression of neuroblastoma and hepatoblastoma",
          "利用期間": "JGAD000334"
        },
        "Xin Chen": {
          "研究代表者": "Xin Chen",
          "所属機関": "University of Hawaii Cancer Center",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Wnt/beta-Catenin or Hippo/YAP target gene expression in hepatoblastoma",
          "利用期間": "JGAD000334"
        },
        "Weng Chuan Peng": {
          "研究代表者": "Weng Chuan Peng",
          "所属機関": "Princess Maxima Center for Pediatric Oncology",
          "研究題目": "オランダ",
          "利用データID": "Towards understanding pediatric liver tumors",
          "利用期間": "JGAD000334"
        }
      },
      "リリース情報": {
        "hum0233.v1": {
          "Research ID": "hum0233.v1",
          "公開日": "2021/05/31",
          "内容": "NGS（Exome、RNA-seq、WGBS）、SNPアレイ、メチル化アレイ",
          "description": "小児肝腫瘍165症例の腫瘍組織および非腫瘍組織から抽出したDNA/RNAを用いたExome、RNA-seq、SNPアレイ、メチル化アレイ、WGBS解析の結果をbam、txt、CEL、bigwigファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0233.v1",
      "DATA": {
        "JGAS000236": {
          "Data Set ID": "JGAS000236",
          "Type of Data": "NGS (Exome)\r\nNGS (RNA-seq)\r\nSNP array\r\nMethylation array\r\nNGS (WGBS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/05/31"
        }
      },
      "SUMMARY": {
        "Aims": "To characterize the genomic profile of hepatoblastoma and hepatocellular carcinoma and then to compare these data to clinical course of the patients for development of novel treatment strategies accoding to tumor biological characteristics",
        "Methods": "Whole Exome Sequencing (NGS), RNA-seq (NGS), SNP array, Methylation array, Whole Genome Bisulfite Sequencing (NGS)",
        "Participants/Materials": "165 clinical hepatoblastoma samples",
        "URL": "https://home.hiroshima-u.ac.jp/eiso/english/home.html"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "Pediatric hepatoblastoma (ICD10: C22.0, C22.2): 112 cases\r\n    tumor tissue: 112 samples\r\n    non-tumor tissue: 112 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor tissues and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT Exome V5 Custom kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S2)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "QC": "-",
          "Mapping Methods": "BWA, Karkinos (in-house mapper)",
          "Coverage (Depth)": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000334",
          "Total Data Volume": "2 TB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Pediatric hepatoblastoma (ICD10: C22.0, C22.2): 113 cases\r\n    tumor tissue: 111 samples\r\n    non-tumor tissue: 28 samples\r\n    (tumor and matched-non tumor pair: 26 cases + tumor tissues only: 85 cases + non-tumor tissues only: 2 cases)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor tissues and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA LT Sample Prep Kit",
          "Fragmentation Methods": "included in the above library construction kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "QC": "-",
          "Mapping Methods": "BWA, Finemap (in-house mapper)",
          "Coverage (Depth)": "-",
          "Total Reads / Uniquely Mapped Reads": "-",
          "Gene Numbers": "86,817",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000334",
          "Total Data Volume": "2 TB (bam [ref: hg19], FPKM [txt])",
          "Comments (Policies)": "NBDC policy"
        },
        "SNP array": {
          "Participants/Materials": "Pediatric hepatoblastoma (ICD10: C22.0, C22.2): 112 cases\r\n    tumor tissue: 112 samples\r\n    non-tumor tissue: 112 samples",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Source": "DNAs extracted from tumor tissues and non-tumor tissues",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Assay Kit 6.0",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000334",
          "Total Data Volume": "2 TB (CEL)",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation array": {
          "Participants/Materials": "Pediatric hepatoblastoma (ICD10: C22.0, C22.2): 146 cases\r\n    tumor tissue: 146 samples\r\n    non-tumor tissue: 32 samples\r\n    (tumor and matched-non tumor pair: 32 cases + tumor tissues only: 114 cases + non-tumor tissues only: 0 case)",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium Human Methylation 450K BeadChip]",
          "Library Source": "DNAs extracted from tumor tissues and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Infinium HumanMethylation450 BeadChip",
          "Algorithms for Calculating Methylation-rate (software)": "Genome Studio",
          "Filtering Methods": "-",
          "Normalization of microarray": "following the standard protocol of Genome Studio",
          "Probe Number": "485,577",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000334",
          "Total Data Volume": "2 TB (beta value [txt, ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "WGBS": {
          "Participants/Materials": "Pediatric hepatoblastoma (ICD10: C22.0, C22.2): 21 cases\r\n    tumor tissue: 20 samples\r\n    non-tumor tissue: 3 samples\r\n    (tumor and matched-non tumor pair: 2 cases + tumor tissues only: 18 cases + non-tumor tissues only: 1 case)",
          "Targets": "WGBS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor tissues and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "EZ DNA Methylation-Gold",
          "Fragmentation Methods": "fragmentation due to bisulfite conversion",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "QC": "high mapping efficiency (58.3%)",
          "Mapping Methods": "Bowtie2 v2.2.5 (Bismark v0.14.3)",
          "Coverage (Depth)": "19.7X",
          "Total Reads / Uniquely Mapped Reads": "Total reads: 627,297,250 (mean) / Uniquely mapped reads: 364,372,627 (mean)",
          "Detecting Methods for Variation": "Bismark (v0.14.3)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000334",
          "Total Data Volume": "2 TB (bigwig [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Eiso Hiyama",
        "Affiliation": "Natural Science Center for Basic Research and Development, Hiroshima University",
        "Project / Group Name": "JPLT-2 project / Japanese study group for Pediatric Liver Tumor (JPLT)",
        "Funds / Grants (Research Project Number)": {
          "7": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (A)",
            "Title": "Next-generation cancer liquid biopsy of childhood cancers using single cell analysis",
            "Project Number": "19H01056"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Jinyan Huang": {
          "Principal Investigator": "Jinyan Huang",
          "Affiliation": "School of Medicine, Zhejiang University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of alternative splicing in malignant tumors",
          "Period of Data Use": "JGAD000334"
        },
        "Tianzhong Yang": {
          "Principal Investigator": "Tianzhong Yang",
          "Affiliation": "Childhood Cancer Genomic Group, Division of Biostatistics, University of Minnesota",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Evaluating germline genetic risk factors of hepatoblastoma onset and survival",
          "Period of Data Use": "JGAD000334"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000334"
        },
        "Yujie Tang": {
          "Principal Investigator": "Yujie Tang",
          "Affiliation": "Department of Histoembryology, Genetics and Developmental Biology, College of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine",
          "Research Title": "China",
          "Data in Use (Dataset ID)": "The key molecular mechanisms underlying the oncogenesis and progression of neuroblastoma and hepatoblastoma",
          "Period of Data Use": "JGAD000334"
        },
        "Xin Chen": {
          "Principal Investigator": "Xin Chen",
          "Affiliation": "University of Hawaii Cancer Center",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Wnt/beta-Catenin or Hippo/YAP target gene expression in hepatoblastoma",
          "Period of Data Use": "JGAD000334"
        },
        "Weng Chuan Peng": {
          "Principal Investigator": "Weng Chuan Peng",
          "Affiliation": "Princess Maxima Center for Pediatric Oncology",
          "Research Title": "Netherlands",
          "Data in Use (Dataset ID)": "Towards understanding pediatric liver tumors",
          "Period of Data Use": "JGAD000334"
        }
      },
      "Release Note": {
        "hum0233.v1": {
          "Research ID": "hum0233.v1",
          "Release Date": "2021/05/31",
          "Type of Data": "NGS (Exome, RNA-seq, WGBS), SNP array, Methylation array",
          "description": "Exome, RNA-seq, SNP array, DNA methylation array and WGBS in 165 cases of pediatric hepatoblastoma were performed using DNA/RNAs extracted from tumor tissues and non-tumor tissues of patients. The data are provided as bam, txt, CEL and bigwig format files.\nNote：\n"
        }
      }
    }
  },
  "hum0232.v1": {
    "ja": {
      "NBDC Research ID": "hum0232.v1",
      "データ": {
        "JGAS000231": {
          "データID": "JGAS000231",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/06/01"
        }
      },
      "研究内容の概要": {
        "目的": "胃がん組織から同定された遺伝子変異を腫瘍由来血漿中循環DNA（ctDNA）としてモニタリングし、個別化腫瘍マーカーとしてのctDNAの臨床的妥当性を検証する",
        "方法": "登録された10症例から、術前および術後の血漿、原発腫瘍組織、末梢血単核細胞（PBMC）を採取した。 原発腫瘍標本は手術直後に3箇所から採取し、すべての標本の細胞密度が顕微鏡下で30％以上であることを確認した。 30の原発腫瘍組織および10のPBMCから抽出したDNAを用いた、がん関連151遺伝子のtarget capture sequencingを実施した。",
        "対象": "胃がんの術前診断においてStage IB以上と診断された症例のうち、書面での同意が得られた10症例",
        "URL": "https://nishizukalab.org/"
      },
      "分子データ": {
        "JGAS000231": {
          "対象": "胃がん（ICD10：C169）：10症例\r\n　　原発腫瘍組織：計30検体（3検体×10症例）\r\n　　PBMC：10検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "がん関連の151遺伝子\r\nClearSeq SS Comprehensive Cancer kits",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "原発腫瘍組織およびPBMCから抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "ClearSeq SS Comprehensive Cancer kits",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000325",
          "総データ量": "64 GB（fastq、bam [ref: GRCh37]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "西塚 哲",
        "所 属 機 関": "岩手医科大学 医歯薬総合研究所 医療開発研究部門",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "血漿中遊離変異DNA定量による食道癌モニタリングシステムの開発",
            "研究課題番号": "17K10605"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA",
          "DOI": "doi: 10.1371/journal.pone.0239966",
          "データID": "JGAD000325"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0232.v1": {
          "Research ID": "hum0232.v1",
          "公開日": "2020/06/01",
          "内容": "NGS（Target Capture）",
          "description": "胃がんStage IB以上と診断された10症例の原発腫瘍組織およびPBMCから抽出したDNAを用いたTarget Capture解析結果をfastqおよびbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0232.v1",
      "DATA": {
        "JGAS000231": {
          "Data Set ID": "JGAS000231",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/06/01"
        }
      },
      "SUMMARY": {
        "Aims": "To evaluate a clinical validity of circulating tumor DNA (ctDNA) of tumor-unique mutations identified in gastric cancer tissues, as a personalized tumor marker.",
        "Methods": "Pre- and post-operational plasma, primary tumor tissues, and peripheral blood mononuclear cells (PBMCs) were collected from 10 enrolled gastric cancer patients. The primary tumor specimens were taken from three regions immediately after the operation, and the cellularity of all specimens was microscopically confirmed to be >30%. DNAs are extracted from 30 primary tumor specimens and 10 PBMCs, and target capture sequencing for 151 genes that have been implicated in a wide range of cancers was performed.",
        "Participants/Materials": "Gastric cancer patients with preoperative diagnosis of Stage IB or higher. An individual written consent was obtained from each participant.",
        "URL": "https://nishizukalab.org/en/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000231": {
          "Participants/Materials": "Gastric cancer (ICD10: C169): 10 cases\r\n    primary tumor tissue: 30 samples\r\n    PBMC: 10 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "Coding regions of the 151 disease-associated genes\r\nClearSeq SS Comprehensive Cancer kits",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from primary tumor tissues and PBMC",
          "Cell Lines": "-",
          "Library Construction (kit name)": "ClearSeq SS Comprehensive Cancer kits",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000325",
          "Total Data Volume": "64 GB (fastq, bam [ref: GRCh37])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Satsoshi Nishizuka",
        "Affiliation": "Division of Biomedical Research and Development, Iwate Medical University Institute for Biomedical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Development of monitoring system for esophageal cancer by quantifying circulating tumor DNA",
            "Project Number": "17K10605"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA",
          "DOI": "doi: 10.1371/journal.pone.0239966",
          "Data Set ID": "JGAD000325"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0232.v1": {
          "Research ID": "hum0232.v1",
          "Release Date": "2020/06/01",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from primary tumor tissues and PBMC of 10 patients with gastric cancer (more than Stage IB) were used for the target capture sequencing analysis (fastq and bam files).\nNote：\n"
        }
      }
    }
  },
  "hum0229.v1": {
    "ja": {
      "NBDC Research ID": "hum0229.v1",
      "データ": {
        "JGAS000230": {
          "データID": "JGAS000230",
          "内容": "NGS（scRNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/05/15"
        }
      },
      "研究内容の概要": {
        "目的": "血液中を流れる細胞のシングルセルRNA-seq（scRNA-seq）を行い、老化に関連する細胞や分子の同定を行う",
        "方法": "10X Genomicsシングルセルキットを用いたscRNA-seq",
        "対象": "スーパーセンチナリアン（110歳以上）7名、その家族の内2名、ならびに、直接血縁関係のない対照者2名",
        "URL": "https://aging-project.riken.jp/research/piero-carninci/"
      },
      "分子データ": {
        "JGAS000230": {
          "対象": "スーパーセンチナリアン：7名\r\n（total RNA library：7名、TCR library：2名）\r\n家族：2名\r\n血縁関係のない対照者：2名",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "TCR library：TCR領域",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "total RNA library：末梢血単核球（PBMC）から抽出したRNA\r\nTCR library：末梢血CD4+ T Cellから抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "total RNA library：Chromium Single Cell 3ʹ v2 Reagent Kits\r\nTCR library：Chromium Single Cell 5ʹ Library Kit、Chromium Single Cell V(D)J Enrichment Kits",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "total RNA library：98 bp\r\nTCR library：150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000324",
          "総データ量": "676 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy、Familial policy および hum0229 policy\r\n誓約書"
        }
      },
      "提供者情報": {
        "研究代表者": "ピエロ・カルニンチ",
        "所 属 機 関": "理化学研究所 生命医科学研究センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians.",
          "DOI": "doi: 10.1073/pnas.1907883116",
          "データID": "JGAD000324"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Bo Li": {
          "研究代表者": "Bo Li",
          "所属機関": "Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center",
          "研究題目": "",
          "利用データID": "Identify novel age-related biomarkers through T cell repertoire sharing",
          "利用期間": "JGAD000324"
        },
        "Elizabeth Anne Gaskell": {
          "研究代表者": "Elizabeth Anne Gaskell",
          "所属機関": "Broad Institute of MIT and Harvard",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Investigating transcriptomic and epigenomic alterations over human aging",
          "利用期間": "JGAD000324"
        },
        "Mohammad Mahdi Karimi": {
          "研究代表者": "Mohammad Mahdi Karimi",
          "所属機関": "King's College London",
          "研究題目": "イギリス",
          "利用データID": "Functional role of transposable elements in ageing",
          "利用期間": "JGAD000324"
        }
      },
      "リリース情報": {
        "hum0229.v1": {
          "Research ID": "hum0229.v1",
          "公開日": "2020/05/15",
          "内容": "NGS（scRNA-seq）",
          "description": "スーパーセンチナリアン（110歳以上）7名、その家族の内2名、ならびに、血縁関係のない対照者2名の血液中の細胞から抽出したRNAを用いたscRNA-seq解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0229.v1",
      "DATA": {
        "JGAS000230": {
          "Data Set ID": "JGAS000230",
          "Type of Data": "NGS (scRNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/05/15"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of age associated molecular markers from blood cells using a single-cell RNA-seq technology",
        "Methods": "Single-cell RNA-seq using 10X Genomics library kit",
        "Participants/Materials": "Supercentenarian (over 110 years old), family members, and unrelated donors",
        "URL": "https://aging-project.riken.jp/en/research/piero-carninci/"
      },
      "MOLECULAR DATA": {
        "JGAS000230": {
          "Participants/Materials": "7 supercentenarians\r\n (7 for total RNA library, 2 of 7 for TCR library)\r\n2 family members\r\n2 unrelated donors",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "TCR library: TCR region",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "total RNA library: RNAs extracted from PBMC\r\nTCR library: RNAs extracted from CD4+ T Cell",
          "Cell Lines": "-",
          "Library Construction (kit name)": "total RNA library: Chromium Single Cell 3ʹ v2 Reagent Kits\r\nTCR library: Chromium Single Cell 5ʹ Library Kit, Chromium Single Cell V(D)J Enrichment Kits",
          "Fragmentation Methods": "Enzymatic Fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "total RNA library: 98 bp\r\nTCR library: 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000324",
          "Total Data Volume": "676 GB (fastq)",
          "Comments (Policies)": "NBDC policy, Familial policy & hum0229 policy\r\nCommitment"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Piero Carninci",
        "Affiliation": "RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians.",
          "DOI": "doi: 10.1073/pnas.1907883116",
          "Data Set ID": "JGAD000324"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Bo Li": {
          "Principal Investigator": "Bo Li",
          "Affiliation": "Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Identify novel age-related biomarkers through T cell repertoire sharing",
          "Period of Data Use": "JGAD000324"
        },
        "Elizabeth Anne Gaskell": {
          "Principal Investigator": "Elizabeth Anne Gaskell",
          "Affiliation": "Broad Institute of MIT and Harvard",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Investigating transcriptomic and epigenomic alterations over human aging",
          "Period of Data Use": "JGAD000324"
        },
        "Mohammad Mahdi Karimi": {
          "Principal Investigator": "Mohammad Mahdi Karimi",
          "Affiliation": "King's College London",
          "Research Title": "United Kingdom of Great Britain and Northern Ireland",
          "Data in Use (Dataset ID)": "Functional role of transposable elements in ageing",
          "Period of Data Use": "JGAD000324"
        }
      },
      "Release Note": {
        "hum0229.v1": {
          "Research ID": "hum0229.v1",
          "Release Date": "2020/05/15",
          "Type of Data": "NGS (scRNA-seq)",
          "description": "RNAs extracted from blood cells from 7 supercentenarians (over 110 years old), 2 family members and 2 unrelated donors were used for the single-cell RNA sequencing analysis (fastq files).\nNote：\n"
        }
      }
    }
  },
  "hum0227.v1": {
    "ja": {
      "NBDC Research ID": "hum0227.v1",
      "データ": {
        "JGAS000228": {
          "データID": "JGAS000228",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/06/04"
        }
      },
      "研究内容の概要": {
        "目的": "アジアにおける胃がんの素因となるライフスタイルと生殖細胞変異の同定",
        "方法": "全エクソームシークエンス解析および全トランスクリプトームシークエンス解析",
        "対象": "胃がん 102症例",
        "URL": "https://www.genome.rcast.u-tokyo.ac.jp/ja/research"
      },
      "分子データ": {
        "Exome": {
          "対象": "胃がん（ICD10：C16）：102症例\r\n      腫瘍組織：102検体\r\n      非腫瘍組織：102検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "手術摘出切片の腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect Human All Exon Kit v4 and v5+ LincRNA",
          "断片化の方法": "超音波断片化（Covaris SS）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000320",
          "総データ量": "3 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "胃がん（ICD10：C161）：81症例\r\n      腫瘍組織：81検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "手術摘出切片の腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Sample Prep Kit",
          "断片化の方法": "上記キットに準拠",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000321",
          "総データ量": "3 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "油谷 浩幸",
        "所 属 機 関": "東京大学先端科学技術研究センター",
        "プロジェクト/研究グループ名": "ゲノムサイエンス分野",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的がん医療実用化研究事業",
            "タイトル": "国際共同研究に資する大規模日本人がんゲノム・オミックス・臨床データ統合解析とゲノム医療推進に向けた知識基盤構築",
            "研究課題番号": "JP20ck0106547"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Defined lifestyle and germline factors predispose Asian populations to gastric cancer",
          "DOI": "doi: 10.1126/sciadv.aav9778",
          "データID": "JGAD000320\r\nJGAD000321\r\nJGAD000322\r\nJGAD000323"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "河野 隆志": {
          "研究代表者": "河野 隆志",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "AYA （Adolescence and Young Adult） 世代がんの個別化予防に資する遺伝要因の同定を目指す研究",
          "利用期間": "JGAD000320, JGAD000321"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000321"
        },
        "牛久 哲男": {
          "研究代表者": "牛久 哲男",
          "所属機関": "東京大学大学院医学系研究科 人体病理学・病理診断学分野",
          "研究題目": "日本",
          "利用データID": "上部消化管腫瘍のゲノム・遺伝子解析とその臨床病理学的意義の解明",
          "利用期間": "JGAD000320, JGAD000321"
        }
      },
      "リリース情報": {
        "hum0227.v1": {
          "Research ID": "hum0227.v1",
          "公開日": "2021/06/04",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "胃がん１０２症例の手術摘出切片の腫瘍組織および非腫瘍組織から抽出したDNA、RNAを用いたWhole Exome Sequencing解析およびRNA-seq解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0227.v1",
      "DATA": {
        "JGAS000228": {
          "Data Set ID": "JGAS000228",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/06/04"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of lifestyle and germline mutations (genetic factors) that predispose to gastric cancer in an Asian population",
        "Methods": "Whole exome sequencing (NGS) and whole transcriptome seuquencing (NGS) analyses",
        "Participants/Materials": "Stomach adenocarcinoma patients",
        "URL": "https://www.genome.rcast.u-tokyo.ac.jp/en/research"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "Stomach adenocarcinoma (ICD10: C16): 102 cases\r\n      tumor tissues: 102 samples\r\n      non-tumor tissues: 102 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from clinical specimens (tumor tissues and matched non-tumor tissues) of stomach adenocarcinoma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect Human All Exon Kit v4 and v5+ LincRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris SS)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000320",
          "Total Data Volume": "3 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Stomach adenocarcinoma (ICD10: C16): 81 cases\r\n      tumor tissues: 81 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from clinical specimens (tumor tissues) of stomach adenocarcinoma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Sample Prep Kit",
          "Fragmentation Methods": "included in the above library construction kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000321",
          "Total Data Volume": "3 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Aburatani",
        "Affiliation": "RCAST, the University of Tokyo",
        "Project / Group Name": "Genome Science laboratory",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Integrated analysis of large-scale Japanese cancer genomic, omics, and clinical data for international collaborative research and construction of a knowledge base for the promotion of genomic medicine",
            "Project Number": "JP20ck0106547"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Defined lifestyle and germline factors predispose Asian populations to gastric cancer",
          "DOI": "doi: 10.1126/sciadv.aav9778",
          "Data Set ID": "JGAD000320\r\nJGAD000321\r\nJGAD000322\r\nJGAD000323"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Takashi Kohno": {
          "Principal Investigator": "Takashi Kohno",
          "Affiliation": "Division of Genome Biology, National Cancer Center Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Identification of genetic risk factors in AYA (Adolescence and Young Adult) cancer",
          "Period of Data Use": "JGAD000320, JGAD000321"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000321"
        },
        "Tetsuo Ushiku": {
          "Principal Investigator": "Tetsuo Ushiku",
          "Affiliation": "Department of Pathology, Graduate School of Medicine, The University of Tokyo",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of upper gastrointestinal tumors and their clinicopathological significance",
          "Period of Data Use": "JGAD000320, JGAD000321"
        }
      },
      "Release Note": {
        "hum0227.v1": {
          "Research ID": "hum0227.v1",
          "Release Date": "2021/06/04",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs and RNAs extracted from clinical specimens (tumor and non-tumor tissues) of 102 stomach adenocarcinoma patients were used for the whole exome sequencing and RNA-seq analyses (fastq files).\nNote：\n"
        }
      }
    }
  },
  "hum0226.v1": {
    "ja": {
      "NBDC Research ID": "hum0226.v1",
      "データ": {
        "JGAS000229": {
          "データID": "JGAS000229",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/06/04"
        }
      },
      "研究内容の概要": {
        "目的": "アジアにおける胃がんの素因となるライフスタイルと生殖細胞変異の同定",
        "方法": "全エクソームシークエンス解析および全トランスクリプトームシークエンス解析",
        "対象": "胃がん141症例",
        "URL": "https://www.genome.rcast.u-tokyo.ac.jp/ja/research"
      },
      "分子データ": {
        "Exome": {
          "対象": "胃がん（ICD10：C16）：141症例\r\n      腫瘍組織：141検体\r\n      非腫瘍組織：141検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "手術摘出切片の腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect Human All Exon Kit v4 and v5+ LincRNA",
          "断片化の方法": "超音波断片化（Covaris SS）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000322",
          "総データ量": "5 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "胃がん（ICD10：C161）：103症例\r\n      腫瘍組織：103検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "手術摘出切片の腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Sample Prep Kit",
          "断片化の方法": "上記キットに準拠",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000323",
          "総データ量": "5 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "油谷 浩幸",
        "所 属 機 関": "東京大学先端科学技術研究センター",
        "プロジェクト/研究グループ名": "ゲノムサイエンス分野",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的がん医療実用化研究事業",
            "タイトル": "国際共同研究に資する大規模日本人がんゲノム・オミックス・臨床データ統合解析とゲノム医療推進に向けた知識基盤構築",
            "研究課題番号": "JP20ck0106547"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Defined lifestyle and germline factors predispose Asian populations to gastric cancer",
          "DOI": "doi: 10.1126/sciadv.aav9778",
          "データID": "JGAD000320\r\nJGAD000321\r\nJGAD000322\r\nJGAD000323"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000323"
        },
        "牛久 哲男": {
          "研究代表者": "牛久 哲男",
          "所属機関": "東京大学大学院医学系研究科 人体病理学・病理診断学分野",
          "研究題目": "日本",
          "利用データID": "上部消化管腫瘍のゲノム・遺伝子解析とその臨床病理学的意義の解明",
          "利用期間": "JGAD000322, JGAD000323"
        }
      },
      "リリース情報": {
        "hum0226.v1": {
          "Research ID": "hum0226.v1",
          "公開日": "2021/06/04",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "胃がん１4１症例の手術摘出切片の腫瘍組織および非腫瘍組織から抽出したDNA、RNAを用いたWhole Exome Sequencing解析およびRNA-seq解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0226.v1",
      "DATA": {
        "JGAS000229": {
          "Data Set ID": "JGAS000229",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/06/04"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of lifestyle and germline mutations (genetic factors) that predispose to gastric cancer in an Asian population",
        "Methods": "Whole exome sequencing (NGS) and whole transcriptome seuquencing (NGS) analyses",
        "Participants/Materials": "Stomach adenocarcinoma patients",
        "URL": "https://www.genome.rcast.u-tokyo.ac.jp/en/research"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "Stomach adenocarcinoma (ICD10: C16): 141 cases\r\n      tumor tissues: 141 samples\r\n      non-tumor tissues: 141 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from clinical specimens (tumor tissues and matched non-tumor tissues) of stomach adenocarcinoma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect Human All Exon Kit v4 and v5+ LincRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris SS)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000322",
          "Total Data Volume": "5 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Stomach adenocarcinoma (ICD10: C16): 103 cases\r\n      tumor tissues: 103 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from clinical specimens (tumor tissues) of stomach adenocarcinoma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Sample Prep Kit",
          "Fragmentation Methods": "included in the above library construction kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000323",
          "Total Data Volume": "5 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Aburatani",
        "Affiliation": "RCAST, the University of Tokyo",
        "Project / Group Name": "Genome Science laboratory",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Integrated analysis of large-scale Japanese cancer genomic, omics, and clinical data for international collaborative research and construction of a knowledge base for the promotion of genomic medicine",
            "Project Number": "JP20ck0106547"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Defined lifestyle and germline factors predispose Asian populations to gastric cancer",
          "DOI": "doi: 10.1126/sciadv.aav9778",
          "Data Set ID": "JGAD000320\r\nJGAD000321\r\nJGAD000322\r\nJGAD000323"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000323"
        },
        "Tetsuo Ushiku": {
          "Principal Investigator": "Tetsuo Ushiku",
          "Affiliation": "Department of Pathology, Graduate School of Medicine, The University of Tokyo",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of upper gastrointestinal tumors and their clinicopathological significance",
          "Period of Data Use": "JGAD000322, JGAD000323"
        }
      },
      "Release Note": {
        "hum0226.v1": {
        },
        "hum0227.v1": {
          "Research ID": "hum0227.v1",
          "Release Date": "2021/06/04",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs and RNAs extracted from clinical specimens (tumor and non-tumor tissues) of 102 stomach adenocarcinoma patients were used for the whole exome sequencing and RNA-seq analyses (fastq files).\nNote：\n"
        }
      }
    }
  },
  "hum0225.v1": {
    "ja": {
      "NBDC Research ID": "hum0225.v1",
      "データ": {
        "JGAS000226": {
          "データID": "JGAS000226",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/05/08"
        }
      },
      "研究内容の概要": {
        "目的": "ヒトT細胞白血病ウイルス（HTLV-1）関連脊髄症（HAM）の遺伝子変異解析を通じて成人T細胞白血病の発症リスクを推定する",
        "方法": "次世代シークエンサーを用いたTarget capture sequencing",
        "対象": "HAM21症例の感染細胞分画（腫瘍細胞）及び非感染細胞分画（非腫瘍細胞）",
        "URL": "http://uchimaru.umin.jp/"
      },
      "分子データ": {
        "JGAS000226": {
          "対象": "HAM（ICD-10：A858/B973）：21症例（46検体）\r\n    感染細胞分画（腫瘍組織）：23検体（2症例は成人T細胞白血病[ATL]発症後の検体を含む）\r\n    非感染細胞分画（非腫瘍組織）：23検体（2症例はATL発症後の検体を含む）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "ATLリスク50遺伝子を含む280遺伝子とHTLV-1 provirus全長領域",
          "Platform": "Illumina [HiSeq 2500/3000]",
          "ライブラリソース": "末梢血単核球（PBMC）の感染細胞分画（腫瘍組織）及び非感染細胞分画（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT HS Target Enrichment System",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000318",
          "総データ量": "238 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山岸 誠 / 山野 嘉久",
        "所 属 機 関": "東京大学大学院新領域創成科学研究科 / 聖マリアンナ医科大学 難病治療研究センター",
        "プロジェクト/研究グループ名": "病態医療科学分野 / 病因病態解析部門",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 難治性疾患実用化研究事業",
            "タイトル": "HAM・HTLV-1陽性難治性疾患の診療ガイドラインに資する統合的レジストリの構築によるエビデンスの創出",
            "研究課題番号": "JP19ek0109356"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis",
          "DOI": "doi: 10.1073/pnas.1920346117",
          "データID": "JGAD000318"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "松岡 雅雄": {
          "研究代表者": "松岡 雅雄",
          "所属機関": "熊本大学大学院生命科学研究部",
          "研究題目": "日本",
          "利用データID": "悪性リンパ腫、成人T細胞白血病・リンパ腫の遺伝・病理学的検討を用いた特性および経過・治療に関する後方視的観察研究",
          "利用期間": "JGAD000318"
        }
      },
      "リリース情報": {
        "hum0225.v1": {
          "Research ID": "hum0225.v1",
          "公開日": "2020/05/08",
          "内容": "NGS（Target Capture）",
          "description": "HTLV-1関連脊髄症（HAM）21症例の感染細胞分画及び非感染細胞分画から抽出したDNAを用いたTarget Capture Sequencing解析結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0225.v1",
      "DATA": {
        "JGAS000226": {
          "Data Set ID": "JGAS000226",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/05/08"
        }
      },
      "SUMMARY": {
        "Aims": "Estimating the risks of developing adult T-cell leukemia (ATL) through a genetic analysis of human T-cell leukemia virus (HTLV-1)-associated myelopathy (HAM)",
        "Methods": "Target capture sequencing by using of NGS technology",
        "Participants/Materials": "HAM 21 cases (infected and uninfected cells)"
      },
      "MOLECULAR DATA": {
        "JGAS000226": {
          "Participants/Materials": "HAM（ICD-10：A858/B973）： 21 cases (46 samples)\r\n    infected cells (tumor cells): 23 samples (including post-ATL specimens for 2 cases)\r\n    uninfected cells (non-tumor cells): 23 samples (including post-ATL specimens for 2 cases)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "280 genes (human) including 50 candidate genes for ATL and whole genome of HTLV-1 provirus",
          "Platform": "Illumina [HiSeq 2500/3000]",
          "Library Source": "DNAs extracted from PBMC (infected and uninfected cells) of HAM patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT HS Target Enrichment System",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000318",
          "Total Data Volume": "238 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Makoto Yamagishi / Yoshihisa Yamano",
        "Affiliation": "Graduate School of Frontier Sciences, The University of Tokyo / Institute of Medical Science, St. Marianna University School of Medicine",
        "Project / Group Name": "Laboratory of Tumor Cell Biology / Department of Rare Disases Research",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development (AMED)",
            "Title": "The establishment of evidence for clinical guideline development on HAM and HTLV-1-related refractory disease through integration of patient registry",
            "Project Number": "JP19ek0109356"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis",
          "DOI": "doi: 10.1073/pnas.1920346117",
          "Data Set ID": "JGAD000318"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Masao Matsuoka": {
          "Principal Investigator": "Masao Matsuoka",
          "Affiliation": "Kumamoto University School of Medicine Hematology, Rheumatology and Infectious Diseases",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Retrospective observational study of characteristics, clinical course and treatment of malignant lymphoma and adult T-cell leukemia/lymphoma with genetic and pathological evaluations",
          "Period of Data Use": "JGAD000318"
        }
      },
      "Release Note": {
        "hum0225.v1": {
          "Research ID": "hum0225.v1",
          "Release Date": "2020/05/08",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from PBMC (infected and uninfected cells) of 21 HAM patients were used for a target capture sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0223.v1": {
    "ja": {
      "NBDC Research ID": "hum0223.v1",
      "データ": {
        "JGAS000232": {
          "データID": "JGAS000232",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/09/01"
        }
      },
      "研究内容の概要": {
        "目的": "血液がん患者の初発時及び再発時の検体を用いて特定の遺伝子の変異解析を行い、病状進行度のサロゲートマーカーになるかどうかを検討する。",
        "方法": "初発時および再発時における骨髄検査検体の骨髄腫細胞より抽出したDNAを用いた126遺伝子のTarget Capture Sequencing解析",
        "対象": "多発性骨髄腫"
      },
      "分子データ": {
        "JGAS000232": {
          "対象": "多発性骨髄腫（ICD10：C90.0）：7症例\r\n    初発時、再発時の骨髄穿刺吸引検体（骨髄腫細胞）：計30検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "126遺伝子",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "骨髄腫細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion Ampliseq Designer™",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "3-1754 bp",
          "QC/Filtering方法": "TaqMan® Assay",
          "重複するリードの除去": "-",
          "マッピング方法": "TMAP",
          "リファレンス配列": "hg19",
          "平均カバー率（Depth）": "2815",
          "変異検出方法": "Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000326",
          "総データ量": "87 GB（vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "照井 康仁",
        "所 属 機 関": "がん研有明病院 血液腫瘍科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "The clonal evolution during long-term clinical course of multiple myeloma",
          "DOI": "doi: 10.1007/s12185-020-02979-7",
          "データID": "JGAD000326"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0223.v1": {
          "Research ID": "hum0223.v1",
          "公開日": "2020/09/01",
          "内容": "NGS（Target Capture）",
          "description": "多発性骨髄腫7症例の初発時および再発時の骨髄穿刺吸引検体（骨髄腫細胞）より抽出したDNAを用いたTarget Capture Sequencing解析結果をvcfファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0223.v1",
      "DATA": {
        "JGAS000232": {
          "Data Set ID": "JGAS000232",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/09/01"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify of the disease status of myeloma and lymphoma by somatic gene mutation analyses",
        "Methods": "gene mutaion analyses using NGS technology at the point of diagnosis, relapse, or proceeding disease",
        "Participants/Materials": "multiple myeloma"
      },
      "MOLECULAR DATA": {
        "JGAS000232": {
          "Participants/Materials": "multiple myeloma (ICD10: C90.0): 7 cases\r\n    myeloma cells from bone marrow aspirates: total 30 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "126 genes",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from myeloma cells isolated from bone marrow samples at the point of diagnosis, relapse, or proceeding disease",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion Ampliseq Designer™",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "3-1754 bp",
          "QC/Filtering Methods": "TaqMan® Assay",
          "Deduplication": "-",
          "Mapping Methods": "TMAP",
          "Reference Genome Sequence": "hg19",
          "Coverage (Depth)": "2815",
          "Detecting Methods for Variation)": "Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000326",
          "Total Data Volume": "87 GB（vcf）",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yasuhito Terui",
        "Affiliation": "Dept of Hematology Oncology, The Cancer Institute Hospital of JFCR",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "The clonal evolution during long-term clinical course of multiple myeloma",
          "DOI": "doi: 10.1007/s12185-020-02979-7",
          "Data Set ID": "JGAD000326"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0223.v1": {
          "Research ID": "hum0223.v1",
          "Release Date": "2020/09/01",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from myeloma cells isolated from bone marrow samples of 7 patients with multiple myeloma (samples collected at the point of diagnosis and relapse or proceeding disease) were used for a target capture sequencing analysis. Vcf files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0222.v1": {
    "ja": {
      "NBDC Research ID": "hum0222.v1",
      "データ": {
        "JGAS000224": {
          "データID": "JGAS000224",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/03/13"
        }
      },
      "研究内容の概要": {
        "目的": "乳がん組織における体細胞バリアントと生殖細胞系列バリアントとを合わせて解析することにより、日本人における家族性乳がんの既知原因遺伝子のバリアントアレルによる発症リスクを明らかにすること",
        "方法": "Illumina HiSeq 2000を使用したTarget Capture解析",
        "対象": "乳がん108症例の末梢血と原発巣のがん組織の124検体"
      },
      "分子データ": {
        "JGAS000224": {
          "対象": "乳がん（ICD10：C50）：115症例（124検体）\r\n    原発巣腫瘍組織と末梢血ペア：108症例（116検体）\r\n    原発巣腫瘍組織のみ：7症例（8検体）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "家族性乳がんの既知原因遺伝子（BRCA1, BRCA2, STK11, NBN, ATM, CHEK2, PALB2, TP53, PTEN, CDH1, RAD51D, RAD51C, BRIP1, RAD50, XRCC2, RAD51B, NF1, EPCAM, MLH1, MSH2, MSH6, PMS2, BARD1, MRE11A, FANCC, BLM, FAM175A, RINT1, FANCM, RECQL）を含む119遺伝子",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "腫瘍組織及び末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSlect XT Custom",
          "断片化の方法": "血液 108検体：超音波断片化（Covaris）\r\n腫瘍 49検体：超音波断片化（Covaris）\r\n腫瘍 75検体：酵素断片化（KAPA HyperPlus Kit）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000315",
          "総データ量": "222 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "大野 真司",
        "所 属 機 関": "がん研有明病院 乳腺センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome",
          "DOI": "doi: 10.1038/s41523-020-0163-1",
          "データID": "JGAD000315"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0222.v1": {
          "Research ID": "hum0222.v1",
          "公開日": "2020/03/13",
          "内容": "NGS（Target Capture）",
          "description": "乳がん115症例の末梢血と原発巣腫瘍組織から抽出したDNAを用いたTarget Capture Sequencing解析結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0222.v1",
      "DATA": {
        "JGAS000224": {
          "Data Set ID": "JGAS000224",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/03/13"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify risk of germline variants of known causal genes for Hereditary Breast Ovarian Cancer Syndrome in Japan by combinatorial analysis of somatic and germline variants in the breast cancer tissue.",
        "Methods": "Target caputure analysis by using Illumina HiSeq 2000",
        "Participants/Materials": "108 whole blood and 124 primary tumor samples from familial breast cancer patients"
      },
      "MOLECULAR DATA": {
        "JGAS000224": {
          "Participants/Materials": "breast cancer (ICD10: C50): 115 cases (124 samples)\r\nprimary tumor tissues and paired blood: 108 cases (116 samples)\r\nprimary tumor tissues only: 7 cases (8 samples)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "119 genes including known causal genes of HBOC syndrome (BRCA1, BRCA2, STK11, NBN, ATM, CHEK2, PALB2, TP53, PTEN, CDH1, RAD51D, RAD51C, BRIP1, RAD50, XRCC2, RAD51B, NF1, EPCAM, MLH1, MSH2, MSH6, PMS2, BARD1, MRE11A, FANCC, BLM, FAM175A, RINT1, FANCM, RECQL, etc.)",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from primary tumor tissues and peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT Custom",
          "Fragmentation Methods": "blood 108 samples : Ultrasonic fragmentation (Covaris)\r\ntumor 49 samples : Ultrasonic fragmentation (Covaris)\r\ntumor 75 samples : DNase (KAPA HyperPlus Kit)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000315",
          "Total Data Volume": "222 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shinji Ohno",
        "Affiliation": "The Cancer Institute Hospital of JFCR",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome",
          "DOI": "doi: 10.1038/s41523-020-0163-1",
          "Data Set ID": "JGAD000315"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0222.v1": {
          "Research ID": "hum0222.v1",
          "Release Date": "2020/03/13",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from primary tumor samples and peripheral blood of 115 patients with breast cancer were used for a target capture sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0221.v1": {
    "ja": {
      "NBDC Research ID": "hum0221.v1",
      "データ": {
        "JGAS000225": {
          "データID": "JGAS000225",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/07/28"
        }
      },
      "研究内容の概要": {
        "目的": "遺伝子発現解析",
        "方法": "iPS細胞株より抽出したRNAを用いたRNA-seq解析",
        "対象": "ファブリー病（小児先天性代謝異常）２症例より樹立したiPS細胞３株"
      },
      "分子データ": {
        "JGAS000225": {
          "対象": "ファブリー病（ICD10：E752）2症例より樹立したiPS細胞株：3細胞株",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血より樹立したiPS細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "断片化の方法": "上記キットに準拠",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "マッピング方法": "STAR（version 2.7.1a）",
          "リファレンス配列": "GRCh38",
          "発現量算出方法（ソフトウェア等）": "RSEM（version 1.2.31）、アノーテーション：Ensembl ver. 98",
          "総リード数 / ユニークにマップされたリード数": "Total reads: 35447368.83（mean） / Uniquely mapped reads: 33238808.83（mean）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000316",
          "総データ量": "14 GB（fastq、txt [Transcripts Per Million]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "粟屋 智就",
        "所 属 機 関": "京都大学大学院 医学研究科 形態形成機構学研究室",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0221.v1": {
          "Research ID": "hum0221.v1",
          "公開日": "2023/07/28",
          "内容": "NGS（RNA-seq）",
          "description": "ファブリー病症例の末梢血から樹立したiPS細胞から抽出したRNAを用いたRNA-seq解析の結果をfastqおよびtxt（Transcripts Per Million）ファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0221.v1",
      "DATA": {
        "JGAS000225": {
          "Data Set ID": "JGAS000225",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/07/28"
        }
      },
      "SUMMARY": {
        "Aims": "Gene expression analysis",
        "Methods": "RNA-seq for a cellular RNA",
        "Participants/Materials": "Fabry disease"
      },
      "MOLECULAR DATA": {
        "JGAS000225": {
          "Participants/Materials": "3 iPS cell lines established from 2 Fabry disease patients (ICD10: E752)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from iPS cells derived from patients' peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "Fragmentation Methods": "According to TruSeq Stranded mRNA Sample Preparation Guide",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Mapping Methods": "STAR (version 2.7.1a)",
          "Reference Genome Sequence": "GRCh38",
          "Detecting Methods for Transcripts": "RSEM (version 1.2.31), annotation: Ensembl ver. 98",
          "Total Reads / Uniquely Mapped Reads": "Total reads: 35447368.83 (mean) / Uniquely mapped reads: 33238808.83 (mean)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000316",
          "Total Data Volume": "14 GB (fastq, txt [Transcripts Per Million])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tomonari Awaya",
        "Affiliation": "Department of Anatomy and Developmental Biology, Kyoto University Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Program for Promoting Platform of Genomics based Drug Discovery, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Development of genetic disease medicine by pharmacogenomics analysis ofspliceswitching compounds",
            "Project Number": "JP18kk0305003"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0221.v1": {
          "Research ID": "hum0221.v1",
          "Release Date": "2023/07/28",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from iPS cells derived from Fabry disease patients were used for RNA-sequencing analysis. Fastq and txt (Transcripts Per Million) files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0220.v1": {
    "ja": {
      "NBDC Research ID": "hum0220.v1",
      "データ": {
        "JGAS000223": {
          "データID": "JGAS000223",
          "内容": "質量分析",
          "制限": "制限公開（Type I）",
          "公開日": "2020/06/02"
        }
      },
      "研究内容の概要": {
        "目的": "静脈採血から血漿凍結までの放置時間が、採血管内の血中タンパク質濃度に与える影響について探索する",
        "方法": "血漿・血清検体を用いて、プロテオーム解析を行う。採血してから遠心により血漿分離するまでの放置条件を振り、血漿と血清中のタンパク質濃度を比較する。得られた結果からタンパク質の濃度と放置時間の関係を検討し、経時的な濃度変化の目立つタンパク質を探索する。",
        "対象": "健常者3名の血液（血漿、血清）",
        "URL": "http://www.ohtsuki-lab.jp/"
      },
      "分子データ": {
        "JGAS000223": {
          "対象": "血漿：健常人3名×6条件（計18検体）\r\n　　　条件：0分室温、15分室温、30分室温、1時間氷上、4時間氷上、8時間氷上\r\n血清：健常人3名（計3検体）",
          "規模": "質量分析",
          "ソース": "静脈血採取から凍結までの放置条件を振った血漿、および血清",
          "試料調製方法": "健常ボランティアから採血後に血液を氷上もしくは室温で指定時間放置し、血清もしくは血漿を調製。血清もしくは血漿検体をsodium deoxycholateおよびN-lauroylsarcosinate存在下でdithiothreitolにより還元し、iodoacetamideによってアルキル化を行った。その後lysyl endopeptideseおよびtyprinで消化した後に、液液抽出および脱塩を行うことによって質量分析試料を調製した。",
          "測定条件": "質量分析：Sciex TripleTOF 5600\r\nLC: DIONEX Ultimate 3000 RSLC nano system\r\nトラップカラム：100 μm ID, 2 cm length, packed with 5 μm Acclaim PepMap100 C18\r\n分析カラム：75 μm ID, 25 cm length, packed with 2 μm Acclaim PepMap C18\r\nSolvent A: 0.1% formic acid in water\r\nSolvent B: 0.1% formic acid in acetonitrile\r\nGradient: 2% B at 0–3 min, to 25% B at 63 min, to 50% B at 78 min, 98% B at 80–85 min, then 100% A, with the flow rate of 300 nl/min\r\n同定用データ取得：Information Dependent Acquisition\r\n定量用データ取得：SWATH (Data Independent Acquisition)",
          "ピーク検出・タンパク同定方法": "タンパク質の同定はInformation Dependent AcquisitionのデータをProteoinPilot 4.5で解析をする事で実施した。同定の信頼性は1% FDRを閾値とした。タンパク質の定量はSWATHのデータをSkylineを用いる事によって実施した。定量の際に用いるスペクトルライブラリは同一検体の同定情報から構築したライブラリや研究室内の蓄積したライブラリを用いた。定量の信頼性は1% FDRを閾値とし、特異的なペプチドのピーク面積の合計をタンパク質の量として計算した。",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000314",
          "JPOST ID": "JPST000553",
          "総データ量": "306 MB\r\nwiff：生の質量分析データの測定条件等が保存されたファイル\r\nwiff.scan：生データ（スペクトルデータ）\r\namf：ProteinPilot softwareを使用してスペクトルのピークを抽出したピークのリストファイル\r\ntxt：ProteinPilot softwareを使用して同定したタンパク質のテキストファイル",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "大槻 純男",
        "所 属 機 関": "熊本大学大学院 生命科学研究部",
        "プロジェクト/研究グループ名": "微生物薬学分野",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業（AMED-CREST）",
            "タイトル": "包括的メタボロミクス・ターゲットプロテオミクスによるがん診断・薬効診断マーカー探索と革新的統合臨床診断ネットワーク構築",
            "研究課題番号": "JP19gm0710013"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Effects of Differences in Pre-Analytical Processing on Blood Protein Profiles Determined With SWATH-MS",
          "DOI": "doi: 10.1016/j.jprot.2020.103824",
          "データID": "JGAD000314"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0220.v1": {
          "Research ID": "hum0220.v1",
          "公開日": "2020/06/02",
          "内容": "質量分析",
          "description": "静脈血採血から血漿凍結までの放置条件が与える血漿・血清中タンパク質への影響を確認するため、質量分析計による測定を実施した結果を提供する（.wiff, .wiff.scan, .mgf, .txt）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0220.v1",
      "DATA": {
        "JGAS000223": {
          "Data Set ID": "JGAS000223",
          "Type of Data": "Mass Spectrometry",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/06/02"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify the stability of blood proteins during pre-analytical blood processing and storage, to compare the proteomes of similarly treated serum and plasma samples.",
        "Methods": "We compared plasma samples prepared by centrifugation after storage of blood at room temperature for 0, 15 or 30 minutes, or under refrigeration at 0-5°C for 1, 4 or 8 hours. We also compared protein levels between plasma and serum. The plasma and serum samples were digested by trypsin and analyzed by mass spectrometer.",
        "Participants/Materials": "Plasma and serum samples from heathy individuals",
        "URL": "http://ohtsuki-lab.jp/en/"
      },
      "MOLECULAR DATA": {
        "JGAS000223": {
          "Participants/Materials": "Plasma: 18 samples from 3 heathy individuals\r\nSerum: 3 samples from 3 heathy individuals",
          "Targets": "Mass Spectrometry",
          "Source": "Plasma and serum samples",
          "Sample Preparation Method": "Blood samples collected from three healthy Japanese volunteers were completely coagulated at room temperature and centrifuged to prepare serum. Matching blood samples from the same volunteers were centrifuged to obtain plasma immediately or after storage at room temperature or at 0-5°C for different periods. The serum and plasma samples were mixed with sodium deoxycholate and N-lauroylsarcosinate, reduced with dithiothreitol, alkylated with iodoacetamide, and digested with lysyl endopeptidase a and then with trypsin. The digested samples were desalted using GL-Tip GC and SDB.",
          "Measurement Conditions": "MS: Sciex TripleTOF 5600\r\nLC: DIONEX Ultimate 3000 RSLC nano system\r\nTrap column: 100 μm ID, 2 cm length, packed with 5 μm Acclaim PepMap100 C18\r\nAnalytical Column: 75 μm ID, 25 cm length, packed with 2 μm Acclaim PepMap C18\r\nSolvent A: 0.1% formic acid in water\r\nSolvent B: 0.1% formic acid in acetonitrile\r\nGradient: 2% B at 0–3 min, to 25% B at 63 min, to 50% B at 78 min, 98% B at 80–85 min, then 100% A, with the flow rate of 300 nl/min\r\nAcquisition Method for Identification: Information Dependent Acquisition\r\nAcquisition Method for Quantification: SWATH (Data Independent Acquisition)",
          "Peak Detection / Protein Identification Method": "For protein identification, data was acquired in a data-dependent acquisition mode, and analyzed by ProteinPilot 4.5 (Sciex) with the Uniprot human reference proteome database (release 2017_06). The peptide identification confidence for the dataset was evaluated versus the false discovery rate (FDR). For protein quantification, data was acquired in the data-independent acquisition mode (SWATH) with a variable precursor ion window, and analyzed by Skyline-daily 3.7 with an in-house spectral library. The target peptide peaks were identified with less than 1% FDR, and all peaks were manually inspected. The levels of proteins were calculated based on the sum of the peak areas of unique unmodified tryptic peptides without miscleavage.",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000314",
          "JPOST ID": "JPST000553",
          "Total Data Volume": "306 MB\r\nwiff: meta data (measument conditions)\r\nwiff.scan: raw spectral data\r\namf: a list of peaks\r\ntxt: a list of proteins",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Sumio Ohtsuki",
        "Affiliation": "Faculty of Life Sciences, Kumamoto University",
        "Project / Group Name": "Laboratory of Pharmaceutical Microbiology",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)",
            "Title": "Cancer diagnosis/drug efficiency evaluation biomarker research by comprehensive metabolomics/targeted proteomics and establishment of innovative integrated clinical diagnosis network",
            "Project Number": "JP19gm0710013"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Effects of Differences in Pre-Analytical Processing on Blood Protein Profiles Determined With SWATH-MS",
          "DOI": "doi: 10.1016/j.jprot.2020.103824",
          "Data Set ID": "JGAD000314"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0220.v1": {
          "Research ID": "hum0220.v1",
          "Release Date": "2020/06/02",
          "Type of Data": "Mass Spectrometry",
          "description": "The plasma samples were prepared by centrifugation after storage of blood at room temperature for 0, 15 or 30 minutes, or under refrigeration at 0-5°C for 1, 4 or 8 hours. The plasma and serum samples were analyzed by mass spectrometer (.wiff, .wiff.scan, .mgf and .txt files).\nNote：\n"
        }
      }
    }
  },
  "hum0218.v1": {
    "ja": {
      "NBDC Research ID": "hum0218.v1",
      "データ": {
        "E-GEAD-344": {
          "データID": "E-GEAD-344",
          "内容": "NGS（scRNA-seq）",
          "制限": "非制限公開",
          "公開日": "2020/10/09"
        }
      },
      "研究内容の概要": {
        "目的": "全身性強皮症の病態に寄与する単球集団の解明",
        "方法": "末梢血から分取した単球のシングルセルRNA-seq",
        "対象": "全身性強皮症",
        "URL": "http://ryumachi.umin.jp/"
      },
      "分子データ": {
        "E-GEAD-344": {
          "対象": "抗Sc1-70抗体陽性全身性強皮症（ICD10：M340）：3症例",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq]",
          "ライブラリソース": "末梢血より単球を分取し、単細胞へ分離した上で抽出したmRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMARTer ICELL8 Reagent 3’ DE Reagent Kit\r\nNextera XT DNA Library Prep Kit",
          "断片化の方法": "Nextera XT DNA Library Prep Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "Read1：25 bp\r\nRead2：100 bp",
          "マッピング方法": "STAR（GRCh38）",
          "フィルタリング（QC）方法": "プライマー、ポリA,ポリT、 low-quality ends（phred quality score < 25）はCutadaptでトリムした。トリム後にリード長 < 20 塩基のリードを除去した。",
          "遺伝子数": "26288",
          "Genomic Expression Archive ID": "E-GEAD-344",
          "総データ量": "49.6 MB（各遺伝子にマップされたリードのカウントデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "藤尾 圭志",
        "所 属 機 関": "東京大学大学院 医学系研究科 アレルギー・リウマチ学",
        "プロジェクト/研究グループ名": "全身性強皮症患者の遺伝子発現解析",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis",
          "DOI": "doi: 10.1016/j.jaut.2020.102547",
          "データID": "JGAD000309\r\nE-GEAD-344"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0218.v1": {
          "Research ID": "hum0218.v1",
          "公開日": "2020/10/09",
          "内容": "NGS（scRNA-seq）",
          "description": "全身性強皮症3症例の末梢血から分取した単球を単細胞へ分離した上でmRNAを抽出し、scRNA-seq解析（HiSeq）を実施した。解析した際の各遺伝子にマップされたリード数を提供する（txt）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0218.v1",
      "DATA": {
        "E-GEAD-344": {
          "Data Set ID": "E-GEAD-344",
          "Type of Data": "NGS (scRNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/10/09"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the subpopulation of monocytes that are related to the pathophysiology of systemic sclerosis",
        "Methods": "Peripheral blood monocytes from 3 systemic sclerosis patients were collected and a single cell RNA-seq was performed for 984 cells.",
        "Participants/Materials": "Systemic sclerosis",
        "URL": "https://www.h.u-tokyo.ac.jp/english/centers-services/clinical-divisions/allergy-and-rheumatology/index.html"
      },
      "MOLECULAR DATA": {
        "E-GEAD-344": {
          "Participants/Materials": "Systemic sclerosis (ICD10: M340): 3 cases",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq]",
          "Library Source": "RNAs extracted from a single cell isolated from peripheral blood monocytes",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMARTer ICELL8 Reagent 3' DE Reagent Kit\r\nNextera XT DNA Library Prep Kit",
          "Fragmentation Methods": "Nextera XT DNA Library Prep Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "Read1: 25 bp\r\nRead2: 100 bp",
          "Mapping Methods": "STAR (GRCh38)",
          "QC Methods": "The sequencing primer, poly-A, and poly-T were trimmed by Cutadapt and low-quality ends (phred quality score < 25) were also trimmed. After trimming, the read (the length of which was < 20 bases) was also removed.",
          "Gene Number": "26288",
          "Genomic Expression Archive ID": "E-GEAD-344",
          "Total Data Volume": "49.6 MB (count data, txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Keishi Fujio",
        "Affiliation": "Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "Gene expression analysis of systemic sclerosis patients.",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis",
          "DOI": "doi: 10.1016/j.jaut.2020.102547",
          "Data Set ID": "JGAD000309\r\nE-GEAD-344"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0218.v1": {
          "Research ID": "hum0218.v1",
          "Release Date": "2020/10/09",
          "Type of Data": "NGS (scRNA-seq)",
          "description": "Peripheral blood monocytes from 3 systemic sclerosis patients were collected and a single cell RNA-seq was performed for 984 cells (HiSeq). Read count data mapped to each gene are provided as txt files.\nNote：\n"
        }
      }
    }
  },
  "hum0217.v1": {
    "ja": {
      "NBDC Research ID": "hum0217.v1",
      "データ": {
        "JGAS000217": {
          "データID": "JGAS000217",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/03/02"
        }
      },
      "研究内容の概要": {
        "目的": "大腸鋸歯状病変（鋸歯状ポリープ）の発癌機序を明らかにすること",
        "方法": "39遺伝子のTarget Capture Sequencing（NGS）",
        "対象": "大腸鋸歯状病変（鋸歯状ポリープ）50症例（腫瘍組織）"
      },
      "分子データ": {
        "JGAS000217": {
          "対象": "大腸鋸歯状病変（鋸歯状ポリープ）（ICD10：C18）：50症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "ACVR2A, AMER1, APC, ARID1A, ATM, AXIN2, \r\nBMP4, BRAF, CDKN2A, CHD7, CHD8, CTNNB1, \r\nDKK1, DKK2, DKK3, DKK4, FBXW7, FZD3, \r\nFZD10, GNAS, GSK3B, HRAS, KRAS, LRP5, \r\nMLH1, MSH6, NRAS, PIF1, PIK3CA, PTEN, \r\nRBL1, RNF43, SMAD4, SOX9, TCF7L2, TELO2, \r\nTGFBR2, TP53, XAF1",
          "Platform": "Thermo Fisher Scientific [Ion Torrent]",
          "ライブラリソース": "大腸鋸歯状病変（鋸歯状ポリープ）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Library Kit Plus",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "約120 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000303",
          "総データ量": "29 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "澤田 武",
        "所 属 機 関": "金沢大学がん進展制御研究所 腫瘍制御研究分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "金沢大学がん進展制御研究所共同研究（平成29年度、30年度）",
            "タイトル": "大腸鋸歯状腺腫を前癌病変とする大腸発癌機構の分子学的解明",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Significance of gene mutations in the Wnt signaling pathway in traditional serrated adenomas of the colon and rectum",
          "DOI": "doi: 10.1371/journal.pone.0229262",
          "データID": "JGAD000303"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0217.v1": {
          "Research ID": "hum0217.v1",
          "公開日": "2020/03/02",
          "内容": "NGS（Target Capture）",
          "description": "50名の大腸鋸歯状病変（鋸歯状ポリープ）から抽出したDNAを用いた39遺伝子のTarget Capture Sequencing解析結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0217.v1",
      "DATA": {
        "JGAS000217": {
          "Data Set ID": "JGAS000217",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/03/02"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify molecular and clinicopathological characteristics of colorectal serrated lesions",
        "Methods": "Targeted capture sequencing analysis of 39 genes mutated in colorectal cancers and/or serrated lesions",
        "Participants/Materials": "50 serrated lesions, including TSAs, SSAs and microvesicular hyperplastic polyps"
      },
      "MOLECULAR DATA": {
        "JGAS000217": {
          "Participants/Materials": "colorectal serrated lesions (ICD10: C18): 50 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "ACVR2A, AMER1, APC, ARID1A, ATM, AXIN2, \r\nBMP4, BRAF, CDKN2A, CHD7, CHD8, CTNNB1, \r\nDKK1, DKK2, DKK3, DKK4, FBXW7, FZD3, \r\nFZD10, GNAS, GSK3B, HRAS, KRAS, LRP5, \r\nMLH1, MSH6, NRAS, PIF1, PIK3CA, PTEN, \r\nRBL1, RNF43, SMAD4, SOX9, TCF7L2, TELO2, \r\nTGFBR2, TP53, XAF1",
          "Platform": "Thermo Fisher Scientific [Ion Torrent]",
          "Library Source": "DNAs extracted from colorectal serrated lesions",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Library Kit Plus",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "about 120 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000303",
          "Total Data Volume": "29 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takeshi Sawada",
        "Affiliation": "Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Collaborative Research Grant of Cancer Research Institute, Kanazawa University",
            "Title": "Molecular analysis of alternative serrated pathway originating from colorectal traditional serrated adenoma",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Significance of gene mutations in the Wnt signaling pathway in traditional serrated adenomas of the colon and rectum",
          "DOI": "doi: 10.1371/journal.pone.0229262",
          "Data Set ID": "JGAD000303"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0217.v1": {
          "Research ID": "hum0217.v1",
          "Release Date": "2020/03/02",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from 50 colorectal serrated lesions were used for a target capture sequencing analysis for 39 genes. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0216.v4": {
    "ja": {
      "NBDC Research ID": "hum0216.v4",
      "データ": {
        "JGAS000216": {
          "データID": "JGAS000216",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/02/07"
        },
        "JGAS000244": {
          "データID": "JGAS000244",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/09/25"
        },
        "JGAS000216（データ追加）": {
          "データID": "JGAS000216（データ追加）",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/29"
        },
        "JGAS000279": {
          "データID": "JGAS000279",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/04/13"
        }
      },
      "研究内容の概要": {
        "目的": "消化器癌を含む固形癌の免疫状態を明らかにする。また、抗腫瘍免疫応答の解明のため、体細胞遺伝子における変異負荷を調査する。",
        "方法": "whole exome sequecing解析",
        "対象": ""
      },
      "分子データ": {
        "JGAS000216": {
          "対象": "肺腺がん（ICD10：C349）：17症例\r\n胃がん（ICD10：C16）：23症例\r\n（腫瘍組織、非腫瘍組織のペア）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "肺腺がんおよび胃がんの腫瘍組織と非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT Human All Exon system",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000302（肺腺がん）\r\nJGAD000327（胃がん）",
          "総データ量": "JGAD000302：230 GB （fastq）\r\nJGAD000327：742 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000244": {
          "対象": "胃がん（ICD10：C16）：26症例\r\n肺がん（ICD10：C34）：9症例\r\n悪性黒色腫（ICD10：C43）：5症例\r\n（腫瘍組織、非腫瘍組織のペア）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "胃がん、肺がんおよび悪性黒色腫の腫瘍組織と非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra DNA Library Prep Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "120-150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000344",
          "総データ量": "782 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000279": {
          "対象": "大腸がん（ICD10：C18.9）：7症例（15検体）\r\n（腫瘍組織、非腫瘍組織のペア）\r\n（1症例は横行結腸の腫瘍組織、S状結腸の腫瘍組織、および非腫瘍組織）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "大腸がんの腫瘍組織と非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra DNA Library Prep Kit\r\nSureSelect Human All Exon Kit v5",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000385",
          "総データ量": "137 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "西川 博嘉",
        "所 属 機 関": "国立がん研究センター 先端医療開発センター 免疫TR分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん医療創生研究事業（P-CREATE）",
            "タイトル": "がん細胞および免疫応答解析に基づくがん免疫療法効果予測診断法の確立",
            "研究課題番号": "JP16cm0106301"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Blockade of EGFR improves responsiveness to PD1 blockade in EGFR-mutated non-small cell lung cancer",
          "DOI": "doi: 10.1126/sciimmunol.aav3937",
          "データID": "JGAD000302"
        },
        "2": {
          "タイトル": "The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies",
          "DOI": "doi: 10.1038/s41590-020-0769-3",
          "データID": "JGAD000344"
        },
        "3": {
          "タイトル": "Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer",
          "DOI": "doi: 10.1172/jci.insight.137365",
          "データID": "JGAD000385"
        }
      },
      "制限公開データの利用者一覧": {
        "河野 隆志": {
          "研究代表者": "河野 隆志",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "AYA （Adolescence and Young Adult） 世代がんの個別化予防に資する遺伝要因の同定を目指す研究",
          "利用期間": "JGAD000302, JGAD000327, JGAD000385"
        },
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000302, JGAD000344"
        }
      },
      "リリース情報": {
        "hum0216.v4": {
          "Research ID": "hum0216.v4",
          "公開日": "2021/04/13",
          "内容": "NGS（Exome）",
          "description": "大腸がん7症例（腫瘍組織およびペア非腫瘍組織、1症例は横行結腸の腫瘍組織、S状結腸の腫瘍組織、および非腫瘍組織）から抽出したDNAを用いた全エクソームシークエンス解析の結果をfastqファイルにて提供する。SureSelect Human All Exon Kit v5によりDNAライブラリを作成し、NovaSeq 6000（Illumina）にて平均長150塩基を解読した（paired-end）。\n"
        },
        "hum0216.v3": {
          "Research ID": "hum0216.v3",
          "公開日": "2021/03/29",
          "内容": "NGS（Exome）",
          "description": "胃がんの手術を実施した23症例（腫瘍組織およびペア非腫瘍組織）から抽出したDNAを用いた全エクソームシークエンス解析の結果をfastqファイルにて提供する。SureSelect XT Human All Exon systemによりDNAライブラリを作成し、HiSeq 2500（Illumina）にて平均長100塩基を解読した（paired-end）。\n"
        },
        "hum0216.v2": {
          "Research ID": "hum0216.v2",
          "公開日": "2020/09/25",
          "内容": "NGS（Exome）",
          "description": "PD-1阻害治療を実施した進行悪性腫瘍患者40症例（胃がん26症例、肺がん9症例、悪性黒色腫5症例）の腫瘍組織およびペア非腫瘍組織から抽出したDNAを用いた全エクソームシークエンス解析の結果をfastqファイルにて提供する。NEBNext Ultra DNA Library Prep KitによりDNAライブラリを作成し、HiSeq 2500（Illumina）にて平均長120-150塩基を解読した（paired-end）。\n"
        },
        "hum0216.v1": {
          "Research ID": "hum0216.v1",
          "公開日": "2020/02/07",
          "内容": "NGS（Exome）",
          "description": "肺腺がんの摘出手術を実施した17症例（腫瘍組織およびペア非腫瘍組織）から抽出したDNAを用いた全エクソームシークエンス解析の結果をfastqファイルにて提供する。SureSelect XT Human All Exon systemによりDNAライブラリを作成し、HiSeq 2500（Illumina）にて平均長100塩基を解読した（paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0216.v4",
      "DATA": {
        "JGAS000216": {
          "Data Set ID": "JGAS000216",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/02/07"
        },
        "JGAS000244": {
          "Data Set ID": "JGAS000244",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/09/25"
        },
        "JGAS000216 (Data addition)": {
          "Data Set ID": "JGAS000216 (Data addition)",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/29"
        },
        "JGAS000279": {
          "Data Set ID": "JGAS000279",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/04/13"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate immune status of solid tumors including gastrointestinal cancer and to investigate tumor mutation burden for clarification of anti-tumor immuno-response.",
        "Methods": "whole exome sequencing analysis",
        "Participants/Materials": ""
      },
      "MOLECULAR DATA": {
        "JGAS000216": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 17 cases\r\ngastric cancer (ICD10: C16): 23 cases\r\n(matched tumor and non-tumor tissues)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor or non-tumor tissues from lung adenocarcinomas and gastric cancers",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT Human All Exon system",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000302 (lung adenocarcinoma)\r\nJGAD000327 (gastric cancer)",
          "Total Data Volume": "JGAD000302: 230 GB (fastq)\r\nJGAD000327: 742 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000244": {
          "Participants/Materials": "gastric cancer (ICD10: C16): 26 cases\r\nlung cancer (ICD10: C34): 9 cases\r\nmalignant melanoma (ICD10: C43): 5 cases\r\n(matched tumor and non-tumor tissues)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor or non-tumor tissues from gastric cancers, lung cancers and malignant melanomas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra DNA Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "120-150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000344",
          "Total Data Volume": "782 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000279": {
          "Participants/Materials": "colorectal cancer (ICD10: C18.9): 7 cases (15 samples)\r\n(matched tumor and non-tumor tissues)\r\n(transverse tumor, sigmoid tumor and matched non-tumor tissues for 1 case)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor or non-tumor tissues from colorectal cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra DNA Library Prep Kit\r\nSureSelect Human All Exon Kit v5",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000385",
          "Total Data Volume": "137 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyoshi Nishikawa",
        "Affiliation": "Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Establishment of predictive methods for cancer immunotherapy based on the evaluation of cancer cells and immune responses",
            "Project Number": "JP16cm0106301"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Blockade of EGFR improves responsiveness to PD1 blockade in EGFR-mutated non-small cell lung cancer",
          "DOI": "doi: 10.1126/sciimmunol.aav3937",
          "Data Set ID": "JGAD000302"
        },
        "2": {
          "Title": "The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies",
          "DOI": "doi: 10.1038/s41590-020-0769-3",
          "Data Set ID": "JGAD000344"
        },
        "3": {
          "Title": "Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer",
          "DOI": "doi: 10.1172/jci.insight.137365",
          "Data Set ID": "JGAD000385"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Takashi Kohno": {
          "Principal Investigator": "Takashi Kohno",
          "Affiliation": "Division of Genome Biology, National Cancer Center Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Identification of genetic risk factors in AYA (Adolescence and Young Adult) cancer",
          "Period of Data Use": "JGAD000302, JGAD000327, JGAD000385"
        },
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000302, JGAD000344"
        }
      },
      "Release Note": {
        "hum0216.v4": {
          "Research ID": "hum0216.v4",
          "Release Date": "2021/04/13",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from matched tumor and non-tumor tissues from 7 patients with colorectal cancer were used for the whole exome sequencing (fastq files). DNA libraries were established with a SureSelect Human All Exon Kit v5 and sequenced by Illumina NovaSeq 6000 system (paired-end; 150 bp). \n"
        },
        "hum0216.v3": {
          "Research ID": "hum0216.v3",
          "Release Date": "2021/03/29",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from matched tumor and non-tumor tissues from 23 patients with gastric cancers were used for the whole exome sequencing (fastq files). DNA libraries were established with a SureSelect XT Human All Exon system and sequenced by Illumina HiSeq 2500 system (paired-end; 100 bp). \n"
        },
        "hum0216.v2": {
          "Research ID": "hum0216.v2",
          "Release Date": "2020/09/25",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from matched tumor and non-tumor tissues from 40 patients with malignancies who received PD-1 blackade therapy were used for the whole exome sequencing (fastq files). DNA libraries were established with a NEBNext Ultra DNA Library Prep Kit and sequenced by Illumina HiSeq 2500 system (paired-end; 120-150 bp). \n"
        },
        "hum0216.v1": {
          "Research ID": "hum0216.v1",
          "Release Date": "2020/02/07",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from matched tumor and non-tumor tissues from 17 patients with lung adenocarcinoma were used for the whole exome sequencing (fastq files). DNA libraries were established with a SureSelect XT Human All Exon system and sequenced by Illumina HiSeq 2500 system (paired-end; 100 bp). \nNote:\n"
        }
      }
    }
  },
  "hum0215.v1": {
    "ja": {
      "NBDC Research ID": "hum0215.v1",
      "データ": {
        "JGAS000532": {
          "データID": "JGAS000532",
          "内容": "NGS（RNA-seq）から得られたTranscripts Per Kilobase Million（TPM）データ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/28"
        }
      },
      "研究内容の概要": {
        "目的": "アルツハイマー病の関連遺伝子群を同定し予知診断、治療に応用する",
        "方法": "血液細胞の網羅的遺伝子発現解析（RNA-seq）",
        "対象": "アルツハイマー病317症例、軽度認知障害432症例および、認知機能正常107名（計856名）",
        "URL": "https://www.ncgg.go.jp/ri/lab/mgc/index.html"
      },
      "分子データ": {
        "JGAS000532": {
          "対象": "アルツハイマー病（ICD10：F00）：317症例\r\n軽度認知障害（ICD10：F06.7）：432症例\r\n認知機能正常：107名",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded Total RNA with Ribo-Zero Globin、IDT for Illumina TruSeq UD Indexes",
          "断片化の方法": "酵素反応（Elute, Prime, Fragment High Mix）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151 bp",
          "マッピング方法": "STAR（ver. 2.5.2b）",
          "リファレンス配列": "GRCh37",
          "リードカウント決定アルゴリズム（ソフトウェア）": "subread package（ver. 1.6.6）",
          "フィルタリング（QC）方法": "FastQC（ver. 0.11.7）、Cutadapt（ver. 1.16）",
          "遺伝子数": "約50,000",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000651",
          "総データ量": "48 MB（csv [TPM data]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "尾崎 浩一",
        "所 属 機 関": "国立長寿医療研究センター 研究所 メディカルゲノムセンター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "長寿医療研究開発費",
            "タイトル": "老年病の精密医療実現に向けた疾患遺伝子機能解明とゲノム−トランスクリプトーム解析研究（21-23）",
            "研究課題番号": "21-23"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Identification of potential blood biomarkers for early diagnosis of Alzheimer’s disease through immune landscape analysis",
          "DOI": "doi: 10.1038/s41514-022-00096-9",
          "データID": "JGAD000651"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0215.v1": {
          "Research ID": "hum0215.v1",
          "公開日": "2022/09/28",
          "内容": "NGS（RNA-seq）から得られたTPMデータ",
          "description": "アルツハイマー病317症例、軽度認知障害432症例および、認知機能正常107名（計856名）の末梢血より抽出したRNAを用いたRNA-seq解析データから算出したTPMデータをcsvファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0215.v1",
      "DATA": {
        "JGAS000532": {
          "Data Set ID": "JGAS000532",
          "Type of Data": "Transcripts Per Kilobase Million (TPM) data calculated from NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/28"
        }
      },
      "SUMMARY": {
        "Aims": "Application to future medicine by analyzing Alzheimer's disease-associated genes",
        "Methods": "Whole RNA-seq of blood cells",
        "Participants/Materials": "Alzheimer's disease, mild cognitive impairment, and healthy individuals"
      },
      "MOLECULAR DATA": {
        "JGAS000532": {
          "Participants/Materials": "Alzheimer's disease (ICD10: F00): 317 cases\r\nMild cognitive impairment (ICD10: F06.7): 432 cases\r\nHealthy controls: 107 individuals",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded Total RNA with Ribo-Zero Globin and IDT for Illumina TruSeq UD Indexes",
          "Fragmentation Methods": "Enzymatic fragmentation (Elute, Prime, Fragment High Mix)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "151 bp",
          "Mapping Methods": "STAR (ver. 2.5.2b)",
          "Reference Genome Sequence": "GRCh37",
          "Detecting method for read count (software)": "subread package (ver. 1.6.6)",
          "QC": "FastQC (ver. 0.11.7) and Cutadapt (ver. 1.16)",
          "Gene Number": "about 50,000",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000651",
          "Total Data Volume": "48 MB (csv [TPM data])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kouichi Ozaki",
        "Affiliation": "Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Research Funding for Longevity Sciences from the NCGG",
            "Title": "Genomic and transcriptome analysis for geriatric diseases.",
            "Project Number": "21-23"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Identification of potential blood biomarkers for early diagnosis of Alzheimer’s disease through immune landscape analysis",
          "DOI": "doi: 10.1038/s41514-022-00096-9",
          "Data Set ID": "JGAD000651"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0215.v1": {
          "Research ID": "hum0215.v1",
          "Release Date": "2022/09/28",
          "Type of Data": "TPM data calculated from NGS (RNA-seq)",
          "description": "RNAs extracted from peripheral blood cells of Alzheimer's disease, mild cognitive impairment, and healthy controls were used for the whole RNA-seq analysis. TPM data calculated from NGS (RNA-seq) are provided (csv).\nNote：\n"
        }
      }
    }
  },
  "hum0214.v8": {
    "ja": {
      "NBDC Research ID": "hum0214.v8",
      "データ": {
        "JGAS000220": {
          "データID": "JGAS000220",
          "内容": "NGS（ATAC-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/03/09"
        },
        "E-GEAD-397": {
          "データID": "E-GEAD-397",
          "内容": "RNA-seqのリードカウント",
          "制限": "非制限公開",
          "公開日": "2021/04/28"
        },
        "E-GEAD-398": {
          "データID": "E-GEAD-398",
          "内容": "Conditional eQTLサマリーデータ（有意データのみ）",
          "制限": "非制限公開",
          "公開日": "2021/04/28"
        },
        "E-GEAD-420": {
          "データID": "E-GEAD-420",
          "内容": "Nominal eQTLデータ（全データ）",
          "制限": "非制限公開",
          "公開日": "2021/04/28"
        },
        "JGAS000296": {
          "データID": "JGAS000296",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/01/21"
        },
        "JGAS000486": {
          "データID": "JGAS000486",
          "内容": "NGS（RNA-seq）解析によるリードカウントデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/08/25"
        },
        "JGAS000598": {
          "データID": "JGAS000598",
          "内容": "NGS（RNA-seq）解析によるリードカウントデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2023/03/28"
        },
        "JGAS000485": {
          "データID": "JGAS000485",
          "内容": "RNA-seqによるB細胞免疫細胞サブセットのB細胞受容体レパトアデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2023/07/06"
        }
      },
      "研究内容の概要": {
        "目的": "免疫細胞における遺伝子発現制御と免疫疾患に対する寄与を解明する",
        "方法": "",
        "対象": "全身性強皮症、全身性エリテマトーデス、筋炎、混合性結合組織病、シェーグレン症候群、関節リウマチ、ベーチェット病、成人スチル病、ANCA関連血管炎、高安動脈炎、対照健常者",
        "URL": "http://ryumachi.umin.jp/"
      },
      "分子データ": {
        "JGAS000220（RNA-seq：全身性強皮症）": {
          "対象": "全身性強皮症（ICD10：M340）：21症例\r\n対照健常者：13名",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血免疫細胞19画分（Naive_B, SM_B, USM_B, DN_B, Plasmablast, Th1, Th2, Th17, Tfh, Naive_CD4, Mem_CD4, Fr._II_eTreg, Naive_CD8, Mem_CD8, mDC, pDC, CD16p_Mono, CD16n_Mono, NK）より抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-seq v4 Ultra Low Input RNA Kit",
          "断片化の方法": "SMART-seq v4 Ultra Low Input RNA Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "マッピング方法": "STAR（hg38）",
          "フィルタリング（QC）方法": "アダプター配列及び3’の低クオリティー塩基をトリムした（Phred quality score < 20）。50塩基未満のリード、及び低クオリティーの塩基を多く含むリード（20%を超える塩基で、Phred quality score < 20）を除去した。ユニークマップ率が80%未満、もしくはユニークマップリード数が5.00 x 106未満のサンプルは除去した。同一サブセット内の遺伝子発現の相関係数（Di）を計算した。Diが0.9未満のサンプルは除去した。",
          "遺伝子数": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000309",
          "総データ量": "125 MB（各遺伝子にマップされたリードのカウントデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000220（RNA-seq：ANCA関連血管炎）": {
          "対象": "ANCA関連血管炎（ICD10：M318）：26症例\r\n対照健常者：28名（上記13名を含む）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血免疫細胞20画分（Naive_B, SM_B, USM_B, DN_B, Plasmablast, Th1, Th2, Th17, Tfh, Naive_CD4, Mem_CD4, Fr._II_eTreg, Naive_CD8, Mem_CD8, mDC, pDC, CD16p_Mono, CD16n_Mono, NK, Neu）より抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-seq v4 Ultra Low Input RNA Kit",
          "断片化の方法": "SMART-seq v4 Ultra Low Input RNA Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "マッピング方法": "STAR（hg38）",
          "フィルタリング（QC）方法": "アダプター配列及び3’の低クオリティー塩基をトリムした（Phred quality score < 20）。50塩基未満のリード、及び低クオリティーの塩基を多く含むリード（20%を超える塩基で、Phred quality score < 20）を除去した。ユニークマップ率が80%未満、もしくはユニークマップリード数が5.00 x 106未満のサンプルは除去した。同一サブセット内の遺伝子発現の相関係数（Di）を計算した。Diが0.9未満のサンプルは除去した。",
          "遺伝子数": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000310",
          "総データ量": "125 MB（各遺伝子にマップされたリードのカウントデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "E-GEAD-397（RNA-seq）": {
          "対象": "全身性エリテマトーデス（ICD10：M329）：62症例\r\n筋炎（ICD10：M339, M332）：65症例\r\n全身性強皮症（ICD10：M340）：67症例\r\n混合性結合組織病（ICD10：M351）：19症例\r\nシェーグレン症候群（ICD10：M350）：18症例\r\n関節リウマチ（ICD10：M0690）：25症例\r\nベーチェット病（ICD10：M352）：23症例\r\n成人スチル病（ICD10：M0610）：18症例\r\nANCA関連血管炎（ICD10：M318）：26症例\r\n高安動脈炎（ICD10：M314）：16症例\r\n対照健常者：92名",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血免疫細胞28画分（Naive_CD4, Mem_CD4, Fr._I_nTreg, Fr._II_eTreg, Fr._III_T, Th1, Th2, Th17, Tfh, NK, Naive_CD8, Mem_CD8, EM_CD8, CM_CD8, TEMRA_CD8, Naive_B, USM_B, SM_B, DN_B, Plasmablast, CL_Mono（別名CD16n_Mono）, CD16p_Mono, Int_Mono, NC_Mono, mDC, pDC, LDG, Neu）より抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-seq v4 Ultra Low Input RNA Kit",
          "断片化の方法": "SMART-seq v4 Ultra Low Input RNA Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "マッピング方法": "STAR（GRCh38）",
          "フィルタリング（QC）方法": "cutadapt (v1.16)およびfastx-toolkit（v0.0.14）を用いてアダプター配列及び3’の低クオリティー塩基をトリムした（Phred quality score < 20）。低クオリティーの塩基が20%を超えるリードを除去した。STAR（v2.5.3）のtwo-pass modeを用いてGRCh38へのマッピングを行った（Gencode version 27アノテーション）。ユニークマップ率が90%未満（Plasmablastでは70%未満、他のB細胞サブセットでは<85%未満）、もしくはユニークマップリード数が6.00 x 10^6未満のサンプルは除去した。遺伝子発現はHTSeq（v 0.11.2）で定量した。各細胞分画で低発現遺伝子（90%を超えるサンプルで10リード未満）を除外し、edgeRのTMMノーマライゼーションを実施、ログcount per million（CPM）変換、ComBatによるバッチ除去を行った上で、同一サブセット内の遺伝子発現のSpearman相関係数を計算し、平均値が0.9未満のサンプルを除外した。",
          "遺伝子数": "53344",
          "Genomic Expression Archive ID": "E-GEAD-397",
          "総データ量": "1.3 GB（疾患名、phase情報、年齢、性別データおよび各遺伝子にマップされたリードのカウントデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "E-GEAD-398 / E-GEAD-420（eQTL）": {
          "対象": "全身性エリテマトーデス（ICD10：M329）：62症例\r\n筋炎（ICD10：M339, M332）：65症例\r\n全身性強皮症（ICD10：M340）：67症例\r\n混合性結合組織病（ICD10：M351）：19症例\r\nシェーグレン症候群（ICD10：M350）：18症例\r\n関節リウマチ（ICD10：M0690）：24症例\r\nベーチェット病（ICD10：M352）：23症例\r\n成人スチル病（ICD10：M0610）：18症例\r\nANCA関連血管炎（ICD10：M318）：25症例\r\n高安動脈炎（ICD10：M314）：16症例\r\n対照健常者：79名",
          "規模": "eQTL",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "全血より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free Library prep kit",
          "断片化の方法": "TruSeq DNA PCR-Free Library prep kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151 bp",
          "マッピング方法": "BWA-MEM（GRCh38）",
          "フィルタリング（QC）方法": "全ゲノムシーケンスデータはGATK（v 4.0.6.0）best practiceに準じて解析した。検出バリアント率が99%未満のサンプルは除外した。遺伝型のインピュテーションにはBEAGLE（v 5.1）を用いた。Call rate <85%, Hardy-Weinberg平衡検定P値<1.0x10-6, マイナーアレル頻度1%未満のバリアントは除外した。",
          "遺伝子数": "E-GEAD-398：19441\r\nE-GEAD-420：22381",
          "eQTL検出方法": "各細胞サブセットで80%を超えるサンプルで5リード未満、もしくは0.5 CPM未満の低発現遺伝子を除外した。常染色体遺伝子発現データのTMMノーマライゼーション、CPM変換、inverse normal transformによるサンプル間ノーマライゼーションを実施した。また隠れた共変量の推測のためPEERを実施した。eQTL解析の共変量として、上位2つの遺伝子主成分、サンプル回収のphase、性別、PEERによる潜在的因子を含めた。Phase 1で回収したMem CD8はPhase 2ではCM CD8とEM CD8として分割しているため、大部分の細胞の含まれるEM CD8と統合してeQTL解析を実施した。各細胞サブセットでのConditional eQTL解析では、QTLtoolsのpermutation passによる10000回のパーミュテーションを実施し、各遺伝子レベルでのFDR <0.05と対応するnominal p-value thresholdを定めた。その上で、QTL toolsのconditional passを用いてforward-backward stepwise regression eQTL analysisを実施した。Nominal eQTL解析では QTL toolsのnominal passを用いて、各遺伝子の転写開始点から1M塩基対のバリアントと遺伝子発現の関連を解析した。",
          "Genomic Expression Archive ID": "E-GEAD-398\r\nE-GEAD-420（2021/6/9: Added columns for REF/ALT allele. Slope indicates the effect size of alternative alleles.）",
          "総データ量": "E-GEAD-398： 3.9 GB（eQTLサマリーデータ [FDR<0.05]、txt）\r\nE-GEAD-420： 38 GB（全eQTLサマリーデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAD000296（RNA-seq）": {
          "対象": "全身性強皮症（ICD10：M340）：50症例\r\n対照健常者：48名\r\n（対象の一部はE-GEAD-397と重複）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血免疫細胞24画分（Naive_CD4, Mem_CD4, Fr._I_nTreg, Fr._II_eTreg, Fr._III_T, Th1, Th2, Th17, Tfh, NK, Naive_CD8, EM_CD8, CM_CD8, TEMRA_CD8, Naive_B, USM_B, SM_B, DN_B, Plasmablast, CL_Mono, Int_Mono, NC_Mono, mDC, pDC）より抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-seq v4 Ultra Low Input RNA Kit",
          "断片化の方法": "SMART-seq v4 Ultra Low Input RNA Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "マッピング方法": "STAR（hg38）",
          "フィルタリング（QC）方法": "アダプター配列及び3’の低クオリティー塩基をトリムした（Phred quality score < 20）。50塩基未満のリード、及び低クオリティーの塩基を多く含むリード（20%を超える塩基で、Phred quality score < 20）を除去した。ユニークマップ率が80%未満、もしくはユニークマップリード数が5.00 x 106未満のサンプルは除去した。同一サブセット内の遺伝子発現の相関係数（Di）を計算した。Diが0.9未満のサンプルは除去した。",
          "遺伝子数": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000406",
          "総データ量": "172.8 MB（各遺伝子にマップされたリードのカウントデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000220（RNA-seq：全身性エリテマトーデス）": {
          "対象": "全身性エリテマトーデス（ICD10：M329）：107症例\r\n対照健常者：92名",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血免疫細胞19画分（Naive_CD4, Mem_CD4, Fr._II_eTreg, Th1, Th2, Th17, Tfh, NK, Naive_CD8, Mem_CD8, Naive_B, USM_B, SM_B, DN_B, Plasmablast, CD16n_Mono, CD16p_Mono, mDC, pDC）より抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Smart-Seq v2（test cohort）、SMART-seq v4 Ultra Low Input RNA Kit（validation cohort）",
          "断片化の方法": "Smart-Seq v2（test cohort）、SMART-seq v4 Ultra Low Input RNA Kit（validation cohort）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "76 bp（test cohort）\r\n100 bp（validation cohort）",
          "マッピング方法": "STAR（GRCh38）",
          "フィルタリング（QC）方法": "FASTQファイルはSTAR（v2.5）によってGRCh38; GenBank assembly GCA_000001405.18にマッピングした。カウントテーブルの作成にはHTSeq-count（v0.6.1）を用いた。fastx-toolkit（v0.0.14）を用いてアダプター配列及び3’の低クオリティー塩基をトリムした（Phred quality score < 20）。ミトコンドリア遺伝子発現は細胞ストレスを反映するため、ミトコンドリア遺伝子発現 <8%をカットオフに追加した。同一サブセット内の遺伝子発現の相関係数（r）を計算し、r2 < 0.8のサンプルは外れ値として除外した。",
          "遺伝子数": "26354（test cohort）\r\n26485（validation cohort）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000371\r\nJGAD000372",
          "総データ量": "250 MB（各遺伝子にマップされたリードのカウントデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000220（ATAC-seq）": {
          "対象": "全身性エリテマトーデス（ICD10：M329）：8症例\r\n対照健常者：8名",
          "規模": "ATAC-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血免疫細胞15画分（Naive_B, SM_B, USM_B, DN_B, Plasmablast, Th1, Th2, Th17, Tfh, Naive_CD4, Mem_CD4, Naive_CD8, CD16p_Mono, CD16n_Mono, NK）より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Fast-ATAC-seq protocol",
          "断片化の方法": "Fast-ATAC-seq protocol",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "102 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000373",
          "総データ量": "27 GB（tdf、bed）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000486（RNA-seq：全身性エリテマトーデス）": {
          "対象": "全身性エリテマトーデス（ICD10：M329）：159症例\r\n（22症例については、経時的な解析を実施）\r\n対照健常者：89名",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500、NovaSeq 6000]",
          "ライブラリソース": "末梢血免疫細胞27画分（Naive_CD4, Mem_CD4, Th1, Th2, Th17, Tfh, Fr._I_nTreg, Fr._II_eTreg, Fr._III_T, Naive_CD8, EM_CD8, CM_CD8, TEMRA_CD8, NK, Naive_B, USM_B, SM_B, DN_B, Plasmablast, CL_Mono (or CD16n_Mono), CD16p_Mono, Int_Mono, NC_Mono, mDC, pDC, Neu, LDG）より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-seq v4 Ultra Low Input RNA Kit",
          "断片化の方法": "SMART-seq v4 Ultra Low Input RNA Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp （HiSeq 2500）、150 bp （NovaSeq 6000）",
          "マッピング方法": "STAR（GRCh38）",
          "フィルタリング（QC）方法": "アダプター配列及び3’の低クオリティー塩基をトリムした（Phred quality score < 20）。低クオリティーの塩基が20%を超えるリードを除去した。ユニークマップ率が80%未満、もしくはユニークマップリード数が5.00 x 106未満のサンプルは除去した。同一サブセット内の遺伝子発現の相関係数（Di）が0.9未満のサンプルは除去した。同一個人のwhole genome sequencingのhetero locusに対するgenotypeの一致率が0.9未満のサンプルは除去した。",
          "遺伝子数": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000603",
          "総データ量": "478.3 MB（各遺伝子にマップされたリードのカウントデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000598（RNA-seq：関節リウマチ）": {
          "対象": "関節リウマチ（ICD10：M0690）：50症例\r\n（15症例については、経時的な解析を実施）\r\n対照健常者：39名\r\n（対象の一部はE-GEAD-397と重複）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血免疫細胞18画分（CD16p_Mono, CL_Mono, DN_B, Fr_II_eTreg, mDC, Mem_CD4, Naive_B, Naive_CD4, Neu, NK, pDC, Plasmablast, SM_B, Tfh, Th1, Th17, Th2, USM_B）より抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-seq v4 Ultra Low Input RNA Kit",
          "断片化の方法": "SMART-seq v4 Ultra Low Input RNA Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "マッピング方法": "STAR（hg38）",
          "フィルタリング（QC）方法": "アダプター配列及び3’の低クオリティー塩基をトリムした（Phred quality score < 20）。50塩基未満のリード、及び低クオリティーの塩基を多く含むリード（20%を超える塩基で、Phred quality score < 20）を除去した。ユニークマップ率が80%未満、もしくはユニークマップリード数が5.00 x 106未満のサンプルは除去した。同一サブセット内の遺伝子発現の相関係数（Di）を計算した。Diが平均-2標準偏差未満のサンプルは除去した。",
          "遺伝子数": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000727",
          "総データ量": "113.9 MB（各遺伝子にマップされたリードのカウントデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000485（B細胞受容体レパトア解析）": {
          "対象": "全身性エリテマトーデス（ICD10：M329）：136症例（159検体、23検体は経時サンプル）\r\n全身性強皮症（ICD10：M340）：90症例（90検体）\r\n筋炎（ICD10：M339, M332）：85症例（85検体）\r\n混合性結合組織病（ICD10：M351）：21症例（21検体）\r\nシェーグレン症候群（ICD10：M350）：18症例（18検体）\r\n関節リウマチ（ICD10：M0690）：27症例（27検体）\r\nベーチェット病（ICD10：M352）：23症例（23検体）\r\n成人スチル病（ICD10：M0610）：18症例（18検体）\r\nANCA関連血管炎（ICD10：M318）：24症例（24検体）\r\n高安動脈炎（ICD10：M314）：16症例（16検体）\r\n対照健常者：13名（13検体）",
          "規模": "RNA-seq / B細胞受容体レパトア解析",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血B細胞5画分（Naive_B, USM_B, SM_B, DN_B, Plasmablast）より抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-Seq v4 Ultra Low Input RNA Kit",
          "断片化の方法": "SMART-Seq v4 Ultra Low Input RNA Kit",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "マッピング方法": "MiXCR",
          "フィルタリング（QC）方法": "アダプター配列及び3’の低クオリティー塩基をトリムした（Phred quality score < 20）。50塩基未満のリード、及び低クオリティーの塩基を多く含むリード（20%を超える塩基で、Phred quality score < 20）を除去した。 ユニークなCDR-H3配列を 500より多く有するサンプルのみ解析に使用した。",
          "B細胞受容体レパトア解析方法（ソフトウェア）": "MiXCR",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000602",
          "総データ量": "12.9 GB（B細胞受容体レパトアデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "藤尾 圭志",
        "所 属 機 関": "東京大学大学院 医学系研究科 アレルギー・リウマチ学",
        "プロジェクト/研究グループ名": "免疫疾患の免疫細胞マルチオミクス解析",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "日本医療研究開発機構（AMED）免疫アレルギー疾患実用化研究事業",
            "タイトル": "自己免疫性疾患の臓器病変局所におけるシングルセルRNAシークエンスを用いたマルチオミックス解析による病態解明基盤の構築",
            "研究課題番号": "JP22ek0410074"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis",
          "DOI": "doi: 10.1016/j.jaut.2020.102547",
          "データID": "JGAD000309\r\nE-GEAD-344"
        },
        "2": {
          "タイトル": "Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls",
          "DOI": "doi: 10.1016/j.jaut.2021.102617",
          "データID": "JGAD000310"
        },
        "3": {
          "タイトル": "Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases",
          "DOI": "doi: 10.1016/j.cell.2021.03.056",
          "データID": "E-GEAD-397\r\nE-GEAD-398\r\nE-GEAD-420"
        },
        "4": {
          "タイトル": "Dysregulation of the gene signature of effector regulatory T cells in the early phase of systemic sclerosis",
          "DOI": "doi: 10.1093/rheumatology/keac031",
          "データID": "JGAD000406"
        },
        "5": {
          "タイトル": "Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus",
          "DOI": "doi: 10.1136/annrheumdis-2021-221464",
          "データID": "JGAD000371\r\nJGAD000372\r\nJGAD000373"
        },
        "6": {
          "タイトル": "Distinct transcriptome architectures underlying lupus establishment and exacerbation",
          "DOI": "doi: 10.1016/j.cell.2022.07.021",
          "データID": "JGAD000603"
        },
        "7": {
          "タイトル": "Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance",
          "DOI": "doi: 10.1136/ard-2022-223645",
          "データID": "JGAD000727\r\nJGAD000731"
        },
        "8": {
          "タイトル": "Multimodal repertoire analysis unveils B cell biology in immune-mediated diseases",
          "DOI": "doi: 10.1136/ard-2023-224421",
          "データID": "JGAD000602"
        }
      },
      "制限公開データの利用者一覧": {
        "Jiucun Wang": {
          "研究代表者": "Jiucun Wang",
          "所属機関": "Department of anthropology and human genetics, Fudan University",
          "研究題目": "中華人民共和国",
          "利用データID": "The role and mechanism study of glycosyltransferase-B3GNT2 in regulating macrophages of Ankylosing Spondylitis",
          "利用期間": "JGAD000309, JGAD000603"
        },
        "Jacob D Jaffe": {
          "研究代表者": "Jacob D Jaffe",
          "所属機関": "Odyssey Therapeutics",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Investigation of immune cell transition states in autoimmune disease",
          "利用期間": "JGAD000309,JGAD000371,JGAD000372,JGAD000603"
        },
        "武田 吉人": {
          "研究代表者": "武田 吉人",
          "所属機関": "大阪大学大学院医学系研究科 呼吸器・免疫内科学",
          "研究題目": "日本",
          "利用データID": "呼吸器系・免疫疾患における細胞外小胞に着目した病態解明および診断法の開発",
          "利用期間": "JGAD000310,JGAD000371,JGAD000372,JGAD000373"
        },
        "Ana Rita Grosso": {
          "研究代表者": "Ana Rita Grosso",
          "所属機関": "Universidade Nova de Lisboa - NOVA School of Science and Technology",
          "研究題目": "ポルトガル",
          "利用データID": "Assessing transcriptional dyregulation of repetitive elements and monoallelic-expressed genes in lupus",
          "利用期間": "JGAD000603"
        },
        "Yong-Fei WANG": {
          "研究代表者": "Yong-Fei WANG",
          "所属機関": "The Chinese University of Hong Kong",
          "研究題目": "香港",
          "利用データID": "Investigating the Molecular Mechanisms of Systemic Lupus Erythematosus Using Functional Genomics Data",
          "利用期間": "JGAD000371,JGAD000372,JGAD000373,JGAD000603"
        },
        "Timothy Vyse": {
          "研究代表者": "Timothy Vyse",
          "所属機関": "King's College LondonMolecular and Medical genetics",
          "研究題目": "イギリス",
          "利用データID": "Sequencing Based Genetic Analysis of Systemic Lupus",
          "利用期間": "JGAD000603"
        }
      },
      "リリース情報": {
        "hum0214.v8": {
          "Research ID": "hum0214.v8",
          "公開日": "2023/07/06",
          "内容": "NGS（B細胞受容体レパトアデータ）",
          "description": "全身性エリテマトーデス、全身性強皮症、筋炎、混合性結合組織病、シェーグレン症候群、関節リウマチ、ベーチェット病、成人スチル病、ANCA関連血管炎、高安動脈炎、対照健常者の末梢血B細胞5画分を分取した。各画分サンプルを用いてRNA-seqを実施し、B細胞受容体配列のマッピングを実施した。B細胞受容体レパトアデータを提供する（txt）。\n"
        },
        "hum0214.v7": {
          "Research ID": "hum0214.v7",
          "公開日": "2023/03/28",
          "内容": "NGS（RNA-seq）",
          "description": "関節リウマチ50症例と対照健常者39名の末梢血免疫細胞18画分を分取し、各画分サンプルを用いてRNA-seqを実施した。サンプルのフィルタリングの上で各遺伝子にマップされたリード数を提供する（txt）。\n"
        },
        "hum0214.v6": {
          "Research ID": "hum0214.v6",
          "公開日": "2022/08/25",
          "内容": "NGS（RNA-seq）",
          "description": "全身性エリテマトーデス患者と対照健常者の末梢血免疫細胞27画分を分取し、各画分サンプルを用いてRNA-seqを実施した。サンプルのフィルタリングの上で各遺伝子にマップされたリード数を提供する（txt）。\n"
        },
        "hum0214.v5": {
          "Research ID": "hum0214.v5",
          "公開日": "2022/03/09",
          "内容": "NGS（RNA-seq、ATAC-seq）",
          "description": "全身性エリテマトーデス患者と対照健常者の末梢血免疫細胞19画分を分取し、各画分サンプルを用いてRNA-seqを実施した。サンプルのフィルタリングの上で各遺伝子にマップされたリード数を提供する（txt）。末梢血免疫細胞15画分でATAC-seqを実施した（tdf、bed）。\n"
        },
        "hum0214.v4": {
          "Research ID": "hum0214.v4",
          "公開日": "2022/01/21",
          "内容": "NGS（RNA-seq）",
          "description": "全身性強皮症50症例、対照健常者48名の末梢血免疫細胞24画分を分取し、各画分から抽出したRNAを用いたRNA-seqを実施した。解析した際の各遺伝子にマップされたリード数を提供する（txt）。\n"
        },
        "hum0214.v3": {
          "Research ID": "hum0214.v3",
          "公開日": "2021/04/28",
          "内容": "NGS（RNA-seqのリードカウント、eQTLサマリーデータ）",
          "description": "全身性エリテマトーデス、筋炎、全身性強皮症、混合性結合組織病、シェーグレン症候群、関節リウマチ、ベーチェット病、成人スチル病、ANCA関連血管炎、高安動脈炎、対照健常者の全血及び末梢血免疫細胞28画分を分取し、全血より全ゲノムシーケンス、各画分サンプルを用いてRNA-seqを実施した。サンプルのフィルタリングと遺伝子発現量の標準化の上で、各免疫細胞画分でeQTL解析を実施した（合計416名）。臨床情報および各遺伝子にマップされたリード数、eQTLサマリーデータを提供する（txt）。\n"
        },
        "hum0214.v2": {
          "Research ID": "hum0214.v2",
          "公開日": "2021/03/05",
          "内容": "NGS（RNA-seq）",
          "description": "ANCA関連血管炎26症例、対照健常者28名の末梢血免疫細胞の様々な画分を分取し、各画分から抽出したRNAを用いたRNA-seqを実施した。解析した際の各遺伝子にマップされたリード数を提供する（txt）。\n"
        },
        "hum0214.v1": {
          "Research ID": "hum0214.v1",
          "公開日": "2020/10/09",
          "内容": "NGS（RNA-seq）",
          "description": "全身性強皮症21症例、対照健常者13名の末梢血免疫細胞の様々な画分を分取し、各画分から抽出したRNAを用いたRNA-seqを実施した。解析した際の各遺伝子にマップされたリード数を提供する（txt）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0214.v8",
      "DATA": {
        "JGAS000220": {
          "Data Set ID": "JGAS000220",
          "Type of Data": "NGS (ATAC-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/03/09"
        },
        "E-GEAD-397": {
          "Data Set ID": "E-GEAD-397",
          "Type of Data": "Read count data from RNA-seq",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/04/28"
        },
        "E-GEAD-398": {
          "Data Set ID": "E-GEAD-398",
          "Type of Data": "Conditional eQTL summary data (significant associations)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/04/28"
        },
        "E-GEAD-420": {
          "Data Set ID": "E-GEAD-420",
          "Type of Data": "Nominal eQTL data (including non-significant associations)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/04/28"
        },
        "JGAS000296": {
          "Data Set ID": "JGAS000296",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/01/21"
        },
        "JGAS000486": {
          "Data Set ID": "JGAS000486",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/08/25"
        },
        "JGAS000598": {
          "Data Set ID": "JGAS000598",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/03/28"
        },
        "JGAS000485": {
          "Data Set ID": "JGAS000485",
          "Type of Data": "B cell receptor repertoire clonotype data from B cell RNA-seq",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/07/06"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the regulation of gene expression in each immune cell subset and its contribution to autoimmune diseases.",
        "Methods": "",
        "Participants/Materials": "Systemic Sclerosis, Systemic Lupus Erythematosus, Myositis, Mixed Connective Tissue Disease, Sjögren’s Syndrome, Rheumatoid Arthritis, Behçet’s Disease, Adult Onset Still’s Disease, ANCA-associated Vasculitis, Takayasu’s Arteritis, healthy individuals",
        "URL": "https://www.h.u-tokyo.ac.jp/english/centers-services/clinical-divisions/allergy-and-rheumatology/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000220 (RNA-seq: Systemic sclerosis)": {
          "Participants/Materials": "Systemic Sclerosis (ICD10: M340): 21 cases\r\n13 healthy controls",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "Total RNAs extracted from 19 immune cell subsets (Naive_B, SM_B, USM_B, DN_B, Plasmablast, Th1, Th2, Th17, Tfh, Naive_CD4, Mem_CD4, Fr._II_eTreg, Naive_CD8, Mem_CD8, mDC, pDC, CD16p_Mono, CD16n_Mono, NK)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Fragmentation Methods": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Mapping Methods": "STAR (hg38)",
          "QC Methods": "The adaptor sequences and 3’ low quality bases (Phred quality score < 20) were trimmed. Short reads (< 50bp) and reads containing many low quality bases (Phred quality score < 20 in > 20% of the bases) were removed. If the uniquely mapped rate was less than 80%, or the number of uniquely mapped reads was 5.00 x 106 reads, the sample was removed before further analysis. The correlation coefficient of the expression data between two samples belonging to the same cell subset and calculated the average of the correlation coefficient (Di). Samples for which Di was less than 0.9 were removed.",
          "Gene Number": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000309",
          "Total Data Volume": "125 MB (count data, txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000220 (RNA-seq: ANCA-associated Vasculitis)": {
          "Participants/Materials": "ANCA-associated Vasculitis (ICD10: M318): 26 cases\r\n28 healthy controls (including above 13 individuals)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "Total RNAs extracted from 20 immune cell subsets (Naive_B, SM_B, USM_B, DN_B, Plasmablast, Th1, Th2, Th17, Tfh, Naive_CD4, Mem_CD4, Fr._II_eTreg, Naive_CD8, Mem_CD8, mDC, pDC, CD16p_Mono, CD16n_Mono, NK, Neu)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Fragmentation Methods": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Mapping Methods": "STAR (hg38)",
          "QC Methods": "The adaptor sequences and 3’ low quality bases (Phred quality score < 20) were trimmed. Short reads (< 50bp) and reads containing many low quality bases (Phred quality score < 20 in > 20% of the bases) were removed. If the uniquely mapped rate was less than 80%, or the number of uniquely mapped reads was 5.00 x 106 reads, the sample was removed before further analysis. The correlation coefficient of the expression data between two samples belonging to the same cell subset and calculated the average of the correlation coefficient (Di). Samples for which Di was less than 0.9 were removed.",
          "Gene Number": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000310",
          "Total Data Volume": "125 MB (count data, txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "E-GEAD-397 (RNA-seq)": {
          "Participants/Materials": "Systemic Lupus Erythematosus (ICD10: M329): 62 cases\r\nMyositis (ICD10: M339, M332): 65 cases\r\nSystemic Sclerosis (ICD10: M340): 67 cases\r\nMixed Connective Tissue Disease (ICD10: M351): 19 cases\r\nSjögren’s Syndrome (ICD10: M350): 18 cases\r\nRheumatoid Arthritis (ICD10: M0690): 25 cases\r\nBehçet’s Disease (ICD10: M352): 23 cases\r\nAdult Onset Still’s Disease (ICD10: M0610): 18 cases\r\nANCA-associated Vasculitis (ICD10: M318: 26 cases\r\nTakayasu’s Arteritis (ICD10: M314): 16 cases\r\n92 healthy controls",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "Total RNAs extracted from 28 immune cell subsets (Naive_CD4, Mem_CD4, Fr._I_nTreg, Fr._II_eTreg, Fr._III_T, Th1, Th2, Th17, Tfh, NK, Naive_CD8, Mem_CD8, EM_CD8, CM_CD8, TEMRA_CD8, Naive_B, USM_B, SM_B, DN_B, Plasmablast, CL_Mono (or CD16n_Mono), CD16p_Mono, Int_Mono, NC_Mono, mDC, pDC, LDG, Neu)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Fragmentation Methods": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Mapping Methods": "STAR (GRCh38)",
          "QC Methods": "From sequenced reads, adaptor sequences were trimmed using cutadapt (v1.16). In addition, 3′- ends with low-quality bases (Phred quality score < 20) were trimmed using the fastx-toolkit (v0.0.14). Reads containing more than 20% low-quality bases were removed. Subsequently, reads were aligned against the GRCh38 reference sequence using STAR (v2.5.3) in two-pass mode with Gencode version 27 annotations. We excluded samples with uniquely mapped read rates < 90% (with the exception of < 70% for plasmablasts and <85% for the other B cell subsets) or unique read counts < 6 × 10^6. Expression was quantified using HTSeq (v 0.11.2.). For QC of the expression data, in each cell population, we filtered low count genes (< 10 in > 90% of samples), normalized between samples with a trimmed mean of M values (TMM) implemented in edgeR software, converted to log-transformed count per million (CPM), removed batch effects using ComBat software and computed inter-sample Spearman’s correlations of expression levels between each sample and the remaining samples from the same cell subset. We excluded samples with mean correlation coefficients less than 0.9.",
          "Gene Number": "53344",
          "Genomic Expression Archive ID": "E-GEAD-397",
          "Total Data Volume": "1.3 GB (clinical data and count data of autosomal genes, txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "E-GEAD-398 / E-GEAD-420 (eQTL)": {
          "Participants/Materials": "Systemic Lupus Erythematosus (ICD10: M329): 62 cases\r\nMyositis (ICD10: M339, M332): 65 cases\r\nSystemic Sclerosis (ICD10: M340): 67 cases\r\nMixed Connective Tissue Disease (ICD10: M351): 19 cases\r\nSjögren’s Syndrome (ICD10: M350): 18 cases\r\nRheumatoid Arthritis (ICD10: M0690): 24 cases\r\nBehçet’s Disease (ICD10: M352): 23 cases\r\nAdult Onset Still’s Disease (ICD10: M0610): 18 cases\r\nANCA-associated Vasculitis (ICD10: M318: 25 cases\r\nTakayasu’s Arteritis (ICD10: M314): 16 cases\r\n79 healthy controls",
          "Targets": "eQTL",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "DNAs extracted from whole blood",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free Library prep kit",
          "Fragmentation Methods": "TruSeq DNA PCR-Free Library prep kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "151 bp",
          "Mapping Methods": "BWA-MEM(GRCh38)",
          "QC Methods": "WGS data processing was performed based on the standardized best-practice method proposed by GATK (v 4.0.6.0). Samples with genotyping call rates < 99% were removed. We used BEAGLE (v 5.1) to impute missing genotypes. Variants with call rate < 85%, HWE P-value < 1.0 x 10-6 or minor allele frequency < 1% were excluded.",
          "Gene Number": "E-GEAD-398: 19441\r\nE-GEAD-420: 22381",
          "Detection method of eQTL": "Genes expressed at low levels (< 5 count in more than 80% samples or < 0.5 CPM in more than 80% samples) were filtered out in each cell subset. The residual autosomal expression data were normalized between samples with TMM, converted to CPM and then normalized across samples using an inverse normal transform. A Probabilistic Estimation of Expression Residuals (PEER) method was applied to normalized expression data to infer hidden covariates. The top 2 genetic principal components, sample collection phase, clinical diagnosis, sex and latent factors were utilized as covariates for eQTL analysis. Mem CD8s, which were collected in Phase1 and divided into CM CD8 and EM CD8 in Phase2, were analyzed jointly with EM CD8 for eQTL analysis because the majority of the Mem CD8 population consisted of EM CD8. For each cell subset conditional eQTL analysis, we used a QTLtools permutation pass with 10,000 permutations to obtain gene-level nominal P value thresholds corresponding to FDR < 0.05. We subsequently performed forward-backward stepwise regression eQTL analysis with a QTLtools conditional pass. For nominal eQTL analysis, we used a QTLtools nominal pass and tested for the association of the variants located within 1Mbp from the TSS of the genes.",
          "Genomic Expression Archive ID": "E-GEAD-398\r\nE-GEAD-420 (2021/6/9: Added columns for REF/ALT allele. Slope indicates the effect size of alternative alleles.)",
          "Total Data Volume": "E-GEAD-398: 3.9 GB (conditional eQTL summary data [FDR<0.05], txt)\r\nE-GEAD-420: 38 GB (nominal eQTL data [full], txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000296 (RNA-seq)": {
          "Participants/Materials": "Systemic Sclerosis (ICD10: M340): 50 cases\r\n48 healthy controls\r\n(including same cases in E-GEAD-397)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "Total RNAs extracted from 24 immune cell subsets (Naive_CD4, Mem_CD4, Fr._I_nTreg, Fr._II_eTreg, Fr._III_T, Th1, Th2, Th17, Tfh, NK, Naive_CD8, EM_CD8, CM_CD8, TEMRA_CD8, Naive_B, USM_B, SM_B, DN_B, Plasmablast, CL_Mono, Int_Mono, NC_Mono, mDC, pDC)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Fragmentation Methods": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Mapping Methods": "STAR (hg38)",
          "QC Methods": "The adaptor sequences and 3’ low quality bases (Phred quality score < 20) were trimmed. Short reads (< 50bp) and reads containing many low quality bases (Phred quality score < 20 in > 20% of the bases) were removed. If the uniquely mapped rate was less than 80%, or the number of uniquely mapped reads was 5.00 x 106 reads, the sample was removed before further analysis. The correlation coefficient of the expression data between two samples belonging to the same cell subset and calculated the average of the correlation coefficient (Di). Samples for which Di was less than 0.9 were removed.",
          "Gene Number": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000309",
          "Total Data Volume": "172.8 MB (count data, txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000220 (RNA-seq: Systemic Lupus Erythematosus)": {
          "Participants/Materials": "Systemic Lupus Erythematosus (ICD10: M329): 107 cases\r\n92 healthy controls",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "Total RNAs extracted from 19 immune cell subsets (Naive_CD4, Mem_CD4, Fr._II_eTreg, Th1, Th2, Th17, Tfh, NK, Naive_CD8, Mem_CD8, Naive_B, USM_B, SM_B, DN_B, Plasmablast, CD16n_Mono, CD16p_Mono, mDC, pDC)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Smart-Seq v2 for the test cohort and SMART-seq v4 Ultra Low Input RNA Kit for the validation cohort",
          "Fragmentation Methods": "Smart-Seq v2 for the test cohort and SMART-seq v4 Ultra Low Input RNA Kit for the validation cohort",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "76 bp (test cohort)\r\n100 bp (validation cohort)",
          "Mapping Methods": "STAR (GRCh38)",
          "QC Methods": "FASTQ files were aligned to the human genome (GRCh38; GenBank assembly GCA_000001405.18) using STAR (v2.5). HTSeq-count (v0.6.1) was used to generate gene counts. In the quality-control analysis, low-quality bases (Phred quality score < 20) were trimmed using the fastx-toolkit (v0.0.14). As the level of mitochondrial transcription is an indicator of cell stress, we applied a cutoff percentage of mitochondrial gene transcripts of < 8%. For detecting outlier samples, Spearman’s correlation for each subset was calculated, and samples with an average r2 < 0.8 were omitted as outliers.",
          "Gene Number": "26354 (test cohort)\r\n26485 (validation cohort)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000371\r\nJGAD000372",
          "Total Data Volume": "250 MB (count data, txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAD000220 (ATAC-seq)": {
          "Participants/Materials": "Systemic Lupus Erythematosus (ICD10: M329): 8 cases\r\n8 healthy controls",
          "Targets": "ATAC-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from 15 immune cell subsets (Naive_B, SM_B, USM_B, DN_B, Plasmablast, Th1, Th2, Th17, Tfh, Naive_CD4, Mem_CD4, Naive_CD8, CD16p_Mono, CD16n_Mono, NK)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Fast-ATAC-seq protocol",
          "Fragmentation Methods": "Fast-ATAC-seq protocol",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "102 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000373",
          "Total Data Volume": "27 GB (tdf, bed)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000486 (RNA-seq: Systemic Lupus Erythematosus)": {
          "Participants/Materials": "Systemic Lupus Erythematosus (ICD10: M329): 159 cases\r\n(22 SLE patients were analyzed longitudinally)\r\n89 healthy controls",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500, NovaSeq 6000]",
          "Library Source": "Total RNAs extracted from 27 immune cell subsets (Naive_CD4, Mem_CD4, Th1, Th2, Th17, Tfh, Fr._I_nTreg, Fr._II_eTreg, Fr._III_T, Naive_CD8, EM_CD8, CM_CD8, TEMRA_CD8, NK, Naive_B, USM_B, SM_B, DN_B, Plasmablast, CL_Mono (or CD16n_Mono), CD16p_Mono, Int_Mono, NC_Mono, mDC, pDC, Neu, LDG)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Fragmentation Methods": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp (HiSeq 2500), 150bp (NovaSeq 6000)",
          "Mapping Methods": "STAR (GRCh38)",
          "QC Methods": "Adaptor sequences were trimmed using Cutadapt and reads containing low-quality bases (Phred quality score < 20 in > 20% of the bases) were removed. Reads were aligned to the human genome within the UCSC Genome Browser (GRCh38) using STAR, and expression was counted with HTSeq. Samples with uniquely mapped read rates < 80% or unique read counts < 5 × 106 were excluded. We calculated Spearman’s correlations of the expressions between two samples from the same cell type and then removed the samples with mean correlation coefficients < 0.9. In addition, samples with the genotype concordance rates",
          "Gene Number": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000603",
          "Total Data Volume": "478.3 MB (count data, txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000598 (RNA-seq: Rheumatoid Arthritis)": {
          "Participants/Materials": "Rheumatoid Arthritis (ICD10: M0690): 50 cases\r\n(15 RA patients were analyzed longitudinally)\r\n39 healthy controls\r\n(including same cases in E-GEAD-397)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "Total RNAs extracted from 18 immune cell subsets (CD16p_Mono, CL_Mono, DN_B, Fr_II_eTreg, mDC, Mem_CD4, Naive_B, Naive_CD4, Neu, NK, pDC, Plasmablast, SM_B, Tfh, Th1, Th17, Th2, USM_B)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Fragmentation Methods": "SMART-seq v4 Ultra Low Input RNA Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Mapping Methods": "STAR (hg38)",
          "QC Methods": "The adaptor sequences and 3’ low quality bases (Phred quality score < 20) were trimmed. Short reads (< 50bp) and reads containing many low quality bases (Phred quality score < 20 in > 20% of the bases) were removed. If the uniquely mapped rate was less than 80%, or the number of uniquely mapped reads was 5.00 x 106 reads, the sample was removed before further analysis. The correlation coefficient of the expression data between two samples belonging to the same cell subset and calculated the average of the correlation coefficient (Di). Samples for which Di was less than the mean – 2SD were removed.",
          "Gene Number": "26353",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000727",
          "Total Data Volume": "113.9 MB (count data, txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000485 (BCR repertoire analysis)": {
          "Participants/Materials": "Systemic Lupus Erythematosus (ICD10: M329): 136 cases (159 samples)\r\nSystemic Sclerosis (ICD10: M340): 90 cases (90 samples)\r\nMyositis (ICD10: M339, M332): 85 cases (85 samples)\r\nMixed Connective Tissue Disease (ICD10: M351): 21 cases (21 samples)\r\nSjögren’s Syndrome (ICD10: M350): 18 cases (18 samples)\r\nRheumatoid Arthritis (ICD10: M0690): 27 cases (27 samples)\r\nBehçet’s Disease (ICD10: M352): 23 cases (23 samples)\r\nAdult Onset Still’s Disease (ICD10: M0610): 18 cases (18 samples)\r\nANCA-associated Vasculitis (ICD10: M318: 24 cases (24 samples)\r\nTakayasu’s Arteritis (ICD10: M314): 16 cases (16 samples)\r\n13 healthy controls (13 samples)",
          "Targets": "RNA-seq / BCR repertoire analysis",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "Total RNAs extracted from 5 B cell subsets (Naive_B, USM_B, SM_B, DN_B, Plasmablast)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-Seq v4 Ultra Low Input RNA Kit",
          "Fragmentation Methods": "SMART-Seq v4 Ultra Low Input RNA Kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Mapping Methods": "MiXCR",
          "QC Methods": "The adaptor sequences and 3’ low quality bases (Phred quality score < 20) were trimmed. Short reads (< 50bp) and reads containing many low quality bases (Phred quality score < 20 in > 20% of the bases) were removed.Samples with more than 500 unique CDR-H3 sequences were used for the analysis.",
          "BCR repertoire analysis Methods (software)": "MiXCR",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000602",
          "Total Data Volume": "12.9 GB (B cell receptor repertoire clonotype data, txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Keishi Fujio",
        "Affiliation": "Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "Immune cell multi-omics analysis of immune-mediated diseases",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Practical Research Project for Allergic Diseases and Immunology, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Integrative multi-omics analysis of autoimmune diseases based on single cell RNA-sequencing of inflammatory organs",
            "Project Number": "JP22ek0410074"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis",
          "DOI": "doi: 10.1016/j.jaut.2020.102547",
          "Data Set ID": "JGAD000309\r\nE-GEAD-344"
        },
        "2": {
          "Title": "Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls",
          "DOI": "doi: 10.1016/j.jaut.2021.102617",
          "Data Set ID": "JGAD000310"
        },
        "3": {
          "Title": "Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases",
          "DOI": "doi: 10.1016/j.cell.2021.03.056",
          "Data Set ID": "E-GEAD-397\r\nE-GEAD-398\r\nE-GEAD-420"
        },
        "4": {
          "Title": "Dysregulation of the gene signature of effector regulatory T cells in the early phase of systemic sclerosis",
          "DOI": "doi: 10.1093/rheumatology/keac031",
          "Data Set ID": "JGAD000406"
        },
        "5": {
          "Title": "Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus",
          "DOI": "doi: 10.1136/annrheumdis-2021-221464",
          "Data Set ID": "JGAD000371\r\nJGAD000372\r\nJGAD000373"
        },
        "6": {
          "Title": "Distinct transcriptome architectures underlying lupus establishment and exacerbation",
          "DOI": "doi: 10.1016/j.cell.2022.07.021",
          "Data Set ID": "JGAD000603"
        },
        "7": {
          "Title": "Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance",
          "DOI": "doi: 10.1136/ard-2022-223645",
          "Data Set ID": "JGAD000727\r\nJGAD000731"
        },
        "8": {
          "Title": "Multimodal repertoire analysis unveils B cell biology in immune-mediated diseases",
          "DOI": "doi: 10.1136/ard-2023-224421",
          "Data Set ID": "JGAD000602"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Jiucun Wang": {
          "Principal Investigator": "Jiucun Wang",
          "Affiliation": "Department of anthropology and human genetics, Fudan University",
          "Research Title": "China",
          "Data in Use (Dataset ID)": "The role and mechanism study of glycosyltransferase-B3GNT2 in regulating macrophages of Ankylosing Spondylitis",
          "Period of Data Use": "JGAD000309, JGAD000603"
        },
        "Jacob D Jaffe": {
          "Principal Investigator": "Jacob D Jaffe",
          "Affiliation": "Odyssey Therapeutics",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Investigation of immune cell transition states in autoimmune disease",
          "Period of Data Use": "JGAD000309,JGAD000371,JGAD000372,JGAD000603"
        },
        "Yoshito Takeda": {
          "Principal Investigator": "Yoshito Takeda",
          "Affiliation": "Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Pathophysiology and diagnostic development with a focus on extracellular vesicles in respiratory and immunological diseases",
          "Period of Data Use": "JGAD000310,JGAD000371,JGAD000372,JGAD000373"
        },
        "Ana Rita Grosso": {
          "Principal Investigator": "Ana Rita Grosso",
          "Affiliation": "Universidade Nova de Lisboa - NOVA School of Science and Technology",
          "Research Title": "Portugal",
          "Data in Use (Dataset ID)": "Assessing transcriptional dyregulation of repetitive elements and monoallelic-expressed genes in lupus",
          "Period of Data Use": "JGAD000603"
        },
        "Yong-Fei WANG": {
          "Principal Investigator": "Yong-Fei WANG",
          "Affiliation": "The Chinese University of Hong Kong",
          "Research Title": "Hong Kong",
          "Data in Use (Dataset ID)": "Investigating the Molecular Mechanisms of Systemic Lupus Erythematosus Using Functional Genomics Data",
          "Period of Data Use": "JGAD000371,JGAD000372,JGAD000373,JGAD000603"
        },
        "Timothy Vyse": {
          "Principal Investigator": "Timothy Vyse",
          "Affiliation": "Molecular and Medical genetics, King's College London",
          "Research Title": "United Kingdom of Great Britain and Northern Ireland",
          "Data in Use (Dataset ID)": "Sequencing Based Genetic Analysis of Systemic Lupus",
          "Period of Data Use": "JGAD000603"
        }
      },
      "Release Note": {
        "hum0214.v8": {
          "Research ID": "hum0214.v8",
          "Release Date": "2023/07/06",
          "Type of Data": "NGS (BCR repertoire analysis)",
          "description": "5 B cell subsets from Systemic Lupus Erythematosus, Systemic Sclerosis, Myositis, Mixed Connective Tissue Disease, Sjögren’s Syndrome, Rheumatoid Arthritis, Behçet’s Disease, Adult Onset Still’s Disease, ANCA-associated Vasculitis, Takayasu’s Arteritis patients and healthy controls were collected. RNA-seq was performed with each B cell subset sample. B cell receptor sequences were aligned. B cell receptor repertoire clonotype data are provided as text files.\n"
        },
        "hum0214.v7": {
          "Research ID": "hum0214.v7",
          "Release Date": "2023/03/28",
          "Type of Data": "NGS (RNA-seq)",
          "description": "18 immune cell subsets from 50 rheumatoid arthritis patients and 39 healthy controls were collected. RNA-seq was performed with each immune cell subset sample. After filtering of the gene expression data, read count data mapped to each gene are provided as txt files.\n"
        },
        "hum0214.v6": {
          "Research ID": "hum0214.v6",
          "Release Date": "2022/08/25",
          "Type of Data": "NGS (RNA-seq)",
          "description": "27 immune cell subsets from 159 systemic lupus erythematosus patients and 89 healthy controls were collected. RNA-seq was performed with each immune cell subset sample. After filtering of the gene expression data, read count data mapped to each gene are provided as txt files.\n"
        },
        "hum0214.v5": {
          "Research ID": "hum0214.v5",
          "Release Date": "2022/03/09",
          "Type of Data": "NGS (RNA-seq, ATAC-seq)",
          "description": "19 immune cell subsets from systemic lupus erythematosus patients and healthy controls were collected. RNA-seq was performed with each immune cell subset sample. After filtering of the gene expression data, read count data mapped to each gene are provided as txt files. ATAC-seq of 15 immune cell subsets was also performed.\n"
        },
        "hum0214.v4": {
          "Research ID": "hum0214.v4",
          "Release Date": "2022/01/21",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from 24 immune cell subsets of 50 systemic sclerosis patients and 48 healthy controls were collected. RNA-seq was performed for each sample. Read count data mapped to each gene are provided as txt files.\n"
        },
        "hum0214.v3": {
          "Research ID": "hum0214.v3",
          "Release Date": "2021/04/28",
          "Type of Data": "NGS (Read count data from RNA-seq, eQTL summary data)",
          "description": "Whole blood and 28 immune cell subsets from Systemic Lupus Erythematosus, Myositis, Systemic Sclerosis, Mixed Connective Tissue Disease, Sjögren’s Syndrome, Rheumatoid Arthritis, Behçet’s Disease, Adult Onset Still’s Disease, ANCA-associated Vasculitis, Takayasu’s Arteritis patients and healthy controls were collected. Whole genome sequencing was performed with whole blood samples. RNA-seq was performed with each immune cell subset samples. After filtering and normalization of the gene expression data, eQTL analysis was performed in each immune cell type (416 individuals in total). Clinical data, read count data and eQTL summary data are provided as txt files.\n"
        },
        "hum0214.v2": {
          "Research ID": "hum0214.v2",
          "Release Date": "2021/03/05",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from various immune cell subsets of 26 ANCA associated vasculitis and 28 healthy controls were collected. RNA-seq was performed for each sample. Read count data mapped to each gene are provided as txt files.\n"
        },
        "hum0214.v1": {
          "Research ID": "hum0214.v1",
          "Release Date": "2020/10/09",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from various immune cell subsets of 21 systemic sclerosis patients and 13 healthy controls were collected. RNA-seq was performed for each sample. Read count data mapped to each gene are provided as txt files.\nNote：\n"
        }
      }
    }
  },
  "hum0213.v1": {
    "ja": {
      "NBDC Research ID": "hum0213.v1",
      "データ": {
        "JGAS000238": {
          "データID": "JGAS000238",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/07/15"
        }
      },
      "研究内容の概要": {
        "目的": "パキスタンのバルチ人の最近の進化の歴史（高原適応）を理解する",
        "方法": "全ゲノムシークエンス",
        "対象": "バルチ人"
      },
      "分子データ": {
        "JGAS000238": {
          "対象": "バルチ人：60名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "State Key Laboratory of Genetic Resources and Evolution",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000337",
          "総データ量": "1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "Min-Sheng Peng",
        "所 属 機 関": "State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology",
        "プロジェクト/研究グループ名": "Demographic History and Local Adaptation in Asian Populations",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Tracing the Genetic Legacy of the Tibetan Empire in the Balti",
          "DOI": "doi: 10.1093/molbev/msaa313",
          "データID": "JGAD000337"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "岡田 随象": {
          "研究代表者": "岡田 随象",
          "所属機関": "大阪大学 医学系研究科 遺伝統計学",
          "研究題目": "日本",
          "利用データID": "多層的オミクス解析による疾患病態の解明",
          "利用期間": "JGAD000337"
        }
      },
      "リリース情報": {
        "hum0213.v1": {
          "Research ID": "hum0213.v1",
          "公開日": "2022/07/15",
          "内容": "NGS（WGS）",
          "description": "バルチ人60名の末梢血から抽出したDNAを用いたWGS解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0213.v1",
      "DATA": {
        "JGAS000238": {
          "Data Set ID": "JGAS000238",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/07/15"
        }
      },
      "SUMMARY": {
        "Aims": "Understanding the recent evolutionary history of the Balti population",
        "Methods": "whole genome sequencing",
        "Participants/Materials": "Baltis"
      },
      "MOLECULAR DATA": {
        "JGAS000238": {
          "Participants/Materials": "60 Baltis individuals",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "State Key Laboratory of Genetic Resources and Evolution",
          "Fragmentation Methods": "Enzyme digestion",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000337",
          "Total Data Volume": "1 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Min-Sheng Peng",
        "Affiliation": "State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Tracing the Genetic Legacy of the Tibetan Empire in the Balti",
          "DOI": "doi: 10.1093/molbev/msaa313",
          "Data Set ID": "JGAD000337"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Yukinori Okada": {
          "Principal Investigator": "Yukinori Okada",
          "Affiliation": "Department of Statistical Genetics, Osaka University Graduate School of Medicine",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Elucidation of disease state by multi-layered omics analysis",
          "Period of Data Use": "JGAD000337"
        }
      },
      "Release Note": {
        "hum0213.v1": {
          "Research ID": "hum0213.v1",
          "Release Date": "2022/07/15",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from peripheral blood cells obtained from 60 Baltis individuals were used for WGS. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0210.v1": {
    "ja": {
      "NBDC Research ID": "hum0210.v1",
      "データ": {
        "JGAS000211": {
          "データID": "JGAS000211",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/04/06"
        }
      },
      "研究内容の概要": {
        "目的": "急性骨髄性白血病と縦隔胚細胞腫瘍の合併症例の遺伝学的な病態解明",
        "方法": "自己正常口腔細胞を対照として、急性骨髄性白血病と縦隔胚細胞腫瘍の両腫瘍部位の全エクソーム解析を行い、腫瘍細胞に生じている体細胞変異を解析する。",
        "対象": "急性骨髄性白血病と縦隔胚細胞腫瘍の合併症例1名",
        "URL": "http://www.med.miyazaki-u.ac.jp/home/2nai/"
      },
      "分子データ": {
        "JGAS000211": {
          "対象": "急性骨髄性白血病と縦隔胚細胞腫瘍の合併症（ICD10：C920, C383）：1症例（3検体）\r\n    骨髄穿刺による骨髄液の腫瘍細胞を含む単核球分画：1検体\r\n    縦隔胚細胞腫瘍の腫瘍組織：1検体\r\n    口腔粘膜（非腫瘍組織）：1検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon v6",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000297",
          "総データ量": "28 GB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "下田 和哉",
        "所 属 機 関": "宮崎大学医学部 内科学講座 消化器血液学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "宮崎大学医学部附属病院臨床研究支援経費",
            "タイトル": "血液腫瘍の発症ハイリスク群同定法の確立",
            "研究課題番号": "30-GH-3"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia.",
          "DOI": "doi: 10.1186/s12885-019-6497-0",
          "データID": "JGAD000297"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0210.v1": {
          "Research ID": "hum0210.v1",
          "公開日": "2020/04/06",
          "内容": "NGS（Exome）",
          "description": "急性骨髄性白血病と縦隔胚細胞腫瘍の合併症1症例の骨髄穿刺による骨髄液の腫瘍細胞を含む単核球分画および縦隔胚細胞腫瘍の腫瘍組織、並びに口腔粘膜（非腫瘍組織）から抽出したDNAを用いた全エクソームシークエンス解析の結果をbamファイルにて提供する。SureSelect Human All Exon v6によりDNAライブラリを作成し、NextSeq 500（Illumina）にて平均長150塩基を解読した（paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0210.v1",
      "DATA": {
        "JGAS000211": {
          "Data Set ID": "JGAS000211",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/04/06"
        }
      },
      "SUMMARY": {
        "Aims": "Elucidation of genomic pathology of a patient with concomitant acute myeloid leukemia and mediastinal germ cell tumor",
        "Methods": "Whole exome sequencing was performed for both acute myeloid leukemia cells and mediastinal germ cell tumor cells, and somatic mutations of both tumor cells were identified, using normal buccal cells as a control.",
        "Participants/Materials": "Patient with concomitant acute myeloid leukemia and mediastinal germ cell tumor"
      },
      "MOLECULAR DATA": {
        "JGAS000211": {
          "Participants/Materials": "Patient with concomitant acute myeloid leukemia and mediastinal germ cell tumor (ICD10: C920, C383): 1 case (3 samples)\r\n    acute myeloid leukemia cells from bone marrow aspirates: 1 sample\r\n    mediastinal germ cell tumor cells: 1 sample\r\n    normal buccal cells: 1 sample",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "DNAs extracted from tumor and non-tumor cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon v6",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000297",
          "Total Data Volume": "28 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kazuya Shimoda",
        "Affiliation": "Division of Gastroenterology and Hematology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Grant-in-Aid for Clinical Research from University of Miyazaki Hospital",
            "Title": "Establishment of a method to identify high-risk groups for the development of hematological tumors.",
            "Project Number": "30-GH-3"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia.",
          "DOI": "doi: 10.1186/s12885-019-6497-0",
          "Data Set ID": "JGAD000297"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0210.v1": {
          "Research ID": "hum0210.v1",
          "Release Date": "2020/04/06",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from acute myeloid leukemia cells, mediastinal germ cell tumor cells, and normal buccal cells were used for the whole exome sequencing analysis. DNA libraries were established with the SureSelect Human All Exon v6 kit and sequenced by Illumina NextSeq 500 platform (paired-end; 150 bp). Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0209.v1": {
    "ja": {
      "NBDC Research ID": "hum0209.v1",
      "データ": {
        "hum0209.v1.var.v1": {
          "データID": "hum0209.v1.var.v1",
          "内容": "DMETおよびダイレクトシークエンス法により決定した変異のGenotype頻度情報",
          "制限": "非制限公開",
          "公開日": "2019/12/13"
        }
      },
      "研究内容の概要": {
        "目的": "関節リウマチ（rheumatoid arthritis：RA）患者におけるメトトレキサート（methotrexate：MTX）の治療効果と副作用に関連する変異を予測因子として構築した予測モデルの評価",
        "方法": "MTXで加療されたRA患者を対象にDrug Metabolizing Enzymes and Transporters Array（DMET）およびダイレクトシークエンス法により1966のgenotypeを決定し、集積する。有効性はEULAR反応性指標を用い、肝機能障害は正常値の1.5倍以上と定義する。genotypeおよび臨床情報によりMTX治療の有効性および肝機能障害の予測モデルを構築する。",
        "対象": "MTXで加療されたRA166症例"
      },
      "分子データ": {
        "hum0209.v1.var.v1": {
          "対象": "関節リウマチ（ICD10：M06.9）：166症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Array：GeneChip® Scanner 3000 7G（Thermo Fisher Scientific）\r\nDirect sequencing：Veriti 96-Well Thermal Cycler and 3730XL DNA Analyzer（Applied Biosystems）",
          "ソース": "MTX治療を受けたRA患者の末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Array：the DMET Plus Premier pack kits（Thermo Fisher Scientific）\r\nDirect sequencing：the BigDye Terminator v3.1 Cycle Sequencing Kit and the BigDye XTerminator Purification Kit（Applied Biosystems）",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Array：the Affymetrix DMET Console Software\r\nDirect sequencing：The 3730xl DNA Analyzer Software",
          "フィルタリング": "copy number variationにある変異、及び、性染色体上の変異は除く",
          "マーカー数（QC後）": "1916 variants",
          "NBDC Dataset ID": "hum0209.v1.var.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）",
          "総データ量": "164 KB（csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "熊谷 俊一",
        "所 属 機 関": "神鋼記念病院 診療部 膠原病リウマチセンター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genetic and clinical prediction models for the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a multicenter cohort study",
          "DOI": "doi: 10.1038/s41397-019-0134-9",
          "データID": "hum0209.v1.var.v1"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0209.v1": {
          "Research ID": "hum0209.v1",
          "公開日": "2019/12/13",
          "内容": "RA166症例を対象にDMETおよびダイレクトシークエンス法により検出した変異のGenotype頻度情報",
          "description": "メトトレキサート（MTX）治療を受けた関節リウマチ（RA）166症例の末梢血から抽出したDNAを対象とし、Drug Metabolizing Enzymes and Transporters Array（DMET；Affymetrix）およびダイレクトシークエンス法により遺伝子型決定をした変異のGenotype頻度情報をcsv形式にて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0209.v1",
      "DATA": {
        "hum0209.v1.var.v1": {
          "Data Set ID": "hum0209.v1.var.v1",
          "Type of Data": "Genotype frequencies for variants detected by the DMET and direct sequencing",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/12/13"
        }
      },
      "SUMMARY": {
        "Aims": "To develop genetic and clinical prediction models for the efficacy and hepatotoxicity of methotrexate (MTX) in patients with rheumatoid arthritis (RA).",
        "Methods": "Among RA patients treated with MTX, 1,966 polymorphisms of 246 enzymes/transporters relevant to pharmacokinetics and pharmacodynamics were detected by the Drug Metabolism Enzymes and Transporters (DMET) microarray and direct sequencing, and clinical variables at baseline were collected. For efficacy, response criteria of the European League Against Rheumatism were used to classify patients as responders or non-responders. Hepatotoxicity was defined as elevations of aspartate aminotransferase or alanine aminotransferase equal to or greater than 1.5 times the reference range upper limit. Genetic and clinical prediction models for the efficacy and hepatotoxicity of MTX were developed in patients with RA.",
        "Participants/Materials": "166 RA patients"
      },
      "MOLECULAR DATA": {
        "hum0209.v1.var.v1": {
          "Participants/Materials": "RA (ICD10: M06.9): 166 cases",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Array: GeneChip® Scanner 3000 7G (Thermo Fisher Scientific)\r\nDirect sequencing: Veriti 96-Well Thermal Cycler and 3730XL DNA Analyzer (Applied Biosystems)",
          "Library Source": "DNA extracted from peripheral blood cells of RA patients treated with MTX",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Array: the DMET Plus Premier pack kits (Thermo Fisher Scientific)\r\nDirect sequencing: the BigDye Terminator v3.1 Cycle Sequencing Kit and the BigDye XTerminator Purification Kit (Applied Biosystems)",
          "Genotype Call Methods (software)": "Array: the Affymetrix DMET Console Software\r\nDirect sequencing: The 3730xl DNA Analyzer Software",
          "Filtering Methods": "SNP loci with copy number variation and loci on the sex chromosome were excluded from the analyses.",
          "Marker Number (after QC)": "1916 variants",
          "NBDC Dataset ID": "hum0209.v1.var.v1\r\n(Click the Dataset ID to download the file)",
          "Total Data Volume": "164 KB (csv)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shunichi Kumagai",
        "Affiliation": "Center for Rheumatic Diseases, Shinko Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genetic and clinical prediction models for the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a multicenter cohort study",
          "DOI": "doi: 10.1038/s41397-019-0134-9",
          "Data Set ID": "hum0209.v1.var.v1"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0209.v1": {
          "Research ID": "hum0209.v1",
          "Release Date": "2019/12/13",
          "Type of Data": "Genotype frequencies for variants detected by the DMET and direct sequencing",
          "description": "DNAs extracted from peripheral blood cells of rheumatoid arthritis (RA) patients treated with methotrexate (MTX) were genotyped by the Drug Metabolizing Enzymes and Transporters (DMET) Array (Affymetrix) and direct sequencing. Genotype frequencies are provided (csv files).\nNote：\n"
        }
      }
    }
  },
  "hum0208.v1": {
    "ja": {
      "NBDC Research ID": "hum0208.v1",
      "データ": {
        "JGAS000214": {
          "データID": "JGAS000214",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/01/20"
        }
      },
      "研究内容の概要": {
        "目的": "頭頸部悪性腫瘍症例の腫瘍組織および末梢血由来単核球を対象とした網羅的な遺伝子解析により、再発・転移予測マーカーの同定、新規分子標的治療法の確立を目指す。",
        "方法": "切除標本から診断に影響のない範囲で腫瘍組織を採取し、抽出したDNAを用いた全エクソームシーケンスを行った。正常組織として、末梢血単核球をコントロールとしている。",
        "対象": "両側外耳道がんおよび片側外耳道がん症例",
        "URL": "http://www.qent.med.kyushu-u.ac.jp/group/research.html"
      },
      "分子データ": {
        "JGAS000214": {
          "対象": "・両側外耳道がん（ICD10：C442）：1症例\r\n　（左右外耳道原発巣＋再発巣：3検体）\r\n・片側外耳道がん（ICD10：C442）：9症例\r\n　（外耳道原発巣：9検体）\r\n・各症例の末梢血単核球（PBMC）：10検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "外耳道がんの腫瘍組織と末梢血単核球から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V6 Kit",
          "断片化の方法": "上記キットに準拠",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000300",
          "総データ量": "128 GB （bam [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 尚志",
        "所 属 機 関": "九州大学病院 耳鼻咽喉科・頭頸部外科",
        "プロジェクト/研究グループ名": "頭頸部腫瘍に対する網羅的ゲノム解析およびそのデータベースの構築",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 若手研究",
            "タイトル": "側頭骨癌におけるインフラマゾーム関連分子の網羅的解析による炎症性発癌機構の解明",
            "研究課題番号": "18K16895"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Squamous cell carcinoma of the external auditory canal and middle ear: an operation combined with preoperative chemoradiotherapy and a free surgical margin.",
          "DOI": "doi: 10.1097/01.mao.0000190463.88873.3d",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0208.v1": {
          "Research ID": "hum0208.v1",
          "公開日": "2020/01/20",
          "内容": "NGS（Exome）",
          "description": "両側外耳道がん1症例および片側外耳道がん9症例の腫瘍組織およびペア末梢血由来単核球（PBMC）から抽出したDNAを用いたExome解析の結果をbamファイルにて提供する。SureSelect Human All Exon V6 KitによりExon領域にしぼり、Illumina HiSeq X Tenにて平均長100塩基を解読した（Single-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0208.v1",
      "DATA": {
        "JGAS000214": {
          "Data Set ID": "JGAS000214",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/01/20"
        }
      },
      "SUMMARY": {
        "Aims": " To clinically identify recurrence and metastasis prediction markers and establish new molecular target therapies, we conducted a conprehensive genetic analysis of head and neck malignant tumor tissues and patient-derived blood.",
        "Methods": "DNA were extracted from tumor tissues and matched normal samples (peripheral blood mononuclear cells: PBMC), and subjected to whole exome sequencing analysis.",
        "Participants/Materials": "Bilateral / unilateral cancer of the external auditory canal"
      },
      "MOLECULAR DATA": {
        "JGAS000214": {
          "Participants/Materials": "- bilateral cancer of the external auditory canal (ICD10: C442): 1 case\r\n    (right and left primary tumor tissues: 2 samples, recurrent tumor tissue: 1 sample)\r\n- unilateral cancer of the external auditory canal (ICD10: C442): 9 cases\r\n    (primary tumor tissues: 9 samples)\r\n- matched PBMC: 10 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "DNAs extracted from tumor and PBMC from patients with cancer of the external auditory canal",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V6 Kit",
          "Fragmentation Methods": "included in the above library construction kit",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000300",
          "Total Data Volume": "128 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takashi Nakagawa",
        "Affiliation": "Department of Otorhinolaryngology, Kyushu University",
        "Project / Group Name": "Comprehensive genetic analysis and database construction for head and neck cancer",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Young Scientists",
            "Title": "Elucidation of inflammatory carcinogenesis by comprehensive analysis of inflammasome-related molecules of temporal bone cancer",
            "Project Number": "18K16895"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Squamous cell carcinoma of the external auditory canal and middle ear: an operation combined with preoperative chemoradiotherapy and a free surgical margin.",
          "DOI": "doi: 10.1097/01.mao.0000190463.88873.3d",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0208.v1": {
          "Research ID": "hum0208.v1",
          "Release Date": "2020/01/20",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor tissues and matched normal tissues (peripheral blood mononuclear cells) derived from 10 patients with cancer of the external auditory canal were used for the whole exome sequencing (bam files). Exons were narrowed down by using of SureSelect Human All Exon V6 Kit and read by Illumina HiSeq X Ten (Single-end: 100 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0207.v1": {
    "ja": {
      "NBDC Research ID": "hum0207.v1",
      "データ": {
        "hum0207.v1.RNA.v1": {
          "データID": "hum0207.v1.RNA.v1",
          "内容": "NGS（RNA-seq）による遺伝子毎のリード数カウント",
          "制限": "非制限公開",
          "公開日": "2020/01/06"
        },
        "hum0207.v1.ChIP.v1": {
          "データID": "hum0207.v1.ChIP.v1",
          "内容": "NGS（ChIP-seq）によるエンリッチ領域ピーク情報",
          "制限": "非制限公開",
          "公開日": "2020/01/06"
        },
        "hum0207.v1.HiC.v1": {
          "データID": "hum0207.v1.HiC.v1",
          "内容": "NGS（Hi-C）によるループ情報",
          "制限": "非制限公開",
          "公開日": "2020/01/06"
        },
        "hum0207.v1.eQTL.v1": {
          "データID": "hum0207.v1.eQTL.v1",
          "内容": "SNPアレイ上の変異に対する遺伝子発現量から算出したeQTL",
          "制限": "非制限公開",
          "公開日": "2020/01/06"
        }
      },
      "研究内容の概要": {
        "目的": "滑膜線維芽細胞の炎症環境応答と関節リウマチの病態形成に対する寄与を解明する",
        "方法": "関節リウマチおよび変形性関節症（コントロール）患者由来の滑膜線維芽細胞を、関節内のサイトカイン（TNF-α, IL-1β, IL-6/sIL-6R, IL-17A, IL-18, IFN-γ, IFN-α, TGF-β1, 複合炎症をシミュレートした全8種のmixture [8-mix]）で24時間刺激した。また、同一患者より末梢血リンパ球5分画（CD4陽性T細胞、CD8陽性T細胞、B細胞、NK細胞、単球）を分取した。各サンプルを用いて、SNPアレイ・ChIP-seq（H3K27ac・H3K4me1・H3K4me3）・Hi-C・RNA-seq解析を実施した。",
        "対象": "関節リウマチ30症例、変形性関節症30症例"
      },
      "分子データ": {
        "hum0207.v1.RNA.v1": {
          "対象": "関節リウマチ（ICD10：M05）：30症例\r\n変形性関節症（ICD10：M06）：30症例\r\n1症例あたり末梢血リンパ球 5分画（CD4陽性T細胞, CD8陽性T細胞, B細胞, NK細胞, 単球）と滑膜線維芽細胞 10条件（無刺激, TNF-α, IL-1β, IL-6/sIL-6R, IL-17A, IL-18, IFN-γ, IFN-α, TGF-β1, 8-mix）：計900検体中、quality control条件をパスした856検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "関節リウマチ・変形性関節症患者由来の各細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "クオリティコントロール方法": "アダプタートリミング cutadapt、クオリティトリミング fastxtoolkit（クオリティスコア < 20の塩基を除去、塩基数 < 50 のリードを除去、クオリティスコア < 20の塩基が20%より多いリードを除去）",
          "重複するリードの除去": "-",
          "リアライメントおよびベースクオリティのキャリブレーション": "-",
          "マッピング方法": "STAR（version 2.5.3）",
          "リファレンス配列": "GENCODE v27（GRCh37 version）",
          "平均カバー率（Depth）": "-",
          "遺伝子構造・新規の転写産物推定・発現量算出方法": "HTSeq（version 0.6.0）",
          "総リード数 / ユニークにマップされたリード数": "1000万-3000万 / 1000万-3000万",
          "対象遺伝子数": "58,325",
          "NBDC Dataset ID": "hum0207.v1.RNA.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "20.5 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0207.v1.ChIP.v1": {
          "対象": "関節リウマチ（ICD10：M05）：20症例\r\n変形性関節症（ICD10：M06）：20症例\r\n1症例あたり、末梢血リンパ球 5分画（CD4陽性T細胞, CD8陽性T細胞, B細胞, NK細胞, 単球）と滑膜線維芽細胞 10条件（無刺激, TNF-α, IL-1β, IL-6/sIL-6R, IL-17A, IL-18, IFN-γ, IFN-α, TGF-β1, 8-mix）を用意し、同じ条件のサンプルを疾患群ごとにプール後、3種の抗体（H3K4me1, H3K4me3, H3K27ac）を用いた免疫沈降を実施：計90検体中、quality control条件をパスした83検体",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "関節リウマチ・変形性関節症患者由来の各細胞に対して免疫沈降実施後抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "CHIP-IT High Sensitivity Kit（Active Motif）、CHIP-IT PBMC Kit（Active Motif）",
          "断片化の方法": "超音波断片化（Covaris S2）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "クオリティコントロール方法": "アダプタートリミング cutadapt、クオリティトリミング fastxtoolkit（クオリティスコア < 20の塩基を除去、塩基数 < 50 のリードを除去、クオリティスコア < 20の塩基が20%より多いリードを除去）",
          "マッピング方法": "Bowtie2",
          "リファレンス配列": "hg19/GRCh37",
          "平均カバー率（Depth）": "-",
          "ピーク検出方法": "MACS 2.0",
          "総リード数 / ユニークにマップされたリード数": "2000万-5000万 / -",
          "NBDC Dataset ID": "hum0207.v1.ChIP.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "158.1 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0207.v1.HiC.v1": {
          "対象": "関節リウマチ（ICD10：M05）：7症例\r\n1症例あたり、滑膜線維芽細胞 3条件（無刺激, TNF-α, 8-mix）を用意し、同じ条件のサンプルをプール：計3検体",
          "規模": "Hi-C",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq series]",
          "ライブラリソース": "関節リウマチ患者由来の各細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Nextera Mate Pair Sample Preparation Kit",
          "断片化の方法": "超音波断片化（Covaris S2）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "クオリティコントロール方法": "“juicer” software内で実施",
          "マッピング方法": "BWA-mem",
          "リファレンス配列": "hg19/GRCh37",
          "平均カバー率（Depth）": "-",
          "ループ検出方法": "HiCCUPS",
          "総リード数 / ユニークにマップされたリード数": "3億7千万- 4億",
          "NBDC Dataset ID": "hum0207.v1.HiC.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "1.3 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0207.v1.eQTL.v1": {
          "対象": "関節リウマチ（ICD10：M05）：30症例\r\n変形性関節症（ICD10：M06）：30症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium OmniExpressExome BeadChips]",
          "ソース": "関節リウマチ・変形性関節症患者由来の各細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "IMPUTE2",
          "フィルタリング": "SNP call rate > 0.99、HWE < 1 × 10-6、sample call rate > 0.98",
          "マーカー数(QC後)": "595,693 SNVs",
          "リファレンス配列": "1000 Genomes Phase 3 panel",
          "eQTL検出方法": "QTLtools、Meta-Tissue software",
          "NBDC Dataset ID": "hum0207.v1.eQTL.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "53.1 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "藤尾 圭志",
        "所 属 機 関": "東京大学大学院 医学系研究科 アレルギー・リウマチ学",
        "プロジェクト/研究グループ名": "ヒト免疫細胞における遺伝子多型と遺伝子発現の関連解析",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "共同研究費（武田薬品工業）",
            "タイトル": "eQTLを基礎とした創薬標的の探索と治療法の開",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis",
          "DOI": "doi: 10.1136/annrheumdis-2020-218189",
          "データID": "hum0207.v1.RNA.v1\r\nhum0207.v1.ChIP.v1\r\nhum0207.v1.HiC.v1\r\nhum0207.v1.eQTL.v1"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0207.v1": {
          "Research ID": "hum0207.v1",
          "公開日": "2020/01/06",
          "内容": "NGS（RNA-seq、ChIP-seq、Hi-C）、eQTL",
          "description": "関節リウマチ30症例および変形性膝関節症30症例（コントロール）由来の滑膜線維芽細胞を、関節内サイトカイン（TNF-α, IL-1β, IL-6/sIL-6R, IL-17A, IL-18, IFN-γ, IFN-α, TGF-β1, 複合炎症をシミュレートした全8種のmixture [8-mix]）により24時間刺激した。また、同一患者より末梢血リンパ球5分画（CD4陽性T細胞、CD8陽性T細胞、B細胞、NK細胞、単球）を分取した。各サンプルより抽出したDNA/RNAを用いたSNPアレイ・ChIP-seq（H3K27ac・H3K4me1・H3K4me3）・Hi-C・RNA-seq解析データのProcesssedデータおよび集計情報を提供する（txtファイル）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0207.v1",
      "DATA": {
        "hum0207.v1.RNA.v1": {
          "Data Set ID": "hum0207.v1.RNA.v1",
          "Type of Data": "Read counts for each gene detected from NGS (RNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/01/06"
        },
        "hum0207.v1.ChIP.v1": {
          "Data Set ID": "hum0207.v1.ChIP.v1",
          "Type of Data": "Peaks from NGS (ChIP-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/01/06"
        },
        "hum0207.v1.HiC.v1": {
          "Data Set ID": "hum0207.v1.HiC.v1",
          "Type of Data": "Loops from NGS (Hi-C)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/01/06"
        },
        "hum0207.v1.eQTL.v1": {
          "Data Set ID": "hum0207.v1.eQTL.v1",
          "Type of Data": "eQTL",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/01/06"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the dynamics of synovial fibroblasts and its association with rheumatoid arthritis pathogenesis.",
        "Methods": "Synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients (as a control) were stimulated with 9 cytokine conditions (IFN-α, IFN-γ, TNF-α, IL-1β, IL-6/sIL-6R, IL-17, TGF-β1, IL-18 and the mixture of these 8 cytokines [8-mix] which simulate synergistic inflammatory environment in arthritic joints) for 24 hours. Five subsets of peripheral blood mononuclear cells (CD4+ T, CD8+ T, B, NK and monocytes) were collected from the same patients. The integrative analysis including expression quantitative trait loci (eQTL) was performed with genome, transcriptome and epigenome data.",
        "Participants/Materials": "Patients with rheumatoid arthritis or osteoarthritis"
      },
      "MOLECULAR DATA": {
        "hum0207.v1.RNA.v1": {
          "Participants/Materials:": "rheumatoid arthritis (ICD10: M05): 30 cases\r\nosteoarthritis (ICD10: M06): 30 cases\r\n5 fractions of PBMCs (CD4+ T, CD8+ T, B, NK and monocytes) and 10 conditions of synovial fibroblasts (unstimulated, IFN-α, IFN-γ, TNF-α, IL-1β, IL-6/sIL-6R, IL-17, TGF-β1, IL-18 and 8-mix) for 1 case each: total 856 samples (44 samples were excluded because of QC)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from cells from rheumatoid arthritis and osteoarthritis patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "QC": "adapter trimming: cutadapt, quality trimming: fastxtoolkit (bases with quality score < 20 were excluded, reads with base number < 50 were excluded, reads including 20% or more of bases with quality score < 20 were excluded)",
          "Deduplication": "-",
          "Calibration of re-alignment and base quality": "-",
          "Mapping Methods": "STAR (version 2.5.3)",
          "Reference Genome Sequence": "GENCODE v27 (GRCh37 version)",
          "Coverage (Depth)": "-",
          "Detecting Methods for Transcripts": "HTSeq (version 0.6.0)",
          "Total Reads / Uniquely Mapped Reads": "10 million - 30 million / 10 million - 30 million",
          "Gene Numbers": "58,325",
          "NBDC Dataset ID": "hum0207.v1.RNA.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "20.5 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0207.v1.ChIP.v1": {
          "Participants/Materials:": "rheumatoid arthritis (ICD10: M05): 20 cases\r\nosteoarthritis (ICD10: M06): 20 cases\r\n5 fractions of PBMCs (CD4+ T, CD8+ T, B, NK and monocytes) and 10 conditions of synovial fibroblasts (unstimulated, IFN-α, IFN-γ, TNF-α, IL-1β, IL-6/sIL-6R, IL-17, TGF-β1, IL-18 and 8-mix) were prepared for 1 case each. Samples under the same condition were pooled and immunoprecipitated with 3 anti-histone antibodies (H3K4me1, H3K4me3, H3K27ac): total 83 samples (7 samples were excluded because of QC)",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs were extracted from cells from rheumatoid arthritis and osteoarthritis patients. Then, samples under the same condition were pooled and immunoprecipitated with anti-histone antibodies.",
          "Cell Lines": "-",
          "Library Construction (kit name)": "CHIP-IT High Sensitivity Kit (Active Motif), CHIP-IT PBMC Kit (Active Motif)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S2)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "QC": "adapter trimming: cutadapt, quality trimming: fastxtoolkit (bases with quality score < 20 were excluded, reads with base number < 50 were excluded, reads including 20% or more of bases with quality score < 20 were excluded)",
          "Mapping Methods": "Bowtie2",
          "Reference Genome Sequence": "hg19/GRCh37",
          "Coverage (Depth)": "-",
          "Detecting Methods for peaks": "MACS 2.0",
          "Total Reads / Uniquely Mapped Reads": "",
          "Gene Numbers": "20 million - 50 million / -",
          "NBDC Dataset ID": "hum0207.v1.ChIP.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "158.1 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0207.v1.HiC.v1": {
          "Participants/Materials:": "rheumatoid arthritis (ICD10: M05): 7 case\r\n3 conditions of synovial fibroblasts (unstimulated, TNF-α, and 8-mix) were prepared for 1 case each. Samples under the same condition were pooled : total 3 samples",
          "Targets": "Hi-C",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq series]",
          "Library Source": "DNAs extracted from pooled cells from rheumatoid arthritis patient",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Nextera Mate Pair Sample Preparation Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S2)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "QC": "performed at \"juicer\" software",
          "Mapping Methods": "BWA-mem",
          "Reference Genome Sequence": "hg19/GRCh37",
          "Coverage (Depth)": "-",
          "Detecting Methods for loops": "HiCCUPS",
          "Total Reads / Uniquely Mapped Reads": "370 million - 400 million",
          "NBDC Dataset ID": "hum0207.v1.HiC.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "1.3 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0207.v1.eQTL.v1": {
          "Participants/Materials": "rheumatoid arthritis (ICD10: M05): 30 cases\r\nosteoarthritis (ICD10: M06): 30 cases",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium OmniExpressExome BeadChips]",
          "Source": "DNAs extracted from cells from rheumatoid arthritis and osteoarthritis patients",
          "Cell Lines": "-",
          "Genotype Call Methods (softwares)": "IMPUTE2",
          "Filtering Methods": "SNP call rate > 0.99, HWE < 1 × 10-6, sample call rate > 0.98",
          "Marker Numbers (after QC)": "595,693 SNVs",
          "Reference Genome Sequence": "1000 Genomes Phase 3 panel",
          "eQTL detection method": "QTLtools, Meta-Tissue software",
          "NBDC Dataset ID": "hum0207.v1.eQTL.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "53.1 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Keishi Fujio",
        "Affiliation": "Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "Association study between gene polymorphism and gene expression in human immune cells",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Joint research fund (Takeda Pharmaceutical Company Limited)",
            "Title": "Search for drug targets and development of therapeutic methods based on eQTL",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis",
          "DOI": "doi: 10.1136/annrheumdis-2020-218189",
          "Data Set ID": "hum0207.v1.RNA.v1\r\nhum0207.v1.ChIP.v1\r\nhum0207.v1.HiC.v1\r\nhum0207.v1.eQTL.v1"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0207.v1": {
          "Research ID": "hum0207.v1",
          "Release Date": "2020/01/06",
          "Type of Data": "NGS (RNA-seq, ChIP-seq, Hi-C), eQTL",
          "description": "Synovial fibroblasts from 30 rheumatoid arthritis and 30 osteoarthritis patients were stimulated with 9 cytokine conditions (IFN-α, IFN-γ, TNF-α, IL-1β, IL-6/sIL-6R, IL-17, TGF-β1, IL-18 and the mixture of these 8 cytokines [8-mix] which simulate synergistic inflammatory environment in arthritic joints) for 24 hours. Five subsets of peripheral blood mononuclear cells (CD4+ T, CD8+ T, B, NK and monocytes) were collected from the patients. The integrative analysis including expression quantitative trait loci (eQTL) was performed with genome, transcriptome and epigenome data. Processed data and aggregated data are provided as text files.\nNote：\n"
        }
      }
    }
  },
  "hum0206.v1": {
    "ja": {
      "NBDC Research ID": "hum0206.v1",
      "データ": {
        "JGAS000207": {
          "データID": "JGAS000207",
          "内容": "NGS（PBAT-seq、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/11/26"
        }
      },
      "研究内容の概要": {
        "目的": "胎盤異常を呈する全胞状奇胎（complete hydatidiform mole: CHM）の病態を解明するため、CHMより樹立したヒト胎盤栄養膜幹細胞（Trophoblastic stem cell：TS）の細胞特性を明らかにする",
        "方法": "遺伝子発現解析（RNA-seq）、メチル化解析（PBAT-seq）",
        "対象": "CHM3症例の胎盤から単離した細胞性栄養膜細胞（Cytotrophoblast cell：CT）2検体、および、CT細胞から樹立したTS細胞株3検体"
      },
      "分子データ": {
        "PBAT-seq": {
          "対象": "CHM（ICD10：O01）：3症例\r\n　TS細胞：3検体",
          "規模": "PBAT-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500/2500]",
          "ライブラリソース": "CHM由来CT細胞から樹立したTS細胞株から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Post-Bisulfite Adaptor-Tagging（PBAT）法",
          "断片化の方法": "PBAT法による（Bisulfite変換に伴うDNA切断）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000292",
          "総データ量": "203 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "CHM（ICD10：O01）：3症例\r\n　CT細胞：2検体\r\n　TS細胞：3検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "CHMの胎盤から単離したCT細胞およびCT細胞から樹立したTS細胞株から抽出したmRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000292",
          "総データ量": "203 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "有馬 隆博",
        "所 属 機 関": "東北大学大学院 医学系研究科 環境遺伝医学総合研究センター 情報遺伝学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業 ユニットタイプ（AMED-CREST）",
            "タイトル": "生殖発生にかかわる細胞のエピゲノム解析基盤研究",
            "研究課題番号": "JP17gm0510011"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Loss of p57KIP2 expression confers resistance to contact inhibition in human androgenetic trophoblast stem cells",
          "DOI": "doi: 10.1073/pnas.1916019116",
          "データID": "JGAD000292"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000292"
        }
      },
      "リリース情報": {
        "hum0206.v1": {
          "Research ID": "hum0206.v1",
          "公開日": "2019/11/26",
          "内容": "NGS（PBAT-seq、RNA-seq）",
          "description": "・WGBS\n全胞状奇胎（CHM）3症例の胎盤から単離した細胞性栄養膜細胞（Cytotrophoblast cell：CT）から樹立した胎盤栄養膜幹細胞（Trophoblastic stem cell：TS）から抽出したDNAを用いたPBAT-seq解析の結果をfastqファイルにて提供する。Post-Bisulfite Adaptor-Tagging（PBAT）法によるライブラリ作製後、HiSeq 1500/2500（Illumina）によりシークエンシングを行っている。\n・RNA-seq\nCHM3症例の胎盤から単離したCT細胞2検体、および、CTから樹立したTS細胞株3検体から抽出したRNAを用いたRNA-seq解析の結果をfastqファイルにて提供する。TruSeq Stranded mRNA LT Sample Prep Kitによるライブラリ作製後、HiSeq 2500（Illumina）によりシークエンシングを行っている。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0206.v1",
      "DATA": {
        "JGAS000207": {
          "Data Set ID": "JGAS000207",
          "Type of Data": "NGS (PBAT-seq, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/11/26"
        }
      },
      "SUMMARY": {
        "Aims": "A complete hydatidiform mole (CHM) is an abnormal pregnancy caused by genetic fertilization disorders. The aim of this study is to establish human trophoblast stem (TS) cell lines from CHMs and elucidate their pathogenesis.",
        "Methods": "Transcriptome analysis (RNA-seq) , Methyloation analysis (PBAT-seq)",
        "Participants/Materials": "Cytotrophoblast (CT) cells isolated from placenta tissues of CHMs and CHM-derived TS cells"
      },
      "MOLECULAR DATA": {
        "PBAT-seq": {
          "Participants/Materials:": "CHM (ICD10: O01): 3 cases\r\n  TS cells: 3 samples",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500/2500]",
          "Library Source": "DNAs extracted from CHM-derived TS cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Post-Bisulfite Adaptor-Tagging (PBAT)",
          "Fragmentation Methods": "PBAT method: fragmentation due to bisulfite conversion",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000292",
          "Total Data Volume": "203 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials:": "CHM (ICD10: O01): 3 cases\r\n  CT cells: 2 samples\r\n  TS cells: 3 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "mRNAs extracted from CT cells isolated from placenta tissues of CHMs and CHM-derived TS cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000292",
          "Total Data Volume": "203 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takahiro Arima",
        "Affiliation": "Department of Informative Genetics, Tohoku University Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)",
            "Title": "Epigenome analysis of cells in the placenta and endometrium forming the fetal-maternal interface",
            "Project Number": "JP17gm0510011"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Loss of p57KIP2 expression confers resistance to contact inhibition in human androgenetic trophoblast stem cells",
          "DOI": "doi: 10.1073/pnas.1916019116",
          "Data Set ID": "JGAD000292"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000292"
        }
      },
      "Release Note": {
        "hum0206.v1": {
          "Research ID": "hum0206.v1",
          "Release Date": "2019/11/26",
          "Type of Data": "NGS (PBAT-seq, RNA-seq)",
          "description": "- PBAT-seq\nDNAs extracted from complete hydatidiform mole (CHM)-derived trophoblastic stem (TS) cells were used for PBAT-sequencing analysis (fastq format files). Libraries were prepared with Post-Bisulfite Adaptor-Tagging (PBAT) and sequenced using HiSeq 1500/2500 (Illumina).\n- RNA-seq\nRNAs extracted from cytotrophoblast (CT) cells isolated from placenta tissues of CHMs and CHM-derived TS cells were used for RNA-sequencing analysis (fastq format files). Libraries were prepared with TruSeq Stranded mRNA LT Sample Prep Kit and sequenced using HiSeq 2500 (Illumina). \nNote：\n"
        }
      }
    }
  },
  "hum0203.v1": {
    "ja": {
      "NBDC Research ID": "hum0203.v1",
      "データ": {
        "JGAS000206": {
          "データID": "JGAS000206",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/06/01"
        }
      },
      "研究内容の概要": {
        "目的": "網羅的ゲノム解析により日本人多発性骨髄腫のゲノムプロファイルを明らかにする",
        "方法": "Targeted capture sequencing",
        "対象": "日本人多発性骨髄腫154症例（原発巣154検体、再発巣6検体、正常末梢血単核球23検体：計183検体）",
        "URL": "https://www.amed.go.jp/program/list/14/01/006.html"
      },
      "分子データ": {
        "JGAS000206": {
          "対象": "多発性骨髄腫（ICD10：C900）：154症例\r\n    原発巣：154検体\r\n    再発巣：6検体\r\n    末梢血単核球細胞：23検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "340遺伝子＋免疫グロブリン再構成領域（IGH, IGK, IGL）",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "骨髄穿刺にて採取した骨髄液をCD138にてソートした凍結骨髄細胞および末梢血単核球細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect custom kit",
          "断片化の方法": "超音波断片化（Covaris ME220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100-200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000291",
          "総データ量": "255 GB\r\n    Data ファイル数：366（fastq）\r\n    Analysis ファイル数：1（vcf [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "堀部 敬三",
        "所 属 機 関": "名古屋医療センター・臨床研究センター",
        "プロジェクト/研究グループ名": "臨床ゲノム情報統合データベース整備事業",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort",
          "DOI": "doi: 10.1111/bjh.16720",
          "データID": "JGAD000291"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0203.v1": {
          "Research ID": "hum0203.v1",
          "公開日": "2020/06/01",
          "内容": "NGS（Target Capture）",
          "description": "多発性骨髄腫154症例の腫瘍組織（骨髄穿刺にて採取した骨髄液をCD138にてソートした凍結骨髄細胞）および正常として末梢血単核球細胞より抽出したDNAを用いたTarget Capture Sequencing（340遺伝子＋免疫グロブリン再構成領域 [IGH, IGK, IGL]）解析結果をfastqファイルおよびvcfファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0203.v1",
      "DATA": {
        "JGAS000206": {
          "Data Set ID": "JGAS000206",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/06/01"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify the genomic feature of Japanese multiple myeloma (MM) patients by comprehensive genetic analyses",
        "Methods": "Targeted capture sequencing",
        "Participants/Materials": "Japanese MM",
        "URL": "https://www.amed.go.jp/en/program/list/14/01/006.html"
      },
      "MOLECULAR DATA": {
        "JGAS000206": {
          "Participants/Materials": "MM (ICD10: C900): 154 cases\r\n    primary tumor tissues: 154 samples\r\n    recurrent tumor tissues: 6 samples\r\n    peripheral blood mononuclear cells as a normal sample: 23 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "340 genes + immunoglobulin variable regions (IGH, IGK, IGL)",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from frozen bone marrow CD138 positive cells isolated from bone marrow aspirates and peripheral blood mononuclear cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect custom kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris ME220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100-200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000291",
          "Total Data Volume": "255 GB\r\n    Data files: 366 (fastq)\r\n    Analysis files: 1 (vcf [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Keizo Horibe",
        "Affiliation": "Clinical Researc Center, Nagoya Medical Center",
        "Project / Group Name": "Program for an Integrated Database of Clinical and Genomic Information",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort",
          "DOI": "doi: 10.1111/bjh.16720",
          "Data Set ID": "JGAD000291"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0203.v1": {
          "Research ID": "hum0203.v1",
          "Release Date": "2020/06/01",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from frozen bone marrow CD138 positive cells isolated from bone marrow aspirates or peripheral blood mononuclear cells of 154 patients with multiple myeloma were used for a target capture sequencing analysis (340 genes + immunoglobulin variable regions ([IGH, IGK, IGL]). Fastq files and vcf files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0202.v1": {
    "ja": {
      "NBDC Research ID": "hum0202.v1",
      "データ": {
        "JGAS000379": {
          "データID": "JGAS000379",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/09"
        }
      },
      "研究内容の概要": {
        "目的": "遺伝子が関係していると考えられている先天性難聴の遺伝要因の同定と生後早期の経過の解明による言語聴覚リハビリテーションの向上",
        "方法": "必要に応じて身体への危険がない聴力検査を行なうとともに、年齢および体重に応じて採取した末梢血より抽出したDNAを用いたWhole Exome Sequencing解析を行う。",
        "対象": "原因不明の両側性・先天性の非症候群性難聴症例と当該症例の両親",
        "URL": "https://tokyo-mc.hosp.go.jp/about/kankakukicenter/k-lab_c.html"
      },
      "分子データ": {
        "JGAS000379": {
          "対象": "先天性難聴（ICD10：H905）：3症例およびその両親（計：9名）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "46バリアント",
          "Platform": "Illumina [HiSeq 2500/4000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Nextera Rapid Capture Exome kit\r\nSureSelect Human All Exon v5",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000493",
          "総データ量": "34.7 kB（xlsx [ref: GRCh37]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "松永 達雄",
        "所 属 機 関": "国立病院機構東京医療センター 臨床研究センター 聴覚・平衡覚研究部",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） オーダーメイド医療の実現プログラム事業",
            "タイトル": "先天性難聴及びH7N9ワクチンに関する多施設共同研究のゲノム付随研究並びに本共同研究で収集された検体に対するBBJとのバンキングシステムの構築",
            "研究課題番号": "JP15km0305011"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Variants Encoding a Restricted Carboxy-Terminal Domain of SLC12A2 Cause Hereditary Hearing Loss in Humans",
          "DOI": "doi: 10.1371/journal.pgen.1008643",
          "データID": "JGAD000493"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0202.v1": {
          "Research ID": "hum0202.v1",
          "公開日": "2022/09/09",
          "内容": "NGS（Exome）",
          "description": "先天性難聴患者3症例とその両親の末梢血から抽出したDNAを用いたwhole exome sequencing解析データ由来の46バリアントの変異データをエクセルファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0202.v1",
      "DATA": {
        "JGAS000379": {
          "Data Set ID": "JGAS000379",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/09"
        }
      },
      "SUMMARY": {
        "Aims": "To analyze genetic background of congenital to prelingual childhood-onset hearing loss to increase efficacy of auditory, speech, and language therapy.",
        "Methods": "DNA samples extracted from peripheral blood samples of prelingual childhood-onset hearing loss patients and their parents were subjected for subsequent genomic analyses. Auditory tests were also underwent.",
        "Participants/Materials": "Patients and their parents"
      },
      "MOLECULAR DATA": {
        "JGAS000379": {
          "Participants/Materials": "Congenital hearing loss (ICD10: H905): \r\n3 cases and their parents (Total: 9 samples)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "46 variants",
          "Platform": "Illumina [HiSeq 2500/4000]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Nextera Rapid Capture Exome kit\r\nSureSelect Human All Exon v5",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000493",
          "Total Data Volume": "34.7 kB (xlsx [ref: GRCh37])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tatsuo Matsunaga",
        "Affiliation": "Division of Hearing and Balance Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Tailor-Made Medical Treatment with the BioBank Japan Project (BBJ), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Multi-Centered Genome-Associated Research for Congenital Hearing Loss and H7N9 Vaccine and Development of the Sample Banking System to BBJ for the Collected Samples",
            "Project Number": "JP15km0305011"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Variants Encoding a Restricted Carboxy-Terminal Domain of SLC12A2 Cause Hereditary Hearing Loss in Humans",
          "DOI": "doi: 10.1371/journal.pgen.1008643",
          "Data Set ID": "JGAD000493"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0202.v1": {
          "Research ID": "hum0202.v1",
          "Release Date": "2022/09/09",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from peripheral blood cells of 3 congenital hearing loss patients and their parents were used for the whole exome sequencing analysis. 46 variants data are provided (xlsx).\nNote：\n"
        }
      }
    }
  },
  "hum0201.v7": {
    "ja": {
      "NBDC Research ID": "hum0201.v7",
      "データ": {
        "JGAS000199": {
          "データID": "JGAS000199",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/12/20"
        },
        "JGAS000237": {
          "データID": "JGAS000237",
          "内容": "NGS（WGS、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/10/06"
        },
        "JGAS000256": {
          "データID": "JGAS000256",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/11/20"
        },
        "JGAS000378": {
          "データID": "JGAS000378",
          "内容": "NGS（RNA-seq、ChIP-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/19"
        },
        "JGAS000350": {
          "データID": "JGAS000350",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/06/06"
        },
        "JGAS000550": {
          "データID": "JGAS000550",
          "内容": "NGS（scRNA-seq、RNA-seq、Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/08/05"
        },
        "JGAD000687": {
          "データID": "JGAD000687",
          "内容": "JGAD000335の加工データ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/12/27"
        }
      },
      "研究内容の概要": {
        "目的": "消化管上皮細胞の、正常組織・炎症組織（消化器炎症性疾患）・腫瘍組織のゲノム解析による形質上の相違の探索",
        "方法": "",
        "対象": ""
      },
      "分子データ": {
        "Exome（JGAS000199／JGAS000550）": {
          "対象": "潰瘍性大腸炎（ICD10：K51）：29症例\r\n　（炎症組織のオルガノイド11検体、非炎症組織のオルガノイド14検体、末梢血12検体）\r\n腫瘍を併発する潰瘍性大腸炎（ICD10：K51, C18, C19, C20）：26症例\r\n　（腫瘍組織のオルガノイド15検体、炎症組織のオルガノイド14検体、非炎症組織のオルガノイド5検体、末梢血10検体）\r\n腫瘍性疾患（ICD10：C18）：2症例\r\n　（正常大腸組織のオルガノイド8検体）\r\n下部消化管内視鏡検査を受けた健常者：16名\r\n　（末梢血10検体、正常組織のオルガノイド24検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500/4000]",
          "ライブラリソース": "疾患組織（腫瘍組織・炎症組織）・正常組織から樹立したオルガノイド、末梢血、および、疾患組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000284\r\nJGAD000669",
          "総データ量": "JGAD000284：488 GB（fastq）\r\nJGAD000669：59.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGS（JGAS000237）": {
          "対象": "腫瘍性疾患：23症例（55検体）\r\n（腫瘍組織および非腫瘍組織より樹立したオルガノイドおよび末梢血）\r\n    小細胞肺がん（ICD10：C34）\r\n    胆道がん（ICD10：C23, C24, C78）\r\n    大腸がん（ICD10：C18-20）\r\n    十二指腸がん（ICD10：C17）\r\n    食道がん（ICD10：C15）\r\n    胃がん（ICD10：C16, C78）\r\n    肝がん（ICD10：C22）\r\n    膵がん（ICD10：C25）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織より樹立したオルガノイドおよび末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "BGIによって作成されたライブラリーを使用",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000335",
          "NBDCおよび生命情報・DDBJ センターによる加工データのID": "JGAD000687\r\n加工方法はこちら",
          "総データ量": "2.752 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq（JGAS000237、JGAS000378）": {
          "対象": "腫瘍性疾患：23＋4症例（35＋5検体）\r\n（腫瘍組織39検体および非腫瘍組織 [正常大腸上皮] 1検体より樹立したオルガノイド）\r\n    小細胞肺がん（ICD10：C34）\r\n    胆道がん（ICD10：C23, C24, C78）\r\n    大腸がん（ICD10：C18-20）\r\n    十二指腸がん（ICD10：C17）\r\n    食道がん（ICD10：C15）\r\n    胃がん（ICD10：C16, C78）\r\n    肝がん（ICD10：C22）\r\n    膵がん（ICD10：C25）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500/X Ten、NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織（正常大腸上皮）より樹立したオルガノイドから抽出したRNA\r\nBET阻害剤を添加した大腸腫瘍組織および非腫瘍組織（正常大腸上皮）由来のオルガノイドから抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Library Prep Kit v2\r\nTruSeq Stranded mRNA Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "250 bp/150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000336\r\nJGAD000492",
          "総データ量": "JGAD000336：2.752 TB（fastq）\r\nJGAD000492：190.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq（JGAS000256）": {
          "対象": "腫瘍性疾患（ICD10：C16）：1症例（1検体）\r\n（正常十二指腸組織より樹立したオルガノイド）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "正常十二指腸組織より樹立したオルガノイドから抽出したRNA\r\n4日間の培養液ローテーションあり、なし、およびローテーションから0、1、2、4日後（6条件）",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Library Prep Kit v2\r\nTruSeq Stranded mRNA Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "250 bp/150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000359",
          "総データ量": "37 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq（JGAS000350）": {
          "対象": "腫瘍性疾患（ICD10：C16）：2症例（11検体）\r\n（大腸腫瘍組織より樹立したオルガノイド）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 4000]",
          "ライブラリソース": "大腸腫瘍組織より樹立したオルガノイドから抽出したRNA\r\n幾つかの条件（抗がん剤投与など）を振って培養した後の細胞、並びに、マーカーを使って分取した細胞集団",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Library Prep Kit v2\r\nTruSeq Stranded mRNA Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "250 bp/150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000464",
          "総データ量": "108.9 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq（JGAS000550）": {
          "対象": "腫瘍性疾患（ICD10：C18）：2症例（8検体）\r\n（正常大腸組織より樹立したオルガノイド）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "正常大腸組織より樹立したオルガノイドから抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Library Prep Kit v2\r\nTruSeq Stranded mRNA Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 x 2 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000669",
          "総データ量": "46.6 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "scRNA-seq（JGAS000550）": {
          "対象": "腫瘍性疾患（ICD10：C16）：1症例（1検体）\r\n（正常大腸組織）",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 4000]",
          "ライブラリソース": "正常大腸組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Single Cell 3′ Library & Gel Bead Kit v2 and the A Chip Kit (10X Genomics)",
          "断片化の方法": "酵素処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "28+91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000669",
          "総データ量": "66.0 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ChIP-seq（JGAS000378）": {
          "対象": "腫瘍性疾患：4症例（5検体）\r\n（腫瘍組織4検体および非腫瘍組織 [正常大腸上皮] 1検体より樹立したオルガノイド）\r\n    大腸がん（ICD10：C18）",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "腫瘍組織非腫瘍組織（正常大腸上皮）より樹立したオルガノイドから抽出したDNAに対し、抗ヒストン抗体（H3K27Ac）を用いて免疫沈降",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina Tagment DNA TDE1 Enzyme and Buffer Kits",
          "断片化の方法": "超音波断片化（Bioruptor Ⅱ）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000492",
          "総データ量": "190.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "佐藤 俊朗",
        "所 属 機 関": "慶應義塾大学医学部 坂口光洋記念講座（オルガノイド医学）",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "5": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（S）",
            "タイトル": "ニッチ構築によるヒト消化器疾患の発症・進展のメカニズムを解き明かす",
            "研究課題番号": "22H04995"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Somatic inflammatory gene mutations in human ulcerative colitis epithelium",
          "DOI": "doi: 10.1038/s41586-019-1844-5",
          "データID": "JGAD000284"
        },
        "2": {
          "タイトル": "An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping",
          "DOI": "doi: 10.1016/j.cell.2020.10.023",
          "データID": "JGAD000335\r\nJGAD000336"
        },
        "3": {
          "タイトル": "An organoid-based organ repurposing approach to treat short bowel syndrome",
          "DOI": "doi: 10.1038/s41586-021-03247-2",
          "データID": "JGAD000359"
        },
        "4": {
          "タイトル": "Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer",
          "DOI": "doi: 10.1038/s41589-022-00984-x",
          "データID": "JGAD000492"
        }
      },
      "制限公開データの利用者一覧": {
        "Klaus H. Kaestner": {
          "研究代表者": "Klaus H. Kaestner",
          "所属機関": "Institue for Diabetes, Obesity & Metabolism at Unversity of Pennsylvania",
          "研究題目": "",
          "利用データID": "Somatic mutation analysis of the pancreas in type 1 diabetes",
          "利用期間": "JGAD000284"
        },
        "Ulf Leser": {
          "研究代表者": "Ulf Leser",
          "所属機関": "Department of Mathematics and Computer Science, Humboldt-Universitaet zu Berlin",
          "研究題目": "",
          "利用データID": "MAPTor-NET: MAPK-mTOR network model driven individualized therapies of pancreatic neuro-endocrine tumors (pNETs)",
          "利用期間": "JGAD000335, JGAD000336"
        },
        "田沼 延公": {
          "研究代表者": "田沼 延公",
          "所属機関": "宮城県立がんセンター 研究所",
          "研究題目": "日本",
          "利用データID": "患者由来オルガノイドを用いた、膵・消化管神経内分泌腫瘍の生物学的特性の解明",
          "利用期間": "JGAD000336"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000336, JGAD000359, JGAD000492"
        }
      },
      "リリース情報": {
        "hum0201.v7": {
          "Research ID": "hum0201.v7",
          "公開日": "2022/12/27",
          "内容": "JGAD000335の加工データ",
          "description": "hum0201.v2のfastqファイル（JGAD000335）に対して、特定の解析パイプラインにより加工したCRAM/gVCF/aggregate VCFファイルを提供する。利用を希望する場合は、データ利用申請書にJGAD000335（元データ）とJGAD000687（加工データ）を記載すること。\n"
        },
        "hum0201.v6": {
          "Research ID": "hum0201.v6",
          "公開日": "2022/08/05",
          "内容": "NGS（scRNA-seq、RNA-seq、Exome）",
          "description": "腫瘍性疾患1症例の正常大腸組織から抽出したRNAを用いたsingle cell RNA sequecing解析結果および腫瘍性疾患2症例の正常大腸組織より樹立したオルガノイドより抽出したDNA、RNAを用いたWhole Exome sequecing解析、RNA sequecing解析の結果をfastqファイルにて提供する。\n"
        },
        "hum0201.v5": {
          "Research ID": "hum0201.v5",
          "公開日": "2022/06/06",
          "内容": "NGS（RNA-seq）",
          "description": "腫瘍性疾患2症例の大腸腫瘍組織より樹立したオルガノイドに対して、幾つかの条件（抗がん剤投与など）を振って培養した後の細胞、並びに、マーカーを使って分取した細胞集団から抽出したRNAを用いたRNA sequecing解析結果をfastqファイルにて提供する。\n"
        },
        "hum0201.v4": {
          "Research ID": "hum0201.v4",
          "公開日": "2021/11/19",
          "内容": "NGS（RNA-seq、ChIP-seq）",
          "description": "腫瘍性疾患4症例の大腸腫瘍組織4検体および非腫瘍組織 （正常大腸上皮）1検体より樹立したオルガノイドから抽出したRNA、DNAを用いたRNA sequecing解析、ChIP-seq解析結果をfastqファイルにて提供する。\n"
        },
        "hum0201.v3": {
          "Research ID": "hum0201.v3",
          "公開日": "2020/11/20",
          "内容": "NGS（RNA-seq）",
          "description": "2D培養した腫瘍性疾患1症例の正常十二指腸オルガノイドの培養液のローテーションの有無による遺伝子発現の変化を解析した。4日間の培養液ローテーションあり、なし、およびローテーションから0、1、2、4日後（6条件）のRNAを抽出し、Hiseq X Tenでシーケンスを行った結果をfastqファイルにて提供する。\n"
        },
        "hum0201.v2": {
          "Research ID": "hum0201.v2",
          "公開日": "2020/10/06",
          "内容": "NGS（WGS、RNA-seq）",
          "description": "腫瘍性疾患の腫瘍組織および非腫瘍組織より樹立したオルガノイドおよび末梢血から抽出したDNA、RNAを用いたWhole Genome sequecing解析、RNA sequecing解析結果をfastqファイルにて提供する。\n"
        },
        "hum0201.v1": {
          "Research ID": "hum0201.v1",
          "公開日": "2019/12/20",
          "内容": "NGS（Exome）",
          "description": "潰瘍性大腸炎、および、腫瘍を併発する潰瘍性大腸炎の疾患組織（腫瘍・炎症部位）並びに正常腸管上皮組織から樹立したオルガノイド、 末梢血、および、患者の疾患組織から抽出したDNAを用いたWhole Exome sequecing解析結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0201.v7",
      "DATA": {
        "JGAS000199": {
          "Data Set ID": "JGAS000199",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/12/20"
        },
        "JGAS000237": {
          "Data Set ID": "JGAS000237",
          "Type of Data": "NGS (WGS, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/10/06"
        },
        "JGAS000256": {
          "Data Set ID": "JGAS000256",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/11/20"
        },
        "JGAS000378": {
          "Data Set ID": "JGAS000378",
          "Type of Data": "NGS (RNA-seq, ChIP-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/19"
        },
        "JGAS000350": {
          "Data Set ID": "JGAS000350",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/06/06"
        },
        "JGAS000550": {
          "Data Set ID": "JGAS000550",
          "Type of Data": "NGS (scRNA-seq, RNA-seq, Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/08/05"
        },
        "JGAD000687": {
          "Data Set ID": "JGAD000687",
          "Type of Data": "Processed data of JGAD000335 by JGA",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/12/27"
        }
      },
      "SUMMARY": {
        "Aims": "Search for differences in genomics and traits among normal cells, digestive non-tumor cells (inflammatory cells), and tumor cells",
        "Methods": "",
        "Participants/Materials": ""
      },
      "MOLECULAR DATA": {
        "Exome (JGAS000199/JGAS000550)": {
          "Participants/Materials": "gastrointestinal inflammatory disease (ICD10: K51): 29 cases\r\ngastrointestinal inflammatory disease with neoplastic disease (ICD10: K51, C18, C19, C20): 26 cases\r\norganoids derived from healthy normal colonic tissues with neoplastic disease (ICD10: C18): 2 cases\r\ncontrols who underwent colonoscopy: 16 individuals",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500/4000]",
          "Library Source": "DNAs extracted from inflammatory/tumor tissues, peripheral blood cells, and organoids established from epithelial tissues of the patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000284\r\nJGAD000669",
          "Total Data Volume": "JGAD000284: 488 GB (fastq)\r\nJGAD000669: 59.5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGS (JGAS000237)": {
          "Participants/Materials": "Neoplastic disease: 23 cases (55 samples)\r\n    Small cell lung cancer (ICD10: C34)\r\n    Biliary tract cancer (ICD10: C23, C24, C78)\r\n    Colon cancer (ICD10: C18-20)\r\n    Duodenal cancer (ICD10: C17)\r\n    Esophageal cancer (ICD10: C15)\r\n    Stomach cancer (ICD10: C16, C78)\r\n    Liver cancer (ICD10: C22)\r\n    Pancreatic cancer (ICD10: C25)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "DNAs extracted from peripheral blood cells and organoids established from normal and cancer tissues of the patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Library was constructed by BGI",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000335",
          "Dataset ID of the Processed data by JGA": "JGAD000687\r\nThe way to Process",
          "Total Data Volume": "2.752 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq (JGAS000237, JGAS000378)": {
          "Participants/Materials": "Neoplastic disease: 23 + 4 cases (35+ 5 samples)\r\n    Small cell lung cancer (ICD10: C34)\r\n    Biliary tract cancer (ICD10: C23, C24, C78)\r\n    Colon cancer (ICD10: C18-20)\r\n    Duodenal cancer (ICD10: C17)\r\n    Esophageal cancer (ICD10: C15)\r\n    Stomach cancer (ICD10: C16, C78)\r\n    Liver cancer (ICD10: C22)\r\n    Pancreatic cancer (ICD10: C25)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500/X Ten, NovaSeq 6000]",
          "Library Source": "RNAs extracted from organoids established from tumor tissues and a normal epithelial tissue of the patients\r\nRNAs extracted from organoids with BET bromodomain inhibitor established from tumor tissues and a normal epithelial tissue of colon cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Library Prep Kit v2\r\nTruSeq Stranded mRNA Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "250 bp/150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000336\r\nJGAD000492",
          "Total Data Volume": "JGAD000336: 2.752 TB (fastq)\r\nJGAD000492: 190.5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq (JGAS000256)": {
          "Participants/Materials": "Neoplastic disease (ICD10: C16): 1 case (1 sample)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "Total RNA extracted from normal duodenum organoids with or without a four-day medium rotation, and after 0, 1, 2 or 4 days of medium rotation",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Library Prep Kit v2\r\nTruSeq Stranded mRNA Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "250 bp/150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000359",
          "Total Data Volume": "37 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq (JGAS000350)": {
          "Participants/Materials": "Neoplastic disease (ICD10: C16): 2 case (11 sample)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 4000]",
          "Library Source": "RNAs extracted from organoids derived from colon cancer tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Library Prep Kit v2\r\nTruSeq Stranded mRNA Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "250 bp/150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000464",
          "Total Data Volume": "108.9 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq (JGAS000550)": {
          "Participants/Materials": "Neoplastic disease (ICD10: C18): 2 case (8 sample)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "Total RNA extracted from normal duodenum organoids with or without a four-day medium rotation, and after 0, 1, 2 or 4 days of medium rotation",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Library Prep Kit v2\r\nTruSeq Stranded mRNA Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 x 2 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000669",
          "Total Data Volume": "46.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "scRNA-seq (JGAS000550)": {
          "Participants/Materials": "Neoplastic disease (ICD10: C16): 1 case (1 sample)",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 4000]",
          "Library Source": "RNAs extracted from organoids from normal colonic tissue",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Single Cell 3′ Library & Gel Bead Kit v2 and the A Chip Kit (10X Genomics)",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "28+91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000669",
          "Total Data Volume": "66.0 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "ChIP-seq (JGAS000378)": {
          "Participants/Materials": "Neoplastic disease: 4 cases (5 samples)\r\n    Colon cancer (ICD10: C18)",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "DNAs extracted from organoids derived from colon cancer tissues and a normal epithelial tissue of the patients, and immunoprecipitated with an anti-histone antibody (H3K27Ac)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina Tagment DNA TDE1 Enzyme and Buffer Kits",
          "Fragmentation Methods": "Ultrasonic fragmentation (Bioruptor Ⅱ)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000492",
          "Total Data Volume": "190.5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshiro Sato",
        "Affiliation": "Department of Organoid Medicine, Keio University School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "5": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (S)",
            "Title": "Elucidating a role of niche construction in pathophysiological mechanism of human digestive diseases",
            "Project Number": "22H04995"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Somatic inflammatory gene mutations in human ulcerative colitis epithelium",
          "DOI": "doi: 10.1038/s41586-019-1844-5",
          "Data Set ID": "JGAD000284"
        },
        "2": {
          "Title": "An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping",
          "DOI": "doi: 10.1016/j.cell.2020.10.023",
          "Data Set ID": "JGAD000335\r\nJGAD000336"
        },
        "3": {
          "Title": "An organoid-based organ repurposing approach to treat short bowel syndrome",
          "DOI": "doi: 10.1038/s41586-021-03247-2",
          "Data Set ID": "JGAD000359"
        },
        "4": {
          "Title": "Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer",
          "DOI": "doi: 10.1038/s41589-022-00984-x",
          "Data Set ID": "JGAD000492"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Klaus H. Kaestner": {
          "Principal Investigator": "Klaus H. Kaestner",
          "Affiliation": "Institue for Diabetes, Obesity & Metabolism at Unversity of Pennsylvania",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Somatic mutation analysis of the pancreas in type 1 diabetes",
          "Period of Data Use": "JGAD000284"
        },
        "Ulf Leser": {
          "Principal Investigator": "Ulf Leser",
          "Affiliation": "Department of Mathematics and Computer Science, Humboldt-Universitaet zu Berlin",
          "Research Title": "",
          "Data in Use (Dataset ID)": "MAPTor-NET: MAPK-mTOR network model driven individualized therapies of pancreatic neuro-endocrine tumors (pNETs)",
          "Period of Data Use": "JGAD000335, JGAD000336"
        },
        "Nobuhiro Tanuma": {
          "Principal Investigator": "Nobuhiro Tanuma",
          "Affiliation": "Miyagi Cancer Center Research Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Study on biological characters of pancreatic and gastrointestinal neuroendocrine tumors using patient-derived organoids.",
          "Period of Data Use": "JGAD000336"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000336, JGAD000359, JGAD000492"
        }
      },
      "Release Note": {
        "hum0201.v7": {
          "Research ID": "hum0201.v7",
          "Release Date": "2022/12/27",
          "Type of Data": "Processed data of JGAD000335 by JGA",
          "description": "The alignment results [CRAM], variant call results per sample [gVCF], and variant call results per dataset [aggregated VCF] processed JGAD000335 in a certain workflow were provided. If you plan to use the data, please indicate both original data (JGAD000335) and processed data (JGAD000687) on the application form for data use.\n"
        },
        "hum0201.v6": {
          "Research ID": "hum0201.v6",
          "Release Date": "2022/08/05",
          "Type of Data": "NGS (scRNA-seq, RNA-seq, Exome)",
          "description": "RNAs extracted from normal colonic tissue from a neoplastic disease patient was used for the single cell RNA sequencing analysis. DNAs and RNAs extracted from organoids established from healthy normal colonic tissues of the patients were used for the whole genome and RNA sequencing analyses. Fastq files are provided.\n"
        },
        "hum0201.v5": {
          "Research ID": "hum0201.v5",
          "Release Date": "2022/06/06",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from organoids derived from colon cancer tissues from neoplastic disease patients were used for the RNA sequencing analysis. Fastq files are provided.\n"
        },
        "hum0201.v4": {
          "Research ID": "hum0201.v4",
          "Release Date": "2021/11/19",
          "Type of Data": "NGS (RNA-seq, ChIP-seq)",
          "description": "DNAs and RNAs extracted from organoids established from colon cancer tissues and a normal epithelial tissue of the patients were used for RNA sequencing and ChIP-seq analyses. Fastq files are provided.\n"
        },
        "hum0201.v3": {
          "Research ID": "hum0201.v3",
          "Release Date": "2020/11/20",
          "Type of Data": "NGS (RNA-seq)",
          "description": "Gene expression of 2D normal duodenum organoids with or without medium rotation was analyzed. Total RNA was extracted from organoids with or without a four-day medium rotation, and after 0, 1, 2 or 4 days of medium rotation, and sequenced with HiSeq X Ten. Fastq files are provided.\n"
        },
        "hum0201.v2": {
          "Research ID": "hum0201.v2",
          "Release Date": "2020/10/06",
          "Type of Data": "NGS (WGS, RNA-seq)",
          "description": "DNAs and RNAs extracted from peripheral blood cells and organoids established from normal and cancer tissues of the patients were used for the whole genome and RNA sequencing analysis. Fastq files are provided.\n"
        },
        "hum0201.v1": {
          "Research ID": "hum0201.v1",
          "Release Date": "2019/12/20",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from inflammatory/tumor tissues from gastrointestinal inflammatory disease patients, peripheral blood cells from patients/controls, and the organoids established from epithelial tissues from patients were used for the whole exome sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0200.v5": {
    "ja": {
      "NBDC Research ID": "hum0200.v5",
      "データ": {
        "JGAS000202": {
          "データID": "JGAS000202",
          "内容": "NGS（Exome）\r\nシングルセルCNV解析",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/29"
        },
        "JGAS000265": {
          "データID": "JGAS000265",
          "内容": "NGS（WGS）\r\nメチル化解析",
          "制限": "制限公開（Type I）",
          "公開日": "2021/05/07"
        },
        "JGAS000202（データ追加）": {
          "データID": "JGAS000202（データ追加）",
          "内容": "NGS（Target Capture）\r\nNGS（Visium Spatial Gene Expression）、病理画像",
          "制限": "制限公開（Type I）",
          "公開日": "2021/10/01"
        },
        "JGAS000290": {
          "データID": "JGAS000290",
          "内容": "NGS（Visium Spatial Gene Expression）、病理画像",
          "制限": "制限公開（Type I）",
          "公開日": "2022/03/02"
        },
        "JGAS000387": {
          "データID": "JGAS000387",
          "内容": "NGS（semibulk RNA-seq）\r\nNGS（scRNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/8/29"
        }
      },
      "研究内容の概要": {
        "目的": "非浸潤性乳管がんの分子生物学的背景に基づいたリスク層別化因子の探索",
        "方法": "臨床的リスク因子に基づいて非浸潤性乳管がん症例、および浸潤性乳管がんを選択し、網羅的遺伝子解析によりリスク因子との関連を検討する。",
        "対象": "ヒト非浸潤性乳管がん、浸潤性乳管がん"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "Exome": {
          "対象": "非浸潤性乳管がん（ICD10：D051）：24症例\r\n      腫瘍組織：28検体\r\n      非腫瘍組織：24検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 3000]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V7",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000287",
          "総データ量": "775 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "シングルセルCNV解析": {
          "対象": "非浸潤性乳管がん（ICD10：D051）：3症例\r\n      腫瘍組織：3検体",
          "規模": "single-cell CNV",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "ソース": "腫瘍組織から調整した細胞",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Chromium Single-Cell DNA Reagent Kit",
          "コピー数決定アルゴリズム（ソフトウェア）": "cellranger-dna-1.1.0 (refdata-GRCh38-1.0.0.)",
          "フィルタリング": "cellranger-dna-1.1.0",
          "コピー数変異数(QC後)": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000287",
          "総データ量": "775 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGS": {
          "対象": "非浸潤性乳管がん（ICD10：D051）：2症例\r\n      腫瘍組織：2検体\r\n      非腫瘍組織：2検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]\r\nNanopore [PromethION]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina：TruSeq DNA Nano\r\nNanopore：SQK_LSK109",
          "断片化の方法": "Illumina：超音波断片化（Covaris M220）\r\nNanopore：-",
          "ライブラリ構築方法": "Illumina：Paired-end\r\nNanopore：Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "Illumina：300 bp\r\nNanopore：-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000368",
          "総データ量": "873 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "メチル化解析": {
          "対象": "非浸潤性乳管がん（ICD10：D051）：1症例\r\n浸潤性乳管がん（ICD10：C509）：2症例\r\n      腫瘍組織：4検体\r\n      非腫瘍組織：3検体",
          "規模": "メチル化解析",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Nanopore [PromethION]",
          "ソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "SQK_LSK109",
          "メチル化率決定アルゴリズム（ソフトウェア）": "Nanopolish",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000368",
          "総データ量": "873 GB（fastq、tsv [ref: GRCh38.p12]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture": {
          "対象": "浸潤性乳管がん（ICD10：C509）：2症例\r\n非浸潤性乳管がん（ICD10：D051）：72症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "180遺伝子",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT custom capture library",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp（100 PE）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000307",
          "総データ量": "455 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Visium Spatial Gene Expression、病理画像 （JGAS000202、JGAS000290）": {
          "対象": "浸潤性乳管がん（ICD10：C509）：2症例\r\n非浸潤性乳管がん（ICD10：D051）：1症例",
          "規模": "Visium Spatial Gene Expression、病理画像",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Visium Spatial Gene Expression Reagent Kits",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "148 bp（28/120 PE）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000308\r\nJGAD000396",
          "総データ量": "JGAD000308：259 GB（fastq、tif）\r\nJGAD000396：594.7 GB（fastq、tif、tsv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "semibulk RNA-seq": {
          "対象": "浸潤性乳管がん（ICD10：C509）：1症例\r\n      腫瘍組織：1検体（同一検体から2個のライブラリを作成）\r\n非浸潤性乳管がん（ICD10：D051）：1症例\r\n      腫瘍組織：1検体（同一検体から10個のライブラリを作成）",
          "規模": "semibulk RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 3000、NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織から調製したセミバルク（細胞塊）",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Drop-Seq Laboratory Protocol, version 3.1",
          "断片化の方法": "Nextera XT（Illumina）によるタグメンテーション",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp （100PE）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000502",
          "総データ量": "272.4 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "scRNA-seq": {
          "対象": "浸潤性乳管がん（ICD10：C509）：1症例\r\n      腫瘍組織、非腫瘍組織：各1検体\r\n非浸潤性乳管がん（ICD10：D051）：1症例\r\n      腫瘍組織、非腫瘍組織：各1検体",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 3000]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から調製した細胞",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium single cell 3’ kit version 3 (10x Genomics)",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "124 bp （26/98PE）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000502",
          "総データ量": "272.4 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "永澤 慧",
        "所 属 機 関": "聖マリアンナ医科大学 外科学 乳腺・内分泌外科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Efficient prediction of a spatial transcriptomics profile better characterizes breast cancer tissue sections without costly experimentation",
          "DOI": "doi: 10.1038/s41598-022-07685-4",
          "データID": "JGAD000396"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0200.v5": {
          "Research ID": "hum0200.v5",
          "公開日": "2022/8/29",
          "内容": "NGS（semibulk RNA-seq、scRNA-seq）",
          "description": "浸潤性乳管がん1症例および非浸潤性乳管がん1症例の腫瘍組織から調製した細胞塊を用いたsemibulk RNA-seq解析の結果、ならびに、浸潤性乳管がん1症例および非浸潤性乳管がん1症例の腫瘍組織と非腫瘍組織から調製したシングルセルを用いたscRNA-seq解析の結果を提供する（fastqファイル）。\n"
        },
        "hum0200.v4": {
          "Research ID": "hum0200.v4",
          "公開日": "2022/03/02",
          "内容": "NGS（Visium Spatial Gene Expression）、病理画像",
          "description": "浸潤性乳管がん1症例の腫瘍組織から抽出したRNAを用いたVisium Spatial Gene Expression解析の結果を病理画像とともに提供する（fastqファイル、tifファイルおよびtsvファイル）。\n"
        },
        "hum0200.v3": {
          "Research ID": "hum0200.v3",
          "公開日": "2021/10/01",
          "内容": "NGS（Target Capture、Visium Spatial Gene Expression）、病理画像",
          "description": "浸潤性乳管がん2症例および非浸潤性乳管がん72症例の腫瘍組織から抽出したDNAを用いたTarget Capture Sequencing解析、並びに浸潤性乳管がん2症例および非浸潤性乳管がん1症例の腫瘍組織から抽出したRNAを用いたVisium Spatial Gene Expression解析の結果を病理画像とともに提供する（fastqファイルおよびtifファイル）。\n"
        },
        "hum0200.v2": {
          "Research ID": "hum0200.v2",
          "公開日": "2021/05/07",
          "内容": "NGS（WGS）、メチル化解析",
          "description": "非浸潤性乳管がん2症例の腫瘍組織および非腫瘍組織から抽出したDNAを用いたWhole Genome Sequencing解析、並びに浸潤性乳管がん2症例および非浸潤性乳管がん1症例の腫瘍組織および非腫瘍組織から抽出したDNAを用いたメチル化解析の結果をfastqファイルおよびtsvファイル（2症例分のCpGメチル化コールデータ）にて提供する。\n"
        },
        "hum0200.v1": {
          "Research ID": "hum0200.v1",
          "公開日": "2021/03/29",
          "内容": "NGS（Exome）、シングルセルCNV解析",
          "description": "非浸潤性乳管がんの腫瘍組織および非腫瘍組織から抽出したDNAを用いたWhole Exome Sequencing解析、および腫瘍組織のシングルセルCNV解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0200.v5",
      "DATA": {
        "JGAS000202": {
          "Data Set ID": "JGAS000202",
          "Type of Data": "NGS (Exome)\r\nsingle-cell CNV analysis",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/29"
        },
        "JGAS000265": {
          "Data Set ID": "JGAS000265",
          "Type of Data": "NGS (WGS)\r\nMethylation analysis",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/05/07"
        },
        "JGAS000202 (Data addition)": {
          "Data Set ID": "JGAS000202 (Data addition)",
          "Type of Data": "NGS (Target Capture)\r\nNGS (Visium Spatial Gene Expression), Histological image",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/10/01"
        },
        "JGAS000290": {
          "Data Set ID": "JGAS000290",
          "Type of Data": "NGS (Visium Spatial Gene Expression), Histological image",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/03/02"
        },
        "JGAS000387": {
          "Data Set ID": "JGAS000387",
          "Type of Data": "NGS (semibulk RNA-seq)\r\nNGS (scRNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/8/29"
        }
      },
      "SUMMARY": {
        "Aims": "Search for risk stratification factors based on the molecular biological background of non-invasive ductal carcinoma",
        "Methods": "Selected the patients with Ductal Carcinoma In Situ (DCIS) or Invasive Ductal Carcinoma (IDC) based on clinical risk factors and examined the association with risk factors by comprehensive gene analyses.",
        "Participants/Materials": "Human Ductal Carcinoma In Situ (DCIS), Invasive Ductal Carcinoma (IDC)"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by \"Genome Science\". \"Genome Science\" is a part of the \"Support Programs for Three Fields in Life Sciences (cancer, genome, and brain sciences)\" established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "Exome": {
          "Participants/Materials": "DCIS (ICD10: D051): 24 cases\r\n      tumor tissues: 28 samples\r\n      non-tumor tissues: 24 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 3000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V7",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000287",
          "Total Data Volume": "775 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "single-cell CNV analysis": {
          "Participants/Materials": "DCIS (ICD10: D051): 3 cases\r\n      tumor tissues: 3 samples",
          "Targets": "single-cell CNV",
          "Target Loci for Capture Methods": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "Source": "single-cells from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Single-Cell DNA Reagent Kit (10x Genomics)",
          "Algorithm for detecting CNVs (software)": "cellranger-dna-1.1.0 (refdata-GRCh38-1.0.0.)",
          "Filtering Methods": "cellranger-dna-1.1.0",
          "CNV number": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000287",
          "Total Data Volume": "775 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGS": {
          "Participants/Materials": "DCIS (ICD10: D051): 2 cases\r\n      tumor tissues: 2 samples\r\n      non-tumor tissues: 2 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]\r\nNanopore [PromethION]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina: TruSeq DNA Nano\r\nNanopore: SQK_LSK109",
          "Fragmentation Methods": "Illumina: Ultrasonic fragmentation (Covaris M220)\r\nNanopore: -",
          "Spot Type": "Illumina: Paired-end\r\nNanopore: Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "Illumina: 300 bp\r\nNanopore: -",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000368",
          "Total Data Volume": "873 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation analysis": {
          "Participants/Materials": "DCIS (ICD10: D051): 1 cases\r\nIDC (ICD10: C509): 2 cases\r\n      tumor tissues: 4 samples\r\n      non-tumor tissues: 3 samples",
          "Targets": "Methylation analysis",
          "Target Loci for Capture Methods": "-",
          "Platform": "Nanopore [PromethION]",
          "Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "SQK_LSK109",
          "Algorithms for Calculating Methylation-rate (software)": "Nanopolish",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000368",
          "Total Data Volume": "873 GB (fastq, tsv [ref: GRCh38.p12])",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture": {
          "Participants/Materials": "IDC (ICD10: C509): 2 cases\r\nDCIS (ICD10: D051): 72 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "180 genes",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT custom capture library",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp (100 PE)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000307",
          "Total Data Volume": "455 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Visium Spatial Gene Expression, Histological image (JGAS000202, JGAS000290)": {
          "Participants/Materials": "IDC (ICD10: C509): 2 cases\r\nDCIS (ICD10: D051): 1 case",
          "Targets": "Visium Spatial Gene Expression, Histological image",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Visium Spatial Gene Expression Reagent Kits",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "148 bp (28/120 PE)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000308\r\nJGAD000396",
          "Total Data Volume": "JGAD000308：259 GB (fastq, tif)\r\nJGAD000396：594.7 GB (fastq, tif, tsv)",
          "Comments (Policies)": "NBDC policy"
        },
        "semibulk RNA-seq": {
          "Participants/Materials": "DCIS (ICD10: D051): 1 case\r\n      tumor tissues: 2 libraries from 1 sample\r\nIDC (ICD10: C509): 1 case\r\n      tumor tissues: 2 libraries from 1 sample",
          "Targets": "semibulk RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 3000, NovaSeq 6000]",
          "Source": "Semibulks (cell clumps) prepared from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Drop-Seq Laboratory Protocol, version 3.1",
          "Fragmentation Methods": "Tagmentation with Nextera XT (Illumina)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp (100PE)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000502",
          "Total Data Volume": "272.4 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "scRNA-seq": {
          "Participants/Materials": "DCIS (ICD10: D051): 1 case\r\n      tumor tissues: 1 sample\r\n      non-tumor tissues: 1 sample\r\nIDC (ICD10: C509): 1 case\r\n      tumor tissues: 1 sample\r\n      non-tumor tissues: 1 sample",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 3000]",
          "Source": "Single cells obtained from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium single cell 3’ kit version 3 (10x Genomics)",
          "Fragmentation Methods": "enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "124 bp (26/98PE)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000502",
          "Total Data Volume": "272.4 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Satoi Nagasawa",
        "Affiliation": "Division of Breast and Endocrine Surgery, Department of Surgery St. Marianna University School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Efficient prediction of a spatial transcriptomics profile better characterizes breast cancer tissue sections without costly experimentation",
          "DOI": "doi: 10.1038/s41598-022-07685-4",
          "Data Set ID": "JGAD000396"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0200.v5": {
          "Research ID": "hum0200.v5",
          "Release Date": "2022/8/29",
          "Type of Data": "NGS (semibulk RNA-seq, scRNA-seq)",
          "description": "Semibulks (cell clumps), prepared from the tumor tissues of Ductal Carcinoma In Situ (DCIS) or Invasive Ductal Carcinoma (IDC), were used for semibulk RNA-seq. Single cells, prepared from the tumor or normal tissues of DCIS and IDC, were used for scRNA-seq. Fastq files are provided.\n"
        },
        "hum0200.v4": {
          "Research ID": "hum0200.v4",
          "Release Date": "2022/03/02",
          "Type of Data": "NGS (Visium Spatial Gene Expression), Histological image",
          "description": "RNAs extracted from tumor tissues of a Invasive Ductal Carcinoma (IDC) patients were used for Visium Spatial Gene Expression Assay. Fastq files, tif files (histological image for Visium Spatial Gene Expression Assay) and a tsv file are provided.\n"
        },
        "hum0200.v3": {
          "Research ID": "hum0200.v3",
          "Release Date": "2021/10/01",
          "Type of Data": "NGS (Target Capture, Visium Spatial Gene Expression), Histological image",
          "description": "DNAs extracted from tumor tissues of 2 Invasive Ductal Carcinoma (IDC) patients and 72 Ductal Carcinoma In Situ (DCIS) patients were used for the target capture sequencing and RNAs extracted from tumor tissues of 2 IDC patients and a DCIS patient were used for Visium Spatial Gene Expression Assay. Fastq files and tif files (histological image for Visium Spatial Gene Expression Assay) are provided.\n"
        },
        "hum0200.v2": {
          "Research ID": "hum0200.v2",
          "Release Date": "2021/05/07",
          "Type of Data": "NGS (WGS), Methylation analysis",
          "description": "DNAs extracted from tumor and non-tumor tissues of 2 Ductal Carcinoma In Situ (DCIS) patients were used for the whole genome sequencing and DNAs extracted from tumor and non-tumor tissues of 2 Invasive Ductal Carcinoma (IDC) patients and a DCIS patient were used for Methylation analysis. Fastq files and tsv files (CpG methylation calls for 2 patients) are provided.\n"
        },
        "hum0200.v1": {
          "Research ID": "hum0200.v1",
          "Release Date": "2021/03/29",
          "Type of Data": "NGS (Exome), single-cell CNV analysis",
          "description": "DNAs extracted from tumor and non-tumor tissues of 25 Ductal Carcinoma In Situ (DCIS) patients were used for the whole exome sequencing and single-cells from tumor tissues of 2 DCIS patients were used for single-cell CNV analysis (fastq files).\nNote：\n"
        }
      }
    }
  },
  "hum0199.v1": {
    "ja": {
      "NBDC Research ID": "hum0199.v1",
      "データ": {
        "JGAS000198": {
          "データID": "JGAS000198",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/06/29"
        }
      },
      "研究内容の概要": {
        "目的": "前立腺がんの発生、進行、治療耐性化における腫瘍組織内の遺伝子発現変化を明らかにする",
        "方法": "前立腺がんの腫瘍組織もしくは非腫瘍組織より抽出したtotal RNAを用いた次世代シークエンサーによるRNA-sequencing解析",
        "対象": "手術の際に摘出した前立腺組織（腫瘍組織および非腫瘍組織）、治療耐性を獲得した症例の再発組織、転移組織"
      },
      "分子データ": {
        "JGAS000198": {
          "対象": "前立腺がん（ICD10：C61）：25症例\r\n    原発巣の腫瘍組織＋非腫瘍組織：6症例\r\n    原発巣の腫瘍組織のみ：13症例\r\n    再発巣の腫瘍組織：4症例\r\n    再発かつ転移巣の腫瘍組織：2症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "手術で摘出した腫瘍組織もしくは非腫瘍組織から抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TrueSeq RNA library preparation",
          "断片化の方法": "上記キットに準拠",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000283",
          "総データ量": "48 GB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "藤村 哲也",
        "所 属 機 関": "東京大学医学部附属病院 泌尿器科",
        "プロジェクト/研究グループ名": "次世代シーケンサーを用いた泌尿器悪性腫瘍における治療標的分子の同定",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "Genetic scoreを用いた前立腺癌治療の個別化",
            "研究課題番号": "15K10576"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors",
          "DOI": "doi: 10.1038/s42003-020-01120-y",
          "データID": "JGAD000283"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000283"
        }
      },
      "リリース情報": {
        "hum0199.v1": {
          "Research ID": "hum0199.v1",
          "公開日": "2020/06/29",
          "内容": "NGS（RNA-seq）",
          "description": "前立腺がん25症例の腫瘍組織もしくは非腫瘍組織から抽出したRNAを用いたRNA-Seq解析データをbamファイルにて提供する。TrueSeq RNA library preparation KitによるRNAライブラリ作製後、HiSeq 2500（Illumina）にて平均長50 bpを読んだ（Single-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0199.v1",
      "DATA": {
        "JGAS000198": {
          "Data Set ID": "JGAS000198",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/06/29"
        }
      },
      "SUMMARY": {
        "Aims": "We analyzed gene expression changes in the development, progression and aquirement of therapeutic resistance of prostate cancer.",
        "Methods": "We extract total RNAs and performed RNA-sequence analysis.",
        "Participants/Materials": "Prostate tissues including benign and tumor tissues obtained by surgery and tumor tissues of metastasis or relapsed"
      },
      "MOLECULAR DATA": {
        "JGAS000198": {
          "Participants/Materials": "Prostate cancer (ICD10: C61): 25 cases\r\n    primary tumor and paired non-tumor tissues: 6 cases\r\n    primary tumor tissues: 13 cases\r\n    metastasis tumor tissues: 4 cases\r\n    metastasis and relapsed tumors tissues: 2 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "total RNAs extracted from surgicallly resected tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TrueSeq RNA library preparation",
          "Fragmentation Methods": "included in the above library construction kit",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000283",
          "Total Data Volume": "48 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tetsuya Fujimura",
        "Affiliation": "Department of Urology, Graduate Scool of Medicine, University of Tokyo",
        "Project / Group Name": "Identification of therapeutic target molecules for urologic cancers by using next generation sequencer",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Personalized medicine for advanced prostate cancer",
            "Project Number": "15K10576"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors",
          "DOI": "doi: 10.1038/s42003-020-01120-y",
          "Data Set ID": "JGAD000283"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000283"
        }
      },
      "Release Note": {
        "hum0199.v1": {
          "Research ID": "hum0199.v1",
          "Release Date": "2020/06/29",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs were extracted from surgicallly resected tumor and non-tumor tissues of 25 prostate cancer patients. Libraries for RNA-seq were prepared with TrueSeq RNA library preparation Kit and RNA-seq was performed by using of HiSeq 2500 (Illumina) (50 bp, Single-end). RNA-seq data are provided as bam files.\nNote：\n"
        }
      }
    }
  },
  "hum0197.v18": {
    "ja": {
      "NBDC Research ID": "hum0197.v18",
      "データ": {
        "JGAS000205": {
          "データID": "JGAS000205",
          "内容": "メタゲノム",
          "制限": "制限公開（Type I）",
          "公開日": "2019/11/15"
        },
        "hum0197.v2.gwas.v1": {
          "データID": "hum0197.v2.gwas.v1",
          "内容": "肺胞蛋白症のGWAS",
          "制限": "非制限公開",
          "公開日": "2020/11/27"
        },
        "JGAS000260": {
          "データID": "JGAS000260",
          "内容": "メタゲノム",
          "制限": "制限公開（Type I）",
          "公開日": "2020/11/27"
        },
        "hum0197.v3.gwas.v1": {
          "データID": "hum0197.v3.gwas.v1",
          "内容": "215形質のGWAS",
          "制限": "非制限公開",
          "公開日": "2021/03/22"
        },
        "JGAS000316": {
          "データID": "JGAS000316",
          "内容": "メタゲノム",
          "制限": "制限公開（Type I）",
          "公開日": "2021/10/12"
        },
        "JGAS000415": {
          "データID": "JGAS000415",
          "内容": "メタゲノム",
          "制限": "制限公開（Type I）",
          "公開日": "2021/12/10"
        },
        "hum0197.v5.gwas.v1": {
          "データID": "hum0197.v5.gwas.v1",
          "内容": "10形質のGWAS",
          "制限": "非制限公開",
          "公開日": "2021/12/21"
        },
        "hum0197.v5.finemap.v1": {
          "データID": "hum0197.v5.finemap.v1",
          "内容": "79形質のFine-mapping",
          "制限": "非制限公開",
          "公開日": "2021/12/21"
        },
        "JGAS000504": {
          "データID": "JGAS000504",
          "内容": "miRNAリードカウント",
          "制限": "制限公開（Type I）",
          "公開日": "2022/02/08"
        },
        "hum0197.v6.eqtl.v1": {
          "データID": "hum0197.v6.eqtl.v1",
          "内容": "eQTL解析データ",
          "制限": "非制限公開",
          "公開日": "2022/02/08"
        },
        "JGAS000530": {
          "データID": "JGAS000530",
          "内容": "メタゲノム",
          "制限": "制限公開（Type I）",
          "公開日": "2022/05/23"
        },
        "JGAS000531": {
          "データID": "JGAS000531",
          "内容": "メタゲノム",
          "制限": "制限公開（Type I）",
          "公開日": "2022/06/03"
        },
        "hum0197.v9.gwas.GCT.v1": {
          "データID": "hum0197.v9.gwas.GCT.v1",
          "内容": "頭蓋内胚細胞腫瘍のGWAS",
          "制限": "非制限公開",
          "公開日": "2022/06/10"
        },
        "hum0197.v10.gwas.v1": {
          "データID": "hum0197.v10.gwas.v1",
          "内容": "9形質のGWAS",
          "制限": "非制限公開",
          "公開日": "2022/06/16"
        },
        "JGAS000543": {
          "データID": "JGAS000543",
          "内容": "scRNA-seqデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/07/21"
        },
        "hum0197.v12": {
          "データID": "hum0197.v12",
          "内容": "微生物ゲノムのMAG・ウイルスのゲノム配列・CRISPR spacer配列",
          "制限": "非制限公開",
          "公開日": "2022/12/01"
        },
        "JGAS000543（データ追加）": {
          "データID": "JGAS000543（データ追加）",
          "内容": "臨床情報",
          "制限": "制限公開（Type I）",
          "公開日": "2023/02/14"
        },
        "JGAS000593": {
          "データID": "JGAS000593",
          "内容": "scRNA-seqデータ、臨床情報",
          "制限": "制限公開（Type I）",
          "公開日": "2023/02/14"
        },
        "hum0197.v3.gwas.v1（データ追加）": {
          "データID": "hum0197.v3.gwas.v1（データ追加）",
          "内容": "5形質のGWAS",
          "制限": "非制限公開",
          "公開日": "2023/02/16"
        },
        "JGAS000600": {
          "データID": "JGAS000600",
          "内容": "メタゲノム",
          "制限": "制限公開（Type I）",
          "公開日": "2023/03/29"
        },
        "hum0197.v16.gwas.v1": {
          "データID": "hum0197.v16.gwas.v1",
          "内容": "15形質のGWAS",
          "制限": "非制限公開",
          "公開日": "2023/06/06"
        },
        "hum0197.v17.hic-gwas.v1": {
          "データID": "hum0197.v17.hic-gwas.v1",
          "内容": "間質性膀胱炎ハンナ型のGWAS",
          "制限": "非制限公開",
          "公開日": "2023/06/27"
        },
        "hum0197.v18.gwas.v1": {
          "データID": "hum0197.v18.gwas.v1",
          "内容": "腸内微生物叢のGWAS\r\n血中代謝物のGWAS\r\nKEGG Gene OrthologおよびKEGG PathwayのGWAS",
          "制限": "非制限公開",
          "公開日": "2023/10/02"
        }
      },
      "研究内容の概要": {
        "目的": "多層的オミクス解析による疾患病態の解明、日本人集団におけるGWASおよび複数集団におけるGWASメタ解析、COVID-19重症化メカニズムの解明",
        "方法": "メタゲノムシークエンス、ゲノムワイド関連解析、small RNA-seq解析、eQTL解析",
        "対象": "日本人集団（95＋103＋227＋30＋136 名）の腸内細菌叢のメタゲノムシークエンスデータ"
      },
      "分子データ": {
        "JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531": {
          "対象": "日本人集団：95＋103＋227＋30＋136 名\r\n炎症性腸疾患症例\r\n   潰瘍性大腸炎 （ICD10：K519）：35症例\r\n   クローン病 （ICD10：K509）：39症例\r\n対照健常者：40名",
          "規模": "メタゲノム",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 3000、NovaSeq 6000]",
          "ライブラリソース": "便より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA Hyper Prep Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000290（日本人集団：95名）\r\nJGAD000363（日本人集団：103名）\r\nJGAD000427（日本人集団：227名）\r\nJGAD000532（日本人集団：30名）\r\nJGAD000649（炎症性腸疾患症例）\r\nJGAD000650（日本人集団：136名）",
          "総データ量": "JGAD000290：477 GB（fastq）\r\nJGAD000363：408 GB（fastq）\r\nJGAD000427：881.2 GB（fastq）\r\nJGAD000532：106.7 GB（fastq）\r\nJGAD000649：374.6 GB （fastq）\r\nJGAD000650：541.4 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v2.gwas.v1": {
          "対象": "肺胞蛋白症（ICD10：J840）：198症例\r\n対照者：395名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium Asian Screening Array]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium Asian Screening Array",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenomeStudio for genotyping, shapeit2 for haplotype phasing, and minimac3 for imputation",
          "関連解析（ソフトウェア）": "PLINK2",
          "フィルタリング": "Sample QC: We excluded samples with low genotyping call rates (call rate < 98%) and in close genetic relation (PI_HAT > 0.175). We included samples of the estimated East Asian ancestry.\r\nVariant QC: We excluded variants with (1) genotyping call rate < 98%, (2) P value for Hardy–Weinberg equilibrium < 1.0 × 10−6, and (3) minor allele count < 5, or (4) > 10% frequency difference with the imputation reference panel.",
          "マーカー数（QC後）": "12,153,232 autosomal variants and 242,876 X-chromosomal variants after QC.",
          "NBDC Dataset ID": "hum0197.v2.gwas.v1\r\n（データのダウンロードは上記Data IDをクリックしてください）\r\nDictionary file",
          "総データ量": "390MB for autosome (txt.gz) and 19MB for X chromosome (txt.gz)",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v3.gwas.v1": {
          "対象": "バイオバンク・ジャパン（179,000名）、UKバイオバンク（361,000名）、FinnGen（136,000名）\r\n形質数：220",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "BBJ：Illumina [HumanOmniExpressExome BeadChip、HumanOmniExpress BeadChip、HumanExome BeadChip]\r\nUK Biobank：Applied Biosystems [UK BiLEVE Axiom Array、UK Biobank Axiom Array]\r\nFinnGen：Thermo Fisher Scientific [FinnGen1 ThermoFisher Arrayなど]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "BBJ：HumanOmniExpressExome BeadChip、HumanOmniExpress BeadChip、HumanExome BeadChip\r\nUK Biobank：UK BiLEVE Axiom Array、UK Biobank Axiom Array\r\nFinnGen：FinnGen1 ThermoFisher Arrayなど",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "BBJ：Eagle、Minimac3\r\nUK Biobank：IMPUTE4\r\nFinnGen：beagle4.1",
          "関連解析（ソフトウェア）": "For binary traits, SAIGE software was used with age, age2, sex, age×sex, age2×sex, and top 20 principal components as covariates. For quantitative traits (biomarkers), BOLT-LMM or plink software was used with the same covariates.\r\n ",
          "フィルタリング": "BBJ：We included imputed variants with Rsq > 0.7.\r\nUK Biobank：We excluded the variants with (i) INFO score ≤ 0.8, (ii) MAF ≤ 0.0001 (except for missense and protein-truncating variants annotated by VEP, which were excluded if MAF ≤ 1 × 10-6), and (iii) PHWE ≤ 1 × 10-10.\r\nFinnGen：We excluded variants with an imputation INFO score < 0.8 or MAF < 0.0001.",
          "マーカー数（QC後）": "BBJ：13,530,797 variants\r\nUK Biobank：13,791,467 variants\r\nFinnGen：16,859,359 variants",
          "NBDC Dataset ID": "hum0197.v3.gwas.v1\r\n（データのダウンロードは上記データIDをクリックし、遷移先のサイトの各Dataset IDをクリックしてください）\r\nDictionary file（BBJ、EUR、META）",
          "総データ量": "BBJ：~1.5G for autosome and ~33M for chrX\r\nUK Biobank：~1.5G for autosome and ~15M for chrX\r\nFinnGen：~740M for autosome and ~20M for chrX",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v5.gwas.v1 / hum0197.v5.finemap.v1": {
          "対象": "バイオバンク・ジャパン（179,000名）\r\n形質数：79",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpressExome BeadChip、HumanOmniExpress BeadChip、HumanExome BeadChip]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpressExome BeadChip、HumanOmniExpress BeadChip、HumanExome BeadChip",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Eagle、Minimac3",
          "関連解析（ソフトウェア）": "GWAS: For binary traits, SAIGE software was used with age, age2, sex, age×sex, age2×sex, and top 20 principal components as covariates. For quantitative traits (biomarkers), BOLT-LMM was used with the same covariates.\r\nFine-mapping: FINEMAP and SuSiE were used with GWAS summary statistics and in-sample dosage LD, allowing up to 10 causal variants per region.",
          "フィルタリング": "GWAS: We included imputed variants with Rsq > 0.7. For binary traits, variants with MAC < 10 were additionally excluded.\r\nFine-mapping: We defined fine-mapping regions based on a 3 Mb window around each lead variant and merged regions if they overlapped. We excluded the major histocompatibility complex (MHC) region (chr 6: 25–36 Mb) from analysis due to extensive LD structure in the region. For each method, we only included variants from successfully fine-mapped regions while excluding those from failed regions (e.g., due to conversion failure or available memory restrictions).",
          "マーカー数（QC後）": "13,531,752 variants（ref: hg19）",
          "NBDC Dataset ID": "hum0197.v5.gwas.v1 / hum0197.v5.finemap.v1\r\n（データのダウンロードは上記データIDをクリックし、遷移先のサイトの各Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "14 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000504": {
          "対象": "日本人集団：141名",
          "規模": "small RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血単核細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMARTer smRNA-Seq Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "マッピング方法": "bowtie（GRCh37）",
          "リードカウント決定アルゴリズム（ソフトウェア）": "featureCounts + miRbase v22",
          "フィルタリング（QC）方法": "We performed adapter trimming using Cutadapt v1.8 and removed reads with a low quality score (Phred quality score < 20 in >20% of total bases) using fastp v0.20.0. Also, we removed reads with a length of >29 bp or <15 bp, which are not expected to be mature miRNAs. Mature miRNAs detected with ≥1 read in at least half of the individuals were included in the dataset.",
          "miRNA数": "343",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000621",
          "総データ量": "54.7 KB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v6.eqtl.v1": {
          "対象": "日本人集団：141名",
          "規模": "eQTL",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "small RNA-seq：Illumina [HiSeq 2500]\r\n全ゲノムシーケンス：Illumina [HiSeq X Ten]",
          "ソース": "JGAS000504のリードカウントデータおよび全血から抽出したgenomic DNAを用いた全ゲノムシーケンスデータ",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "small RNA-seq：JGAS000504を参照のこと\r\n全ゲノムシーケンス：TruSeq DNA PCR-Free Library Preparation Kit",
          "遺伝子型/リードカウント決定アルゴリズム（ソフトウェア）": "リードカウントについてはJGAS000504を参照のこと\r\n全ゲノムシーケンスデータはBWA-MEM v0.7.13を用いGRCh37にアラインメントし、GATK v3.8-0を用いbest practiceに準じて解析した。",
          "フィルタリング": "リードカウントについてはJGAS000504を参照のこと\r\n全ゲノムシーケンスデータはGenotype call rate <90%, ExcessHet > 60, Hardy-Weinberg平衡検定P値<1.0×10−10のバリアントを除外した上で、Beagle v5.1によるgenotype imputationを実施した。",
          "マーカー数（QC後）": "リードカウントについてはJGAS000504を参照のこと\r\n全ゲノムシーケンスデータ：12,171,854 variants",
          "eQTL検出方法": "We analyzed the association between genetic variants with minor allele frequency (MAF) ≥ 0.01 within a cis-window around each miRNA (±1 Mb of the mature miRNA) and normalized expression values using MatrixEQTL v2.3.",
          "NBDC Dataset ID": "hum0197.v6.eqtl.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "1.1 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v9.gwas.GCT.v1": {
          "対象": "頭蓋内胚細胞腫瘍（ICD10：C719）：133症例\r\n対照者：762名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium Asian Screening Array]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium Asian Screening Array",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "遺伝子型決定：GenomeStudio\r\nハプロタイプフェージング：shapeit2 for haplotype phasing\r\nインピュテーション：minimac3",
          "関連解析（ソフトウェア）": "PLINK2",
          "フィルタリング": "サンプルQC：\r\n① 検体毎のgenotyping call rate < 0.97、② PI_HAT > 0.17、③ 非東アジア系、に該当する場合除外\r\nバリアントQC：\r\n① genotyping call rate < 0.99、② minor allele count < 5、③ P-value for Hardy–Weinberg equilibrium in controls < 1.0 × 10^−5 、④ > 10% allele frequency difference with the imputation reference panel or the allele frequency panel of Tohoku Medical Megabank Project、に該当する場合除外\r\nインピュテーション後のQC：\r\n① Rsq < 0.7、② minor allele frequency < 0.5%、に該当する場合除外",
          "マーカー数（QC後）": "7,803,874 autosomal variants\r\n181,867 X-chromosomal variants",
          "NBDC Dataset ID": "hum0197.v9.gwas.GCT.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "248 MB （txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v10.gwas.v1": {
          "対象": "バイオバンク・ジャパン（161,801名）、UKバイオバンク（377,581名）\r\n   疾患群：自己免疫疾患 [関節リウマチ（ICD10：M05）、バセドウ病（ICD10：C719）、1型糖尿病（ICD10：E10）]\r\n                 アレルギー疾患 [気管支喘息（ICD10：J45）、アトピー性皮膚炎（ICD10：L20）、花粉症（ICD10：J301）]\r\n   対照群：自己免疫・アレルギー疾患を有さない登録者\r\n   （各コホート内で疾患群間にはサンプルオーバーラップあり）\r\n   形質数：9",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "BBJ：Illumina [HumanOmniExpressExome BeadChip、HumanOmniExpress BeadChip、HumanExome BeadChip]\r\nUK Biobank：Applied Biosystems [UK BiLEVE Axiom Array、UK Biobank Axiom Array]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "BBJ：HumanOmniExpressExome BeadChip、HumanOmniExpress BeadChip、HumanExome BeadChip\r\nUK Biobank：UK BiLEVE Axiom Array、UK Biobank Axiom Array",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "BBJ：Eagle、Minimac3\r\nUK Biobank：IMPUTE4",
          "関連解析（ソフトウェア）": "SAIGE software was used with age,　sex, and top five principal components as covariates\r\nRE2C software was used for the multi-trait meta-analysis adjusting for sample overlap between GWAS summary data",
          "フィルタリング": "Rsq < 0.7 および MAF < 0.005 のバリアントを除外",
          "マーカー数（QC後）": "BBJ：8,374,220 autosomal variants for individual trait／8,369,174 autosomal variants for meta-analysis\r\nUK Biobank：10,864,380 autosomal variants for individual trait／10,858,065 autosomal variants for meta-analysis\r\nBBJ＋UK Biobank： 5,965,154 autosomal variants for meta-analysis",
          "NBDC Dataset ID": "hum0197.v10.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックし、遷移先のサイトのファイルダウンロードリンクをクリックしてください）\r\nDictionary file",
          "総データ量": "BBJ：～760MB for individual trait／～430MB for multi-trait meta-analysis\r\nUK Biobank：～1.1GB for individual trait／～550MB for multi-trait meta-analysis\r\nBBJ＋UK Biobank：～310MB for multi-trait meta-analysis",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        " JGAS000543 / JGAS000593": {
          "対象": "COVID-19患者（ICD10：U071）：30＋43症例\r\n健常者：31＋44名",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血単核細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Next GEM Single Cell 5’ Library & Gel Bead Kit v1.1、 Chromium Next GEM Chip G Single Cell Kit 、Single Index Kit T Set A",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "91 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000662\r\nJGAD000722",
          "総データ量": "1.3＋2.0 TB （fastq、xlsx [臨床情報]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v12.MAG.v1": {
          "対象": "日本人腸内微生物ゲノム\r\n   JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531、公開データ（DRA006684）より取得",
          "規模": "メタゲノム",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500/3000、NovaSeq 6000]",
          "ライブラリソース": "JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531、DRA006684より取得した配列",
          "検体情報（購入の場合）": "-",
          "MAGの構築方法": "metaspades,dastools(metabat2、maxbin2、concoct)によるde novo assembly + binning",
          "DDBJ Sequence Read Archive ID": "JGA MAG：20220531NSUB000031HIGH_JGA_JMAG_GENOME_*.acclist（JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531）\r\nDRA014186（JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531）\r\nDRA014188（JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531）\r\nDRA014191（JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531）\r\nDRA014192（JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531）\r\nTPA MAG： EMNX01000001-EMNX01000025、EMNY01000001-EMNY01000068、EMNZ01000001-EMNZ01000149、EMOA01000001-EMOA01000067（DRA006684）\r\nDRA014184（DRA006684）",
          "総データ量": "JGA MAG：153 GB（fasta）\r\nDRA014186：11.5 GB（fasta）\r\nDRA014188：11.9 GB（fasta）\r\nDRA014191：12.2 GB（fasta）\r\nDRA014192：5.75 GB（fasta）\r\nTPA MAG：11.9 MB（fasta）\r\nDRA014184 ：3.65 GB（fasta）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v12.VIRUS.v1": {
          "対象": "日本人腸内微生物ゲノム\r\n   JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531、公開データ（DRA006684）より取得",
          "規模": "NGS（WGS）",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500/3000、NovaSeq 6000]",
          "ライブラリソース": "JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531、DRA006684より取得した配列",
          "検体情報（購入の場合）": "-",
          "ウイルスゲノム構築方法": "metaspadesによるde novo assemblyの後に、virfinder及びvirsorterによってウイルスゲノムを検出。",
          "DDBJ Sequence Read Archive ID": "JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531：BRDB01000001-BRDB01028816\r\nDRA006684：EMNW01000001-EMNW01002579",
          "総データ量": "JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531：1.09 GB（fasta）\r\nDRA006684：98.3 MB（fasta）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v12.CRISPR.v1": {
          "対象": "日本人腸内微生物ゲノム\r\n   JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531、公開データ（DRA006684）より取得",
          "規模": "メタゲノム",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500/3000、NovaSeq 6000]",
          "ライブラリソース": "JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531、DRA006684より取得した配列",
          "検体情報（購入の場合）": "-",
          "CRISPR配列構築方法": "MAG配列に対してMINCEDを適用。",
          "DDBJ Sequence Read Archive ID": "DRA014186（JGAS000205／JGAS000260／JGAS000316／JGAS000415／JGAS000530／JGAS000531）\r\nDRA014184（DRA006684）",
          "総データ量": "DRA014184：17.9 MB（fasta）\r\nDRA014186：1.43 MB（fasta）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000600": {
          "対象": "日本人：88 名（ショットガンシークエンス）\r\n健常者：73 名（120検体）（ショットガンシークエンス）\r\n   - フェノール・クロロホルム法によるDNA抽出：73検体\r\n   - DNeasy PowerSoil Pro KitによるDNA抽出：47検体\r\n日本人：5 名（高深度ショットガンシークエンス）",
          "規模": "メタゲノム",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 3000、NovaSeq 6000]",
          "ライブラリソース": "便より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA Hyper Prep Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000729",
          "総データ量": "2.6 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v16.gwas.v1": {
          "対象": "バイオバンク・ジャパン（180,215名）、UKバイオバンク（377,441名）\r\nFinnGen、BCAC、PRACTICALの要約統計量を含めたメタ解析（乳がん：648,746名、前立腺がん：482,080名）\r\n疾患群：胆道がん（ICD10：C22.1、23-24）、乳がん（ICD10：C50）、子宮頸がん（ICD10：C53）、大腸がん（ICD10：C18-20）、子宮体がん（ICD10：C54）、食道がん（ICD10：C15）、胃がん（ICD10：C16）、肝細胞がん（ICD10：C22.0）、肺がん（ICD10：C34）、非ホジキンリンパ腫（ICD10：C82-83）、卵巣がん（ICD10：C56）、膵がん（ICD10：C25）、前立腺がん（ICD10：C61）\r\n対照群：がんに罹患していない登録者\r\n   （各コホート内で疾患群間にはサンプルオーバーラップあり）\r\n   形質数：15",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "BBJ：Illumina [HumanOmniExpressExome BeadChip、HumanOmniExpress BeadChip、HumanExome BeadChip]\r\nUK Biobank：Applied Biosystems [UK BiLEVE Axiom Array、UK Biobank Axiom Array]\r\nFinnGen：Thermo Fisher Scientific [FinnGen1 ThermoFisher Arrayなど]\r\nBCAC：Illumina [iCOGS OncoArray]\r\nPRACTICAL：Illumina [iCOGS OncoArray]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "BBJ：HumanOmniExpressExome BeadChip、HumanOmniExpress BeadChip、HumanExome BeadChip\r\nUK Biobank：UK BiLEVE Axiom Array、UK Biobank Axiom Array\r\nFinnGen：FinnGen1 ThermoFisher Arrayなど\r\nBCAC：Infinium OncoArray-500K v1.0 BeadChip Kit\r\nPRACTICAL：Infinium OncoArray-500K v1.0 BeadChip Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "BBJ：Eagle、Minimac3\r\nUK Biobank：IMPUTE4\r\nFinnGen：beagle4.1\r\nBCAC：IMPUTE2\r\nPRACTICAL：IMPUTE2",
          "関連解析（ソフトウェア）": "SAIGE software was used with age, sex, and top five principal components as covariates\r\nRE2C software was used for the multi-trait meta-analysis adjusting for sample overlap between GWAS summary data",
          "フィルタリング": "各データセットのsample QCとVariant QC：Read meファイルをご参照ください。\r\nRsq < 0.7 および MAF < 0.01 のバリアントを除外",
          "マーカー数（QC後）": "BBJ：13MN（7,398,798）、each cancer（7,442,557 （7,420,485-7,444,681））\r\nUK Biobank：13MN（9,602,853）、each cancer（9,620,786　（9,620,343-9,620,935））\r\nBBJ＋UK Biobank：13MN（5,374,018）、each cancer（5,696,155 （5,677,934-5,698,357））\r\nBBJ＋UK Biobank＋FinnGen＋BCAC（乳がん）：5,104,756\r\nBBJ＋UK Biobank＋FinnGen＋PRACTICAL（前立腺がん）：5,105,796\r\nBBJ＋UK Biobank＋FinnGen＋BCAC＋PRACTICAL（乳がん＋前立腺がん）：5,100,089\r\n   （each cancerについてはmean （min-max）を記載）",
          "NBDC Dataset ID": "hum0197.v16.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックし、遷移先のサイトのファイルダウンロードリンクをクリックしてください）\r\nDictionary file",
          "総データ量": "BBJ：13MN（287 MB）、each cancer（625 （605-633）MB）\r\nUK Biobank：13MN（362 MB）、each cancer（841 （814-859） MB）\r\nBBJ＋UK Biobank：13MN（202 MB）、each cancer（260 （255-264） MB）\r\nBBJ＋UK Biobank＋FinnGen＋BCAC（乳がん）：242 MB\r\nBBJ＋UK Biobank＋FinnGen＋PRACTICAL（前立腺がん）：243 MB\r\nBBJ＋UK Biobank＋FinnGen＋BCAC＋PRACTICAL（乳がん＋前立腺がん）：253 MB\r\n   （each cancerについてはmean （min-max）を記載）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v17.hic-gwas.v1": {
          "対象": "間質性膀胱炎ハンナ型（ICD10：N301）：144症例\r\n対照者：41,516名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium Asian Screening Array]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium Asian Screening Array",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "遺伝子型決定：GenomeStudio\r\nハプロタイプフェージング：shapeit4\r\nインピュテーション：minimac4",
          "関連解析（ソフトウェア）": "SAIGE",
          "フィルタリング": "Sample QC: We excluded individuals with low genotyping call rates (call rate < 98%). We included individuals of the estimated Japanese ancestry using PCA.\r\nVariant QC: We excluded variants with (1) genotyping call rate < 99%, (2) minor allele count < 5, (3) P-value for Hardy–Weinberg equilibrium < 1.0 × 10^−10, and (4) > 5% allele frequency difference compared with the imputation reference panel or the allele frequency panel of Tohoku Medical Megabank Project.\r\nPost-imputation QC: We excluded imputed variants with Rsq < 0.7 and minor allele frequency < 0.5%.",
          "マーカー数（QC後）": "7,909,790 variants（hg19）",
          "NBDC Dataset ID": "hum0197.v17.hic-gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "700 MB （txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0197.v18.gwas.v1": {
          "対象": "日本人集団：524名（423種の微生物）\r\n日本人集団：362名（306種の代謝物）\r\n日本人集団：524名（KEGG Gene OrthologおよびKEGG Pathway）",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "SNP array：Illumina [Infinium Asian Screening Array]\r\nWhole genome sequencing：Illumina [HiSeq X Ten]\r\nMetagenome shotgun sequencing：Illumina [HiSeq 2500/3000、NovaSeq 6000]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "SNP array：Infinium Asian Screening Array\r\nWhole genome sequencing：TruSeq DNA PCR-Free Library Preparation Kit\r\nMetagenome shotgun sequencing：KAPA Hyper Prep Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "・SNP array：\r\n     遺伝子型決定：GenomeStudio\r\n     ハプロタイプフェージング：shapeit4 \r\n     インピュテーション：minimac4 \r\n・WGS：\r\n     WA-MEM v0.7.13、GATK v3.8-0",
          "関連解析（ソフトウェア）": "PLINK2",
          "フィルタリング": "・SNP array data：\r\n      サンプル QC：We excluded individuals with low genotyping call rates (call rate < 98%). We included individuals of the estimated Asian ancestry using PCA. \r\n      バリアント QC：We excluded variants with (1) genotyping call rate < 99%, (2) minor allele count < 5, (3) P-value for Hardy–Weinberg equilibrium < 1.0 × 10^−10, and (4) > 5% allele frequency difference compared with the imputation reference panel or the allele frequency panel of Tohoku Medical Megabank Project. \r\n      インピュテーション後のQC：We excluded imputed variants with Rsq < 0.7 and minor allele frequency < 1%. \r\n・WGS：\r\n     We excluded variants with genotype call rate <90%, ExcessHet > 60, Hardy-Weinberg P<1.0×10−10\r\n     After imputation with Beagle v5.1, we excluded imputed variants with minor allele frequency < 1%.",
          "マーカー数（QC後）": "腸内微生物叢/KEGG （SNP array）: 7,213,470 variants（hg19）\r\n血中代謝物（WGS）: 6,840,258 variants（GRCh37）",
          "NBDC Dataset ID": "hum0197.v18.gwas.v1（腸内微生物叢、血中代謝物、KEGG）\r\n（データのダウンロードは上記リンクをクリックし、遷移先のサイトのファイルダウンロードリンクをクリックしてください）\r\nDictionary file",
          "総データ量": "腸内微生物叢：206 GB\r\n血中代謝物：90.7 GB\r\nKEGG：300 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "岡田 随象",
        "所 属 機 関": "大阪大学大学院 医学系研究科 遺伝統計学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "9": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.",
          "DOI": "doi: 10.1136/annrheumdis-2019-215743",
          "データID": "JGAD000290"
        },
        "2": {
          "タイトル": "Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.",
          "DOI": "doi: 10.1038/s41467-021-21011-y",
          "データID": "hum0197.v2.gwas.v1"
        },
        "3": {
          "タイトル": "A metagenome-wide association study of gut microbiome in patients with multiple sclerosis revealed novel disease pathology.",
          "DOI": "doi: 10.3389/fcimb.2020.585973",
          "データID": "JGAD000363"
        },
        "4": {
          "タイトル": "A cross-population atlas of genetic associations for 220 human phenotypes.",
          "DOI": "doi: 10.1038/s41588-021-00931-x",
          "データID": "hum0197.v3.gwas.v1"
        },
        "5": {
          "タイトル": "Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese",
          "DOI": "doi: 10.1136/annrheumdis-2021-220687",
          "データID": "JGAD000427"
        },
        "6": {
          "タイトル": "Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease",
          "DOI": "doi: 10.1136/annrheumdis-2021-221267",
          "データID": "JGAD000532"
        },
        "7": {
          "タイトル": "Insights from complex trait fine-mapping across diverse populations",
          "DOI": "doi: 10.1101/2021.09.03.21262975",
          "データID": "hum0197.v5.gwas.v1\r\nhum0197.v5.finemap.v1"
        },
        "8": {
          "タイトル": "Genetic architecture of microRNA expression and its link to complex diseases in the Japanese population.",
          "DOI": "doi: 10.1093/hmg/ddab361",
          "データID": "JGAD000621\r\nhum0197.v6.eqtl.v1"
        },
        "9": {
          "タイトル": "Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic components.",
          "DOI": "doi: 10.1136/annrheumdis-2022-222460",
          "データID": "hum0197.v10.gwas.v1"
        },
        "10": {
          "タイトル": "DOCK2 is involved in the host genetics and biology of severe COVID-19",
          "DOI": "doi: 10.1038/s41586-022-05163-5",
          "データID": "JGAD000662"
        },
        "11": {
          "タイトル": "Prokaryotic and viral genomes recovered from 787 Japanese gut metagenomes revealed microbial features linked to diets, populations, and diseases",
          "DOI": "doi: 10.1016/j.xgen.2022.100219",
          "データID": "hum0197.v12"
        },
        "12": {
          "タイトル": "Reconstruction of the personal information from human genome reads in gut metagenome sequencing data",
          "DOI": "doi: 10.1038/s41564-023-01381-3",
          "データID": "JGAD000729"
        },
        "13": {
          "タイトル": "Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis",
          "DOI": "doi: 10.1038/s41467-023-39136-7",
          "データID": "hum0197.v16.gwas.v1"
        },
        "14": {
          "タイトル": "Genome-wide association analysis identifies susceptibility loci within the major histocompatibility complex region for Hunner-type interstitial cystitis",
          "DOI": "doi: 10.1016/j.xcrm.2023.101114",
          "データID": "hum0197.v17.hic-gwas.v1"
        },
        "15": {
          "タイトル": "Integrated analysis of gut microbiome, host genetics, and plasma metabolites revealed the gut microbiome–host interaction in the Japanese population",
          "DOI": "",
          "データID": "hum0197.v18.gwas.v1"
        }
      },
      "制限公開データの利用者一覧": {
        "Ilana Brito": {
          "研究代表者": "Ilana Brito",
          "所属機関": "Cornell University Meinig School of Biomedical Engineering",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Comparative metagenomics of lupus patients' microbiomes",
          "利用期間": "JGAD000290, JGAD000363, JGAD000427, JGAD000532"
        },
        "Yongxin Li": {
          "研究代表者": "Yongxin Li",
          "所属機関": "Department of Chemistry, The University of Hong Kong",
          "研究題目": "香港",
          "利用データID": "Comparison of gut bacterial diversity and composition in MS/EAE",
          "利用期間": "JGAD000363"
        }
      },
      "リリース情報": {
        "hum0197.v18": {
          "Research ID": "hum0197.v18",
          "公開日": "2023/10/02",
          "内容": "腸内微生物叢、血中代謝物、KEGG Gene OrthologおよびKEGG Pathwayのゲノムワイド関連解析",
          "description": "日本人集団524名の末梢血から抽出したDNAを用いた腸内微生物叢のゲノムワイド関連解析データ、日本人集団362名の末梢血から抽出したDNAを用いた血中代謝物のゲノムワイド関連解析データ、日本人集団524名の末梢血から抽出したDNAを用いたKEGG Gene OrthologおよびKEGG Pathwayのゲノムワイド関連解析データを提供する（txt）。\n"
        },
        "hum0197.v17": {
          "Research ID": "hum0197.v17",
          "公開日": "2023/06/27",
          "内容": "間質性膀胱炎ハンナ型のゲノムワイド関連解析",
          "description": "間質性膀胱炎ハンナ型144症例および健常者41,516名の末梢血から抽出したDNAを用いたSNPアレイ解析によりgenotypeを決定し、Imputation後、GWASを実施した結果（統計情報）を提供する（txt）。\n"
        },
        "hum0197.v16": {
          "Research ID": "hum0197.v16",
          "公開日": "2023/06/06",
          "内容": "15形質のゲノムワイド関連解析",
          "description": "バイオバンク・ジャパン180,215名およびUKバイオバンク377,441名の末梢血から抽出したDNAを用いた、15形質のゲノムワイド関連解析データ、ならびに、FinnGen、Breast Cancer Association Consortium（BCAC）、Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome（PRACTICAL）の要約統計量を含めたメタ解析（乳がん：648,746名、前立腺がん：482,080名）データを提供する（txt）。\n"
        },
        "hum0197.v15": {
          "Research ID": "hum0197.v15",
          "公開日": "2023/03/29",
          "内容": "メタゲノム",
          "description": "下記のメタゲノム関連解析データを提供する（fastq）。\n・日本人88名の便より抽出したDNAを用いた、ショットガンシークエンスデータ。\n・健常者73名の便より抽出したDNA（フェノール・クロロホルム法＋DNeasy PowerSoil Pro Kit）を用いた、ショットガンシークエンスデータ。\n・日本人5名の便より抽出したDNAを用いた、高深度ショットガンシークエンスデータ。\n"
        },
        "hum0197.v14": {
          "Research ID": "hum0197.v14",
          "公開日": "2023/02/16",
          "内容": "5形質のゲノムワイド関連解析",
          "description": "日本人集団および多人種集団（バイオバンク・ジャパン：179,000名、UKバイオバンク：361,000名、FinnGen：136,000名）の末梢血から抽出したDNAを用いた、5形質のゲノムワイド関連解析データを提供する（txt）。\n"
        },
        "hum0197.v13": {
          "Research ID": "hum0197.v13",
          "公開日": "2023/02/14",
          "内容": "scRNA-seqデータ、臨床情報",
          "description": "日本人集団におけるCOVID-19患者43症例と健常者44名の末梢血単核細胞（PBMC）から抽出したRNAを用いたscRNA-seq解析データ（fastq）、およびhum0019.v11とhum0197.v13の臨床情報（xlsx）を提供する。\n"
        },
        "hum0197.v12": {
          "Research ID": "hum0197.v12",
          "公開日": "2022/12/01",
          "内容": "微生物ゲノムのMAG、ウイルスのゲノム配列、CRISPR spacer配列",
          "description": "hum0197.v7およびhum0197.v8のメタゲノム関連解析に関連して得られた日本人腸内微生物のMAG・ウイルスのゲノム配列・CRISPR spacer配列を提供する（fasta）。\n"
        },
        "hum0197.v11": {
          "Research ID": "hum0197.v11",
          "公開日": "2022/07/21",
          "内容": "scRNA-seqデータ",
          "description": "日本人集団におけるCOVID-19患者30症例と健常者31名の末梢血単核細胞（PBMC）から抽出したRNAを用いたscRNA-seq解析データを提供する（fastq）。\n"
        },
        "hum0197.v10": {
          "Research ID": "hum0197.v10",
          "公開日": "2022/06/16",
          "内容": "9形質のゲノムワイド関連解析",
          "description": "バイオバンク・ジャパン161,801名およびUKバイオバンク377,583名の末梢血から抽出したDNAを用いた、9形質のゲノムワイド関連解析データを提供する（txt）。\n"
        },
        "hum0197.v9": {
          "Research ID": "hum0197.v9",
          "公開日": "2022/06/10",
          "内容": "頭蓋内胚細胞腫瘍のゲノムワイド関連解析",
          "description": "頭蓋内胚細胞腫瘍133症例および健常者762名の末梢血から抽出したDNAを用いたSNPアレイ解析によりgenotypeを決定し、Imputation後、GWASを実施した結果（統計情報）を提供する（txt）。\n"
        },
        "hum0197.v8": {
          "Research ID": "hum0197.v8",
          "公開日": "2022/06/03",
          "内容": "メタゲノム",
          "description": "日本人集団136名の便より抽出したDNAを用いた、全ゲノムショットガンシークエンスによるメタゲノム関連解析データを提供する（fastq）。\n"
        },
        "hum0197.v7": {
          "Research ID": "hum0197.v7",
          "公開日": "2022/05/23",
          "内容": "メタゲノム",
          "description": "潰瘍性大腸炎35症例、クローン病39症例、対照健常者40名の便より抽出したDNAを用いた、全ゲノムショットガンシークエンスによるメタゲノム関連解析データを提供する（fastq）。\n"
        },
        "hum0197.v6": {
          "Research ID": "hum0197.v6",
          "公開日": "2022/02/08",
          "内容": "miRNAリードカウント、eQTL解析データ",
          "description": "日本人集団141名の全血および末梢血単核球（PBMC）を分取し、全血から抽出したgenomic DNAを用いた全ゲノムシーケンス、PBMCから抽出したRNAを用いたsmall RNA-seqを実施した。個人毎のmiRNAリードカウントデータおよびeQTLサマリーデータを提供する（txt）。\n"
        },
        "hum0197.v5": {
          "Research ID": "hum0197.v5",
          "公開日": "2021/12/21",
          "内容": "10形質のゲノムワイド関連解析、79形質のFine-mapping",
          "description": "日本人集団（バイオバンク・ジャパン：179,000名）の末梢血から抽出したDNAを用いた、10形質のゲノムワイド関連解析データおよび79形質のFine-mappingデータを提供する（txt）。\n"
        },
        "hum0197.v4": {
          "Research ID": "hum0197.v4",
          "公開日": "2021/12/10",
          "内容": "メタゲノム",
          "description": "日本人集団227＋30名の便より抽出したDNAを用いた、全ゲノムショットガンシークエンスによるメタゲノム関連解析データを提供する（fastq）。\n"
        },
        "hum0197.v3": {
          "Research ID": "hum0197.v3",
          "公開日": "2021/03/22",
          "内容": "215形質のゲノムワイド関連解析",
          "description": "日本人集団および多人種集団（バイオバンク・ジャパン：179,000名、UKバイオバンク：361,000名、FinnGen：136,000名）の末梢血から抽出したDNAを用いた、215形質のゲノムワイド関連解析データを提供する（txt）。\n"
        },
        "hum0197.v2": {
          "Research ID": "hum0197.v2",
          "公開日": "2020/11/27",
          "内容": "肺胞蛋白症のゲノムワイド関連解析、メタゲノム",
          "description": "・肺胞蛋白症198症例および対照者395名の末梢血から抽出したDNAを用いてSNPアレイによりgenotypeを決定、Imputation後、GWASを実施した結果（統計情報）を提供する（txt）。\n・日本人集団103名の便より抽出したDNAを用いた、全ゲノムショットガンシークエンスによるメタゲノム関連解析データを提供する（fastq）。\n"
        },
        "hum0197.v1": {
          "Research ID": "hum0197.v1",
          "公開日": "2019/11/15",
          "内容": "メタゲノム",
          "description": "日本人集団95名の便より抽出したDNAを用いた、全ゲノムショットガンシークエンスによるメタゲノム関連解析データを提供する（fastq）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0197.v18",
      "DATA": {
        "JGAS000205": {
          "Data Set ID": "JGAS000205",
          "Type of Data": "Metagenome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/11/15"
        },
        "hum0197.v2.gwas.v1": {
          "Data Set ID": "hum0197.v2.gwas.v1",
          "Type of Data": "GWAS for autoimmune pulmonary alveolar proteinosis",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/11/27"
        },
        "JGAS000260": {
          "Data Set ID": "JGAS000260",
          "Type of Data": "Metagenome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/11/27"
        },
        "hum0197.v3.gwas.v1": {
          "Data Set ID": "hum0197.v3.gwas.v1",
          "Type of Data": "GWAS for 215 phenotypes",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/03/22"
        },
        "JGAS000316": {
          "Data Set ID": "JGAS000316",
          "Type of Data": "Metagenome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/10/12"
        },
        "JGAS000415": {
          "Data Set ID": "JGAS000415",
          "Type of Data": "Metagenome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/12/10"
        },
        "hum0197.v5.gwas.v1": {
          "Data Set ID": "hum0197.v5.gwas.v1",
          "Type of Data": "GWAS for 10 phenotypes",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/12/21"
        },
        "hum0197.v5.finemap.v1": {
          "Data Set ID": "hum0197.v5.finemap.v1",
          "Type of Data": "Fine-mapping for 79 phenotypes",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/12/21"
        },
        "JGAS000504": {
          "Data Set ID": "JGAS000504",
          "Type of Data": "Read count data of miRNA",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/02/08"
        },
        "hum0197.v6.eqtl.v1": {
          "Data Set ID": "hum0197.v6.eqtl.v1",
          "Type of Data": "eQTL data",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/02/08"
        },
        "JGAS000530": {
          "Data Set ID": "JGAS000530",
          "Type of Data": "Metagenome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/05/23"
        },
        "JGAS000531": {
          "Data Set ID": "JGAS000531",
          "Type of Data": "Metagenome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/06/03"
        },
        "hum0197.v9.gwas.GCT.v1": {
          "Data Set ID": "hum0197.v9.gwas.GCT.v1",
          "Type of Data": "GWAS for intracranial germ cell tumors",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/06/10"
        },
        "hum0197.v10.gwas.v1": {
          "Data Set ID": "hum0197.v10.gwas.v1",
          "Type of Data": "GWAS for 9 phenotypes",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/06/16"
        },
        "JGAS000543": {
          "Data Set ID": "JGAS000543",
          "Type of Data": "Raw sequencing data of single-cell RNA-seq",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/07/21"
        },
        "hum0197.v12": {
          "Data Set ID": "hum0197.v12",
          "Type of Data": "MAG, Viral genome and CRISPR spacers of Microbial genome",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/12/01"
        },
        "JGAS000543 (data addition)": {
          "Data Set ID": "JGAS000543 (data addition)",
          "Type of Data": "clinical data",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/02/14"
        },
        "JGAS000593": {
          "Data Set ID": "JGAS000593",
          "Type of Data": "Raw sequencing data of single-cell RNA-seq, clinical data",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/02/14"
        },
        "hum0197.v3.gwas.v1 (data addition)": {
          "Data Set ID": "hum0197.v3.gwas.v1 (data addition)",
          "Type of Data": "GWAS for 5 phenotypes",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/02/16"
        },
        "JGAS000600": {
          "Data Set ID": "JGAS000600",
          "Type of Data": "Metagenome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/03/29"
        },
        "hum0197.v16.gwas.v1": {
          "Data Set ID": "hum0197.v16.gwas.v1",
          "Type of Data": "GWAS for 15 phenotypes",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/06/06"
        },
        "hum0197.v17.hic-gwas.v1": {
          "Data Set ID": "hum0197.v17.hic-gwas.v1",
          "Type of Data": "GWAS for Hunner-type interstitial cystitis",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/06/27"
        },
        "hum0197.v18.gwas.v1": {
          "Data Set ID": "hum0197.v18.gwas.v1",
          "Type of Data": "GWAS for gut microbiome\r\nGWAS for plasma metabolite\r\nGWAS for KEGG Gene Ortholog and KEGG Pathway",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/10/02"
        }
      },
      "SUMMARY": {
        "Aims": "Elucidation of disease biology based on trans-omics analysis, GWAS in the Japanese and trans-ethnic populations, Elucidation of the mechanism of COVID-19 severity",
        "Methods": "Metagenome shotgun sequencing, genome-wide association study (GWAS), small RNA-seq and eQTL analyses",
        "Participants/Materials": ""
      },
      "MOLECULAR DATA": {
        "JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531": {
          "Participants/Materials:": "95+103+227+30+136 Japanese individuals\r\nInflammatory Bowel Disease\r\n   35 Ulcerative Colitis\r\n   39 Crohn's disease\r\n40 Healthy controls",
          "Targets": "Metagenome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 3000, NovaSeq 6000]",
          "Library Source": "DNA extracted from gut microbiome",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Hyper Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000290 (95 Japanese individuals)\r\n JGAD000363 (103 Japanese individuals)\r\nJGAD000427 (227 Japanese individuals)\r\nJGAD000532 (30 Japanese individuals)\r\nJGAD000649 (Inflammatory Bowel Disease)\r\nJGAD000650 (136 Japanese individuals)",
          "Total Data Volume": "JGAD000290：477 GB（fastq）\r\nJGAD000363：408 GB（fastq）\r\nJGAD000427：881.2 GB（fastq）\r\nJGAD000532：106.7 GB（fastq）\r\nJGAD000649：374.6 GB （fastq）\r\nJGAD000650：541.4 GB（fastq）",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v2.gwas.v1": {
          "Participants/Materials": "Autoimmune pulmonary alveolar proteinosis cases (ICD10: J840): 198\r\nControl participants: 395",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium Asian Screening Array]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Infinium Asian Screening Array",
          "Genotype Call Methods (software)": "GenomeStudio for genotyping, shapeit2 for haplotype phasing, and minimac3 for imputation",
          "Association Analysis (software)": "PLINK2",
          "Filtering Methods": "Sample QC: We excluded samples with low genotyping call rates (call rate < 98%) and in close genetic relation (PI_HAT > 0.175). We included samples of the estimated East Asian ancestry.\r\nVariant QC: We excluded variants with (1) genotyping call rate < 98%, (2) P value for Hardy–Weinberg equilibrium < 1.0 × 10−6, and (3) minor allele count < 5, or (4) > 10% frequency difference with the imputation reference panel.",
          "Marker Number (after QC)": "12,153,232 autosomal variants and 242,876 X-chromosomal variants after QC.",
          "NBDC Dataset ID": "hum0197.v2.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "390MB for autosome (txt.gz) and 19MB for X chromosome (txt.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v3.gwas.v1": {
          "Participants/Materials": "Biobank Japan (n = 179,000), UK biobank (n = 361,000), FinnGen (n = 136,000), no. Phenotypes: 220",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "BBJ: Illumina [HumanOmniExpressExome BeadChip, HumanOmniExpress BeadChip, HumanExome BeadChip]\r\nUK Biobank: Applied Biosystems [UK BiLEVE Axiom Array, UK Biobank Axiom Array]\r\nFinnGen: Thermo Fisher Scientific [FinnGen1 ThermoFisher Array or other genotyping arrays]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "BBJ: HumanOmniExpressExome BeadChip, HumanOmniExpress BeadChip, HumanExome BeadChip\r\nUK Biobank: UK BiLEVE Axiom Array, UK Biobank Axiom Array\r\nFinnGen: FinnGen1 ThermoFisher Array or other genotyping arrays",
          "Genotype Call Methods (software)": "BBJ: Eagle, Minimac3\r\nUK Biobank: IMPUTE4\r\nFinnGen: beagle4.1",
          "Association Analysis (software)": "For binary traits, SAIGE software was used with age, age2, sex, age×sex, age2×sex, and top 20 principal components as covariates. For quantitative traits (biomarkers), BOLT-LMM or plink software was used with the same covariates.\r\n ",
          "Filtering Methods": "BBJ: We included imputed variants with Rsq > 0.7.\r\nUK Biobank: We excluded the variants with (i) INFO score ≤ 0.8, (ii) MAF ≤ 0.0001 (except for missense and protein-truncating variants annotated by VEP, which were excluded if MAF ≤ 1 × 10-6), and (iii) PHWE ≤ 1 × 10-10.\r\nFinnGen: We excluded variants with an imputation INFO score < 0.8 or MAF < 0.0001.",
          "Marker Number (after QC)": "BBJ: 13,530,797 variants\r\nUK Biobank: 13,791,467 variants\r\nFinnGen: 16,859,359 variants",
          "NBDC Dataset ID": "hum0197.v3.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file (BBJ, EUR, META)",
          "Total Data Volume": "BBJ: ~1.5G for autosome and ~33M for chrX\r\nUK Biobank: ~1.5G for autosome and ~15M for chrX\r\nFinnGen: ~740M for autosome and ~20M for chrX",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v5.gwas.v1 / hum0197.v5.finemap.v1": {
          "Participants/Materials": "Biobank Japan (n = 179,000), no. Phenotypes: 79",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpressExome BeadChip, HumanOmniExpress BeadChip, HumanExome BeadChip]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpressExome BeadChip, HumanOmniExpress BeadChip, HumanExome BeadChip",
          "Genotype Call Methods (software)": "Eagle, Minimac3",
          "Association Analysis (software)": "GWAS: For binary traits, SAIGE software was used with age, age2, sex, age×sex, age2×sex, and top 20 principal components as covariates. For quantitative traits (biomarkers), BOLT-LMM was used with the same covariates.\r\nFine-mapping: FINEMAP and SuSiE were used with GWAS summary statistics and in-sample dosage LD, allowing up to 10 causal variants per region.",
          "Filtering Methods": "GWAS: We included imputed variants with Rsq > 0.7. For binary traits, variants with MAC < 10 were additionally excluded.\r\nFine-mapping: We defined fine-mapping regions based on a 3 Mb window around each lead variant and merged regions if they overlapped. We excluded the major histocompatibility complex (MHC) region (chr 6: 25–36 Mb) from analysis due to extensive LD structure in the region. For each method, we only included variants from successfully fine-mapped regions while excluding those from failed regions (e.g., due to conversion failure or available memory restrictions).",
          "Marker Number (after QC)": "13,531,752 variants (ref: hg19)",
          "NBDC Dataset ID": "hum0197.v5.gwas.v1 / hum0197.v5.finemap.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "14 GB",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000504": {
          "Participants/Materials:": "141 Japanese individuals",
          "Targets": "small RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from PBMC",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMARTer smRNA-Seq Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Mapping Methods": "bowtie (GRCh37)",
          "Detecting method for read count (software)": "featureCounts + miRbase v22",
          "QC": "We performed adapter trimming using Cutadapt v1.8 and removed reads with a low quality score (Phred quality score < 20 in >20% of total bases) using fastp v0.20.0. Also, we removed reads with a length of >29 bp or <15 bp, which are not expected to be mature miRNAs. Mature miRNAs detected with ≥1 read in at least half of the individuals were included in the dataset.",
          "miRNA number": "343",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000621",
          "Total Data Volume": "54.7 KB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v6.eqtl.v1": {
          "Participants/Materials": "141 Japanese individuals",
          "Targets": "eQTL",
          "Target Loci for Capture Methods": "-",
          "Platform": "small RNA-seq: Illumina [HiSeq 2500]\r\nWGS: Illumina [HiSeq X Ten]",
          "Library Source": "read count data of JGAS000504 and whole genome sequencing data using genomic DNA exracted from whole blood",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "small RNA-seq: See JGAS000504\r\nWGS: TruSeq DNA PCR-Free Library Preparation Kit",
          "Genotype Call / Detecting read count Methods (software)": "See JGAS000504 for read count data.\r\nWGS: Sequenced reads were aligned against the reference human genome with the decoy sequence (GRCh37, human_g1k_v37_decoy) using BWA-MEM v0.7.13.",
          "QC": "See JGAS000504 for read count data.\r\nWGS: We removed the variants (i)with low genotyping call rates (<0.90), (ii)with ExcessHet > 60 or (iii) with Hardy–Weinberg Pvalue < 1.0 × 10−10. Genotype refinement was performed using Beagle v5.1.",
          "Marker Number (after QC)": "See JGAS000504 for read count data.\r\nWGS: 12,171,854 variants",
          "eQTL algorithm": "We analyzed the association between genetic variants with minor allele frequency (MAF) ≥ 0.01 within a cis-window around each miRNA (±1 Mb of the mature miRNA) and normalized expression values using MatrixEQTL v2.3.",
          "NBDC Dataset ID": "hum0197.v6.eqtl.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "1.1 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v9.gwas.GCT.v1": {
          "Participants/Materials": "Intracranial germ cell tumors cases (ICD10: C719): 133\r\nControl participants: 762",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium Asian Screening Array]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Infinium Asian Screening Array",
          "Genotype Call Methods (software)": "GenomeStudio for genotyping\r\nshapeit2 for haplotype phasing\r\nminimac3 for imputation",
          "Association Analysis (software)": "PLINK2",
          "Filtering Methods": "Sample QC: \r\nWe excluded individuals (i) with genotyping call rate < 0.97, (ii) in close kinship (PI_HAT > 0.17), and (iii) estimated of non-East Asian ancestry were excluded.\r\nVariant QC: \r\nWe excluded variants with (i) genotyping call rate < 0.99, (ii) minor allele count < 5, (iii) P value for Hardy–Weinberg equilibrium < 1.0 × 10−5 in controls, and (iv) > 10% allele frequency difference with the imputation reference panel or the allele frequency panel of Tohoku Medical Megabank Project.\r\nPost-imputation QC: \r\nWe excluded imputed variants with Rsq < 0.7 and minor allele frequency < 0.5%.",
          "Marker Number (after QC)": "7,803,874 autosomal variants\r\n181,867 X-chromosomal variants",
          "NBDC Dataset ID": "hum0197.v9.gwas.GCT.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "248 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v10.gwas.v1": {
          "Participants/Materials": "Biobank Japan (n=161,801), UK biobank (n=377,583), no. Phenotypes: 9\r\n   Patients: Autoimmune [Rheumatoid arthritis (ICD10: M05), Graves' disease (ICD10: C719), type I diabetes mellitus (ICD10: E10)]\r\n                  Allergy [asthma (ICD10: J45), Atopic dermatitis (ICD10: L20), Pollinosis (ICD10: J301)]\r\n   Controls: non-autoimmune +non-allergy individuals\r\n(There is overlap among patients in each disease category)",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "BBJ: Illumina [HumanOmniExpressExome BeadChip, HumanOmniExpress BeadChip, HumanExome BeadChip]\r\nUK Biobank: Applied Biosystems [UK BiLEVE Axiom Array, UK Biobank Axiom Array]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "BBJ: HumanOmniExpressExome BeadChip, HumanOmniExpress BeadChip, HumanExome BeadChip\r\nUK Biobank: UK BiLEVE Axiom Array, UK Biobank Axiom Array",
          "Genotype Call Methods (software)": "BBJ: Eagle, Minimac3\r\nUK Biobank: IMPUTE4",
          "Association Analysis (software)": "SAIGE software was used with age, sex, and top five principal components as covariates.\r\nRE2C software was used for the multi-trait meta-analysis adjusting for sample overlap between GWAS summary data.",
          "Filtering Methods": "We excluded the variants with Rsq < 0.7 and MAF < 0.005.",
          "Marker Number (after QC)": "BBJ: 8,374,220 autosomal variants for individual trait / 8,369,174 autosomal variants for meta-analysis\r\nUKB: 10,864,380 autosomal variants for individual trait / 10,858,065 autosomal variants for meta-analysis\r\nBBJ + UK Biobank: 5,965,154 autosomal variants for meta-analysis",
          "NBDC Dataset ID": "hum0197.v10.gwas.v1\r\n(Click the Dataset ID to download the files)\r\nDictionary file",
          "Total Data Volume": "BBJ: ~ 760MB for individual trait / ~ 430MB for multi-trait meta-analysis\r\nUK Biobank: ~ 1.1GB for individual trait / ~ 550MB for multi-trait meta-analysis\r\nBBJ+UK Biobank: ~ 310MB for multi-trait meta-analysis",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000543 / JGAS000593": {
          "Participants/Materials": "COVID-19 (ICD10: U071) : 30 + 43 cases\r\nHealthy controls : 31 + 44 individuals",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from PBMC",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Next GEM Single Cell 5’ Library & Gel Bead Kit v1.1, Chromium Next GEM Chip G Single Cell Kit, Single Index Kit T Set A",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "91 bp",
          "NBDC Dataset ID": "JGAD000662\r\nJGAD000722",
          "Total Data Volume": "1.3 + 2.0 TB （fastq, xlsx [clinical data]）",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v12.MAG.v1": {
          "Participants/Materials:": "Japanese gut microbiome\r\n   JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531, Public data (DRA006684)",
          "Targets": "Metagenome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500/3000, NovaSeq 6000]",
          "Library Source": "JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531, DRA006684",
          "Cell Lines": "-",
          "MAG methods": "De novo assembly with metaspades was performed. Then, binning with dastools (metabat2、maxbin2、concoct) was applied.",
          "JDDBJ Sequence Read Archive ID": "JGA MAG: 20220531NSUB000031HIGH_JGA_JMAG_GENOME_*.acclist.txt\r\nDRA014186 (JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531) \r\nDRA014188 (JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531) \r\nDRA014191 (JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531) \r\nDRA014192 (JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531) \r\nTPA MAG: EMNX01000001-EMNX01000025、EMNY01000001-EMNY01000068、EMNZ01000001-EMNZ01000149, EMOA01000001-EMOA01000067\r\nDRA014184 (DRA006684)",
          "Total Data Volume": "JGA MAG: 153 GB (fasta) \r\nDRA014186: 11.5 GB (fasta) \r\nDRA014188: 11.9 GB (fasta) \r\nDRA014191: 12.2 GB (fasta) \r\nDRA014192: 5.75 GB (fasta) \r\nTPA MAG: 11.9 MB (fasta) \r\nDRA014184: 3.65 GB (fasta)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v12.VIRUS.v1": {
          "Participants/Materials:": "Japanese gut microbiome\r\n   JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531, Public data (DRA006684)",
          "Targets": "NGS (WGS)",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500/3000, NovaSeq 6000]",
          "Library Source": "JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531, DRA006684",
          "Cell Lines": "-",
          "Virus genome contsruction": "De novo assembly with metaspades was performed. Then, viral contigs were detected with virfinder and virsorter.",
          "JDDBJ Sequence Read Archive ID": "JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531: BRDB01000001-BRDB01028816\r\nDRA006684: EMNW01000001-EMNW01002579",
          "Total Data Volume": "JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531: 1.09 GB (fasta) \r\nDRA006684: 98.3 MB (fasta)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v12.CRISPR.v1": {
          "Participants/Materials:": "Japanese gut microbiome\r\n   JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531, Public data (DRA006684)",
          "Targets": "NGS (WGS)",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500/3000, NovaSeq 6000]",
          "Library Source": "JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531, DRA006684",
          "Cell Lines": "-",
          "CRISPR contsruction": "MINCED was applied to the MAGs.",
          "DDBJ Sequence Read Archive ID": "DRA014186 (JGAS000205 / JGAS000260 / JGAS000316 / JGAS000415 / JGAS000530 / JGAS000531) \r\nDRA014184 (DRA006684)",
          "Total Data Volume": "DRA014184: 17.9 MB (fasta) \r\nDRA014186: 1.43 MB (fasta)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000600": {
          "Participants/Materials:": "88 Japanese individuals (shotgun sequencing)\r\n73 healthy individuals (shotgun sequencing)\r\n   - DNA extraction was performed with phenol-chloroform extraction: 73 samples\r\n   - DNA extraction with DNeasy PowerSoil Pro kit: 47 samples\r\n5 Japanese individuals (deep shotgun sequencing)",
          "Targets": "Metagenome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 3000, NovaSeq 6000]",
          "Library Source": "DNA extracted from gut microbiome",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Hyper Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000729",
          "Total Data Volume": "2.6 TB（fastq）",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v16.gwas.v1": {
          "Participants/Materials": "BioBank Japan (n=180,215), UK Biobank (n=377,441)\r\nlarge-scale meta-analysis including the summary statistics of other cohorts (FinnGen, BCAC, and PRACTICAL) for breast and prostate cancer (n=648,746 and 482,080)\r\nno. Phenotypes: 15\r\n      Patients: biliary tract (ICD10: C22.1, 23-24), breast (ICD10: C509, cervical (ICD10: C53), colorectal (ICD10: C18-20), endometrial (ICD10: C54), esophageal (ICD10: C15), gastric (ICD10: C16), hepatocellular (ICD10: C22.0), lung (ICD10: C34), non-Hodgkin's lymphoma (ICD10: C82-83), ovarian (ICD10: C56), pancreatic (ICD10: C25), and prostate (ICD10: C61) cancer\r\n      Controls: without cancer individuals\r\n(There is overlap among patients in each disease category)",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "BBJ: Illumina [HumanOmniExpressExome BeadChip, HumanOmniExpress BeadChip, HumanExome BeadChip]\r\nUK Biobank: Applied Biosystems [UK BiLEVE Axiom Array, UK Biobank Axiom Array]\r\nFinnGen: Thermo Fisher Scientific [FinnGen1 ThermoFisher Array or other genotyping arrays]\r\nBCAC: Illumina [iCOGS OncoArray]\r\nPRACTICAL: Illumina [iCOGS OncoArray]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "BBJ: HumanOmniExpressExome BeadChip, HumanOmniExpress BeadChip, HumanExome BeadChip\r\nUK Biobank: UK BiLEVE Axiom Array, UK Biobank Axiom Array\r\nFinnGen: FinnGen1 ThermoFisher Array or other genotyping arrays\r\nBCAC: Infinium OncoArray-500K v1.0 BeadChip Kit\r\nPRACTICAL: Infinium OncoArray-500K v1.0 BeadChip Kit",
          "Genotype Call Methods (software)": "BBJ: Eagle, Minimac3\r\nUK Biobank: IMPUTE4\r\nFinnGen: beagle4.1\r\nBCAC: IMPUTE2\r\nPRACTICAL: IMPUTE2",
          "Association Analysis (software)": "SAIGE software was used with age, sex, and top five principal components as covariates.\r\nRE2C software was used for the multi-trait meta-analysis adjusting for sample overlap between GWAS summary data.",
          "Filtering Methods": "Sample QC and Variant QC for each dataset: refer to ReadMe file\r\nWe excluded the variants with Rsq < 0.7 and MAF < 0.01.",
          "Marker Number (after QC)": "BBJ: 13MN (7,398,798) , each cancer (7,442,557 (7,420,485-7,444,681))\r\nUK Biobank: 13MN (9,602,853), each cancer (9,620,786　 (9,620,343-9,620,935))\r\nBBJ + UK Biobank: 13MN (5,374,018), each cancer (5,696,155 (5,677,934-5,698,357))\r\nBBJ + UK Biobank + FinnGen + BCAC (breast cancer): 5,104,756\r\nBBJ + UK Biobank + FinnGen + PRACTICAL (prostate cancer): 5,105,796\r\nBBJ + UK Biobank + FinnGen + BCAC + PRACTICAL (breast cancer + prostate cancer): 5,100,089\r\n   *mean (min-max) for each cancer",
          "NBDC Dataset ID": "hum0197.v16.gwas.v1\r\n(Click the Dataset ID to download the files)\r\nDictionary file",
          "Total Data Volume": "BBJ: 13MN (287 MB), each cancer (625 (605-633) MB)\r\nUK Biobank: 13MN (362 MB), each cancer (841 (814-859) MB)\r\nBBJ + UK Biobank: 13MN (202 MB), each cancer (260 (255-264) MB)\r\nBBJ + UK Biobank + FinnGen + BCAC (breast cancer): 242 MB\r\nBBJ + UK Biobank + FinnGen + PRACTICAL (prostate cancer): 243 MB\r\nBBJ + UK Biobank + FinnGen + BCAC + PRACTICAL (breast cancer + prostate cancer): 253 MB\r\n   *mean (min-max) for each cancer",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v17.hic-gwas.v1": {
          "Participants/Materials": "Hunner-type interstitial cystitis cases (ICD10: N301): 144\r\nControl participants: 41,516",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium Asian Screening Array]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Infinium Asian Screening Array",
          "Genotype Call Methods (software)": "GenomeStudio for genotyping\r\nshapeit4 for haplotype phasing\r\nminimac4 for imputation",
          "Association Analysis (software)": "SAIGE",
          "Filtering Methods": "Sample QC: We excluded individuals with low genotyping call rates (call rate < 98%). We included individuals of the estimated Japanese ancestry using PCA.\r\nVariant QC: We excluded variants with (1) genotyping call rate < 99%, (2) minor allele count < 5, (3) P-value for Hardy–Weinberg equilibrium < 1.0 × 10^−10, and (4) > 5% allele frequency difference compared with the imputation reference panel or the allele frequency panel of Tohoku Medical Megabank Project.\r\nPost-imputation QC: We excluded imputed variants with Rsq < 0.7 and minor allele frequency < 0.5%.",
          "Marker Number (after QC)": "7,909,790 variants (hg19)",
          "NBDC Dataset ID": "hum0197.v17.hic-gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "700 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0197.v18.gwas.v1": {
          "Participants/Materials": "524 Japanese individuals　(423 species in the gut microbiome)\r\n306 Japanese individuals　(306 plasma metabolites)\r\n524 Japanese individuals　(KEGG Gene Ortholog and KEGG Pathway)",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "SNP array: Illumina [Infinium Asian Screening Array]\r\nWhole genome sequencing: Illumina [HiSeq X Ten]\r\nMetagenome shotgun sequencing: Illumina [HiSeq 2500/3000、NovaSeq 6000]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "SNP array: Infinium Asian Screening Array\r\nWhole genome sequencing: TruSeq DNA PCR-Free Library Preparation Kit\r\nMetagenome shotgun sequencing: KAPA Hyper Prep Kit",
          "Genotype Call Methods (software)": "SNP array:\r\n      Genotyping: GenomeStudio\r\n     Haplotype phasing: shapeit4 \r\n     Imputation: minimac4 \r\nWGS: \r\n     WA-MEM v0.7.13 + GATK v3.8-0",
          "Association Analysis (software)": "PLINK2",
          "Filtering Methods": "SNP array data: \r\n      Sample QC: We excluded individuals with low genotyping call rates (call rate < 98%). We included individuals of the estimated Asian ancestry using PCA. \r\n       Variant QC: We excluded variants with (1) genotyping call rate < 99%, (2) minor allele count < 5, (3) P-value for Hardy–Weinberg equilibrium < 1.0 × 10^−10, and (4) > 5% allele frequency difference compared with the imputation reference panel or the allele frequency panel of Tohoku Medical Megabank Project. \r\n      Post-imputation QC: We excluded imputed variants with Rsq < 0.7 and minor allele frequency < 1%. \r\nWGS:\r\n     We excluded variants with genotype call rate <90%, ExcessHet > 60, Hardy-Weinberg P<1.0×10−10\r\n     After imputation with Beagle v5.1, we excluded imputed variants with minor allele frequency < 1%.",
          "Marker Number (after QC)": "Gut microbiome/KEGG (SNP array): 7,213,470 variants (hg19)\r\nMetabolome (WGS): 6,840,258 variants (GRCh37)",
          "NBDC Dataset ID": "hum0197.v18.gwas.v1 (Gut microbiome, Plasma metabolites, KEGG)\r\n(Click the link above to download the files)\r\nDictionary file",
          "Total Data Volume": "Gut microbiome: 206 GB\r\nMetabolome: 90.7 GB\r\nKEGG: 300 MB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yukinori Okada",
        "Affiliation": "Department of Statistical Genetics, Osaka University Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "9": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.",
          "DOI": "doi: 10.1136/annrheumdis-2019-215743",
          "Data Set ID": "JGAD000290"
        },
        "2": {
          "Title": "Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.",
          "DOI": "doi: 10.1038/s41467-021-21011-y",
          "Data Set ID": "hum0197.v2.gwas.v1"
        },
        "3": {
          "Title": "A metagenome-wide association study of gut microbiome in patients with multiple sclerosis revealed novel disease pathology.",
          "DOI": "doi: 10.3389/fcimb.2020.585973",
          "Data Set ID": "JGAD000363"
        },
        "4": {
          "Title": "A global atlas of genetic associations of 220 deep phenotypes",
          "DOI": "doi: 10.1101/2020.10.23.20213652",
          "Data Set ID": "hum0197.v3.gwas.v1"
        },
        "5": {
          "Title": "Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese",
          "DOI": "doi: 10.1136/annrheumdis-2021-220687",
          "Data Set ID": "JGAD000427"
        },
        "6": {
          "Title": "Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease",
          "DOI": "doi: 10.1136/annrheumdis-2021-221267",
          "Data Set ID": "JGAD000532"
        },
        "7": {
          "Title": "Insights from complex trait fine-mapping across diverse populations",
          "DOI": "doi: 10.1101/2021.09.03.21262975",
          "Data Set ID": "hum0197.v5.gwas.v1\r\nhum0197.v5.finemap.v1"
        },
        "8": {
          "Title": "Genetic architecture of microRNA expression and its link to complex diseases in the Japanese population.",
          "DOI": "doi: 10.1093/hmg/ddab361",
          "Data Set ID": "JGAD000621\r\nhum0197.v6.eqtl.v1"
        },
        "9": {
          "Title": "Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic components.",
          "DOI": "doi: 10.1136/annrheumdis-2022-222460",
          "Data Set ID": "hum0197.v10.gwas.v1"
        },
        "10": {
          "Title": "DOCK2 is involved in the host genetics and biology of severe COVID-19",
          "DOI": "doi: 10.1038/s41586-022-05163-5",
          "Data Set ID": "JGAD000662"
        },
        "11": {
          "Title": "Prokaryotic and viral genomes recovered from 787 Japanese gut metagenomes revealed microbial features linked to diets, populations, and diseases",
          "DOI": "doi: 10.1016/j.xgen.2022.100219",
          "Data Set ID": "hum0197.v12"
        },
        "12": {
          "Title": "Reconstruction of the personal information from human genome reads in gut metagenome sequencing data",
          "DOI": "doi: 10.1038/s41564-023-01381-3",
          "Data Set ID": "JGAD000729"
        },
        "13": {
          "Title": "Pan-cancer and cross-population genome-wide association studies dissect shared genetic backgrounds underlying carcinogenesis",
          "DOI": "doi: 10.1038/s41467-023-39136-7",
          "Data Set ID": "hum0197.v16.gwas.v1"
        },
        "14": {
          "Title": "Genome-wide association analysis identifies susceptibility loci within the major histocompatibility complex region for Hunner-type interstitial cystitis",
          "DOI": "doi: 10.1016/j.xcrm.2023.101114",
          "Data Set ID": "hum0197.v17.hic-gwas.v1"
        },
        "15": {
          "Title": "Integrated analysis of gut microbiome, host genetics, and plasma metabolites revealed the gut microbiome–host interaction in the Japanese population",
          "DOI": "",
          "Data Set ID": "hum0197.v18.gwas.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Ilana Brito": {
          "Principal Investigator": "Ilana Brito",
          "Affiliation": "Meinig School of Biomedical Engineering, Cornell University",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Comparative metagenomics of lupus patients' microbiomes",
          "Period of Data Use": "JGAD000290, JGAD000363, JGAD000427, JGAD000532"
        },
        "Yongxin Li": {
          "Principal Investigator": "Yongxin Li",
          "Affiliation": "Department of Chemistry, The University of Hong Kong",
          "Research Title": "Hong Kong",
          "Data in Use (Dataset ID)": "Comparison of gut bacterial diversity and composition in MS/EAE",
          "Period of Data Use": "JGAD000363"
        }
      },
      "Release Note": {
        "hum0197.v18": {
          "Research ID": "hum0197.v18",
          "Release Date": "2023/10/02",
          "Type of Data": "GWAS for gut microbiome, plasma metabolite, KEGG Gene Ortholog and KEGG Pathway",
          "description": "DNAs extracted from the Japanese populations were genotyped, imputed, and genome-wide association studies for gut microbiome, plasma metabolite, KEGG Gene Ortholog and KEGG Pathway were performed (text file).\n"
        },
        "hum0197.v17": {
          "Research ID": "hum0197.v17",
          "Release Date": "2023/06/27",
          "Type of Data": "GWAS for Hunner-type interstitial cystitis",
          "description": "DNAs extracted from peripheral blood cells of patients with Hunner-type interstitial cystitis were genotyped, imputed, and genome-wide association study was performed (text file).\n"
        },
        "hum0197.v16": {
          "Research ID": "hum0197.v16",
          "Release Date": "2023/06/06",
          "Type of Data": "GWAS for 15 phenotypes",
          "description": "DNAs extracted from the Japanese and trans-ethnic populations were genotyped, imputed, and genome-wide association studies and meta analyses for 15 phenotypes were performed (text file).\n"
        },
        "hum0197.v15": {
          "Research ID": "hum0197.v15",
          "Release Date": "2023/03/29",
          "Type of Data": "Metagenome",
          "description": "Metagenome analyses of the gut microbiome in the Japanese population and healthy individuals were performed by utilizing whole-genome shotgun sequencing. Fastq files are provided.\n- Shotgun sequencing data for 88 Japanese individuals\n- Shotgun sequencing data for 73 healthy individuals (DNA extraction was performed with phenol-chloroform extraction). Among these individuals, 47 were also subjected to DNA extraction with DNeasy PowerSoil Pro kit and sequenced.\n- Deep shotgun sequencing data for 5 Japanese individuals\n"
        },
        "hum0197.v14": {
          "Research ID": "hum0197.v14",
          "Release Date": "2023/02/16",
          "Type of Data": "GWAS for 5 phenotypes",
          "description": "DNAs extracted from the Japanese and trans-ethnic populations were genotyped, imputed, and genome-wide association studies and meta analyses for 5 phenotypes were performed (text file).\n"
        },
        "hum0197.v13": {
          "Research ID": "hum0197.v13",
          "Release Date": "2023/02/14",
          "Type of Data": "Raw sequencing data of single-cell RNA-seq, clinical data",
          "description": "RNAs extracted from PBMCs of 43 COVID-19 patients and 44 healthy controls were subjected to single-cell RNA-seq analysis. Fastq files are provided. Clinical data for hum0197.v11 and hum0197.v13 are provided as xlsx files.\n"
        },
        "hum0197.v12": {
          "Research ID": "hum0197.v12",
          "Release Date": "2022/12/01",
          "Type of Data": "Microbial genome: MAG, Viral genome, CRISPR spacers",
          "description": "Assembled microbial genome sequences obteined from metagenome analysis at hum0197.v7 and hum0197.v8 are provided (fasta files).\n"
        },
        "hum0197.v11": {
          "Research ID": "hum0197.v11",
          "Release Date": "2022/07/21",
          "Type of Data": "Raw sequencing data of single-cell RNA-seq",
          "description": "RNAs extracted from PBMCs of 30 COVID-19 patients and 31 healthy controls were subjected to single-cell RNA-seq analysis. Fastq files are provided.\n"
        },
        "hum0197.v10": {
          "Research ID": "hum0197.v10",
          "Release Date": "2022/06/16",
          "Type of Data": "GWAS for 9 phenotypes",
          "description": "DNAs extracted from the Japanese and British populations were genotyped, imputed, genome-wide association studies, and meta analyses for 9 phenotypes were performed (text file).\n"
        },
        "hum0197.v9": {
          "Research ID": "hum0197.v9",
          "Release Date": "2022/06/10",
          "Type of Data": "GWAS for Intracranial germ cell tumors",
          "description": "DNAs extracted from patients with intracranial germ cell tumors were genotyped, imputed, and performed a genome-wide association study (text file).\n"
        },
        "hum0197.v8": {
          "Research ID": "hum0197.v8",
          "Release Date": "2022/06/03",
          "Type of Data": "Metagenome",
          "description": "Metagenome analysis of the gut microbiome in the Japanese population was performed by utilizing whole-genome shotgun sequencing. Fastq files are provided.\n"
        },
        "hum0197.v7": {
          "Research ID": "hum0197.v7",
          "Release Date": "2022/05/23",
          "Type of Data": "Metagenome",
          "description": "A metagenome-wide association study of gut microbiome in Inflammatory Bowel Disease (35 Ulcerative Colitis and 39 Crohn's disease) and 40 Healthy controls was performed by utilizing whole-genome shotgun sequencing. Fastq files are provided.\n"
        },
        "hum0197.v6": {
          "Research ID": "hum0197.v6",
          "Release Date": "2022/02/08",
          "Type of Data": "Read count data of miRNA, eQTL summary data",
          "description": "- RNAs extracted from PBMCs of 141 Japanese individuals were subjected to small RNA-seq analysis. Read count data of miRNAs is provided as a txt file.\n- gDNAs extracted from whole blood of 141 Japanese individuals were subjected to whole genome sequencing analysis. miRNA-eQTL mapping was performed. eQTL summary data is provided as a txt file.\n"
        },
        "hum0197.v5": {
          "Research ID": "hum0197.v5",
          "Release Date": "2021/12/21",
          "Type of Data": "GWAS for 10 phenotypes, Fine-mapping for 79 phenotypes",
          "description": "- DNAs extracted from the Japanese populations were genotyped, imputed, and genome-wide association study for 10 phenotypes were performed (text file).\n- DNAs extracted from the Japanese populations were genotyped, imputed, and fine-mapping study for 79 phenotypes were performed (text file).\n"
        },
        "hum0197.v4": {
          "Research ID": "hum0197.v4",
          "Release Date": "2021/12/10",
          "Type of Data": "Metagenome",
          "description": "A metagenome-wide association study of gut microbiome in the Japanese population was performed by utilizing whole-genome shotgun sequencing. Fastq files are provided.\n"
        },
        "hum0197.v3": {
          "Research ID": "hum0197.v3",
          "Release Date": "2021/03/22",
          "Type of Data": "GWAS for 215 phenotypes",
          "description": "DNAs extracted from the Japanese and trans-ethnic populations were genotyped, imputed, and genome-wide association studies and meta analyses for 215 phenotypes were performed (text file).\n"
        },
        "hum0197.v2": {
          "Research ID": "hum0197.v2",
          "Release Date": "2020/11/27",
          "Type of Data": "GWAS for autoimmune pulmonary alveolar proteinosis, Metagenome",
          "description": "- DNAs extracted from autoimmune pulmonary alveolar proteinosis patients were genotyped, imputed, and genome-wide association study was performed (text file).\n- A metagenome-wide association study of gut microbiome in the Japanese population was performed by utilizing whole-genome shotgun sequencing. Fastq files are provided.\n"
        },
        "hum0197.v1": {
          "Research ID": "hum0197.v1",
          "Release Date": "2019/11/15",
          "Type of Data": "Metagenome",
          "description": "A metagenome-wide association study of gut microbiome in the Japanese population was performed by utilizing whole-genome shotgun sequencing. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0196.v1": {
    "ja": {
      "NBDC Research ID": "hum0196.v1",
      "データ": {
        "hum0196.v1.gwas.v1": {
          "データID": "hum0196.v1.gwas.v1",
          "内容": "自殺者と非自殺者、および自殺時の年齢についてのGWASメタ解析",
          "制限": "非制限公開",
          "公開日": "2019/12/20"
        }
      },
      "研究内容の概要": {
        "目的": "自殺リスクに関するバイオマーカーの同定と、その臨床応用",
        "方法": "自殺者と非自殺者の網羅的遺伝子多型データを用いたゲノムワイド関連解析",
        "対象": "自殺者746名、非自殺者14,049名（バイオバンクジャパンのデータ）"
      },
      "分子データ": {
        "hum0196.v1.gwas.v1": {
          "対象": "【自殺者 （ICD10：X83） vs. 非自殺者】\r\n　1st set：自殺者 386例、非自殺対照 7,458例\r\n　2nd set：自殺者 360例、非自殺対照 6,591例\r\n　計：自殺者 746例、非自殺対照 14,049例\r\n【自殺時の年齢】\r\n　1st set：自殺者 366例、2nd set：自殺者 353例\r\n　計：自殺者 719例",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "1st set： Illumina [HumanOmniExpress-24 BeadChip]\r\n2nd set： Illumina [HumanOmniExpressExome-8 BeadChip]",
          "ソース": "死後組織・末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress / OmniExpressExome Beadchip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac [imputation （1000 genomes Phase 3）]\r\nGenCall software （GenomeStudio）",
          "関連解析ソフトウェア": "Rvtests software\r\nMETAL software",
          "フィルタリング": "以下のクライテリアに該当するvariantを除外\r\n・sample call rate < 0.98, SNV call rate < 0.98, MAF < 0.01\r\n・対照者群で HWE P < 1 x 10-6\r\n・1st set、2nd setそれぞれにおいて、Imputation quality (Rsq) < 0.7",
          "マーカー数（QC後）": "【自殺者 vs. 非自殺者】 8,381,404 SNPs（hg19）\r\n【自殺時の年齢】 8,555,734 SNPs（hg19）",
          "NBDC Dataset ID": "hum0196.v1.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "420 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "菱本 明豊",
        "所 属 機 関": "神戸大学大学院 医学研究科 精神医学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（B）",
            "タイトル": "ストレス・うつ・自殺ー負のスパイラルを結ぶ分子機構の解明",
            "研究課題番号": "17H04249"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genome-wide association studies identify polygenic effects for completed suicide in the Japanese population",
          "DOI": "doi: 10.1038/s41386-019-0506-5",
          "データID": "hum0196.v1.gwas.v1"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0196.v1": {
          "Research ID": "hum0196.v1",
          "公開日": "2019/12/20",
          "内容": "自殺者と非自殺者、および自殺時の年齢についてのゲノムワイド関連解析メタ解析",
          "description": "自殺者746名および非自殺者14,049名を対象とし、自殺者と非自殺者、および自殺時の年齢についてのGWASメタ解析を行なった結果をtxt fileにて提供する。遺伝子型決定には、Illumina HumanOmniExpress-24 BeadChipおよびHumanOmniExpressExome-8 BeadChipを使用している。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0196.v1",
      "DATA": {
        "hum0196.v1.gwas.v1": {
          "Data Set ID": "hum0196.v1.gwas.v1",
          "Type of Data": "meta-analyses of GWAS datasets for suicides vs. non-suicide individuals and for age at suicide",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/12/20"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of biomarkers for risk of suicide and application to clinical use",
        "Methods": "GWAS",
        "Participants/Materials": "Individuals who died by suicide"
      },
      "MOLECULAR DATA": {
        "hum0196.v1.gwas.v1": {
          "Participants/Materials": "[Suicide (ICD10：X83) vs. Non-suicide]\r\n  1st set: Suicide: 386 cases, Non-suicide: 7,458 cases\r\n  2nd set: Suicide: 360 cases, Non-suicide: 6,591 cases\r\n  Total: Suicide: 746 cases, Non-suicide: 14,049 cases\r\n[Age at Suicide]\r\n  1st set: Suicide: 366 cases, 2nd set: Suicide: 353 cases\r\n  Total: Suicide: 719 cases",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "1st set: Illumina [HumanOmniExpress-24 BeadChip]\r\n2nd set: Illumina [HumanOmniExpressExome-8 BeadChip]",
          "Library Source": "gDNAs extracted from postmortem tissues or peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress / OmniExpressExome Beadchip kit",
          "Genotype Call Methods (software)": "minimac [imputation (1000 genomes Phase 3)]\r\nGenCall software (GenomeStudio)",
          "Association Analysis (software)": "Rvtests software\r\nMETAL software",
          "Filtering Methods": "Variants which match the following criteria were excluded:\r\n- sample call rate < 0.98, SNV call rate < 0.98, MAF < 0.01,\r\n- HWE P < 1 x 10-6 in control\r\n- imputation quality of Rsq < 0.7 in each of the 1st and 2nd dataset",
          "Marker Number (after QC)": "[Suicide vs. Non-suicide] 8,381,404 SNPs (hg19)\r\n[Age at Suicide] 8,555,734 SNPs (hg19)",
          "NBDC Dataset ID": "hum0196.v1.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "420 MB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Akitoyo Hishimoto",
        "Affiliation": "Department of Psychiatry, Kobe University Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Investigation on molecular mechanism causing the downward spiral of Stress, Depression, and Suicide",
            "Project Number": "17H04249"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genome-wide association studies identify polygenic effects for completed suicide in the Japanese population",
          "DOI": "doi: 10.1038/s41386-019-0506-5",
          "Data Set ID": "hum0196.v1.gwas.v1"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0196.v1": {
          "Research ID": "hum0196.v1",
          "Release Date": "2019/12/20",
          "Type of Data": "meta-analyses of GWAS datasets for suicides vs. non-suicide individuals and for age at suicide",
          "description": "Result of meta analyses of the case-control GWAS datasets for suicides vs. non-suicide individuals and for age at suicide (txt file). Genotypes were determined by using of Illumina HumanOmniExpress-24 BeadChip and HumanOmniExpressExome-8 BeadChip.\nNote：\n"
        }
      }
    }
  },
  "hum0195.v3": {
    "ja": {
      "NBDC Research ID": "hum0195.v3",
      "データ": {
        "JGAS000190": {
          "データID": "JGAS000190",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/26"
        },
        "JGAS000234": {
          "データID": "JGAS000234",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/26"
        },
        "JGAS000269": {
          "データID": "JGAS000269",
          "内容": "NGS（Exome、Target Capture、 RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/03/02"
        },
        "JGAS000269 （データ追加）": {
          "データID": "JGAS000269 （データ追加）",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/03/18"
        }
      },
      "研究内容の概要": {
        "目的": "消化器がんの病態進展に関わる遺伝子異常を明らかにすること",
        "方法": "全ゲノム解析、全エクソン解析、トランスクリプトーム解析、および、targeted deep sequencing解析",
        "対象": ""
      },
      "分子データ": {
        "JGAS000190（WGS）": {
          "対象": "結節内結節型肝がん（ICD10：C220）：5症例（計23検体）\r\n      腫瘍組織：14検体\r\n      非腫瘍組織：5検体\r\n      末梢血より単離したリンパ球：4検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織、非腫瘍組織および末梢血より単離したリンパ球から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free Sample Prep Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000273",
          "総データ量": "1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000234、JGAS000296、JGAS000296追加（Exome）": {
          "対象": "C型肝炎ウイルス排除後に肝がんを発症した慢性肝炎/肝硬変（ICD10：K746、C220）：12症例\r\n      腫瘍組織：12検体\r\n      末梢血より単離したリンパ球：12検体\r\n胃がんを伴う慢性胃炎（ICD10：C169）：11症例\r\n      腫瘍組織：11検体、非腫瘍組織：38検体、末梢血：11検体\r\n胃がん（ICD10：C169）：1 ＋ 1症例\r\n      腫瘍組織：2検体、非腫瘍組織：2＋3検体、末梢血：1＋1検体\r\n胃粘膜下腫瘍（ICD10：D371）：3症例\r\n      非腫瘍組織：6検体、末梢血：3検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "肝がん症例の腫瘍組織および末梢血より単離したリンパ球から抽出したDNA\r\n胃がんおよび胃粘膜下腫瘍症例の腫瘍組織、非腫瘍組織、ならびに末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Exome RDY kit",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000331：肝がん\r\nJGAD000375：胃がん\r\nJGAD000629：胃がん（追加分）",
          "総データ量": "JGAD000331：450 GB（fastq）\r\nJGAD000375：523.6 GB（fastq）\r\nJGAD000629：268.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000234、JGAS000296（RNA-seq） ": {
          "対象": "C型肝炎ウイルス排除後に肝がんを発症した慢性肝炎/肝硬変（ICD10：K746、C220）：20症例\r\n      非腫瘍組織：20検体\r\nC型肝炎ウイルス陽性肝硬変かつ肝がん（ICD10：K746、C220）：3症例\r\n      腫瘍組織：8検体\r\n      非腫瘍組織：3検体\r\nC型肝炎ウイルス陰性肝がん（ICD10：C220）：2症例\r\n      腫瘍組織：7検体\r\n      非腫瘍組織：2検体\r\n胃がん（ICD10：C169）：6症例\r\n      非腫瘍組織 : （腸上皮化生 5検体、非化生 3検体）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 4000、NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したRNA\r\n非腫瘍組織（腺管のみ）から抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Sample Preparation v2 Guide, Part # 15026495",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000332\r\nJGAD000375",
          "総データ量": "JGAD000332：450 GB（fastq）\r\nJGAD000375：20.9 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000269（Target Capture）": {
          "対象": "胃がん（ICD10：C169）：26症例（2症例はExomeと重複）\r\n      非腫瘍組織：96検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "98遺伝子",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "胃がん症例の非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "xGen custom-designed Gene Capture Pools (IDT)",
          "断片化の方法": "酵素断片化（enzymatic fragmentation kit Lotus (IDT)",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000375",
          "総データ量": "523.6 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "髙井 淳",
        "所 属 機 関": "京都大学大学院 医学研究科 消化器内科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution",
          "DOI": "doi: 10.1002/path.5533",
          "データID": "JGAD000273"
        },
        "2": {
          "タイトル": "Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus",
          "DOI": "doi: 10.1093/carcin/bgab014",
          "データID": "JGAD000332"
        },
        "3": {
          "タイトル": "Expansion of gastric intestinal metaplasia with copy number aberrations contributes to field cancerization",
          "DOI": "doi: 10.1158/0008-5472.CAN-21-1523",
          "データID": "JGAD000375"
        }
      },
      "制限公開データの利用者一覧": {
        "Jinyan Huang": {
          "研究代表者": "Jinyan Huang",
          "所属機関": "Zhejiang University School of Medicine",
          "研究題目": "",
          "利用データID": "Comprehensive analysis of alternative splicing in malignant tumors",
          "利用期間": "JGAD000273"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000332"
        }
      },
      "リリース情報": {
        "hum0195.v3": {
          "Research ID": "hum0195.v3",
          "公開日": "2022/03/18",
          "内容": "NGS（Exome）",
          "description": "胃がん1症例のマルチサンプル（胃がん、腺腫、化生、胃底腺ポリープ、正常胃組織、末梢血、各1検体）から抽出したDNAを用いたWhole exome sequencing解析データをfastqファイルにて提供する。\n"
        },
        "hum0195.v2": {
          "Research ID": "hum0195.v2",
          "公開日": "2022/03/02",
          "内容": "NGS（Exome、Target Capture、RNA-seq）",
          "description": "胃がん36症例および胃粘膜下腫瘍3症例の腫瘍組織、非腫瘍組織、ならびに末梢血から抽出したDNAを用いたExome、Target Capture解析の結果をfastqファイルにて提供する。また、胃がん6症例の非腫瘍組織（腸上皮化生5検体、非化生3検体）の腺管のみから抽出したtotal RNAを用いたRNA-seq解析結果もfastqファイルにて提供する。\n"
        },
        "hum0195.v1": {
          "Research ID": "hum0195.v1",
          "公開日": "2021/03/26",
          "内容": "NGS（WGS、Exome、RNA-seq）",
          "description": "・結節内結節型肝がん5症例の腫瘍組織、非腫瘍組織、および末梢血より単離したリンパ球から抽出したDNAを用いたWGS解析の結果をfastqファイルにて提供する。\n・C型肝炎ウイルス排除後に肝がんを発症した慢性肝炎/肝硬変20症例、C型肝炎ウイルス陽性肝硬変/肝がん3症例、および、C型肝炎ウイルス陰性肝がん2症例の腫瘍組織、非腫瘍組織、および末梢血より単離したリンパ球から抽出したDNA/RNAを用いたExome、RNA-seq解析の結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0195.v3",
      "DATA": {
        "JGAS000190": {
          "Data Set ID": "JGAS000190",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/26"
        },
        "JGAS000234": {
          "Data Set ID": "JGAS000234",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/26"
        },
        "JGAS000269": {
          "Data Set ID": "JGAS000269",
          "Type of Data": "NGS (Exome, Target Capture, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/03/02"
        },
        "JGAS000269 (Dataset addition)": {
          "Data Set ID": "JGAS000269 (Dataset addition)",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/03/18"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the genetic changes in the progression of gastrointestinal and hepatobiliary tumors",
        "Methods": "whole genome sequencing, whole exome sequencing, RNA sequencing, and targeted deep sequencing analysis",
        "Participants/Materials": ""
      },
      "MOLECULAR DATA": {
        "JGAS000190 (WGS)": {
          "Participants/Materials": "nodule-in-nodule hepatocellular carcinoma (ICD10: C220): 5 cases (total: 23 samples)\r\n      tumor tissues: 14 samples\r\n      non-tumor tissues: 5 samples\r\n      lymphocytes isolated from peripheral blood: 4 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor tissues, non-tumor tissues, and lymphocytes isolated from peripheral blood of hepatocellular carcinoma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free Sample Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000273",
          "Total Data Volume": "1 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000234, JGAS000269, JGAS000269 (Dataset addition) (Exome)": {
          "Participants/Materials": "liver cirrhosis and hepatocellular carcinoma after hepatitis C virus eradication (ICD10: K746, C220): 12 cases\r\n      tumor tissues: 12 samples\r\n      lymphocytes isolated from peripheral blood: 12 samples\r\nchronic gastritis with gastric cancer (ICD10: C169): 11 cases\r\n      tumor tissues: 11 samples, non-tumor tissues: 38 samples, peripheral blood: 11 samples\r\ngastric cancer (ICD10: C169): 1 + 1 case\r\n      tumor tissues: 2 samples\r\n      non-tumor tissues: 2 + 3 samples & peripheral blood: 1 + 1 sample\r\ngastric submucosal tumor (ICD10: D371): 3 cases\r\n      non-tumor tissues: 6 samples, peripheral blood: 3 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from tumor tissues and lymphocytes isolated from peripheral blood of hepatocellular carcinoma\r\nDNAs extracted from tumor tissues, non-tumor tissues, and peripheral blood samples of gastric cancer and gastric submucosal tumor",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Exome RDY kit",
          "Fragmentation Methods": "Enzymatic Fragmentation",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000331: hepatocellular carcinoma\r\nJGAD000375: gastric cancer\r\nJGAD000629: gastric cancer (Dataset addition)",
          "Total Data Volume": "JGAD000331: 450 GB (fastq)\r\nJGAD000375: 523.6 GB (fastq)\r\nJGAD000629: 268.8 GB（fastq）",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000234, JGAS000269 (RNA-seq)": {
          "Participants/Materials": "liver cirrhosis and hepatocellular carcinoma after hepatitis C virus eradication (ICD10: K746, C220): 20 cases\r\n      non-tumor tissues: 20 samples\r\nhepatitis C virus positive cirrhosis and hepatocellular carcinoma (ICD10: K746, C220): 3 cases\r\n      tumor tissues: 8 samples\r\n      non-tumor tissues: 3 samples\r\nhepatitis C virus negative hepatocellular carcinoma (ICD10: C220): 2 cases\r\n      tumor tissues: 7 samples\r\n      non-tumor tissues: 2 samples\r\ngastric cancer (ICD10: C169): 6 cases\r\n  intestinal metaplasia (IM) 5 samples, non-IM 3samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 4000, NovaSeq 6000]",
          "Library Source": "RNAs extracted from tumor tissues and non-tumor tissues of hepatocellular carcinoma\r\nTotal RNAs extracted from non-tumor tissues (only gland duct) of IM samples and non-IM samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Sample Preparation v2 Guide, Part # 15026495",
          "Fragmentation Methods": "Enzymatic Fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000332\r\nJGAD000375",
          "Total Data Volume": "JGAS000234: 450 GB (fastq)\r\nJGAS000375: 20.9 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000269 (Target Capture)": {
          "Participants/Materials": "gastric cancer (ICD10: C169): 26 case (including 2 same cases in exome analysis)\r\n      non-tumor tissues: 96 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "98 genes",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from non-tumor tissues of gastric cancer",
          "Cell Lines": "-",
          "Library Construction (kit name)": "xGen custom-designed Gene Capture Pools (IDT)",
          "Fragmentation Methods": "enzymatic fragmentation （enzymatic fragmentation kit Lotus (IDT)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000375",
          "Total Data Volume": "523.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Atsushi Takai",
        "Affiliation": "Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution",
          "DOI": "doi: 10.1002/path.5533",
          "Data Set ID": "JGAD000273"
        },
        "2": {
          "Title": "Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus",
          "DOI": "doi: 10.1093/carcin/bgab014",
          "Data Set ID": "JGAD000332"
        },
        "3": {
          "Title": "Expansion of gastric intestinal metaplasia with copy number aberrations contributes to field cancerization",
          "DOI": "doi: 10.1158/0008-5472.CAN-21-1523",
          "Data Set ID": "JGAD000375"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Jinyan Huang": {
          "Principal Investigator": "Jinyan Huang",
          "Affiliation": "School of Medicine, Zhejiang University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of alternative splicing in malignant tumors",
          "Period of Data Use": "JGAD000273"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000332"
        }
      },
      "Release Note": {
        "hum0195.v3": {
          "Research ID": "hum0195.v3",
          "Release Date": "2022/03/18",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor tissues, non-tumor tissues, and peripheral blood samples of 1 patients with gastric cancer were used for whole exome sequencing (fastq files).\n"
        },
        "hum0195.v2": {
          "Research ID": "hum0195.v2",
          "Release Date": "2022/03/02",
          "Type of Data": "NGS (Exome, Target Capture, RNA-seq)",
          "description": "DNAs extracted from tumor tissues, non-tumor tissues, and peripheral blood samples of 36 patients with gastric cancer and 3 patients with gastric submucosal tumor patients were used for whole exome sequencing and target capture sequencing analyses (fastq files).\nTotal RNAs extracted from non-tumor tissues (only gland duct) of 5 IM samples and 3 non-IM samples were used for RNA sequencing analysis (fastq files).\n"
        },
        "hum0195.v1": {
          "Research ID": "hum0195.v1",
          "Release Date": "2021/03/26",
          "Type of Data": "NGS (WGS, Exome, RNA-seq)",
          "description": "- DNAs extracted from tumor tissues, non-tumor tissues, and lymphocytes isolated from peripheral blood of 5 nodule-in-nodule hepatocellular carcinoma patients were used for whole genome sequencing analyses (fastq files).\n- DNAs/RNAs extracted from tumor tissues, non-tumor tissues, and lymphocytes isolated from peripheral blood of 20 liver cirrhosis and hepatocellular carcinoma after hepatitis C virus eradication, 3 hepatitis C virus positive cirrhosis and hepatocellular carcinoma and 2 hepatitis C virus negative hepatocellular carcinoma patients were used for whole exome sequencing and RNA sequencing analysis (fastq files).\nNote：\n"
        }
      }
    }
  },
  "hum0194.v1": {
    "ja": {
      "NBDC Research ID": "hum0194.v1",
      "データ": {
        "JGAS000189": {
          "データID": "JGAS000189",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/05/11"
        }
      },
      "研究内容の概要": {
        "目的": "手術、放射線と並び重要ながんの治療法である薬物療法（化学療法剤、分子標的薬剤、免疫チェックポイント阻害剤）は、高い有効性を示す一方で、薬効の個人差や薬剤耐性も分かってきており、そのメカニズムを解明することがより効果的な新規治療法開発につながると期待される。本研究では、進行性肺がんを対象とし、薬物療法前・後の腫瘍組織の遺伝子解析により、治療抵抗性機構を明らかにすることを目的としている。",
        "方法": "がん研究会有明病院を受診された肺がん症例から摘出した組織（腫瘍組織）等より抽出したDNAやRNAを対象とした高速塩基配列解析装置用いた解析",
        "対象": "肺がん症例",
        "URL": "https://www.jfcr.or.jp/chemotherapy/department/fundamental/index.html"
      },
      "分子データ": {
        "JGAS000189": {
          "対象": "肺がん（ICD10：C34）：2症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "ABL1, AKT1, AKT3, ALK, APC, ATM, AXL, BCL2L11, \r\nBRAF, BRCA1, BRCA2, CCND1, CDH1, CD274, CDKN2A, \r\nCFTR, CREBBP, CSF1R, CTNNA3, CTNNB1, CUL3, DCC, \r\nEGFR, EPHA2, EPHA7, ERBB2, ERBB3, ERBB4, FBXW7, \r\nFGFR1, FGFR2, FGFR3, FGFR4, FLT3, FOXA1, FOXP1, \r\nGNA11, GNAQ, GNAS, GRM3, HGF, HNF1A, HRAS, \r\nIDH1, IDH2, IGF1R, JAK2, JAK3, KDR, KEAP1, KIT, \r\nKLF4, KRAS, MAP2K1, MAP2K2, MC1R, MCL1, MED12, \r\nMERTK, MET, MITF, MLH1, MLL2, MLL3, MPL, MSH2, \r\nMSH6, MTOR, MYC, MYCN, NF1, NF2, NFE2L2, NOTCH1, \r\nNOTCH2, NPM1, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, \r\nPIK3C2B, PIK3CA, PIK3CG, PMS2, PTCH1, PTEN, PTPN11, \r\nRAC1, RAC2, RB1, RET, ROCK2, ROS1, SH2B3, SLIT2, \r\nSMAD4, SMARCA4, SMARCB1, SMO, SOX2, SPOP, \r\nSRC, STK11, TP53, TRAF7, TSC1, TSC2, VHL",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent Haloplex HS カスタムキット",
          "断片化の方法": "キット付属の制限酵素カクテルによる切断",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000272",
          "総データ量": "128 MB（bam, vcf [ref: hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "片山 量平",
        "所 属 機 関": "公益財団法人がん研究会",
        "プロジェクト/研究グループ名": "がん化学療法センター 基礎研究部",
        "科研費/助成金（Research Project Number）": {
          "5": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的がん医療実用化研究事業",
            "タイトル": "免疫抑制性分子の分泌型バリアントを介した腫瘍免疫微小環境変化と新規治療標的探索",
            "研究課題番号": "JP19ck0106472"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models",
          "DOI": "doi: 10.1038/s41467-019-11496-z",
          "データID": "JGAD000272"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000272"
        }
      },
      "リリース情報": {
        "hum0194.v1": {
          "Research ID": "hum0194.v1",
          "公開日": "2020/05/11",
          "内容": "NGS（Target Capture）",
          "description": "肺がん2症例の腫瘍組織から抽出したDNAを用いたTarget Capture Sequencing解析結果をbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0194.v1",
      "DATA": {
        "JGAS000189": {
          "Data Set ID": "JGAS000189",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/05/11"
        }
      },
      "SUMMARY": {
        "Aims": "To study the molecular mechanisms of drug resistance in lung cancer patients by using of their tumor cells",
        "Methods": "Target Capture Sequencing",
        "Participants/Materials": "tumor tissues from ROS1-rearranged non-small cell lung cancer patients",
        "URL": "https://www.jfcr.or.jp/english/chemotherapy/department/fundamental/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000189": {
          "Participants/Materials": "Lung adenocarcinoma (ICD10: C34): 2 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "ABL1, AKT1, AKT3, ALK, APC, ATM, AXL, BCL2L11,\r\nBRAF, BRCA1, BRCA2, CCND1, CDH1, CD274, CDKN2A, \r\nCFTR, CREBBP, CSF1R, CTNNA3, CTNNB1, CUL3, DCC, \r\nEGFR, EPHA2, EPHA7, ERBB2, ERBB3, ERBB4, FBXW7, \r\nFGFR1, FGFR2, FGFR3, FGFR4, FLT3, FOXA1, FOXP1, \r\nGNA11, GNAQ, GNAS, GRM3, HGF, HNF1A, HRAS, \r\nIDH1, IDH2, IGF1R, JAK2, JAK3, KDR, KEAP1, KIT, \r\nKLF4, KRAS, MAP2K1, MAP2K2, MC1R, MCL1, MED12, \r\nMERTK, MET, MITF, MLH1, MLL2, MLL3, MPL, MSH2, \r\nMSH6, MTOR, MYC, MYCN, NF1, NF2, NFE2L2, NOTCH1, \r\nNOTCH2, NPM1, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, \r\nPIK3C2B, PIK3CA, PIK3CG, PMS2, PTCH1, PTEN, PTPN11, \r\nRAC1, RAC2, RB1, RET, ROCK2, ROS1, SH2B3, SLIT2, \r\nSMAD4, SMARCA4, SMARCB1, SMO, SOX2, SPOP, \r\nSRC, STK11, TP53, TRAF7, TSC1, TSC2, VHL",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent HaloPlex HS Custom Kits",
          "Fragmentation Methods": "Restriction enzyme digestion (included in the above library construction kit)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000272",
          "Total Data Volume": "128 MB (bam, vcf [ref: hg38])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Ryohei Katayama",
        "Affiliation": "Japanese Foundation for Cancer Research",
        "Project / Group Name": "Div of Exp Chemother, Cancer Chemotherapy Center",
        "Funds / Grants (Research Project Number)": {
          "5": {
            "Name": "Practical Research for Innovative Cancer Control, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Mechanisms of checkpoint inhibitor resistance through secretable immunosuppressive variants",
            "Project Number": "JP19ck0106472"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models",
          "DOI": "doi: 10.1038/s41467-019-11496-z",
          "Data Set ID": "JGAD000272"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000272"
        }
      },
      "Release Note": {
        "hum0194.v1": {
          "Research ID": "hum0194.v1",
          "Release Date": "2020/05/11",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from tumor tissues of 2 patients with lung cancer were used for a target capture sequencing analysis (bam files).\nNote：\n"
        }
      }
    }
  },
  "hum0192.v1": {
    "ja": {
      "NBDC Research ID": "hum0192.v1",
      "データ": {
        "JGAS000196": {
          "データID": "JGAS000196",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/04/23"
        }
      },
      "研究内容の概要": {
        "目的": "治療前のcell free DNA 測定によって大腸・直腸がん患者のオリゴメタスタシスに対する放射線・陽子線治療後の予後との相関を明らかにすること",
        "方法": "放射線もしくは陽子線治療前に採取した血液検体からcell free DNA量を測定し、予後との相関関係について検討するため、放射線・陽子線治療を受けた大腸・直腸がん症例の治療前末梢血（血漿）中のcell free DNAを抽出し、がん遺伝子（circulating tumor DNA）の検出をNCCオンコパネルv2を用いて実施した。",
        "対象": "2005年4月から2017年12月までの期間に治療を受け、治療前血液検体が保存されている大腸・直腸がん症例"
      },
      "分子データ": {
        "JGAS000196": {
          "対象": "大腸・直腸がん（ICD10：C18.9、C20 ）：20症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "NCC Oncopanel v2\r\nhttps://www.ncc.go.jp/jp/information/pr_release/2019/0529/index.html",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "末梢血（血漿）から抽出したcell free DNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT HS",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000279",
          "総データ量": "50 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中村 匡希",
        "所 属 機 関": "国立がん研究センター東病院 放射線治療科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 若手研究",
            "タイトル": "オリゴメタスタシスの予後予測としてのcell free DNAの有効性検証の研究",
            "研究課題番号": "18K15611"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy",
          "DOI": "doi: 10.21873/anticanres.14835",
          "データID": "JGAD000279"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0192.v1": {
          "Research ID": "hum0192.v1",
          "公開日": "2021/04/23",
          "内容": "NGS（Target Capture）",
          "description": "放射線・陽子線治療を受けた大腸・直腸がん20症例の治療前末梢血（血漿）から抽出したcell free DNAを用いたTarget Capture（NCC Oncopanel v2）解析結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0192.v1",
      "DATA": {
        "JGAS000196": {
          "Data Set ID": "JGAS000196",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/04/23"
        }
      },
      "SUMMARY": {
        "Aims": "Detection of mutation in liquid biopsy (cell free DNA)",
        "Methods": "Target sequence by using of NCCv2 Oncopanel",
        "Participants/Materials": "Colon cancer patients"
      },
      "MOLECULAR DATA": {
        "JGAS000196": {
          "Participants/Materials": "Colon cancer (ICD10: C18.9, C20): 20 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "NCC Oncopanel v2\r\nhttps://www.ncc.go.jp/en/information/press_release/20190717/20190717152024.html",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "cell free DNA extracted from plasma of peripheral blood",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT HS",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000279",
          "Total Data Volume": "50 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masaki Nakamura",
        "Affiliation": "Department of Radiation Oncology, National Cancer Center Hospital East",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Grant-in-Aid for Early-Career Scientists",
            "Title": "Research of cell free DNA as a prognostic biomarker of oligometastasis",
            "Project Number": "18K15611"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy",
          "DOI": "doi: 10.21873/anticanres.14835",
          "Data Set ID": "JGAD000279"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0192.v1": {
          "Research ID": "hum0192.v1",
          "Release Date": "2021/04/23",
          "Type of Data": "NGS (Target Capture)",
          "description": "Cell free DNA extracted from plasma of peripheral blood from colon cancer patients were used for the target capture sequencing analysis (NCC Oncopanel v2). Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0191.v1": {
    "ja": {
      "NBDC Research ID": "hum0191.v1",
      "データ": {
        "DRA008575": {
          "データID": "DRA008575",
          "内容": "NGS（RNA-seq）",
          "制限": "非制限公開",
          "公開日": "2020/06/05"
        }
      },
      "研究内容の概要": {
        "目的": "膵がん症例の腫瘍組織を用いて膵がん発症者の免疫状態をモニタリングし、予後との関連を検討する",
        "方法": "膵がん（腫瘍組織）から抽出したRNAを用いたRNA-Seq解析データを用いた発現解析および腫瘍浸潤リンパ球予測",
        "対象": "根治手術実施後の膵がん症例"
      },
      "分子データ": {
        "DRA008575": {
          "対象": "膵がん（ICD10：C25.9）：17症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500/4000]",
          "ライブラリソース": "腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "-",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end / Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50bp（SE）、100bp（PE）",
          "DDBJ Sequence Read Archive ID": "DRA008575",
          "総データ量": "100 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "垣見 和宏",
        "所 属 機 関": "東京大学医学部附属病院 免疫細胞治療学講座",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "遺伝子変異由来ネオエピトープを標的としたがん免疫治療の開発",
            "研究課題番号": "16K07162"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer",
          "DOI": "doi: 10.1016/j.bbrc.2017.12.083",
          "データID": "DRA008575"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0191.v1": {
          "Research ID": "hum0191.v1",
          "公開日": "2020/06/05",
          "内容": "NGS（RNA-seq）",
          "description": "膵がん17症例の腫瘍組織から抽出したRNAを用いたRNA-Seq解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0191.v1",
      "DATA": {
        "DRA008575": {
          "Data Set ID": "DRA008575",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/06/05"
        }
      },
      "SUMMARY": {
        "Aims": "To explore prognostic biomarkers using RNAseq data from tumor tissues of resected pancreatic cancer patients",
        "Methods": "Analyses of gene expression and lymphocyte enrichment in the tumor tissues by using of RNA-seq data",
        "Participants/Materials": "Patients with pancreatic cancer who underwent curative surgery"
      },
      "MOLECULAR DATA": {
        "DRA008575": {
          "Participants/Materials": "Pancreatic cancer (ICD10: C25.9): 17 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500/4000]",
          "Library Source": "RNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "-",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end / Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp (SE), 100 bp (PE)",
          "DDBJ Sequence Read Archive ID": "DRA008575",
          "Total Data Volume": "100 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kazuhiro Kakimi",
        "Affiliation": "Department of Immunotherapeutics, The University of Tokyo Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Development of cancer immunotherapy targeting mutation-derived neoantigens",
            "Project Number": "16K07162"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer",
          "DOI": "doi: 10.1016/j.bbrc.2017.12.083",
          "Data Set ID": "DRA008575"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0191.v1": {
          "Research ID": "hum0191.v1",
          "Release Date": "2020/06/05",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from tumor tissues of 17 pancreatic cancer patients were used for the RNA sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0188.v1": {
    "ja": {
      "NBDC Research ID": "hum0188.v1",
      "データ": {
        "JGAS000179": {
          "データID": "JGAS000179",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/06/28"
        }
      },
      "研究内容の概要": {
        "目的": "胃がん細胞株のゲノム解析による治療標的同定",
        "方法": "Whole Exome sequecingおよびRNA-seq",
        "対象": "胃がん細胞株OCUM-8, OCUM-9"
      },
      "分子データ": {
        "Exome": {
          "対象": "胃がん細胞株：OCUM-8、OCUM-9",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "日本人胃がん細胞株（OCUM-8、OCUM-9）から抽出したDNA",
          "検体情報（購入の場合）": "細胞株は大阪市立大学の八代正和博士より供与された",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V5",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "103 bp / 104 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000260",
          "総データ量": "95 GB（fastq、bam [ref：hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "胃がん細胞株：OCUM-8、OCUM-9",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "日本人胃がん細胞株（OCUM-8、OCUM-9）から抽出したRNA",
          "検体情報（購入の場合）": "細胞株は大阪市立大学の八代正和博士より供与された",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra Directional RNA Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "103 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000260",
          "総データ量": "95 GB（fastq、bam [ref：hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "間野 博行",
        "所 属 機 関": "国立がん研究センター研究所細胞情報学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的先端研究開発支援事業 インキュベートタイプ（LEAP）",
            "タイトル": "がん治療標的探索プロジェクト",
            "研究課題番号": "JP17am0001001"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Identification of candidates for driver oncogenes in scirrhous-type gastric cancer cell lines.",
          "DOI": "doi: 10.1111/cas.14111",
          "データID": "JGAD000260"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000260"
        }
      },
      "リリース情報": {
        "hum0188.v1": {
          "Research ID": "hum0188.v1",
          "公開日": "2019/06/28",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "胃がん細胞株（OCUM-8、OCUM-9）から抽出したDNAおよびRNAを用いたWhole Exome sequecingデータおよびRNA-seqデータをfastqおよびbamファイルにて提供する。ゲノムDNAよりエクソン領域をSureSelect Human All Exon V5で濃縮しHiSeq 2500で解析した。また純化したRNAをNEBNext Ultra Directional RNA Library Prep Kitによりライブラリー調整し、HiSeq 2500で解析した。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0188.v1",
      "DATA": {
        "JGAS000179": {
          "Data Set ID": "JGAS000179",
          "Type of Data": "NGS (Exome、RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/06/28"
        }
      },
      "SUMMARY": {
        "Aims": "Screening of therapeutic targets in gastric cancer cell lines",
        "Methods": "Whole Exome sequecing and RNA-seq",
        "Participants/Materials": "Gastric cancer cell lines, OCUM-8 and OCUM-9"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "Gastric cancer cell lines: OCUM-8 and OCUM-9",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from Japanese gastric cancer cell lines",
          "Cell Lines": "Cell lines were provided by Dr. Masakazu Yashiro at Osaka City University",
          "Library Construction (kit name)": "Ultrasonic fragmentation (Covaris)",
          "Fragmentation Methods": "SureSelect Human All Exon V5",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "103 bp / 104 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000260",
          "Total Data Volume": "95 GB (fastq, bam [ref: hg38])",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Gastric cancer cell lines: OCUM-8 and OCUM-9",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from Japanese gastric cancer cell lines",
          "Cell Lines": "Cell lines were provided by Dr. Masakazu Yashiro at Osaka City University",
          "Library Construction (kit name)": "NEBNext Ultra Directional RNA Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "103 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000260",
          "Total Data Volume": "95 GB (fastq, bam [ref: hg38])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Mano",
        "Affiliation": "Division of Cellular Signaling, National Cancer Center Research Institute",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Leading Advanced Projects for medical innovation (LEAP), Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Project for Exploration of Therapeutic Targets in Cancer",
            "Project Number": "JP17am0001001"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Identification of candidates for driver oncogenes in scirrhous-type gastric cancer cell lines.",
          "DOI": "doi: 10.1111/cas.14111",
          "Data Set ID": "JGAD000260"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000260"
        }
      },
      "Release Note": {
        "hum0188.v1": {
          "Research ID": "hum0188.v1",
          "Release Date": "2019/06/28",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "Genomic DNA and total RNA were isolated from each cell line (OCUM-8、OCUM-9). DNA was subjected to enrichment of exonic fragments with a SureSelect Human All Exon V5 followed by nucleotide sequencing with the HiSeq 2500 platform using the paired-end option. Total RNA was subjected to RNA-seq with HiSeq 2500 using a NEBNext Ultra Directional RNA Library Prep Kit. Data are provided as fastq and bam files.\nNote：\n"
        }
      }
    }
  },
  "hum0187.v2": {
    "ja": {
      "NBDC Research ID": "hum0187.v2",
      "データ": {
        "JGAS000194": {
          "データID": "JGAS000194",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/05/12"
        },
        "JGAS000233": {
          "データID": "JGAS000233",
          "内容": "NGS（Exome、RNA-seq）、Methylation array",
          "制限": "制限公開（Type I）",
          "公開日": "2021/05/31"
        }
      },
      "研究内容の概要": {
        "目的": "肝細胞がんゲノムへのウイルスゲノム挿入部位解析",
        "方法": "ウイルスキャプチャーシーケンス（NGS)、Exome（NGS）、RNA-seq（NGS）、DNA_methylation（Infinium450K）",
        "対象": "肝細胞がん　243＋160症例",
        "URL": "https://www.genome.rcast.u-tokyo.ac.jp/ja/research"
      },
      "分子データ": {
        "Target Capture": {
          "対象": "肝細胞がん（ICD10：C220）：243症例\r\n　腫瘍組織：243検体\r\n　非腫瘍組織：59検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "Virus integration site（ウイルス配列と、ウイルスのヒト融合配列、および非特異的に生じるウイルス以外のヒト配列を含む）",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "肝がんの手術摘出組織の腫瘍組織および非腫瘍組織（腫瘍組織の周辺組織）から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect XT custom kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "約200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000277",
          "総データ量": "640 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Exome": {
          "対象": "肝細胞がん（ICD10：C220）：160症例\r\n　腫瘍組織：160検体\r\n　非腫瘍組織：160検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SeqCap EZ HGSC VCRome2.1 design1（42 Mb, NimbleGen）、SureSelect Human All Exon Kit V4/V5（Agilent Technologies）",
          "断片化の方法": "超音波断片化（Covaris S2）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000328",
          "総データ量": "7 TB（fastq、bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "肝細胞がん（ICD10：C220）：160症例\r\n　腫瘍組織：160検体\r\n　非腫瘍組織：31検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA",
          "断片化の方法": "上記キットに準拠",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000329",
          "総データ量": "7 TB（fastq、bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Methylation array": {
          "対象": "肝細胞がん（ICD10：C220）：160症例\r\n　腫瘍組織：160検体\r\n　非腫瘍組織：28検体",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium Human Methylation 450K BeadChip]",
          "ソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium HumanMethylation450 BeadChip",
          "メチル化率決定アルゴリズム（ソフトウェア）": "Genome Studio",
          "フィルタリング": "-",
          "プローブ数(QC後)": "485,577 methylation sites",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000330",
          "総データ量": "7 TB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "油谷 浩幸",
        "所 属 機 関": "東京大学先端科学技術研究センター",
        "プロジェクト/研究グループ名": "ゲノムサイエンス分野",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "がんゲノム解析で残された微小コピー数変化の検出とその意義の解明",
            "研究課題番号": "17K07195"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection",
          "DOI": "doi: 10.1158/1078-0432.CCR-18-4041",
          "データID": "JGAD000277"
        },
        "2": {
          "タイトル": "Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression",
          "DOI": "doi: 10.1158/0008-5472.CAN-20-0225",
          "データID": "JGAD000328\r\nJGAD000329\r\nJGAD000330"
        }
      },
      "制限公開データの利用者一覧": {
        "河野 隆志": {
          "研究代表者": "河野 隆志",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "AYA （Adolescence and Young Adult） 世代がんの個別化予防に資する遺伝要因の同定を目指す研究",
          "利用期間": "JGAD000277, JGAD000328, JGAD000329, JGAD000330"
        },
        "Jinyan Huang": {
          "研究代表者": "Jinyan Huang",
          "所属機関": "Zhejiang University School of Medicine",
          "研究題目": "",
          "利用データID": "Comprehensive analysis of alternative splicing in malignant tumors",
          "利用期間": "JGAD000277"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000329"
        },
        "Jian Cao": {
          "研究代表者": "Jian Cao",
          "所属機関": "Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Analyzing oncovirus in NBDC tumor sequencing data",
          "利用期間": "JGAD000277,JGAD000328,JGAD000329,JGAD000330"
        }
      },
      "リリース情報": {
        "hum0187.v2": {
          "Research ID": "hum0187.v2",
          "公開日": "2021/05/31",
          "内容": "NGS（Exome、RNA-seq）、Methylation array",
          "description": "肝細胞がん160症例の腫瘍組織および非腫瘍組織より抽出したDNA/RNAを用いたWES、 RNA-seq、methylation（Infinium450K）解析結果をfastq、bam、およびtxtファイルにて提供する。\n"
        },
        "hum0187.v1": {
          "Research ID": "hum0187.v1",
          "公開日": "2020/05/12",
          "内容": "NGS（Target Capture）",
          "description": "肝細胞がん243症例の腫瘍組織および59症例の非腫瘍組織（腫瘍組織の周辺組織）から抽出したgDNAを用いたウイルスゲノム挿入部位（ウイルスキャプチャーシークエンシング）解析結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0187.v2",
      "DATA": {
        "JGAS000194": {
          "Data Set ID": "JGAS000194",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/05/12"
        },
        "JGAS000233": {
          "Data Set ID": "JGAS000233",
          "Type of Data": "NGS (Exome, RNA-seq), Methylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/05/31"
        }
      },
      "SUMMARY": {
        "Aims": "Impact of viral integration into the host genome on development of hepatocellular carcinoma",
        "Methods": "Virus capture sequencing (NGS), Exome (NGS), RNA-seq (NGS), DNA_methylation (Infinium450K)",
        "Participants/Materials": "hepatocellular carcinoma",
        "URL": "https://www.genome.rcast.u-tokyo.ac.jp/en/research"
      },
      "MOLECULAR DATA": {
        "Target Capture": {
          "Participants/Materials": "hepatocellular carcinoma (ICD10: C220): 243 cases\r\n  tumor tissue: 243 samples\r\n  non-tumor tissue: 59 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "Virus integration site (including viral genome sequences, viral-human fusion sequences, and nonspecific human genome sequences)",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "gDNAs extracted from tumor and non-tumor tissues of hepatocellular carcinoma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect XT custom kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000277",
          "Total Data Volume": "640 GB（fastq）",
          "Comments (Policies)": "NBDC policy"
        },
        "Exome": {
          "Participants/Materials": "hepatocellular carcinoma (ICD10: C220): 160 cases\r\n  tumor tissue: 160 samples\r\n  non-tumor tissue: 160 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SeqCap EZ HGSC VCRome2.1 design1 (42 Mb, NimbleGen), SureSelect Human All Exon Kit V4/V5 (Agilent Technologies)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S2)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000328",
          "Total Data Volume": "7 TB (fastq, bam)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "hepatocellular carcinoma (ICD10: C220): 160 cases\r\n  tumor tissue: 160 samples\r\n  non-tumor tissue: 31 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA",
          "Fragmentation Methods": "included in the above library construction kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000329",
          "Total Data Volume": "7 TB (fastq, bam)",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation array": {
          "Participants/Materials": "hepatocellular carcinoma (ICD10: C220): 160 cases\r\n  tumor tissue: 160 samples\r\n  non-tumor tissue: 28 samples",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium Human Methylation 450K BeadChip]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Infinium HumanMethylation450 BeadChip",
          "Algorithms for Calculating Methylation-rate (software)": "Genome Studio",
          "Filtering Methods": "-",
          "Probe Number (after QC)": "485,577 methylation sites",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000330",
          "Total Data Volume": "7 TB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Aburatani",
        "Affiliation": "RCAST, the University of Tokyo",
        "Project / Group Name": "Genome Science laboratory",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Focal copy number alteration and its functional role in carcinogenesis: unmet needs in cancer genome analysis",
            "Project Number": "17K07195"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection",
          "DOI": "doi: 10.1158/1078-0432.CCR-18-4041",
          "Data Set ID": "JGAD000277"
        },
        "2": {
          "Title": "Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression",
          "DOI": "doi: 10.1158/0008-5472.CAN-20-0225",
          "Data Set ID": "JGAD000328\r\nJGAD000329\r\nJGAD000330"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Takashi Kohno": {
          "Principal Investigator": "Takashi Kohno",
          "Affiliation": "Division of Genome Biology, National Cancer Center Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Identification of genetic risk factors in AYA (Adolescence and Young Adult) cancer",
          "Period of Data Use": "JGAD000277, JGAD000328, JGAD000329, JGAD000330"
        },
        "Jinyan Huang": {
          "Principal Investigator": "Jinyan Huang",
          "Affiliation": "School of Medicine, Zhejiang University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of alternative splicing in malignant tumors",
          "Period of Data Use": "JGAD000277"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000329"
        },
        "Jian Cao": {
          "Principal Investigator": "Jian Cao",
          "Affiliation": "Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Analyzing oncovirus in NBDC tumor sequencing data",
          "Period of Data Use": "JGAD000277,JGAD000328,JGAD000329,JGAD000330"
        }
      },
      "Release Note": {
        "hum0187.v2": {
          "Research ID": "hum0187.v2",
          "Release Date": "2021/05/31",
          "Type of Data": "NGS (Exome, RNA-seq), Methylation array",
          "description": "DNA/RNAs extracted from tumor and non-tumor tissues of hepatocellular carcinoma patients were used for exome, RNA-seq and DNA methylation analysis (Infinium450K). Fastq, bam and txt files are provided.\n"
        },
        "hum0187.v1": {
          "Research ID": "hum0187.v1",
          "Release Date": "2020/05/12",
          "Type of Data": "NGS (Target Capture)",
          "description": "gDNAs extracted from tumor and non-tumor tissues of hepatocellular carcinoma patients were used for a virus capture sequencing analysis. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0184.v2": {
    "ja": {
      "NBDC Research ID": "hum0184.v2",
      "データ": {
        "JGAS000239": {
          "データID": "JGAS000239",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type II）",
          "公開日": "2020/09/01"
        },
        "JGAS000239にデータ追加": {
          "データID": "JGAS000239にデータ追加",
          "内容": "NGS（WGS）のbam/gvcfデータ",
          "制限": "制限公開（Type II）",
          "公開日": "2022/02/18"
        }
      },
      "研究内容の概要": {
        "目的": "東北メディカル・メガバンク計画は、大規模ゲノムコホート研究を行うことにより、地域医療の復興に貢献し、創薬研究や個別化医療等の次世代医療体制の構築を目指す事業である。これまで、4000人を超える検体の全ゲノムシークエンス解析を行い、日本人の遺伝的多様性をカタログ化したデータセット「日本人全ゲノム参照パネル」を作成した。これを用いて、インピュテーション精度の向上、疾患リスク予測の精度を向上、さらに日本人のゲノム研究の基盤を提供することを目的とする。",
        "方法": "全ゲノムシークエンス",
        "対象": "日本人一般住民 4,566名",
        "URL": "https://www.megabank.tohoku.ac.jp/"
      },
      "分子データ": {
        "JGAS000239": {
          "対象": "日本人一般住民：4,566名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500、NovaSeq 6000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free Library Prep Kit",
          "断片化の方法": "超⾳波断⽚化（Covaris LE220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "HiSeq 2500：162 bp / 259 bp\r\nNovaSeq 6000：150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000338\r\nJGAD000339",
          "総データ量": "JGAD000338：260 TB（fastq）\r\nJGAD000339：230 TB（bam、gvcf、vcf [ref：GRCh37/hg19（hs37d5）]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および hum0184 policy\r\n東北メディカル・メガバンク機構のスパコンに関するお問い合わせ先：emailProtector.addCloakedMailto(\"ep_2ec4c28d\", 0);"
        },
        "JGAS000239への追加": {
          "対象": "日本人一般住民：4,566名",
          "規模": "WGS",
          "ソース": "JGAD000338のfastqファイル",
          "クオリティコントロール方法": "リードのbase qualityが全体的に悪い検体、リード毎の%GCの結果にて異常を示した検体を除去。\r\nAlignment後、Low mapping rate検体、Insert sizeがおかしい検体、メタデータの性別情報とalingment結果より推定される性別情報が不一致な検体、性染色体異常疑いの検体を除去。\r\nGenotyping時に、VQSR、DP/GP filter (DP < 5, GQ < 20, DP > 60 && GQ < 95を除去）、heterozygosity filter (F>=0.05 を除去)、HWE filter (p < 10-6を除去）、Repeat & Low Complexity filterを実施。\r\n1000 genomes projectと合わせたPCAを実施し、日本人クラスタから大きく外れる検体を除外。\r\nその後、Genome-In-A-Bottleプロジェクトから公開されているHighConfidenceRegionリストに記載のある領域のバリアントにフラグを付与。",
          "重複するリードの除去": "Picard 2.10.6",
          "リアライメントおよびベースクオリティのキャリブレーション": "GATK 3.7",
          "マッピング方法": "BWA mem 0.7.12",
          "マッピングクオリティ": "GATK 3.7 HaplotypeCallerで変異コール時にMAPQ<20のリードを除外",
          "マッピングの際のリファレンス配列": "GRCh37/hg19（hs37d5）",
          "平均カバー率（Depth）": "HiSeq 2500：31.8x、NovaSeq 6000：28.0x",
          "変異検出方法": "GATK 3.7 HaplotypeCaller",
          "SNV数（QC後）": "76,768,387（常染色体）\r\n2,898,518（X 染色体）",
          "INDEL数（QC後）": "10,202,908（常染色体）\r\n410,435（X 染色体）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000625：GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のデータです。詳しくはこちらをご覧ください。",
          "総データ量": "230 TB（bam、vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および hum0184 policy\r\n東北メディカル・メガバンク機構のスパコンに関するお問い合わせ先：emailProtector.addCloakedMailto(\"ep_5b876b78\", 0);"
        }
      },
      "提供者情報": {
        "研究代表者": "山本 雅之",
        "所 属 機 関": "東北大学 東北メディカル・メガバンク機構",
        "プロジェクト/研究グループ名": "東北メディカル・メガバンク計画",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 医療研究開発推進事業費補助金",
            "タイトル": "東北メディカル・メガバンク計画（岩手医科大学）一般会計分",
            "研究課題番号": "JP20km0105004"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome",
          "DOI": "doi: 10.1038/s41439-019-0059-5",
          "データID": "hum0015.v3.3.5kjpnv2.v1"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0184.v2": {
          "Research ID": "hum0184.v2",
          "公開日": "2022/02/18",
          "内容": "NGS（WGS）のbam/gvcfデータ",
          "description": "JGAD000338に含まれるwhole genome sequencing解析データに対し、GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のbam/gvcfデータを追加した。\n"
        },
        "hum0184.v1": {
          "Research ID": "hum0184.v1",
          "公開日": "2020/09/01",
          "内容": "NGS（WGS）",
          "description": "日本人一般住民約5000名の末梢血より抽出したDNAを用いた、HiSeq2500、NovaSeq6000（Illumina）によるWhole Genome Sequencingデータ（fastq、bam、gvcf）を提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0184.v2",
      "DATA": {
        "JGAS000239": {
          "Data Set ID": "JGAS000239",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type II)",
          "Release Date": "2020/09/01"
        },
        "JGAS000239 (Dataset addition)": {
          "Data Set ID": "JGAS000239 (Dataset addition)",
          "Type of Data": "bam/gvcf data of NGS（WGS）",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/02/18"
        }
      },
      "SUMMARY": {
        "Aims": "Tohoku University Tohoku Medical Megabank Organization (ToMMo) and Iwate Tohoku Medical Megabank Organization (IMM) were founded to establish an advanced medical system to foster the reconstruction from the Great East Japan Earthquake. These organizations are developing a biobank that includes medical and genome information for supporting health and welfare in the Tohoku area. In the first stage, the part of our mission was to sequence the 4,000 individuals to construct Japanese whole-genome reference panel.",
        "Methods": "Whole genome sequencing",
        "Participants/Materials": "4,566 Japanese general residents",
        "URL": "https://www.megabank.tohoku.ac.jp/english/"
      },
      "MOLECULAR DATA": {
        "JGAS000239": {
          "Participants/Materials:": "4,566 Japanese general residents",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500, NovaSeq 6000]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris LE220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "HiSeq 2500: 162 bp / 259 bp\r\nNovaSeq 6000: 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000338\r\nJGAD000339",
          "Total Data Volume": "JGAD000338: 260 TB (fastq)\r\nJGAD000339: 230 TB (bam, gvcf, vcf [ref: GRCh37/hg19 (hs37d5)])",
          "Comments (Policies)": "NBDC policy & hum0184 policy\r\nContact Information of ToMMo Supercomputer: emailProtector.addCloakedMailto(\"ep_beaa9879\", 0);"
        },
        "JGAS000239 (Dataset addition)": {
          "Participants/Materials:": "4,566 Japanese general residents",
          "Targets": "WGS",
          "Source": "fastq files of JGAD000338",
          "QC": "Data with bad base quality and high %GC content were removed.\r\nAligment:\r\nData matched for the following condition were removed.\r\n- Low mapping rate\r\n- Different insert size\r\n- Gender information mismatch between meta-data and genotype data\r\n- Suspected sex chromosome aberration\r\nGenotyping:\r\nGATK’s best practices includes a variant filtering step following Variant Quality Score Recalibration (VQSR)\r\n- DP/GP (DP < 5, GQ < 20, DP > 60, GQ < 95 )\r\n- Heterozygosity (F>=0.05)\r\n- Hardy-Weinberg equilibrium (p < 10^-6）\r\n- Repeat & Low Complexity\r\nPrincipal Component Analysis (PCA):\r\nPCA was performed with individuals included in the 1000 genomes project and outliers from Japanese cluster were removed.\r\nAfter these filtering steps, variants located in the regions listed as the HighConfidenceRegion (Genome-In-A-Bottle project) were flagged.",
          "Deduplication": "Picard 2.10.6",
          "Calibration for re-alignment and base quality": "GATK 3.7",
          "Mapping Methods": "BWA mem 0.7.12",
          "Mapping Quality": "Reads with MAPQ< 20 were excluded at variant calling with GATK 3.7 HaplotypeCaller",
          "Reference Genome Sequence": "GRCh37/hg19 (hs37d5)",
          "Coverage (Depth)": "HiSeq 2500: 31.8x, NovaSeq 6000: 28.0x",
          "Detecting Methods for Variation": "GATK 3.7 HaplotypeCaller",
          "SNV Numbers (after QC)": "76,768,387 (Autosomal Chromosomes)\r\n2,898,518 (X Chromosome)",
          "INDEL Numbers (after QC)": "10,202,908 (Autosomal Chromosomes)\r\n410,435 (X Chromosome)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000625: Whole genome sequencing analyzed data included in the JGAD000117 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J). Lean more..",
          "Total Data Volume": "230 TB (bam, vcf)",
          "Comments (Policies)": "NBDC policy & hum0184 policy\r\nContact Information of ToMMo Supercomputer: emailProtector.addCloakedMailto(\"ep_a5481aec\", 0);"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masayuki Yamamoto",
        "Affiliation": "Tohoku Medical Megabank Organization",
        "Project / Group Name": "Tohoku Medical Megabank Project",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Japan Agency for Medical Research and Development (AMED)",
            "Title": "Tohoku Medical Megabank Project (Iwate Medical University) General Accounting",
            "Project Number": "JP20km0105004"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome",
          "DOI": "doi: 10.1038/s41439-019-0059-5",
          "Data Set ID": "hum0015.v3.3.5kjpnv2.v1"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0184.v2": {
          "Research ID": "hum0184.v2",
          "Release Date": "2022/02/18",
          "Type of Data": "bam/gvcf data of NGS（WGS）",
          "description": "Whole genome sequencing analyzed data included in the JGAD000338 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. Bam files and gvcf files were added. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J).\n"
        },
        "hum0184.v1": {
          "Research ID": "hum0184.v1",
          "Release Date": "2020/09/01",
          "Type of Data": "NGS (WGS)",
          "description": "Whole genome sequencing by Illumina HiSeq2500 and NovaSeq6000 was performed using DNAs extracted from peripheral blood cells of 5,000 Japanese general residents (fastq, bam, gvcf).\nNote：\n"
        }
      }
    }
  },
  "hum0182.v5": {
    "ja": {
      "NBDC Research ID": "hum0182.v5",
      "データ": {
        "JGAS000180": {
          "データID": "JGAS000180",
          "内容": "NGS（WGS）：RK014～RK281\r\n（fast5データの追加）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/12"
        },
        "DRA008482": {
          "データID": "DRA008482",
          "内容": "NGS（WGS）：NA18943",
          "制限": "非制限公開",
          "公開日": "2019/06/20"
        },
        "JGAS000516": {
          "データID": "JGAS000516",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/05/27"
        }
      },
      "研究内容の概要": {
        "目的": "全ゲノムシークエンスによる構造異常の包括的解析",
        "方法": "長鎖一分子シークエンサー（nanopore）およびHiSeq 2000、Genome Analyzer IIx（Illumina）による全ゲノムシークエンス"
      },
      "分子データ": {
        "JGAS000180": {
          "対象": "肝臓がん （ICD10：C22.0）：42症例\r\n　　腫瘍組織：42検体、腫瘍組織周辺の非腫瘍組織：42検体\r\n乳がん細胞株（MCF-7）：1検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Nanopore [MinION]",
          "ライブラリソース": "腫瘍組織および腫瘍組織周辺の非腫瘍組織、ならびに、乳がん細胞株から抽出したRNA",
          "検体情報（購入の場合）": "MCF-7：コスモバイオ 株式会社より購入したRNA",
          "ライブラリ作製方法（キット名）": "Ligation Sequencing Kit （SQK-LSK109）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "1411.4 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000635",
          "総データ量": "2.7 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "DRA008482": {
          "対象": "③ RK001～RK338（ICGC日本人肝臓がん174症例の正常細胞）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000, Genome Analyzer IIx]",
          "ライブラリソース": "肝臓がん患者の末梢血（正常組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA LT Sample Prep Kit、TruSeq Nano DNA Low Throughput Library Prep Kit、Paired-End DNA Sample Prep Kit、TruSeq Nano DNA Library Preparation Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "QC/Filtering方法": "-",
          "重複するリードの除去": "Picard",
          "マッピング方法": "bwa",
          "リファレンス配列": "hg19",
          "平均カバー率（Depth）": "30X",
          "変異検出方法": "VCMM（Shigemizu et al. Sci Rep (2013))",
          "構造変異検出方法": "IMSindel法の後複数サンプルを合わせて解析（Shigemizu et al. Sci Rep (2018), Wong et al. Genome Med (2019)*ref1）",
          "SNV数（QC後）": "5,239,921",
          "SV数（QC後）": "4,378",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000261",
          "総データ量": "3 GB（VCF [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "藤本 明洋",
        "所 属 機 関": "東京大学大学院 医学系研究科 人類遺伝学教室",
        "プロジェクト/研究グループ名": "国立研究開発法人日本医療研究開発機構 ゲノム医療実現推進プラットフォーム事業「先端ゲノム研究開発」プロジェクト",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 臨床ゲノム情報統合データベース整備事業",
            "タイトル": "B型肝炎に関する統合的臨床ゲノムデータベースの構築を目指す研究",
            "研究課題番号": "JP18kk0205007"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Identification of intermediate-sized deletions and inference of their impact on gene expression in a human population.",
          "DOI": "doi: 10.1186/s13073-019-0656-4",
          "データID": "JGAD000261DRA008482"
        },
        "2": {
          "タイトル": "Whole-genome sequencing with long reads reveals complex structure and origin of structural variation in human genetic variations and somatic mutations in cancer",
          "DOI": "doi: 10.1186/s13073-021-00883-1",
          "データID": "JGAD000261"
        }
      },
      "制限公開データの利用者一覧": {
        "Shuaicheng Li": {
          "研究代表者": "Shuaicheng Li",
          "所属機関": "City University of Hong Kong",
          "研究題目": "",
          "利用データID": "A new method to construct the haplotypes of viral integration regions based on multiple sequencing data.",
          "利用期間": "JGAS000180, DRA008482"
        },
        "Zeng Tianfu": {
          "研究代表者": "Zeng Tianfu",
          "所属機関": "Laboratory of Omics Technology and Bioinformatics, Sichuan University",
          "研究題目": "中華人民共和国",
          "利用データID": "Study on Heterogeneity of Hepatocellular Carcinoma Based on Nanopore Sequencing Technology",
          "利用期間": "JGAD000635"
        }
      },
      "リリース情報": {
        "hum0182.v5": {
          "Research ID": "hum0182.v5",
          "公開日": "2022/05/27",
          "内容": "NGS（RNA-seq）",
          "description": "国際がんゲノムコンソーシアム（ICGC）の際に収集した日本人肝臓がん42症例の腫瘍組織および腫瘍組織周辺の非腫瘍組織由来のRNA（計84検体）、ならびに、乳がん細胞株（MCF-7）から抽出したRNAを対象としたRNA-seq解析データのfastqファイルを提供する。\n"
        },
        "hum0182.v4": {
          "Research ID": "hum0182.v4",
          "公開日": "2021/11/12",
          "内容": "NGS（WGS）",
          "description": "国際がんゲノムコンソーシアム（ICGC）の際に収集した日本人肝臓がん11症例の末梢血（正常細胞）および腫瘍組織由来DNA（RK014、RK019、RK020、RK067、RK085、RK0143、RK147、RK156、RK157、RK167、RK281）を対象とし、長鎖シークエンサー（nanopore）による全ゲノムシークエンスを行った際のfast5ファイルを提供する。\n"
        },
        "hum0182.v3": {
          "Research ID": "hum0182.v3",
          "公開日": "2021/01/06",
          "内容": "NGS（WGS）",
          "description": "国際がんゲノムコンソーシアム（ICGC）の際に収集した日本人肝臓がん11症例の末梢血（正常細胞）および腫瘍組織由来DNA（RK014、RK019、RK020、RK067、RK085、RK0143、RK147、RK156、RK157、RK167、RK281）を対象とし、長鎖シークエンサー（nanopore）による全ゲノムシークエンスを行った。fastqファイルを提供する。\n"
        },
        "hum0182.v2": {
          "Research ID": "hum0182.v2",
          "公開日": "2020/05/12",
          "内容": "NGS（WGS）",
          "description": "国際がんゲノムコンソーシアム（ICGC）の際に収集した日本人肝臓がん174症例の末梢血（正常細胞）由来DNA（RK001～RK338）を対象とし、全ゲノムシークエンスデータの再解析を行った。vcfファイルを提供する。\n"
        },
        "hum0182.v1": {
          "Research ID": "hum0182.v1",
          "公開日": "2019/06/20",
          "内容": "NGS（WGS）",
          "description": "国際がんゲノムコンソーシアム（ICGC）の際に収集した日本人肝臓がん１症例の末梢血（正常細胞）由来DNA（RK067）およびHapMap日本人検体（NA18943）を対象とし、長鎖シークエンサー（nanopore）による全ゲノムシークエンスを行った。fastqファイルを提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0182.v5",
      "DATA": {
        "JGAS000180": {
          "Data Set ID": "JGAS000180",
          "Type of Data": "NGS (WGS): RK014-RK281\r\n(fast5 sequencing data)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/12"
        },
        "DRA008482": {
          "Data Set ID": "DRA008482",
          "Type of Data": "NGS (WGS): NA18943",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/06/20"
        },
        "JGAS000516": {
          "Data Set ID": "JGAS000516",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/05/27"
        }
      },
      "SUMMARY": {
        "Aims": "Indetification of stractural variations by using of long read whole genome sequencing data",
        "Methods": "Whole genome sequencing with Nanopore sequencer, HiSeq 2000 and Genome Analyzer IIx (Illumina)",
        "Participants/Materials": "DNA samples from 2 Japanese individuals."
      },
      "MOLECULAR DATA": {
        "JGAS000180": {
          "Participants/Materials": "HCC (ICD10: C22.0): 42 cases\r\n   tumor liver tissues: 42 samples\r\n   matched non-tumor liver tissues: 42 samples\r\nBreast cancer cell line (MCF-7): 1 sample",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Nanopore [MinION]",
          "Library Source": "RNAs derived from tumor and matched non-tumor liver tissues and breast cancer cell line",
          "Cell Lines": "MCF-7; RNA was purchased from Cosmo Bio Co., Ltd.",
          "Library Construction (kit name)": "Ligation Sequencing Kit (SQK-LSK109)",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "1411.4 bp",
          "Japanese Genotype-phenotype Archive Dataset ID / DDBJ Sequence Read Archive ID": "JGAD000635",
          "Total Data Volume": "2.7 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "DRA008482": {
          "Participants/Materials": "3) RK001-RK338 (liver cancer patients): 174 cases",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000, Genome Analyzer IIx]",
          "Library Source": "DNA extracted from blood sample (normal cell) of liver cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA LT Sample Prep Kit, TruSeq Nano DNA Low Throughput Library Prep Kit, Paired-End DNA Sample Prep Kit, TruSeq Nano DNA Library Preparation Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "QC/Filtering Methods": "-",
          "Deduplication": "Picard",
          "Mapping Methods": "bwa",
          "Reference Genome Sequence": "hg19",
          "Coverage (Depth)": "30X",
          "Detecting Methods for Variation": "VCMM (Shigemizu et al. Sci Rep (2013))",
          "Detecting Methods for Structural Variation": "IMSindel and joint-call recovery method (Shigemizu et al. Sci Rep (2018), Wong et al. Genome Med (2019)*ref1)",
          "SNV Numbers (after QC)": "5,239,921",
          "SV Numbers (after QC)": "4,378",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000261",
          "Total Data Volume": "3 GB (VCF [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Affiliation": "Department of Human Genetics, Graduate School of Medicine,The University of Tokyo",
        "Project / Group Name": "Japan Agency for Medical Research and Development (AMED)",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Program for Integrated Database of Clinical and Genomic Information, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Construction of integrated clinical genome database regarding hepatitis B related diseases",
            "Project Number": "JP18kk0205007"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Identification of intermediate-sized deletions and inference of their impact on gene expression in a human population.",
          "DOI": "doi: 10.1186/s13073-019-0656-4",
          "Data Set ID": "JGAD000261DRA008482"
        },
        "2": {
          "Title": "Whole-genome sequencing with long reads reveals complex structure and origin of structural variation in human genetic variations and somatic mutations in cancer",
          "DOI": "doi: 10.1186/s13073-021-00883-1",
          "Data Set ID": "JGAD000261"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Shuaicheng Li": {
          "Principal Investigator": "Shuaicheng Li",
          "Affiliation": "City University of Hong Kong",
          "Research Title": "",
          "Data in Use (Dataset ID)": "A new method to construct the haplotypes of viral integration regions based on multiple sequencing data.",
          "Period of Data Use": "JGAS000180, DRA008482"
        },
        "Zeng Tianfu": {
          "Principal Investigator": "Zeng Tianfu",
          "Affiliation": "Laboratory of Omics Technology and Bioinformatics, Sichuan University",
          "Research Title": "China",
          "Data in Use (Dataset ID)": "Study on Heterogeneity of Hepatocellular Carcinoma Based on Nanopore Sequencing Technology",
          "Period of Data Use": "JGAD000635"
        }
      },
      "Release Note": {
        "hum0182.v5": {
          "Research ID": "hum0182.v5",
          "Release Date": "2022/05/27",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs derived from 42 Japanese tumor liver tissues and 42 matched non-tumor liver tissues collected by ICGC and RNA from breast cancer cell line MCF-7 were used for RNA sequencing analysis. Fastq files are provided.\n"
        },
        "hum0182.v4": {
          "Research ID": "hum0182.v4",
          "Release Date": "2021/11/12",
          "Type of Data": "NGS (WGS)",
          "description": "Oxford Nanopore long-reads fast5 sequencing data from DNA of 11 Japanese liver cancer patients' (RK014, RK019, RK020, RK067, RK085, RK0143, RK147, RK156, RK157, RK167, RK281) samples and matched normal samples are provided.\n"
        },
        "hum0182.v3": {
          "Research ID": "hum0182.v3",
          "Release Date": "2021/01/06",
          "Type of Data": "NGS (WGS)",
          "description": "DNA samples from Japanese individuals (a liver cancer patient [ICGC: RK014, RK019, RK020, RK067, RK085, RK0143, RK147, RK156, RK157, RK167, RK281]) were used for whole genome sequencing with Nanopore sequencer. Fastq files are provided.\n"
        },
        "hum0182.v2": {
          "Research ID": "hum0182.v2",
          "Release Date": "2020/05/12",
          "Type of Data": "NGS (WGS)",
          "description": "DNA samples from Japanese individuals (174 liver cancer patients [ICGC: RK001-RK338]) were used for whole genome sequencing, and WGS data was analyzed with VCMM and IMSindel methods. VCF files are provided.\n"
        },
        "hum0182.v1": {
          "Research ID": "hum0182.v1",
          "Release Date": "2019/06/20",
          "Type of Data": "NGS (WGS)",
          "description": "DNA samples from Japanese individuals (a liver cancer patient [ICGC: RK067] and a HapMap sample [NA18943]) were used for whole genome sequencing with Nanopore sequencer. Fastq files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0181.v1": {
    "ja": {
      "NBDC Research ID": "hum0181.v1",
      "データ": {
        "hum0181.v1.apcc.v1": {
          "データID": "hum0181.v1.apcc.v1",
          "内容": "病理スライドガラス画像",
          "制限": "非制限公開",
          "公開日": "2019/09/25"
        }
      },
      "研究内容の概要": {
        "目的": "原発性アルドステロン症（Primary Aldosteronism; PA）は二次性高血圧の原因として最も頻度が高い疾患である。これまでに、アルドステロン（Aldosterone; ALDO）合成酵素（CYP11B2）の免疫組織化学染色により、ALDO合成が従来考えられてきた球状層だけでなく、副腎皮質嚢下のCYP11B2が強発現する結節状構造(Aldosterone producing cell cluster; APCC 新規命名)においても行われることを報告した１。APCCの数と大きさは50歳までは年齢とともに増加する２。本研究では、50歳以上の症例におけるAPCCの数と大きさの変化について検討する。（１：J Clin Endocrinol Metab 2010;95,2296-305、２：Int J Endocrinol 2016;7834356）",
        "方法": "50歳以上の剖検症例（50-103歳、85症例）の副腎検体を用いて、CYP11B2と3-beta-hydroxysteroid dehydrogenase (HSD3B2) の免疫組織化学染色を行い、切片あたりのAPCCの面積の割合（APCC area per whole adrenal area [AA / WAA]、％）および切片の面積当たりのAPCCの数（number of APCC [NOA] / WAA）を算出して統計学的解析を行った。",
        "対象": "埼玉医科大学病院において剖検を行った50歳以上の症例"
      },
      "分子データ": {
        "hum0181.v1.apcc.v1": {
          "対象": "病理解剖を施行された50歳以上（50-103歳）の症例：85症例",
          "規模": "-",
          "組織": "病理解剖にて摘出された副腎切片検体",
          "固定化方法": "10%ホルマリン",
          "抗原賦活化方法（温度、溶液、PH, 時間）": "EnVision FLEX Kit, High pH (Agilent, ＃K8002)",
          "ブロッキング（試薬、時間）": "EnVision FLEX Kit, High pH (Agilent, ＃K8002)",
          "免疫染色一次抗体（抗体のメーカー・型番、使用濃度、反応温度・時間）": "CYP11B2：CYPIIB2-4Ell-1G7（in house antibody）\r\nHSD3B2：文献2参照",
          "免疫染色二次抗体（抗体のメーカー・型番、使用濃度、反応温度・時間）": "CYP11B2：EnVision FLEX Kit, High pH (Agilent, ＃K8002)\r\nHSD3B2：EnVision FLEX Kit, High pH (Agilent, ＃K8002)",
          "発色（試薬、時間）": "EnVision FLEX Kit, High pH (Agilent, ＃K8002)",
          "免染工程における洗浄（試薬、時間）": "EnVision FLEX Kit, High pH (Agilent, ＃K8002)",
          "NBDC Dataset ID": "hum0181.v1.apcc.v1\r\n    ・染色毎の一括ダウンロード\r\n        CYP11B2/HSD3B2/HE（各約50 GB：染色画像106ファイルずつ）\r\n    ・Case毎のダウンロード",
          "総データ量": "147 GB（svs）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "西本 紘嗣郎",
        "所 属 機 関": "埼玉医科大学国際医療センター 泌尿器腫瘍科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "冲中記念成人病研究所「研究助成」",
            "タイトル": "アルドステロン産生腺腫に判明したイオンチャネル・ポンプ遺伝子体細胞変異が腺腫形成に関与する分子基盤の解明",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Expression of aldosterone synthase cyp11b2 was inversely correlated with longevity.",
          "DOI": "doi: 10.1016/j.jsbmb.2019.04.010",
          "データID": "-"
        },
        "2": {
          "タイトル": "Development of monoclonal antibodies against the human 3beta-hydroxysteroid dehydrogenase/isomerase isozymes.",
          "DOI": "doi: 10.1016/j.steroids.2017.08.011",
          "データID": "-"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0181.v1": {
          "Research ID": "hum0181.v1",
          "公開日": "2019/09/25",
          "内容": "病理スライドガラス画像",
          "description": "何らかの疾患により副腎の病理解剖を受けた50歳以上（50-103歳）の85名を対象にCYP11B2・HSD3B2・HE免疫組織化学染色を実施した際の病理スライドガラス画像をsvs形式ファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0181.v1",
      "DATA": {
        "hum0181.v1.apcc.v1": {
          "Data Set ID": "hum0181.v1.apcc.v1",
          "Type of Data": "histological data (Immunostaining for CYP11B2, 3β-HSD, hematoxylin and eosin staining)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/09/25"
        }
      },
      "SUMMARY": {
        "Aims": "Immunohistochemistry of human aldosterone synthase (CYP11B2) has revealed that most of aldosterone is autonomously produced in aldosterone-producing cell clusters (APCCs) beneath the capsule of adult adrenals rather than physiologically in the zona glomerulosa (ZG)1. APCCs have been occasionally found to harbor a somatic mutation of ion channel/pump genes, and number and size of APCCs increase with age until 50 years old2, were reported so far. In this study, we aimed to study if APCCs are increased in individuals older than 50 years where the reninangiotensin system (RAS) is generally suppressed due to aging.",
        "Methods": "Archival adrenal gland were immunohistochemically analyzed using antibodies for aldosterone-synthase (CYP11B2) and 3β-hydroxysteroid dehydrogenase (3β-HSD). APCC areas per whole adrenal area (AA / WAA) and number of APCC per whole adrenal area (NOA / WAA) were measured and used for statistical analyses.",
        "Participants/Materials": "85 anatomical individuals in the Saitama Medical University Hospital, who died at ages from 50 to 103 years."
      },
      "MOLECULAR DATA": {
        "hum0181.v1.apcc.v1": {
          "Participants/Materials": "Anatomical cases who were more than 50 years old (50 to 103 years): 85 cases",
          "Targets": "-",
          "Organ/Tissue": "adrenal glands",
          "Immobilization method": "10% formalin",
          "Antigen activation method (temperature, reagent, PH, time)": "EnVision FLEX Kit, High pH (Agilent, ＃K8002)",
          "Blocking method (reagent, time)": "EnVision FLEX Kit, High pH (Agilent, ＃K8002)",
          "Primary antibodies for IHC（manufacturer, Cat. #, conc., temp., time）": "CYP11B2：CYPIIB2-4Ell-1G7 (in house antibody)\r\nHSD3B2：see ref2",
          "Secondary antibodies for IHC（manufacturer, Cat. #, conc., temp., time）": "CYP11B2：EnVision FLEX Kit, High pH (Agilent, ＃K8002)\r\nHSD3B2：EnVision FLEX Kit, High pH (Agilent, ＃K8002)",
          "Chromogen (reagent, time)": "EnVision FLEX Kit, High pH (Agilent, ＃K8002)",
          "Washing (reagent, time)": "EnVision FLEX Kit, High pH (Agilent, ＃K8002)",
          "NBDC Dataset ID": "hum0181.v1.apcc.v1\r\n  - Download files per staining\r\n    CYP11B2/HSD3B2/HE (about 50 GB each: 106 IHC images each)\r\n  - Download files per Case",
          "Total Data Volume": "147 GB (svs)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koshiro Nishimoto",
        "Affiliation": "Saitama Medical University International Medical Center, Department of UroOncology",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Okinaka Memorial Institute for Medical Research Grant",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Expression of aldosterone synthase cyp11b2 was inversely correlated with longevity.",
          "DOI": "doi: 10.1016/j.jsbmb.2019.04.010",
          "Data Set ID": "-"
        },
        "2": {
          "Title": "Development of monoclonal antibodies against the human 3beta-hydroxysteroid dehydrogenase/isomerase isozymes.",
          "DOI": "doi: 10.1016/j.steroids.2017.08.011",
          "Data Set ID": "-"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0181.v1": {
          "Research ID": "hum0181.v1",
          "Release Date": "2019/09/25",
          "Type of Data": "histological data (Immunostaining for CYP11B2, 3β-HSD, hematoxylin and eosin staining)",
          "description": "Archival adrenal gland were immunohistochemically analyzed using antibodies for aldosterone-synthase (CYP11B2) and 3β-hydroxysteroid dehydrogenase (3β-HSD). Histological data (immunostaining for CYP11B2, 3β-HSD, hematoxylin and eosin staining) were provided (svs files). \nNote：\n"
        }
      }
    }
  },
  "hum0180.v1": {
    "ja": {
      "NBDC Research ID": "hum0180.v1",
      "データ": {
        "JGAS000170": {
          "データID": "JGAS000170",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/12"
        }
      },
      "研究内容の概要": {
        "目的": "RNAスプライシング異常によって生じる疾患の遺伝子解析",
        "方法": "RNA-Seq",
        "対象": "家族性自律神経異常症の線維芽細胞",
        "URL": "http://www.anat1dadb.med.kyoto-u.ac.jp/"
      },
      "分子データ": {
        "JGAS000170": {
          "対象": "家族性自律神経異常症（ICD10：G90.1）：2症例（6検体）\r\n    2症例それぞれDMSO、RECTAS、TG003で処理",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "線維芽細胞より抽出したRNA",
          "検体情報（購入の場合）": "GM04663, GM04589, GM04899, GM02343, 41865, 41866, 35659, 35673, 35677, GM03987, GM04664, GM00850, GM02342, HD100CAU, HD100AA（Coriell研究所より分与）",
          "ライブラリ作製方法（キット名）": "Ion Total RNA-Seq Kit v2",
          "断片化の方法": "",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "",
          "クオリティコントロール方法": "",
          "重複するリードの除去": "",
          "リアライメントおよびベースクオリティのキャリブレーション": "",
          "マッピング方法": "",
          "リファレンス配列": "",
          "平均カバー率（Depth）": "",
          "遺伝子構造・新規の転写産物推定・発現量算出方法": "",
          "総リード数 / ユニークにマップされたリード数": "",
          "対象遺伝子数": "",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000248",
          "総データ量": "50 GB\r\n    Data ファイル数：6（fastq）\r\n    Analysis ファイル数：6（transcripts per million：TPM値 [txt]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "網代 将彦",
        "所 属 機 関": "京都大学大学院 医学研究科 創薬医薬講座",
        "プロジェクト/研究グループ名": "",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） ゲノム創薬基盤推進研究事業",
            "タイトル": "スプライシング操作化合物を対象としたファーマコゲノミクス解析に基づく遺伝性難病治療薬の開発研究",
            "研究課題番号": "JP18kk0305003"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia.",
          "DOI": "doi: 10.1038/s41467-021-24705-5",
          "データID": "JGAD000248"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000248"
        }
      },
      "リリース情報": {
        "hum0180.v1": {
          "Research ID": "hum0180.v1",
          "公開日": "2021/03/12",
          "内容": "NGS（RNA-seq）",
          "description": "Coriell研究所から分与された家族性自律神経異常症２症例の線維芽細胞から抽出したRNAを対象としたRNA-seq解析データをfastqファイルおよびテキスト形式（transcripts per million：TPM値）にて提供する。Ion Total RNA-Seq Kit v2によるRNAライブラリ作製後、Ion Proton（Thermo Fisher Scientific）にて配列を読んだ（Single-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0180.v1",
      "DATA": {
        "JGAS000170": {
          "Data Set ID": "JGAS000170",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/12"
        }
      },
      "SUMMARY": {
        "Aims": "Gene expression analysis of diseases caused by abnormal RNA splicing",
        "Methods": "RNA-Seq for a cellular RNA",
        "Participants/Materials": "Familial Dysautonomia",
        "URL": "http://www.anat1dadb.med.kyoto-u.ac.jp/?lang=en"
      },
      "MOLECULAR DATA": {
        "JGAS000170": {
          "Participants/Materials": "Familial Dysautonomia (ICD10: G90.1): 2 cases (6 samples)\r\n    under DMSO, RECTAS and TG003 treatment",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "GM04663, GM04589, GM04899, GM02343, 41865, 41866, 35659, 35673, 35677, GM03987, GM04664, GM00850, GM02342, HD100CAU, HD100AA (provided by Coriell institute)",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "RNAs extracted from fibroblasts",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion Total RNA-Seq Kit v2",
          "Fragmentation Methods": "",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "",
          "QC": "",
          "Deduplication": "",
          "Calibration of re-alignment and base quality": "",
          "Mapping Methods": "",
          "Reference Genome Sequence": "",
          "Coverage (Depth)": "",
          "Detecting Methods for Transcripts": "",
          "Total Reads / Uniquely Mapped Reads": "",
          "Gene Numbers": "",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000248",
          "Total Data Volume": "50 GB\r\n    Data files: 6 (fastq)\r\n    Analysis files: 6 (transcripts per million: TPM [txt])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masahiko Ajiro",
        "Affiliation": "Department of Drug Discovery Medicine, Kyoto University Graduate School of Medicine",
        "Project / Group Name": "",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Program for Promoting Platform of Genomics based Drug Discovery, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Development of genetic disease medicine by pharmacogenomics analysis ofspliceswitching compounds",
            "Project Number": "JP18kk0305003"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia.",
          "DOI": "doi: 10.1038/s41467-021-24705-5",
          "Data Set ID": "JGAD000248"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000248"
        }
      },
      "Release Note": {
        "hum0180.v1": {
          "Research ID": "hum0180.v1",
          "Release Date": "2021/03/12",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from fibroblasts of 2 Familial Dysautonomia cases provided by Coriell institute were used for RNA-seq analysis. Libraries for RNA-seq were prepared with Ion Total RNA-Seq Kit v2 and RNA-seq was performed by using of Thermo Fisher Scientific [Ion Proton] (Single-end). Fastq files and txt files (transcripts per million: TPM) are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0179.v1": {
    "ja": {
      "NBDC Research ID": "hum0179.v1",
      "データ": {
        "JGAS000186": {
          "データID": "JGAS000186",
          "内容": "メタゲノム",
          "制限": "制限公開（Type I）",
          "公開日": "2020/04/03"
        },
        "DRA009794": {
          "データID": "DRA009794",
          "内容": "メタゲノム（ヒト配列除去済み）",
          "制限": "非制限公開",
          "公開日": "2020/04/03"
        }
      },
      "研究内容の概要": {
        "目的": "ロングリードデータにより、口腔内細菌叢・ファージ叢に関する理解がどれだけ深まるかを検討する",
        "方法": "保存キット（OMNIgeneORAL OM-501）で保存された唾液から酵素法にて抽出したbulk DNAを用いたPromethION（１フローセルにつき１サンプル）によるショットガンメタゲノム解読",
        "対象": "日本人集団の唾液",
        "URL": "http://neo-virology.org/"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000186 / DRA009794": {
          "対象": "健常者：4名",
          "規模": "メタゲノム",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "１．Nanopore [PromethION]\r\n２．Illumina [HiSeq]",
          "ライブラリソース": "唾液より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "１．ligation sequencing kit（SQK-LSK109）\r\n２．Nextera XT",
          "断片化の方法": "-",
          "ライブラリ構築方法": "１．Single-end\r\n２．Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "１．可変, 平均13kb\r\n２．300 bp",
          "ヒト配列除去方法": "EDGE pipeline",
          "DDBJ Sequence Read Archive ID": "DRA009794",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000268",
          "総データ量": "１．473 GB（fastq、txt）\r\n２．186 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "矢原 耕史",
        "所 属 機 関": "国立感染症研究所・薬剤耐性研究センター",
        "プロジェクト/研究グループ名": "新学術領域「ネオウイルス学」",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Long-read metagenomics using PromethION uncovers novel oral bacteriophages, their abundance, and interaction with host bacteria",
          "DOI": "doi: 10.1038/s41467-020-20199-9",
          "データID": "JGAS000186DRA009794"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0179.v1": {
          "Research ID": "hum0179.v1",
          "公開日": "2020/04/03",
          "内容": "メタゲノム",
          "description": "健常人4名の唾液からDNAを抽出し、PromethIONによるロングリードシークエンスを行った。配列データ（fastq）と得られたリードの詳細情報（txt）を提供する（JGAD000268）。併せて、ヒト配列を除去したメタゲノム配列情報を非制限公開データとして提供する（DRA009794）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0179.v1",
      "DATA": {
        "JGAS000186": {
          "Data Set ID": "JGAS000186",
          "Type of Data": "Metagenome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/04/03"
        },
        "DRA009794": {
          "Data Set ID": "DRA009794",
          "Type of Data": "Metagenome",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/04/03"
        }
      },
      "SUMMARY": {
        "Aims": "To reveal to what extent long-read data of PromethION deeps our understanding of oral microbiome and virome",
        "Methods": "Shutgun metagenome sequencing of bulk DNA extracted from saliva stored in OMNIgeneORAL OM-501 using a enzymatic method",
        "Participants/Materials": "Saliva of Japanese healthy individuals",
        "URL": "http://neo-virology.org/en/"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by \"Genome Science\". \"Genome Science\" is a part of the \"Support Programs for Three Fields in Life Sciences (cancer, genome, and brain sciences)\" established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000186 / DRA009794": {
          "Participants/Materials:": "4 healthy individuals",
          "Targets": "Metagenome",
          "Target Loci for Capture Methods": "-",
          "Platform": "1. Nanopore [PromethION]\r\n2. Illumina [HiSeq]",
          "Library Source": "DNA extracted from saliva",
          "Cell Lines": "-",
          "Library Construction (kit name)": "1. ligation sequencing kit (SQK-LSK109)\r\n2. Nextera XT",
          "Fragmentation Methods": "-",
          "Spot Type": "1. Single-end\r\n2. Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "1. variable, 13kb on average\r\n2. 300 bp",
          "Human Sequence removal Methods": "EDGE pipeline",
          "DDBJ Sequence Read Archive ID": "DRA009794",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000268",
          "Total Data Volume": "1. 473 GB (fastq, txt)\r\n2. 186 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koji Yahara",
        "Affiliation": "Antimicrobial Resistance Research Center, National Institute of Infectious Diseases",
        "Project / Group Name": "Neo-virology",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Long-read metagenomics using PromethION uncovers novel oral bacteriophages, their abundance, and interaction with host bacteria",
          "DOI": "doi: 10.1038/s41467-020-20199-9",
          "Data Set ID": "JGAS000186DRA009794"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0179.v1": {
          "Research ID": "hum0179.v1",
          "Release Date": "2020/04/03",
          "Type of Data": "Metagenome",
          "description": "A long-read metagenome sequencing of bulk DNA extracted from saliva was performed by using of PromethION. Fastq files and sequencing summary data (txt) are provided (JGAD000268). Additionally, metagenome sequence data without human sequence are also provided as an unrestricted-access data (DRA009794).\nNote：\n"
        }
      }
    }
  },
  "hum0177.v1": {
    "ja": {
      "NBDC Research ID": "hum0177.v1",
      "データ": {
        "JGAS000197": {
          "データID": "JGAS000197",
          "内容": "NGS（PBAT-seq、RNA-seq、ChIP-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/04/27"
        }
      },
      "研究内容の概要": {
        "目的": "H3F3A遺伝子変異をもつ悪性神経膠腫におけるDNAメチル化解析",
        "方法": "悪性神経膠腫症例の腫瘍組織から抽出したDNA・RNAを用いたPBAT-seq（14症例＋細胞株1種）、RNA-seq（14症例中の5症例＋細胞株1種）およびChIP-seq（細胞株1種）",
        "対象": "悪性神経膠腫"
      },
      "分子データ": {
        "PBAT-seq": {
          "対象": "悪性神経膠腫（ICD10：C71.9）：14症例＋細胞株1種",
          "規模": "PBAT-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "悪性神経膠腫の腫瘍組織および細胞株から抽出したDNA",
          "検体情報（購入の場合）": "IFO50356（JCRB）",
          "ライブラリ作製方法（キット名）": "TACS ligation-mediated PBAT*ref1",
          "断片化の方法": "超音波断片化（Covaris S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000280",
          "総データ量": "1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "悪性神経膠腫（ICD10：C71.9）：5症例＋細胞株：1種",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "悪性神経膠腫の腫瘍組織および細胞株から抽出したRNA",
          "検体情報（購入の場合）": "IFO50356（JCRB）",
          "ライブラリ作製方法（キット名）": "TruSeq stranded mRNA Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000281",
          "総データ量": "1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ChIP-seq": {
          "対象": "悪性神経膠腫（ICD10：C71.9）細胞株：1種",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "悪性神経膠腫細胞株（全細胞溶解液[コントロール]1検体、免疫沈降2検体）から抽出したDNA\r\n免疫沈降：ウサギモノクローナル抗体（抗H3.3抗体、抗H3.3 G34V抗体）",
          "検体情報（購入の場合）": "IFO50356（JCRB）",
          "ライブラリ作製方法（キット名）": "SMARTer ThruPLEX DNA-seq Kit",
          "断片化の方法": "超音波断片化（Covaris S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000282",
          "総データ量": "1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "伊藤 隆司",
        "所 属 機 関": "九州大学大学院医学研究院 医化学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究（研究領域提案型）",
            "タイトル": "次世代エピゲノム解析技術の開発とその応用",
            "研究課題番号": "17H06305"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Highly efficient single-stranded DNA ligation technique improves low-input whole-genome bisulfite sequencing by post-bisulfite adaptor tagging",
          "DOI": "doi: 10.1093/nar/gkz435",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000281"
        }
      },
      "リリース情報": {
        "hum0177.v1": {
          "Research ID": "hum0177.v1",
          "公開日": "2020/04/27",
          "内容": "NGS（PBAT-seq、RNA-seq、ChIP-seq）",
          "description": "・PBAT-seq\nこのバージョンでは、悪性神経膠腫14症例の腫瘍組織および細胞株1種から抽出したDNAを用いたPBAT-seq解析の結果をfastqファイルにて提供する。TACS ligation-mediated PBAT（Miura F, Nucleic Acids Res. 2019）によるライブラリ作製後、Hiseq X Ten（Illumina）によりシークエンシングを行っている。\n・RNA-seq\nこのバージョンでは、悪性神経膠腫5症例の腫瘍組織および細胞株1種から抽出したRNAを用いたRNA-seq解析の結果をfastqファイルにて提供する。TruSeq stranded mRNA Kitによるライブラリ作製後、NovaSeq 6000（Illumina）によりシークエンシングを行っている。\n・ChIP-seq\nこのバージョンでは、悪性神経膠腫細胞株1種から抽出したDNAを用いたChIP-seq解析の結果をfastqファイルにて提供する。SMARTer ThruPLEX DNA-seq Kitおよび抗H3.3抗体および抗H3.3 G34V抗体を用いた免疫沈降によりライブラリを作製し、NovaSeq 6000（Illumina）によりシークエンシングを行っている。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0177.v1",
      "DATA": {
        "JGAS000197": {
          "Data Set ID": "JGAS000197",
          "Type of Data": "NGS (PBAT-seq, RNA-seq, ChIP-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/04/27"
        }
      },
      "SUMMARY": {
        "Aims": "DNA methylome analyses and expression analysis for malignant glioma harbouring H3F3A gene mutation",
        "Methods": "PBAT-seq, RNA-seq and ChIP-seq",
        "Participants/Materials": "14 Malignant glioma patients and 1 cell line"
      },
      "MOLECULAR DATA": {
        "PBAT-seq": {
          "Participants/Materials:": "Malignant glioma (ICD10: C71.9): 14 cases + 1 cell line",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "DNAs extracted from tumor tissues of malignant glioma and a cell line",
          "Cell Lines": "IFO50356 (JCRB)",
          "Library Construction (kit name)": "TACS ligation-mediated PBAT*ref1",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000280",
          "Total Data Volume": "1 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials:": "Malignant glioma (ICD10: C71.9): 5 cases + 1 cell line",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from tumor tissues of malignant glioma and a cell line",
          "Cell Lines": "IFO50356 (JCRB)",
          "Library Construction (kit name)": "TruSeq stranded mRNA Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000281",
          "Total Data Volume": "1 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "ChIP-seq": {
          "Participants/Materials:": "1 Cell line of malignant glioma (ICD10: C71.9)",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from a cell line of malignant glioma (1 control [whole cell lysate] and 2 immunoprecipitation samples). Anti- histone H3.3 rabbit monoclonal antibody and anti- histone H3.3 G34V rabbit monoclonal antibody were used for immunoprecipitation.",
          "Cell Lines": "IFO50356 (JCRB)",
          "Library Construction (kit name)": "SMARTer ThruPLEX DNA-seq Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000282",
          "Total Data Volume": "1 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takashi Ito",
        "Affiliation": "Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Priority Areas (Research in a proposed research area)",
            "Title": "Development and applications of next generation epigenome analysis technologies",
            "Project Number": "17H06305"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Highly efficient single-stranded DNA ligation technique improves low-input whole-genome bisulfite sequencing by post-bisulfite adaptor tagging",
          "DOI": "doi: 10.1093/nar/gkz435",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000281"
        }
      },
      "Release Note": {
        "hum0177.v1": {
          "Research ID": "hum0177.v1",
          "Release Date": "2020/04/27",
          "Type of Data": "NGS (PBAT-seq, RNA-seq, ChIP-seq)",
          "description": "- PBAT-seq\nDNAs extracted from tumor tissues of malignant glioma and cell line were used for PBAT-sequencing analysis (fastq format files). Libraries were prepared with TACS ligation-mediated PBAT (Miura F, Nucleic Acids Res. 2019) and sequenced using Hiseq X Ten (Illumina).\n- RNA-seq\nRNAs extracted from tumor tissues of malignant glioma and cell line were used for RNA-sequencing analysis (fastq format files). Libraries were prepared with TruSeq stranded mRNA Kit and sequenced using NovaSeq 6000 (Illumina). \n- ChIP-seq\nDNAs extracted from cell line of malignant glioma were used for ChIP sequencing analysis (fastq format files). Libraries were prepared with SMARTer ThruPLEX DNA-seq Kit. Anti- H3.3 antibody and anti- H3.3 G34V antibody were used for immunoprecipitation. ChIP-Seq libraries were sequenced using NovaSeq 6000 (Illumina).\nNote：\n"
        }
      }
    }
  },
  "hum0176.v1": {
    "ja": {
      "NBDC Research ID": "hum0176.v1",
      "データ": {
        "JGAS000172": {
          "データID": "JGAS000172",
          "内容": "NGS（Exome、Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/10/02"
        }
      },
      "研究内容の概要": {
        "目的": "子宮及び卵巣がん肉腫におけるドライバー変異の体系的探索",
        "方法": "Illumina HiSeq 2000を使用した Exome / Target Capture解析",
        "対象": "子宮がん肉腫92症例、卵巣がん肉腫17症例の正常組織（非腫瘍組織）と原発巣の腫瘍組織",
        "URL": "http://genomeportal.jfcr.or.jp"
      },
      "分子データ": {
        "Exome": {
          "対象": "子宮がん肉腫（ICD10：C549）：1症例（2検体）\r\n卵巣がん肉腫（ICD10：C56）：3症例（6検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V4 or V5",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000250",
          "総データ量": "646 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture": {
          "対象": "子宮がん肉腫（ICD10：C549）：91症例（182検体）\r\n卵巣がん肉腫（ICD10：C56）：14症例（28検体）",
          "規模": "Target Capture (CS-A, CS-B)",
          "対象領域（Target Captureの場合）": "CS-A: 491 genes, 2.605 Mbps\r\nCS-B: 114 genes, 422.9 kbps",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT Custom",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000250",
          "総データ量": "646 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "森 誠一",
        "所 属 機 関": "がんプレシジョン医療研究センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "5": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "子宮・卵巣癌肉腫の悪性度・予後に寄与するがん免疫微小環境の解析",
            "研究課題番号": "18K07338"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "万代 昌紀": {
          "研究代表者": "万代 昌紀",
          "所属機関": "京都大学医学部医学研究科 婦人科学産科学教室",
          "研究題目": "",
          "利用データID": "多様な臨床情報を考慮した婦人科悪性腫瘍患者の尾ミックス解析（全ゲノム・全トランスクリプト-ム・プロテオーム・メタボローム解析）による個別化治療の探索",
          "利用期間": "JGAD000250"
        },
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000250"
        }
      },
      "リリース情報": {
        "hum0176.v1": {
          "Research ID": "hum0176.v1",
          "公開日": "2019/10/02",
          "内容": "NGS（Exome、Target Capture）",
          "description": "子宮がん肉腫92症例（184検体）、卵巣がん肉腫17症例（34検体）の正常組織（非腫瘍組織）と原発巣の腫瘍組織から抽出したDNAを用いたExome解析およびTarget Capture解析結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0176.v1",
      "DATA": {
        "JGAS000172": {
          "Data Set ID": "JGAS000172",
          "Type of Data": "NGS (Exome, Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/10/02"
        }
      },
      "SUMMARY": {
        "Aims": "Comprehensive sequencing analyses of uterine and ovarian carcinosarcoma",
        "Methods": "Exome / target caputer analysis by using Illumina Hiseq 2000",
        "Participants/Materials": "109 primary tumor and mached normal (non-tumor) tissues from uterin or ovarian carcinosarcoma patients"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "Uterine carcinosarcoma (ICD10: C549): 1 case (2 samples)\r\nOvarian carcinosarcoma (ICD10: C56): 3 case (6 samples)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from tumor and paired non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V4 or V5",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000250",
          "Total Data Volume": "646 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture": {
          "Participants/Materials": "Uterine carcinosarcoma (ICD10: C549): 91 case (182 samples)\r\nOvarian carcinosarcoma (ICD10: C56): 14 case (28 samples)",
          "Targets": "Target Capture (CS-A, CS-B)",
          "Target Loci for Capture Methods": "CS-A: 491 genes, 2.605 Mbps\r\nCS-B: 114 genes, 422.9 kbps",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from tumor and paired non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT Custom",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000250",
          "Total Data Volume": "646 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Seiichi Mori",
        "Affiliation": "Cancer Precison Medicine Center",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "5": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Immune microenvironment analyses of uterine and ovarian carcinosarcoma.",
            "Project Number": "18K07338"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Masaki Mandai": {
          "Principal Investigator": "Masaki Mandai",
          "Affiliation": "Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000250"
        },
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Integrated analyses of omics (genomics, transcriptomics, proteomics and metabolomics) associated with clinical variables for developing indivisualizedtreatment in gynecological malignancy",
          "Period of Data Use": "JGAD000250"
        }
      },
      "Release Note": {
        "hum0176.v1": {
          "Research ID": "hum0176.v1",
          "Release Date": "2019/10/02",
          "Type of Data": "NGS (Exome, Target Capture)",
          "description": "DNAs extracted from primary tumor and mached normal (non-tumor) tissues of uterin and ovarian carcinosarcoma were used for the whole exome sequencing analysis and target capture sequencing analysis (fastq files).\nNote：\n"
        }
      }
    }
  },
  "hum0175.v1": {
    "ja": {
      "NBDC Research ID": "hum0175.v1",
      "データ": {
        "JGAS000174": {
          "データID": "JGAS000174",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/10/02"
        }
      },
      "研究内容の概要": {
        "目的": "患者層別化のための新規バイオマーカーや治療抵抗性にかかわる関連分子を標的とした新規治療法の開発",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "子宮類内膜腺がん69症例の原発巣腫瘍組織および非腫瘍組織",
        "URL": "http://genomeportal.jfcr.or.jp"
      },
      "分子データ": {
        "JGAS000174": {
          "対象": "子宮類内膜腺がん（ICD10：C541）：69症例\r\n（原発巣腫瘍組織：118検体、非腫瘍組織：69検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "腫瘍組織と非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V4 or V5",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000254",
          "総データ量": "5 TB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "竹島 信宏",
        "所 属 機 関": "がん研有明病院 婦人科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "5": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "子宮・卵巣癌肉腫の悪性度・予後に寄与するがん免疫微小環境の解析",
            "研究課題番号": "18K07338"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma.",
          "DOI": "doi: 10.1016/j.ajpath.2019.09.022",
          "データID": "JGAD000254"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "万代 昌紀": {
          "研究代表者": "万代 昌紀",
          "所属機関": "京都大学医学部医学研究科 婦人科学産科学教室",
          "研究題目": "",
          "利用データID": "多様な臨床情報を考慮した婦人科悪性腫瘍患者の尾ミックス解析（全ゲノム・全トランスクリプト-ム・プロテオーム・メタボローム解析）による個別化治療の探索",
          "利用期間": "JGAD000254"
        }
      },
      "リリース情報": {
        "hum0175.v1": {
          "Research ID": "hum0175.v1",
          "公開日": "2019/10/02",
          "内容": "NGS（Exome）",
          "description": "子宮類内膜腺がん69症例の原発巣腫瘍組織（118検体）および非腫瘍組織（69検体）（計187検体）から抽出したDNAを用いたExome解析の結果をfastqファイルにて提供する。SureSelect Human All Exon V4またはV5によりExon領域にしぼり、Illumina HiSeq 2000にて平均長101塩基を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0175.v1",
      "DATA": {
        "JGAS000174": {
          "Data Set ID": "JGAS000174",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/10/02"
        }
      },
      "SUMMARY": {
        "Aims": "Development of actionable molecular targets and/or biomarkers for prognostication and patient stratification",
        "Methods": "Exome analysis by using Illumina HiSeq 2000",
        "Participants/Materials": "primary tumor tissues and non-tumor tissues from 69 endometrial carcinoma patients"
      },
      "MOLECULAR DATA": {
        "JGAS000174": {
          "Participants/Materials": "Endometrial carcinoma (ICD10: C541): 69 cases\r\n(tumor tissues: 118 samples, non-tumor tissues: 69 samples)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from tumor or non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V4 or V5",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000254",
          "Total Data Volume": "5 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Nobuhiro Takeshima",
        "Affiliation": "The Cancer Institute Hospital of JFCR",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "5": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Immune microenvironment analyses of uterine and ovarian carcinosarcoma.",
            "Project Number": "18K07338"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma.",
          "DOI": "doi: 10.1016/j.ajpath.2019.09.022",
          "Data Set ID": "JGAD000254"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Masaki Mandai": {
          "Principal Investigator": "Masaki Mandai",
          "Affiliation": "Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Integrated analyses of omics (genomics, transcriptomics, proteomics and metabolomics) associated with clinical variables for developing indivisualizedtreatment in gynecological malignancy",
          "Period of Data Use": "JGAD000254"
        }
      },
      "Release Note": {
        "hum0175.v1": {
          "Research ID": "hum0175.v1",
          "Release Date": "2019/10/02",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor or non-tumor tissues from 69 cases of endometrial carcinoma were used for the whole exome sequencing (fastq files). Exons were narrowed down by using of SureSelect Human All Exon V4 or V5 and read by Illumina HiSeq 2000 (Paired-end: 101 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0174.v5": {
    "ja": {
      "NBDC Research ID": "hum0174.v5",
      "データ": {
        "JGAS000173": {
          "データID": "JGAS000173",
          "内容": "NGS（WGS）：Sequence raw data、サンプルごとのStructural Variantsデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2020/10/06"
        },
        "JGAS000173（データ追加）": {
          "データID": "JGAS000173（データ追加）",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/11/27"
        },
        "JGAS000580": {
          "データID": "JGAS000580",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/06/29"
        },
        "JGAS000286": {
          "データID": "JGAS000286",
          "内容": "NGS（WGS）：Sequence raw data、サンプルごとのStructural Variantsデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2023/07/06"
        },
        "JGAS000505": {
          "データID": "JGAS000505",
          "内容": "NGS（WGS）：Sequence raw data、一部サンプルごとのhaplotypeデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2023/07/10"
        }
      },
      "研究内容の概要": {
        "目的": "日本人ゲノムにおける構造変異の多様性をデータベース化する",
        "方法": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプルをPacBio Sequel/Sequel II、10X Chromium、およびNanopore PromethIONによりシークエンスし、構造変異の解析を行った。",
        "対象": "日本人由来B細胞株・DNAバンク（医薬基盤・健康・栄養研究所）から分譲されたサンプル、合計10検体＋11検体＋177検体＋141検体"
      },
      "分子データ": {
        "JGAS000173": {
          "対象": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル：10検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "１．PacBio [Sequel]\r\n２．10x Genomics [Chromium Controller]",
          "ライブラリソース": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル",
          "検体情報（購入の場合）": "日本人由来B細胞株・DNAバンク（医薬基盤・健康・栄養研究所）\r\nhttps://bioresource.nibiohn.go.jp/psc/",
          "ライブラリ作製方法（キット名）": "１．the library prep. kit for SMRT sequencing by Pacific Biosciences\r\n２．10X Genomics-Chromium system",
          "断片化の方法": "１．Megaruptor, g-tube\r\n２．None",
          "ライブラリ構築方法": "１．Single-end\r\n２．Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "１．14000 bp\r\n２．151 bp",
          "QC方法": "１．Qubit, Pulsed-field gel electrophoresis, TapeStation, Bioanalyzer\r\n２．qPCR, Bioanalyzer",
          "マッピング方法": "１．minimap2\r\n２．longranger by 10X Genomics",
          "平均カバー率（Depth）": "１．29x\r\n２．19x",
          "構造変異検出方法": "１．Sniffles\r\n２．longranger by 10X Genomics",
          "構造多型数": "１．16870/sample\r\n２．5100/sample",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000251",
          "総データ量": "1 TB（fastq, bam [ref: unmapped], bed, vcf [ref: hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000173（データ追加）": {
          "対象": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル：11検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "PacBio [Sequel]",
          "ライブラリソース": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル",
          "検体情報（購入の場合）": "日本人由来B細胞株・DNAバンク（医薬基盤・健康・栄養研究所）\r\nhttps://bioresource.nibiohn.go.jp/psc/",
          "ライブラリ作製方法（キット名）": "the library prep. kit for SMRT sequencing by Pacific Biosciences",
          "断片化の方法": "Megaruptor, g-tube",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "14000 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000251",
          "総データ量": "3.44 TB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000580": {
          "対象": "日本人由来B細胞株・DNAバンクから分譲されたB細胞より抽出したDNAサンプル：1検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "MHC、LRC、Chr1、SMN1/SMN2領域",
          "Platform": "Nanopore [PromethION]",
          "ライブラリソース": "日本人由来B細胞株・DNAバンクから分譲されたB細胞1検体より抽出したDNAサンプル",
          "検体情報（購入の場合）": "日本人由来B細胞株・DNAバンク（医薬基盤・健康・栄養研究所）\r\nhttps://bioresource.nibiohn.go.jp/psc/",
          "ライブラリ作製方法（キット名）": "Ultra-Long DNA Sequencing Kit（SQK-ULK001）",
          "断片化の方法": "トランスポゼースを用いた断片化",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "56.2 Kbp〜63.8 Kbp（N50）",
          "マッピング方法": "minimap2（v2.24）with \"-x map-ont\"",
          "マッピングクオリティ": "-",
          "マッピングの際のリファレンス配列": "T2T-CHM13v2.0",
          "平均カバー率（Depth）": "81x〜104 x（median）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000706",
          "総データ量": "1.4 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000286": {
          "対象": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル：177検体\r\n    （CCS：112検体、CLR：65検体）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "PacBio [Sequel、Sequel II]",
          "ライブラリソース": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル",
          "検体情報（購入の場合）": "日本人由来B細胞株・DNAバンク（医薬基盤・健康・栄養研究所）\r\nhttps://bioresource.nibiohn.go.jp/psc/",
          "ライブラリ作製方法（キット名）": "the library prep. kit for SMRT sequencing by Pacific Biosciences",
          "断片化の方法": "Megaruptor, g-tube",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "14000 bp",
          "QC方法": "Qubit, Pulsed-field gel electrophoresis, TapeStation, Bioanalyzer",
          "マッピング方法": "minimap2（hg38-no_alt）",
          "平均カバー率（Depth）": "CCS：9.5 x\r\nCLR：36 x",
          "SNVコール": "DeepVariant",
          "SNVハプロタイピング": "WhatsHap",
          "構造変異検出方法": "pbsv",
          "２倍体アセンブリ": "HiCanu",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000392",
          "総データ量": "31.8 TB（bam、vcf、fasta）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000505": {
          "対象": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル：177検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "PacBio [Sequel II]",
          "ライブラリソース": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル",
          "検体情報（購入の場合）": "日本人由来B細胞株・DNAバンク（医薬基盤・健康・栄養研究所）\r\nhttps://bioresource.nibiohn.go.jp/psc/",
          "ライブラリ作製方法（キット名）": "the library prep. kit for SMRT sequencing by Pacific Biosciences",
          "断片化の方法": "Megaruptor",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "14,949 bp",
          "QC方法": "Qubit, NanoDrop, TapeStation, Femto Pulse, Pulsed-field gel electrophoresis",
          "マッピング方法": "minimap2（hg38-no_alt）",
          "平均カバー率（Depth）": "CCS：9.06x",
          "SNVコール": "DeepVariant",
          "SNVハプロタイピング": "WhatsHap",
          "構造変異検出方法": "pbsv",
          "２倍体アセンブリ": "HiCanu",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000622",
          "総データ量": "7.5 TB（30検体：bam、vcf、contig_fasta、147検体：fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "森下 真一",
        "所 属 機 関": "東京大学大学院新領域創成科学研究科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Rapid and ongoing evolution of repetitive sequence structures in human centromeres.",
          "DOI": "doi: 10.1126/sciadv.abd9230",
          "データID": "JGAD000251"
        },
        "2": {
          "タイトル": "JTK: targeted diploid genome assembler",
          "DOI": "doi: 10.1093/bioinformatics/btad398",
          "データID": "JGAD000706"
        },
        "3": {
          "タイトル": "A landscape of complex tandem repeats within individual human genomes",
          "DOI": "doi: 10.1038/s41467-023-41262-1",
          "データID": "JGAD000392JGAD000622"
        }
      },
      "制限公開データの利用者一覧": {
        "高地 雄太": {
          "研究代表者": "高地 雄太",
          "所属機関": "東京医科歯科大学 難治疾患研究所 ゲノム機能多様性分野",
          "研究題目": "日本",
          "利用データID": "機能性遺伝子多型の網羅的解析を介した多因子疾患の病態解明",
          "利用期間": "JGAD000251"
        }
      },
      "リリース情報": {
        "hum0174.v5": {
          "Research ID": "hum0174.v5",
          "公開日": "2023/07/10",
          "内容": "NGS（WGS）",
          "description": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル177検体を用いた、PacBio [Sequel II]によるLong Read Whole Genome Sequencingデータ（30検体については、bam [アライメント、HiFiリード]、fasta [アセンブルコンティグ]、vcf [SNV/structural variations/SNP haplotype]、147検体についてはfastq）を提供する。\n"
        },
        "hum0174.v4": {
          "Research ID": "hum0174.v4",
          "公開日": "2023/07/06",
          "内容": "NGS（WGS）",
          "description": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル177検体を用いた、PacBio [Sequel、Sequel II]によるLong Read Whole Genome Sequencingデータ（bam、fasta）、およびStructural Variantsデータ（vcf）を提供する。\n"
        },
        "hum0174.v3": {
          "Research ID": "hum0174.v3",
          "公開日": "2023/06/29",
          "内容": "NGS（WGS）",
          "description": "日本人由来B細胞株・DNAバンクから分譲されたB細胞1検体より抽出したDNAサンプルを用いた、 Nanopore [PromethION]によるLong Read Whole Genome Sequencingデータ（bam）を提供する。\n"
        },
        "hum0174.v2": {
          "Research ID": "hum0174.v2",
          "公開日": "2020/11/27",
          "内容": "NGS（WGS）",
          "description": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル11検体を用いた、PacBio [Sequel]によるLong Read Whole Genome Sequencingデータ（bam）を提供する。\n"
        },
        "hum0174.v1": {
          "Research ID": "hum0174.v1",
          "公開日": "2020/10/06",
          "内容": "NGS（WGS）",
          "description": "日本人由来B細胞株・DNAバンクから分譲されたDNAサンプル10検体を用いた、PacBio [Sequel]、10x Genomics [Chromium Controller]によるLong Read Whole Genome Sequencingデータ（fastq, bam）、およびStructural Variantsデータ（vcf, bed）を提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0174.v5",
      "DATA": {
        "JGAS000173": {
          "Data Set ID": "JGAS000173",
          "Type of Data": "NGS (WGS): Sequence raw data, Structural Variants data for each sample",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/10/06"
        },
        "JGAS000173 (Data addition)": {
          "Data Set ID": "JGAS000173 (Data addition)",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/11/27"
        },
        "JGAS000580": {
          "Data Set ID": "JGAS000580",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/06/29"
        },
        "JGAS000286": {
          "Data Set ID": "JGAS000286",
          "Type of Data": "NGS (WGS): Sequence raw data, Structural Variants data for each sample",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/07/06"
        },
        "JGAS000505": {
          "Data Set ID": "JGAS000505",
          "Type of Data": "NGS (WGS): Sequence raw data, haplotype data for each sample",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/07/10"
        }
      },
      "SUMMARY": {
        "Aims": "To build a database of genomic structural variants in Japanese population",
        "Methods": "We sequenced genomic DNAs using PacBio, 10X Genomics and Nanopore sequencing technologies, and analyzed genomic structural variations.",
        "Participants/Materials": "Japanese (collected by Japanese B cell DNA bank)"
      },
      "MOLECULAR DATA": {
        "JGAS000173": {
          "Participants/Materials:": "Purified DNA from Japanese-origin B cell lines: 10 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "1. PacBio [Sequel]\r\n2. 10x Genomics [Chromium Controller]",
          "Library Source": "Purified DNA from Japanese-origin B cell lines",
          "Cell Lines": "the Health Science Research Resources Bank (HSRRB), the National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)",
          "Library Construction (kit name)": "1. the library prep. kit for SMRT sequencing by Pacific Biosciences\r\n2. 10X Genomics-Chromium system",
          "Fragmentation Methods": "1. Megaruptor, g-tube\r\n2. None",
          "Spot Type": "1. Single-end\r\n2. Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "1. 14000 bp\r\n2. 151 bp",
          "QC Methods": "1. Qubit, Pulsed-field gel electrophoresis, TapeStation, Bioanalyzer\r\n2. qPCR, Bioanalyzer",
          "Mapping Methods": "1. minimap2\r\n2. longranger by 10X Genomics",
          "Depth (average)": "1. 29x\r\n2. 19x",
          "Structural Variants Detection Methods": "1. Sniffles\r\n2. longranger by 10X Genomics",
          "Polymorphism Number (after QC)": "1. 16870/sample\r\n2. 11700/sample",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000251",
          "Total Data Volume": "1 TB (fastq, bam [ref: unmapped], bed, vcf [ref: hg38])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000173 (Data addition)": {
          "Participants/Materials:": "Purified DNA from Japanese-origin B cell liens: 11 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "PacBio [Sequel]",
          "Library Source": "Purified DNA from Japanese-origin B cell lines",
          "Cell Lines": "the Health Science Research Resources Bank (HSRRB), the National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)",
          "Library Construction (kit name)": "the library prep. kit for SMRT sequencing by Pacific Biosciences",
          "Fragmentation Methods": "Megaruptor, g-tube",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "14000 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000251",
          "Total Data Volume": "3.44 TB (bam)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000580": {
          "Participants/Materials:": "Purified DNA from Japanese-origin B cell liens: 1 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "MHC, LRC, Chr1, SMN1/SMN2",
          "Platform": "Nanopore [PromethION]",
          "Library Source": "Purified DNA from Japanese-origin B cell lines",
          "Cell Lines": "the Health Science Research Resources Bank (HSRRB), the National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)",
          "Library Construction (kit name)": "Ultra-Long DNA Sequencing Kit (SQK-ULK001)",
          "Fragmentation Methods": "Transposase-based",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "56.2 Kbp ~ 63.8 Kbp (N50)",
          "Mapping Methods": "minimap2 (v2.24) with \"-x map-ont\"",
          "Mapping Quality": "-",
          "Reference Genome Sequence": "T2T-CHM13v2.0",
          "Coverage (Depth)": "81x ~ 104x (median)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000706",
          "Total Data Volume": "1.4 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000286": {
          "Participants/Materials:": "Purified DNA from Japanese-origin B cell lines: 177 samples\r\n    (CCS: 112 samples, CLR: 65 samples)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "PacBio [Sequel, Sequel II]",
          "Library Source": "Purified DNA from Japanese-origin B cell lines",
          "Cell Lines": "the Health Science Research Resources Bank (HSRRB), the National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)",
          "Library Construction (kit name)": "the library prep. kit for SMRT sequencing by Pacific Biosciences",
          "Fragmentation Methods": "Megaruptor, g-tube",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "14000 bp",
          "QC Methods": "Qubit, Pulsed-field gel electrophoresis, TapeStation, Bioanalyzer",
          "Mapping Methods": "minimap2",
          "Depth (average)": "CCS: 9.5x\r\nCLR: 36x",
          "SNV Call": "DeepVariant",
          "SNV Haplotyping": "WhatsHap",
          "Structural Variants Detection Methods": "pbsv",
          "diploid assembly": "HiCanu",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000392",
          "Total Data Volume": "31.8 TB (bam, vcf, fasta)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000505": {
          "Participants/Materials:": "Purified DNA from Japanese-origin B cell lines: 177 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "PacBio [Sequel II]",
          "Library Source": "Purified DNA from Japanese-origin B cell lines",
          "Cell Lines": "the Health Science Research Resources Bank (HSRRB), the National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)",
          "Library Construction (kit name)": "the library prep. kit for SMRT sequencing by Pacific Biosciences",
          "Fragmentation Methods": "Megaruptor",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "14,949 bp",
          "QC Methods": "Qubit, NanoDrop, TapeStation, Femto Pulse, Pulsed-field gel electrophoresis",
          "Mapping Methods": "minimap2 (hg38-no_alt)",
          "Depth (average)": "CCS: 9.06x",
          "SNV Call": "DeepVariant",
          "SNV Haplotyping": "WhatsHap",
          "Structural Variants Detection Methods": "pbsv",
          "diploid assembly": "HiCanu",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000622",
          "Total Data Volume": "7.5 TB (bam/vcf/contig_fasta for 30 samples, fastq for 147 samples)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shinichi Morishita",
        "Affiliation": "Graduate School of Frontier Sciences, the University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Rapid and ongoing evolution of repetitive sequence structures in human centromeres.",
          "DOI": "doi: 10.1126/sciadv.abd9230",
          "Data Set ID": "JGAD000251"
        },
        "2": {
          "Title": "JTK: targeted diploid genome assembler",
          "DOI": "doi: 10.1093/bioinformatics/btad398",
          "Data Set ID": "JGAD000706"
        },
        "3": {
          "Title": "A landscape of complex tandem repeats within individual human genomes",
          "DOI": "doi: 10.1038/s41467-023-41262-1",
          "Data Set ID": "JGAD000392JGAD000622"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Yuta Kochi": {
          "Principal Investigator": "Yuta Kochi",
          "Affiliation": "Department of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic study of complex diseases through comprehensive analysis of functional genetic variations",
          "Period of Data Use": "JGAD000251"
        }
      },
      "Release Note": {
        "hum0174.v5": {
          "Research ID": "hum0174.v5",
          "Release Date": "2023/07/10",
          "Type of Data": "NGS (WGS)",
          "description": "Long read whole genome sequencing analysis by PacBio [Sequel II] was performed by using purified DNA from Japanese-origin B cell lines. Sequence raw data (bam [alignoment, HiFi read], contig_fasta, SNV-structural variations haplotype data for 30 samples, and fastq for 147 samples)  are processed data are provided.\n"
        },
        "hum0174.v4": {
          "Research ID": "hum0174.v4",
          "Release Date": "2023/07/06",
          "Type of Data": "NGS (WGS)",
          "description": "Long read whole genome sequencing by PacBio [Sequel, Sequel II] were performed by using purified DNA from Japanese-origin B cell lines. Sequence raw data (bam, fasta) and structural variants data for each sample (vcf) are provided.\n"
        },
        "hum0174.v3": {
          "Research ID": "hum0174.v3",
          "Release Date": "2023/06/29",
          "Type of Data": "NGS (WGS)",
          "description": "Long read whole genome sequencing by Nanopore [PromethION] was performed by using purified DNA from the Japanese-origin B cell lines. Sequence raw data (bam) are provided.\n"
        },
        "hum0174.v2": {
          "Research ID": "hum0174.v2",
          "Release Date": "2020/11/27",
          "Type of Data": "NGS (WGS)",
          "description": "Long read whole genome sequencing by PacBio [Sequel] was performed by using purified DNA from Japanese-origin B cell lines. Sequence raw data (bam) are provided.\n"
        },
        "hum0174.v1": {
          "Research ID": "hum0174.v1",
          "Release Date": "2020/10/06",
          "Type of Data": "NGS (WGS)",
          "description": "Long read whole genome sequencing by PacBio [Sequel] and 10x Genomics [Chromium Controller] were performed by using purified DNA from Japanese-origin B cell lines. Sequence raw data (fastq, bam) and structural variants data for each sample (vcf, bed) are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0173.v1": {
    "ja": {
      "NBDC Research ID": "hum0173.v1",
      "データ": {
        "JGAS000171": {
          "データID": "JGAS000171",
          "内容": "NGS（RRBS）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/04/23"
        }
      },
      "研究内容の概要": {
        "目的": "遺伝要因および環境要因が子どもの健康に与える影響の探索。 胎内および出生後の健康状態と環境要因を調査し、疾患に関連するエピゲノム変化の同定、腸内細菌叢の解析、疾患の予測バイオマーカーの確立を通して、慢性疾患リスク低減に役立つような早期の予防的介入方法を探索し、次世代の健康増進に役立てる。",
        "方法": "Reduced Representation Bisulfite Sequencing（RRBS）",
        "対象": "臍帯組織（正常分娩）",
        "URL": "http://cpms.chiba-u.jp/kids/"
      },
      "分子データ": {
        "JGAS000171": {
          "対象": "臍帯組織（正常分娩）：30検体",
          "規模": "RRBS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq]",
          "ライブラリソース": "臍帯組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "RRBS法（Ovation RRBS Methyl-Seq System 1-16、EpiTect Fast Bisulfite Conversion kits）",
          "断片化の方法": "制限酵素MspIによる消化",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000249",
          "総データ量": "44 GB（bam [ref：GRCh38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "森 千里",
        "所 属 機 関": "千葉大学・予防医学センター",
        "プロジェクト/研究グループ名": "Chiba Study of Mother and Child Health (C-MACH)",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Chiba study of Mother and Children's Health (C-MACH): cohort study with omics analyses.",
          "DOI": "doi: 10.1136/bmjopen-2015-010531",
          "データID": "JGAD000249"
        },
        "2": {
          "タイトル": "DNA methylome of human neonatal umbilical cord: Enrichment of differentially methylated regions compared to umbilical cord blood DNA at transcription factor genes involved in body patterning and effects of maternal folate deficiency or children’s sex.",
          "DOI": "doi: 10.1371/journal.pone.0214307",
          "データID": "JGAD000249"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0173.v1": {
          "Research ID": "hum0173.v1",
          "公開日": "2019/04/23",
          "内容": "NGS（RRBS）",
          "description": "正常分娩の臍帯組織から抽出したDNAを用いたReduced Representation Bisulfite Sequencing（RRBS）データ（bam）を提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0173.v1",
      "DATA": {
        "JGAS000171": {
          "Data Set ID": "JGAS000171",
          "Type of Data": "NGS (RRBS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/04/23"
        }
      },
      "SUMMARY": {
        "Aims": "to explore the effects of genetic and environmental factors, particularly the fetal environment and post-birth living environment, on children's health and to identify potential biomarkers for these effects.",
        "Methods": "Reduced Representation Bisulfite Sequencing (RRBS)",
        "Participants/Materials": "human umbilical cords",
        "URL": "-"
      },
      "MOLECULAR DATA": {
        "JGAS000171": {
          "Participants/Materials:": "human umbilical cords: 30 samples",
          "Targets": "RRBS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq]",
          "Library Source": "DNA extracted from human umbilical cords",
          "Cell Lines": "-",
          "Library Construction (kit name)": "RRBS method (Ovation RRBS Methyl-Seq System 1-16, EpiTect Fast Bisulfite Conversion kits)",
          "Fragmentation Methods": "MspI restriction enzymes for target DNA digestion",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000249",
          "Total Data Volume": "44 GB (bam [ref: GRCh38])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Chisato Mori",
        "Affiliation": "Chiba University・Center for Preventive Medical Sciences",
        "Project / Group Name": "Chiba Study of Mother and Child Health (C-MACH)",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Chiba study of Mother and Children's Health (C-MACH): cohort study with omics analyses.",
          "DOI": "doi: 10.1136/bmjopen-2015-010531",
          "Data Set ID": "JGAD000249"
        },
        "2": {
          "Title": "DNA methylome of human neonatal umbilical cord: Enrichment of differentially methylated regions compared to umbilical cord blood DNA at transcription factor genes involved in body patterning and effects of maternal folate deficiency or children’s sex.",
          "DOI": "doi: 10.1371/journal.pone.0214307",
          "Data Set ID": "JGAD000249"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0173.v1": {
          "Research ID": "hum0173.v1",
          "Release Date": "2019/04/23",
          "Type of Data": "NGS (RRBS)",
          "description": "DNAs extracted from human umbilical cords were used for Reduced Representation Bisulfite Sequencing (RRBS). Bam files were provided.\nNote：\n"
        }
      }
    }
  },
  "hum0169.v2": {
    "ja": {
      "NBDC Research ID": "hum0169.v2",
      "データ": {
        "JGAS000178": {
          "データID": "JGAS000178",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/06/01"
        },
        "JGAS000178（データ追加）": {
          "データID": "JGAS000178（データ追加）",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/07/17"
        }
      },
      "研究内容の概要": {
        "目的": "遺伝子解析により、ヒト由来中枢神経原発悪性リンパ腫の細胞株と、細胞株を樹立する際に用いた中枢神経原発悪性リンパ腫を持つ患者の腫瘍組織を比較する",
        "方法": "全エキソン解析（copy number alteration及びsingle nucleotide variant）",
        "対象": "樹立した９種類のヒト由来中枢神経原発悪性リンパ腫細胞株（PDX；第１～４世代 ）及び中枢神経原発悪性リンパ腫症例の腫瘍組織ならびに末梢血"
      },
      "分子データ": {
        "JGAS000178": {
          "対象": "中枢神経原発悪性リンパ腫（ICD10：C859）：9症例\r\n    YML9：Patient Derived Xenograft（PDX）マウス（第1世代、第2世代）及び患者腫瘍組織ならびに末梢血\r\n    YML11：PDXマウス（第1世代）及び患者腫瘍組織ならびに末梢血\r\n    YML3：PDXマウス（第2世代）及び患者腫瘍組織ならびに末梢血\r\n    YML4：PDXマウス（第1世代、第4世代）及び患者腫瘍組織ならびに末梢血\r\n    YML8：PDXマウス（第1世代）及び患者腫瘍組織ならびに末梢血\r\n    YML12：PDXマウス（第1世代、第2世代）及び患者腫瘍組織ならびに末梢血\r\n    YML15：PDXマウス（第1世代）及び患者腫瘍組織ならびに末梢血\r\n    YML16：PDXマウス（第1世代、第2世代、第3世代）及び患者腫瘍組織ならびに末梢血\r\n    YML17：PDXマウス（第1世代）及び患者腫瘍組織ならびに末梢血",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "細胞株及び腫瘍組織ならびに末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext® Ultra™ DNA Library Prep Kit for Illumina®、SureSelect Human All Exon V6",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "クオリティコントロール方法": "Quality Value 20未満の塩基をマスク",
          "マッピング方法": "bwa-mem、bowtie2",
          "平均カバー率": "84%（20X以上）",
          "コピー数決定アルゴリズム（ソフトウェア）": "Log-R ratio（calculated with in-house pipline）",
          "フィルタリング": "リード数20以上、変異率10%以上",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Mutect2、Varscan2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000259",
          "総データ量": "101 GB + 150 GB\r\n    Data ファイル数：7（bam） + 25 (bam [ref：hg38]）\r\n    Analysis ファイル数：10（tab [ref：hg38]） + 36（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山本 哲哉",
        "所 属 機 関": "横浜市立大学脳神経外科",
        "プロジェクト/研究グループ名": "Neurosurgical-Oncology lab, Yokohama City University",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A Rapid Genotyping Panel for Detection of Primary Central Nervous System Lymphoma",
          "DOI": "doi: 10.1182/blood.2020010137",
          "データID": "JGAD000259"
        },
        "2": {
          "タイトル": "A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma",
          "DOI": "doi: 10.1158/0008-5472.CAN-20-2425",
          "データID": "JGAD000259"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0169.v2": {
          "Research ID": "hum0169.v2",
          "公開日": "2020/07/17",
          "内容": "NGS（Exome）",
          "description": "中枢神経原発悪性リンパ腫7症例の腫瘍組織および末梢血と、腫瘍組織から樹立した7種類（YML3, 4, 8, 12, 15, 16, 17）のPatient Derived Xenograft（PDX）から抽出したDNAを用いたExome解析結果（copy number alteration及びsingle nucleotide variant）を追加した。\n"
        },
        "hum0169.v1": {
          "Research ID": "hum0169.v1",
          "公開日": "2019/06/01",
          "内容": "NGS（Exome）",
          "description": "中枢神経原発悪性リンパ腫2症例の腫瘍組織および末梢血と、腫瘍組織から樹立した2種類（YML9, YML11）のPatient Derived Xenograft（PDX）から抽出したDNAを用いたExome解析結果（copy number alteration及びsingle nucleotide variant）を提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0169.v2",
      "DATA": {
        "JGAS000178": {
          "Data Set ID": "JGAS000178",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/06/01"
        },
        "JGAS000178 (Data addition)": {
          "Data Set ID": "JGAS000178 (Data addition)",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/07/14"
        }
      },
      "SUMMARY": {
        "Aims": "to compare genomic alterations between tumor tissues from Primary Central Nervous System Lymphoma (PCNSL) patients and xenograft samples derived from PCNSL patients",
        "Methods": "whole exome sequencing",
        "Participants/Materials": "Nine samples, including patient derived xenograft (PDX) mice, tumor samples and peripheral blood cells from PCNSL patients"
      },
      "MOLECULAR DATA": {
        "JGAS000178": {
          "Participants/Materials": "PCNSL (ICD10: C859): 9 cases\r\n    YML9: PDX (first and second passages), tumor samples and peripheral blood cells from PCNSL patients\r\n    YML11: PDX (first passages), tumor samples and peripheral blood cells from PCNSL patients\r\n    YML3: PDX (second passages), tumor samples and peripheral blood cells from PCNSL patients\r\n    YML4: PDX (first and fourth passages), tumor samples and peripheral blood cells from PCNSL patients\r\n    YML8: PDX (first passages), tumor samples and peripheral blood cells from PCNSL patients\r\n    YML12: PDX (first and second passages), tumor samples and peripheral blood cells from PCNSL patients\r\n    YML15: PDX (first passages), tumor samples and peripheral blood cells from PCNSL patients\r\n    YML16: PDX (first, second and third passages), tumor samples and peripheral blood cells from PCNSL patients\r\n    YML17: PDX (first passages), tumor samples and peripheral blood cells from PCNSL patients",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor tissues and peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext® Ultra™ DNA Library Prep Kit for Illumina®, SureSelect Human All Exon V6",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "QC": "nucleotides with Quality Value ＜20 were masked",
          "Mapping Methods": "bwa-mem, bowtie2",
          "Coverage (Depth)": "84% (≧20X)",
          "Algorithm for detecting CNVs (software)": "Log-R ratio (calculated with in-house pipline)",
          "Filtering Methods": "read length ≧20, mutation rate ≧10%",
          "Genotype Call Methods (software)": "Mutect2, Varscan2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000259",
          "Total Data Volume": "101 GB + 150 GB\r\n    Data files: 7 (bam) + 25 (bam [ref: hg38])\r\n    Analysis files: 10 (tab [ref: hg38]) + 36 (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tetsuya Yamamoto",
        "Affiliation": "Department of Neurosurgery, Yokohama City University",
        "Project / Group Name": "Neurosurgical-Oncology lab, Yokohama City University",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A Rapid Genotyping Panel for Detection of Primary Central Nervous System Lymphoma",
          "DOI": "doi: 10.1182/blood.2020010137",
          "Data Set ID": "JGAD000259"
        },
        "2": {
          "Title": "A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma",
          "DOI": "doi: 10.1158/0008-5472.CAN-20-2425",
          "Data Set ID": "JGAD000259"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0169.v2": {
          "Research ID": "hum0169.v2",
          "Release Date": "2020/07/17",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor cells and peripheral blood cells of seven PCNSL patients and patient derived xenograft samples (YML3, 4, 8, 12, 15, 16, 17), were used for whole exome sequencing. Copy number alteration and single nucleotide variant data were provided.\n"
        },
        "hum0169.v1": {
          "Research ID": "hum0169.v1",
          "Release Date": "2019/06/01",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor cells and peripheral blood cells of two PCNSL patients and patient derived xenograft samples (YML9 and YML11), were used for whole exome sequencing. Copy number alteration and single nucleotide variant data were provided.\nNote：\n"
        }
      }
    }
  },
  "hum0168.v1": {
    "ja": {
      "NBDC Research ID": "hum0168.v1",
      "データ": {
        "JGAS000169": {
          "データID": "JGAS000169",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/11/08"
        }
      },
      "研究内容の概要": {
        "目的": "子宮腺筋症の原因遺伝子の探索",
        "方法": "子宮腺筋症の腺筋症病変部、併発内膜症病変部、併発筋腫病変部、周辺子宮筋層、腹水中単核球、末梢血から抽出したDNAを用いた全エクソン解析",
        "対象": "子宮腺筋症"
      },
      "分子データ": {
        "JGAS000169": {
          "対象": "子宮腺筋症（ICD10：N80.0）：51症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "子宮腺筋症の腺筋症病変部、併発内膜症病変部、併発筋腫病変部、周辺子宮筋層、腹水中単核球、末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra DNA library prep kit for Illumina、Agilent V6 plus custom probes",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000247",
          "総データ量": "2 TB （bam [ref：hg38）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "河津 正人",
        "所 属 機 関": "国立がん研究センター研究所",
        "プロジェクト/研究グループ名": "細胞情報学分野",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "LCM法による子宮腺筋症凍結検体の高感度遺伝子変異検出法の確立",
            "研究課題番号": "19K07708"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations",
          "DOI": "doi: 10.1038/s41467-019-13708-y",
          "データID": "JGAD000247"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0168.v1": {
          "Research ID": "hum0168.v1",
          "公開日": "2019/11/08",
          "内容": "NGS（Exome）",
          "description": "子宮腺筋症51症例の腺筋症病変部、併発内膜症病変部、併発筋腫病変部、周辺子宮筋層、腹水中単核球、末梢血から抽出したDNAを使用したExome解析の結果をbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0168.v1",
      "DATA": {
        "JGAS000169": {
          "Data Set ID": "JGAS000169",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/11/08"
        }
      },
      "SUMMARY": {
        "Aims": "Analysis of genetic background of adenomyosis",
        "Methods": "Whole exome sequencing was performed on fresh fronzen samples from adenomyosis individuals",
        "Participants/Materials": "51 patients of adenomyosis"
      },
      "MOLECULAR DATA": {
        "JGAS000169": {
          "Participants/Materials": "adenomyosis: 51 cases",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from fresh frozen samples (adenomyosis, co-occurring endometriosis, co-occurring leiomyoma, co-occurring ovarian cancer, normal myometrium, monocytic cells in ascitic fluid, peripheral blood cells) from adenomyosis individuals",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra DNA library prep kit for Illumina, Agilent V6 plus custom probes",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000247",
          "Total Data Volume": "2 TB (bam [ref: hg38])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masahito Kawazu",
        "Affiliation": "National Cancer Center Research Institute",
        "Project / Group Name": "Division of Cellular Signaling",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Establishment of highly sensitive SNV detection method of WES for uterine adenomyosis by LCM method.",
            "Project Number": "19K07708"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations",
          "DOI": "doi: 10.1038/s41467-019-13708-y",
          "Data Set ID": "JGAD000247"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0168.v1": {
          "Research ID": "hum0168.v1",
          "Release Date": "2019/11/08",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from fresh fronzen samples from 51 adenomyosis ptients were used for the whole exome sequencing. Bam files are provided.\nNote：\n"
        }
      }
    }
  },
  "hum0167.v1": {
    "ja": {
      "NBDC Research ID": "hum0167.v1",
      "データ": {
        "hum0167.v1.meta.v1": {
          "データID": "hum0167.v1.meta.v1",
          "内容": "SUAレベルに関するGWASのメタ解析",
          "制限": "非制限公開",
          "公開日": "2019/07/23"
        }
      },
      "研究内容の概要": {
        "目的": "血清尿酸値（SUA）の変動に関連する遺伝要因を同定する",
        "方法": "GWASメタ解析",
        "対象": "３つの日本人コホート研究への参加者（日本多施設共同コホート研究【J-MICC study】：10,621名、北名古屋ゲノム疫学研究【KING study】：2,095名、バイオバンクジャパン【BBJ】：109,029名）",
        "URL": "http://ndmc-ipb.browse.jp/research.shtml"
      },
      "分子データ": {
        "hum0167.v1.meta.v1": {
          "対象": "[GWAS-1]\r\n　　J-MICC study：10,621名\r\n[GWAS-2]\r\n　　KING study：2,095名\r\n[GWAS-3]\r\n　　BBJ：109,029名",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpressExome-8、660W-Quad、Omni2.5-8、OmniExpress-12、OmniExpress-24、HumanOmniExpressExome、HumanOmniExpress、HumanExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpressExome-8、660W-Quad、Omni2.5-8、OmniExpress-12、OmniExpress-24、HumanOmniExpressExome、HumanOmniExpress、HumanExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "SHAPEIT3 & minimac3 (1000G phase3v5; individuals of all ancestry) / MACH & minimac (1000G phase1v3; individuals of East Asian ancestry)\r\nGenomeStudio / BeadStudio",
          "関連解析（ソフトウェア）": "EPACTS / mach2qtl\r\nMETAL",
          "フィルタリング": "Post-imputation QC: Imputation quality (Rsq) < 0.7 in BBJ / Rsq < 0.3 in othersまたはMAF < 0.005を除外",
          "マーカー数(QC後)": "5,864,938 SNPs（hg19）",
          "NBDC Dataset ID": "hum0167.v1.meta.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "80 MB（tsv.zip）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "松尾 洋孝",
        "所 属 機 関": "防衛医科大学校 分子生体制御学講座",
        "プロジェクト/研究グループ名": "",
        "科研費/助成金（Research Project Number）": {
          "10": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "新たな代謝相関の提案に向けたELOVL2プロモーター領域DNAメチル化制御の解明",
            "研究課題番号": "18K06942"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals",
          "DOI": "doi: 10.1038/s42003-019-0339-0",
          "データID": "hum0167.v1.meta.v1"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0167.v1": {
          "Research ID": "hum0167.v1",
          "公開日": "2019/07/23",
          "内容": "血清尿酸値に関するGWASのメタ解析",
          "description": "３つの日本人コホート研究（J-MICC study：10,621名、KING study：2,095名、BBJ：109,029名）それぞれにおいて実施された血清尿酸値の変動値に関するGWASのメタ解析結果を提供する（txt）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0167.v1",
      "DATA": {
        "hum0167.v1.meta.v1": {
          "Data Set ID": "hum0167.v1.meta.v1",
          "Type of Data": "meta analysis of 3 GWASs for SUA level",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/07/23"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify the susceptibility genetic loci for serum uric acid (SUA) level",
        "Methods": "GWAS meta analysis",
        "Participants/Materials": "Participants of 3 Japanese cohorts (the Japan Multi-Institutional Collaborative Cohort [J-MICC] study, the KIta Nagoya Genomic epidemiological studies [KING] study, and the Bio Bank Japan [BBJ] study)"
      },
      "MOLECULAR DATA": {
        "hum0167.v1.meta.v1": {
          "Participants/Materials": "[GWAS-1]\r\n   - J-MICC study: 10,621 participants\r\n[GWAS-2]\r\n   - KING study: 2,095 participants\r\n[GWAS-3]\r\n   - BBJ: 109,029 participants",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpressExome-8, 660W-Quad, Omni2.5-8, OmniExpress-12, OmniExpress-24, HumanOmniExpressExome, HumanOmniExpress, HumanExome BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpressExome-8, 660W-Quad, Omni2.5-8, OmniExpress-12, OmniExpress-24, HumanOmniExpressExome, HumanOmniExpress, HumanExome BeadChip kit",
          "Genotype Call Methods (software)": "SHAPEIT3 & minimac3 (1000G phase3v5; individuals of all ancestry) / MACH & minimac (1000G phase1v3; individuals of East Asian ancestry)\r\nGenomeStudio / BeadStudio",
          "Association Analysis (software)": "EPACTS / mach2qtl\r\nMETAL",
          "Filtering Methods": "Post-imputation QC: Variants with imputation quality of Rsq < 0.7 in BBJ or Rsq < 0.3 in others were excluded. We also excluded variants with MAF < 0.005.",
          "Marker Number (after QC)": "5,864,938 SNPs (hg19)",
          "NBDC Dataset ID": "hum0167.v1.meta.v1\r\n (Click the Dataset ID to download the file) \r\nDictionary file",
          "Total Data Volume": "80 MB (tsv.zip)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hirotaka Matsuo",
        "Affiliation": "Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College",
        "Project / Group Name": "",
        "Funds / Grants (Research Project Number)": {
          "10": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Elucidation of the significance of DNA methylation at the ELOVL2 promoter for the proposal of new metabolic correlations",
            "Project Number": "18K06942"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals",
          "DOI": "doi: 10.1038/s42003-019-0339-0",
          "Data Set ID": "hum0167.v1.meta.v1"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0167.v1": {
          "Research ID": "hum0167.v1",
          "Release Date": "2019/07/23",
          "Type of Data": "meta analysis of 3 GWASs for SUA level",
          "description": "Result of meta analysis of 3 GWASs for SUA level in 3 Japanese cohorts (J-MICC study, KING study, and BBJ) was provided (txt file). \nNote：\n"
        }
      }
    }
  },
  "hum0166.v1": {
    "ja": {
      "NBDC Research ID": "hum0166.v1",
      "データ": {
        "hum0166.v1.gwas.v1": {
          "データID": "hum0166.v1.gwas.v1",
          "内容": "炎症性腸疾患1221症例に対するチオプリン製剤による副作用（白血球減少症、脱毛症）の有無に関するGWAS",
          "制限": "非制限公開",
          "公開日": "2019/07/30"
        }
      },
      "研究内容の概要": {
        "目的": "チオプリン製剤の副作用に関連する遺伝因子の探索",
        "方法": "ゲノムワイド関連解析",
        "対象": "炎症性腸疾患（クローン病、潰瘍性大腸炎、腸管ベーチェット病）患者"
      },
      "分子データ": {
        "hum0166.v1.gwas.v1": {
          "対象": "炎症性腸疾患：1221症例\r\n　　クローン病（ICD10：K509）：516症例\r\n　　潰瘍性大腸炎（ICD10：K519）：674症例\r\n　　腸管ベーチェット病（ICD10：M352）：16症例\r\n　　炎症性腸疾患（分類不能）（ICD10：K523）：15症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Japonica Array v1]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Axiom 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Affymetrix Power Tools (version 1.16.1, Affymetrix)",
          "Imputation方法": "・EAGLE (v 2.4) for prephasing\r\n・IMPUTE4 (v 1.0) ＋ 2KJPN (reference panel)",
          "フィルタリング": "・SNVs with low imputation quality\r\n (with a posterior genotype probability of < 0.8 for each genotype or with info score < 0.5 for each variant)\r\n・call rate < 0.97\r\n・minor allele frequency (MAF) < 0.01 or 0.05\r\n (0.01 for GWASs of > 50 cases, 0.05 for GWASs of low-frequency adverse events or conditional GWASs on rs116855232)\r\n・Hardy–Weinberg equilibrium (HWE) p < 1 × 10^−6",
          "マーカー数（QC後）": "5,831,032 SNPs（hg19）",
          "NBDC Dataset ID": "hum0166.v1.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "282 MB（csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "角田 洋一",
        "所 属 機 関": "東北大学病院・消化器内科",
        "プロジェクト/研究グループ名": "MENDEL study group",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） ゲノム創薬基盤推進研究事業",
            "タイトル": "チオプリン不耐例を判別するNUDT15 R139C遺伝子多型検査キットの開発を軸とした炎症性腸疾患におけるゲノム医療実用化フレームワークの確立",
            "研究課題番号": "JP18kk0305002"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.",
          "DOI": "doi: 10.1007/s00535-018-1486-7",
          "データID": "hum0166.v1.gwas.v1"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0166.v1": {
          "Research ID": "hum0166.v1",
          "公開日": "2019/07/30",
          "内容": "炎症性腸疾患1221症例に対するチオプリン製剤による副作用（白血球減少症、脱毛症）の有無に関するゲノムワイド関連解析",
          "description": "炎症性腸疾患1221症例の末梢血から抽出したDNAを用いて遺伝子型を決定し（Affymetrix Japonica Array v1）、チオプリン製剤による副作用の有無に関するGWASを実施した結果（統計情報）をcsv fileにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0166.v1",
      "DATA": {
        "hum0166.v1.gwas.v1": {
          "Data Set ID": "hum0166.v1.gwas.v1",
          "Type of Data": "GWAS for 1221 patients of inflammatory bowel diseases with thiopurine-induced adverse events (leukopenia, alopecia)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/07/30"
        }
      },
      "SUMMARY": {
        "Aims": "Discovery of genetic factors associated with thiopurine-induced severe adverse events",
        "Methods": "Genome-wide association study",
        "Participants/Materials": "Patients with inflammatory bowel diseases (Crohn's disease, Ulcerative Colitis, Gastrointestinal Behçet's disease)"
      },
      "MOLECULAR DATA": {
        "hum0166.v1.gwas.v1": {
          "Participants/Materials": "inflammatory bowel diseases: 1221 cases\r\n    Crohn's disease (ICD10: K509): 516 cases\r\n    Ulcerative Colitis (ICD10: K519): 674 cases\r\n    Gastrointestinal Behçet's disease (ICD10: M352): 16 cases\r\n    other inflammatory bowel diseases (ICD10: K523): 15 cases",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Japonica Array v1]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Axiom 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "Affymetrix Power Tools (version 1.16.1, Affymetrix)",
          "Imputation Methods": "・EAGLE (v 2.4) for prephasing\r\n・IMPUTE4 (v 1.0) ＋ 2KJPN (reference panel)",
          "Filtering Methods": "・SNVs with low imputation quality\r\n (with a posterior genotype probability of < 0.8 for each genotype or with info score < 0.5 for each variant)\r\n・call rate < 0.97\r\n・minor allele frequency (MAF) < 0.01 or 0.05\r\n (0.01 for GWASs of > 50 cases, 0.05 for GWASs of low-frequency adverse events or conditional GWASs on rs116855232)\r\n・Hardy–Weinberg equilibrium (HWE) p < 1 × 10^−6",
          "Marker Number (after QC)": "5,831,032 SNPs (hg19)",
          "NBDC Dataset ID": "hum0166.v1.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "282 MB (csv)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yoichi Kakuta",
        "Affiliation": "Tohoku University Hospital, Department of Gastroenterology",
        "Project / Group Name": "MENDEL study group",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Program for Promoting Platform of Genomics based Drug Discovery, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Framework development for genomic medicine in inflammatory bowel disease based on the NUDT15 R139C genotyping kit to find the patients intolerant to thiopurines.",
            "Project Number": "JP18kk0305002"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.",
          "DOI": "doi: 10.1007/s00535-018-1486-7",
          "Data Set ID": "hum0166.v1.gwas.v1"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0166.v1": {
          "Research ID": "hum0166.v1",
          "Release Date": "2019/07/30",
          "Type of Data": "GWAS for 1221 patients of Inflammatory bowel disease with thiopurine-induced adverse events (Leukopenia, Alopecia)",
          "description": "gDNAs extracted from peripheral blood cells of 1221 patiants with an inflammatory bowel disease were genotyped by using of Affymetrix Japonica Array v1 and performed a genome-wide association study. Statistical analyses data were provided as csv files.\nNote：\n"
        }
      }
    }
  },
  "hum0165.v1": {
    "ja": {
      "NBDC Research ID": "hum0165.v1",
      "データ": {
        "JGAS000162": {
          "データID": "JGAS000162",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/05/07"
        }
      },
      "研究内容の概要": {
        "目的": "家族性骨髄異形成症候群の原因遺伝子の探索",
        "方法": "家族性骨髄異形成症候群の1家系に関して、HiSeq 2500による全エクソン解析を行い、原因となる遺伝子変異の同定を試みた。",
        "対象": "家族性骨髄異形成症候群患者２症例"
      },
      "分子データ": {
        "JGAS000162": {
          "対象": "家族性骨髄異形成症候群（ICD10：D46）：2症例（1家系）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血および口腔内粘膜から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext® Ultra™ DNA Library Prep Kit for Illumina®",
          "断片化方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000240",
          "総データ量": "139 GB（bam [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および Familial policy"
        }
      },
      "提供者情報": {
        "研究代表者": "古屋 淳史",
        "所 属 機 関": "東京大学医学部附属病院　血液・腫瘍内科",
        "プロジェクト/研究グループ名": "家族性骨髄異形成症候群の原因遺伝子の探索および機能解析",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 特別研究員奨励費",
            "タイトル": "家族性骨髄異形成症候群の原因遺伝子およびその分子機構の解明",
            "研究課題番号": "15J03679"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination.",
          "DOI": "doi: 10.1038/s41375-019-0385-0",
          "データID": "JGAD000240"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0165.v1": {
          "Research ID": "hum0165.v1",
          "公開日": "2019/05/07",
          "内容": "NGS (Exome)",
          "description": "家族性骨髄異形成症候群1家系2症例の末梢血および口腔内粘膜から抽出したDNAを使用したExome解析の結果をbamファイルにて提供する。\nIllumina HiSeq 2500を用いて平均長125塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0165.v1",
      "DATA": {
        "JGAS000162": {
          "Data Set ID": "JGAS000162",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/05/07"
        }
      },
      "SUMMARY": {
        "Aims": "Investigation of a causal gene of familial myelodysplastic syndromes (MDS)",
        "Methods": "Whole exome sequencing was performed in two MDS patients in the same pedigree.",
        "Participants/Materials": "Two patients of myelodysplastic syndromes"
      },
      "MOLECULAR DATA": {
        "JGAS000162": {
          "Participants/Materials": "familial myelodysplastic syndrome (ICD10: D46): 2 cases (in one pedigree)",
          "Targets": "NGS (Exome)",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from peripheral blood cells and buccal mucosae",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext® Ultra™ DNA Library Prep Kit for Illumina®",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000240",
          "Total Data Volume": "139 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy & Familial policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Junji Koya",
        "Affiliation": "The Universiy of Tokyo Hospital, Department of Hematology and Oncology",
        "Project / Group Name": "Investigation of a causal gene of familial myelodysplastic syndromes and its molecular mechanism",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for JSPS Research Fellows",
            "Title": "Investigation of a causal gene and a molecular mechanism of familial myelodysplastic syndromes",
            "Project Number": "15J03679"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination.",
          "DOI": "doi: 10.1038/s41375-019-0385-0",
          "Data Set ID": "JGAD000240"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0165.v1": {
          "Research ID": "hum0165.v1",
          "Release Date": "2019/05/07",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from peripheral blood cells and buccal mucosae from two familial MDS patients were used for the whole exome sequencing (bam files). Sequencing was performed with Illumina HiSeq 2500 (125 bp, Paired-end).\nNote：\n"
        }
      }
    }
  },
  "hum0164.v1": {
    "ja": {
      "NBDC Research ID": "hum0164.v1",
      "データ": {
        "JGAS000160": {
          "データID": "JGAS000160",
          "内容": "住民コホートに参加した9,187名の日焼けに関するGWAS",
          "制限": "制限公開（Type I）",
          "公開日": "2018/12/14"
        }
      },
      "研究内容の概要": {
        "目的": "日本人の日焼けについてのゲノムワイド関連解析",
        "方法": "ゲノムワイド関連解析",
        "対象": "住民コホートに参加した9,187名の遺伝子型データと日焼けに関するアンケート情報",
        "URL": "http://iwate-megabank.org/"
      },
      "分子データ": {
        "JGAS000160": {
          "対象": "住民コホートに参加した9,187名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium OmniExpressExome-8]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina Infinium OmniExpressExome-8 Beadchip Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "関連解析（ソフトウェア）": "線形混合モデル（ソフトウェア：BOLT-LMM v2.3.2）\r\n年齢、性別、第１から第１０主成分得点で調整",
          "フィルタリング": "検体：Call rate > 0.98\r\nSNP：HWE P < 0.0001、MAF < 0.01、Missing rate > 0.05",
          "マーカー数（QC後）": "6,193,994 SNPs（reference：hg19）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000238\r\nDictionary file\r\n* GWAS_summary_statistics_JST_Combined_set.txt.gz\r\n宮城県または岩手県在住の日本人9,187人を対象とした日本人のスキンタイプにおけるGWAS統計情報\r\n* GWAS_summary_statistics_JST_Miyagi.txt.gz\r\n宮城県在住の日本人4,475人を対象とした日本人のスキンタイプにおけるGWAS統計情報\r\n* GWAS_summary_statistics_JST_Iwate.txt.gz\r\n岩手県在住の日本人4,712人を対象とした日本人のスキンタイプにおけるGWAS統計情報",
          "総データ量": "463 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "長﨑 正朗",
        "所 属 機 関": "東北メディカル・メガバンク機構 ゲノム解析部門",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "日本医療研究開発機構 ゲノム医療実現推進プラットフォーム事業",
            "タイトル": "AMEDが行うゲノム医療研究支援サービスを支える研究開発基盤の整備",
            "研究課題番号": "JP18km0405001"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "小川 誠司": {
          "研究代表者": "小川 誠司",
          "所属機関": "京都大学 医学研究科",
          "研究題目": "-",
          "利用データID": "造血器腫瘍における遺伝子異常の網羅的解析",
          "利用期間": "JGAD000238"
        }
      },
      "リリース情報": {
        "hum0164.v1": {
          "Research ID": "hum0164.v1",
          "公開日": "2018/12/14",
          "内容": "住民コホートに参加した9,187名の日焼けに関するゲノムワイド関連解析",
          "description": "住民コホートにおいて日焼けに関するアンケートを実施し、回答を得た9,187名の末梢血から抽出したDNAを対象にSNPアレイを用いたGenotypingを行い（Illumina [Infinium OmniExpressExome-8]）、GWASを行った結果（統計解析結果）を提供する（txt）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0164.v1",
      "DATA": {
        "JGAS000160": {
          "Data Set ID": "JGAS000160",
          "Type of Data": "GWAS for skin tanning ability of 9,187 participants",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/12/14"
        }
      },
      "SUMMARY": {
        "Aims": "Identify the genetic factors related to tanning ability in Japanese",
        "Methods": "Genome-wide association study",
        "Participants/Materials": "Genotypedata and quetionnaire based skin tanning ability information of 9,187 participants of Tohoku Medical Megabank Organization cohort study",
        "URL": "http://iwate-megabank.org/en/"
      },
      "MOLECULAR DATA": {
        "JGAS000160": {
          "Participants/Materials": "9,187 participants of Tohoku Medical Megabank Organization cohort study",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium OmniExpressExome-8]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina Infinium OmniExpressExome-8 Beadchip Kit",
          "Genotype Call Methods (software)": "GenCall software (GenomeStudio)",
          "Association Analysis (software)": "linear mixed model (software: BOLT-LMM v2.3.2)\r\nadjusted by age, sex and 1-10 principal component scores",
          "Filtering Methods": "Sample: Call rate > 0.98\r\nSNP: HWE P < 0.0001, MAF < 0.01, Missing rate > 0.05",
          "Marker Number (after QC)": "6,193,994 SNPs (reference: hg19)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000238\r\nDictionary file\r\n* GWAS_summary_statistics_JST_Combined_set.txt.gz\r\nGWAS summary statistics of Japanese Skin Type for 9,187 Japanese individuals in Miyagi and Iwate prefectures\r\n* GWAS_summary_statistics_JST_Miyagi.txt.gz\r\nGWAS summary statistics of Japanese Skin Type for 4,475 Japanese individuals in Miyagi prefecture\r\n* GWAS_summary_statistics_JST_Iwate.txt.gz\r\nGWAS summary statistics of Japanese Skin Type for 4,712 Japanese individuals in Iwate prefecture",
          "Total Data Volume": "463 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masao Nagasaki",
        "Affiliation": "Department of Integrative Genomics, Tohoku Medical Megabank Organization",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Platform Program for Promotion of Genome Medicine, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Facilitation of R&D Platform for AMED Genome Mecidine Support",
            "Project Number": "JP18km0405001"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Seishi Ogawa": {
          "Principal Investigator": "Seishi Ogawa",
          "Affiliation": "Department of Medical Science, Kyoto University",
          "Research Title": "-",
          "Data in Use (Dataset ID)": "Comprehensive analysis of genetic alterations in hematological malignancies",
          "Period of Data Use": "JGAD000238"
        }
      },
      "Release Note": {
        "hum0164.v1": {
          "Research ID": "hum0164.v1",
          "Release Date": "2018/12/14",
          "Type of Data": "GWAS for skin tanning ability of 9,187 participants",
          "description": "DNAs extracted from peripheral blood cells of 9,187 participants of Tohoku Medical Megabank Organization cohort study were genotyped by using of Illumina [Infinium OmniExpressExome-8] and performed genome-wide association study (text file).\nNote：\n"
        }
      }
    }
  },
  "hum0163.v3": {
    "ja": {
      "NBDC Research ID": "hum0163.v3",
      "データ": {
        "hum0163.v1.freq.v1": {
          "データID": "hum0163.v1.freq.v1",
          "内容": "NGS（Target Capture）",
          "制限": "非制限公開",
          "公開日": "2018/12/14"
        },
        "hum0163.v2.nat2.v1": {
          "データID": "hum0163.v2.nat2.v1",
          "内容": "NGS（NAT2ハプロタイプ同定）",
          "制限": "非制限公開",
          "公開日": "2021/02/09"
        },
        "hum0163.v3.BPgwas.v1": {
          "データID": "hum0163.v3.BPgwas.v1",
          "内容": "水疱性類天疱瘡のGWAS",
          "制限": "非制限公開",
          "公開日": "2023/04/21"
        }
      },
      "研究内容の概要": {
        "目的": "精神・神経疾患及びがん治療における薬効・副作用に関連する遺伝子・代謝産物（バイオマーカー）を同定し、将来の、ゲノム情報に基づいた層別化医療（stratified medicine）の実現の足がかりとする。",
        "方法": "精神・神経疾患及びがん患者を対象に、DNA、血漿及びカルテ情報を収集する。薬物動態に関連する100遺伝子（Pharmacogene）を対象としたターゲット・リシークエンス解析やヒト白血球抗原（Human Leukocyte Antigen: HLA）タイピング等のゲノム解析、メタボローム解析、ファーマコカイネティクス解析により、薬剤応答性関連遺伝子・代謝産物（バイオマーカー）を探索する。",
        "対象": "ラモトリギン、クロザピンなどの向精神薬による治療症例、レゴラフェニブ、トラスツズマブ、ニボルマブなどのがん分子標的治療薬による治療症例、抗てんかん薬による治療症例",
        "URL": "http://www.riken.jp/research/labs/ims/pharmacogen/"
      },
      "分子データ": {
        "hum0163.v1.freq.v1 / hum0163.v2.nat2.v1": {
          "対象": "精神・神経疾患及びがん患者：計990症例\r\n    てんかん（ICD10：G402）・双極性障害（ICD10：F319）：343症例（ラモトリギン投与症例）\r\n    統合失調症（ICD10：F209）：454症例\r\n    乳がん（ICD10：C509）：65症例（トラスツズマブ投与症例）\r\n    大腸がん（ICD10：C189）：83症例（レゴラフェニブ投与症例）\r\n    悪性黒色腫（ICD10：C439）：45症例（ニボルマブ投与症例）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "薬物動態関連100遺伝子コーディング領域1846variants＋CYP2D6遺伝子のディプロタイプ＋NAT2遺伝子のディプロタイプ",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "自作のMultiplexPCR",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "250 bp x 2",
          "NBDC Dataset ID": "hum0163.v1.freq.v1\r\nhum0163.v2.nat2.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "hum0163.v1.freq.v1：55 KB（csv.zip）\r\nhum0163.v2.nat2.v1：1 KB（csv.zip）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0163.v3.BPgwas.v1": {
          "対象": "水疱性類天疱瘡（ICD10：L12.0）：90症例\r\n対照健常者（日本人由来B細胞株）：737検体",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium OmniExpressExome BeadChip]",
          "ソース": "水疱性類天疱瘡患者の末梢血およびB細胞株から抽出したDNA",
          "検体情報（購入の場合）": "日本人由来B細胞株（PSC細胞株）：財団法人ヒューマンサイエンス振興財団より購入",
          "調整試薬（キット名、バージョン）": "Illumina Infinium OmniExpressExome BeadChip",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "フィルタリング": "sample call rate < 0.99、SNP call rate < 0.99、HWE-P < 1x10^-6",
          "マーカー数（QC後）": "526,267 SNPs（常染色体、hg19）",
          "NBDC Dataset ID": "hum0163.v3.BPgwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "42.5 MB（xlsx）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "莚田 泰誠",
        "所 属 機 関": "理化学研究所 生命医科学研究センター ファーマコゲノミクス研究チーム",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構 難治性疾患実用化研究事業",
            "タイトル": "水疱性類天疱瘡の発症機序の解明と発症リスク因子の同定",
            "研究課題番号": "JP22ek0109430"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes.",
          "DOI": "doi: 10.18632/oncotarget.25712",
          "データID": "hum0163.v1.freq.v1"
        },
        "2": {
          "タイトル": "Association of Genetic Variants of HLA-DQA1 with Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors",
          "DOI": "doi: 10.1016/j.jid.2023.04.017",
          "データID": "hum0163.v3.BPgwas.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0163.v3": {
          "Research ID": "hum0163.v3",
          "公開日": "2023/04/21",
          "内容": "水疱性類天疱瘡のゲノムワイド関連解析",
          "description": "水疱性類天疱瘡90症例の末梢血およびPSC細胞株737検体から抽出したDNAを用いたSNP-chipによる配列決定後、GWASを実施した統計解析データをxlsxファイルにて提供する。\n"
        },
        "hum0163.v2": {
          "Research ID": "hum0163.v2",
          "公開日": "2021/02/09",
          "内容": "NGS（NAT2ハプロタイプ同定）",
          "description": "hum0163.v1のデータより同定したNAT2遺伝子ディプロタイプ頻度情報をcsvファイルにて提供する。\n"
        },
        "hum0163.v1": {
          "Research ID": "hum0163.v1",
          "公開日": "2018/12/14",
          "内容": "NGS（Target Capture）",
          "description": "精神・神経疾患およびがん罹患者の末梢血から抽出したDNAを使用し、薬物動態関連100遺伝子コーディング領域に存在する1846variantsおよびCYP2D6遺伝子のディプロタイプを対象としたTarget Capture（NGS）を実施した際の、990症例分の1846 variantsの頻度情報およびCYP2D6遺伝子の頻度情報をcsvファイルにて提供する。自作のMultiplexPCRによってライブラリを作製し、Illumina [MiSeq]にて平均長377 bpのDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0163.v3",
      "DATA": {
        "hum0163.v1.freq.v1": {
          "Data Set ID": "hum0163.v1.freq.v1",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/12/14"
        },
        "hum0163.v2.nat2.v1": {
          "Data Set ID": "hum0163.v2.nat2.v1",
          "Type of Data": "NGS (NAT2 haplotype)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/02/09"
        },
        "hum0163.v3.BPgwas.v1": {
          "Data Set ID": "hum0163.v3.BPgwas.v1",
          "Type of Data": "GWAS for bullous pemphigoid",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/04/21"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of biomarkers associated with efficacy and adverse drug reactions in therapeutics for psychiatric/neurological disorders or cancers, leading to establishment of stratified medicine based on pharmacogenomic information.",
        "Methods": "DNA/plasma samples and clinical information are collected from patients with psychiatric/neurological disorders or cancers. Targeted NGS analysis focusing on 100 pharmacogenes, HLA typing, metabolome analysis, and pharmacokinetic analysis were conducted to identify biomarkers associated with drug responses.",
        "Participants/Materials": "",
        "URL": "http://www.riken.jp/en/research/labs/ims/pharmacogen/"
      },
      "MOLECULAR DATA": {
        "hum0163.v1.freq.v1 / hum0163.v2.nat2.v1": {
          "Participants/Materials": "990 patients with psychiatric/neurological disorders or cancers\r\n    - epilepsy (ICD10: G402) / bipolar disorder (ICD10: F319): 343 cases (receiving lamotrigine)\r\n    - schizophrenia (ICD10: F209): 454 cases\r\n    - breast cancer (ICD10: C509): 65 cases (receiving trastuzumab)\r\n    - colorectal cancer (ICD10: C189): 83 cases (receiving regorafenib)\r\n    - malignant melanoma (ICD10: C439): 45 cases (receiving nivolumab)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "diplotype of coding regions of 100 pharmacogenes (1846 variants), CYP2D6 gene and NAT2 gene",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "in-house MultiplexPCR",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "250 bp x 2",
          "NBDC Dataset ID": "hum0163.v1.freq.v1\r\nhum0163.v2.nat2.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "hum0163.v1.freq.v1: 55 KB (csv.zip)\r\nhum0163.v2.nat2.v1: 1 KB (csv.zip)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0163.v3.BPgwas.v1": {
          "Participants/Materials": "bullous pemphigoid (ICD10: L12.0): 90 cases\r\n737 healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium OmniExpressExome BeadChip]",
          "Source": "DNA extracted from peripheral blood cells of bullous pemphigoid patients and B-lymphoblast cell lines",
          "Cell Lines": "737 general populations derived from Epstein-Barr virus-transformed B-lymphoblast cell lines of unrelated Japanese individuals established by the Pharma SNP Consortium (PSC)",
          "Reagents (Kit, Version)": "Illumina Infinium OmniExpressExome BeadChip",
          "Genotype Call Methods (software)": "GenCall software (GenomeStudio)",
          "Filtering Methods": "sample call rate < 0.99, SNP call rate < 0.99, HWE-P < 1x10^-6",
          "Marker Number (after QC)": "526,267 SNPs (on autosomal chromosomes, hg19)",
          "NBDC Dataset ID": "hum0163.v3.BPgwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "6 MB (txt.zip)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Taisei Mushiroda",
        "Affiliation": "RIKEN Center for Integrative Medical Sciences, Laboratory for Pharmacogenomics",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Practical Research Project for Rare / Intractable Diseases",
            "Title": "Elucidation of the pathogenesis and risk factors of bullous pemphigoid",
            "Project Number": "JP22ek0109430"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "GSTP1 rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes.",
          "DOI": "doi: 10.18632/oncotarget.25712",
          "Data Set ID": "hum0163.v1.freq.v1"
        },
        "2": {
          "Title": "Association of Genetic Variants of HLA-DQA1 with Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors",
          "DOI": "doi: 10.1016/j.jid.2023.04.017",
          "Data Set ID": "hum0163.v3.BPgwas.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0163.v3": {
          "Research ID": "hum0163.v3",
          "Release Date": "2023/04/21",
          "Type of Data": "GWAS for bullous pemphigoid",
          "description": "DNAs extracted from peripheral blood cells of bullous pemphigoid patients and B-lymphoblast cells were genotyped by using of Illumina Infinium OmniExpressExome BeadChip and a genome-wide association study was performed (xlsx file).\n"
        },
        "hum0163.v2": {
          "Research ID": "hum0163.v2",
          "Release Date": "2021/02/09",
          "Type of Data": "NGS (NAT2 haplotype)",
          "description": "Genotype frequencies of NAT2 identified from the targeted capture sequencing (NGS) analysis were provided (csv file).\n"
        },
        "hum0163.v1": {
          "Research ID": "hum0163.v1",
          "Release Date": "2018/12/14",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from peripheral blood cells of patients with psychiatric/neurological disorders or cancers were used for the targeted NGS analysis focusing on 100 pharmacogenes and CYP2D6. Allele frequencies of 100 pharmacogenes (1846 variants) and genotype frequencies of CYP2D6 for 990 patients were provided (csv file). \nLibraries were prepared by using of in-house multiplexPCR and read by Illumina [MiSeq] (paired-end: average read length 377 bp)\nNote:\n"
        }
      }
    }
  },
  "hum0161.v2": {
    "ja": {
      "NBDC Research ID": "hum0161.v2",
      "データ": {
        "JGAS000156": {
          "データID": "JGAS000156",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/06/04"
        },
        "JGAD000688": {
          "データID": "JGAD000688",
          "内容": "JGAD000234の加工データ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/12/27"
        }
      },
      "研究内容の概要": {
        "目的": "日本人の肝芽腫におけるゲノム変異を探索する",
        "方法": "肝芽腫切除切片における非腫瘍組織（正常組織）および腫瘍組織より抽出したDNAを使用したNGSライブラリーを作成後、Illumina HiSeq 2500にて塩基配列を決定する。",
        "対象": "肝芽腫患者の非腫瘍組織および腫瘍組織のDNA"
      },
      "分子データ": {
        "JGAS000156": {
          "対象": "肝芽腫（ICD10：C22.2）：33 症例\r\n　　腫瘍組織：33 検体\r\n　　非腫瘍組織：33 検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "肝芽腫切除切片における非腫瘍組織および腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Nano DNA Low Throughput Library Prep Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "126 bp",
          "Japanese Genotype-phenotype Archive Data set ID": "JGAD000234",
          "NBDCおよび生命情報・DDBJ センターによる加工データのID": "JGAD000688\r\n加工方法はこちら",
          "総データ量": "4 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 英刀",
        "所 属 機 関": "理化学研究所 生命医科学研究センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0161.v2": {
          "Research ID": "hum0161.v2",
          "公開日": "2022/12/27",
          "内容": "JGAD000234の加工データ",
          "description": "hum0161.v1のfastqファイル（JGAD000234）に対して、特定の解析パイプラインにより加工したCRAM/gVCF/aggregate VCFファイルを提供する。利用を希望する場合は、データ利用申請書にJGAD000234（元データ）とJGAD000688（加工データ）を記載すること。\n"
        },
        "hum0161.v1": {
          "Research ID": "hum0161.v1",
          "公開日": "2021/06/04",
          "内容": "NGS（WGS）",
          "description": "肝芽腫切除切片の非腫瘍組織（正常組織）および腫瘍組織から抽出したDNAを使用したWGS解析の結果（HiSeq 2500）をFastqファイルで提供する（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0161.v2",
      "DATA": {
        "JGAS000156": {
          "Data Set ID": "JGAS000156",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/06/04"
        },
        "JGAS000688": {
          "Data Set ID": "JGAS000688",
          "Type of Data": "Processed data of JGAD000234 by JGA",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/12/27"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate genomic alterations of Japanese hepatoblastomas",
        "Methods": "DNAs were extracted from hepatoblastoma tissues and paired non-cancer (normal) tissues. NGS libaraies were prepared by using TruSeq Nano DNA Low Throughput Library Prep Kit for whole genome sequencing (WGS). Sequencing was perfomred by Illumina HiSeq 2500.",
        "Participants/Materials": "DNAs extracted from cancer tissues and non-cancer tissues of Japanese hepatoblastoma patients."
      },
      "MOLECULAR DATA": {
        "JGAS000156": {
          "Participants/Materials": "hepatoblastoma (ICD10: C22.2): 33 cases\r\n          cancer tissues: 33 samples\r\n          paired non-cancer tissues: 33 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from cancer tissues and paired non-cancer tissues from hepatoblastoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Nano DNA Low Throughput Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000234",
          "Dataset ID of the Processed data by JGA": "JGAD000688\r\nThe way to Process",
          "Total Data Volume": "4 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hidewaki Nakagawa",
        "Affiliation": "RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0161.v2": {
          "Research ID": "hum0161.v2",
          "Release Date": "2022/12/27",
          "Type of Data": "Processed data of JGAD000234 by JGA",
          "description": "The alignment results [CRAM], variant call results per sample [gVCF], and variant call results per dataset [aggregated VCF] processed JGAD000234 in a certain workflow were provided. If you plan to use the data, please indicate both original data (JGAD000234) and processed data (JGAD000688) on the application form for data use.\n"
        },
        "hum0161.v1": {
          "Research ID": "hum0161.v1",
          "Release Date": "2021/06/04",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from cancer tissues and paired non-cancer (normal) tissues obtained from hepatoblastoma patients were used for WGS (HiSeq 2500). Fastq files are provided (Paired-end).\nNote:\n"
        }
      }
    }
  },
  "hum0160.v2": {
    "ja": {
      "NBDC Research ID": "hum0160.v2",
      "データ": {
        "JGAS000155": {
          "データID": "JGAS000155",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/05/28"
        },
        "JGAS000155 にデータ追加": {
          "データID": "JGAS000155 にデータ追加",
          "内容": "NGS（WGS）のbam/gvcfデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/13"
        }
      },
      "研究内容の概要": {
        "目的": "日本人の食道がんにおけるゲノム変異を探索する",
        "方法": "食道がん切除切片における非腫瘍組織（正常組織）および腫瘍組織より抽出したDNAを使用したNGSライブラリーを作成後、Illumina HiSeq 2000/2500/X Fiveにて塩基配列を決定する。",
        "対象": "食道がん患者の非腫瘍組織および腫瘍組織のDNA"
      },
      "分子データ": {
        "JGAS000155": {
          "対象": "食道がん（ICD10：C15）：20 症例\r\n　　腫瘍組織：20 検体\r\n　　非腫瘍組織：20 検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500/X Five]",
          "ライブラリソース": "食道がん切除切片における非腫瘍組織および腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Nano DNA Low Throughput Library Prep Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100-150 bp",
          "クオリティコントロール方法": "リードのbase qualityが全体的に悪い検体、リード毎の%GCの結果にて異常を示した検体を除去。\r\nAlignment後、Low mapping rate検体、Insert sizeがおかしい検体、メタデータの性別情報とalingment結果より推定される性別情報が不一致な検体、性染色体異常疑いの検体を除去。\r\nGenotyping時に、VQSR、DP/GP filter (DP < 5, GQ < 20, DP > 60 && GQ < 95を除去）、heterozygosity filter (F>=0.05 を除去)、HWE filter (p < 10-6を除去）、Repeat & Low Complexity filterを実施。\r\n1000 genomes projectと合わせたPCAを実施し、日本人クラスタから大きく外れる検体を除外。\r\nその後、Genome-In-A-Bottleプロジェクトから公開されているHighConfidenceRegionリストに記載のある領域のバリアントにフラグを付与。",
          "重複するリードの除去": "Picard 2.10.6",
          "リアライメントおよびベースクオリティのキャリブレーション": "GATK 3.7",
          "マッピング方法": "BWA mem 0.7.12",
          "マッピングクオリティ": "GATK 3.7 HaplotypeCallerで変異コール時にMAPQ<20のリードを除外",
          "マッピングの際のリファレンス配列": "GRCh37/hg19（hs37d5）",
          "平均カバー率（Depth）": "HiSeq 2000/2500/X Five：31.8x",
          "変異検出方法": "GATK 3.7 HaplotypeCaller",
          "SNV数（QC後）": "76,768,387（常染色体）\r\n2,898,518（X 染色体）",
          "INDEL数（QC後）": "10,202,908（常染色体）\r\n410,435（X 染色体）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000233（fastq）\r\nJGAD000405（bam、vcf）：GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のデータです。詳しくはこちらをご覧ください。",
          "総データ量": "3 TB（fastq） ＋ 1.8 TB（bam、vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 英刀",
        "所 属 機 関": "理化学研究所 生命医科学研究センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "木下 健吾": {
          "研究代表者": "木下 健吾",
          "所属機関": "東北大学 東北メディカル・メガバンク機構",
          "研究題目": "日本人全ゲノムデータベースの構築",
          "利用データID": "JGAD000233",
          "利用期間": "2019/06/24-2022/03/31"
        },
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用データID": "JGAD000233",
          "利用期間": "2019/08/05-2023/03/31"
        }
      },
      "リリース情報": {
        "hum0160.v2": {
          "Research ID": "hum0160.v2",
          "公開日": "2021/07/13",
          "内容": "NGS（WGS）のbam/gvcfデータ",
          "description": "JGAD000233に含まれるwhole genome sequencing解析データに対し、GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のbam/gvcfデータを追加した。\n"
        },
        "hum0160.v1": {
          "Research ID": "hum0160.v1",
          "公開日": "2019/05/28",
          "内容": "NGS（WGS）",
          "description": "食道がん切除切片の非腫瘍組織（正常組織）および腫瘍組織から抽出したDNAを使用したWGS解析の結果（HiSeq 2000/2500/X Five）をFastqファイルで提供する（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0160.v2",
      "DATA": {
        "JGAS000155": {
          "Data Set ID": "JGAS000155",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/05/28"
        },
        "JGAS000155 (Data addition)": {
          "Data Set ID": "JGAS000155 (Data addition)",
          "Type of Data": "bam/gvcf data of NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/13"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate genomic alterations of Japanese esophageal squamous cell carcinomas",
        "Methods": "DNAs were extracted from esophageal squamous cell carcinoma tissues and paired non-cancer (normal) tissues. NGS libaraies were prepared by using TruSeq Nano DNA Low Throughput Library Prep Kit for whole genome sequencing (WGS). Sequencing was perfomred by Illumina HiSeq 2000/2500/X Five.",
        "Participants/Materials": "DNAs extracted from cancer tissues and non-cancer tissues of Japanese esophageal squamous cell carcinoma patients."
      },
      "MOLECULAR DATA": {
        "JGAS000155": {
          "Participants/Materials": "esophageal squamous cell carcinoma (ICD10: C15): 20 cases\r\n          cancer tissues: 20 samples\r\n          paired non-cancer tissues: 20 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500/X Five]",
          "Library Source": "DNAs extracted from cancer tissues and paired non-cancer tissues from esophageal squamous cell carcinoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Nano DNA Low Throughput Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100-150 bp",
          "QC": "Data with bad base quality and high %GC content were removed.\r\nAligment:\r\nData matched for the following condition were removed.\r\n- Low mapping rate\r\n- Different insert size\r\n- Gender information mismatch between meta-data and genotype data\r\n- Suspected sex chromosome aberration\r\nGenotyping:\r\nGATK’s best practices includes a variant filtering step following Variant Quality Score Recalibration (VQSR)\r\n- DP/GP (DP < 5, GQ < 20, DP > 60, GQ < 95 )\r\n- Heterozygosity (F>=0.05)\r\n- Hardy-Weinberg equilibrium (p < 10^-6)\r\n- Repeat & Low Complexity\r\nPrincipal Component Analysis (PCA):\r\nPCA was performed with individuals included in the 1000 genomes project and outliers from Japanese cluster were removed.\r\n \r\nAfter these filtering steps, variants located in the regions listed as the HighConfidenceRegion (Genome-In-A-Bottle project) were flagged.",
          "Deduplication": "Picard 2.10.6",
          "Calibration for re-alignment and base quality": "GATK 3.7",
          "Mapping Methods": "BWA mem 0.7.12",
          "Mapping Quality": "Reads with MAPQ<20 were excluded at variant calling with GATK 3.7 HaplotypeCaller",
          "Reference Genome Sequence": "GRCh37/hg19 (hs37d5)",
          "Coverage (Depth)": "HiSeq 2000/2500/XFive: 31.8x",
          "Detecting Methods for Variation": "GATK 3.7 HaplotypeCaller",
          "SNV Numbers (after QC)": "76,768,387 (Autosomal Chromosomes)\r\n2,898,518 (X Chromosome)",
          "INDEL Numbers (after QC)": "10,202,908 (Autosomal Chromosomes)\r\n410,435 (X Chromosome)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000233 (fastq)\r\nJGAD000405 (bam, vcf): Whole genome sequencing analyzed data included in the JGAD000117 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J). Lean more..",
          "Total Data Volume": "3 TB (fastq) + 1.8 TB (bam, vcf)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hidewaki Nakagawa",
        "Affiliation": "RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Kengo Kinoshita": {
          "Principal Investigator": "Kengo Kinoshita",
          "Affiliation": "Tohoku Medical Megabank Organization",
          "Research Title": "Construction of Japanese whole genome database",
          "Data in Use (Dataset ID)": "JGAD000233",
          "Period of Data Use": "2019/06/24-2022/03/31"
        },
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Data in Use (Dataset ID)": "JGAD000233",
          "Period of Data Use": "2019/08/05-2023/03/31"
        }
      },
      "Release Note": {
        "hum0160.v2": {
          "Research ID": "hum0160.v2",
          "Release Date": "2021/07/13",
          "Type of Data": "bam/gvcf data of NGS (WGS)",
          "description": "Whole genome sequencing analyzed data included in the JGAD000233 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. Bam files and gvcf files were added. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J).\n"
        },
        "hum0160.v1": {
          "Research ID": "hum0160.v1",
          "Release Date": "2019/05/28",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from cancer tissues and paired non-cancer (normal) tissues obtained from esophageal squamous cell carcinoma patients were used for WGS (HiSeq 2000/2500/X Five). Fastq files are provided (Paired-end).\nNote:\n"
        }
      }
    }
  },
  "hum0159.v2": {
    "ja": {
      "NBDC Research ID": "hum0159.v2",
      "データ": {
        "JGAS000157": {
          "データID": "JGAS000157",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/06/01"
        },
        "JGAD000689": {
          "データID": "JGAD000689",
          "内容": "JGAD000235の加工データ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/12/27"
        }
      },
      "研究内容の概要": {
        "目的": "日本人の大腸がんにおけるゲノム変異を探索する",
        "方法": "大腸がん切除切片における非腫瘍組織（正常組織）および腫瘍組織より抽出したDNAを使用したNGSライブラリーを作成後、Illumina HiSeq 2000にて塩基配列を決定する。",
        "対象": "大腸がん患者の非腫瘍組織および腫瘍組織のDNA"
      },
      "分子データ": {
        "JGAS000157": {
          "対象": "大腸がん（ICD10：C18）：10 症例\r\n　　腫瘍組織：10 検体\r\n　　非腫瘍組織：10 検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "大腸がん切除切片における非腫瘍組織および腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA LT Sample Prep Kit、および、\r\nTruSeq Nano DNA Low Throughput Library Prep Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000235",
          "NBDCおよび生命情報・DDBJ センターによる加工データのID": "JGAD000689\r\n加工方法はこちら",
          "総データ量": "2 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 英刀",
        "所 属 機 関": "理化学研究所 生命医科学研究センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "-",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "河野 隆志": {
          "研究代表者": "河野 隆志",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "AYA （Adolescence and Young Adult） 世代がんの個別化予防に資する遺伝要因の同定を目指す研究",
          "利用データID": "JGAD000235",
          "利用期間": "2021/11/29-2025/03/31"
        }
      },
      "リリース情報": {
        "hum0159.v2": {
          "Research ID": "hum0159.v2",
          "公開日": "2022/12/27",
          "内容": "JGAD000235の加工データ",
          "description": "hum0159.v1のfastqファイル（JGAD000235）に対して、特定の解析パイプラインにより加工したCRAM/gVCF/aggregate VCFファイルを提供する。利用を希望する場合は、データ利用申請書にJGAD000235（元データ）とJGAD000689（加工データ）を記載すること。\n"
        },
        "hum0159.v1": {
          "Research ID": "hum0159.v1",
          "公開日": "2021/06/01",
          "内容": "NGS（WGS）",
          "description": "大腸がん切除切片の非腫瘍組織（正常組織）および腫瘍組織から抽出したDNAを使用したWGS解析の結果（HiSeq 2000）をFastqファイルで提供する（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0159.v2",
      "DATA": {
        "JGAS000157": {
          "Data Set ID": "JGAS000157",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/06/01"
        },
        "JGAD000689": {
          "Data Set ID": "JGAD000689",
          "Type of Data": "Processed data of JGAD000235 by JGA",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/12/27"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate genomic alterations of Japanese colorectal cancers",
        "Methods": "DNAs were extracted from colorectal cancer tissues and paired non-cancer (normal) tissues. NGS libaraies were prepared by using TruSeq DNA LT Sample Prep Kit or TruSeq Nano DNA Low Throughput Library Prep Kit for whole genome sequencing (WGS). Sequencing was perfomred by Illumina HiSeq 2000.",
        "Participants/Materials": "DNAs extracted from cancer tissues and non-cancer tissues of Japanese colorectal cancer patients."
      },
      "MOLECULAR DATA": {
        "JGAS000157": {
          "Participants/Materials": "colorectal cancer (ICD10: C18): 10 cases\r\n          cancer tissues: 10 samples\r\n          paired non-cancer tissues: 10 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from cancer tissues and paired non-cancer tissues from colorectal cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA LT Sample Prep Kit, \r\nTruSeq Nano DNA Low Throughput Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000235",
          "Dataset ID of the Processed data by JGA": "JGAD000689\r\nThe way to Process",
          "Total Data Volume": "2 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hidewaki Nakagawa",
        "Affiliation": "RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "-",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Takashi Kohno": {
          "Principal Investigator": "Takashi Kohno",
          "Affiliation": "Division of Genome Biology, National Cancer Center Research Institute",
          "Research Title": "Identification of genetic risk factors in AYA (Adolescence and Young Adult) cancer",
          "Data in Use (Dataset ID)": "JGAD000235",
          "Period of Data Use": "2021/11/29-2025/03/31"
        }
      },
      "Release Note": {
        "hum0159.v2": {
          "Research ID": "hum0159.v2",
          "Release Date": "2022/12/27",
          "Type of Data": "Processed data of JGAD000235 by JGA",
          "description": "The alignment results [CRAM], variant call results per sample [gVCF], and variant call results per dataset [aggregated VCF] processed JGAD000235 in a certain workflow were provided. If you plan to use the data, please indicate both original data (JGAD000235) and processed data (JGAD000689) on the application form for data use.\n"
        },
        "hum0159.v1": {
          "Research ID": "hum0159.v1",
          "Release Date": "2021/06/01",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from cancer tissues and paired non-cancer (normal) tissues obtained from colorectal cancer patients were used for WGS (HiSeq 2000). Fastq files are provided (Paired-end).\nNote:\n"
        }
      }
    }
  },
  "hum0158.v3": {
    "ja": {
      "NBDC Research ID": "hum0158.v3",
      "データ": {
        "JGAS000151": {
          "データID": "JGAS000151",
          "内容": "NGS（WGS）\r\nNGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/10/22"
        },
        "JGAS000151 にデータ追加": {
          "データID": "JGAS000151 にデータ追加",
          "内容": "NGS（WGS）のbam/gvcfデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/13"
        }
      },
      "研究内容の概要": {
        "目的": "日本人の肝臓がんにおけるゲノム変異を探索する",
        "方法": "肝臓がん切除切片における腫瘍組織および非腫瘍組織または末梢血より抽出したDNAもしくはRNAを使用したNGSライブラリーを作成後、Illumina HiSeqまたは Genome Analyzerにて塩基配列を決定する。",
        "対象": "肝臓がん（肝細胞がん、肝内胆管がん、混合型肝がん）患者の非腫瘍組織および腫瘍組織のDNA・RNA"
      },
      "分子データ": {
        "NGS（WGS）": {
          "対象": "肝臓がん：258 症例 + 5 症例\r\n（肝細胞がん [ICD10：C220]、肝内胆管がん [ICD10：C221]、混合型肝がん [ICD10：C227]）\r\n　　腫瘍組織：301 検体 + 5 検体\r\n　　非腫瘍組織：265 検体（末梢血：257 検体、肝臓：3 検体 + 末梢血：5 検体）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000, Genome Analyzer IIx, NovaSeq 6000]",
          "ライブラリソース": "肝臓がん切除切片における腫瘍組織および非腫瘍組織または末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA LT Sample Prep Kit、TruSeq Nano DNA Low Throughput Library Prep Kit、Paired-End DNA Sample Prep Kit、TruSeq Nano DNA Library Preparation Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "クオリティコントロール方法": "リードのbase qualityが全体的に悪い検体、リード毎の%GCの結果にて異常を示した検体を除去。\r\nAlignment後、Low mapping rate検体、Insert sizeがおかしい検体、メタデータの性別情報とalingment結果より推定される性別情報が不一致な検体、性染色体異常疑いの検体を除去。\r\nGenotyping時に、VQSR、DP/GP filter (DP < 5, GQ < 20, DP > 60 && GQ < 95を除去）、heterozygosity filter (F>=0.05 を除去)、HWE filter (p < 10-6を除去）、Repeat & Low Complexity filterを実施。\r\n1000 genomes projectと合わせたPCAを実施し、日本人クラスタから大きく外れる検体を除外。\r\nその後、Genome-In-A-Bottleプロジェクトから公開されているHighConfidenceRegionリストに記載のある領域のバリアントにフラグを付与。",
          "重複するリードの除去": "Picard 2.10.6",
          "リアライメントおよびベースクオリティのキャリブレーション": "GATK 3.7",
          "マッピング方法": "BWA mem 0.7.12",
          "マッピングクオリティ": "GATK 3.7 HaplotypeCallerで変異コール時にMAPQ<20のリードを除外",
          "マッピングの際のリファレンス配列": "GRCh37/hg19（hs37d5）",
          "平均カバー率（Depth）": "HiSeq 2000：31.8x、Genome Analyzer IIx：30.0x、NovaSeq 6000：28.0x",
          "変異検出方法": "GATK 3.7 HaplotypeCaller",
          "SNV数（QC後）": "76,768,387（常染色体）\r\n2,898,518（X 染色体）",
          "INDEL数（QC後）": "10,202,908（常染色体）\r\n410,435（X 染色体）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000228（fastq）\r\nJGAD000404（220 症例の非腫瘍組織由来データを解析したbam/vcf）：GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のデータです。詳しくはこちらをご覧ください。",
          "総データ量": "48 TB（fastq） ＋ 581 GB（fastq） ＋ 25.2 TB（bam、vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "NGS（RNA-seq）": {
          "対象": "肝臓がん：238 症例\r\n（肝細胞がん [ICD10：C220]、肝内胆管がん [ICD10：C221]、混合型肝がん [ICD10：C227]）\r\n　　腫瘍組織：238 検体\r\n　　非腫瘍組織：201 検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000, Genome Analyzer IIx]",
          "ライブラリソース": "肝臓がん切除切片における腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Sample Prep Kit v2 もしくは TruSeq Stranded mRNA Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000229",
          "総データ量": "3 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 英刀",
        "所 属 機 関": "理化学研究所 生命医科学研究センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.",
          "DOI": "doi: 10.1038/ng.3547",
          "データID": "JGAD000228\r\nJGAD000229"
        },
        "2": {
          "タイトル": "Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.",
          "DOI": "doi: 10.1016/j.ccell.2019.04.007",
          "データID": "JGAD000228\r\nJGAD000229"
        }
      },
      "制限公開データの利用者一覧": {
        "木下 健吾": {
          "研究代表者": "木下 健吾",
          "所属機関": "東北大学 東北メディカル・メガバンク機構",
          "研究題目": "",
          "利用データID": "日本人全ゲノムデータベースの構築",
          "利用期間": "JGAD000228"
        },
        "寶珍 輝尚": {
          "研究代表者": "寶珍 輝尚",
          "所属機関": "京都工芸繊維大学・情報工学・人間科学系",
          "研究題目": "",
          "利用データID": "機械学習によるヒトゲノム変異の解析",
          "利用期間": "JGAD000228, JGAD000229"
        },
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000228, JGAD000229"
        },
        "小笠原 理": {
          "研究代表者": "小笠原 理",
          "所属機関": "国立遺伝学研究所 生命情報・DDBJセンター",
          "研究題目": "",
          "利用データID": "JGA/AGDゲノムデータを利用したヒトゲノム解析ワークフローの評価",
          "利用期間": "JGAD000228, JGAD000229"
        },
        "Kichoon Lee": {
          "研究代表者": "Kichoon Lee",
          "所属機関": "Department of Animal Sciences, The Ohio State University",
          "研究題目": "",
          "利用データID": "Investigation on allele-specific gene expressions in humans",
          "利用期間": "JGAD000228, JGAD000229"
        },
        "Jinyan Huang": {
          "研究代表者": "Jinyan Huang",
          "所属機関": "Zhejiang University School of Medicine",
          "研究題目": "",
          "利用データID": "Comprehensive analysis of alternative splicing in malignant tumors",
          "利用期間": "JGAD000228, JGAD000404"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000229"
        }
      },
      "リリース情報": {
        "hum0158.v3": {
          "Research ID": "hum0158.v3",
          "公開日": "2021/07/13",
          "内容": "NGS（WGS）のbam/gvcfデータ",
          "description": "JGAD000228に含まれるwhole genome sequencing解析データに対し、GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のbam/gvcfデータを追加した。\n"
        },
        "hum0158.v2": {
          "Research ID": "hum0158.v2",
          "公開日": "2019/06/21",
          "内容": "NGS（WGS）",
          "description": "肝臓がん5症例のWGSデータ（Fastq・20ファイル）を追加した。\n"
        },
        "hum0158.v1": {
          "Research ID": "hum0158.v1",
          "公開日": "2018/10/22",
          "内容": "NGS（WGS、RNA-seq）",
          "description": "肝臓がん切除切片における腫瘍組織および非腫瘍組織または末梢血から抽出したDNAおよびRNAを使用したWGS解析、および、RNA-seq解析の結果（HiSeq または Genome Analyzer）をFastqファイルで提供する（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0158.v3",
      "DATA": {
        "JGAS000151": {
          "Data Set ID": "JGAS000151",
          "Type of Data": "NGS (WGS)\r\nNGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/10/22"
        },
        "JGAS000151 (Data addition)": {
          "Data Set ID": "JGAS000151 (Data addition)",
          "Type of Data": "bam/gvcf data of NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/13"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate genomic alterations of Japanese liver cancers",
        "Methods": "DNAs and RNAs were extracted from liver cancer tissues and paired non-cancer (normal) tissues or blood samples. NGS libaraies were prepared for whole genome sequencing (WGS) and RNA-seq. Sequencing was perfomred by Illumina HiSeq or Genome Analyzer.",
        "Participants/Materials": "DNAs and RNAs extracted from cancer tissues and normal tissues of Japanese liver cancer patients."
      },
      "MOLECULAR DATA": {
        "NGS (WGS)": {
          "Participants/Materials": "liver cancer (ICD10: C220, 221, 227): 258 cases + 5 cases\r\n          cancer tissues: 301 samples + 5 samples\r\n          paired non-cancer tissues: 265 samples (257 blood samples, 3 liver tissues + 5 blood samples)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000, Genome Analyzer IIx, NovaSeq 6000]",
          "Library Source": "DNAs extracted from cancer tissues and paired non-cancer tissues or blood samples from liver cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA LT Sample Prep Kit, TruSeq Nano DNA Low Throughput Library Prep Kit, Paired-End DNA Sample Prep Kit, TruSeq Nano DNA Library Preparation Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "QC": "Data with bad base quality and high %GC content were removed.\r\nAligment:\r\nData matched for the following condition were removed.\r\n- Low mapping rate\r\n- Different insert size\r\n- Gender information mismatch between meta-data and genotype data\r\n- Suspected sex chromosome aberration\r\nGenotyping:\r\nGATK’s best practices includes a variant filtering step following Variant Quality Score Recalibration (VQSR)\r\n- DP/GP (DP < 5, GQ < 20, DP > 60, GQ < 95 )\r\n- Heterozygosity (F>=0.05)\r\n- Hardy-Weinberg equilibrium (p < 10^-6)\r\n- Repeat & Low Complexity\r\nPrincipal Component Analysis (PCA):\r\nPCA was performed with individuals included in the 1000 genomes project and outliers from Japanese cluster were removed.\r\n \r\nAfter these filtering steps, variants located in the regions listed as the HighConfidenceRegion (Genome-In-A-Bottle project) were flagged.",
          "Deduplication": "Picard 2.10.6",
          "Calibration for re-alignment and base quality": "GATK 3.7",
          "Mapping Methods": "BWA mem 0.7.12",
          "Mapping Quality": "Reads with MAPQ<20 were excluded at variant calling with GATK 3.7 HaplotypeCaller",
          "Reference Genome Sequence": "GRCh37/hg19 (hs37d5)",
          "Coverage (Depth)": "HiSeq 2000: 31.8x, Genome Analyzer IIx: 30.0x, NovaSeq 6000: 28.0x",
          "Detecting Methods for Variation": "GATK 3.7 HaplotypeCaller",
          "SNV Numbers (after QC)": "76,768,387 (Autosomal Chromosomes)\r\n2,898,518 (X Chromosome)",
          "INDEL Numbers (after QC)": "10,202,908 (Autosomal Chromosomes)\r\n410,435 (X Chromosome)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000228 (fastq)\r\nJGAD000404 (bam/vcf files of non-tumor tissues derived from 220 liver cancer patients): Whole genome sequencing analyzed data included in the JGAD000117 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J). Lean more..",
          "Total Data Volume": "48 TB (fastq) + 581 GB (fastq) + 25.2 TB (bam, vcf)",
          "Comments (Policies)": "NBDC policy"
        },
        "NGS (RNA-seq)": {
          "Participants/Materials:": "liver cancer (ICD10: C220, 221, 227): 238 cases\r\n          cancer tissues: 238 samples\r\n          paired non-cancer tissues: 201 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000, Genome Analyzer IIx]",
          "Library Source": "RNAs extracted from cancer tissues and paired non-cancer tissues from liver cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Sample Prep Kit v2 or TruSeq Stranded mRNA Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000229",
          "Total Data Volume": "3 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hidewaki Nakagawa",
        "Affiliation": "RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.",
          "DOI": "doi: 10.1038/ng.3547",
          "Data Set ID": "JGAD000228\r\nJGAD000229"
        },
        "2": {
          "Title": "Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.",
          "DOI": "doi: 10.1016/j.ccell.2019.04.007",
          "Data Set ID": "JGAD000228\r\nJGAD000229"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Kengo Kinoshita": {
          "Principal Investigator": "Kengo Kinoshita",
          "Affiliation": "Tohoku Medical Megabank Organization",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Construction of Japanese whole genome database",
          "Period of Data Use": "JGAD000228"
        },
        "Teruhisa Hochin": {
          "Principal Investigator": "Teruhisa Hochin",
          "Affiliation": "Faculty of Information and Human Sciences, Kyoto Institute of Technology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Analysis of mutation of human genome using Machine Learning",
          "Period of Data Use": "JGAD000228, JGAD000229"
        },
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000228, JGAD000229"
        },
        "Osamu Ogasawara": {
          "Principal Investigator": "Osamu Ogasawara",
          "Affiliation": "Bioinformation and DDBJ Center, National Institute of Genetics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Evaluation of human genome analysis workflow using JGA/AGD genome data.",
          "Period of Data Use": "JGAD000228, JGAD000229"
        },
        "Kichoon Lee": {
          "Principal Investigator": "Kichoon Lee",
          "Affiliation": "Department of Animal Sciences, The Ohio State University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Investigation on allele-specific gene expressions in humans",
          "Period of Data Use": "JGAD000228, JGAD000229"
        },
        "Jinyan Huang": {
          "Principal Investigator": "Jinyan Huang",
          "Affiliation": "School of Medicine, Zhejiang University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of alternative splicing in malignant tumors",
          "Period of Data Use": "JGAD000228, JGAD000404"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000229"
        }
      },
      "Release Note": {
        "hum0158.v3": {
          "Research ID": "hum0158.v3",
          "Release Date": "2021/07/13",
          "Type of Data": "bam/gvcf data of NGS (WGS)",
          "description": "Whole genome sequencing analyzed data included in the JGAD000228 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. Bam files and gvcf files were added. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J).\n"
        },
        "hum0158.v2": {
          "Research ID": "hum0158.v2",
          "Release Date": "2019/06/21",
          "Type of Data": "NGS (WGS)",
          "description": "20 WGS data (fastq) for 5 liver cancer patients were added.\n"
        },
        "hum0158.v1": {
          "Research ID": "hum0158.v1",
          "Release Date": "2018/10/22",
          "Type of Data": "NGS (WGS, RNA-seq)",
          "description": "DNAs and RNAs extracted from cancer tissues and paired non-cancer (normal) tissues or blood samples obtained from liver cancer patients were used for WGS and RNA-seq (HiSeq or Genome Analyzer). Fastq files are provided (Paired-end).\nNote:\n"
        }
      }
    }
  },
  "hum0157.v1": {
    "ja": {
      "NBDC Research ID": "hum0157.v1",
      "データ": {
        "JGAS000164": {
          "データID": "JGAS000164",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/08/19"
        }
      },
      "研究内容の概要": {
        "目的": "がんのクリニカルシークエンスおよび付随研究としての網羅的ゲノム・エピゲノム解析",
        "方法": "腫瘍FFPE検体から抽出したDNA、RNA、および対照コントロールとして同一症例の正常血液から抽出したDNAをNextSeq（Illumina）を用いて配列決定した",
        "対象": "183症例のがん（肺がん53例、肉腫39例、大腸がん24例、子宮がん15例、卵巣がん12例、子宮肉腫8例、下咽頭癌4例、腺様嚢胞がん4例、原発不明がん5例、その他組織型のがん19例）"
      },
      "分子データ": {
        "JGAS000164": {
          "対象": "がん：183症例（腫瘍FFPE検体および正常血液検体のペア）\r\n　　肺がん（ICD10：C34）：53症例\r\n　　肉腫（ICD10：C40-41）：39症例\r\n　　大腸がん（ICD10：C17-20）：24症例\r\n　　子宮がん（ICD10：C54）：15症例\r\n　　卵巣がん（ICD10：C56）：12症例\r\n　　子宮肉腫（ICD10：C54）：8症例\r\n　　下咽頭癌がん（ICD10：C13）：4症例\r\n　　腺様嚢胞がん（ICD10：C07-08）：4症例\r\n　　原発不明がん（ICD10：D48）：5症例\r\n　　その他組織型のがん：19症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "DNAパネルは464遺伝子\r\nRNAパネルは449遺伝子\r\nsupplementary table 1参照\r\nhttp://todaioncopanel.umin.jp/",
          "Platform": "Illumina [NextSeq]",
          "ライブラリソース": "腫瘍FFPE検体から抽出したDNA, RNA、および正常血液から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelectXT Custom kit",
          "断片化の方法": "酵素反応（Kapa Biosystems）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000242",
          "総データ量": "3 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "宮園 浩平",
        "所 属 機 関": "東京大学大学院医学系研究科 分子病理学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん医療創生研究事業（P-CREATE）",
            "タイトル": "ヒト上皮性腫瘍の発生・進展機構の解明と新規治療標的の同定",
            "研究課題番号": "JP18cm0106502"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens.",
          "DOI": "doi: 10.1111/cas.13968",
          "データID": "JGAD000242"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000242"
        }
      },
      "リリース情報": {
        "hum0157.v1": {
          "Research ID": "hum0157.v1",
          "公開日": "2019/08/19",
          "内容": "NGS（Target Capture）",
          "description": "腫瘍FFPE検体から抽出したDNA, RNA、および対照コントロールとして同一症例の正常血液から抽出したDNAを用いたTarget Capture解析結果をfastqファイルにて提供する。NextSeq（Illumina）によるDNAパネルおよびRNAパネルを用いた配列決定を実施した。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0157.v1",
      "DATA": {
        "JGAS000164": {
          "Data Set ID": "JGAS000164",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/08/19"
        }
      },
      "SUMMARY": {
        "Aims": "Cancer clinical sequence and accompanying research for comprehensive genomic and epigenomic analyses",
        "Methods": "DNA and RNA from tumor tissues (FFPE) and DNA from normal blood cells were subjected to target capture DNA panel sequencing and RNA panel sequencing by using of NextSeq (Illumina).",
        "Participants/Materials": "183 cancer cases (lung cancer: 53, soft tissue sarcoma: 39, colon cancer: 24, endometrial cancer: 15, ovarian cancer: 12, endometrial sarcoma: 8, hypopharyngeal cancer: 4, adenoid cystic carcinoma: 4, cancer of unknown primary: 5, other types of cancer: 19)"
      },
      "MOLECULAR DATA": {
        "JGAS000164": {
          "Participants/Materials": "cancer: 183 cases\r\n (tumor tissues [FFPE sample] and normal blood cells)\r\n     lung cancer (ICD10: C34): 53 cases\r\n     soft tissue sarcoma (ICD10: C40-41): 39 cases\r\n     colon cancer (ICD10: C17-20): 24 cases\r\n     endometrial cancer (ICD10: C54): 15 cases\r\n     ovarian cancer (ICD10: C56): 12 cases\r\n     endometrial sarcoma (ICD10: C54): 8 cases\r\n     hypopharyngeal cancer (ICD10: C13): 4 cases\r\n     adenoid cystic carcinoma (ICD10: C07-08): 4 cases\r\n     cancer of unknown primary (ICD10: D48): 5 cases\r\n     other types of cancer: 19 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "DNA panel: 464 genes\r\nRNA panel: 449 genes\r\ngenes are listed in supplementary table 1",
          "Platform": "Illumina [NextSeq]",
          "Library Source": "DNAs extracted from tumor tissues and peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelectXT Custom kit",
          "Fragmentation Methods": "Enzymatic Shearing (Kapa Biosystems)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000242",
          "Total Data Volume": "3 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kohei Miyazono",
        "Affiliation": "Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Elucidation of initiation and progression mechanism of human epithelial tumors towards identification of novel therapeutic targets",
            "Project Number": "JP18cm0106502"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens.",
          "DOI": "doi: 10.1111/cas.13968",
          "Data Set ID": "JGAD000242"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000242"
        }
      },
      "Release Note": {
        "hum0157.v1": {
          "Research ID": "hum0157.v1",
          "Release Date": "2019/08/19",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNA and RNA from tumor tissues (FFPE) and DNA from normal blood cells were subjected to target capture DNA panel and RNA panel by NextSeq (Illumina). Fastq files were provided.\nNote:\n"
        }
      }
    }
  },
  "hum0156.v1": {
    "ja": {
      "NBDC Research ID": "hum0156.v1",
      "データ": {
        "JGAS000227": {
          "データID": "JGAS000227",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/30"
        }
      },
      "研究内容の概要": {
        "目的": "食道がんに対する化学放射線療法の耐性機構を明らかにする",
        "方法": "内視鏡生検もしくは切除検体から採取した腫瘍組織と末梢血（正常組織）から抽出したDNAを用いた全エクソンシーケンス解析",
        "対象": "化学放射線治療を受けた食道がん33症例",
        "URL": "https://www.beppu.kyushu-u.ac.jp/gekareview/"
      },
      "分子データ": {
        "JGAS000227": {
          "対象": "食道がん（ICD10：C159）：33症例\r\n    腫瘍組織：52検体\r\n    末梢血：33検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "食道がんの腫瘍組織および末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect XT Human All Exon V5+Reg",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000319",
          "総データ量": "1 TB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "三森 功士",
        "所 属 機 関": "九州大学病院 別府病院 外科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "科学研究費助成事業 若手研究（B）",
            "タイトル": "次世代シークエンサーを用いた遺伝子統合解析による食道癌化学放射線療法耐性の解明",
            "研究課題番号": "26861003"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy",
          "DOI": "doi: 10.1158/0008-5472.CAN-21-0653",
          "データID": "JGAD000319"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0156.v1": {
          "Research ID": "hum0156.v1",
          "公開日": "2021/07/30",
          "内容": "NGS（Exome）",
          "description": "食道がん33症例の腫瘍組織および末梢血から抽出したDNAを用いたExome解析の結果をfastqファイルにて提供する。Agilent SureSelect XT Human All Exon V5＋RegによりExon領域にしぼり、Illumina HiSeq 2500にて平均長100塩基を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0156.v1",
      "DATA": {
        "JGAS000227": {
          "Data Set ID": "JGAS000227",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/30"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify mechanisms of resistance to chemoradiotherapy for esophageal cancer",
        "Methods": "DNA was extracted from peripheral blood cells and tumor tissues obtained by endoscopyc biopsy or surgery. Then whole exome sequencing was performed.",
        "Participants/Materials": "Esophageal cancers treated with chemoradioherapy",
        "URL": "https://www.beppu.kyushu-u.ac.jp/gekareview/en/"
      },
      "MOLECULAR DATA": {
        "JGAS000227": {
          "Participants/Materials": "Esophageal cancer: 33 cases\r\n    tumor tissues: 52 samples\r\n    peripheral blood: 33 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor tissues or peripheral blood from esophageal cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect XT Human All Exon V5+Reg",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000319",
          "Total Data Volume": "1 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koshi Mimori",
        "Affiliation": "Department of Surgery, Kyushu University Beppu Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "KAKENHI Grant-in-Aid for Young Scientists (B)",
            "Title": "Next-generation sequencing approach detect chemoradiotherapy response in esophageal cancer",
            "Project Number": "26861003"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy",
          "DOI": "doi: 10.1158/0008-5472.CAN-21-0653",
          "Data Set ID": "JGAD000319"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0156.v1": {
          "Research ID": "hum0156.v1",
          "Release Date": "2021/07/30",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor tissues and peripheral blood cells from 33 esophageal cancer patients were used for the whole exome sequencing analysis (fastq files). Exons were narrowed down by using of Agilent SureSelect XT Human All Exon V5 + Reg and read by Illumina HiSeq 2500 (Paired-end: 100 bp).\nNote:\n"
        }
      }
    }
  },
  "hum0153.v1": {
    "ja": {
      "NBDC Research ID": "hum0153.v1",
      "データ": {
        "JGAS000177": {
          "データID": "JGAS000177",
          "内容": "NGS（Exome、RNA-seq、Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/09/20"
        }
      },
      "研究内容の概要": {
        "目的": "脱分化型脂肪肉腫および腱鞘巨細胞種の疾患発症・予後に関連する遺伝子の探索",
        "方法": "腫瘍組織および同一患者の非腫瘍組織（血液もしくは周辺正常組織）より抽出したDNA・RNAを用いたWhole Exome Sequencing（WES）、RNA-seq、ならびにTarget Capture Sequencing",
        "対象": ""
      },
      "分子データ": {
        "Exome": {
          "対象": "脱分化脂肪肉腫（ICD10：C49）：29症例\r\n・腫瘍組織：脱分化型成分29検体、高分化型成分8検体\r\n・非腫瘍組織（末梢血）：29検体\r\n腱鞘巨細胞種（ICD10：D21）：10症例\r\n・腫瘍組織：10検体\r\n・非腫瘍組織：10検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織もしくは末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "脱分化脂肪肉腫：SureSelect XT Human All Exon V5 + IncRNA kit\r\n腱鞘巨細胞種：SureSelect Exome V5 kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "脱分化脂肪肉腫：JGAD000257\r\n腱鞘巨細胞種：JGAD000258",
          "総データ量": "1 TB（bam、fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "脱分化脂肪肉腫（ICD10：C49）：19症例\r\n・腫瘍組織：脱分化型成分19検体、高分化型成分7検体\r\n腱鞘巨細胞種（ICD10：D21）：18症例\r\n・腫瘍組織：18検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Prep kit または TruSeq RNA Access Library Prep kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "脱分化脂肪肉腫：JGAD000257\r\n腱鞘巨細胞種：JGAD000258",
          "総データ量": "1 TB（bam、fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture": {
          "対象": "腱鞘巨細胞種（ICD10：D21）：34症例\r\n・腫瘍組織：34検体\r\n・非腫瘍組織：34検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "CBL遺伝子領域",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "PCRにてCBL遺伝子の全エクソン領域を増幅＋TruSeq Nano DNA Library Prepkit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000258",
          "総データ量": "1 TB（bam、fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "松田 浩一 / 平田 真",
        "所 属 機 関": "東京大学 大学院新領域創成科学研究科 / 医科学研究所 ヒトゲノム解析センター",
        "プロジェクト/研究グループ名": "骨軟部腫瘍ゲノムコンソーシアム",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（A）",
            "タイトル": "骨軟部腫瘍における診断マーカーの同定と腫瘍概念の再構築を目指した融合遺伝子の探索",
            "研究課題番号": "16H02676"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations",
          "DOI": "doi: 10.1002/ijc.32421",
          "データID": "JGAD000257\r\nJGAD000258"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Valerie Brunton": {
          "研究代表者": "Valerie Brunton",
          "所属機関": "Edinburgh Cancer Research UK Centrer",
          "研究題目": "",
          "利用データID": "Genomic analysis of soft tissue sarcoma",
          "利用期間": "JGAD000257, JGAD000258"
        },
        "William Tapper": {
          "研究代表者": "William Tapper",
          "所属機関": "Human Development and Health, University of Southampton",
          "研究題目": "イギリス",
          "利用データID": "Utilising sarcoma omic information to identify disease gene networks and associated novel therapies for patients",
          "利用期間": "JGAD000257"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000257, JGAD000258"
        }
      },
      "リリース情報": {
        "hum0153.v1": {
          "Research ID": "hum0153.v1",
          "公開日": "2019/09/20",
          "内容": "NGS（Exome、RNA-seq、Target Capture）",
          "description": "脱分化型脂肪肉腫および腱鞘巨細胞種の腫瘍組織及び非腫瘍組織（末梢血もしくは周辺正常組織）から抽出したDNA・RNAを用いた全エクソン解析、全トランスクリプトーム解析およびターゲットキャプチャーシークエンス解析結果をfastqおよびbamファイルにて提供する。\n脱分化型脂肪肉腫および同一患者の末梢血よりDNA・RNAを抽出後、Agilent SureSelect XT Human All Exon V5 + IncRNA kit（WES)、TruSeq Stranded mRNA Prep kit または TruSeq RNA Access Library Prep kit (RNA seq)にてライブラリを作成し、Illumina HiSeq 2500にて配列解読を行った。\n腱鞘巨細胞種および同一患者の非腫瘍組織（周辺正常組織）よりDNA・RNAを抽出後、Agilent SureSelect Exome V5 kit（WES)、TruSeq Stranded mRNA Prep kitもしくはTruSeq RNA Access Library Prep kit (RNA seq)にてライブラリを作成しIllumina HiSeq 2500にてシークエンスを行った。Target sequenceはCBL遺伝子の全エクソン領域をPCRにて増幅後、TruSeq Nano DNA Library Prepkitにてライブラリーを作成、MiSeqにて配列解読を行った。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0153.v1",
      "DATA": {
        "JGAS000177": {
          "Data Set ID": "JGAS000177",
          "Type of Data": "NGS (Exome, RNA-seq, Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/09/20"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of genetics alterations of dedifferentiated liposarcoma and tendon sheath giant cell tumors (TSGCT)",
        "Methods": "DNAs and RNAs were extracted from tumor and paired non-tumor tissues (peripheral blood or adjacent normal tissues). Whole exome sequencing (WES), RNA sequencing, and target capture sequencing were performed by HiSeq 2500 or MiSeq (Illumina).",
        "Participants/Materials": "29 dedifferentiated liposarcoma and 36 TSGCT patients"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "Dedifferentiated liposarcoma (ICD10: C49): 29 cases\r\n - 29 dedifferentiated components, 8 well-differentiated components, and 29 peripheral blood tissues\r\nTSGCT (ICD10: D21): 10 cases\r\n - 10 tumor tissues and 10 non-tumor tissues",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues/peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Dedifferentiated liposarcoma: SureSelect XT Human All Exon V5 + IncRNA kit\r\nTSGCT: SureSelect Exome V5 kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "Dedifferentiated liposarcoma: JGAD000257\r\nTSGCT: JGAD000258",
          "Total Data Volume": "1 TB (bam, fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Dedifferentiated liposarcoma (ICD10: C49): 19 cases\r\n - 19 Dedifferentiated components and 7 well-differentiated components\r\nTSGCT (ICD10: C49): 18 cases\r\n - 18 tumor tissues",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Prep kit or TruSeq RNA Access Library Prep kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "Dedifferentiated liposarcoma: JGAD000257\r\nTSGCT: JGAD000258",
          "Total Data Volume": "1 TB (bam, fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture": {
          "Participants/Materials": "TSGCT (ICD10: C49): 34 cases\r\n - 34 tumor tissues and 34 non-tumorl tissues",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "exon regions of CBL gene",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "PCR + TruSeq Nano DNA Library Prepkit",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end or Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000258",
          "Total Data Volume": "1 TB (bam, fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koichi Matsuda / Makoto Hirata",
        "Affiliation": "Graduate school of Frontier Science / Institute of Medical Science, The University of Tokyo",
        "Project / Group Name": "Japan Sarcome genome consortium",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (A)",
            "Title": "Analysis of fusion transcripts in bone and soft tissue tumors for indentification of novel disease biomarker and reorganization of disease classification.",
            "Project Number": "16H02676"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations",
          "DOI": "doi: 10.1002/ijc.32421",
          "Data Set ID": "JGAD000257\r\nJGAD000258"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Valerie Brunton": {
          "Principal Investigator": "Valerie Brunton",
          "Affiliation": "Edinburgh Cancer Research UK Centrer",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Genomic analysis of soft tissue sarcoma",
          "Period of Data Use": "JGAD000257, JGAD000258"
        },
        "William Tapper": {
          "Principal Investigator": "William Tapper",
          "Affiliation": "Human Development and Health, University of Southampton",
          "Research Title": "United Kingdom of Great Britain and Northern Ireland",
          "Data in Use (Dataset ID)": "Utilising sarcoma omic information to identify disease gene networks and associated novel therapies for patients",
          "Period of Data Use": "JGAD000257"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000257, JGAD000258"
        }
      },
      "Release Note": {
        "hum0153.v1": {
          "Research ID": "hum0153.v1",
          "Release Date": "2019/09/20",
          "Type of Data": "NGS (Exome, RNA-seq, Target Capture)",
          "description": "DNAs and RNAs were extracted from tumor and paired non-tumor (or peripheral blood) tissues of dedifferentiated liposarcoma and Tendon sheath giant cell tumors (TSGCT). Data are provided as bam and fastq files.\n[dedifferentiated liposarcoma / well-dediffirentiated liposarcoma] \nNGS libaraies were prepared by using of Agilent SureSelect XT Human All Exon V5 + IncRNA kit for DNA and TruSeq Stranded mRNA Prep kit or TruSeq RNA Access Library Prep kit for RNA. Whole exome sequencing (WES) and RNA Sequencing were perfomred by Illumina HiSeq 2500.\n[TSGCT]\nNGS libaraies were prepared by using of Agilent SureSelect Exome V5 kit for DNA and TruSeq Stranded mRNA Prep kit or TruSeq RNA Access Library Prep kit for RNA, and PCR + TruSeq Nano DNA Library Prepkit for DNA. WES, RNA-seq, and Target Capture Sequencing were perfomred by Illumina HiSeq 2500 or MiSeq.\nNote：\n"
        }
      }
    }
  },
  "hum0152.v2": {
    "ja": {
      "NBDC Research ID": "hum0152.v2",
      "データ": {
        "JGAS000182": {
          "データID": "JGAS000182",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/09/20"
        },
        "JGAS000529": {
          "データID": "JGAS000529",
          "内容": "NGS（WGS、Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/11/15"
        }
      },
      "研究内容の概要": {
        "目的": "脱分化型脂肪肉腫のゲノム異常の解析",
        "方法": "Exome sequencing、RNA sequencing、Whole genome sequencing",
        "対象": "脱分化型脂肪肉腫37症例の腫瘍組織および非腫瘍組織、lipoblastoma-like tumor of the vulva（LLTV）1症例の腫瘍組織および血液"
      },
      "分子データ": {
        "Exome（JGAS000182）": {
          "対象": "脱分化型脂肪肉腫（ICD10：C480, C490, C492, C493）：37症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect XT Human All Exon V5",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000264",
          "総データ量": "880 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq（JGAS000182）": {
          "対象": "脱分化型脂肪肉腫（ICD10：C480, C490, C492, C493）：37症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ribo-Zero Gold kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000264",
          "総データ量": "880 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGS（JGAS000529）": {
          "対象": "LLTV（ICD10：C49、C51）：1症例",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織および血液から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Twist Library Preparation EF kit",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "BWA-MEM",
          "マッピングクオリティ": "MAPQ < 20 を除外",
          "マッピングの際のリファレンス配列": "hg38",
          "平均カバー率（Depth）": "81",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000648",
          "総データ量": "233.6 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Exome（JGAS000529）": {
          "対象": "LLTV（ICD10：C49、C51）：1症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織および血液から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Twist Library Preparation EF kit、Twist Comprehensive Exome Panel",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end or Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "マッピング方法": "BWA-MEM",
          "マッピングクオリティ": "MAPQ < 20 を除外",
          "マッピングの際のリファレンス配列": "hg38",
          "平均カバー率（Depth）": "431",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000648",
          "総データ量": "233.6 GB（bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq（JGAS000529）": {
          "対象": "LLTV（ICD10：C49、C51）：1症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra Directional RNA Library Prep Kit for Illumina",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000648",
          "総データ量": "233.6 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "市川 仁",
        "所 属 機 関": "国立がん研究センター 研究所 臨床ゲノム解析部門",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "国立がん研究センター研究開発費",
            "タイトル": "拡張型コアファシリティ機能による、TR／リバースTRの総合支援を含む研究・開発支援",
            "研究課題番号": "26-A-3"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Frequent amplification of receptor tyrosine kinase genes in well-differentiated/ dedifferentiated liposarcoma",
          "DOI": "doi: 10.18632/oncotarget.14652",
          "データID": "JGAD000264"
        },
        "2": {
          "タイトル": "Comprehensive genetic analysis of a lipoblastoma-like tumor of the vulva",
          "DOI": "doi: 10.1016/j.joscr.2022.09.002",
          "データID": "JGAD000648"
        }
      },
      "制限公開データの利用者一覧": {
        "Valerie Brunton": {
          "研究代表者": "Valerie Brunton",
          "所属機関": "Edinburgh Cancer Research UK Centrer",
          "研究題目": "",
          "利用データID": "Genomic analysis of soft tissue sarcoma",
          "利用期間": "JGAD000264"
        },
        "William Tapper": {
          "研究代表者": "William Tapper",
          "所属機関": "Human Development and Health, University of Southampton",
          "研究題目": "イギリス",
          "利用データID": "Utilising sarcoma omic information to identify disease gene networks and associated novel therapies for patients",
          "利用期間": "JGAD000264"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000264"
        }
      },
      "リリース情報": {
        "hum0152.v2": {
          "Research ID": "hum0152.v2",
          "公開日": "2022/11/15",
          "内容": "NGS（WGS、Exome、RNA-seq）",
          "description": "lipoblastoma-like tumor of the vulva（LLTV）1症例の腫瘍組織および血液から抽出したDNA・RNAを用いた全ゲノム解析、全エクソン解析および全トランスクリプトーム解析結果をfastqならびにbamファイルにて提供する。WGS：Illumina NovaSeq 6000にて平均長150塩基のDNA断片を解読した（Paired-end）。Exome：Twist Comprehensive Exome Panelを用いてExon領域にしぼりIllumina NovaSeq 6000にて平均長150塩基のDNA断片を解読した（Paired-end）。RNA-seq：NEBNext Ultra Directional RNA Library Prep Kit for IlluminaによるRNAライブラリ作製後、Illumina NovaSeq 6000にて平均長150 bpを読んだ（Paired-end）。\n"
        },
        "hum0152.v1": {
          "Research ID": "hum0152.v1",
          "公開日": "2019/09/20",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "脱分化型脂肪肉腫の腫瘍組織及び非腫瘍組織から抽出したDNA・RNAを用いた全エクソン解析および全トランスクリプトーム解析結果をfastqファイルにて提供する。Agilent SureSelect XT Human All Exon V5を用いてExon領域にしぼりIllumina HiSeq 2500にて平均長75塩基のDNA断片を解読した（Paired-end）。Ribo-Zero Gold kitによるRNAライブラリ作製後、Illumina HiSeq 2500にて平均長75 bpを読んだ（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0152.v2",
      "DATA": {
        "JGAS000182": {
          "Data Set ID": "JGAS000182",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/09/20"
        },
        "JGAS000529": {
          "Data Set ID": "JGAS000529",
          "Type of Data": "NGS (WGS, Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/11/15"
        }
      },
      "SUMMARY": {
        "Aims": "Analysis of genomic alterations in dedifferentiated liposarcoma",
        "Methods": "Exome sequencing, RNA sequencing, Whole genome sequencing",
        "Participants/Materials": "37 patients with dedifferentiated liposarcoma, a patient with lipoblastoma-like tumor of the vulva (LLTV)"
      },
      "MOLECULAR DATA": {
        "Exome (JGAS000182)": {
          "Participants/Materials": "Dedifferentiated liposarcoma (ICD10: C480, C490, C492, C493): 37 cases",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect XT Human All Exon V5",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000264",
          "Total Data Volume": "880 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq (JGAS000182)": {
          "Participants/Materials": "Dedifferentiated liposarcoma (ICD10: C480, C490, C492, C493): 37 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ribo-Zero Gold kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000264",
          "Total Data Volume": "880 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGS (JGAS000529)": {
          "Participants/Materials": "LLTV (ICD10: C49、C51): 1 case",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNA extracted from tumor tissue and blood",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Twist Library Preparation EF kit",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "BWA-MEM",
          "Mapping Quality": "MAPQ < 20 were excluded",
          "Reference Genome Sequence": "hg38",
          "Coverage (Depth)": "81",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000648",
          "Total Data Volume": "233.6 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        },
        "Exome (JGAS000529)": {
          "Participants/Materials": "LLTV (ICD10: C49、C51): 1 case",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNA extracted from tumor tissue and blood",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Twist Library Preparation EF kit, Twist Comprehensive Exome Panel",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Mapping Methods": "BWA-MEM",
          "Mapping Quality": "MAPQ < 20 were excluded",
          "Reference Genome Sequence": "hg38",
          "Coverage (Depth)": "431",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000648",
          "Total Data Volume": "233.6 GB (bam)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq (JGAS000529)": {
          "Participants/Materials": "LLTV (ICD10: C49、C51): 1 case",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNA extracted from tumor tissue",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra Directional RNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000648",
          "Total Data Volume": "233.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hitoshi Ichikawa",
        "Affiliation": "Department of Clinical Genomics, National Cancer Center Research Institute",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "National Cancer Center Research and Development Funds",
            "Title": "-",
            "Project Number": "26-A-1"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Frequent amplification of receptor tyrosine kinase genes in well-differentiated/ dedifferentiated liposarcoma",
          "DOI": "doi: 10.18632/oncotarget.14652",
          "Data Set ID": "JGAD000264"
        },
        "2": {
          "Title": "Comprehensive genetic analysis of a lipoblastoma-like tumor of the vulva",
          "DOI": "doi: 10.1016/j.joscr.2022.09.002",
          "Data Set ID": "JGAD000648"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Valerie Brunton": {
          "Principal Investigator": "Valerie Brunton",
          "Affiliation": "Edinburgh Cancer Research UK Centrer",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Genomic analysis of soft tissue sarcoma",
          "Period of Data Use": "JGAD000264"
        },
        "William Tapper": {
          "Principal Investigator": "William Tapper",
          "Affiliation": "Human Development and Health, University of Southampton",
          "Research Title": "United Kingdom of Great Britain and Northern Ireland",
          "Data in Use (Dataset ID)": "Utilising sarcoma omic information to identify disease gene networks and associated novel therapies for patients",
          "Period of Data Use": "JGAD000264"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000264"
        }
      },
      "Release Note": {
        "hum0152.v2": {
          "Research ID": "hum0152.v2",
          "Release Date": "2022/11/15",
          "Type of Data": "NGS (WGS, Exome, RNA-seq)",
          "description": "DNAs and RNAs were extracted from tumor tissue and blood of a patient with lipoblastoma-like tumor of the vulva (LLTV). Whole genome sequencing was performed by llumina NovaSeq 6000 (150 bp, Paired-end). Exons were narrowed down by using of Twist Comprehensive Exome Panel and read by llumina NovaSeq 6000 (150 bp, Paired-end). Libraries for RNA-seq were prepared with NEBNext Ultra Directional RNA Library Prep Kit for Illumina and RNA-seq was performed with llumina NovaSeq 6000 (150 bp, Paired-end). Data are provided as fastq and bam files.\n"
        },
        "hum0152.v1": {
          "Research ID": "hum0152.v1",
          "Release Date": "2019/09/20",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs and RNAs were extracted from tumor and non-tumor tissues of dedifferentiated liposarcoma. Exons were narrowed down by using of Agilent SureSelect XT Human All Exon V5 and read by llumina HiSeq 2500 (75 bp, Paired-end). Libraries for RNA-seq were prepared with Ribo-Zero Gold kit and RNA-seq was performed with llumina HiSeq 2500 (75 bp, Paired-end). Data are provided as fastq files.\nNote：\n"
        }
      }
    }
  },
  "hum0148.v1": {
    "ja": {
      "NBDC Research ID": "hum0148.v1",
      "データ": {
        "JGAS000149": {
          "データID": "JGAS000149",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/06/20"
        }
      },
      "研究内容の概要": {
        "目的": "腎細胞がんの診断および治療標的遺伝子の探索",
        "方法": "腫瘍組織から抽出したRNAを用いたRNAseqによる網羅的遺伝子発現解析",
        "対象": "がん研究会有明病院の腎がん患者由来の原発巣（43症例）並びに転移巣（24症例）の腫瘍組織"
      },
      "分子データ": {
        "JGAS000149": {
          "対象": "腎がん（ICD10：C64）：67症例\r\n      原発巣：43症例\r\n      転移巣：24症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Genome Analyzer IIx]",
          "ライブラリソース": "腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Sample Prep Kit v2",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "51 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000223\r\nJGAD000224\r\nJGAD000225",
          "総データ量": "67 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および Cancer Research Use Only"
        }
      },
      "提供者情報": {
        "研究代表者": "湯浅 健",
        "所 属 機 関": "がん研究会有明病院・泌尿器科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "喫煙科学研究財団",
            "タイトル": "腎癌における遺伝子変異・発現異常を基にした治療体系確立への基礎研究",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "ADP-ribosylation factor-like 4C is a predictive biomarker of poor prognosis in patients with renal cell carcinoma",
          "DOI": "PMID: 30906638",
          "データID": "JGAD000223\r\nJGAD000224\r\nJGAD000225"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0148.v1": {
          "Research ID": "hum0148.v1",
          "公開日": "2019/06/20",
          "内容": "NGS（RNA-seq）",
          "description": "腎癌患者由来の原発巣並びに転移巣の腫瘍組織から抽出したRNAを用いたRNA-seqデータをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0148.v1",
      "DATA": {
        "JGAS000149": {
          "Data Set ID": "JGAS000149",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/06/20"
        }
      },
      "SUMMARY": {
        "Aims": "The exploratory research of diagnositic biomarkers and therapeutic targets of renal cell carcinoma.",
        "Methods": "RNA-seq",
        "Participants/Materials": "Primary and metastatic tumor tissues of renal cell carcinomas"
      },
      "MOLECULAR DATA": {
        "JGAS000149": {
          "Participants/Materials": "renal cell carcinomas (ICD10: C64): 67 cases\r\n      primary tissues: 43 cases\r\n      metastatic tissues: 24 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Genome Analyzer IIx]",
          "Library Source": "RNAs extracted from primary and metastatic tumor tissues of renal cell carcinomas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Sample Prep Kit v2",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "51 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000223\r\nJGAD000224\r\nJGAD000225",
          "Total Data Volume": "67 GB (fastq)",
          "Comments (Policies)": "NBDC policy & Cancer Research Use Only"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takeshi Yuasa",
        "Affiliation": "The Cancer Institute Hospital of Japanese Foundation for Cancer Research (JFCR)",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Smoking Research Foundation",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "ADP-ribosylation factor-like 4C is a predictive biomarker of poor prognosis in patients with renal cell carcinoma",
          "DOI": "PMID: 30906638",
          "Data Set ID": "JGAD000223\r\nJGAD000224\r\nJGAD000225"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0148.v1": {
          "Research ID": "hum0148.v1",
          "Release Date": "2019/06/20",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from primary and metastatic tissues of renal cell carcinomas were used for RNA-seq analysis (fastq files). \nNote：\n"
        }
      }
    }
  },
  "hum0147.v3": {
    "ja": {
      "NBDC Research ID": "hum0147.v3",
      "データ": {
        "JGAS000145": {
          "データID": "JGAS000145",
          "内容": "NGS（RNA-seq）\r\nNGS（ChIP-seq）\r\nNGS（PBAT-seq）\r\nNGS（ATAC-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/05/25"
        },
        "JGAS000312": {
          "データID": "JGAS000312",
          "内容": "NGS（scRNA-seq）\r\nNGS（bulk RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/02/18"
        },
        "JGAS000454": {
          "データID": "JGAS000454",
          "内容": "NGS（bulk RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/05/08"
        }
      },
      "研究内容の概要": {
        "目的": "制御性T細胞（Treg）特異的エピゲノムの解析、ならびに、がん、自己免疫疾患における免疫担当細胞の解析",
        "方法": "RNA-seq、ChIP-seq、PBAT-seq、ATAC-seq、single cell RNA-seq、bulk RNA-seq",
        "対象": "健常人4名（STR1、STR5、STR6、BDR1）、がん患者7＋3症例"
      },
      "分子データ": {
        "NGS（RNA-seq）": {
          "対象": "健常人：2名（STR1、STR5）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "ライブラリソース": "健常人末梢血下記５分画から抽出したRNA\r\n　　・Fraction 1：naive Treg\r\n　　・Fraction 2：effector Treg\r\n　　・Fraction 3：Foxp3+ effector conventional T cells\r\n　　・Fraction 5：effector conventional T cells\r\n　　・Fraction 6：naive T cells",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA Library Preparation Kit",
          "断片化の方法": "KAPA Frag",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000214",
          "総データ量": "1.6 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "NGS（ChIP-seq）": {
          "対象": "健常人：1名（STR1）",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "ライブラリソース": "健常人末梢血下記５分画から抽出したDNAに対し、抗ヒストン抗体（H3K27ac）を用いて免疫沈降\r\n　　・Fraction 1：naive Treg\r\n　　・Fraction 2：effector Treg\r\n　　・Fraction 3：Foxp3+ effector conventional T cells\r\n　　・Fraction 5：effector conventional T cells\r\n　　・Fraction 6：naive T cells",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA Library Preparation Kit",
          "断片化の方法": "Branson model1250D",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000214",
          "総データ量": "1.6 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "NGS（PBAT-seq）": {
          "対象": "健常人：4名（STR1、STR5、STR6、BDR1）",
          "規模": "PBAT-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500/NovaSeq 6000]",
          "ライブラリソース": "健常人末梢血下記５分画から抽出したDNA\r\n　　・Fraction 1：naive Treg\r\n　　・Fraction 2：effector Treg\r\n　　・Fraction 3：Foxp3+ effector conventional T cells\r\n　　・Fraction 5：effector conventional T cells\r\n　　・Fraction 6：naive T cells",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "EZ DNAMethylation-Gold Kit ver.2.1.3, ACCEL-NGS METHYL-SEQ DNA LIBRARY KIT ver3.0",
          "断片化の方法": "ACCEL-NGS METHYL-SEQ DNA LIBRARY KIT ver3.0",
          "ライブラリ構築方法": "Paired-end and Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100bp, 150bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000214",
          "総データ量": "1.6 TB（fastq, tab [ref: GRCh38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "NGS（ATAC-seq）": {
          "対象": "健常人：2名（STR1、STR5）",
          "規模": "ATAC-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "ライブラリソース": "健常人末梢血下記５分画から抽出したDNA\r\n　　・Fraction 1：naive Treg\r\n　　・Fraction 2：effector Treg\r\n　　・Fraction 3：Foxp3+ effector conventional T cells\r\n　　・Fraction 5：effector conventional T cells\r\n　　・Fraction 6：naive T cells",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA Library Preparation Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000214",
          "総データ量": "1.6 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "NGS（scRNA-seq）": {
          "対象": "健常人：1名（STR5）\r\nがん：5症例\r\n    膀胱がん（ICD10：C67）、大腸がん（ICD10：C20）、腎がん（ICD10：C64）、肺がん（ICD10：C34.3）、卵巣がん（ICD10：C56）",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 3000]",
          "ライブラリソース": "健常人末梢血T細胞およびがん患者腫瘍浸潤T細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "BD Rhapsody Targeted mRNA kits",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000423",
          "総データ量": "279.9 GB（fastq、csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "NGS（bulk RNA-seq）": {
          "対象": "腎がん（ICD10：C64）：2症例\r\n    末梢血T細胞：各6分画（Fr1, Fr2, Fr3, Fr4, Fr5, Fr6）\r\n    腫瘍浸潤T細胞：各4分画（Fr2, Fr3, Fr4, Fr5）\r\n肺がん（ICD10：C34）：3症例\r\n    腫瘍浸潤T細胞：各2分画",
          "規模": "bulk RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500/4000]",
          "ライブラリソース": "末梢血T細胞分画および腫瘍浸潤T細胞分画から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA Hyper Prep Kit",
          "断片化の方法": "KAPA Frag",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "腎がん：JGAD000423\r\n肺がん：JGAD000571",
          "総データ量": "JGAD000423：279.9 GB（fastq）\r\nJGAD000571：7.6 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "坂口 志文",
        "所 属 機 関": "大阪大学 免疫学フロンティア研究センター 実験免疫学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業インキュベートタイプ（AMED-LEAP）",
            "タイトル": "制御性T細胞を標的とした免疫応答制御技術に関する研究開発",
            "研究課題番号": "JP18gm0010005"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases",
          "DOI": "doi: 10.1016/j.immuni.2020.04.006",
          "データID": "JGAD000214"
        },
        "2": {
          "タイトル": "CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory",
          "DOI": "doi: 10.1073/pnas.2114282119",
          "データID": "JGAD000423"
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000214"
        },
        "高地 雄太": {
          "研究代表者": "高地 雄太",
          "所属機関": "東京医科歯科大学 難治疾患研究所 ゲノム機能多様性分野",
          "研究題目": "日本",
          "利用データID": "機能性遺伝子多型の網羅的解析を介した多因子疾患の病態解明",
          "利用期間": "JGAD000214"
        }
      },
      "リリース情報": {
        "hum0147.v3": {
          "Research ID": "hum0147.v3",
          "公開日": "2023/05/08",
          "内容": "NGS（bulk RNA-seq）",
          "description": "肺がん患者3症例の腫瘍浸潤T細胞から抽出したRNAを対象としたbulk RNA-seqを行った結果を提供する。\n"
        },
        "hum0147.v2": {
          "Research ID": "hum0147.v2",
          "公開日": "2022/02/18",
          "内容": "NGS（scRNA-seq、bulk RNA-seq）",
          "description": "健常人1名の末梢血T細胞およびがん患者5症例の腫瘍浸潤T細胞から抽出したRNAを対象としたsingle cell RNA-Seq、ならびにがん患者2症例の末梢血T細胞分画および腫瘍浸潤T細胞分画から抽出したRNAを対象としたbulk RNA-seqを行った結果を提供する。\n"
        },
        "hum0147.v1": {
          "Research ID": "hum0147.v1",
          "公開日": "2020/05/25",
          "内容": "NGS（RNA-seq、ChIP-seq、PBAT-seq、ATAC-seq）",
          "description": "健常人4名の末梢血５分画（Fr1：naive Treg、Fr2：effector Treg、Fr3：Foxp3+ effector conventional T cells、Fr5：effector conventional T cells、Fr6：naive T cells）から抽出したDNA/RNAを対象としたRNA-seq、ChIP-seq（H3K27ac）、PBAT-seq、ATAC-seqを行った結果を提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0147.v3",
      "DATA": {
        "JGAS000145": {
          "Data Set ID": "JGAS000145",
          "Type of Data": "NGS (RNA-seq)\r\nNGS (ChIP-seq)\r\nNGS (PBAT-seq)\r\nNGS (ATAC-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/05/25"
        },
        "JGAS000312": {
          "Data Set ID": "JGAS000312",
          "Type of Data": "NGS (scRNA-seq)\r\nNGS (bulk RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/02/18"
        },
        "JGAS000454": {
          "Data Set ID": "JGAS000454",
          "Type of Data": "NGS (bulk RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/05/08"
        }
      },
      "SUMMARY": {
        "Aims": "Analysis of epigenetic status of regulatory T cells (Treg) and analysis of immune cells in cancers and autoimmune diseases",
        "Methods": "RNA-seq, ChIP-seq, PBAT-seq, ATAC-seq, single cell RNA-seq, and bulk RNA-seq",
        "Participants/Materials": "Healthy donors and cancer patients"
      },
      "MOLECULAR DATA": {
        "NGS (RNA-seq)": {
          "Participants/Materials:": "2 healthy donors (STR1, STR5)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "Library Source": "RNAs extracted from 5 fractions from peripheral blood cells of healthy donors\r\n       - Fraction 1: naive Treg\r\n       - Fraction 2: effector Treg\r\n       - Fraction 3: Foxp3+ effector conventional T cells\r\n       - Fraction 5: effector conventional T cells\r\n       - Fraction 6: naive T cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Library Preparation Kit",
          "Fragmentation Methods": "KAPA Frag",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp on average",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000214",
          "Total Data Volume": "1.6 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "NGS (ChIP-seq)": {
          "Participants/Materials:": "1 healthy donor (STR1)",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "Library Source": "DNAs extracted from 5 fractions from peripheral blood cells of healthy donors, and immunoprecipitated with an anti-histone antibody (H3K27ac)\r\n       - Fraction 1: naive Treg\r\n       - Fraction 2: effector Treg\r\n       - Fraction 3: Foxp3+ effector conventional T cells\r\n       - Fraction 5: effector conventional T cells\r\n       - Fraction 6: naive T cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Library Preparation Kit",
          "Fragmentation Methods": "Branson model1250D",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp on average",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000214",
          "Total Data Volume": "1.6 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "NGS (PBAT-seq)": {
          "Participants/Materials:": "4 healthy donors (STR1, STR5, STR6, BDR1)",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500/NovaSeq 6000]",
          "Library Source": "DNAs extracted from 5 fractions from peripheral blood cells of healthy donors\r\n       - Fraction 1: naive Treg\r\n       - Fraction 2: effector Treg\r\n       - Fraction 3: Foxp3+ effector conventional T cells\r\n       - Fraction 5: effector conventional T cells\r\n       - Fraction 6: naive T cells\r\n ",
          "Cell Lines": "-",
          "Library Construction (kit name)": "EZ DNAMethylation-Gold Kit ver.2.1.3, ACCEL-NGS METHYL-SEQ DNA LIBRARY KIT ver3.0",
          "Fragmentation Methods": "ACCEL-NGS METHYL-SEQ DNA LIBRARY KIT ver3.0",
          "Spot Type": "Paired-end and Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100bp, 150bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000214",
          "Total Data Volume": "1.6 TB (fastq, tab [ref: GRCh38])",
          "Comments (Policies)": "NBDC policy"
        },
        "NGS (ATAC-seq)": {
          "Participants/Materials:": "2 healty donors (STR1, STR5)",
          "Targets": "ATAC-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "Library Source": "DNAs extracted from 5 fractions from peripheral blood cells of healthy donors\r\n       - Fraction 1: naive Treg\r\n       - Fraction 2: effector Treg\r\n       - Fraction 3: Foxp3+ effector conventional T cells\r\n       - Fraction 5: effector conventional T cells\r\n       - Fraction 6: naive T cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Library Preparation Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp on average",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000214",
          "Total Data Volume": "1.6 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "NGS (scRNA-seq)": {
          "Participants/Materials:": "1 healthy donor (STR5)\r\n5 cancer patients\r\n    Bladder cancer (ICD10: C67), Colon cancer (ICD10: C20), Kidney cancer (ICD10: C64), Lung cancer (ICD10: C34.3), Ovarian cancer (ICD10: C56)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 3000]",
          "Library Source": "RNAs extracted from T cells of peripheral blood mononuclear cells from a healthy donor and tumor-infiltrating T cells from cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "BD Rhapsody Targeted mRNA kits",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000423",
          "Total Data Volume": "279.9 GB (fastq, csv)",
          "Comments (Policies)": "NBDC policy"
        },
        "NGS (bulk RNA-seq)": {
          "Participants/Materials:": "Kidney cancer (ICD10: C64): 2 cases\r\n    T cells of peripheral blood mononuclear cells: 6 fractions each\r\n    tumor-infiltrating T cells: 4 fractions each\r\nLung cancer (ICD10: C34): 3 cases\r\n    tumor-infiltrating T cells: 2 fractions each",
          "Targets": "bulk RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500/4000]",
          "Library Source": "RNAs extracted from T cell fractions of peripheral blood mononuclear cells and tumor-infiltrating T cell fractions",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Hyper Prep Kit",
          "Fragmentation Methods": "KAPA Frag",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "Kidney cancer: JGAD000423\r\nLung cancer: JGAD000571",
          "Total Data Volume": "JGAD000423: 279.9 GB (fastq)\r\nJGAD000571: 7.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shimon Sakaguchi",
        "Affiliation": "Experimental Immunology, IFReC, Osaka University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Leading Advanced Projects for medical innovation, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-LEAP)",
            "Title": "Study of Immunoregulatory technology targeting regulatory T cells",
            "Project Number": "JP18gm0010005"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases",
          "DOI": "doi: 10.1016/j.immuni.2020.04.006",
          "Data Set ID": "JGAD000214"
        },
        "2": {
          "Title": "CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory",
          "DOI": "doi: 10.1073/pnas.2114282119",
          "Data Set ID": "JGAD000423"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000214"
        },
        "Yuta Kochi": {
          "Principal Investigator": "Yuta Kochi",
          "Affiliation": "Department of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic study of complex diseases through comprehensive analysis of functional genetic variations",
          "Period of Data Use": "JGAD000214"
        }
      },
      "Release Note": {
        "hum0147.v3": {
          "Research ID": "hum0147.v3",
          "Release Date": "2022/12/08",
          "Type of Data": "NGS (bulk RNA-seq)",
          "description": "RNA extracted from tumor-infiltrating T cell fractions were used for bulk RNA-seq analysis.\n"
        },
        "hum0147.v2": {
          "Research ID": "hum0147.v2",
          "Release Date": "2022/02/18",
          "Type of Data": "NGS (scRNA-seq, bulk RNA-seq)",
          "description": "RNA extracted from T cells of peripheral blood mononuclear cells from a healthy donor and tumor-infiltrating T cells from cancer patients were used for single cell RNA-seq analysis. RNA extracted from T cell fractions of peripheral blood mononuclear cells and tumor-infiltrating T cell fractions were used for bulk RNA-seq analysis.\n"
        },
        "hum0147.v1": {
          "Research ID": "hum0147.v1",
          "Release Date": "2020/05/25",
          "Type of Data": "NGS (RNA-seq, ChIP-seq, PBAT-seq, ATAC-seq)",
          "description": "DNA/RNA extracted from 5 fractions from peripheral blood cells of healthy individuals (Fr1: naive Treg, Fr2: effector Treg, Fr3: Foxp3+ effector conventional T cells, Fr5: effector conventional T cells, Fr6: naive T cells) were used for RNA-seq, ChIP-seq, PBAT-seq, and ATAC-seq analyses.\nNote：\n"
        }
      }
    }
  },
  "hum0146.v1": {
    "ja": {
      "NBDC Research ID": "hum0146.v1",
      "データ": {
        "DRA007187": {
          "データID": "DRA007187",
          "内容": "NGS（RRBS）",
          "制限": "非制限公開",
          "公開日": "2019/02/19"
        }
      },
      "研究内容の概要": {
        "目的": "生殖補助医療を受けたシルバーラッセル症候群（Silver-Russell Syndrome：SRS）症例におけるメチル化変化を解明する",
        "方法": "Reduced Representation Bisulfite Sequencing (RRBS)",
        "対象": "生殖補助医療を受けたSRS症例、生殖補助医療を受けていないSRS症例、および、対照健常児",
        "URL": "http://www.med.tohoku.ac.jp/about/laboratory/101.html"
      },
      "分子データ": {
        "DRA007187": {
          "対象": "生殖補助医療を受けたSRS（ICD10：Q871）：5症例\r\n生殖補助医療を受けていないSRS（ICD10：Q871）：5症例\r\n対照健常児：10名",
          "規模": "RRBS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Reduced representation bisulfite sequncing (RRBS)法",
          "断片化の方法": "制限酵素MspIによる消化",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp（アダプターを含む）",
          "メチレーション率算出方法": "Bismark methylation extractor (v.0.9.0)",
          "DDBJ Sequence Read Archive ID": "DRA007187",
          "総データ量": "38.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "有馬 隆博",
        "所 属 機 関": "東北大学大学院医学系研究科 環境遺伝医学総合研究センター 情報遺伝学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（B）",
            "タイトル": "ART由来出生児の遺伝的安全性に関するエピゲノムコホート研究",
            "研究課題番号": "17H04335"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Association of four imprinting disorders and ART.",
          "DOI": "doi: 10.1186/s13148-019-0623-3",
          "データID": "DRA007187"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0146.v1": {
          "Research ID": "hum0146.v1",
          "公開日": "2019/02/19",
          "内容": "NGS（RRBS）",
          "description": "生殖補助医療を受けたSilver-Russell Syndrome（SRS）症例、生殖補助医療を受けていないSRS症例、および対照健常児の末梢血から抽出したDNAを使用したメチレーション（RRBS）解析結果データ（Fastq）を提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0146.v1",
      "DATA": {
        "DRA007187": {
          "Data Set ID": "DRA007187",
          "Type of Data": "NGS (RRBS)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/02/19"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate DNA methylation change in Silver-Russell Syndrome (SRS) patients with assisted reproduction technologies (ART)",
        "Methods": "Reduced Representation Bisulfite Sequencing (RRBS)",
        "Participants/Materials": "SRS patients born after assisted reproduction technologies (ART), spontaneously conceived SRS patients, and spontaneously conceived children",
        "URL": "http://www.med.tohoku.ac.jp/english/about/laboratory/101.html"
      },
      "MOLECULAR DATA": {
        "DRA007187": {
          "Participants/Materials:": "5 SRS patients born after ART (ICD10: Q871)\r\n5 spontaneously conceived SRS patients (ICD10: Q871)\r\n10 spontaneously conceived children",
          "Targets": "RRBS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Reduced representation bisulfite sequncing (RRBS)",
          "Fragmentation Methods": "MspI restriction enzymes for target DNA digestion",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp (includes adaptors)",
          "Calculation for Methylation Rate": "Bismark methylation extractor (v.0.9.0)",
          "DDBJ Sequence Read Archive ID": "DRA007187",
          "Total Data Volume": "38.5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takahiro Arima",
        "Affiliation": "Department of Informative Genetics, Environment and Genome Research Center, Tohoku University Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Epigenetic cohort study in the ART-derived children",
            "Project Number": "17H04335"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Association of four imprinting disorders and ART.",
          "DOI": "doi: 10.1186/s13148-019-0623-3",
          "Data Set ID": "DRA007187"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0146.v1": {
          "Research ID": "hum0146.v1",
          "Release Date": "2019/02/19",
          "Type of Data": "NGS (RRBS)",
          "description": "DNAs extracted from SRS patients born after assisted reproduction technologies (ART), spontaneously conceived SRS patients, and spontaneously conceived children were used for Reduced Representation Bisulfite Sequencing (RRBS). Fastq files were provided.\nNote：\n"
        }
      }
    }
  },
  "hum0145.v1": {
    "ja": {
      "NBDC Research ID": "hum0145.v1",
      "データ": {
        "JGAS000222": {
          "データID": "JGAS000222",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/04/03"
        }
      },
      "研究内容の概要": {
        "目的": "大腸がんの転移再発を正確に予測するバイオマーカーの同定",
        "方法": "以下の組織より抽出したDNAを対象としたTarget capture deep sequencing",
        "対象": "術前化学療法後に外科的切除を行なった進行大腸癌１０症例",
        "URL": "https://www.beppu.kyushu-u.ac.jp/gekareview/"
      },
      "分子データ": {
        "JGAS000222": {
          "対象": "大腸がん（ICD10：C189）：10症例 36検体\r\n　・術前化学療法前に内視鏡を用いて採取した原発巣の腫瘍組織：10症例 10検体\r\n　・術前化学療法後切除切片の腫瘍組織：10症例 10検体\r\n　・術前化学療法後切除切片の非腫瘍組織：10症例 10検体\r\n　・末梢血の血漿：3症例 4検体\r\n　・転移巣切除切片の腫瘍組織：2症例 2検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "ClearSeq Halo HS Cancer Research Panel",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "大腸がんの原発巣（FFPE）、手術切除切片の腫瘍組織と非腫瘍組織、血漿、転移巣切除切片の腫瘍組織から抽出したから抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect/HaloPlex ターゲットエンリッチメントシステム",
          "断片化の方法": "酵素処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000313",
          "総データ量": "193 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "三森 功士",
        "所 属 機 関": "九州大学病院 別府病院 外科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "公益財団法人新日本先進医療研究財団　平成29年度助成金（2017）",
            "タイトル": "網羅的遺伝子異常解析と数理学的シミュレーションにもとづく大腸癌肝転移に対する肝切除前化学療法のprecision medicine構築",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy.",
          "DOI": "doi: 10.1038/s41416-018-0208-5",
          "データID": "JGAD000313"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0145.v1": {
          "Research ID": "hum0145.v1",
          "公開日": "2020/06/19",
          "内容": "NGS（Target Capture）",
          "description": "術前化学療法後に外科的切除を行なった進行大腸癌10症例の原発巣、手術切除切片の腫瘍組織と非腫瘍組織、末梢血血漿、転移巣切除切片の腫瘍組織から抽出したDNAを用いたHaloPlex Cancer Research PanelによるTarget Capture Sequencing解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0145.v1",
      "DATA": {
        "JGAS000222": {
          "Data Set ID": "JGAS000222",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/04/03"
        }
      },
      "SUMMARY": {
        "Aims": "To identify the biomarkers of predicting metastasis and reccurence in colorectal cancer (CRC).",
        "Methods": "Genomic DNAs were extracted from several samples (as shown below) and performed a target capture deep sequencing analysis by using of the HaloPlex Cancer Research Panel.",
        "Participants/Materials": "Ten colorectal cancer patients with locally advanced primary tumors who underwent primary tumor resection following NAC",
        "URL": "https://www.beppu.kyushu-u.ac.jp/gekareview/en/"
      },
      "MOLECULAR DATA": {
        "JGAS000222": {
          "Participants/Materials": "Colorectal cancer (ICD10: C189): 10 cases (36 samples)\r\n   - Primary tumor tissues obtained by endoscopic biopsy prior to NAC: 10 cases (10 samples)\r\n   - Tumor tissues from resected specimens after NAC: 10 cases (10 samples)\r\n   - Non-tumor tissues from resected specimens after NAC: 10 cases (10 samples)\r\n   - Blood plasma: 3 cases (4 samples)\r\n   - Metastatic tumor tissues from resected specimens: 2 cases (2 samples)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "ClearSeq Halo HS Cancer Research Panel",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor and matched non-tumor tissues from CRCs",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect/HaloPlex Target Enrichment System",
          "Fragmentation Methods": "Enzymatic Shearing",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000313",
          "Total Data Volume": "193 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koshi Mimori",
        "Affiliation": "Department of Surgery, Kyushu University Beppu Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "The Shinnihon Foundation of Advanced Medical Treatment Research (2017)",
            "Title": "Construction of precision medicine about neoadjuvant chemotherapy for hepatic metastasis of colorectal cancer by using comprehensive gene aberration analysis and mathematical simulation.",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy.",
          "DOI": "doi: 10.1038/s41416-018-0208-5",
          "Data Set ID": "JGAD000313"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0145.v1": {
          "Research ID": "hum0145.v1",
          "Release Date": "2020/04/03",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from tumor tissues (primary tumor obtained prior to NAC / after NAC, and metastatic tumor), normal intestinal mucosa, and blood plasma from 10 colorectal cancer patients were used for a target capture deep sequencing by using of the HaloPlex Cancer Research Panel. Fastq files are provided. \nNote：\n"
        }
      }
    }
  },
  "hum0144.v1": {
    "ja": {
      "NBDC Research ID": "hum0144.v1",
      "データ": {
        "JGAS000147": {
          "データID": "JGAS000147",
          "内容": "NGS（RNA-seq）\r\nメチル化アレイ\r\nSNPアレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2020/01/10"
        }
      },
      "研究内容の概要": {
        "目的": "B前駆細胞性急性リンパ性白血病を併発するダウン症候群症例について、次世代シーケンサーを用いた種々の解析技術により疾患発症の原因となる遺伝子異常を同定する。",
        "方法": "SNPアレイデータ、全RNAシーケンスデータ、および、メチル化アレイデータを統合的に解析する",
        "対象": "前駆細胞性急性リンパ性白血病を併発するダウン症候群 43症例",
        "URL": "http://square.umin.ac.jp/ped/clinical-research/about.html"
      },
      "分子データ": {
        "RNA-seq": {
          "対象": "B前駆細胞性急性リンパ性白血病を併発するダウン症候群（ICD10：C91.0）：25症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "B前駆細胞性急性リンパ性白血病を併発するダウン症候群症例の骨髄液（腫瘍細胞含む）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra RNA library prep kit for the Illumina",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000221",
          "総データ量": "189 GB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "メチル化アレイ": {
          "対象": "B前駆細胞性急性リンパ性白血病を併発するダウン症候群（ICD10：C91.0）：36症例",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium MethylationEPIC BeadChip、Infinium HumanMethylation450 BeadChip]",
          "ソース": "B前駆細胞性急性リンパ性白血病を併発するダウン症候群症例の骨髄液（腫瘍細胞含む）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "EpiTect Fast Bisulﬁte Conversion Kit、Infinium MethylationEPIC",
          "メチル化率決定アルゴリズム（ソフトウェア）": "iScan system、GenomeStudio Software （Illumina）",
          "プローブ数": "450k/850k",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000221",
          "総データ量": "189 GB（idat）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "SNPアレイ": {
          "対象": "B前駆細胞性急性リンパ性白血病を併発するダウン症候群（ICD10：C91.0）：36症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [GeneChip Human Mapping 250K Nsp、CytoScan HD]",
          "ソース": "B前駆細胞性急性リンパ性白血病を併発するダウン症候群症例の骨髄液（腫瘍細胞含む）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Cytoscan HD kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Genotyping Console ver. 4.2.0.26",
          "マーカー数": "750k/250k SNPs",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000221",
          "総データ量": "189 GB（CEL）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "滝田 順子",
        "所 属 機 関": "東京大学大学院 医学系研究科 生殖・発達・加齢医学専攻 小児医学講座",
        "プロジェクト/研究グループ名": "造血器腫瘍における遺伝子異常の網羅的解析",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業　基盤研究（B）",
            "タイトル": "マルチオミックス情報を基盤とした難治性小児がんに対する新規克服法の開発",
            "研究課題番号": "17H04224"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome",
          "DOI": "doi: 10.1111/cas.14160",
          "データID": "JGAD000221"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Jinyan Huang": {
          "研究代表者": "Jinyan Huang",
          "所属機関": "Zhejiang University School of Medicine",
          "研究題目": "",
          "利用データID": "Comprehensive analysis of alternative splicing in malignant tumors",
          "利用期間": "JGAD000221"
        },
        "Ching Lau": {
          "研究代表者": "Ching Lau",
          "所属機関": "Pediatric Oncology, The Jackson Laboratory for Genomic Medicine",
          "研究題目": "アメリカ合衆国",
          "利用データID": "AML in Down's Syndrome",
          "利用期間": "JGAD000221"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000221"
        }
      },
      "リリース情報": {
        "hum0144.v1": {
          "Research ID": "hum0144.v1",
          "公開日": "2020/01/10",
          "内容": "NGS（RNA-seq）、メチル化アレイ、SNPアレイ",
          "description": "B前駆細胞性急性リンパ性白血病を併発するダウン症候群43症例の骨髄液（腫瘍細胞含む）から抽出したDNA/RNAを用いたRNA-seq、メチル化アレイ、SNPアレイ解析結果をbam、idat、CELファイル形式で提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0144.v1",
      "DATA": {
        "JGAS000147": {
          "Data Set ID": "JGAS000147",
          "Type of Data": "NGS (RNA-seq)\r\nMethylation array\r\nSNP array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/01/10"
        }
      },
      "SUMMARY": {
        "Aims": "To explore genetic alteratoins in pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome",
        "Methods": "SNP array, whole transcriptome sequencing, and DNA methylation array were performed in cases of pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome",
        "Participants/Materials": "43 pediatric B-cell precursor acute lymphoblastic leukemia cases in Down syndrome"
      },
      "MOLECULAR DATA": {
        "RNA-seq": {
          "Participants/Materials": "pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome (ICD10: C91.0): 25 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "RNAs extracted from bone marrow aspirates of pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrom patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEB NEBNext Ultra RNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "restriction enzyme reaction",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000221",
          "Total Data Volume": "189 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation array": {
          "Participants/Materials": "pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome (ICD10: C91.0): 36 cases",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium MethylationEPIC BeadChip, Infinium HumanMethylation450 BeadChip]",
          "Library Source": "DNAs extracted from bone marrow aspirates of pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrom patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "EpiTect Fast Bisulﬁte Conversion Kit, Infinium MethylationEPIC",
          "Algorithms for Calculating Methylation-rate (software)": "iScan system and GenomeStudio Software (Illumina)",
          "Probe Number": "450k/850k",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000221",
          "Total Data Volume": "189 GB (idat)",
          "Comments (Policies)": "NBDC policy"
        },
        "SNP array": {
          "Participants/Materials": "pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome (ICD10: C91.0): 36 cases",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "",
          "Platform": "Affymetrix [GeneChip Human Mapping 250k Nsp, Cytoscan HD]",
          "Source": "DNAs extracted from bone marrow aspirates of pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrom patients",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Cytoscan HD kit",
          "Genotype Call Methods (software)": "Genotyping Console ver. 4.2.0.26",
          "Marker number": "750k/250k SNPs",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000221",
          "Total Data Volume": "189 GB (CEL)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Junko Takita",
        "Affiliation": "Department of Pediatrics, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "Comprehensive analysis of genetic aberrations in hematologic malignancies",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Development for novel therapeutic stratagies of intractable pediatric cancers based on the multi-omics analysis",
            "Project Number": "17H04224"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome",
          "DOI": "doi: 10.1111/cas.14160",
          "Data Set ID": "JGAD000221"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Jinyan Huang": {
          "Principal Investigator": "Jinyan Huang",
          "Affiliation": "School of Medicine, Zhejiang University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of alternative splicing in malignant tumors",
          "Period of Data Use": "JGAD000221"
        },
        "Ching Lau": {
          "Principal Investigator": "Ching Lau",
          "Affiliation": "Pediatric Oncology, The Jackson Laboratory for Genomic Medicine",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "AML in Down's Syndrome",
          "Period of Data Use": "JGAD000221"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000221"
        }
      },
      "Release Note": {
        "hum0144.v1": {
          "Research ID": "hum0144.v1",
          "Release Date": "2020/01/10",
          "Type of Data": "NGS (RNA-seq), Methylation array, SNP array",
          "description": "SNP array, whole transcriptome sequencing, and DNA methylation array in 43 cases of pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome were performed using DNA/RNAs extracted from bone marrow aspirates of patients. The data are provided as bam, idat and CEL format files.\nNote：\n"
        }
      }
    }
  },
  "hum0141.v1": {
    "ja": {
      "NBDC Research ID": "hum0141.v1",
      "データ": {
        "JGAS000135": {
          "データID": "JGAS000135",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/05/09"
        }
      },
      "研究内容の概要": {
        "目的": "頭頸部がんにおける免疫制御の解明",
        "方法": "RNA-seq",
        "対象": "頭頸部がん",
        "URL": "http://www.med.nagoya-cu.ac.jp/immunol.dir/index.html"
      },
      "分子データ": {
        "JGAS000135": {
          "対象": "頭頸部がん：4症例（15検体）\r\n　HNC1：声門上がん（ICD10：C32.1）\r\n　HNC10：舌根部がん（ICD10：C01）\r\n　HNC14：梨状陥凹がん（ICD10：C12）\r\n　HNC18：下咽頭後部がん（ICD10：C13.2）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "ライブラリソース": "頭頚部がん（腫瘍組織）に浸潤したCD4+ T細胞の以下の分画から抽出したRNA\r\n　　・Double Positive（DP）：CD25+ CTLA4+ Treg細胞\r\n　　・CD25：CD25+ T細胞\r\n　　・CTLA4：CTLA4+ T細胞\r\n　　・Double Negative（DN）：CD25- CTLA4- T細胞",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA Library Preparation Kit",
          "断片化の方法": "KAPA Frag",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000204",
          "総データ量": "70 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "坂口 志文",
        "所 属 機 関": "大阪大学免疫学フロンティア研究センター 実験免疫学",
        "プロジェクト/研究グループ名": "名古屋市立大学大学院医学研究科免疫学教室",
        "科研費/助成金（Research Project Number）": {
          "5": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究（研究領域提案型）",
            "タイトル": "紫外線で誘導されるネオ・セルフと制御性T細胞による自己免疫治療法の開発",
            "研究課題番号": "17H05798"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Regulatory T cells expressing abundant CTLA-4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer.",
          "DOI": "doi: 10.1002/ijc.32024",
          "データID": "JGAD000204"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Robert Tsai": {
          "研究代表者": "Robert Tsai",
          "所属機関": "Institute of Biosciences & Technology, Texas A&M Health Science Center",
          "研究題目": "",
          "利用データID": "Genome-wide Discovery of new Plasma DNA Mehylation Makers for Tracking the Progression of NAFLD to NASH and HCC",
          "利用期間": "JGAD000204"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000204"
        }
      },
      "リリース情報": {
        "hum0141.v1": {
          "Research ID": "hum0141.v1",
          "公開日": "2019/05/09",
          "内容": "NGS（RNA-seq）",
          "description": "頭頚部がん4症例の腫瘍組織から単離したTreg細胞や類縁細胞から抽出したRNA15検体を用いたRNA-Seq解析データをfastqファイルにて提供する。KAPA Library Preparation KitによるRNAライブラリ作製後、Thermo Fisher Scientific [Ion S5]にて平均長150 bpを読んだ（Single-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0141.v1",
      "DATA": {
        "JGAS000135": {
          "Data Set ID": "JGAS000135",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/05/09"
        }
      },
      "SUMMARY": {
        "Aims": "Analysis of immune regulation in head and neck cancer",
        "Methods": "RNA-seq",
        "Participants/Materials": "Head and neck cancer",
        "URL": "http://www.med.nagoya-cu.ac.jp/immunol.dir/new1.html"
      },
      "MOLECULAR DATA": {
        "JGAS000135": {
          "Participants/Materials": "Head and neck cancer: 4cases (15 samples)\r\n    HNC1: Malignant neoplasm of supraglottis (ICD10: C32.1)\r\n    HNC10: Malignant neoplasm of base of tongue (ICD10: C01)\r\n    HNC14: Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx (ICD10: C12)\r\n    HNC18: Malignant neoplasm of posterior wall of hypopharynx (ICD10: C13.2)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "Library Source": "RNAs extracted from isolated cells using different markers from tumor tissues of head and neck cancer\r\n   - Double Positive (DP): CD25+ CTLA4+ Treg cells\r\n   - CD25: CD25+ T cells\r\n   - CTLA4: CTLA4+ T cells\r\n   - Double Negative (DN): CTLA4- CD25- T cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Library Preparation Kit",
          "Fragmentation Methods": "KAPA Frag",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp on average",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000204",
          "Total Data Volume": "70 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shimon Sakaguchi",
        "Affiliation": "Experimental Immunology, IFReC, Osaka University",
        "Project / Group Name": "Department of Immunology, Nagoya City University Graduate School of Medical Sciences",
        "Funds / Grants (Research Project Number)": {
          "5": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)",
            "Title": "Developing a new therapy for autoimmnue dieseases using regulatory T cell and neo-self induced by ultraviolet",
            "Project Number": "17H05798"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Regulatory T cells expressing abundant CTLA-4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer.",
          "DOI": "doi: 10.1002/ijc.32024",
          "Data Set ID": "JGAD000204"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Robert Tsai": {
          "Principal Investigator": "Robert Tsai",
          "Affiliation": "Institute of Biosciences & Technology, Texas A&M Health Science Center",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Genome-wide Discovery of new Plasma DNA Mehylation Makers for Tracking the Progression of NAFLD to NASH and HCC",
          "Period of Data Use": "JGAD000204"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000204"
        }
      },
      "Release Note": {
        "hum0141.v1": {
          "Research ID": "hum0141.v1",
          "Release Date": "2019/05/09",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from isolated cells using different markers from tumor tissues of head and neck cancers. Libraries for RNA-seq were prepared with KAPA Library Preparation Kit and RNA-seq was performed with Thermo Fisher Scientific [Ion S5] (150 bp on average, Single-end). RNA-seq data are provided as fastq. \nNote：\n"
        }
      }
    }
  },
  "hum0140.v1": {
    "ja": {
      "NBDC Research ID": "hum0140.v1",
      "データ": {
        "JGAS000158": {
          "データID": "JGAS000158",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/11/19"
        }
      },
      "研究内容の概要": {
        "目的": "術前に化学放射線療法を受けた直腸がん症例における分子プロファイリングをもとにした治療効果予測法の確立",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "術前に化学放射線療法を受けた直腸がん74症例（原発巣腫瘍組織および非腫瘍組織）"
      },
      "分子データ": {
        "JGAS000158": {
          "対象": "術前に化学放射線療法を受けた直腸がん（ICD10：C20 [NG80]）：74症例（計148検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "原発巣の腫瘍組織および非腫瘍組織（もしくは末梢血）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Custom(v5n)及びSureSelect Custom(v5)\r\n    ・v5n側：SureSelect Human All Exon V5 + lincRNA + Virus\r\n    ・v5側：SureSelect Human All Exon V5 + lincRNA",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000236",
          "総データ量": "2 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "秋吉 高志",
        "所 属 機 関": "がん研有明病院",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業　基盤研究（C）",
            "タイトル": "全エクソンシークエンスによる直腸癌術前放射線化学療法効果予測遺伝子の同定",
            "研究課題番号": "15K10156"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer.",
          "DOI": "doi: 10.1002/bjs.11179",
          "データID": "JGAD000236"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000236"
        }
      },
      "リリース情報": {
        "hum0140.v1": {
          "Research ID": "hum0140.v1",
          "公開日": "2019/11/19",
          "内容": "NGS（Exome）",
          "description": "術前に化学放射線療法を受けた直腸がん74症例の原発巣（腫瘍組織）および非腫瘍組織（もしくは末梢血）から抽出したDNAを用いたExome解析の結果をfastqファイルにて提供する。SureSelect Custom(v5n)及びSureSelect Custom(v5)を用いてExon領域にしぼりIllumina [HiSeq 2000]にて平均長200塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0140.v1",
      "DATA": {
        "JGAS000158": {
          "Data Set ID": "JGAS000158",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/11/19"
        }
      },
      "SUMMARY": {
        "Aims": "Establishment of novel prediction method of preoperative chemoradiothearpeutic effect based on the molecular profiling in rectal cancer patients",
        "Methods": "Exome analysis by using Illumina Hiseq 2000",
        "Participants/Materials": "74 rectal cancer patients treated with preoperative chemoraidotherapy"
      },
      "MOLECULAR DATA": {
        "JGAS000158": {
          "Participants/Materials": "74 rectal cancer (ICD10: C20 [NG80]) treated with preoperative chemoraidotherapy",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from non-tumor tissues (or peripheral blood cells as normal tissues)  and the primary tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Custom(v5n) or SureSelect Custom(v5)\r\n    - v5n: SureSelect Human All Exon V5 + lincRNA + Virus\r\n    - v5: SureSelect Human All Exon V5 + lincRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000236",
          "Total Data Volume": "2 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takashi Akiyoshi",
        "Affiliation": "The Cancer Institute Hospital of JFCR",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Genomic Profile of Responders to Preoperative Chemoradiotherapy for Advanced Rectal Cancer",
            "Project Number": "15K10156"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer.",
          "DOI": "doi: 10.1002/bjs.11179",
          "Data Set ID": "JGAD000236"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000236"
        }
      },
      "Release Note": {
        "hum0140.v1": {
          "Research ID": "hum0140.v1",
          "Release Date": "2019/11/19",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from non-tumor tissues (or blood cells as normal tissues) and the primary tumor tissues from 74 rectal cancer treated with preoperative chemoraidotherapy were used for whole exome sequencing analysis (fastq files). Exons were narrowed down by using of SureSelect Custom(v5n) or SureSelect Custom(v5) and read by Illumina [HiSeq 2000] (paired-end: 200 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0139.v1": {
    "ja": {
      "NBDC Research ID": "hum0139.v1",
      "データ": {
        "JGAS000136": {
          "データID": "JGAS000136",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/07/10"
        }
      },
      "研究内容の概要": {
        "目的": "人工多能性幹細胞の未分化性維持および分化指向性におけるKRAS分子が果たす役割を解明する",
        "方法": "罹患細胞にKRAS G13C 変異を有するRAS 関連自己免疫性リンパ球増殖症候群様疾患（RALD） 患者骨髓よりiPS細胞を樹立し、同時に変異を有さない対照健常株を得て、未分化維持、分化誘導等の条件下で分子生物学的手法により特性比較を行った。尚、本疾患の KRAS 変異は後天性に獲得されるため、同一患者骨髄中にKRAS変異(-)細胞とKRAS変異細胞が共存しており、本研究で用いた２つのiPS細胞クローンはいずれも患者由来である。",
        "対象": "１名のRALD患者骨髓細胞より同時に樹立したiPS細胞クローン：KRAS変異株１、KRAS変異(-)健常株１（いずれも患者由来）。iPS 細胞を未分化条件のまま、KRAS変異株・対照健常株それぞれ1検体ずつExome 解析を行った。"
      },
      "分子データ": {
        "JGAS000136": {
          "対象": "1症例のRALD患者（ICD10：D763）骨髓細胞より樹立したiPS細胞クローン\r\n      KRAS変異株：1検体\r\n      対照健常株：1検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "ライブラリソース": "iPS細胞クローンから抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V5",
          "断片化の方法": "SureSelect QXT Human All Exon V5：酵素反応を用いた断片化（トランスポゼース）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000205",
          "総データ量": "32 GB\r\n    Data ファイル数：4（fastq）\r\n    Analysis ファイル数：2（bam [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "大津 真",
        "所 属 機 関": "東京大学・医科学研究所",
        "プロジェクト/研究グループ名": "疾患特異的iPS細胞を活用した難病研究",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 再生医療実現拠点ネットワークプログラム",
            "タイトル": "疾患特異的iPS細胞を活用した難病研究",
            "研究課題番号": "JP16bm0609006JP17bm0804004"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Status of KRAS in iPS cells impacts upon self-renewal and differentiation propensity.",
          "DOI": "doi: 10.1016/j.stemcr.2018.06.008",
          "データID": "JGAD000205"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0139.v1": {
          "Research ID": "hum0139.v1",
          "公開日": "2018/07/10",
          "内容": "NGS（Exome）",
          "description": "1症例のRALD患者骨髓細胞より樹立したiPS細胞クローン（KRAS変異株およびKRAS変異[-]健常株）それぞれの細胞から抽出したDNAを用いたExome解析の結果をfastqおよびbamファイルにて提供する。SureSelect Human All Exon V5を用いてExon領域にしぼりIllumina [HiSeq 1500]にて配列を読んだ（Paired-end: 100 bp x 2）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0139.v1",
      "DATA": {
        "JGAS000136": {
          "Data Set ID": "JGAS000136",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/07/10"
        }
      },
      "SUMMARY": {
        "Aims": "To address how status of KRAS in iPS cells impacts upon self-renewal and differentiation propensity",
        "Methods": "Roles of KRAS on stemness were investigated in the context of induced pluripotent stem cells (iPSCs). KRAS mutant (G13C/WT) and wild-type isogenic (WT/WT) iPSCs from a Ras-associated autoimmune leukoproliferative disorder (RALD) patient were used. Retention of self-renewal and capacity for neuronal differentiation were compared.",
        "Participants/Materials": "A RALD patient-derived iPSC clones (one with KRAS G13C mutation and the other one with no mutation derived from the same patient)."
      },
      "MOLECULAR DATA": {
        "JGAS000136": {
          "Participants/Materials": "iPSCs from 1 RALD patient (ICD10: D763)\r\n      KRAS mutant (G13C/WT) iPSCs: 1 sample\r\n      wild-type isogenic (WT/WT) iPSCs: 1 sample",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "Library Source": "DNAs extracted from each iPSC",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V5",
          "Fragmentation Methods": "SureSelect QXT Human All Exon V5: Enzymatic Shearing (transposase-based library prep)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000205",
          "Total Data Volume": "32 GB\r\n    Data files: 4 (fastq)\r\n    Analysis files: 2 (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Makoto Otsu",
        "Affiliation": "Institute of Medical Science, University of Tokyo",
        "Project / Group Name": "The program for intractable diseases research utilizing disease-specific iPS cells",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Research Center Network for Realization of Regenerative Medicine, Japan Agency for Medical Research and Development (AMED)",
            "Title": "The program for intractable diseases research utilizing disease-specific iPS cells",
            "Project Number": "JP16bm0609006JP17bm0804004"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Status of KRAS in iPS cells impacts upon self-renewal and differentiation propensity.",
          "DOI": "doi: 10.1016/j.stemcr.2018.06.008",
          "Data Set ID": "JGAD000205"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0139.v1": {
          "Research ID": "hum0139.v1",
          "Release Date": "2018/07/10",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from KRAS mutant (G13C/WT) and wild-type isogenic (WT/WT) iPSCs extructed from a RALD patient were used for whole-exome sequence analysis (fastq and bam files). Exons were narrowed down by using of SureSelect Human All Exon V5 and read by Illumina [HiSeq 1500]  (paired-end: 100 bp x 2).\nNote：\n"
        }
      }
    }
  },
  "hum0138.v2": {
    "ja": {
      "NBDC Research ID": "hum0138.v2",
      "データ": {
        "JGAS000134": {
          "データID": "JGAS000134",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/07/31"
        },
        "JGAS000134（データ追加）": {
          "データID": "JGAS000134（データ追加）",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/26"
        }
      },
      "研究内容の概要": {
        "目的": "肝がんの発生母地となる肝硬変再生結節の発がんポテンシャルを明らかにすること",
        "方法": "全エクソン解析および全トランスクリプトーム解析",
        "対象": "肝硬変、肝がん症例および健常者"
      },
      "分子データ": {
        "Exome": {
          "対象": "肝硬変（ICD10：K746）：1症例（10検体）\r\n肝がん（ICD10：C220）：4症例（4検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "肝硬変病変部、腫瘍組織、及び非腫瘍組織切片から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon v5",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000203",
          "総データ量": "152 GB（bam [ref：GRCh37]、fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "肝硬変（ICD10：K746）：9症例（15検体）\r\n健常者：7名\r\n    生体肝移植手術の過程で得られた健常者の正常肝組織の余剰組織",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 4000]",
          "ライブラリソース": "肝硬変症例の肝硬変病変部、非腫瘍組織切片及び健常者の正常肝組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Sample Preparation v2",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000203",
          "総データ量": "肝硬変症例：152 GB（bam [ref：GRCh37]、fastq）\r\n健常者：16.7 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "高井 淳",
        "所 属 機 関": "京都大学大学院 医学研究科 消化器内科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（B）",
            "タイトル": "肝硬変\"再生結節\"の細胞クローン動態と発癌機構の解明",
            "研究課題番号": "17H04158"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.",
          "DOI": "doi: 10.1007/s00535-019-01555-z",
          "データID": "JGAD000203"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Robert Tsai": {
          "研究代表者": "Robert Tsai",
          "所属機関": "Institute of Biosciences & Technology, Texas A&M Health Science Center",
          "研究題目": "",
          "利用データID": "Genome-wide Discovery of new Plasma DNA Mehylation Makers for Tracking the Progression of NAFLD to NASH and HCC",
          "利用期間": "JGAD000203"
        },
        "Jinyan Huang": {
          "研究代表者": "Jinyan Huang",
          "所属機関": "Zhejiang University School of Medicine",
          "研究題目": "",
          "利用データID": "Comprehensive analysis of alternative splicing in malignant tumors",
          "利用期間": "JGAD000203"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000203"
        }
      },
      "リリース情報": {
        "hum0138.v2": {
          "Research ID": "hum0138.v2",
          "公開日": "2021/03/26",
          "内容": "NGS（RNA-seq）",
          "description": "健常者7名の正常肝組織から抽出したRNAを用いた全トランスクリプトーム解析結果をfastqファイルにて提供する。TruSeq RNA Sample Preparation v2キットによるRNAライブラリ作製後、Illumina HiSeq 4000にて平均長100bpを読んだ（Paired-end）。\n"
        },
        "hum0138.v1": {
          "Research ID": "hum0138.v1",
          "公開日": "2020/07/31",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "肝硬変および肝がん症例の腫瘍組織及び非腫瘍組織切片から抽出したDNA・RNAを用いた全エクソン解析および全トランスクリプトーム解析結果をfastqおよびbamファイルにて提供する。SureSelect Human All Exon v5を用いてExon領域にしぼりIllumina HiSeq 2500にて平均長100bpのDNA断片を解読した（Paired-end）。TruSeq RNA Sample Preparation v2キットによるRNAライブラリ作製後、Illumina HiSeq 4000にて平均長100bpを読んだ（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0138.v2",
      "DATA": {
        "JGAS000134": {
          "Data Set ID": "JGAS000134",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/07/31"
        },
        "JGAS000134 (Data addition)": {
          "Data Set ID": "JGAS000134 (Data addition)",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/26"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the oncogenic potential of regeneration nodules in cirrhotic liver.",
        "Methods": "whole exome sequencing and RNA sequencing",
        "Participants/Materials": "liver cirrhosis, hepatocellular carcinoma and healthy donor"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "Liver cirrhosis (ICD10: K746): 1 case (10 samples)\r\nHepatocellular carcinoma (ICD10: C220): 4 cases (4 samples)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor, non-tumor, and cirrhosis tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon v5",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000203",
          "Total Data Volume": "152 GB (bam [ref: GRCh37], fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "Liver cirrhosis (ICD10: K746): 9 cases (15 samples)\r\n7 healthy donors\r\n    Normal livers from healthy donors for living-donor liver transplantation",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 4000]",
          "Library Source": "RNAs extracted from non-tumor and cirrhosis tissues from liver cirrhosis patients and normal livers from healthy donors",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Sample Preparation v2",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000203",
          "Total Data Volume": "Liver cirrhosis: 152 GB (bam [ref: GRCh37], fastq)\r\nHealthy donor: 16.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Atsushi Takai",
        "Affiliation": "Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Role of regeneration nodule in cirrhotic liver on tumorigenesis",
            "Project Number": "17H04158"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.",
          "DOI": "doi: 10.1007/s00535-019-01555-z",
          "Data Set ID": "JGAD000203"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Robert Tsai": {
          "Principal Investigator": "Robert Tsai",
          "Affiliation": "Institute of Biosciences & Technology, Texas A&M Health Science Center",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Genome-wide Discovery of new Plasma DNA Mehylation Makers for Tracking the Progression of NAFLD to NASH and HCC",
          "Period of Data Use": "JGAD000203"
        },
        "Jinyan Huang": {
          "Principal Investigator": "Jinyan Huang",
          "Affiliation": "School of Medicine, Zhejiang University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of alternative splicing in malignant tumors",
          "Period of Data Use": "JGAD000203"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000203"
        }
      },
      "Release Note": {
        "hum0138.v2": {
          "Research ID": "hum0138.v2",
          "Release Date": "2021/03/26",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs were extracted from normal livers from 7 healthy donors. Libraries for RNA-seq were prepared with TruSeq RNA Sample Preparation v2 and RNA-seq was performed with HiSeq 4000 (paired-end: 100 bp). Data are provided as fastq files.\n"
        },
        "hum0138.v1": {
          "Research ID": "hum0138.v1",
          "Release Date": "2020/07/31",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs and RNAs were extracted from tumor, non-tumor and cirrhosis tissues of liver cirrhosis and hepatocellular carcinoma. Exons were narrowed down by using of SureSelect Human All Exon v5 and read by Illumina HiSeq 2500 (paired-end: 100 bp). Libraries for RNA-seq were prepared with TruSeq RNA Sample Preparation v2 and RNA-seq was performed with HiSeq 4000 (paired-end: 100 bp). Data are provided as fastq and bam files.\nNote：\n"
        }
      }
    }
  },
  "hum0137.v1": {
    "ja": {
      "NBDC Research ID": "hum0137.v1",
      "データ": {
        "JGAS000144": {
          "データID": "JGAS000144",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/12/21"
        }
      },
      "研究内容の概要": {
        "目的": "1型糖尿病の疾患感受性遺伝子を明らかにする。",
        "方法": "NGS解析（Target Capture）",
        "対象": "1型糖尿病症例",
        "URL": "http://www.jds.or.jp/modules/study/index.php?content_id=4"
      },
      "分子データ": {
        "JGAS000144": {
          "対象": "1型糖尿病（ICD10：E10）：32症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "1. chr.12: 53,551,446-53,574,693\r\n2. chr.12: 53,585,106-53,601,000",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Amplicon Sequencing",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000213",
          "総データ量": "21 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "池上 博司",
        "所 属 機 関": "近畿大学医学部内分泌・代謝・糖尿病内科",
        "プロジェクト/研究グループ名": "日本糖尿病学会１型糖尿病調査研究委員会　遺伝子解析チームコアメンバー",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A genome-wide association study confirming a strong effect of HLA and identifying variants in CSAD/lnc-ITGB7-1 on chromosome 12q13.13 associated with susceptibility to fulminant type 1 diabetes",
          "DOI": "doi: 10.2337/db18-0314",
          "データID": "JGAD000213"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0137.v1": {
          "Research ID": "hum0137.v1",
          "公開日": "2018/12/21",
          "内容": "NGS（Target Capture）",
          "description": "1型糖尿病32症例の末梢血から抽出したDNAを用いたTarget Capture解析結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0137.v1",
      "DATA": {
        "JGAS000144": {
          "Data Set ID": "JGAS000144",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/12/21"
        }
      },
      "SUMMARY": {
        "Aims": "To identify susceptibility genes to type 1 diabetes",
        "Methods": "NGS (Target Capture)",
        "Participants/Materials": "Type 1 diabetes"
      },
      "MOLECULAR DATA": {
        "JGAS000144": {
          "Participants/Materials": "Type 1 diabetes (ICD10: E10): 32 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "1. chr.12: 53,551,446-53,574,693\r\n2. chr.12: 53,585,106-53,601,000",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Amplicon Sequencing",
          "Fragmentation Methods": "enzymatic shearing",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000213",
          "Total Data Volume": "21 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroshi Ikegami",
        "Affiliation": "Department of Endocrinology, Metabolism and Diabetes Kinkdai University Faculty of Medicine",
        "Project / Group Name": "Core member for genetic analysis in the committee on type 1 diabetes, Japan Diabetes Society.",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A genome-wide association study confirming a strong effect of HLA and identifying variants in CSAD/lnc-ITGB7-1 on chromosome 12q13.13 associated with susceptibility to fulminant type 1 diabetes",
          "DOI": "doi: 10.2337/db18-0314",
          "Data Set ID": "JGAD000213"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0137.v1": {
          "Research ID": "hum0137.v1",
          "Release Date": "2018/12/21",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from peripheral blood cells of 32 type 1 diabetes patients were used for target capture sequencing analysis (fastq files).\nNote:\n"
        }
      }
    }
  },
  "hum0136.v3": {
    "ja": {
      "NBDC Research ID": "hum0136.v3",
      "データ": {
        "hum0136.v1.gwas.v1": {
          "データID": "hum0136.v1.gwas.v1",
          "内容": "日本人B型肝炎ワクチン（ビームゲン）接種者1,193名のGWAS統計情報",
          "制限": "非制限公開",
          "公開日": "2018/05/22"
        },
        "hum0136.v2.hep-gwas.v1": {
          "データID": "hum0136.v2.hep-gwas.v1",
          "内容": "日本人B型肝炎ワクチン（ヘプタバックス）接種者555名のGWAS統計情報",
          "制限": "非制限公開",
          "公開日": "2021/03/05"
        },
        "JGAS000341": {
          "データID": "JGAS000341",
          "内容": "日本人B型肝炎ワクチン（ビームゲン）接種者1,193名の個人毎のGenotypingデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2021/10/01"
        }
      },
      "研究内容の概要": {
        "目的": "B型肝炎ワクチンの効果に関連する宿主遺伝因子の同定",
        "方法": "ゲノムワイド関連解析",
        "対象": "日本人B型肝炎ワクチン（ビームゲン）接種者1,193例、日本人B型肝炎ワクチン（ヘプタバックス）接種者555例",
        "URL": "http://www.ncgmkohnodai.go.jp/genome/index.html"
      },
      "分子データ": {
        "hum0136.v1.gwas.v1 / JGAS000341": {
          "対象": "日本人B型肝炎ワクチン（ビームゲン）接種者（Total：1,193名）\r\n　　・ワクチン低反応群（107名、HBsAb 10mIU/mL以下）\r\n　　・ワクチン中反応群（351名、HBsAb 10mIU/mL超、100 mIU/mL以下）\r\n　　・ワクチン高反応群（735名、HBsAb 100mIU/mL超）\r\n日本人B型肝炎ワクチン（ビームゲン）接種者（30歳未満：864名）\r\n　　・ワクチン低反応群（56名、HBsAb 10mIU/mL以下）\r\n　　・ワクチン中反応群（226名、HBsAb 10mIU/mL超、100 mIU/mL以下）\r\n　　・ワクチン高反応群（582名、HBsAb 100mIU/mL超）",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix AXIOM 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（Genotyping Console ver. 4.2.0.26）",
          "フィルタリング": "overall call rate < 0.95、SNP call rate < 0.95、\r\nHWE P < 0.001、MAF < 0.05、Regression P < 0.05",
          "マーカー数（QC後）": "① 低反応群：0、中反応群：1、高反応群：2、とした回帰分析（年齢・性別で補正）\r\n 　　➡ 22,044 SNPs（hg19）[Figure 2]\r\n② 30歳未満のみを対象とした、低反応群：0、中反応群：1、高反応群：2、とした回帰分析（年齢・性別で補正）\r\n 　　➡ 21,580 SNPs（hg19）[Supplementary Figure 4]\r\n③ 低反応群：0、高反応群：1、とした回帰分析（年齢・性別で補正）\r\n 　　➡ 23,765 SNPs（hg19）[Supplementary Figure 5]",
          "NBDC Dataset ID": "hum0136.v1.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000452",
          "総データ量": "hum0136.v1.gwas.v1：7.3 MB\r\nJGAD000452：34.4 GB（CEL）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0136.v2.hep-gwas.v1": {
          "対象": "日本人B型肝炎ワクチン（ヘプタバックス）接種者（Total：555名）\r\n　　・ワクチン低反応群（66名、HBsAb 10mIU/mL以下）\r\n　　・ワクチン中反応群（184名、HBsAb 10mIU/mL超、100 mIU/mL以下）\r\n　　・ワクチン高反応群（305名、HBsAb 100mIU/mL超）",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix AXIOM 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（Genotyping Console ver. 4.2.0.26）",
          "フィルタリング": "overall call rate < 0.95、SNP call rate < 0.95、\r\nHWE P < 0.001、MAF < 0.05、Regression P < 0.05",
          "マーカー数（QC後）": "① 日本人ヘプタバックス接種者におけるワクチン低反応群（n=66）とワクチン反応群（n=489）を比較したGWAS結果（Imputation後）\r\n 　　➡ 279,671 SNPs（hg19）[Figure1a]\r\n② 日本人ヘプタバックス接種者におけるワクチン低反応群（n=66）とワクチン高反応群（n=305）を比較したGWAS結果（Imputation後）\r\n 　　➡ 292,028 SNPs（hg19）[Figure1b]\r\n③ 日本人ヘプタバックス接種者におけるワクチン低反応群（n=66）とワクチン反応群（n=489）を比較したGWAS結果（Imputation前）\r\n 　　➡ 22,770 SNPs（hg19）[Supplementary Figure 1a]\r\n④ 日本人ヘプタバックス接種者におけるワクチン低反応群（n=66）とワクチン高反応群（n=305）を比較したGWAS結果（Imputation前）\r\n 　　➡ 23,717 SNPs（hg19）[Supplementary Figure 1b]\r\n⑤ 日本人ヘプタバックス接種者およびビームゲン接種者におけるワクチン低反応群（n=66+107）とワクチン反応群（n=489+1086）を比較したGWAS結果（Imputation後）\r\n 　　➡ 310,312 SNPs（hg19）[Supplementary Figure 2a]\r\n⑥ 日本人ヘプタバックス接種者およびビームゲン接種者におけるワクチン低反応群（n=66+107）とワクチン反応群（n=305+735）を比較したGWAS結果（Imputation後）\r\n 　　➡ 317,176 SNPs（hg19）[Supplementary Figure 2b]\r\n⑦ 日本人ヘプタバックス接種者におけるワクチン低反応群（n=66）と日本人ビームゲン接種者におけるワクチン低反応群（n=107）を比較したGWAS結果（Imputation後）\r\n 　　➡ 285,687 SNPs（hg19）[Supplementary Figure 3a]\r\n⑧ 日本人ヘプタバックス接種者におけるワクチン中反応群（n=184）と日本人ビームゲン接種者におけるワクチン中反応群（n=351）を比較したGWAS結果（Imputation後）\r\n 　　➡ 312,192 SNPs（hg19）[Supplementary Figure 3b]\r\n⑨ 日本人ヘプタバックス接種者におけるワクチン高反応群（n=305）と日本人ビームゲン接種者におけるワクチン高反応群（n=735）を比較したGWAS結果（Imputation後）\r\n 　　➡ 321,074 SNPs（hg19）[Supplementary Figure 3c]",
          "NBDC Dataset ID": "hum0136.v2.hep-gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "500 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "溝上 雅史",
        "所 属 機 関": "国立国際医療研究センター",
        "プロジェクト/研究グループ名": "ゲノム医科学プロジェクト",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "日本医療研究開発機構（AMED）肝炎等克服緊急対策研究事業",
            "タイトル": "B型肝炎ウイルスおよびヒトゲノムの解析に基づくクリニカルシークエンスに向けた研究",
            "研究課題番号": "JP20fk0210056"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Key HLA‐DRB1‐DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine",
          "DOI": "doi: 10.1002/hep.29876",
          "データID": "hum0136.v1.gwas.v1"
        },
        "2": {
          "タイトル": "Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines",
          "DOI": "doi: 10.1038/s41598-021-82986-8",
          "データID": "hum0136.v2.hep-gwas.v1"
        }
      },
      "制限公開データの利用者一覧": {
        "宮川 卓": {
          "研究代表者": "宮川 卓",
          "所属機関": "東京都医学総合研究所 睡眠プロジェクト",
          "研究題目": "日本",
          "利用データID": "過眠を呈する睡眠障害（各種過眠症・概日リズム睡眠障害・睡眠時無呼吸症候群・睡眠関連運動障害・睡眠時随伴症など）の病態に関与する遺伝子の探索とその機能及び末梢血リンパ球の自己抗原特異的増殖反応の研究",
          "利用期間": "JGAD000452"
        }
      },
      "リリース情報": {
        "hum0136.v3": {
          "Research ID": "hum0136.v3",
          "公開日": "2021/10/01",
          "内容": "日本人B型肝炎ワクチン（ビームゲン）接種者1,193名の個人毎のGenotypingデータ",
          "description": "日本人B型肝炎ワクチン（ビームゲン）接種者1,193名の末梢血から抽出したDNAを対象としたSNPアレイ（Affymetrix AXIOM genome-Wide ASI 1 array）によるGenotype決定の際の個人毎のSNPアレイデータをCELファイルにて提供する。\n"
        },
        "hum0136.v2": {
          "Research ID": "hum0136.v2",
          "公開日": "2021/03/05",
          "内容": "日本人B型肝炎ワクチン（ヘプタバックス）接種者555名のゲノムワイド関連解析",
          "description": "日本人B型肝炎ワクチン（ヘプタバックス）接種者555名の末梢血から抽出したDNAを対象とし、SNPアレイ（Affymetrix AXIOM genome-Wide ASI 1 array）によりGenotypeを決定し、ワクチン低反応群（66 例）、ワクチン中反応群（184 例）、ワクチン高反応群（305 例）の 3 群に分けたGWASを実施した結果（統計情報）をcsvファイルにて提供する。\n"
        },
        "hum0136.v1": {
          "Research ID": "hum0136.v1",
          "公開日": "2018/05/22",
          "内容": "日本人B型肝炎ワクチン（ビームゲン）接種者1,193名のゲノムワイド関連解析",
          "description": "日本人B型肝炎ワクチン（ビームゲン）接種者1,193名の末梢血から抽出したDNAを対象とし、SNPアレイ（Affymetrix AXIOM genome-Wide ASI 1 array）によりGenotypeを決定し、ワクチン低反応群（107 例）、ワクチン中反応群（351 例）、ワクチン高反応群（735 例）の 3 群に分けたGWASを実施した結果（統計情報）をcsvファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0136.v3",
      "DATA": {
        "hum0136.v1.gwas.v1": {
          "Data Set ID": "hum0136.v1.gwas.v1",
          "Type of Data": "GWAS for 1,193 Japanese individuals vaccinated with a HB vaccine (Bimmugen)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/05/22"
        },
        "hum0136.v2.hep-gwas.v1": {
          "Data Set ID": "hum0136.v2.hep-gwas.v1",
          "Type of Data": "GWAS for 555 Japanese individuals vaccinated with a HB vaccine (Heptavax)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/03/05"
        },
        "JGAS000341": {
          "Data Set ID": "JGAS000341",
          "Type of Data": "Genotypes for 1,193 Japanese individuals vaccinated with a HB vaccine (Bimmugen)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/10/01"
        }
      },
      "SUMMARY": {
        "Aims": "To identify host genetic factors associated with response to a HB vaccination",
        "Methods": "Genome-wide association study",
        "Participants/Materials": "1,193 Japanese individuals vaccinated with a HB vaccine (Bimmugen) and 555 Japanese individuals vaccinated with a HB vaccine (Heptavax)",
        "URL": "http://www.ncgmkohnodai.go.jp/genome/english/index.html"
      },
      "MOLECULAR DATA": {
        "hum0136.v1.gwas.v1 / JGAS000341": {
          "Participants/Materials": "1,193 Japanese individuals vaccinated with a HB vaccine (Bimmugen)\r\n    - Low responders (n=107, HBsAb ≤ 10mIU/mL)\r\n    - Intermediate responders (n=351, 10mIU/mL < HBsAb ≤ 100mIU/mL)\r\n    - High responders (n=735, HBsAb >100mIU/mL)\r\n864 Japanese individuals under the age of 30 years vaccinated with a HB vaccine (Bimmugen)\r\n    - Low responders (n=56, HBsAb ≤ 10mIU/mL)\r\n    - Intermediate responders (n=226, 10mIU/mL < HBsAb ≤ 100mIU/mL)\r\n    - High responders (n=582, HBsAb >100mIU/mL)",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix AXIOM 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "GenCall software (Genotyping Console ver. 4.2.0.26)",
          "Filtering Methods": "overall call rate < 0.95, SNP call rate < 0.95, \r\nHWE P < 0.001, MAF < 0.05, Regression P < 0.05",
          "Marker Number (after QC)": "I. Regression analysis for low (0), intermediate (1), and high (2) responders (covariates: age nad gender): 22,044 SNPs (hg19) [Figure 2]\r\nII. Regression analysis for low (0), intermediate (1), and high (2) responders under the age of 30 years (covariates: age nad gender): 21,580 SNPs (hg19) [Supplementary Figure 4]\r\nIII. Regression analysis for low (0) and high (1) responders (covariates: age nad gender): 23,765 SNPs (hg19) [Supplementary Figure 4]",
          "NBDC Dataset ID": "hum0136.v1.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000452",
          "Total Data Volume": "hum0136.v1.gwas.v1: 7.3 MB\r\nJGAD000452: 34.4 GB（CEL）",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0136.v2.hep-gwas.v1": {
          "Participants/Materials": "555 Japanese individuals vaccinated with a HB vaccine (Heptavax)\r\n    - Low responders (n=66, HBsAb ≤ 10mIU/mL)\r\n    - Intermediate responders (n=184, 10mIU/mL < HBsAb ≤ 100mIU/mL)\r\n    - High responders (n=305, HBsAb >100mIU/mL)",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix AXIOM 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "GenCall software (Genotyping Console ver. 4.2.0.26)",
          "Filtering Methods": "overall call rate < 0.95, SNP call rate < 0.95, \r\nHWE P < 0.001, MAF < 0.05, Regression P < 0.05",
          "Marker Number (after QC)": "I. GWAS for low responders (n=66) and responders (n=489) with Heptavax (after imputation): 279,671 SNPs (hg19) [Figure 1a]\r\nII. GWAS for low responders (n=66) and high responders (n=305) with Heptavax (after imputation): 292,028 SNPs (hg19) [Figure 1b]\r\nIII. GWAS for low responders (n=66) and responders (n=489) with Heptavax (before imputation): 22,770 SNPs (hg19) [Supplementary Figure 1a]\r\nIV. GWAS for low responders (n=66) and high responders (n=305) with Heptavax (before imputation): 23,717 SNPs (hg19) [Supplementary Figure 1b]\r\nV. GWAS for low responders (n=66 + 107) and responders (n=489 + 1086) with Heptavax and Bimmugen (after imputation): 310,312 SNPs (hg19) [Supplementary Figure 2a]\r\nVI. GWAS for low responders (n=66 + 107) and high responders (n=305 + 735) with Heptavax and Bimmugen (after imputation): 317,176 SNPs (hg19) [Supplementary Figure 2b]\r\nVII. GWAS for low responders with Heptavax (n=66) and low responders with Bimmugen (n=107) (after imputation): 285,687 SNPs (hg19) [Supplementary Figure 3a]\r\nVIII. GWAS for intermediate responders with Heptavax (n=184) and intermediate responders with Bimmugen (n=351) (after imputation): 312,192 SNPs (hg19) [Supplementary Figure 3b]\r\nIX. GWAS for high responders with Heptavax (n=305) and high responders with Bimmugen (n=735) (after imputation): 321,074 SNPs (hg19) [Supplementary Figure 3c]",
          "NBDC Dataset ID": "hum0136.v2.hep-gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "500 MB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masashi Mizokami",
        "Affiliation": "Natinal Center for Global Health and Medicine",
        "Project / Group Name": "Genome Medical Science Project",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science Program for Basic and Clinical Research on Hepatitis",
            "Title": "Study for clinical sequening based on genome analysis of host and viral factors",
            "Project Number": "JP20fk0210056"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Key HLA‐DRB1‐DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine",
          "DOI": "doi: 10.1002/hep.29876",
          "Data Set ID": "hum0136.v1.gwas.v1"
        },
        "2": {
          "Title": "Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines",
          "DOI": "doi: 10.1038/s41598-021-82986-8",
          "Data Set ID": "hum0136.v2.hep-gwas.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Taku Miyagawa": {
          "Principal Investigator": "Taku Miyagawa",
          "Affiliation": "Sleep Disorders Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Search for genes involved in the pathogenesis of sleep disorders presenting with hypersomnia (various hypersomnias, circadian rhythm sleep disorders, sleep apnea syndrome, sleep-related movement disorders, sleep paralysis, etc.) and study of their functions and autoantigen-specific responses of peripheral blood lymphocytes",
          "Period of Data Use": "JGAD000452"
        }
      },
      "Release Note": {
        "hum0136.v3": {
          "Research ID": "hum0136.v3",
          "Release Date": "2021/10/01",
          "Type of Data": "Genotypes for 1,193 Japanese individuals vaccinated with the HB vaccine (Bimmugen)",
          "description": "Individual genotype data for 1,193 Japanese individuals vaccinated with a HB vaccine (Bimmugen) is provided (CEL files).\n"
        },
        "hum0136.v2": {
          "Research ID": "hum0136.v2",
          "Release Date": "2021/03/05",
          "Type of Data": "GWAS for 555 Japanese individuals vaccinated with the HB vaccine (Heptavax)",
          "description": "DNAs extracted from 555 Japanese individuals vaccinated with a HB vaccine (Heptavax) were genotyped by using of Affymetrix AXIOM genome-Wide ASI 1 arrays and genome-wide association studies were performed (csv file).\n"
        },
        "hum0136.v1": {
          "Research ID": "hum0136.v1",
          "Release Date": "2018/05/22",
          "Type of Data": "GWAS for 1,193 Japanese individuals vaccinated with the HB vaccine (Bimmugen)",
          "description": "DNAs extracted from 1,193 Japanese individuals vaccinated with a HB vaccine (Bimmugen) were genotyped by using of Affymetrix AXIOM genome-Wide ASI 1 arrays and genome-wide association studies were performed (csv file).\nNote:\n"
        }
      }
    }
  },
  "hum0134.v1": {
    "ja": {
      "NBDC Research ID": "hum0134.v1",
      "データ": {
        "JGAS000087": {
          "データID": "JGAS000087",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/04/06"
        }
      },
      "研究内容の概要": {
        "目的": "Bリンパ腫の有効な治療法開発に役立つ分子標的、および患者層別化のためのゲノム・エピゲノムマーカーの同定",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "Bリンパ腫60症例の原発巣及び再発巣の腫瘍組織、非腫瘍組織"
      },
      "分子データ": {
        "JGAS000087": {
          "対象": "Bリンパ腫：60症例（合計147検体）\r\n　非腫瘍組織（正常組織）：60検体\r\n　腫瘍組織（原発巣・転移巣）：87検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "Bリンパ腫60症例の原発巣及び再発巣の腫瘍組織、非腫瘍組織より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V4 ＋ lincRNA、SureSelect Human All Exon V5 ＋ lincRNA",
          "断片化の方法": "超音波断片化（Covaris E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000087",
          "総データ量": "3 TB （fastq [294 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山口 俊晴",
        "所 属 機 関": "がん研究会有明病院",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業（科学研究費補助金）（特定奨励費）",
            "タイトル": "先進的がん治療法開発のためのマルチオミック解析による基盤的基礎研究（患者腫瘍検体のゲノム・エピゲノム情報解析とデータベース構築）",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "-",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0134.v1": {
          "Research ID": "hum0134.v1",
          "公開日": "2018/04/06",
          "内容": "NGS（Exome）",
          "description": "Bリンパ腫60症例の原発巣及び再発巣の腫瘍組織、非腫瘍組織より抽出したDNAを使用したExome解析の結果をFastqファイルにて提供する。\nSureSelect Human All Exon V4 ＋ lincRNA、SureSelect Human All Exon V5 ＋ lincRNAによりExon領域にしぼり、HiSeq 2000にて平均長100塩基を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0134.v1",
      "DATA": {
        "JGAS000087": {
          "Data Set ID": "JGAS000087",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/04/06"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of molecular targets for development effective therapeutic methods and genomic or epigenomic markers for stratification of B cell lymphoma patients.",
        "Methods": "Exome analysis by using of Illumina HiSeq 2000",
        "Participants/Materials": "147 normal, primary tumor, and recurrent tumor samples from 60 B cell lymphoma patients"
      },
      "MOLECULAR DATA": {
        "JGAS000087": {
          "Participants/Materials": "B cell lymphoma: 60 cases (Total: 147 samples)\r\n   non-tumor tissue: 60 samples\r\n   tumor tissue (metastasis/recurrence): 87 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues from 60 B cell lymphoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V4 + lincRNA, SureSelect Human All Exon V5 + lincRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000087",
          "Total Data Volume": "3 TB (fastq [294 files])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshiharu Yamaguchi",
        "Affiliation": "The Cancer Institute Hospital of Japanese Foundation For Cancer Research (JFCR)",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "JSPS KAKENHI",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "-",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0134.v1": {
          "Research ID": "hum0134.v1",
          "Release Date": "2018/04/06",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from 147 normal, primary tumor, and recurrent tumor tissues from 60 B cell lymphoma patients were used for the whole exome sequencing (fastq files).\nExons were narrowed down by using of SureSelect Human All Exon V4 + lincRNA, SureSelect Human All Exon V5 + lincRNA and read by Illumina HiSeq 2000 (paired-end: 100 bp).\nNote:\n"
        }
      }
    }
  },
  "hum0133.v1": {
    "ja": {
      "NBDC Research ID": "hum0133.v1",
      "データ": {
        "JGAS000086": {
          "データID": "JGAS000086",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/04/06"
        }
      },
      "研究内容の概要": {
        "目的": "胃がんの有効な治療法開発に役立つ分子標的、および患者層別化のためのゲノム・エピゲノムマーカーの同定",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "胃がん75症例の原発巣及び再発巣の腫瘍組織、非腫瘍組織"
      },
      "分子データ": {
        "JGAS000086": {
          "対象": "胃がん：75症例（合計214検体）\r\n　非腫瘍組織（正常組織）：75検体\r\n　腫瘍組織（原発巣・転移巣）：139検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "胃がん75症例の原発巣及び再発巣の腫瘍組織、非腫瘍組織より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V4 ＋ lincRNA、SureSelect Human All Exon V5 + lincRNA",
          "断片化の方法": "超音波断片化（Covaris E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000086",
          "総データ量": "5 TB （fastq [428 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山口 俊晴",
        "所 属 機 関": "がん研究会有明病院",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業（科学研究費補助金）（特定奨励費）",
            "タイトル": "先進的がん治療法開発のためのマルチオミック解析による基盤的基礎研究（患者腫瘍検体のゲノム・エピゲノム情報解析とデータベース構築）",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "-",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用データID": "JGAD000086",
          "利用期間": "2019/08/05-2023/03/31"
        },
        "万代 昌紀": {
          "研究代表者": "万代 昌紀",
          "所属機関": "京都大学医学部医学研究科 婦人科学産科学教室",
          "研究題目": "多様な臨床情報を考慮した婦人科悪性腫瘍患者の尾ミックス解析（全ゲノム・全トランスクリプト-ム・プロテオーム・メタボローム解析）による個別化治療の探索",
          "利用データID": "JGAD000086",
          "利用期間": "2020/03/13-2025/03/31"
        }
      },
      "リリース情報": {
        "hum0133.v1": {
          "Research ID": "hum0133.v1",
          "公開日": "2018/04/06",
          "内容": "NGS（Exome）",
          "description": "胃がん75症例の原発巣及び再発巣の腫瘍組織、非腫瘍組織より抽出したDNAを使用したExome解析の結果をFastqファイルにて提供する。\nSureSelect Human All Exon V4＋lincRNA、SureSelect Human All Exon V5＋lincRNAによりExon領域にしぼり、HiSeq 2000にて平均長100塩基を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0133.v1",
      "DATA": {
        "JGAS000086": {
          "Data Set ID": "JGAS000086",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/04/06"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of molecular targets for development effective therapeutic methods and genomic or epigenomic markers for stratification of gastric cancer patients.",
        "Methods": "Exome analysis by using of Illumina HiSeq 2000",
        "Participants/Materials": "214 normal, primary tumor, and metastasis tumor samples from 75 gastric cancer patients"
      },
      "MOLECULAR DATA": {
        "JGAS000086": {
          "Participants/Materials": "gastric cancer: 75 cases (Total: 214 samples)\r\n   non-tumor tissue: 75 samples\r\n   tumor tissue (metastasis/recurrence): 139 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues from 75 gastric cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V4 + lincRNA, SureSelect Human All Exon V5 + lincRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000086",
          "Total Data Volume": "5 TB (fastq [428 files])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshiharu Yamaguchi",
        "Affiliation": "The Cancer Institute Hospital of Japanese Foundation For Cancer Research (JFCR)",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "JSPS KAKENHI",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "-",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Data in Use (Dataset ID)": "JGAD000086",
          "Period of Data Use": "2019/08/05-2023/03/31"
        },
        "Masaki Mandai": {
          "Principal Investigator": "Masaki Mandai",
          "Affiliation": "Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics",
          "Research Title": "Integrated analyses of omics (genomics, transcriptomics, proteomics and metabolomics) associated with clinical variables for developing indivisualizedtreatment in gynecological malignancy",
          "Data in Use (Dataset ID)": "JGAD000086",
          "Period of Data Use": "2020/03/13-2025/03/31"
        }
      },
      "Release Note": {
        "hum0133.v1": {
          "Research ID": "hum0133.v1",
          "Release Date": "2018/04/06",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from 214 normal, primary tumor, and metastasis tumor tissues from 75 gastric cancer patients were used for the whole exome sequencing (fastq files).\nExons were narrowed down by using of SureSelect Human All Exon V4 + lincRNA, SureSelect Human All Exon V5 + lincRNA and read by Illumina HiSeq 2000 (paired-end: 100 bp).\nNote:\n"
        }
      }
    }
  },
  "hum0132.v1": {
    "ja": {
      "NBDC Research ID": "hum0132.v1",
      "データ": {
        "JGAS000137": {
          "データID": "JGAS000137",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/09/07"
        }
      },
      "研究内容の概要": {
        "目的": "ベトナム戦争中にダイオキシンに暴露した兵士の子供に知的障害が見られることがある。知的障害の原因遺伝子を探索すること、および、ダイオキシンが突然変異に与える影響の検出を目的としている。",
        "方法": "Illumina社のHiSeq 2500を用いた全ゲノムシークエンス",
        "対象": "ダイオキシン暴露者（退役軍人）とその妻と子の9トリオ（計27名）"
      },
      "分子データ": {
        "JGAS000137": {
          "対象": "ダイオキシン暴露者（退役軍人）とその妻と知的障害を持つ子の9トリオ（計27名）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Nano DNA Library Preparation Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp もしくは 93 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000206",
          "総データ量": "1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 英刀",
        "所 属 機 関": "理化学研究所・統合生命医科学研究センター・ゲノムシーケンス解析チーム",
        "プロジェクト/研究グループ名": "ベトナム人トリオゲノムプロジェクト",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "the Ministry of Science and Technology (Vietnam)",
            "タイトル": "血中ダイオキシンレベルが上昇しているベトナム人における遺伝子変異の同定",
            "研究課題番号": "Grant DTDL.CN-05/15"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Whole genome sequencing and mutation rate analysis of trios with paternal dioxin exposure.",
          "DOI": "doi: 10.1002/humu.23585",
          "データID": "JGAD000206"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0132.v1": {
          "Research ID": "hum0132.v1",
          "公開日": "2018/09/07",
          "内容": "NGS（WGS）",
          "description": "ベトナム戦争中にダイオキシンに暴露された兵士、妻、知的障害を持つ子（９トリオ：計２７名）の末梢血から抽出したDNAを使用した全ゲノム解析の結果をfastqファイルにて提供する。Illumina [HiSeq 2500]にて平均長101塩基または93塩基を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0132.v1",
      "DATA": {
        "JGAS000137": {
          "Data Set ID": "JGAS000137",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/09/07"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of genetic alterations in Vietnamese individuals with elevated blood dioxin level",
        "Methods": "Whole genome sequencing by HiSeq 2500 (Illumina)",
        "Participants/Materials": "Nine trios of the father exposed to dioxin for a few years and his wife and child with mental retardation (total 27 individuals)"
      },
      "MOLECULAR DATA": {
        "JGAS000137": {
          "Participants/Materials": "9 trios of the father exposed to dioxin and his wife and child with mental retardation (total 27 individuals)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Nano DNA Library Preparation Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp or 93 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000206",
          "Total Data Volume": "1 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hidewaki Nakagawa",
        "Affiliation": "Laboratory of Genome Sequencing Analysis, RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "Vietnamese trio sequencing project",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "the Ministry of Science and Technology (Vietnam)",
            "Title": "Identification of genetic alterations in Vietnamese individuals with elevated blood dioxin level",
            "Project Number": "Grant DTDL.CN-05/15"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Whole genome sequencing and mutation rate analysis of trios with paternal dioxin exposure.",
          "DOI": "doi: 10.1002/humu.23585",
          "Data Set ID": "JGAD000206"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0132.v1": {
          "Research ID": "hum0132.v1",
          "Release Date": "2018/09/07",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from peripheral blood cells from nine trios of the Vietnamese People’s Army exposed to dioxin and his wife and child with mental retardation were used for a whole genome sequencing analysis (fastq). Sequencing was performed by Illumina [HiSeq 2500] (Paired-end: 101 bp or 93 bp).\nNote:\n"
        }
      }
    }
  },
  "hum0131.v1": {
    "ja": {
      "NBDC Research ID": "hum0131.v1",
      "データ": {
        "JGAS000132": {
          "データID": "JGAS000132",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/11/20"
        }
      },
      "研究内容の概要": {
        "目的": "ウィリアム症候群（Williams Syndrome：WS）におけるトランスクリプトーム解析",
        "方法": "WS患者および成人健常者から抽出した血液から抽出したRNAを用いたRNA-Sequencing解析",
        "対象": "WS6症例と成人健常者8名",
        "URL": "http://www.kyoto-u.ac.jp/ja/research/research_results/2018/181026_1.html"
      },
      "分子データ": {
        "JGAS000132": {
          "対象": "WS（ICD10：Q253）：6症例\r\n成人健常者：8名",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "WS患者および成人健常者の末梢血から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion Total RNA-Seq Kit v2",
          "断片化の方法": "Low input RiboMinus Eukaryote System v2",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000143",
          "総データ量": "54 GB（fastqおよびtxt [Transcripts Per Kilo-base Million：TPM]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および 民間企業における利用禁止"
        }
      },
      "提供者情報": {
        "研究代表者": "木村 亮",
        "所 属 機 関": "京都大学大学院医学研究科 形態形成機構学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "遺伝子発現制御ネットワークに着目したウィリアムス症候群の病態解明と治療への応用",
            "研究課題番号": "16K09965"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrative network analysis reveals biological pathways associated with Williams syndrome",
          "DOI": "doi: 10.1111/jcpp.12999",
          "データID": "JGAD000143"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000143"
        }
      },
      "リリース情報": {
        "hum0131.v1": {
          "Research ID": "hum0131.v1",
          "公開日": "2018/11/20",
          "内容": "NGS（RNA-seq）",
          "description": "ウィリアム症候群6症例および成人健常者8名の末梢血から抽出したRNAを用いたRNA-Seq解析データをfastqおよびtxtファイルにて提供する。Ion Total RNA-Seq Kit v2によるRNAライブラリ作製後、Thermo Fisher Scientific [Ion Proton]にて平均長100 bpを読んだ（Single-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0131.v1",
      "DATA": {
        "JGAS000132": {
          "Data Set ID": "JGAS000132",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/11/20"
        }
      },
      "SUMMARY": {
        "Aims": "Transcriptome analysis for Williams Syndrome (WS)",
        "Methods": "RNA-sequencing",
        "Participants/Materials": "WS patients and healthy adult individuals"
      },
      "MOLECULAR DATA": {
        "JGAS000132": {
          "Participants/Materials": "6 WS patients (ICD10: Q253)\r\n8 healthy adults as controls",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "RNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion Total RNA-Seq Kit v2",
          "Fragmentation Methods": "Low input RiboMinus Eukaryote System v2",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000143",
          "Total Data Volume": "54 GB (fastq, txt [Transcripts Per Kilo-base Million: TPM])",
          "Comments (Policies)": "NBDC policy & Company User Limit"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Ryo Kimura",
        "Affiliation": "Department of Anatomy and Developmental Biology, Graduate School of Medicine, Kyoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Integrative network analysis of Williams syndrome",
            "Project Number": "16K09965"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrative network analysis reveals biological pathways associated with Williams syndrome",
          "DOI": "doi: 10.1111/jcpp.12999",
          "Data Set ID": "JGAD000143"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000143"
        }
      },
      "Release Note": {
        "hum0131.v1": {
          "Research ID": "hum0131.v1",
          "Release Date": "2018/11/20",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs were extracted from peripheral blood cells obtained from 6 Williams Syndrome patients and 8 healthy adult contorols. Libraries for RNA-seq were prepared with Ion Total RNA-Seq Kit v2 and RNA-seq was performed with Thermo Fisher Scientific [Ion Proton] (100 bp, Single-end). RNA-seq data are provided as fastq and txt files. \nNote:\n"
        }
      }
    }
  },
  "hum0130.v2": {
    "ja": {
      "NBDC Research ID": "hum0130.v2",
      "データ": {
        "JGAS000150": {
          "データID": "JGAS000150",
          "内容": "NGS（Exome、Target Capture、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/01/18"
        },
        "JGAS000289": {
          "データID": "JGAS000289",
          "内容": "NGS（scRNA-seq、bulk RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/27"
        }
      },
      "研究内容の概要": {
        "目的": "POEMS症候群（polyneuropathy, organomegaly, endocrinopathy, M-Protein, and skin changes syndrome）における形質細胞の遺伝学的特徴を他の形質細胞性疾患と比較する。POEMS症候群患者の骨髄形質細胞におけるシングルセルRNAシークエンスを行い、POEMSクローンの遺伝子発現の特徴を明らかにすることで、本疾患の分子病態解明を行う。",
        "方法": "POEMS症候群における形質細胞のゲノム解析および3疾患（POEMS症候群、多発性骨髄腫、単クローン性免疫グロブリン血症 [monoclonal gammopathy of undetermined significance：MGUS]）の遺伝子発現解析。患者骨髄からCD138陽性形質細胞をMACSとFACSによって純化し、Fluidigm C1を用いてシングルセルソートとライブラリー作成を行い、Illumina HiSeq 3000にてRNAシークエンスを行った。また、SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing、NEBNext Ultra DNALibrary Prep Kitを用いてライブラリーを作成し、Illumina HiSeq 2000にてRNAシークエンスを行った。",
        "対象": "POEMS症候群（20＋14症例）、多発性骨髄腫（4＋5症例）、MGUS（5＋2症例）、正常コントロール（骨髄浸潤のない悪性リンパ腫：4症例）の形質細胞"
      },
      "分子データ": {
        "Exome": {
          "対象": "POEMS症候群（ICD10：C90.2）：15症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "Coding exons",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "POEMS症候群の腫瘍細胞（骨髄形質細胞）と正常細胞（頬粘膜細胞）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human ALL Exon V5",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "121 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000226",
          "総データ量": "171 GB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture": {
          "対象": "POEMS症候群（ICD10：C90.2）：20症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "Coding exons of selected genes",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "POEMS症候群の腫瘍細胞（骨髄形質細胞）と正常細胞（頬粘膜細胞）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "custom designed SureSelect XT2 Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "273 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000226",
          "総データ量": "171 GB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "POEMS症候群（ICD10：C90.2）：5症例\r\n多発性骨髄腫（ICD10：C90.0）：4症例\r\nMGUS（ICD10：D47.2）：5症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq1500]",
          "ライブラリソース": "POEMS症候群、多発性骨髄腫、MGUSの腫瘍細胞（骨髄形質細胞）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing、NEBNext Ultra DNALibrary Prep Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "60 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000226",
          "総データ量": "171 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "bulk RNA-seq": {
          "対象": "POEMS症候群（ICD10：C90.2）：4症例\r\n多発性骨髄腫（ICD10：C90.0）：3症例\r\n正常コントロール（骨髄浸潤のないリンパ腫）：2症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "POEMS症候群、多発性骨髄腫、骨髄浸潤のない悪性リンパ腫の腫瘍細胞（CD138陽性骨髄形質細胞）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing、NEBNext Ultra DNALibrary Prep Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "60 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000395",
          "総データ量": "12.6 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "scRNA-seq": {
          "対象": "POEMS症候群（ICD10：C90.2）：11症例（うち1症例はJGAD000226と重複）\r\n多発性骨髄腫（ICD10：C90.0）：2症例\r\nMGUS（ICD10：D47.2）：2症例\r\n正常コントロール （骨髄浸潤のない悪性リンパ腫）：2症例",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 3000]",
          "ライブラリソース": "POEMS症候群、多発性骨髄腫、MGUS、骨髄浸潤のない悪性リンパ腫の腫瘍細胞（CD138陽性骨髄形質細胞）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Fluidigm C1",
          "断片化の方法": "Tagmentation using Nextera XT DNA Sample Preparation kit（Illumina）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000395",
          "総データ量": "350.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "堺田 恵美子",
        "所 属 機 関": "千葉大学大学院医学研究院・細胞治療内科学（千葉大学病院 血液内科）",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "6": {
            "科研費・助成金名": "科学研究費助成事業　基盤研究（C）",
            "タイトル": "POEMS症候群における微小クローン同定による診断治療戦略の確立",
            "研究課題番号": "22K08471"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genetic and transcriptional landscape of plasma cells in POEMS syndrome.",
          "DOI": "doi: 10.1038/s41375-018-0348-x",
          "データID": "JGAD000226"
        },
        "2": {
          "タイトル": "Unraveling unique features of plasma cell clones in POEMS syndrome by single-cell analysis",
          "DOI": "doi: 10.1172/jci.insight.151482",
          "データID": "JGAD000395"
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000226"
        }
      },
      "リリース情報": {
        "hum0130.v2": {
          "Research ID": "hum0130.v2",
          "公開日": "2022/09/27",
          "内容": "NGS（scRNA-seq、bulk RNA-seq）",
          "description": "POEMS症候群11症例、多発性骨髄腫2例、MGUS2例、骨髄浸潤のない悪性リンパ腫2例の骨髄液から単離したCD138陽性形質細胞から抽出したRNAを使用したscRNA-seq解析データ（fastq）を提供する。また、POEMS症候群4症例、多発性骨髄腫3症例、骨髄浸潤のない悪性リンパ腫2例に対してFACS純化を行った複数の骨髄形質細胞から抽出したRNAを使用したbulk RNA-seq解析データ（fastq）を提供する。\n"
        },
        "hum0130.v1": {
          "Research ID": "hum0130.v1",
          "公開日": "2019/01/18",
          "内容": "NGS（Exome、Target Capture、RNA-seq）",
          "description": "POEMS症候群20症例、多発性骨髄腫4例、MGUS5例の骨髄液から単離した形質細胞から抽出したDNAおよびRNAを使用したExome解析データ（bam）、Target Capture解析データ（bam）、および、RNA-seq解析データ（fastq）を提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0130.v2",
      "DATA": {
        "JGAS000150": {
          "Data Set ID": "JGAS000150",
          "Type of Data": "NGS (Exome, Target Capture, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/01/18"
        },
        "JGAS000289": {
          "Data Set ID": "JGAS000289",
          "Type of Data": "NGS (scRNA-seq, bulk RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/27"
        }
      },
      "SUMMARY": {
        "Aims": "To compare genetic features of plasma cells from polyneuropathy, organomegaly, endocrinopathy, M-Protein, and skin changes (POEMS) syndrome, multiple myeloma (MM), and monoclonal gammopathy of undetermined significance (MGUS). We herein performed single-cell RNA sequencing (scRNA-Seq) and bulk RNA sequencing of bone marrow (BM) plasma cells from patients with POEMS syndrome. These data unveil unique features of POEMS clones among plasma cell neoplasms and enhance our understanding of the pathogenesis of POEMS syndrome.",
        "Methods": "Genomic analysis of POEMS syndrome, and gene expression analysis of 3 dieases. For scRNA-Seq, CD138+ plasma cells were purified by FACS after MACS CD138 positive selection from BM aspiration samples. Single cell isolation and library preparation were performed by Fluidigm C1, and then the samples were read by single-end sequencing with Illumina HiSeq 3000. For bulk RNA-Seq, library preparation were performed by SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing and NEBNext Ultra DNALibrary Prep Kit, and then the samples were read by paired-end sequencing with Illumina HiSeq 2000.",
        "Participants/Materials": "Plasma cells from POEMS syndrome, MM, MGUS, and Normal control (lymphoma without BM invasion)"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "POEMS syndrome (ICD10: C90.2): 15 cases",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "Coding exons",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA purified from Plasma cells or buccal cell of POEMS syndrome, MM, MGUS",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human ALL Exon V5",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end or Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "121 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000226",
          "Total Data Volume": "171 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture": {
          "Participants/Materials": "POEMS syndrome (ICD10: C90.2): 20 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "Coding exons",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNA purified from Plasma cells or buccal cell of POEMS syndrome, MM, MGUS",
          "Cell Lines": "-",
          "Library Construction (kit name)": "custom designed SureSelect XT2 Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "273 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000226",
          "Total Data Volume": "171 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "POEMS syndrome (ICD10: C90.2): 5 cases\r\nMM (ICD10: C90.0): 4 cases\r\nMGUS (ICD10: D47.2): 5 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "",
          "Platform": "Illumina [HiSeq 1500]",
          "Library Source": "RNA purified from Plasma cells or buccal cell of POEMS syndrome, MM and MGUS",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing, NEBNext Ultra DNALibrary Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "60 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000226",
          "Total Data Volume": "171 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "bulk RNA-seq": {
          "Participants/Materials": "POEMS syndrome (ICD10: C90.2): 4 cases\r\nMM (ICD10: C90.0): 3 cases\r\nNormal control (lymphoma without BM invasion): 2 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "RNA purified from Plasma cells or buccal cell of POEMS syndrome and normal controls",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing, NEBNext Ultra DNALibrary Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "60 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000395",
          "Total Data Volume": "12.6 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "scRNA-seq": {
          "Participants/Materials": "POEMS syndrome (ICD10: C90.2): 11 cases (1 case is also used for JGAD000226)\r\nMM (ICD10: C90.0): 2 cases\r\nMGUS (ICD10: D47.2): 2 cases\r\nlymphoma without BM invasion (Control): 2 cases",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 3000]",
          "Library Source": "RNA purified from CD138+ plasma cells of POEMS syndrome, MM, MGUS and lymphoma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Fluidigm C1",
          "Fragmentation Methods": "Tagmentation using Nextera XT DNA Sample Preparation kit (Illumina)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000395",
          "Total Data Volume": "350.5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Emiko Sakaida",
        "Affiliation": "Chiba University Graduate school of Medicine, Clinical Cell Bilogy and Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "6": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (S)",
            "Title": "Establishment of diagnostic and therapeutic strategies by identification of small clones in POEMS syndrome",
            "Project Number": "22K08471"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genetic and transcriptional landscape of plasma cells in POEMS syndrome.",
          "DOI": "doi: 10.1038/s41375-018-0348-x",
          "Data Set ID": "JGAD000226"
        },
        "2": {
          "Title": "Unraveling unique features of plasma cell clones in POEMS syndrome by single-cell analysis",
          "DOI": "doi: 10.1172/jci.insight.151482",
          "Data Set ID": "JGAD000395"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000226"
        }
      },
      "Release Note": {
        "hum0130.v2": {
          "Research ID": "hum0130.v2",
          "Release Date": "2022/09/27",
          "Type of Data": "NGS (scRNA-seq, bulk RNA-seq)",
          "description": "RNAs extracted from CD138+ plasma cells of 11 POEMS syndrome, 2 MM, 2 MGUS and 2 normal control (lymphoma without BM invasion) were used for the single-cell RNA sequencing (fastq files).\nRNAs extracted from CD138 + plasma cells of 4 POEMS syndrome, 3 MM and 2 normal control were used for the bulk RNA sequencing analyses (fastq files).\n"
        },
        "hum0130.v1": {
          "Research ID": "hum0130.v1",
          "Release Date": "2019/01/18",
          "Type of Data": "NGS (Exome, Target Capture, RNA-seq)",
          "description": "DNAs and RNAs extracted from plasma cells of 20 POEMS syndrome, 4 MM and 5 MGUS patients were used for the whole exome sequencing analysis (bam files), target capture seqencing analysis (bam files), and RNA sequencing analysis (fastq files).\nNote:\n"
        }
      }
    }
  },
  "hum0129.v1": {
    "ja": {
      "NBDC Research ID": "hum0129.v1",
      "データ": {
        "JGAS000131": {
          "データID": "JGAS000131",
          "内容": "NGS（ChIP-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/04/06"
        }
      },
      "研究内容の概要": {
        "目的": "CHARGE症候群患者における中枢神経系の機能解析",
        "方法": "CHARGE症候群患者由来線維芽細胞から樹立したiPS細胞溶解液、および、iPS細胞を神経上皮様細胞（神経前駆細胞）へ分化誘導した細胞溶解液に対して免疫沈降（抗ヒストン抗体：H3K27ac [Acetyl Lys27]）を実施後、DNAを調整してChIP-seqを実施した。",
        "対象": "CHARGE症候群2症例（CH1、CH2）"
      },
      "分子データ": {
        "JGAS000131": {
          "対象": "CHARGE症候群（ICD10：Q878）：2症例（2検体ずつ計4検体）",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "CHARGE症候群患者由来皮膚線維芽細胞より樹立したiPS細胞から分化誘導した神経上皮様細胞から抽出したDNA\r\n抗ヒストン抗体（H3K27ac）を用いて免疫沈降",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA Hyper Preparation kit",
          "断片化の方法": "超音波断片化（Covaris社、 S2）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000142",
          "総データ量": "9 GB\r\n　Data ファイル数：16 （fastq）\r\n　Analysis ファイル数：8 （wig [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "岡野 栄之",
        "所 属 機 関": "慶應義塾大学医学部",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 再生医療実用化研究事業",
            "タイトル": "ヒト iPS 由来神経前駆細胞の腫瘍形成能のメカニズムとその制御による安全性 確保の検討",
            "研究課題番号": "JP15bk0104009"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitors",
          "DOI": "doi: 10.1101/gad.301887.117",
          "データID": "JGAD000142"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0129.v1": {
          "Research ID": "hum0129.v1",
          "公開日": "2018/04/06",
          "内容": "NGS（ChIP-seq）",
          "description": "CHARGE症候群患者由来皮膚線維芽細胞より樹立したiPS細胞から誘導した神経上皮様細胞より抽出したDNAを用いたChIP-seq解析の結果をfastqファイルにて提供する。抗ヒストン抗体（H3K27ac）を用いて免疫沈降後、KAPA Hyper Preparation Kitを用いてChIP-seqライブラリを作製し、Illumina HiSeq 2500によりシングルエンドシークエンシングを行っている（50 bp）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0129.v1",
      "DATA": {
        "JGAS000131": {
          "Data Set ID": "JGAS000131",
          "Type of Data": "NGS (ChIP-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/04/06"
        }
      },
      "SUMMARY": {
        "Aims": "Functional analysis of neural cells derived from CHARGE syndrome patients' fibroblast cells",
        "Methods": "Establishment of iPS cells from CHARGE syndrome patients' fibroblast cells",
        "Participants/Materials": "iPS cells or neuroepithelial-like stem cells induced from iPS cells established from CHARGE syndrome patients' skin fibroblast cells"
      },
      "MOLECULAR DATA": {
        "JGAS000131": {
          "Participants/Materials": "CHARGE syndrome patient (ICD10: Q878): 3 cases \r\n(2 samples each, total 4 samples)",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from long-term self-renewing neuroepithelial-like stem cells induced from iPS cells established from skin fibroblasts of CHARGE syndrome patients\r\nanti-histone antibody (H3K27ac) was used for immunoprecipitation",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Hyper Preparation kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S2)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000142",
          "Total Data Volume": "9 GB\r\n　　Data files : 16 (fastq)\r\n　　Analysis files : 8 (wig [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hideyuki Okano",
        "Affiliation": "Keio University School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Research Project for Practical Application of Regenerative Medicine, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Mechanism of tumorigenesis of human iPSC-derived neural progenitor/stem cells",
            "Project Number": "JP15bk0104009"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitors",
          "DOI": "doi: 10.1101/gad.301887.117",
          "Data Set ID": "JGAD000142"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0129.v1": {
          "Research ID": "hum0129.v1",
          "Release Date": "2018/04/06",
          "Type of Data": "NGS (ChIP-seq)",
          "description": "DNAs extracted from long-term self-renewing neuroepithelial-like stem cells induced from iPS cells established of skin fibroblasts from CHARGE syndrome patients were used for ChIP-seq analyses (fastq format files). Anti-histone antibody (H3K27ac) was used for immunoprecipitation. ChIP-Seq libraries were prepared by using KAPA Hyper Preparation Kit and sequenced by Illumina HiSeq 2500 (50 bp, single-end).\nNote：\n"
        }
      }
    }
  },
  "hum0128.v1": {
    "ja": {
      "NBDC Research ID": "hum0128.v1",
      "データ": {
        "JGAS000153": {
          "データID": "JGAS000153",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/10/29"
        }
      },
      "研究内容の概要": {
        "目的": "好酸球性副鼻腔炎の病態解析",
        "方法": "慢性副鼻腔炎症例の鼻茸から抽出したRNAを用いたRNA-seq",
        "対象": "好酸球性副鼻腔炎を含む慢性副鼻腔炎症例"
      },
      "分子データ": {
        "JGAS000153": {
          "対象": "好酸球性副鼻腔炎を含む慢性副鼻腔炎（ICD10：J329）：6症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "慢性副鼻腔炎症例の鼻茸（ポリープ）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Sample Prep Kit",
          "断片化の方法": "高温条件下での2価陽イオンによる断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000231",
          "総データ量": "20 MB (カウントデータ、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "藤枝 重治",
        "所 属 機 関": "福井大学医学部 耳鼻咽喉科・頭頸部外科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polyps",
          "DOI": "doi: 10.1038/s41598-018-29612-2",
          "データID": "JGAD000231"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0128.v1": {
          "Research ID": "hum0128.v1",
          "公開日": "2018/10/29",
          "内容": "NGS（RNA-seq）",
          "description": "好酸球性副鼻腔炎を含む慢性副鼻腔炎6症例の鼻茸から抽出したRNAを用いたRNA-seqのリードカウントデータをテキストファイルにて提供する。TruSeq RNA Sample Prep KitによるRNAライブラリ作製後、Illumina [HiSeq 2000]にて平均長100 bpを読んだ（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0128.v1",
      "DATA": {
        "JGAS000153": {
          "Data Set ID": "JGAS000153",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/10/29"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate the pathology of eosinophilic chronic rhinosinusitis",
        "Methods": "RNAs were extracted from nasal polyps of 6 patients with chronic rhinosinusitis, and performed RNA sequencing.",
        "Participants/Materials": "Patients with chronic rhinosinusitis with nasal polyp"
      },
      "MOLECULAR DATA": {
        "JGAS000153": {
          "Participants/Materials": "chronic rhinosinusitis with nasal polyps (ICD10: J329): 6 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "RNAs extracted from nasal polyps of chronic rhinosinusitis patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Sample Prep Kit",
          "Fragmentation Methods": "divalent cation under high tempreture",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000231",
          "Total Data Volume": "20 MB (count data, txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shigeharu Fujieda",
        "Affiliation": "Departments of Otorhinolaryngology Head & Neck Surgery, Faculty of Medical Sciences, University of Fukui",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polyps",
          "DOI": "doi: 10.1038/s41598-018-29612-2",
          "Data Set ID": "JGAD000231"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0128.v1": {
          "Research ID": "hum0128.v1",
          "Release Date": "2018/10/29",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs were extracted from nasal polyps of 6 chronic rhinosinusitis patients. Libraries for RNA-seq were prepared with TruSeq RNA Sample Prep Kit and RNA-seq was performed with Illumina [HiSeq 2000] (100 bp, Paired-end). Read count data from RNA-seq are provided as txt files. \nNote：\n"
        }
      }
    }
  },
  "hum0127.v2": {
    "ja": {
      "NBDC Research ID": "hum0127.v2",
      "データ": {
        "JGAS000130": {
          "データID": "JGAS000130",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/04/14"
        },
        "JGAS000274": {
          "データID": "JGAS000274",
          "内容": "NGS（Exome；体細胞変異）\r\nNGS（Exome；生殖細胞系列変異）\r\nNGS（Exome；CNV）\r\nNGS（DNA Amplicon-seq、Exome）\r\nマイクロアレイ\r\nNGS（RNA Amplicon-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/08"
        }
      },
      "研究内容の概要": {
        "目的": "腫瘍組織におけるPOLE遺伝子領域の変異の探索、および、がんの発生や進展過程に関与すると考えられる遺伝子内に高頻度に存在する変異を探索することで、分子生物学的特徴を検出し、新たながん診療技術の開発を目指す",
        "方法": "末梢血の白血球（非腫瘍組織）や手術摘出組織（腫瘍組織、非腫瘍組織）から抽出したDNAおよびRNAを対象に、NGSによるWhole Exome seq、DNA amplicon-seq、RNA amplicon-seq、およびマイクロアレイを実施する。",
        "対象": "",
        "URL": "https://www.scchr.jp/project-hope.html"
      },
      "分子データ": {
        "JGAS000130（Exome）": {
          "対象": "POLE変異および高頻度変異を保有するがん：91症例\r\n（ICD10：C00-D48）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "手術摘出組織（腫瘍組織）および末梢血の白血球（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Exome RDY Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end, multiplex PCR",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "180 bp",
          "マッピング方法": "Torrent Suite",
          "QC方法": "Torrent Suite",
          "変異検出方法": "Torrent Suite plugin Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000141",
          "総データ量": "75 MB（NBDC-91sample.renamed.vcf [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000274（Exome；体細胞変異）": {
          "対象": "腫瘍組織と末梢血（白血球）のペア解析による体細胞変異を保有するがん：5419症例\r\n（ICD10：C00-D48）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "全遺伝子",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "手術摘出組織（腫瘍組織）および末梢血の白血球（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Exome RDY Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end, multiplex PCR",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "180 bp",
          "マッピング方法": "Torrent Suite",
          "QC方法": "Torrent Suite",
          "変異検出方法": "Torrent Suite plugin Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "総データ量": "36.5 MB（HOPE-5000.WES.somatic-mutation.vcf [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000274（Exome；生殖細胞系列変異）": {
          "対象": "がん患者末梢血（白血球）における遺伝性腫瘍の原因遺伝子（49遺伝子）の病原性変異の頻度情報：5419症例\r\n（ICD10：C00-D48）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "遺伝性腫瘍の原因遺伝子（49遺伝子）",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "末梢血の白血球（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Exome RDY Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end, multiplex PCR",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "180 bp",
          "マッピング方法": "Torrent Suite",
          "QC方法": "Torrent Suite",
          "変異検出方法": "Torrent Suite plugin Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "総データ量": "12 KB（HOPE-5000.WES.germline-mutation.vcf [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000274（Exome；CNV）": {
          "対象": "腫瘍組織と末梢血（白血球）のペア解析によるCNV（loss）に関する情報：5433症例\r\n腫瘍組織と末梢血（白血球）のペア解析によるCNV（gain）に関する情報：5433症例\r\n（ICD10：C00-D48）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "880遺伝子（がん遺伝子とがん抑制遺伝子）",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "手術摘出組織（腫瘍組織）および末梢血の白血球（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Exome RDY Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end, multiplex PCR",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "180 bp",
          "マッピング方法": "Torrent Suite",
          "QC方法": "Torrent Suite",
          "変異検出方法": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "総データ量": "6.77 MB（HOPE-5000.CNV.loss.tab）\r\n6.26 MB（HOPE-5000.CNV.gain.tab）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000274（DNA Amplicon-seq、Exome）": {
          "対象": "腫瘍組織 [がん関連409遺伝子Panel]と末梢血（白血球）[Exome]のペア解析による体細胞変異：5407症例\r\n（ICD10：C00-D48）",
          "規模": "DNA Amplicon-seq (腫瘍組織）\r\nExome （血液）",
          "対象領域（Target Captureの場合）": "がん関連409遺伝子\r\n（Ion AmpliSeq Comprehensive Cancer Panel）\r\n全遺伝子（Exome)",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "手術摘出組織（腫瘍組織）および末梢血の白血球（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq™ Library Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end, multiplex PCR",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp（Panel）\r\n180 bp（Exome）",
          "マッピング方法": "Torrent Suite",
          "QC方法": "Torrent Suite",
          "変異検出方法": "Torrent Suite plugin Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "総データ量": "2.19 MB（HOPE-5000.CCP.somatic-mutation.vcf [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000274（マイクロアレイ）": {
          "対象": "がん患者の腫瘍組織： 5063症例\r\nがん患者の腫瘍組織近傍の非腫瘍組織： 5063症例\r\n（ICD10：C00-D48）",
          "規模": "マイクロアレイ",
          "対象領域（Target Captureの場合）": "全遺伝子",
          "Platform": "チップ：SurePrint G3 Human Gene Expression 8 × 60 K v2 Microarray\r\nスキャナー：Agilent Technologies [DNA Microarray Scanner]",
          "ソース": "手術摘出組織（腫瘍組織および非腫瘍組織）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Low Input Quick Amp Labeling Kit One color",
          "フィルタリング": "The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default parameters (protocol GE1-v1_91 and Grid: 012391_D_20060331) to obtain background subtracted and spatially detrended Processed Signal intensities. Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.",
          "マイクロアレイ標準化方法": "75パーセンタイル",
          "QC方法": "Agilent Feature Extraction software",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "総データ量": "27.3 MB（HOPE-5000.GEP.tumor.tab）\r\n27.4 MB（HOPE-5000.GEP.normal.tab）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000274（RNA Amplicon-seq）": {
          "対象": "既知の融合遺伝子を保有するがん：95症例\r\n（ICD10：C00-D48）",
          "規模": "RNA Amplicon-seq",
          "対象領域（Target Captureの場合）": "491融合遺伝子のBreakpointを挟む約100塩基領域",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "手術摘出組織（腫瘍組織）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Custom Panel / Ion AmpliSeq™ Library Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end, multiplex PCR",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "マッピング方法": "Torrent Suite",
          "QC方法": "Torrent Suite",
          "変異検出方法": "Ion Reporter",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "総データ量": "8 KB（HOPE-5000.Fusion.tab）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山口 建",
        "所 属 機 関": "静岡県立静岡がんセンター",
        "プロジェクト/研究グループ名": "プロジェクトHOPE （High-tech Omics-based Patient Evaluation）（がんのマルチオミクス解析）/ 静岡がんセンター",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE—",
          "DOI": "doi: 10.2220/biomedres.35.407",
          "データID": ""
        },
        "2": {
          "タイトル": "Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations",
          "DOI": "doi: 10.1038/s41598-018-26967-4",
          "データID": "JGAD000141"
        },
        "3": {
          "タイトル": "Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes",
          "DOI": "doi: 10.2220/biomedres.37.367",
          "データID": ""
        },
        "4": {
          "タイトル": "Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors",
          "DOI": "doi: 10.1038/s41598-017-00219-3",
          "データID": ""
        },
        "5": {
          "タイトル": "Next generation sequencing approach for detecting 491 fusion genes from human cancer",
          "DOI": "doi: 10.2220/biomedres.37.51",
          "データID": ""
        },
        "6": {
          "タイトル": "Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients",
          "DOI": "doi: 10.1111/cas.14290",
          "データID": "JGAD000380"
        }
      },
      "制限公開データの利用者一覧": {
        "三森 功士": {
          "研究代表者": "三森 功士",
          "所属機関": "九州大学病院別府病院 外科",
          "研究題目": "トランスオミクス解析による日本人乳癌の分子的特徴の解明",
          "利用データID": "JGAD000141, JGAD000380",
          "利用期間": "2021/05/24-2022/06/30"
        },
        "万代 昌紀": {
          "研究代表者": "万代 昌紀",
          "所属機関": "京都大学医学部医学研究科 婦人科学産科学教室",
          "研究題目": "多様な臨床情報を考慮した婦人科悪性腫瘍患者の尾ミックス解析（全ゲノム・全トランスクリプト-ム・プロテオーム・メタボローム解析）による個別化治療の探索",
          "利用データID": "JGAD000141, JGAD000380",
          "利用期間": "2021/10/14-2025/03/31"
        }
      },
      "リリース情報": {
        "hum0127.v2": {
          "Research ID": "hum0127.v2",
          "公開日": "2021/03/08",
          "内容": "NGS（Exome、DNA Amplicon-seq、RNA Amplicon-seq）、マイクロアレイ",
          "description": "静岡がんセンター病院にて手術を受けたがん患者5143例を対象とし、手術摘出組織（腫瘍組織および非腫瘍組織）ならびに末梢血の白血球（非腫瘍組織）から抽出したDNAおよびRNAを用いたExome、DNA amplicon-seq、RNA amplicon-seq解析を実施。配列の解読にはIon Proton（Thermo Fisher Scientific）を用いた。腫瘍組織、非腫瘍組織の変異情報（vcf）およびCNVデータ（tab）、DNA amplicon-seq（409遺伝子パネル）解析結果（vcf）、RNA amplicon-seq（491融合遺伝子パネル）解析結果（tab）を提供する。また、上記RNAを対象とした、SurePrint G3 Human Gene Expression 8 × 60 K v2 Microarray（Agilent Technologies）によるマイクロアレイ解析結果（tab）を提供する。\n"
        },
        "hum0127.v1": {
          "Research ID": "hum0127.v1",
          "公開日": "2020/04/14",
          "内容": "NGS（Exome）",
          "description": "静岡がんセンター病院にて手術を受けたがん患者2042例のうち、POLE遺伝子領域内の変異、および、がん関連遺伝子内に高頻度で変異を持つ（高頻度遺伝子変異）91症例を対象とし、手術摘出組織（腫瘍組織）ならびに末梢血の白血球（非腫瘍組織）から抽出したDNAを用いたExome解析を実施。腫瘍組織と非腫瘍組織の塩基配列を比較し、腫瘍特異的な変異情報を提供する（vcf）。配列の解読にはIon Proton（Thermo Fisher Scientific）を用いた。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0127.v2",
      "DATA": {
        "JGAS000130": {
          "Data Set ID": "JGAS000130",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/04/14"
        },
        "JGAS000274": {
          "Data Set ID": "JGAS000274",
          "Type of Data": "NGS (Exome; somatic mutation)\r\nNGS (Exome; germline mutation)\r\nNGS (Exome; CNV)\r\nNGS (DNA Amplicon-seq, Exome)\r\nMicroarray\r\nNGS (RNA Amplicon-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/08"
        }
      },
      "SUMMARY": {
        "Aims": "clarify the molecular profiling and sequential somatic mutation shift in hypermutator tumors harborig POLE mutations",
        "Methods": "DNAs and RNAs extracted from peripheral blood cells, tumor and non-tumor tissues are analyzed by whole-exome sequencing, DNA amplicon sequencing, RNA amplicon sequencing and Microarray.",
        "Participants/Materials": "",
        "URL": "https://www.scchr.jp/en/institute/projecthope.html"
      },
      "MOLECULAR DATA": {
        "JGAS000130 (Exome)": {
          "Participants/Materials": "91 cancer patients with hypermutator tumors harborig POLE mutations\r\n(ICD10: C00-D48)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from peripheral blood cells (non-tumor tissues) and surgically dissected tumor tissues (tumor tissues)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Exome RDY Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end, multiplex PCR",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "180 bp",
          "Mapping Methods": "Torrent Suite",
          "QC methods": "Torrent Suite",
          "Mutation Detection Methods": "Torrent Suite plugin Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000141",
          "Total Data Volume": "75 MB (NBDC-91sample.renamed.vcf [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000274 (Exome; somatic mutation)": {
          "Participants/Materials": "Pair samples of tumor tissue and peripheral blood (white blood cell) from 5419 Japanese cancer patients\r\n(ICD10: C00-D48)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from white blood cells (as a germ line) and surgically dissected tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Exome RDY Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end, multiplex PCR",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "180 bp",
          "Mapping Methods": "Torrent Suite",
          "QC methods": "Torrent Suite",
          "Mutation Detection Methods": "Torrent Suite plugin Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "Total Data Volume": "36.5 MB (HOPE-5000.WES.somatic-mutation.vcf [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000274 (Exome; germline mutation)": {
          "Participants/Materials": "White blood cells (as a germ line) of 5419 Japanese cancer patients\r\n(ICD10: C00-D48)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "Hereditary tumor-associated genes (49 genes)",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from white blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Exome RDY Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end, multiplex PCR",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "180 bp",
          "Mapping Methods": "Torrent Suite",
          "QC methods": "Torrent Suite",
          "Mutation Detection Methods": "Torrent Suite plugin Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "Total Data Volume": "12 KB (HOPE-5000.WES.germline-mutation.vcf [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000274 (Exome; CNV)": {
          "Participants/Materials": "Pair samples of tumor tissue and peripheral blood (white blood cell) from 5433 Japanese cancer patients\r\nPair samples of tumor tissue and peripheral blood (white blood cell) from 5433 Japanese cancer patients\r\n(ICD10: C00-D48)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "880 genes (cancer driver gene and tumor supprresor gene)",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from peripheral blood cells (non-tumor tissues) and surgically dissected tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Exome RDY Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end, multiplex PCR",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "180 bp",
          "Mapping Methods": "Torrent Suite",
          "QC methods": "Torrent Suite",
          "Mutation Detection Methods": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "Total Data Volume": "6.77 MB (HOPE-5000.CNV.loss.tab)\r\n6.26 MB (HOPE-5000.CNV.gain.tab)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000274 (DNA Amplicon-seq, Exome)": {
          "Participants/Materials": "Pair samples of tumor tissue and peripheral blood (white blood cell) from 5407 Japanese cancer patients\r\n(ICD10: C00-D48)",
          "Targets": "DNA Amplicon-seq (tumor tissue)\r\nExome (white blood)",
          "Target Loci for Capture Methods": "a panel of 409 cancer related genes\r\n（Ion AmpliSeq Comprehensive Cancer Panel）\r\nExome",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "DNAs extracted from white blood cells (as a germ line) and surgically dissected tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq™ Library Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end, multiplex PCR",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp (Panel)\r\n180 bp (Exome)",
          "Mapping Methods": "Torrent Suite",
          "QC methods": "Torrent Suite",
          "Mutation Detection Methods": "Torrent Suite plugin Variant Caller",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "Total Data Volume": "2.19 MB (HOPE-5000.CCP.somatic-mutation.vcf [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000274 (Microarray)": {
          "Participants/Materials": "Tumor tissue of 5063 Japanese cancer patients\r\nNon cancerous tissue of 5063 Japanese cancer patients\r\n(ICD10: C00-D48)",
          "Targets": "Microarray",
          "Target Loci for Capture Methods": "-",
          "Platform": "Chip: Agilent Technologies [SurePrint G3 Human Gene Expression 8 × 60 K v2 Microarray]\r\nScanner: Agilent Technologies [DNA Microarray Scanner]",
          "Source": "RNA extracted from tumor and non cancerous tissues",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Low Input Quick Amp Labeling Kit One color",
          "Filtering Methods": "The scanned images were analyzed with Feature Extraction Software 9.1 (Agilent) using default parameters (protocol GE1-v1_91 and Grid: 012391_D_20060331) to obtain background subtracted and spatially detrended Processed Signal intensities. Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.",
          "Normalization of microarray": "75 percentile",
          "QC methods": "Agilent Feature Extraction software",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "Total Data Volume": "27.3 MB (HOPE-5000.GEP.tumor.tab)\r\n27.4 MB (HOPE-5000.GEP.normal.tab)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000274 (RNA Amplicon-seq)": {
          "Participants/Materials": "Tumorr tissues of 95 Japanese cancer patients\r\n(ICD10: C00-D48)",
          "Targets": "RNA Amplicon-seq",
          "Target Loci for Capture Methods": "Custom panel of 491 fusion genes",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "Library Source": "RNAs extracted from surgically dissected tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Custom Panel / Ion AmpliSeq™ Library Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end, multiplex PCR",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Mapping Methods": "Torrent Suite",
          "QC methods": "Torrent Suite",
          "Mutation Detection Methods": "Ion Reporter",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000380",
          "Total Data Volume": "8 KB (HOPE-5000.Fusion.tab)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Ken Yamaguchi",
        "Affiliation": "Shizuoka Cancer Center",
        "Project / Group Name": "Project HOPE (High-tech Omics-based Patient Evaluation) / Shizuoka Cancer Center",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE—",
          "DOI": "doi: 10.2220/biomedres.35.407",
          "Data Set ID": ""
        },
        "2": {
          "Title": "Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations",
          "DOI": "doi: 10.1038/s41598-018-26967-4",
          "Data Set ID": "JGAD000141"
        },
        "3": {
          "Title": "Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes",
          "DOI": "doi: 10.2220/biomedres.37.367",
          "Data Set ID": ""
        },
        "4": {
          "Title": "Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors",
          "DOI": "doi: 10.1038/s41598-017-00219-3",
          "Data Set ID": ""
        },
        "5": {
          "Title": "Next generation sequencing approach for detecting 491 fusion genes from human cancer",
          "DOI": "doi: 10.2220/biomedres.37.51",
          "Data Set ID": ""
        },
        "6": {
          "Title": "Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients",
          "DOI": "doi: 10.1111/cas.14290",
          "Data Set ID": "JGAD000380"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Koshi Mimori": {
          "Principal Investigator": "Koshi Mimori",
          "Affiliation": "Department of Surgery, Kyushu University Beppu Hospital",
          "Research Title": "Transomic analysis of molecular characterization of Japanese breast cancer",
          "Data in Use (Dataset ID)": "JGAD000141, JGAD000380",
          "Period of Data Use": "2021/05/24-2022/06/30"
        },
        "Masaki Mandai": {
          "Principal Investigator": "Masaki Mandai",
          "Affiliation": "Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics",
          "Research Title": "Integrated analyses of omics (genomics, transcriptomics, proteomics and metabolomics) associated with clinical variables for developing indivisualizedtreatment in gynecological malignancy",
          "Data in Use (Dataset ID)": "JGAD000141, JGAD000380",
          "Period of Data Use": "2021/10/14-2025/03/31"
        }
      },
      "Release Note": {
        "hum0127.v2": {
          "Research ID": "hum0127.v2",
          "Release Date": "2021/03/08",
          "Type of Data": "NGS (Exome, DNA Amplicon-seq, RNA Amplicon-seq), Microarray",
          "description": "DNAs and RNAs extracted from white blood cells (non-tumor tissues) and surgically dissected tumor and non-tumor tissues from 5143 cancer patients were used for whole exome sequencing analysis (vcf, tab), DNA amplicon sequencing analysis (vcf), and RNA amplicon sequencing analysis (tab). Sequencing were performed using Ion Proton (Thermo Fisher Scientific). Microarray analysis (tab) was performed by using of SurePrint G3 Human Gene Expression 8 × 60 K v2 Microarray (Agilent Technologies).\n"
        },
        "hum0127.v1": {
          "Research ID": "hum0127.v1",
          "Release Date": "2020/04/14",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from blood cells (non-tumor tissues) and surgically dissected tumor tissues from 91 cancer patients with hypermutator tumors harborig POLE mutations were used for whole exome sequencing analysis. Variants information only in the tumor tissues were provided (vcf files). Sequencing were performed using Ion Proton (Thermo Fisher Scientific).\nNote:\n"
        }
      }
    }
  },
  "hum0126.v2": {
    "ja": {
      "NBDC Research ID": "hum0126.v2",
      "データ": {
        "hum0126.v1.gwas.v1": {
          "データID": "hum0126.v1.gwas.v1",
          "内容": "小児ネフローゼ症候群224症例および対照419名のGWAS",
          "制限": "非制限公開",
          "公開日": "2018/04/27"
        },
        "hum0126.v2.imp-gwas.v1": {
          "データID": "hum0126.v2.imp-gwas.v1",
          "内容": "小児ネフローゼ症候群987症例および対照3,206名のGWAS",
          "制限": "非制限公開",
          "公開日": "2020/09/01"
        }
      },
      "研究内容の概要": {
        "目的": "小児ネフローゼ症候群の疾患感受性遺伝子を、ゲノムワイド関連解析（GWAS）等を用いて同定し、その発症機序の解明に資する",
        "方法": "GWAS",
        "対象": "対照健常者419名、および、成人期に移行した症例も含め小児期に発症したネフローゼ症候群224症例"
      },
      "分子データ": {
        "hum0126.v1.gwas.v1": {
          "対象": "小児ネフローゼ症候群（ICD10：N049）：224症例\r\n対照健常者：419名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Japonica Array v1]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Axiom 2.0 Reagent kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Axiom Analysis suite 1.0.0.3",
          "フィルタリング": "Sample Call rate < 0.97, SNP call rate < 0.97, HWE P < 0.0001, MAF < 0.05",
          "マーカー数（QC後）": "495,887 SNPs（hg19）",
          "NBDC Dataset ID": "hum0126.v1.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "11.6 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0126.v2.imp-gwas.v1": {
          "対象": "小児ネフローゼ症候群（ICD10：N049）：987症例\r\n対照健常者：3,206名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Japonica Array v1 / v2]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Axiom 2.0 Reagent kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Axiom Analysis suite 1.0.0.3",
          "フィルタリング": "Sample Call rate < 0.97, SNP call rate < 0.97, HWE P < 0.0001, MAF < 0.05\r\nImputation quality (Rsq) < 0.5",
          "マーカー数（QC後）": "6,834,340 SNPs（hg19）",
          "NBDC Dataset ID": "hum0126.v2.imp-gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "459 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "飯島 一誠",
        "所 属 機 関": "神戸大学大学院 医学研究科 内科系講座 小児科学分野",
        "プロジェクト/研究グループ名": "The Research Consortium on Genetics of Childhood Idiopathic Nephrotic Syndrome in Japan",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 国際共同研究加速基金（国際共同研究強化（Ｂ））",
            "タイトル": "小児ネフローゼ症候群疾患感受性遺伝子及び薬剤感受性遺伝子同定のための国際共同研究",
            "研究課題番号": "18KK0244"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Strong Association of the HLA-DR/DQ Locus with Childhood Steroid-Sensitive Nephrotic Syndrome in the Japanese Population.",
          "DOI": "doi: 10.1681/ASN.2017080859",
          "データID": "hum0126.v1.gwas.v1"
        },
        "2": {
          "タイトル": "Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome.",
          "DOI": "doi: 10.1016/j.kint.2020.05.029",
          "データID": "hum0126.v2.imp-gwas.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0126.v2": {
          "Research ID": "hum0126.v2",
          "公開日": "2020/09/01",
          "内容": "小児ネフローゼ症候群987症例および対照3,206名のゲノムワイド関連解析",
          "description": "小児ネフローゼ症候群987症例および対照健常者3,206名の末梢血より抽出したDNAを対象とし、SNPアレイ（Affymetrix Japonica Array v1およびv2）によりGenotypeを決定し、GWASを実施した結果（Imputation後データ）をcsv fileにて提供する。\n"
        },
        "hum0126.v1": {
          "Research ID": "hum0126.v1",
          "公開日": "2018/04/27",
          "内容": "小児ネフローゼ症候群224症例および対照419名のゲノムワイド関連解析",
          "description": "小児ネフローゼ症候群224症例および対照健常者419名の末梢血より抽出したDNAを対象とし、SNPアレイ（Affymetrix Japonica Array v1）によりGenotypeを決定し、GWASを実施した結果（統計情報）をcsv fileにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0126.v2",
      "DATA": {
        "hum0126.v1.gwas.v1": {
          "Data Set ID": "hum0126.v1.gwas.v1",
          "Type of Data": "GWAS for 224 Childhood Idiopathic Nephrotic Syndrome patients and 419 healthy adult controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/04/27"
        },
        "hum0126.v2.imp-gwas.v1": {
          "Data Set ID": "hum0126.v2.imp-gwas.v1",
          "Type of Data": "GWAS for 3,206 Childhood Idiopathic Nephrotic Syndrome patients and 987 healthy adult controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/09/01"
        }
      },
      "SUMMARY": {
        "Aims": "To identify the novel disease susceptibility genes for Childhood Idiopathic Nephrotic Syndrome",
        "Methods": "GWAS",
        "Participants/Materials": "Healthy controls and Childhood Idiopathic Nephrotic Syndrome patients"
      },
      "MOLECULAR DATA": {
        "hum0126.v1.gwas.v1": {
          "Participants/Materials": "224 Childhood Idiopathic Nephrotic Syndrome patients (ICD10: N049) and 419 healthy adult controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Japonica Array v1]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Axiom 2.0 Reagent kit",
          "Genotype Call Methods (software)": "Axiom Analysis suite 1.0.0.3",
          "Filtering Methods": "Sample Call rate < 0.97, SNP call rate < 0.97, HWE P < 0.0001, MAF < 0.05",
          "Marker Number (after QC)": "495,887 SNPs (hg19)",
          "NBDC Dataset ID": "hum0126.v1.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "11.6 MB",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0126.v2.imp-gwas.v1": {
          "Participants/Materials": "987 Childhood Idiopathic Nephrotic Syndrome patients (ICD10: N049) and 3,206 healthy adult controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Japonica Array v1 / v2]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Axiom 2.0 Reagent kit",
          "Genotype Call Methods (software)": "Axiom Analysis suite 1.0.0.3",
          "Filtering Methods": "Sample Call rate < 0.97, SNP call rate < 0.97, HWE P < 0.0001, MAF < 0.05\r\nImputation quality (Rsq) < 0.5",
          "Marker Number (after QC)": "6,834,340 SNPs (hg19)",
          "NBDC Dataset ID": "hum0126.v2.imp-gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "459 MB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kazumoto Iijima",
        "Affiliation": "Department of Pediatrics, Kobe University Graduate School of Medicine",
        "Project / Group Name": "The Research Consortium on Genetics of Childhood Idiopathic Nephrotic Syndrome in Japan",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))",
            "Title": "Joint International Research for identification of disease-susceptible genes and drug-sensitive genes in childhood nephrotic syndrome",
            "Project Number": "18KK0244"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Strong Association of the HLA-DR/DQ Locus with Childhood Steroid-Sensitive Nephrotic Syndrome in the Japanese Population.",
          "DOI": "doi: 10.1681/ASN.2017080859",
          "Data Set ID": "hum0126.v1.gwas.v1"
        },
        "2": {
          "Title": "Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome.",
          "DOI": "doi: 10.1016/j.kint.2020.05.029",
          "Data Set ID": "hum0126.v2.imp-gwas.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0126.v2": {
          "Research ID": "hum0126.v2",
          "Release Date": "2020/09/01",
          "Type of Data": "GWAS for 3,206 Childhood Idiopathic Nephrotic Syndrome patients and 987 healthy adult controls",
          "description": "DNAs extracted from 3,206 Childhood Idiopathic Nephrotic Syndrome patients and 987 healthy adult controls were genotyped by using of Affymetrix Japonica Array v1 and a genome-wide association study was performed (csv file).\n"
        },
        "hum0126.v1": {
          "Research ID": "hum0126.v1",
          "Release Date": "2018/04/27",
          "Type of Data": "GWAS for 224 Childhood Idiopathic Nephrotic Syndrome patients and 419 healthy adult controls",
          "description": "DNAs extracted from 224 Childhood Idiopathic Nephrotic Syndrome patients and 419 healthy adult controls were genotyped by using of Affymetrix Japonica Array v1 and a genome-wide association study was performed (csv file).\nNote:\n"
        }
      }
    }
  },
  "hum0125.v1": {
    "ja": {
      "NBDC Research ID": "hum0125.v1",
      "データ": {
        "JGAS000127": {
          "データID": "JGAS000127",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/11/05"
        }
      },
      "研究内容の概要": {
        "目的": "自己免疫疾患における免疫担当細胞の解析",
        "方法": "RNA-seq",
        "対象": "クローン病3症例の病変部および大腸がん4症例の切除切片の中の非腫瘍組織（正常大腸組織）について、分離マーカーの違い（CD14-CD11c- / CD14-CD11c- / CD14+CD11c-CD163low）によって単離した細胞から抽出したRNA"
      },
      "分子データ": {
        "JGAS000127": {
          "対象": "クローン病（ICD10：K50）：3症例\r\n大腸がん：4症例（非腫瘍組織）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "ライブラリソース": "クローン病の病変部および大腸がんの切除切片の中の非腫瘍組織（正常大腸組織）について、分離マーカーの違い（CD14-CD11c- / CD14-CD11c- / CD14+CD11c-CD163low）によって単離した細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA Library Preparation Kit",
          "断片化の方法": "KAPA Frag",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000138",
          "総データ量": "86 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "坂口 志文",
        "所 属 機 関": "大阪大学免疫学フロンティア研究センター 実験免疫学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 若手研究（B）",
            "タイトル": "炎症性腸疾患における抗原提示細胞の異常活性化の機序および機能解析",
            "研究課題番号": "17K16546"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Innate Myeloid Cell Subset-Specific Gene Expression Patterns in the Human Colon are Altered in Crohn’s Disease Patients",
          "DOI": "doi: 10.1159/000490890",
          "データID": "JGAD000138"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000138"
        }
      },
      "リリース情報": {
        "hum0125.v1": {
          "Research ID": "hum0125.v1",
          "公開日": "2018/11/05",
          "内容": "NGS（RNA-seq）",
          "description": "クローン病3症例の病変部および大腸がん4症例の切除切片の中の非腫瘍組織（正常大腸組織）について、分離マーカーの違い（CD14-CD11c- / CD14-CD11c- / CD14+CD11c-CD163low）によって単離した細胞から抽出したRNAを用いたRNA-Seq解析データをfastqファイルにて提供する。KAPA Library Preparation KitによるRNAライブラリ作製後、Thermo Fisher Scientific [Ion S5]にて平均長150 bpを読んだ（Single-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0125.v1",
      "DATA": {
        "JGAS000127": {
          "Data Set ID": "JGAS000127",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/11/05"
        }
      },
      "SUMMARY": {
        "Aims": "Analysis of immune cells in autoimmune diseases",
        "Methods": "RNA-seq",
        "Participants/Materials": "Lesions from Crohn's disease patients and normal colorectal tissues from colorectal cancer patients"
      },
      "MOLECULAR DATA": {
        "JGAS000127": {
          "Participants/Materials": "Crohn's disease (ICD10: K50): 3 cases\r\ncolorectal cancer: 4 cases (normal tissues)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [Ion S5]",
          "Library Source": "RNAs extracted from isolated cells using different markers (CD14-CD11c- / CD14-CD11c- / CD14+CD11c-CD163low) from lesions of Crohn's diseases and normal colorectal tissues of colorectal cancers",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Library Preparation Kit",
          "Fragmentation Methods": "KAPA Frag",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp on average",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000138",
          "Total Data Volume": "86 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shimon Sakaguchi",
        "Affiliation": "Experimental Immunology, IFReC, Osaka University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Young Scientists (B)",
            "Title": "Mechanism and function analysis of abnormal activation of antigen presenting cells in inflammatory bowel disease",
            "Project Number": "17K16546"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Innate Myeloid Cell Subset-Specific Gene Expression Patterns in the Human Colon are Altered in Crohn’s Disease Patients",
          "DOI": "doi: 10.1159/000490890",
          "Data Set ID": "JGAD000138"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000138"
        }
      },
      "Release Note": {
        "hum0125.v1": {
          "Research ID": "hum0125.v1",
          "Release Date": "2018/11/05",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs were extracted from isolated cells using different markers (CD14-CD11c- / CD14-CD11c- / CD14+CD11c-CD163low) from tumor tissues of Crohn's diseases and non-tumor tissues of colorectal cancers. Libraries for RNA-seq were prepared with KAPA Library Preparation Kit and RNA-seq was performed with Thermo Fisher Scientific [Ion S5] (150 bp on average, Single-end). RNA-seq data are provided as fastq. \nNote:\n"
        }
      }
    }
  },
  "hum0124.v1": {
    "ja": {
      "NBDC Research ID": "hum0124.v1",
      "データ": {
        "JGAS000129": {
          "データID": "JGAS000129",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/04/06"
        }
      },
      "研究内容の概要": {
        "目的": "ヒト上皮成長因子受容体（epidermal growth factor receptor：EGFR）遺伝子変異をもつ肺がん発癌関連遺伝子同定",
        "方法": "エクソーム解析",
        "対象": "EGFR遺伝子変異をもつ肺がん症例",
        "URL": "http://www.med.niigata-u.ac.jp/resp/welcome.html"
      },
      "分子データ": {
        "JGAS000129": {
          "対象": "EGFR遺伝子変異をもつ肺がん（ICD10：C34）：3症例（1家系）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Target Enrichment System Human All Exon V2",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "Japanese Genotype-phenotype Archive Data set ID": "JGAD000140",
          "総データ量": "9 GB （bam [ref：hg18]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "菊地 利明",
        "所 属 機 関": "新潟大学大学院 医歯学総合研究科",
        "プロジェクト/研究グループ名": "呼吸器･感染症内科学分野",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 挑戦的萌芽研究",
            "タイトル": "ＥＧＦＲ（上皮成長因子受容体）遺伝子変異陽性肺癌の分子遺伝学的発生母地の解明",
            "研究課題番号": "24659399"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer.",
          "DOI": "doi: 10.1111/cas.13233",
          "データID": "JGAD000140"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000140"
        }
      },
      "リリース情報": {
        "hum0124.v1": {
          "Research ID": "hum0124.v1",
          "公開日": "2018/04/06",
          "内容": "NGS（Exome）",
          "description": "ヒト上皮成長因子受容体遺伝子（EGFR）変異をもつ肺がん3症例（1家系）の末梢血より抽出したDNAを使用したExome解析の結果をbamファイルにて提供する。\nSureSelect Target Enrichment System Human All Exon V2によりExon領域にしぼり、Illumina HiSeq 2000にて平均長50塩基を解読した（Single-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0124.v1",
      "DATA": {
        "JGAS000129": {
          "Data Set ID": "JGAS000129",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/04/06"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of the genes associated with epidermal growth factor receptor (EGFR)-mutant lung cancer",
        "Methods": "exome sequencing",
        "Participants/Materials": "lung cancer patients with EGFR-mutants"
      },
      "MOLECULAR DATA": {
        "JGAS000129": {
          "Participants/Materials": "EGFR-mutant lung cancer (ICD10: C34): 3 cases (in 1 family)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Target Enrichment System Human All Exon V2",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000140",
          "Total Data Volume": "9 GB (bam [ref: hg18])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshiaki Kikuchi",
        "Affiliation": "Niigata University Graduate School of Medical and Dental Sciences",
        "Project / Group Name": "Department of Respiratory Medicine and Infectious Diseases",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for challenging Exploratory Research",
            "Title": "Molecular genetics of EGFR-mutant lung cancer",
            "Project Number": "24659399"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer.",
          "DOI": "doi: 10.1111/cas.13233",
          "Data Set ID": "JGAD000140"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000140"
        }
      },
      "Release Note": {
        "hum0124.v1": {
          "Research ID": "hum0124.v1",
          "Release Date": "2018/04/06",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from peripheral blood cells from 3 EGFR-mutant lung cancer patients were used for the whole exome sequencing (bam files).\nExons were narrowed down by using of SureSelect Target Enrichment System Human All Exon V2 and read by Illumina HiSeq 2000 (single-end: 50 bp).\nNote:\n"
        }
      }
    }
  },
  "hum0122.v1": {
    "ja": {
      "NBDC Research ID": "hum0122.v1",
      "データ": {
        "DRA006622\r\nDRA007336\r\nDRA008459": {
          "データID": "DRA006622\r\nDRA007336\r\nDRA008459",
          "内容": "NGS（WGS）",
          "制限": "非制限公開",
          "公開日": "2020/01/14"
        },
        "E-GEAD-311": {
          "データID": "E-GEAD-311",
          "内容": "SNPアレイ",
          "制限": "非制限公開",
          "公開日": "2020/01/14"
        }
      },
      "研究内容の概要": {
        "目的": "ゲノム初期化におけるゲノム不安定性を明らかにする",
        "方法": "樹立したiPS細胞、および樹立に用いた初代細胞について、全ゲノムシークエンシングおよびSNPアレイを実施し、変異解析を行う。",
        "対象": "市販のヒト培養細胞、およびそれから誘導したiPS細胞株",
        "URL": "https://www.qst.go.jp/"
      },
      "分子データ": {
        "WGS": {
          "対象": "ヒト臍帯血由来単核細胞（タカラバイオD10118）：4検体（CB_1, CB_2-1, CB_2-2, CB_2-3）\r\n　　- CB_1から誘導したiPS細胞：5検体\r\n　　- CB_2-1から誘導したiPS細胞：3検体\r\n　　- CB_2-2から誘導したiPS細胞：3検体\r\n　　- CB_2-3から誘導したiPS細胞：3検体\r\n成人皮膚線維芽細胞（クラボウKF4109）：1検体（adult human dermal fibroblast [HDFa]）\r\n　　- HDFaから誘導したiPS細胞：8検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "樹立したiPS細胞、および樹立に用いた購入細胞それぞれから抽出したDNA",
          "検体情報（購入の場合）": "タカラバイオ（D10118）：\r\nhttp://catalog.takara-bio.co.jp/product/basic_info.php?unitid=U100007076\r\nクラボウ（KF4109）：\r\nhttps://www.kurabo.co.jp/bio/product/products.php?M=L&A=C&PPID=118",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free Library Prep Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "400 bp",
          "DDBJ Sequence Read Archive ID": "DRA006622（CB_1）\r\nDRA007336（HDFa）\r\nDRA008459（CB_1, CB_2-1, CB_2-2, CB_2-3）",
          "総データ量": "2 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "SNPアレイ": {
          "対象": "ヒト臍帯血由来単核細胞細胞（タカラバイオD10118）：1検体（CB_1）\r\n　　- CB_1から誘導したiPS細胞：4検体\r\n成人皮膚線維芽細胞（クラボウKF4109）：1検体（adult human dermal fibroblast [HDFa]）\r\n　　- HDFaから誘導したiPS細胞：2検体",
          "規模": "genome wide SNVs/CNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium Omni2.5-8 v1.4 BeadChip]",
          "ソース": "樹立したiPS細胞、および樹立に用いた初代細胞それぞれから抽出したDNA",
          "検体情報（購入の場合）": "タカラバイオ（D10118）：\r\nhttp://catalog.takara-bio.co.jp/product/basic_info.php?unitid=U100007076\r\nクラボウ（KF4109）：\r\nhttps://www.kurabo.co.jp/bio/product/products.php?M=L&A=C&PPID=118",
          "調整試薬（キット名、バージョン）": "Infinium Omni2.5-8 v1.4 BeadChip Kit",
          "コピー数決定アルゴリズム（ソフトウェア）": "GenomeStudio（Illumina）",
          "マーカー数": "約250万 CNVs",
          "Genomic Expression Archive ID": "E-GEAD-311",
          "総データ量": "1 GB（idat、txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "荒木 良子、安倍 真澄",
        "所 属 機 関": "研究開発法人量子科学技術研究開発機構 放射線医学総合研究所 放射線障害治療研究部",
        "プロジェクト/研究グループ名": "幹細胞研究グループ",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 挑戦的萌芽研究",
            "タイトル": "ゲノムワイド放射線影響解析法の開発",
            "研究課題番号": "17K20053"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency",
          "DOI": "doi: 10.1038/s41467-019-13830-x",
          "データID": "DRA006622\r\nDRA007336\r\nDRA008459\r\nE-GEAD-311"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0122.v1": {
          "Research ID": "hum0122.v1",
          "公開日": "2020/01/14",
          "内容": "NGS（WGS）、SNPアレイ",
          "description": "市販のヒト培養細胞（成人皮膚線維芽細胞、ヒト臍帯血由来単核細胞）と、培養細胞から誘導したiPS細胞から抽出したDNAを用いた、全ゲノムシークエンシングおよびSNPアレイ解析結果をfastqおよびidat/txtファイル形式にて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0122.v1",
      "DATA": {
        "DRA006622\r\nDRA007336\r\nDRA008459": {
          "Data Set ID": "DRA006622\r\nDRA007336\r\nDRA008459",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/01/14"
        },
        "E-GEAD-311": {
          "Data Set ID": "E-GEAD-311",
          "Type of Data": "SNP array",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/01/14"
        }
      },
      "SUMMARY": {
        "Aims": "Elucidation of genome instability during genome reprogramming",
        "Methods": "Whole genome sequencing and copy number variation analysis using SNP array of iPS cells and their parental cells to identify genetic abberations",
        "Participants/Materials": "Human iPS cells derived from commercially-available primary cells",
        "URL": "https://www.qst.go.jp/site/qst-english/"
      },
      "MOLECULAR DATA": {
        "WGS": {
          "Participants/Materials": "Mononuclear Cells from Cord Blood (Takara D10118): 4 sample (CB_1, CB_2-1, CB_2-2, and CB_2-3)\r\n    - iPS cells derived from CB_1: 5 samples\r\n    - iPS cells derived from CB_2-1: 3 samples\r\n    - iPS cells derived from CB_2-2: 3 samples\r\n    - iPS cells derived from CB_2-3: 3 samples\r\nHuman Dermal Fibroblast (KURABO KF4109): 1 sample (adult human dermal fibroblast [HDFa])\r\n    - iPS cells derived from HDFa: 8 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "DNAs extracted from iPS cells and their parental cells",
          "Cell Lines": "TaKaRa Bio (D10118):\r\nhttp://catalog.takara-bio.co.jp/product/basic_info.php?unitid=U100007076\r\nKURABO (KF4109):\r\nhttps://www.kurabo.co.jp/bio/product/products.php?M=L&A=C&PPID=118",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "400 bp",
          "DDBJ Sequence Read Archive ID": "DRA006622 (CB_1)\r\nDRA007336 (HDFa)\r\nDRA008459 (CB_1, CB_2-1, CB_2-2, CB_2-3)",
          "Total Data Volume": "2 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "SNP array": {
          "Participants/Materials": "Mononuclear Cells from Cord Blood (Takara D10118): 1 sample (CB_1)\r\n    - iPS cells derived from CB_1: 4 samples\r\nHuman Dermal Fibroblast (KURABO KF4109): 1 sample (HDFa)\r\n    - iPS cells derived from HDFa: 2 samples",
          "Targets": "genome wide SNVs/CNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium Omni2.5-8 v1.4 BeadChip]",
          "Source": "DNAs extracted from iPS cells and their parental cells",
          "Cell Lines": "TaKaRa Bio (D10118):\r\nhttp://catalog.takara-bio.co.jp/product/basic_info.php?unitid=U100007076\r\nKURABO (KF4109):\r\nhttps://www.kurabo.co.jp/bio/product/products.php?M=L&A=C&PPID=118",
          "Reagents (Kit, Version)": "Infinium Omni2.5-8 v1.4 BeadChip Kit",
          "Genotype Call Methods (software)": "GenomeStudio (Illumina)",
          "Marker number": "About 2,500,000 CNVs",
          "Genomic Expression Archive Dataset ID": "E-GEAD-311",
          "Total Data Volume": "1 GB (idat, txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Ryoko Araki and Masumi Abe",
        "Affiliation": "National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, Department of Basic Medical Sciences for Radiation Damages",
        "Project / Group Name": "Stem cell biology group",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for challenging Exploratory Research",
            "Title": "Development of genome-wide analysis for radiation effects",
            "Project Number": "17K20053"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency",
          "DOI": "doi: 10.1038/s41467-019-13830-x",
          "Data Set ID": "DRA006622\r\nDRA007336\r\nDRA008459\r\nE-GEAD-311"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0122.v1": {
          "Research ID": "hum0122.v1",
          "Release Date": "2020/01/14",
          "Type of Data": "NGS (WGS), SNP array",
          "description": "Whole genome sequencing and SNP array were performed using DNAs extracted from human iPS cells and their parental cells. The data are provided as fastq and idat/txt format files.\nNote:\n"
        }
      }
    }
  },
  "hum0120.v4": {
    "ja": {
      "NBDC Research ID": "hum0120.v4",
      "データ": {
        "JGAS000221": {
          "データID": "JGAS000221",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/04/03"
        },
        "DRA011183": {
          "データID": "DRA011183",
          "内容": "NGS（Exome）",
          "制限": "非制限公開",
          "公開日": "2020/04/03"
        },
        "DRA011184": {
          "データID": "DRA011184",
          "内容": "NGS（RNA-seq）",
          "制限": "非制限公開",
          "公開日": "2020/04/03"
        },
        "DRA011185": {
          "データID": "DRA011185",
          "内容": "NGS（Target Capture）",
          "制限": "非制限公開",
          "公開日": "2020/10/30"
        },
        "E-GEAD-396": {
          "データID": "E-GEAD-396",
          "内容": "メチル化アレイ",
          "制限": "非制限公開",
          "公開日": "2021/12/06"
        },
        "DRA010902": {
          "データID": "DRA010902",
          "内容": "NGS（WGBS）",
          "制限": "非制限公開",
          "公開日": "2021/12/06"
        },
        "JGAS000549": {
          "データID": "JGAS000549",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/07/29"
        }
      },
      "研究内容の概要": {
        "目的": "大腸がん、胃がん、乳がんの転移再発を正確に予測するバイオマーカーの同定",
        "方法": "原発巣・転移巣の切除切片（腫瘍組織および正常粘膜）から抽出したDNA/RNAを用いた全エクソームシーケンス、RNA-seq、およびT細胞のレパトア解析、ならびにメチレーションアレイおよびWhole genome bisulfite sequencing解析。治療前後で経時的に血漿サンプルを採取し、抽出した血中循環腫瘍DNAを用いたTarget Capture Sequencing解析。",
        "対象": "原発巣切除後に肺・肝転移をきたしたstage 1、2の大腸がん、胃がん、乳がん",
        "URL": "https://www.beppu.kyushu-u.ac.jp/gekareview/"
      },
      "分子データ": {
        "Exome": {
          "対象": "大腸がん（ICD10：C189）：10症例36検体\r\n　・腫瘍組織（大腸：10検体、肝臓：9検体、肺：5検体）\r\n　・非腫瘍組織（大腸：8検体、肺：4検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "大腸がんの腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human ALL Exon V5",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID / DDBJ Sequence Read Archive ID": "非腫瘍組織：JGAD000311\r\n腫瘍組織：DRA011183",
          "総データ量": "414 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "大腸がん（ICD10：C189）：10症例20検体\r\n　・原発巣：8検体、転移巣：12検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "大腸がんの腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect Strand Specific RNA Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "DDBJ Sequence Read Archive ID": "DRA011184",
          "総データ量": "414 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture（DRA011185）": {
          "対象": "大腸がん（ICD10：C189）：10症例20検体\r\n　・原発巣：8検体、転移巣：12検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "T細胞受容体βサブユニット領域",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "大腸がんの腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA HiFi HotStart Ready Mix PCR Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "DDBJ Sequence Read Archive ID": "DRA011185",
          "総データ量": "16 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture （JGAS000549）": {
          "対象": "大腸がん（ICD10：C189）：10症例\r\n　・経時的に採取した血漿サンプル：77 検体\r\n　　　　　（根治術前1回、ならびに、後2～12回）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "exome sequence解析により同定した原発巣および転移巣に共通する遺伝子変異部位452ヶ所を含む領域（対象遺伝子一覧）",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "経時的に取得した血漿から抽出した血中循環腫瘍より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelectXT Custom 1kb-499kb （Agilent Technologies）",
          "断片化の方法": "超音波断片化 （Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000667",
          "総データ量": "410.4 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "メチル化アレイ": {
          "対象": "大腸がん（ICD10：C189）：16症例\r\n胃がん（ICD10：C169）：16症例\r\n乳がん（ICD10：C509）：16症例\r\n　・原発巣：16検体ずつ",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [iScan]",
          "ソース": "大腸がん、胃がん、乳がんの原発巣の腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium MethylationEPIC Kit, v1.0",
          "メチル化率決定アルゴリズム（ソフトウェア）": "GenomeStudio Methylation Module v1.8",
          "プローブ数": "866,836",
          "Genomic Expression Archive ID": "E-GEAD-396",
          "総データ量": "1.3 GB （idat）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGBS": {
          "対象": "大腸がん（ICD10：C189）：9症例18検体\r\n　・原発巣：9検体、転移巣：9検体",
          "規模": "WGBS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "大腸がんの腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Miura F, et al.. Nucleic Acids Research (2019), 47, e85.",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "DDBJ Sequence Read Archive ID": "DRA010902",
          "総データ量": "1101 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "三森 功士",
        "所 属 機 関": "九州大学病院 別府病院 外科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん医療創生研究事業（P-CREATE）",
            "タイトル": "微小環境多様性に連動する難治がんの分子遺伝学的多様性創成機構の解明と新たながん治療法・予測医療技術の開発",
            "研究課題番号": "JP19cm0106504"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin.",
          "DOI": "doi: 10.1038/s41417-021-00401-w",
          "データID": "E-GEAD-396\r\nDRA010902"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用データID": "JGAD000311",
          "利用期間": "2020/09/18-2023/03/31"
        }
      },
      "リリース情報": {
        "hum0120.v4": {
          "Research ID": "hum0120.v4",
          "公開日": "2022/07/29",
          "内容": "NGS（Target Capture）",
          "description": "大腸がん10症例の根治術前後で経時的に取得した血漿から抽出した血中循環腫瘍より抽出したDNAを用いたTarget Capture Sequencing解析の結果をfastqファイルにて提供する。\n"
        },
        "hum0120.v3": {
          "Research ID": "hum0120.v3",
          "公開日": "2021/12/06",
          "内容": "メチル化アレイ、NGS（WGBS）",
          "description": "大腸がん、胃がん、乳がんそれぞれ16症例の原発巣の腫瘍組織から抽出したDNAを用いたメチル化アレイ解析、並びに、大腸がん9症例の原発巣および転移巣の腫瘍組織から抽出したDNAを用いたWGBS解析データをidatおよびfastqファイルにて提供する。\n"
        },
        "hum0120.v2": {
          "Research ID": "hum0120.v2",
          "公開日": "2020/10/30",
          "内容": "NGS（Target Capture）",
          "description": "大腸がん10症例の原発巣および転移巣（肺・肝臓）切除切片の腫瘍組織から抽出したRNAを用いたT細胞のレパトア解析データをfastqファイルにて提供する。\n"
        },
        "hum0120.v1": {
          "Research ID": "hum0120.v1",
          "公開日": "2020/04/03",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "大腸がん10症例の原発巣および転移巣（肺・肝臓）切除切片の腫瘍組織および非腫瘍組織（正常粘膜）から抽出したDNAおよびRNAを用いたExome解析およびRNA-seq解析データをfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0120.v4",
      "DATA": {
        "JGAS000221": {
          "Data Set ID": "JGAS000221",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/04/03"
        },
        "DRA011183": {
          "Data Set ID": "DRA011183",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/04/03"
        },
        "DRA011184": {
          "Data Set ID": "DRA011184",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/04/03"
        },
        "DRA011185": {
          "Data Set ID": "DRA011185",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/10/30"
        },
        "E-GEAD-396": {
          "Data Set ID": "E-GEAD-396",
          "Type of Data": "Methylation array",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/12/06"
        },
        "DRA010902": {
          "Data Set ID": "DRA010902",
          "Type of Data": "NGS (WGBS)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2021/12/06"
        },
        "JGAS000549": {
          "Data Set ID": "JGAS000549",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/07/29"
        }
      },
      "SUMMARY": {
        "Aims": "To identify the biomarkers of predicting metastasis and recurrence in colorectal cancer (CRC), gastric cancer, and breast cancer.",
        "Methods": "",
        "Participants/Materials": "10 cases of stage 1 and 2 CRCs, which cases occurred liver or lung metastasis.",
        "URL": "https://www.beppu.kyushu-u.ac.jp/gekareview/en/"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "CRC (ICD10: C189): 10 cases (36 samples)\r\n   - tumor tissues (colon: 10 samples, liver: 9 samples, lung: 5 samples) \r\n   - non-tumor mucosa tissues (colon: 8 samples, lung: 4 samples)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor and matched non-tumor tissues from CRCs",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human ALL Exon V5",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID / DDBJ Sequence Read Archive ID": "non-tumor tissues: JGAD000311\r\ntumor tissues: DRA011183",
          "Total Data Volume": "414 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "CRC (ICD10: C189): 10 cases (20 samples)\r\n   - primary tumor tissues: 8 samples\r\n   - metastatic tumor tissues: 12 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor tissues from CRC",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect Strand Specific RNA Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "DDBJ Sequence Read Archive ID": "DRA011184",
          "Total Data Volume": "414 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture (DRA011185)": {
          "Participants/Materials": "CRC (ICD10: C189): 10 cases (20 samples)\r\n   - primary tumor tissues: 8 samples\r\n   - metastatic tumor tissues: 12 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "T-cell receptor β chain region",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor tissues from CRC",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA HiFi HotStart Ready Mix PCR Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "DDBJ Sequence Read Archive ID": "DRA011185",
          "Total Data Volume": "16 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture (JGAS000549)": {
          "Participants/Materials": "CRC (ICD10: C189): 10 cases\r\n   - circulating tumor DNA samples from patients' plasma: 77 samples (before/after radical surgery)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "452 mutated genes commoned in primary tumor and metastatic tumor (mutated genes list)",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "Circulating tumor DNA extracted from CRC patients' plasma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelectXT Custom 1kb-499kb (Agilent Technologies)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000667",
          "Total Data Volume": "410.4 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation array": {
          "Participants/Materials": "CRC (ICD10: C189): 16 cases\r\ngastric cancer (ICD10: C169): 16 cases\r\nbreast cancer (ICD10: C509): 16 cases\r\n   - primary tumor tissues: 16 samples each",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [iScan]",
          "Source": "DNAs extracted from tumor tissues from CRC, gastric cancer, and breast cance",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Infinium MethylationEPIC Kit, v1.0",
          "Algorithms for Calculating Methylation-rate (software)": "GenomeStudio Methylation Module v1.8",
          "Probe Number": "866,836",
          "Genomic Expression Archive Dataset ID": "E-GEAD-396",
          "Total Data Volume": "1.3 GB (idat)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGBS": {
          "Participants/Materials": "CRC (ICD10: C189): 9 cases (18 samples)\r\n   - primary tumor tissues: 9 samples\r\n   - metastatic tumor tissues: 9 samples",
          "Targets": "WGBS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "DNAs extracted from tumor tissues from CRC",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Miura F, et al.. Nucleic Acids Research (2019), 47, e85.",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "DDBJ Sequence Read Archive ID": "DRA010902",
          "Total Data Volume": "1101 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koshi Mimori",
        "Affiliation": "Department of Surgery, Kyushu University Beppu Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Understanding of molecular mechanisms to generate genetic heterogeneity associated with micro-environmental diversity for development of novel therapy and diagnostic technology in intractable cancers.",
            "Project Number": "JP19cm0106504"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin.",
          "DOI": "doi: 10.1038/s41417-021-00401-w",
          "Data Set ID": "E-GEAD-396\r\nDRA010902"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Data in Use (Dataset ID)": "JGAD000311",
          "Period of Data Use": "2019/09/18-2023/03/31"
        }
      },
      "Release Note": {
        "hum0120.v4": {
          "Research ID": "hum0120.v4",
          "Release Date": "2022/07/29",
          "Type of Data": "NGS (Target Capture)",
          "description": "Circulating tumor DNA were extracted from plasma of 10 colorectal cancer patients and targeted sequence were performed. Fastq files are provided. \n"
        },
        "hum0120.v3": {
          "Research ID": "hum0120.v3",
          "Release Date": "2021/12/06",
          "Type of Data": "Methylation array, NGS (WGBS)",
          "description": "DNAs extracted from tumor tissues (the primary tumor) from 16 colorectal cancer, 16 gastric cancer, and 16 breast cancer patients and DNAs extracted from tumor tissues (primary and metastatic tumor) from 9 colorectal cancer patients were used for the methylation array and WGBS analysis respectively. IDAT and Fastq files are provided. \n"
        },
        "hum0120.v2": {
          "Research ID": "hum0120.v2",
          "Release Date": "2020/10/30",
          "Type of Data": "NGS (Target Capture)",
          "description": "RNAs extracted from tumor tissues (primary and metastatic tumor) from 10 colorectal cancer patients were used for the TCR repertoire analysis. Fastq files are provided. \n"
        },
        "hum0120.v1": {
          "Research ID": "hum0120.v1",
          "Release Date": "2020/04/03",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs and RNAs extracted from tumor tissues (primary and metastatic tumor) or non-tumor tissue from 10 colorectal cancer patients were used for the whole exome sequencing and RNA-seq. Fastq files are provided. \nNote:\n"
        }
      }
    }
  },
  "hum0119.v1": {
    "ja": {
      "NBDC Research ID": "hum0119.v1",
      "データ": {
        "JGAS000126": {
          "データID": "JGAS000126",
          "内容": "NAFLD264症例および対照7672名のGWAS\r\nNASH580症例および対照7672名のGWAS\r\nNASH-HCC58症例および対照7672名のGWAS",
          "制限": "制限公開（Type I）",
          "公開日": "2019/01/31"
        }
      },
      "研究内容の概要": {
        "目的": "非アルコール性肝疾患（nonalcoholic fatty liver disease：NAFLD）、非アルコール性肝炎（nonalcoholic steatohepatitis：NASH)、NASH由来肝がん（NASH-HCC）関連遺伝因子の探索",
        "方法": "SNPアレイによるゲノムスキャン",
        "対象": "NAFLD（Matteoni Type 1 and 2）：264症例、NASH（Matteoni Type 3 and 4）：580症例、NASH-HCC：58症例、対照群：7672名"
      },
      "分子データ": {
        "JGAS000126": {
          "対象": "NAFLD（ICD10：K76.0）：264症例\r\nNASH（ICD10：K75.81）：580症例\r\nNASH-HCC（ICD10：C220）：58症例\r\n対照者：7672名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Human610-Quad BeadChip]\r\nIllumina [HumanCoreExome BeadChip]\r\nIllumina [HumanOmni2.5-Quad BeadChip]",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina Human610-Quad BeadChip Kit\r\nIllumina HumanCoreExome BeadChip Kit\r\nIllumina HumanOmni2.5-Quad BeadChip Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenomeStudio（Illumina）",
          "フィルタリング": "sample call-rate < 0.95、PCAにより日本人集団から逸脱、近縁（pihat > 0.38）\r\nSNP call-rate < 0.99、HWE-p < 1e-6、MAF < 0.01を除外",
          "マーカー数（QC後）": "93,606 SNPs（hg19）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000137",
          "総データ量": "26 MB（xlsx）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "松田 文彦",
        "所 属 機 関": "京都大学大学院医学研究科附属ゲノム医学センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "厚生労働科学研究費補助金 肝炎等克服緊急対策研究事業",
            "タイトル": "非アルコール性脂肪性肝疾患の病態解明と診断法、治療法の開発に関する研究",
            "研究課題番号": "H20-Hepatitis-general-008"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers",
          "DOI": "doi: 10.1371/journal.pone.0185490",
          "データID": "JGAD000137"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "竹原 徹郎": {
          "研究代表者": "竹原 徹郎",
          "所属機関": "大阪大学大学院医学系研究科 消化器内科学",
          "研究題目": "慢性肝疾患の病態進展を予測するバイオマーカーとなる遺伝子多型・変異の探索",
          "利用データID": "JGAD000137",
          "利用期間": "2021/03/16-2022/03/31"
        }
      },
      "リリース情報": {
        "hum0119.v1": {
          "Research ID": "hum0119.v1",
          "公開日": "2019/01/31",
          "内容": "NAFLD264症例および対照7672名のGWAS\r\nNASH580症例および対照7672名のGWAS\r\nNASH-HCC58症例および対照7672名のGWAS",
          "description": "大阪府立吹田病院「非アルコール性脂肪性肝疾患の病態解明と診断法の開発に関する研究」において収集した非アルコール性肝疾患（NAFLD）：902症例（NAFLD群：264名、非アルコール性脂肪肝炎（NASH）群：580名、NASHから肝がんを発症した患者群：58名）および、「ながはま0次コホート健診」および愛知県がんセンターの「初診患者を対象にしたがん遺伝子多型と環境要因の交互作用の研究」において収集した健常者：7672名（ながはま：4653名、愛知がんセンター：3019名）、計8574名の末梢血から抽出したDNAを用いてSNPアレイによるGenotypingを実施し（Illumina [Human610-Quad BeadChip、HumanCoreExome BeadChip、HumanOmni2.5-Quad BeadChip]）、GWASを行った結果（各群のカウント情報と統計解析結果）を提供する（xlsx）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0119.v1",
      "DATA": {
        "JGAS000126": {
          "Data Set ID": "JGAS000126",
          "Type of Data": "GWAS for NAFLD, NASH, and NASH-HCC",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/01/31"
        }
      },
      "SUMMARY": {
        "Aims": "Discovery of genetic factors for NAFLD, NASH and NASH derived hepatocellular carcinoma",
        "Methods": "Genome scan by SNP array",
        "Participants/Materials": "NAFLD patients (include 580 NASH and 58 NASH-HCC) : 902, controls : 7672"
      },
      "MOLECULAR DATA": {
        "JGAS000126": {
          "Participants/Materials": "NAFLD (ICD10: K76.0): 264 patients\r\nNASH (ICD10: K75.81): 580 patients\r\nNASH-HCC (ICD10: C220): 58 patients\r\n7672 healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Human610-Quad BeadChip]\r\nIllumina [HumanCoreExome BeadChip]\r\nIllumina [HumanOmni2.5-Quad BeadChip]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina Human610-Quad BeadChip Kit\r\nIllumina HumanCoreExome BeadChip Kit\r\nIllumina HumanOmni2.5-Quad BeadChip Kit",
          "Genotype Call Methods (software)": "GenomeStudio (Illumina)",
          "Filtering Methods": "Exclusion criteria : sample call-rate < 0.95, PCA outlier of Japanese population, encrypted relatedness (pihat > 0.38)\r\nSNP call-rate < 0.99, HWE-p < 1e-6, MAF< 0.01",
          "Marker Number (after QC)": "93,606 SNPs (hg19)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000137",
          "Total Data Volume": "26 MB (xlsx)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Fumihiko Matsuda",
        "Affiliation": "Center for Genomic Medicine, Kyoto University Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Health and Labour Sciences Research Grant for Research on Hepatitis",
            "Title": "Research and development of pathophysiology, diagnostic tool and treatment in nonalcoholic fatty liver disease",
            "Project Number": "H20-Hepatitis-general-008"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers",
          "DOI": "doi: 10.1371/journal.pone.0185490",
          "Data Set ID": "JGAD000137"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Tetsuo Takehara": {
          "Principal Investigator": "Tetsuo Takehara",
          "Affiliation": "Gastroenterology and Hepatology, Graduate School of Medicine, Osaka University",
          "Research Title": "A study of gene polymorphism and mutation to predict the progression of chronic liver disease",
          "Data in Use (Dataset ID)": "JGAD000137",
          "Period of Data Use": "2021/03/16-2022/03/31"
        }
      },
      "Release Note": {
        "hum0119.v1": {
          "Research ID": "hum0119.v1",
          "Release Date": "2019/01/31",
          "Type of Data": "GWAS for NAFLD, NASH, and NASH-HCC",
          "description": "DNAs extracted from peripheral blood cells of 902 NAFLD patients (264 NAFLDs, 580 NASHs, and 58 NASH-HCCs) and 7672 healthy controls were genotyped by using of Illumina [Human610-Quad BeadChip、HumanCoreExome BeadChip、HumanOmni2.5-Quad BeadChip] and genome-wide association studies wrer performed (xlsx file).\nNote:\n"
        }
      }
    }
  },
  "hum0118.v1": {
    "ja": {
      "NBDC Research ID": "hum0118.v1",
      "データ": {
        "JGAS000124": {
          "データID": "JGAS000124",
          "内容": "NGS（CAGE-seq）\r\nサンガー法",
          "制限": "制限公開（Type I）",
          "公開日": "2017/12/11"
        }
      },
      "研究内容の概要": {
        "目的": "子宮体がんのリンパ節転移有無を鑑別するバイオマーカー探索",
        "方法": "CAGE（Cap Analysis of Gene Expression）、サンガー法",
        "対象": "子宮体がん17症例の摘出組織（腫瘍組織）から抽出したRNA"
      },
      "分子データ": {
        "CAGE-seq": {
          "対象": "子宮体がん（ICD10：C54.1）の摘出組織（腫瘍組織）：15検体",
          "規模": "CAGE-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "子宮体がん摘出組織の腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "CAGE assay （※論文Method参照）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000135",
          "総データ量": "5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "※CAGE assayの参照論文": {
          "対象": "子宮体がん（ICD10：C54.1）の摘出組織（腫瘍組織）：3検体（1検体はCAGE-seqと重複）",
          "規模": "サンガー法",
          "対象領域（Target Captureの場合）": "TACC2（chr10:123,748,689-124,014,057 [ref: hg19]）",
          "Platform": "Thermo Fisher Scientific (ABI) 3500 Genetic Analyzer",
          "ライブラリソース": "子宮体がん摘出組織の腫瘍組織から抽出したRNAを逆転写したcDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "BigDye Terminator v3.1 Cycle Sequencing kit",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000135",
          "総データ量": "5 GB（fasta）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "林崎 良英",
        "所 属 機 関": "理化学研究所 予防医療・診断技術開発プログラム",
        "プロジェクト/研究グループ名": "CAGE法による子宮体がんにおける新規バイオマーカーの網羅的解析（順天堂大学 寺尾泰久）",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "理化学研究所 予防医療・診断技術開発プログラム 運営費交付金",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis.",
          "DOI": "doi: 10.1038/s41598-017-14418-5",
          "データID": "JGAD000135"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0118.v1": {
          "Research ID": "hum0118.v1",
          "公開日": "2017/12/11",
          "内容": "NGS（CAGE-seq）、サンガー法",
          "description": " 子宮体がん17症例から摘出した腫瘍組織からRNAを抽出し、全染色体を対象としたCAGE-seq（Illumina HiSeq 2500）、および、TACC2領域（cDNA）を対象としたサンガー法（Thermo Fisher Scientific (ABI) 3500 Genetic Analyzer）による配列決定を実施した結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0118.v1",
      "DATA": {
        "JGAS000124": {
          "Data Set ID": "JGAS000124",
          "Type of Data": "NGS (CAGE-seq)\r\nSanger sequencing",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/12/11"
        }
      },
      "SUMMARY": {
        "Aims": "exploration of biomarkers discriminating lymph node metastasis in endometrial cancers",
        "Methods": "CAGE (Cap Analysis of Gene Expression), Sanger sequencing",
        "Participants/Materials": "surgically dissected tumor tissues from 17 endometrial cancer patients"
      },
      "MOLECULAR DATA": {
        "CAGE-seq": {
          "Participants/Materials": "15 endometrial cancer patients (ICD10: C54.1)",
          "Targets": "CAGE-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNA extracted from surgically dissected tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "CAGE assay (*References)",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000135",
          "Total Data Volume": "5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "*References for CAGE assay": {
          "Participants/Materials": "3 endometrial cancer patients (ICD10: C54.1)",
          "Targets": "Sanger sequencing",
          "Target Loci for Capture Methods": "TACC2(chr10:123,748,689-124,014,057 [ref: hg19])",
          "Platform": "Thermo Fisher Scientific (ABI) 3500 Genetic Analyzer",
          "Library Source": "cDNA synthesize from RNA extracted from surgically dissected tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "BigDye Terminator v3.1 Cycle Sequencing kit",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000135",
          "Total Data Volume": "5 GB (fasta)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yoshihide Hayashizaki",
        "Affiliation": "RIKEN Preventive Medicine and Diagnosis Innovation Program",
        "Project / Group Name": "Genome-wide exploration for biomarkers in endometrial cancer by using CAGE (Yasuhisa Terao, Juntendo University)",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Research Grant to RIKEN Preventive Medicine and Diagnosis Innovation Program from MEXT",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis.",
          "DOI": "doi: 10.1038/s41598-017-14418-5",
          "Data Set ID": "JGAD000135"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0118.v1": {
          "Research ID": "hum0118.v1",
          "Release Date": "2017/12/11",
          "Type of Data": "NGS (CAGE-seq), Sanger-seq",
          "description": "RNAs extracted from surgically dissected tumor tissues from 17 patients with endometrial cancer were used for CAGE-seq (Illumina HiSeq 2500) and reverse-transcribed samples (complementary DNA [cDNA]) were used for Sanger-seq for TACC2 (Thermo Fisher Scientific (ABI) 3500 Genetic Analyzer). Fastq formated files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0117.v1": {
    "ja": {
      "NBDC Research ID": "hum0117.v1",
      "データ": {
        "JGAS000125": {
          "データID": "JGAS000125",
          "内容": "メチル化アレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2017/12/11"
        }
      },
      "研究内容の概要": {
        "目的": "アルツハイマー病における神経細胞特異的メチル化変化の検出",
        "方法": "Illumina Infinium® Human Methylation 450K BeadChip",
        "対象": "アルツハイマー病30症例、対照健常者30名"
      },
      "分子データ": {
        "JGAS000125": {
          "対象": "アルツハイマー病（ICD10：G309）：30症例\r\n対照健常者：30名",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina Infinium® Human Methylation 450K BeadChip",
          "ソース": "剖検脳組織から抽出した神経細胞核由来のDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "バイサルファイト変換：EZ DNA Methylation Kit（Zymo Research）\r\nメチル化解析：Infinium® Human Methylation 450K BeadChip（Illumina）",
          "メチル化率決定アルゴリズム（ソフトウェア）": "iScan scanner（Illumina）",
          "フィルタリング": "-",
          "マイクロアレイ標準化方法": "-",
          "プローブ数": "487,557 プローブ（raw data）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000136",
          "総データ量": "1 TB（idat）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "岩田 淳",
        "所 属 機 関": "東京大学医学部附属病院 神経内科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 脳科学研究戦略推進プログラム",
            "タイトル": "孤発性アルツハイマー病アミロイド蓄積の原因に即した治療薬と診断用バイオマーカーの開発",
            "研究課題番号": "JP16dm0107069"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.",
          "DOI": "doi: 10.1073/pnas.1707151114",
          "データID": "JGAD000136"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0117.v1": {
          "Research ID": "hum0117.v1",
          "公開日": "2017/12/11",
          "内容": "メチル化アレイ",
          "description": "アルツハイマー病患者および対照健常者の剖検脳組織から抽出した神経細胞核由来のDNAを対象とし、Illumina Infinium® Human Methylation 450K BeadChipにてメチル化解析を行った結果をidat形式にて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0117.v1",
      "DATA": {
        "JGAS000125": {
          "Data Set ID": "JGAS000125",
          "Type of Data": "Methylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/12/11"
        }
      },
      "SUMMARY": {
        "Aims": "Detecting Neuron-specifc methylation changes in Alzheimer's disease brain",
        "Methods": "Illumina Infinium® Human Methylation 450K BeadChip",
        "Participants/Materials": "30 Alzheimer's diseasepatients and 30 healthy controls"
      },
      "MOLECULAR DATA": {
        "JGAS000125": {
          "Participants/Materials": "Alzheimer's disease (ICD10：G309): 30 cases\r\nHealthy control: 30 individuals",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina Infinium® Human Methylation 450K BeadChip",
          "Library Source": "DNAs extracted from autopsied brain tissue",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Bisulfite Conversion: EZ DNA Methylation™ Kit (Zymo Research)\r\nMethylation analysis: Infinium® Human Methylation 450K BeadChip (Illumina)",
          "Algorithms for Calculating Methylation-rate (software)": "iScan scanner (Illumina)",
          "Filtering Methods": "-",
          "Normalization of microarray": "-",
          "Probe Number": "487,557 probes (raw data)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000136",
          "Total Data Volume": "1 TB (idat)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Atsushi Iwata",
        "Affiliation": "The University of Tokyo Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Strategic Research Program for Brain Sciences, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Development of a new disease-modifying therapy and early diagnostic method of Alzheimer’s disease based on a cause of amyloid deposition observed in sporadic type",
            "Project Number": "JP16dm0107069"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.",
          "DOI": "doi: 10.1073/pnas.1707151114",
          "Data Set ID": "JGAD000136"
        },
        "2": {
          "Title": "-",
          "DOI": "-",
          "Data Set ID": "-"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0117.v1": {
          "Research ID": "hum0117.v1",
          "Release Date": "2017/12/11",
          "Type of Data": "Methylation array",
          "description": "DNAs extracted from autopsied brain tissues of Alzheimer's disease patients and healthy controls were used for methylation analysis with Illumina Infinium® Human Methylation 450K BeadChip (idat format).\nNote：\n"
        }
      }
    }
  },
  "hum0116.v1": {
    "ja": {
      "NBDC Research ID": "hum0116.v1",
      "データ": {
        "JGAS000122": {
          "データID": "JGAS000122",
          "内容": "NGS（Target Capture）：AML Cancer Panel\r\nNGS（Target Capture）：41遺伝子",
          "制限": "制限公開（Type I）",
          "公開日": "2020/11/20"
        }
      },
      "研究内容の概要": {
        "目的": "ヒト急性骨髄性白血病関連遺伝子変異の同定",
        "方法": "Target Captureシークエンシング（Acute Myeloid Leukemia Cancer Panel、ならびに、41遺伝子）",
        "対象": "急性骨髄性白血病症例より採取した白血病幹細胞、ならびに、白血病幹細胞を輸注した免疫不全マウスの内、白血病を発症したヒト化マウスから採取したヒト白血病細胞",
        "URL": "http://www.riken.jp/research/labs/ims/hum_dis_model/"
      },
      "分子データ": {
        "Target Capture：AML Cancer Panel": {
          "対象": "急性骨髄性白血病（ICD10：C920）：19症例\r\n    白血病幹細胞33検体、Pre-白血病幹細胞2検体、T細胞6検体、B細胞2検体（計43検体）\r\n    19症例のうち12症例の白血病幹細胞を輸注した免疫不全マウス（ヒト化マウス）の内、白血病を発症したヒト化マウス37匹から採取したヒト白血病細胞37検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "xGen® Acute Myeloid Leukemia Cancer Panel",
          "Platform": "Illumina [HiSeq 1500]",
          "ライブラリソース": "白血病幹細胞、Pre-白血病幹細胞、T細胞、B細胞から抽出したDNA\r\n白血病幹細胞を輸注した免疫不全マウス（ヒト化マウス）の内、白血病を発症したヒト化マウスから採取したヒト白血病細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA Hyper Prep kit\r\nxGen@ Acute Myeloid Leukemia Cancer Panel",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000133",
          "総データ量": "423 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture：41遺伝子": {
          "対象": "急性骨髄性白血病（ICD10：C920）：106症例\r\n    ①急性骨髄性白血病患者の末梢血（白血病細胞）45検体\r\n    ②急性骨髄性白血病患者の骨髄液（白血病細胞）19検体\r\n    ③急性骨髄性白血病患者の検体（末梢血もしくは骨髄液の白血病細胞）もしくはヒト白血病細胞を移植後に白血病を発症した免疫不全マウスの検体（脾臓もしくは骨髄液から分離したヒト白血病細胞）を免疫不全マウスに移植し、白血病を発症したマウスの脾臓（ヒト白血病細胞）6検体\r\n    ④急性骨髄性白血病患者の検体（末梢血もしくは骨髄液の白血病細胞）もしくはヒト白血病細胞を移植後に白血病を発症した免疫不全マウスの検体（脾臓もしくは骨髄液から分離したヒト白血病細胞）を免疫不全マウスに移植し、白血病を発症したマウスの骨髄液（ヒト白血病細胞）36検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "41遺伝子（NRAS, KRAS, FLT3, TP53, NPM1, KIT, IDH1, IDH2, SF3B1, U2AF1, TET2, DNMT3A, ASXL1, ASXL2, BCOR, RUNX1, KMT2A(MLL), WT1(WT-1), GATA2, STAG2, RAD21, SMC1A, SMC3, MPL, NF1, PTPN11, CSF3R, CBL, CEBPA, SRSF2, DHX15, ZRSR2, EZH2, SETBP1, KDM6A, ETV6, CUX1, PHF6, MGA, ZBTB7A, PPM1D）の翻訳領域",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "急性骨髄性白血病患者の末梢血または骨髄液（白血病細胞）から抽出したDNA\r\n急性骨髄性白血病患者の検体（末梢血もしくは骨髄液の白血病細胞）もしくはヒト白血病細胞を移植後に白血病を発症した免疫不全マウスの検体（脾臓もしくは骨髄液から分離したヒト白血病細胞）を免疫不全マウスに移植し、白血病を発症したマウスの脾臓または骨髄液（ヒト白血病細胞）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "multiplex PCR + 2nd PCR",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000355",
          "総データ量": "23 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "石川 文彦",
        "所 属 機 関": "理化学研究所統合生命医科学センター・ヒト疾患モデル研究チーム",
        "プロジェクト/研究グループ名": "白血病再発克服プロジェクト",
        "科研費/助成金（Research Project Number）": {
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways",
          "DOI": "doi: 10.1126/scitranslmed.aao1214",
          "データID": "JGAD000133"
        },
        "2": {
          "タイトル": "Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive Acute Myeloid Leukemia",
          "DOI": "doi: 10.1038/s43018-021-00177-w",
          "データID": "JGAD000355"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0116.v1": {
          "Research ID": "hum0116.v1",
          "公開日": "2020/11/20",
          "内容": "NGS（Target Capture）",
          "description": "・急性骨髄性白血病患者19症例から採取した白血病幹細胞、Pre-白血病幹細胞、T細胞、B細胞、および、19症例のうち12症例の患者から作製した白血病ヒト化マウスから採取したヒト白血病細胞を用いたAML Cancer panel（NGS）データをfastqファイルにて提供する。KAPA Hyper Prep kitおよびxGen® Acute Myeloid Leukemia Cancer Panelにてライブラリー作成後、HiSeq 1500にて平均長50bpのDNA断片を解読した（Single-end）。\n・急性骨髄性白血病106症例の患者末梢血もしくは骨髄液、患者検体を移植し白血病を発症したマウスの骨髄液もしくは脾臓細胞（全て白血病細胞）から抽出したDNAを用いたTarget Captureシークエンシング解析データをfastqファイルにて提供する。対象領域となる41遺伝子領域を7つに分けてデザインしたプライマーを用いたmultiplex PCRを行い、2nd PCRでそれぞれ異なるバーコードを付けてDNAライブラリー作成後poolし、HiSeq 2500にてpaired-endで解読した。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0116.v1",
      "DATA": {
        "JGAS000122": {
          "Data Set ID": "JGAS000122",
          "Type of Data": "NGS (Target Capture): AML cancer panel\r\nNGS (Target Capture): 41 genes",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/11/20"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of somatic mutations associated with acute myeloid leukemia (AML) pathogenesis.",
        "Methods": "Target Capture sequencing (Acute Myeloid Leukemia Cancer Panel and 41 genes)",
        "Participants/Materials": "Leukemia stem cells from AML patients or humanized mice with leukemia derived from immune deficiency mice which were infused with human leukemia stem cells",
        "URL": "http://www.riken.jp/en/research/labs/ims/hum_dis_model/"
      },
      "MOLECULAR DATA": {
        "Target Capture: AML cancer panel": {
          "Participants/Materials": "AML (ICD10: C920): 19 cases\r\n    Leukemia stem cell: 33 samples, Pre-leukemia stem cell: 2 samples, T-cell: 6 samples, B-cell: 2 samples (total 43 samples)\r\n     37 human leukemia stem cell samples from 37 humanized mice with leukemia derived from immune deficiency mice which were infused with human leukemia stem cell from 12 patients with AML",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "xGen® Acute Myeloid Leukemia Cancer Panel",
          "Platform": "Illumina [HiSeq 1500]",
          "Library Source": "DNAs extracted from leukemia stem cells, pre-leukemia stem cells, T-cell and B-cells\r\nDNAs extracted from leukemia stem cells from humanized mice with leukemia derived from immune deficiency mice which were infused with human leukemia stem cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Hyper Prep kit\r\nxGen@ Acute Myeloid Leukemia Cancer Panel",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000133",
          "Total Data Volume": "423 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture: 41 genes": {
          "Participants/Materials": "AML (ICD10: C920): 106 cases\r\n    1) peripheral blood: 45 samples\r\n    2) bone marrow aspirate: 19 samples\r\n    3) human leukemia cells from spleen of humanized mice with leukemia derived from immune deficiency mice which were infused with peripheral blood, bone marrow aspirate or samples from patients with AML: 6 samples\r\n    4) human leukemia cells from bone marrow aspirate of humanized mice with leukemia derived from immune deficiency mice which were infused with peripheral blood, bone marrow aspirate or samples from patients with AML: 36 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "Coding region of 41 genes (NRAS, KRAS, FLT3, TP53, NPM1, KIT, IDH1, IDH2, SF3B1, U2AF1, TET2, DNMT3A, ASXL1, ASXL2, BCOR, RUNX1, KMT2A(MLL), WT1(WT-1), GATA2, STAG2, RAD21, SMC1A, SMC3, MPL, NF1, PTPN11, CSF3R, CBL, CEBPA, SRSF2, DHX15, ZRSR2, EZH2, SETBP1, KDM6A, ETV6, CUX1, PHF6, MGA, ZBTB7A, PPM1D)",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from peripheral blood and bone marrow aspirate\r\nDNAs extracted from human leukemia cells from spleen and bone marrow aspirate of humanized mice with leukemia derived from immune deficiency mice which were infused with peripheral blood, bone marrow aspirate or samples from patients with AML",
          "Cell Lines": "-",
          "Library Construction (kit name)": "multiplex PCR + 2nd PCR",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000355",
          "Total Data Volume": "23 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Fumihiko Ishikawa",
        "Affiliation": "Laboratory for Human Disease Models, Riken Center for Integrative Medical Sciences",
        "Project / Group Name": "Target AML project",
        "Funds / Grants (Research Project Number)": {
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways",
          "DOI": "doi: 10.1126/scitranslmed.aao1214",
          "Data Set ID": "JGAD000133"
        },
        "2": {
          "Title": "Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive Acute Myeloid Leukemia",
          "DOI": "doi: 10.1038/s43018-021-00177-w",
          "Data Set ID": "JGAD000355"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0116.v1": {
          "Research ID": "hum0116.v1",
          "Release Date": "2020/11/20",
          "Type of Data": "NGS (Target Capture)",
          "description": "- DNAs extracted from leukemia stem cells, pre-leukemia stem cells, T-cell, B-cells, and leukemia stem cells from humanized mice were used for the Target Capture sequencing analysis (fastq files). Libraries were prepared by using of KAPA Hyper Prep kit and xGen® Acute Myeloid Leukemia Cancer Panel and sequenced by HiSeq 1500 (single-end: 50 bp).\n- DNAs extracted from peripheral blood, bone marrow aspirate from AML patients and human leukemia cells from spleen and bone marrow aspirate of humanized mice with leukemia derived from immune deficiency mice which were infused with peripheral blood, bone marrow aspirate or samples from patients with AML were used for the Target Capture sequencing analysis (fastq files). 1st PCR was performed to amplify target regions from blood derived or manipulated DNAs, followed by the 2nd PCR to add 8-bp barcode and adapter sequences. Then, DNA libraries were sequenced by HiSeq 2500 (paired-end).\nNote：\n"
        }
      }
    }
  },
  "hum0115.v1": {
    "ja": {
      "NBDC Research ID": "hum0115.v1",
      "データ": {
        "JGAS000121": {
          "データID": "JGAS000121",
          "内容": "マイクロアレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2020/05/15"
        },
        "DRA006296": {
          "データID": "DRA006296",
          "内容": "NGS（RNA-seq）",
          "制限": "非制限公開",
          "公開日": "2020/05/15"
        }
      },
      "研究内容の概要": {
        "目的": "転写因子などの外来性遺伝子カセットを誘導したトランスクリプトームの解析",
        "方法": "RNAシーケンスおよびマイクロアレイ解析",
        "対象": "SEES3に外来性遺伝子（主にtranscriptional factor：TF）を導入して樹立したES細胞株（TF-hESC）。",
        "URL": "http://www.jst.go.jp/kisoken/crest/project/35/35_04.html"
      },
      "分子データ": {
        "JGAS000121": {
          "対象": "SEES3にTFを導入して樹立したES細胞株（TF-hESC）：計448検体\r\n（116遺伝子×2株（一部1株）×2条件）",
          "規模": "マイクロアレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "チップ：Agilent SurePrint G3 Human GE v2 8x60K Microarray（Design ID: 039494）\r\nスキャナー：Agilent SureScan G4900DA",
          "ソース": "SEES3細胞に116種のTFをそれぞれ導入し、TF誘導後もしくは非誘導条件で48時間培養した細胞から抽出したmRNA",
          "検体情報（購入の場合）": "https://www2.brc.riken.jp/lab/cell/detail.cgi?cell_no=HES0008",
          "調整試薬（キット名、バージョン）": "Agilent Low Input Quick Amp Labeling Kit, one-color（Agilent Technologies）",
          "フィルタリング": "-",
          "マイクロアレイ標準化方法": "補正前のIntensityデータを提供",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000132",
          "総データ量": "14 GB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "DRA006296": {
          "対象": "SEES3にTFを導入して樹立したES細胞株（TF-hESC）：計2300検体\r\n（437遺伝子×2株（一部1株）×2条件以上）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "SEES3細胞に437種のTFをそれぞれ導入し、TF誘導後もしくは非誘導条件で48時間、および、指定された時間培養した細胞から抽出したmRNA",
          "検体情報（購入の場合）": "https://www2.brc.riken.jp/lab/cell/detail.cgi?cell_no=HES0008",
          "ライブラリ作製方法（キット名）": "SureSelect Strand Specific RNA Library Preparation Kit for Illumina（Agilent Technologies）",
          "断片化の方法": "RNA Seq Fragmentation Mixと温度（94℃） によるRNAの断片化",
          "ライブラリ構築方法": "Single-end : 2240検体、Paired-end : 60検体",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "Single-end：50 bp、Paired-end：202もしくは302 bp",
          "DDBJ Sequence Read Archive ID": "DRA006296",
          "総データ量": "2.48 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "洪 実",
        "所 属 機 関": "慶應義塾大学医学部 坂口光洋記念システム医学講座",
        "プロジェクト/研究グループ名": "JST CREST：研究領域「生命動態の理解と制御のための基盤技術の創出」　/　洪グループ「動的遺伝子ネットワークの多次元構造解析による高精度な細胞分化制御技術の開発」",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "CREST／生命動態の理解と制御のための基盤技術の創出",
            "タイトル": "動的遺伝子ネットワークの多次元構造解析による高精度な細胞分化制御技術の開発",
            "研究課題番号": "JPMJCR12W4"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Generation and Profiling of 2,135 Human ESC Lines for the Systematic Analyses of Cell States Perturbed by Inducing Single Transcription Factors",
          "DOI": "doi: 10.1016/j.celrep.2020.107655",
          "データID": "JGAD000132DRA006296"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0115.v1": {
          "Research ID": "hum0115.v1",
          "公開日": "2020/05/15",
          "内容": "マイクロアレイおよびRNA-seqデータ",
          "description": "SEES 3に外来性遺伝子（主にtranscriptional factor：TF）を導入して樹立したES細胞株（TF-hESC）の発現データを提供する。RNA-seqでは計2300検体分のデータ（437遺伝子×2株（一部1株）×2条件以上）を非制限公開データとしてfastqファイルを、マイクロアレイ解析では計448検体分のデータ（116遺伝子×2株（一部1株）×2条件）を制限公開データとしてtxtファイルを、それぞれ提供する。\nTFを導入したSEES3細胞から樹立したTF-hESCについて、それぞれの誘導および培養条件で培養した細胞からmRNAを抽出。SureSelect Strand Specific RNA Library Preparation Kit for Illumina（Agilent Technologies）を用いてRNA-seqのライブラリーを作成後、Illumina [HiSeq 2000/2500]により平均長50 bp（Single-end）、202もしくは302 bp（Paired-end）を読んだ。また、上記mRNAを対象とした、Agilent SurePrint G3 Human GE v2 8x60K Microarrayによるマイクロアレイ解析結果（補正前のintensityデータ）を提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0115.v1",
      "DATA": {
        "JGAS000121": {
          "Data Set ID": "JGAS000121",
          "Type of Data": "Microarray",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/05/15"
        },
        "DRA006296": {
          "Data Set ID": "DRA006296",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/05/15"
        }
      },
      "SUMMARY": {
        "Aims": "Transcriptome analyses for transgene induced ES cell (TF-hESC) lines which carry open reading frame (ORF) of transcriptional factors (TFs).",
        "Methods": "RNA sequencing and Microarray assay",
        "Participants/Materials": "Transcriptome data of each transcriptional factor induced human embryonic stem cell (TF-hESC) lines which were derived from SEES3.",
        "URL": "http://www.jst.go.jp/kisoken/crest/en/project/35/e35_04.html"
      },
      "MOLECULAR DATA": {
        "JGAS000121": {
          "Participants/Materials": "TF-hESC lines: total 448 samples \r\n(116 genes x [1 or 2 clones] x 2 culture conditions)",
          "Targets": "Microarray",
          "Target Loci for Capture Methods": "-",
          "Platform": "Chip: Agilent SurePrint G3 Human GE v2 8x60K Microarray (Design ID: 039494)\r\nScanner: Agilent SureScan G4900DA",
          "Library Source": "mRNA extracted from TF-hESC cells under each condition",
          "Cell Lines": "https://www2.brc.riken.jp/lab/cell/detail.cgi?cell_no=HES0008",
          "Reagents (Kit, Version)": "Agilent Low Input Quick Amp Labeling Kit, one-color (Agilent Technologies)",
          "Filtering Methods": "-",
          "Normalization of microarray": "Raw intensity data are provided",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000132",
          "Total Data Volume": "14 GB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "DRA006296": {
          "Participants/Materials": "TF-hESC lines: total 2300 samples\r\n (437 genes x [1 or 2 lines] x [2 or more culture conditions])",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "mRNA extracted from TF-hESC cells under each condition",
          "Cell Lines": "https://www2.brc.riken.jp/lab/cell/detail.cgi?cell_no=HES0008",
          "Library Construction (kit name)": "SureSelect Strand Specific RNA Library Preparation Kit for Illumina (Agilent Technologies)",
          "Fragmentation Methods": "RNA Seq Fragmentation Mix and heat treatment (94℃)",
          "Spot Type": "Single-end : 2240 samples, Paired-end : 60 samples",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "Single-end : 50 bp, Paired-end : 202 or 302 bp",
          "DDBJ Sequence Read Archive ID": "DRA006296",
          "Total Data Volume": "2.48 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Affiliation": "Department of Systems Medicine, Mitsunada SakaguchiLaboratory, Keio University School of Medicine",
        "Project / Group Name": "JST CREST: Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics / Controlling cell differentiation with precision through understanding the structure and dynamics of gene regulatory networks",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "CREST / Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics",
            "Title": "Controlling cell differentiation with precision through understanding the structure and dynamics of gene regulatory networks",
            "Project Number": "JPMJCR12W4"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Generation and Profiling of 2,135 Human ESC Lines for the Systematic Analyses of Cell States Perturbed by Inducing Single Transcription Factors",
          "DOI": "doi: 10.1016/j.celrep.2020.107655",
          "Data Set ID": "JGAD000132DRA006296"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0115.v1": {
          "Research ID": "hum0115.v1",
          "Release Date": "2020/05/15",
          "Type of Data": "RNA-seq and microarray data",
          "description": "Transcriptome data of transcriptional factor (TF) induced human embryonic stem cell (TF-hESC) lines which were derived from SEES3 are provided. RNA-seq data from total of 2300 samples (437 genes x [1 or 2 lines] x [2 or more culture conditions]) are provided as unrestricted access data (fastq), and microarray intensity data from total of 448 samples (116 genes x [1 or 2 lines] x 2 culture condition) are provided as controlled-access data (txt).\nmRNAs were extracted from each TF-hESC line under a few culture conditions. Libraries for RNA-seq were prepared using SureSelect Strand Specific RNA Library Preparation Kit for Illumina (Agilent Technologies) and RNA-seq was performed with Illumina [HiSeq 2000/2500] (single-end : 50 bp, paired-end : 202 or 302 bp). Microarray analysis was performed by using of Agilent SurePrint G3 Human GE v2 8x60K Microarray.\nNote：\n"
        }
      }
    }
  },
  "hum0114.v3": {
    "ja": {
      "NBDC Research ID": "hum0114.v3",
      "データ": {
        "hum0114.v1.gwas.v1": {
          "データID": "hum0114.v1.gwas.v1",
          "内容": "乾癬282症例および対照426名のGWAS",
          "制限": "非制限公開",
          "公開日": "2017/12/18"
        },
        "DRA007411": {
          "データID": "DRA007411",
          "内容": "NGS（Target Capture）",
          "制限": "非制限公開",
          "公開日": "2019/04/12"
        },
        "JGAS000314": {
          "データID": "JGAS000314",
          "内容": "NGS（WGS + Target Capture、Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/08/10"
        }
      },
      "研究内容の概要": {
        "目的": "日本人細胞株由来のゲノムデータを用いた遺伝統計解析の実施",
        "方法": "ゲノムワイド関連解析の実施（乾癬）、および、HLA領域に対するTarget capture sequenceの実施、ならびに、KIR領域におけるgenotype imputation reference panelの構築",
        "対象": "日本人細胞株由来ゲノム"
      },
      "分子データ": {
        "hum0114.v1.gwas.v1": {
          "対象": "乾癬（ICD10：L400）：282症例（JBIC細胞株）\r\n対照：426名（JBIC細胞株）",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanCoreExome BeadChip]",
          "ソース": "JCRB生物資源バンクの日本人由来Ｂ細胞株\r\n（JBIC細胞株の健常人：426 名、及び乾癬患者282名）から抽出したDNA",
          "検体情報（購入の場合）": "http://www.jbic.or.jp/enterprise/developer/013.html",
          "調整試薬（キット名、バージョン）": "Illumina HumanCoreExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "フィルタリング": "sample call rate < 0.99, SNP call rate < 0.99, HWE-P < 1x10^-7",
          "マーカー数（QC後）": "255,632 SNPs（常染色体、hg19）",
          "NBDC Dataset ID": "hum0114.v1.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "6 MB（txt.zip）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "DRA007411": {
          "対象": "日本人細胞株（JBIC細胞株）：560検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "HLA領域\r\n（HLA-A, -B, -C, -DMA, -DMB, -DOA, -DOB, -DPA1, -DPB1, -DQA1, -DQB1, -DRA, -DRB1, -DRB2, -DRB3, -DRB4, -DRB5, -DRB6, -DRB7, -DRB8, -DRB9, -E, -F, -G, -H, -J, -L, -V, MICA, MICB, TAP1, TAP2）",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "日本人細胞株から抽出したDNA",
          "検体情報（購入の場合）": "http://www.jbic.or.jp/enterprise/developer/013.html",
          "ライブラリ作製方法（キット名）": "KAPA Hyper Prep Plus、SeqCap EZ choice",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "602 bp",
          "DDBJ Sequence Read Archive ID": "DRA007411",
          "総データ量": "約215 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000314：WGS + Target Capture": {
          "対象": "日本人細胞株（JBIC細胞株）：689検体",
          "規模": "WGS、Target Capture",
          "対象領域（Target Captureの場合）": "KIR遺伝子",
          "Platform": "WGS：Illumina [HiSeq X Ten、NovaSeq]\r\nTarget Capture：Illumina [MiSeq]",
          "ライブラリソース": "日本人細胞株から抽出したDNA",
          "検体情報（購入の場合）": "http://www.jbic.or.jp/enterprise/developer/013.html",
          "ライブラリ作製方法（キット名）": "KAPA Hyper Prep Plus、SeqCap EZ choice",
          "断片化の方法": "WGS：超音波断片化\r\nTarget Capture：酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "WGS：151 bp\r\nTarget Capture：350/250 bp",
          "マッピング方法": "bwa",
          "マッピングの際のリファレンス配列": "GRCh37",
          "リファレンスパネルに含まれるvariant数": "1,959",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000425",
          "総データ量": "1.1MB（vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000314：Target Capture": {
          "対象": "日本人細胞株（JBIC細胞株）：1,173検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "KIR遺伝子",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "日本人細胞株から抽出したDNA",
          "検体情報（購入の場合）": "http://www.jbic.or.jp/enterprise/developer/013.html",
          "ライブラリ作製方法（キット名）": "KAPA Hyper Prep Plus、SeqCap EZ choice",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "350/250 bp",
          "マッピング方法": "bwa",
          "マッピングの際のリファレンス配列": "GRCh37",
          "平均カバー率（Depth）": "140.6",
          "リファレンスパネルに含まれるvariant数": "118",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000425",
          "総データ量": "0.3 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "岡田 随象",
        "所 属 機 関": "大阪大学大学院医学系研究科 遺伝統計学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） ゲノム医療実現推進プラットフォーム事業（先端ゲノム研究開発）",
            "タイトル": "遺伝統計学に基づく日本人集団のゲノム個別化医療の実装",
            "研究課題番号": "JP21km0405211"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Variants at HLA-A, HLA-C, and HLA-DQB1 confer risk of psoriasis vulgaris in Japanese",
          "DOI": "doi: 10.1016/j.jid.2017.10.001",
          "データID": "hum0114.v1.gwas.v1"
        },
        "2": {
          "タイトル": "Genetic and phenotypic landscape of the major histocompatibilty complex region in the Japanese population.",
          "DOI": "doi: 10.1038/s41588-018-0336-0",
          "データID": "DRA007411"
        },
        "3": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "福永 航也": {
          "研究代表者": "福永 航也",
          "所属機関": "国立医薬品食品衛生研究所 医薬安全科学部",
          "研究題目": "日本",
          "利用データID": "重篤な皮膚有害事象の診断・治療と遺伝子マーカーに関する研究",
          "利用期間": "JGAD000425"
        }
      },
      "リリース情報": {
        "hum0114.v3": {
          "Research ID": "hum0114.v3",
          "公開日": "2021/08/10",
          "内容": "NGS（WGS, Target Capture）",
          "description": "日本人細胞株（JBIC細胞株）1,173検体から抽出したDNAを使用して取得したWGSデータ（KIR遺伝子周辺のSNV）ならびにTarget Capture Sequencingデータ（KIR遺伝子アレル）から作成したKIR領域のgenotype imputation reference panelを提供する（vcf）。\n"
        },
        "hum0114.v2": {
          "Research ID": "hum0114.v2",
          "公開日": "2019/04/12",
          "内容": "NGS（Target Capture）",
          "description": "日本人細胞株（JBIC細胞株）560検体から抽出したDNAを使用し、HLA領域を対象としたTarget capture sequenceを実施した結果をfastqファイルにて提供する。\n"
        },
        "hum0114.v1": {
          "Research ID": "hum0114.v1",
          "公開日": "2017/12/18",
          "内容": "乾癬282症例および対照426名のゲノムワイド関連解析",
          "description": "JCRB生物資源バンクの日本人由来Ｂ細胞株（JBIC細胞株の乾癬282症例および健常人426名）から抽出したDNAを対象とし、SNPアレイ（Illumina HumanCoreExome BeadChip）によりGenotypeを決定し、GWASを実施した結果（統計情報）をテキストファイル形式（常染色体上のゲノムワイドSNPの関連統計量）にて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0114.v3",
      "DATA": {
        "hum0114.v1.gwas.v1": {
          "Data Set ID": "hum0114.v1.gwas.v1",
          "Type of Data": "GWAS for psoriasis",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/12/18"
        },
        "DRA007411": {
          "Data Set ID": "DRA007411",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/04/12"
        },
        "JGAS000314": {
          "Data Set ID": "JGAS000314",
          "Type of Data": "NGS (WGS + Target Capture, Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/08/10"
        }
      },
      "SUMMARY": {
        "Aims": "Analysis of statistical genetics using cell line genotype data of Japanese ancestry",
        "Methods": "Genome-wide association study for psoriasis, Target capture sequence for HLA regioin, Construction of imputation reference panel of the KIR region",
        "Participants/Materials": "Cell line genotype data of Japanese ancestry"
      },
      "MOLECULAR DATA": {
        "hum0114.v1.gwas.v1": {
          "Participants/Materials": "282 psoriasis patients (ICD10: L400)\r\n426 healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanCoreExome BeadChip]",
          "Library Source": "DNA extracted from B cell lines of Japanese ancestry",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina HumanCoreExome BeadChip kit",
          "Genotype Call Methods (software)": "GenCall software（GenomeStudio）",
          "Filtering Methods": "sample call rate < 0.99, SNP call rate < 0.99, HWE-P < 1x10^-7",
          "Marker Number (after QC)": "255,632 SNPs (on autosomal chromosomes、hg19)",
          "NBDC Dataset ID": "hum0114.v1.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "6 MB (txt.zip)",
          "Comments (Policies)": "NBDC policy"
        },
        "DRA007411": {
          "Participants/Materials": "Cell lines of the Japanese population: 560 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "HLA region\r\n (HLA-A, -B, -C, -DMA, -DMB, -DOA, -DOB, -DPA1, -DPB1, -DQA1, -DQB1, -DRA, -DRB1, -DRB2, -DRB3, -DRB4, -DRB5, -DRB6, -DRB7, -DRB8, -DRB9, -E, -F, -G, -H, -J, -L, -V, MICA, MICB, TAP1, TAP2)",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNA extracted from cell lines of Japanese population",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Hyper Prep Plus, SeqCap EZ choice",
          "Fragmentation Methods": "Enzymatic Shearing",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "602 bp",
          "DDBJ Sequence Read Archive ID": "DRA007411",
          "Total Data Volume": "about 215 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS0000314: WGS + Target Capture": {
          "Participants/Materials": "Cell lines of the Japanese population: 689 samples",
          "Targets": "WGS, Target Capture",
          "Target Loci for Capture Methods": "KIR gene",
          "Platform": "WGS: Illumina [HiSeq X Ten, NovaSeq]\r\nTarget Capture: Illumina [MiSeq]",
          "Library Source": "DNA extracted from cell lines of Japanese population",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Hyper Prep Plus, SeqCap EZ choice",
          "Fragmentation Methods": "WGS: Ultrasonic fragmentation\r\nTarget Capture: Enzymatic shearing",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "WGS: 151 bp\r\nTarget 350/250 bp",
          "Mapping Methods": "bwa",
          "Reference Genome Sequence": "GRCh37",
          "Variant Numbers in reference panel": "1,959",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000425",
          "Total Data Volume": "1.1 MB (vcf)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000314: Target Capture": {
          "Participants/Materials": "Cell lines of the Japanese population: 1,173 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "KIR gene",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNA extracted from cell lines of Japanese population",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA Hyper Prep Plus, SeqCap EZ choice",
          "Fragmentation Methods": "Enzymatic shearing",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "350/250 bp",
          "Mapping Methods": "bwa",
          "Reference Genome Sequence": "GRCh37",
          "Coverage (Depth)": "140.6",
          "Variant Numbers in reference panel": "118",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000425",
          "Total Data Volume": "0.3 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yukinori Okada",
        "Affiliation": "Department of Statistical Genetics, Osaka University Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Advanced Genome Research and Bioinformatics Study to Facilitate Medical Innovation (GRIFIN), Platform Program for Promotion of Genome Medicine, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Implementation of genomic prediction medicine based on statistical genetics",
            "Project Number": "JP21km0405211"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Variants at HLA-A, HLA-C, and HLA-DQB1 confer risk of psoriasis vulgaris in Japanese",
          "DOI": "doi: 10.1016/j.jid.2017.10.001",
          "Data Set ID": "hum0114.v1.gwas.v1"
        },
        "2": {
          "Title": "Genetic and phenotypic landscape of the major histocompatibilty complex region in the Japanese population.",
          "DOI": "doi: 10.1038/s41588-018-0336-0",
          "Data Set ID": "DRA007411"
        },
        "3": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Koya Fukunaga": {
          "Principal Investigator": "Koya Fukunaga",
          "Affiliation": "Division of Medical Safety Science, National Institute of Health Sciences",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Research on the diagnosis, treatment, and biomarkers for severe cutaneous adverse reactions",
          "Period of Data Use": "JGAD000425"
        }
      },
      "Release Note": {
        "hum0114.v3": {
          "Research ID": "hum0114.v3",
          "Release Date": "2021/08/10",
          "Type of Data": "NGS (WGS, Target Capture)",
          "description": "An imputation reference panel of the KIR region was build with WGS data and target capture sequencing data. DNAs extracted from cell lines of Japanese population (1,173 samples) were used for a WGS and a target capture sequencing analysis for KIR region.\n"
        },
        "hum0114.v2": {
          "Research ID": "hum0114.v2",
          "Release Date": "2019/04/12",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from cell lines of Japanese population (560 samples) were used for a target capture sequencing analysis for HLA region (fastq file).\n"
        },
        "hum0114.v1": {
          "Research ID": "hum0114.v1",
          "Release Date": "2017/12/18",
          "Type of Data": "GWAS for psoriasis",
          "description": "DNAs extracted from B cell lines of Japanese ancestry (282 psoriasis patients and 426 healthy controls) were genotyped by using of Illumina HumanCoreExome BeadChip and a genome-wide association study was performed (txt file).\nNote:\n"
        }
      }
    }
  },
  "hum0113.v3": {
    "ja": {
      "NBDC Research ID": "hum0113.v3",
      "データ": {
        "JGAS000119": {
          "データID": "JGAS000119",
          "内容": "NGS（CAGE-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/04/24"
        },
        "JGAS000142": {
          "データID": "JGAS000142",
          "内容": "NGS（CAGE-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/30"
        },
        "JGAS000318": {
          "データID": "JGAS000318",
          "内容": "NGS（CAGE-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/07/29"
        }
      },
      "研究内容の概要": {
        "目的": "パーキンソン病（Parkinson’s Disease: PD）のRNAバイオマーカーの同定",
        "方法": "Transcriptome sequencing（CAGE-seq）",
        "対象": "PD 39症例および神経疾患を持たない（non-PD）対照健常者20名の全血"
      },
      "分子データ": {
        "JGAS000119": {
          "対象": "パーキンソン病（ICD10：G20）39症例および神経疾患を持たない対照健常者20名\r\nPARK2変異を有するパーキンソン病（ICD10：G20）2症例（3検体）および対照健常者3名（3検体）より樹立したiPS細胞由来神経細胞とNSCのペア（6検体）",
          "規模": "CAGE-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "全血、iPS細胞由来神経細胞、および、iPS細胞由来NSCから抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "nAnT-iCAGE プロトコル（PMID: 24927836）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "whole blood, iPS-derived neurons, and iPS-derived NSCs （JGAD000129 and JGAD000211）： Single-end\r\niPS-derived neurons and NSCs （JGA000429）： Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "47-50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000129：全血\r\nJGAD000211：iPS細胞由来神経細胞＋NSC\r\nJGAD000429：iPS細胞由来神経細胞＋NSC",
          "総データ量": "JGAD000129：35 GB（fastq）\r\nJGAD000211：88 GB（fastq）\r\nJGAD000429：32 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "ピエロ・カルニンチ",
        "所 属 機 関": "理化学研究所 生命医科学研究センター ゲノム機能医科学研究部門",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson’s Disease",
          "DOI": "doi: 10.1038/s41597-019-0022-9",
          "データID": "JGAD000129"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0113.v3": {
          "Research ID": "hum0113.v3",
          "公開日": "2022/07/29",
          "内容": "NGS（CAGE-seq）",
          "description": "hum0113.v2のCAGEライブラリに対し、Paired-endによりCAGE-seqを行った結果をfastqファイルにて提供する。\n"
        },
        "hum0113.v2": {
          "Research ID": "hum0113.v2",
          "公開日": "2021/07/30",
          "内容": "NGS（CAGE-seq）",
          "description": "PARK2変異を有するパーキンソン病2症例（3検体）ならびに対照健常者3名（3検体）より樹立したiPS細胞由来神経細胞から抽出したRNAを使用してCAGEライブラリを作成し、HiSeq 2500（Illumina）によるCAGE-seqを行った結果をfastqファイルにて提供する。\n"
        },
        "hum0113.v1": {
          "Research ID": "hum0113.v1",
          "公開日": "2020/04/24",
          "内容": "NGS（CAGE-seq）",
          "description": "パーキンソン病39症例、神経疾患を持たない対照健常者20名の全血から抽出したRNAを使用してCAGEライブラリを作成し、HiSeq 2500（Illumina）によるCAGE-seqを行った結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0113.v3",
      "DATA": {
        "JGAS000119": {
          "Data Set ID": "JGAS000119",
          "Type of Data": "NGS (CAGE-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/04/24"
        },
        "JGAS000142": {
          "Data Set ID": "JGAS000142",
          "Type of Data": "NGS (CAGE-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/30"
        },
        "JGAS000318": {
          "Data Set ID": "JGAS000318",
          "Type of Data": "NGS (CAGE-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/07/29"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of RNA biomarkers in Parkinson's disease (PD) patients",
        "Methods": "Transcriptome sequencing (CAGE-seq)",
        "Participants/Materials": "Whole blood samples from 39 PD patients and 20 non-PD (healthy) controls"
      },
      "MOLECULAR DATA": {
        "JGAS000119": {
          "Participants/Materials": "PD patients (ICD10: G20) and non-PD (healthy) controls\r\n- Whole blood: 39 PD patients and 20 non-PD controls \r\n- iPS-derived neurons and NSCs: 2 PD patients (3 samples) with PARK2 mutations and 3 non-PD controls",
          "Targets": "CAGE-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNA extracted from whole blood, iPS-derived neurons, and iPS-derived NSCs",
          "Cell Lines": "-",
          "Library Construction (kit name)": "nAnT-iCAGE protocol (PMID: 24927836)",
          "Fragmentation Methods": "-",
          "Spot Type": "whole blood, iPS-derived neurons and NSCs (JGAD000129 and JGAD000211): Single-end\r\niPS-derived neurons and NSCs (JGAD000429): Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "47-50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000129: whole blood\r\nJGAD000211: iPS-derived neurons and NSCs\r\nJGAD000429: iPS-derived neurons and NSCs",
          "Total Data Volume": "JGAD000129: 35 GB (fastq)\r\nJGAD000211: 88 GB (fastq)\r\nJGAD000429: 32 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Piero Carninci",
        "Affiliation": "RIKEN Center for Integrative Medicine Science, Division of Genomic Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson’s Disease",
          "DOI": "doi: 10.1038/s41597-019-0022-9",
          "Data Set ID": "JGAD000129"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0113.v3": {
          "Research ID": "hum0113.v3",
          "Release Date": "2022/07/29",
          "Type of Data": "NGS (CAGE-seq)",
          "description": "CAGE libraries in hum0113.v2 were resequenced with HiSeq 2500 (paired-end). Sequencing outputs are provided in fastq files.\n"
        },
        "hum0113.v2": {
          "Research ID": "hum0113.v2",
          "Release Date": "2021/07/30",
          "Type of Data": "NGS (CAGE-seq)",
          "description": "CAGE libraries were prepared using RNA extracted from iPS derived neuron samples. In total, libraries for 3 Parkinson's disease (PD) samples provided by 2 PD patients with PARK2 mutations and 3 control samples were prepared in this manner. Deep sequencing analysis on the libraries was performed with HiSeq 2500 (Illumina) and provided in fastq files.\n"
        },
        "hum0113.v1": {
          "Research ID": "hum0113.v1",
          "Release Date": "2020/04/24",
          "Type of Data": "NGS (CAGE-seq)",
          "description": "RNAs extracted from whole blood samples from 39 PD patients and 20 non-PD (healthy) contorols were used for preparation of CAGE libraries. Deep sequencing analysis on the libraries was performed with HiSeq 2500 (Illumina) and provided in fastq files.\nNote:\n"
        }
      }
    }
  },
  "hum0112.v1": {
    "ja": {
      "NBDC Research ID": "hum0112.v1",
      "データ": {
        "JGAS000112\r\n（JGA000122）": {
          "データID": "JGAS000112\r\n（JGA000122）",
          "内容": "NGS（PBAT-seq）\r\nNGS（ChIP-seq）\r\nNGS（RNA-seq）\r\nNGS（miRNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/12/14"
        }
      },
      "研究内容の概要": {
        "目的": "受精卵よりヒト胎盤幹細胞株を樹立し、その細胞特性に関する基礎的な研究を行う。",
        "方法": "PBAT-seq、ChIP-seq、RNA-seq、miRNA-seq",
        "対象": "ヒト胎盤幹細胞２系統",
        "URL": "http://crest-ihec.jp/、http://ihec-epigenomes.net/"
      },
      "分子データ": {
        "PBAT-seq": {
          "対象": "ヒト胎盤幹細胞：３サンプル（系統：１、培養条件：３）",
          "規模": "PBAT-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "ライブラリソース": "ヒト胎盤幹細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Post-Bisulfite Adaptor-Tagging（PBAT）法",
          "断片化の方法": "PBAT法",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000121",
          "総データ量": "315 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ChIP-seq": {
          "対象": "ヒト胎盤幹細胞：18サンプル（系統：１、培養条件：３、抗体：6種 [抗H3K4me3, H3K4me1, H3K9me3, H3K27ac, H3K27me3, H3K36me3抗体]）＋１ネガティブコントロール",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "ヒト胎盤幹細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ovation Ultralow System V2 kit (NuGEN)",
          "断片化の方法": "超音波断片化（Covaris社、M220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD0000121",
          "総データ量": "315 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "ヒト胎盤幹細胞：６サンプル（系統：２、培養条件：３）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "ヒト胎盤幹細胞より抽出したmRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA LT Sample Prep Kit (Illumina)",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000121",
          "総データ量": "315 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "miRNA-seq": {
          "対象": "ヒト胎盤幹細胞：３サンプル（系統：１、培養条件：３）",
          "規模": "miRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "ライブラリソース": "ヒト胎盤幹細胞より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Small RNA Library Prep Set for Illumina (New England Biolabs)",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "64 or 68 bp（アダプター込み）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000121",
          "総データ量": "315 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "有馬 隆博",
        "所 属 機 関": "東北大学大学院医学系研究科 環境遺伝医学総合研究センター 情報遺伝学分野",
        "プロジェクト/研究グループ名": "革新的先端研究開発支援事業（AMED-CREST） 国際ヒトエピゲノムコンソーシアム（IHEC）佐々木チーム",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業（AMED-CREST）",
            "タイトル": "生殖発生にかかわる細胞のエピゲノム解析基盤研究",
            "研究課題番号": "JP17gm0510011"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Derivation of Human Trophoblast Stem Cells",
          "DOI": "doi: 10.1016/j.stem.2017.11.004",
          "データID": "JGAD000121\r\nJGAD000115 (hum0086)"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Nehemiah Alvarez": {
          "研究代表者": "Nehemiah Alvarez",
          "所属機関": "De Novo Genomics Corporation",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000121"
        },
        "R. Michael Roberts": {
          "研究代表者": "R. Michael Roberts",
          "所属機関": "University of Missouri, Animal Sciences / Biochemistry",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000121"
        },
        "Zhigang Xue": {
          "研究代表者": "Zhigang Xue",
          "所属機関": "School of Medicine and Life Science, Tongji University",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000121"
        },
        "Todd Macfarlan": {
          "研究代表者": "Todd Macfarlan",
          "所属機関": "National Institute of Child Health and Human Development",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000121"
        },
        "Howard Fine": {
          "研究代表者": "Howard Fine",
          "所属機関": "Weill Cornell Medicine",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000121"
        },
        "William S.B. Yeung": {
          "研究代表者": "William S.B. Yeung",
          "所属機関": "Department of Obstetrics and Gynaecology, the University of Hong Kong",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000121"
        },
        "Hui Li": {
          "研究代表者": "Hui Li",
          "所属機関": "Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of Medicine",
          "研究題目": "",
          "利用データID": "Derivation of Human Induced Trophoblast Stem Cells from Embryonic Stem Cells",
          "利用期間": "JGAD000121"
        },
        "Thorold W. Theunissen": {
          "研究代表者": "Thorold W. Theunissen",
          "所属機関": "Washington University School of Medicine in St. Louis",
          "研究題目": "",
          "利用データID": "Assessment of trophoblast fates derived from human pluripotent stem cells",
          "利用期間": "JGAD000121"
        },
        "Lin GAO": {
          "研究代表者": "Lin GAO",
          "所属機関": "The Hong Kong University of Science and Technology",
          "研究題目": "",
          "利用データID": "Defining the transcriptional regulatory roles of retrotransposons in human placenta cells.",
          "利用期間": "JGAD000121"
        },
        "Gianluca Ursini": {
          "研究代表者": "Gianluca Ursini",
          "所属機関": "Lieber Institute for Brain Development, Johns Hopkins University School of Medicine",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Analysis of the transcriptional profile of Human Trophoblast Stem Cells",
          "利用期間": "JGAD000121"
        },
        "Ming-an Sun": {
          "研究代表者": "Ming-an Sun",
          "所属機関": "揚州大学 College of Veterinary Medicine",
          "研究題目": "中華人民共和国",
          "利用データID": "The activation and function of endogenous retroviruses in mammalian placentae",
          "利用期間": "JGAD000121"
        },
        "Xinzhi Zhao": {
          "研究代表者": "Xinzhi Zhao",
          "所属機関": "International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University",
          "研究題目": "中華人民共和国",
          "利用データID": "Research on epigenetic regulations of placenta-specific enhancers associated with preeclampsia.",
          "利用期間": "JGAD000121"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000121"
        }
      },
      "リリース情報": {
        "hum0112.v1": {
          "Research ID": "hum0112.v1",
          "公開日": "2017/12/14",
          "内容": "NGS（PBAT-seq）\r\nNGS（ChIP-seq）\r\nNGS（RNA-seq）\r\nNGS（miRNA-seq）",
          "description": "ヒト胎盤幹細胞より抽出したDNAを用いたPBAT-seq解析の結果をfastqファイルにて提供する。Post-Bisulfite Adaptor-Tagging（PBAT）法によりライブラリを作製し、Illumina [HiSeq 1500]によりシングルエンドシークエンシングを行っている（101 bp）。\nヒト胎盤幹細胞より抽出したDNAを用いたChIP-seq解析の結果をfastqファイルにて提供する。抗H3K4me3, H3K4me1, H3K9me3, H3K27ac, H3K27me3, H3K36me3抗体を用いて免疫沈降後Ovation Ultralow System V2 kit (NuGEN)を用いてChIP-seqライブラリを作製し、Illumina [HiSeq 2500]によりペアエンドシークエンシングを行っている（126 bp）。\nヒト胎盤幹細胞より抽出したmRNAを用いたRNA-seq解析の結果をfastqファイルにて提供する。TruSeq Stranded mRNA LT Sample Prep Kit (Illumina)を用いてライブラリを作製し、Illumina [HiSeq 2500]によりペアエンドシークエンシングを行っている（101 bp）。 \nヒト胎盤幹細胞より抽出したRNAを用いたmiRNA-seq解析の結果をfastqファイルにて提供する。NEBNext Small RNA Library Prep Set for Illumina (New England Biolabs)を用いてライブラリを作製し、Illumina [HiSeq 1500]によりシングルエンドシークエンシングを行っている（64 bp）。\nNote：マッピング済のデータが間もなくIHEC Data Portal（http://ihec-epigenomes.org/）より利用可能となります\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0112.v1",
      "DATA": {
        "JGAS000112\r\n(JGA000122)": {
          "Data Set ID": "JGAS000112\r\n(JGA000122)",
          "Type of Data": "NGS (PBAT-seq)\r\nNGS (ChIP-seq)\r\nNGS (RNA-seq)\r\nNGS (miRNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/12/14"
        }
      },
      "SUMMARY": {
        "Aims": "To establish human trophoblast stem cells from blastocyst, and to characterize them.",
        "Methods": "PBAT-seq, ChIP-seq, RNA-seq, and miRNA-seq",
        "Participants/Materials": "trophoblast stem cell (TS)",
        "URL": "http://crest-ihec.jp/english/index.html, http://ihec-epigenomes.org/"
      },
      "MOLECULAR DATA": {
        "PBAT-seq": {
          "Participants/Materials:": "trophoblast stem cell: 3 samples (1 TS, 3 culture conditions)",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "Library Source": "DNAs extracted from trophoblast stem cell",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Post-Bisulfite Adaptor-Tagging (PBAT)",
          "Fragmentation Methods": "PBAT method: fragmentation due to bisulfite conversion",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000121",
          "Total Data Volume": "315 GB",
          "Comments (Policies)": "NBDC policy"
        },
        "ChIP-seq": {
          "Participants/Materials:": "trophoblast stem cell: 18 samples (TS: 1, 3 culture conditions, 6 antibodies [anti H3K4me3, H3K4me1, H3K9me3, H3K27ac, H3K27me3, H3K36me3 antibodies]) + 1 negative control",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from trophoblast stem cell",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ovation Ultralow System V2 kit (NuGEN)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris M220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000121",
          "Total Data Volume": "315 GB",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials:": "trophoblast stem cell: 6 samples (2 TSs, 3 culture conditions)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "mRNAs extracted from trophoblast stem cell",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA LT Sample Prep Kit (Illumina)",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000121",
          "Total Data Volume": "315 GB",
          "Comments (Policies)": "NBDC policy"
        },
        "miRNA-seq": {
          "Participants/Materials:": "trophoblast stem cell: 3 samples (1 TS, 3 culture conditions)",
          "Targets": "miRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "Library Source": "RNAs extracted from trophoblast stem cell",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Small RNA Library Prep Set for Illumina (New England Biolabs)",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "64 or 68 bp (including adaptor) bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000121",
          "Total Data Volume": "315 GB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takahiro Arima",
        "Affiliation": "Department of Informative Genetics, Environment and Genome Research Center,Tohoku University Graduate School of Medicine",
        "Project / Group Name": "Core Research and Evolutional Science and Technology (CREST), International Human Epigenome Consortium (IHEC), Sasaki Team",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)",
            "Title": "Epigenome analysis of cells in the placenta and endometrium forming the fetal-maternal interface",
            "Project Number": "JP17gm0510011"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Derivation of Human Trophoblast Stem Cells",
          "DOI": "doi: 10.1016/j.stem.2017.11.004",
          "Data Set ID": "JGAD000121\r\nJGAD000115 (hum0086)"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Nehemiah Alvarez": {
          "Principal Investigator": "Nehemiah Alvarez",
          "Affiliation": "De Novo Genomics Corporation",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000121"
        },
        "R. Michael Roberts": {
          "Principal Investigator": "R. Michael Roberts",
          "Affiliation": "University of Missouri, Animal Sciences / Biochemistry",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000121"
        },
        "Zhigang Xue": {
          "Principal Investigator": "Zhigang Xue",
          "Affiliation": "School of Medicine and Life Science, Tongji University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000121"
        },
        "Todd Macfarlan": {
          "Principal Investigator": "Todd Macfarlan",
          "Affiliation": "National Institute of Child Health and Human Development",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000121"
        },
        "Howard Fine": {
          "Principal Investigator": "Howard Fine",
          "Affiliation": "Weill Cornell Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000121"
        },
        "William S.B. Yeung": {
          "Principal Investigator": "William S.B. Yeung",
          "Affiliation": "Department of Obstetrics and Gynaecology, the University of Hong Kong",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000121"
        },
        "Hui Li": {
          "Principal Investigator": "Hui Li",
          "Affiliation": "Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Derivation of Human Induced Trophoblast Stem Cells from Embryonic Stem Cells",
          "Period of Data Use": "JGAD000121"
        },
        "Thorold W. Theunissen": {
          "Principal Investigator": "Thorold W. Theunissen",
          "Affiliation": "Washington University School of Medicine in St. Louis",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Assessment of trophoblast fates derived from human pluripotent stem cells",
          "Period of Data Use": "JGAD000121"
        },
        "Lin GAO": {
          "Principal Investigator": "Lin GAO",
          "Affiliation": "The Hong Kong University of Science and Technology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Defining the transcriptional regulatory roles of retrotransposons in human placenta cells.",
          "Period of Data Use": "JGAD000121"
        },
        "Gianluca Ursini": {
          "Principal Investigator": "Gianluca Ursini",
          "Affiliation": "Lieber Institute for Brain Development, Johns Hopkins University School of Medicine",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Analysis of the transcriptional profile of Human Trophoblast Stem Cells",
          "Period of Data Use": "JGAD000121"
        },
        "Ming-an Sun": {
          "Principal Investigator": "Ming-an Sun",
          "Affiliation": "Yangzhou University College of Veterinary Medicine",
          "Research Title": "China",
          "Data in Use (Dataset ID)": "The activation and function of endogenous retroviruses in mammalian placentae",
          "Period of Data Use": "JGAD000121"
        },
        "Xinzhi Zhao": {
          "Principal Investigator": "Xinzhi Zhao",
          "Affiliation": "International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University",
          "Research Title": "China",
          "Data in Use (Dataset ID)": "Research on epigenetic regulations of placenta-specific enhancers associated with preeclampsia.",
          "Period of Data Use": "JGAD000121"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000121"
        }
      },
      "Release Note": {
        "hum0112.v1": {
          "Research ID": "hum0112.v1",
          "Release Date": "2017/12/14",
          "Type of Data": "NGS (PBAT-seq)\r\nNGS (ChIP-seq)\r\nNGS (RNA-seq)\r\nNGS (miRNA-seq)",
          "description": "DNAs extracted from trophoblast stem cell were used for PBAT-seq analyses (fastq format files). Libraries were prepared by Post-Bisulfite Adaptor-Tagging (PBAT) and sequencing was performed with Illumina [HiSeq 1500] (101 bp, single-end).\nDNAs extracted from trophoblast stem cell were used for ChIP-seq analyses (fastq format files). Anti H3K4me3, H3K4me1, H3K9me3, H3K27ac, H3K27me3, H3K36me3 antibodies were used for immunoprecipitation. ChIP-Seq libraries were prepared by using Ovation Ultralow System V2 kit (NuGEN) and sequenced using Illumina [HiSeq 2500] (126 bp, paired-end).\nmRNAs extracted from trophoblast stem cell were used for RNA-seq analyses (fastq format files). Libraries were prepared by using TruSeq Stranded mRNA LT Sample Prep Kit (Illumina) and sequencing was performed with Illumina [HiSeq 2500] (101 bp, paired-end).\nRNAs extracted from trophoblast stem cell were used for miRNA-seq analyses (fastq format files). Libraries were prepared by using NEBNext Small RNA Library Prep Set for Illumina (New England Biolabs) and sequencing was performed with Illumina [HiSeq 1500] (64 bp, single-end).\nNote: The processed data will soon be released on the IHEC Data Portal (http://ihec-epigenomes.org/)\n"
        }
      }
    }
  },
  "hum0111.v3": {
    "ja": {
      "NBDC Research ID": "hum0111.v3",
      "データ": {
        "JGAS000103": {
          "データID": "JGAS000103",
          "内容": "NGS（RNA-seq）\r\nNGS（Amplicon-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/07/31"
        },
        "JGAS000141": {
          "データID": "JGAS000141",
          "内容": "NGS（Amplicon-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/05/31"
        },
        "JGAS000242": {
          "データID": "JGAS000242",
          "内容": "NGS（Amplicon-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/02/19"
        }
      },
      "研究内容の概要": {
        "目的": "胃がんにおける腫瘍浸潤リンパ球の遺伝子解析",
        "方法": "Illumina HiSeq 2000を使用したRNA-seqおよびIllumina MiSeqを使用したT/B細胞抗原受容体mRNAのターゲットシーケンシング",
        "対象": "びまん性胃がん30症例（RNA-seqは腫瘍組織のみ。Amplicon-seqは腫瘍組織とその近傍の非腫瘍組織のペア）、胃がん60＋15症例（Amplicon-seq：腫瘍組織とその近傍の非腫瘍組織のペア）"
      },
      "分子データ": {
        "JGAS000103（RNA-seq）": {
          "対象": "びまん性胃がん（ICD10：C16）：30症例（腫瘍組織のみ）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Sample Prep Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000105",
          "総データ量": "5.1MB（FPKM値 [txt]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000103（Amplicon-seq）": {
          "対象": "びまん性胃がん（ICD10：C16）：30症例（腫瘍組織と非腫瘍組織のペア）",
          "規模": "Amplicon-seq",
          "対象領域（Target Captureの場合）": "TCRα、TCRβ、IgVH、IgVκ/λ遺伝子のV領域からC領域まで",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Amplicon",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000104",
          "総データ量": "64 GB（fastq [480 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000141（Amplicon-seq）": {
          "対象": "胃がん（ICD10：C16）：60症例（腫瘍組織と非腫瘍組織のペア）",
          "規模": "Amplicon-seq",
          "対象領域（Target Captureの場合）": "IgVH遺伝子のV領域からC領域まで",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Amplicon",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000210",
          "総データ量": "101 GB（fastq [240 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000242（Amplicon-seq）": {
          "対象": "胃がん（ICD10：C16）：102症例（腫瘍組織と非腫瘍組織のペア）\r\n    内87症例はJGAD000104、JGAD000210と重複",
          "規模": "Amplicon-seq",
          "対象領域（Target Captureの場合）": "IgHV、IgKV、IgLV遺伝子のV領域からC領域まで",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Amplicon",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000342",
          "総データ量": "228 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "石川 俊平",
        "所 属 機 関": "東京大学 医学系研究科 衛生学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 創薬基盤推進研究事業",
            "タイトル": "ゲノム情報科学と機械学習に基づく高機能抗体のデザイン開発技術に関する研究",
            "研究課題番号": "JP18ak0101096"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Immunogenetic Profiling for Gastric Cancers Identifies Sulfated Glycosaminoglycans as Major and Functional B-cell Antigens among Human Malignancies",
          "DOI": "doi: 10.1016/j.celrep.2017.07.016",
          "データID": "JGAD000104\r\nJGAD000105"
        },
        "2": {
          "タイトル": "Capturing the differences between humoral immunity in the normal and tumor environments from repertoire-seq of B-cell receptors using supervised machine learning.",
          "DOI": "doi:10.1186/s12859-019-2853-y",
          "データID": "JGAD000210"
        },
        "3": {
          "タイトル": "Focal adhesion ribonucleoprotein complex proteins are major humoral cancer antigens and targets in autoimmune diseases",
          "DOI": "doi: 10.1038/s42003-020-01305-5",
          "データID": "JGAD000342"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0111.v3": {
          "Research ID": "hum0111.v3",
          "公開日": "2021/02/19",
          "内容": "NGS（Amplicon-seq）",
          "description": "胃がん102症例の腫瘍組織と非腫瘍組織から抽出したRNAを用いたAmplicon-seq（IgHV、IgKV、IgLV遺伝子のV領域からC領域）の結果を、fastqファイルにて提供する。PCRによりライブラリ作製後、MiSeq（Illumina）にて平均長300 bp x 2を読んだ（Paired-end）。\n"
        },
        "hum0111.v2": {
          "Research ID": "hum0111.v2",
          "公開日": "2019/05/31",
          "内容": "NGS（Amplicon-seq）",
          "description": "胃がん60症例の腫瘍組織と非腫瘍組織から抽出したRNAを用いたAmplicon-seq（IgVH遺伝子のV領域からC領域）の結果を、fastqファイルにて提供する。PCRによりライブラリ作製後、MiSeq（Illumina）にて平均長300 bp x 2を読んだ（Paired-end）。\n"
        },
        "hum0111.v1": {
          "Research ID": "hum0111.v1",
          "公開日": "2017/07/31",
          "内容": "NGS（RNA-seq、Amplicon-seq）",
          "description": "びまん性胃がん30症例の腫瘍組織から抽出したRNAを用いたRNA-seq、および、腫瘍組織と非腫瘍組織から抽出したRNAを用いたAmplicon-seq（TCRα、TCRβ、IgVH、IgVκ/λ遺伝子のV領域からC領域）の結果を、テキストフィル（cuffnormの出力）およびfastqファイルにて提供する。TruSeq Stranded mRNA Sample Prep KitによるRNAライブラリ作製後、HiSeq 2000（Illumina）にて平均長100 bp x 2を読み（Paired-end）FPKM（Fragments Per Kilobase of transcript per Million mapped fragments）値を算出した。一方、Amplicon-seqでは、PCRによりライブラリ作製後、MiSeq（Illumina）にて平均長300 bp x 2を読んだ（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0111.v3",
      "DATA": {
        "JGAS000103": {
          "Data Set ID": "JGAS000103",
          "Type of Data": "NGS (RNA-seq)\r\nNGS (Amplicon-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/07/31"
        },
        "JGAS000141": {
          "Data Set ID": "JGAS000141",
          "Type of Data": "NGS (Amplicon-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/05/31"
        },
        "JGAS000242": {
          "Data Set ID": "JGAS000242",
          "Type of Data": "NGS (Amplicon-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/02/19"
        }
      },
      "SUMMARY": {
        "Aims": "Genomic analysis of tumor infiltrating lymphocytes in gastric cancer",
        "Methods": "RNA-seq by Illumina HiSeq 2000 and amplicon sequencing of T/B cell antigen receptors by Illumina MiSeq",
        "Participants/Materials": "Specimens of 30 diffuse-type gastric carcinoma and 60 + 15 gastric carcinoma (matched tumor and normal tissue)"
      },
      "MOLECULAR DATA": {
        "JGAS000103 (RNA-seq)": {
          "Participants/Materials": "diffuse-type gastric carcinoma (ICD10: C16): 30 cases\r\n(tumor tissues only)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "RNAs extracted from cancer tissues from gastric carcinoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Sample Prep Kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000105",
          "Total Data Volume": "5.1 MB (FPKM [txt])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000103 (Amplicon-seq)": {
          "Participants/Materials": "diffuse-type gastric carcinoma (ICD10: C16): 30 cases\r\n(matched tumor and normal tissues)",
          "Targets": "Amplicon-seq",
          "Target Loci for Capture Methods": "V region to C region of TCRα, TCRβ, IgVH and IgVκ/λ genes",
          "Platform": "Illumina [Miseq]",
          "Library Source": "RNAs extracted from cancer and normal tissues from gastric carcinoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Amplicon",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000104",
          "Total Data Volume": "64 GB (fastq [480 files])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000141 (Amplicon-seq)": {
          "Participants/Materials": "gastric carcinoma (ICD10: C16): 60 cases\r\n(matched tumor and normal tissues)",
          "Targets": "Amplicon-seq",
          "Target Loci for Capture Methods": "V region to C region of IgVH gene",
          "Platform": "Illumina [Miseq]",
          "Library Source": "RNAs extracted from cancer and normal tissues from gastric carcinoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Amplicon",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000210",
          "Total Data Volume": "101 GB (fastq [240 files])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000242 (Amplicon-seq)": {
          "Participants/Materials": "gastric carcinoma (ICD10: C16): 102 cases\r\n(matched tumor and normal tissues)\r\n(including 87 same cases in JGAD000104 and JGAD000210)",
          "Targets": "Amplicon-seq",
          "Target Loci for Capture Methods": "V region to C region of IgHV, IgKV and IgLV gene",
          "Platform": "Illumina [Miseq]",
          "Library Source": "RNAs extracted from cancer and normal tissues from gastric carcinoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Amplicon",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000342",
          "Total Data Volume": "228 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shumpei Ishikawa",
        "Affiliation": "Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Research on Development of New Drugs, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Study of designing technology of high performance antibodies based on clinical genome data science and machine learning",
            "Project Number": "JP18ak0101096"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Immunogenetic Profiling for Gastric Cancers Identifies Sulfated Glycosaminoglycans as Major and Functional B-cell Antigens among Human Malignancies",
          "DOI": "doi: 10.1016/j.celrep.2017.07.016",
          "Data Set ID": "JGAD000104\r\nJGAD000105"
        },
        "2": {
          "Title": "Capturing the differences between humoral immunity in the normal and tumor environments from repertoire-seq of B-cell receptors using supervised machine learning.",
          "DOI": "doi:10.1186/s12859-019-2853-y",
          "Data Set ID": "JGAD000210"
        },
        "3": {
          "Title": "Focal adhesion ribonucleoprotein complex proteins are major humoral cancer antigens and targets in autoimmune diseases",
          "DOI": "doi: 10.1038/s42003-020-01305-5",
          "Data Set ID": "JGAD000342"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0111.v3": {
          "Research ID": "hum0111.v3",
          "Release Date": "2021/02/19",
          "Type of Data": "NGS (Amplicon-seq)",
          "description": "RNAs were extracted from tumor and normal tissues of 102 gastric carcinoma patients. Libraries for Amplicon-seq (V region to C region of IgVH) were prepared by PCR and Amplicon-seq was performed by Illumina Miseq (300 bp x 2, Paired-end). The sequences are provided as fastq files.\n"
        },
        "hum0111.v2": {
          "Research ID": "hum0111.v2",
          "Release Date": "2019/05/31",
          "Type of Data": "NGS (Amplicon-seq)",
          "description": "RNAs were extracted from tumor and normal tissues of 60 gastric carcinoma patients. Libraries for Amplicon-seq (V region to C region of IgVH) were prepared by PCR and Amplicon-seq was performed by Illumina Miseq (300 bp x 2, Paired-end). The sequences are provided as fastq files.\n"
        },
        "hum0111.v1": {
          "Research ID": "hum0111.v1",
          "Release Date": "2017/07/31",
          "Type of Data": "NGS (RNA-seq, Amplicon-seq)",
          "description": "RNAs were extracted from tumor and normal tissues of 30 diffuse-type gastric carcinoma patients. Libraries for RNA-seq were prepared using TruSeq Stranded mRNA Sample Prep Kit and a deep sequencing was performed by using of Illumina HiSeq 2000 (100 bp x 2, Paired-end). The FPKM（Fragments Per Kilobase of transcript per Million mapped fragments）values are provided as a txt file. Libraries for Amplicon-seq (V region to C region of TCRα, TCRβ, IgVH and IgVκ/λ) were prepared by PCR and Amplicon-seq was performed by Illumina Miseq (300 bp x 2, Paired-end). The sequences are provided as fastq files.\nNote:\n"
        }
      }
    }
  },
  "hum0108.v1": {
    "ja": {
      "NBDC Research ID": "hum0108.v1",
      "データ": {
        "JGAS000111": {
          "データID": "JGAS000111",
          "内容": "メチル化アレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2017/06/26"
        }
      },
      "研究内容の概要": {
        "目的": "パニック症に関わるDNAメチル化の探索",
        "方法": "メチル化アレイによりパニック症患者および健常者のゲノムワイドなメチル化率を取得後、ケース・コントロール解析を実施",
        "対象": "パニック症48症例、対照健常者48名（一卵性双生児不一致例を１組含む）"
      },
      "分子データ": {
        "JGAS000111": {
          "対象": "パニック症患者（ICD10：F410）：48症例\r\n対照健常者：48名\r\n（一卵性双生児不一致例１組を含む）",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina Infinium® Human Methylation 450K BeadChip",
          "ソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "バイサルファイト変換：EZ DNA Methylation™ Kit\r\nメチル化解析：Infinium® Human Methylation 450K BeadChip kit",
          "メチル化率決定アルゴリズム（ソフトウェア）": "iScan system and GenomeStudio Software",
          "フィルタリング": "detection P value < 0.01のβ値は欠測値とした上で以下の条件を満たすprobeについて解析対象とした\r\n (1) probe call rate >95% \r\n(2) 性染色体上にない \r\n(3) probeがその配列にマイナーアリル頻度が5%以上のSNPを含まない \r\n(4) probeがゲノム上のターゲット領域以外にハイブリダイズする可能性があると報告されていない*1",
          "マイクロアレイ標準化方法": "(1) Lumi: quantile normalizationbeta mixture quantile*2\r\n(2) BMIQ normalization*3 \r\n(3) ComBat*4",
          "プローブ数(QC後)": "376,602 methylation sites （reference: hg19）",
          "Japanese Genotype-phenotype Archive Data set ID": "JGAD000120",
          "総データ量": "485 MB（xlsx）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "徳永 勝士",
        "所 属 機 関": "東京大学大学院 医学系研究科 国際保健学専攻 人類遺伝学教室",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "武田科学振興財団医学系研究奨励",
            "タイトル": "全ゲノムDNAメチル化関連解析によるパニック障害候補遺伝部位の探索",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Epigenome-wide association study of DNA methylation in panic disorder",
          "DOI": "doi: 10.1186/s13148-016-0307-1",
          "データID": "JGAD000120"
        },
        "2": {
          "タイトル": "-",
          "DOI": "-",
          "データID": "-"
        }
      },
      "制限公開データの利用者一覧": {
        "Brock Christensen": {
          "研究代表者": "Brock Christensen",
          "所属機関": "Geisel School of Medicine at Dartmouth - Department of Epidemiology",
          "研究題目": "JGAD000120",
          "利用データID": "2018/08/06-2020/09/28",
          "利用期間": null
        }
      },
      "リリース情報": {
        "hum0108.v1": {
          "Research ID": "hum0108.v1",
          "公開日": "2017/06/26",
          "内容": "メチル化アレイ",
          "description": "パニック症患者および対照健常者の末梢血から抽出したDNAを対象としてIllumina Infinium® Human Methylation 450K BeadChipにてメチル化解析を行い、メチル化率のデータを用いた関連解析の結果をエクセルファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0108.v1",
      "DATA": {
        "JGAS000111": {
          "Data Set ID": "JGAS000111",
          "Type of Data": "Methylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/06/26"
        }
      },
      "SUMMARY": {
        "Aims": "Searching for DNA methylation sites associated with panic disorder",
        "Methods": "Epigenome-wide DNA methylation analysis using array technology and case-control analysis",
        "Participants/Materials": "Patients of panic disorder and healthy controls"
      },
      "MOLECULAR DATA": {
        "JGAS000111": {
          "Participants/Materials": "Panic disorder (ICD10: F410) : 48 cases\r\nHealthy controls: 48 samples\r\n（including a pair of discordant monozygotic twins)",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina Infinium® Human Methylation 450K BeadChip",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Bisulfite Conversion: EZ DNA Methylation™ Kit\r\nMethylation analysis: Infinium® Human Methylation 450K BeadChip kit",
          "Algorithms for Calculating Methylation-rate (software)": "iScan system and GenomeStudio Software",
          "Filtering Methods": "(1) detection p value of each probe ≥ 0.01 \r\n(2) probe call rate >95% \r\n(3) on autosomal chromosomes\r\n(4) does not include SNP which minor allele frequency is greater than or equal to 5%\r\n(5) hybridizes to a specific sequence*1",
          "Normalization of microarray": "(1) Lumi: quantile normalizationbeta mixture quantile*2\r\n(2) BMIQ normalization*3 \r\n(3) ComBat*4",
          "Probe Number (after QC)": "376,602 methylation sites (reference: hg19)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000120",
          "Total Data Volume": "485 MB (xlsx)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Katsushi Tokunaga",
        "Affiliation": "Department of Human Genetics, Graduate School of Medicine, the University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Takeda Science Foundation",
            "Title": "Genome-wide association analysis to identify new candidate genomic loci associated with panic disorder",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Epigenome-wide association study of DNA methylation in panic disorder",
          "DOI": "doi: 10.1186/s13148-016-0307-1",
          "Data Set ID": "JGAD000120"
        },
        "2": {
          "Title": "-",
          "DOI": "-",
          "Data Set ID": "-"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0108.v1": {
          "Research ID": "hum0108.v1",
          "Release Date": "2017/06/26",
          "Type of Data": "Methylation array",
          "description": "DNAs extracted from peripheral blood cells of 48 panic disorder patients and 48 healthy control subjects were used for methylation analysis. Methylation levels, β values, were calculated from the values detected by IIllumina Infinium® Human Methylation 450K BeadChip (excel format).\nNote:\n"
        }
      }
    }
  },
  "hum0107.v2": {
    "ja": {
      "NBDC Research ID": "hum0107.v2",
      "データ": {
        "JGAS000099": {
          "データID": "JGAS000099",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/10/02"
        },
        "JGAS000218": {
          "データID": "JGAS000218",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/06/01"
        }
      },
      "研究内容の概要": {
        "目的": "基底細胞母斑症候群の原因変異の同定及び変異遺伝子の解析",
        "方法": "",
        "対象": "ヒトの基底細胞母斑症候群4症例",
        "URL": "http://www.tdc.ac.jp/college/activity/tabid/526/Default.aspx"
      },
      "分子データ": {
        "JGAS000099": {
          "対象": "ヒトの基底細胞母斑症候群（ICD10：Q859）4症例\r\n　　口腔粘膜由来の線維芽細胞：4サンプル\r\n　　口腔粘膜組織：1サンプル",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "口腔粘膜由来の線維芽細胞：Illumina [HiSeq 2500]\r\n口腔粘膜組織：Illumina [HiSeq 4000]",
          "ライブラリソース": "口腔粘膜由来の線維芽細胞および口腔粘膜組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Sure Select Human All Exon v5 kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000099",
          "総データ量": "2 GB（fastq [10 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000218": {
          "対象": "ヒトの基底細胞母斑症候群（ICD10：Q859）1症例\r\n　　口腔粘膜由来の線維芽細胞より樹立したiPS細胞から分化した骨芽細胞：3サンプル\r\n　　線維芽細胞セルラインより樹立したiPS細胞から分化した骨芽細胞：3サンプル",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "口腔粘膜およびセルラインの線維芽細胞より樹立したiPS細胞から分化した骨芽細胞より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "HiSeq SBS Kit v4",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000304",
          "総データ量": "13 GB\r\n    Data ファイル数：12（fastq）\r\n    Analysis ファイル数：6（bam [ref：GRCh38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "東 俊文",
        "所 属 機 関": "東京歯科大学 生化学講座",
        "プロジェクト/研究グループ名": "顎骨疾患プロジェクト",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "東京歯科大学顎骨疾患プロジェクト研究助成",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Multi-layered mutation in hedgehog-related genes in Gorlin syndrome may affect the phenotype",
          "DOI": "doi: 10.1371/journal.pone.0184702",
          "データID": "JGAD000099"
        },
        "2": {
          "タイトル": "Hedgehog activation regulates human osteoblastogenesis.",
          "DOI": "doi: 10.1016/j.stemcr.2020.05.008",
          "データID": "JGAD000304"
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000304"
        }
      },
      "リリース情報": {
        "hum0107.v2": {
          "Research ID": "hum0107.v2",
          "公開日": "2020/06/01",
          "内容": "NGS（RNA-seq）",
          "description": "このバージョンでは、基底細胞母斑症候群1症例の口腔粘膜由来の線維芽細胞および線維芽細胞セルラインより樹立したiPS細胞から分化した骨芽細胞各3サンプルから抽出したRNAを用いたRNA-seq解析の結果をFastqファイルにて提供する。HiSeq SBS Kit v4を用いてライブラリを作成しHiSeq 2500にて平均長125bpのRNA断片を解読した（Paired-end）。\n"
        },
        "hum0107.v1": {
          "Research ID": "hum0107.v1",
          "公開日": "2017/10/02",
          "内容": "NGS（Exome）",
          "description": "このバージョンでは、基底細胞母斑症候群4症例の口腔粘膜由来の線維芽細胞4サンプルおよび口腔粘膜組織1サンプルから抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。Sure Select Human All Exon v5 kitを用いてExon領域にしぼりHiSeq 2500/4000にて平均長100bpのDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0107.v2",
      "DATA": {
        "JGAS000099": {
          "Data Set ID": "JGAS000099",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/10/02"
        },
        "JGAS000218": {
          "Data Set ID": "JGAS000218",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/06/01"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of cause mutations and analysis of novel mutated genes of Gorlin syndrome",
        "Methods": "Exome sequence analysis, RNA sequence analysis",
        "Participants/Materials": "Patients with Gorlin syndrome : 4 cases",
        "URL": "-"
      },
      "MOLECULAR DATA": {
        "JGAS000099": {
          "Participants/Materials": "Gorlin syndrome (ICD10: Q859) : 4 cases\r\n    oral mucosa fibroblast : 4 samples\r\n    oral mucosa : 1 sample",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "oral mucosa fibroblast: Illumina [HiSeq 2500]\r\noral mucosa: Illumina [HiSeq 4000]",
          "Library Source": "DNAs extracted from oral mucosa fibroblasts and oral mucosa",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Sure Select Human All Exon v5 kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000099",
          "Total Data Volume": "2 GB (fastq [10 files])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000218": {
          "Participants/Materials": "Gorlin syndrome (ICD10: Q859) : 1 case\r\n    osteoblast differentiated from iPS cells established from oral mucosa fibroblast : 3 samples\r\n　osteoblast differentiated from iPS cells established from oral fibroblast cell line : 3 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from osteoblast differentiated from iPS cells established from oral mucosa fibroblast or fibroblast cell line",
          "Cell Lines": "-",
          "Library Construction (kit name)": "HiSeq SBS Kit v4",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000304",
          "Total Data Volume": "13 GB\r\n    Data files: 12 (fastq)\r\n    Analysis files: 6 (bam [ref：GRCh38])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshifumi Azuma",
        "Affiliation": "Tokyo Dental Collage department of biochemistry",
        "Project / Group Name": "Tokyo Dental College Research Branding Project",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Tokyo Dental College Research Branding Project",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Multi-layered mutation in hedgehog-related genes in Gorlin syndrome may affect the phenotype",
          "DOI": "doi: 10.1371/journal.pone.0184702",
          "Data Set ID": "JGAD000099"
        },
        "2": {
          "Title": "Hedgehog activation regulates human osteoblastogenesis.",
          "DOI": "doi: 10.1016/j.stemcr.2020.05.008",
          "Data Set ID": "JGAD000304"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000304"
        }
      },
      "Release Note": {
        "hum0107.v2": {
          "Research ID": "hum0107.v2",
          "Release Date": "2020/06/01",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from osteoblast differentiated from iPS cells established from oral mucosa fibroblast from 1 patient with Gorlin syndrome or fibroblast cell line were used for the RNA sequencing (fastq files). \nLibraries were prepared by using of HiSeq SBS Kit v4 and read by HiSeq 2500 (paired-end: 125 bp).\n"
        },
        "hum0107.v1": {
          "Research ID": "hum0107.v1",
          "Release Date": "2017/10/02",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from oral mucosa fibroblasts and oral mucosa from 4 patients with Gorlin syndrome were used for the whole exome sequencing (fastq files). \nExons were narrowed down by using of Sure Select Human All Exon v5 kit and read by HiSeq 2500/4000 (paired-end: 100 bp).\nNote:\n"
        }
      }
    }
  },
  "hum0106.v1": {
    "ja": {
      "NBDC Research ID": "hum0106.v1",
      "データ": {
        "JGAS000139": {
          "データID": "JGAS000139",
          "内容": "NGS（scRNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/09/05"
        }
      },
      "研究内容の概要": {
        "目的": "ヒト大腸がん組織の細胞多様性・階層性解析",
        "方法": "RNA-seqによる一細胞解析",
        "対象": "大腸がん3症例由来の3次元培養細胞各1細胞から抽出したRNA",
        "URL": "https://www.jfcr.or.jp/laboratory/department/cell_biology/www/index.html"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000139": {
          "対象": "3名の大腸がん（ICD10：C18）患者由来3次元培養細胞\r\n・大腸がん2症例由来の腫瘍組織\r\n　　（HCT24から2検体、HCT25から3検体）\r\n・大腸がん1症例由来の非腫瘍組織（HCT71）\r\nから樹立された培養細胞",
          "規模": "scRNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "培養細胞各1細胞から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Single Cell 3' v1 Reagent kit",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp [Read1(transcript) 50bp, Read2(UMI) 15bp, Index1(CellBarcode) 14bp and Index2 (Sample Index) 8bp]",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000208",
          "総データ量": "44 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "八尾 良司",
        "所 属 機 関": "がん研究会・がん研究所・細胞生物部",
        "プロジェクト/研究グループ名": "オルガノイドプロジェクト",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "先進ゲノム解析研究推進プラットフォーム",
            "研究課題番号": "16H06279"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer",
          "DOI": "doi: 10.1016/j.stemcr.2021.02.012",
          "データID": "JGAD000208"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0106.v1": {
          "Research ID": "hum0106.v1",
          "公開日": "2022/09/05",
          "内容": "NGS（scRNA-seq）",
          "description": "大腸がん3症例由来の3次元培養細胞各1細胞から抽出したRNAを用いたsingle-cell RNA-Seq解析データをfastqファイルにて提供する。Chromium Single Cell 3' v1 Reagent kitによるRNAライブラリ作製後、Illumina HiSeq 2500にて50 bpを読んだ（Single-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0106.v1",
      "DATA": {
        "JGAS000139": {
          "Data Set ID": "JGAS000139",
          "Type of Data": "NGS (scRNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/09/05"
        }
      },
      "SUMMARY": {
        "Aims": "analysis of cellular diversity and hierarchy of human colorectal cancer (CRC)",
        "Methods": "single cell RNA-seq",
        "Participants/Materials": "culture tissues derived from CRC patients",
        "URL": "https://www.jfcr.or.jp/laboratory/department/cell_biology/www/index.html"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000139": {
          "Participants/Materials": "CRC (ICD10: C18) patients\r\n5 tumor tissues derived from 2 CRC patients (HCT24, HCT25)\r\n    (2 cells from HCT24 and 3 cells from HCT25)\r\nnon-tumor tissues derived from 1 CRC patient (HCT71)",
          "Targets": "scRNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from single cells of culture tissues derived from CRC patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Single Cell 3' v1 Reagent kit",
          "Fragmentation Methods": "Enzymatic fragmentation",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp [Read1(transcript) 50bp, Read2(UMI) 15bp, Index1(CellBarcode) 14bp and Index2 (Sample Index) 8bp]",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000208",
          "Total Data Volume": "44 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Ryoji Yao",
        "Affiliation": "The Cancer Institute of JFCR",
        "Project / Group Name": "project orgnaoid",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "Platform for advanced genome science",
            "Project Number": "16H06279"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer",
          "DOI": "doi: 10.1016/j.stemcr.2021.02.012",
          "Data Set ID": "JGAD000208"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0106.v1": {
          "Research ID": "hum0106.v1",
          "Release Date": "2022/09/05",
          "Type of Data": "NGS (scRNA-seq)",
          "description": "RNAs were extracted from single cells of culture tissues derived from 3 CRC patients. Libraries for single-cell RNA-seq were prepared with Chromium Single Cell 3' v1 Reagent kit and scRNA-seq was performed with Illumina HiSeq 2500 (50 bp, Single-end). scRNA-seq data are provided as fastq files.\nNote:\n"
        }
      }
    }
  },
  "hum0103.v4": {
    "ja": {
      "NBDC Research ID": "hum0103.v4",
      "データ": {
        "JGAS000109": {
          "データID": "JGAS000109",
          "内容": "NGS（WGS）\r\nNGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/02/27"
        },
        "JGAS000109 にデータ追加": {
          "データID": "JGAS000109 にデータ追加",
          "内容": "NGS（WGS）のbam/gvcfデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/13"
        },
        "JGAS000389": {
          "データID": "JGAS000389",
          "内容": "NGS（WGS）\r\nNGS（Exome）\r\nNGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/01/18"
        }
      },
      "研究内容の概要": {
        "目的": "日本人の胆道がんにおけるゲノム変異を探索する",
        "方法": "胆道がん切除切片における非腫瘍組織（正常組織）および腫瘍組織より抽出したDNA/RNAを使用したNGSライブラリーを作成後、Illumina HiSeq 2000/2500、NovaSeq 6000にて塩基配列を決定する。",
        "対象": "胆道がん症例の腫瘍組織および非腫瘍組織のDNA/RNA、ならびに正常胆嚢の非腫瘍組織のRNA"
      },
      "分子データ": {
        "WGS（JGAS000109）": {
          "対象": "胆道がん（ICD10：C22, 23, 24）：14 症例 + 3 症例\r\n　　腫瘍組織：23 検体 + 6 検体\r\n　　非腫瘍組織：14 検体 + 3 検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500、NovaSeq 6000]",
          "ライブラリソース": "胆道がん切除切片における腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA Sample Prep kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "クオリティコントロール方法": "リードのbase qualityが全体的に悪い検体、リード毎の%GCの結果にて異常を示した検体を除去。\r\nAlignment後、Low mapping rate検体、Insert sizeがおかしい検体、メタデータの性別情報とalingment結果より推定される性別情報が不一致な検体、性染色体異常疑いの検体を除去。\r\nGenotyping時に、VQSR、DP/GP filter (DP < 5, GQ < 20, DP > 60 && GQ < 95を除去）、heterozygosity filter (F>=0.05 を除去)、HWE filter (p < 10-6を除去）、Repeat & Low Complexity filterを実施。\r\n1000 genomes projectと合わせたPCAを実施し、日本人クラスタから大きく外れる検体を除外。\r\nその後、Genome-In-A-Bottleプロジェクトから公開されているHighConfidenceRegionリストに記載のある領域のバリアントにフラグを付与。",
          "重複するリードの除去": "Picard 2.10.6",
          "リアライメントおよびベースクオリティのキャリブレーション": "GATK 3.7",
          "マッピング方法": "BWA mem 0.7.12",
          "マッピングクオリティ": "GATK 3.7 HaplotypeCallerで変異コール時にMAPQ<20のリードを除外",
          "マッピングの際のリファレンス配列": "GRCh37/hg19（hs37d5）",
          "平均カバー率（Depth）": "HiSeq 2000/2500：31.8x、NovaSeq 6000：28.0x",
          "変異検出方法": "GATK 3.7 HaplotypeCaller",
          "SNV数（QC後）": "76,768,387（常染色体）\r\n2,898,518（X 染色体）",
          "INDEL数（QC後）": "10,202,908（常染色体）\r\n410,435（X 染色体）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000117（fastq）（EGAS00001000678 [EGAD00001000809]に含まれる）\r\nJGAD000403（bam、vcf）：GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のデータです。詳しくはこちらをご覧ください。",
          "総データ量": "2.4 TB（fastq） + 375 GB（fastq） + 1.6 TB（bam、vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Exome（JGAS000109、JGAS000389）": {
          "対象": "胆道がん（ICD10：C22, 23, 24）：81 症例\r\n　　腫瘍組織：138 検体\r\n　　非腫瘍組織：128 検体\r\n胆道がん（ICD10：C221, C240, C248, C23）：29 症例（3症例はWGSに含まれる）\r\n　　腫瘍組織：29 検体\r\n　　非腫瘍組織：29 検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "胆道がん切除切片における腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Nextera Rapid Capture kit、もしくは\r\nSureSelect Exome V5 kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "93 bp or 126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000118\r\nJGAD000505",
          "総データ量": "1.7＋0.6 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGS（JGAS000389）": {
          "対象": "胆道がん（ICD10：C221, C240, C248, C23）：17 症例\r\n　　腫瘍組織：17 検体\r\n　　非腫瘍組織：17 検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500、NovaSeq 6000]",
          "ライブラリソース": "胆道がん切除切片における腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA Sample Prep kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "126 bp or 151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000504",
          "総データ量": "2.0 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq（JGAS000389）": {
          "対象": "胆道がん（ICD10：C221, C240, C248, C23）：100 症例（KAPA：44 症例、TruSeq：73 症例、両方実施：17 症例）\r\n　　腫瘍組織：100 検体（KAPA：44 検体、TruSeq：73 検体）\r\n正常胆嚢：4 名\r\n　　非腫瘍組織：4 検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "胆道がん切除切片における腫瘍組織および膵がん手術症例から採取した正常胆嚢から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "KAPA RNA HyperPrep Kit\r\nTruSeq Stranded mRNA Sample Prep kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp or 126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000506",
          "総データ量": "640 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中川 英刀",
        "所 属 機 関": "理化学研究所 生命医科学研究センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん医療創生研究事業（P-CREATE）",
            "タイトル": "がんゲノム解析による新規免疫療法および複合免疫療法開発のためのシーズ探索",
            "研究課題番号": "JP20cm0106552"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genomic characterization of biliary tract cancers identifies their driver genes and predisposing mutations.",
          "DOI": "doi: 10.1016/j.jhep.2018.01.009",
          "データID": "JGAD000117\r\nJGAD000118"
        },
        "2": {
          "タイトル": "Molecular Classification and Tumor Microenvironment Characterization of Gallbladder Cancer by Comprehensive Genomic and Transcriptomic Analysis",
          "DOI": "doi: 10.3390/cancers13040733",
          "データID": "JGAD000504\r\nJGAD000505\r\nJGAD000506"
        },
        "3": {
          "タイトル": "Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase",
          "DOI": "doi: 10.18632/oncotarget.28021",
          "データID": "JGAD000504\r\nJGAD000505\r\nJGAD000506"
        }
      },
      "制限公開データの利用者一覧": {
        "柴田 龍弘": {
          "研究代表者": "柴田 龍弘",
          "所属機関": "国立がん研究センター研究所・がんゲノミクス分野",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000117, JGAD000118"
        },
        "木下 健吾": {
          "研究代表者": "木下 健吾",
          "所属機関": "東北大学 東北メディカル・メガバンク機構",
          "研究題目": "",
          "利用データID": "日本人全ゲノムデータベースの構築",
          "利用期間": "JGAD000117"
        },
        "Justo Lorenzo Bermejo": {
          "研究代表者": "Justo Lorenzo Bermejo",
          "所属機関": "Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University Hospital",
          "研究題目": "ドイツ",
          "利用データID": "Genomic characterization of gallbladder tumors from patients worldwide",
          "利用期間": "JGAD000118, JGAD000505"
        }
      },
      "リリース情報": {
        "hum0103.v4": {
          "Research ID": "hum0103.v4",
          "公開日": "2022/01/18",
          "内容": "NGS（WGS、Exome、RNA-seq）",
          "description": "胆道がん43症例の腫瘍組織および非腫瘍組織から抽出したDNAを用いたWGS解析データならびにExome解析データ、胆道がん100症例の腫瘍組織および正常胆嚢（4名）の正常組織より抽出したRNAを用いたRNA-seq解析データをFastqファイルで提供する。\n"
        },
        "hum0103.v3": {
          "Research ID": "hum0103.v3",
          "公開日": "2021/07/13",
          "内容": "NGS（WGS）のbam/gvcfデータ",
          "description": "JGAD000117に含まれるwhole genome sequencing解析データに対し、GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のbam/gvcfデータを追加した。\n"
        },
        "hum0103.v2": {
          "Research ID": "hum0103.v2",
          "公開日": "2019/06/21",
          "内容": "NGS（WGS）",
          "description": "胆道がん3症例のWGSデータ（Fastq・14ファイル）を追加した。\n"
        },
        "hum0103.v1": {
          "Research ID": "hum0103.v1",
          "公開日": "2018/02/27",
          "内容": "NGS（WGS、Exome）",
          "description": "胆道がん切除切片の非腫瘍組織（正常組織）および腫瘍組織から抽出したDNAを使用したWGS解析、および、Exome解析の結果（HiSeq 2000/2500）をFastqファイルで提供する（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0103.v4",
      "DATA": {
        "JGAS000109": {
          "Data Set ID": "JGAS000109",
          "Type of Data": "NGS (WGS)\r\nNGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/02/27"
        },
        "JGAS000109 (Data addition)": {
          "Data Set ID": "JGAS000109 (Data addition)",
          "Type of Data": "bam/gvcf data of NGS（WGS）",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/13"
        },
        "JGAS000389": {
          "Data Set ID": "JGAS000389",
          "Type of Data": "NGS (WGS)\r\nNGS (Exome)\r\nNGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/01/18"
        }
      },
      "SUMMARY": {
        "Aims": "To investigate genomic alterations of Japanese biliary tract cancers",
        "Methods": "DNAs/RNA were extracted from biliary tract cancer and paired non-cancer (normal) tissues. NGS libaraies were prepared by using TruSeq DNA Sample Prep kit (Illumina) for whole genome sequencing (WGS), Nextera Rapid Capture kit (Illumina) / Agilent SureSelect Exome V5 kit for whole exome sequencing (WES) and KAPA RNA HyperPrep Kit / TruSeq Stranded mRNA for RNA sequencing. Sequencing was perfomred by Illumina HiSeq 2000/2500 or NovaSeq 6000.",
        "Participants/Materials": "Japanese biliary tract cancer patients, normal gallbladder tissue"
      },
      "MOLECULAR DATA": {
        "WGS (JGAS000109)": {
          "Participants/Materials": "biliary tract cancer (ICD10: C22, 23, 24): 14 cases + 3 cases\r\n          cancer tissues: 23 samples + 6 samples\r\n          paired non-cancer tissues: 14 samples + 3 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500, NovaSeq 6000]",
          "Library Source": "DNAs extracted from cancer and paired non-cancer (normal) tissues from biliary tract cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA Sample Prep kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "QC": "Data with bad base quality and high %GC content were removed.\r\nAligment:\r\nData matched for the following condition were removed.\r\n- Low mapping rate\r\n- Different insert size\r\n- Gender information mismatch between meta-data and genotype data\r\n- Suspected sex chromosome aberration\r\nGenotyping:\r\nGATK’s best practices includes a variant filtering step following Variant Quality Score Recalibration (VQSR)\r\n- DP/GP (DP < 5, GQ < 20, DP > 60, GQ < 95 )\r\n- Heterozygosity (F>=0.05)\r\n- Hardy-Weinberg equilibrium (p < 10^-6）\r\n- Repeat & Low Complexity\r\nPrincipal Component Analysis (PCA):\r\nPCA was performed with individuals included in the 1000 genomes project and outliers from Japanese cluster were removed.\r\n \r\nAfter these filtering steps, variants located in the regions listed as the HighConfidenceRegion (Genome-In-A-Bottle project) were flagged.",
          "Deduplication": "Picard 2.10.6",
          "Calibration for re-alignment and base quality": "GATK 3.7",
          "Mapping Methods": "BWA mem 0.7.12",
          "Mapping Quality": "Reads with MAPQ< 20 were excluded at variant calling with GATK 3.7 HaplotypeCaller",
          "Reference Genome Sequence": "GRCh37/hg19 (hs37d5)",
          "Coverage (Depth)": "HiSeq 2000/2500: 31.8x, NovaSeq 6000: 28.0x",
          "Detecting Methods for Variation": "GATK 3.7 HaplotypeCaller",
          "SNV Numbers (after QC)": "76,768,387 (Autosomal Chromosomes)\r\n2,898,518 (X Chromosome)",
          "INDEL Numbers (after QC)": "10,202,908 (Autosomal Chromosomes)\r\n410,435 (X Chromosome)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000117 (fastq) (included in EGAS00001000678 [EGAD00001000809])\r\nJGAD000403 (bam, vcf): Whole genome sequencing analyzed data included in the JGAD000117 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J). Lean more..",
          "Total Data Volume": "2.4 TB (fastq) + 375 GB (fastq) + 1.6 TB (bam, vcf)",
          "Comments (Policies)": "NBDC policy"
        },
        "Exome (JGAS000109, JGAS000389)": {
          "Participants/Materials": "biliary tract cancer (ICD10: C22, 23, 24): 81 cases\r\n          cancer tissues: 138 samples\r\n          paired non-cancer 128 samples\r\nbiliary tract cancer (ICD10: C221, C240, C248, C23): 29 cases (including 3 cases used for WGS)\r\n          cancer tissues: 29 samples\r\n          paired non-cancer tissues: 29 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "DNAs extracted from cancer and paired non-cancer (normal) tissues from biliary tract cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Nextera Rapid Capture kit or SureSelect Exome V5 kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "93 bp or 126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000118\r\nJGAD000505",
          "Total Data Volume": "1.7 + 0.6 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGS (JGAS000389)": {
          "Participants/Materials": "biliary tract cancer (ICD10: C221, C240, C248, C23): 17 cases\r\n          cancer tissues: 17 samples\r\n          paired non-cancer tissues: 17 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500, NovaSeq 6000]",
          "Library Source": "DNAs extracted from cancer and paired non-cancer (normal) tissues from biliary tract cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA Sample Prep kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "126 bp or 151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000504",
          "Total Data Volume": "2.0 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq (JGAS000389)": {
          "Participants/Materials": "biliary tract cancer (ICD10: C221, C240, C248, C23): 100 cases (KAPA: 44 cases, TruSeq: 73 cases, both protocols: 17 cases)\r\n          cancer tissues: 100 samples (KAPA: 44 samples, TruSeq: 73 samples)\r\nnormal gallbladder: 4 cases (collected from pancreatic cancer surgery cases)\r\n          non-cancer tissues: 4 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 25000]",
          "Library Source": "RNAs extracted from cancer tissues from biliary tract cancer patients and non-cancer tissues from normal gallbladders",
          "Cell Lines": "-",
          "Library Construction (kit name)": "KAPA RNA HyperPrep Kit\r\nTruSeq Stranded mRNA Sample Prep kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp or 126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000506",
          "Total Data Volume": "640 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hidewaki Nakagawa",
        "Affiliation": "RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Search for seeds for the development of novel immunotherapies and combined immunotherapies by cancer genome analysis",
            "Project Number": "JP20cm0106552"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genomic characterization of biliary tract cancers identifies their driver genes and predisposing mutations.",
          "DOI": "doi: 10.1016/j.jhep.2018.01.009",
          "Data Set ID": "JGAD000117\r\nJGAD000118"
        },
        "2": {
          "Title": "Molecular Classification and Tumor Microenvironment Characterization of Gallbladder Cancer by Comprehensive Genomic and Transcriptomic Analysis",
          "DOI": "doi: 10.3390/cancers13040733",
          "Data Set ID": "JGAD000504\r\nJGAD000505\r\nJGAD000506"
        },
        "3": {
          "Title": "Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase",
          "DOI": "doi: 10.18632/oncotarget.28021",
          "Data Set ID": "JGAD000504\r\nJGAD000505\r\nJGAD000506"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Tatsuhiro Shibata": {
          "Principal Investigator": "Tatsuhiro Shibata",
          "Affiliation": "Division of Cancer Genomics, National Cancer Center Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000117, JGAD000118"
        },
        "Kengo Kinoshita": {
          "Principal Investigator": "Kengo Kinoshita",
          "Affiliation": "Tohoku Medical Megabank Organization",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Construction of Japanese whole genome database",
          "Period of Data Use": "JGAD000117"
        },
        "Justo Lorenzo Bermejo": {
          "Principal Investigator": "Justo Lorenzo Bermejo",
          "Affiliation": "Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University Hospital",
          "Research Title": "Germany",
          "Data in Use (Dataset ID)": "Genomic characterization of gallbladder tumors from patients worldwide",
          "Period of Data Use": "JGAD000118, JGAD000505"
        }
      },
      "Release Note": {
        "hum0103.v4": {
          "Research ID": "hum0103.v4",
          "Release Date": "2022/01/18",
          "Type of Data": "NGS（WGS, Exome, RNA-seq）",
          "description": "DNAs extracted from cancer tissues and paired non-cancer (normal) tissues obtained from biliary tract cancer patients were used for WGS and Exome (Paired-end). RNAs extracted from non-cancer tissues obtained from normal gallbladder were used for RNA-seq (Paired-end). Fastq files are provided.\n"
        },
        "hum0103.v3": {
          "Research ID": "hum0103.v3",
          "Release Date": "2021/07/13",
          "Type of Data": "bam/gvcf data of NGS（WGS）",
          "description": "Whole genome sequencing analyzed data included in the JGAD000117 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. Bam files and gvcf files were added. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J).\n"
        },
        "hum0103.v2": {
          "Research ID": "hum0103.v2",
          "Release Date": "2019/06/21",
          "Type of Data": "NGS (WGS)",
          "description": "14 WGS data (fastq) for 3 biliary tract cancer patients were added.\n"
        },
        "hum0103.v1": {
          "Research ID": "hum0103.v1",
          "Release Date": "2018/02/27",
          "Type of Data": "NGS (WGS, Exome)",
          "description": "DNAs extracted from cancer tissues and paired non-cancer (normal) tissues obtained from biliary tract cancer patients were used for WGS and Exome (Paired-end). Fastq files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0101.v1": {
    "ja": {
      "NBDC Research ID": "hum0101.v1",
      "データ": {
        "JGAS000098": {
          "データID": "JGAS000098",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/05/11"
        }
      },
      "研究内容の概要": {
        "目的": "EBウイルス関連リンパ腫を発症した原発性免疫不全が疑われる患者の原因遺伝子の解明",
        "方法": "次世代シーケンサーを用いたターゲットエクソーム解析",
        "対象": "EBウイルス関連リンパ腫を発症し、原発性免疫不全が疑われた患者２名およびその両親（計４名）　　",
        "URL": "https://crc.nnh.go.jp/departments/infectious_diseases/"
      },
      "分子データ": {
        "JGAS000098": {
          "対象": "EBウイルス関連リンパ腫を発症した原発性免疫不全症候群（ICD10：D849）：2症例およびその両親",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "2,761 遺伝子のエクソン領域（7 Mb）",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina TruSight Exome Kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000098",
          "総データ量": "3 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および hum0101 policy"
        }
      },
      "提供者情報": {
        "研究代表者": "岩谷 靖雅",
        "所 属 機 関": "（独）国立病院機構 名古屋医療センター 臨床研究センター 感染・免疫研究部",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia",
          "DOI": "doi: 10.1038/s41598-018-25260-8",
          "データID": "JGAD000098"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0101.v1": {
          "Research ID": "hum0101.v1",
          "公開日": "2018/05/11",
          "内容": "NGS（Target Capture）",
          "description": "EBウイルス関連リンパ腫を発症した原発性免疫不全症2症例およびその両親の末梢血から抽出したDNAを用いたエクソーム解析（2,761 遺伝子）の結果をFastqファイルにて提供する。Illumina TruSight Exome Kitを用いて2,761 遺伝子のExon領域にしぼりIllumina [MiSeq]にて平均長75塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0101.v1",
      "DATA": {
        "JGAS000098": {
          "Data Set ID": "JGAS000098",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/05/11"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of gene mutations in the patients with primary immunodeficiency characterized by EBV-associated B-cell lymphoma",
        "Methods": "targeted exome sequencing",
        "Participants/Materials": "two patients with primary immunodeficiency (PID) characterized by EBV-associated B-cell lymphoma and their parents",
        "URL": "https://crc.nnh.go.jp/en/departments/infectious_diseases/"
      },
      "MOLECULAR DATA": {
        "JGAS000098": {
          "Participants/Materials": "2 patients with primary immunodeficiency (PID) characterized by EBV-associated B-cell lymphoma (ICD10: D849) and their parents (total: 4 samples)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "exon regions of 2,761 genes (7 Mb)",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "DNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina TruSight Exome Kit",
          "Fragmentation Methods": "",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000098",
          "Total Data Volume": "3 GB (fastq)",
          "Comments (Policies)": "NBDC policy & hum0101 policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yasumasa Iwatani",
        "Affiliation": "Department of Infectious Diseases and Immunology, Clinical Research Center, National Hospital Organization Nagoya Medical Center",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia",
          "DOI": "doi: 10.1038/s41598-018-25260-8",
          "Data Set ID": "JGAD000098"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0101.v1": {
          "Research ID": "hum0101.v1",
          "Release Date": "2018/05/11",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from peripheral blood cells obtained from two patients with primary immunodeficiency characterized by EBV-associated B-cell lymphoma and their parents were used for targeted exome sequencing (fastq files). Exons for 2761 genes were narrowed down by using of Illumina TruSight Exome Kit and read by Illumina [MiSeq] (paired-end: 75 bp).\nNote:\n"
        }
      }
    }
  },
  "hum0099.v1": {
    "ja": {
      "NBDC Research ID": "hum0099.v1",
      "データ": {
        "JGAS000085": {
          "データID": "JGAS000085",
          "内容": "RNA-seqによる遺伝子発現量データ（FPKM情報）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/04/24"
        },
        "hum0099.v1.eqtl.v1": {
          "データID": "hum0099.v1.eqtl.v1",
          "内容": "eQTL解析の結果：各varinatの対象遺伝子に対する統計量（effect size, P-value等）のまとめ",
          "制限": "非制限公開",
          "公開日": "2017/04/24"
        }
      },
      "研究内容の概要": {
        "目的": "ヒト免疫細胞における遺伝子多型と遺伝子発現の関連解析",
        "方法": "5種類の免疫細胞（CD4陽性T細胞、CD8陽性T細胞、B細胞、NK細胞、単球）からtotal RNAを、全血からgenomic DNAとtotal RNAを精製し、genotypingおよびRNA-seqを実施した。",
        "対象": "日本人健常者 105名（男性21名、女性84名）、1名につき6 サンプル（5種類の免疫細胞+全血）"
      },
      "分子データ": {
        "JGAS000085": {
          "対象": "健常者：105名（男性21名、女性84名）\r\n5種類の免疫細胞（CD4陽性T細胞、CD8陽性T細胞、B細胞、NK細胞、単球）および全血（計6サンプルずつ）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "5種類の免疫細胞（CD4陽性T細胞、CD8陽性T細胞、B細胞、NK細胞、単球）および全血より抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA Library Prep Kits (Illumina)",
          "断片化の方法": "熱変性",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "クオリティコントロール方法（除外基準）": "Total read counts < 2 x 107 、Mapping rates < 90%、Mean inter-sample correlation coefficients < 0.94",
          "マッピング方法": "Tophat2",
          "リファレンス配列": "GRCh37",
          "遺伝子構造・新規の転写産物推定・発現量算出方法": "Cufflinks + Gencode version 19 gene model (in FPKM unit)",
          "総リード数 / ユニークにマップされたリード数": "平均 4.52 x 107 / 4.39 x 107",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000085",
          "総データ量": "53 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0099.v1.eqtl.v1": {
          "対象": "健常者：105名（男性21名、女性84名）",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium OmniExpressExome BeadChips]",
          "ソース": "全血より抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina Infinium OmniExpressExome BeadChips kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "Imputation方法": "IMPUTE2 + 1000 Genomes Phase 1 v3",
          "フィルタリング": "MAF≥0.05, average maximum posterior probability ≥ 0.9, INFO ≥ 0.4 (5,600,101 variants)",
          "マーカー数(QC後)": "563,436 SNPs（reference sequence: hg19）",
          "NBDC Dataset ID": "hum0099.v1.eqtl.v1",
          "総データ量": "1778.8 MB (txt)",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "武田薬品工業株式会社との共同研究",
            "タイトル": "eQTLを基礎とした創薬標的の探索と治療法の開発",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis",
          "DOI": "doi:10.1038/ng.3885",
          "データID": "JGAD000085\r\nhum0099.v1.eqtl.v1"
        }
      },
      "制限公開データの利用者一覧": {
        "Kyuyoung Song": {
          "研究代表者": "Kyuyoung Song",
          "所属機関": "University of Ulsan college of medicine",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000085"
        },
        "角田 達彦": {
          "研究代表者": "角田 達彦",
          "所属機関": "東京医科歯科大学・難治疾患研究所・医科学数理分野",
          "研究題目": "",
          "利用データID": "オーダーメイド医療のためのシーケンス、画像データなどの解析に関する研究",
          "利用期間": "JGAD000085"
        },
        "高地 雄太": {
          "研究代表者": "高地 雄太",
          "所属機関": "東京医科歯科大学 難治疾患研究所 ゲノム機能多様性分野",
          "研究題目": "日本",
          "利用データID": "機能性遺伝子多型の網羅的解析を介した多因子疾患の病態解明",
          "利用期間": "JGAD000085"
        }
      },
      "リリース情報": {
        "hum0099.v1": {
          "Research ID": "hum0099.v1",
          "公開日": "2017/04/24",
          "内容": "RNA-seqによる遺伝子発現量データ（FPKM情報）\r\neQTL解析の結果：各varinatの対象遺伝子に対する統計量（effect size、 P-value等）のまとめ",
          "description": "健常者105名（男性21名、女性84名）の末梢血単核細胞から5種類の免疫細胞（CD4陽性T細胞、CD8陽性T細胞、B細胞、NK細胞、単球）を単離し、各細胞からtotal RNAを抽出した。また、全血からDNAとtotal RNAを抽出した。 \nDNAに対しては、Infinium OmniExpressExome BeadChips（Illumina）を用いたgenotypingを実施し、total RNAに対しては、TruSeq Stranded mRNA Library Prep Kits（Illumina）を用いてRNA-seqのライブラリーを作成後、HiSeq 2500により平均長125bpを読んだ（paired-end）。 \nRNA-seqの結果は制限公開データとして個別検体の遺伝子毎の発現量をFPKM値として提供する（txt）。また、SNPアレイ情報については非制限公開データとして統計解析結果を提供する（txt）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0099.v1",
      "DATA": {
        "JGAS000085": {
          "Data Set ID": "JGAS000085",
          "Type of Data": "RNA-seq \r\n(Fragments Per Kilobase of exon per Million mapped fragments: FPKM)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/04/24"
        },
        "hum0099.v1.eqtl.v1": {
          "Data Set ID": "hum0099.v1.eqtl.v1",
          "Type of Data": "eQTL \r\n(Summary of stats for each variant [ex. effect size, P-value])",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/04/24"
        }
      },
      "SUMMARY": {
        "Aims": "Expression quantitative trait loci analysis using human immune cells",
        "Methods": "Total RNA from whole blood cells and five immune cell populations (CD4+ T cells, CD8+ T cells, B cells, NK cells, and monocytes) and genomic DNA isolated from whole blood cells were used for RNA-seq and genotyping, respectively.",
        "Participants/Materials": "105 Japanese healthy volunteers"
      },
      "MOLECULAR DATA": {
        "JGAS000085": {
          "Participants/Materials": "105 healthy volunteers (21 males, 84 females)\r\nFive immune cell populations (CD4+ T cells, CD8+ T cells, B cells, NK cells, and monocytes) and whole blood cells (6 samples each)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "total RNAs extracted from five immune cell populations (CD4+ T cells, CD8+ T cells, B cells, NK cells, and monocytes) and whole blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA Library Prep Kits",
          "Fragmentation Methods": "heat denaturation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "QC": "Total read counts < 2 x 107 、Mapping rates < 90%、Mean inter-sample correlation coefficients < 0.94",
          "Mapping Methods": "Tophat2",
          "Reference Genome Sequence": "GRCh37",
          "Detecting Methods for Variation": "Cufflinks + Gencode version 19 gene model (in FPKM unit)",
          "Total Reads / Uniquely Mapped Reads": "4.52 x 107 / 4.39 x 107 on average",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000085",
          "Total Data Volume": "53 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0099.v1.eqtl.v1": {
          "Participants/Materials": "105 healthy volunteers (21 males, 84 females)",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium OmniExpressExome BeadChips]",
          "Library Source": "gDNA extracted from whole blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Infinium OmniExpressExome BeadChips kit",
          "Genotype Call Methods (softwares)": "GenCall software (GenomeStudio)",
          "Imputation Methods": "IMPUTE2 + 1000 Genomes Phase 1 v3",
          "Filtering Methods": "MAF ≥ 0.05, average maximum posterior probability ≥ 0.9, INFO ≥ 0.4 (5,600,101 variants)",
          "Marker Numbers (after QC)": "563,436 SNPs (reference sequence: hg19)",
          "NBDC Dataset ID": "hum0099.v1.eqtl.v1",
          "Total Data Volume": "1778.8 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Collaboration with Takeda Pharmaceutical Company Limited.",
            "Title": "Identification of treatment targets based on eQTL",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis",
          "DOI": "doi:10.1038/ng.3885",
          "Data Set ID": "JGAD000085\r\nhum0099.v1.eqtl.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Kyuyoung Song": {
          "Principal Investigator": "Kyuyoung Song",
          "Affiliation": "University of Ulsan college of medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000085"
        },
        "Tatsuhiko Tsunoda": {
          "Principal Investigator": "Tatsuhiko Tsunoda",
          "Affiliation": "Department of Medical Science Mathematics, Medical Research Institute, Tokyo Medical and Dental University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Research on sequence, image data analysis for precision medicine",
          "Period of Data Use": "JGAD000085"
        },
        "Yuta Kochi": {
          "Principal Investigator": "Yuta Kochi",
          "Affiliation": "Department of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic study of complex diseases through comprehensive analysis of functional genetic variations",
          "Period of Data Use": "JGAD000085"
        }
      },
      "Release Note": {
        "hum0099.v1": {
          "Research ID": "hum0099.v1",
          "Release Date": "2017/04/24",
          "Type of Data": "RNA-seq (FPKM)\r\neQTL: summary of stats for each variant (ex. effect size, P-value)",
          "description": "Total RNAs were extructed from five immune cell populations (CD4+ T cells, CD8+ T cells, B cells, NK cells and monocytes) and whole blood cells. Genomic DNAs were also extracted from whole blood cells. \nGenotyping was performed by Infinium OmniExpressExome BeadChips (Illumina). Libraries for RNA-seq were prepared using TruSeq Stranded mRNA Library Prep Kits (Illumina) and RNA-seq was performed with the Illumina HiSeq 2500 sequencer (125 bp, Paired-end). \nIndividual FPKM values are provided as Controlled-access data (txt) and results of statistical analysis are provided as Unrestricted-access data (txt).\nNote:\n"
        }
      }
    }
  },
  "hum0097.v1": {
    "ja": {
      "NBDC Research ID": "hum0097.v1",
      "データ": {
        "JGAS000094": {
          "データID": "JGAS000094",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/05/25"
        }
      },
      "研究内容の概要": {
        "目的": "再生不良性貧血の病態解明",
        "方法": "エクソーム解析",
        "対象": "第6染色体短腕の片親性ダイソミー陽性再生不良性貧血患者"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000094": {
          "対象": "第6染色体短腕の片親性ダイソミー陽性再生不良性貧血\r\n（ICD10：D61.9）：5症例\r\n（ライブラリソースに記載の3種、計15検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "口腔内粘膜および末梢血の以下の2分画から抽出したDNA\r\n　　・Loss of heterozygosity（LOH）分画\r\n　　・Wild type（WT）分画",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V5+UTRs Kit",
          "断片化の方法": "超音波断片化（Covaris社、E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000094",
          "総データ量": "1 TB（fastq [30 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中尾 眞二",
        "所 属 機 関": "金沢大学 医薬保健研究域 医学系 細胞移植学講座",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業　基盤研究（B）",
            "タイトル": "再生不良性貧血におけるゲノム異常を利用した造血抑制因子の同定",
            "研究課題番号": "24390243"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia.",
          "DOI": "doi: 10.1182/blood-2016-11-752378",
          "データID": "-"
        },
        "2": {
          "タイトル": "Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia.",
          "DOI": "doi: 10.1016/j.exphem.2016.05.013",
          "データID": "-"
        },
        "3": {
          "タイトル": "Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.",
          "DOI": "doi: 10.1056/NEJMoa1414799",
          "データID": "-"
        },
        "4": {
          "タイトル": "Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.",
          "DOI": "doi: 10.1182/blood-2011-07-365189",
          "データID": "-"
        },
        "5": {
          "タイトル": "Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia..",
          "DOI": "doi: 10.1182/bloodadvances.2017013953",
          "データID": "JGAD000094"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0097.v1": {
          "Research ID": "hum0097.v1",
          "公開日": "2018/05/25",
          "内容": "NGS（Exome）",
          "description": "第6染色体短腕の片親性ダイソミー陽性再生不良性貧血5症例の末梢血由来（LOH分画［6番染色体短腕において認められるuniparental disomy]および正常分画）と、口腔内粘膜から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon V5+UTRs Kit（Agilent）用いてExon領域にしぼりHiSeq 2500（Illumina）にて平均長101 bpのDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0097.v1",
      "DATA": {
        "JGAS000094": {
          "Data Set ID": "JGAS000094",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/05/25"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the pathogenicity of aplastic anemia with uniparental disomy in 6p",
        "Methods": "Exome sequence analysis",
        "Participants/Materials": "Patients with aplastic anemia with uniparental disomy in 6p"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by \"Genome Science\". \"Genome Science\" is a part of the \"Support Programs for Three Fields in Life Sciences (cancer, genome, and brain sciences)\" established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000094": {
          "Participants/Materials": "Aplastic anemia with uniparental disomy in 6p\r\n(ICD10：D61.9): 5 cases",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from oral swab and peripheral blood cells\r\n　　　- Loss of heterozygosity (LOH) fraction\r\n　　　- Wild type (WT) fraction",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V5+UTRs Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000094",
          "Total Data Volume": "1 TB (fastq [30 files])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shinji Nakao",
        "Affiliation": "Cellular Transplantation Biology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University. Graduate School of Medical Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Identification of hematopoiesis regulator with genomic abnormality in patients with aplastic anemia",
            "Project Number": "24390243"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia.",
          "DOI": "doi: 10.1182/blood-2016-11-752378",
          "Data Set ID": "-"
        },
        "2": {
          "Title": "Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia.",
          "DOI": "doi: 10.1016/j.exphem.2016.05.013",
          "Data Set ID": "-"
        },
        "3": {
          "Title": "Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.",
          "DOI": "doi: 10.1056/NEJMoa1414799",
          "Data Set ID": "-"
        },
        "4": {
          "Title": "Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.",
          "DOI": "doi: 10.1182/blood-2011-07-365189",
          "Data Set ID": "-"
        },
        "5": {
          "Title": "Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia..",
          "DOI": "doi: 10.1182/bloodadvances.2017013953",
          "Data Set ID": "JGAD000094"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0097.v1": {
          "Research ID": "hum0097.v1",
          "Release Date": "2018/05/25",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from peripheral blood cells and oral swab from 5 patients with aplastic anemia with uniparental disomy in 6p were used for the whole exome sequencing (fastq files).\nExons were narrowed down by using of SureSelect Human All Exon V5+UTRs Kit (Agilent) and read by HiSeq 2500 (Illumina) (paired-end: 101 bp).\nNote:\n"
        }
      }
    }
  },
  "hum0096.v2": {
    "ja": {
      "NBDC Research ID": "hum0096.v2",
      "データ": {
        "JGAS000090": {
          "データID": "JGAS000090",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/05/25"
        },
        "JGAS000138": {
          "データID": "JGAS000138",
          "内容": "メチル化アレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2019/11/18"
        }
      },
      "研究内容の概要": {
        "目的": "多数の小児T細胞性急性リンパ芽球性白血病（小児T-ALL）検体について、次世代シーケンサーを用いた種々の遺伝子解析技術により、疾患発症の原因となる遺伝子異常をゲノムワイドに同定し、解析する。",
        "方法": "小児T-ALL123例の検体のRNA-seq解析を行い、融合遺伝子を同定し、発現データの解析をする。うち、79例に対してDNAメチル化アレイ解析を行い、発現データと統合的に解析をする。",
        "対象": "小児T-ALL 123症例"
      },
      "分子データ": {
        "JGAS000090": {
          "対象": "小児T-ALL（ICD10：C91.0）：123症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "小児T-ALL患者の骨髄液や末梢血、リンパ節から抽出したtotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Library Prep Kit\r\nNEBNext Ultra RNA Library Prep Kit for Illumina",
          "断片化の方法": "酵素反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "108 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000090",
          "総データ量": "927 GB （bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000138": {
          "対象": "小児T-ALL（ICD10：C91.0）：79症例",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium MethylationEPIC]",
          "ソース": "小児T-ALL患者の骨髄液や末梢血、リンパ節から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "EpiTect Fast Bisulﬁte Conversion Kit、Infinium MethylationEPIC",
          "メチル化率決定アルゴリズム（ソフトウェア）": "-",
          "プローブ数": "866,554プローブ（raw data）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000207",
          "総データ量": "2 GB（idat）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "滝田 順子",
        "所 属 機 関": "東京大学大学院 医学系研究科 生殖・発達・加齢医学専攻 小児医学講座",
        "プロジェクト/研究グループ名": "",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業　基盤研究（B）",
            "タイトル": "マルチオミックス情報を基盤とした難治性小児がんに対する新規克服法の開発",
            "研究課題番号": "17H04224"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Recurrent PU.1 (SPI1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia",
          "DOI": "doi: 10.1038/ng.3900",
          "データID": "JGAD000090"
        },
        "2": {
          "タイトル": "DNA methylation-based classiﬁcation reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes",
          "DOI": "doi: 10.1038/s41375-019-0626-2",
          "データID": "JGAD000207"
        }
      },
      "制限公開データの利用者一覧": {
        "Jinyan HUANG": {
          "研究代表者": "Jinyan HUANG",
          "所属機関": "Shanghai Jiao Tong University School of Medicine, State Key Laboratory Of Medical Genomics, Rui-jin Hospital",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000090"
        },
        "BERNARD Olivier": {
          "研究代表者": "BERNARD Olivier",
          "所属機関": "Institut Gustave Roussy",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000090"
        },
        "Jun J Yang": {
          "研究代表者": "Jun J Yang",
          "所属機関": "Department of Pharmaceutical Science, St. Jude Children's Hospital",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000090"
        },
        "Charles G. Mullighan": {
          "研究代表者": "Charles G. Mullighan",
          "所属機関": "Pathology Department, St. Jude Children's Research Hospital",
          "研究題目": "",
          "利用データID": "Genomic analysis for acute lymphoblastic leukemia",
          "利用期間": "JGAD000090"
        },
        "Takaomi Sanda": {
          "研究代表者": "Takaomi Sanda",
          "所属機関": "Cancer Science Institute of Singapore, National University of Singapore",
          "研究題目": "",
          "利用データID": "Sequencing and Expression Analyses in T-Cell Leukemia Using Publicly-Available Datasets",
          "利用期間": "JGAD000090, JGAD000207"
        },
        "Charles de Bock": {
          "研究代表者": "Charles de Bock",
          "所属機関": "Children's Cancer Institute, University of New South Wales",
          "研究題目": "",
          "利用データID": "Elusidating the role of the TCF7-SPI1 fusion in T cell acute lymphoblastic leukemia",
          "利用期間": "JGAD000090"
        },
        "Chengyu Liang": {
          "研究代表者": "Chengyu Liang",
          "所属機関": "The Wistar institute",
          "研究題目": "",
          "利用データID": "Oncogenic mechanism of T-cell lymphoblastic leukemia",
          "利用期間": "JGAD000090, JGAD000207"
        },
        "安田 貴彦": {
          "研究代表者": "安田 貴彦",
          "所属機関": "名古屋医療センター 臨床研究センター",
          "研究題目": "",
          "利用データID": "造血器疾患の分子病態の解明ならびに有効かつ安全性の高い治療法開発を目指した基盤研究",
          "利用期間": "JGAD000090"
        },
        "Jinyan Huang": {
          "研究代表者": "Jinyan Huang",
          "所属機関": "Zhejiang University School of Medicine",
          "研究題目": "",
          "利用データID": "Comprehensive analysis of alternative splicing in malignant tumors",
          "利用期間": "JGAD000090, JGAD000207"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000090"
        }
      },
      "リリース情報": {
        "hum0096.v2": {
          "Research ID": "hum0096.v2",
          "公開日": "2019/11/18",
          "内容": "メチル化アレイ",
          "description": "RNA-seq解析を行った小児T-ALL患者123症例のうち79症例の骨髄液や末梢血、リンパ節から抽出したDNAを対象とし、Illumina Infinium MethylationEPICにてメチル化解析を行った結果をidatファイルにて提供する。\n"
        },
        "hum0096.v1": {
          "Research ID": "hum0096.v1",
          "公開日": "2017/05/25",
          "内容": "NGS（RNA-seq）",
          "description": "小児T細胞性急性リンパ芽球性白血病（小児T-ALL）患者の骨髄液や末梢血、リンパ節から抽出したtotal RNAを使用し、RNA-seq解析した結果をbamファイルにて提供する。illumina TruSeq RNA Library Prep KitまたはNEB NEBNext Ultra RNA Library Prep Kit for IlluminaによるRNAライブラリ作製後、HiSeq 2500（Illumina）にて平均長108 bpを読んだ（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0096.v2",
      "DATA": {
        "JGAS000090": {
          "Data Set ID": "JGAS000090",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/05/25"
        },
        "JGAS000138": {
          "Data Set ID": "JGAS000138",
          "Type of Data": "Methylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/11/18"
        }
      },
      "SUMMARY": {
        "Aims": "To explore genetic alteratoins in pediatric T-cell acute lymphoblastic leukemia (T-ALL), we performed genome wide analysis using next generation sequencing methods.",
        "Methods": "We performed whole transcriptome sequencing in 123 pediatric T-ALL for detecting gene fusion and analysing expression data. Among them, 79 cases were further analyzed in DNA metylation array.",
        "Participants/Materials": "123 pediatric T-ALL patients"
      },
      "MOLECULAR DATA": {
        "JGAS000090": {
          "Participants/Materials": "pediatric T-ALL patients (ICD10: C91.0): 123 cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "total RNAs extracted from bone marrow aspirates, peripheral blood cells, or lymph nodes of pediatric T-ALL patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Library Prep Kit\r\nNEBNext Ultra RNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "restriction enzyme reaction",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "108 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000090",
          "Total Data Volume": "927 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000138": {
          "Participants/Materials": "pediatric T-ALL patients (ICD10: C91.0): 79 cases",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium MethylationEPIC]",
          "Library Source": "DNAs extracted from bone marrow aspirates, peripheral blood cells, or lymph nodes of pediatric T-ALL patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "EpiTect Fast Bisulﬁte Conversion Kit, Infinium MethylationEPIC",
          "Algorithms for Calculating Methylation-rate (software)": "-",
          "Probe Number": "866,554 probes (raw data)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000207",
          "Total Data Volume": "2 GB (idat)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Junko Takita",
        "Affiliation": "Department of Pediatrics, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Development for novel therapeutic stratagies of intractable pediatric cancers based on the multi-omics analysis",
            "Project Number": "17H04224"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Recurrent PU.1 (SPI1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia",
          "DOI": "doi: 10.1038/ng.3900",
          "Data Set ID": "JGAD000090"
        },
        "2": {
          "Title": "DNA methylation-based classiﬁcation reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes",
          "DOI": "doi: 10.1038/s41375-019-0626-2",
          "Data Set ID": "JGAD000207"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Jinyan HUANG": {
          "Principal Investigator": "Jinyan HUANG",
          "Affiliation": "Shanghai Jiao Tong University School of Medicine, State Key Laboratory Of Medical Genomics, Rui-jin Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000090"
        },
        "BERNARD Olivier": {
          "Principal Investigator": "BERNARD Olivier",
          "Affiliation": "Institut Gustave Roussy",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000090"
        },
        "Jun J Yang": {
          "Principal Investigator": "Jun J Yang",
          "Affiliation": "Department of Pharmaceutical Science, St. Jude Children's Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000090"
        },
        "Charles G. Mullighan": {
          "Principal Investigator": "Charles G. Mullighan",
          "Affiliation": "Pathology Department, St. Jude Children's Research Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Genomic analysis for acute lymphoblastic leukemia",
          "Period of Data Use": "JGAD000090"
        },
        "Takaomi Sanda": {
          "Principal Investigator": "Takaomi Sanda",
          "Affiliation": "Cancer Science Institute of Singapore, National University of Singapore",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Sequencing and Expression Analyses in T-Cell Leukemia Using Publicly-Available Datasets",
          "Period of Data Use": "JGAD000090, JGAD000207"
        },
        "Charles de Bock": {
          "Principal Investigator": "Charles de Bock",
          "Affiliation": "Children's Cancer Institute, University of New South Wales",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elusidating the role of the TCF7-SPI1 fusion in T cell acute lymphoblastic leukemia",
          "Period of Data Use": "JGAD000090"
        },
        "Chengyu Liang": {
          "Principal Investigator": "Chengyu Liang",
          "Affiliation": "The Wistar institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Oncogenic mechanism of T-cell lymphoblastic leukemia",
          "Period of Data Use": "JGAD000090, JGAD000207"
        },
        "Takahiko Yasuda": {
          "Principal Investigator": "Takahiko Yasuda",
          "Affiliation": "Clinical Research Center, Nagoya Medical Center",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Basic research aimed at elucidating the molecular pathology and developing effective and safe treatment methods for hematological diseases",
          "Period of Data Use": "JGAD000090"
        },
        "Jinyan Huang": {
          "Principal Investigator": "Jinyan Huang",
          "Affiliation": "School of Medicine, Zhejiang University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of alternative splicing in malignant tumors",
          "Period of Data Use": "JGAD000090, JGAD000207"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000090"
        }
      },
      "Release Note": {
        "hum0096.v2": {
          "Research ID": "hum0096.v2",
          "Release Date": "2019/11/18",
          "Type of Data": "Methylation array",
          "description": "DNAs extracted from bone marrow aspirates, peripheral blood cells, or lymph nodes of pediatric T-ALL patients were used for methylation analysis with Illumina Infinium MethylationEPIC (idat format). \n"
        },
        "hum0096.v1": {
          "Research ID": "hum0096.v1",
          "Release Date": "2017/05/25",
          "Type of Data": "NGS (RNA-seq)",
          "description": "Total RNAs were extracted from bone marrow aspirates, peripheral blood cells, or lymph nodes of pediatric T-ALL patients. Libraries for RNA-seq were prepared using Illumina TruSeq RNA Library Prep Kit or NEB NEBNext Ultra RNA Library Prep Kit for Illumina and RNA-seq was performed with the Illumina HiSeq 2500 sequencer (108 bp, Paired-end). The sequences are provided as bam files. \nNote:\n"
        }
      }
    }
  },
  "hum0095.v1": {
    "ja": {
      "NBDC Research ID": "hum0095.v1",
      "データ": {
        "JGAS000092": {
          "データID": "JGAS000092",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/07/30"
        }
      },
      "研究内容の概要": {
        "目的": "大腸における発がん早期の遺伝子変異の特徴を明らかにし、発がん機序を解明する",
        "方法": "診断に影響のない範囲で切除標本の腫瘍組織および非腫瘍組織（正常粘膜：症例コントロール）を採取した上でDNAを抽出し全エクソームシーケンスを実施した。",
        "対象": "大腸腺腫もしくは大腸がん早期病変　計10症例",
        "URL": "https://www.beppu.kyushu-u.ac.jp/geka/index.html"
      },
      "分子データ": {
        "JGAS000092": {
          "対象": "大腸腺腫もしくは大腸がん早期病変：計10症例\r\n63検体（腫瘍組織：53検体、非腫瘍組織（正常大腸粘膜組織）：10検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "大腸腺腫もしくは大腸がん早期病変の腫瘍組織と非腫瘍組織（正常大腸粘膜組織）より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human ALL Exon V5",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000092",
          "総データ量": "682 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "三森 功士",
        "所 属 機 関": "九州大学病院 別府病院 外科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業　若手研究（B）",
            "タイトル": "次世代シーケンサーによる大腸前がん病変からがんへの進化に関わる遺伝子の解明",
            "研究課題番号": "16K19107"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer",
          "DOI": "doi: 10.1038/s41467-018-05226-0",
          "データID": "JGAD000092"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000092"
        }
      },
      "リリース情報": {
        "hum0095.v1": {
          "Research ID": "hum0095.v1",
          "公開日": "2018/07/30",
          "内容": "NGS（Exome）",
          "description": "大腸腺腫もしくは大腸がん早期病変の腫瘍組織と非腫瘍組織（正常大腸粘膜組織）より抽出したDNAを使用したExome解析の結果をfastqファイルにて提供する。SureSelect Human All Exon V5によりExon領域にしぼり、HiSeq 2500（Illumina）にて平均長100塩基を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0095.v1",
      "DATA": {
        "JGAS000092": {
          "Data Set ID": "JGAS000092",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/07/30"
        }
      },
      "SUMMARY": {
        "Aims": "to investigate the genomic signature and the mechanism of early stage of colorectal carcinogenesis",
        "Methods": "DNAs were extracted from tumor tissues and matched normal samples and performed whole exome sequencing",
        "Participants/Materials": "10 cases of colorectal adenomas or precancerous lesions of colorectal cancers (PCRCs) in total",
        "URL": "https://www.beppu.kyushu-u.ac.jp/geka/en/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000092": {
          "Participants/Materials": "colorectal adenomas or PCRCs: 10 cases in total\r\n(63 samples [tumor tissues: 53 samples, non-tumor tissues: 10 samples])",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor tissues or non-tumor tissues (normal colonic mucosa tissues) from colorectal adenomas or PCRCs",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human ALL Exon V5",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000092",
          "Total Data Volume": "682 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koshi Mimori",
        "Affiliation": "Department of Surgery, Kyushu University Beppu Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Young Scientists (B)",
            "Title": "Investigation into the genes associated with the colorectal cancer evolution in the early stage of carcinogenesis",
            "Project Number": "16K19107"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer",
          "DOI": "doi: 10.1038/s41467-018-05226-0",
          "Data Set ID": "JGAD000092"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000092"
        }
      },
      "Release Note": {
        "hum0095.v1": {
          "Research ID": "hum0095.v1",
          "Release Date": "2018/07/30",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumor tissues and non-tumor tissues from 10 cases of colorectal adenomas or precancerous lesions of colorectal cancers (PCRCs) were used for the whole exome sequencing (fastq files). Exons were narrowed down by using of SureSelect Human ALL Exon V5 and read by HiSeq 2500 (Illumina) (Paired-end: 100 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0094.v11": {
    "ja": {
      "NBDC Research ID": "hum0094.v11",
      "データ": {
        "JGAS000095": {
          "データID": "JGAS000095",
          "内容": "NGS（WGS、Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/09/04"
        },
        "JGAS000105": {
          "データID": "JGAS000105",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/01/22"
        },
        "JGAS000113": {
          "データID": "JGAS000113",
          "内容": "NGS（Exome、RNA-seq、RNA access）\r\nメチル化アレイ、SNPアレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2019/02/12"
        },
        "JGAS000128": {
          "データID": "JGAS000128",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/08/14"
        },
        "JGAS000215": {
          "データID": "JGAS000215",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/10/26"
        },
        "JGAS000270": {
          "データID": "JGAS000270",
          "内容": "NGS（Exome、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/01/29"
        },
        "JGAS000297": {
          "データID": "JGAS000297",
          "内容": "NGS（Exome、RNA-seq、Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/02"
        },
        "JGAS000360": {
          "データID": "JGAS000360",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/10/22"
        },
        "JGAS000095（データ追加）": {
          "データID": "JGAS000095（データ追加）",
          "内容": "NGS（Iso-seq、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/10/26"
        },
        "JGAS000335": {
          "データID": "JGAS000335",
          "内容": "NGS（WGS、Exome、RNA-seq、Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/05/23"
        },
        "JGAS000534": {
          "データID": "JGAS000534",
          "内容": "NGS（Target Capture、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/11/08"
        }
      },
      "研究内容の概要": {
        "目的": "ゲノム解析による乳がん、肺腺がん、大腸がん、および、肺多形がんの病態解明、ならびに、デスモイド腫瘍の分子プロファイリングと臨床病理学的解析による新規バイオマーカーの同定",
        "方法": "HiSeq2000/2500によるWhole Genome Sequencing (WGS)、Whole Exome Sequencing (WES)、RNA-seq、RNA access、メチル化アレイ、SNPアレイ、および、Target Capture。WGS、WES、メチル化アレイ、および、SNPアレイは腫瘍組織とペア正常組織を解析している。また、検体ゲノムのlarge structral variantsを同定するために、10X Chromiumを使いシーケンシングと解析を行った。また、PacBioのSequelを用いて、Single-Molecule Real-Time（SMRT）シーケンシングを行った。",
        "対象": "手術切除切片（腫瘍組織および非腫瘍組織）、末梢血（正常組織）",
        "URL": "https://www.ncc.go.jp/jp/ri/division/genetics/index.html"
      },
      "分子データ": {
        "WGS（JGAS000095）": {
          "対象": "トリプルネガティブ乳がん（ICD10：C50）：16症例",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "乳がんの切除標本（腫瘍組織およびペア非腫瘍組織）もしくは末梢血（正常組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext® Ultra™ DNA Library Prep Kit for Illumina®",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "103 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000095",
          "総データ量": "8.94 TB（bam [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Exome": {
          "対象": "トリプルネガティブ乳がん（ICD10：C50）：36症例\r\n肺腺がん（ICD10：C349）：43症例\r\nMSI-H大腸がん（ICD10：C18, C19, C20）：149症例\r\n肝転移を有する大腸がん：12症例、肝転移を有さない大腸がん：16症例（ICD10：C18, C19, C20）\r\n肺腺がん（ICD10：C34）：126症例\r\nデスモイド腫瘍（ICD10：D48.1）：64症例\r\n肺多形がん（NCBI MedGen UID：87198）：19症例（腫瘍組織：12症例、非腫瘍組織：18症例、うちペア11症例）\r\n大腸がん（ICD10：C189）：128症例（141検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500、NovaSeq 6000]",
          "ライブラリソース": "乳がん、肺腺がん、大腸がん、デスモイド腫瘍、および、肺多形がんの切除標本（腫瘍組織およびペア非腫瘍組織）もしくは末梢血（正常組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext® Ultra™ DNA Library Prep Kit for Illumina®、SureSelect Human All Exon V5、SureSelect Human All Exon V6",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "乳がん、肺腺がん：103 bp\r\nMSI-H大腸がん：104 bp または 135 bp\r\n大腸がん（JGAD000139）：100 bp または 103 bp\r\n肺腺がん（JGAD000301）：134 bp または 137 bp\r\nデスモイド腫瘍：134 bp または 137 bp\r\n肺多形がん：133 bp\r\n大腸がん（JGAD000446）：125 bp、150 bpまたは151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "乳がん：JGAD000095\r\n肺腺がん：JGAD000110\r\nMSI-H大腸がん：JGAD000122\r\n大腸がん：JGAD000139\r\n肺腺がん：JGAD000301\r\nデスモイド腫瘍：JGAD000376\r\n肺多形がん：JGAD000407\r\n大腸がん：JGAD000446",
          "総データ量": "JGAD000095：8.94 TB（bam [ref：hg19]）\r\nJGAD000110：955.16 GB（bam [ref：hg19/hg38]）\r\nJGAD000122：5.99 TB（bam [ref：hg38]）\r\nJGAD000139：1.36 TB（bam [ref：hg38]）\r\nJGAD000301：5 TB（bam [ref：hg38]）\r\nJGAD000376：2.8 TB（bam [ref：hg38]）\r\nJGAD000407：786.9 GB（bam [ref：hg38]）\r\nJGAD000446：7.5 TB（bam [ref：hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy（JGAD000095、JGAD000122、JGAD000139、JGAD000301、JGAD000376、JGAD000407、JGAD000446）\r\nNBDC policy および 民間企業における利用禁止（JGAD000110）"
        },
        "RNA-seq": {
          "対象": "トリプルネガティブ乳がん（ICD10：C50）：23症例（うち2症例を再解析[JGAD000457]）\r\nエストロゲン受容体陽性乳がん（ICD10：C50）：17症例\r\nHER2陽性乳がん（ICD10：C50）：15症例\r\n肺腺がん（ICD10：C349）：43症例\r\nMSI-H大腸がん（ICD10：C18, C19, C20）：94症例\r\n肝転移を有する大腸がん：12症例、肝転移を有さない大腸がん：16症例（ICD10：C18, C19, C20）\r\n肺腺がん（ICD10：C34）：126症例\r\nデスモイド腫瘍（ICD10：D48.1）：55症例\r\n肺多形がん（NCBI MedGen UID：87198）：33症例48検体（凍結検体：12症例12検体、FFPE：21症例36検体）\r\n大腸がん（ICD10：C189）：141症例170検体（凍結腫瘍検体、14症例はRNA-seqのみ実施）\r\n唾液腺導管がん（ICD10：C089）：67症例67検体（凍結検体：19症例19検体、FFPE：48症例48検体)",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "乳がん、肺腺がん、大腸がん、デスモイド腫瘍、肺多形がんおよび唾液腺導管がんの切除標本、凍結検体ならびにFFPE（腫瘍組織）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina®\r\n肺多形がんのFFPE：TruSeq RNA Access Library Prep kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "乳がん、肺腺がん：103 bp\r\nMSI-H大腸がん：104 bp または 135 bp\r\n大腸がん（JGAD000139）：133 bp\r\n肺腺がん（JGAD000301）：134 bp または 137 bp\r\nデスモイド腫瘍：134 bp または 137 bp\r\n肺多形がん：132 bp または 133 bp\r\n大腸がん（JGAD000446）：125 bpまたは127 bp\r\n乳がん（JGAD000457）：100 bp\r\n唾液腺導管がん：132 bp または 133 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "乳がん：JGAD000095、JGAD000457\r\n肺腺がん：JGAD000111\r\nMSI-H大腸がん：JGAD000122\r\n大腸がん：JGAD000139\r\n肺腺がん：JGAD000301\r\nデスモイド腫瘍：JGAD000376\r\n肺多形がん：JGAD000407\r\n大腸がん：JGAD000446\r\n唾液腺導管がん：JGAD000653",
          "総データ量": "JGAD000095：8.94 TB（fastq）\r\nJGAD000111：1.31 TB（fastq）\r\nJGAD000122：5.99 TB（fastq）\r\nJGAD000139：1.91 TB（fastq）\r\nJGAD000301：5 TB（fastq）\r\nJGAD000376：2.8 TB（fastq）\r\nJGAD000407：786.9 GB（fastq）\r\nJGAD000446：7.5 TB（fastq）\r\nJGAD000457：41.2 GB（fastq）\r\nJGAD000653：970.3 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy（JGAD000095、JGAD000122、JGAD000139、JGAD000301、JGAD000376、JGAD000407、JGAD000446、JGAD000457、JGAD000653）\r\nNBDC policy および 民間企業における利用禁止（JGAD000111）"
        },
        "RNA access": {
          "対象": "MSI-H大腸がん（ICD10：C18, C19, C20）：18症例",
          "規模": "RNA access",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "大腸がんの切除標本（腫瘍組織）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq® RNA Access Library Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "104 bp または 135 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000122",
          "総データ量": "5.99 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "メチル化アレイ": {
          "対象": "MSI-H大腸がん（ICD10：C18, C19, C20）：93症例\r\n正常組織：20検体",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium Human MethylationEPIC BeadChip]",
          "ソース": "大腸がんの切除標本（腫瘍組織およびペア非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium Human MethylationEPIC BeadChip Kit",
          "メチル化率決定アルゴリズム（ソフトウェア）": "GenomeStudio（Illumina）",
          "フィルタリング": "Detection P-value ≧ 0.05",
          "マイクロアレイ標準化方法": "-",
          "プローブ数": "867,926 プローブ数",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000122",
          "総データ量": "5.99 TB (tsv)",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "SNP array": {
          "対象": "MSI-H大腸がん（ICD10：C18, C19, C20）：25症例",
          "規模": "genome wide CNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmni2.5-8 BeadChip]",
          "ソース": "大腸がんの切除標本（腫瘍組織およびペア非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium HumanOmni2.5-8 kit",
          "コピー数決定アルゴリズム（ソフトウェア）": "GenomeStudio（Illumina）",
          "フィルタリング": "Illumina Infinium Assay Ver.2.1. に記載",
          "コピー数変異数(QC後)": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000122",
          "総データ量": "5.99 TB（tsv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture": {
          "対象": "肺多形がん（NCBI MedGen UID：87198）：20症例50検体（腫瘍組織：20症例37検体、非腫瘍組織：13症例13検体、うちペア13症例）\r\n大腸がん（ICD10：C189）：31症例49検体\r\n唾液腺導管がん（ICD10：C089）：67症例67検体（凍結検体：19症例19検体、FFPE：48症例48検体、正常周囲組織：66症例66検体）",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "Todai OncoPanel\r\nhttp://todaioncopanel.umin.jp/",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "肺多形がん、大腸がん、唾液腺導管がんの凍結検体もしくはFFPE（腫瘍組織およびペア非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelectXT Custom kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "肺多形がん： 132 bp または 133 bp\r\n大腸がん： 125 bp\r\n唾液腺導管がん： 128 bp、132 bp、133 bp、145 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "肺多形がん： JGAD000407\r\n大腸がん： JGAD000446\r\n唾液腺導管がん： JGAD000653",
          "総データ量": "肺多形がん： 786.9 GB（bam [ref：hg38]）\r\n大腸がん： 7.5 TB （bam [ref：hg38]）\r\n唾液腺導管がん： 970.3 GB （bam [ref：hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGS（JGAS000360）": {
          "対象": "肺腺がん（ICD10：C34）：7症例\r\n　　非腫瘍組織と腫瘍組織ペア3症例、腫瘍組織のみ4症例\r\nMSI-H大腸がん（ICD10：C18, C19, C20）：12症例\r\n　　全て非腫瘍組織と腫瘍組織ペア\r\nトリプルネガティブ乳がん（ICD10：C50）：11症例\r\n　　全て腫瘍組織のみ",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "ライブラリソース": "肺がん、大腸がん、乳がんの腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "10x Genomics Chromium Genome Sequencing Solution",
          "断片化の方法": "10x Genomics Chromium Genome Sequencing Solution",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000474",
          "総データ量": "3.3 TB（fastq, bed, vcf [ref：hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Iso-seq": {
          "対象": "トリプルネガティブ乳がん（ICD10：C50）：14症例\r\nエストロゲン受容体陽性乳がん（ICD10：C50）：8症例",
          "規模": "Iso-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "PacBio [Sequel]",
          "ライブラリソース": "乳がんの切除標本（腫瘍組織）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMRTbell Template Prep Kit 1.0",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000457",
          "総データ量": "41.2 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGS（JGAS000335）": {
          "対象": "大腸がん（ICD10：C189）：21症例\r\n　　（WESも実施：3症例、TGSも実施：18症例）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Novaseq6000]",
          "ライブラリソース": "大腸がんの凍結検体（腫瘍組織および非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-free Library Prep Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000446",
          "総データ量": "7.5 TB （bam [ref：hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "間野 博行 ／ 高阪 真路",
        "所 属 機 関": "国立がん研究センター研究所 細胞情報学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "7": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） ゲノム医療実現推進プラットフォーム事業",
            "タイトル": "ヒトゲノム De Novo 情報解析テクノロジーの創出",
            "研究課題番号": "JP19km0405204"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency",
          "DOI": "doi: 10.1371/journal.pgen.1006853",
          "データID": "JGAD000095"
        },
        "2": {
          "タイトル": "Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.",
          "DOI": "doi: 10.1111/cas.13313",
          "データID": "JGAD000110、JGAD000111"
        },
        "3": {
          "タイトル": "Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers",
          "DOI": "doi: 10.1158/1078-0432.CCR-18-1574",
          "データID": "JGAD000122"
        },
        "4": {
          "タイトル": "Genomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genes",
          "DOI": "doi: 10.1111/cas.14127",
          "データID": "JGAD000139"
        },
        "5": {
          "タイトル": "Identification of Novel CD74-NRG2α Fusion From Comprehensive Profiling of Lung Adenocarcinoma in Japanese Never or Light Smokers",
          "DOI": "doi: 10.1016/j.jtho.2020.01.021",
          "データID": "JGAD000301"
        },
        "6": {
          "タイトル": "Comprehensive molecular and clinicopathological profiling of desmoid tumors",
          "DOI": "doi: 10.1016/j.ejca.2020.12.001",
          "データID": "JGAD000376"
        },
        "7": {
          "タイトル": "Comprehensive molecular profiling of pulmonary pleomorphic carcinoma.",
          "DOI": "doi: 10.1038/s41698-021-00201-3",
          "データID": "JGAD000407"
        },
        "8": {
          "タイトル": "Multi-sample Full-length Transcriptome Analysis of 22 Breast Cancer Clinical Specimens with Long-Read Sequencing",
          "DOI": "doi: 10.1101/2020.07.15.199851",
          "データID": "JGAD000457"
        },
        "9": {
          "タイトル": "Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing",
          "DOI": "doi: 10.1002/cam4.4710",
          "データID": "JGAD000446"
        },
        "10": {
          "タイトル": "Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling",
          "DOI": "doi: 10.1038/s41698-022-00324-1",
          "データID": "JGAD000653"
        }
      },
      "制限公開データの利用者一覧": {
        "Subhajyoti De": {
          "研究代表者": "Subhajyoti De",
          "所属機関": "Rutgers Cancer Institute, Rutgers the State University of New Jersey",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000095"
        },
        "Youping Deng": {
          "研究代表者": "Youping Deng",
          "所属機関": "Department of Complementary and Integrative Medicine, University of Hawai Manoa",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000110, JGAD000111"
        },
        "佐藤 哲也": {
          "研究代表者": "佐藤 哲也",
          "所属機関": "合同会社みらか中央研究所・基盤研究部",
          "研究題目": "",
          "利用データID": "制限公開クリニカルシーケンスデータを利用したリンチ症候群大腸がん関連マーカー遺伝子の探索",
          "利用期間": "JGAD000095, JGAD000122"
        },
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000095, JGAD000110, JGAD000111, JGAD000122"
        },
        "Ruping Sun": {
          "研究代表者": "Ruping Sun",
          "所属機関": "Department of laboratory medicine and pathology, University of Minnesota",
          "研究題目": "",
          "利用データID": "Accounting for Copy Number States in Quantifying Tumor Heterogeneity",
          "利用期間": "JGAD000095"
        },
        "万代 昌紀": {
          "研究代表者": "万代 昌紀",
          "所属機関": "京都大学医学部医学研究科 婦人科学産科学教室",
          "研究題目": "",
          "利用データID": "多様な臨床情報を考慮した婦人科悪性腫瘍患者の尾ミックス解析（全ゲノム・全トランスクリプト-ム・プロテオーム・メタボローム解析）による個別化治療の探索",
          "利用期間": "JGAD000095, JGAD000110, JGAD000111, JGAD000122"
        },
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000110, JGAD000301, JGAD000407"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000095, JGAD000111, JGAD000122, JGAD000139, JGAD000301, JGAD000376, JGAD000407, JGAD000457"
        },
        "垣内 伸之": {
          "研究代表者": "垣内 伸之",
          "所属機関": "京都大学 白眉センター",
          "研究題目": "日本",
          "利用データID": "固形腫瘍における遺伝子異常の網羅的解析",
          "利用期間": "JGAD000122"
        },
        "王 晋": {
          "研究代表者": "王 晋",
          "所属機関": "中山大学附属腫瘍病院",
          "研究題目": "中華人民共和国",
          "利用データID": "デスモイド腫瘍のゲノミクス研究",
          "利用期間": "JGAD000376"
        }
      },
      "リリース情報": {
        "hum0094.v11": {
          "Research ID": "hum0094.v11",
          "公開日": "2022/11/08",
          "内容": "NGS（Target Capture、RNA-seq）",
          "description": "唾液腺導管がん67症例67検体（凍結検体：19症例19検体、FFPE検体48症例48検体）の腫瘍組織並びに周辺正常組織（66症例66検体）より抽出したDNAを用いたTarget Capture Sequencing（Todai OncoPanel）解析、並びに、67症例（凍結検体：19症例19検体、FFPE検体48症例48検体）の腫瘍組織から抽出したRNAを用いたRNA-seq解析データを解析の結果をbam（reference：hg38）もしくはfastq形式にて提供する。\n"
        },
        "hum0094.v10": {
          "Research ID": "hum0094.v10",
          "公開日": "2022/05/23",
          "内容": "NGS（WGS、Exome、RNA-seq、Target Capture）",
          "description": "大腸がんの凍結検体（腫瘍組織およびペア非腫瘍組織）から抽出したDNAを用いたWES解析結果（128症例141検体）、Target Capture解析（31症例49検体）、WES検体およびターゲットシーケンス検体のうち20症例31検体（WES：3症例、TGS：18症例）に対して実施したWGS解析の結果をbam形式にて提供する。また、凍結腫瘍検体（141症例170検体）から抽出したRNAを用いたRNA-seq解析の結果をfastq形式にて提供する。\n"
        },
        "hum0094.v9": {
          "Research ID": "hum0094.v9",
          "公開日": "2021/12/10",
          "内容": "NGS（Iso-seq、RNA-seq）",
          "description": " 乳がん22症例の切除切片（腫瘍組織）から抽出したRNAを使用したIso-seq解析およびRNA-seq解析の結果をfastq形式にて提供する。\n"
        },
        "hum0094.v7": {
          "Research ID": "hum0094.v7",
          "公開日": "2021/07/02",
          "内容": "NGS（Exome、RNA-seq、Target Capture）",
          "description": "肺多形がん19症例の凍結検体（腫瘍組織およびペア非腫瘍組織）から抽出したDNAを使用したExome解析、12症例の凍結検体（腫瘍組織）および21症例のFFPE検体（腫瘍組織）から抽出したRNAを使用したRNA-seq解析、ならびに20症例のFFPE検体（腫瘍組織およびペア非腫瘍組織）から抽出したDNAを使用したTarget Capture解析の結果をbam（reference：hg38）もしくはfastq形式にて提供する。\n"
        },
        "hum0094.v6": {
          "Research ID": "hum0094.v6",
          "公開日": "2021/01/29",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "デスモイド腫瘍64症例の腫瘍凍結検体およびペア非腫瘍組織から抽出したDNA、および55症例の腫瘍凍結検体から抽出したRNAを使用したExome解析およびRNA-seq解析の結果をbam（reference：hg38）もしくはfastq形式にて提供する。\n"
        },
        "hum0094.v5": {
          "Research ID": "hum0094.v5",
          "公開日": "2020/10/26",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "肺腺がん126症例の腫瘍凍結検体およびペア非腫瘍組織から抽出したDNAおよびRNAを使用したExome解析およびRNA-seq解析の結果をbam（reference：hg38）もしくはfastq形式にて提供する。\n"
        },
        "hum0094.v4": {
          "Research ID": "hum0094.v4",
          "公開日": "2020/08/14",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "肝転移を有する大腸がん12症例、肝転移を有さない大腸がん16症例の切除切片（腫瘍組織およびペア非腫瘍組織）から抽出したDNAおよびRNAを使用したExome解析およびRNA-seq解析の結果をbam（reference：hg38）もしくはfastq形式にて提供する。\n"
        },
        "hum0094.v3": {
          "Research ID": "hum0094.v3",
          "公開日": "2019/02/12",
          "内容": "NGS（Exome、RNA-seq、RNA access）、メチル化アレイ、SNPアレイ",
          "description": "MSI-H大腸がん150症例の切除切片（腫瘍組織およびペア非腫瘍組織）から抽出したDNAおよびRNAを使用したExome解析、RNA-seq解析、RNA-access解析、メチル化解析、コピー数多型解析の結果をbam（reference：hg38）、fastqもしくはtsv形式にて提供する。\n"
        },
        "hum0094.v2": {
          "Research ID": "hum0094.v2",
          "公開日": "2018/01/22",
          "内容": "NGS（Exome、RNA-seq）",
          "description": "肺腺がん43症例の切除切片（腫瘍組織およびペア非腫瘍組織）から抽出したDNAおよびRNAを使用したExome解析およびRNA-seq解析の結果をbam（reference：hg19/hg38）もしくはfastq形式にて提供する。\n"
        },
        "hum0094.v1": {
          "Research ID": "hum0094.v1",
          "公開日": "2017/09/04",
          "内容": "NGS（WGS、Exome、RNA-seq）",
          "description": " 乳がん68症例の切除切片（腫瘍組織およびペア非腫瘍組織）もしくは末梢血（正常組織）から抽出したDNAおよびRNAを使用したWGS解析、Exome解析およびRNA-seq解析の結果をbam（reference：hg19）もしくはfastq形式にて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0094.v11",
      "DATA": {
        "JGAS000095": {
          "Data Set ID": "JGAS000095",
          "Type of Data": "NGS (WGS, Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/09/04"
        },
        "JGAS000105": {
          "Data Set ID": "JGAS000105",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/01/22"
        },
        "JGAS000113": {
          "Data Set ID": "JGAS000113",
          "Type of Data": "NGS (Exome, RNA-seq, RNA access), \r\nMethylation array, SNP array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/02/12"
        },
        "JGAS000128": {
          "Data Set ID": "JGAS000128",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/08/14"
        },
        "JGAS000215": {
          "Data Set ID": "JGAS000215",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/10/26"
        },
        "JGAS000270": {
          "Data Set ID": "JGAS000270",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/01/29"
        },
        "JGAS000297": {
          "Data Set ID": "JGAS000297",
          "Type of Data": "NGS (Exome, RNA-seq, Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/02"
        },
        "JGAS000360": {
          "Data Set ID": "JGAS000360",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/10/22"
        },
        "JGAS000095 (Data addition)": {
          "Data Set ID": "JGAS000095 (Data addition)",
          "Type of Data": "NGS (Iso-seq, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/10/26"
        },
        "JGAS000335": {
          "Data Set ID": "JGAS000335",
          "Type of Data": "NGS (WGS, Exome, RNA-seq, Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/05/26"
        },
        "JGAS000534": {
          "Data Set ID": "JGAS000534",
          "Type of Data": "NGS (Target Capture, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/11/08"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of oncogenic alteration in breast cancer, lung adenocarcinoma, colorectal cancer (CRC) and pulmonary pleomorphic carcinoma through genomic analysis. To identify new biomarkers of desmoid tumor by investigating the molecular profiles in combination with the clinicopathological characteristics.",
        "Methods": "Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), RNA-seq and Target Capture sequencing were performed with HiSeq 2000/2500. Methylation analysis was performed with Infinium MethylationEPIC Kit. SNP array was performed with HumanOmni2.5-8. Genomic DNA was purified from each sample; We sequenced those genomic DNAs using 10X Genomics sequencing technologies, and analyzed genomic structural variations. Long-read sequencing was performed with the Pacific Biosciences Single-Molecule Real-Time (SMRT) sequencing technology.",
        "Participants/Materials": "Surgically resected breast cancer, lung adenocarcinoma, CRC and desmoid tumor tissues and paired non-tumor tissues or peripheral blood cells (as normal tissues)",
        "URL": "https://www.ncc.go.jp/en/ri/division/genetics/index.html"
      },
      "MOLECULAR DATA": {
        "WGS (JGAS000095)": {
          "Participants/Materials": "Triple negative breast cancer (ICD10: C50): 16 cases",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "DNAs extracted from tumor tissues and paired non-tumor tissues or peripheral blood cells as non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext® Ultra™ DNA Library Prep Kit for Illumina®",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "103 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000095",
          "Total Data Volume": "8.94 TB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "Exome": {
          "Participants/Materials": "Triple negative breast cancer (ICD10: C50): 36 cases\r\nLung adenocarcinoma (ICD10: C349): 43 cases\r\nMSI-H CRC (ICD10: C18, 19, 20): 149 cases\r\nCRC with liver metastasis: 12 cases, CRC without liver metastasis: 16 cases (ICD10: C18, 19, 20)\r\nLung adenocarcinoma (ICD10: C34): 126 cases\r\nDesmoid tumor (ICD10: D48.1): 64 cases\r\nPulmonary pleomorphic carcinoma (NCBI MedGen UID: 87198): 19 cases [30 samples] (tumor tissue: 12 cases [12 samples], non-tumor tissue: 18 cases [18 samples], paired samples from 11 cases)\r\nColorectal cancer (ICD10: C189): 128 cases [141 samples]",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500, NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor tissues and paired non-tumor tissues or peripheral blood cells as non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext® Ultra™ DNA Library Prep Kit for Illumina®, SureSelect Human All Exon V5, SureSelect Human All Exon V6",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "breast cancer and lung adenocarcinoma: 103 bp\r\nMSI-H CRC: 104 bp or 135 bp\r\nCRC: 100 bp or 103 bp\r\nlung adenocarcinoma (JGAD000301): 134 bp or 137 bp\r\ndesmoid tumor: 134 bp or 137 bp\r\npulmonary pleomorphic carcinoma: 133 bp\r\ncolorectal cancer: 125 bp, 150 bp or 151 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "Triple negative breast cancer: JGAD000095\r\nLung adenocarcinoma: JGAD000110\r\nMSI-H CRC: JGAD000122\r\nCRC: JGAD000139\r\nLung adenocarcinoma: JGAD000301\r\nDesmoid tumor: JGAD000376\r\nPulmonary pleomorphic carcinoma: JGAD000407\r\nColorectal cancer: JGAD000446",
          "Total Data Volume": "JGAD000095: 8.94 TB (bam [ref: hg19])\r\nJGAD000110: 955.16 GB (bam [ref: hg19/hg38])\r\nJGAD000122: 5.99 TB (bam [ref: hg38])\r\nJGAD000139: 1.36 TB (bam [ref: hg38])\r\nJGAD000301: 5 TB (bam [ref: hg38])\r\nJGAD000376: 2.8 TB (bam [ref: hg38])\r\nJGAD000407: 786.9 GB (bam [ref: hg19/hg38])\r\nJGAD000446: 7.5 TB (bam [ref: hg38])",
          "Comments (Policies)": "NBDC policy (JGAD000095, JGAD000122, JGAD000139, JGAD000301, JGAD000376, JGAD000407, JGAD000446)\r\nNBDC policy & Company User Limit (JGAD000110)"
        },
        "RNA-seq": {
          "Participants/Materials": "Triple negative breast cancer (ICD10: C50): 23 cases (including 2 cases for JGAD000457)\r\nEstrogen receptor-positive breast cancer (ICD10: C50): 17 cases\r\nHER2-positive breast cance (ICD10: C50)r: 15 cases\r\nLung adenocarcinoma (ICD10: C349): 43 cases \r\nMSI-H CRC (ICD10: C18, 19, 20): 94 cases\r\nCRC with liver metastasis: 12 cases, CRC without liver metastasis: 16 cases (ICD10: C18, 19, 20)\r\nLung adenocarcinoma (ICD10: C34): 126 cases\r\nDesmoid tumor (ICD10: D48.1): 55 cases\r\nPulmonary pleomorphic carcinoma (NCBI MedGen UID: 87198): 33 cases [48 samples] (fresh frozen samples: 12 cases [12 samples], FFPE samples: 21 cases [36 samples])\r\nColorectal cancer (ICD10: C189): 141 cases [170 samples] (including 14 cases used for RNA-seq only)\r\nSalivary duct carcinoma (ICD10: C089): 67 cases [fresh-frozen tissue samples: 19, FFPE samples: 48]",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "RNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina®\r\nFFPE samples of pulmonary pleomorphic carcinoma: TruSeq RNA Access Library Prep kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "Breast cancer and lung adenocarcinoma: 103 bp\r\nMSI-H CRC: 104 bp or 135 bp\r\nCRC (JGAD000139): 133 bp\r\nLung adenocarcinoma (JGAD000301): 134 bp or 137 bp\r\nDesmoid tumor: 134 bp or 137 bp\r\nPulmonary pleomorphic carcinoma: 132 bp or 133 bp\r\nBreast cancer (JGAD000457): 100 bp\r\nColorectal cancer: 125 bp or 127 bp\r\nSalivary duct carcinoma: 132 bp or 133 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "Breast cancers: JGAD000095, JGAD000457\r\nLung adenocarcinoma: JGAD000111\r\nMSI-H CRC: JGAD000122\r\nCRC: JGAD000139\r\nLung adenocarcinoma: JGAD000301 (fastq)\r\nDesmoid tumor: JGAD000376\r\nPulmonary pleomorphic carcinoma: JGAD000407\r\nColorectal cancer: JGAD000446\r\nSalivary duct carcinoma: JGAD000653",
          "Total Data Volume": "JGAD000095: 8.94 TB (fastq)\r\nJGAD000111: 1.31 TB (fastq)\r\nJGAD000122: 5.99 TB (fastq)\r\nJGAD000139: 1.91 TB (fastq)\r\nJGAD000301: 5 TB (fastq)\r\nJGAD000376: 2.8 TB (fastq)\r\nJGAD000407: 786.9 GB (fastq)\r\nJGAD000446: 7.5 TB (fastq)\r\nJGAD000457: 41.2 GB (fastq)\r\nJGAD000653: 970.3 GB (fastq)",
          "Comments (Policies)": "NBDC policy (JGAD000095, JGAD000122, JGAD000139, JGAD000301, JGAD000376, JGAD000407, JGAD000446, JGAD000457, JGAD000653)\r\nNBDC policy & Company User Limit(JGAD000111)"
        },
        "RNA access": {
          "Participants/Materials": "MSI-H CRC (ICD10: C18, 19, 20): 18 cases",
          "Targets": "RNA access",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "RNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq® RNA Access Library Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "104 bp or 135 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000122 (fastq)",
          "Total Data Volume": "5.99 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation array": {
          "Participants/Materials": "MSI-H CRC (ICD10: C18, 19, 20): 93 cases\r\nnormal tissues: 20 samples",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium Human MethylationEPIC BeadChip]",
          "Source": "DNAs extracted from tumor tissues and paired non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Infinium Human MethylationEPIC BeadChip Kit",
          "Algorithms for Calculating Methylation-rate (software)": "GenomeStudio (Illumina)",
          "Filtering Methods": "Detection P-value >= 0.05",
          "Normalization of microarray": "-",
          "Probe Number": "867,926 Probe Numbers",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000122",
          "Total Data Volume": "5.99 TB (tsv)",
          "Comments (Policies)": "NBDC policy"
        },
        "SNP array": {
          "Participants/Materials:": "MSI-H CRC (ICD10: C18, 19, 20): 25 cases",
          "Targets": "genome wide CNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmni2.5-8 BeadChip]",
          "Source": "DNAs extracted from tumor tissues and paired non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Infinium HumanOmni2.5-8 kit",
          "Algorithm for detecting CNVs (software)": "GenomeStudio (Illumina)",
          "Filtering Methods": "As described in 'Illumine Infinium Assay Ver.2.1.'",
          "CNV number": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000122",
          "Total Data Volume": "5.99 TB (tsv)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture": {
          "Participants/Materials": "Pulmonary pleomorphic carcinoma (NCBI MedGen UID: 87198): 20 cases [50 samples] (tumor tissue: 20 cases [37 samples], non-tumor tissue: 13 cases [13 samples], paired samples from 13 cases)\r\nColorectal cancer (ICD10: C189): 31 cases [49 samples]\r\nSalivary duct carcinoma (ICD10: C089): 67 cases [67 samples] (fresh-frozen tissue samples: 19, FFPE samples: 48, normal tissue surrounding tumors: 66 samples)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "Todai OncoPanel\r\nhttp://todaioncopanel.umin.jp/",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from tumor tissues and paired non-tumor tissues (FFPE)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelectXT Custom kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "Pulmonary pleomorphic carcinoma: 132 bp or 133 bp\r\nColorectal cancer: 125 bp\r\nSalivary duct carcinoma: 128 bp, 132 bp, 133 bp, 145 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "Pulmonary pleomorphic carcinoma: JGAD000407\r\nColorectal cancer: JGAD000446\r\nSalivary duct carcinoma: JGAD000653",
          "Total Data Volume": "JGAD000407: 786.9 GB (bam [ref: hg19/hg38])\r\nJGAD000446: 7.5 TB (bam [ref: hg38)\r\nJGAD000653 : 970.3 GB (bam [ref: hg38)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGS (JGAS000360)": {
          "Participants/Materials": "Lung adenocarcinoma (ICD10: C34): 7 cases (tumor tissues and paired non-tumor tissues for 3 cases; tumor tissues only for 4 cases)\r\nMSI-H CRC (ICD10: C18, C19, C20): 12 cases (tumor tissues and paired non-tumor tissues)\r\nTriple negative breast cancer (ICD10: C50): 11 cases (tumor tissues only)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "10x Genomics Chromium Genome Sequencing Solution",
          "Fragmentation Methods": "10x Genomics Chromium Genome Sequencing Solution",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000474",
          "Total Data Volume": "3.3 TB (fastq, bed, vcf [ref：hg38])",
          "Comments (Policies)": "NBDC policy"
        },
        "Iso-seq": {
          "Participants/Materials": "Triple negative breast cancer (ICD10: C50): 14 cases\r\nEstrogen receptor-positive breast cancer (ICD10: C50): 8 cases",
          "Targets": "Iso-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "PacBio [Sequel]",
          "Library Source": "RNAs extracted from tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMRTbell Template Prep Kit 1.0",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "-",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000457",
          "Total Data Volume": "41.2 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGS (JGAS000335)": {
          "Participants/Materials": "Colorectal cancer (ICD10: C189): 21 cases (including 3 cases used for WES, 18 cases used for TGS)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Novaseq6000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-free Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000446",
          "Total Data Volume": "7.5 TB (bam [ref：hg38])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Mano / Shinji Kohsaka",
        "Affiliation": "Division of Cellular Signaling, National Cancer Center Research Institute",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "7": {
            "Name": "Platform Program for Promotion of Genome Medicine, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Informatics for analyzing de novo human genome assemblies",
            "Project Number": "JP19km0405204"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency",
          "DOI": "doi: 10.1371/journal.pgen.1006853",
          "Data Set ID": "JGAD000095"
        },
        "2": {
          "Title": "Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.",
          "DOI": "doi: 10.1111/cas.13313",
          "Data Set ID": "JGAD000110, JGAD000111"
        },
        "3": {
          "Title": "Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers",
          "DOI": "doi: 10.1158/1078-0432.CCR-18-1574",
          "Data Set ID": "JGAD000122"
        },
        "4": {
          "Title": "Genomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genes",
          "DOI": "doi: 10.1111/cas.14127",
          "Data Set ID": "JGAD000139"
        },
        "5": {
          "Title": "Identification of Novel CD74-NRG2α Fusion From Comprehensive Profiling of Lung Adenocarcinoma in Japanese Never or Light Smokers",
          "DOI": "doi: 10.1016/j.jtho.2020.01.021",
          "Data Set ID": "JGAD000301"
        },
        "6": {
          "Title": "Comprehensive molecular and clinicopathological profiling of desmoid tumors",
          "DOI": "doi: 10.1016/j.ejca.2020.12.001",
          "Data Set ID": "JGAD000376"
        },
        "7": {
          "Title": "Comprehensive molecular profiling of pulmonary pleomorphic carcinoma.",
          "DOI": "doi: 10.1038/s41698-021-00201-3",
          "Data Set ID": "JGAD000407"
        },
        "8": {
          "Title": "Multi-sample Full-length Transcriptome Analysis of 22 Breast Cancer Clinical Specimens with Long-Read Sequencing",
          "DOI": "doi: 10.1101/2020.07.15.199851",
          "Data Set ID": "JGAD000457"
        },
        "9": {
          "Title": "Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing",
          "DOI": "doi: 10.1002/cam4.4710",
          "Data Set ID": "JGAD000446"
        },
        "10": {
          "Title": "Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling",
          "DOI": "doi: 10.1038/s41698-022-00324-1",
          "Data Set ID": "JGAD000653"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Subhajyoti De": {
          "Principal Investigator": "Subhajyoti De",
          "Affiliation": "Rutgers Cancer Institute, Rutgers the State University of New Jersey",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000095"
        },
        "Youping Deng": {
          "Principal Investigator": "Youping Deng",
          "Affiliation": "Department of Complementary and Integrative Medicine, University of Hawai Manoa",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000110, JGAD000111"
        },
        "Tetsuya Sato": {
          "Principal Investigator": "Tetsuya Sato",
          "Affiliation": "Research Department, Miraca Research Institute G.K.",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Search for Lynch syndrome colorectal cancer-related genes using contolled-access clinical sequence data",
          "Period of Data Use": "JGAD000095, JGAD000122"
        },
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000095, JGAD000110, JGAD000111, JGAD000122"
        },
        "Ruping Sun": {
          "Principal Investigator": "Ruping Sun",
          "Affiliation": "Department of laboratory medicine and pathology, University of Minnesota",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Accounting for Copy Number States in Quantifying Tumor Heterogeneity",
          "Period of Data Use": "JGAD000095"
        },
        "Masaki Mandai": {
          "Principal Investigator": "Masaki Mandai",
          "Affiliation": "Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Integrated analyses of omics (genomics, transcriptomics, proteomics and metabolomics) associated with clinical variables for developing indivisualizedtreatment in gynecological malignancy",
          "Period of Data Use": "JGAD000095, JGAD000110, JGAD000111, JGAD000122"
        },
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000110, JGAD000301, JGAD000407"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000095, JGAD000111, JGAD000122, JGAD000139, JGAD000301, JGAD000376, JGAD000407, JGAD000457"
        },
        "Nobuyuki Kakiuchi": {
          "Principal Investigator": "Nobuyuki Kakiuchi",
          "Affiliation": "The Hakubi Center for Advanced Research, Kyoto University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Comprehensive analysis of genetic aberrations in solid tumors",
          "Period of Data Use": "JGAD000122"
        },
        "Jin Wang": {
          "Principal Investigator": "Jin Wang",
          "Affiliation": "Sun Yat-sen University Cancer Center",
          "Research Title": "China",
          "Data in Use (Dataset ID)": "Genomics study of desmoid tumor",
          "Period of Data Use": "JGAD000376"
        }
      },
      "Release Note": {
        "hum0094.v11": {
          "Research ID": "hum0094.v11",
          "Release Date": "2022/11/08",
          "Type of Data": "NGS (Target Capture, RNA-seq)",
          "description": "DNAs and RNAs extracted from fresh frozen or FFPE specimens (tumor tissues and paired non-tumor tissues) from 67 salivary duct carcinoma were used for Target Capture sequencing and RNA-seq (bam [reference: hg38] and fastq files).\n"
        },
        "hum0094.v10": {
          "Research ID": "hum0094.v10",
          "Release Date": "2022/05/23",
          "Type of Data": "NGS (WGS, Exome, RNA-seq, Target Capture)",
          "description": "DNAs and RNAs extracted from fresh-frozen specimens (tumor tissues and paired non-tumor tissues) from 173 colorectal cancer patients were used for WGS, WES, RNA-seq and Target Capture sequencing (bam [reference: hg38] and fastq files).\n"
        },
        "hum0094.v9": {
          "Research ID": "hum0094.v9",
          "Release Date": "2021/10/26",
          "Type of Data": "NGS (Iso-seq, RNA-seq)",
          "description": "RNAs extracted from surgically resected breast cancer tissues obtained from 22 breast cancer patients were used for Iso-seq and RNA-seq (fastq files).\n"
        },
        "hum0094.v7": {
          "Research ID": "hum0094.v7",
          "Release Date": "2021/07/02",
          "Type of Data": "NGS (Exome, RNA-seq, Target Capture)",
          "description": "DNAs and RNAs extracted from fresh frozen or FFPE specimens (tumor tissues and paired non-tumor tissues) from 35 pulmonary pleomorphic carcinoma patients were used for WES, RNA-seq and Target Capture sequencing (bam [reference: hg38] and fastq files).\n"
        },
        "hum0094.v6": {
          "Research ID": "hum0094.v6",
          "Release Date": "2021/01/29",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs were extracted from fresh frozen tumor specimens and paired non-tumor tissues from 64 desmoid tumor patients. RNAs were extracted from tumor specimens obtained from 55 desmoid tumor patients. DNAs/RNAs were used for WES/RNA-seq (bam [reference: hg38] and fastq files).\n"
        },
        "hum0094.v5": {
          "Research ID": "hum0094.v5",
          "Release Date": "2020/10/26",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs from fresh frozen tumor specimens and paired non-tumor tissues and RNAs from tumor specimens obtained from 126 lung adenocarcinoma patients were used for WES and RNA-seq (bam [reference: hg38] and fastq files).\n"
        },
        "hum0094.v4": {
          "Research ID": "hum0094.v4",
          "Release Date": "2020/08/14",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs and RNAs extracted from surgically resected colorectal cancer tissues and paired non-tumor tissues obtained from 12 colorectal cancer patients with liver metastasis and 16 colorectal cancer patients without liver metastasis were used for WES and RNA-seq (bam [reference: hg38] and fastq files).\n"
        },
        "hum0094.v3": {
          "Research ID": "hum0094.v3",
          "Release Date": "2019/02/12",
          "Type of Data": "NGS (Exome, RNA-seq, RNA access), Methylation array, SNP array",
          "description": "DNAs and RNAs extracted from surgically resected colorectal cancer tissues and paired non-tumor tissues obtained from 150 MSI-H colorectal cancer patients were used for WES, RNA-seq, RNA access, Methylation adday, and SNP array (bam [reference: hg38], fastq and tsv files).\n"
        },
        "hum0094.v2": {
          "Research ID": "hum0094.v2",
          "Release Date": "2018/01/22",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "DNAs and RNAs extracted from surgically resected lung adenocarcinoma tissues and paired non-tumor tissues obtained from 43 lung adenocarcinoma patients were used for WES and RNA-seq (bam [reference: hg19/hg38] and fastq files).\n"
        },
        "hum0094.v1": {
          "Research ID": "hum0094.v1",
          "Release Date": "2017/09/04",
          "Type of Data": "NGS (WGS, Exome, RNA-seq)",
          "description": "DNAs and RNAs extracted from surgically resected breast cancer tissues and paired non-tumor tissues or peripheral blood cells obtained from 68 breast cancer patients were used for WGS, WES and RNA-seq (bam [reference: hg19] and fastq files).\nNote：\n"
        }
      }
    }
  },
  "hum0091.v1": {
    "ja": {
      "NBDC Research ID": "hum0091.v1",
      "データ": {
        "JGAS000082": {
          "データID": "JGAS000082",
          "内容": "NGS（PBAT-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/12"
        },
        "JGAS000165": {
          "データID": "JGAS000165",
          "内容": "NGS（ChIP-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/12"
        },
        "JGAS000081": {
          "データID": "JGAS000081",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/12"
        }
      },
      "研究内容の概要": {
        "目的": "国際ヒトエピゲノムコンソーシアム（The International Human Epigenome Consortium: IHEC）に参画し、年齢・性別の異なる複数の日本人検体から得られた正常細胞等の高品質な標準エピゲノムプロファイルを取得し、データを広く公開して研究基盤形成に貢献する。",
        "方法": "胃粘膜から腺管分離法で純化した表層粘液細胞 （腺窩上皮細胞）を対象とするChIP-seq解析、RNA-seq解析、PBAT-seq解析",
        "対象": "胃粘膜から腺管分離法で純化した表層粘液細胞 （腺窩上皮細胞） 14種類（正常： 14検体）",
        "URL": "https://pathology.med.keio.ac.jp/"
      },
      "分子データ": {
        "JGAS000082": {
          "対象": "胃粘膜から腺管分離法で純化した表層粘液細胞 （腺窩上皮細胞）14種類（正常：14細胞）",
          "規模": "PBAT-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "胃粘膜から腺管分離法で純化した表層粘液細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Post-Bisulfite Adaptor-Tagging（PBAT）法\r\n（http://crest-ihec.jp/epigenome/index.html）",
          "断片化の方法": "Post-bisulfite adaptor-tagging（PBAT）法による（Bisulfite変換に伴うDNA切断）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000082",
          "総データ量": "1 TB（fastq [41 files / 25,928,851,326 reads]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000165": {
          "対象": "胃粘膜から腺管分離法で純化した表層粘液細胞 （腺窩上皮細胞） 14種類（正常：14細胞）",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "胃粘膜から腺管分離法で純化した表層粘液細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "抗H3K4me3、H3K9me3、 H3K27me3、H3K27ac、H3K4me1、H3K36me3モノクローナル抗体（東京工業大学木村宏教授提供）を用いて免疫沈降",
          "断片化の方法": "超音波断片化（BRANSON SLPe, amplitude 40%, on 30 sec and off 30 sec, 10 cycles, on ice）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "36 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000243",
          "総データ量": "65 GB（fastq [49 files / 1,981,314,349 reads]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000081": {
          "対象": "胃粘膜から腺管分離法で純化した表層粘液細胞 （腺窩上皮細胞）14種類（正常：14細胞）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "胃粘膜から腺管分離法で純化した表層粘液細胞より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Strand Specific RNA kit",
          "断片化の方法": "二価陽イオンと温度（94℃） によるRNAの断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000081",
          "総データ量": "79 GB（fastq [22 files / 1,202,044,862 reads]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "金井 弥栄",
        "所 属 機 関": "慶應義塾大学医学部病理学教室",
        "プロジェクト/研究グループ名": "革新的先端研究開発支援事業（AMED-CREST） 国際ヒトエピゲノムコンソーシアム（IHEC）金井チーム",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業（AMED-CREST）",
            "タイトル": "「エピゲノム研究に基づく診断・治療へ向けた新技術の創出」領域",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000081"
        }
      },
      "リリース情報": {
        "hum0091.v1": {
          "Research ID": "hum0091.v1",
          "公開日": "2021/03/12",
          "内容": "NGS（PBAT-seq、ChIP-seq、RNA-seq）",
          "description": "胃粘膜から腺管分離法で純化した表層粘液細胞 （腺窩上皮細胞）より抽出したDNAを用いたPBAT-seq解析の結果をfastqファイルにて提供する。Post-Bisulfite Adaptor-Tagging（PBAT）法（http://crest-ihec.jp/epigenome/index.html）でライブラリ作製し、HiSeq 2000（Illumina）によりシングルエンドシークエンシングを行っている。\n胃粘膜から腺管分離法で純化した表層粘液細胞 （腺窩上皮細胞）より抽出したDNAを用いたChIP-seq解析の結果をfastqファイルにて提供する。抗H3K4me3,H3K9me3, H3K27me3, H3K27ac, H3K4me1, H3K36me3モノクローナル抗体（東京工業大学木村宏教授提供）を用いて免疫沈降後ChIP-seqライブラリを作製し、HiSeq 2500（Illumina）によりシークエンシング行っている。\n胃粘膜から腺管分離法で純化した表層粘液細胞 （腺窩上皮細胞）より抽出したRNAを用いたRNA-seq解析の結果をfastqファイルにて提供する。Agilent SureSelect Strand Specific RNA kitによるライブラリ作製、Hiseq2000(Illumina)での100bpペアエンドシークエンシングを行っている。 \nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0091.v1",
      "DATA": {
        "JGAS000082": {
          "Data Set ID": "JGAS000082",
          "Type of Data": "NGS (PBAT-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/12"
        },
        "JGAS000165": {
          "Data Set ID": "JGAS000165",
          "Type of Data": "NGS (ChIP-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/12"
        },
        "JGAS000081": {
          "Data Set ID": "JGAS000081",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/12"
        }
      },
      "SUMMARY": {
        "Aims": "The aim of this study is to participate in International Human Epigenome Consortium (http://ihec-epigenomes.org/), through disclosure of quality reference epigenome profiles in normal and diseased cells obtained from multiple Japanese people.",
        "Methods": "ChIP-Seq, RNA-seq and PBAT-seq analysis about normal human foveolar epithelial cells of the stomach purified from gastrectomy specimens using crypt isolation method.",
        "Participants/Materials": "Normal human foveolar epithelial cells of the stomach purified from gastrectomy specimens using crypt isolation method : 14 cells",
        "URL": "https://pathology.med.keio.ac.jp/home-e/"
      },
      "MOLECULAR DATA": {
        "JGAS000082": {
          "Participants/Materials:": "Normal human foveolar epithelial cells of the stomach purified from gastrectomy specimens using crypt isolation method : 14",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNAs extracted from normal human foveolar epithelial cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Post-Bisulfite Adaptor-Tagging (PBAT) method\r\n(http://crest-ihec.jp/english/epigenome/index.html)",
          "Fragmentation Methods": "PBAT method: fragmentation due to bisulfite conversion",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000082",
          "Total Data Volume": "1 TB (fastq [41 files / 25,928,851,326 reads]）",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000165": {
          "Participants/Materials:": "Normal human foveolar epithelial cells of the stomach purified from gastrectomy specimens using crypt isolation method : 14",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "gDNAs extracted from normal human foveolar epithelial cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Anti H3K4me3, H3K9me3, H3K27me3, H3K27ac, H3K4me1 and H3K36me3 mouse monoclonal antibodies, kindly provided by Dr. Hiroshi Kimura, Tokyo Institute of Technology, were used for immunoprecipitation.",
          "Fragmentation Methods": "Ultrasonic fragmentation (BRANSON SLPe, amplitude 40%, on 30 sec and off 30 sec, 10 cycles, on ice)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "36 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000243",
          "Total Data Volume": "65 GB (fastq [49 files / 1,981,314,349 reads])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000081": {
          "Participants/Materials:": "Normal human foveolar epithelial cells of the stomach purified from gastrectomy specimens using crypt isolation method : 14",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source/span>": "Total RNA extracted from normal human foveolar epithelial cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Strand Specific RNA kit",
          "Fragmentation Methods": "Purified poly-A RNA was fragmented with heat treatment and divalent cations.",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000081",
          "Total Data Volume": "79 GB(fastq [22 files / 1,202,044,862 reads]）",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yae Kanai",
        "Affiliation": "Department of Pathology, Keio University School of Medicine",
        "Project / Group Name": "AMED-CREST International Human Epigenome Consortium (IHEC) Team Kanai",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)",
            "Title": "Development of Fundamental Technologies for Diagnosis and Therapy Based upon Epigenome Analysis",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000081"
        }
      },
      "Release Note": {
        "hum0091.v1": {
          "Research ID": "hum0091.v1",
          "Release Date": "2021/03/12",
          "Type of Data": "NGS (PBAT-seq, ChIP-seq, RNA-seq)",
          "description": "gDNAs extracted from normal human foveolar epithelial cells of the stomach purified from gastrectomy specimens using crypt isolation method were used for analyses (fastq format files). After library preparation by post-bisulfite adaptor-tagging (PBAT, http://crest-ihec.jp/english/epigenome/index.html) and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Single-end).\nAnti H3K4me3,H3K9me3, H3K27me3, H3K27ac, H3K4me1 and H3K36me3 mouse monoclonal antibodies, kindly provided Dr. Hiroshi Kimura, Tokyo Institute of Technology, were used for immunoprecipitation. ChIP-Seq libraries were sequenced using the HiSeq 2500 (Illumina) platform.\nTotal RNAs extracted from normal human foveolar epithelial cells of the stomach purified from gastrectomy specimens using crypt isolation method were used for whole transcriptome-sequencing analysis (fastq format files). cDNAs were prepared using the Agilent SureSelect Strand Specific RNA kit and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Paired-end). \nNote:\n"
        }
      }
    }
  },
  "hum0090.v1": {
    "ja": {
      "NBDC Research ID": "hum0090.v1",
      "データ": {
        "JGAS000078": {
          "データID": "JGAS000078",
          "内容": "NGS（PBAT-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/11/18"
        },
        "JGAS000079": {
          "データID": "JGAS000079",
          "内容": "NGS（ChIP-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/11/18"
        },
        "JGAS000080": {
          "データID": "JGAS000080",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/11/18"
        }
      },
      "研究内容の概要": {
        "目的": "国際ヒトエピゲノムコンソーシアム（The International Human Epigenome Consortium: IHEC）に参画し、年齢・性別の異なる複数の日本人検体から得られた正常細胞等の高品質な標準エピゲノムプロファイルを取得し、データを広く公開して研究基盤形成に貢献する。",
        "方法": "大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞を対象とするChIP-seq解析、RNA-seq解析、PBAT-seq解析",
        "対象": "大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞12種類（正常：12例）",
        "URL": "https://pathology.med.keio.ac.jp/"
      },
      "分子データ": {
        "JGAS000078": {
          "対象": "大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞12種類（正常：12細胞）",
          "規模": "PBAT-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Post-Bisulfite Adaptor-Tagging（PBAT）法\r\n（http://crest-ihec.jp/epigenome/index.html）",
          "断片化の方法": "Post-bisulfite adaptor-tagging（PBAT）法による（Bisulfite変換に伴うDNA切断）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000078",
          "総データ量": "1 TB (fastq [61files / 23,164,882,050 reads])",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000079": {
          "対象": "大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞12種類（正常：12細胞）",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "抗H3K4me3、H3K9me3、H3K27me3、H3K27ac、H3K4me1、H3K36me3モノクローナル抗体（東京工業大学木村宏教授提供）を用いて免疫沈降",
          "断片化の方法": "超音波断片化（BRANSON SLPe, amplitude 40%, on 30 sec and off 30 sec, 10 cycles, on ice）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "36 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000079",
          "総データ量": "171 GB （fastq [85 files / 2,619,042,051 reads]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000080": {
          "対象": "大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞12種類（正常：12細胞）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Strand Specific RNA kit",
          "断片化の方法": "二価陽イオンと温度（94℃） によるRNAの断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000080",
          "総データ量": "91 GB （fastq [25 files / 1,189,610,268 reads]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "金井 弥栄",
        "所 属 機 関": "慶應義塾大学医学部病理学教室",
        "プロジェクト/研究グループ名": "革新的先端研究開発支援事業（AMED-CREST） 国際ヒトエピゲノムコンソーシアム（IHEC）金井チーム",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業（AMED-CREST）",
            "タイトル": "「エピゲノム研究に基づく診断・治療へ向けた新技術の創出」領域",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Guillaume Bourque": {
          "研究代表者": "Guillaume Bourque",
          "所属機関": "McGill University / McGill University & Genome Quebec Innovation Center",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000078\r\nJGAD000079\r\nJGAD000080"
        },
        "Martin Hirst": {
          "研究代表者": "Martin Hirst",
          "所属機関": "BC Cancer",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000078\r\nJGAD000079\r\nJGAD000080"
        },
        "Anton Wellstein": {
          "研究代表者": "Anton Wellstein",
          "所属機関": "Georgetown University School of Medicine, Department of Oncology",
          "研究題目": "",
          "利用データID": "Biomarkers to evaluate immune related adverse events (irAEs) due to treatment with immune checkpoint inhibitors (ICIs)",
          "利用期間": "JGAD000078"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000080"
        }
      },
      "リリース情報": {
        "hum0090.v1": {
          "Research ID": "hum0090.v1",
          "公開日": "2016/11/18",
          "内容": "NGS（PBAT-seq、ChIP-seq、RNA-seq）",
          "description": "大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞より抽出したDNAを用いたPBAT-seq解析の結果をfastqファイルにて提供する。Post-Bisulfite Adaptor-Tagging（PBAT）法（http://crest-ihec.jp/epigenome/index.html）でライブラリ作製し、HiSeq 2000（Illumina）によりシングルエンドシークエンシングを行っている。\n大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞より抽出したDNAを用いたChIP-seq解析の結果をfastqファイルにて提供する。抗H3K4me3,H3K9me3, H3K27me3, H3K27ac, H3K4me1, H3K36me3モノクローナル抗体（東京工業大学木村宏教授提供）を用いて免疫沈降後ChIP-seqライブラリを作製し、HiSeq 2500（Illumina）によりシークエンシングを行っている。\n大腸（右半結腸、左半結腸、直腸）粘膜から腺管分離法で純化した吸収上皮細胞より抽出したRNAを用いたRNA-seq解析の結果をfastqファイルにて提供する。Agilent SureSelect Strand Specific RNA kitによるライブラリ作製、HiSeq 2000（Illumina）での100bpペアエンドシークエンシングを行っている。 \nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0090.v1",
      "DATA": {
        "JGAS000078": {
          "Data Set ID": "JGAS000078",
          "Type of Data": "NGS (PBAT-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/11/18"
        },
        "JGAS000079": {
          "Data Set ID": "JGAS000079",
          "Type of Data": "NGS (ChIP-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/11/18"
        },
        "JGAS000080": {
          "Data Set ID": "JGAS000080",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/11/18"
        }
      },
      "SUMMARY": {
        "Aims": "The aim of this study is to participate in International Human Epigenome Consortium (http://ihec-epigenomes.org/), through disclosure of quality reference epigenome profiles in normal and diseased cells obtained from multiple Japanese people.",
        "Methods": "ChIP-Seq, RNA-seq and PBAT-seq analysis about normal human absorptive epithelial cells purified from colorectal partial resection specimens.",
        "Participants/Materials": "Normal human absorptive epithelial cells purified from colorectal partial resection specimens",
        "URL": "https://pathology.med.keio.ac.jp/home-e/"
      },
      "MOLECULAR DATA": {
        "JGAS000078": {
          "Participants/Materials:": "Normal human absorptive epithelial cells purified from colorectal partial resection specimens : 12",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNAs extracted from normal human absorptive epithelial cells purified from colorectal partial resection specimens",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Post-Bisulfite Adaptor-Tagging (PBAT) method\r\n(http://crest-ihec.jp/english/epigenome/index.html)",
          "Fragmentation Methods": "PBAT method: fragmentation due to bisulfite conversion",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000078",
          "Total Data Volume": "1 TB (fastq [61files / 23,164,882,050 reads])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000079": {
          "Participants/Materials:": "Normal human absorptive epithelial cells purified from colorectal partial resection specimens : 12",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "gDNAs extracted from normal human absorptive epithelial cells purified from colorectal partial resection specimens",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Anti H3K4me3, H3K9me3, H3K27me3, H3K27ac, H3K4me1 and H3K36me3 mouse monoclonal antibodies, kindly provided by Dr. Hiroshi Kimura, Tokyo Institute of Technology, were used for immunoprecipitation.",
          "Fragmentation Methods": "Ultrasonic fragmentation (BRANSON SLPe, amplitude 40%, on 30 sec and off 30 sec, 10 cycles, on ice)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "36 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000079",
          "Total Data Volume": "171 GB (fastq [85 files / 2,619,042,051 reads])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000080": {
          "Participants/Materials:": "Normal human absorptive epithelial cells purified from colorectal partial resection specimens : 12",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source/span>": "Total RNA extracted from normal human absorptive epithelial cells purified from colorectal partial resection specimens",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect Strand Specific RNA kit",
          "Fragmentation Methods": "Purified poly-A RNA was fragmented with heat treatment and divalent cations.",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000080",
          "Total Data Volume": "91 GB (fastq [25 files / 1,189,610,268 reads])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yae Kanai",
        "Affiliation": "Department of Pathology, Keio University School of Medicine",
        "Project / Group Name": "AMED-CREST International Human Epigenome Consortium (IHEC) Team Kanai",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)",
            "Title": "Development of Fundamental Technologies for Diagnosis and Therapy Based upon Epigenome Analysis",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Guillaume Bourque": {
          "Principal Investigator": "Guillaume Bourque",
          "Affiliation": "McGill University / McGill University & Genome Quebec Innovation Center",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000078\r\nJGAD000079\r\nJGAD000080"
        },
        "Martin Hirst": {
          "Principal Investigator": "Martin Hirst",
          "Affiliation": "BC Cancer",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000078\r\nJGAD000079\r\nJGAD000080"
        },
        "Anton Wellstein": {
          "Principal Investigator": "Anton Wellstein",
          "Affiliation": "Georgetown University School of Medicine, Department of Oncology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Biomarkers to evaluate immune related adverse events (irAEs) due to treatment with immune checkpoint inhibitors (ICIs)",
          "Period of Data Use": "JGAD000078"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000080"
        }
      },
      "Release Note": {
        "hum0090.v1": {
          "Research ID": "hum0090.v1",
          "Release Date": "2016/11/18",
          "Type of Data": "NGS (PBAT-seq, ChIP-seq, RNA-seq)",
          "description": "gDNAs extracted from normal human absorptive epithelial cells purified from colorectal partial resection specimens were used for analyses (fastq format files). After library preparation by post-bisulfite adaptor-tagging (PBAT, http://crest-ihec.jp/english/epigenome/index.html) and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Single-end).\nAnti H3K4me3,H3K9me3, H3K27me3, H3K27ac, H3K4me1 and H3K36me3 mouse monoclonal antibodies, kindly provided Dr. Hiroshi Kimura, Tokyo Institute of Technology, were used for immunoprecipitation. ChIP-Seq libraries were sequenced using the HiSeq 2500 (Illumina) platform.\nTotal RNAs extracted from normal human absorptive epithelial cells purified from colorectal partial resection specimens were used for whole transcriptome-sequencing analysis (fastq format files). cDNAs were prepared using the Agilent SureSelect Strand Specific RNA kit and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Paired-end). \nNote:\n"
        }
      }
    }
  },
  "hum0088.v2": {
    "ja": {
      "NBDC Research ID": "hum0088.v2",
      "データ": {
        "JGAS000077": {
          "データID": "JGAS000077",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/02/08"
        },
        "JGAS000096": {
          "データID": "JGAS000096",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/02/08"
        },
        "JGAS000077 データ追加": {
          "データID": "JGAS000077 データ追加",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2019/09/10"
        }
      },
      "研究内容の概要": {
        "目的": "transforming growth factor (TGF)-βスーパーファミリーのサブファミリーの１つであるbone morphogenetic protein（BMP）がグリオーマ幹細胞に与える影響と、BMPによるグリオーマ幹細胞の制御メカニズムを明らかにする。",
        "方法": "BMPの標的遺伝子を同定するため、神経膠芽腫（glioblastoma）由来細胞株より抽出したDNAを用いたwhole genome sequencing（WGS）およびRNAを用いたRNA-seq解析を実施。",
        "対象": "神経膠芽腫由来細胞株 2株",
        "URL": "http://beta-lab.umin.ac.jp/"
      },
      "分子データ": {
        "JGAS000077": {
          "対象": "神経膠芽腫（ICD10：C71.9）：2症例（TGS-01、TGS-04）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Genome Analyzer IIx]\r\nThermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "JGAD000077：RNA抽出24時間前にBMP-4で刺激した神経膠芽腫から樹立したグリオーマ幹細胞株（TGS-01、TGS-04）より抽出したmRNA\r\nJGAD000263：RNA抽出24時間前に、(1) Ad-EPHA6(WT)、Ad-EPHA6(K757R)もしくはAd-LacZを感染し、(2) BMP-2で刺激もしくは無刺激とされた、神経膠芽腫から樹立したグリオーマ幹細胞株（TGS-01）より抽出したmRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "ScriptSeq v2 RNA-seq Library Preparation Kit（Epicentre）\r\nIon Total RNA-seq Kit v2 （Thermo Fisher Scientific）",
          "断片化の方法": "Genome Analyzer IIx：酵素反応\r\nIon Proton：酵素反応（RNase III）",
          "ライブラリ構築方法": "Genome Analyzer IIx：Paired-end\r\nIon Proton：Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "Genome Analyzer IIx：76 bp\r\nIon Proton：200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000077\r\nJGAD000263",
          "総データ量": "JGAD000077：43 GB（fastq）\r\nJGAD000263：50 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000096": {
          "対象": "神経膠芽腫（ICD10：C71.9）：1症例（TGS-01）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Thermo Fisher Scientific [Ion Proton]",
          "ライブラリソース": "神経膠芽腫から樹立したグリオーマ幹細胞株より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion Fragment plus library Kit\r\nIon PI Template OT2 200 Kit v3\r\nIon PI Sequencing 200 Kit v3\r\n（Thermo Fisher Scientific）",
          "断片化の方法": "超音波断片化（Bioruptor UCD-200）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000096",
          "総データ量": "13 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "宮園 浩平",
        "所 属 機 関": "東京大学大学院 医学系研究科 分子病理学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "5": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究（研究領域提案型）",
            "タイトル": "TGF-βファミリーによる細胞分化とダイバーシティー獲得の分子基盤",
            "研究課題番号": "17H06326"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.",
          "DOI": "doi: 10.1038/onc.2017.112",
          "データID": "JGAD000077"
        },
        "2": {
          "タイトル": "Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.",
          "DOI": "doi: 10.1002/ijc.31179",
          "データID": "JGAD000077\r\nJGAD000096"
        },
        "3": {
          "タイトル": "Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.",
          "DOI": "doi: 10.1111/cas.14187",
          "データID": "JGAD000263"
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000077\r\nJGAD000263"
        }
      },
      "リリース情報": {
        "hum0088.v2": {
          "Research ID": "hum0088.v2",
          "公開日": "2019/09/10",
          "内容": "NGS（RNA-seq）",
          "description": "1症例の神経膠芽腫由来細胞（TGS-01）から抽出したmRNAを使用したRNA-seqデータ（fastqファイル）を追加した。\n"
        },
        "hum0088.v1": {
          "Research ID": "hum0088.v1",
          "公開日": "2019/02/08",
          "内容": "NGS（RNA-seq）\r\nNGS（WGS）",
          "description": "・2症例の神経膠芽腫由来細胞（TGS-01およびTGS-04）から抽出したmRNAを使用したRNA-seqデータをfastqファイルにて提供する。ScriptSeq v2 RNA-seq Library Preparation Kit （Epicentre）またはIon Total RNA-seq Kit v2 （Thermo Fisher Scientific）にてライブラリ作製後、Genome Analyzer IIx（paired-end）またはIon Proton（single-end）でのシークエンシングを行っている。\n・1症例の神経膠芽腫由来細胞（TGS-01）から抽出したDNAを使用したWGSデータをfastqファイルにて提供する。Ion Fragment plus library Kit（Thermo Fisher Scientific）にてライブラリ作製後、Ion Proton（single-end）でのシークエンシングを行っている。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0088.v2",
      "DATA": {
        "JGAS000077": {
          "Data Set ID": "JGAS000077",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/02/08"
        },
        "JGAS000096": {
          "Data Set ID": "JGAS000096",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/02/08"
        },
        "JGAS000077 (Data addition)": {
          "Data Set ID": "JGAS000077 (Data addition)",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/09/10"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the effect and its mechanism of BMP signaling on glioma initiating cells",
        "Methods": "Target genes were identified by RNA-seq to elucidate the mechanism of regulation of glioma initiating cells by BMP. Genomic DNA was extracted from glioma initiating cells and whole genome sequencing was performed.",
        "Participants/Materials": "Patient-derived glioblastoma cell lines (tumor initiating cells), 2 lines"
      },
      "MOLECULAR DATA": {
        "JGAS000077": {
          "Participants/Materials": "2 glioblastomas (ICD10：C71.9) (TGS-01, TGS-04)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Genome Analyzer IIx] \r\nThermo Fisher Scientific [IonProton]",
          "Library Source": "JGAD000077: mRNA extracted from glioblastoma cell lines (TGS-01, TGS-04) stimulated with BMP-4 for 24 h prior to RNA extraction\r\nJGAD000263: mRNA extracted from a glioblastoma cell line (TGS-01) infected with Ad-EPHA6(WT), Ad-EPHA6(K757R) or Ad-LacZ (MOI 60) with or without BMP-2 stimulation for 24 h prior to RNA extraction",
          "Cell Lines": "-",
          "Library Construction (kit name)": "ScriptSeq v2 RNA-seq Library Preparation Kit (Epicentre）\r\nIon Total RNA-seq Kit v2 (Thermo Fisher Scientific)",
          "Fragmentation Methods": "Genome Analyzer IIx: Enzymatic Shearing (included in the kit)\r\nIonProton: Enzymatic Shearing (included in the kit: RNase III)",
          "Spot Type": "Genome Analyzer IIx: Paired-end\r\nIonProton: Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "Genome Analyzer IIx: 76 bp\r\nIonProton: 200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000077\r\nJGAD000263",
          "Total Data Volume": "JGAD000077: 43 GB (fastq)\r\nJGAD000263: 50 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000096": {
          "Participants/Materials": "1 glioblastoma (ICD10：C71.9) (TGS-01)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Thermo Fisher Scientific [IonProton]",
          "Library Source": "gDNA extracted from glioblastoma cell line (tumor initiating cells)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion Fragment plus library Kit\r\nIon PI Template OT2 200 Kit v3 \r\nIon PI Sequencing 200 Kit v3\r\n(Thermo Fisher Scientific)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Bioruptor UCD-200)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000096",
          "Total Data Volume": "13 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kohei Miyazono",
        "Affiliation": "Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "5": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)",
            "Title": "Molecular mechanisms of cell differentiation and diversity by TGF-beta family members",
            "Project Number": "17H06326"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.",
          "DOI": "doi: 10.1038/onc.2017.112",
          "Data Set ID": "JGAD000077"
        },
        "2": {
          "Title": "Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.",
          "DOI": "doi: 10.1002/ijc.31179",
          "Data Set ID": "JGAD000077\r\nJGAD000096"
        },
        "3": {
          "Title": "Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.",
          "DOI": "doi: 10.1111/cas.14187",
          "Data Set ID": "JGAD000263"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000077\r\nJGAD000096"
        }
      },
      "Release Note": {
        "hum0088.v2": {
          "Research ID": "hum0088.v2",
          "Release Date": "2019/09/10",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNA-seq data from 1 patient-derived glioblastoma cell line (tumor initiating cells) (TGS-01) were added (fastq format).\n"
        },
        "hum0088.v1": {
          "Research ID": "hum0088.v1",
          "Release Date": "2019/02/08",
          "Type of Data": "NGS (RNA-seq)\r\nNGS (WGS)",
          "description": "mRNAs were extracted from 2 patient-derived glioblastoma cell lines (tumor initiating cells) (TGS-01, TGS-04), and the sequences were read by using of Genome Analyzer IIx (Illumina) / IonProton (Thermo Fisher Scientific). The sequences are provided as fastq format.\nGenomic DNA was extracted from 1 patient-derived glioblastoma cell line (tumor initiating cell) (TGS-01), and whole genome sequencing was performed with IonProton (Thermo Fisher Scientific). The sequences are provided as fastq format.\nNote:\n"
        }
      }
    }
  },
  "hum0086.v3": {
    "ja": {
      "NBDC Research ID": "hum0086.v3",
      "データ": {
        "JGAS000073（JGA000074）\r\nJGAS000107（JGA000117）": {
          "データID": "JGAS000073（JGA000074）\r\nJGAS000107（JGA000117）",
          "内容": "NGS（PBAT-seq）\r\nNGS（ChIP-seq）\r\nNGS（RNA-seq）\r\nNGS（small RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/09/25\r\n2017/12/26\r\n2018/06/26"
        }
      },
      "研究内容の概要": {
        "目的": "国際ヒトエピゲノムコンソーシアム（The International Human Epigenome Consortium: IHEC）に参画し、日本人検体から得られた胎盤組織の高品質な標準エピゲノムプロファイルを取得し、データを広く公開し研究基盤形成に貢献する。",
        "方法": "PBAT-seq、ChIP-seq、RNA-seq、small RNA-seq",
        "対象": "胎盤（細胞性栄養膜細胞 [正常/CT、胎児発育不全/FGR-CT、妊娠高血圧症候群/PE-CT、18トリソミー/Tri-18-CT]、合胞体栄養膜細胞 [ST]、絨毛外栄養膜細胞 [EVT]、FemaleのCTから作製したヒト胎盤幹細胞 [TS]およびTSをST/EVTへ分化させた細胞、MaleのCTから作製したヒト胎盤幹細胞 [TS]およびTSをST/EVTへ分化させた細胞、絨毛間質細胞）、子宮内膜（間質細胞、腺上皮細胞）、全胞状奇胎",
        "URL": "http://crest-ihec.jp/index.html"
      },
      "分子データ": {
        "PBAT-seq": {
          "対象": "胎盤（細胞性栄養膜細胞 [正常、胎児発育不全（ICD10：P059）、妊娠高血圧症候群（ICD10：O149）、18トリソミー（ICD10：Q913）]、栄養膜幹細胞、合胞体栄養膜細胞、絨毛外栄養膜細胞）、子宮内膜（間質細胞、腺上皮細胞）、全胞状奇胎（ICD10：O010）、FemaleのCTから作製したTS（未分化、STへ分化、EVTへ分化）、MaleのCTから作製したTS（未分化）：計28検体",
          "規模": "PBAT-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500/2500]",
          "ライブラリソース": "胎盤（細胞性栄養膜細胞、栄養幹細胞、合胞体栄養膜細胞、絨毛外栄養膜細胞）、子宮内膜（間質細胞、腺上皮細胞）、全胞状奇胎、ヒト胎盤幹細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Post-Bisulfite Adaptor-Tagging（PBAT）法",
          "断片化の方法": "PBAT法による（Bisulfite変換に伴うDNA切断）",
          "ライブラリ構築方法": "Paired-end、Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000073\r\nJGAD000115",
          "総データ量": "JGAD000073：4.08 TB（fastq）\r\nJGAD000115：339.44 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "ChIP-seq": {
          "対象": "胎盤（細胞性栄養膜細胞、栄養膜幹細胞、合胞体栄養膜細胞、絨毛外栄養膜細胞、絨毛間質細胞）、子宮内膜（間質細胞、腺上皮細胞）、FemaleのCTから作製したTS（未分化、STへ分化、EVTへ分化）：計25検体",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "抗体：6種（H3K4me3、H3K4me1、H3K9me3、H3K27ac、H3K27me3、H3K36me3）＋Input",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "胎盤（細胞性栄養膜細胞、栄養幹細胞、合胞体栄養膜細胞、絨毛外栄養膜細胞、絨毛間質細胞）、子宮内膜（間質細胞、腺上皮細胞）、ヒト胎盤幹細胞より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ovation Ultralow System V2 kit (NuGEN) および NEBNext UltraII DNA Library Prep Kit for Illumina",
          "断片化の方法": "超音波断片化（Covaris社、 M220）",
          "ライブラリ構築方法": "Paired-end、Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "51-126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000073\r\nJGAD000115",
          "総データ量": "JGAD000073：4.08 TB（fastq）\r\nJGAD000115：339.44 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "胎盤（細胞性栄養膜細胞 [正常、胎児発育不全（ICD10：P059）、妊娠高血圧症候群（ICD10：O149）、18トリソミー（ICD10：Q913）]、栄養膜幹細胞、合胞体栄養膜細胞、絨毛外栄養膜細胞、絨毛間質細胞）、子宮内膜（間質細胞、腺上皮細胞）、FemaleのCTから作製したTS（未分化、STへ分化、EVTへ分化）、MaleのCTから作製したTS（未分化、STへ分化、EVTへ分化）：計34検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "胎盤（細胞性栄養膜細胞、栄養幹細胞、合胞体栄養膜細胞、絨毛外栄養膜細胞、絨毛間質細胞）、子宮内膜（間質細胞、腺上皮細胞）、ヒト胎盤幹細胞より抽出したmRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101-126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000073\r\nJGAD000115",
          "総データ量": "JGAD000073：4.08 TB（fastq）\r\nJGAD000115：339.44 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "small RNA-seq": {
          "対象": "胎盤（細胞性栄養膜細胞 [正常、胎児発育不全（ICD10：P059）、妊娠高血圧症候群（ICD10：O149）、18トリソミー（ICD10：Q913）]、栄養膜幹細胞、合胞体栄養膜細胞、絨毛外栄養膜細胞）、子宮内膜（間質細胞、腺上皮細胞）、FemaleのCTから作製したTS（未分化、STへ分化、EVTへ分化）：計23検体",
          "規模": "small RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500/2500]",
          "ライブラリソース": "胎盤（細胞性栄養膜細胞、栄養幹細胞、合胞体栄養膜細胞、絨毛外栄養膜細胞）、子宮内膜（間質細胞、腺上皮細胞）、ヒト胎盤幹細胞より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Small RNA Library Prep Set for Illumina",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "64 or 68 bp（アダプター込み）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000073\r\nJGAD000115",
          "総データ量": "JGAD000073：4.08 TB（fastq）\r\nJGAD000115：339.44 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "佐々木 裕之",
        "所 属 機 関": "九州大学 生体防御医学研究所",
        "プロジェクト/研究グループ名": "革新的先端研究開発支援事業（AMED-CREST） 国際ヒトエピゲノムコンソーシアム（IHEC）佐々木チーム",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業（AMED-CREST）",
            "タイトル": "「エピゲノム研究に基づく診断・治療へ向けた新技術の創出」領域",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "The International Human Epigenome Consortium: A blueprint for scientific collaboration and discovery.",
          "DOI": "doi: 10.1016/j.cell.2016.11.007",
          "データID": "JGAD000073"
        },
        "2": {
          "タイトル": "Allele-specific methylome and transcriptome analysis reveals widespread imprinting in the human placenta",
          "DOI": "doi: 10.1016/j.ajhg.2016.08.021",
          "データID": "JGAD000038 (hum0040)"
        },
        "3": {
          "タイトル": "Derivation of Human Trophoblast Stem Cells",
          "DOI": "doi: 10.1016/j.stem.2017.11.004",
          "データID": "JGAD000115\r\nJGAD000121 (hum0112)"
        }
      },
      "制限公開データの利用者一覧": {
        "Nehemiah Alvarez": {
          "研究代表者": "Nehemiah Alvarez",
          "所属機関": "De Novo Genomics Corporation",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "R. Michael Roberts": {
          "研究代表者": "R. Michael Roberts",
          "所属機関": "University of Missouri, Animal Sciences / Biochemistry",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Guillaume Bourque": {
          "研究代表者": "Guillaume Bourque",
          "所属機関": "McGill University / McGill University & Genome Quebec Innovation Center",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Martin Hirst": {
          "研究代表者": "Martin Hirst",
          "所属機関": "BC Cancer",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Zhaobo Lin": {
          "研究代表者": "Zhaobo Lin",
          "所属機関": "ShanghaiTech University",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Zhigang Xue": {
          "研究代表者": "Zhigang Xue",
          "所属機関": "School of Medicine and Life Science, Tongji University",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Todd Macfarlan": {
          "研究代表者": "Todd Macfarlan",
          "所属機関": "National Institute of Child Health and Human Development",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "William S.B. Yeung": {
          "研究代表者": "William S.B. Yeung",
          "所属機関": "Department of Obstetrics and Gynaecology, the University of Hong Kong",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Amir Eden": {
          "研究代表者": "Amir Eden",
          "所属機関": "Department of Cell and Developmental Biology, Insitute of Life Sciences, The Hebrew University of Jerusalem",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Austin Smith": {
          "研究代表者": "Austin Smith",
          "所属機関": "Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge",
          "研究題目": "",
          "利用データID": "Comparison of trophoblast stem cell cultures",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Thorold W. Theunissen": {
          "研究代表者": "Thorold W. Theunissen",
          "所属機関": "Washington University School of Medicine in St. Louis",
          "研究題目": "",
          "利用データID": "Assessment of trophoblast fates derived from human pluripotent stem cells",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Hui Li": {
          "研究代表者": "Hui Li",
          "所属機関": "Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of Medicine",
          "研究題目": "",
          "利用データID": "Derivation of Human Induced Trophoblast Stem Cells from Embryonic Stem Cells",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "大串 雅俊": {
          "研究代表者": "大串 雅俊",
          "所属機関": "京都大学 ウイルス・再生医科学研究所 発生システム制御分野",
          "研究題目": "",
          "利用データID": "ヒト多能性幹細胞の分化ポテンシャルに関する研究",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Anton Wellstein": {
          "研究代表者": "Anton Wellstein",
          "所属機関": "Georgetown University School of Medicine, Department of Oncology",
          "研究題目": "",
          "利用データID": "Biomarkers to evaluate immune related adverse events (irAEs) due to treatment with immune checkpoint inhibitors (ICIs)",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Kichoon Lee": {
          "研究代表者": "Kichoon Lee",
          "所属機関": "Department of Animal Sciences, The Ohio State University",
          "研究題目": "",
          "利用データID": "Investigation on allele-specific gene expressions in humans",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "秦 健一郎": {
          "研究代表者": "秦 健一郎",
          "所属機関": "国立成育医療研究センター研究所 周産期病態研究部",
          "研究題目": "",
          "利用データID": "胎児発育異常の遺伝子・ゲノム解析",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Lin GAO": {
          "研究代表者": "Lin GAO",
          "所属機関": "The Hong Kong University of Science and Technology",
          "研究題目": "",
          "利用データID": "Defining the transcriptional regulatory roles of retrotransposons in human placenta cells.",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Gianluca Ursini": {
          "研究代表者": "Gianluca Ursini",
          "所属機関": "Lieber Institute for Brain Development, Johns Hopkins University School of Medicine",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Analysis of the transcriptional profile of Human Trophoblast Stem Cells",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Ming-an Sun": {
          "研究代表者": "Ming-an Sun",
          "所属機関": "揚州大学 College of Veterinary Medicine",
          "研究題目": "中華人民共和国",
          "利用データID": "The activation and function of endogenous retroviruses in mammalian placentae",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000073\r\nJGAD000115"
        },
        "Wilfried Haerty": {
          "研究代表者": "Wilfried Haerty",
          "所属機関": "Earlham Institute",
          "研究題目": "イギリス",
          "利用データID": "Understanding epigenetic drift in a transient reproductive tissue - defining the effects on gestation ageing and cell identity within the placenta",
          "利用期間": "JGAD000073\r\nJGAD000115"
        }
      },
      "リリース情報": {
        "hum0086.v3": {
          "description": "・胎盤絨毛間質細胞のRNA-seqデータ\n・細胞性栄養膜細胞（胎児発育不全、妊娠高血圧症候群、18トリソミー）のPBAT-seq、RNA-seq、small RNA-seqデータ \n・全胞状奇胎のPBAT-seqデータ \nの追加。\n"
        },
        "hum0086.v3\r\nhum0086.v2\r\nhum0086.v1": {
          "Research ID": "hum0086.v3\r\nhum0086.v2\r\nhum0086.v1",
          "公開日": "2018/06/26\r\n2017/12/26\r\n2017/09/25",
          "内容": "NGS（PBAT-seq）\r\nNGS（ChIP-seq）\r\nNGS（RNA-seq）\r\nNGS（small RNA-seq）"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0086.v3",
      "DATA": {
        "JGAS000073（JGA000074）\r\nJGAS000107（JGA000117）": {
          "Data Set ID": "JGAS000073（JGA000074）\r\nJGAS000107（JGA000117）",
          "Type of Data": "NGS (PBAT-seq)\r\nNGS (ChIP-seq)\r\nNGS (RNA-seq)\r\nNGS (small RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/09/25\r\n2017/12/26\r\n2018/06/26"
        }
      },
      "SUMMARY": {
        "Aims": "As a member of the International Human Epigenome Consortium (IHEC), we obtain high-quality standard epigenome profiles of placenta tissue from Japanese donors, and open the data to public to promote basic research in human epigenome.",
        "Methods": "PBAT-seq, ChIP-seq, RNA-seq, and small RNA-seq",
        "Participants/Materials": "placenta (cytotrophoblast [normal/CT, fetal growth restriction/FGR-CT, preeclampsia/PE-CT, trisomy 18/Tri-18-CT], syncytiotrophoblast [ST], extravillous trophoblast [EVT], trophoblast stem cells [TS] derived from female/male CT, ST differentiated from TS, EVT differentiated from TS, stroma), uterus (endometrium epithelial, stroma), hydatidiform mole",
        "URL": "http://crest-ihec.jp/english/index.html"
      },
      "MOLECULAR DATA": {
        "PBAT-seq": {
          "Participants/Materials:": "placenta (cytotrophoblast [normal, fetal growth restriction (ICD10: P059), preeclampsia (ICD10: O149), trisomy 18 (ICD10: Q913)], syncytiotrophoblast, extravillous trophoblast), uterus (endometrium epithelial, stroma), hydatidiform mole (ICD10: O010), female TS, ST from TS and EVT from TS / male TS: total 28 samples",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500/2500]",
          "Library Source": "DNAs extracted from placenta (cytotrophoblast, syncytiotrophoblast, extravillous trophoblast), uterus (endometrium epithelial, stroma), hydatidiform mole, or trophoblast stem cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Post-Bisulfite Adaptor-Tagging (PBAT) method",
          "Fragmentation Methods": "PBAT method: fragmentation due to bisulfite conversion",
          "Spot Type": "Paired-end / Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000073\r\nJGAD000115",
          "Total Data Volume": "JGAD000073: 4.08 TB (fastq)\r\nJGAD000115: 339.44 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "ChIP-seq": {
          "Participants/Materials:": "placenta (cytotrophoblast, syncytiotrophoblast, extravillous trophoblast, stroma) and uterus (endometrium epithelial, stroma), female TS, ST from TS, EVT from TS: total 25 samples",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "antibodies: H3K4me3, H3K4me1, H3K9me3, H3K27ac, H3K27me3, H3K36me3\r\nInput",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from placenta (cytotrophoblast, syncytiotrophoblast, extravillous trophoblast, stroma), uterus (endometrium epithelial, stroma), trophoblast stem cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ovation Ultralow System V2 kit (NuGEN) and NEBNext UltraII DNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris M220)",
          "Spot Type": "Paired-end / Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "51 - 126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000073\r\nJGAD000115",
          "Total Data Volume": "JGAD000073: 4.08 TB (fastq)\r\nJGAD000115: 339.44 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials:": "placenta (cytotrophoblast [normal, fetal growth restriction (ICD10: P059), preeclampsia (ICD10: O149), trisomy 18 (ICD10: Q913)], syncytiotrophoblast, extravillous trophoblast, stroma) and uterus (endometrium epithelial, stroma), female TS, ST from TS, EVT from TS / male TS, ST from TS, EVT from TS: total 34 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "mRNAs extracted from placenta (cytotrophoblast, syncytiotrophoblast, extravillous trophoblast, stroma), uterus (endometrium epithelial, stroma), or trophoblast stem cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 - 126 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000073\r\nJGAD000115",
          "Total Data Volume": "JGAD000073: 4.08 TB (fastq)\r\nJGAD000115: 339.44 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "small RNA-seq": {
          "Participants/Materials:": "placenta (cytotrophoblast [normal, fetal growth restriction (ICD10: P059), preeclampsia (ICD10: O149), trisomy 18 (ICD10: Q913)], syncytiotrophoblast, extravillous trophoblast) and uterus (endometrium epithelial, stroma), female TS, ST from TS, and EVT from TS: total 23 samples",
          "Targets": "small RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500/2500]",
          "Library Source": "RNAs extracted from placenta (cytotrophoblast, syncytiotrophoblast, extravillous trophoblast), uterus (endometrium epithelial, stroma), or trophoblast stem cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Small RNA Library Prep Set for Illumina",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "64/68 bp (including adaptor)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000073\r\nJGAD000115",
          "Total Data Volume": "JGAD000073: 4.08 TB (fastq)\r\nJGAD000115: 339.44 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Sasaki",
        "Affiliation": "Medical Institute of Bioregulation, Kyushu University",
        "Project / Group Name": "Core Research and Evolutional Science and Technology (CREST), International Human Epigenome Consortium (IHEC), Sasaki Team",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)",
            "Title": "Development of Fundamental Technologies for Diagnosis and Therapy Based upon Epigenome Analysis",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "The International Human Epigenome Consortium: A blueprint for scientific collaboration and discovery.",
          "DOI": "doi: 10.1016/j.cell.2016.11.007",
          "Data Set ID": "JGAD000073"
        },
        "2": {
          "Title": "Allele-specific methylome and transcriptome analysis reveals widespread imprinting in the human placenta",
          "DOI": "doi: 10.1016/j.ajhg.2016.08.021",
          "Data Set ID": "JGAD000038 (hum0040)"
        },
        "3": {
          "Title": "Derivation of Human Trophoblast Stem Cells",
          "DOI": "doi: 10.1016/j.stem.2017.11.004",
          "Data Set ID": "JGAD000115\r\nJGAD000121 (hum0112)"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Nehemiah Alvarez": {
          "Principal Investigator": "Nehemiah Alvarez",
          "Affiliation": "De Novo Genomics Corporation",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "R. Michael Roberts": {
          "Principal Investigator": "R. Michael Roberts",
          "Affiliation": "University of Missouri, Animal Sciences / Biochemistry",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Guillaume Bourque": {
          "Principal Investigator": "Guillaume Bourque",
          "Affiliation": "McGill University / McGill University & Genome Quebec Innovation Center",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Martin Hirst": {
          "Principal Investigator": "Martin Hirst",
          "Affiliation": "BC Cancer",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Zhaobo Lin": {
          "Principal Investigator": "Zhaobo Lin",
          "Affiliation": "ShanghaiTech University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Zhigang Xue": {
          "Principal Investigator": "Zhigang Xue",
          "Affiliation": "School of Medicine and Life Science, Tongji University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Todd Macfarlan": {
          "Principal Investigator": "Todd Macfarlan",
          "Affiliation": "National Institute of Child Health and Human Development",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "William S.B. Yeung": {
          "Principal Investigator": "William S.B. Yeung",
          "Affiliation": "Department of Obstetrics and Gynaecology, the University of Hong Kong",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Amir Eden": {
          "Principal Investigator": "Amir Eden",
          "Affiliation": "Department of Cell and Developmental Biology, Insitute of Life Sciences, The Hebrew University of Jerusalem",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Austin Smith": {
          "Principal Investigator": "Austin Smith",
          "Affiliation": "Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comparison of trophoblast stem cell cultures",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Thorold W. Theunissen": {
          "Principal Investigator": "Thorold W. Theunissen",
          "Affiliation": "Washington University School of Medicine in St. Louis",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Assessment of trophoblast fates derived from human pluripotent stem cells",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Hui Li": {
          "Principal Investigator": "Hui Li",
          "Affiliation": "Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Derivation of Human Induced Trophoblast Stem Cells from Embryonic Stem Cells",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Masatoshi Ohgushi": {
          "Principal Investigator": "Masatoshi Ohgushi",
          "Affiliation": "Lab. of Developmental System, Instutute for Frontier Life and Medical Sciences, Kyoto University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Exploring differentiaton potential of human pluripotent stem cells",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Anton Wellstein": {
          "Principal Investigator": "Anton Wellstein",
          "Affiliation": "Georgetown University School of Medicine, Department of Oncology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Biomarkers to evaluate immune related adverse events (irAEs) due to treatment with immune checkpoint inhibitors (ICIs)",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Kichoon Lee": {
          "Principal Investigator": "Kichoon Lee",
          "Affiliation": "Department of Animal Sciences, The Ohio State University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Investigation on allele-specific gene expressions in humans",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Kenichiro Hata": {
          "Principal Investigator": "Kenichiro Hata",
          "Affiliation": "Maternal fetal biology, National Research Institute for Child Health and Development",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Genetic and genomic analysis of fetal developmental abnormalities",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Lin GAO": {
          "Principal Investigator": "Lin GAO",
          "Affiliation": "The Hong Kong University of Science and Technology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Defining the transcriptional regulatory roles of retrotransposons in human placenta cells.",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Gianluca Ursini": {
          "Principal Investigator": "Gianluca Ursini",
          "Affiliation": "Lieber Institute for Brain Development, Johns Hopkins University School of Medicine",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Analysis of the transcriptional profile of Human Trophoblast Stem Cells",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        },
        "Wilfried Haerty": {
          "Principal Investigator": "Wilfried Haerty",
          "Affiliation": "Earlham Institute",
          "Research Title": "United Kingdom of Great Britain and Northern Ireland",
          "Data in Use (Dataset ID)": "Understanding epigenetic drift in a transient reproductive tissue - defining the effects on gestation ageing and cell identity within the placenta",
          "Period of Data Use": "JGAD000073\r\nJGAD000115"
        }
      },
      "Release Note": {
        "hum0086.v3": {
          "description": "Data addition of\n- RNA-seq data for placental stroma\n- PBAT-seq, RNA-seq, and small RNA-seq data for cytotrophoblast (fetal growth restriction, preeclampsia, trisomy 18)\n- PBAT-seq data for hydatidiform mole\n"
        },
        "hum0086.v3\r\nhum0086.v2\r\nhum0086.v1": {
          "Research ID": "hum0086.v3\r\nhum0086.v2\r\nhum0086.v1",
          "Release Date": "2018/06/26\r\n2017/12/26\r\n2017/09/25",
          "Type of Data": "NGS (PBAT-seq)\r\nNGS (ChIP-seq)\r\nNGS (RNA-seq)\r\nNGS (small RNA-seq)"
        }
      }
    }
  },
  "hum0085.v2": {
    "ja": {
      "NBDC Research ID": "hum0085.v2",
      "データ": {
        "JGAS000108": {
          "データID": "JGAS000108",
          "内容": "アレイCGH\r\nNGS（WGS）\r\nNGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/10/16"
        },
        "JGAS000108\r\nデータ追加": {
          "データID": "JGAS000108\r\nデータ追加",
          "内容": "NGS（Exome）\r\nNGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/09/25"
        }
      },
      "研究内容の概要": {
        "目的": "悪性中皮腫はアスベスト曝露が主要因となる極めて予後不良の悪性腫瘍である。その治療成績の向上のためには腫瘍組織における変異やゲノム構造異常等、分子生物学的特性を把握し、早期診断、治療標的分子の同定が必要である。近年の家族性悪性中皮腫の報告からも、遺伝的背景と易罹患性との関連研究も重要である。悪性中皮腫の罹患者数が他の腫瘍に比べて少ないため、解析対象は日本人だけでなく、悪性中皮腫罹患者数が多い米国人やトルコ人検体も解析し、人種にかかわらず悪性中皮腫患者に共通するゲノム特性を抽出することを目的とする。",
        "方法": "3p21を対象とした高解像度アレイCGH、および、次世代シーケンス解析（Whole Genome Sequencing [WGS]、Target Capture Sequencing、Whole Exome Sequencing）",
        "対象": "悪性中皮腫患者の腫瘍組織および末梢血（非腫瘍組織）から抽出したDNA"
      },
      "分子データ": {
        "JGAS000108（CGH）": {
          "対象": "悪性中皮腫（ICD10：D48）：計32症例\r\n・日本人：9症例（腫瘍と末梢血ペア）\r\n・米国人：21症例（腫瘍と末梢血ペア）、2症例（腫瘍のみ）",
          "規模": "アレイCGH",
          "対象領域（Target Captureの場合）": "3p21上に位置する251個のrefseq遺伝子（表１）",
          "Platform": "Agilent SurePrint G3 8x60K CGHカスタムアレイ",
          "ソース": "腫瘍組織および末梢血（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Agilent DNA labeling kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "データ解析：Agilent CytoGenomics 3.0.5.1. \r\n　　　　　　標準化：GC補正（window size = 2 kb）およびdiploid peak centralization\r\n　　　　　　収差補正：Aberration Detection Method（ADM-2）アルゴリズム",
          "フィルタリング": "領域内プローブ ≥3\r\n各アレイ毎に1アレル分の変化をログ比で設定",
          "マーカー数（フィルタ後）": "コントロールグリッド：3886\r\n標準化プローブグループ ：1262\r\n繰り返し搭載プローブグループ：5000",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000116",
          "総データ量": "1.55 GB（text [34 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および Cancer Research Use Only"
        },
        "JGAS000108（WGS）": {
          "対象": "悪性中皮腫（ICD10：D48）：1症例（日本人）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ライブラリソース": "腫瘍組織および末梢血（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Illumina TruSeq DNA sample preparation kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000116",
          "総データ量": "152 GB（fastq [4 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および Cancer Research Use Only"
        },
        "JGAS000108（Target Capture）": {
          "対象": "家族性悪性中皮腫（ICD10：D48）：38症例（米国人）\r\n・Agilent Haloplex Target EnrichmentとIllumina Truseq Custom Amplicon両方実施：25症例\r\n・Agilent Haloplex Target Enrichmentのみ実施：13症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "Agilent Haloplex Target Enrichment：69遺伝子（表3）\r\nIllumina Truseq Custom Amplicon：68遺伝子（表3）",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "末梢血（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent Haloplex Target Enrichment、Illumina Truseq Custom Amplicon",
          "断片化の方法": "Agilent Haloplex Target Enrichment：制限酵素消化\r\nIllumina Truseq Custom Amplicon：PCR",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "Agilent Haloplex Target Enrichment：150 bp\r\nIllumina Truseq Custom Amplicon：250 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000116",
          "総データ量": "20 GB（fastq [142 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および Cancer Research Use Only"
        },
        "JGAS000108（Exome）": {
          "対象": "家族性悪性中皮腫（ICD10：D48）：2症例（米国人）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 4000]",
          "ライブラリソース": "末梢血（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect V4-post",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000116",
          "総データ量": "20 GB（fastq [4 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および Cancer Research Use Only"
        }
      },
      "提供者情報": {
        "研究代表者": "大村谷 昌樹",
        "所 属 機 関": "兵庫医科大学 遺伝学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "5": {
            "科研費・助成金名": "Grant-in-Aid for Researchers from Hyogo College of Medicine",
            "タイトル": "本学悪性中皮腫患者で検出される生殖細胞系列変異の疾患への寄与の検証",
            "研究課題番号": "2017"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma",
          "DOI": "doi: 10.1073/pnas.1612074113",
          "データID": "JGAD000116"
        },
        "2": {
          "タイトル": "A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations",
          "DOI": "doi: 10.1200/JCO.2018.79.0352",
          "データID": "JGAD000116"
        }
      },
      "制限公開データの利用者一覧": {
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用データID": "JGAD000116",
          "利用期間": "2020/09/18-2023/03/31"
        }
      },
      "リリース情報": {
        "hum0085.v2": {
          "Research ID": "hum0085.v2",
          "公開日": "2018/09/25",
          "内容": "NGS（Exome、Target Capture）",
          "description": "米国人家族性悪性中皮腫40症例の末梢血（非腫瘍組織）から抽出したDNAを使用したWhole Exome Sequencing解析、およびターゲットキャプチャーシーケンス解析の結果をFastqファイルにて提供する。\n"
        },
        "hum0085.v1": {
          "Research ID": "hum0085.v1",
          "公開日": "2017/10/16",
          "内容": "アレイCGH、NGS（WGS、Target Capture）",
          "description": "悪性中皮腫32症例（日本人：9症例、米国人：23症例）の腫瘍組織および末梢血（非腫瘍組織）から抽出したDNAを使用したアレイCGH解析、WGS解析、およびターゲットキャプチャーシーケンス解析の結果をテキストおよびFastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0085.v2",
      "DATA": {
        "JGAS000108": {
          "Data Set ID": "JGAS000108",
          "Type of Data": "Array CGH\r\nNGS (WGS)\r\nNGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/10/16"
        },
        "JGAS000108\r\n(Data addition)": {
          "Data Set ID": "JGAS000108\r\n(Data addition)",
          "Type of Data": "NGS (Exome)\r\nNGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/09/25"
        }
      },
      "SUMMARY": {
        "Aims": "Malignant mesotheliomas (MMs) are highly aggressive adult malignancies and exposure to asbestos is the major factor involved in MM pathogenesis. It is desirable for a better understanding of the molecular pathogenesis of MM will lead to more specific and effective targeted therapies. It is reported that germline mutation in a specific gene associates familial MMs. New candidate markers to determine a subject’s predisposition to MM and for early detection need to be identified. Analysis of genomic DNA from MM tumors and reference peripheral blood cells from Japan, USA, and Turkey's patients are ongoing to find the common genomic characters beyond race.",
        "Methods": "Array CGH for chromosome 3p21, Whole Genome Sequencing (NGS), Target Capture Sequencing (NGS) and Whole Exome Sequencing (NGS)",
        "Participants/Materials": "Genomic DNA from MM tumors and reference peripheral blood cells"
      },
      "MOLECULAR DATA": {
        "JGAS000108 (CGH)": {
          "Participants/Materials": "MMs (ICD10: D48): total 32 cases\r\n - Japanese: 9 cases (tumors and peripheral blood cells)\r\n - American: 21 cases (tumors and peripheral blood cells), 2 cases (tumors only)",
          "Targets": "Array CGH",
          "Target Loci for Capture Methods": "251 refseq genes on chr3p21 (Table 1)",
          "Platform": "The Agilent SurePrint G3 8x60K CGH Custom Microarray",
          "Library Source": "gDNA from MM tumors and reference peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent DNA labeling kit",
          "Genotype Call Methods (softwares)": "Data analysis was performed using Agilent CytoGenomics 3.0.5.1. Normalization parameters were set on the GC correction (window size = 2 kb) and diploid peak centralization; the aberration detection was using algorithm ADM-2.",
          "Filtering Methods": "For the aberration filter, the minimum number of probes in regions was set to three and the minimum absolute average log-ratio of region was set to each array.",
          "Marker Numbers (after Filtering)": "Agilent Control Grid : 3886, Agilent Normalization Probe Group : 1262, Agilent Replicate Probe Group : 5000",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000116",
          "Total Data Volume": "1.55 GB (text [34 files])",
          "Comments (Policies)": "NBDC policy & Cancer Research Use Only"
        },
        "JGAS000108 (WGS)": {
          "Participants/Materials": "MMs (ICD10: D48): 1 case (Japanese)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Library Source": "gDNA from MM tumors and reference peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "IlluminaTruSeq DNA sample preparation kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000116",
          "Total Data Volume": "152 GB (fastq [4 files])",
          "Comments (Policies)": "NBDC policy & Cancer Research Use Only"
        },
        "JGAS000108 (Target Capture)": {
          "Participants/Materials": "familial MMs (ICD10: D48): 38 cases (American)\r\n - Agilent Haloplex Target Enrichment & Illumina Truseq Custom Amplicon: 25 cases\r\n - Agilent Haloplex Target Enrichment only: 13 cases",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "Agilent Haloplex Target Enrichment: 69 genes (Table 3)\r\nIllumina Truseq Custom Amplicon: 68 genes (Table 3)",
          "Platform": "Illumina [MiSeq]",
          "Library Source": "gDNA from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Haloplex Target Enrichment, Truseq Custom Amplicon",
          "Fragmentation Methods": "Agilent Haloplex Target Enrichment: restriction enzyme digestion\r\nIllumina Truseq Custom Amplicon: PCR",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "Agilent Haloplex Target Enrichment: 150 bp\r\nIllumina Truseq Custom Amplicon: 250 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000116",
          "Total Data Volume": "20 GB (fastq [142 files])",
          "Comments (Policies)": "NBDC policy & Cancer Research Use Only"
        },
        "JGAS000108 (Exome)": {
          "Participants/Materials": "familial MMs (ICD10: D48): 2 cases (American)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 4000]",
          "Library Source": "gDNA from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina SureSelect V4-post",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000116",
          "Total Data Volume": "20 GB (fastq [4 files])",
          "Comments (Policies)": "NBDC policy & Cancer Research Use Only"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masaki Ohmuraya",
        "Affiliation": "Department of Genetics, Hyogo College of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "5": {
            "Name": "Grant-in-Aid for Researchers from Hyogo College of Medicine",
            "Title": "Genetic variants associated with increased risk of malignant mesothelioma in Japanese.",
            "Project Number": "2017"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma",
          "DOI": "doi: 10.1073/pnas.1612074113",
          "Data Set ID": "JGAD000116"
        },
        "2": {
          "Title": "A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations",
          "DOI": "doi: 10.1200/JCO.2018.79.0352",
          "Data Set ID": "JGAD000116"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Data in Use (Dataset ID)": "JGAD000116",
          "Period of Data Use": "2020/09/18-2023/03/31"
        }
      },
      "Release Note": {
        "hum0085.v2": {
          "Research ID": "hum0085.v2",
          "Release Date": "2018/09/25",
          "Type of Data": "Array CGH, NGS (Exome, Target Capture)",
          "description": "gDNA extracted from peripheral blood cells (non-tumor) obtained from 40 American familial malignant mesothelioma patients were used for whole exome sequencing analysis and target capture sequencing analysis (fastq files).\n"
        },
        "hum0085.v1": {
          "Research ID": "hum0085.v1",
          "Release Date": "2017/10/16",
          "Type of Data": "Array CGH, NGS (WGS, Target Capture)",
          "description": "gDNA extracted from malignant mesothelioma tumors and peripheral blood cells (non-tumor) obtained from 9 Japanese and 23 American malignant mesothelioma patients were used for Array CGH , whole genome sequencing analysis and target capture sequencing analysis (text and fastq files).\nNote:\n"
        }
      }
    }
  },
  "hum0083.v2": {
    "ja": {
      "NBDC Research ID": "hum0083.v2",
      "データ": {
        "JGAS000070": {
          "データID": "JGAS000070",
          "内容": "NGS （CAGE-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/10/28"
        },
        "JGAS000488": {
          "データID": "JGAS000488",
          "内容": "NGS （CAGE-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/01/24"
        }
      },
      "研究内容の概要": {
        "目的": "扁平上皮がん・非扁平上皮がんを鑑別するバイオマーカーの探索",
        "方法": "CAGE（Cap Analysis of Gene Expression）",
        "対象": "97＋38症例の肺がん（扁平上皮がんおよび非扁平上皮がん）および10症例の胸膜中皮腫摘出組織"
      },
      "分子データ": {
        "JGAS000070 / JGAS000488": {
          "対象": "肺がん（扁平上皮がんおよび非扁平上皮がん）（ICD10：C34）：97＋38症例\r\n胸膜中皮腫（ICD10：C450）：10症例",
          "規模": "CAGE-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "肺がんおよび胸膜中皮腫の摘出腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "CAGE assay（※論文Method参照）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000070\r\nJGAD000605",
          "総データ量": "45＋30 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "林崎 良英 / 向後 泰司",
        "所 属 機 関": "理化学研究所 予防医療・診断技術開発プログラム / 理化学研究所 科技ハブ産連本部",
        "プロジェクト/研究グループ名": "CAGE法による胸部悪性腫瘍における新規バイオマーカーの網羅的解析（順天堂大学 高持一矢）",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 創薬等ライフサイエンス研究支援基盤事業 創薬等先端技術支援基盤プラットフォーム（BINDS）",
            "タイトル": "",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung",
          "DOI": "doi: 10.1186/s12885-016-2792-1",
          "データID": "JGAD000070\r\nJGAD000605"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "堀江 真史": {
          "研究代表者": "堀江 真史",
          "所属機関": "東京大学 保健健康推進本部",
          "研究題目": "",
          "利用データID": "JGAD000070",
          "利用期間": "2017/01/11-2021/11/30"
        }
      },
      "リリース情報": {
        "hum0083.v2": {
          "Research ID": "hum0083.v2",
          "公開日": "2022/01/24",
          "内容": "NGS（CAGE-seq）",
          "description": "38症例の肺がん（扁平上皮がんおよび非扁平上皮がん）および10症例の胸膜中皮腫摘出組織より抽出したRNAを使用してCAGEライブラリを作成し、Illumina HiSeq 2500によるシークエンシングを行った結果をfastqファイルにて提供する。\n"
        },
        "hum0083.v1": {
          "Research ID": "hum0083.v1",
          "公開日": "2016/10/28",
          "内容": "NGS（CAGE-seq）",
          "description": "97症例の肺がん（扁平上皮がんおよび非扁平上皮がん）摘出組織より抽出したRNAを使用してCAGEライブラリを作成し、Illumina HiSeq 2500によるシークエンシングを行った結果をfastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0083.v2",
      "DATA": {
        "JGAS000070": {
          "Data Set ID": "JGAS000070",
          "Type of Data": "NGS (CAGE-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/10/28"
        },
        "JGAS000488": {
          "Data Set ID": "JGAS000488",
          "Type of Data": "NGS (CAGE-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/01/24"
        }
      },
      "SUMMARY": {
        "Aims": "exploration of biomarkers discriminating squamous cell carcinoma from other lung cancers",
        "Methods": "CAGE (Cap Analysis of Gene Expression)",
        "Participants/Materials": "97 + 48 surgically dissected tissues"
      },
      "MOLECULAR DATA": {
        "JGAS000070 / JGAS000488": {
          "Participants/Materials": "lung cancer (ICD10: C34): 97 + 38 cases\r\nmalignant pleural mesothelioma (ICD10: C450): 10 cases",
          "Targets": "CAGE-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNA extracted from surgically dissected tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "CAGE assay (*References)",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000070\r\nJGAD000605",
          "Total Data Volume": "45 + 30 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yoshihide Hayashizaki / Yasushi Kogo",
        "Affiliation": "RIKEN Preventive Medicine and Diagnosis Innovation Program / RIKEN Cluster for Science, Technology and Innovation Hub",
        "Project / Group Name": "Genome-wide exploration for biomarkers in thoracic malignant tumors by using CAGE (Kazuya Takamochi, Juntendo University)",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Platform for Drug Discovery, Informatics, and Structural Life Science",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung",
          "DOI": "doi: 10.1186/s12885-016-2792-1",
          "Data Set ID": "JGAD000070\r\nJGAD000605"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Masafumi Horie": {
          "Principal Investigator": "Masafumi Horie",
          "Affiliation": "​Division for Health Service Promotion, The University of Tokyo",
          "Research Title": "",
          "Data in Use (Dataset ID)": "JGAD000070",
          "Period of Data Use": "2017/01/11-2021/11/30"
        }
      },
      "Release Note": {
        "hum0083.v2": {
          "Research ID": "hum0083.v2",
          "Release Date": "2022/01/24",
          "Type of Data": "NGS (CAGE-seq)",
          "description": "RNA extracted from surgically dissected tissues from 38 patients with lung cancer and 10 patients with malignant pleural mesothelioma were used for the preparation of CAGE libraries. Deep sequencing analysis on the libraries was performed with the Illumina HiSeq 2500 sequencer (47 bp, single-end) and provided in fastq and bam format files (reference: hg19).\n"
        },
        "hum0083.v1": {
          "Research ID": "hum0083.v1",
          "Release Date": "2016/10/28",
          "Type of Data": "NGS (CAGE-seq)",
          "description": "RNA extracted from surgically dissected tissues from 97 patients with lung cancer were used for the preparation of CAGE libraries. Deep sequencing analysis on the libraries was performed with the Illumina HiSeq 2500 sequencer (47 bp, single-end) and provided in fastq and bam format files (reference: hg19).\nNote:\n"
        }
      }
    }
  },
  "hum0082.v2": {
    "ja": {
      "NBDC Research ID": "hum0082.v2",
      "データ": {
        "hum0082.v1.AFFY6.0.v1": {
          "データID": "hum0082.v1.AFFY6.0.v1",
          "内容": "Affymetrix Genome-Wide Human SNP Array 6.0により決定した日本人健常者418名のGentoypeカウント情報",
          "制限": "非制限公開",
          "公開日": "2017/09/26"
        },
        "JGAS000120": {
          "データID": "JGAS000120",
          "内容": "Affymetrix Axiom Genome-Wide ASI 1 Arrayにより決定した日本人健常者419名のGenotypeデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2017/10/03"
        },
        "hum0082.v1.Axiom.v1": {
          "データID": "hum0082.v1.Axiom.v1",
          "内容": "Affymetrix Axiom Genome-Wide ASI 1 Arrayにより決定した日本人健常者419名のGenotypeカウント情報",
          "制限": "非制限公開",
          "公開日": "2017/09/26"
        }
      },
      "研究内容の概要": {
        "目的": "日本人健常者におけるゲノム全域のSNPを解析",
        "方法": "（1）Affymetrix Genome-Wide Human SNP Array 6.0を使用して約90万個の変異のGenotypeを決定",
        "対象": "日本人健常者419名",
        "URL": "http://www.humgenet.m.u-tokyo.ac.jp"
      },
      "分子データ": {
        "hum0082.v1.AFFY6.0.v1/JGAS000120": {
          "対象": "日本人健常者 ：418名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Birdseed version 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000130",
          "フィルタリング": "overall call rate < 0.97、SNP call rate < 0.95、HWE P < 0.001、MAF < 0.01",
          "マーカー数（QC後）": "647,318 SNPs（hg19）",
          "NBDC Dataset ID": "hum0082.v1.AFFY6.0.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "集計情報：69 MB（csv）\r\nGenotypeデータ：約30 GB（CEL、CHP）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0082.v1.Axiom.v1/JGAS000120": {
          "対象": "日本人健常者 ：419名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix AXIOM 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Genotyping Console v4.1",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000131",
          "フィルタリング": "overall call rate < 0.97、SNP call rate < 0.95、HWE P < 0.001、MAF < 0.01",
          "マーカー数（QC後）": "490,744 SNPs（hg19）",
          "NBDC Dataset ID": "hum0082.v1.Axiom.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "集計情報：41 MB（csv）\r\nGenotypeデータ：約30 GB（CEL、CHP）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "徳永 勝士",
        "所 属 機 関": "東京大学大学院 医学系研究科",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "先端技術を駆使したHLA多型・進化・疾病に関する統合的研究",
            "研究課題番号": "22133008"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A polymorphism in CCR1/CCR3 is associated with narcolepsy",
          "DOI": "doi: 10.1016/j.bbi.2015.05.003",
          "データID": "hum0082.v1.AFFY6.0.v1\r\nJGAD000130"
        },
        "2": {
          "タイトル": "Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia",
          "DOI": "doi: 10.7717/peerj.66",
          "データID": "hum0082.v1.AFFY6.0.v1\r\nJGAD000130"
        },
        "3": {
          "タイトル": "Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population",
          "DOI": "doi: 10.1016/j.ajhg.2012.08.010",
          "データID": "hum0082.v1.Axiom.v1\r\nJGAD000131"
        },
        "4": {
          "タイトル": "IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement",
          "DOI": "doi: 10.1016/j.jaci.2014.12.1916",
          "データID": "hum0082.v1.Axiom.v1\r\nJGAD000131"
        }
      },
      "制限公開データの利用者一覧": {
        "宮川 卓": {
          "研究代表者": "宮川 卓",
          "所属機関": "東京都医学総合研究所 睡眠プロジェクト",
          "研究題目": "日本",
          "利用データID": "過眠を呈する睡眠障害（各種過眠症・概日リズム睡眠障害・睡眠時無呼吸症候群・睡眠関連運動障害・睡眠時随伴症など）の病態に関与する遺伝子の探索とその機能及び末梢血リンパ球の自己抗原特異的増殖反応の研究",
          "利用期間": "JGAD000131"
        }
      },
      "リリース情報": {
        "hum0082.v2": {
          "Research ID": "hum0082.v2",
          "公開日": "2017/10/03",
          "内容": "日本人健常者419名の個人毎のGenotypeデータ",
          "description": "日本人健常者419名の個人毎のGenotypeデータを提供する（制限公開）。\n"
        },
        "hum0082.v1": {
          "Research ID": "hum0082.v1",
          "公開日": "2017/09/26",
          "内容": "日本人健常者419名のゲノムワイドSNPs（遺伝子型情報）",
          "description": "日本人健常者 419名の末梢血より抽出したDNAを使用し、下記各手法によりGenotypeを決定した。遺伝子型カウント情報をcsvファイル（非制限公開）にて提供する。\n　　遺伝子型決定に使用したSNPアレイは以下の通り。\n　　　・Genome-Wide Human SNP Array 6.0（Affymetrix）\n　　　・Axiom Genome-Wide ASI 1 Array（Affymetrix）\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0082.v2",
      "DATA": {
        "hum0082.v1.AFFY6.0.v1": {
          "Data Set ID": "hum0082.v1.AFFY6.0.v1",
          "Type of Data": "Genotype count for genome wide SNPs on the Affymetrix Genome-Wide Human SNP Array 6.0",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/09/26"
        },
        "JGAS000120": {
          "Data Set ID": "JGAS000120",
          "Type of Data": "Genotypes for genome wide SNPs using the Affymetrix Axiom Genome-Wide ASI 1 Array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/10/03"
        },
        "hum0082.v1.Axiom.v1": {
          "Data Set ID": "hum0082.v1.Axiom.v1",
          "Type of Data": "Genotype count for genome wide SNPs on the Affymetrix Axiom Genome-Wide ASI 1 Array",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/09/26"
        }
      },
      "SUMMARY": {
        "URL": "http://www.humgenet.m.u-tokyo.ac.jp/index.en.html"
      },
      "MOLECULAR DATA": {
        "hum0082.v1.AFFY6.0.v1/JGAS000120": {
          "Materials": "418 healthy Japanese",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "Genotype Call Methods (softwares)": "Birdseed version 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000130",
          "Filtering Methods": "overall call rate < 0.97, SNP call rate < 0.95, HWE P < 0.001, MAF < 0.01",
          "Marker Numbers (after QC)": "647,318 SNPs (hg19)",
          "NBDC Dataset ID": "hum0082.v1.AFFY6.0.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "Stats: 69 MB (csv)\r\nGenotype data: about 30 GB (CEL, CHP)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0082.v1.Axiom.v1/JGAS000120": {
          "Materials": "419 healthy Japanese",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix AXIOM 2.0 Reagent Kit",
          "Genotype Call Methods (softwares)": "Genotyping Console v4.1",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000131",
          "Filtering Methods": "overall call rate < 0.97, SNP call rate < 0.95, HWE P < 0.001, MAF < 0.01",
          "Marker Numbers (after QC)": "490,744 SNPs (hg19)",
          "NBDC Dataset ID": "hum0082.v1.Axiom.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "Stats: 41 MB (csv)\r\nGenotype data: about 30 GB (CEL, CHP)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Katsushi Tokunaga",
        "Affiliation": "The University of Tokyo, Graduate School of Medicine",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "HLA and diseases",
            "Project Number": "22133008"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A polymorphism in CCR1/CCR3 is associated with narcolepsy",
          "DOI": "doi: 10.1016/j.bbi.2015.05.003",
          "Data Set ID": "hum0082.v1.AFFY6.0.v1\r\nJGAD000130"
        },
        "2": {
          "Title": "Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia",
          "DOI": "doi: 10.7717/peerj.66",
          "Data Set ID": "hum0082.v1.AFFY6.0.v1\r\nJGAD000130"
        },
        "3": {
          "Title": "Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population",
          "DOI": "doi: 10.1016/j.ajhg.2012.08.010",
          "Data Set ID": "hum0082.v1.Axiom.v1\r\nJGAD000131"
        },
        "4": {
          "Title": "IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement",
          "DOI": "doi: 10.1016/j.jaci.2014.12.1916",
          "Data Set ID": "hum0082.v1.Axiom.v1\r\nJGAD000131"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Taku Miyagawa": {
          "Principal Investigator": "Taku Miyagawa",
          "Affiliation": "Sleep Disorders Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Search for genes involved in the pathogenesis of sleep disorders presenting with hypersomnia (various hypersomnias, circadian rhythm sleep disorders, sleep apnea syndrome, sleep-related movement disorders, sleep paralysis, etc.) and study of their functions and autoantigen-specific responses of peripheral blood lymphocytes",
          "Period of Data Use": "JGAD000131"
        }
      },
      "Release Note": {
        "hum0082.v2": {
          "Research ID": "hum0082.v2",
          "Release Date": "2017/10/03",
          "Type of Data": "Individual genotype data for 419 healthy Japanese",
          "description": "Individual genotype data for 419 healthy Japanese is provided (controlled-access).\n"
        },
        "hum0082.v1": {
          "Research ID": "hum0082.v1",
          "Release Date": "2017/09/26",
          "Type of Data": "Genome wide SNPs data for 419 healthy Japanese",
          "description": "Genome-wide SNPs were genotyped using following arrays for 419 healthy Japanese. Genotype count data is provided (csv files).\n　　　(1) Genome-wide 900,000 SNPs using Affymetrix Human SNP Array 6.0 \n　　　(2) Genome-wide 600,000 SNPs using Affymetrix Axiom ASI 1 Array \nNote:\n"
        }
      }
    }
  },
  "hum0079.v1": {
    "ja": {
      "NBDC Research ID": "hum0079.v1",
      "データ": {
        "JGAS000068": {
          "データID": "JGAS000068",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/02/18"
        }
      },
      "研究内容の概要": {
        "目的": "封入体筋炎筋発現プロファイルにより炎症と変性の病態を解明すること",
        "方法": "封入体筋炎症例、多発筋炎症例、筋疾患の無い対照者の筋組織を用いたRNA-sequencing",
        "対象": "封入体筋炎症例、多発筋炎症例、筋疾患の無い対照者"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000068": {
          "対象": "封入体筋炎（ICD10：G724）：53症例\r\n多発筋炎（ICD10：M332）：6症例\r\n対照者：9名",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "筋組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded Total RNA with ribo-zero gold",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000068",
          "総データ量": "721.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "後藤 順",
        "所 属 機 関": "東京大学大学院 医学系研究科 神経内科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "次世代シーケンサーを用いた封入体筋炎筋発現プロファイルによる炎症と変性の病態解明",
            "研究課題番号": "26461265"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Muscle transcriptomics shows overexpression of cadherin 1 in inclusion body myositis",
          "DOI": "doi: 10.1002/ana.26304",
          "データID": "JGAD000068"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Pietro Fratta": {
          "研究代表者": "Pietro Fratta",
          "所属機関": "University College London",
          "研究題目": "イギリス",
          "利用データID": "TDP-43 pathology and loss of function in the skeletal muscle",
          "利用期間": "JGAD000068"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000068"
        }
      },
      "リリース情報": {
        "hum0079.v1": {
          "Research ID": "hum0079.v1",
          "公開日": "2022/02/18",
          "内容": "NGS（RNA-seq）",
          "description": "封入体筋炎53症例、多発筋炎6症例、および筋疾患の無い対照者9名の筋組織から抽出したRNAを用いたRNA-sequencing解析結果をFastqファイルにて提供する（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0079.v1",
      "DATA": {
        "JGAS000068": {
          "Data Set ID": "JGAS000068",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/02/18"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the pathogenesis of inclusion body myositis",
        "Methods": "RNA-sequencing analysis in 53 patients with inclusion body myositis, 6 patients with polymyositis, and 9 controls",
        "Participants/Materials": "Patients with inclusion body myositis, patients with polymyositis, and controls/Muscle biopsy samples"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000068": {
          "Participants/Materials": "inclusion body myositis (ICD10: G724): 53 cases\r\npolymyositis (ICD10: M332): 6 cases\r\n9 controls",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from skeletal muscle",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded Total RNA with ribo-zero gold",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000068",
          "Total Data Volume": "721.5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Jun Goto",
        "Affiliation": "Department of Neurology, The University of Tokyo, Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Expression profiling study in inclusion body myositis employing next-generation sequencer",
            "Project Number": "26461265"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Muscle transcriptomics shows overexpression of cadherin 1 in inclusion body myositis",
          "DOI": "doi: 10.1002/ana.26304",
          "Data Set ID": "JGAD000068"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Pietro Fratta": {
          "Principal Investigator": "Pietro Fratta",
          "Affiliation": "University College London",
          "Research Title": "United Kingdom of Great Britain and Northern Ireland",
          "Data in Use (Dataset ID)": "TDP-43 pathology and loss of function in the skeletal muscle",
          "Period of Data Use": "JGAD000068"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000068"
        }
      },
      "Release Note": {
        "hum0079.v1": {
          "Research ID": "hum0079.v1",
          "Release Date": "2022/02/18",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNAs extracted from skeletal muscle samples obtained from inclusion body myositis patients, polymyositis patients, and controls were used for RNA-sequencing (Paired-end). Fastq files are provided.\nNote:\n"
        }
      }
    }
  },
  "hum0076.v1": {
    "ja": {
      "NBDC Research ID": "hum0076.v1",
      "データ": {
        "hum0076.v1": {
          "データID": "hum0076.v1",
          "内容": "PBC 487症例および健常対照者476名のGWAS",
          "制限": "非制限公開",
          "公開日": "2016/10/05"
        }
      },
      "研究内容の概要": {
        "目的": "日本人原発性胆汁性肝硬変（Primary Biliary Cholangitis：PBC）の発症に関わる遺伝因子の網羅的遺伝子解析",
        "方法": "Affymetrix Axiom ASI 1 Arrayを使用して約60万個の一塩基多型（Single Nucleotide Polymorphisms：SNPs）の遺伝子型を決定後ゲノムワイド関連解析（Genome-Wide Association Study：GWAS）を実施",
        "対象": "PBC 487 症例、および、健常対照者 476名"
      },
      "分子データ": {
        " hum0076.v1 ": {
          "対象": "PBC：487症例\r\n健常対照者：476名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "AXIOM 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（Genotyping Console ver. 4.2.0.26）",
          "フィルタリング": "Sample Call rate < 0.97, SNP call rate < 0.95, HWE P < 0.001, MAF < 0.05",
          "マーカー数（QC後）": "425,736 SNPs（hg19）",
          "NBDC Dataset ID": "hum0076.v1.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "55 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中村 稔",
        "所 属 機 関": "国立病院機構（NHO） 長崎医療センター 臨床研究センター",
        "プロジェクト/研究グループ名": " PBC Consortium in Japan（PBCCJP）",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究(C)",
            "タイトル": "日本人原発性胆汁性肝硬変の病態形成に関わる遺伝因子同定のための網羅的遺伝子解析",
            "研究課題番号": "23591006"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population",
          "DOI": "doi: 10.1016/j.ajhg.2012.08.010",
          "データID": "hum0076.v1.gwas.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0076.v1": {
          "Research ID": "hum0076.v1",
          "公開日": "2016/10/05",
          "内容": "ゲノムワイド関連解析",
          "description": "PBC 487症例、および、健常対照者 476名について、Affymetrix Axiom ASI 1 Arrayを使用して約60万個の一塩基多型（Single Nucleotide Polymorphisms：SNPs）の遺伝子型を決定後、ゲノムワイド関連解析（Genome-Wide Association Study：GWAS）を実施した結果を提供する（csv file）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0076.v1",
      "DATA": {
        "hum0076.v1": {
          "Data Set ID": "hum0076.v1",
          "Type of Data": "GWAS",
          "Criteria": "Unrestricted-access",
          "Release Date": "2016/10/05"
        }
      },
      "SUMMARY": {
        "Aims": "Genome-wide search for susceptibility genes to primary biliary cholangitis (PBC)",
        "Methods": "SNP-based genome-wide association study",
        "Participants/Materials": "487 PBCs and 476 healthy controls"
      },
      "MOLECULAR DATA": {
        "hum0076.v1": {
          "Participants/Materials": "487 PBCs\r\n476 healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "AXIOM 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "GenCall software (Genotyping Console ver. 4.2.0.26)",
          "Filtering Methods": "Sample Call rate < 0.97, SNP call rate < 0.95, HWE P < 0.001, MAF < 0.05",
          "Marker Number (after QC)": "425,736 SNPs (hg19)",
          "NBDC Dataset ID": "hum0076.v1.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "55 MB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Minoru Nakamura",
        "Affiliation": "Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center",
        "Project / Group Name": "PBC Consortium in Japan (PBCCJP)",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Genome-wide association study to detect disease-associated genes in Japanese patients with primary biliary cirrhosis",
            "Project Number": "23591006"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population",
          "DOI": "doi: 10.1016/j.ajhg.2012.08.010",
          "Data Set ID": "hum0076.v1.gwas.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0076.v1": {
          "Research ID": "hum0076.v1",
          "Release Date": "2016/10/05",
          "Type of Data": "GWAS",
          "description": "A genome-wide association study for PBC was performed using SNPs on Affymetrix Axiom ASI 1 Array (420,928 SNPs).\nNote:\n"
        }
      }
    }
  },
  "hum0075.v3": {
    "ja": {
      "NBDC Research ID": "hum0075.v3",
      "データ": {
        "hum0075.v1.gwas.v1": {
          "データID": "hum0075.v1.gwas.v1",
          "内容": "B型肝炎ウイルスキャリア 181症例、および、\r\n健常対照者 184名のGWAS",
          "制限": "非制限公開",
          "公開日": "2017/09/25"
        },
        "hum0075.v1.virus.v1": {
          "データID": "hum0075.v1.virus.v1",
          "内容": "B型肝炎ウイルスキャリア 181症例、および、\r\nB型肝炎ウイルス排除群 185症例のGWAS",
          "制限": "非制限公開",
          "公開日": "2017/09/25"
        },
        "hum0075.v1.clear.v1": {
          "データID": "hum0075.v1.clear.v1",
          "内容": "B型肝炎ウイルス排除群 185症例、および、\r\n健常対照者 184名のGWAS",
          "制限": "非制限公開",
          "公開日": "2017/09/25"
        },
        "hum0075.v2.hcc.v1": {
          "データID": "hum0075.v2.hcc.v1",
          "内容": "B型ウイルス陽性肝がん 473症例、および、\r\nB型肝炎ウイルスキャリア群 516症例のGWAS",
          "制限": "非制限公開",
          "公開日": "2019/02/19"
        },
        "hum0075.v3.Thai-gwas.v1": {
          "データID": "hum0075.v3.Thai-gwas.v1",
          "内容": "タイ人B型肝炎 329症例、および、\r\nタイ人健常対照者 318名のGWAS",
          "制限": "非制限公開",
          "公開日": "2022/05/27"
        }
      },
      "研究内容の概要": {
        "目的": "B型肝炎ウイルス感染の病態別における宿主遺伝因子の探索",
        "方法": "対象1〜3について、Affymetrix Genome-Wide Human SNP Array 6.0を使用して約90万個の一塩基多型（Single Nucleotide Polymorphisms：SNPs）の遺伝子型を決定後ゲノムワイド関連解析（Genome-Wide Association Study：GWAS）を実施",
        "対象": "1． B型肝炎ウイルスキャリア 181症例、および、健常対照者 184名",
        "URL": "http://www.ncgmkohnodai.go.jp/kanen_meneki/index.html"
      },
      "分子データ": {
        "hum0075.v1.gwas.v1": {
          "対象": "B型肝炎ウイルスキャリア：181症例\r\n健常対照者：184名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Genotyping Console v4.1 software（Birdseed v1）",
          "フィルタリング": "Sample call rate < 0.95、SNP call rate < 0.95、HWE P < 0.001\r\nPearson's chi-square test P < 1.0ｘ10^-4",
          "マーカー数（QC後）": "104 autosomal SNPs（NCBI Build 36.3）",
          "NBDC Dataset ID": "hum0075.v1.gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "14 KB (csv)",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0075.v1.virus.v1": {
          "対象": "B型肝炎ウイルスキャリア：181症例\r\nB型肝炎ウイルス排除群：185症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Genotyping Console v4.1 software（Birdseed v1）",
          "フィルタリング": "Sample call rate < 0.95、SNP call rate < 0.95、HWE P < 0.001\r\nPearson's chi-square test P < 1.0ｘ10^-4",
          "マーカー数（QC後）": "88 autosomal SNPs （NCBI Build 36.3）",
          "NBDC Dataset ID": "hum0075.v1.virus.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "12 KB（csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0075.v1.clear.v1": {
          "対象": "B型肝炎ウイルス排除群：185症例\r\n健常対照者：184名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Genotyping Console v4.1 software（Birdseed v1）",
          "フィルタリング": "Sample call rate < 0.95、SNP call rate < 0.95、HWE P < 0.001\r\nPearson's chi-square test without P < 1.0ｘ10^-4",
          "マーカー数（QC後）": "90 autosomal SNPs （NCBI Build 36.3）",
          "NBDC Dataset ID": "hum0075.v1.clear.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "12 KB（csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0075.v2.hcc.v1": {
          "対象": "B型肝炎ウイルス陽性肝がん（ICD10：B181）：473症例\r\nB型肝炎ウイルキャリア群（慢性肝炎および無症候キャリア）：516症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Axiom 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Genotyping Console v4.2.0.26 software",
          "フィルタリング": "Sample call rate < 0.97、SNP call rate < 0.95、MAF < 0.03、HWE P < 0.001\r\nPearson's chi-square test without P < 0.05",
          "マーカー数（QC後）": "24,123 autosomal SNPs",
          "NBDC Dataset ID": "hum0075.v2.hcc.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "5.6 MB（xlsx）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0075.v3.Thai-gwas.v1": {
          "対象": "タイ人B型肝炎（ICD10：B169）：329症例\r\n  （肝がん（ICD10：C220）を併発している患者を含む）\r\nタイ人健常対照者：318名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Axiom 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Genotyping Console software （v4.2.0.26）\r\nIMPUTE2 software (v2.3.2) with 1000 Genomes phase III reference panel",
          "関連解析（ソフトウェア）": "PLINK (v1.9)",
          "フィルタリング": "Imputation前の対象SNP除去：SNP call rate < 0.97、MAF < 0.01、HWE P < 1×10^-6\r\nImputation後の対象SNP除去：info metric < 0.8",
          "マーカー数（imputation & QC後）": "6,317,183 autosomal variants（GRCh37）",
          "NBDC Dataset ID": "hum0075.v3.Thai-gwas.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "600 MB（plink.assoc）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "溝上 雅史",
        "所 属 機 関": "国立国際医療研究センター 肝炎免疫研究センター 肝疾患研究部",
        "プロジェクト/研究グループ名": "ゲノム医科学プロジェクト",
        "科研費/助成金（Research Project Number）": {
          "6": {
            "科研費・助成金名": "国立研究開発法人日本医療研究開発機構（AMED） 肝炎等克服実用化研究事業 肝炎等克服緊急対策研究事業",
            "タイトル": "B型肝炎ウイルスおよびヒトゲノムの解析に基づくクリニカルシークエンスに向けた研究",
            "研究課題番号": "JP20fk0210056"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genome-Wide Association Study Confirming Association of HLA-DP with Protection against Chronic Hepatitis B and Viral Clearance in Japanese and Korean",
          "DOI": "doi: 10.1371/journal.pone.0039175",
          "データID": "hum0075.v1.gwas.v1\r\nhum0075.v1.virus.v1\r\nhum0075.v1.clear.v1"
        },
        "2": {
          "タイトル": "Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma",
          "DOI": "doi: 10.1038/s41598-018-26217-7",
          "データID": "hum0075.v2.hcc.v1"
        },
        "3": {
          "タイトル": "Genome-wide association study for chronic hepatitis B infection in the Thai population",
          "DOI": "doi: 10.3389/fgene.2022.887121",
          "データID": "hum0075.v3.Thai-gwas.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0075.v3": {
          "Research ID": "hum0075.v3",
          "公開日": "2022/05/27",
          "内容": "ゲノムワイド関連解析",
          "description": "タイ人B型肝炎（肝がんを併発している患者を含む）329症例およびタイ人健常対照者318名の末梢血から抽出したDNAについて、Affymetrix Axiom Genome-Wide ASI 1 Arrayを使用して約60万バリアントのgenotypeを決定後、imputationを実施し、GWASを行った結果を提供する（plink.assoc file）。\n"
        },
        "hum0075.v2": {
          "Research ID": "hum0075.v2",
          "公開日": "2019/02/19",
          "内容": "ゲノムワイド関連解析",
          "description": "B型肝炎ウイルス陽性肝がん473症例、および、B型肝炎ウイルスキャリア群（慢性肝炎および無症候キャリア）516症例について、Affymetrix Axiom Genome-Wide ASI 1 Arrayを使用して約60万SNPsの遺伝子型を決定後、GWAS結果を提供する（xlsx file）。\n"
        },
        "hum0075.v1": {
          "Research ID": "hum0075.v1",
          "公開日": "2017/09/25",
          "内容": "ゲノムワイド関連解析",
          "description": "以下の対象について、Affymetrix Genome-Wide Human SNP Array 6.0を使用して約90万個の一塩基多型（Single Nucleotide Polymorphisms：SNPs）の遺伝子型を決定後ゲノムワイド関連解析（Genome-Wide Association Study：GWAS）を実施した結果を提供する（csv file）。\n1.  B型肝炎ウイルスキャリア 181症例、健常対照者 184名（hum0075.v1.gwas.v1）\n2.  B型肝炎ウイルスキャリア 181症例、B型肝炎ウイルス排除群 185症例（hum0075.v1.virus.v1）\n3.  B型肝炎ウイルス排除群 185症例、健常対照者 184名（hum0075.v1.clear.v1）\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0075.v3",
      "DATA": {
        "hum0075.v1.gwas.v1": {
          "Data Set ID": "hum0075.v1.gwas.v1",
          "Type of Data": "GWAS for 181 HBV carriers and 184 controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/09/25"
        },
        "hum0075.v1.virus.v1": {
          "Data Set ID": "hum0075.v1.virus.v1",
          "Type of Data": "GWAS for 181 HBV carriers and 185 spontaneously HBV-resolved individuals",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/09/25"
        },
        "hum0075.v1.clear.v1": {
          "Data Set ID": "hum0075.v1.clear.v1",
          "Type of Data": "GWAS for 185 spontaneously HBV-resolved individuals and 184 controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/09/25"
        },
        "hum0075.v2.hcc.v1": {
          "Data Set ID": "hum0075.v2.hcc.v1",
          "Type of Data": "GWAS for 473 HBV-positive HCC patients and 516 HBV carriers",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/02/19"
        },
        "hum0075.v3.Thai-gwas.v1": {
          "Data Set ID": "hum0075.v3.Thai-gwas.v1",
          "Type of Data": "GWAS for 329 patients with chronic HBV infection and 318 healthy controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/05/27"
        }
      },
      "SUMMARY": {
        "Aims": "Search for susceptibility genes to hepatitis virus B (HBV)-related diseases",
        "Methods": "SNP-based genome-wide association study (GWAS)",
        "Participants/Materials": ""
      },
      "MOLECULAR DATA": {
        "hum0075.v1.gwas.v1": {
          "Participants/Materials": "181 HBV carriers and 184 controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "Genotype Call Methods (software)": "Genotyping Console v4.1 software (Birdseed v1)",
          "Filtering Methods": "Sample call rate < 0.95, SNP call rate < 0.95, HWE P < 0.001\r\nChi-square test P < 1.0ｘ10^-4",
          "Marker Number (after QC)": "104 autosomal SNPs (ref: Build 36.3)",
          "NBDC Dataset ID": "hum0075.v1.gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "14 KB (csv)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0075.v1.virus.v1": {
          "Participants/Materials": "181 HBV carriers and 185 spontaneously HBV-resolved individuals",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "Genotype Call Methods (software)": "Genotyping Console v4.1 software (Birdseed v1)",
          "Filtering Methods": "Sample call rate < 0.95, SNP call rate < 0.95, HWE P < 0.001\r\nChi-square test P < 1.0ｘ10^-4",
          "Marker Number (after QC)": "88 autosomal SNPs (ref: Build 36.3)",
          "NBDC Dataset ID": "hum0075.v1.virus.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "12 KB (csv)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0075.v1.clear.v1": {
          "Participants/Materials": "185 spontaneously HBV-resolved individuals and 184 controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "Genotype Call Methods (software)": "Genotyping Console v4.1 software (Birdseed v1)",
          "Filtering Methods": "Sample call rate < 0.95, SNP call rate < 0.95, HWE P < 0.001\r\nChi-square test P < 1.0ｘ10^-4",
          "Marker Number (after QC)": "90 autosomal SNPs (ref: Build 36.3)",
          "NBDC Dataset ID": "hum0075.v1.clear.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "12 KB (csv)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0075.v2.hcc.v1": {
          "Participants/Materials": "473 HBV-positive HCC patients (ICD10: B181) \r\n516 HBV carriers including chronic hepatitis and asymptomatic carriers",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Axiom 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "Genotyping Console v4.2.0.26 software",
          "Filtering Methods": "Sample call rate < 0.97, SNP call rate < 0.95, MAF P < 0.03, HWE P < 0.001\r\nChi-square test P < 0.05",
          "Marker Number (after QC)": "24,123 autosomal SNPs",
          "NBDC Dataset ID": "hum0075.v2.hcc.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "5.8 MB (xls)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0075.v3.Thai-gwas.v1": {
          "Participants/Materials": "329 patients with chronic HBV infection (ICD10: B169) \r\n   [including liver cancer (ICD10: C220) patients]\r\n318 healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Axiom 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "Genotyping Console v4.2.0.26 software\r\nIMPUTE2 v2.3.2 software",
          "Association Analysis (software)": "PLINK v1.9 software",
          "Filtering Methods": "pre-imputation QC: SNP call rate < 0.97, MAF P < 0.01, HWE P < 1 x10^-6\r\nafter imputation QC: SNPs with an info metric < 0.8 were excluded.",
          "Marker Number (after QC)": "6,317,183 autosomal variants (GRCh37)",
          "NBDC Dataset ID": "hum0075.v3.Thai-gwas.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "600 MB (plink.assoc)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masashi Mizokami",
        "Affiliation": "Department of Liver Diseases, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine",
        "Project / Group Name": "Genome Medical Science Project",
        "Funds / Grants (Research Project Number)": {
          "6": {
            "Name": "Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science Program for Basic and Clinical Research on Hepatitis, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Study for clinical sequening based on genome analysis of host and viral factors",
            "Project Number": "JP20fk0210056"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genome-Wide Association Study Confirming Association of HLA-DP with Protection against Chronic Hepatitis B and Viral Clearance in Japanese and Korean",
          "DOI": "doi: 10.1371/journal.pone.0039175",
          "Data Set ID": "hum0075.v1.gwas.v1\r\nhum0075.v1.virus.v1\r\nhum0075.v1.clear.v1"
        },
        "2": {
          "Title": "Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma",
          "DOI": "doi: 10.1038/s41598-018-26217-7",
          "Data Set ID": "hum0075.v2.hcc.v1"
        },
        "3": {
          "Title": "Genome-wide association study for chronic hepatitis B infection in the Thai population",
          "DOI": "doi: 10.3389/fgene.2022.887121",
          "Data Set ID": "hum0075.v3.Thai-gwas.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0075.v3": {
          "Research ID": "hum0075.v3",
          "Release Date": "2022/05/27",
          "Type of Data": "GWAS",
          "description": "A genome-wide association study for 329 patients with chronic HBV infection and 318 healthy controls in Thailand was performed using variants on Affymetrix Axiom Genome-Wide ASI 1 Array (plink.assoc file).\n"
        },
        "hum0075.v2": {
          "Research ID": "hum0075.v2",
          "Release Date": "2019/02/19",
          "Type of Data": "GWAS",
          "description": "A genome-wide association study for 473 HBV-positive HCC patients and 516 HBV carriers including chronic hepatitis and asymptomatic carriers was performed using SNPs on Affymetrix Axiom Genome-Wide ASI 1 Array (xlsx file).\n"
        },
        "hum0075.v1": {
          "Research ID": "hum0075.v1",
          "Release Date": "2017/09/25",
          "Type of Data": "GWAS",
          "description": " Genome-wide association studies for each group were performed using SNPs on Affymetrix Genome-Wide Human SNP Array 6.0.\n(1) 181 HBV carriers and 184 controls (hum0075.v1.gwas.v1)\n(2) 181 HBV carriers and 185 spontaneously HBV-resolved individuals (hum0075.v1.virus.v1)\n(3) 185 spontaneously HBV-resolved individuals and 184 controls (hum0075.v1.clear.v1)\nNote:\n"
        }
      }
    }
  },
  "hum0074.v2": {
    "ja": {
      "NBDC Research ID": "hum0074.v2",
      "データ": {
        "hum0074.v1.vr.v1": {
          "データID": "hum0074.v1.vr.v1",
          "内容": "NVR 78症例、SVR 51症例、VR 64症例のGWAS",
          "制限": "非制限公開",
          "公開日": "2018/02/27"
        },
        "hum0074.v1.plt.v1": {
          "データID": "hum0074.v1.plt.v1",
          "内容": "C型肝炎PEG-IFN/RBV併用療法による\r\n血小板減少＋ 94症例および\r\n血小板減少－ 196症例のGWAS",
          "制限": "非制限公開",
          "公開日": "2018/02/27"
        },
        "hum0074.v1.Hb.v1": {
          "データID": "hum0074.v1.Hb.v1",
          "内容": "進展に伴うヘモグロビン減少＋ 94症例および\r\nヘモグロビン減少－ 209症例のGWAS",
          "制限": "非制限公開",
          "公開日": "2018/02/27"
        },
        "hum0074.v2.hcc.v1": {
          "データID": "hum0074.v2.hcc.v1",
          "内容": "SVR後肝がん発症 123症例および\r\n肝がんを発症していない 333症例のGWAS",
          "制限": "非制限公開",
          "公開日": "2018/09/25"
        }
      },
      "研究内容の概要": {
        "目的": "テーラーメイド医療を目指した肝炎ウイルスデータベース構築",
        "方法": "対象1〜3について、Affymetrix Genome-Wide Human SNP Array 6.0を使用して約90万個の一塩基多型（Single Nucleotide Polymorphisms：SNPs）の遺伝子型を決定後、ゲノムワイド関連解析（Genome-Wide Association Study：GWAS）を実施",
        "対象": "",
        "URL": "http://www2.kuh.kumamoto-u.ac.jp/gastro/"
      },
      "分子データ": {
        "hum0074.v1.vr.v1": {
          "対象": "PEG-IFN/RBVの治療応答性（血中C型肝炎ウイルス排除の有無）\r\n　　　NVR（排除無）：78症例\r\n　　　SVR（持続的排除有）：51症例\r\n　　　VR（排除有）：64症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Birdseed version 3",
          "フィルタリング": "Sample call rate < 0.95、SNP call rate < 0.95、\r\nHWE P < 0.001、Chi-square test (allelic model) P < 1 x 10^-4",
          "マーカー数（QC後）": "NVR vs VR：43 SNPs（hg18）\r\nNVR vs SVR：2 SNPs（hg18）",
          "NBDC Dataset ID": "hum0074.v1.vr.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "3 KB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0074.v1.plt.v1": {
          "対象": "C型肝炎PEG-IFN/RBV併用療法による血小板減少\r\n　　　血小板減少有：107症例\r\n　　　血小板減少無：196症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Birdseed version 3",
          "フィルタリング": "Sample call rate < 0.95、SNP call rate < 0.95、\r\nHWE P < 0.001、Chi-square test (allelic model) P < 1 x 10^-4",
          "マーカー数（QC後）": "66 SNPs（hg18）",
          "NBDC Dataset ID": "hum0074.v1.plt.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "9 KB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0074.v1.Hb.v1": {
          "対象": "進展に伴うヘモグロビン減少\r\n　　　ヘモグロビン減少有：94症例\r\n　　　ヘモグロビン減少無：209症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Birdseed version 3",
          "フィルタリング": "Sample call rate < 0.95、SNP call rate < 0.95、\r\nHWE P < 0.001、Chi-square test (allelic model) P < 1 x 10^-4",
          "マーカー数（QC後）": "32 SNPs（hg18）",
          "NBDC Dataset ID": "hum0074.v1.Hb.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "5 KB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0074.v2.hcc.v1": {
          "対象": "インターフェロン治療によるC型肝炎ウイルス排除（SVR）後の肝発がん（ICD10：C220）\r\n　　　治療終了後1年以上経過して肝がんを発症した群：123症例\r\n　　　治療終了後5年以上経過して肝がんを発症していない群：333症例",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array Plate]、DigiTag2 assay、TaqMan SNP Genotyping Assays",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix AXIOM 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Genotyping Console v4.1",
          "フィルタリング": "Sample call rate < 0.95、SNP call rate < 0.95、MAF < 0.05、\r\nHWE P < 0.001、Chi-square test (allelic model) P < 1 x 10^-4",
          "マーカー数（QC後）": "70 SNPs（hg18）",
          "NBDC Dataset ID": "hum0074.v2.hcc.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "22 KB（xlsx）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "田中 靖人",
        "所 属 機 関": "熊本大学大学院 生命科学研究部 消化器内科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 肝炎等克服緊急対策研究事業",
            "タイトル": "Ｃ型肝炎の新たな治療関連因子及び治癒後の病態進展・改善に関連する宿主因子等の同定を目指したゲノムワイド研究",
            "研究課題番号": "JP18fk0210001"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C",
          "DOI": "doi: 10.1038/ng.449",
          "データID": "hum0074.v1.vr.v1"
        },
        "2": {
          "タイトル": "Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C",
          "DOI": "doi: 10.1093/hmg/ddr249",
          "データID": "hum0074.v1.plt.v1\r\nhum0074.v1.Hb.v1"
        },
        "3": {
          "タイトル": "Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection",
          "DOI": "doi: 10.1053/j.gastro.2017.01.041",
          "データID": "hum0074.v2.hcc.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0074.v2": {
          "Research ID": "hum0074.v2",
          "公開日": "2018/09/25",
          "内容": "C型肝炎ウイルス排除（SVR）後の肝発がんに関するゲノムワイド関連解析",
          "description": "インターフェロン治療によるC型肝炎ウイルス排除（SVR）後の肝発がん：治療終了後1年以上経過して肝がんを発症した群（123例） vs. 治療終了後5年以上経過して肝がんを発症していない群（333例）について、Affymetrix Axiom Genome-Wide ASI 1 Array Plateを使用して遺伝子型決定を行い、ゲノムワイド関連解析（Genome-Wide Association Study：GWAS）を実施した結果を提供する（xlsx file）。\n"
        },
        "hum0074.v1": {
          "Research ID": "hum0074.v1",
          "公開日": "2018/02/27",
          "内容": "C型肝炎ウイルス感染に関するゲノムワイド関連解析\r\n（ウイルス排除、血小板減少、ヘモグロビン減少）",
          "description": "以下の対象について、Affymetrix Genome-Wide Human SNP Array 6.0を使用して遺伝子型決定を行い、ゲノムワイド関連解析（Genome-Wide Association Study：GWAS）を実施した結果を提供する（cvs file）。\n1. C型肝炎ウイルス著効（血中C型肝炎ウイルス排除の有無）\n　　　C型肝炎ウイルスRNAの陰性化が得られない群（null virological response［NVR］）：78症例\n　　　C型肝炎ウイルスRNAの持続陰性を示す群（sustained virological response［SVR］）：51症例\n　　　C型肝炎ウイルス応答群（virological response［VR］：SVR + transient virologic response［TVR］群）：64症例\n2. C型肝炎PEG-IFN/RBV併用療法による血小板減少\n　　　血小板減少有：107症例\n　　　血小板減少無：196症例\n3. 進展に伴うヘモグロビン減少\n　　　ヘモグロビン減少有：94症例\n　　　ヘモグロビン減少無：209症例\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0074.v2",
      "DATA": {
        "hum0074.v1.vr.v1": {
          "Data Set ID": "hum0074.v1.vr.v1",
          "Type of Data": "GWAS for 78 NVR and 64 VR\r\nGWAS for 78 NVR and 51 SVR",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/02/27"
        },
        "hum0074.v1.plt.v1": {
          "Data Set ID": "hum0074.v1.plt.v1",
          "Type of Data": "GWAS for 107 HCV patients with decrease of PLT in response to PEG-IFN/RBV treatment and 196 HCV patients without decrease of PLT in response to PEG-IFN/RBV treatment",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/02/27"
        },
        "hum0074.v1.Hb.v1": {
          "Data Set ID": "hum0074.v1.Hb.v1",
          "Type of Data": "GWAS for 94 HCV patients with Hb reduction and 209 HCV patients without Hb reduction",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/02/27"
        },
        "hum0074.v2.hcc.v1": {
          "Data Set ID": "hum0074.v2.hcc.v1",
          "Type of Data": "GWAS for HCC development after eradication of HCV by IFN-based treatment\r\n123 patients who developed HCC\r\n333 patients who did not develop HCC",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/09/25"
        }
      },
      "SUMMARY": {
        "Aims": "Genome-wide association studies on Hepatitis C virus-related diseases and construction of genome database",
        "Methods": "SNP-based genome-wide association studies",
        "Participants/Materials": "",
        "URL": "https://researchmap.jp/Yasuhito_Tanaka?lang=en"
      },
      "MOLECULAR DATA": {
        "hum0074.v1.vr.v1": {
          "Participants/Materials": "virologic response\r\n　　　78 null virologic response\r\n　　　64 virologic response\r\n　　　51 sustained virologic response",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "Genotype Call Methods (software)": "Birdseed version 3",
          "Filtering Methods": "Sample call rate < 0.95, SNP call rate < 0.95, \r\nHWE P < 0.001, Chi-square test (allelic model) P < 1 x 10^-4",
          "Marker Number (after QC)": "NVR vs VR: 43 SNPs (hg18)\r\nNVR vs SVR: 2 SNPs (hg18)",
          "NBDC Dataset ID": "hum0074.v1.vr.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "3 KB",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0074.v1.plt.v1": {
          "Participants/Materials": "decrease of PLT in response to PEG-IFN/RBV treatment\r\n　　　107 HCV patients with decrease of PLT\r\n　　　196 HCV patients without decrease of PLT",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "Genotype Call Methods (software)": "Birdseed version 3",
          "Filtering Methods": "Sample call rate < 0.95, SNP call rate < 0.95, \r\nHWE P < 0.001, Chi-square test (allelic model) P < 1 x 10^-4",
          "Marker Number (after QC)": "66 SNPs (hg18)",
          "NBDC Dataset ID": "hum0074.v1.plt.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "9 KB",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0074.v1.Hb.v1": {
          "Participants/Materials": "Hb reduction\r\n　　　94 HCV patients with Hb reduction\r\n　　　209 HCV patients without Hb reduction",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "Genotype Call Methods (software)": "Birdseed version 3",
          "Filtering Methods": "Sample call rate < 0.95, SNP call rate < 0.95, \r\nHWE P < 0.001, Chi-square test (allelic model) P < 1 x 10^-4",
          "Marker Number (after QC)": "32 SNPs (hg18)",
          "NBDC Dataset ID": "hum0074.v1.Hb.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "5 KB",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0074.v2.hcc.v1": {
          "Participants/Materials": "HCC development after eradication of HCV by IFN-based treatment (ICD10: C220)\r\n　　　123 patients who developed HCC\r\n　　　333 patients who did not develop HCC",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array Plate], DigiTag2 Assay, TaqMan SNP Genotyping Assays",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Axiom 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "Genotyping Console v4.1",
          "Filtering Methods": "Sample call rate < 0.95, SNP call rate < 0.95, MAF < 0.05, \r\nHWE P < 0.001, Chi-square test (allelic model) P < 1 x 10^-4",
          "Marker Number (after QC)": "70 SNPs (hg18)",
          "NBDC Dataset ID": "hum0074.v2.hcc.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "22 KB (xslx)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yasuhito Tanaka",
        "Affiliation": "Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Research Program on Hepatitis, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Genome-wide research for identification of host factors associated with liver disease progression or improvement after hepatitis C virus eradication.",
            "Project Number": "18fk0210001h0003"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C",
          "DOI": "doi: 10.1038/ng.449",
          "Data Set ID": "hum0074.v1.vr.v1"
        },
        "2": {
          "Title": "Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C",
          "DOI": "doi: 10.1093/hmg/ddr249",
          "Data Set ID": "hum0074.v1.plt.v1\r\nhum0074.v1.Hb.v1"
        },
        "3": {
          "Title": "Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection",
          "DOI": "doi: 10.1053/j.gastro.2017.01.041",
          "Data Set ID": "hum0074.v2.hcc.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0074.v2": {
          "Research ID": "hum0074.v2",
          "Release Date": "2018/09/25",
          "Type of Data": "GWAS for hepatocellular carcinoma (HCC) development after eradication of HCV by IFN-based treatment",
          "description": " A genome-wide association study for HCC development after eradication of HCV by IFN-based treatment (123 patients who developed HCC vs. 333 patients who did not develop HCC) was performed by using of Affymetrix Axiom Genome-Wide ASI 1 Array Plate (70 SNPs).\n"
        },
        "hum0074.v1": {
          "Research ID": "hum0074.v1",
          "Release Date": "2018/02/27",
          "Type of Data": "GWAS for patients with HCV infection (virologic response, platelet [PLT] reduction, and hemoglobin [Hb] reduction)",
          "description": " A genome-wide association studies for following symptoms were performed by using of Affymetrix Genome-Wide Human SNP Array 6.0.\n(1) 78 null virologic response, 64 virologic response, and 51 sustained virologic response (43 SNPs)\n(2) 107 HCV patients with decrease of PLT in response to PEG-IFN/RBV treatment and 196 HCV patients without decrease of PLT in response to PEG-IFN/RBV treatment (66 SNPs)\n(3) 94 HCV patients with Hb reduction and 209 HCV patients without Hb reduction (32 SNPs)\nNote：\n"
        }
      }
    }
  },
  "hum0072.v1": {
    "ja": {
      "NBDC Research ID": "hum0072.v1",
      "データ": {
        "hum0072.v1.nrc.v1": {
          "データID": "hum0072.v1.nrc.v1",
          "内容": "情動脱力発作を伴うナルコレプシー患者409症例および対照健常者1562名のGWAS",
          "制限": "非制限公開",
          "公開日": "2017/12/26"
        },
        "hum0072.v1.ehs.v1": {
          "データID": "hum0072.v1.ehs.v1",
          "内容": "HLA-DQB1*06:02陰性真性過眠症125症例およびHLA-DQB1*06:02陰性対照健常者562名のGWAS",
          "制限": "非制限公開",
          "公開日": "2017/12/26"
        }
      },
      "研究内容の概要": {
        "目的": "ナルコレプシーおよび各種睡眠障害の感受性遺伝子の同定と機能解析",
        "方法": "Affymetrix Genome-Wide Human SNP Array 6.0を使用して約90万個の一塩基多型（Single Nucleotide Polymorphisms：SNPs）の遺伝子型を決定後ゲノムワイド関連解析（Genome-Wide Association Study：GWAS）、および機能解析を実施",
        "対象": "情動脱力発作を伴うナルコレプシー患者409症例と対照健常者1562名、およびHLA-DQB1*06:02陰性真性過眠症125症例とHLA-DQB1*06:02陰性対照健常者562名",
        "URL": "http://www.humgenet.m.u-tokyo.ac.jp/"
      },
      "分子データ": {
        " hum0072.v1.narco.v1": {
          "対象": "情動脱力発作を伴うナルコレプシー患者：409症例\r\n対照健常者：1562名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Birdseed (version 1.5.5)",
          "フィルタリング": "Sample call rate < 0.95、SNP call rate < 0.97、HWE P (in control) < 0.001",
          "マーカー数（QC後）": "525,198 autosomal non-HLA SNPs（hg18）",
          "NBDC Dataset ID": "hum0072.v1.nrc.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "69 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0072.v1.ehs.v1": {
          "対象": "HLA-DQB1*06:02陰性真性過眠症：125症例\r\nHLA-DQB1*06:02陰性対照健常者：562名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Birdseed (version 1.5.5)",
          "フィルタリング": "Sample call rate < 0.95、SNP call rate < 0.99、HWE P < 0.001",
          "マーカー数(QC後)": "508,309 SNPs（hg18）",
          "NBDC Dataset ID": "hum0072.v1.ehs.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "31.6 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "徳永 勝士",
        "所 属 機 関": "東京大学大学院 医学系研究科",
        "プロジェクト/研究グループ名": "人類遺伝学教室",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "文部科学省科学研究費補助金　新学術領域研究",
            "タイトル": "HLA遺伝子群の多様性と疾病解析",
            "研究課題番号": "22133008"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A polymorphism in CCR1/CCR3 is associated with narcolepsy",
          "DOI": "doi: 10.1016/j.bbi.2015.05.003",
          "データID": "hum0072.v1.nrc.v1"
        },
        "2": {
          "タイトル": "Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia",
          "DOI": "doi: 10.7717/peerj.66",
          "データID": "hum0072.v1.ehs.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0072.v1": {
          "Research ID": "hum0072.v1",
          "公開日": "2017/12/26",
          "内容": "ゲノムワイド関連解析",
          "description": "以下の対象について、Affymetrix Genome-Wide Human SNP Array 6.0を使用して遺伝子型決定を行い、ゲノムワイド関連解析を実施した結果を提供する（csv file）。\n1．情動脱力発作を伴うナルコレプシー患者：409症例、対照健常者：1562名\n2．HLA-DQB1*06:02陰性真性過眠症：125症例、HLA-DQB1*06:02陰性対照健常者：562名\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0072.v1",
      "DATA": {
        "hum0072.v1.nrc.v1": {
          "Data Set ID": "hum0072.v1.nrc.v1",
          "Type of Data": "GWAS for 409 patients with narcolepsy-cataplexy and 1562 healthy controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/12/26"
        },
        "hum0072.v1.ehs.v1": {
          "Data Set ID": "hum0072.v1.ehs.v1",
          "Type of Data": "GWAS for 125 patients with HLA-DQB1*06:02 negative essential hypersomnia and 562 HLA-DQB1*06:02 negative healthy controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/12/26"
        }
      },
      "SUMMARY": {
        "Aims": "Identification and functional analyses of susceptibility genes to narcolepsy and other sleep disorders",
        "Methods": "SNP-based genome-wide association study and functional analysis",
        "Participants/Materials": "　(1) 409 patients with narcolepsy-cataplexy and 1562 healthy controls",
        "URL": "http://www.humgenet.m.u-tokyo.ac.jp/index.en.html"
      },
      "MOLECULAR DATA": {
        "hum0072.v1.nrc.v1": {
          "Participants/Materials": "409 patients with narcolepsy-cataplexy\r\n1562 healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "Genotype Call Methods (software)": "Birdseed (version 1.5.5)",
          "Filtering Methods": "Sample call rate < 0.95, SNP call rate < 0.97, HWE P (in control) < 0.001",
          "Marker Number (after QC)": "525,198 autosomal non-HLA SNPs (hg18)",
          "NBDC Dataset ID": "hum0072.v1.nrc.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "69 MB",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0072.v1.ehs.v1": {
          "Participants/Materials": "125 patients with HLA-DQB1*06:02 negative essential hypersomnia\r\n562 HLA-DQB1*06:02 negative healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Genome-Wide Human SNP Array 6.0]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Genome-Wide Human SNP Nsp/Sty Assay Kit 6.0",
          "Genotype Call Methods (software)": "Birdseed (version 1.5.5)",
          "Filtering Methods": "Sample call rate < 0.95, SNP call rate < 0.99, HWE P < 0.001",
          "Marker Number (after QC)": "508,309 SNPs (hg18)",
          "NBDC Dataset ID": "hum0072.v1.ehs.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "31.6 MB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Katsushi Tokunaga",
        "Affiliation": "Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "Department of Human Genetics",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "Variation and disease associations of HLA genes",
            "Project Number": "22133008"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A polymorphism in CCR1/CCR3 is associated with narcolepsy",
          "DOI": "doi: 10.1016/j.bbi.2015.05.003",
          "Data Set ID": "hum0072.v1.nrc.v1"
        },
        "2": {
          "Title": "Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia",
          "DOI": "doi: 10.7717/peerj.66",
          "Data Set ID": "hum0072.v1.ehs.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0072.v1": {
          "Research ID": "hum0072.v1",
          "Release Date": "2017/12/26",
          "Type of Data": "GWAS",
          "description": " (1) A genome-wide association study for 409 patients with narcolepsy-cataplexy and 1562 healthy controls was performed using 525,198 autosomal non-HLA SNPs (Affymetrix Genome-Wide Human SNP Array 6.0).\n(2) A genome-wide association study for 125 patients with HLA-DQB1*06:02 negative essential hypersomnia and 562 HLA-DQB1*06:02 negative healthy controls was performed using 508,366 SNPs (Affymetrix Genome-Wide Human SNP Array 6.0).\nNote：\n"
        }
      }
    }
  },
  "hum0070.v1": {
    "ja": {
      "NBDC Research ID": "hum0070.v1",
      "データ": {
        "JGAS000115": {
          "データID": "JGAS000115",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/05/11"
        }
      },
      "研究内容の概要": {
        "目的": "Birt-Hogg-Dube 症候群に発症した腎がんにおける遺伝子変異を明らかにする。",
        "方法": "全エキソン解析",
        "対象": "Birt-Hogg-Dube 症候群15症例",
        "URL": "http://www-user.yokohama-cu.ac.jp/~urology/wp/"
      },
      "分子データ": {
        "JGAS000115": {
          "対象": "バート・ホッグ・デュベ症候群：15症例\r\n　腎臓がん腫瘍組織29検体、及び非腫瘍組織（正常腎組織）15検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "腎臓がん腫瘍組織及び非腫瘍組織（正常腎組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect v.5 + lncRNA kit",
          "断片化の方法": "超音波断片化（Covaris S1）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000125",
          "総データ量": "485 GB（bam [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "矢尾 正祐",
        "所 属 機 関": "横浜市立大学大学院医学研究科・泌尿器科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん研究シーズ戦略的育成プログラム（P-DIRECT）",
            "タイトル": "バート・ホッグ・デュベ症候群の分子病態解明と新規の診断マーカーおよび治療標的分子の探索研究",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes.",
          "DOI": "doi: 10.1093/hmg/ddy181",
          "データID": "JGAD000125"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Maher Eamonn": {
          "研究代表者": "Maher Eamonn",
          "所属機関": "University of Cambridge",
          "研究題目": "イギリス",
          "利用データID": "Molecular Pathology of Human Genetic Disease",
          "利用期間": "JGAD000125"
        }
      },
      "リリース情報": {
        "hum0070.v1": {
          "Research ID": "hum0070.v1",
          "公開日": "2018/05/11",
          "内容": "NGS（Exome）",
          "description": "バート・ホッグ・デュベ症候群に発症した腎臓がん腫瘍組織及び非腫瘍組織（正常腎組織）から抽出したDNAを用いたExome解析の結果をbamファイルにて提供する。Agilent SureSelect v.5 + lncRNA kitを用いてExon領域にしぼりIllumina [HiSeq 2000]にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0070.v1",
      "DATA": {
        "JGAS000115": {
          "Data Set ID": "JGAS000115",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/05/11"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of gene mutations in Birt-Hogg-Dube (BHD) associated kidney cancer",
        "Methods": "Whole exome sequencing",
        "Participants/Materials": "15 BHD-associated kidney cancers"
      },
      "MOLECULAR DATA": {
        "JGAS000115": {
          "Participants/Materials": "Birt-Hogg-Dube (BHD) associated kidney cancer: 15 cases\r\n  29 kidney cancer samples and 15 normal kidney samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from kidney cancer and matched normal kidney samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect v.5 + lncRNA kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S1)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000125",
          "Total Data Volume": "485 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masahiro Yao",
        "Affiliation": "Department of Urology, Yokohama City University Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Elucidation of molecular pathogenesis and exploration for novel diagnostic marker and therapeutic target of Birt-Hogg-Dubé (BHD) syndrome-associated kidney cancer",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes.",
          "DOI": "doi: 10.1093/hmg/ddy181",
          "Data Set ID": "JGAD000125"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Maher Eamonn": {
          "Principal Investigator": "Maher Eamonn",
          "Affiliation": "University of Cambridge",
          "Research Title": "United Kingdom of Great Britain and Northern Ireland",
          "Data in Use (Dataset ID)": "Molecular Pathology of Human Genetic Disease",
          "Period of Data Use": "JGAD000125"
        }
      },
      "Release Note": {
        "hum0070.v1": {
          "Research ID": "hum0070.v1",
          "Release Date": "2018/05/11",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from Birt-Hogg-Dube (BHD) associated kidney cancer samples and normal kidney samples were used for the whole exome sequencing (bam files). Exons were narrowed down by using of Agilent SureSelect v.5 + lncRNA kit and read by Illumina [HiSeq 2000] (paired-end: 100 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0069.v1": {
    "ja": {
      "NBDC Research ID": "hum0069.v1",
      "データ": {
        "JGAS000064": {
          "データID": "JGAS000064",
          "内容": "NGS（small RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/12/09"
        }
      },
      "研究内容の概要": {
        "目的": "神経疾患患者の脳脊髄液（CSF）および血清中のエクソソーム分画におけるsmall RNA（miRNA）のプロファイリングを次世代シークエンサーを用いて行うことで、有用性の高いバイオマーカーを探索する。",
        "方法": "腰椎穿刺によりCSFおよび血清を採取し、超遠心法によりエクソソーム分画を分離後Total RNAを抽出した。Small RNAライブラリーはTruSeq Small RNA Library Prep Kit（Illumina社）を用いて作製し、10-30塩基のRNAを解析のターゲットとしてPCR 15サイクルで増幅後、HiSeq 2500（Illumina社）を用いて50 baseを読んだ（single-end）。Small RNAシークエンスデータはBWA（version 0.5.9）を用いてhuman reference genome（hg19）にマッピング、small RNAクラスターのmiRNAへのアノテーションにはmiRbase（version 20）を用いた。また、miRdeep2 package（version 2.0.0.7）の‘quantifier.pl’スクリプトを用いたデータ処理、解析もあわせて施行した。",
        "対象": "3名の神経筋疾患患者から得られた脳脊髄液および血清ペア（合計6検体）",
        "URL": "http://www.tmd.ac.jp/med/nuro/study.html#study01_3"
      },
      "分子データ": {
        "JGAS000064": {
          "対象": "神経筋疾患：3症例\r\n脳脊髄液および血清ペア　（合計 6検体、12サンプル）",
          "規模": "small RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "脳脊髄液および血清のエクソソーム分画から抽出したTotal RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Small RNA Library Prep Kit（Illumina社）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000064",
          "総データ量": "5 GB\r\n　Data ファイル数：12 （fastq）\r\n　Analysis ファイル数：1 （other [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "横田 隆徳",
        "所 属 機 関": "東京医科歯科大学大学院 脳神経病態学分野（神経内科）",
        "プロジェクト/研究グループ名": "体液中マイクロRNA測定技術基盤開発プロジェクト",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代治療・診断実現のための創薬基盤技術開発事業 / 新エネルギー・産業技術総合開発機構（NEDO）",
            "タイトル": "体液中マイクロRNA測定技術基盤開発",
            "研究課題番号": "JP16ae0101016"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes.",
          "DOI": "doi: 10.1016/j.neulet.2016.10.042",
          "データID": "JGAD000064"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Ana M. Aransay": {
          "研究代表者": "Ana M. Aransay",
          "所属機関": "CIC bioGUNE",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000064"
        }
      },
      "リリース情報": {
        "hum0069.v1": {
          "Research ID": "hum0069.v1",
          "公開日": "2016/12/09",
          "内容": "NGS（small RNA-seq）",
          "description": "神経筋疾患3症例から採取した脳脊髄液および血清ペア（合計6検体）から抽出したtotal RNAを使用し、small RNA-seq解析した結果をFastqファイルにて提供する。TruSeq Small RNA Library Prep Kit（Illumina社）によるmiRNAライブラリ作製後、10-30塩基のRNAをターゲットとしてHiSeq 2500にて平均長50ベースを読んだ（single-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0069.v1",
      "DATA": {
        "JGAS000064": {
          "Data Set ID": "JGAS000064",
          "Type of Data": "NGS (small RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/12/09"
        }
      },
      "SUMMARY": {
        "Aims": "MicroRNAs (miRNAs), particularly those found in human body fluids, have been suggested as potential biomarkers. Among various body fluids, the cerebrospinal fluid (CSF) shows promise as a profiling target for diagnosis and monitoring of neurological diseases. However, relevant genome-scale studies are limited and no studies have profiled exosomal miRNAs in CSF. Therefore, we conducted a next-generation sequencing-based survey of small RNAs in the exosomal and non-exosomal (supernatant) fractions of healthy human CSF as well as serum in each donor. Our data provided the first landscape of small RNAs in CSF exosome.",
        "Methods": "Samples were derived from three donors and subjected to a NGS-based survey. CSF samples were obtained via lumbar puncture, centrifuged to remove contaminating cells. Corresponding serum samples were simultaneously isolated from peripheral blood. Samples were further divided into exosomal and supernatant fractions via ultracentrifugation. Total RNA was isolated from each individual fractionated sample (Qiagen). Small RNA libraries were prepared using a TruSeq Small RNA Library Prep Kit (Illumina). Individual libraries were prepared with unique indexes, pooled and subjected to 50-base reads in single lanes of a HiSeq 2500 system (Illumina). Small RNA sequences were aligned to the human reference genome (hg19) using BWA (version 0.5.9). Small RNA clusters were annotated as miRNAs when their genomic coordinates overlapped with those of miRNAs registered in miRbase (version 20). The number of reads aligned within each individual cluster was normalized to counts per million (CPM) after applying a normalization factor based on the relative log expression method via edgeR. Post-processed reads were also analysed using the script ‘quantifier.pl’ in the miRdeep2 package (version 2.0.0.7; based on the miRbase database).",
        "Participants/Materials": "CSF and serum samples from three donors (neuromuscular disease patients) were analyzed.",
        "URL": "http://www.tmd.ac.jp/med/nuro/study2-e.html"
      },
      "MOLECULAR DATA": {
        "JGAS000064": {
          "Participants/Materials": "Neuromuscular disease (control group) : 3 patients\r\n(6 pairs of CSF and serum samples, total 12 samples)",
          "Targets": "small RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "Total RNA extracted from exosome of CSF and serum samples from three donors",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Small RNA Library Prep Kit (Illumina)",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000064",
          "Total Data Volume": "5 GB\r\n　　Data files : 12 (fastq)\r\n　　Analysis files : 1 (other [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takanori Yokota",
        "Affiliation": "Tokyo Medical and Dental University, Department of Neurology and Neurological Science",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Project Focused on Developing Key Technology for Discovering and Manufacturing Drugs for Next-Generation Treatment and Diagnosis, Japan Agency for Medical Research and Development (AMED) / New Energy and Industrial Technology Development Organization (NEDO)",
            "Title": "Development of Diagnostic Technology for Detection of miRNA in Body Fluids",
            "Project Number": "JP16ae0101016"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes.",
          "DOI": "doi: 10.1016/j.neulet.2016.10.042",
          "Data Set ID": "JGAD000064"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Ana M. Aransay": {
          "Principal Investigator": "Ana M. Aransay",
          "Affiliation": "CIC bioGUNE",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000064"
        }
      },
      "Release Note": {
        "hum0069.v1": {
          "Research ID": "hum0069.v1",
          "Release Date": "2016/12/09",
          "Type of Data": "NGS (small RNA-seq)",
          "description": "Total RNAs extracted from CSF and serum samples from three donors (neuromuscular disease patients) were used for the small RNA-seq (Fastq files).\nSmall RNA libraries were prepared using a TruSeq Small RNA Library Prep Kit (Illumina) and subjected to 50-base reads in single lanes of a HiSeq 2500 system (Illumina).\nNote：\n"
        }
      }
    }
  },
  "hum0068.v8": {
    "ja": {
      "NBDC Research ID": "hum0068.v8",
      "データ": {
        "JGAS000065": {
          "データID": "JGAS000065",
          "内容": "NGS（WGS：NovaSeq 6000）\r\nNGS（WGS：PromethION）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/10/19"
        },
        "JGAS000349": {
          "データID": "JGAS000349",
          "内容": "NGS（RNA-seq：PromethION）\r\nNGS（RNA-seq：NovaSeq 6000）\r\nNGS（WGS：PromethION）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/12/14"
        },
        "JGAS000349（データ追加）": {
          "データID": "JGAS000349（データ追加）",
          "内容": "NGS（scDNA-seq：NovaSeq 6000）\r\nNGS（RNA-seq：NovaSeq 6000）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/03/23"
        },
        "JGAD000670": {
          "データID": "JGAD000670",
          "内容": "JGAD000252の加工データ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/12/27"
        },
        "JGAS000570": {
          "データID": "JGAS000570",
          "内容": "NGS（WGS：NovaSeq 6000）\r\nNGS（WGS：PromethION）\r\nNGS（RNA-seq：NovaSeq 6000、HiSeq 2000）\r\nNGS（Target Capture）\r\nNGS（Visium Spatial Gene Expression）、病理画像\r\nMultiplex Fluorescence Immunostaining",
          "制限": "制限公開（Type I）",
          "公開日": "2023/02/10"
        },
        "JGAS000570（データ追加）": {
          "データID": "JGAS000570（データ追加）",
          "内容": "Xenium In Situ Gene Expression",
          "制限": "制限公開（Type I）",
          "公開日": "2023/09/22"
        }
      },
      "研究内容の概要": {
        "目的": "ナノポアシークエンサーMinIONを用いた肺腺がんの変異検出手法の確立",
        "方法": "【PCR amplicon Seq】ナノポアシークエンサーMinIONによるアンプリコンシークエンス",
        "対象": "肺腺がん8症例＋21症例＋74症例",
        "URL": "http://kero.hgc.jp/"
      },
      "分子データ": {
        "PCR amplicon Seq": {
          "対象": "肺腺がん（ICD10：C349）：8症例（7検体）",
          "規模": "PCR amplicon Seq",
          "対象領域（Target Captureの場合）": "EGFR・KRAS領域、および、EML4-ALK・KIF5B-RET領域\r\n検体１：EML4-ALK保有1症例（EML4-ALK領域）と KIF5B-RET保有１症例（KIF5B-RET領域）の増幅産物の混合検体（１検体）\r\n検体２～７：EGFRとKRAS領域の増幅産物（６検体）",
          "Platform": "Nanopore［MinION］",
          "ライブラリソース": "肺腺がん組織より抽出したRNAを逆転写したcDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Nanopore Sequencing Kit（Oxford Nanopore Technologies社）",
          "断片化の方法": "PCR",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "367 Mb",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000065",
          "総データ量": "889 MB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGS：NovaSeq 6000": {
          "対象": "肺腺がん（ICD10：C349）：21＋56症例（42＋112検体）\r\n　　腫瘍組織：21＋56検体\r\n　　非腫瘍組織：21＋56検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "肺腺がんの腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Nano DNA Library Prep kit、TruSeq DNA PCR-Free Library Prep Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "2.8 Tb",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000252\r\nJGAD000696",
          "NBDCおよび生命情報・DDBJ センターによる加工データのID": "JGAD000670\r\n加工方法はこちら",
          "総データ量": "2 TB＋23.9 TB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGS：PromethION": {
          "対象": "肺腺がん（ICD10：C349）：21＋42症例（41＋8＋81検体）\r\n　　腫瘍組織：21＋4＋42検体\r\n　　非腫瘍組織：20 ＋4＋39検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Nanopore [PromethION]",
          "ライブラリソース": "肺腺がんの腫瘍組織および非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SQK-LSK109",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "2.7 Tb",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000253\r\nJGAD000463\r\nJGAD000696",
          "総データ量": "2.4 TB ＋1.4 TB＋23.9 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq：PromethION": {
          "対象": "肺腺がん（ICD10：C349）：6症例（12検体）\r\n　　腫瘍組織：6検体\r\n　　非腫瘍組織：6検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Nanopore [PromethION]",
          "ライブラリソース": "肺腺がんの腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing、SQK-LSK109",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "平均 850 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000463",
          "総データ量": "1.4 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq：NovaSeq 6000、HiSeq 2000": {
          "対象": "肺腺がん（ICD10：C349）：6＋5＋26症例 （12＋5＋26検体）\r\n　　腫瘍組織：6＋5＋26検体\r\n　　非腫瘍組織：6検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000、HiSeq 2000]",
          "ライブラリソース": "肺腺がんの腫瘍組織および非腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing、Nextera XT DNA Library Preparation Kit、TruSeq Stranded mRNA Library Prep、TruSeq Stranded Total RNA Library Prep Gold、SMART-Seq Stranded Kit",
          "断片化の方法": "Tagmentation（Nextera XT DNA Library Preparation Kit）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000463\r\nJGAD000696",
          "総データ量": "1.4 TB＋941.7 GB＋23.9 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "scDNA-seq": {
          "対象": "肺腺がん（ICD10：C349）：2症例\r\n　　腫瘍組織：2検体",
          "規模": "scDNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "肺腺がんの腫瘍組織より単離した細胞から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Single Cell DNA Reagent Kits（10x Genomics）",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000463",
          "総データ量": "941.7 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Target Capture": {
          "対象": "肺腺がん（ICD10：C349）：36症例\r\n　　腫瘍組織：36検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "NCC Oncopanel v2\r\nhttps://www.ncc.go.jp/jp/information/pr_release/2019/0529/index.html",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "肺腺がんの腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect NCC oncopanel",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000696",
          "総データ量": "23.9 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Visium Spatial Gene Expression、病理画像": {
          "対象": "肺腺がん（ICD10：C349）：3症例\r\n　　腫瘍組織：3検体",
          "規模": "Visium Spatial Gene Expression、病理画像",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "ライブラリソース": "肺腺がんの腫瘍組織から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Visium Spatial Gene Expression Reagent Kits",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "118 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000696",
          "総データ量": "102.1 GB（fastq、png、json、csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Multiplex Fluorescence Immunostaining": {
          "対象": "肺腺がん（ICD10：C349）：3症例\r\n　　腫瘍組織：3検体",
          "規模": "Multiplex Fluorescence Immunostaining",
          "対象領域（Target Captureの場合）": "Cycle/蛍光タンパク質対応表",
          "Platform": "Akoya Biosciences [PhenoCycler]",
          "ライブラリソース": "肺腺がんの腫瘍組織",
          "検体情報（購入の場合）": "-",
          "細胞処理方法（キット名）": "Staining Kit for PhenoCycler",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000696",
          "総データ量": "102.1 GB（qptiff）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Xenium In Situ Gene Expression": {
          "対象": "肺腺がん（ICD10：C349）：1症例＋1症例\r\n　　腫瘍組織：1検体＋1検体",
          "規模": "Xenium In Situ Gene Expression",
          "対象領域（Target Captureの場合）": "302遺伝子（Human Lung panel：202遺伝子、カスタム：100遺伝子）",
          "Platform": "10x Genomics [Xenium Analyzer]",
          "ソース": "肺腺がんの腫瘍組織",
          "検体情報（購入の場合）": "-",
          "調整試薬（パネル、キット名、バージョンなど）": "Xenium Slides & Sample Prep Reagents\r\nXenium Decoding Reagents\r\nXenium Decoding Consumables",
          "解析ソフトウェア（可視化ツールなど）": "xenium-1.1.0.2\r\nxenium-1.5.1.2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000696",
          "総データ量": "肺腺がん：16.1＋2.1 GB（csv、h5、html、json、mtx、tiff、parquet、tsv、xenium、zarr）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "河野 隆志",
        "所 属 機 関": "国立がん研究センター ゲノム生物学研究分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "5": {
            "科研費・助成金名": "",
            "タイトル": "",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Sequencing and phasing cancer mutations in lung cancers using a long-read portable sequencer.",
          "DOI": "doi: 10.1093/dnares/dsx027",
          "データID": "JGAD000065"
        },
        "2": {
          "タイトル": "Long-read sequencing for non-small-cell lung cancer genomes",
          "DOI": "doi: 10.1101/gr.261941.120",
          "データID": "JGAD000252JGAD000253"
        },
        "3": {
          "タイトル": "Phasing analysis of lung cancer genomes using a long read sequencer",
          "DOI": "doi: 10.1038/s41467-022-31133-6",
          "データID": "JGAD000252JGAD000253JGAD000463"
        },
        "4": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000252"
        }
      },
      "リリース情報": {
        "hum0068.v8": {
          "Research ID": "hum0068.v8",
          "公開日": "2023/09/22",
          "内容": "Xenium In Situ Gene Expression",
          "description": "肺腺がん1症例の腫瘍組織に対して実施した10xによるXenium高性能in situ遺伝子発現マッピングデータをcsv、h5、html、json、mtx、tiff、parquet、tsv、xenium、zarrファイルにて提供する。\n"
        },
        "hum0068.v7": {
          "Research ID": "hum0068.v7",
          "公開日": "2023/06/19",
          "内容": "Xenium In Situ Gene Expression",
          "description": "肺腺がん1症例の腫瘍組織に対して実施した10xによるXenium高性能in situ遺伝子発現マッピングデータをcsv、h5、html、json、mtx、tiff、parquet、tsv、xenium、zarrファイルにて提供する。\n"
        },
        "hum0068.v6": {
          "Research ID": "hum0068.v6",
          "公開日": "2023/02/10",
          "内容": "NGS（WGS、RNA-seq、Target Capture、Visium Spatial Gene Expression）、病理画像、Multiplex Fluorescence Immunostaining",
          "description": "肺腺がん74症例の腫瘍組織および非腫瘍組織から抽出したDNA/RNAを対象としたWGS解析、RNA-seq解析、ならびにTarget Capture解析の結果をfastqファイルにて提供する。TruSeq Nano DNA Library Prep kit、TruSeq DNA PCR-Free Library Prep Kit、SQK-LSK109、SMART-Seq v4 Ultra Low Input RNA Kit、Nextera XT DNA Library Preparation Kit、TruSeq Stranded mRNA Library Prep、TruSeq Stranded Total RNA Library Prep Gold、SMART-Seq Stranded KitおよびSureSelect NCC oncopanelにてライブラリを作製し、NovaSeq、HiSeqおよびナノポアシークエンサーPromethIONを用いてシークエンスを行った。\n肺腺がん3症例の腫瘍組織に対して実施したIlluminaによる空間トランスクリプトームVisiumシークエンスデータをfastq、png、json、csvファイルにて提供する。\n肺腺がん3症例の腫瘍組織に対して実施したPhenoCyclerシステムによる多重蛍光免疫染色データをqptiffファイルにて提供する。\n"
        },
        "hum0068.v5": {
          "Research ID": "hum0068.v5",
          "公開日": "2022/12/27",
          "内容": "JGAD000252の加工データ",
          "description": "hum0068.v2のfastqファイル（JGAD000252）に対して、特定の解析パイプラインにより加工したCRAM/gVCF/aggregate VCFファイルを提供する。利用を希望する場合は、データ利用申請書にJGAD000252（元データ）とJGAD000670（加工データ）を記載すること。\n"
        },
        "hum0068.v4": {
          "Research ID": "hum0068.v4",
          "公開日": "2022/03/23",
          "内容": "NGS（scDNA-seq、RNA-seq）",
          "description": "肺腺がん2症例の腫瘍組織から単離した細胞から抽出したDNAを対象としたsingle cellのWGS解析結果をfastqファイルにて提供する。Chromium Single Cell DNA Reagent Kits にてライブラリを作製し、NovaSeqを用いてシークエンスを行った。\n肺腺がん5症例の腫瘍組織から抽出したRNAを対象としたRNA-seq解析の結果をfastqファイルにて提供する。SMART-Seq v4 Ultra Low Input RNA Kitにてライブラリを作製し、NovaSeqを用いてシークエンスを行った。\n"
        },
        "hum0068.v3": {
          "Research ID": "hum0068.v3",
          "公開日": "2021/12/14",
          "内容": "NGS（RNA-seq、WGS）",
          "description": "肺腺がん11症例の腫瘍組織および非腫瘍組織から抽出したRNA/DNAを対象としたRNA-seq解析ならびにWGS解析の結果をfastqファイルにて提供する。SMART-Seq v4 Ultra Low Input RNA KitおよびSQK-LSK109にてライブラリを作製し、NovaSeqおよびナノポアシークエンサーPromethIONを用いてシークエンスを行った。\n"
        },
        "hum0068.v2": {
          "Research ID": "hum0068.v2",
          "公開日": "2020/10/19",
          "内容": "NGS（WGS）",
          "description": "肺腺がん21症例の腫瘍組織および非腫瘍組織から抽出したDNAを対象としたWGS解析の結果をfastqファイルにて提供する。TruSeq Nano DNA Library Prep kitおよびSQK-LSK109にてライブラリを作製し、NovaSeqおよびナノポアシークエンサーPromethIONを用いてシークエンスを行った。\n"
        },
        "hum0068.v1": {
          "Research ID": "hum0068.v1",
          "公開日": "2017/07/10",
          "内容": "NGS（PCR amplicon Seq）",
          "description": "肺腺がん8症例の腫瘍組織から抽出したRNAを対象とし、逆転写反応の後にPCRによって目的領域を増幅した。Nanopore Sequencing Kitにてライブラリを作製し、MinION（Oxford Nanopore Technologies社）を用いたシークエンスの結果をFastqファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0068.v8",
      "DATA": {
        "JGAS000065": {
          "Data Set ID": "JGAS000065",
          "Type of Data": "NGS (WGS: NovaSeq 6000)\r\nNGS (WGS: PromethION)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/10/19"
        },
        "JGAS000349": {
          "Data Set ID": "JGAS000349",
          "Type of Data": "NGS (RNA-seq: PromethION)\r\nNGS (RNA-seq: NovaSeq 6000)\r\nNGS (WGS: PromethION)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/12/14"
        },
        "JGAS000349 (Data addition)": {
          "Data Set ID": "JGAS000349 (Data addition)",
          "Type of Data": "NGS (scDNA-seq : NovaSeq 6000)\r\nNGS (RNA-seq : NovaSeq 6000)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/03/23"
        },
        "JGAD000670": {
          "Data Set ID": "JGAD000670",
          "Type of Data": "Processed data of JGAD000252 by JGA",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/12/27"
        },
        "JGAS000570": {
          "Data Set ID": "JGAS000570",
          "Type of Data": "NGS (WGS: NovaSeq 6000)\r\nNGS (WGS: PromethION)\r\nNGS (RNA-seq : NovaSeq 6000, HiSeq 2000)\r\nNGS (Target Capture)\r\nNGS (Visium Spatial Gene Expression), Histological image\r\nMultiplex Fluorescence Immunostaining",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/02/10"
        },
        "JGAS000570 (Data addition)": {
          "Data Set ID": "JGAS000570 (Data addition)",
          "Type of Data": "Xenium In Situ Gene Expression",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/09/22"
        }
      },
      "SUMMARY": {
        "Aims": "Establishing a method for detecting variations of lung adenocarcinoma",
        "Methods": "[PCR amplicon Seq] Amplicon sequencing by using of MinION (Nanopore)",
        "Participants/Materials": "Lung adenocarcinoma",
        "URL": "http://kero.hgc.jp/"
      },
      "MOLECULAR DATA": {
        "PCR amplicon Seq": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 8 cases (7 samples)",
          "Targets": "PCR amplicon Seq",
          "Target Loci for Capture Methods": "sample 1: Amplicons from EML4-ALK positive case (EML4-ALK region) and KIF5B-RET positive case (KIF5B-RET region) were mixed (1 sample)\r\nsample 2 - 7: Amplicons from 6 cases (EGFR and KRAS regions) ",
          "Platform": "Nanopore [MinION]",
          "Library Source": "cDNA were synthesized from mRNA extracted from lung adenocarcinomas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Nanopore Sequencing Kit (Oxford Nanopore Technologies)",
          "Fragmentation Methods": "PCR",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "367 Mb",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000065",
          "Total Data Volume": "889 MB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGS: NovaSeq 6000": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 21 + 56 cases (42 + 112 samples)\r\n          tumor tissues: 21 + 56 samples\r\n          normal tissues: 21 + 56 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor and normal tissues of lung adenocarcinomas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Nano DNA Library Prep kit, TruSeq DNA PCR-Free Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "2.8 Tb",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000252\r\nJGAD000696",
          "Dataset ID of the Processed data by JGA": "JGAD000670\r\nThe way to Process",
          "Total Data Volume": "2 + 23.9 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGS: PromethION": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 21 + 42 cases (41 + 8 + 81 samples)\r\n          tumor tissues: 21 + 4 + 42 samples\r\n          normal tissues: 20 + 4 + 39 samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Nanopore [PromethION]",
          "Library Source": "DNAs extracted from tumor and normal tissues of lung adenocarcinomas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SQK-LSK109",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "2.7 Tb",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000253\r\nJGAD000463\r\nJGAD000696",
          "Total Data Volume": "2.4 + 1.4 + 23.9 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq: PromethION": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 6 cases (12 samples)\r\n          tumor tissues: 6 samples\r\n          normal tissues: 6 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Nanopore [PromethION]",
          "Library Source": "RNAs extracted from tumor and normal tissues of lung adenocarcinomas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing, SQK-LSK109",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "850 bp on average",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000463",
          "Total Data Volume": "1.4 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq: NovaSeq 6000, HiSeq 2000": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 6 + 5 + 26 cases (12 + 5 + 26 samples)\r\n          tumor tissues: 6 + 5 + 26 samples\r\n          normal tissues: 6 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000, HiSeq 2000]",
          "Library Source": "RNAs extracted from tumor and normal tissues of lung adenocarcinomas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing, Nextera XT DNA Library Preparation Kit, TruSeq Stranded mRNA Library Prep, TruSeq Stranded Total RNA Library Prep Gold, SMART-Seq Stranded Kit",
          "Fragmentation Methods": "Tagmentation (Nextera XT DNA Library Preparation Kit)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000463\r\nJGAD000696",
          "Total Data Volume": "1.4 TB + 941.7 GB + 23.9 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "scDNA-seq": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 2 cases\r\n          tumor tissues: 2 samples",
          "Targets": "scDNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from single cells in tumor tissues of lung adenocarcinomas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Single Cell DNA Reagent Kits (10x Genomics)",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000463",
          "Total Data Volume": "941.7 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Target Capture": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 36 cases\r\n          tumor tissues: 36 samples",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "NCC Oncopanel v2\r\nhttps://www.ncc.go.jp/en/information/press_release/20190717/20190717152024.html",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "DNAs extracted from tumor tissues of lung adenocarcinomas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect NCC oncopanel",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000696",
          "Total Data Volume": "23.9 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "Visium Spatial Gene Expression, Histological image": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 3 cases\r\n          tumor tissues: 3 samples",
          "Targets": "Visium Spatial Gene Expression, Histological image",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NovaSeq 6000]",
          "Library Source": "RNAs extracted from tumor tissues of lung adenocarcinomas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Visium Spatial Gene Expression Reagent Kits",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "118 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000696",
          "Total Data Volume": "102.1 GB (fastq, png, json, csv)",
          "Comments (Policies)": "NBDC policy"
        },
        "Multiplex Fluorescence Immunostaining": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 3 cases\r\n          tumor tissues: 3 samples",
          "Targets": "Multiplex Fluorescence Immunostaining",
          "Target Loci for Capture Methods": "cycle/probe information",
          "Platform": "Akoya Biosciences [PhenoCycler]",
          "Library Source": "tumor tissues of lung adenocarcinomas",
          "Cell Lines": "-",
          "Cell Treatment Method (kit name)": "Staining Kit for PhenoCycler",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000696",
          "Total Data Volume": "102.1 GB (qptiff)",
          "Comments (Policies)": "NBDC policy"
        },
        "Xenium In Situ Gene Expression": {
          "Participants/Materials": "lung adenocarcinoma (ICD10: C349): 1 + 1 cases\r\n          tumor tissues: 1 + 1 samples",
          "Targets": "Xenium In Situ Gene Expression",
          "Target Loci for Capture Methods": "302 genes (Human Lung panel: 202 genes, custom: 100 genes）",
          "Platform": "10x Genomics [Xenium Analyzer]",
          "Source": "tumor tissues of lung adenocarcinomas",
          "Cell Lines": "-",
          "Reagents (Panel, Kit, Version)": "Xenium Slides & Sample Prep Reagents\r\nXenium Decoding Reagents\r\nXenium Decoding Consumables",
          "Software": "xenium-1.1.0.2\r\nxenium-1.5.1.2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000696",
          "Total Data Volume": "lung adenocarcinoma: 16.1 + 2.1 GB (csv, h5, html, json, mtx, tiff, parquet, tsv, xenium, zarr)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takashi Kono",
        "Affiliation": "Division of Genome Biology, National Cancer Center Research Institute",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "5": {
            "Name": "",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Sequencing and phasing cancer mutations in lung cancers using a long-read portable sequencer.",
          "DOI": "doi: 10.1093/dnares/dsx027",
          "Data Set ID": "JGAD000065"
        },
        "2": {
          "Title": "Long-read sequencing for non-small-cell lung cancer genomes",
          "DOI": "doi: 10.1101/gr.261941.120",
          "Data Set ID": "JGAD000252JGAD000253"
        },
        "3": {
          "Title": "Phasing analysis of lung cancer genomes using a long read sequencer",
          "DOI": "doi: 10.1038/s41467-022-31133-6",
          "Data Set ID": "JGAD000252JGAD000253JGAD000463"
        },
        "4": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000252"
        }
      },
      "Release Note": {
        "hum0068.v8": {
          "Research ID": "hum0068.v8",
          "Release Date": "2023/09/22",
          "Type of Data": "Xenium In Situ Gene Expression",
          "description": "Tumor tissue of a lung adenocarcinoma patient was used for Xenium In Situ Gene Expression Assay. Csv, h5, html, json, mtx, tiff, parquet, tsv, xenium, and zarr files are provided.\n"
        },
        "hum0068.v7": {
          "Research ID": "hum0068.v7",
          "Release Date": "2023/06/19",
          "Type of Data": "Xenium In Situ Gene Expression",
          "description": "Tumor tissue of a lung adenocarcinoma patient was used for Xenium In Situ Gene Expression Assay. Csv, h5, html, json, mtx, tiff, parquet, tsv, xenium, and zarr files are provided.\n"
        },
        "hum0068.v6": {
          "Research ID": "hum0068.v6",
          "Release Date": "2023/02/10",
          "Type of Data": "NGS (WGS, RNA-seq, Target Capture, Visium Spatial Gene Expression), histological image, Multiplex Fluorescence Immunostaining",
          "description": "DNAs/RNAs were extracted from 3 lung adenocarcinoma patients. Libraries were prepared using TruSeq Nano DNA Library Prep kit, TruSeq DNA PCR-Free Library Prep Kit, SQK-LSK109, SMART-Seq v4 Ultra Low Input RNA Kit, Nextera XT DNA Library Preparation Kit, TruSeq Stranded mRNA Library Prep, TruSeq Stranded Total RNA Library Prep Gold, SMART-Seq Stranded Kit and SureSelect NCC oncopanel and DNA/RNA sequencing was performed by using of NovaSeq, HiSeq and PromethION. Fastq files are provided (paired-end / single-end).\nRNAs extracted from tumor tissues of 3 lung adenocarcinoma patients were used for Visium Spatial Gene Expression Assay. Fastq, png, json and csv files are provided.\nTumor tissues of 3 lung adenocarcinoma patients were used for multiplex fluorescence immunostaining. Qptiff files are provided.\n"
        },
        "hum0068.v5": {
          "Research ID": "hum0068.v5",
          "Release Date": "2022/12/27",
          "Type of Data": "Processed data of JGAD000252 by JGA",
          "description": "The alignment results [CRAM], variant call results per sample [gVCF], and variant call results per dataset [aggregated VCF] processed JGAD000252 in a certain workflow were provided. If you plan to use the data, please indicate both original data (JGAD000252) and processed data (JGAD000670) on the application form for data use.\n"
        },
        "hum0068.v4": {
          "Research ID": "hum0068.v4",
          "Release Date": "2022/03/23",
          "Type of Data": "NGS (scDNA-seq, RNA-seq)",
          "description": "Single-cell DNAs were extracted from 2 lung adenocarcinoma patients. Libraries were prepared using Chromium Single Cell DNA Reagent Kits (10x Genomics) and DNA sequencing was performed by using of NovaSeq. Fastq files are provided (paired-end).\nRNAs were extracted from 5 lung adenocarcinoma patients. Libraries were prepared using SMART-Seq v4 Ultra Low Input RNA Kit and RNA sequencing was performed by using of NovaSeq. Fastq files are provided (paired-end).\n"
        },
        "hum0068.v3": {
          "Research ID": "hum0068.v3",
          "Release Date": "2021/12/14",
          "Type of Data": "NGS (RNA-seq, WGS)",
          "description": "RNAs/DNAs were extracted from 11 lung adenocarcinoma patients. Libraries were prepared using SMART-Seq v4 Ultra Low Input RNA Kit / SQK-LSK109 and RNA/DNA sequencing was performed by using of NovaSeq and PromethION. Fastq files are provided (paired-end / single-end).\n"
        },
        "hum0068.v2": {
          "Research ID": "hum0068.v2",
          "Release Date": "2020/10/19",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs were extracted from 21 lung adenocarcinoma patients. Libraries were prepared using TruSeq Nano DNA Library Prep kit / SQK-LSK109 and DNA sequencing was performed by using of NovaSeq and PromethION. Fastq files are provided (paired-end / single-end).\n"
        },
        "hum0068.v1": {
          "Research ID": "hum0068.v1",
          "Release Date": "2017/07/10",
          "Type of Data": "NGS (PCR amplicon seq)",
          "description": "RNAs were extracted from 8 lung adenocarcinoma patients. After reverse transcription reaction, target regions were amplified by PCR. Libraries were prepared using Nanopore Sequencing Kit and DNA sequencing was performed by using of MinION (Oxford Nanopore Technologies). Fastq files are provided (single-end).\nNote:\n"
        }
      }
    }
  },
  "hum0067.v1": {
    "ja": {
      "NBDC Research ID": "hum0067.v1",
      "データ": {
        "JGAS000076": {
          "データID": "JGAS000076",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/05/18"
        }
      },
      "研究内容の概要": {
        "目的": "卵巣明細胞腺がんに対する新規バイオマーカーの検索と化学療法感受性に関する検討",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "卵巣明細胞腺がん55症例の腫瘍組織と非腫瘍組織（末梢血または間質組織）の合計110検体",
        "URL": "http://p-direct.jfcr.or.jp/program/group02/team01.html"
      },
      "分子データ": {
        "JGAS000076": {
          "対象": "卵巣明細胞腺がん：55症例\r\n腫瘍組織および非腫瘍組織（末梢血または間質組織）：計110検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "腫瘍組織もしくは非腫瘍組織（末梢血または間質組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Custom Kit （SureSelect Human All Exon V5 + lincRNA）",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000076",
          "総データ量": "2 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "杉山 徹",
        "所 属 機 関": "岩手医科大学 医学部 産婦人科学講座",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "文部科学省　次世代がん研究シーズ戦略的育成プログラム",
            "タイトル": "卵巣がんにおける化学療法効果規定因子の探索",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "-",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "万代 昌紀": {
          "研究代表者": "万代 昌紀",
          "所属機関": "京都大学医学部医学研究科婦人科学産科学教室",
          "研究題目": "",
          "利用データID": "多様な臨床情報を考慮した婦人科悪性腫瘍患者のオミックス解析（全ゲノム・全トランスクリプト-ム・プロテオーム・メタボローム解析）による個別化治療の探索",
          "利用期間": "JGAD000076"
        },
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000076"
        },
        "角田 達彦": {
          "研究代表者": "角田 達彦",
          "所属機関": "東京大学生物科学専攻 医科学数理研究室",
          "研究題目": "",
          "利用データID": "オーダーメイド医療のためのシーケンス、画像データなどの解析に関する研究（9）",
          "利用期間": "JGAD000076"
        }
      },
      "リリース情報": {
        "hum0067.v1": {
          "Research ID": "hum0067.v1",
          "公開日": "2017/05/18",
          "内容": "NGS（Exome）",
          "description": "このバージョンでは、卵巣明細胞腺がん55症例の腫瘍組織もしくは非腫瘍組織（末梢血または間質組織）から抽出したDNAを使用したExome解析の結果をFastqファイルにて提供する。HiSeq 2000（Illumina）を用いて平均長150から200塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0067.v1",
      "DATA": {
        "JGAS000076": {
          "Data Set ID": "JGAS000076",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/05/18"
        }
      },
      "SUMMARY": {
        "Aims": "To identify novel predictive biomarkers of response to chemotherapy for clear cell carcinoma of the ovary",
        "Methods": "whole exome sequencing by using of Illumina HiSeq 2000",
        "Participants/Materials": "110 samples (non-tumor and tumor tissues) from 55 ovarian clear cell carcinoma patients",
        "URL": "http://p-direct.jfcr.or.jp/english/"
      },
      "MOLECULAR DATA": {
        "JGAS000076": {
          "Participants/Materials": "ovarian clear cell carcinoma: 55 cases \r\n(tumor: 55 samples and non-tumor: 55 samples)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Custom Kit (SureSelect Human All Exon V5 + lincRNA)",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000076",
          "Total Data Volume": "2 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toru Sugiyama",
        "Affiliation": "Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Project for Development of Innovative Research on Cancer Therapeutics",
            "Title": "Identifiying the predictive factors for response to chemoherapy in ovarian cancer",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "-",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Masaki Mandai": {
          "Principal Investigator": "Masaki Mandai",
          "Affiliation": "Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Integrated analyses of omics (genomics, transcriptomics, proteomics and metabolomics) associated with clinical variables for developing indivisualizedtreatment in gynecological malignancy",
          "Period of Data Use": "JGAD000076"
        },
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000076"
        },
        "Tatsuhiko Tsunoda": {
          "Principal Investigator": "Tatsuhiko Tsunoda",
          "Affiliation": "Department of Biological Sciences, Graduate School of Science, The University of Tokyo",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Research on sequence, image data analysis for precision medicine (9)",
          "Period of Data Use": "JGAD000076"
        }
      },
      "Release Note": {
        "hum0067.v1": {
          "Research ID": "hum0067.v1",
          "Release Date": "2017/05/18",
          "Type of Data": "NGS (Exome)",
          "description": " DNAs extracted from110 non-tumor or tumor tissues (55 ovarian clear cell carcinoma patients) were used for the whole exome sequencing (fastq files).\n Exons were narrowed down by using of SureSelect Human All Exon V5 + lincRNA and read by Illumina HiSeq 2000 (paired-end: 100 bp x 2).\nNote：\n"
        }
      }
    }
  },
  "hum0066.v1": {
    "ja": {
      "NBDC Research ID": "hum0066.v1",
      "データ": {
        "JGAS000060": {
          "データID": "JGAS000060",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/08/01"
        }
      },
      "研究内容の概要": {
        "目的": "大腸がんのゲノムレベルの腫瘍内不均一性について明らかにする",
        "方法": "大腸がんと肝転移巣の腫瘍組織および非腫瘍組織より抽出したDNAを使用したエクソーム解析",
        "対象": "根治的腫瘍切除術を実施した大腸がん9症例",
        "URL": "https://www.kyushu-u.ac.jp/f/5858/2016_02_19_2.pdf"
      },
      "分子データ": {
        "JGAS000060": {
          "対象": "大腸がん：9症例（84検体 [腫瘍組織：71検体、肝転移巣：4検体、非腫瘍組織：9検体]）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "大腸がん症例の腫瘍組織、非腫瘍組織、および肝転移巣より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon Kit v4.0 （Agilent Technologies）\r\n　　　1症例9検体（腫瘍組織：8検体、非腫瘍組織1検体）\r\nSureSelect Human All Exon Kit v5.0 （Agilent Technologies）\r\n　　　8症例75検体（腫瘍組織：63検体、肝転移巣：4検体、非腫瘍組織：8検体）",
          "断片化の方法": "超音波断片化（Covaris社）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000060",
          "総データ量": "1545 GB（fastq [1650 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "三森 功士",
        "所 属 機 関": "九州大学病院 別府病院 外科",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "HPCI戦略プログラム　分野1",
            "タイトル": "予測する生命科学・医療および創薬基盤",
            "研究課題番号": "SCLS課題4"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.",
          "DOI": "doi: 10.1371/journal.pgen.1005778",
          "データID": "JGAD000060"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Christina Curtis": {
          "研究代表者": "Christina Curtis",
          "所属機関": "Stanford Univ.",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000060"
        },
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000060"
        },
        "Ruping Sun": {
          "研究代表者": "Ruping Sun",
          "所属機関": "Department of laboratory medicine and pathology, University of Minnesota",
          "研究題目": "",
          "利用データID": "Accounting for Copy Number States in Quantifying Tumor Heterogeneity",
          "利用期間": "JGAD000060"
        }
      },
      "リリース情報": {
        "hum0066.v1": {
          "Research ID": "hum0066.v1",
          "公開日": "2016/08/01",
          "内容": "NGS（Exome）",
          "description": "根治的腫瘍切除術を実施した大腸がん9症例の腫瘍組織、肝転移巣、および非腫瘍組織（正常組織）から抽出したDNAを使用したExome解析の結果をFastqファイルにて提供する。\nAgilent社のSureSelect Human All Exon V4またはV5を使用してExon領域にしぼり、HiSeq 2000にて平均長227塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0066.v1",
      "DATA": {
        "JGAS000060": {
          "Data Set ID": "JGAS000060",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/08/01"
        }
      },
      "SUMMARY": {
        "Aims": "Investigating a genomic-level intratumor heterogeneity in colorectal carcinoma",
        "Methods": "DNA were extracted from multiregional tumor samples and performed a whole exome sequencing analysis",
        "Participants/Materials": "Samples which obtained during surgery from patients who underwent radical resection of primary and/or liver metastatic tumors"
      },
      "MOLECULAR DATA": {
        "JGAS000060": {
          "Participants/Materials": "colorectal carcinoma: 9 cases (84 samples [tumor tissues: 71 samples, non-cancerous tissues: 9 samples, liver metastatic tumor tissues: 4 samples]）",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from tumor, non-cancerous tissues or liver metastatic tumor tissues from colorectal carcinoma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon Kit v4.0 (Agilent Technologies)\r\n　　　1 cases 9 samples (tumor tissues: 8 samples, non-cancerous tissues: 1 sample)\r\nSureSelect Human All Exon Kit v5.0 (Agilent Technologies)\r\n　　　8 cases 75 samples (tumor tissues: 63 samples, non-cancerous tissues: 8 samples, liver metastatic tumor tissues: 4 samples)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000060",
          "Total Data Volume": "1545 GB (1650 fastq files)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koshi Mimori",
        "Affiliation": "Department of Surgery, Kyushu University Beppu Hospital",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Strategic Programs for Innovative Research (SPIRE) Field 1",
            "Title": "Supercomputational Life Science",
            "Project Number": "SCLS Theme4"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.",
          "DOI": "doi: 10.1371/journal.pgen.1005778",
          "Data Set ID": "JGAD000060"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Christina Curtis": {
          "Principal Investigator": "Christina Curtis",
          "Affiliation": "Stanford Univ.",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000060"
        },
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000060"
        },
        "Ruping Sun": {
          "Principal Investigator": "Ruping Sun",
          "Affiliation": "Department of laboratory medicine and pathology, University of Minnesota",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Accounting for Copy Number States in Quantifying Tumor Heterogeneity",
          "Period of Data Use": "JGAD000060"
        }
      },
      "Release Note": {
        "hum0066.v1": {
          "Research ID": "hum0066.v1",
          "Release Date": "2016/08/01",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from tumors, non-cancerous tissues or liver metastatic tumors from 9 colorectal carcinomas were used for the whole exome sequencing (Fastq files).\nExons were narrowed down by using of SureSelect Human All Exon v4/v5 and read by Illumina HiSeq 2000 (paired-end: 100 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0065.v1": {
    "ja": {
      "NBDC Research ID": "hum0065.v1",
      "データ": {
        "JGAS000089": {
          "データID": "JGAS000089",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/04/06"
        }
      },
      "研究内容の概要": {
        "目的": "大腸がん、肺がん、子宮頸部小細胞がんについて、患者間の多様性をカバーするCTOS（cancer tissue-originated spheroid）パネルを構築し、CTOSの調製、培養、細胞株化、移植、継代における質的変化を病理学的、生化学的、分子生物学的に検証する。",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "大腸がん、肺がん、子宮頸部小細胞がん",
        "URL": "http://www.mc.pref.osaka.jp/en/department/biochem/"
      },
      "分子データ": {
        "JGAS000089": {
          "対象": "大腸がん：8症例、肺がん：2症例、子宮頸部小細胞がん：2症例\r\n　1. 血球細胞：12検体（大腸がん 8検体、肺がん 2検体、子宮頸部小細胞がん 2検体）\r\n　2. CTOS（初代）：患者さんの腫瘍組織から調整したCTOS：5検体（大腸がん2検体、肺がん2検体、子宮頸部小細胞がん1検体）\r\n　3. CTOS（継代）：\r\n　　a. 2. のCTOS をマウスに移植して得られた腫瘍組織から調整したCTOS：14検体\r\n　　　1代：1検体（大腸がん1検体）\r\n　　　2代：4検体（子宮頸部小細胞がん1検体、大腸がん3検体）\r\n　　　3代：5検体（大腸がん3検体、肺がん2検体）\r\n　　　5代：4検体（大腸がん2検体、肺がん2検体）\r\n　　b. 2. のCTOSをin vitroで培養した細胞から調整したCTOS：3検体（肺がん2検体、大腸がん1検体）\r\n　　　2代：1検体（肺がん1検体）\r\n　　　5代：2検体（肺がん1検体、大腸がん1検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "血球細胞およびCTOSから抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V5 + lincRNA",
          "断片化の方法": "超音波断片化（Covaris E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000089",
          "総データ量": "1 TB\r\n　Data ファイル数：68（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "井上 正宏",
        "所 属 機 関": "大阪国際がんセンター 生化学部",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん研究シーズ戦略的育成プログラム（P-DIRECT）",
            "タイトル": "患者腫瘍移植モデルとex vivo培養間のシャトルシステムによる革新的な臨床効果評価技術の開発",
            "研究課題番号": "JP15cm0106155"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "投稿準備中",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0065.v1": {
          "Research ID": "hum0065.v1",
          "公開日": "2018/04/06",
          "内容": "NGS（Exome）",
          "description": "大腸がん、肺がん、子宮頸部小細胞がん症例由来CTOSパネルを使用したExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon V5 + lincRNAを用いてExon領域にしぼりIllumina HiSeq 2000にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0065.v1",
      "DATA": {
        "JGAS000089": {
          "Data Set ID": "JGAS000089",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/04/06"
        }
      },
      "SUMMARY": {
        "Aims": "This study aimed at establishment of CTOS (cancer tissue-originated spheroid) panel covering intra-patient heterogeneity for colorectal cancer, lung cancer and small cell carcinoma of the cervix. With the panel, changes in preparation, culture, and xenograft were pathologically, biochemically, and molecular biologically monitored.",
        "Methods": "Exome analysis by using Illumina HiSeq 2000",
        "Participants/Materials": "Colorectal cancer, Lung cancer, Small cell carcinoma of uterine cervix",
        "URL": "http://www.mc.pref.osaka.jp/en/department/biochem/"
      },
      "MOLECULAR DATA": {
        "JGAS000089": {
          "Participants/Materials": "colorectal cancer: 8 cases, lung cancer: 2 cases, small cell carcinoma of uterine cervix: 2case\r\n　1. blood cells: 12 samples \r\n(colorectal cancer: 8 samples, lung cancer: 2 samples, small cell carcinoma of uterine cervix: 2samples)\r\n　2. CTOS (primary culture): CTOS derived from patient tumors: 5 samples\r\n (colorectal cancer: 2 samples, lung cancer: 2 samples, small cell carcinoma of uterine cervix: 1 sample)\r\n　3. CTOS (subculture): \r\n　　a. CTOS prepared from a CTOS (the same as 2)-derived mouse xenograft: 14 samples\r\n　　　1st subculture: 1 sample (colorectal cancer: 1 sample)\r\n　　　2nd subculture: 4 samples (small cell carcinoma of uterine cervix: 1 sample, colorectal cancer: 3 samples)\r\n　　　3rd subculture: 5 samples (colorectal cancer: 3 samples, lung cancer: 2 samples)\r\n　　　5th subculture: 4 samples (colorectal cancer: 2 samples, lung cancer: 2 samples)\r\n　　b. CTOS (the same as 2) cultured in vitro: 3 samples (lung cancer: 2 samples, colorectal cancer: 1 sample)\r\n　　　2nd subculture: 1 sample (lung cancer: 1 sample)\r\n　　　5th subculture: 2 samples (lung cancer: 1 sample, colorectal cancer: 1 sample)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from blood cells and CTOSs",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V5 + lincRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris, E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000089",
          "Total Data Volume": "1 TB\r\n　Data files : 68 (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masahiro Inoue",
        "Affiliation": "Department of Biochemistry, Osaka International Cancer Institute",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Development of an innovative drug evaluation system using a shuttle system between patient-derived tumors and an ex vivo assay",
            "Project Number": "JP15cm0106155"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "-",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0065.v1": {
          "Research ID": "hum0065.v1",
          "Release Date": "2018/04/06",
          "Type of Data": "NGS (Exome)",
          "description": "CTOS panel derived from colorectal cancer, lung cancer and small cell carcinoma of uterine cervix patients was used for the whole exome sequencing (fastq files). Exons were narrowed down by using of SureSelect Human All Exon V5 + lincRNA and read by Illumina HiSeq 2000 (paired-end: 100 bp\nNote：\n"
        }
      }
    }
  },
  "hum0064.v1": {
    "ja": {
      "NBDC Research ID": "hum0064.v1",
      "データ": {
        "JGAS000061": {
          "データID": "JGAS000061",
          "内容": "【ゲノム・遺伝子解析研究】大腸がん、胃がん、肺がんの臨床情報、多型情報、発現情報、メチル化情報\r\n【後ろ向き研究】大腸がん、胃がん、肺がん、糖尿病・腎障害、循環器疾患、呼吸器疾患症例の臨床情報",
          "制限": "制限公開（Type I）",
          "公開日": "2016/08/26"
        }
      },
      "研究内容の概要": {
        "目的": " ",
        "方法": "",
        "対象": "27,934 遺伝子、胃がん：23,288遺伝子、大腸がん：23,295遺伝子）",
        "URL": "https://www.giar.gunma-u.ac.jp/program/program_kawabata/"
      },
      "分子データ": {
        "【ゲノム・遺伝子解析研究】": {
          "対象⋆１": "大腸がん：106症例、胃がん：62症例、肺がん：173症例",
          "規模": "【ダイレクトシークエンス法】XRCC1-1449delGGCC、TYMS_3UTR_6R_INS、TYMS_5UTR_3R_VNTR、EGFR、KRAS、BRAF、ERBB2、TP53\r\n【TaqMan法】ABCB1、ABCC1、ABCC2、CYP1B1、CYP2A6、CYP2C8、CYP3A4、CYP3A5、DPYD、ERCC1、ERCC2、GSTP1、UGT1A1、XRCC1、XRCC3　　　各遺伝子の変異（rsID等）一覧参照\r\n【GSTM1 GSTT1 deletion mutant multiplex PCR法⋆2】 GSTM1、GSTT1 \r\n【qRT-PCR法】 ABCB1、ABCC1、ABCC2、ABCG2、ACTB、ALAD、ASPRV1、BCL2、BRCA1、C20orf43、DMKN、DPYD、ERCC1、GAPDH、GDA、GSTP1、HPRT1、KRAS、MFTHR、OPRT、RRM1、TMEM18、TOP1、TUBB3、TYMS、UGT2B10、UMPS\r\n【COBRA法】 APC、CDKN2A、MLH1\r\n【マイクロアレイ法】 41,000 probes⋆3 （対象：27,934 遺伝子、胃がん：23,288遺伝子、大腸がん：23,295遺伝子）\r\n【治療・臨床情報】 項目一覧参照",
          "Platform": "【ダイレクトシークエンス法】\r\n　　シーケンサー：ABI社 Genetic Analyzer 3130\r\n【TaqMan法】\r\n　　解析キット：Thermo Fisher Scientific社 TaqMan® SNP Genotyping Assays\r\n　　qPCR装置：Roche社 LightCycler 480II\r\n【qRT-PCR法】\r\n　　qPCRキット：Thermo Fisher Scientific社 ABsolute QPCR Mix\r\n　　qPCR装置：Roche社 LightCycler 480II\r\n【COBRA法】\r\n　　バイサルファイト処理：ZYMO Research社 EZ DNA Methylation-Gold Kit\r\n　　PCRキット：Thermo Fisher Scientific社 AmpliTaqGold\r\n【マイクロアレイ法】\r\n　　ラベリング：Agilent社　Quick-Amp Labeling Kit\r\n　　チップ：Agilent社 Whole Human Genome DNA マイクロアレイ 4x44K \r\n　　スキャナー：Agilent社 G2565BA",
          "ソース": "【ダイレクトシークエンス法】 腫瘍組織もしくは非腫瘍組織から抽出したDNA\r\n【TaqMan法】 腫瘍組織もしくは非腫瘍組織から抽出したDNA\r\n【qRT-PCR法】 腫瘍組織から抽出したRNA\r\n【COBRA法】 腫瘍組織から抽出したDNA\r\n【マイクロアレイ法】 腫瘍組織から抽出したRNA",
          "マイクロアレイ標準化方法": "JGA000061の実験の補足情報を参照のこと",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000061",
          "総データ量": "37 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "*1": {
          "対象⋆4": "【がん症例】\r\n大腸がん：313 症例\r\n胃がん：166 症例\r\n肺がん：344 症例\r\n \r\n【非がん症例】\r\n糖尿病・腎障害：300 症例\r\n循環器疾患：357 症例\r\n呼吸器疾患：49 症例",
          "規模": "治療情報、臨床情報（検査値情報・高齢者特性情報）\r\n項目一覧参照",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000061",
          "総データ量": "1 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "西山 正彦",
        "所 属 機 関": "群馬大学大学院 医学系研究科 病態腫瘍薬理学分野",
        "プロジェクト/研究グループ名": "厚生労働科学研究費補助金・第３次対がん総合戦略研究事業",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "厚生労働科学研究費補助金・第３次対がん総合戦略研究経費",
            "タイトル": "高齢者がん治療アルゴリズム開発のためのガイドポスト・データベースの構築と必須情報及びその推定モデルの策定",
            "研究課題番号": "一般-010"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts.",
          "DOI": "-",
          "データID": "JGAS000061"
        },
        "2": {
          "タイトル": "Impact of age on epidermal growth factor receptor mutation in lung cancer.",
          "DOI": "doi: 10.1016/j.lungcan.2012.09.006",
          "データID": "JGAS000061"
        },
        "3": {
          "タイトル": "Association between a genome-wide association study-identified locus and the risk of lung cancer in Japanese population.",
          "DOI": "doi: 10.1097/JTO.0b013e3182475028",
          "データID": "JGAS000061"
        },
        "4": {
          "タイトル": "Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)",
          "DOI": "doi: 10.1016/S1470-2045(12)70139-0",
          "データID": "JGAS000061"
        },
        "5": {
          "タイトル": "Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis.",
          "DOI": "doi: 10.1093/jnci/djt269",
          "データID": "JGAS000061"
        },
        "6": {
          "タイトル": "Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.",
          "DOI": "doi: 10.1007/s00595-015-1301-5",
          "データID": "JGAS000061"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0064.v1": {
          "Research ID": "hum0064.v1",
          "公開日": "2016/08/26",
          "内容": "【ゲノム・遺伝子解析研究】\r\n大腸がん、胃がん、肺がんの臨床情報、多型情報、発現情報、メチル化情報\r\n【後ろ向き研究】\r\n大腸がん、胃がん、肺がん、糖尿病・腎障害、循環器疾患、呼吸器疾患症例の臨床情報",
          "description": "以下の研究に関するデータの一覧および発現アレイの補正後の値をtxtファイルにて提供する。\n【ゲノム・遺伝子解析研究】\n　 大腸がん、胃がん、肺がん症例の治療情報、臨床情報、遺伝子型データ（ダイレクトシークエンス法、TaqMan法）、発現解析データ（qRT-PCR法）、メチル化解析データ（Combined Bisulfite Restriction Analysis：COBRA法）、大腸がん、および、胃がん症例の発現アレイの標準化値（マイクロアレイ法）\n【後ろ向き研究】\n　大腸がん、胃がん、肺がん、糖尿病・腎障害、循環器疾患、呼吸器疾患症例の治療情報、および、臨床情報（検査値・高齢者特性）\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0064.v1",
      "DATA": {
        "JGAS000061": {
          "Data Set ID": "JGAS000061",
          "Type of Data": "1. Genome & Genetic research \r\ngenotype, methylation, gene expression, clinical data for colorectal, gastric, or lung cancer patients.\r\n2. Retrospective study \r\nclinical data for colorectal cancer, gastric cancer, lung cancer, cardiovascular disorders, respiratory dysfunction, diabetes, or nephropathy patients.",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/08/26"
        }
      },
      "SUMMARY": {
        "Aims": "",
        "Methods": "",
        "Participants/Materials": "",
        "URL": "https://www.giar.gunma-u.ac.jp/en/program/program_kawabata/"
      },
      "MOLECULAR DATA": {
        "1. Genome & Genetic research": {
          "Participants/Materials⋆１": "colorectal cancer: 106 cases\r\ngastric cancer: 62 cases\r\nlung cancer: 173 cases",
          "Targets": "-Direct sequencing\r\n　　XRCC1-1449delGGCC, TYMS_3UTR_6R_INS, TYMS_5UTR_3R_VNTR, EGFR, KRAS, BRAF, ERBB2, TP53\r\n-TaqMan analysis \r\n　　ABCB1, ABCC1, ABCC2, CYP1B1, CYP2A6, CYP2C8, CYP3A4, CYP3A5, DPYD, ERCC1, ERCC2, GSTP1, UGT1A1, XRCC1, XRCC3　　　Genetic mutation List (Gene name, chromosomal positon, rs ID) \r\n-GSTM1 GSTT1 deletion mutant multiplex PCR⋆2\r\n　　GSTM1, GSTT1 \r\n-qRT-PCR \r\n　　ABCB1, ABCC1, ABCC2, ABCG2, ACTB, ALAD, ASPRV1, BCL2, BRCA1, C20orf43, DMKN, DPYD, ERCC1, GAPDH, GDA, GSTP1, HPRT1, KRAS, MFTHR, OPRT, RRM1, TMEM18, TOP1, TUBB3, TYMS, UGT2B10, UMPS\r\n-COBRA assay \r\n　　APC, CDKN2A, MLH1\r\n-cDNA microarray \r\n　　41,000 probes⋆3 (control: 27,934 genes, gastric cancer: 23,288 genes, colorectal cancer: 23,295 genes)\r\n-Clinical data \r\n　　Dictionary file",
          "Target Loci for Capture Methods": "-",
          "Platform": "-Direct sequencing\r\n　　Sequencer: Genetic Analyzer 3130 (Applied Biosystems)\r\n-TaqMan analysis\r\n　　Analysis kit: TaqMan® SNP Genotyping Assays (Thermo Fisher Scientific)\r\n　　qPCR instrument: LightCycler 480II (Roche)\r\n-qRT-PCR\r\n　　qPCR kit: ABsolute QPCR Mix (Thermo Fisher Scientific)\r\n　　qPCR instrument: LightCycler 480II (Roche)\r\n-COBRA assay\r\n　　Bisulfite Treatment: EZ DNA Methylation-Gold Kit (ZYMO Research)\r\n　　PCR kit: AmpliTaqGold (Thermo Fisher Scientific)\r\n-cDNA microarray\r\n　　Labeling: Quick-Amp Labeling Kit (Agilent Technologies)\r\n　　Chip: Whole Human Genome Microarray 4x44K (Agilent Technologies) \r\n　　Scanner: G2565BA (Agilent Technologies)",
          "Library Source": "-Direct sequencing DNAs extracted from tumors or non-cancerous tissues\r\n-TaqMan analysis DNAs extracted from tumors or non-cancerous tissues\r\n-qRT-PCR RNAs extracted from tumors\r\n-COBRA assay DNAs extracted from tumors\r\n-cDNA microarray RNAs extracted from tumors",
          "Normalization of microarray": "Refer to JGA000061 experimental support information",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000061",
          "Total Data Volume": "37 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "*1": {
          "Participants/Materials⋆4": "2-1. Cancer cases\r\n    colorectal cancer: 313 cases\r\n    gastric cancer: 166 cases\r\n    lung cancer: 344 cases\r\n \r\n2-2. Non-cancerous cases\r\n    diabetes and nephropathy: 300 cases\r\n    cardiovascular disorder: 357 cases\r\n    respiratory dysfunction: 49 cases",
          "Targets": "Clinical data\r\nTreatment information (specific information of elderly people and test values)\r\nDictionary file",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000061",
          "Total Data Volume": "1 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masahiko Nishiyama",
        "Affiliation": "Department of Molecular Pharmacology and Oncology, Gunma University Graduate School of Medicine",
        "Project / Group Name": "Third Term Comprehensive Control Research for Cancer Health and Labor Sciences Research Grants of the Ministry of Health, Labor and Welfare of Japan.",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Third Term Comprehensive Control Research for Cancer Health and Labor Sciences Research Grants of the Ministry of Health, Labor and Welfare of Japan.",
            "Title": "Geriatric Oncology Database of genotypes and methylation, gene expression, clinical data, and survey results on psychosocial and physical conditions in Japanese elderly cancer patients to establish truly effective treatment strategy",
            "Project Number": "General-010"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts.",
          "DOI": "-",
          "Data Set ID": "JGAS000061"
        },
        "2": {
          "Title": "Impact of age on epidermal growth factor receptor mutation in lung cancer.",
          "DOI": "doi: 10.1016/j.lungcan.2012.09.006",
          "Data Set ID": "JGAS000061"
        },
        "3": {
          "Title": "Association between a genome-wide association study-identified locus and the risk of lung cancer in Japanese population.",
          "DOI": "doi: 10.1097/JTO.0b013e3182475028",
          "Data Set ID": "JGAS000061"
        },
        "4": {
          "Title": "Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)",
          "DOI": "doi: 10.1016/S1470-2045(12)70139-0",
          "Data Set ID": "JGAS000061"
        },
        "5": {
          "Title": "Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis.",
          "DOI": "doi: 10.1093/jnci/djt269",
          "Data Set ID": "JGAS000061"
        },
        "6": {
          "Title": "Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.",
          "DOI": "doi: 10.1007/s00595-015-1301-5",
          "Data Set ID": "JGAS000061"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0064.v1": {
          "Research ID": "hum0064.v1",
          "Release Date": "2016/08/26",
          "Type of Data": "1. Genome & Genetic research \r\n   Genotype, methylation, gene expression, clinical data for colorectal, gastric, or lung cancer patients.\r\n2. Retrospective study \r\n   Clinical data for colorectal cancer, gastric cancer, lung cancer, cardiovascular disorder, respiratory dysfunction, diabetes, or nephropathy patients.",
          "description": "This study provides the following data in text files:\n1. Genome & Genetic research\n      Clinical data, genotype data (direct sequencing, TaqMan assay), gene expression data (qRT-PCR) and methylation data (COBRA assay) for colorectal, gastric, or lung cancer patients. \n      Normalized values of cDNA microarray for colorectal or gastric cancer patients.\n2. Retrospective study\n      Collection of clinical data about colorectal cancer, gastric cancer, lung cancer, diabetes, nephropathy, cardiovascular disorder, or respiratory dysfunction patients.\nNote：\n"
        }
      }
    }
  },
  "hum0061.v1": {
    "ja": {
      "NBDC Research ID": "hum0061.v1",
      "データ": {
        "JGAS000057": {
          "データID": "JGAS000057",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/02/20"
        }
      },
      "研究内容の概要": {
        "目的": "多発性肺がん同胞症例の原因遺伝子異常を同定する。",
        "方法": "全エキソームシーケンス解析",
        "対象": "多発性肺がん同胞2症例"
      },
      "分子データ": {
        "JGAS000057": {
          "対象": "多発性肺がん：2症例（同胞）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "家族性多発性肺がん2症例の末梢血より抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "BGI exome sequencing service",
          "断片化の方法": "BGI exome sequencing service",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "90 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000057",
          "総データ量": "29 GB\r\n　　Data ファイル：8 （fastq）\r\n　　Analysis ファイル：4（vcf [ref：hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "加藤 菊也",
        "所 属 機 関": "大阪府立成人病センター",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "財団法人大阪難病研究財団医学研究助成",
            "タイトル": "稀少癌同胞症例ゲノム解析による遺伝性癌原因遺伝子の探索",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Homozygous inactivation of CHEK2 is linked to a familial case of multiple primary lung cancer with accompanying cancers in other organs",
          "DOI": "doi: 10.1101/mcs.a001032",
          "データID": "JGAD000057"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000057"
        }
      },
      "リリース情報": {
        "hum0061.v1": {
          "Research ID": "hum0061.v1",
          "公開日": "2017/02/20",
          "内容": "NGS（Exome）",
          "description": "家族性多発性肺がん2症例（同胞）の末梢血より抽出したgDNAを使用したExome解析の結果をFastqファイルにて提供する。\nBGI exome sequencing serviceを使用してExon領域にしぼり、HiSeq 2000にて平均長 90塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0061.v1",
      "DATA": {
        "JGAS000057": {
          "Data Set ID": "JGAS000057",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/02/20"
        }
      },
      "SUMMARY": {
        "Aims": "To identify causative genetic aberrations in multiple primary lung cancer",
        "Methods": "Whole exome sequencing (Illumina HiSeq 2000)",
        "Participants/Materials": "Siblings developed multiple primary lung cancers"
      },
      "MOLECULAR DATA": {
        "JGAS000057": {
          "Participants/Materials": "Siblings developed multiple primary lung cancers",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells of siblings developed multiple primary lung cancers",
          "Cell Lines": "-",
          "Library Construction (kit name)": "BGI exome sequencing service",
          "Fragmentation Methods": "BGI exome sequencing service",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "90 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000057",
          "Total Data Volume": "29 GB\r\n　　Data files: 8 (fastq)\r\n　　Analysis files: 4 (vcf [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kikuya Kato",
        "Affiliation": "Osaka Medical Center for Cancer and Cardiovascular Diseases",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "The Osaka Medical Research Foundation for Intractable Diseases",
            "Title": "Searching causative genes of familial cancers by genome analyses of sibling patients with rare cancer",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Homozygous inactivation of CHEK2 is linked to a familial case of multiple primary lung cancer with accompanying cancers in other organs",
          "DOI": "doi: 10.1101/mcs.a001032",
          "Data Set ID": "JGAD000057"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000057"
        }
      },
      "Release Note": {
        "hum0061.v1": {
          "Research ID": "hum0061.v1",
          "Release Date": "2017/02/20",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from peripheral blood cells of siblings developed multiple primary lung cancers were used for the whole exome sequencing (fastq files). DNA fragments containing whole coding exons were concentrated using BGI exome sequencing service and a multiplex sequencing was performed by using of the Illumina HiSeq 2000 sequencer (90 bp, Paired-end).\nNote：\n"
        }
      }
    }
  },
  "hum0060.v1": {
    "ja": {
      "NBDC Research ID": "hum0060.v1",
      "データ": {
        "JGAS000075": {
          "データID": "JGAS000075",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/04/03"
        }
      },
      "研究内容の概要": {
        "目的": "再発・転移性乳がんの原発巣と再発巣の腫瘍組織を同一患者から採取し、全エクソンシーケンス解析（Whole Exome Sequencing: WES）等による分子プロファイリングを実施することで、再発・転移性乳がんの特徴を検出する。",
        "方法": "Illumina HiSeq 2000を使用したWES",
        "対象": "乳がん65症例の非腫瘍組織、原発巣（腫瘍組織）、および、転移巣（腫瘍組織）の合計175検体"
      },
      "分子データ": {
        "JGAS000075": {
          "対象": "再発・転移性乳がん：65症例（175検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "非腫瘍組織、原発巣（腫瘍組織）、および、転移巣（腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V5 + lincRNA",
          "断片化の方法": "超音波断片化（Covaris E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000075",
          "総データ量": "4 TB（fastq [350 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "三木 義男",
        "所 属 機 関": "東京医科歯科大学 難治疾患研究所",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業（科学研究費補助金）（特定奨励費）",
            "タイトル": "先進的がん治療法開発のためのマルチオミック解析による基盤的基礎研究（患者腫瘍検体のゲノム・エピゲノム情報解析とデータベース構築）",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "万代 昌紀": {
          "研究代表者": "万代 昌紀",
          "所属機関": "京都大学医学部医学研究科 婦人科学産科学教室",
          "研究題目": "",
          "利用データID": "多様な臨床情報を考慮した婦人科悪性腫瘍患者の尾ミックス解析（全ゲノム・全トランスクリプト-ム・プロテオーム・メタボローム解析）による個別化治療の探索",
          "利用期間": "JGAD000075"
        },
        "河野 隆志": {
          "研究代表者": "河野 隆志",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "AYA（Adolescence and Young Adult）世代がんの個別化予防に資する遺伝要因の同定を目指す研究",
          "利用期間": "JGAD000075"
        }
      },
      "リリース情報": {
        "hum0060.v1": {
          "Research ID": "hum0060.v1",
          "公開日": "2018/04/03",
          "内容": "NGS（Exome）",
          "description": "再発・転移性乳がんの65症例の非腫瘍組織、原発巣（腫瘍組織）、および、転移巣（腫瘍組織）の合計175検体から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon V5 + lincRNAを用いてExon領域にしぼりIllumina HiSeq 2000にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0060.v1",
      "DATA": {
        "JGAS000075": {
          "Data Set ID": "JGAS000075",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/04/03"
        }
      },
      "SUMMARY": {
        "Aims": "To find the characteristics of recurrent / metastatic breast cancers by carrying out a \"molecular profiling\", mainly the exome sequence analysis of cancerous tissues of the primary and recurrence tumors from the same patient with recurrent / metastatic breast cancer.",
        "Methods": "Whole exome sequencing by using of Illumina HiSeq 2000",
        "Participants/Materials": "Total of 175 normal, primary tumor, and metastasis tumor samples from 65 breast cancer patients"
      },
      "MOLECULAR DATA": {
        "JGAS000075": {
          "Participants/Materials": "65 patient with recurrent / metastatic breast cancer",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from normal, primary tumor and metastasis tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V5 + lincRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000075",
          "Total Data Volume": "4 TB (fastq [350 files])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yoshio Miki",
        "Affiliation": "Medical Research Institute, Tokyo Medical and Dental University",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "JSPS KAKENHI",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Masaki Mandai": {
          "Principal Investigator": "Masaki Mandai",
          "Affiliation": "Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Integrated analyses of omics (genomics, transcriptomics, proteomics and metabolomics) associated with clinical variables for developing indivisualizedtreatment in gynecological malignancy",
          "Period of Data Use": "JGAD000075"
        },
        "Takashi Kohno": {
          "Principal Investigator": "Takashi Kohno",
          "Affiliation": "Division of Genome Biology, National Cancer Center Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Identification of genetic risk factors in AYA (Adolescence and Young Adult) cancer",
          "Period of Data Use": "JGAD000075"
        }
      },
      "Release Note": {
        "hum0060.v1": {
          "Research ID": "hum0060.v1",
          "Release Date": "2018/04/03",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from 175 normal, primary tumor and metastasis tumor samples from 65 breast cancer patients were used for the whole exome sequencing (fastq files).\nExons were narrowed down by using of SureSelect Human All Exon V5 + lincRNA and read by Illumina HiSeq 2000 (paired-end: 100 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0059.v1": {
    "ja": {
      "NBDC Research ID": "hum0059.v1",
      "データ": {
        "JGAS000104": {
          "データID": "JGAS000104",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/04/06"
        }
      },
      "研究内容の概要": {
        "目的": "漿液性卵巣がんにおいて分子プロファイリングをもとに難治がん克服のための新たな治療戦略を確立する。",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "卵巣がん65症例の正常組織と原発巣・再発巣の腫瘍組織の合計148検体"
      },
      "分子データ": {
        "JGAS000104": {
          "対象": "卵巣がん：65症例（合計148検体）\r\n　正常組織：67検体\r\n　腫瘍組織：81検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "正常組織と原発巣・再発巣の腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V4 + lincRNA\r\nSureSelect Human All Exon V5 + lincRNA",
          "断片化の方法": "超音波断片化（Covaris E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000109",
          "総データ量": "3 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "加藤 一喜",
        "所 属 機 関": "がん研有明病院",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業（科学研究費補助金）（特定奨励費）",
            "タイトル": "先進的がん治療法開発のためのマルチオミック解析による基盤的基礎研究（患者腫瘍検体のゲノム・エピゲノム情報解析とデータベース構築）",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "-",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "万代 昌紀": {
          "研究代表者": "万代 昌紀",
          "所属機関": "京都大学医学部医学研究科婦人科学産科学教室",
          "研究題目": "",
          "利用データID": "多様な臨床情報を考慮した婦人科悪性腫瘍患者の尾ミックス解析（全ゲノム・全トランスクリプト-ム・プロテオーム・メタボローム解析）による個別化治療の探索",
          "利用期間": "JGAD000109"
        },
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000109"
        }
      },
      "リリース情報": {
        "hum0059.v1": {
          "Research ID": "hum0059.v1",
          "公開日": "2018/04/06",
          "内容": "NGS（Exome）",
          "description": "卵巣がん65症例の正常組織と原発巣、再発巣の腫瘍組織から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。\nSureSelect Human All Exon V4 + lincRNA または SureSelect Human All Exon V5 + lincRNAを用いてExon領域にしぼりIllumina HiSeq 2000にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0059.v1",
      "DATA": {
        "JGAS000104": {
          "Data Set ID": "JGAS000104",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/04/06"
        }
      },
      "SUMMARY": {
        "Aims": "Establishment of novel therapeutic strategy to overcome intractable cancer by molecular profiling of serous ovarian cancer",
        "Methods": "Exome analysis by using Illumina HiSeq 2000",
        "Participants/Materials": "148 normal, primary tumor and relapse tumor tissues from 65 ovarian cancer"
      },
      "MOLECULAR DATA": {
        "JGAS000104": {
          "Participants/Materials": "ovarian cancer: 65 cases (total: 148 samples)\r\n   non-tumor tissues: 67 samples\r\n   tumor tissues: 81 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Hiseq 2000]",
          "Library Source": "DNAs extracted from non-tumor, primary tumor, and relapse tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V4 + lincRNA\r\nSureSelect Human All Exon V5 + lincRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000109",
          "Total Data Volume": "3 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kazuyoshi Kato",
        "Affiliation": "The Cancer Institute Hospital of JFCR",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "JSPS KAKENHI",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "-",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Masaki Mandai": {
          "Principal Investigator": "Masaki Mandai",
          "Affiliation": "Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Integrated analyses of omics (genomics, transcriptomics, proteomics and metabolomics) associated with clinical variables for developing indivisualizedtreatment in gynecological malignancy",
          "Period of Data Use": "JGAD000109"
        },
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000109"
        }
      },
      "Release Note": {
        "hum0059.v1": {
          "Research ID": "hum0059.v1",
          "Release Date": "2018/04/06",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from normal, primary tumor and relapse tumor tissues from 65 ovarian cancer patients were used for the whole exome sequencing (fastq files).\nExons were narrowed down by using of SureSelect Human All Exon V4 + lincRNA or SureSelect Human All Exon V5 + lincRNA and read by Illumina Hiseq 2000 (paired-end: 100 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0058.v1": {
    "ja": {
      "NBDC Research ID": "hum0058.v1",
      "データ": {
        "JGAS000091": {
          "データID": "JGAS000091",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2018/04/06"
        }
      },
      "研究内容の概要": {
        "目的": "大腸がんの有効な治療法開発に役立つ分子標的、および患者層別化のためのゲノム・エピゲノムマーカーの同定",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "大腸がん89症例の正常組織と、原発巣及び転移巣の腫瘍組織"
      },
      "分子データ": {
        "JGAS000091": {
          "対象": "大腸がん：89症例（合計297検体）\r\n　非腫瘍組織（正常組織）：89検体\r\n　腫瘍組織（原発巣・転移巣）：208検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "大腸がん89症例の正常組織、原発巣及び転移巣の腫瘍組織より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V4 + lincRNA、SureSelect Human All Exon V5 + lincRNA",
          "断片化の方法": "超音波断片化（Covaris E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000091",
          "総データ量": "6 TB （fastq [594 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山口 俊晴",
        "所 属 機 関": "がん研究会有明病院",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業（科学研究費補助金）（特定奨励費）",
            "タイトル": "先進的がん治療法開発のためのマルチオミック解析による基盤的基礎研究（患者腫瘍検体のゲノム・エピゲノム情報解析とデータベース構築）",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "-",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "寶珍 輝尚": {
          "研究代表者": "寶珍 輝尚",
          "所属機関": "京都工芸繊維大学・情報工学・人間科学系",
          "研究題目": "",
          "利用データID": "機械学習によるヒトゲノム変異の解析",
          "利用期間": "JGAD000091"
        },
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000091"
        },
        "万代 昌紀": {
          "研究代表者": "万代 昌紀",
          "所属機関": "京都大学医学部医学研究科 婦人科学産科学教室",
          "研究題目": "",
          "利用データID": "多様な臨床情報を考慮した婦人科悪性腫瘍患者の尾ミックス解析（全ゲノム・全トランスクリプト-ム・プロテオーム・メタボローム解析）による個別化治療の探索",
          "利用期間": "JGAD000091"
        }
      },
      "リリース情報": {
        "hum0058.v1": {
          "Research ID": "hum0058.v1",
          "公開日": "2018/04/06",
          "内容": "NGS（Exome）",
          "description": "大腸がん89症例の正常組織と、原発巣及び転移巣の腫瘍組織より抽出したDNAを使用したExome解析の結果をFastqファイルにて提供する。\nSureSelect Human All Exon V4 + lincRNA、SureSelect Human All Exon V5 + lincRNAによりExon領域にしぼり、HiSeq 2000にて平均長100塩基を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0058.v1",
      "DATA": {
        "JGAS000091": {
          "Data Set ID": "JGAS000091",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/04/06"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of molecular targets for development effective therapeutic methods and genomic or epigenomic markers for stratification of colorectal cancer patients.",
        "Methods": "Exome analysis by using of Illumina HiSeq 2000",
        "Participants/Materials": "297 normal, primary tumor, and metastasis tumor samples from 89 colorectal cancer patients"
      },
      "MOLECULAR DATA": {
        "JGAS000091": {
          "Participants/Materials": "colorectal cancer: 89 cases (Total: 297 samples)\r\n   non-tumor tissue: 89 samples\r\n   tumor tissue (metastasis/recurrence): 208 samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from tumor and non-tumor tissues from 89 colorectal cancer patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V4 + lincRNA, SureSelect Human All Exon V5 + lincRNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000091",
          "Total Data Volume": "6 TB (fastq [594 files])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Toshiharu Yamaguchi",
        "Affiliation": "The Cancer Institute Hospital of Japanese Foundation For Cancer Research (JFCR)",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "JSPS KAKENHI",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "-",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Teruhisa Hochin": {
          "Principal Investigator": "Teruhisa Hochin",
          "Affiliation": "Faculty of Information and Human Sciences, Kyoto Institute of Technology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Analysis of mutation of human genome using Machine Learning",
          "Period of Data Use": "JGAD000091"
        },
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000091"
        },
        "Masaki Mandai": {
          "Principal Investigator": "Masaki Mandai",
          "Affiliation": "Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Integrated analyses of omics (genomics, transcriptomics, proteomics and metabolomics) associated with clinical variables for developing indivisualizedtreatment in gynecological malignancy",
          "Period of Data Use": "JGAD000091"
        }
      },
      "Release Note": {
        "hum0058.v1": {
          "Research ID": "hum0058.v1",
          "Release Date": "2018/04/06",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs extracted from 297 normal, primary tumor, and metastasis tumor tissues from 89 colorectal cancer patients were used for the whole exome sequencing (fastq files).\nExons were narrowed down by using of SureSelect Human All Exon V4 + lincRNA, SureSelect Human All Exon V5 + lincRNA and read by Illumina HiSeq 2000 (paired-end: 100 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0056.v1": {
    "ja": {
      "NBDC Research ID": "hum0056.v1",
      "データ": {
        "hum0056.v1.freq.v1": {
          "データID": "hum0056.v1.freq.v1",
          "内容": "（1）SNPsのアリル頻度情報（WGS）",
          "制限": "非制限公開",
          "公開日": "2018/03/30"
        },
        "hum0056.v1.ch3.v1": {
          "データID": "hum0056.v1.ch3.v1",
          "内容": "（2）各CpG部位の平均メチル化率情報（WGBS）",
          "制限": "非制限公開",
          "公開日": "2018/03/30"
        },
        "hum0056.v1.fpkm.v1": {
          "データID": "hum0056.v1.fpkm.v1",
          "内容": "（3）各遺伝子の平均FPKM値（RNA-seq）",
          "制限": "非制限公開",
          "公開日": "2018/03/30"
        }
      },
      "研究内容の概要": {
        "目的": "いわて東北メディカル・メガバンク機構（IMM）が実施した多層オミックス参照パネルを研究コミュニティに提供すること。",
        "方法": "東北メディカル・メガバンク計画地域住民コホート参加者197名のバフィーコートもしくは末梢血より単離した単球、CD4陽性Tリンパ球、好中球を対象に、次世代シークエンサーによる全ゲノムシークエンス（Whole Genome Sequencing: WGS）、全ゲノムバイサルファイトシークエンス（Whole Genome Bisulfite Sequencing: WGBS）およびRNA シークエンス（RNA Sequencing: RNA-seq）を実施した。197名のSNPsのアリル頻度情報、CpG部位のメチル化率情報、各転写物のFPKM値情報を提供する。",
        "対象": "IMM地域住民コホート102名の単球、102名のCD4陽性Tリンパ球、94名の好中球（計：197名）",
        "URL": "http://imethyl.iwate-megabank.org/"
      },
      "分子データ": {
        "hum0056.v1.freq.v1": {
          "対象": "IMMの地域住民コホート：197名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500/HiSeq X]",
          "ライブラリソース": "102名の単球、102名のCD4陽性Tリンパ球、94名の好中球より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free HT Sample Prep Kit",
          "断片化の方法": "超音波断片化（Covaris社、LE220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "162 bp（好中球72検体のみ150 bp）",
          "クオリティコントロール方法": "qMiSeq*1",
          "重複するリードの除去": "無",
          "リアライメントおよびベースクオリティのキャリブレーション": "無",
          "マッピング方法": "Bowtie2（version 2.1.0）",
          "リファレンス配列": "GRCh37d5",
          "平均カバー率（Depth）": "40.9 ×",
          "変異検出方法": "Bcftools software（ver. 0.1.17-dev）",
          "総リード数 / ユニークにマップされたリード数": "230,956,735,490 / 228,318,012,630\r\n（単球：58,859,522,366 / 57,737,359,722）\r\n（CD4陽性Tリンパ球：58,964,563,094 / 57,845,976,317）\r\n（好中球：113,132,650,030 / 112,734,676,591）\r\n※マップされたリード数：複数マップの候補がある場合にはランダムに1か所にアライメントしている。",
          "フィルタリング": "マイナーアリルカウント（minor allele count：MAC） > 1",
          "SNP数（QC後）": "単球：8,129,415 SNPs\r\nCD4陽性Tリンパ球：8,137,443 SNPs\r\n好中球：8,175,808 SNPs",
          "NBDC Dataset ID": "hum0056.v1.freq.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください） \r\nDictionary file",
          "総データ量": "単球：403 MB（txt）\r\nCD4陽性Tリンパ球：403.5 MB（txt）\r\n好中球：409 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "*1": {
          "対象": "IMMの地域住民コホート：197名",
          "規模": "WGBS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "102名の単球、102名のCD4陽性Tリンパ球、94名の好中球より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA Methylation Kit",
          "断片化の方法": "バイサルファイト反応",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "クオリティコントロール方法": "電気泳動とqPCR",
          "重複するリードの除去": "SAMtools（ver.0.1.19）",
          "リアライメントおよびベースクオリティのキャリブレーション": "無",
          "マッピング方法": "NovoAlign（ver.3.02.08）",
          "リファレンス配列": "GRCh37d5",
          "平均カバー率（Depth）": "単球：31.1 ± 1.6\r\nCD4陽性Tリンパ球：31.0 ± 1.6\r\n好中球：54.7 ± 1.6",
          "メチル化コール・メチル化率算出方法": "NovoMethyl（ver.3.02.08）",
          "総リード数 / ユニークにマップされたリード数": "単球：780,709,034 ± 45,934,514 / 624,432,868 ± 38,766,158\r\nCD4陽性Tリンパ球：779,212,752 ± 40,833,955 / 667,934,331 ± 33,002,407\r\n好中球：1,144,935,054 ± 33,512,764 / 994,992,101 ± 32,667,070",
          "NBDC Dataset ID": "hum0056.v1.ch3.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "単球：1.4 GB（txt）\r\nCD4陽性Tリンパ球：1.4 GB（txt）\r\n好中球：1.5 GB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0056.v1.ch3.v1": {
          "対象": "IMMの地域住民コホート：197名",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "102名の単球、102名のCD4陽性Tリンパ球、94名の好中球より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Library Preparation Kit v2",
          "断片化の方法": "高温条件下での2価陽イオンによる断片化",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "125 bp",
          "クオリティコントロール方法": "電気泳動とqPCR",
          "重複するリードの除去": "無",
          "リアライメントおよびベースクオリティのキャリブレーション": "無",
          "マッピング方法": "TopHat（ver. 2.0.13）",
          "リファレンス配列": "GRCh37、Human GENCODE Gene Set（release 19）",
          "平均カバー率（Depth）": "-",
          "遺伝子構造・新規の転写産物推定・発現量算出方法": "cuffquantとcuffnorm",
          "総リード数 / ユニークにマップされたリード数": "単球：33,917,157 ± 3,153,528 / 27,390,039 ± 2,494,286\r\nCD4陽性Tリンパ球：35,175,996 ± 1,275,575 / 27,506,624 ± 1,669,459\r\n好中球：47,040,140 ± 6,289,540 / 43,241,139 ± 8,491,065",
          "対象遺伝子数": "単球：16,282 genes\r\nCD4陽性Tリンパ球：18,299 genes\r\n好中球：14,534 genes",
          "NBDC Dataset ID": "hum0056.v1.fpkm.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください） \r\nDictionary file",
          "総データ量": "単球：818 KB（txt）\r\nCD4陽性Tリンパ球：919 KB（txt）\r\n好中球：731 KB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "清水 厚志",
        "所 属 機 関": "岩手医科大学 災害復興事業本部",
        "プロジェクト/研究グループ名": "いわて東北メディカル・メガバンク機構（http://iwate-megabank.org/）／生体情報解析部門",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構 医療研究開発推進事業費補助金",
            "タイトル": "東北メディカル・メガバンク計画（岩手医科大学）東日本大震災復興特別会計分",
            "研究課題番号": "JP18km0105003"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genome-wide identification of inter-individually variable DNA methylation sites improves the efficacy of epigenetic association studies",
          "DOI": "doi: 10.1038/s41525-017-0016-5",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0056.v1": {
          "Research ID": "hum0056.v1",
          "公開日": "2018/03/30",
          "内容": "NGS（WGS、WGBS、RNA-seq）",
          "description": "IMM地域住民コホート197名の末梢血より単離した102名の単球、102名のCD4陽性Tリンパ球、および94名の好中球より抽出したDNA・RNAを対象にWGS、WGBS、RNA-seqを実施し、以下の結果についてtxt形式にて提供する。\n（1）　WGSからのSNPsの遺伝子型頻度情報\nTruSeq DNA PCR-Free HT Sample Prep Kitによりライブラリを作製し、Illumina [HiSeq 2500およびHiSeq X]にて平均162bpもしくは150bpの断片を解読し（Paired-end）、1%よりも頻度の高い一塩基多型のアリル頻度情報を提供する。\n（2）　WGBSからの各CpG部位の平均メチル化率情報\nTruSeq DNA Methylation Kitによりライブラリを作製し、Illumina [HiSeq 2500]にて平均125bpの断片を解読し（Paired-end）、NovoMethyl（ver.0.1.19）によりメチル化率を算出した結果を提供する。\n（3）　RNA-seqからの平均FPKM値\nTruSeq RNA Library Preparation Kit v2によりライブラリを作製し、Illumina [HiSeq 2500]にて平均125bpの断片を解読し（Single-end）、遺伝子毎のFPKM値を算出した結果を提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0056.v1",
      "DATA": {
        "hum0056.v1.freq.v1": {
          "Data Set ID": "hum0056.v1.freq.v1",
          "Type of Data": "(1) Allele frequencies from WGS",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/03/30"
        },
        "hum0056.v1.ch3.v1": {
          "Data Set ID": "hum0056.v1.ch3.v1",
          "Type of Data": "(2) Methylation rates at each CpG site from WGBS",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/03/30"
        },
        "hum0056.v1.fpkm.v1": {
          "Data Set ID": "hum0056.v1.fpkm.v1",
          "Type of Data": "(3) Average of FPKM values from RNA-seq",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/03/30"
        }
      },
      "SUMMARY": {
        "Aims": "To provide genome and multi-layer omics data from a population based cohort (Iwate Medical Megabank: IMM) to research communities",
        "Methods": "Allele frequencies based on whole genome sequencing (WGS), methylation rates based on whole genome bisulfite sequencing (WGBS), and FPKM values based on RNA sequencing (RNA-seq) of 102 monocytes, 102 CD4+ T cells, and 94 neutrophils (total 197 individuals from IMM cohort) isolated from peripheral blood cells.",
        "Participants/Materials": "Monocytes and CD4+ T cells from 102 individuals, and neutrophils from 94 individuals in each (total 197 individuals)",
        "URL": "http://imethyl.iwate-megabank.org/"
      },
      "MOLECULAR DATA": {
        "hum0056.v1.freq.v1": {
          "Participants/Materials": "IMM cohort: 197 individuals",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500/HiSeq X]",
          "Library Source": "DNAs extracted from 102 monocytes, 102 CD4+ T cells, and 94 neutrophils",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free HT Sample Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris LE220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "162 bp (72 neutrophils: 150 bp)",
          "QC": "qMiSeq*1",
          "Deduplication": "none",
          "Calibration for re-alignment and base quality": "none",
          "Mapping Methods": "Bowtie2 (version 2.1.0)",
          "Reference Genome Sequence": "GRCh37d5",
          "Coverage (Depth)": "40.9 ×",
          "Detecting Methods for Variation": "Bcftools software (ver. 0.1.17-dev)",
          "Total Reads / Uniquely Mapped Reads": "230,956,735,490 / 228,318,012,630\r\n(Monocytes: 58,859,522,366 / 57,737,359,722)\r\n(CD4+ T cells: 58,964,563,094 / 57,845,976,317)\r\n(neutrophils: 113,132,650,030 / 112,734,676,591)\r\n*mapped reads: a read which had multiple mapped locations was aligned to one site randomly.",
          "Filtering Methods": "minor allele count (MAC) > 1",
          "SNP Numbers (after QC)": "Monocytes: 8,129,415 SNPs\r\nCD4+ T cells: 8,137,443 SNPs\r\nNeutrophils: 8,175,808 SNPs",
          "NBDC Dataset ID": "hum0056.v1.freq.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "Monocytes: 403 MB (txt)\r\nCD4+ T cells: 403.5 MB (txt)\r\nneutrophils: 409 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "*1": {
          "Participants/Materials": "IMM cohort : 197 individuals",
          "Targets": "WGBS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from 102 monocytes, 102 CD4+ T cells, and 94 neutrophils",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA Methylation Kit",
          "Fragmentation Methods": "bisulfite conversion reaction",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "QC": "electrophoresis and qPCR",
          "Deduplication": "SAMtools (ver.0.1.19)",
          "Calibration of re-alignment and base quality": "none",
          "Mapping Methods": "NovoAlign (ver.3.02.08)",
          "Reference Genome Sequence": "GRCh37d5",
          "Coverage (Depth)": "Monocytes: 31.1 ± 1.6\r\nCD4+T cells: 31.0 ± 1.6\r\nNeutrophils: 54.7 ± 1.6",
          "Detecting Methods for Variation": "NovoMethyl (ver.3.02.08)",
          "Total Reads / Uniquely Mapped Reads": "Monocytes: 780,709,034 ± 45,934,514 / 624,432,868 ± 38,766,158\r\nCD4+ T cells: 779,212,752 ± 40,833,955 / 667,934,331 ± 33,002,407\r\nNeutrophils: 1,144,935,054 ± 33,512,764 / 994,992,101 ± 32,667,070",
          "NBDC Dataset ID": "hum0056.v1.ch3.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "Monocytes: 1.4 GB (txt)\r\nCD4+ T cells: 1.4 GB (txt)\r\nneutrophils: 1.5 GB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0056.v1.ch3.v1": {
          "Participants/Materials": "IMM cohort : 197 individuals",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from 102 monocytes, 102 CD4+ T cells, and 94 neutrophils",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Library Preparation Kit v2",
          "Fragmentation Methods": "divalent cation under high temperature",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "125 bp",
          "QC": "electrophoresis and qPCR",
          "Deduplication": "none",
          "Calibration of re-alignment and base quality": "none",
          "Mapping Methods": "TopHat (ver. 2.0.13)",
          "Reference Genome Sequence": "GRCh37, Human GENCODE Gene Set (release 19)",
          "Coverage (Depth)": "-",
          "Detecting Methods for Variation": "cuffquant and cuffnorm",
          "Total Reads / Uniquely Mapped Reads": "Monocytes: 33,917,157 ± 3,153,528 / 27,390,039 ± 2,494,286\r\nCD4+ T cells: 35,175,996 ± 1,275,575 / 27,506,624 ± 1,669,459\r\nNeutrophils: 47,040,140 ± 6,289,540 / 43,241,139 ± 8,491,065",
          "Gene Numbers": "Monocytes: 16,282 genes\r\nCD4+ T cells: 18,299 genes\r\nNeutrophils: 14,534 genes",
          "NBDC Dataset ID": "hum0056.v1.fpkm.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "Monocytes: 818 KB (txt)\r\nCD4+ T cells: 919 KB (txt)\r\nneutrophils: 731 KB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Atsushi Shimizu",
        "Affiliation": "Disaster Reconstruction Center, Iwate Medical University",
        "Project / Group Name": "Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Japan Agency for Medical Research and Development (AMED)",
            "Title": "Tohoku Medical Megabank Project (Iwate Medical University) Special Account of the Great East Japan Earthquake Disaster Recovery",
            "Project Number": "JP18km0105003"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genome-wide identification of inter-individually variable DNA methylation sites improves the efficacy of epigenetic association studies",
          "DOI": "doi: 10.1038/s41525-017-0016-5",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0056.v1": {
          "Research ID": "hum0056.v1",
          "Release Date": "2018/03/30",
          "Type of Data": "NGS (WGS, WGBS, RNA-seq)",
          "description": "This article provides following analisys results about gDNAs and RNA extracted from high quality purified monocytes, CD4+ T cells, and neutrophil from 197 participants\n(1) Allele Frequencies from WGS\nMultiplex sequence was performed with Illumina [HiSeq 2500/HiSeq X] (162 bp or 150 bp, Paired-end) after library preparation by using of TruSeq DNA PCR-Free HT Sample Prep Kit. Allele counts of SNPs more than 1 are provided (txt file).\n(2) Methylation Rate at each CpG site from WGBS\nMultiplex sequence was performed with Illumina [HiSeq 2500] (125 bp, Paired-end) after library preparation by TruSeq DNA Methylation Kit. Methylation Rates at each CpG site are provided (txt file).\n(3) Average of FPKM value from RNA-seq\nMultiplex sequence was performed with Illumina [HiSeq 2500] (125 bp, Single-end) after library preparation by TruSeq RNA Library Preparation Kit v2. Averages of FPKM values for each gene are provided (txt file).\nNote：\n"
        }
      }
    }
  },
  "hum0055.v1": {
    "ja": {
      "NBDC Research ID": "hum0055.v1",
      "データ": {
        "JGAS000059": {
          "データID": "JGAS000059",
          "内容": "NGS（RNA-seq）\r\nメチル化アレイ",
          "制限": "制限公開（Type I）",
          "公開日": "2017/02/20"
        }
      },
      "研究内容の概要": {
        "目的": "ゲノムワイドなエピゲノム解析（mRNA発現定量）を用いた検討により、非アルコール性脂肪肝性疾患（non-alcoholic fatty liver disease：NAFLD）の発症や進展に関連した遺伝子を同定し、その病態を明らかにする。",
        "方法": "肝臓組織から抽出したmRNAを対象としたRNA-seq解析、および、肝臓組織から抽出したDNAを対象としたメチル化アレイ解析",
        "対象": "NAFLD患者由来の肝臓組織56検体についてはRNAシークエンスとメチル化解析の両方、4検体はRNAシークエンスのみ、4検体はDNAメチル化解析のみ、（計64検体）"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "RNA-seq": {
          "対象": "NAFLD患者由来の肝臓組織：60検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "NAFLD患者由来の肝臓組織から抽出したmRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelectXT RNA Target Enrichment for Illumina Multiplexed Sequencing",
          "断片化の方法": "化学的に断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000059",
          "総データ量": "307 GB（fastq [3,516,104,874 reads / 974 files）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "メチル化アレイ": {
          "対象": "NAFLD患者由来の肝臓組織：60検体（56検体RNA-seqと重複）",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina Infinium® Human Methylation 450K BeadChip",
          "ソース": "NAFLD患者由来の肝臓組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "バイサルファイト変換：EZ DNA Methylation™ Kit（Zymo Research） \r\nメチル化解析：Infinium® Human Methylation 450K BeadChip kit（Illumina）",
          "メチル化率決定アルゴリズム（ソフトウェア）": "GenomeStudio Software （Illumina）",
          "フィルタリング": "除外プローブ：\r\n2サンプル以上で蛍光強度がバックグランドと区別できないプローブ（検出力　p>0.05）\r\n5%以上のサンプルでビーズ数が3未満のプローブ\r\nSNPが存在するプローブ\r\n交差反応するプローブ",
          "マイクロアレイ標準化方法": "DNAメチル化の生データはインターナル・コントロールのプローブで補正。\r\n2つのタイププローブについてはbeta-mixture quantile normalizationにて補正。\r\nバッチエフェクトはComBat（R/Bioconductor package ChAM）にて補正。",
          "プローブ数(QC後)": "431,736 CpGs（常染色体上、reference [hg19]）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000059",
          "総データ量": "300 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "堀田 紀久子",
        "所 属 機 関": "大阪大学 医学部附属病院 未来医療開発部",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "科学研究費助成事業　基盤研究（C）",
            "タイトル": "非アルコール性脂肪肝障害の発症・進行に関連する遺伝素因と環境因子の解析",
            "研究課題番号": "26460999"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Identification of core gene networks and hub genes associated with progression of nonalcoholic fatty liver disease by RNA sequencing",
          "DOI": "doi: 10.1111/hepr.12877",
          "データID": "JGAD000059"
        },
        "2": {
          "タイトル": "Identification of the genomic region under epigenetic regulation during nonalcoholic fatty liver disease progression.",
          "DOI": "doi: 10.1111/hepr.12992",
          "データID": "JGAD000059"
        }
      },
      "制限公開データの利用者一覧": {
        "Pablo Giraudi": {
          "研究代表者": "Pablo Giraudi",
          "所属機関": "Fondazione Italiana Fegato",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000059"
        },
        "野島 正寛": {
          "研究代表者": "野島 正寛",
          "所属機関": "東京大学・医科学研究所",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000059"
        },
        "Robert Tsai": {
          "研究代表者": "Robert Tsai",
          "所属機関": "Institute of Biosciences & Technology, Texas A&M Health Science Center",
          "研究題目": "",
          "利用データID": "Genome-wide Discovery of new Plasma DNA Mehylation Makers for Tracking the Progression of NAFLD to NASH and HCC",
          "利用期間": "JGAD000059"
        },
        "堀田 紀久子": {
          "研究代表者": "堀田 紀久子",
          "所属機関": "大阪大谷大学 薬学部　薬物治療学講座",
          "研究題目": "",
          "利用データID": "非アルコール性脂肪肝疾患のエピゲノム解析",
          "利用期間": "JGAD000059"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000059"
        }
      },
      "リリース情報": {
        "hum0055.v1": {
          "Research ID": "hum0055.v1",
          "公開日": "2017/02/20",
          "内容": "NGS（RNA-seq）\r\nメチル化アレイ",
          "description": "非アルコール性脂肪肝疾患患者由来の肝臓組織から抽出したmRNAを使用したRNA-seq解析の結果をFastqファイルで、肝臓組織から抽出したDNAを使用したメチル化アレイ解析をtxtファイル（メチル化のβ値）にて提供する。\nRNA-seqは、Agilent SureSelectXT RNA Target Enrichment for Illumina Multiplexed SequencingによるRNAライブラリ作製後、HiSeq 2500にて平均長100 ベースを読んだ（Paired-end）。\n肝臓組織から抽出したDNAを対象としてIllumina社Human Methylation 450K BeadChipによるメチル化解析を実施。メチル化率のβ値を計算した。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0055.v1",
      "DATA": {
        "JGAS000059": {
          "Data Set ID": "JGAS000059",
          "Type of Data": "NGS (RNA-seq)\r\nMethylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/02/20"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the mRNA expression related to the development and/or progression of non-alcoholic fatty liver disease (NAFLD).",
        "Methods": "RNA-seq and Methylation array analysis by using of mRNA or DNA purified from liver tissues",
        "Participants/Materials": "64 NAFLD patients"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "RNA-seq": {
          "Participants/Materials": "Human liver tissues from NAFLD patients: 60 samples",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "mRNAs extracted from NAFLD liver tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelectXT RNA Target Enrichment for Illumina Multiplexed Sequencing",
          "Fragmentation Methods": "chemical fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000059",
          "Total Data Volume": "307 GB (fastq [3,516,104,874 reads / 974 files)",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation array": {
          "Participants/Materials": "Human liver tissues from NAFLD patients: 60 samples (56 are same samples as RNA-seq)",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina Infinium® Human Methylation 450K BeadChip",
          "Library Source": "DNAs extracted from NAFLD liver tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Bisulfite Conversion: EZ DNA Methylation™ Kit (Zymo Research)\r\nMethylation analysis: Infinium® Human Methylation 450K BeadChip kit (Illumina)",
          "Algorithms for Calculating Methylation-rate (software)": "GenomeStudio Software (Illumina)",
          "Filtering Methods": "Probes as shown below were excluded:\r\nwith intensities indistinguishable from the background (detection P-value > 0.05) in more than one sample\r\nwith a bead count < 3 in at least 5 % of samples\r\nincluding any SNPs \r\ncross-reactive",
          "Normalization of microarray": "Raw DNA methylation data were preprocessed by normalizing to appropriate internal control probes. The effects of two types of CpG probes on CpG methylation measurements were corrected using beta-mixture quantile normalization, and batch effects were corrected using a ComBat normalization method in the R/Bioconductor package ChAMP.",
          "Probe Number (after QC)": "431,736 CpGs (on autosomal chromosomes, reference [hg19])",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000059",
          "Total Data Volume": "300 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Kikuko Hotta",
        "Affiliation": "Department of Medical Innovation, Osaka University Hospital",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Analysis of genetic predisposition and environmental factors related to the onset and progression of nonalcoholic fatty liver disease",
            "Project Number": "26460999"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Identification of core gene networks and hub genes associated with progression of nonalcoholic fatty liver disease by RNA sequencing",
          "DOI": "doi: 10.1111/hepr.12877",
          "Data Set ID": "JGAD000059"
        },
        "2": {
          "Title": "Identification of the genomic region under epigenetic regulation during nonalcoholic fatty liver disease progression.",
          "DOI": "doi: 10.1111/hepr.12992",
          "Data Set ID": "JGAD000059"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Pablo Giraudi": {
          "Principal Investigator": "Pablo Giraudi",
          "Affiliation": "Fondazione Italiana Fegato",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000059"
        },
        "Masanori Nojima": {
          "Principal Investigator": "Masanori Nojima",
          "Affiliation": "The Institute of Medical Science, The University of Tokyo",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000059"
        },
        "Robert Tsai": {
          "Principal Investigator": "Robert Tsai",
          "Affiliation": "Institute of Biosciences & Technology, Texas A&M Health Science Center",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Genome-wide Discovery of new Plasma DNA Mehylation Makers for Tracking the Progression of NAFLD to NASH and HCC",
          "Period of Data Use": "JGAD000059"
        },
        "Kikuko Hotta": {
          "Principal Investigator": "Kikuko Hotta",
          "Affiliation": "Laboratory of Pathophysiology and Pharmacotherapeutics Faculty of Pharmacy, Osaka Ohtani University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Genomic and epigenomic analysis of liver disease (nonalcoholic fatty liver disease, virus hepatitis, alcoholic hepatitis, cirrhosis, and hepatocellular carcinoma)",
          "Period of Data Use": "JGAD000059"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000059"
        }
      },
      "Release Note": {
        "hum0055.v1": {
          "Research ID": "hum0055.v1",
          "Release Date": "2017/02/20",
          "Type of Data": "NGS (RNA-seq)\r\nMethylation array",
          "description": "Human liver mRNA or DNA purified from non-alcoholic fatty liver disease patients were used for RNA-seq (fastq) and Methylation array (txt [β value of methylation]).\nAgilent SureSelectXT RNA Target Enrichment for Illumina Multiplexed Sequencing was used for preparing libraries and read by Illumina HiSeq 2500 (paired-end: 100 bp).\nIllumina Infinium® Human Methylation 450K BeadChip was used for Methylation analysis.\nNote：\n"
        }
      }
    }
  },
  "hum0053.v2": {
    "ja": {
      "NBDC Research ID": "hum0053.v2",
      "データ": {
        "JGAS000062": {
          "データID": "JGAS000062",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/07/20"
        },
        "JGAS000176": {
          "データID": "JGAS000176",
          "内容": "NGS（WGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/04/14"
        }
      },
      "研究内容の概要": {
        "目的": "アスベスト曝露によって発症する悪性胸膜中皮腫の網羅的ゲノム解析により新規分子標的治療法候補分子の同定を行うとともに、新たな分子診断・治療法の開発を目指す",
        "方法": "Whome Exome Sequencing（Exome）：悪性胸膜中皮腫患者の外科手術検体あるいは樹立した中皮腫細胞株、および、同一症例の末梢血より抽出したゲノムDNAを用いて全エクソームシークエンス解析を行った。Whole Genome Sequencing（WGS）：悪性胸膜中皮腫患者の外科手術検体（腫瘍組織）より樹立した中皮腫細胞株より抽出したDNAを対象としたWGS解析を、large structral variantsを同定するために10X Chromiumを用いて行った。",
        "対象": "悪性胸膜中皮腫38症例 （患者由来中皮腫細胞株12例を含む）",
        "URL": "http://hdc-tsrg.com/"
      },
      "分子データ": {
        "JGAS000062": {
          "対象": "悪性胸膜中皮腫：38症例（腫瘍組織および非腫瘍組織ペア：76検体）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "悪性胸膜中皮腫患者の外科手術検体あるいは樹立した中皮腫細胞株より抽出したDNA（腫瘍組織）\r\n同一症例の末梢血から抽出したDNA（非腫瘍組織）",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V4 or V5 plus lncRNA （Agilent社）",
          "断片化の方法": "超音波断片化（Covaris社、E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000062",
          "総データ量": "596 GB（bam [76 files / ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000176": {
          "対象": "悪性胸膜中皮腫：12症例（腫瘍組織）",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "ライブラリソース": "悪性胸膜中皮腫患者の外科手術検体（腫瘍組織）から樹立した中皮腫細胞株より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Chromium Genome Library & Gel Bead Kit v2",
          "断片化の方法": "Chromium Genome Library & Gel Bead Kit v2",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp x2",
          "QC方法": "default of 10x genomics SV-calling algorithms",
          "マッピング方法": "Long Ranger Pipeline",
          "平均カバー率（Depth）": "46",
          "構造変異検出方法": "Long Ranger Pipeline",
          "構造多型数": "2399",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000256",
          "総データ量": "949 GB\r\n    Data ファイル数：24（fastq）\r\n    Analysis ファイル数：36（bed、vcf [ref：hg38]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "中野 孝司",
        "所 属 機 関": "兵庫医科大学 呼吸器内科",
        "プロジェクト/研究グループ名": "次世代がん研究シーズ戦略的育成プログラム",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん医療創生研究事業（P-CREATE）",
            "タイトル": "悪性中皮腫のゲノム異常と代謝・細胞特性の包括的理解による新規分子標的の同定",
            "研究課題番号": "JP19cm0106606"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrative molecular characterization of malignant pleural mesothelioma.",
          "DOI": "doi: 10.1158/2159-8290.CD-18-0804",
          "データID": "JGAD000062"
        }
      },
      "制限公開データの利用者一覧": {
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000062"
        }
      },
      "リリース情報": {
        "hum0053.v2": {
          "Research ID": "hum0053.v2",
          "公開日": "2020/04/14",
          "内容": "NGS（WGS）",
          "description": "日本人の悪性胸膜中皮腫患者の外科手術検体から樹立した中皮腫細胞株より抽出したゲノムDNAを用いた10x Genomics Chromium ControllerによるLong Read Whole Genome Sequencingデータ（fastq）およびサンプルごとのStructural Variantsデータ（vcf, bed）を提供する。\n"
        },
        "hum0053.v1": {
          "Research ID": "hum0053.v1",
          "公開日": "2016/07/20",
          "内容": "NGS（Exome）",
          "description": "日本人の悪性胸膜中皮腫患者の外科手術検体あるいは樹立した中皮腫細胞株より抽出したゲノムDNA、および、末梢血から抽出したDNAを用いた全Exome解析の結果をbamファイルにて提供する。\nSureSelect All Exon kitによりExon領域を濃縮したライブラリーを作成し、Illumina HiSeq 2000/2500にて約250-350 bpの断片をPair-end法によりシーケンスを行った。得られたfastqファイルをBWA、NovoAlignにてヒト参照配列hg19にマッピングし、bamファイルを得た。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0053.v2",
      "DATA": {
        "JGAS000062": {
          "Data Set ID": "JGAS000062",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/07/20"
        },
        "JGAS000176": {
          "Data Set ID": "JGAS000176",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/04/14"
        }
      },
      "SUMMARY": {
        "Aims": "Malignant pleural mesothelioma which is associated with asbestos exposure is highly aggressive and refractory to conventional therapeutic modalities. The aim of this study is identification of new targets for molecular target therapy by next generation sequencing and application of the genomic data to new diagnostic and therapeutic strategies for malignant pleural mesothelioma patients.",
        "Methods": "Exome: We extracted genomic DNAs from surgical specimens or established mesothelioma cell lines from Japanese malignant pleural mesothelioma patients. We also extracted control DNAs from peripheral blood of the same patients. We performed whole exome sequencing using these DNAs.WGS: We extracted genomic DNAs from established mesothelioma cell lines from Japanese malignant pleural mesothelioma patients. We sequenced those genomic DNAs using 10X Genomics sequencing technologies, and analyzed genomic structural variations.",
        "Participants/Materials": "38 Malignant pleural mesothelioma patients (including 12 established mesothelioma cell lines)",
        "URL": "https://www.pref.aichi.jp/cancer-center/english/ri/01division/03cancer_biology/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000062": {
          "Participants/Materials": "38 Malignant pleural mesothelioma patients\r\n(38 pairs of tumor tissue and non-tumor tissue: 76 samples)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "Genomic DNAs extracted from surgical specimens or established mesothelioma cell lines from malignant pleural mesothelioma patients\r\nControl DNAs from peripheral blood cells of the same patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V4 or V5 plus lncRNA (Agilent Technologies)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000062",
          "Total Data Volume": "596 GB (bam [76 files / ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000176": {
          "Participants/Materials": "12 Malignant pleural mesothelioma patients\r\n(12 tumor tissues)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "10x Genomics [Chromium Controller]",
          "Library Source": "Genomic DNAs extracted from established mesothelioma cell lines from malignant pleural mesothelioma patients",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Chromium Genome Library & Gel Bead Kit v2",
          "Fragmentation Methods": "Chromium Genome Library & Gel Bead Kit v2",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp x2",
          "QC Methods": "default of 10x genomics SV-calling algorithms",
          "Mapping Methods": "Long Ranger Pipeline",
          "Depth (average)": "46",
          "Structural Variants Detection Methods": "Long Ranger Pipeline",
          "Polymorphism Number (after QC)": "2399",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000256",
          "Total Data Volume": "949 GB\r\n    Data files: 24 (fastq)\r\n    Analysis files: 36 (vcf, bed [ref: hg38])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takashi Nakano",
        "Affiliation": "Hyogo College of Medicine, Division of Respiratory Medicine",
        "Project / Group Name": "Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Identification of novel molecular targets by comprehensive understanding of genomic abnormalities and metabolic and cellular characteristics of malignant mesothelioma",
            "Project Number": "JP19cm0106606"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrative molecular characterization of malignant pleural mesothelioma.",
          "DOI": "doi: 10.1158/2159-8290.CD-18-0804",
          "Data Set ID": "JGAD000062"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000062"
        }
      },
      "Release Note": {
        "hum0053.v2": {
          "Research ID": "hum0053.v2",
          "Release Date": "2020/04/14",
          "Type of Data": "NGS (WGS)",
          "description": "DNAs extracted from established mesothelioma cell lines from Japanese malignant pleural mesothelioma patients were sequenced using 10X Genomics sequencing technologies. Fastq files and vcf/bed files for structural variants are provided.\n"
        },
        "hum0053.v1": {
          "Research ID": "hum0053.v1",
          "Release Date": "2016/07/20",
          "Type of Data": "NGS (Exome)",
          "description": "DNAs were extracted from \n(1) surgical specimens or established mesothelioma cell lines from Japanese malignant pleural mesothelioma patients\n(2) peripheral blood cells of the same patients as controls.\nDNA fragments containing whole coding exons were concentrated using SureSelect Human All Exon V4 or V5 plus lncRNA (Agilent Technologies) followed by 100 bp paired-end sequencing with HiSeq 2000/2500 (Illumina). Fastq files were mapped onto a reference genome hg19 with BWA and NovoAlign (bam files).\nNote：\n"
        }
      }
    }
  },
  "hum0050.v1": {
    "ja": {
      "NBDC Research ID": "hum0050.v1",
      "データ": {
        "JGAS000053": {
          "データID": "JGAS000053",
          "内容": "NGS（CAGE-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/09/30"
        }
      },
      "研究内容の概要": {
        "目的": "HBV感染者の血液のトランスクリプトームを理解する。",
        "方法": "血液からRNAを抽出し、Cap Analysis of Gene Expression（CAGE）ライブラリを作成後、シークエンシングを実施",
        "対象": "抗ウイルス療法未施行のGenotype Cの男性HBVキャリア"
      },
      "分子データ": {
        "JGAS000053": {
          "対象": "抗ウイルス療法未施行のGenotype Cの男性HBVキャリア：8症例",
          "規模": "CAGE-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "抗ウイルス療法未施行のGenotype Cの男性HBVキャリアの血液より抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "nAnT-iCAGE v2.1",
          "断片化の方法": "断片化なし",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000053",
          "総データ量": "3 GB（fastq、bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "松浦 知和",
        "所 属 機 関": "東京慈恵会医科大学 臨床検査医学講座",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 肝炎等克服実用化研究事業 Ｂ型肝炎創薬実用化等研究事業",
            "タイトル": "次世代生命基盤技術を用いたB型肝炎制圧のための創薬研究",
            "研究課題番号": "JP15fk0310004"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Single-nucleotide-resolution mapping of HBV promoters in infected human livers and hepatocellular carcinoma",
          "DOI": "doi: 10.1128/JVI.01625-16",
          "データID": "JGAS000053"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0050.v1": {
          "Research ID": "hum0050.v1",
          "公開日": "2016/09/30",
          "内容": "NGS（CAGE-seq）",
          "description": " 抗ウイルス療法未施行のGenotype Cの男性HBVキャリアの血液より抽出したRNAを使用してCAGEライブラリを作成し、Illumina HiSeq 2000によるシークエンシングを行った結果をfastqおよびbamファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0050.v1",
      "DATA": {
        "JGAS000053": {
          "Data Set ID": "JGAS000053",
          "Type of Data": "NGS (CAGE-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/09/30"
        }
      },
      "SUMMARY": {
        "Aims": "Understand blood transcriptome of HBV positive blood.",
        "Methods": "Extract RNA from whole blood and prepare CAGE libraries for deep sequencing",
        "Participants/Materials": "HBV (Genotype C) positive blood samples derived from untreated patients (men)"
      },
      "MOLECULAR DATA": {
        "JGAS000053": {
          "Participants/Materials": "8 HBV (Genotype C) positive blood samples derived from untreated patients (men)",
          "Targets": "CAGE-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "RNA extracted from whole blood samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "nAnT-iCAGE v2.1",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "47 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000053",
          "Total Data Volume": "3 GB (fastq, bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tomokazu Matsuura",
        "Affiliation": "The Jikei University School of Medicine, Rinsho Kensa Igaku Koza",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Division of Infectious Disease Research, Research Program on Hepatitis, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Drug Discovery Research for Complete Cure of Chronic Hepatitis Type B Utilizing The Next Generation Life Science Technologies",
            "Project Number": "JP15fk0310004"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Single-nucleotide-resolution mapping of HBV promoters in infected human livers and hepatocellular carcinoma",
          "DOI": "doi: 10.1128/JVI.01625-16",
          "Data Set ID": "JGAS000053"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0050.v1": {
          "Research ID": "hum0050.v1",
          "Release Date": "2016/09/30",
          "Type of Data": "NGS (CAGE-seq)",
          "description": "RNA extracted from HBV (Genotype C) positive whole blood samples derived from untreated patients (men) were used for preparation of CAGE libraries. Deep sequencing analysis on the libraries was performed with the Illumina HiSeq 2000 sequencer (47 bp, single-end) and provided in fastq and bam format files (Reference: hg19).\nNote：\n"
        }
      }
    }
  },
  "hum0048.v1": {
    "ja": {
      "NBDC Research ID": "hum0048.v1",
      "データ": {
        "DRA004251": {
          "データID": "DRA004251",
          "内容": "NGS（Exome）",
          "制限": "非制限公開",
          "公開日": "2016/02/05"
        }
      },
      "研究内容の概要": {
        "目的": "国際多施設共同研究によって、ファーター乳頭部腫瘍の分子遺伝学的な特徴を明らかにし、治療法の開発に貢献する。",
        "方法": " イルミナHiSeq 2000および2500を使用し、60名のファーター乳頭部がんの全エクソン解析を実施。",
        "対象": "臨床・病理的に診断されたファーター乳頭部腫瘍60症例（日本人28症例、米国人32症例）",
        "URL": "http://www.ncc.go.jp/jp/information/press_release_20160126.html"
      },
      "分子データ": {
        "DRA004251": {
          "対象": "ファーター乳頭部がん：60症例（日本人28症例、米国人32症例）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "腫瘍組織から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon Kit v4.0 （Agilent Technologies）",
          "断片化方法": "超音波断片化（Covaris SS）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "100 bp x 2",
          "DDBJ Sequence Read Archive ID": "DRA004251",
          "総データ量": "600 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": " 谷内田 真一",
        "所 属 機 関": "国立がん研究センター研究所・臨床ゲノミクス研究ユニット、大阪大学大学院 医学系研究科 医学部 ゲノム生物学講座 がんゲノム情報学",
        "プロジェクト/研究グループ名": "",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "システム生物学的アプローチによる希少がんの分子病態解明と臨床病態の予測",
            "研究課題番号": "25134719"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma",
          "DOI": "doi: 10.1016/j.ccell.2015.12.012",
          "データID": "DRA004251"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0048.v1": {
          "Research ID": "hum0048.v1",
          "公開日": "2016/02/05",
          "内容": "NGS (Exome)",
          "description": "このバージョンでは、ファーター乳頭部がん60症例（日本人28症例、米国人32症例）について、腫瘍組織から抽出したgDNAを使用したExome解析の結果をFastqファイルにて提供する。\nIllumina (HiSeq 2000および2500)を用いて平均長2 x 100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0048.v1",
      "DATA": {
        "DRA004251": {
          "Data Set ID": "DRA004251",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2016/02/05"
        }
      },
      "SUMMARY": {
        "Aims": "The genomic biology of ampullary carcinomas is currently poorly defined, we have conducted an in-depth analysis of the genomic abnormalities of these carcinomas through an international multicenter collaboration to establish a potential basis for treatments of this disease.",
        "Methods": "Whole exome sequencing was performed on the Illumina HiSeq 2000/2500 platforms in a discovery set of 60 ampullary carcinomas.",
        "Participants/Materials": "We investigated a large cohort of clinically and pathologically well-characterized patients with ampullary cancer that included 28 Japanese patients and 32 American patients.",
        "URL": "http://www.ncc.go.jp/jp/information/press_release_20160126.html"
      },
      "MOLECULAR DATA": {
        "DRA004251": {
          "Participants/Materials": "60 patients with an ampullary cancer\r\n(28 Japanese patients and 32 American patients)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "gDNAs extracted from ampullary carcinomas specimen",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon Kit v4.0 (Agilent Technologies)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris SS)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp x 2",
          "DDBJ Sequence Read Archive ID": "DRA004251",
          "Total Data Volume": "600 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shinichi Yachida",
        "Affiliation": "Laboratory of Clinical Genomics, National Cancer Center Research Institute / Department of Cancer Genome Informatics, Graduate School of Medicine/Faculty of Medicine, Osaka University",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "Molecular pathological analysis and prediction of clinical course of a rare tumor by systematic approach to biology",
            "Project Number": "25134719"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma",
          "DOI": "doi: 10.1016/j.ccell.2015.12.012",
          "Data Set ID": "DRA004251"
        },
        "2": {
          "Title": "-",
          "DOI": "-",
          "Data Set ID": "-"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0048.v1": {
          "Research ID": "hum0048.v1",
          "Release Date": "2016/02/05",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from ampullary carcinomas obtained from 60 patients (28 Japanese patients and 32 American patients) were used for the whole exome sequencing (fastq files). DNA fragments containing whole coding exons were concentrated using SureSelect Human All Exon Kit v4.0 (Agilent Technologies) and multiplex sequence was performed with the Illumina HiSeq 2000 / 2500 sequencer (2 x 100 bp, Paired-end).\nNote：\n"
        }
      }
    }
  },
  "hum0045.v1": {
    "ja": {
      "NBDC Research ID": "hum0045.v1",
      "データ": {
        "JGAS000047": {
          "データID": "JGAS000047",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/03/29"
        }
      },
      "研究内容の概要": {
        "目的": "思春期・若年成人急性リンパ芽球性白血病（Acute Lymphoblastic Leukemia: ALL）の発症の原因となる遺伝子異常を同定する。",
        "方法": "Illumina HiSeq 2000 / 2500を使用したRNA-seq解析",
        "対象": "フィラデルフィア染色体陰性ALL 99症例、フィラデルフィア染色体陽性ALL 3症例、セルライン 5検体、正常血球細胞 8検体",
        "URL": "https://www.ncc.go.jp/jp/ri/division/genetics/index.html"
      },
      "分子データ": {
        "JGAS000047": {
          "対象": "フィラデルフィア染色体陰性ALL：99症例、フィラデルフィア染色体陽性ALL：3症例、\r\nセルライン：5検体、正常血球細胞：8検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "【フィラデルフィア染色体陰性/陽性ALL検体】\r\n末梢血もしくは骨髄液から抽出したmRNA\r\n【セルライン、正常血球細胞】\r\n培養された細胞から抽出したmRNA",
          "検体情報（購入の場合）": "セルライン、正常血球細胞（Takara/Lonzaより購入）",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra Directional RNA Library Prep Kit for Illumina",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "104 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000047",
          "総データ量": "3.29 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "間野 博行",
        "所 属 機 関": "国立がん研究センター研究所 細胞情報学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 革新的先端研究開発支援事業 インキュベートタイプ（LEAP）",
            "タイトル": "がん治療標的探索プロジェクト",
            "研究課題番号": "15653406"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Recurrent DUX4 fusions in B-cell acute lymphoblastic leukemia of adolescents and young adults",
          "DOI": "doi:10.1038/ng.3535",
          "データID": "JGAD000047"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Jinyan Huang": {
          "研究代表者": "Jinyan Huang",
          "所属機関": "Zhejiang University School of Medicine",
          "研究題目": "",
          "利用データID": "Comprehensive analysis of alternative splicing in malignant tumors",
          "利用期間": "JGAD000047"
        },
        "Robert Bradley": {
          "研究代表者": "Robert Bradley",
          "所属機関": "Fred Hutchinson Cancer Research Center, Public Health Science",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000047"
        },
        "Christine Harrison": {
          "研究代表者": "Christine Harrison",
          "所属機関": "Northern Institute for Cnacer Research, Newcastle University",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000047"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000047"
        }
      },
      "リリース情報": {
        "hum0045.v1": {
          "Research ID": "hum0045.v1",
          "公開日": "2016/03/29",
          "内容": "NGS（RNA-Seq）",
          "description": "フィラデルフィア染色体陰性または陽性ALL症例の末梢血、もしくは骨髄液から抽出したmRNAと、セルラインおよび正常血球細胞の培養細胞から抽出したmRNAを使用し、RNA-Seq解析した結果をFastqファイルにて提供する。NEBNext Ultra Directional RNA Library Prep Kit for Illuminaによるライブラリ作製後、HiSeq 2000もしくは2500にて平均長104塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0045.v1",
      "DATA": {
        "JGAS000047": {
          "Data Set ID": "JGAS000047",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/03/29"
        }
      },
      "SUMMARY": {
        "Aims": "Screening of oncogenic fusion genes in acute lymphoblastic leukemia (ALL) in adolescents and young adults",
        "Methods": "RNA-seq by using HiSeq 2000 / 2500",
        "Participants/Materials": "99 Philadelphia chromosome-negative (Ph-) ALLs, 3 Philadelphia chromosome-positive (Ph+) ALLs, 5 cell lines, 8 normal hematopoietic cells",
        "URL": "https://www.ncc.go.jp/en/ri/division/genetics/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000047": {
          "Participants/Materials": "99 Ph- ALLs\r\n3 Ph+ ALLs,\r\n5 cell lines\r\n8 normal hematopoietic cells",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "[Ph- / + ALL cases]\r\nmRNA extracted from peripheral blood cells or bone marrow aspirates\r\n[cell lines, normal hematopoietic cells]\r\nmRNA extracted from cultured cells",
          "Cell Lines": "cell lines, normal hematopoietic cells (Takara/Lonza)",
          "Library Construction (kit name)": "NEBNext Ultra Directional RNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "Heat treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "104 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000047",
          "Total Data Volume": "3.29 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Mano",
        "Affiliation": "Division of Cellular Signaling, National Cancer Center Research Institute",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Leading Advanced Projects for medical innovation (LEAP), Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Projects for exploration of therapeutic targets in cancer",
            "Project Number": "15653406"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Recurrent DUX4 fusions in B-cell acute lymphoblastic leukemia of adolescents and young adults",
          "DOI": "doi:10.1038/ng.3535",
          "Data Set ID": "JGAD000047"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Jinyan Huang": {
          "Principal Investigator": "Jinyan Huang",
          "Affiliation": "School of Medicine, Zhejiang University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of alternative splicing in malignant tumors",
          "Period of Data Use": "JGAD000047"
        },
        "Robert Bradley": {
          "Principal Investigator": "Robert Bradley",
          "Affiliation": "Fred Hutchinson Cancer Research Center, Public Health Science",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000047"
        },
        "Christine Harrison": {
          "Principal Investigator": "Christine Harrison",
          "Affiliation": "Northern Institute for Cnacer Research, Newcastle University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000047"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000047"
        }
      },
      "Release Note": {
        "hum0045.v1": {
          "Research ID": "hum0045.v1",
          "Release Date": "2016/03/29",
          "Type of Data": "NGS (RNA-seq)",
          "description": "mRNAs extracted from \n(1) peripheral blood cells and bone marrow aspirates of Philadelphia chromosome-negative / -positive ALL cases\n(2) cell lines and normal hematopoietic cells \nwere used for RNA-seq (Fastq files). \nThe NEBNext Ultra Directional RNA Library Prep Kit for Illumina was used for preparing libraries and read by Illumina HiSeq 2000 / 2500 (paired-end, 104 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0044.v1": {
    "ja": {
      "NBDC Research ID": "hum0044.v1",
      "データ": {
        "DRA004162": {
          "データID": "DRA004162",
          "内容": "NGS（ChIP-seq）",
          "制限": "非制限公開",
          "公開日": "2016/10/31"
        }
      },
      "研究内容の概要": {
        "目的": "成人T細胞白血病（ATL）細胞株（ED）のエピゲノムを調べる",
        "方法": "クロマチン免疫沈降後シークエンス",
        "対象": "ATL細胞株ED",
        "URL": "http://www.caids.kumamoto-u.ac.jp/satou/index.html"
      },
      "分子データ": {
        "DRA004162": {
          "対象": "1名のATL罹患者の細胞から樹立したセルライン（ATL細胞株ED）",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [NextSeq 500]",
          "ライブラリソース": "ATL細胞株EDから抽出したクロマチンDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra DNA Library Prep Kit",
          "断片化の方法": "超音波断片化（Diagenode社　Bioruptor USD-200）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "300 bp",
          "DDBJ Sequence Read Archive ID": "DRA004162",
          "総データ量": "159.5 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "佐藤 賢文",
        "所 属 機 関": "熊本大学 国際先端医学機構",
        "プロジェクト/研究グループ名": "佐藤研究室",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "公益財団法人 武田科学振興財団",
            "タイトル": "HTLV-1 を起点とした成人 T 細胞白血病発症メカ ニズム解明と早期診断法の確立",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome",
          "DOI": "doi: 10.1073/pnas.1423199113",
          "データID": "DRA004162"
        },
        "2": {
          "タイトル": " ",
          "DOI": " ",
          "データID": " "
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0044.v1": {
          "Research ID": "hum0044.v1",
          "公開日": "2016/10/31",
          "内容": "NGS（ChIP-Seq）",
          "description": "成人T細胞白血病（ATL）罹患者の細胞から樹立したセルライン（ATL細胞株ED）を使用したChIP-seqデータをFastqファイルにて提供する。CTCF遺伝子に対する抗体、ヒストンに対する抗体（H3K36me3、H3K4me3、H3K9ac、H2A.Z）、IgG（コントロール）を使用したクロマチン免疫沈降後ChIP-Seqライブラリを作製し、Illumina NextSeq 500によるシーケンシングを行っている。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0044.v1",
      "DATA": {
        "DRA004162": {
          "Data Set ID": "DRA004162",
          "Type of Data": "NGS (ChIP-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2016/10/31"
        }
      },
      "SUMMARY": {
        "Aims": "Epigenetic analysis of adult T-cell leukemia-lymphoma (ATL) cell line",
        "Methods": "ChIP-seq",
        "Participants/Materials": "ATL cell line; ED",
        "URL": "http://www.caids.kumamoto-u.ac.jp/satou/research-e.html"
      },
      "MOLECULAR DATA": {
        "DRA004162": {
          "Participants/Materials:": "ED cell line derived from 1 patient with ATL",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [NextSeq 500]",
          "Library Source": "Chromatin DNA extracted from ED",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra DNA Library Prep Kit",
          "Fragmentation Methods": "Bioruptor USD-200 (Diagenode)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "300 bp",
          "DDBJ Sequence Read Archive ID": "DRA004162",
          "Total Data Volume": "159.5 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Satou Yorifumi",
        "Affiliation": "International Research Center for Medical Sciences, Kumamoto University",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Takeda Science Foundation",
            "Title": "Elucidation of the mechanisms underlying HTLV-1-mediated ATL leukemogenesis",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome",
          "DOI": "doi: 10.1073/pnas.1423199113",
          "Data Set ID": "DRA004162"
        },
        "2": {
          "Title": " ",
          "DOI": " ",
          "Data Set ID": " "
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0044.v1": {
          "Research ID": "hum0044.v1",
          "Release Date": "2016/10/31",
          "Type of Data": "NGS (ChIP-Seq)",
          "description": "One chromatin DNA sample extracted from an ALT cell line (ED) was used for ChIP-Seq analysis (fastq format files). \nAfter immunoprecipitation using anti-CTCF, anti-histon (H3K36me3, H3K4me3, H3K9ac, H2A.Z), and rabbit polyclonal control IgG, ChIP-Seq libraries were sequenced using Illumina NextSeq 500 platform.\nNote：\n"
        }
      }
    }
  },
  "hum0043.v1": {
    "ja": {
      "NBDC Research ID": "hum0043.v1",
      "データ": {
      },
      "研究内容の概要": {
        "目的": "アルツハイマー病（AD）治療薬の薬効評価基準の最適化を行うために、ADの病態を忠実に反映するサロゲートマーカー (surrogate marker)を定めておく必要がある。J-ADNI研究は、MRIやPETなどの画像サロゲートマーカーの長期的変化に関する一定の基準値を作成するとともにその妥当性を証明するために臨床/神経心理検査データ、血液・脳脊髄液サンプルを並行して収集することを目的とする。",
        "対象": " 研究参加者(縦断研究組入数）537名（内訳：健常高齢者健常群154名、軽度認知機能障害（MCI）234名、早期アルツハイマー病149名）"
      },
      "分子データ": {
      },
      "提供者情報": {
        "研究代表者": "岩坪 威",
        "所 属 機 関": "東京大学大学院医学系研究科 神経病理学分野",
        "プロジェクト/研究グループ名": "Japanese Alzheimer's Disease Neuroimaging Intiative (J-ADNI) (著者一覧、引用する際の記載要領）",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "国立研究開発法人科学技術振興機構ライフサイエンスデータベース統合推進事業（統合化推進プログラム）",
            "タイトル": "ヒト脳疾患画像データベース統合化研究",
            "研究課題番号": "なし"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.",
          "DOI": "doi: 10.1016/j.jalz.2018.03.009",
          "データID": "JGAD000051"
        }
      },
      "制限公開データの利用者一覧": {
        "Michael C Donohue": {
          "研究代表者": "Michael C Donohue",
          "所属機関": "University of Southern California, Alzheimers Therapeutic Research Institute",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "高橋 竜一": {
          "研究代表者": "高橋 竜一",
          "所属機関": "兵庫県立リハビリテーション西播磨病院 神経内科",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "石井 賢二": {
          "研究代表者": "石井 賢二",
          "所属機関": "地方独立行政法人東京都健康長寿医療センター 研究所神経画像研究チーム",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "松田 博史": {
          "研究代表者": "松田 博史",
          "所属機関": "国立精神・神経医療研究センター 脳病態統合イメージングセンター",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "Weining Robieson": {
          "研究代表者": "Weining Robieson",
          "所属機関": "AbbVie",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "千田 道雄": {
          "研究代表者": "千田 道雄",
          "所属機関": "公益財団法人先端医療振興財団 先端医療センター分子イメージング研究グループ",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "青島 健": {
          "研究代表者": "青島 健",
          "所属機関": "エーザイ株式会社 hhcデータクリエーションセンター",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "加藤 隆司": {
          "研究代表者": "加藤 隆司",
          "所属機関": "国立長寿医療研究センター 放射線診療部",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "菊池 正史": {
          "研究代表者": "菊池 正史",
          "所属機関": "MSD株式会社 グローバル研究開発本部 クリニカルリサーチ 中枢神経領域",
          "研究題目": "",
          "利用データID": "臨床情報およびゲノム情報を用いた認知症オミックス解析",
          "利用期間": "JGAD000051"
        },
        "鈴木 洋史": {
          "研究代表者": "鈴木 洋史",
          "所属機関": "東京大学医学部附属病院 薬剤部",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "大河内 正康": {
          "研究代表者": "大河内 正康",
          "所属機関": "大阪大学大学院医学系研究科 精神医学教室",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "Joyce Suhy": {
          "研究代表者": "Joyce Suhy",
          "所属機関": "Bioclinica, Inc.",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "鈴木 利治": {
          "研究代表者": "鈴木 利治",
          "所属機関": "北海道大学 大学院薬学研究院",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "Danielle Harvey": {
          "研究代表者": "Danielle Harvey",
          "所属機関": "UC Davis, Division of Biostatistics",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "Jae-Won Jang": {
          "研究代表者": "Jae-Won Jang",
          "所属機関": "Department of Neurology, Kangwon National University Hospital",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "佐々木 雅之": {
          "研究代表者": "佐々木 雅之",
          "所属機関": "九州大学大学院 医学研究院 保健学部門 医用量子線科学分野",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "椎野 顯彦": {
          "研究代表者": "椎野 顯彦",
          "所属機関": "滋賀医科大学・神経難病研究センター",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "笠井 清登": {
          "研究代表者": "笠井 清登",
          "所属機関": "東京大学医学部附属病院 精神神経科",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "李 元中": {
          "研究代表者": "李 元中",
          "所属機関": "富士フイルム株式会社　画像技術センター",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "岩田 淳": {
          "研究代表者": "岩田 淳",
          "所属機関": "東京大学医学部附属病院 神経内科",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "山元 敏正": {
          "研究代表者": "山元 敏正",
          "所属機関": "埼玉医科大学病院 神経内科 脳卒中内科",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "鈴木 一詩": {
          "研究代表者": "鈴木 一詩",
          "所属機関": "防衛医科大学校 脳神経内科",
          "研究題目": "",
          "利用データID": "臨床情報データベースを用いた脳神経疾患の自然歴の研究",
          "利用期間": "JGAD000051"
        },
        "舟根 司": {
          "研究代表者": "舟根 司",
          "所属機関": "株式会社 日立製作所 研究開発グループ 基礎研究センター",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "深見 忠典": {
          "研究代表者": "深見 忠典",
          "所属機関": "山形大学 大学院理工学研究科",
          "研究題目": "",
          "利用データID": "J-ADNIデータベースを用いたMRI/PET画像統合による縦断的解析",
          "利用期間": "JGAD000051"
        },
        "山口 修平": {
          "研究代表者": "山口 修平",
          "所属機関": "島根大学 医学部内科学第三",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "石田 学": {
          "研究代表者": "石田 学",
          "所属機関": "株式会社ERISA",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "小野 徹太郎": {
          "研究代表者": "小野 徹太郎",
          "所属機関": "大日本印刷 情報イノベーション事業部Ｃ＆Ｉセンター第１マーケティングコミュニケーション本部第１企画開発部ＩＣＴビジネス開発グループ",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "渡邊 小百合": {
          "研究代表者": "渡邊 小百合",
          "所属機関": "ヤンセンファーマ株式会社研究開発本部クリニカルサイエンス統括部",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "Eric Westman": {
          "研究代表者": "Eric Westman",
          "所属機関": "Karolinska Institutet, NVS Department, Division of Clinical Geriatris",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "Nancy Maserijian": {
          "研究代表者": "Nancy Maserijian",
          "所属機関": "Biogen",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "菊地 正隆": {
          "研究代表者": "菊地 正隆",
          "所属機関": "東京大学 大学院新領域創成科学研究科",
          "研究題目": "日本",
          "利用データID": "臨床情報およびゲノム情報を用いた認知症オミックス解析",
          "利用期間": "JGAD000051"
        },
        "Chiristian Nunez": {
          "研究代表者": "Chiristian Nunez",
          "所属機関": "Parc Sanitari Sant Joan de Déu, Research Unit",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "冨田 尚希": {
          "研究代表者": "冨田 尚希",
          "所属機関": "東北大学病院 加齢・老年病科",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000051"
        },
        "須田 顕": {
          "研究代表者": "須田 顕",
          "所属機関": "横浜市立大学付属病院 精神科",
          "研究題目": "",
          "利用データID": "公開データベースを用いたアルツハイマー型認知症の免疫学的バイオマーカーと臨床的特徴の検討",
          "利用期間": "JGAD000051"
        },
        "古和 久朋": {
          "研究代表者": "古和 久朋",
          "所属機関": "神戸大学大学院保健学研究科 リハビリテーション科学領域 脳機能・精神障害分野",
          "研究題目": "",
          "利用データID": "J-ADNI研究データベース解析による高齢者認知機能検査の最適化",
          "利用期間": "JGAD000051"
        },
        "Martin Hofmann-Apitius": {
          "研究代表者": "Martin Hofmann-Apitius",
          "所属機関": "Department for Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing SCAI",
          "研究題目": "",
          "利用データID": "The Virtual Brain - Cloud (Personalized Recommendations for Neurodegenerative Diseases)",
          "利用期間": "JGAD000051"
        },
        "宮下 哲典": {
          "研究代表者": "宮下 哲典",
          "所属機関": "新潟大学脳研究所 遺伝子機能解析学分野",
          "研究題目": "",
          "利用データID": "認知症のオミックス情報解析",
          "利用期間": "JGAD000051"
        },
        "Colin L Masters": {
          "研究代表者": "Colin L Masters",
          "所属機関": "AIBL, The Florey Institute, The University of Melbourne",
          "研究題目": "",
          "利用データID": "The Australian Imaging and Biomarker Study (AIBL) Flagship Study of Ageing",
          "利用期間": "JGAD000051"
        },
        "Pieter Jelle Visser": {
          "研究代表者": "Pieter Jelle Visser",
          "所属機関": "Maastricht University, Department of Psychiatry and Neuropsychology, and VU University Medical Centre, Department of Neurology",
          "研究題目": "",
          "利用データID": "Amyloid Biomarker Study",
          "利用期間": "JGAD000051"
        },
        "平川 晃弘": {
          "研究代表者": "平川 晃弘",
          "所属機関": "東京医科歯科大学 医学部附属病院 臨床試験管理センター 生物統計学・データサイエンス部",
          "研究題目": "",
          "利用データID": "認知機能評価データを用いた疾患進行予測モデルの開発と実証",
          "利用期間": "JGAD000051"
        },
        "竹村 昌彦": {
          "研究代表者": "竹村 昌彦",
          "所属機関": "株式会社 Open Health Initiative",
          "研究題目": "",
          "利用データID": "認知機能低下予測モデルの作成および検証",
          "利用期間": "JGAD000051"
        },
        "Junko Hara": {
          "研究代表者": "Junko Hara",
          "所属機関": "EMBIC Research & Development",
          "研究題目": "",
          "利用データID": "Developing Hierarchical Bayesian Cognitive Processing Models for Description, Group Differentiation, and Prediction with Wordlist Memory Test",
          "利用期間": "JGAD000051"
        },
        "Hieab Adams": {
          "研究代表者": "Hieab Adams",
          "所属機関": "Clinical Genetics, Erasmus MC",
          "研究題目": "",
          "利用データID": "Uncovering Neurodegenerative Insights Through Ethnic Diversity",
          "利用期間": "JGAD000051"
        },
        "枡田 大生": {
          "研究代表者": "枡田 大生",
          "所属機関": "千葉大学大学院医学研究院 脳神経内科学",
          "研究題目": "",
          "利用データID": "日本人多発性硬化症および視神経脊髄炎関連疾患患者における脳萎縮と認知機能の解析",
          "利用期間": "JGAD000051"
        },
        "Yoon Seong Choi": {
          "研究代表者": "Yoon Seong Choi",
          "所属機関": "Yonsei University College of Medicine",
          "研究題目": "",
          "利用データID": "A deep learning model for Alzheimer disease based on 18F-FDG=PET: prognostication of mild cognitive impairment",
          "利用期間": "JGAD000051"
        },
        "酒谷 薫": {
          "研究代表者": "酒谷 薫",
          "所属機関": "株式会社医光テクノロジーズ AICOGラボ",
          "研究題目": "",
          "利用データID": "ヒトデータベース（J-ADNI）の解析による認知症のリスク判定に関する研究",
          "利用期間": "JGAD000051"
        },
        "Qian Gao": {
          "研究代表者": "Qian Gao",
          "所属機関": "Cytox　Group Head of Genetics and Bioinformatics (Research and Development)",
          "研究題目": "",
          "利用データID": "Proposed project title: Evaluation of the performance of genoSCORE for predicting onset of Alzheimer’s disease in a Japanese population",
          "利用期間": "JGAD000051"
        },
        "Gregor Kuhlenbaeumer": {
          "研究代表者": "Gregor Kuhlenbaeumer",
          "所属機関": "The University Medical Center Schleswig-Holstein",
          "研究題目": "",
          "利用データID": "Conducting a genome-wide association study investigating antibody-mediated encephalitides.",
          "利用期間": "JGAD000051"
        },
        "Marcus Makowski": {
          "研究代表者": "Marcus Makowski",
          "所属機関": "Technical University of Munich",
          "研究題目": "",
          "利用データID": "Replication of neural network predictions on independent test data",
          "利用期間": "JGAD000051"
        },
        "Ting-Wei Weng": {
          "研究代表者": "Ting-Wei Weng",
          "所属機関": "Taipei Medical UniversityTranslational Imaging Research Center",
          "研究題目": "台湾",
          "利用データID": "Building a national model of data hub for healthy aging",
          "利用期間": "JGAD000051"
        },
        "Sandra Black": {
          "研究代表者": "Sandra Black",
          "所属機関": "LC Campbell Cognitive Neurology Research Unit, Sunnybrook Research Institute",
          "研究題目": "カナダ",
          "利用データID": "Comparative study on the longitudinal changes in cerebral small vessel disease between Japanese and Western country populations",
          "利用期間": "JGAD000051"
        },
        "安藤 達哉": {
          "研究代表者": "安藤 達哉",
          "所属機関": "武田薬品工業（株） リサーチ",
          "研究題目": "日本",
          "利用データID": "J-ADNIヒト脳画像データを利用した神経変性疾患を検出する機械学習予測モデルの開発",
          "利用期間": "JGAD000051"
        },
        "Fan Yi": {
          "研究代表者": "Fan Yi",
          "所属機関": "Zhejiang University College of Computer Science and Technology",
          "研究題目": "中華人民共和国",
          "利用データID": "Research on the analysis method of chronic disease evolution process based on data mining of electronic medical records",
          "利用期間": "JGAD000051"
        },
        "Chengan Guo": {
          "研究代表者": "Chengan Guo",
          "所属機関": "School of Information and Communication Engineering, Dalian University of Technology",
          "研究題目": "中華人民共和国",
          "利用データID": "Research on early diagnoses for Alzheimer's disease and mild cognitive impairment based on deep learning",
          "利用期間": "JGAD000051"
        },
        "Sreevani Katabathula": {
          "研究代表者": "Sreevani Katabathula",
          "所属機関": "Case Western Reserve University",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Subtype Analysis in Mild cognitive impairment of Alzheimer’s disease",
          "利用期間": "JGAD000051"
        },
        "安田 実樹大": {
          "研究代表者": "安田 実樹大",
          "所属機関": "関西学院大学",
          "研究題目": "日本",
          "利用データID": "fMRIデータに基づく脳内ネットワークの分析手法の構築",
          "利用期間": "JGAD000051"
        }
      },
      "リリース情報": {
        "hum0043.v1": {
          "Research ID": "hum0043.v1",
          "公開日": "2016/1/29",
          "内容": "構造MRI画像ならびにFreeSurferによる領域分割結果\r\n読影結果を付与したFDGならびにアミロイドPET画像\r\nUS-ADNI互換の臨床/神経心理検査データ\r\nApoE遺伝子型、血液・脳脊髄液サンプルデータ",
          "description": "このバージョンでは、縦断研究に組入れられた研究参加者全員537名（内訳：健常高齢者健常群154名、軽度認知機能障害（MCI）234名、早期アルツハイマー病(AD)149名）のデータを公開した。追跡期間は、早期アルツハイマー病：２年間、健常高齢者健常群ならびに軽度認知機能障害（MCI）：3年間。\n"
        },
        "GE": {
          "PET SCANNER_VENDOR": "GE",
          "PETSCANNER_MODEL": "Discovery ST Elite Performance"
        },
        "Hitachi": {
          "MRI SCANNER_VENDOR": "Hitachi",
          "MRI SCANNER_MODEL": "ECHELON"
        },
        "Philips": {
          "PET SCANNER_VENDOR": "Philips",
          "PETSCANNER_MODEL": "GEMINI GXL"
        },
        "Siemens": {
          "PET SCANNER_VENDOR": "Siemens",
          "PETSCANNER_MODEL": "ECAT EXACT HR47"
        },
        "Toshiba": {
          "PET SCANNER_VENDOR": "Toshiba",
          "PETSCANNER_MODEL": "Aquiduo"
        },
        "Shimadzu": {
          "PET SCANNER_VENDOR": "Shimadzu",
          "PETSCANNER_MODEL": "HEADTOME V"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0043.v1",
      "DATA": {
      },
      "SUMMARY": {
        "Aims": "Japanese ADNI aims to establish imaging and biofluid markers that can predict and monitor the progression of changes in the brains of elderly individuals with AD, mild cognitive impairment (MCI) or normal cognition, and eventually be used as a surrogate markers for the clinical trials of DMDs for AD.",
        "Methods": "The research protocol includes structural MRI analysis, FDG and amyloid PET, CSF sampling, apoE genotyping, combined with a set of clinical and psychometric tests that were prepared to achieve the highest compatibility to those used in US-ADNI.",
        "Participants/Materials": "：Participants enrolled in a longitudinal study: 537 (healthly elderly controls: 154, mild cognitive impairment (MCI): 234, Alzheimer's disease (AD): 149)"
      },
      "MOLECULAR DATA": {
      },
      "DATA PROVIDER": {
        "Principal Investigator": " Takeshi Iwatsubo",
        "Affiliation": "Department of Neuropathology, Graduate School of Medicine, the University of Tokyo",
        "Project / Group Name": " Japanese Alzheimer's disease neuroimaging initiative (J-ADNI)  (List of Authors, Citation Information)",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Life Science Database Integration Project (Database Integration Coordination Program) of Japan Science and Technology Agency",
            "Title": "Study on integration of the human brain related diseases imaging data",
            "Project Number": "None"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.",
          "DOI": "doi: 10.1016/j.jalz.2018.03.009",
          "Data Set ID": "JGAD000051"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michael C Donohue": {
          "Principal Investigator": "Michael C Donohue",
          "Affiliation": "University of Southern California, Alzheimers Therapeutic Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Ryuichi Takahashi": {
          "Principal Investigator": "Ryuichi Takahashi",
          "Affiliation": "Hyogo Prefectural Rehabilitation Hospital at Nishi-Harima, Department of Neurology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Kenji Ishii": {
          "Principal Investigator": "Kenji Ishii",
          "Affiliation": "Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Neuroimaging Research Team",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Hiroshi Matsuda": {
          "Principal Investigator": "Hiroshi Matsuda",
          "Affiliation": "National Center of Neurology and Psychiatry, Integrative Brain Imaging Center",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Weining Robieson": {
          "Principal Investigator": "Weining Robieson",
          "Affiliation": "AbbVie",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Michio Senda": {
          "Principal Investigator": "Michio Senda",
          "Affiliation": "Division of Molecular Imaging, Institute of Biomedical Research and Innovation",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Ken Aoshima": {
          "Principal Investigator": "Ken Aoshima",
          "Affiliation": "hhc Data Creation Center, Eisai Co., Ltd.",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Takashi Kato": {
          "Principal Investigator": "Takashi Kato",
          "Affiliation": "Department of Radiology, National Center for Geriatrics and Gerontology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Masashi Kikuchi": {
          "Principal Investigator": "Masashi Kikuchi",
          "Affiliation": "MSD K.K. Japan Development Clinical Research Neuroscience Group",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Omics research for dementia based on clinical and genome data",
          "Period of Data Use": "JGAD000051"
        },
        "Hiroshi Suzuki": {
          "Principal Investigator": "Hiroshi Suzuki",
          "Affiliation": "Department of Pharmacy, The University of Tokyo Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Masayasu Okochi": {
          "Principal Investigator": "Masayasu Okochi",
          "Affiliation": "Department of Psychiatry, Osaka University Graduate School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Joyce Suhy": {
          "Principal Investigator": "Joyce Suhy",
          "Affiliation": "Bioclinica, Inc.",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Toshiharu Suzuki": {
          "Principal Investigator": "Toshiharu Suzuki",
          "Affiliation": "Faculty of Pharmaceutical Sciences, Hokkaido University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Danielle Harvey": {
          "Principal Investigator": "Danielle Harvey",
          "Affiliation": "UC Davis, Division of Biostatistics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Jae-Won Jang": {
          "Principal Investigator": "Jae-Won Jang",
          "Affiliation": "Department of Neurology, Kangwon National University Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Masayuki Sasaki": {
          "Principal Investigator": "Masayuki Sasaki",
          "Affiliation": "Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Akihiko Shiino": {
          "Principal Investigator": "Akihiko Shiino",
          "Affiliation": "Molecular Neuroscience Research Center, Shiga University of Medical Science",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Kiyoto Kasai": {
          "Principal Investigator": "Kiyoto Kasai",
          "Affiliation": "Department of Neuropsychiatry, the University of Tokyo Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Yuanzhong Li": {
          "Principal Investigator": "Yuanzhong Li",
          "Affiliation": "Imaging Technology Center, FUJIFILM Corpration",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Atsushi Iwata": {
          "Principal Investigator": "Atsushi Iwata",
          "Affiliation": "Department of Neurology, the University of Tokyo Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Tosimasa Yamamoto": {
          "Principal Investigator": "Tosimasa Yamamoto",
          "Affiliation": "Saitama Medical University Neurology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Kazushi Suzuki": {
          "Principal Investigator": "Kazushi Suzuki",
          "Affiliation": "National Defense Medical College",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Natural history study of neurodegenerative diseases using clinical research data",
          "Period of Data Use": "JGAD000051"
        },
        "Tsukasa Funane": {
          "Principal Investigator": "Tsukasa Funane",
          "Affiliation": "Hitachi, Ltd., Research & Development Group, Center for Exploratory Research",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Tadanori Fukami": {
          "Principal Investigator": "Tadanori Fukami",
          "Affiliation": "Graduate school of science and engineering, Yamagata University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Longitudinal analysis for J-ADNI database by MRI/PET image fusion",
          "Period of Data Use": "JGAD000051"
        },
        "Shuhei Yamaguchi": {
          "Principal Investigator": "Shuhei Yamaguchi",
          "Affiliation": "Department of Internal Medicine III, Faculty of Medicine, Shimane University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Manabu Ishida": {
          "Principal Investigator": "Manabu Ishida",
          "Affiliation": "ERISA Co., Ltd.",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Tetsutaro Ono": {
          "Principal Investigator": "Tetsutaro Ono",
          "Affiliation": "Dai Nippon Printing Co., Ltd.\r\nCommunication & Information Center / Information Innovation Operations",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Sayuri Watanabe": {
          "Principal Investigator": "Sayuri Watanabe",
          "Affiliation": "Janssen pharmaceutical K.K, R&D, Clinical science division",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Eric Westman": {
          "Principal Investigator": "Eric Westman",
          "Affiliation": "Karolinska Institutet, NVS Department, Division of Clinical Geriatris",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Nancy Maserijian": {
          "Principal Investigator": "Nancy Maserijian",
          "Affiliation": "Biogen",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Masataka Kikuchi": {
          "Principal Investigator": "Masataka Kikuchi",
          "Affiliation": "Department of Computational Biology and Medical Sciences, Graduate School of Frontier Science, The University of Tokyo",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Omics research for dementia based on clinical and genome data",
          "Period of Data Use": "JGAD000051"
        },
        "Chiristian Nunez": {
          "Principal Investigator": "Chiristian Nunez",
          "Affiliation": "Parc Sanitari Sant Joan de Déu, Research Unit",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Naoki Tomita": {
          "Principal Investigator": "Naoki Tomita",
          "Affiliation": "Geriatric medicine and neuroimaging, Tohoku university hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000051"
        },
        "Akira Suda": {
          "Principal Investigator": "Akira Suda",
          "Affiliation": "Department of Psychiatry, Yokohama City University Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Retrospective investigation on relationship between immunological biomarkers and clinical findings of Alzheimer's disease",
          "Period of Data Use": "JGAD000051"
        },
        "Hisatomo Kowa": {
          "Principal Investigator": "Hisatomo Kowa",
          "Affiliation": "Division of Cognitive and Psychiatric Rehabilitation, Dept of Rehabilitation Science, Kobe University Graduate School of Health Sciences",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Optimizing Evaluation Method for Cognitive Function of Aged People Based on the J-ADNI Database",
          "Period of Data Use": "JGAD000051"
        },
        "Martin Hofmann-Apitius": {
          "Principal Investigator": "Martin Hofmann-Apitius",
          "Affiliation": "Department for Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing SCAI",
          "Research Title": "",
          "Data in Use (Dataset ID)": "The Virtual Brain - Cloud (Personalized Recommendations for Neurodegenerative Diseases)",
          "Period of Data Use": "JGAD000051"
        },
        "Akinori Miyashita": {
          "Principal Investigator": "Akinori Miyashita",
          "Affiliation": "Department of Molecular Genetics, Brain Research Institute, Niigata University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Study on dementia with large-scare omics data",
          "Period of Data Use": "JGAD000051"
        },
        "Colin L Masters": {
          "Principal Investigator": "Colin L Masters",
          "Affiliation": "AIBL, The Florey Institute, The University of Melbourne",
          "Research Title": "",
          "Data in Use (Dataset ID)": "The Australian Imaging and Biomarker Study (AIBL) Flagship Study of Ageing",
          "Period of Data Use": "JGAD000051"
        },
        "Pieter Jelle Visser": {
          "Principal Investigator": "Pieter Jelle Visser",
          "Affiliation": "Maastricht University, Department of Psychiatry and Neuropsychology, and VU University Medical Centre, Department of Neurology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Amyloid Biomarker Study",
          "Period of Data Use": "JGAD000051"
        },
        "Akihiro Hirakawa": {
          "Principal Investigator": "Akihiro Hirakawa",
          "Affiliation": "Clinical Research Center, Medical Hospital, Tokyo Medical and Dental University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Development and validation of disease progression prediction model in Alzheimer’s disease using cognitive assessment data",
          "Period of Data Use": "JGAD000051"
        },
        "Masahiko Takemura": {
          "Principal Investigator": "Masahiko Takemura",
          "Affiliation": "Open Health Initiative",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Developing and validating models that predict cognitive decline",
          "Period of Data Use": "JGAD000051"
        },
        "Junko Hara": {
          "Principal Investigator": "Junko Hara",
          "Affiliation": "EMBIC Research & Development",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Developing Hierarchical Bayesian Cognitive Processing Models for Description, Group Differentiation, and Prediction with Wordlist Memory Test",
          "Period of Data Use": "JGAD000051"
        },
        "Hieab Adams": {
          "Principal Investigator": "Hieab Adams",
          "Affiliation": "Clinical Genetics, Erasmus MC",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Uncovering Neurodegenerative Insights Through Ethnic Diversity",
          "Period of Data Use": "JGAD000051"
        },
        "Hiroki Masuda": {
          "Principal Investigator": "Hiroki Masuda",
          "Affiliation": "Department of Neurology, Graduate School of Medicine, Chiba University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Analysis of the longitudinal brain atrophy and cognitive function in patients with multiple sclesosis and neuromyelitis optica spectrum disorder.",
          "Period of Data Use": "JGAD000051"
        },
        "Yoon Seong Choi": {
          "Principal Investigator": "Yoon Seong Choi",
          "Affiliation": "Yonsei University College of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "A deep learning model for Alzheimer disease based on 18F-FDG=PET: prognostication of mild cognitive impairment",
          "Period of Data Use": "JGAD000051"
        },
        "Kaoru Sakatani": {
          "Principal Investigator": "Kaoru Sakatani",
          "Affiliation": "AICOG Labo, Iko Health Technologies",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Study on the risk prediction of dementia by analyzing the Human Database: J-ADNI",
          "Period of Data Use": "JGAD000051"
        },
        "Qian Gao": {
          "Principal Investigator": "Qian Gao",
          "Affiliation": "Cytox　Group Head of Genetics and Bioinformatics (Research and Development)",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Proposed project title: Evaluation of the performance of genoSCORE for predicting onset of Alzheimer’s disease in a Japanese population",
          "Period of Data Use": "JGAD000051"
        },
        "Gregor Kuhlenbaeumer": {
          "Principal Investigator": "Gregor Kuhlenbaeumer",
          "Affiliation": "The University Medical Center Schleswig-Holstein",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Conducting a genome-wide association study investigating antibody-mediated encephalitides.",
          "Period of Data Use": "JGAD000051"
        },
        "Marcus Makowski": {
          "Principal Investigator": "Marcus Makowski",
          "Affiliation": "Technical University of Munich",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Replication of neural network predictions on independent test data",
          "Period of Data Use": "JGAD000051"
        },
        "Ting-Wei Weng": {
          "Principal Investigator": "Ting-Wei Weng",
          "Affiliation": "Translational Imaging Research Center, Taipei Medical University",
          "Research Title": "Taiwan",
          "Data in Use (Dataset ID)": "Building a national model of data hub for healthy aging",
          "Period of Data Use": "JGAD000051"
        },
        "Sandra Black": {
          "Principal Investigator": "Sandra Black",
          "Affiliation": "LC Campbell Cognitive Neurology Research Unit, Sunnybrook Research Institute",
          "Research Title": "Canada",
          "Data in Use (Dataset ID)": "Comparative study on the longitudinal changes in cerebral small vessel disease between Japanese and Western country populations",
          "Period of Data Use": "JGAD000051"
        },
        "Tatsuya Ando": {
          "Principal Investigator": "Tatsuya Ando",
          "Affiliation": "Computational Biology, Research, Takeda Pharmaceutical Company Limited",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Development of machine learning prediction model for detecting neurodegenerative diseases using J-ADNI human brain image data",
          "Period of Data Use": "JGAD000051"
        },
        "Fan Yi": {
          "Principal Investigator": "Fan Yi",
          "Affiliation": "Zhejiang University College of Computer Science and Technology",
          "Research Title": "China",
          "Data in Use (Dataset ID)": "Research on the analysis method of chronic disease evolution process based on data mining of electronic medical records",
          "Period of Data Use": "JGAD000051"
        },
        "Chengan Guo": {
          "Principal Investigator": "Chengan Guo",
          "Affiliation": "School of Information and Communication Engineering, Dalian University of Technology",
          "Research Title": "China",
          "Data in Use (Dataset ID)": "Research on early diagnoses for Alzheimer's disease and mild cognitive impairment based on deep learning",
          "Period of Data Use": "JGAD000051"
        },
        "Sreevani Katabathula": {
          "Principal Investigator": "Sreevani Katabathula",
          "Affiliation": "Case Western Reserve University",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Subtype Analysis in Mild cognitive impairment of Alzheimer’s disease",
          "Period of Data Use": "JGAD000051"
        },
        "Mikihiro Yasuda": {
          "Principal Investigator": "Mikihiro Yasuda",
          "Affiliation": "Kwansei Gakuin University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of a method for analyzing brain networks based on fMRI data",
          "Period of Data Use": "JGAD000051"
        }
      },
      "Release Note": {
        "hum0043.v1": {
          "Research ID": "hum0043.v1",
          "Release Date": "2016/1/29",
          "Type of Data": "Structural MRI images and parcellation by FreeSurfer\r\nFDG and amyloid PET images including interpretation\r\nPeripheral Blood, Cerebrospinal Fluid (CSF) and ApoE genotype\r\nUS-ADNI compatible clinical and psychometric tests",
          "description": "Data obtained from all 537 participants enrolled in a longitudinal study (healthly elderly controls: 154, mild cognitive impairment (MCI): 234, Alzheimer's disease (AD): 149) was released. The follow-up span of the study was 2 years for AD and 3 years for the controls and MCI.\n"
        },
        "GE": {
          "PET SCANNER_VENDOR": "GE",
          "PETSCANNER_MODEL": "Discovery ST Elite Performance"
        },
        "Hitachi": {
          "MRI SCANNER_VENDOR": "Hitachi",
          "MRI SCANNER_MODEL": "ECHELON"
        },
        "Philips": {
          "PET SCANNER_VENDOR": "Philips",
          "PETSCANNER_MODEL": "GEMINI GXL"
        },
        "Siemens": {
          "PET SCANNER_VENDOR": "Siemens",
          "PETSCANNER_MODEL": "ECAT EXACT HR47"
        },
        "Toshiba": {
          "PET SCANNER_VENDOR": "Toshiba",
          "PETSCANNER_MODEL": "Aquiduo"
        },
        "Shimadzu": {
          "PET SCANNER_VENDOR": "Shimadzu",
          "PETSCANNER_MODEL": "HEADTOME V"
        }
      }
    }
  },
  "hum0042.v1": {
    "ja": {
      "NBDC Research ID": "hum0042.v1",
      "データ": {
        "hum0042.v1.TMJ.v1": {
          "データID": "hum0042.v1.TMJ.v1",
          "内容": "TMJ（日本人105症例、韓国人41症例）および\r\nnon-TMJ（日本人193名、韓国人181名）のGWAS",
          "制限": "制限公開（Type I）",
          "公開日": "2016/03/02"
        },
        "hum0042.v1.3MA.v1": {
          "データID": "hum0042.v1.3MA.v1",
          "内容": "下顎に一本以上の第三大臼歯先天性欠如有（日本人40症例、韓国人40症例）、\r\n上顎に一本以上の第三大臼歯先天性欠如有（日本人62症例、韓国人63症例）、\r\n上下何れかに一本以上の第三大臼歯先天性欠如有（日本人78症例、韓国人71症例）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/03/02"
        }
      },
      "研究内容の概要": {
        "目的": "東アジア人集団（日本人および韓国人）における、１．変性顎関節症　および　２．第三大臼歯先天性欠如（親不知）　の感受性遺伝子の同定",
        "方法": "Illumina HumanOmniExpress BeadChipを用いて遺伝子型を決定",
        "対象": "１．日本人と韓国人の変性顎関節症（degenerative bony changes of the temporomandibular joint：TMJ）罹患者146名と非罹患者（non-TMJ）374名"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "hum0042.v1": {
          "対象": "１．TMJ\r\n　　　TMJ：146症例（日本人105症例、韓国人41症例）\r\n　　　non-TMJ：374名（日本人193名、韓国人181名）\r\n２．第三大臼歯先天性欠如\r\n２－１．下顎に一本以上の第三大臼歯先天性欠如\r\n　　　有（日本人40症例、韓国人40症例）\r\n　　　無（日本人224名、韓国人183名）\r\n２－２．上顎に一本以上の第三大臼歯先天性欠如\r\n　　　有（日本人62症例、韓国人63症例）\r\n　　　無（日本人202名、韓国人160名）\r\n２－３．上下何れかに一本以上の第三大臼歯先天性欠如\r\n　　　有（日本人78症例、韓国人71症例）\r\n　　　無（日本人186名、韓国人152名）",
          "規模": "GWAS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress BeadChip]",
          "ソース": "唾液より抽出されたDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina HumanOmniExpress BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "フィルタリング": "Sample Call rate ≤ 0.98, SNP call rate ≤ 0.98, MAF < 3%, HWE P < 1 x 10^-6",
          "マーカー数(QC後)": "１．日本人：550,005 SNPs、韓国人：545,797 SNPs\r\n２．日本人：547,727 SNPs、韓国人：545,945 SNPs",
          "NBDC Dataset ID": "１．hum0042.v1.TMJ.v1\r\n２．hum0042.v1.3MA.v1\r\n Dictionary file",
          "総データ量": "１．198 MB （zip [xlsx]）\r\n２．589 MB （zip [xlsx]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山口 徹太郎",
        "所 属 機 関": "昭和大学歯学部歯科矯正学講座",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援",
            "研究課題番号": "221S0002"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genome-wide association study of degenerative bony changes of the temporomandibular joint.",
          "DOI": "doi:10.1111/odi.12141",
          "データID": "hum0042.v1.TMJ.v1"
        },
        "2": {
          "タイトル": "A genome-wide association study of third molar agenesis in Japanese and Korean populations.",
          "DOI": "doi:10.1038/jhg.2013.106",
          "データID": "hum0042.v1.3MA.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0042.v1": {
          "Research ID": "hum0042.v1",
          "公開日": "2016/03/02",
          "内容": "顎関節症（日本人105症例、韓国人41症例）と非顎関節症群（日本人193名、韓国人181名）のゲノムワイド関連解析\r\n第三大臼歯先天性欠如有りと無しのゲノムワイド関連解析",
          "description": "１：変性顎関節症罹患者146症例と非罹患者374名に対してIllumina HumanOmniExpress BeadChipを用いて遺伝子型決定を行ない、各遺伝子型カウントと統計解析結果を提供する（日本人、韓国人それぞれの集団内の解析および両群のメタ解析結果）。\n２：下顎に一本以上の第三大臼歯先天性欠如\n・有り（日本人40症例、韓国人40症例）と無し（日本人224名、韓国人183名）\n・上顎に一本以上の第三大臼歯先天性欠如有り（日本人62症例、韓国人63症例）と無し（日本人202名、韓国人160名）\n・上下何れかに一本以上の第三大臼歯先天性欠如有り（日本人78症例、韓国人71症例）と無し（日本人186名、韓国人152名）\nに対してIllumina HumanOmniExpress Beadchipを用いて遺伝子型決定を行ない、各遺伝子型カウントと統計解析結果を提供する（日本人、韓国人それぞれの集団内の解析および両群のメタ解析結果）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0042.v1",
      "DATA": {
        "hum0042.v1.TMJ.v1": {
          "Data Set ID": "hum0042.v1.TMJ.v1",
          "Type of Data": "GWAS in TMJ (105 Japanese cases, 41 Korean cases) and\r\nnon-TMJ (193 Japanese controls, 181 Korean controls)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/03/02"
        },
        "hum0042.v1.3MA.v1": {
          "Data Set ID": "hum0042.v1.3MA.v1",
          "Type of Data": "mandibular third molar agenesis (40 Japanese cases, 40 Korean cases),\r\nmaxillary third molar agenesis (62 Japanese cases, 63 Korean cases),\r\nat least one-third molar agenesis (78 Japanese cases, 71 Korean cases)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/03/02"
        }
      },
      "SUMMARY": {
        "Aims": "To identify susceptibility genes associated with degenerative bony changes of the temporomandibular joint (TMJ) and third molar agenesis.",
        "Methods": "Illumina HumanOmniExpress BeadChip was used for genotyping.",
        "Participants/Materials": "(1) 146 cases with TMJ and 374 controls (non-TMJ) in the Japanese and Korean populations"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "hum0042.v1": {
          "Participants/Materials:": "(1) TMJ\r\n　　TMJ: 146 cases (105 Japanese cases, 41 Korean cases)\r\n　　non-TMJ: 374 controls (193 Japanese controls, 181 Korean controls)\r\n(2) third molar agenesis\r\n(2-1) mandibular third molar agenesis\r\n　　　with third molar agenesis (40 Japanese cases, 40 Korean cases)\r\n　　　without third molar agenesis (224 Japanese controls, 183 Korean controls)\r\n(2-2) maxillary third molar agenesis\r\n　　　with third molar agenesis (62 Japanese cases, 63 Korean cases)\r\n　　　without third molar agenesis (202 Japanese controls, 160 Korean controls)\r\n(2-3) at least one-third molar agenesis \r\n　　　with third molar agenesis (78 Japanese cases, 71 Korean cases)\r\n　　　without third molar agenesis (186 Japanese controls, 152 Korean controls)",
          "Targets": "GWAS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress BeadChip]",
          "Source": "gDNAs extracted from saliva",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina HumanOmniExpress BeadChip kit",
          "Genotyping Call Methods (software)": "GenCall software (GenomeStudio)",
          "Filtering Methods": "Sample Call rate ≤ 0.98, SNP call rate ≤ 0.98, MAF ≤ 3%, HWE P < 1 x 10^-6",
          "Marker Number (after QC)": "(1) Japanese: 550,005 SNPs, Korean: 545,797 SNPs\r\n(2) Japanese: 547,727 SNPs, Korean: 545,945 SNPs",
          "NBDC Dataset ID": "(1) hum0042.v1.TMJ.v1\r\n(2) hum0042.v1.3MA.v1\r\n Dictionary file",
          "Total Data Volume": "(1) 198 MB (zip [xlsx])\r\n(2) 589 MB (zip [xlsx])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tetsutarou Yamaguchi",
        "Affiliation": "Showa University School of Dentistry",
        "Project / Group Name": "",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI\r\nGrant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "Genome Science",
            "Project Number": "221S0002"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genome-wide association study of degenerative bony changes of the temporomandibular joint.",
          "DOI": "doi:10.1111/odi.12141",
          "Data Set ID": "hum0042.v1.TMJ.v1"
        },
        "2": {
          "Title": "A genome-wide association study of third molar agenesis in Japanese and Korean populations.",
          "DOI": "doi:10.1038/jhg.2013.106",
          "Data Set ID": "hum0042.v1.3MA.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0042.v1": {
          "Research ID": "hum0042.v1",
          "Release Date": "2016/03/02",
          "Type of Data": "GWAS for 146 cases with TMJ and 374 non-TMJ in Japanese and Korean populations\r\nGWAS for 149 cases with at least one-third molar agenesis and 338 controls in Japanese and Korean populations",
          "description": "(1) A genome-wide association study for TMJ was performed using 550,005 SNPs (Japanese) and 545,797 SNPs (Korean) (Illumina HumanOmniExpress Beadchip).\n(2) Genome-wide association studies for each category of third molar agenesis were performed by using of Illumina HumanOmniExpress Beadchip.\n(2-1) mandibular third molar agenesis\n　　　with third molar agenesis (40 Japanese cases, 40 Korean cases)\n　　　without third molar agenesis (224 Japanese controls, 183 Korean controls)\n(2-2) maxillary third molar agenesis\n　　　with third molar agenesis (62 Japanese cases, 63 Korean cases)\n　　　without third molar agenesis (202 Japanese controls, 160 Korean controls)\n(2-3) at least one-third molar agenesis\n 　　　with third molar agenesis (78 Japanese cases, 71 Korean cases)\n　　　without third molar agenesis (186 Japanese controls, 152 Korean controls)\nLists of genotype counts for each polymorphism and results of statistics in each population  are provided (xlsx file format).\nNote：\n"
        }
      }
    }
  },
  "hum0041.v1": {
    "ja": {
      "NBDC Research ID": "hum0041.v1",
      "データ": {
        "JGAS000052": {
          "データID": "JGAS000052",
          "内容": "NGS（Exome、Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/01/12"
        }
      },
      "研究内容の概要": {
        "目的": "転移や再発を伴う進行がんの殆どは、依然として治療抵抗性があり、難治性がんである。肝がんの多施設検体コホートに基づく難治性規定分子の同定と分子標的治療の開発をテーマに、腫瘍組織および非腫瘍組織の全エキソン配列解析、網羅的エピゲノム解析、網羅的遺伝子発現解析を実施することにより、難治性肝がんを規定するドライバー遺伝子の候補を同定し、発がんメカニズム解析による新規治療法の開発、予防医学への応用を図る。",
        "方法": "難治性肝がんの指標には、ミラノ基準（基準外：腫瘍径5 cm以下単発腫瘍、または腫瘍径3 cm以内3個以内腫瘍、かつ遠隔転移・肉眼的脈管浸潤なし、基準内：少なくとも術後2年以内無再発）を用いた。主腫瘍組織、および周囲の非腫瘍組織からDNAを抽出し、Genome-Wide Human SNP Array 6.0（Affymetrix）を用いたSNP解析による検証を行った後、全エキソン配列解析を施行した。全エキソン配列解析は、BWAによるhg19リファレンスゲノムへのマッピング、およびGATKによるリアラインメント・リキャリブレーションを経て、VarScan、MuTect、SomaticIndelDetector、FATHMMなどを組み合わせたフィルター、およびIGVによる目視確認を経て、変異の選択を行った。",
        "対象": "難治性肝がんは高率に再発をきたす疾患であるが、再発しても治療可能なミラノ基準内の再発であれば再切除などで治癒可能であることが多いが、ミラノ基準外再発では治癒困難であり、しばしば致死的となる。本課題では、肝がんの致死的再発解明の観点から、根治的肝切除手術を施行した原発性肝細胞がん33症例（ミラノ基準外再発例16症例と基準内再発例17症例）の手術時切除切片（腫瘍組織及び非腫瘍組織）を用いた。",
        "URL": "http://www.tmd.ac.jp/grad/monc/index.html　（分子腫瘍医学分野）"
      },
      "分子データ": {
        "JGAS000052": {
          "対象": "難治性肝がん33症例の腫瘍組織および周囲の非腫瘍組織\r\n　　　・ミラノ基準外再発例：16症例\r\n　　　・ミラノ基準内例：17症例",
          "規模": "Exome、Target Capture",
          "対象領域（Target Captureの場合）": "SureSelect Human All Exon V4 + HBVゲノム + lincRNA",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "主腫瘍組織および周囲の非腫瘍組織から抽出したgDNA\r\n（フェノール・クロロホルム法）",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V4",
          "断片化の方法": "超音波断片化（Covaris社、 S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000052",
          "総データ量": "1759 GB （fastq.gz）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "田中 真二",
        "所 属 機 関": "東京医科歯科大学大学院 医歯学総合研究科（医系） 分子腫瘍医学分野",
        "プロジェクト/研究グループ名": "次世代がん研究シーズ戦略的育成プログラム「分子プロファイリングによる新規標的同定を通じた難治がん治療法開発」",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん研究シーズ戦略的育成プログラム（P-DIRECT）",
            "タイトル": "「分子プロファイリングによる新規標的同定を通じた難治がん治療法開発」（肝がんの多施設検体コホートに基づく難治性規定分子の同定と分子標的治療の開発）",
            "研究課題番号": "JP15cm0106064"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "投稿準備中",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0041.v1": {
          "Research ID": "hum0041.v1",
          "公開日": "2017/01/12",
          "内容": "NGS（Exome、Target Capture）",
          "description": "原発性肝細胞がん33症例の腫瘍組織および非腫瘍組織から抽出したDNAを使用したExome解析（SureSelect）およびHBVとlincRNAのtarget capture解析の結果をFastqファイルで提供する。SureSelect Human All Exon V4にて平均長200 塩基を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0041.v1",
      "DATA": {
        "JGAS000052": {
          "Data Set ID": "JGAS000052",
          "Type of Data": "NGS (Exome, Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/01/12"
        }
      },
      "SUMMARY": {
        "Aims": "Advanced cancers with metastasis and/or recurrence are usually resistant and refractory to treatment. In our studies, whole exome sequencing analysis, comprehensive epigenetic analysis and genome-wide expression analysis were performed using cancerous and non-cancerous tissues derived from multicentric cohort study of hepatocellular carcinoma (HCC). The aim of the studies is identification of the refractoriness-related deriver genes for application to novel molecular targeted therapy and preventive medicine.",
        "Methods": "The materials were obtained from thirty three patients underwent curative hepatectomy for HCC at Department of Hepato-Biliary-Pancreatic Surgery, Tokyo Medical and Dental University Hospital. Written informed consent from these patients, as well as the institutional review board approved was obtained. The determination of the refractory HCC group (16 cases) was based on the point of the recurrence patterns in accordance with Milan criteria for the recurrent tumor (solitary <5cm, or up to 3 nodules <3 cm, without major vascular invasion or distant metastasis) that has been proposed as the useful criteria of the liver transplantation for HCC. The cellular DNA was extracted from the cancerous and non-cancerous tissues of primary HCC by the phenol-chloroform method. After SNP certification using Genome-Wide Human SNP Array 6.0 (Affymetrix), whole exome sequencing was performed at the Cancer Institute of JFCR, as the support infrastructure. Exome sequencing was performed using HiSeq 2000 (Illumina), and the obtained reads were mapped to the human reference genome (hg19) using BWA software. GATK software was used for local realignment base call recalibration. Single nucleotide variants (SNVs) and indels were analyzed by VarScan, MuTect, SomaticIndelDetector and FATHMM software, as well as visual confirmation by IGV software.",
        "Participants/Materials": "The studies are intended for refractory HCC. High frequency of the tumor recurrence even after curative resection is one of the major difficulties in the treatment of HCC. According to our previous studies, not the recurrence itself, but the recurrence pattern has critical effects on prognosis of the patient with HCC. Then, we analyzed the cancerous and non-cancerous tissues of primary HCC on the point of the recurrence patterns in accordance with or without Milan criteria.",
        "URL": "http://www.tmd.ac.jp/grad/monc/en/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000052": {
          "Participants/Materials": "33 cancerous and non-cancerous tissues of primary HCC　\r\n・Recurrence patterns in accordance without Milan criteria : 16 cases\r\n・Recurrence patterns in accordance with Milan criteria : 17 cases",
          "Targets": "Exome, Target Capture",
          "Target Loci for Capture Methods": "SureSelect Human All Exon V4, HBVgemone, lincRNA",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from cancerous and non-cancerous tissues\r\n(Phenol–chloroform extraction)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V4",
          "Fragmentation Methods": "Covaris S220",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000052",
          "Total Data Volume": "1759 GB (fastq.gz)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shinji Tanaka",
        "Affiliation": "Department of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University",
        "Project / Group Name": "Project for Development of Innovative Research on Cancer Therapeutics",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Development of the Intractable Cancer Therapies through the New Target Identification by the Molecular Profiling",
            "Project Number": "JP15cm0106064"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "under publishing",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0041.v1": {
          "Research ID": "hum0041.v1",
          "Release Date": "2017/01/12",
          "Type of Data": "NGS (Exome, Target Capture)",
          "description": "gDNA extracted from cancerous and non-cancerous tissues derived from 33 patients with refractory hepatocellular carcinoma (HCC) were used for whole exome sequencing analysis (fastq files). \n SureSelect Human All Exon V4 was used for preparing libraries and read by Illumina HiSeq 2000 (paired-end, 2 x 100 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0040.v1": {
    "ja": {
      "NBDC Research ID": "hum0040.v1",
      "データ": {
        "JGAS000038": {
          "データID": "JGAS000038",
          "内容": "NGS（WGS）\r\nNGS（Exome）\r\nNGS（WGBS）\r\nNGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/09/16"
        }
      },
      "研究内容の概要": {
        "目的": "ヒト胎盤におけるインプリント制御領域およびインプリント遺伝子の同定",
        "方法": "母親由来アリルと父親由来方アリルを区別するため、Whole Genome Sequencing （WGS）もしくはWhole Exon sequencing （WES）解析を用い、ヒト胎盤および母体血より一塩基多型情報を取得した。次に、ヒト胎盤サンプルのBisulfite sequencing（BS-seq）解析およびRNA-seq解析を行い、アリル特異的DNAメチル化および遺伝子発現解析を行った。",
        "対象": "ヒト胎盤および母体血"
      },
      "分子データ": {
        "WGS": {
          "対象": "胎盤　：2検体\r\n母体血：2検体",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "胎盤および母体血から抽出したゲノムDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Nano DNA LT Sample Prep Kit",
          "断片化の方法": "超音波断片化（Covaris社、 M220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000038",
          "総データ量": "約 540 GB (fastq.gz)",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Exome": {
          "対象": "胎盤　：24検体\r\n母体血：24検体",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "胎盤および母体血から抽出したゲノムDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V5+UTRs Kit および\r\nTruSeq Nano DNA LT Sample Prep Kit",
          "断片化の方法": "超音波断片化（Covaris社、 M220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000038",
          "総データ量": "約 490 GB (fastq.gz)",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "WGBS": {
          "対象": "胎盤：15検体",
          "規模": "WGBS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "胎盤から抽出したゲノムDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "PBAT法 もしくは NEBNext Ultra DNA Library Prep Kit",
          "断片化の方法": "超音波断片化（Covaris社、 M220）\r\nPBAT法は断片化なし",
          "ライブラリ構築方法": "Paired-end もしくは Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000038",
          "総データ量": "約 320 GB (fastq.gz)",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "胎盤 ：21検体",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "胎盤から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded mRNA LT Sample Prep Kit",
          "断片化の方法": "熱処理",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000038",
          "総データ量": "約 220 GB (fastq.gz)",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "有馬 隆博",
        "所 属 機 関": "東北大学大学院 医学系研究科 環境遺伝医学総合研究センター 情報遺伝学分野",
        "プロジェクト/研究グループ名": "生殖発生にかかわる細胞のエピゲノム解析基盤研究",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業（AMED-CREST）",
            "タイトル": "生殖発生にかかわる細胞のエピゲノム解析基盤研究",
            "研究課題番号": "JP17gm0510011"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Allele-specific methylome and transcriptome analysis reveals widespread imprinting in the human placenta",
          "DOI": "doi: 10.1016/j.ajhg.2016.08.021",
          "データID": "JGAD000038"
        },
        "2": {
          "タイトル": "Derivation of Human Trophoblast Stem Cells",
          "DOI": "doi: 10.1016/j.stem.2017.11.004",
          "データID": "JGAD000038JGAX000007522JGAX000007532JGAX000007538JGAX000007488"
        }
      },
      "制限公開データの利用者一覧": {
        "Martin Hirst": {
          "研究代表者": "Martin Hirst",
          "所属機関": "BC Cancer",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000038"
        },
        "Zhigang Xue": {
          "研究代表者": "Zhigang Xue",
          "所属機関": "School of Medicine and Life Science, Tongji University",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000038"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000038"
        }
      },
      "リリース情報": {
        "hum0040.v1": {
          "Research ID": "hum0040.v1",
          "公開日": "2016/09/16",
          "内容": "NGS（WGS、Exome、WGBS、RNA-seq）",
          "description": "以下の検体から抽出したゲノムDNAおよびRNAを使用し、WGS、Exome、WGBS、RNA-seq解析の結果をFastqファイルにて提供する。\n・WGS　（母体血：2検体、胎盤：2検体）\n・Exome　（母体血：24検体、胎盤：24検体）\n・WGBS　（胎盤：15検体）\n・RNA-seq　（胎盤：21検体）\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0040.v1",
      "DATA": {
        "JGAS000038": {
          "Data Set ID": "JGAS000038",
          "Type of Data": "NGS (WGS)\r\nNGS (Exome)\r\nNGS (WGBS)\r\nNGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/09/16"
        }
      },
      "SUMMARY": {
        "Aims": "Genome-wide identification of parent-of-origin dependent DNA methylation and gene expression in the human placenta",
        "Methods": "SNPs in human placentas and maternal blood cells were identified using Whole-Genome or Exome sequencing. Allele-specific DNA methylation and gene expression analyses were performed using the human placentas.",
        "Participants/Materials": "Human placentas and maternal blood samples"
      },
      "MOLECULAR DATA": {
        "WGS": {
          "Participants/Materials": "2 human placentas\r\n2 maternal blood samples",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "gDNAs extracted from human placentas and maternal blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Nano DNA LT Sample Prep Kit (Illumina)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris M220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000038",
          "Total Data Volume": "About 540 GB (fastq.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "Exome": {
          "Participants/Materials": "24 human placentas\r\n24 maternal blood samples",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "gDNAs extracted from human placentas and maternal blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V5+UTRs Kit (Agilent)\r\nTruSeq Nano DNA LT Sample Prep Kit (Illumina)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris M220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000038",
          "Total Data Volume": "About 490 GB (fastq.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "WGBS": {
          "Participants/Materials": "15 human placentas",
          "Targets": "WGBS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "gDNAs extracted from human placentas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "PBAT or NEBNext Ultra DNA Library Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris M220)\r\nNo fragmentation for PBAT",
          "Spot Type": "Paired-end or Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000038",
          "Total Data Volume": "About 320 GB (fastq.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "21 human placentas",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from human placentas",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded mRNA LT Sample Prep Kit (Illumina)",
          "Fragmentation Methods": "Heat Treatment",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000038",
          "Total Data Volume": "About 220 GB (fastq.gz)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takahiro Arima",
        "Affiliation": "Department of Informative Genetics, Environment and Genome Research Center, Tohoku University Graduate School of Medicine",
        "Project / Group Name": "Epigenome Analysis of Cells in the Placenta and Endometrium Forming the Fetal-maternal Interface",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)",
            "Title": "Epigenome analysis of cells in the placenta and endometrium forming the fetal-maternal interface",
            "Project Number": "JP17gm0510011"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Allele-specific methylome and transcriptome analysis reveals widespread imprinting in the human placenta",
          "DOI": "doi: 10.1016/j.ajhg.2016.08.021",
          "Data Set ID": "JGAD000038"
        },
        "2": {
          "Title": "Derivation of Human Trophoblast Stem Cells",
          "DOI": "doi: 10.1016/j.stem.2017.11.004",
          "Data Set ID": "JGAD000038JGAX000007522JGAX000007532JGAX000007538JGAX000007488"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Martin Hirst": {
          "Principal Investigator": "Martin Hirst",
          "Affiliation": "BC Cancer",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000038"
        },
        "Zhigang Xue": {
          "Principal Investigator": "Zhigang Xue",
          "Affiliation": "School of Medicine and Life Science, Tongji University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000038"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000038"
        }
      },
      "Release Note": {
        "hum0040.v1": {
          "Research ID": "hum0040.v1",
          "Release Date": "2016/09/16",
          "Type of Data": "NGS (WGS, Exome, WGBS, RNA-seq)",
          "description": "gDNAs and RNA extracted from human placentas or maternal blood cells obtained from following patients were used for the WGS, Exome, WGBS and RNA-seq (fastq files). \n  1) WGS (2 human placentas and 2 maternal blood cells)\n  2) Exome (24 human placentas and 24 maternal blood cells)\n  3) WGBS (15 human placentas)\n  4) RNA-seq (21 human placentas)\nNote：\n"
        }
      }
    }
  },
  "hum0039.v1": {
    "ja": {
      "NBDC Research ID": "hum0039.v1",
      "データ": {
        "JGAS000039": {
          "データID": "JGAS000039",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/12/27"
        }
      },
      "研究内容の概要": {
        "目的": "消化管間質腫瘍のチロシンキナーゼ阻害剤に対する獲得耐性機構の解明",
        "方法": "腫瘍のエキソーム解析",
        "対象": "イマチニブに対して病理学的に耐性と診断された消化管間質腫瘍症例"
      },
      "分子データ": {
        "JGAS000039": {
          "対象": "イマチニブに対して病理学的に耐性と診断された\r\n消化管間質腫瘍（原発腫瘍、体制腫瘍）：4症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq1500]",
          "ライブラリソース": "切除腫瘍組織から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V5+UTRs",
          "断片化の方法": "超音波断片化（Covaris社）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000039",
          "総データ量": "202 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy および hum0039 policy"
        }
      },
      "提供者情報": {
        "研究代表者": "高橋 剛",
        "所 属 機 関": "大阪大学大学院 医学系研究科 外科学講座 消化器外科学",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "-",
          "DOI": "-",
          "データID": "-"
        },
        "2": {
          "タイトル": " ",
          "DOI": " ",
          "データID": " "
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0039.v1": {
          "Research ID": "hum0039.v1",
          "公開日": "2016/12/27",
          "内容": "NGS（Exome）",
          "description": "イマチニブに対して病理学的に耐性と診断された消化管間質腫瘍4症例の腫瘍組織から抽出したDNAを用いたExome解析を行なった。\nSureSelect Human All Exon V5+UTRsを用いてExon領域にしぼり、Illumina HiSeq 1500にて平均長101bpのDNA断片を解読した（Paired-end ）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0039.v1",
      "DATA": {
        "JGAS000039": {
          "Data Set ID": "JGAS000039",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/12/27"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify the mechanism of TKI resistant in gastrointstinal stromal tumors",
        "Methods": "Exome DNA sequence analysis for imatinib resistant gastrointestinal stromal tumor (GIST)",
        "Participants/Materials": "GIST diagnosed pathologically as a imatinib resistant lesion"
      },
      "MOLECULAR DATA": {
        "JGAS000039": {
          "Participants/Materials": "Imatinib resistant GIST : 4 cases",
          "Targets": "NGS (Exome)",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "Library Source": "gDNA from Surgical tumor specimen",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V5+UTRs",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000039",
          "Total Data Volume": "202 GB (fastq)",
          "Comments (Policies)": "NBDC policy & hum0039 policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tsuyoshi Takahashi",
        "Affiliation": "Department of Surgery, Osaka university graduate school of medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "-",
          "DOI": "-",
          "Data Set ID": "-"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0039.v1": {
          "Research ID": "hum0039.v1",
          "Release Date": "2016/12/27",
          "Type of Data": "NGS (Exome)",
          "description": "Genomic DNA was extracted from Imatinib-resistant GIST and subjected to the enrichment of exon fragments by using SureSelect Human All Exon V5+UTRs. \n It was sequenced 101 bases from both ends of them with a HiSeq 1500 system (Illumina) with paired-end mode (fastq files).\nNote:\n"
        }
      }
    }
  },
  "hum0038.v1": {
    "ja": {
      "NBDC Research ID": "hum0038.v1",
      "データ": {
        "JGAS000041": {
          "データID": "JGAS000041",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/11/18"
        }
      },
      "研究内容の概要": {
        "目的": "家族性致死性不整脈の原因遺伝子を明らかにし、病態を明らかにすること",
        "方法": "HiSeq 2000を用いたエクソーム解析",
        "対象": "家族性致死性不整脈11症例",
        "URL": "https://cvmp.med.nagasaki-u.ac.jp/"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000041": {
          "対象": "家族性致死性不整脈：11症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon 50 Mb Kit",
          "断片化の方法": "超音波断片化（Covaris社、E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000041",
          "総データ量": "118 GB（fastq [22 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "蒔田 直昌",
        "所 属 機 関": "長崎大学大学院 医歯薬学総合研究科 分子生理学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "心臓イオンチャネルの遺伝子異常と機能破綻の分子基盤",
            "研究課題番号": "22136007"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Successful control of life-threatening polymorphic ventricular tachycardia by radiofrequency catheter ablation in an infant.",
          "DOI": "doi: 10.1007/s00380-013-0390-6",
          "データID": "JGAD000041"
        },
        "2": {
          "タイトル": "Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death.",
          "DOI": "doi: 10.1038/ng.2712",
          "データID": "JGAD000041"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0038.v1": {
          "Research ID": "hum0038.v1",
          "公開日": "2015/11/18",
          "内容": "NGS（Exome）",
          "description": "家族性致死性不整脈11症例の末梢血から抽出したDNAを用い、Exome解析を行った結果をfastq形式にて提供する。\nSureSelect Human All Exon 50 Mb KitによりExon領域にしぼり、HiSeq 2000にて平均長100 bpの断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0038.v1",
      "DATA": {
        "JGAS000041": {
          "Data Set ID": "JGAS000041",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/11/18"
        }
      },
      "SUMMARY": {
        "Aims": "The purpose of this study is to identify a causative gene in an inherited cardiac arrhythmia",
        "Methods": "Exome sequence analysis (HiSeq 2000)",
        "Participants/Materials": "Patients with an inherited cardiac arrhythmia",
        "URL": "https://cvmp.med.nagasaki-u.ac.jp/?lang=en"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000041": {
          "Participants/Materials": "11 Patients with an inherited cardiac arrhythmia",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon 50 Mb Kit (Agilent)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000041",
          "Total Data Volume": "118 GB (fastq [22 files])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Naomasa Makita",
        "Affiliation": "Department of Molecular Physiology, Nagasaki University Graduate School of Biomedical Sciences",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Grant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "Molecular basis of cardiac channelopathies",
            "Project Number": "22136007"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Successful control of life-threatening polymorphic ventricular tachycardia by radiofrequency catheter ablation in an infant.",
          "DOI": "doi: 10.1007/s00380-013-0390-6",
          "Data Set ID": "JGAD000041"
        },
        "2": {
          "Title": "Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death.",
          "DOI": "doi: 10.1038/ng.2712",
          "Data Set ID": "JGAD000041"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0038.v1": {
          "Research ID": "hum0038.v1",
          "Release Date": "2015/11/18",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from peripheral blood cells obtained from 11 patients with an inherited cardiac arrhythmia were used for the whole exome sequencing (fastq files). DNA fragments containing whole coding exons were concentrated using SureSelect Human All Exon 50 Mb Kit (Agilent) and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Paired-end).\nNote:\n"
        }
      }
    }
  },
  "hum0037.v1": {
    "ja": {
      "NBDC Research ID": "hum0037.v1",
      "データ": {
        "JGAS000035": {
          "データID": "JGAS000035",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/09/24"
        }
      },
      "研究内容の概要": {
        "目的": "関節リウマチ（Rheumatoid Arthritis：RA）感受性遺伝子の探索",
        "方法": "エクソーム解析によるRA感受性候補遺伝子の取得と、得られた候補遺伝子の症例対照研究による検証",
        "対象": "RA患者39症例、対照健常者10名分（女性5名分、男性5名分それぞれの検体を等量ずつ混ぜたPooled DNA）"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000035": {
          "対象": "RA患者：39症例\r\n男性健常人5名分の検体をプールしたサンプル：1\r\n女性健常人5名分の検体をプールしたサンプル：1",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon 50 Mb Kit（Agilent社）",
          "断片化の方法": "超音波断片化（Covaris社）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000035 （GRCh37_decoy）",
          "総データ量": "680 GB（bam）、143 MB（vcf）*1",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "光永 滋樹",
        "所 属 機 関": "東海大学医学部 基礎医学系分子生命科学",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "リシーケンシングによる関節リウマチ感受性稀少変異の探索",
            "研究課題番号": "22510213"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Aggregation of rare/low-frequency variants of the mitochondria respiratory chain-related proteins in rheumatoid arthritis patients.",
          "DOI": "doi: 10.1038/jhg.2015.50",
          "データID": "JGAD000035"
        },
        "2": {
          "タイトル": "Exome sequencing identifies novel rheumatoid arthritis-susceptible variants in the BTNL2.",
          "DOI": "doi: 10.1038/jhg.2013.2",
          "データID": "JGAD000035"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0037.v1": {
          "Research ID": "hum0037.v1",
          "公開日": "2015/09/24",
          "内容": "NGS（Exome）",
          "description": "関節リウマチ患者39症例、男性健常者5名および女性健常者5名の末梢血から抽出したDNAを用いたExome解析を行なった。健常者群については、5名の検体を等量ずつ混ぜたPooled DNAを男女別に作成し解析に用いた。関節リウマチ患者39症例についてはBAM形式、健常者それぞれのPooled DNAについてはvcf形式にて提供する。SureSelect Human All Exon 50 Mb Kit（Agilent社）を用いてExon領域にしぼり、Illumin HiSeq 2000にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0037.v1",
      "DATA": {
        "JGAS000035": {
          "Data Set ID": "JGAS000035",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/09/24"
        }
      },
      "SUMMARY": {
        "Aims": "Searching for rare/low frequency variants in rheumatoid arthritis (RA)",
        "Methods": "Obtaining of susceptible candidate genes for RA by exome sequencing and validation methods",
        "Participants/Materials": "Patients with RA as cases and healthy individuals as controls"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000035": {
          "Participants/Materials": "39 RAs\r\nOne pooled DNA of 5 healthy men\r\nOne pooled DNA of 5 healthy women",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon 50 Mb Kit (Agilent)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000035 (GRCh37_decoy)",
          "Total Data Volume": "680 GB (BAM format files), 143 MB (vcf format files) *1",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shigeki Mitsunaga",
        "Affiliation": "Department of Molecular Life Sciences Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine",
        "Project / Group Name": "",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Exome sequencing for disease gene discovery in rheumatoid arthritis",
            "Project Number": "22510213"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Aggregation of rare/low-frequency variants of the mitochondria respiratory chain-related proteins in rheumatoid arthritis patients.",
          "DOI": "doi: 10.1038/jhg.2015.50",
          "Data Set ID": "JGAD000035"
        },
        "2": {
          "Title": "Exome sequencing identifies novel rheumatoid arthritis-susceptible variants in the BTNL2.",
          "DOI": "doi: 10.1038/jhg.2013.2",
          "Data Set ID": "JGAD000035"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0037.v1": {
          "Research ID": "hum0037.v1",
          "Release Date": "2015/09/24",
          "Type of Data": "NGS (Exome)",
          "description": "Genomic DNAs extracted from peripheral blood cells of 39 RA patients and 10 healthy individuals (including 5 males and 5 females) were used for this study. Five gDNAs were equally mixed as a \"pooled DNA\" for healthy males. In the same way, a pooled DNA was prepared for healthy women. Exons were captured using the SureSelect Human All Exon 50 Mb Kit (Agilent) and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Paired-end). BAM files for 39 RAs and vcf files for 2 pooled DNAs were provided.\nNote:\n"
        }
      }
    }
  },
  "hum0036.v1": {
    "ja": {
      "NBDC Research ID": "hum0036.v1",
      "データ": {
        "DRA003736": {
          "データID": "DRA003736",
          "内容": "NGS (Exome)",
          "制限": "非制限公開",
          "公開日": "2015/08/01"
        }
      },
      "研究内容の概要": {
        "目的": "市販されている４種類の全エクソームキャプチャープラットフォーム間の性能比較",
        "方法": "各エクソンキャプチャープラットフォーム (Roche/NimbleGen [SeqCap EZ Human Exome Library v3.0]、Illumina [Nextera Rapid Capture Exome（v1.2）]、Agilent [SureSelect XT Human All Exon v5、SureSelect QXT Human All Exon v5]）ごとにシークエンスライブラリを作成し、Illumina社のHiSeq 2500により全エクソームシークエンシングを実施",
        "対象": "コリエル医学研究所より購入したHapMap-JPT検体由来のセルライン: 2名"
      },
      "分子データ": {
        "DRA003736": {
          "対象": "コリエル医学研究所より購入したHapMap-JPT検体由来のセルライン: 2名分",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "-",
          "検体情報（購入の場合）": "https://catalog.coriell.org/1/NHGRI/Collections/HapMap-Collections/Japanese-in-Tokyo-Japan-JPT",
          "ライブラリ作製方法（キット名）": "Roche/NimbleGen [SeqCap EZ Human Exome Library v3.0]\r\nIllumina [Nextera Rapid Capture Exome（v1.2）]\r\nAgilent [SureSelect XT Human All Exon v5]\r\nAgilent [SureSelect QXT Human All Exon v5]",
          "断片化方法": "Roche/NimbleGen [SeqCap EZ Human Exome Library v3.0]：超音波断片化（Covaris社）\r\nIllumina [Nextera Rapid Capture Exome (v1.2)]：酵素反応を用いた断片化（トランスポゾーム ）\r\nAgilent [SureSelect XT Human All Exon v5]：超音波断片化（Covaris社）\r\nAgilent [SureSelect QXT Human All Exon v5]：酵素反応を用いた断片化（トランスポゾーム ）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "161 bp x 2",
          "DDBJ Sequence Read Archive ID": "DRA003736",
          "総データ量": "65 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "久保 充明",
        "所 属 機 関": "理化学研究所統合生命医科学研究センター",
        "プロジェクト/研究グループ名": "疾患多様性医科学研究部門",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Performance comparison of four commercial human whole-exome capture platforms.",
          "DOI": "doi: 10.1038/srep12742",
          "データID": "DRA003736"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0036.v1": {
          "Research ID": "hum0036.v1",
          "公開日": "2015/08/01",
          "内容": "NGS (Exome)",
          "description": " このバージョンでは、コリエル医学研究所より購入したHapMap-JPT検体由来のセルライン2検体を対象とし、Roche/NimbleGen [SeqCap EZ Human Exome Library v3.0]、Illumina [Nextera Rapid Capture Exome（v1.2）]、Agilent [SureSelect XT Human All Exon v5、SureSelect QXT Human All Exon v5] の4種類の各エクソンキャプチャプラットフォームをそれぞれ用いてエクソン領域を絞り込み、HiSeq 2500（Illumina）により全エクソームシーケンシングを実施した結果をfastq形式にて提供する（Paired-end: 161 bp x 2）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0036.v1",
      "DATA": {
        "DRA003736": {
          "Data Set ID": "DRA003736",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2015/08/01"
        }
      },
      "SUMMARY": {
        "Aims": "Performance comparison of four commercial human whole-exome capture platforms.",
        "Methods": "Each exome captured sequencing library was produced from one of four different technologies: Roche/NimbleGen’s SeqCap EZ Human Exome Library v3.0, Illumina’s Nextera Rapid Capture Exome (v1.2), Agilent’s SureSelect XT Human All Exon v5 and Agilent’s SureSelect QXT. The captured DNA was sequenced using the Illumina HiSeq 2500 platform with paired-end reads of 161 bp for insert libraries according to the manufacturer’s instructions.",
        "Participants/Materials": "EBV-transformed lymphoblastoid cell lines (LCL) derived from two HapMap-JPT samples obtained from Coriell."
      },
      "MOLECULAR DATA": {
        "DRA003736": {
          "Participants/Materials": "EBV-transformed lymphoblastoid cell lines (LCL) derived from two HapMap-JPT samples obtained from Coriell.",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "-",
          "Cell Lines": "https://catalog.coriell.org/1/NHGRI/Collections/HapMap-Collections/Japanese-in-Tokyo-Japan-JPT",
          "Library Construction (kit name)": "Roche/NimbleGen [SeqCap EZ Human Exome Library v3.0]\r\nIllumina [Nextera Rapid Capture Exome (v1.2)]\r\nAgilent [SureSelect XT Human All Exon v5]\r\nAgilent [SureSelect QXT Human All Exon v5]",
          "Fragmentation Methods": "Roche/NimbleGen [SeqCap EZ Human Exome Library v3.0]：Ultrasonic fragmentation (Covaris)\r\nIllumina [Nextera Rapid Capture Exome (v1.2)]：Tagmentation reaction (transposon cleaving)\r\nAgilent [SureSelect XT Human All Exon v5]：Ultrasonic fragmentation (Covaris)\r\nAgilent [SureSelect QXT Human All Exon v5]：Tagmentation reaction (transposon cleaving)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "161 bp x 2",
          "DDBJ Sequence Read Archive ID": "DRA003736",
          "Total Data Volume": "65 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": " Michiaki Kubo",
        "Affiliation": "RIKEN Center for Integrative Medical Science",
        "Project / Group Name": "Core for Genomic Medicine",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Performance comparison of four commercial human whole-exome capture platforms.",
          "DOI": "doi: 10.1038/srep12742",
          "Data Set ID": "DRA003736"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0036.v1": {
          "Research ID": "hum0036.v1",
          "Release Date": "2015/08/01",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from EBV-transformed lymphoblastoid cell lines (LCL) derived from two HapMap-JPT samples obtained from Coriell were used for the whole exome sequencing (fastq files). DNA fragments containing whole coding exons were concentrated using SeqCap EZ Human Exome Library v3.0 (Roche/NimbleGen), Illumina [Nextera Rapid Capture Exome v1.2 (Illumina), SureSelect XT Human All Exon v5 (Agilent) or SureSelect QXT Human All Exon v5 (Agilent) and multiplex sequence was performed with the Illumina HiSeq 2500 sequencer (161 bp x 2, Paired-end).\nNote:\n"
        }
      }
    }
  },
  "hum0035.v5": {
    "ja": {
      "NBDC Research ID": "hum0035.v5",
      "データ": {
        "JGAS000036": {
          "データID": "JGAS000036",
          "内容": "RMSおよびPPBのNGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/09/16"
        },
        "JGAS000046": {
          "データID": "JGAS000046",
          "内容": "NBのSNP-chip\r\nNBのTarget amplicon deep sequencing（NGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/12/26"
        },
        "JGAS000088": {
          "データID": "JGAS000088",
          "内容": "PBLのSNP-chip\r\nPBLのメチル化アレイ\r\nPBLのNGS（Exome）\r\nPBLのNGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2017/12/26"
        },
        "JGAS000188": {
          "データID": "JGAS000188",
          "内容": "HBLのSNP-chip\r\nHBLのメチル化アレイ\r\nHBLのNGS（Target Capture）\r\nHBLのNGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/05/29"
        },
        "JGAS000204": {
          "データID": "JGAS000204",
          "内容": "小児胚細胞腫瘍のSNP-chip\r\n小児胚細胞腫瘍のメチル化アレイ\r\n小児胚細胞腫瘍のNGS（Target Capture）\r\n小児胚細胞腫瘍のNGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/12/14"
        },
        "JGAS000246": {
          "データID": "JGAS000246",
          "内容": "小児高リスク神経芽腫のNGS（RNA-seq）\r\n小児高リスク神経芽腫のNGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2020/12/18"
        }
      },
      "研究内容の概要": {
        "目的": "多数の固形腫瘍性疾患検体について、種々の遺伝子解析技術を用いて、固形腫瘍性疾患の発症の原因となる遺伝子異常をゲノムワイドに同定する",
        "方法": " ",
        "対象": "",
        "URL": "http://square.umin.ac.jp/ped/about/group/r-blood.html"
      },
      "分子データ": {
        "JGAS000036、JGAS000088（Exome）": {
          "対象": "RMS：16症例、PPB：7症例、PBL：10症例",
          "規模": "NGS（Exome）",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "小児横紋筋肉腫、胸膜肺芽腫、小児膵芽腫の腫瘍組織、および対応する末梢血（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human ALL Exon（50Mb kit, v4/v5）",
          "断片化方法": "超音波断片化（Covaris社、S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "75-108 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000036\r\nEGAD00001000822 / EGAS00001000662（PPB）\r\nEGAD00001001105 / EGAS00001000884（RMS）\r\nJGAD000088",
          "総データ量": "JGAD000036：497.04 GB（bam [ref: hg19]）\r\nJGAD000088：179.80 GB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000046、JGAS000088、JGAS000188、JGAS000204（SNP-chip）": {
          "対象": "NB（ICD10：C749）：522症例 （*論文で使用500症例はこちら）\r\n神経芽腫細胞株：39検体\r\nPBL：10症例\r\nHBL：59症例、HBL細胞株：2検体（ICD10：C222）\r\n小児胚細胞腫瘍（ICD10：C809）：51症例",
          "規模": "SNP-chip",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [GeneChip Human Mapping 250k Nspl、Cytoscan HD]",
          "ソース": "神経芽腫、小児膵芽腫の腫瘍組織、および対応する末梢血（非腫瘍組織）、小児肝芽腫、小児胚細胞腫瘍の腫瘍組織、並びに神経芽腫細胞株およびHBL細胞株から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Affymetrix Cytoscan HD kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Copy Number for GeneChip software (CNAG) and allele-specific copy-number analysis using anonymous references (AsCNAR)",
          "マーカー数": "GeneChip Human Mapping 250K Nsp Array : 262,264 CNVs\r\nCytoScan HD Array : 2,696,550 CNVs",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000046\r\nJGAD000088\r\nJGAD000270\r\nJGAD000289",
          "総データ量": "JGAD000046：32.42 GB（CEL）\r\nJGAD000088：179.80 GB（CEL）\r\nJGAD000270：483 GB（CEL）\r\nJGAD000289：413 GB（CEL）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000046（Target amplicon deep sequencing）": {
          "対象": "NB（ICD10：C749）：522症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "159症例（NB_001～NB_159）：\r\nCHEK1, MRE11A, H2AFX, TP53, BRCA1, CHEK2, BARD1\r\n500症例（リスト参照）：\r\nALK, MYCN, ATRX, ARID1A, ARID1B, PHOX2B, PTPN11, HRAS, KRAS, NRAS",
          "Platform": "Illumina [HiSeq 2000、MiSeq]",
          "ライブラリソース": "神経芽腫の腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "The NEBNext Ultra DNA Library Prep Kit for Illumina",
          "断片化の方法": "超音波断片化（Covaris社、E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp or 150 bp",
          "マッピング方法": "BWA",
          "変異検出方法": "SAMtools",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000046",
          "総データ量": "32.42 GB （xlsx [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000088、JGAS000188、JGAS000204（メチル化アレイ）": {
          "対象": "PBL：10症例\r\nHBL：59症例、HBL細胞株：2検体（ICD10：C222）\r\n小児胚細胞腫瘍（ICD10：C809）：51症例",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Infinium MethylationEPIC]",
          "ソース": "小児膵芽腫、小児肝芽腫、および小児胚細胞腫瘍の腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Infinium MethylationEPIC kit",
          "メチル化率決定アルゴリズム（ソフトウェア）": "-",
          "フィルタリング": "-",
          "マイクロアレイ標準化方法": "-",
          "プローブ数": "450K プローブ（raw data）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000088\r\nJGAD000270\r\nJGAD000289",
          "総データ量": "JGAD000088：179.80 GB（idat）\r\nJGAD000270：483 GB（idat）\r\nJGAD000289：413 GB（idat）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000088、JGAS000188、JGAS000204、JGAS000246（RNA-seq）": {
          "対象": "PBL：10症例\r\nHBL：59症例、HBL細胞株：2検体（ICD10：C222）\r\n小児胚細胞腫瘍（ICD10：C809）：49症例\r\n小児高リスク神経芽腫（ICD10：C749）：30症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "小児膵芽腫、小児肝芽腫、小児胚細胞腫瘍および小児高リスク神経芽腫の腫瘍組織、並びにHBL細胞株から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "BioLabs NEBNext Ultra RNA Library Prep Kit for Illumina\r\nIllumina TruSeq RNA Sample Preparation Kit v2",
          "断片化方法": "上記キットに準拠",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "108 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000088\r\nJGAD000270\r\nJGAD000289\r\nJGAD000346",
          "総データ量": "JGAD000088：179.80 GB（raw array data）\r\nJGAD000270：483 GB（bam [ref: hg19]）\r\nJGAD000289：413 GB（bam [ref: hg19]）\r\nJGAD000346：239 GB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000188、JGAS000204、JGAS000246（Target Capture）": {
          "対象": "HBL：59症例、HBL細胞株：2検体（ICD10：C222）\r\n小児胚細胞腫瘍（ICD10：C809）：51症例\r\n小児高リスク神経芽腫（ICD10：C749）：30症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "小児がんに関連する380の遺伝子または領域\r\n（380遺伝子/領域の一覧）",
          "Platform": "Illumina [HiSeq 2000、MiSeq]",
          "ライブラリソース": "小児肝芽腫、小児胚細胞腫瘍および小児高リスク神経芽腫の腫瘍組織とHBL細胞株から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "The NEBNext Ultra DNA Library Prep Kit for Illumina",
          "断片化の方法": "超音波断片化（Covaris社、E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp or 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000270\r\nJGAD000289\r\nJGAD000346",
          "総データ量": "JGAD000270：483 GB（bam [ref: hg19]）\r\nJGAD000289：413 GB（bam [ref: hg19]）\r\nJGAD000346：42.5 GB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "滝田 順子",
        "所 属 機 関": "東京大学大学院医学系研究科 生殖・発達・加齢医学専攻 小児医学講座",
        "プロジェクト/研究グループ名": "東京大学小児科血液腫瘍グループ/次世代がん研究シーズ戦略的育成プログラム「統合的ゲノムスキャニングによる難治性小児固形腫瘍の新規標的分子の探索」",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "2019年度公益財団法人がんの子どもを守る会治療研究助成金",
            "タイトル": "小児胚細胞腫瘍の包括的なゲノム解析及び治療標的の探索",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.",
          "DOI": "doi: 10.1038/ncomms8557",
          "データID": "JGAD000036 EGAD00001001105"
        },
        "2": {
          "タイトル": "Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma.",
          "DOI": "doi: 10.1158/0008-5472.CAN-13-2470",
          "データID": "JGAD000036 EGAD00001000822"
        },
        "3": {
          "タイトル": "Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis.",
          "DOI": "doi: 10.18632/oncotarget.22495",
          "データID": "JGAD000046"
        },
        "4": {
          "タイトル": "Integrated molecular characterization of the lethal pediatric cancer pancreatoblastoma.",
          "DOI": "doi: 10.1158/0008-5472.CAN-17-2581",
          "データID": "JGAD000088"
        },
        "5": {
          "タイトル": "Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets",
          "DOI": "doi: 10.1038/s41698-020-0125-y",
          "データID": "JGAD000270"
        },
        "6": {
          "タイトル": "Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets",
          "DOI": "doi: 10.1038/s42003-020-01267-8",
          "データID": "JGAD000289"
        },
        "7": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Jiguang Wang": {
          "研究代表者": "Jiguang Wang",
          "所属機関": "The Hong Kong university of science and technology",
          "研究題目": "香港",
          "利用データID": "Germline and somatic mutations in pediatric germ cell tumor.",
          "利用期間": "JGAD000289"
        },
        "Weng Chuan Peng": {
          "研究代表者": "Weng Chuan Peng",
          "所属機関": "Princess Maxima Center for Pediatric Oncology",
          "研究題目": "オランダ",
          "利用データID": "Towards understanding pediatric liver tumors",
          "利用期間": "JGAD000270"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000088JGAD000270JGAD000289JGAD000346"
        },
        "Yujie Tang": {
          "研究代表者": "Yujie Tang",
          "所属機関": "Department of Histoembryology, Genetics and Developmental Biology, College of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine",
          "研究題目": "中華人民共和国",
          "利用データID": "The key molecular mechanisms underlying the oncogenesis and progression of neuroblastoma and hepatoblastoma",
          "利用期間": "JGAD000270"
        }
      },
      "リリース情報": {
        "hum0035.v5": {
          "Research ID": "hum0035.v5",
          "公開日": "2020/12/18",
          "内容": "NGS（RNA-seq、Target Capture）",
          "description": "このバージョンでは、小児高リスク神経芽腫30症例の腫瘍組織を対象とした以下の解析結果を追加した（JGAS000246）。\n・RNA-seq解析：BioLabs NEBNext Ultra RNA Library Prep Kit for Illuminaを用いてライブラリを作製し、HiSeq 2500にて平均長108塩基断片を解読した（Paired-end）。\n・Target Capture解析：塩基配列型決定には、HiSeq 2000、MiSeq（Illumina）を使用している。\n"
        },
        "hum0035.v4": {
          "Research ID": "hum0035.v4",
          "公開日": "2020/12/14",
          "内容": "NGS（Target Capture、RNA-seq）、SNP-chip、メチル化アレイ",
          "description": "このバージョンでは、小児胚細胞腫瘍51症例の腫瘍組織を対象とした以下の解析結果を追加した（JGAS000204）。\n・SNP-chip解析：Copy Number Variation (CNV)の決定には、GeneChip Human Mapping 250k NsplもしくはCytoscan HD（Affymetrix）を使用している。\n・Target Capture解析：塩基配列型決定には、HiSeq 2000、MiSeq（Illumina）を使用している。\n・RNA-seq解析：BioLabs NEBNext Ultra RNA Library Prep Kit for Illumina もしくはIllumina TruSeq RNA Sample Preparation Kit v2 を用いてライブラリを作製し、HiSeq 2500にて平均長108塩基断片を解読した（Paired-end）。\n・メチル化アレイ解析：Infinium MethylationEPIC（Illumina）を用いてメチル化解析を行った。\n"
        },
        "hum0035.v3": {
          "Research ID": "hum0035.v3",
          "公開日": "2020/05/29",
          "内容": "NGS（Target Capture、RNA-seq）、SNP-chip、メチル化アレイ",
          "description": "このバージョンでは、小児肝芽腫59症例の腫瘍組織とHBL細胞株2検体を対象とした以下の解析結果を追加した（JGAS000188）。\n・SNP-chip解析：Copy Number Variation (CNV)の決定には、GeneChip Human Mapping 250k NsplもしくはCytoscan HD（Affymetrix）を使用している。\n・Target Capture解析：塩基配列型決定には、HiSeq 2000、MiSeq（Illumina）を使用している。\n・RNA-seq解析：BioLabs NEBNext Ultra RNA Library Prep Kit for Illumina もしくはIllumina TruSeq RNA Sample Preparation Kit v2 を用いてライブラリを作製し、HiSeq 2500にて平均長108塩基断片を解読した（Paired-end）。\n・メチル化アレイ解析：Infinium MethylationEPIC（Illumina）を用いてメチル化解析を行った。\n"
        },
        "hum0035.v2": {
          "Research ID": "hum0035.v2",
          "公開日": "2017/12/26",
          "内容": "NGS（Exome、Target amplicon deep sequencing、RNA-seq）、SNP-chip、メチル化アレイ",
          "description": "このバージョンでは、神経芽腫522症例、小児膵芽腫10症例の腫瘍組織と、対応する末梢血（非腫瘍組織）、神経芽腫細胞株39検体を対象とした以下の解析結果を追加した（JGAS000046、JGAS000088）。\n・SNP-chip解析：神経芽腫522症例、小児膵芽腫10症例の腫瘍組織と、対応する末梢血（非腫瘍組織）、神経芽腫細胞株39検体\nCopy Number Variation (CNV)の決定には、GeneChip Human Mapping 250k NsplもしくはCytoscan HD（Affymetrix）を使用している。\n・NGSによるTarget amplicon deep sequencing：神経芽腫 522症例の腫瘍組織\n塩基配列型決定には、HiSeq 2000、MiSeq（Illumina）を使用している。\n・エクソーム解析：小児膵芽腫10症例の腫瘍組織と、対応する末梢血（非腫瘍組織）\nSureSelect Human ALL Exon kit（50Mb kit, v4もしくはv5）を用いてExon領域にしぼり、HiSeq 2000/2500にて平均長75-108塩基のDNA断片を解読した（Paired-end）。\n・RNA-seq解析：小児膵芽腫10症例の腫瘍組織のみ\nBioLabs NEBNext Ultra RNA Library Prep Kit for Illumina もしくはIllumina TruSeq RNA Sample Preparation Kit v2 を用いてライブラリを作製し、HiSeq 2500にて平均長108塩基断片を解読した（Paired-end）。\n・メチル化アレイ解析：小児膵芽腫10症例の腫瘍組織のみ\nInfinium MethylationEPIC（Illumina）を用いてメチル化解析を行った。\n"
        },
        "hum0035.v1": {
          "Research ID": "hum0035.v1",
          "公開日": "2015/09/16",
          "内容": "NGS（Exome）",
          "description": "このバージョンでは、小児横紋筋肉腫16症例および胸膜肺芽腫7症例の腫瘍組織と、対応する末梢血（非腫瘍組織）をペアでエクソーム解析し、その結果をbamファイルにて提供する（JGAS000036）。SureSelect Human ALL Exon kit（50Mb kit, v4）を用いてExon領域にしぼり、HiSeq 2000/2500にて平均長75-108塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0035.v5",
      "DATA": {
        "JGAS000036": {
          "Data Set ID": "JGAS000036",
          "Type of Data": "NGS (Exome) for RMS and PPB",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/09/16"
        },
        "JGAS000046": {
          "Data Set ID": "JGAS000046",
          "Type of Data": "SNP-chip for NB\r\nTarget amplicon deep sequencing (NGS) for NB",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/12/26"
        },
        "JGAS000088": {
          "Data Set ID": "JGAS000088",
          "Type of Data": "SNP-chip for PBL\r\nMethylation array for PBL\r\nNGS (Exome) for PBL\r\nNGS (RNA-seq) for PBL",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/12/26"
        },
        "JGAS000188": {
          "Data Set ID": "JGAS000188",
          "Type of Data": "SNP-chip for HBL\r\nMethylation array for HBL\r\nNGS (Target Capture) for HBL\r\nNGS (RNA-seq) for HBL",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/05/29"
        },
        "JGAS000204": {
          "Data Set ID": "JGAS000204",
          "Type of Data": "SNP-chip for pediatric germ cell tumors\r\nMethylation array for pediatric germ cell tumors\r\nNGS (Target Capture) for pediatric germ cell tumors\r\nNGS (RNA-seq) for pediatric germ cell tumors",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/12/14"
        },
        "JGAS000246": {
          "Data Set ID": "JGAS000246",
          "Type of Data": "NGS (RNA-seq) for high-risk neuroblastoma\r\nNGS (Target Capture) for high-risk neuroblastoma",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2020/12/18"
        }
      },
      "SUMMARY": {
        "Aims": "To explore genetic alterations in solid tumors, we performed genome wide analysis using next generation sequencing methods.",
        "Methods": "",
        "Participants/Materials": ""
      },
      "MOLECULAR DATA": {
        "JGAS000036, JGAS000088 (Exome)": {
          "Participants/Materials": "16 RMSs, 7 PPBs, and 10 PBLs",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "DNA extracted from tumor tissues and peripheral blood cells as non-tumor tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human ALL Exon kit (50Mb kit, v4/v5)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75-108 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000036\r\nEGAD00001000822 / EGAS00001000662 (PPB)\r\nEGAD00001001105 / EGAS00001000884 (RMS)\r\nJGAD000088",
          "Total Data Volume": "JGAD000036: 497.04 GB (bam [ref: hg19])\r\nJGAD000088: 179.80 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000046, JGAS000088, JGAS000188, JGAS000204 (SNP-chip)": {
          "Participants/Materials": "522 NBs (ICD10: C749) (*sample list used in the paper)\r\n39 neuroblastoma cell lines\r\n10 PBLs\r\n59 HBLs and 2 HBL cell lines (ICD10: C222)\r\n51 patients with pediatric germ cell tumors (ICD10: C809)",
          "Targets": "SNP-chip",
          "Target Loci for Capture Methods": "",
          "Platform": "Affymetrix [GeneChip Human Mapping 250k Nspl, Cytoscan HD]",
          "Library Source": "DNAs extracted from neuroblastoma cell lines, HBL cell lines, tumor tissues of NB, HBL and pediatric germ cell tumors, and peripheral blood cells of NB as non-tumor tissues",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Affymetrix Cytoscan HD kit",
          "Genotype Call Methods (software)": "Copy Number for GeneChip software (CNAG) and allele-specific copy-number analysis using anonymous references (AsCNAR)",
          "Marker Number": "GeneChip Human Mapping 250K Nsp Array : 262,264 CNVs\r\nCytoScan HD Array : 2,696,550 CNVs",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000046\r\nJGAD000088\r\nJGAD000270\r\nJGAD000289",
          "Total Data Volume": "JGAD000046: 32.42 GB (CEL)\r\nJGAD000088: 179.80 GB (CEL)\r\nJGAD000188: 483 GB (CEL)\r\nJGAD000289: 413 GB (CEL)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000046 (Target amplicon deep sequencing)": {
          "Participants/Materials": "522 NBs (ICD10: C749)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "159 cases (NB_001~NB_159): \r\nCHEK1, MRE11A, H2AFX, TP53, BRCA1, CHEK2, BARD1\r\n500 cases (*see sample list): \r\nALK, MYCN, ATRX, ARID1A, ARID1B, PHOX2B, PTPN11, HRAS, KRAS, NRAS",
          "Platform": "Illumina [HiSeq 2000, MiSeq]",
          "Library Source": "DNAs extracted from neuroblastoma (tumor tissues)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "The NEBNext Ultra DNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp or 150 bp",
          "Mapping": "BWA",
          "Mutation Detection Methods": "SAMtools",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000046",
          "Total Data Volume": "32.42 GB (xlsx [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000088, JGAS000188, JGAS000204 (Methylation array)": {
          "Participants/Materials": "10 PBLs\r\n59 HBLs and 2 HBL cell lines (ICD10: C222)\r\n51 patients with pediatric germ cell tumors (ICD10: C809)",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Infinium MethylationEPIC]",
          "Library Source": "DNAs extracted from tumor tissues of pancreatoblastoma, hepatoblastoma and pediatric germ cell tumors, and HBL cell lines",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Infinium MethylationEPIC kit",
          "Algorithms for Calculating Methylation-rate (software)": "-",
          "Filtering Methods": "-",
          "Normalization of microarray": "-",
          "Probe Number": "450K probes (raw data)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000088\r\nJGAD000270\r\nJGAD000289",
          "Total Data Volume": "JGAD000088: 179.80 GB (idat)\r\nJGAD000270: 483 GB (idat)\r\nJGAD000289: 413 GB (idat)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000088, JGAS000188, JGAS000204, JGAS000246 (RNA-seq)": {
          "Participants/Materials": "10 PBLs\r\n59 HBLs and 2 HBL cell lines (ICD10: C222)\r\n49 patients with pediatric germ cell tumors (ICD10: C809)\r\n30 high-risk neuroblastoma patients (ICD10: C749)",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "RNAs extracted from tumor tissues of pancreatoblastoma, hepatoblastoma, pediatric germ cell tumors and neuroblastoma, and HBL cell lines",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra RNA Library Prep Kit for Illumina\r\nTruSeq RNA Sample Preparation Kit v2",
          "Fragmentation Methods": "included in the above library construction kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "108 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000088\r\nJGAD000270\r\nJGAD000289\r\nJGAD000346",
          "Total Data Volume": "JGAD000088: 179.80 GB (raw array data)\r\nJGAD000270: 483 GB (bam [ref: hg19])\r\nJGAD000289: 413 GB (bam [ref: hg19])\r\nJGAD000346: 239 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000188, JGAS000204, JGAS000246 (Target Capture)": {
          "Participants/Materials": "59 HBLs and 2 HBL cell lines (ICD10: C222)\r\n51 patients with pediatric germ cell tumors (ICD10: C809)\r\n30 high-risk neuroblastoma patients (ICD10: C749)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "380 genes or regions associated with paediatric cancers\r\n(list of 380 genes & regions)",
          "Platform": "Illumina [HiSeq 2000, MiSeq]",
          "Library Source": "DNAs extracted from tumor tissues of hepatoblastoma, pediatric germ cell tumors and neuroblastoma, and HBL cell lines",
          "Cell Lines": "-",
          "Library Construction (kit name)": "The NEBNext Ultra DNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp or 150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000270\r\nJGAD000289\r\nJGAD000346",
          "Total Data Volume": "JGAD000270: 483 GB (bam [ref: hg19])\r\nJGAD000289: 413 GB (bam [ref: hg19])\r\nJGAD000346: 42.5 GB (bam [ref: hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Junko Takita",
        "Affiliation": "Graduate School of Medicine, The University of Tokyo",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Children's Cancer Association of Japan: Therapeutic Research Grants",
            "Title": "Comprehensive genetic analysis and searching for drug target discovery in pediatric germ cell tumors",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.",
          "DOI": "doi: 10.1038/ncomms8557",
          "Data Set ID": "JGAD000036 EGAD00001001105"
        },
        "2": {
          "Title": "Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma.",
          "DOI": "doi: 10.1158/0008-5472.CAN-13-2470",
          "Data Set ID": "JGAD000036 EGAD00001000822"
        },
        "3": {
          "Title": "Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis.",
          "DOI": "doi: 10.18632/oncotarget.22495",
          "Data Set ID": "JGAD000046"
        },
        "4": {
          "Title": "Integrated molecular characterization of the lethal pediatric cancer pancreatoblastoma.",
          "DOI": "doi: 10.1158/0008-5472.CAN-17-2581",
          "Data Set ID": "JGAD000088"
        },
        "5": {
          "Title": "Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets",
          "DOI": "doi: 10.1038/s41698-020-0125-y",
          "Data Set ID": "JGAD000270"
        },
        "6": {
          "Title": "Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets",
          "DOI": "doi: 10.1038/s42003-020-01267-8",
          "Data Set ID": "JGAD000289"
        },
        "7": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Jiguang Wang": {
          "Principal Investigator": "Jiguang Wang",
          "Affiliation": "The Hong Kong university of science and technology",
          "Research Title": "Hong Kong",
          "Data in Use (Dataset ID)": "Germline and somatic mutations in pediatric germ cell tumor.",
          "Period of Data Use": "JGAD000289"
        },
        "Weng Chuan Peng": {
          "Principal Investigator": "Weng Chuan Peng",
          "Affiliation": "Princess Maxima Center for Pediatric Oncology",
          "Research Title": "Netherlands",
          "Data in Use (Dataset ID)": "Towards understanding pediatric liver tumors",
          "Period of Data Use": "JGAD000270"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000088JGAD000270JGAD000289JGAD000346"
        },
        "Yujie Tang": {
          "Principal Investigator": "Yujie Tang",
          "Affiliation": "Department of Histoembryology, Genetics and Developmental Biology, College of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine",
          "Research Title": "China",
          "Data in Use (Dataset ID)": "The key molecular mechanisms underlying the oncogenesis and progression of neuroblastoma and hepatoblastoma",
          "Period of Data Use": "JGAD000270"
        }
      },
      "Release Note": {
        "hum0035.v5": {
          "Research ID": "hum0035.v5",
          "Release Date": "2020/12/20",
          "Type of Data": "NGS (RNA-seq, Target Capture)",
          "description": "Analyses data about 30 high-risk neuroblastoma patients (JGAS000246) were added.\n• RNA-seq: RNA library was builded using BioLabs NEBNext Ultra RNA Library Prep Kit for Illumina, and read by Illumina HiSeq 2500 (paired-end: 108 bp).\n• Target Capture Sequencing: HiSeq 2000 and MiSeq (Illumina) were used for the sequencing analysis.\n"
        },
        "hum0035.v4": {
          "Research ID": "hum0035.v4",
          "Release Date": "2020/12/14",
          "Type of Data": "NGS (Target Capture, RNA-seq), SNP-chip, Methylation array",
          "description": "Analyses data about 51 patients with pediatric germ cell tumors (JGAS000204) were added.\n• SNP-chip: GeneChip Human Mapping 250k Nspl (Affymetrix) was used for genotyping.\n• Target Capture Sequencing: HiSeq 2000 and MiSeq (Illumina) were used for the sequencing analysis.\n• RNA-seq: RNA library was builded using BioLabs NEBNext Ultra RNA Library Prep Kit for Illumina or Illumina TruSeq RNA Sample Preparation Kit v2, and read by Illumina HiSeq 2500 (paired-end: 108 bp).\n• Methylation array: Infinium MethylationEPIC (Illumina) was used for the methylation analysis.\n"
        },
        "hum0035.v3": {
          "Research ID": "hum0035.v3",
          "Release Date": "2020/05/29",
          "Type of Data": "NGS (Target Capture, RNA-seq), SNP-chip, Methylation array",
          "description": "Analyses data about 59 hepatoblastoma (HBL) patients and 2 HBL cell lines (JGAS000188) were added.\n• SNP-chip: GeneChip Human Mapping 250k Nspl (Affymetrix) was used for genotyping.\n• Target Capture Sequencing: HiSeq 2000 and MiSeq (Illumina) were used for the sequencing analysis.\n• RNA-seq: RNA library was builded using BioLabs NEBNext Ultra RNA Library Prep Kit for Illumina or Illumina TruSeq RNA Sample Preparation Kit v2, and read by Illumina HiSeq 2500 (paired-end: 108 bp).\n• Methylation array: Infinium MethylationEPIC (Illumina) was used for the methylation analysis.\n"
        },
        "hum0035.v2": {
          "Research ID": "hum0035.v2",
          "Release Date": "2017/12/26",
          "Type of Data": "NGS (Exome, Target amplicon deep sequencing, RNA-seq), SNP-chip, Methylation array",
          "description": "Analyses data about 522 neuroblastoma (NB) patients, 39 neuroblastoma cell lines (JGAS000046), and 10 pancreatoblastoma (PBL) patients (JGAS000088) were added.\n• SNP-chip: 39 neuroblastoma cell lines and tumor tissues and peropheral blood cells (non-tumor tissues) from 522 NBs and 10 PBLs\n        GeneChip Human Mapping 250k Nspl (Affymetrix) was used for genotyping.\n• Target amplicon deep sequencing: tumor tissues from 522 NBs \n        HiSeq 2000, MiSeq (Illumina) was used for genotyping.\n• Exome: tumor tissues and peripheral blood cells (as non-tumor tissues) from 10 PBLs\n        Exons were narrowed down by using of SureSelect Human ALL Exon kit (50Mb kit, v4/v5) and read by Illumina HiSeq 2000/2500 (paired-end: 75-108 bp).\n• RNA-seq: tumor tissues from 10 PBLs\n        RNA library was builded using BioLabs NEBNext Ultra RNA Library Prep Kit for Illumina or Illumina TruSeq RNA Sample Preparation Kit v2, and read by Illumina HiSeq 2500 (paired-end: 108 bp).\n• Methylation array: tumor tissues from 10 PBLs\n        Infinium MethylationEPIC (Illumina) was used for methylation analysis.\n"
        },
        "hum0035.v1": {
          "Research ID": "hum0035.v1",
          "Release Date": "2015/09/16",
          "Type of Data": "NGS (Exome)",
          "description": "  DNAs extracted from fresh tumors and corresponding normal blood samples of 16 rhabdomyosarocoma and 7 pleuropulmonary blastoma patients were used for the whole exome sequencing (bam files) (JGAS000036). DNA fragments containing whole coding exons were concentrated using SureSelect Human ALL Exon kit (50Mb kit, v4) followed by 75-108 bp paired-end sequencing by Hiseq 2000/2500 (Illumina).\nNote:\n"
        }
      }
    }
  },
  "hum0034.v1": {
    "ja": {
      "NBDC Research ID": "hum0034.v1",
      "データ": {
        "JGAS000037": {
          "データID": "JGAS000037",
          "内容": "Exome（NGS）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/10/01"
        }
      },
      "研究内容の概要": {
        "目的": "難治療性の小細胞肺がん（small cell lung cancer: SCLC）を対象として網羅的ゲノム解析を実施し、新たな治療標的を発見することにより新しい分子標的治療法の開発に結びつけること",
        "方法": "ホルマリン固定ないしメタノール固定された組織より抽出したゲノムDNA断片から SureSelect Human All Exon V4+UTRs Kit（Agilent Technologies）を用いて全エクソンを含む71Mb領域をキャプチャし、Illumina HiSeq 2000により100-bpペアエンドシークエンスを行った。",
        "対象": "1992-2012年に国立がん研究センター東病院 呼吸器内科の肺がんデータベースに登録された小細胞肺がん約1042例のうち、手術・生検が施行され、小細胞肺がんの病理診断が確定し、全エクソンシークエンスに必要なゲノムDNAが抽出可能だった51例"
      },
      "分子データ": {
        "JGAS000037": {
          "対象": "1992-2012年に国立がん研究センター東病院 呼吸器内科の肺がんデータベースに登録された小細胞肺がん約1042例のうち、手術・生検が施行され、小細胞肺がんの病理診断が確定し、全エクソンシークエンスに必要なゲノムDNAが抽出可能だった51例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "ホルマリン固定ないしメタノール固定された組織より抽出したゲノムDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V4+UTRs Kit",
          "断片化の方法": "超音波断片化（Covaris社、S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000037",
          "総データ量": "3 TB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "後藤 功一",
        "所 属 機 関": "国立がん研究センター 東病院呼吸器内科",
        "プロジェクト/研究グループ名": "難治性の小細胞肺がんを対象とした網羅的ゲノム解析による新しい分子標的治療法の開発",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん研究シーズ戦略的育成プログラム（P-DIRECT）",
            "タイトル": "小細胞肺がんの全ゲノム網羅的解析による治療標的の探索",
            "研究課題番号": "JP15cm0106063"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.",
          "DOI": "doi: 10.1097/JTO.0000000000000250",
          "データID": "JGAD000037"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Anton Berns": {
          "研究代表者": "Anton Berns",
          "所属機関": "The Netherlands Cancer Institute, Division of Molecular Genetics",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000037"
        },
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000037"
        }
      },
      "リリース情報": {
        "hum0034.v1": {
          "Research ID": "hum0034.v1",
          "公開日": "2015/10/01",
          "内容": "Exome (NGS)",
          "description": "小細胞肺がんのホルマリン固定ないしメタノール固定された組織より抽出したゲノムDNAを用いたExome解析の結果をfastqファイルにて提供する。SureSelect Human All Exon V4+UTRs Kit（Agilent社）を用いて全エクソンを含む71Mb領域に絞り込み、Illumina社のHiSeq 2000による100-bpペアエンドシークエンスを行った。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0034.v1",
      "DATA": {
        "JGAS000037": {
          "Data Set ID": "JGAS000037",
          "Type of Data": "Exome (NGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/10/01"
        }
      },
      "SUMMARY": {
        "Aims": "Identifying new therapeutic targets of small cell lung cancer (SCLC), genome-wide mutation analysis has been performed.",
        "Methods": "Genomic DNA was extracted from formalin-fixed or methanol-fixed tissue samples. 71 Mb of DNA fragments containing whole coding exons were concentrated using SureSelect Human All Exon V4+UTRs Kit (Agilent Technologies) followed by 100-bp paired end sequencing by HiSeq 2000 (Illumina).",
        "Participants/Materials": "51 of 1042 cases of pathologically diagnosed small seen lung cancer that were registered to National Cancer Hospital East Lung Cancer Database in 1992-2012, and which surgically resected or biopsy samples were suitable for DNA extraction for further analyses."
      },
      "MOLECULAR DATA": {
        "JGAS000037": {
          "Participants/Materials": "51 SCLCs",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "Genomic DNA extracted from formalin-fixed or methanol-fixed tissue samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V4+UTRs Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000037",
          "Total Data Volume": "3 TB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koichi Goto",
        "Affiliation": "Department of Thoracic Oncology, National Cancer Center Hospital East",
        "Project / Group Name": "Development of molecular targeted therapy for small cell lung cancer by comprehensive genome analysis",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Development of molecular targeted therapy for small cell lung cancer by comprehensive genome analysis",
            "Project Number": "JP15cm0106063"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.",
          "DOI": "doi: 10.1097/JTO.0000000000000250",
          "Data Set ID": "JGAD000037"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Anton Berns": {
          "Principal Investigator": "Anton Berns",
          "Affiliation": "The Netherlands Cancer Institute, Division of Molecular Genetics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000037"
        },
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000037"
        }
      },
      "Release Note": {
        "hum0034.v1": {
          "Research ID": "hum0034.v1",
          "Release Date": "2015/10/01",
          "Type of Data": "Exome (NGS)",
          "description": "DNAs extracted formalin-fixed or methanol-fixed tissue samples of small seen lung cancer were used for the whole exome sequencing (fastq files). 71 Mb of DNA fragments containing whole coding exons were concentrated using SureSelect Human All Exon V4+UTRs Kit (Agilent Technologies) followed by 100-bp paired end sequencing by HiSeq 2000 (Illumina).\nNote:\n"
        }
      }
    }
  },
  "hum0033.v1": {
    "ja": {
      "NBDC Research ID": "hum0033.v1",
      "データ": {
        "DRA003516": {
          "データID": "DRA003516",
          "内容": "NGS (RNA-seq)",
          "制限": "非制限公開",
          "公開日": "2015/04/28"
        }
      },
      "研究内容の概要": {
        "目的": "ヒト唾液には直径が30～100nmの膜小胞であるエキソソームIとエキソソームIIが存在している。本研究では、エキソソームI、エキソソームIIおよび全唾液に含まれるlong RNA（protein-coding RNA and long non-coding RNA）の量の比較を実施することを目的としている。",
        "方法": "吐出法を用いて採取した唾液からエキソソームIとエキソソームIIを純化し、RNAを抽出した。Short non-coding RNAを除いたものをライブラリとし、次世代シークエンサーを用いてRNA量を検討した。",
        "対象": "日本人成人健常者1名の唾液から純化したエキソソームI、エキソソームIIおよび全唾液を使用した。",
        "URL": "http://pharm.thu.ac.jp/research/unit/makukinou.html"
      },
      "分子データ": {
        "DRA003516": {
          "対象": "日本人成人女性（健常者）1名の全唾液および\r\n唾液から純化したエキソソームIおよびエキソソームII（3検体）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Genome Analyzer IIx]",
          "ライブラリソース": "唾液から純化したエキソソームI、エキソソームIIおよび全唾液中のLong RNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "RampUP RNA amplification Kit（Genisphere）にてRNA増幅後にrandom primerにて逆転写を行い、末端修復、A付加、アダプターライゲーション後、200-400bpのcDNAをPCR増幅して作成した",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "36-51 bp",
          "DDBJ Sequence Read Archive ID": "DRA003516",
          "総データ量": "3.9 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "矢ノ下 良平",
        "所 属 機 関": "帝京平成大学・薬学部・薬学科",
        "プロジェクト/研究グループ名": "膜機能研究ユニット",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学技術振興機構 「産学共同シーズイノベーション化事業・顕在化ステージ」",
            "タイトル": "医薬品開発に応用できる生体成分由来ナノキャリアの開発",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing.",
          "DOI": "doi.org/10.1248/bpb.b12-00607",
          "データID": "DRA003516"
        },
        "2": {
          "タイトル": " ",
          "DOI": " ",
          "データID": " "
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0033.v1": {
          "Research ID": "hum0033.v1",
          "公開日": "2015/04/28",
          "内容": "NGS (RNA-seq)",
          "description": "このバージョンでは、日本人成人女性（健常人）の全唾液、唾液から純化したエキソソームIおよびエキソソームIIから抽出したRNAの内、short non-coding RNAを除いたものをライブラリとし、Genome Analyzer IIx（Illumina）にて配列を読んでいる（Single-end: 36-51 bp）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0033.v1",
      "DATA": {
        "DRA003516": {
          "Data Set ID": "DRA003516",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2015/05/01"
        }
      },
      "SUMMARY": {
        "Aims": "Human whole saliva (WS) contains two types of exosomes (exosome I and exosome II) that are small membrane vesicle (30-100 nm in diameter). To clarify the host defense functions of exosomes, we investigated long RNA components (protein-coding RNAs and long non-coding RNAs) of exosome I, exosome II, and WS by next generation sequencing.",
        "Methods": "Human whole saliva was collected by discharge. Long RNA components (protein-coding RNA and long non-coding RNA) of exosome I, exosome II, and WS were analyzed by next generation sequencing.",
        "Participants/Materials": "Human whole saliva was collected from one Japanese healthy female volunteer with written informed consent.",
        "URL": "http://pharm.thu.ac.jp/research/unit/makukinou.html"
      },
      "MOLECULAR DATA": {
        "DRA003516": {
          "Participants/Materials": "One Japanese healthy female volunteer",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Genome Analyzer IIx]",
          "Library Source": "Long RNA components (protein-coding RNA and long non-coding RNA) of exosome I, exosome II, and WS",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Isolated RNA samples from exosome I, exosome II, and WS were amplified using the RampUP RNA Amplification Kit (Genisphere, PA, USA). cDNAs were generated using the amplified sense RNA, according to the manufacturer (Illumina Inc., CA, USA). The cDNA fraction in the range of 200–400 nucleotides was extracted and amplified by PCR.",
          "Fragmentation Method": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "36-51 bp",
          "DDBJ Sequence Read Archive ID": "DRA003516",
          "Total Data Volume": "3.9 GB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Ryohei Yanoshita",
        "Affiliation": "Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Teikyo Heisei University",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Japan Science and Technology Agency (JST) Industry-academia Joint Seeds Innovation Project",
            "Title": "Development of a nanocarrier derived from biogenic substances for application to drug development.",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing.",
          "DOI": "doi.org/10.1248/bpb.b12-00607",
          "Data Set ID": "DRA003516"
        },
        "2": {
          "Title": "-",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0033.v1": {
          "Research ID": "hum0033.v1",
          "Release Date": "2015/05/01",
          "Type of Data": "NGS (RNA-seq)",
          "description": "In this version, total RNAs were extracted from human whole saliva (WS) and two types of salivary exosomes (exosome I and exosome II) purified from WS of a single healthy female Japanese (38 years old) and short RNA fraction was removed from total RNAs. cDNA library was constructed from the resulting RNAs. The cDNA was sequenced for 51 cycles, single-end, on the Illumina Genome Analyzer IIx. The primer/adapter sequences of the read sequences were removed and the trimmed reads with lengths shorter than 36 bases were discarded.\nNote:\n"
        }
      }
    }
  },
  "hum0032.v1": {
    "ja": {
      "NBDC Research ID": "hum0032.v1",
      "データ": {
        "JGAS000026": {
          "データID": "JGAS000026",
          "内容": "NGS（PBAT-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/07/22"
        },
        "JGAS000027": {
          "データID": "JGAS000027",
          "内容": "NGS（ChIP-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/07/22"
        },
        "JGAS000028": {
          "データID": "JGAS000028",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/07/22"
        }
      },
      "研究内容の概要": {
        "目的": "国際ヒトエピゲノムコンソーシアム（The International Human Epigenome Consortium: IHEC）に参画し、年齢・性別の異なる複数の日本人検体から得られた正常細胞等の高品質な標準エピゲノムプロファイルを取得し、データを広く公開して研究基盤形成に貢献する。",
        "方法": "肝部分切除術検体から純化した肝細胞を対象とするPBAT-seq解析、ChIP-seq解析、RNA-seq解析",
        "対象": "肝部分切除術検体から純化した肝細胞 8種類（正常：6例、B型肝炎ウイルス感染陽性：1症例、C型肝炎ウイルス感染陽性：1症例）",
        "URL": "https://pathology.med.keio.ac.jp/"
      },
      "分子データ": {
        "JGAS000026": {
          "対象": "肝部分切除術検体から純化した肝細胞 8種類（正常6検体、B型肝炎ウィルス感染陽性1検体、C型肝炎ウィルス感染陽性1検体）",
          "規模": "PBAT-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "肝部分切除術検体から純化した肝細胞",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Post-Bisulfite Adaptor-Tagging（PBAT）法\r\n（http://crest-ihec.jp/epigenome/index.html）",
          "断片化の方法": "Post-bisulfite adaptor-tagging（PBAT）法による（Bisulfite変換に伴うDNA切断）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000026",
          "総データ量": "76 GB（fastq [8664 files / 16,901,103,593 reads]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000027": {
          "対象": "肝部分切除術検体から純化した肝細胞 8種類（正常6検体、B型肝炎ウィルス感染陽性1検体、C型肝炎ウィルス感染陽性1検体）",
          "規模": "ChIP-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "肝部分切除術検体から純化した肝細胞",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "抗H3K4me3、H3K9me3、H3K27me3、H3K27ac、H3K4me1、H3K36me3モノクローナル抗体（東京工業大学木村宏教授提供）を用いて免疫沈降",
          "断片化の方法": "超音波断片化（BRANSON SLPe, amplitude 40%, on 30 sec and off 30 sec, 10 cycles, on ice）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "36 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000027",
          "総データ量": "90 GB（fastq [601 files / 2,299,849 reads]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000028": {
          "対象": "肝部分切除術検体から純化した肝細胞 8種類（正常6検体、B型肝炎ウィルス感染陽性1検体、C型肝炎ウィルス感染陽性1検体）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "肝部分切除術検体から純化した肝細胞",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq RNA Library Preparation Kit v2 ないし\r\nSureSelect Strand Specific RNA kit",
          "断片化の方法": "二価陽イオンと温度（94℃） によるRNAの断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000028",
          "総データ量": "76 GB（fastq [644 files / 1,092,677,168 reads）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "金井 弥栄",
        "所 属 機 関": "慶應義塾大学医学部病理学教室",
        "プロジェクト/研究グループ名": "革新的先端研究開発支援事業（AMED-CREST） 国際ヒトエピゲノムコンソーシアム（IHEC）金井チーム",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業（AMED-CREST）",
            "タイトル": "「エピゲノム研究に基づく診断・治療へ向けた新技術の創出」領域",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Amplification-free whole-genome bisulfite sequencing by post-bisulfite adaptor tagging.",
          "DOI": "doi: 10.1093/nar/gks454",
          "データID": "JGAD000026"
        },
        "2": {
          "タイトル": "Multilayer-omics analyses of human cancers: exploration of biomarkers and drug targets based on the activities of the International Human Epigenome Consortium.",
          "DOI": "doi: 10.3389/fgene.2014.00024",
          "データID": "-"
        }
      },
      "制限公開データの利用者一覧": {
        "Guillaume Bourque": {
          "研究代表者": "Guillaume Bourque",
          "所属機関": "McGill University / McGill University & Genome Quebec Innovation Center",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000026\r\nJGAD000027\r\nJGAD000028"
        },
        "Martin Hirst": {
          "研究代表者": "Martin Hirst",
          "所属機関": "BC Cancer",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000026\r\nJGAD000027\r\nJGAD000028"
        },
        "Quan Long": {
          "研究代表者": "Quan Long",
          "所属機関": "University of Calgary, Faculty of Medicine, Department of Biochemistry & Molecular Biology",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000026\r\nJGAD000027\r\nJGAD000028"
        },
        "Anton Wellstein": {
          "研究代表者": "Anton Wellstein",
          "所属機関": "Georgetown University School of Medicine, Department of Oncology",
          "研究題目": "",
          "利用データID": "Biomarkers to evaluate immune related adverse events (irAEs) due to treatment with immune checkpoint inhibitors (ICIs)",
          "利用期間": "JGAD000026"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000028"
        }
      },
      "リリース情報": {
        "hum0032.v1": {
          "Research ID": "hum0032.v1",
          "公開日": "2016/07/22",
          "内容": "NGS（PBAT-seq、ChIP-seq、RNA-seq）",
          "description": "肝部分切除術検体から純化した肝細胞から抽出したDNAを用いWGBS解析した結果をFastqファイルにて提供する。Post-Bisulfite Adaptor-Tagging（PBAT）法（http://crest-ihec.jp/epigenome/index.html）でライブラリ作製し、HiSeq 2000（Illumina）によりシングルエンドシークエンシングを行っている。\n肝部分切除術検体から純化した肝細胞から抽出したDNAを用いChIP-seq解析した結果をFastqファイルにて提供する。抗H3K4me3,H3K9me3, H3K27me3, H3K27ac, H3K4me1, H3K36me3モノクローナル抗体（東京工業大学木村宏教授提供）を用いて免疫沈降後ChIP-Seqライブラリを作製し、HiSeq 2000もしくは2500（Illumina）によりシークエンシング行っている。\n肝部分切除術検体から純化した肝細胞から抽出したDNAを用いRNA-seq解析した結果をFastqファイルにて提供するIllumina TruSeq RNA Library Preparation Kit v2 ないし Agilent SureSelect Strand Specific RNA kitによるライブラリ作製、HiSeq 2000（Illumina）での100bpペアエンドシークエンシングを行っている。 \nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0032.v1",
      "DATA": {
        "JGAS000026": {
          "Data Set ID": "JGAS000026",
          "Type of Data": "NGS (PBAT-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/07/22"
        },
        "JGAS000027": {
          "Data Set ID": "JGAS000027",
          "Type of Data": "NGS (ChIP-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/07/22"
        },
        "JGAS000028": {
          "Data Set ID": "JGAS000028",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/07/22"
        }
      },
      "SUMMARY": {
        "Aims": "The aim of this study is to participate in International Human Epigenome Consortium (http://ihec-epigenomes.org/), through disclosure of quality reference epigenome profiles in normal and diseased cells obtained from multiple Japanese people.",
        "Methods": "ChIP-Seq, RNA-seq and PBAT-seq analysis about normal and diseased human hepatocytes purified from partial hepatectomy specimens.",
        "Participants/Materials": "Normal and diseased human hepatocytes purified from partial hepatectomy specimens (normal human hepatocytes: 6, hepatitis B virus (HBV)-positive human hepatocyte 1 and hepatitis C virus (HCV)-positive human hepatocyte 1.",
        "URL": "https://pathology.med.keio.ac.jp/home-e/"
      },
      "MOLECULAR DATA": {
        "JGAS000026": {
          "Participants/Materials:": "Normal and diseased human hepatocytes purified from partial hepatectomy specimens\r\n- Normal human hepatocytes: 6\r\n- HBV-positive human hepatocyte 1: 1\r\n- HCV-positive human hepatocyte 1: 1",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNAs extracted from normal and diseased human hepatocytes purified from partial hepatectomy specimens",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Post-Bisulfite Adaptor-Tagging (PBAT) method\r\n(http://crest-ihec.jp/english/epigenome/index.html)",
          "Fragmentation Methods": "PBAT method: fragmentation due to bisulfite conversion",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000026",
          "Total Data Volume": "76 GB (fastq [8664 files / 16,901,103,593 reads])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000027": {
          "Participants/Materials:": "Normal and diseased human hepatocytes purified from partial hepatectomy specimens\r\n- Normal human hepatocytes: 6\r\n- HBV-positive human hepatocyte 1: 1\r\n- HCV-positive human hepatocyte 1: 1",
          "Targets": "ChIP-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "gDNAs extracted from normal and diseased human hepatocytes purified from partial hepatectomy specimens",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Anti H3K4me3, H3K9me3, H3K27me3, H3K27ac, H3K4me1 and H3K36me3 mouse monoclonal antibodies, kindly provided by Dr. Hiroshi Kimura, Tokyo Institute of Technology, were used for immunoprecipitation.",
          "Fragmentation Methods": "Ultrasonic fragmentation (BRANSON SLPe, amplitude 40%, on 30 sec and off 30 sec, 10 cycles, on ice)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "36 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000027",
          "Total Data Volume": "90 GB (fastq [601 files / 2,299,849 reads])",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000028": {
          "Participants/Materials:": "Normal and diseased human hepatocytes purified from partial hepatectomy specimens\r\n- Normal human hepatocytes: 6\r\n- HBV-positive human hepatocyte 1: 1\r\n- HCV-positive human hepatocyte 1: 1",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source/span>": "Total RNA extracted from normal and diseased human hepatocytes purified from partial hepatectomy specimens.",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq RNA Library Preparation Kit v2 (Illumina)\r\nSureSelect Strand Specific RNA kit (Agilent)",
          "Fragmentation Methods": "Purified poly-A RNA was fragmented with heat treatment and divalent cations.",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000028",
          "Total Data Volume": "76 GB (fastq [644 files / 1,092,677,168 reads])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yae Kanai",
        "Affiliation": "Department of Pathology, Keio University School of Medicine",
        "Project / Group Name": "AMED-CREST International Human Epigenome Consortium (IHEC) Team Kanai",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST)",
            "Title": "Development of Fundamental Technologies for Diagnosis and Therapy Based upon Epigenome Analysis",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Amplification-free whole-genome bisulfite sequencing by post-bisulfite adaptor tagging.",
          "DOI": "doi: 10.1093/nar/gks454",
          "Data Set ID": "JGAD000026"
        },
        "2": {
          "Title": "Multilayer-omics analyses of human cancers: exploration of biomarkers and drug targets based on the activities of the International Human Epigenome Consortium.",
          "DOI": "doi: 10.3389/fgene.2014.00024",
          "Data Set ID": "-"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Guillaume Bourque": {
          "Principal Investigator": "Guillaume Bourque",
          "Affiliation": "McGill University / McGill University & Genome Quebec Innovation Center",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000026\r\nJGAD000027\r\nJGAD000028"
        },
        "Martin Hirst": {
          "Principal Investigator": "Martin Hirst",
          "Affiliation": "BC Cancer",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000026\r\nJGAD000027\r\nJGAD000028"
        },
        "Quan Long": {
          "Principal Investigator": "Quan Long",
          "Affiliation": "University of Calgary, Faculty of Medicine, Department of Biochemistry & Molecular Biology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000026\r\nJGAD000027\r\nJGAD000028"
        },
        "Anton Wellstein": {
          "Principal Investigator": "Anton Wellstein",
          "Affiliation": "Georgetown University School of Medicine, Department of Oncology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Biomarkers to evaluate immune related adverse events (irAEs) due to treatment with immune checkpoint inhibitors (ICIs)",
          "Period of Data Use": "JGAD000026"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000028"
        }
      },
      "Release Note": {
        "hum0032.v1": {
          "Research ID": "hum0032.v1",
          "Release Date": "2016/07/22",
          "Type of Data": "NGS (PBAT-seq, ChIP-seq, RNA-seq)",
          "description": "gDNAs extracted from normal and diseased human hepatocytes purified from partial hepatectomy specimens were used for analyses (fastq format files). After library preparation by post-bisulfite adaptor-tagging (PBAT, http://crest-ihec.jp/english/epigenome/index.html) and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Single-end).\nAnti H3K4me3,H3K9me3, H3K27me3, H3K27ac, H3K4me1 and H3K36me3 mouse monoclonal antibodies, kindly provied Dr. Hiroshi Kimura, Tokyo Institute of Technology, were used for immunoprecipitation. ChIP-Seq libraries were sequenced using the HiSeq 2000 or 2500 (Illumina) platform.\nTotal RNAs extracted from normal and diseased human hepatocytes purified from partial hepatectomy specimens were used for whole transcriptome-sequencing analysis (fastq format files). cDNAs were prepared using the TruSeq RNA Library Preparation Kit v2 (Illumina) or SureSelect Strand Specific RNA kit (Agilent) and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Paired-end). \nNote:\n"
        }
      }
    }
  },
  "hum0031.v1": {
    "ja": {
      "NBDC Research ID": "hum0031.v1",
      "データ": {
      },
      "研究内容の概要": {
        "目的": "日本人の健常者ならびに精神疾患患者の脳画像データを収載したデータベースを整備て研究者コミュニティに提供することで、病態解明研究を活性化する。",
        "方法": "国内３カ所の臨床施設にてT1強調脳構造画像データと臨床情報を収集し、匿名化と品質チェックを実施。",
        "対象": "健常者129例、統合失調症37症例、単極性うつ病8症例、双極性障害2症例",
        "URL": "http://npsy.umin.jp/、http://cbsn-mri.umin.jp/"
      },
      "分子データ": {
      },
      "提供者情報": {
        "研究代表者": "笠井 清登",
        "所 属 機 関": "東京大学大学院 医学系研究科 精神医学分野",
        "プロジェクト/研究グループ名": "包括型脳科学研究推進支援ネットワーク・脳画像総合データベース支援活動",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "国立研究開発法人科学技術振興機構 ライフサイエンスデータベース統合推進事業（統合化推進プログラム）",
            "タイトル": "ヒト脳疾患画像データベース統合化研究",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "安田 実樹大": {
          "研究代表者": "安田 実樹大",
          "所属機関": "関西学院大学",
          "研究題目": "日本",
          "利用データID": "fMRIデータに基づく脳内ネットワークの分析手法の構築",
          "利用期間": "JGAD000042,JGAD000043,JGAD000044,JGAD000045"
        }
      },
      "リリース情報": {
        "hum0031.v1": {
          "Research ID": "hum0031.v1",
          "公開日": "2015/11/20",
          "内容": "日本人の健常者ならびに精神疾患患者の脳画像データ",
          "description": "このバージョンでは、健常者129例、統合失調症37症例、単極性うつ病8症例、双極性障害2症例のT1強調脳構造画像データと臨床情報を公開した。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0031.v1",
      "DATA": {
      },
      "SUMMARY": {
        "Aims": "Constructing database of magnetic resonance imaging of the brain and the ancillary clinical information for multisite collaboration studies",
        "Methods": "T1-weighted whole-brain structural images with clinical information of individuals with schizophrenia, mood disorders (unipolar and bipolar disorders) and healthy controls were acquired at three clinical sites in Japan. The data were anonymized and checked for quality.",
        "Participants/Materials": "176 cases (normal control: 129; schizophrenia: 37; unipolar disorder: 8; biporlar disorder: 2)",
        "URL": " http://npsy.umin.jp/, http://cbsn-mri.umin.jp/"
      },
      "MOLECULAR DATA": {
      },
      "DATA PROVIDER": {
        "Principal Investigator": " Kiyoto Kasai",
        "Affiliation": "Department of Neuropsychiatry, Graduate School of Medicine, the University of Tokyo",
        "Project / Group Name": " Comprehensive Brain Science Network (CBSN)",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "Life Science Database Integration Project (Database Integration Coordination Program) of Japan Science and Technology Agency",
            "Title": "Study on integration of the human brain related diseases imaging data",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": " ",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Mikihiro Yasuda": {
          "Principal Investigator": "Mikihiro Yasuda",
          "Affiliation": "Kwansei Gakuin University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of a method for analyzing brain networks based on fMRI data",
          "Period of Data Use": "JGAD000042,JGAD000043,JGAD000044,JGAD000045"
        }
      },
      "Release Note": {
        "hum0031.v1": {
          "Research ID": "hum0031.v1",
          "Release Date": "2015/11/20",
          "Type of Data": "Neuroimaging data of Japanese sample of healthy people and patients with neuropsychiatric disorders",
          "description": "T1-weighted whole-brain structural images with clinical information of 37 individuals with schizophrenia, 8 unipolar disorders, 2 bipolar disorders and 129 healthy controls were released.\nNote:\n"
        }
      }
    }
  },
  "hum0030.v1": {
    "ja": {
      "NBDC Research ID": "hum0030.v1",
      "データ": {
        "JGAS000022": {
          "データID": "JGAS000022",
          "内容": "がんゲノムコピー数解析",
          "制限": "制限公開（Type I）",
          "公開日": "2015/04/21"
        }
      },
      "研究内容の概要": {
        "目的": "卵巣明細胞腺がんと他の卵巣がん組織型におけるゲノムコピー数の違いを比較することで、卵巣明細胞腺がんの分子生物学的特徴を明らかにする。",
        "方法": "ゲノムワイドSNPタイピングアレイを使用し約26万個のSNPプローブの蛍光強度を測定し、がんと正常を比較することでコピー数異常を検出する。",
        "対象": "卵巣がん57症例（腫瘍組織・末梢血、計114検体）"
      },
      "分子データ": {
        "JGAS000022": {
          "対象": "卵巣がん：57症例 \r\n（卵巣明細胞腺がん：31症例、漿液性腺がん：14症例、類内膜腺がん：12症例）",
          "規模": "genome wide CNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [GeneChip Human Mapping 250K Nsp Array]",
          "ソース": "卵巣がん切片から腫瘍組織および非腫瘍組織を取り分け、DNAを抽出",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "GeneChip Human Mapping 250K Nsp Array",
          "コピー数決定アルゴリズム（ソフトウェア）": "genome imbalance map（GIM）algorithm（doi:10.1016/j.bbrc.2005.06.040）",
          "フィルタリング": "-",
          "コピー数変異数(QC後)": "262,264 CNVs",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000022",
          "総データ量": "17.5 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "織田 克利",
        "所 属 機 関": "東京大学医学部 産科婦人科学教室",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "3": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 次世代がん研究シーズ戦略的育成プログラム（P-DIRECT）",
            "タイトル": "「分子プロファイリングによる新規標的同定を通じた難治がん治療法開発」 （進行性卵巣がんの治療感受性を規定する遺伝子変異の同定）",
            "研究課題番号": "11114014"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas",
          "DOI": "doi: 10.1371/journal.pone.0128066",
          "データID": "JGAD000022"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "小西 郁生": {
          "研究代表者": "小西 郁生",
          "所属機関": "京都大学大学院医学研究科",
          "研究題目": "",
          "利用データID": "JGAD000022",
          "利用期間": "2015/07/13-2017/03/31"
        },
        "万代 昌紀": {
          "研究代表者": "万代 昌紀",
          "所属機関": "京都大学医学部医学研究科婦人科学産科学教室",
          "研究題目": "多様な臨床情報を考慮した婦人科悪性腫瘍患者の尾ミックス解析（全ゲノム・全トランスクリプト-ム・プロテオーム・メタボローム解析）による個別化治療の探索",
          "利用データID": "JGAD000022",
          "利用期間": "2018/10/04-2025/03/31"
        }
      },
      "リリース情報": {
        "hum0030.v1": {
          "Research ID": "hum0030.v1",
          "公開日": "2015/04/21",
          "内容": "卵巣がん57症例のコピー数解析",
          "description": "Affymetrix [GeneChip Human Mapping 250K Nsp Array]を使用した卵巣がん切片の腫瘍組織および末梢血における約26万SNPs情報をCELファイルにて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0030.v1",
      "DATA": {
        "JGAS000022": {
          "Data Set ID": "JGAS000022",
          "Type of Data": "Copy Number Variations in cancer genome",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/04/21"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify the molecular biological difference between ovarian clear cell carcinoma and other histological subtypes carcinomas by comparing the copy number variants.",
        "Methods": "Gene Chip Human Mapping 250K Nsp Arrays were used for detecting the signal intensity of about 260 thousands SNPs and intensities of ovarian clear cell carcinoma were compared to the ones of non-carcinoma.",
        "Participants/Materials": "57 ovarian carcinoma patients (ovarian cancer cells and peripheral blood cells: total 114 samples)"
      },
      "MOLECULAR DATA": {
        "JGAS000022": {
          "Participants/Materials:": "Surgical samples were obtained from 57 patients\r\n(31 clear cell carcinomas, 14 serous adenocarcinomas, and 12 endometrioid adenocarcinomas)",
          "Targets": "genome wide CNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [GeneChip Human Mapping 250K Nsp Array]",
          "Source": "gDNAs extracted from ovarian cancer cells and peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "GeneChip Human Mapping 250K Nsp Array",
          "Algorithm for detecting CNVs (software)": "genome imbalance map (GIM) algorithm (doi:10.1016/j.bbrc.2005.06.040)",
          "CNV number": "262,264 CNVs",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000022",
          "Total Data Volume": "17.5 GB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Katsutoshi Oda",
        "Affiliation": "Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "3": {
            "Name": "Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Japan Agency for Medical Research and Development (AMED)",
            "Title": "Development of the Intractable Cancer Therapies through the New Target Identification by the Molecular Profiling (The Identification of the Gene Variation to Regulate the Treatment Sensitivity of the Progressive Ovarian Cancer)",
            "Project Number": "11114014"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas",
          "DOI": "doi: 10.1371/journal.pone.0128066",
          "Data Set ID": "JGAD000022"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Ikuo Konishi": {
          "Principal Investigator": "Ikuo Konishi",
          "Affiliation": "Kyoto University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "JGAD000022",
          "Period of Data Use": "2015/07/13-2017/03/31"
        },
        "Masaki Mandai": {
          "Principal Investigator": "Masaki Mandai",
          "Affiliation": "Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics",
          "Research Title": "Integrated analyses of omics (genomics, transcriptomics, proteomics and metabolomics) associated with clinical variables for developing indivisualizedtreatment in gynecological malignancy",
          "Data in Use (Dataset ID)": "JGAD000022",
          "Period of Data Use": "2018/10/04-2025/03/31"
        }
      },
      "Release Note": {
        "hum0030.v1": {
          "Research ID": "hum0030.v1",
          "Release Date": "2015/04/21",
          "Type of Data": "CNV analysis using 57 ovarian carcinoma patients",
          "description": "Signal intensities for 260K CNVs of 57 ovarian carcinomas were decided by using of GeneChip Human Mapping 250K Nsp Arrays (Affymetrix) (CEL files).\nNote:\n"
        }
      }
    }
  },
  "hum0029.v2": {
    "ja": {
      "NBDC Research ID": "hum0029.v2",
      "データ": {
        "hum0029.v1.freq.v1": {
          "データID": "hum0029.v1.freq.v1",
          "内容": "SJSのGWAS",
          "制限": "非制限公開",
          "公開日": "2016/03/09"
        },
        "hum0029.v2.var.v1": {
          "データID": "hum0029.v2.var.v1",
          "内容": "SJS/TENのGWAS",
          "制限": "非制限公開",
          "公開日": "2020/12/21"
        }
      },
      "研究内容の概要": {
        "目的": "感冒薬を服用することによって発症するスティーブンス・ジョンソン症候群/中毒性表皮壊死融解症（SJS/TEN）の感受性遺伝子の同定",
        "方法": "Affymetrix Axiom ASI 1 Arrayを使用して約60万個の一塩基多型（Single Nucleotide Polymorphisms：SNPs）の遺伝子型を決定後ゲノムワイド関連解析（Genome-Wide Association Study：GWAS）を実施。また、NGSによる全ゲノム配列解析より検出されたバリアント（SNV、INDEL、構造多型）を用いたGWASを実施。",
        "対象": "SJS症例、SJS/TEN症例、対照健常者",
        "URL": "http://frontier-medueta.com/"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "hum0029.v1.freq.v1": {
          "対象": "SJS：117症例\r\n対照健常者：691名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "AXIOM 2.0 Reagent Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（Genotyping Console ver. 4.2.0.26）",
          "フィルタリング": "Sample Call rate < 0.95, SNP call rate < 0.97, HWE P < 0.001",
          "マーカー数(QC後)": "449,205 SNPs （hg19）",
          "NBDC Dataset ID": "hum0029.v1.freq.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "130 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0029.v2.var.v1": {
          "対象": "SJS/TEN（ICD10：L511）：133症例\r\n対照健常者：418名",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "TruSeq® DNA PCR-Free Sample Prep Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GATK3.8 HaplotypeCaller, MELT 2.1.4, LUMPY 0.2.3, SVTyper 0.6.1",
          "フィルタリング": "variant call rates < 95%, MAF < 1%, or HWE p-value < 1×10^-5",
          "マーカー数(QC後)": "7,173,860 variants（hg19）",
          "NBDC Dataset ID": "hum0029.v2.var.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "122 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "上田 真由美",
        "所 属 機 関": "京都府立医科大学　医学研究科",
        "プロジェクト/研究グループ名": "感覚器未来医療学および眼科学教室",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援",
            "研究課題番号": "221S0002"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement.",
          "DOI": "doi: 10.1016/j.jaci.2014.12.1916",
          "データID": "hum0029.v1.freq.v1"
        },
        "2": {
          "タイトル": "Mapping of susceptible variants for cold medicine-related Stevens-Johnson syndrome by whole-genome resequencing",
          "DOI": "doi: 10.1038/s41525-021-00171-2",
          "データID": "hum0029.v2.var.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0029.v2": {
          "Research ID": "hum0029.v2",
          "公開日": "2020/12/21",
          "内容": "スティーブンス・ジョンソン症候群/中毒性表皮壊死融解症 （SJS/TEN）133症例、対照健常者418名のゲノムワイド関連解析",
          "description": "日本人SJS/TEN133症例、および日本人対照健常者418名の717,386 variantsの統計情報。\n遺伝子型決定には、Illumina [HiSeq X Ten]を使用している。\n"
        },
        "hum0029.v1": {
          "Research ID": "hum0029.v1",
          "公開日": "2016/03/09",
          "内容": "スティーブンス・ジョンソン症候群（SJS）117症例、対照健常者691名のゲノムワイド関連解析",
          "description": "日本人SJS117症例、および日本人対照健常者691名の449,205 SNPsの統計情報。\n遺伝子型決定には、Affymetrix [Axiom Genome-Wide ASI 1 Array]を使用している。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0029.v2",
      "DATA": {
        "hum0029.v1.freq.v1": {
          "Data Set ID": "hum0029.v1.freq.v1",
          "Type of Data": "GWAS for SJS",
          "Criteria": "Unrestricted-access",
          "Release Date": "2016/03/09"
        },
        "hum0029.v2.var.v1": {
          "Data Set ID": "hum0029.v2.var.v1",
          "Type of Data": "GWAS for SJS/TEN",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/12/21"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of new susceptibility gene(s) to cole medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)",
        "Methods": "SNP-based and SNV/INDEL/structural variation-based genome-wide association study.",
        "Participants/Materials": "Patients with cold medicine-related SJS/TEN and healthy controls",
        "URL": "http://frontier-medueta.com/english/index.html"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "hum0029.v1.freq.v1": {
          "Participants/Materials:": "117 SJS patients and 691 healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Affymetrix [Axiom Genome-Wide ASI 1 Array]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "AXIOM 2.0 Reagent Kit",
          "Genotype Call Methods (software)": "Genotyping Console ver. 4.2.0.26",
          "Filtering Methods": "Sample Call rate < 0.95, SNP call rate < 0.97, HWE P < 0.001",
          "Marker Number (after QC)": "449,205 SNPs (hg19)",
          "NBDC Dataset ID": "hum0029.v1.freq.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "130 MB",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0029.v2.var.v1": {
          "Participants/Materials:": "133 SJS/TEN patients (ICD10: L511) and 418 healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Ten]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "TruSeq® DNA PCR-Free Sample Prep Kit",
          "Genotype Call Methods (software)": "GATK3.8 HaplotypeCaller, MELT 2.1.4, LUMPY 0.2.3, SVTyper 0.6.1",
          "Filtering Methods": "variant call rates < 95%, MAF < 1%, or HWE p-value < 1×10^-5",
          "Marker Number (after QC)": "7,173,860 variants (hg19)",
          "NBDC Dataset ID": "hum0029.v2.var.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "122 MB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Mayumi Ueta",
        "Affiliation": "Kyoto Prefectural University of Medicine",
        "Project / Group Name": "Department of Frontier Medical Science and Technology for Ophthalmology",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "Genome Science",
            "Project Number": "221S0002"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement.",
          "DOI": "doi: 10.1016/j.jaci.2014.12.1916",
          "Data Set ID": "hum0029.v1.freq.v1"
        },
        "2": {
          "Title": "Mapping of susceptible variants for cold medicine-related Stevens-Johnson syndrome by whole-genome resequencing",
          "DOI": "doi: 10.1038/s41525-021-00171-2",
          "Data Set ID": "hum0029.v2.var.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0029.v2": {
          "Research ID": "hum0029.v2",
          "Release Date": "2020/12/21",
          "Type of Data": "Genome-wide association study for 133 SJS/TEN patients and 418 controls in Japanese",
          "description": "Genome-wide association study for 133 SJS/TEN patients and 418 controls were performed using 7,173,860 variants (Illumina [HiSeq X Ten]). \n"
        },
        "hum0029.v1": {
          "Research ID": "hum0029.v1",
          "Release Date": "2016/03/09",
          "Type of Data": "SNP-based genome-wide association study for 117 SJS patients and 691 controls in Japanese",
          "description": "SNP-based genome-wide association study for 117 SJS patients and 691 controls were performed using 449,205 SNPs (Affymetrix [Axiom Genome-Wide ASI 1 Array]). \nNote:\n"
        }
      }
    }
  },
  "hum0028.v2": {
    "ja": {
      "NBDC Research ID": "hum0028.v2",
      "データ": {
        "JGAS000018": {
          "データID": "JGAS000018",
          "内容": "HLA-DQA1領域の遺伝子型情報およびHLA-DQA1アリル情報の追加",
          "制限": "制限公開（Type I）",
          "公開日": "2018/06/05"
        }
      },
      "研究内容の概要": {
        "目的": "HLA遺伝子型推定に用いる日本人健常者参照データの作成",
        "対象": "日本人健常者908名",
        "URL": "http://www.ims.riken.jp/"
      },
      "分子データ": {
        "JGAS000018": {
          "対象": "日本人健常者：908名",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "HLA領域（chr6:29,000,000-34,000,000, GRCh37）\r\n対象変異数：8817個\r\n（SNP：7149個, HLA 2-digit/4-digit：226個, HLA amino acid polymorphisms：1442個）\r\nHLA座位：HLA-A, -C, -B, -DRB1, -DQA1, -DQB1, -DPA1, -DPB1",
          "Platform": "Illumina [HumanOmniExpress BeadChip, HumanExome BeadChip, Immunochip, HumanHap550v3 Genotyping BeadChip], WAKFlow HLA typing kit",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina [HumanOmniExpress BeadChip, HumanExome BeadChip, Immunochip, HumanHap550v3 Genotyping BeadChip], WAKFlow HLA typing kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "フィルタリング": "Sample Call rate < 0.98, SNP call rate < 0.99, HWE-P < 1x10^-6",
          "マーカー数(QC後)": "8817 SNPs（GRCh37）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000018",
          "総データ量": "50 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "久保 充明",
        "所 属 機 関": "理化学研究所 統合生命医科学研究センター",
        "プロジェクト/研究グループ名": "基盤技術開発研究チーム、統計解析研究チーム",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "文部科学省 科学技術試験研究委託事業費",
            "タイトル": "オーダーメイド医療の実現プログラム（第3期）",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Construction of a population-specific HLA imputation reference panel and its application to Graves’ disease risk in Japanese",
          "DOI": "doi:10.1038/ng.3310",
          "データID": "JGAD000018"
        }
      },
      "制限公開データの利用者一覧": {
        "河野 隆志": {
          "研究代表者": "河野 隆志",
          "所属機関": "国立がん研究センター研究所",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000018"
        },
        "三森 経世": {
          "研究代表者": "三森 経世",
          "所属機関": "京都大学医学研究科臨床免疫学講座",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000018"
        },
        "野口 恵美子": {
          "研究代表者": "野口 恵美子",
          "所属機関": "筑波大学 医学医療系遺伝医学",
          "研究題目": "日本",
          "利用データID": "炎症性肺疾患の遺伝素因に関する研究",
          "利用期間": "JGAD000018"
        },
        "岡田 随象": {
          "研究代表者": "岡田 随象",
          "所属機関": "大阪大学大学院医学系研究科・遺伝統計学",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000018"
        },
        "野入 英世": {
          "研究代表者": "野入 英世",
          "所属機関": "東京大学・医学部付属病院",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000018"
        },
        "桐野 洋平": {
          "研究代表者": "桐野 洋平",
          "所属機関": "横浜市立大学医学部 幹細胞免疫制御内科学",
          "研究題目": "",
          "利用データID": "免疫チェックポイント阻害剤及び抗CTLA-4抗体による免疫関連有害事象発症の遺伝学的予測法の確立",
          "利用期間": "JGAD000018"
        },
        "莚田 泰誠": {
          "研究代表者": "莚田 泰誠",
          "所属機関": "理化学研究所 生命医科学研究センター ファーマコゲノミクス研究チーム",
          "研究題目": "",
          "利用データID": "小麦アレルギーの遺伝子多型解析",
          "利用期間": "JGAD000018"
        },
        "吉藤 元": {
          "研究代表者": "吉藤 元",
          "所属機関": "京都大学大学院医学研究科 内科学講座臨床免疫学",
          "研究題目": "日本",
          "利用データID": "自己免疫疾患関連遺伝因子に関する研究",
          "利用期間": "JGAD000018"
        },
        "野口　恵美子": {
          "研究代表者": "野口　恵美子",
          "所属機関": "筑波大学 医学医療系遺伝医学",
          "研究題目": "",
          "利用データID": "食物アレルギーの発症要因の解明",
          "利用期間": "JGAD000018"
        },
        "福永 航也": {
          "研究代表者": "福永 航也",
          "所属機関": "国立医薬品食品衛生研究所 医薬安全科学部",
          "研究題目": "日本",
          "利用データID": "重篤な皮膚有害事象の診断・治療と遺伝子マーカーに関する研究",
          "利用期間": "JGAD000018"
        },
        "高地 雄太": {
          "研究代表者": "高地 雄太",
          "所属機関": "東京医科歯科大学 難治疾患研究所 ゲノム機能多様性分野",
          "研究題目": "日本",
          "利用データID": "機能性遺伝子多型の網羅的解析を介した多因子疾患の病態解明",
          "利用期間": "JGAD000018"
        }
      },
      "リリース情報": {
        "hum0028.v2": {
          "Research ID": "hum0028.v2",
          "公開日": "2018/06/05",
          "内容": "HLA-DQA1領域の遺伝子型情報およびHLA-DQA1アリル情報の追加",
          "description": "Illumina（HumanOmniExpress BeadChip, HumanExome BeadChip, Immunochip, HumanHap550v3 Genotyping BeadChip）を使用して決定した、日本人健常者908名のHLA領域の遺伝子型および、WAKFlow HLA typing kitを使用して決定したHLAアリル（7座位）情報に加えてシーケンス情報を基に決定したHLA-DQA1アリルの情報を、SNP2HLAソフトウェアの出力ファイル形式（.bed, .bgl.phased, .bim, .fam, .FRQ.frq, .markers）にて提供する。\n"
        },
        "hum0028.v1": {
          "Research ID": "hum0028.v1",
          "公開日": "2015/06/02",
          "内容": "HLA領域（7座位）の遺伝子型情報およびHLAアリル情報",
          "description": "Illumina（HumanOmniExpress BeadChip, HumanExome BeadChip, Immunochip, HumanHap550v3 Genotyping BeadChip）を使用して決定した、日本人健常者908名のHLA領域の遺伝子型および、WAKFlow HLA typing kitを使用して決定したHLAアリル（7座位）情報を、SNP2HLAソフトウェアの出力ファイル形式（.bed, .bgl.phased, .bim, .fam, .FRQ.frq, .markers）にて提供する。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0028.v2",
      "DATA": {
        "JGAS000018": {
          "Data Set ID": "JGAS000018",
          "Type of Data": "HLA-DQA1 alleles and SNPs were added",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/06/05"
        }
      },
      "SUMMARY": {
        "Aims": "Construction of the HLA imputation reference panel of the Japanese healthy controls",
        "Methods": "SNPs in the HLA region were genotyped by Illumina BeadChips (HumanOmniExpress BeadChip, HumanExome BeadChip, Immunochip, HumanHap550v3 Genotyping BeadChip) and HLA alleles (HLA-A/C/B/DRB1/DQA1/DQB1/DPA1/DPB1) were determined by WAKFlow HLA typing kit or sequence based method.",
        "Participants/Materials": "908 Japanese healthy controls",
        "URL": "http://www.ims.riken.jp/english/"
      },
      "MOLECULAR DATA": {
        "JGAS000018": {
          "Participants/Materials:": "908 Japanese healthy controls",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "HLA region (chr6:29,000,000-34,000,000, GRCh37)\r\n8817 polymorphisms\r\n(7149 SNPs, HLA 2-digit/4-digit polymorphisms: 226, HLA amino acid polymorphisms: 1442)",
          "Platform": "Illumina BeadChips [HumanOmniExpress BeadChip, HumanExome BeadChip, Immunochip, HumanHap550v3 Genotyping BeadChip] and WAKFlow HLA typing kit",
          "Source": "gDNAs extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina BeadChip Kits [HumanOmniExpress BeadChip, HumanExome BeadChip, Immunochip, HumanHap550v3 Genotyping BeadChip] and WAKFlow HLA typing kit",
          "Genotyping Call Methods (software)": "GenCall software (GenomeStudio)",
          "Filtering Methods": "Sample Call Rate < 0.98, SNP Call Rate < 0.99, HWE-P < 1x10^-6",
          "Marker Number (after QC)": "8817 SNPs (GRCh37)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000018",
          "Total Data Volume": "50 MB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Michiaki Kubo",
        "Affiliation": "RIKEN Center for Integrative Medical Science",
        "Project / Group Name": "Laboratory for Genotyping Development and Laboratory for Statistical Analysis",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Ministry of Education, Culture, Sports, Science and Technology in Japan",
            "Title": "Tailor-made Medical Treatment Program (the 3rd phase)",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Construction of a population-specific HLA imputation reference panel and its application to Graves’ disease risk in Japanese",
          "DOI": "doi:10.1038/ng.3310",
          "Data Set ID": "JGAD000018"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Takashi Kohno": {
          "Principal Investigator": "Takashi Kohno",
          "Affiliation": "National Cancer Center, Division of Genome Biology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000018"
        },
        "Tsuneyo Mimori": {
          "Principal Investigator": "Tsuneyo Mimori",
          "Affiliation": "Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000018"
        },
        "Emiko Noguchi": {
          "Principal Investigator": "Emiko Noguchi",
          "Affiliation": "Department of Medical Genetics, Faculty of Medicine, University of Tsukuba",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Research on genetic predisposition to inflammatory lung disease",
          "Period of Data Use": "JGAD000018"
        },
        "Yukinori Okada": {
          "Principal Investigator": "Yukinori Okada",
          "Affiliation": "Department of Statistical Genetics, Osaka University Graduate School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000018"
        },
        "Eisei Noiri": {
          "Principal Investigator": "Eisei Noiri",
          "Affiliation": "The University of Tokyo・University Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000018"
        },
        "Yohei Kirino": {
          "Principal Investigator": "Yohei Kirino",
          "Affiliation": "Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Genetic analysis for an immune-related adverse event caused by immune checkpoint inhibitors",
          "Period of Data Use": "JGAD000018"
        },
        "Taisei Mushiroda": {
          "Principal Investigator": "Taisei Mushiroda",
          "Affiliation": "Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences",
          "Research Title": "",
          "Data in Use (Dataset ID)": "SNP analysis of wheat allergy",
          "Period of Data Use": "JGAD000018"
        },
        "Hajime Yoshifuji": {
          "Principal Investigator": "Hajime Yoshifuji",
          "Affiliation": "Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "To impute HLA alleles of patients with autoimmune diseases and helathy people to fine-map the HLA region to clarify the associations between the HLA locus and diseases susceptibility or diseases' phenotypes",
          "Period of Data Use": "JGAD000018"
        },
        "Koya Fukunaga": {
          "Principal Investigator": "Koya Fukunaga",
          "Affiliation": "Division of Medical Safety Science, National Institute of Health Sciences",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Research on the diagnosis, treatment, and biomarkers for severe cutaneous adverse reactions",
          "Period of Data Use": "JGAD000018"
        },
        "Yuta Kochi": {
          "Principal Investigator": "Yuta Kochi",
          "Affiliation": "Department of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic study of complex diseases through comprehensive analysis of functional genetic variations",
          "Period of Data Use": "JGAD000018"
        }
      },
      "Release Note": {
        "hum0028.v2": {
          "Research ID": "hum0028.v2",
          "Release Date": "2018/06/05",
          "Type of Data": "Data on HLA-DQA1 alleles and SNPs were added.",
          "description": "SNPs in the HLA region were genotyped by Illumina BeadChips (HumanOmniExpress BeadChip, HumanExome BeadChip, Immunochip, HumanHap550v3 Genotyping BeadChip) and HLA alleles (HLA-A/C/B/DRB1/DQA1/DQB1/DPA1/DPB1) were determined by WAKFlow HLA typing kit or sequence based method for 908 Japanese healthy controls. Data files are provided as SNP2HLA output files (.bed, .bgl.phased, .bim, .fam, .FRQ.frq, .markers).\n"
        },
        "hum0028.v1": {
          "Research ID": "hum0028.v1",
          "Release Date": "2015/06/02",
          "Type of Data": "HLA alleles and SNPs in the HLA region (7 Loci)",
          "description": "SNPs in the HLA region were genotyped by Illumina BeadChips (HumanOmniExpress BeadChip, HumanExome BeadChip, Immunochip, HumanHap550v3 Genotyping BeadChip) and HLA alleles (HLA-A/C/B/DRB1/DQB1/DPA1/DPB1) were determined by WAKFlow HLA typing kit for 908 Japanese healthy controls. Data files are provided as SNP2HLA output files (.bed, .bgl.phased, .bim, .fam, .FRQ.frq, .markers).\nNote:\n"
        }
      }
    }
  },
  "hum0027.v1": {
    "ja": {
      "NBDC Research ID": "hum0027.v1",
      "データ": {
        "JGAS000024\r\nJGAS000040": {
          "データID": "JGAS000024\r\nJGAS000040",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/07/28"
        }
      },
      "研究内容の概要": {
        "目的": "侵襲性歯周炎罹患者の全エクソン領域を解読することにより、（１）侵襲性歯周炎データベースの作成、および（２）侵襲性歯周炎の疾患関連遺伝子（一塩基多型および挿入欠失）の探索を行い、関連遺伝子について機能解析を実施することで、侵襲性歯周炎の予防・診断・治療方針の確立を目指す。",
        "方法": " Illumina HiSeq 2000を使用したExome解析",
        "対象": "侵襲性歯周炎患者44症例（アメリカ歯周病学会の診断基準に基づき診断）",
        "URL": "http://www.dent.osaka-u.ac.jp/admission/admission_000301.html"
      },
      "分子データ": {
        "JGAS000024／JGAS000040": {
          "対象": "侵襲性歯周炎患者：44症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect Human All Exon V5（50M）kit",
          "断片化の方法": "超音波断片化（Covaris社、 E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000024 （hg18）1症例\r\nJGAD000040 （hg19）43症例",
          "総データ量": "460 GB（fastq、bam、vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy \r\n公開日より1年間は民間企業での利用禁止"
        }
      },
      "提供者情報": {
        "研究代表者": " 村上 伸也",
        "所 属 機 関": "大阪大学大学院 歯学研究科",
        "プロジェクト/研究グループ名": "",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "マトリックス分解酵素カテプシンAが歯周組織再生に及ぼす影響",
            "研究課題番号": "15K11385"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "投稿中",
          "DOI": "-",
          "データID": "-"
        },
        "2": {
          "タイトル": " ",
          "DOI": " ",
          "データID": " "
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0027.v1": {
          "Research ID": "hum0027.v1",
          "公開日": "2016/07/28",
          "内容": "NGS（Exome）",
          "description": "侵襲性歯周炎44症例より提供された末梢血からDNAを抽出し、全エクソーム配列を解読した結果をFastq/bam/vcfファイルにて提供する。\nAgilent SureSelect Human All Exon V5（50M）kitを用いてExon領域にしぼり、HiSeq 2000にて150 bpのDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0027.v1",
      "DATA": {
        "JGAS000024\r\nJGAS000040": {
          "Data Set ID": "JGAS000024\r\nJGAS000040",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/07/28"
        }
      },
      "SUMMARY": {
        "Aims": "To identify polymorphisms (SNP and Indel) of responsible genes for Japanese aggressive periodontitis by whole exon sequencing (WES) analysis. Then, functional analyses forf the responsible genes were assessed by in vivo/vitro biological experiments.",
        "Methods": "WES by using of HiSeq 2000 (Illumina).",
        "URL": "http://www.dent.osaka-u.ac.jp/english/g_school/facilities/periodontology.html"
      },
      "MOLECULAR DATA": {
        "JGAS000024 / JGAS000040": {
          "Materials": "44 Japanese aggressive periodontitis patients",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect Human All Exon V5 (50M) kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "DDBJ Sequence Read Archive ID": "JGAD000024 （hg18）\r\nJGAD000040 （hg19）",
          "Total Data Volume": "460 GB (fastq, bam, vcf)",
          "Comments (Policies)": "NBDC policy\r\nAcademic Use Only (till 2017/07/28)"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shinya Murakami",
        "Affiliation": "Division of Oral Biology and Disease Control, Department of Periodontology, Osaka University Graduate School of Dentistry",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Effects of cathepsin A on the regeneration of periodontal tissue",
            "Project Number": "15K11385"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "-",
          "DOI": "-",
          "Data Set ID": "-"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0027.v1": {
          "Research ID": "hum0027.v1",
          "Release Date": "2016/07/28",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from peripheral blood cells of 44 Japanese aggressive periodontitis patients were used for whole exon sequencing (fastq files). Exons were captured using Agilent SureSelect Human All Exon V5 (50M) kit and a multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (150 bp, Paired-end).\nNote:\n"
        }
      }
    }
  },
  "hum0024.v1": {
    "ja": {
      "NBDC Research ID": "hum0024.v1",
      "データ": {
        "JGAS000023": {
          "データID": "JGAS000023",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/04/16"
        }
      },
      "研究内容の概要": {
        "目的": "高齢者に好発する慢性骨髄性腫瘍である骨髄異形成症候群（MDS）および関連骨髄性腫瘍のRNAスプライシング因子やDNAメチル化に関わる遺伝子を網羅的に解析する。",
        "方法": "Illumina（Genome Analyzer IIxおよびHiSeq 2000/2500）を使用したExome解析",
        "対象": "骨髄異形成症候群13症例および慢性骨髄単球性白血病1症例の腫瘍組織と非腫瘍組織",
        "URL": "http://plaza.umin.ac.jp/kyoto_tumorpatho/"
      },
      "分子データ": {
        "JGAS000023": {
          "対象": "骨髄異形成症候群13症例および慢性骨髄単球性白血病1症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Genome Analyzer IIx、HiSeq 2000/2500]",
          "ライブラリソース": "腫瘍組織：末梢血、骨髄液\r\n非腫瘍組織：口腔粘膜",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human ALL Exon kit（38 Mb, 50 Mb kit, v4）",
          "断片化の方法": "超音波断片化（Covaris S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "75-108 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000023",
          "総データ量": "300 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "小川 誠司",
        "所 属 機 関": "京都大学大学院 医学研究科 腫瘍生物学講座",
        "プロジェクト/研究グループ名": "",
        "科研費/助成金（Research Project Number）": {
          "6": {
            "科研費・助成金名": "内閣府\r\n最先端研究開発支援プログラム（FIRST）",
            "タイトル": "未解決のがんと心臓病を撲滅する最適医療開発",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Frequent pathway mutations of splicing machinery in myelodysplasia.",
          "DOI": "doi: 10.1038/nature10496",
          "データID": "JGAD000023"
        },
        "2": {
          "タイトル": "Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.",
          "DOI": "doi: 10.1038/ng.2731",
          "データID": "JGAD000023"
        },
        "3": {
          "タイトル": "The landscape of somatic mutations in Down syndrome-related myeloid disorders.",
          "DOI": "doi: 10.1038/ng.2759",
          "データID": "JGAD000023"
        },
        "4": {
          "タイトル": "Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.",
          "DOI": "doi: 10.1038/leu.2013.336",
          "データID": "JGAD000023"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0024.v1": {
          "Research ID": "hum0024.v1",
          "公開日": "2015/04/16",
          "内容": "NGS（Exome）",
          "description": "このバージョンでは、骨髄異形成症候群13症例および慢性骨髄単球性白血病1症例の腫瘍組織と非腫瘍組織から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human ALL Exon kit（38 Mb, 50 Mb kit, v4）を用いてExon領域にしぼり、Genome Analyzer IIxおよびHiSeq 2000/2500にて平均長75-108塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0024.v1",
      "DATA": {
        "JGAS000023": {
          "Data Set ID": "JGAS000023",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/04/16"
        }
      },
      "SUMMARY": {
        "Aims": "To perform a comprehensive analysis of genetic alterations of myelodysplastic syndromes (MDS) and related myeloid neoplasms (myelodysplasia).",
        "Methods": "Whole-exome sequencing of gDNAs extracted from leukemic cells and paired non-leukemic cells (Illumina Genome Analyzer IIx, HiSeq 2000, and HiSeq 2500).",
        "Participants/Materials": "13 MDSs and 1 chronic myelomonocytic leukemia (CMML) (leukemic cells and paired non-leukemic cells)",
        "URL": "http://plaza.umin.ac.jp/kyoto_tumorpatho/"
      },
      "MOLECULAR DATA": {
        "JGAS000023": {
          "Participants/Materials:": "13 MDSs and 1 CMML",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Genome Analyzer IIx, HiSeq 2000/2500]",
          "Library Source": "Leukemic cells: peripheral blood, bone marrow aspirate\r\nNon-leukemic cells: oral mucosa",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human ALL Exon kit (38Mb, 50Mb kit, v4)",
          "Fragmentation Methods": "Covaris (S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "75-108 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000023",
          "Total Data Volume": "300 GB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Seishi Ogawa",
        "Affiliation": "Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University",
        "Project / Group Name": "",
        "Funds / Grants (Research Project Number)": {
          "6": {
            "Name": "Cabinet Office, Government of Japan\r\nFunding Program for World-Leading Innovative R&D on Science and Technology (FIRST)",
            "Title": "Development of medical technologies for treating intractable cancers and cardiovascular diseases",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Frequent pathway mutations of splicing machinery in myelodysplasia.",
          "DOI": "doi: 10.1038/nature10496",
          "Data Set ID": "JGAD000023"
        },
        "2": {
          "Title": "Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.",
          "DOI": "doi: 10.1038/ng.2731",
          "Data Set ID": "JGAD000023"
        },
        "3": {
          "Title": "The landscape of somatic mutations in Down syndrome-related myeloid disorders.",
          "DOI": "doi: 10.1038/ng.2759",
          "Data Set ID": "JGAD000023"
        },
        "4": {
          "Title": "Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.",
          "DOI": "doi: 10.1038/leu.2013.336",
          "Data Set ID": "JGAD000023"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0024.v1": {
          "Research ID": "hum0024.v1",
          "Release Date": "2015/04/16",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from peripheral blood, bone marrow aspirate, and oral mucosa of 13 MDSs and 1 CMML were used for the whole exome sequencing (Fastq files). Exons were narrowed down by using of SureSelect Human All Exon v.4 and read by Illumina Genome Analyzer IIx, HiSeq 2000/2500 (paired-end: 75-108 bp).\nNote:\n"
        }
      }
    }
  },
  "hum0023.v1": {
    "ja": {
      "NBDC Research ID": "hum0023.v1",
      "データ": {
        "JGAS000016": {
          "データID": "JGAS000016",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/01/28"
        }
      },
      "研究内容の概要": {
        "目的": "高血圧症の遺伝因子の解明",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "III度以上の本態性高血圧患者30症例"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000016": {
          "対象": "III度以上の本態性高血圧患者30症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon 50 Mb Kit （Agilent社）",
          "断片化の方法": "超音波断片化（Covaris社、S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000016",
          "総データ量": "405 GB (634 files)",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "三木 哲郎",
        "所 属 機 関": "愛媛大学大学院医学系研究科 老年・神経・総合診療内科学",
        "プロジェクト/研究グループ名": "ミレニアム・ゲノムプロジェクト",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（B）",
            "タイトル": "期縦断大規模ゲノム疫学研究による生活習慣病発症の遺伝因子に関するエビデンス構築",
            "研究課題番号": "21390099"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0023.v1": {
          "Research ID": "hum0023.v1",
          "公開日": "2015/01/28",
          "内容": "NGS（Exome）",
          "description": "このバージョンでは、III度以上の本態性高血圧患者30症例の末梢血から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon 50 Mb Kit（Agilent社）を用いてExon領域にしぼり、Illumina 社 HiSeq 2000にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0023.v1",
      "DATA": {
        "JGAS000016": {
          "Data Set ID": "JGAS000016",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/01/28"
        }
      },
      "SUMMARY": {
        "Aims": "Identify susceptible genes in hypertension",
        "Methods": "Whole Exome sequencing by using of Illumina HiSeq 2000",
        "Participants/Materials": "Patients with severe hypertension"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000016": {
          "Participants/Materials": "Thirty patients with severe hypertension.",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon 50 Mb Kit (Agilent)",
          "Fragmentation Methods": "Covaris (S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000016",
          "Total Data Volume": "405 GB (634 files)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tetsurou Miki",
        "Affiliation": "Department of Geriatric Medicine and Neurology, Ehime University, Graduate School of Medicine",
        "Project / Group Name": "Millennium Genome Project",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Identification of genetic predisposition to non-communicable diseases by a large-scale longitudinal genetic epidemiological study.",
            "Project Number": "21390099"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0023.v1": {
          "Research ID": "hum0023.v1",
          "Release Date": "2015/01/28",
          "Type of Data": "NGS (Exome)",
          "description": "Genomic DNAs from 30 severe hypertension patients were extracted from peripheral blood cells, and subjected to the enrichment of exon fragments by using SureSelect system (Agilent). We sequenced 100~105 bases from both ends of them with a Illumina HiSeq 2000 system with paired-end mode (fastq format file).\nNote：\n"
        }
      }
    }
  },
  "hum0022.v1": {
    "ja": {
      "NBDC Research ID": "hum0022.v1",
      "データ": {
        "JGAS000017": {
          "データID": "JGAS000017",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/02/02"
        }
      },
      "研究内容の概要": {
        "目的": "白血病患者への治療として実施される造血幹細胞移植後に発症する、移植ドナー細胞由来白血病（Donor Cell Leukemia：DCL）の発症メカニズムの解明",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "DCL患者１症例と移植ドナー1名"
      },
      "分子データ": {
        "JGAS000017": {
          "対象": "DCL患者1症例（白血病、その寛解期、再発期、ドナー由来白血病後期）および移植ドナー1名（正常末梢血）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "骨髄中白血病細胞および末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Kit（Agilent社）",
          "断片化の方法": "超音波断片化（Covaris社、S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000017\r\n（BM-P1 白血病、BM-P2 寛解期、BM-P3 再発期、BM-P4 ドナー由来白血病後期、BM-D1 移植ドナー末梢血）",
          "総データ量": "500 GB（bam [ref: GRCh37]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "清井 仁",
        "所 属 機 関": "名古屋大学大学院 医学系研究科 血液・腫瘍内科学",
        "プロジェクト/研究グループ名": "次世代がん研究戦略推進プロジェクト「創薬コンセプトに基づく戦略的治療デザインの確立」白血病ゲノムに基づく層別化治療の確立",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "次世代がん研究シーズ戦略的育成プログラム（P-DIRECT）",
            "タイトル": "臨床１：創薬コンセプトに基づく戦略的治療デザインの確立",
            "研究課題番号": "臨床１－①：白血病ゲノムに基づく層別化治療の確立"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation",
          "DOI": "doi:10.1038/leu.2013.278",
          "データID": "JGAD000017"
        },
        "2": {
          "タイトル": " ",
          "DOI": " ",
          "データID": " "
        }
      },
      "制限公開データの利用者一覧": {
        "小川誠司": {
          "研究代表者": "小川誠司",
          "所属機関": "京都大学大学院医学研究科",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000017"
        }
      },
      "リリース情報": {
        "hum0022.v1": {
          "Research ID": "hum0022.v1",
          "公開日": "2015/02/02",
          "内容": "NGS（Exome）",
          "description": "このバージョンでは、移植ドナー細胞由来白血病患者1症例の各病期（白血病、その寛解期、再発期、ドナー由来白血病後期）における骨髄中白血病細胞・末梢血から抽出したDNA、および、移植ドナー1例の末梢血から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Kitを用いてExon領域にしぼり、Illumina 社 HiSeq 2000にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0022.v1",
      "DATA": {
        "JGAS000017": {
          "Data Set ID": "JGAS000017",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/02/02"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify the molecular mechanism underlying malignant transformation of Donor-cell derived leukemia (DCL).",
        "Methods": "Whole Exome Sequencing was performed by using of Illumina HiSeq 2000.",
        "Participants/Materials": "One DCL patient and one donor"
      },
      "MOLECULAR DATA": {
        "JGAS000017": {
          "Participants/Materials": "One DCL patient (cells were obtained at the points of initial acute myeloid leukemia, remission stage, relapsed stage, and DCL at late stage). One donor (normal peripheral blood)",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "Genomic DNAs were extracted from leukemic cells from bone marrow aspirate or peripheral blood.",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Kit (Agilent)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000017",
          "Total Data Volume": "500 GB (bam [ref: GRCh37])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hitoshi Kiyoi",
        "Affiliation": "Department of Hematology and Oncology, Nagoya University Graduate School of Medicine",
        "Project / Group Name": "Project for Development of Innovative Research on Cancer Therapeutics , Team for Strategic Therapy Design",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)",
            "Title": "Therapy 1 : Establishment of the strategic therapy design based on the development of molecular-targeted drugs",
            "Project Number": "Therapy 1 - ① : Establishment of the optimal remedy based on the leukemia genome study"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation",
          "DOI": "doi:10.1038/leu.2013.278",
          "Data Set ID": "JGAD000017"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Seishi Ogawa": {
          "Principal Investigator": "Seishi Ogawa",
          "Affiliation": "Kyoto University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000017"
        }
      },
      "Release Note": {
        "hum0022.v1": {
          "Research ID": "hum0022.v1",
          "Release Date": "2015/02/02",
          "Type of Data": "NGS (Exome)",
          "description": "From a single patient, following specimens were obtained for initial acute myeloid leukemia, remission stage, relapsed stage, and DCL at late stage. Donor cells were also obtained. Genomic DNA was extracted from blood cells, and subjected to the enrichment of exon fragments by using SureSelect system (Agilent). We sequenced 100~105 bases from both ends of them with a Illumina HiSeq2000 system with paired-end mode.\nNote：\n"
        }
      }
    }
  },
  "hum0021.v3": {
    "ja": {
      "NBDC Research ID": "hum0021.v3",
      "データ": {
        "JGAS000014": {
          "データID": "JGAS000014",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/01/26"
        },
        "JGAS000273": {
          "データID": "JGAS000273",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/03/05"
        },
        "JGAS000273（データ追加）": {
          "データID": "JGAS000273（データ追加）",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2021/04/20"
        }
      },
      "研究内容の概要": {
        "目的": "双極性障害関連遺伝子の同定",
        "方法": "Illumina HiSeq 2000/2500を使用したExome解析",
        "対象": "健常一卵性双生児3組6例、双極性障害発症者およびその両親（トリオ）",
        "URL": "http://mdmd.riken.jp/"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000014": {
          "対象": "健常一卵性双生児3組6例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon 50 Mb Kit",
          "断片化の方法": "超音波断片化（Covaris S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000014",
          "総データ量": "118 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000273": {
          "対象": "双極性障害発症者（ICD10：F31）およびその両親（トリオ）：66＋78家系（198＋234名）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "唾液もしくは末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon V5（50 Mb）Kit\r\nSureSelect Human All Exon V6r2+lncRNA+mtDNA",
          "断片化の方法": "超音波断片化（Covaris S2）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000379",
          "総データ量": "1.1 TB＋848.1 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "加藤 忠史",
        "所 属 機 関": "理化学研究所 脳科学総合研究センター",
        "プロジェクト/研究グループ名": "精神疾患動態研究チーム",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 脳科学研究戦略推進プログラム",
            "タイトル": "トリオサンプルのシーケンス解析による、遺伝子型によって定義される双極性障害の一群の同定",
            "研究課題番号": "JP20dm0107133"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations.",
          "DOI": "doi: 10.1038/mp.2016.69",
          "データID": "JGAD000379"
        },
        "2": {
          "タイトル": "Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder",
          "DOI": "doi: 10.1038/s41467-021-23453-w",
          "データID": "JGAD000379"
        }
      },
      "制限公開データの利用者一覧": {
        "Hailiang Huang": {
          "研究代表者": "Hailiang Huang",
          "所属機関": "The Broad Institute Stanley Center",
          "研究題目": "",
          "利用データID": "Asian Bipolar Genetics Network (A-BIG-NET）",
          "利用期間": "JGAD000014JGAD000379"
        },
        "中杤 昌弘": {
          "研究代表者": "中杤 昌弘",
          "所属機関": "名古屋大学大学院医学系研究科　総合保健学専攻 実社会情報健康医療学",
          "研究題目": "日本",
          "利用データID": "遺伝子解析による脳とこころの病気に対するかかりやすさ（発症脆弱性）や薬の効きめや副作用（治療反応性）等の解明に関する研究",
          "利用期間": "JGAD000379"
        }
      },
      "リリース情報": {
        "hum0021.v3": {
          "Research ID": "hum0021.v3",
          "公開日": "2021/04/20",
          "内容": "NGS（Exome）",
          "description": "双極性障害発症者およびその両親（トリオ）78家系（234名）の唾液から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon V5 KitまたはSureSelect Human All Exon V6r2+lncRNA+mtDNAを用いてExon領域にしぼり、Illumina HiSeq2000/2500にて平均長101塩基のDNA断片を解読した（Paired-end）。\n"
        },
        "hum0021.v2": {
          "Research ID": "hum0021.v2",
          "公開日": "2021/03/05",
          "内容": "NGS（Exome）",
          "description": "双極性障害発症者およびその両親（トリオ）66家系（198名）の唾液から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon V5 Kitを用いてExon領域にしぼり、Illumina HiSeq2000/2500にて平均長101塩基のDNA断片を解読した（Paired-end）。\n"
        },
        "hum0021.v1": {
          "Research ID": "hum0021.v1",
          "公開日": "2015/01/26",
          "内容": "NGS（Exome）",
          "description": "このバージョンでは、健常一卵性双生児3組6例の末梢血から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon 50 Mb Kit（Agilent社）を用いてExon領域にしぼり、Illumina 社 HiSeq 2000にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0021.v3",
      "DATA": {
        "JGAS000014": {
          "Data Set ID": "JGAS000014",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/01/26"
        },
        "JGAS000273": {
          "Data Set ID": "JGAS000273",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/03/05"
        },
        "JGAS000273 (Data addition)": {
          "Data Set ID": "JGAS000273 (Data addition)",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/04/20"
        }
      },
      "SUMMARY": {
        "Aims": "Identify genes relevant to bipolar disorder",
        "Methods": "Whole exome sequence analysis using Illumina HiSeq 2000/2500",
        "Participants/Materials": "Three pairs of healthy monozygotic twins, 66 trios with bipolar disorder proband and unaffected parents",
        "URL": "http://mdmd.riken.jp/en/"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000014": {
          "Participants/Materials": "Three pairs of healthy monozygotic twins",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon 50 Mb Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000014",
          "Total Data Volume": "118 GB",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000273": {
          "Participants/Materials": "66 + 78 trios with bipolar disorder proband (ICD10: F31) and unaffected parents",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "gDNA extracted from saliva or peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon V5 (50 Mb) Kit\r\nSureSelect Human All Exon V6r2+lncRNA+mtDNA",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S2)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "101 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000379",
          "Total Data Volume": "1.1 TB + 848.1 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Tadafumi Kato",
        "Affiliation": "RIKEN Brain Science Institute",
        "Project / Group Name": "Laboratory of Molecular Dynamics of Mental Disorders",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Strategic Research Program for Brain Sciences, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Identification of genetically defined subsets of bipolar disorder by trio sequencing.",
            "Project Number": "JP20dm0107133"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations.",
          "DOI": "doi: 10.1038/mp.2016.69",
          "Data Set ID": "JGAD000379"
        },
        "2": {
          "Title": "Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder",
          "DOI": "doi: 10.1038/s41467-021-23453-w",
          "Data Set ID": "JGAD000379"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Hailiang Huang": {
          "Principal Investigator": "Hailiang Huang",
          "Affiliation": "The Broad Institute Stanley Center",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Asian Bipolar Genetics Network (A-BIG-NET)",
          "Period of Data Use": "JGAD000014\r\nJGAD000379"
        },
        "Masahiro Nakatochi": {
          "Principal Investigator": "Masahiro Nakatochi",
          "Affiliation": "Public Health Informatics Unit, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Research on elucidation of susceptibility to brain and mental diseases (vulnerability to disease onset) and efficacy and side effects of drugs (treatment responsiveness) through genetic analysis",
          "Period of Data Use": "JGAD000379"
        }
      },
      "Release Note": {
        "hum0021.v3": {
          "Research ID": "hum0021.v3",
          "Release Date": "2021/04/20",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from saliva or peripheral blood cells of 78 trios with bipolar disorder proband and unaffected parents were used for Exome sequencing analysis (fastq format files). Exons were captured using the SureSelect Human All Exon V5 or V6r2+lncRNA+mtDNA Kit and multiplex sequence was performed with the Illumina HiSeq 2000/2500 sequencer (101 bp, Paired-end).\n"
        },
        "hum0021.v2": {
          "Research ID": "hum0021.v2",
          "Release Date": "2021/03/05",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from saliva or peripheral blood cells of 66 trios with bipolar disorder proband and unaffected parents were used for Exome sequencing analysis (fastq format files). Exons were captured using the SureSelect Human All Exon V5 Kit and multiplex sequence was performed with the Illumina HiSeq 2000/2500 sequencer (101 bp, Paired-end).\n"
        },
        "hum0021.v1": {
          "Research ID": "hum0021.v1",
          "Release Date": "2015/01/26",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from peripheral blood cells of 3 pairs of healthy monozygotic twins were used for Exome sequencing analysis (fastq format files). Exons were captured using the SureSelect Human All Exon 50 Mb Kit and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Paired-end).\nNote：\n"
        }
      }
    }
  },
  "hum0020.v1": {
    "ja": {
      "NBDC Research ID": "hum0020.v1",
      "データ": {
        "JGAS000013": {
          "データID": "JGAS000013",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/01/08"
        }
      },
      "研究内容の概要": {
        "目的": "筋萎縮性側索硬化症の遺伝因子の解明",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "家族性筋萎縮性側索硬化症患者11症例"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000013": {
          "対象": "家族性筋萎縮性側索硬化症患者：11症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon 50 Mb Kit（Agilent社）",
          "断片化の方法": "超音波断片化（Covaris社、S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000013",
          "総データ量": "110 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "田中 章景",
        "所 属 機 関": "横浜市立大学大学院 医学研究科 神経内科学・脳卒中医学",
        "プロジェクト/研究グループ名": "",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "パーソナルゲノム解析に基づくALSの疾患関連遺伝子探索と病態解明",
            "研究課題番号": "22129005"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0020.v1": {
          "Research ID": "hum0020.v1",
          "公開日": "2015/01/08",
          "内容": "NGS（Exome）",
          "description": "このバージョンでは、家族性筋萎縮性側索硬化症患者11症例の末梢血から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon 50 Mb Kitを用いてExon領域にしぼり、Illumina 社 HiSeq 2000にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0020.v1",
      "DATA": {
        "JGAS000013": {
          "Data Set ID": "JGAS000013",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/01/08"
        }
      },
      "SUMMARY": {
        "Aims": "To identify causative genes in amyotrophic lateral sclerosis (ALS).",
        "Methods": "Whole exome sequence analysis using Illumina HiSeq 2000.",
        "Participants/Materials": "11 familial ALS patients"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000013": {
          "Participants/Materials": "11 familial ALS patients",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon 50 Mb Kit (Agilent)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000013",
          "Total Data Volume": "110 GB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Fumiaki Tanaka",
        "Affiliation": "Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine",
        "Project / Group Name": "",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "Elucidation of causative genes and pathogenesis of ALS through personal genome analysis",
            "Project Number": "22129005"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0020.v1": {
          "Research ID": "hum0020.v1",
          "Release Date": "2015/01/08",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from peripheral blood cells of 11 familial ALS patients were used for Exome sequencing analysis (fastq format files). Exons were captured using the SureSelect Human All Exon 50 Mb Kit and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Paired-end).\nNote：\n"
        }
      }
    }
  },
  "hum0019.v1": {
    "ja": {
      "NBDC Research ID": "hum0019.v1",
      "データ": {
        "JGAS000011": {
          "データID": "JGAS000011",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/04/01"
        }
      },
      "研究内容の概要": {
        "目的": "消化器がんの発生・進展に重要な役割を果たす長鎖ncRNAの同定",
        "方法": "Illumina HiSeq 2500を使用したRNA-seq解析",
        "対象": "消化器がん17症例（腫瘍組織/非腫瘍組織、計32検体）",
        "URL": "http://web.sapmed.ac.jp/biochem2/"
      },
      "分子データ": {
        "acknowledgement": "※当該データは、文部科学省科学研究費新学術領域研究（研究領域提案型）『生命科学系３分野支援活動』に採択された「ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援」（「ゲノム支援」）による支援を受けました。",
        "JGAS000011": {
          "対象": "消化器がん患者：17症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "消化器がん切片から腫瘍組織と非腫瘍組織を取り分け、polyA RNAを抽出",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect XT RNA Target Enrichment for Illumina Multiplexed Sequencing",
          "断片化の方法": "上記kit中のRNA Seq Fragmentation Mix",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000011",
          "総データ量": "104 GB（fastq [1,193,969.914 reads / 338 files]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "篠村 恭久",
        "所 属 機 関": "札幌医科大学  消化器・免疫・リウマチ内科学講座",
        "プロジェクト/研究グループ名": "札幌医科大学・分子生物学講座との共同研究",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 若手研究（Ａ）",
            "タイトル": "大腸癌の発癌や進展に深く関与しうる長鎖ｎｃＲＮＡの量的・質的な異常の探索",
            "研究課題番号": "24680092"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "-",
          "DOI": "",
          "データID": ""
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000011"
        }
      },
      "リリース情報": {
        "hum0019.v1": {
          "Research ID": "hum0019.v1",
          "公開日": "2015/04/01",
          "内容": "NGS（RNA-seq）",
          "description": "このバージョンでは、日本人消化器癌患者17症例の消化器がん切片から腫瘍組織と非腫瘍組織を取り分け、polyA RNAを抽出してRNA-seqを実施した。Agilent SureSelect XT RNA Target Enrichment for Illumina Multiplexed Sequencingを用い、HiSeq 2500にて解読した結果をfastqファイルにて提供する（平均長100塩基 x 2）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0019.v1",
      "DATA": {
        "JGAS000011": {
          "Data Set ID": "JGAS000011",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/04/01"
        }
      },
      "SUMMARY": {
        "Aims": "To identify novel long non-coding RNAs critically involved in gastrointestinal cancer.",
        "Methods": "Exome and RNA-seq experiments were performed to investigate quantitative and qualitative abnormalities of long non-coding RNAs in gastrointestinal cancer (Illumina HiSeq 2500)",
        "Participants/Materials": "Genomic DNA and polyA RNA were extracted from specimens in 17 gastrointestinal cancer patients. Cancer and non-cancerous tissues were used: total 32 samples)",
        "URL": "http://web.sapmed.ac.jp/biochem2/"
      },
      "MOLECULAR DATA": {
        "acknowledgement": "This study was supported by “Genome Science”. “Genome Science” is a part of the “Support Programs for Three Fields in Life Sciences (cancer, genome and brain sciences)” established by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the Grant-in-Aid for Scientific Research on Innovative Areas.",
        "JGAS000011": {
          "Participants/Materials:": "17 gastrointestinal cancer patients",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "polyA RNAs were extracted from gastrointestinal cancer and non-cancerous tissues.",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect XT RNA Target Enrichment for Illumina Multiplexed Sequencing",
          "Fragmentation Methods": "RNA Seq Fragmentation Mix in the kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000011",
          "Total Data Volume": "104 GB (fastq [1,193,969.914 reads / 338 files])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yasuhisa Shinomura",
        "Affiliation": "Department of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University",
        "Project / Group Name": "Collaborate with Department of Molecular Biology, Sapporo Medical University",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (A)",
            "Title": "Systematic investigation of quantitative and qualitative abnormalities of long non-coding RNAs critically involved in colorectal cancer",
            "Project Number": "24680092"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "-",
          "DOI": "",
          "Data Set ID": ""
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000011"
        }
      },
      "Release Note": {
        "hum0019.v1": {
          "Research ID": "hum0019.v1",
          "Release Date": "2015/04/01",
          "Type of Data": "NGS (RNA-seq)",
          "description": "RNA-seq was performed by using of polyA RNAs extracted from 17 gastrointestinal cancer and non-cancerous tissues (Illumina HiSeq 2500, 100bp x 2, paired-end).\nNote：\n"
        }
      }
    }
  },
  "hum0018.v1": {
    "ja": {
      "NBDC Research ID": "hum0018.v1",
      "データ": {
        "JGAS000009": {
          "データID": "JGAS000009",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/02/03"
        }
      },
      "研究内容の概要": {
        "目的": "神経筋変性疾患の原因遺伝子または疾患感受性遺伝子および病態の解明",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "神経筋変性疾患14症例、および対照健常者7例"
      },
      "分子データ": {
        "JGAS000009": {
          "対象": "神経筋変性疾患14症例、および対照健常者7名",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon 50 Mb Kit",
          "断片化の方法": "超音波断片化（Covaris S220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000009",
          "総データ量": "260 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "辻 省次",
        "所 属 機 関": "東京大学大学院　医学系研究科　神経内科学",
        "プロジェクト/研究グループ名": " ",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "文部科学省科学研究費新学術領域研究（研究領域提案型）",
            "タイトル": "ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・高度情報解析支援",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Multiple-System Atrophy Research Collaboration. Mutations in COQ2 in familial and sporadic multiple-system atrophy.",
          "DOI": "doi:10.1056/NEJMoa1212115",
          "データID": "JGAD000009"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0018.v1": {
          "Research ID": "hum0018.v1",
          "公開日": "2015/02/03",
          "内容": "NGS（Exome）",
          "description": "このバージョンでは、神経筋変性疾患14症例、および対照健常者7例の末梢血から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon 50 Mb Kitを用いてExon領域にしぼりIllumina 社 HiSeq 2000にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0018.v1",
      "DATA": {
        "JGAS000009": {
          "Data Set ID": "JGAS000009",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/02/03"
        }
      },
      "SUMMARY": {
        "Aims": "Identify causative genes or susceptible genes in neurodegenerative diseases",
        "Methods": "Exome sequence analysis using Illumina HiSeq 2000",
        "Participants/Materials": "14 patients with multiple system atrophy and 7 healthy control subjects"
      },
      "MOLECULAR DATA": {
        "JGAS000009": {
          "Participants/Materials": "Fourteen patients with multiple system atrophy and 7 healthy control subjects",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon 50 Mb Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris S220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000009",
          "Total Data Volume": "260 GB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shoji Tsuji",
        "Affiliation": "Department of Neurology, Graduate School of Medicine, The University of Tokyo",
        "Project / Group Name": "",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Ministry of Education, Culture, Sports, Science and Technology Japan (MEXT) KAKENHI",
            "Title": "Genome Science",
            "Project Number": "211S0002"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Multiple-System Atrophy Research Collaboration. Mutations in COQ2 in familial and sporadic multiple-system atrophy.",
          "DOI": "doi:10.1056/NEJMoa1212115",
          "Data Set ID": "JGAD000009"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0018.v1": {
          "Research ID": "hum0018.v1",
          "Release Date": "2015/02/03",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from peripheral blood cells of 14 patients with multiple system atrophy and 7 healthy control subjects were used for Exome sequencing analysis (fastq format files). Exons were captured using the SureSelect Human All Exon 50 Mb Kit and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Paired-end).\nNote：\n"
        }
      }
    }
  },
  "hum0017.v1": {
    "ja": {
      "NBDC Research ID": "hum0017.v1",
      "データ": {
        "JGAS000021": {
          "データID": "JGAS000021",
          "内容": "NGS（Exome 、RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2016/02/22"
        }
      },
      "研究内容の概要": {
        "目的": "中枢神経原発悪性リンパ腫（primary central nervous system lymphoma: PCNSL）は原因不明な脳内リンパ腫であり、有効な治療に乏しい。全エクソン配列解析を行うことでタンパクコード遺伝子の体細胞変異を発見し、PCNSLのがん化機構の解明を目指す。",
        "方法": "脳外科手術によって摘出されたPCNSL試料と、同一患者より得られた末梢血単核球（計41ペア）よりゲノムDNAおよびRNAを抽出し、Exome解析、RNA-seq解析を行った。",
        "対象": "PCNSL患者：41症例",
        "URL": "https://www.ncc.go.jp/jp/ri/division/genetics/index.html"
      },
      "分子データ": {
        "Exome": {
          "対象": "PCNSL患者：41症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "脳外科手術によって摘出されたPCNSL試料\r\n同一患者より得られた末梢血単核球の\r\n計41ペアから抽出したゲノムDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect ver. 5\r\nNEBNext Ultra DNA Library Prep Kit for Illumina",
          "断片化の方法": "超音波断片化（Covaris LE220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100-105 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000021",
          "総データ量": "1.65 TB（bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "PCNSL患者：30症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "脳外科手術によって摘出されたPCNSL試料から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra Directional RNA Library Prep Kit for Illumina（New England BioLabs）",
          "断片化の方法": "上記kit中のRNA Seq Fragmentation Mix",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000021",
          "総データ量": "350 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "間野 博行",
        "所 属 機 関": "国立がん研究センター研究所 細胞情報学分野",
        "プロジェクト/研究グループ名": "PCNSL Genomic Analysis",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "日本医療研究開発機構 革新的先端研究開発支援事業インキュベートタイプ（AMED-LEAP）",
            "タイトル": "がん治療標的探索プロジェクト",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genomic characterization of primary central nervous system lymphoma",
          "DOI": "doi: 10.1007/s00401-016-1536-2",
          "データID": "JGAD000021"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Li WEI": {
          "研究代表者": "Li WEI",
          "所属機関": "National Key Laboratory of Birth Defects and Reproductive Health, Chongqing Institute of Population and Family Planning",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000021"
        },
        "Mosquera Orgueira, Adrian": {
          "研究代表者": "Mosquera Orgueira, Adrian",
          "所属機関": "Institute for Research in Health at Santiago de Compostela (IDIS)",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000021"
        },
        "Margaret A. Shipp": {
          "研究代表者": "Margaret A. Shipp",
          "所属機関": "Dana-Farber Cancer Institute",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000021"
        },
        "服部 圭一郎": {
          "研究代表者": "服部 圭一郎",
          "所属機関": "筑波大学 血液内科",
          "研究題目": "",
          "利用データID": "中枢神経原発悪性リンパ腫の発症を支持する脳内免疫環境細胞の同定",
          "利用期間": "JGAD000021"
        },
        "小川 誠司": {
          "研究代表者": "小川 誠司",
          "所属機関": "京都大学大学院医学研究科 腫瘍生物学講座",
          "研究題目": "",
          "利用データID": "造血器腫瘍における遺伝子異常の網羅的解析",
          "利用期間": "JGAD000021"
        },
        "Jessica Okosun": {
          "研究代表者": "Jessica Okosun",
          "所属機関": "Barts Cancer Institute, Queen Mary University of London",
          "研究題目": "",
          "利用データID": "Dissecting the molecular heterogeneity and evolution of central nervous system lymphomas",
          "利用期間": "JGAD000021"
        },
        "Wei Hua": {
          "研究代表者": "Wei Hua",
          "所属機関": "復旦大学附属華山医院 神経外科",
          "研究題目": "中華人民共和国",
          "利用データID": "Genomic and molecular characterization of primary central nervous system lymphoma",
          "利用期間": "JGAD000021"
        },
        "齋藤 竜太": {
          "研究代表者": "齋藤 竜太",
          "所属機関": "名古屋大学大学院医学系研究科 脳神経外科学",
          "研究題目": "日本",
          "利用データID": "脳腫瘍の発生、進展に関わる遺伝子異常と腫瘍微小環境の形成に関する研究",
          "利用期間": "JGAD000021"
        },
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000021"
        }
      },
      "リリース情報": {
        "hum0017.v1": {
          "Research ID": "hum0017.v1",
          "公開日": "2016/02/22",
          "内容": "NGS（ExomeおよびRNA-seq）",
          "description": " このバージョンでは、脳外科手術によって摘出されたPCNSL試料と、同一患者より得られた末梢血単核球のペアから抽出したゲノムDNAおよびPCNSL試料から抽出したRNAを対象とし、以下の解析を行った。\n• Exome（41症例）\n SureSelect ver. 5（Agilent）によりエクソン領域を絞り込み、HiSeq 2000（Illumina）のPaired-end modeにより両端100-105塩基の配列を決定、bam file形式にて提供する。\n• RNA-seq（30症例）\nNEBNext Ultra Directional RNA Library Prep KitによるRNAライブラリ作製後、HiSeq 2000（Illumina）のPaired-end modeにより平均長100塩基を解読した（fastq file形式にて提供）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0017.v1",
      "DATA": {
        "JGAS000021": {
          "Data Set ID": "JGAS000021",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/02/22"
        }
      },
      "SUMMARY": {
        "Aims": "Primary central nervous system lymphoma (PCNSL) is a rare type lymphoma confined to the central nervous system. Effective therapies against PCNSL are severely limited. By conducting whole exome sequencing of PCNSL specimens, we aimed to reveal molecular mechanism underlying PCNSL carcinogenesis.",
        "Methods": "Genomic DNA was extracted from surgically resected PCNSL tissues and paired peripheral blood, and subjected to Exome analysis. RNA extracted from surgically resected PCNSL tissues was subjected to RNA-seq analysis.",
        "Participants/Materials": "Forty-one cases diagnosed to have PCNSL",
        "URL": "https://www.ncc.go.jp/en/ri/division/genetics/index.html"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "41 PCNSL cases",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "Genomic DNA extracted from surgically resected PCNSL tissues and paired peripheral blood cells (41 pairs)",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Kit ver. 5\r\nNEBNext Ultra DNA Library Prep Kit for Illumina",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris LE220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100-105 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000021",
          "Total Data Volume": "1.65 TB (bam file, reference : hg19)",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "30 PCNSL cases",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "RNA extracted from surgically resected PCNSL tissues",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra Directional RNA Library Prep Kit for Illumina（New England BioLabs）",
          "Fragmentation Methods": "RNA Seq Fragmentation Mix in the above library construction kit",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000021",
          "Total Data Volume": "350 GB (fastq file)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Mano",
        "Affiliation": "Division of Cellular Signaling, National Cancer Center Research Institute",
        "Project / Group Name": "PCNSL Genomic Analysis",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "Leading Advanced Projects for medical innovation, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-LEAP)",
            "Title": "Project for novel therapeutic targets in cancer",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genomic characterization of primary central nervous system lymphoma",
          "DOI": "doi: 10.1007/s00401-016-1536-2",
          "Data Set ID": "JGAD000021"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Li WEI": {
          "Principal Investigator": "Li WEI",
          "Affiliation": "National Key Laboratory of Birth Defects and Reproductive Health, Chongqing Institute of Population and Family Planning",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000021"
        },
        "Mosquera Orgueira, Adrian": {
          "Principal Investigator": "Mosquera Orgueira, Adrian",
          "Affiliation": "Institute for Research in Health at Santiago de Compostela (IDIS)",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000021"
        },
        "Margaret A. Shipp": {
          "Principal Investigator": "Margaret A. Shipp",
          "Affiliation": "Dana-Farber Cancer Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000021"
        },
        "Keiichiro Hattori": {
          "Principal Investigator": "Keiichiro Hattori",
          "Affiliation": "Department of Hematology, University of Tsukuba",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Indentification of neuroinflammatory cells supporting the development of primary central nervous system lymphoma",
          "Period of Data Use": "JGAD000021"
        },
        "Seishi Ogawa": {
          "Principal Investigator": "Seishi Ogawa",
          "Affiliation": "Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of genetic alterations in hematological malignancies.",
          "Period of Data Use": "JGAD000021"
        },
        "Jessica Okosun": {
          "Principal Investigator": "Jessica Okosun",
          "Affiliation": "Barts Cancer Institute, Queen Mary University of London",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Dissecting the molecular heterogeneity and evolution of central nervous system lymphomas",
          "Period of Data Use": "JGAD000021"
        },
        "Wei Hua": {
          "Principal Investigator": "Wei Hua",
          "Affiliation": "Huashan Hospital, Fudan University Neurosurgery",
          "Research Title": "China",
          "Data in Use (Dataset ID)": "Genomic and molecular characterization of primary central nervous system lymphoma",
          "Period of Data Use": "JGAD000021"
        },
        "Ryuta Saito": {
          "Principal Investigator": "Ryuta Saito",
          "Affiliation": "Department of Neurosurgery, Nagoya University Graduate School of Medicine",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis during the progression of brain tumors and its impact on tumor microenvironment formation",
          "Period of Data Use": "JGAD000021"
        },
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000021"
        }
      },
      "Release Note": {
        "hum0017.v1": {
          "Research ID": "hum0017.v1",
          "Release Date": "2016/02/22",
          "Type of Data": "NGS (Exome, RNA-seq)",
          "description": "• Exome: 41 samples\nGenomic DNAs were extracted from surgically resected PCNSL tissues and paired peripheral blood cells, and subjected to the enrichment of exon fragments by using SureSelect system (Agilent). They were sequenced 100-105 bases from both ends with a HiSeq 2000 system (Illumina) with paired-end mode (bam files).\n• RNA-seq: 30 samples\nRNAs extracted from surgically resected PCNSL tissues were used for RNA-seq (fastq).\n RNA liberally builded using NEBNext Ultra Directional RNA Library Prep Kit for Illumina (New England BioLabs) and read by Illumina HiSeq 2000 (paired-end: 100 bp).\nNote：\n"
        }
      }
    }
  },
  "hum0016.v1": {
    "ja": {
      "NBDC Research ID": "hum0016.v1",
      "データ": {
        "DRA002604": {
          "データID": "DRA002604",
          "内容": "NGS（ChIP-seq、RNA-seq）",
          "制限": "非制限公開",
          "公開日": "2016/09/30"
        }
      },
      "研究内容の概要": {
        "目的": "精巣特異的クロマチン関連因子の精子細胞における発現を解析することで、精子細胞のクロマチン形成のメカニズムを解明する",
        "方法": "精子細胞において発現が認められた因子に関して、調整した精巣組織細胞のクロマチンを用いたChIP-seq解析（ヒストン抗体H3.5およびH3.3を使用）、および、対応検体のRNA-seq解析",
        "対象": "正常ヒト精巣組織細胞",
        "URL": "http://tx.bioreg.kyushu-u.ac.jp"
      },
      "分子データ": {
        "DRA002604": {
          "対象": "1名の正常ヒト精巣組織細胞",
          "規模": "H3.5・H3.3特異的な抗体によってIPされる領域 (ChIP-seq)\r\nおよび同検体のInput data（whole genome）とRNA-seq（whole genome）",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "ライブラリソース": "精巣組織細胞から抽出したDNAおよびRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "NEBNext Ultra DNA Library Prep Kit for Illumina（ChIP-seq）\r\nNEBNext Ultra Directional RNA Library Prep Kit for Illumina（RNA-seq）",
          "断片化の方法": "MNase（ChIP-seq）\r\n上記キットに準拠（RNA-seq）",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "50 bp（depth: 0.5-0.8）",
          "DDBJ Sequence Read Archive ID": "DRA002604",
          "総データ量": "15 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "大川 恭行",
        "所 属 機 関": "九州大学 生体防御医学研究所 トランスクリプトミクス分野",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": " ",
            "タイトル": " ",
            "研究課題番号": " "
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Histone H3.5 forms an unstable nucleosome and accumulates around transcription start sites in human testis",
          "DOI": "doi: 10.1186/s13072-016-0051-y",
          "データID": "DRA002604"
        },
        "2": {
          "タイトル": " ",
          "DOI": " ",
          "データID": " "
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0016.v1": {
          "Research ID": "hum0016.v1",
          "公開日": "2016/09/30",
          "内容": "ChIP-seq (抗体H3.3および抗体H3.5)、Input data\r\nRNA-seq",
          "description": " このバージョンでは、1名の正常ヒト精巣組織細胞を対象とし、ヒストン抗体H3.5およびH3.3を使用したIPによりライブラリを作成したChIP-seqおよび同検体のInput data、ならびにRNA-seq（Illumina HiSeq 1500）のfastqファイルを提供する（Single-end： 50 bp）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0016.v1",
      "DATA": {
        "DRA002604": {
          "Data Set ID": "DRA002604",
          "Type of Data": "NGS (ChIP-seq, RNA-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2016/09/30"
        }
      },
      "SUMMARY": {
        "Aims": "To elucidate the mechanism of chromatin formation in human sperm cells.",
        "Methods": "Analysis of ChIP-seq data of the testis-specific histone variant H3.5 (with H3.3 as control) and RNA-seq data in testis cells",
        "Participants/Materials": "Normal testis cells",
        "URL": "http://www.nibb.ac.jp/potentia/nucleosome/English/e_index.html"
      },
      "MOLECULAR DATA": {
        "DRA002604": {
          "Participants/Materials:": "Normal human testis cells",
          "Targets": "IP with specific antibody for H3.3 and H3.5 (ChIP-seq),\r\n Input data (whole genome), and RNA-seq data (whole genome)",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 1500]",
          "Library Source": "gDNA and total RNA extracted from human testis cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "NEBNext Ultra DNA Library Prep Kit for Illumina (ChIP-seq)\r\nNEBNext Ultra Directional RNA Library Prep Kit for Illumina (RNA-seq)",
          "Fragmentation Methods": "MNase (ChIP-seq)\r\nNEBNext Ultra Directional RNA Library Prep Kit (RNA-seq)",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "50 bp (depth: 0.5-0.8)",
          "DDBJ Sequence Read Archive ID": "DRA002604",
          "Total Data Volume": "15 GB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Yasuyuki Ohkawa",
        "Affiliation": "Division of Transcriptomics, Medical Institute of Bioregulation, Kyushu university",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": " ",
            "Title": " ",
            "Project Number": " "
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Histone H3.5 forms an unstable nucleosome and accumulates around transcription start sites in human testis",
          "DOI": "doi: 10.1186/s13072-016-0051-y",
          "Data Set ID": "DRA002604"
        },
        "2": {
          "Title": " ",
          "DOI": " ",
          "Data Set ID": " "
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0016.v1": {
          "Research ID": "hum0016.v1",
          "Release Date": "2016/09/30",
          "Type of Data": "ChIP-seq (IP with H3.3 and 3.5), Input data\r\nRNA-seq",
          "description": " ChIP-seq data (IP with histone specific antibodies: H3.3 and H3.5), Input data, and RNA-seq data from one human adult testis cells are provided (Illumina HiSeq 1500, single-end, 50 bp）.\nNote：\n"
        }
      }
    }
  },
  "hum0015.v3": {
    "ja": {
      "NBDC Research ID": "hum0015.v3",
      "データ": {
        "hum0015.v1.freq.v1": {
          "データID": "hum0015.v1.freq.v1",
          "内容": "全染色体領域を対象としたNGSにて1070名の塩基配列を決定し、検出されたバリアントから常染色体上の既知のSNVの内頻度が5％を超えるものについての頻度情報",
          "制限": "非制限公開",
          "公開日": "2014/10/14"
        },
        "JGAS000159": {
          "データID": "JGAS000159",
          "内容": "日本人3,552名の常染色体、X染色体、ミトコンドリアのアレル頻度情報",
          "制限": "制限公開（Type I）",
          "公開日": "2018/12/27"
        },
        "hum0015.v3.3.5kjpnv2.v1": {
          "データID": "hum0015.v3.3.5kjpnv2.v1",
          "内容": "日本人3,552名の常染色体、X染色体、ミトコンドリアのアレル頻度情報",
          "制限": "非制限公開",
          "公開日": "2019/01/11"
        }
      },
      "研究内容の概要": {
        "目的": "東日本大震災の被災地を含む住民集団におけるゲノムの多型を把握するとともに、遺伝子と疾病との関係を明らかにして、未来型の個別化予防・医療に役立てる基盤を確立すること",
        "方法": " 末梢血からゲノムDNAを抽出してライブラリとし、NGS（Illumina HiSeq 2500）により塩基配列を決定後多型箇所を検出した。",
        "対象": "東北メディカル・メガバンク機構の地域住民コホート調査に参加した20歳以上の1070人の成人",
        "URL": "http://www.megabank.tohoku.ac.jp/"
      },
      "分子データ": {
        "hum0015.v1.freq.v1": {
          "対象": "日本人成人健常人：1070名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free HT sample prep kit",
          "断片化方法": "超音波断片化（Covaris LE220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "-",
          "クオリティコントロール方法": "-",
          "マッピング方法": "-",
          "マッピングクオリティ": "-",
          "平均カバー率（Depth）": "32.4 x",
          "変異検出方法": "-",
          "マーカー数": "4,301,546 SNPs（hg19）",
          "NBDC Dataset ID": "hum0015.v1.freq.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）",
          "総データ量": "339 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000159（hum0015.v3.3.5kjpnv2.v1[非制限公開]にアクセス制限が変更されました。hum0015.v3.3.5kjpnv2.v1をご参照ください。）": {
          "対象": "日本人一般住民：3,552名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free HT sample prep kit",
          "断片化方法": "超音波断片化（Covaris LE220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "162 bp または 259 bp",
          "クオリティコントロール方法": "quantitative MiSeq（doi: 10.1016/j.ab.2014.08.015）",
          "マッピング方法": "-",
          "マッピングクオリティ": "-",
          "平均カバー率（Depth）": "162PE: 27.2x, 259PE: 21.3x",
          "変異検出方法": "-",
          "マーカー数": "常染色体：約50,500,000 SNVs + Indels\r\nX染色体：約2,000,000 SNVs + Indels\r\nミトコンドリア：約2,500 SNVs",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000237",
          "総データ量": "2 GB（vcf [ref：GRCh37/hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0015.v3.3.5kjpnv2.v1": {
          "対象": "日本人一般住民：3,552名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free HT sample prep kit",
          "断片化方法": "超音波断片化（Covaris LE220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "162 bp または 259 bp",
          "クオリティコントロール方法": "quantitative MiSeq（doi: 10.1016/j.ab.2014.08.015）",
          "マッピング方法": "-",
          "マッピングクオリティ": "-",
          "平均カバー率（Depth）": "162PE: 27.2x, 259PE: 21.3x",
          "変異検出方法": "-",
          "マーカー数": "常染色体：約50,500,000 SNVs + Indels\r\nX染色体：約2,000,000 SNVs + Indels\r\nミトコンドリア：約2,500 SNVs",
          "NBDC Dataset ID": "hum0015.v3.3.5kjpnv2.v1\r\n    ・SNVアレル頻度（常染色体）\r\n    ・SNVアレル頻度（X染色体［PAR1+PAR2］）\r\n    ・SNVアレル頻度（X染色体［PAR1+XTR+PAR2］）\r\n    ・SNVアレル頻度（ミトコンドリア）\r\n    ・indelアレル頻度（常染色体）\r\n    ・indelアレル頻度（X染色体［PAR1+PAR2］）\r\n    ・indelアレル頻度（X染色体［PAR1+XTR+PAR2］）\r\n（データのダウンロードは各項目名をクリックしてください）\r\nmetadata",
          "総データ量": "2 GB（vcf [ref：GRCh37/hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": " 山本 雅之",
        "所 属 機 関": "東北大学 東北メディカル・メガバンク機構",
        "プロジェクト/研究グループ名": "東北メディカル・メガバンク",
        "科研費/助成金（Research Project Number）": {
          "4": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 医療研究開発推進事業費補助金",
            "タイトル": "東北メディカル・メガバンク計画（岩手医科大学）一般会計分",
            "研究課題番号": "JP18km0105004"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals",
          "DOI": "doi:10.1038/ncomms9018",
          "データID": "hum0015.v1.freq.v1"
        },
        "2": {
          "タイトル": "3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome",
          "DOI": "doi: 10.1038/s41439-019-0059-5",
          "データID": "hum0015.v3.3.5kjpnv2.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0015.v3": {
          "Research ID": "hum0015.v3",
          "公開日": "2019/01/11",
          "内容": "日本人3,552名の常染色体、X染色体、ミトコンドリアのアレル頻度情報",
          "description": "このバージョンでは、制限公開データ（Type I）として当初公開していたJGAD000159のアクセス制限（制限公開[Type I]）を非制限公開データ（hum0015.v3.3.5kjpnv2.v1）に変更し、公開を開始した。\n"
        },
        "hum0015.v2": {
          "Research ID": "hum0015.v2",
          "公開日": "2018/12/27",
          "内容": "日本人3,552名の常染色体、X染色体、ミトコンドリアのアレル頻度情報",
          "description": "日本人3,552名の全ゲノム塩基配列を決定し、常染色体、X染色体、ミトコンドリアDNA上のSNVs・In/delsのアレル頻度情報を提供する。\n塩基配列決定はIllumina [HiSeq 2500]を使用。\n"
        },
        "hum0015.v1": {
          "Research ID": "hum0015.v1",
          "公開日": "2014/10/14",
          "内容": "常染色体上に存在する頻度が5％を超える既知SNPの日本人成人1070人における頻度情報",
          "description": "全染色体領域を対象としたNGSにて日本人成人1070名の塩基配列を決定し、検出された変異の内集団内頻度が5％を超える常染色体上の既知SNPsの集団内頻度情報。\n塩基配列決定はIllumina [HiSeq 2500]を使用。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0015.v3",
      "DATA": {
        "hum0015.v1.freq.v1": {
          "Data Set ID": "hum0015.v1.freq.v1",
          "Type of Data": "Frequencies of known autosomal SNPs whose minor allele frequencies are more than 5% in 1070 participants.",
          "Criteria": "Unrestricted-access",
          "Release Date": "2014/10/14"
        },
        "JGAS000159": {
          "Data Set ID": "JGAS000159",
          "Type of Data": "Allele frequencies of SNVs/Indels on autosomal chromosomes, X-chromosome, and mitochondrial DNA in 3552 participants",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/12/27"
        },
        "hum0015.v3.3.5kjpnv2.v1": {
          "Data Set ID": "hum0015.v3.3.5kjpnv2.v1",
          "Type of Data": "Allele frequencies of SNVs/Indels on autosomal chromosomes, X-chromosome, and mitochondrial DNA in 3552 participants",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/01/11"
        }
      },
      "SUMMARY": {
        "Aims": "Construction of the whole-genome reference panel of Japanese individuals by deep whole-genome sequencing",
        "Methods": "DNA was extracted from the blood samples of the subjects. We conducted whole-genome sequencing by using HiSeq 2500. After genotype calling for each individual, genotype frequencies were pooled, and allele frequencies were calculated.",
        "Participants/Materials": "",
        "URL": "https://www.megabank.tohoku.ac.jp/english/"
      },
      "MOLECULAR DATA": {
        "hum0015.v1.freq.v1": {
          "Participants/Materials": "1070 healthy Japanese individuals living in Miyagi prefecture",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Hiseq 2500]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free HT sample prep kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris LE220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "-",
          "QC Methods": "-",
          "Mapping Methods": "-",
          "Mapping Quality": "-",
          "Coverage（Depth）": "32.4 x",
          "Variation Detection Methods": "-",
          "Marker Number": "4,301,546 SNPs (hg19)",
          "NBDC Dataset ID": "hum0015.v1.freq.v1\r\n(Click the Dataset ID to download the file)",
          "Total Data Volume": "339 MB",
          "Comments (Policies)": "NBDC policy"
        },
        " JGAS000159 （The access level was changed to \"Un-restricted Access\". Please have a look at hum0015.v3.3.5kjpnv2.v1.)": {
          "Participants/Materials": "3552 individuals from the general populations in Japan",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Hiseq 2500]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free HT sample prep kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris LE220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "162 bp or 259 bp",
          "QC Methods": "quantitative MiSeq (doi: 10.1016/j.ab.2014.08.015)",
          "Mapping Methods": "-",
          "Mapping Quality": "-",
          "Coverage（Depth）": "162PE: 27.2x, 259PE: 21.3x",
          "Variation Detection Methods": "-",
          "Marker Number": "About 50,500,000 SNVs/Indels on autosomes\r\nAbout 2,000,000 SNVs/Indels on X-chromosome\r\nAbout 2,500 SNVs on mitochondrial DNA",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000237",
          "Total Data Volume": "2 GB (vcf [ref: GRCh37/hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0015.v3.3.5kjpnv2.v1": {
          "Participants/Materials": "3552 individuals from the general populations in Japan",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Hiseq 2500]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free HT sample prep kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris LE220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "162 bp or 259 bp",
          "QC Methods": "quantitative MiSeq (doi: 10.1016/j.ab.2014.08.015)",
          "Mapping Methods": "-",
          "Mapping Quality": "-",
          "Coverage（Depth）": "162PE: 27.2x, 259PE: 21.3x",
          "Variation Detection Methods": "-",
          "Marker Number": "About 50,500,000 SNVs/Indels on autosomes\r\nAbout 2,000,000 SNVs/Indels on X-chromosome\r\nAbout 2,500 SNVs on mitochondrial DNA",
          "NBDC Dataset ID": "hum0015.v3.3.5kjpnv2.v1\r\n    -Allele frequencies of SNVs (autosomes)\r\n    -Allele frequencies of SNVs (X-chromosome [PAR1+PAR2])\r\n    -Allele frequencies of SNVs (X-chromosome [PAR1+XTR+PAR2])\r\n    -Allele frequencies of SNVs (mitochondrial DNA)\r\n    -Allele frequencies of Indels (autosomes)\r\n    -Allele frequencies of Indels (X-chromosome [PAR1+PAR2])\r\n    -Allele frequencies of Indels (X-chromosome [PAR1+XTR+PAR2])\r\n(Click each data name to download the file)\r\nmetadata",
          "Total Data Volume": "2 GB (vcf [ref: GRCh37/hg19])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Masayuki Yamamoto",
        "Affiliation": "Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University",
        "Project / Group Name": "Tohoku Medical Megabank Organization",
        "Funds / Grants (Research Project Number)": {
          "4": {
            "Name": "Japan Agency for Medical Research and Development (AMED)",
            "Title": "Tohoku Medical Megabank Project (Iwate Medical University) General Accounting",
            "Project Number": "JP18km0105004"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals",
          "DOI": "doi:10.1038/ncomms9018",
          "Data Set ID": "hum0015.v1.freq.v1"
        },
        "2": {
          "Title": "3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome",
          "DOI": "doi: 10.1038/s41439-019-0059-5",
          "Data Set ID": "hum0015.v3.3.5kjpnv2.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0015.v3": {
          "Research ID": "hum0015.v3",
          "Release Date": "2019/01/11",
          "Type of Data": "Allele frequencies of SNVs and In/dels on autosomal chromosomes, X-chromosome and mitochondrial DNA in 3552 participants",
          "description": "The access level of JGAD000159 (Controlled-access [Type I]) was changed to \"Unrestricted-access\" (hum0015.v3.3.5kjpnv2.v1).\n"
        },
        "hum0015.v2": {
          "Research ID": "hum0015.v2",
          "Release Date": "2018/12/27",
          "Type of Data": "Allele frequencies of SNVs and In/dels on autosomal chromosomes, X-chromosome and mitochondrial DNA in 3552 participants",
          "description": "Whole-genome sequencing by using of HiSeq 2500 was performed. After genotype calling for each individual, genotypes of 3552 individuals were pooled, and allele frequencies were calculated. Allele frequencies of SNVs and Indels on autosomal chromosomes, X-chromosome, and mitochondrial DNA in 3552 participants were provided.\n"
        },
        "hum0015.v1": {
          "Research ID": "hum0015.v1",
          "Release Date": "2014/10/14",
          "Type of Data": "Frequencies of known autosomal SNPs whose minor allele frequencies are more than 5% in 1070 participants.",
          "description": " Whole-genome sequencing by using of HiSeq 2500 was performed. After genotype calling for each individual, genotypes of 1070 individuals were pooled, and allele frequencies were calculated. Autosomal SNPs (minor allele frequency > 5%) that matched known SNPs in dbSNP138 were selected.\nNote：\n"
        }
      }
    }
  },
  "hum0014.v31": {
    "ja": {
      "NBDC Research ID": "hum0014.v31",
      "データ": {
        "hum0014.v1.freq.v1": {
          "データID": "hum0014.v1.freq.v1",
          "内容": "心筋梗塞1,666症例および\r\n対照健常者3,198名のGWAS",
          "制限": "非制限公開",
          "公開日": "2014/09/30"
        },
        "hum0014.v2.jsnp.934ctrl.v1": {
          "データID": "hum0014.v2.jsnp.934ctrl.v1",
          "内容": "健常者934名の遺伝子型カウント情報\r\n（JSNPのデータ）",
          "制限": "非制限公開",
          "公開日": "2015/12/28"
        },
        "35疾患": {
          "データID": "35疾患",
          "内容": "35疾患各約190症例における遺伝子型カウント情報\r\n（JSNPのデータ）",
          "制限": "非制限公開",
          "公開日": "2015/12/28"
        },
        "hum0014.v2.jsnp.182ec.v1": {
          "データID": "hum0014.v2.jsnp.182ec.v1",
          "内容": "食道がん182症例の遺伝子型カウント情報\r\n（JSNPのデータ）",
          "制限": "非制限公開",
          "公開日": "2015/12/28"
        },
        "hum0014.v2.jsnp.92als.v1": {
          "データID": "hum0014.v2.jsnp.92als.v1",
          "内容": "筋萎縮性側索硬化症92症例の遺伝子型カウント情報\r\n（JSNPのデータ）",
          "制限": "非制限公開",
          "公開日": "2015/12/28"
        },
        "hum0014.v3.T2DM-1.v1": {
          "データID": "hum0014.v3.T2DM-1.v1",
          "内容": "２型糖尿病9,817症例および\r\n対照者6,763名のGWAS",
          "制限": "非制限公開",
          "公開日": "2016/01/28"
        },
        "hum0014.v3.T2DM-2.v1": {
          "データID": "hum0014.v3.T2DM-2.v1",
          "内容": "２型糖尿病5,646症例および\r\n対照者19,420名のGWAS",
          "制限": "非制限公開",
          "公開日": "2016/01/28"
        },
        "hum0014.v4.AD.v1": {
          "データID": "hum0014.v4.AD.v1",
          "内容": "アトピー性皮膚炎患者1,472症例および\r\n対照者7,966名のGWAS",
          "制限": "非制限公開",
          "公開日": "2016/02/02"
        },
        "hum0014.v5.AF.v1": {
          "データID": "hum0014.v5.AF.v1",
          "内容": "心房細動患者8,180症例および対照者28,612名のGWAS",
          "制限": "非制限公開",
          "公開日": "2017/05/18"
        },
        "JGAS000101": {
          "データID": "JGAS000101",
          "内容": "心房細動患者8,180症例のPhenotypeデータ、Genotypeデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2017/05/18"
        },
        "hum0014.v6.158k.v1": {
          "データID": "hum0014.v6.158k.v1",
          "内容": "158,284名のBMIのGWAS",
          "制限": "非制限公開",
          "公開日": "2017/09/08"
        },
        "JGAS000114": {
          "データID": "JGAS000114",
          "内容": "バイオバンクジャパン1,037名のWGSデータと1000ゲノムプロジェクト（Phase3v5）2504名のWGSのvcfファイルを統合したgenotype imputation用のreference panel",
          "制限": "制限公開（Type I）",
          "公開日": "2019/09/27"
        },
        "hum0014.v7.POAG.v1": {
          "データID": "hum0014.v7.POAG.v1",
          "内容": "開放隅角緑内障3,980症例および\r\n対照者18,815名のGWAS",
          "制限": "非制限公開",
          "公開日": "2018/04/04"
        },
        "hum0014.v8.58qt.v1": {
          "データID": "hum0014.v8.58qt.v1",
          "内容": "162,255名の58臨床検査値のGWAS",
          "制限": "非制限公開",
          "公開日": "2018/05/01"
        },
        "hum0014.v9.Men.v1\r\nhum0014.v9.MP.v1": {
          "データID": "hum0014.v9.Men.v1\r\nhum0014.v9.MP.v1",
          "内容": "初潮年齢データを有する女性67,029名および閉経年齢データを有する女性43,861名のGWAS",
          "制限": "非制限公開",
          "公開日": "2018/08/07"
        },
        "JGAS000140": {
          "データID": "JGAS000140",
          "内容": "乳がん7,104症例と対照者23,731名の遺伝性乳がん原因11遺伝子翻訳領域のTarget Capture Sequencingデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2018/10/16"
        },
        "hum0014.v12.T2DMwN.v1": {
          "データID": "hum0014.v12.T2DMwN.v1",
          "内容": "２型糖尿病腎症2,809症例および\r\n２型糖尿病対照5,592症例のGWASメタ解析",
          "制限": "非制限公開",
          "公開日": "2018/12/10"
        },
        "hum0014.v13.T2DMmeta.v1": {
          "データID": "hum0014.v13.T2DMmeta.v1",
          "内容": "２型糖尿病36,614症例および\r\n対照者155,150名のGWASメタ解析",
          "制限": "非制限公開",
          "公開日": "2019/01/25"
        },
        "hum0014.v14.smok.v1": {
          "データID": "hum0014.v14.smok.v1",
          "内容": "日本人集団165,436名における喫煙習慣のGWAS",
          "制限": "非制限公開",
          "公開日": "2019/03/26"
        },
        "hum0014.v15.ht.v1": {
          "データID": "hum0014.v15.ht.v1",
          "内容": "159,095名の身長のGWAS",
          "制限": "非制限公開",
          "公開日": "2019/09/27"
        },
        "JGAS000203": {
          "データID": "JGAS000203",
          "内容": "遺伝性前立腺がん7,636症例と対照者12,366名の遺伝性前立腺がん原因8遺伝子翻訳領域のTarget Capture Sequencingデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2019/10/07"
        },
        "hum0014.v17": {
          "データID": "hum0014.v17",
          "内容": "40疾患のGWAS",
          "制限": "非制限公開",
          "公開日": "2019/10/08"
        },
        "hum0014.v18": {
          "データID": "hum0014.v18",
          "内容": "乳がんのGWAS",
          "制限": "非制限公開",
          "公開日": "2019/11/26"
        },
        "hum0014.v19": {
          "データID": "hum0014.v19",
          "内容": "日本人集団165,084名における食習慣のGWAS",
          "制限": "非制限公開",
          "公開日": "2020/04/20"
        },
        "hum0014.v20.cad.v1": {
          "データID": "hum0014.v20.cad.v1",
          "内容": "冠動脈疾患のGWAS",
          "制限": "非制限公開",
          "公開日": "2020/08/17"
        },
        "hum0014.v21": {
          "データID": "hum0014.v21",
          "内容": "虚血性心疾患のGWAS",
          "制限": "非制限公開",
          "公開日": "2020/08/25"
        },
        "JGAS000293": {
          "データID": "JGAS000293",
          "内容": "2003年から2007年度にバイオバンク・ジャパンに登録されたサンプル（約20万例）から抽出された11,234名の23遺伝子における全てのエクソン領域のTarget Capture Sequencingn解析より得られた体細胞変異データおよびSNPアレイにより得られた染色体変異データ",
          "制限": "制限公開（Type I）",
          "公開日": "2021/05/21"
        },
        "JGAS000114 にデータ追加": {
          "データID": "JGAS000114 にデータ追加",
          "内容": "JGAD000220のWGSデータのbam/gvcfデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/13"
        },
        "JGAS000327": {
          "データID": "JGAS000327",
          "内容": "膵がん1,005症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/26"
        },
        "JGAS000346": {
          "データID": "JGAS000346",
          "内容": "大腸がん12,503症例および対照者23,705名の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/26"
        },
        "JGAS000381": {
          "データID": "JGAS000381",
          "内容": "心筋梗塞1,765症例、認知症199症例のWGSデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/01/25"
        },
        "JGAS000414": {
          "データID": "JGAS000414",
          "内容": "腎がん740症例および対照者5,996名の遺伝性腫瘍関連27遺伝子および腎がん関連13遺伝子翻訳領域のTarget Capture Sequencingデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2022/04/01"
        },
        "hum0014.v27.surv.v1": {
          "データID": "hum0014.v27.surv.v1",
          "内容": "BBJ第1コホート137,693名の生存に関するGWAS",
          "制限": "非制限公開",
          "公開日": "2022/12/31"
        },
        "hum0014.v28.MEs.v1": {
          "データID": "hum0014.v28.MEs.v1",
          "内容": "BBJ第1コホート4,880名のmobile element多型頻度情報",
          "制限": "非制限公開",
          "公開日": "2023/04/05"
        },
        "hum0014.v29.AF.v1": {
          "データID": "hum0014.v29.AF.v1",
          "内容": "心房細動患者9,826症例および対照者140,446名のGWAS（BBJ）\r\n心房細動患者77,690症例および対照者1,167,040名のGWASメタ解析（BBJ、欧米人、FinnGen）",
          "制限": "非制限公開",
          "公開日": "2023/04/05"
        },
        "JGAS000347": {
          "データID": "JGAS000347",
          "内容": "リンパ腫1,982症例の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2023/04/20"
        },
        "JGAS000592": {
          "データID": "JGAS000592",
          "内容": "対照者37,592名（BBJの非がん対象者）の遺伝性腫瘍関連27遺伝子翻訳領域のTarget Capture Sequencingデータ",
          "制限": "制限公開（Type I）",
          "公開日": "2023/04/20"
        },
        "JGAD000690": {
          "データID": "JGAD000690",
          "内容": "JGAD000220（BBJ1,026名のWGS）の加工データ（CRAM、gVCF）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/09/01"
        },
        "JGAD000758": {
          "データID": "JGAD000758",
          "内容": "JGAD000220（BBJ1,026名のWGS）の加工データ（joint call）（aggregate VCF）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/09/01"
        },
        "JGAD000679": {
          "データID": "JGAD000679",
          "内容": "JGAD000220（reference panel）の加工データ（NBDC-DDBJ imputation server用データ）",
          "制限": "制限公開（Type I）",
          "公開日": "2023/09/01"
        }
      },
      "研究内容の概要": {
        "目的": "日本人における疾患関連遺伝子の特定、日本人における転移因子挿入多型の網羅的探索",
        "方法": "Human610-Quad BeadChip、HumanHap550v3 Genotyping BeadChip、HumanOmniExpress-12 BeadChip、HumanExome BeadChip、 OmniExpressExome Beadchip（Illumina社）、high-density oligonucleotide arrays （Perlegen Sciences社）、もしくはインベーダー法（Hologic Japan社）により遺伝子型を決定し、心筋梗塞、２型糖尿病、アトピー性皮膚炎、心房細動、Body Mass Index（BMI）、開放隅角緑内障、58形質、初潮・閉経年齢、喫煙習慣、身長、42疾患（4疾患は以前のリリースと一部重複あり）、食習慣、および冠動脈疾患のゲノムワイド関連解析（Genome Wide Association Study：GWAS）や２型糖尿病腎症および２型糖尿病発症のGWASメタ解析を実施。また、Illumina社 HiSeq 2500/X Fiveを用いて、BBJ第1コホート1,026名、心筋梗塞1,765症例、および認知症199症例の全ゲノムシークエンス（Whole Genome Sequencing：WGS）を実施した。乳がん7,104症例と対照者23,731名における遺伝性乳がん原因11遺伝子翻訳領域、遺伝性前立腺がん7,636症例と対照者12,366名における遺伝性前立腺がん原因8遺伝子翻訳領域、バイオバンクジャパン11,234名における23遺伝子、膵がん1,005症例、大腸がん12,503症例および対照者23,705名、腎がん740症例および対照者5,996名、リンパ腫1,982症例、胃がん10,366症例および対照者37,592名の遺伝性腫瘍関連27遺伝子翻訳領域ならびに腎がん740症例および対照者5,996名の腎がん関連13遺伝子翻訳領域のTarget Capture Sequencingを実施した。遺伝性乳がん原因11遺伝子翻訳領域、遺伝性前立腺がん原因8遺伝子翻訳領域、バイオバンクジャパン11,234名における23遺伝子、遺伝性腫瘍関連27遺伝子翻訳領域および腎がん関連13遺伝子翻訳領域のTarget Capture Sequencingを実施した。バイオバンクジャパン1,037名のWGSデータから作成したvcfファイルと1000ゲノムプロジェクト（Phase3v5）2504名のvcfファイルを統合し、genotype imputation用reference panelを作成した。バイオバンクジャパン137,693名について、男女別にCox回帰分析を実施した。当研究室が開発したソフトウェアを用い、バイオバンクジャパンの第1コホート4,880名のWGSデータから転移因子多型の同定を行った。バイオバンクジャパンの心房細動ケース9,826人とコントロール140,446人で心房細動GWASを実施し、さらに欧米人の心房細動GWAS（http://csg.sph.umich.edu/willer/public/afib2018; 60,620人ケースと970,216人コントロール、FinnGen; https://www.finngen.fi/en; 7,244人ケースと56,378人コントロール）とメタ解析を行った。メタ解析の結果からポリジェニックリスクスコアを構築した。",
        "対象": "オーダーメイド医療実現化プロジェクトおよびオーダーメイド医療の実現プログラム参加者",
        "URL": "http://www.biobankjp.org/index.html"
      },
      "分子データ": {
        "hum0014.v1.freq.v1": {
          "対象": "心筋梗塞：1,666症例、対照健常者：3,198名",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Human610-Quad BeadChip、HumanHap550v3 Genotyping BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina Human610-Quad Beadchip",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "フィルタリング": "Sample Call rate < 0.98, SNP call rate < 0.99, HWE P < 1 x 10^-6",
          "マーカー数(QC後)": "455,781 SNPs （hg18/GRCh36）",
          "NBDC Dataset ID": "hum0014.v1.freq.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "71.3 MB（xlsx）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v2.jsnp.934ctrl.v1": {
          "対象": "健常者：934名（JSNP）",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanHap550v3 Genotyping BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina HumanHap550v3 Genotyping BeadChip",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "フィルタリング": "Sample Call rate < 0.98, SNP call rate < 0.99, HWE P < 1 x 10^-6",
          "マーカー数(QC後)": "515,286 SNPs",
          "NBDC Dataset ID": "hum0014.v2.jsnp.934ctrl.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "32.2 MB（zip [xls]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "35疾患": {
          "対象": "悪性腫瘍 （肺がん、乳がん、胃がん、大腸・直腸がん、前立腺がん）\r\n心血管系疾患 （心不全、心筋梗塞，不安定狭心症、安定狭心症、不整脈、閉塞性動脈硬化症）\r\n脳血管障害 （脳梗塞、脳動脈瘤）\r\n呼吸器疾患 （間質性肺炎＆肺線維症、肺気腫、気管支喘息）\r\n慢性肝疾患 （C型慢性肝炎、肝硬変）\r\n眼疾患 （白内障、緑内障）\r\nその他 （てんかん、歯周病、尿路結石、ネフローゼ症候群、子宮筋腫、子宮内膜症、\r\n骨粗鬆症、関節リウマチ、筋萎縮性側索硬化症、花粉症、アトピー性皮膚炎、\r\n過敏性症候群（薬疹）、高脂血症、糖尿病、バセドウ病）\r\n各約190症例",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Perlegen Sciences [high-density oligonucleotide arrays]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "-",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "-",
          "フィルタリング": "-",
          "マーカー数(QC後)": "約20万SNPs （b129）",
          "データセット": "悪性腫瘍 （肺がん、乳がん、胃がん、大腸・直腸がん、前立腺がん）\r\n心血管系疾患 （心不全、心筋梗塞、不安定狭心症、安定狭心症、不整脈、閉塞性動脈硬化症）\r\n脳血管障害 （脳梗塞、脳動脈瘤）\r\n呼吸器疾患 （間質性肺炎＆肺線維症、肺気腫、気管支喘息）\r\n慢性肝疾患 （C型慢性肝炎、肝硬変）\r\n眼疾患 （白内障、緑内障）\r\nその他 （てんかん、歯周病、尿路結石、ネフローゼ症候群、子宮筋腫、子宮内膜症、\r\n骨粗鬆症、関節リウマチ、筋萎縮性側索硬化症、花粉症、アトピー性皮膚炎、\r\n過敏性症候群（薬疹）、高脂血症、糖尿病、バセドウ病）\r\n（データのダウンロードは上記疾患名をクリックしてください）\r\nDictionary file",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v2.jsnp.182ec.v1": {
          "対象": "食道がん：182症例（JSNP）",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanHap550v3 Genotyping BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina HumanHap550v3 Genotyping BeadChip",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "フィルタリング": "Sample Call rate < 0.98, SNP call rate < 0.99, HWE P < 1 x 10^-6",
          "マーカー数(QC後)": "503,734 SNPs",
          "NBDC Dataset ID": "hum0014.v2.jsnp.182ec.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "6.6 MB（zip [txt]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v2.jsnp.92als.v1": {
          "対象": "筋萎縮性側索硬化症：92症例（JSNP）",
          "規模": "large-scale case-control association study",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Hologic Japan [Invader]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Invader assay system（Third Wave Technologies）",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "ABI PRISM SDS versions 2.0 - 2.2",
          "フィルタリング": "SNP call rate ≥ 0.95（疾患群、対照群）, HWE P ≥1.0 x 10^-2（対照群）",
          "マーカー数(QC後)": "48,939 SNPs",
          "NBDC Dataset ID": "hum0014.v2.jsnp.92als.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "3.2 MB（zip [txt]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v3.T2DM-1.v1": {
          "対象": "２型糖尿病：9,817症例、\r\n対照者：6,763名（健常者および糖尿病を合併していない脳動脈瘤、食道がん、子宮体がん、肺気腫、緑内障の患者）",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [OmniExpressExome Beadchip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina OmniExpressExome Beadchip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "フィルタリング": "Sample Call rate < 0.98, SNP call rate < 0.99, MAF < 0.01 HWE P < 1 x 10^-6 in control",
          "マーカー数(QC後)": "552,915 SNPs （hg19）",
          "NBDC Dataset ID": "hum0014.v3.T2DM-1.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "84.0 MB（xlsx）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v3.T2DM-2.v1": {
          "対象": "２型糖尿病：5,646症例、\r\n対照者：19,420名 （糖尿病を合併していない大腸-直腸がん、乳がん、前立腺がん、肺がん、胃がん、\r\n閉塞性動脈硬化症、不整脈、脳梗塞、心筋梗塞、胆嚢・胆管がん、膵がん、過敏性症候群（薬疹）、\r\n関節リウマチ、筋萎縮性側索硬化症、肝がん、肝硬変、骨粗鬆症、子宮筋腫の患者）",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Human610-Quad BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina Human610-Quad Beadchip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "フィルタリング": "Sample Call rate < 0.98, SNP call rate < 0.99, MAF < 0.01 HWE P < 1 x 10^-6 in control",
          "マーカー数(QC後)": "479,088 SNPs （hg18）",
          "NBDC Dataset ID": "hum0014.v3.T2DM-2.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "72.6 MB（xlsx）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v4.AD.v1": {
          "対象": "アトピー性皮膚炎：1,472症例、\r\n対照者：7,966名（健常者およびアトピー性皮膚炎と気管支喘息のいずれも合併していない脳動脈瘤、食道がん、子宮体がん、肺気腫、緑内障の患者）",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress-12 BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress-12 BeadChip",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac [imputation（1000 genomes Phase I v3 ）]",
          "関連解析（ソフトウェア）": "mach2dat [GWAS]",
          "フィルタリング": "GenotypingのQC：sample call rate < 0.98, SNV call rate < 0.99, 対照者群で HWE P < 1 x 10^-6\r\nImputationのQC：リファレンスパネルで HWE P < 1 x 10^-6 もしくは MAF < 0.01\r\n     　                     GWASデータセットとリファレンスパネルのアレル頻度差 > 0.16",
          "マーカー数(QC後)": "約770万 SNVs（hg19）",
          "NBDC Dataset ID": "hum0014.v4.AD.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "ADGWAS_auto.txt （525 MB）\r\nADGWAS_X_females.txt （17 MB）\r\nADGWAS_X_males.txt （15 MB）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000101 / hum0014.v5.AF.v1": {
          "対象": "心房細動：8,180症例\r\n対照者：28,612名",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac [imputation（1000 genomes Phase I v3 ）]\r\nGenCall software（GenomeStudio）",
          "関連解析（ソフトウェア）": "mach2dat [GWAS]",
          "フィルタリング": "GenotypingのQC：sample call rate < 0.98, SNV call rate < 0.99, 対照者群で HWE P < 1 x 10^-6\r\nImputationのQC：リファレンスパネルで HWE P < 1 x 10^-6 もしくは MAF < 0.01\r\n     　                     GWASデータセットとリファレンスパネルのアレル頻度差 > 0.16\r\n                              R square < 0.9",
          "マーカー数(QC後)": "約500万 SNVs（hg19）",
          "Phenotype情報": "性別、年齢",
          "NBDC Dataset ID / \r\nJapanese Genotype-phenotype \r\nArchive Dataset ID": "【GWAS集計情報】\r\nhum0014.v5.AF.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file\r\n【個別データ（心房細動群のみ）】\r\nPhenotype：JGAD000101\r\nGenotype：JGAD000102",
          "総データ量": "GWAS：485 MB（txt）\r\nPhenotype、Genotype：1 GB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000114 / hum0014.v6.158k.v1": {
          "対象": "182,505名（内、BMI研究で使用した対象数：158,284名）",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac [imputation（1000 genomes Phase I v3 ）] \r\nGenCall software（GenomeStudio）",
          "関連解析（ソフトウェア）": "mach2qtl (v1.1.3)",
          "フィルタリング": "GenotypingのQC：sample call rate < 0.98, SNV call rate < 0.99, HWE P < 1 x 10^-6 \r\nImputation referenceのQC:\r\n　以下の条件に該当するSNVはreferenceから除外:\r\n　1) HWE P < 1 x 10^-6、2) MAF < 0.01\r\nImputation後のQC:\r\n　Imputation quality (Rsq) < 0.7　を除外。",
          "マーカー数(QC後)": "常染色体：約600万 SNVs (hg19)\r\nX染色体：約15万 SNVs (hg19)",
          "NBDC Dataset ID / \r\nJapanese Genotype-phenotype \r\nArchive Dataset ID": "【GWAS】\r\nhum0014.v6.158k.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file\r\n【個別データ】\r\nPhenotypeデータ（BMI）：JGAD000124\r\nGenotypeデータ：JGAD000123\r\n遺伝型情報に関する詳細\r\nアレイプローブの取り扱いに関する情報",
          "総データ量": "GWAS：406 MB（zip）\r\nPhenotypeデータ（BMI）：3.32 MB（txt.gz）\r\nGenotypeデータ：26.3 GB（csv.gz）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v7.POAG.v1": {
          "対象": "開放隅角緑内障（ICD10：H401）：3,980症例（男性：1,997、女性：1,983）\r\n対照者：18,815名（男性：7,817、女性：10,998）",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac（ver. 0.1.1）[imputation（1000 genomes Phase I v3 ）]",
          "関連解析（ソフトウェア）": "mach2dat（ver. 1.0.19）",
          "フィルタリング": "GenotypingのQC：sample call rate < 0.98, SNV call rate < 0.99, MAF < 0.5%, \r\n　　　　　　　　  対照者群で HWE P < 1 x 10^-6 \r\nImputationのQC：リファレンスパネルで HWE P < 1 x 10^-6 もしくは MAF < 0.01 　 \r\n　　　　　　　　GWASデータセットとリファレンスパネルのアレル頻度差 > 0.16 \r\nImputation後のQC：Imputation quality (Rsq) < 0.7を除外。\r\n　　　　　　　　　さらに、ベータが4未満もしくは4を超えるものは公開用に除外。",
          "マーカー数(QC後)": "常染色体：5,961,428 SNPs（hg19）\r\n男性X染色体：147,351 SNPs（hg19）\r\n女性X染色体：147,353 SNPs（hg19）",
          "NBDC Dataset ID": "hum0014.v7.POAG-1.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "113 MB（txt.zip）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000114 / hum0014.v8.58qt.v1": {
          "対象": "162,255名の58臨床検査値",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac [imputation（1000 genomes Phase I v3 ）] \r\nGenCall software（GenomeStudio）",
          "関連解析（ソフトウェア）": "mach2qtl（v1.1.3）",
          "フィルタリング": "GenotypingのQC：sample call rate < 0.98, SNV call rate < 0.99, HWE P < 1 x 10^-6 \r\nImputation referenceのQC:\r\n　以下の条件に該当するSNVはreferenceから除外:\r\n　1) HWE P < 1 x 10^-6、2) MAF < 0.01\r\nImputation後のQC:\r\n　Imputation quality (Rsq) < 0.7　を除外。",
          "マーカー数(QC後)": "常染色体：5,961,600 SNVs（hg19）\r\nX染色体：147,353 SNVs（hg19）",
          "HDLコレステロール": "JGAD000145",
          "LDLコレステロール": "JGAD000146",
          "中性脂肪": "JGAD000147",
          "血糖": "JGAD000148",
          "ヘモグロビンA1c": "JGAD000149",
          "アルブミン": "JGAD000151",
          "非アルブミン蛋白": "JGAD000152",
          "アルブミン/グロブリン比": "JGAD000153",
          "血清クレアチニン": "JGAD000155",
          "推算糸球体濾過量": "JGAD000156",
          "尿酸": "JGAD000157",
          "カリウム": "JGAD000159",
          "クロール": "JGAD000160",
          "カルシウム": "JGAD000161",
          "無機リン": "JGAD000162",
          "硫酸亜鉛混濁試験": "JGAD000164",
          "アスパラギン酸アミノ基転移酵素": "JGAD000165",
          "アラニンアミノ基転移酵素": "JGAD000166",
          "アルカリフォスファターゼ": "JGAD000167",
          "ガンマグルタミルトランスフェラーゼ": "JGAD000168",
          "プロトロンビン時間": "JGAD000170",
          "フィブリノーゲン": "JGAD000171",
          "クレアチンキナーゼ": "JGAD000172",
          "乳酸脱水素酵素": "JGAD000173",
          "C反応性蛋白": "JGAD000174",
          "好中球数": "JGAD000176",
          "好酸球数": "JGAD000177",
          "好塩基球数": "JGAD000178",
          "単球数": "JGAD000179",
          "リンパ球数": "JGAD000180",
          "赤血球数": "JGAD000181",
          "ヘモグロビン濃度": "JGAD000182",
          "ヘマトクリット値": "JGAD000183",
          "平均赤血球容積": "JGAD000184",
          "平均赤血球ヘモグロビン量": "JGAD000185",
          "平均赤血球ヘモグロビン濃度": "JGAD000186",
          "血小板数": "JGAD000187",
          "拡張期血圧": "JGAD000189",
          "平均血圧": "JGAD000190",
          "脈圧": "JGAD000191",
          "後壁厚": "JGAD000193",
          "左室拡張末期径": "JGAD000194",
          "左室収縮末期径": "JGAD000195",
          "左室心筋重量": "JGAD000196",
          "左室心筋重量係数": "JGAD000197",
          "相対的壁厚": "JGAD000198",
          "左室内径短縮率": "JGAD000199",
          "左室駆出率": "JGAD000200",
          "E/A比": "JGAD000201",
          "総データ量": "GWAS：平均 123 MB（zip）\r\nPhenotypeデータ（58形質）：平均 2.4 MB（txt.gz）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v9.Men.v1 / hum0014.v9.MP.v1": {
          "対象": "初潮年齢データを有する女性67,029名\r\n閉経年齢データを有する女性43,861名",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac [imputation（1000 genomes Phase I v3 ）] \r\nGenCall software（GenomeStudio）",
          "関連解析（ソフトウェア）": "mach2qtl (v1.1.3)",
          "フィルタリング": "GenotypingのQC：sample call rate < 0.98, SNV call rate < 0.99, MAF < 0.5%, \r\n　　　　　　　　  対照者群で HWE P < 1 x 10^-6 \r\nImputationのQC：リファレンスパネルで HWE P < 1 x 10^-6 もしくは MAF < 0.01 　 \r\n　　　　　　　　GWASデータセットとリファレンスパネルのアレル頻度差 > 0.16 \r\nImputation後のQC：Imputation quality (Rsq) < 0.7を除外。\r\n　　　　　　　　　さらに、ベータが4未満もしくは4を超えるものは公開用に除外。",
          "マーカー数(QC後)": "9,296,729 SNPs (hg19)",
          "NBDC Dataset ID": "初潮：hum0014.v9.Men.v1\r\n閉経：hum0014.v9.MP.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\n初潮：Dictionary file\r\n閉経：Dictionary file",
          "総データ量": "初潮：181 MB（txt.gz）\r\n閉経：186 MB（txt.gz）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000114 （JGAD000220 / JGAD000410 / JGAD000690 / JGAD000758）": {
          "対象": "2003年から2007年度にバイオバンク・ジャパンに登録された47疾患患者：1,026名",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Nano DNA Library Preparation Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "160 bp",
          "クオリティコントロール方法": "リードのbase qualityが全体的に悪い検体、リード毎の%GCの結果にて異常を示した検体を除去。\r\nAlignment後、Low mapping rate検体、Insert sizeがおかしい検体、メタデータの性別情報とalingment結果より推定される性別情報が不一致な検体、性染色体異常疑いの検体を除去。\r\nGenotyping時に、VQSR、DP/GP filter (DP < 5, GQ < 20, DP > 60 && GQ < 95を除去）、heterozygosity filter (F>=0.05 を除去)、HWE filter (p < 10-6を除去）、Repeat & Low Complexity filterを実施。\r\n1000 genomes projectと合わせたPCAを実施し、日本人クラスタから大きく外れる検体を除外。\r\nその後、Genome-In-A-Bottleプロジェクトから公開されているHighConfidenceRegionリストに記載のある領域のバリアントにフラグを付与。",
          "重複するリードの除去": "Picard 2.10.6",
          "リアライメントおよびベースクオリティのキャリブレーション": "GATK 3.7",
          "マッピング方法": "BWA mem 0.7.12",
          "マッピングクオリティ": "GATK 3.7 HaplotypeCallerで変異コール時にMAPQ<20のリードを除外",
          "マッピングの際のリファレンス配列": "GRCh37/hg19（hs37d5）",
          "平均カバー率（Depth）": "31.8x",
          "変異検出方法": "GATK 3.7 HaplotypeCaller",
          "SNV数（QC後）": "76,768,387（常染色体）\r\n2,898,518（X 染色体）",
          "INDEL数（QC後）": "10,202,908（常染色体）\r\n410,435（X 染色体）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000220（fastq）\r\nJGAD000410（bam、vcf）：GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のデータです。詳しくはこちらをご覧ください。",
          "NBDCおよび生命情報・DDBJ センターによる加工データのID": "JGAD000690\r\nJGAD000758（joint call）\r\n加工方法はこちら",
          "総データ量": "JGAD000220：73 TB（fastq）\r\nJGAD000410：49 TB（bam、vcf）\r\nJGAD000690：52.1 TB（bam、bai、vcf、document）\r\nJGAD000758：203.8 GB（vcf_aggregate、tabix）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000140": {
          "対象": "乳がん（ICD10：C509）：7,104症例\r\n対照者：23,731名",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "遺伝性乳がんの原因11遺伝子（ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, NF1, PALB2, PTEN, STK11, TP53）の翻訳領域",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "2X Platinum Multiplex PCR Master Mix (Thermo Fisher Scientific)を用いたmultiplex PCRで対象遺伝子領域を抽出し、2nd PCRにより、KAPA HiFi DNA Polymeraseを用いてHiSeqに必要なバーコード配列およびアダプター配列を付加 *1",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000209",
          "総データ量": "1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "※1": {
          "対象": "[GWAS-1]\r\n　　２型糖尿病腎症：2,380症例、２型糖尿病対照（腎症非発症群）：5,234症例\r\n[GWAS-2]\r\n　　２型糖尿病腎症：429症例、２型糖尿病対照（腎症非発症群）：358症例",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [OmniExpressExome Beadchip、Human610-Quad BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina OmniExpressExome Beadchip kit　\r\nIllumina Human610-Quad Beadchip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "MACH and Minimac（1000 Genomes phased JPT, CHB and Han Chinese South data n = 275, March 2012）\r\nGenCall software（GenomeStudio）",
          "関連解析（ソフトウェア）": "mach2dat",
          "フィルタリング": "sample call rate < 0.98, SNV call rate < 0.99, MAF < 0.1%, \r\n対照者群で HWE P < 1 x 10-6",
          "マーカー数(QC後)": "7,521,072 SNPs（hg19）",
          "NBDC Dataset ID": "hum0014.v12.T2DMwN.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "310 MB（csv.zip）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v12.T2DMwN.v1": {
          "対象": "[GWAS-1]\r\n　　２型糖尿病（ICD-10：E11）：9,804症例、対照者：6,728名\r\n[GWAS-2]\r\n　　２型糖尿病（ICD-10：E11）：5,639症例、対照者：19,407名\r\n[GWAS-3]\r\n　　２型糖尿病（ICD-10：E11）：18,688症例、対照者：121,950名\r\n[GWAS-4]\r\n　　２型糖尿病（ICD-10：E11）：2,483症例、対照者：7,065名",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome、Human610-Quad BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome、Human610-Quad Beadchip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac [imputation(1000 genomes Phase 3)]\r\nGenCall software（GenomeStudio）",
          "関連解析（ソフトウェア）": "mach2dat (v1.0.24)",
          "フィルタリング": "GenotypingのQC：\r\nGWAS1, GWAS3, GWAS4除外基準\r\n(i) hetero count < 5\r\n(ii) 各chipでHWE P < 1.0 × 10^-6\r\n(iii) in-house WGSデータとのジェノタイプ一致率 < 0.99\r\n(iv) SNV call rate < 0.99\r\n \r\nGWAS2除外基準\r\n(i) SNV call rate < 0.99\r\n(ii) MAF < 0.01\r\n(iii) differential missingness P < 1.0 × 10^-6\r\n(iv) HWE P < 1.0 × 10^-6\r\n \r\nImputationのQC：\r\nリファレンスパネルで HWE P < 1 × 10^-6 もしくは MAF < 0.01を除外\r\n3つ以上のGWASでImputation quality (Rsq) < 0.3となったものを除外",
          "マーカー数(QC後)": "12,557,761 SNPs（hg19）",
          "NBDC Dataset ID": "hum0014.v13.T2DMmeta.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "257 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v13.T2DMmeta.v1": {
          "対象": "165,436名の喫煙習慣データ",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac [imputation（1000 genomes Phase I v3 ）] \r\nGenCall software（GenomeStudio）",
          "関連解析（ソフトウェア）": "BOLT-LMM（v2.2）\r\nProbABEL（v0.4.5; for X chromosome）",
          "フィルタリング": "GenotypingのQC：sample call rate < 0.98, SNV call rate < 0.99, HWE P < 1 x 10^-6 \r\nImputation referenceのQC:\r\n　以下の条件に該当するSNVはreferenceから除外:\r\n　1) HWE P < 1 x 10^-6、2) MAF < 0.01\r\nImputation後のQC:\r\n　Imputation quality (Rsq) < 0.7 and MAF < 0.01を除外",
          "マーカー数(QC後)": "常染色体：5,961,480 SNVs（hg19）\r\n男性X染色体（喫煙開始年齢）：163,412 SNVs（hg19）\r\n女性X染色体（喫煙開始年齢）：146,130 SNVs（hg19）\r\n男性X染色体（喫煙本数）：166,111 SNVs（hg19）\r\n女性X染色体（喫煙本数）：146,114 SNVs（hg19）\r\n男性X染色体（喫煙歴）：166,138 SNVs（hg19）\r\n女性X染色体（喫煙歴）：146,146 SNVs（hg19）\r\n男性X染色体（禁煙歴の有無）：166,142 SNVs（hg19）\r\n女性X染色体（禁煙歴の有無）：146,118 SNVs（hg19）",
          "NBDC Dataset ID": "hum0014.v14.asi.v1（喫煙開始年齢）\r\nhum0014.v14.cpd.v1（喫煙本数）\r\nhum0014.v14.ens.v1（喫煙歴）\r\nhum0014.v14.fcs.v1（禁煙歴の有無）\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "1.9 GB（txt.gz）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v14.smok.v1": {
          "対象": "・1,026名のWGSデータ（JGAD000220）を含むバイオバンクジャパン1,037名のWGSデータのvcfファイル（WGSデータの分子データは上記参照のこと）\r\n・1000ゲノムプロジェクト（Phase3v5）2,504名のWGSのvcfファイル（ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20130502/）",
          "規模": "WGS解析により検出された変異情報の統合（常染色体およびX染色体上のvariants）",
          "対象領域（Target Captureの場合）": "-",
          "クオリティコントロール方法※": "We set exclusion criteria for genotypes as follows: \r\n(1) DP < 5, (2) GQ < 20, or (3) DP > 60 and GQ < 95, and regarded these genotypes as missing. \r\nVariants with call rates < 90% were excluded before variant quality score recalibration (VQSR). \r\nAfter VQSR, we excluded variants located in low-complexity regions (LCR), as defined by mdust software were excluded. \r\nFinally, we used BEAGLE to impute missing genotypes.",
          "重複するリードの除去※": "picard (versions 1.106)",
          "リアライメントおよびベースクオリティのキャリブレーション※": "GATK (version 3.2-2)",
          "マッピング方法※": "BWA-MEM (version 0.7.5a)",
          "マッピングクオリティ※": "MAPQ < 20 を除外（HaplotypeCaller）",
          "マッピングの際のリファレンス配列※": "GRCh37/hg19, hs37d5",
          "平均カバー率（Depth）※": "aimed at 30x depth",
          "変異検出方法※": "GATK HaplotypeCaller (version 3.2-2)",
          "vcfファイルの統合方法": "常染色体：Impute2\r\nX染色体：Beagle（男性）、Impute2（女性）",
          "リファレンスパネルに含まれるvariant数": "61,608,817 variants（常染色体：59,387,070variants、X染色体：2,221,747variants）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000220",
          "NBDCおよび生命情報・DDBJ センターによる加工データのID": "JGAD000679\r\n加工方法はこちら",
          "総データ量": "約15 GB（vcf.gz）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000114 reference panel": {
          "対象": "バイオバンクジャパンに参加した159,095名\r\n（男性：86,257名、女性：72,838名）",
          "規模": "genome wide variants",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "Minimac3 [imputation reference panel using WGS data of the biobank Japan project (N=1,037) and 1KGP p3v5 ALL (N=2,504)]",
          "関連解析（ソフトウェア）": "BOLT-LMM (ver2.2)、mach2qtl",
          "フィルタリング": "Sample QCs：1) call rate < 98%、2) closely related samples (PI_HAT > 0.175)、3) outlier from Japanese cluster determined by PCA using GCTA を除外。\r\nImputation後のQC：Imputation quality (Rsq) < 0.3　を除外。",
          "マーカー数(QC後)": "常染色体：27,211,524 variants（hg19）\r\n男性X染色体：684,533 variants（hg19）\r\n女性X染色体：684,533 variants（hg19）",
          "NBDC Dataset ID": "hum0014.v15.ht.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "約663 MB（txt.gz）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v15.ht.v1": {
          "対象": "遺伝性前立腺がん（ICD10：C61）：7,636症例\r\n対照者：12,366名",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "遺伝性前立腺がんの原因8遺伝子（ATM, BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, NBN, PALB2）の翻訳領域",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "2X Platinum Multiplex PCR Master Mix (Thermo Fisher Scientific)を用いたmultiplex PCRで対象遺伝子領域を抽出し、2nd PCRにより、KAPA HiFi DNA Polymeraseを用いてHiSeqに必要なバーコード配列およびアダプター配列を付加 *1",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000288",
          "総データ量": "2.2 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000203": {
          "対象": "42疾患（ICD10 code）\r\n不整脈（I499）、気管支喘息（J459）、アトピー性皮膚炎（L209）、\r\n胆嚢・胆管がん（C23, C240）、白内障（H269）、\r\n脳動脈瘤（I671）、子宮頸がん（C539）、B型慢性肝炎（B181）、\r\nC型慢性肝炎（B182）、COPD（J449）、肝硬変（K746）、\r\n大腸・直腸がん（C189, C20）、心不全（I509, I500）、薬疹（L270）、\r\n子宮体がん（C549）、子宮内膜症（N809）、てんかん（G409）、\r\n食道がん（C159）、胃がん（C169）、緑内障（H409）、バセドウ病（E050）、\r\n造血器腫瘍（C81-96）、肝がん（C220）、肺線維症（J849, J841）、\r\n脳梗塞（I639）、ケロイド（L910）、肺がん（C349）、\r\nネフローゼ症候群（N049）、骨粗鬆症（M8199）、卵巣がん（C56）、\r\n膵がん（C259）、歯周病（K054）、ASO（I709）、花粉症（J301）、\r\n前立腺がん（C61）、肺結核（A169）、関節リウマチ（M0690）、\r\n糖尿病（E14）、尿路結石症（N209）、子宮筋腫（D259）、乳がん（C509）\r\n虚血性心疾患（I200、I209、I219）",
          "規模": "genome wide variants",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac3 [imputation（1000 genomes Phase 3 v5 ）]\r\nGenCall software（GenomeStudio）",
          "関連解析（ソフトウェア）": "SAIGE（v0.29.4.2）",
          "フィルタリング": "Imputation後のQC:\r\n　Imputation quality (Rsq) < 0.7　を除外",
          "マーカー数(QC後)": "常染色体：8,712,794 variants（hg19）\r\nX染色体：207,198 variants（hg19）",
          "気管支喘息": "hum0014.v17.BA.v1",
          "アトピー性皮膚炎＊": "hum0014.v17.AD.v1",
          "胆嚢・胆管がん": "hum0014.v17.GCc.v1",
          "白内障": "hum0014.v17.Cat.v1",
          "脳動脈瘤": "hum0014.v17.CA.v1",
          "子宮頸がん": "hum0014.v17.CeC.v1",
          "B型慢性肝炎": "hum0014.v17.CHB.v1",
          "C型慢性肝炎": "hum0014.v17.CHC.v1",
          "COPD": "hum0014.v17.COPD.v1",
          "肝硬変": "hum0014.v17.Cir.v1",
          "大腸・直腸がん": "hum0014.v17.CC.v1",
          "心不全＊": "hum0014.v17.HF.v1",
          "薬疹": "hum0014.v17.DE.v1",
          "子宮体がん": "hum0014.v17.UC.v1",
          "子宮内膜症": "hum0014.v17.EM.v1",
          "てんかん": "hum0014.v17.Ep.v1",
          "食道がん": "hum0014.v17.EC.v1",
          "胃がん": "hum0014.v17.GC.v1",
          "緑内障＊": "hum0014.v17.Gla.v1",
          "バセドウ病": "hum0014.v17.GD.v1",
          "造血器腫瘍": "hum0014.v17.HT.v1",
          "肝がん": "hum0014.v17.LiC.v1",
          "肺線維症": "hum0014.v17.IP.v1",
          "脳梗塞": "hum0014.v17.CI.v1",
          "ケロイド": "hum0014.v17.Kel.v1",
          "肺がん": "hum0014.v17.LuC.v1",
          "ネフローゼ症候群": "hum0014.v17.NS.v1",
          "骨粗鬆症": "hum0014.v17.OP.v1",
          "卵巣がん": "hum0014.v17.OC.v1",
          "膵がん": "hum0014.v17.PaC.v1",
          "歯周病": "hum0014.v17.PD.v1",
          "ASO": "hum0014.v17.PAD.v1",
          "花粉症": "hum0014.v17.Hay.v1",
          "前立腺がん": "hum0014.v17.PrC.v1",
          "肺結核": "hum0014.v17.PT.v1",
          "関節リウマチ": "hum0014.v17.RA.v1",
          "糖尿病＊": "hum0014.v17.DM.v1",
          "尿路結石症": "hum0014.v17.Uro.v1",
          "子宮筋腫": "hum0014.v17.UF.v1",
          "乳がん": "hum0014.v18.BC.v1",
          "虚血性心疾患": "hum0014.v21.CAD.v1",
          "総データ量": "常染色体：0.9-1.3 GB程度（txt）\r\nX染色体：20-30 MB程度（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v17 / hum0014.v18 / hum0014.v21": {
          "対象": "165,084名の食習慣（13項目）",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）\r\nMACH\r\nminimac (v.0.1.1) [imputation（1000 genomes Phase I v3 ）]",
          "関連解析（ソフトウェア）": "BOLT-LMM（v2.2）for autosomes\r\nProbABEL（v0.4.5）for X chromosome",
          "フィルタリング": "GenotypingのQC：sample call rate < 0.98, SNV call rate < 0.99, MAF < 0.005\r\nImputation referenceのQC:\r\n　HWE P < 1 x 10^-6、MAF < 0.01に該当するSNVを除外\r\nImputation後のQC:\r\n　Imputation quality (Rsq) < 0.7 and MAF < 0.01を除外",
          "マーカー数(QC後)": "常染色体：5,961,480 variants（hg19）\r\nX染色体：148,568 variants for female、170,117 variants for male（hg19）",
          "1週間あたりの飲酒量": "hum0014.v19.dpw.v1",
          "コーヒー摂取頻度": "hum0014.v19.cafe.v1",
          "緑茶摂取頻度": "hum0014.v19.tea.v1",
          "牛乳摂取頻度": "hum0014.v19.milk.v1",
          "ヨーグルト摂取頻度": "hum0014.v19.ygt.v1",
          "チーズ摂取頻度": "hum0014.v19.cheese.v1",
          "納豆摂取頻度": "hum0014.v19.natto.v1",
          "豆腐摂取頻度": "hum0014.v19.tofu.v1",
          "魚摂取頻度": "hum0014.v19.fish.v1",
          "小魚摂取頻度": "hum0014.v19.sfish.v1",
          "野菜摂取頻度": "hum0014.v19.vege.v1",
          "肉摂取頻度": "hum0014.v19.meat.v1",
          "総データ量": "各形質：約420 MB（txt.zip）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v19": {
          "対象": "冠動脈疾患（ICD10：I20-25)：25,892症例\r\n対象者：142,336名",
          "規模": "genome wide variants",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）\r\nminimac3（BBJ-CAD reference panel）",
          "関連解析（ソフトウェア）": "PLINK2",
          "フィルタリング": "Imputation後のQC: Imputation quality (Rsq) < 0.3 または MAF < 0.0002 を除外",
          "マーカー数(QC後)": "常染色体：19,707,525 variants（hg19）",
          "NBDC Dataset ID": "hum0014.v20.gwas.v1（統計解析データ）\r\nhum0014.v20.prs.v1（ポリジェニックリスクスコア）\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "約413 MB（txt.gz）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v20.cad.v1": {
          "対象": "2003年から2007年度にバイオバンク・ジャパンに登録されたサンプル（約20万例）から抽出された11,234名",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "下記の23遺伝子における全てのエクソン領域\r\nASXL1, CBL, CEBPA, DDX41, DNMT3A, ETV6, EZH2, GATA2, GNAS, GNB1, IDH1, IDH2, JAK2, KRAS, MYD88, NRAS, PPM1D, RUNX1, SF3B1, SRSF2, TET2, TP53, U2AF1",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "ライブラリ作成は下記の論文に記載された方法で実施した。\r\nMomozawa, Y., et al. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population. Hum Mol Genet 25, 5027-5034 (2016).",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "クオリティコントロール方法": "Depth 20以上の領域が98%以上のサンプルを解析対象とした。",
          "マッピング方法": "bwa",
          "マッピングクオリティ": "≥40",
          "マッピングの際のリファレンス配列": "hg19",
          "平均カバー率": "x800",
          "変異検出方法": "Genomon pipeline",
          "フィルタリング方法": "Genomon pipeline",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000399",
          "総データ量": "5.3 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000293（Target Capture）": {
          "対象": "2003年から2007年度にバイオバンク・ジャパンに登録されたサンプル（約20万例）から抽出された11,234名",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、OmniExpressExome]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina Infinium OmniExpress, Infinium OmniExpressExome v.1.0, or v.1.2",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）",
          "染色体変異検出アルゴリズム（ソフトウェア）": "ハプロタイプ情報に基づくアリル不均衡の検出法（下記の論文を参照）\r\nTerao, C., et al. Chromosomal alterations among age-related haematopoietic clones in Japan. Nature (2020).",
          "フィルタリング": "上記の３バージョンのアレイの全てでカバーされているSNPsを使用した",
          "マーカー数（QC後）": "515,355",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000400",
          "総データ量": "5.3 MB（csv）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000293（SNPアレイ）": {
          "対象": "膵がん（ICD10：C25）：1,005症例\r\n大腸がん（ICD10：C18、C19、C20）：12,503症例\r\n腎がん（ICD10：C64）：740症例\r\nリンパ腫（ICD10：C81、C82、C83、C84、C85、C86、C88、C91）：1,982症例\r\n胃がん（ICD10：C16）：10,366症例\r\n対照者：23,705名＋5,996名＋37,592名",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "遺伝性腫瘍関連27遺伝子（APC, ATM, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDK4, CDKN2A, CDH1, CHEK2, EPCAM, HOXB13, NBN, NF1, MLH1, MSH2, MSH6, MUTYH, PALB2, PMS2, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53）の翻訳領域",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "2X Platinum Multiplex PCR Master Mix（Thermo Fisher Scientific）を用いたmultiplex PCRで対象遺伝子領域を抽出し、2nd PCRにより、KAPA HiFi DNA Polymeraseを用いてHiSeqに必要なバーコード配列およびアダプター配列を付加 *1",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "膵がん：JGAD000438\r\n大腸がん：JGAD000458\r\n23,705名の対照者：JGAD000459\r\n腎がんと5,996名の対照者：JGAD000531\r\nリンパ腫：JGAD000460\r\n胃がん：JGAD000720\r\n37,592名の対照者：JGAD000721",
          "総データ量": "JGAD000438：78 GB（fastq）\r\nJGAD000458：956 GB（fastq）\r\nJGAD000459：1.9 TB（fastq）\r\nJGAD000531：961.8 GB（fastq）\r\nJGAD000460：126 GB（fastq）\r\nJGAD000720、JGAD000721：3.4 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000327 / JGAS000346 / JGAS000414 / JGAS000347 / JGAS000592": {
          "対象": "腎がん（ICD10：C64）：740症例\r\n対照者：5,996名",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "腎がん関連13遺伝子（VHL、 BAP1、FH、FLCN、MET、TSC1、TSC2、MITF、SDHA、SDHB、SDHC、SDHD、CDC73）の翻訳領域",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "2X Platinum Multiplex PCR Master Mix (Thermo Fisher Scientific)を用いたmultiplex PCRで対象遺伝子領域を抽出し、2nd PCRにより、KAPA HiFi DNA Polymeraseを用いてHiSeqに必要なバーコード配列およびアダプター配列を付加 *1",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000531",
          "総データ量": "961.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000414": {
          "対象": "2003年から2017年度にバイオバンク・ジャパンに登録された症例：1,964名\r\n    心筋梗塞（ICD10：I21）：1,765症例\r\n    認知症（ICD10：F00-03）：199症例",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X Five]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free Prep kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151 bp",
          "クオリティコントロール方法": "リードのbase qualityが全体的に悪い検体、リード毎の%GCの結果にて異常を示した検体を除去。\r\nAlignment後、Low mapping rate検体、Insert sizeがおかしい検体、メタデータの性別情報とalingment結果より推定される性別情報が不一致な検体、性染色体異常疑いの検体を除去。\r\nGenotyping時に、VQSR、DP/GP filter (DP < 5, GQ < 20, DP > 60 && GQ < 95を除去）、heterozygosity filter (F>=0.05 を除去)、HWE filter (p < 10-6を除去）、Repeat & Low Complexity filterを実施。\r\n1000 genomes projectと合わせたPCAを実施し、日本人クラスタから大きく外れる検体を除外。\r\nその後、Genome-In-A-Bottleプロジェクトから公開されているHighConfidenceRegionリストに記載のある領域のバリアントにフラグを付与。",
          "重複するリードの除去": "Picard 2.10.6",
          "リアライメントおよびベースクオリティのキャリブレーション": "GATK 3.7",
          "マッピング方法": "BWA mem 0.7.12",
          "マッピングクオリティ": "GATK 3.7 HaplotypeCallerで変異コール時にMAPQ<20のリードを除外",
          "マッピングの際のリファレンス配列": "GRCh37/hg19（hs37d5）",
          "平均カバー率（Depth）": "心筋梗塞：15.0x、認知症：30.0x",
          "変異検出方法": "GATK 3.7 HaplotypeCaller",
          "SNV数（QC後）": "76,768,387（常染色体）\r\n2,898,518（X 染色体）",
          "INDEL数（QC後）": "10,202,908（常染色体）\r\n410,435（X 染色体）",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000495（fastq）\r\nJGAD000496（bam、vcf）：GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のデータです。詳しくはこちらをご覧ください。",
          "総データ量": "188.4 TB（fastq、bam、vcf）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000381": {
          "対象": "BBJ第1コホート：137,693名",
          "規模": "genome wide variants",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "minimac [imputation（1000 genomes Phase I v3 ）]\r\nGenCall software（GenomeStudio）",
          "関連解析（ソフトウェア）": "mach2qtl（v1.1.3）\r\nSPACox",
          "フィルタリング": "GenotypingのQC：sample call rate < 0.98, SNV call rate < 0.99, HWE P < 1 x 10^-6 \r\nImputation referenceのQC:\r\n　以下の条件に該当するSNVはreferenceから除外:\r\n　1) HWE P < 1 x 10^-6、2) MAF < 0.01\r\nImputation後のQC:\r\n　Imputation quality (Rsq) < 0.7　を除外。",
          "マーカー数(QC後)": "6,108,833 variants（hg19）",
          "NBDC Dataset ID": "hum0014.v27.surv.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "789 MB（txt.gz）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v27.surv.v1": {
          "対象": "BBJ第1コホート4880名のWGSデータ（下記データを含む）\r\n    ・1,026名のWGSデータ（JGAD000220）\r\n    ・心筋梗塞症例1,765名および認知症症例199名のWGSデータ（JGAD000495）\r\n    ・胃がん症例255名のWGSデータ（AGDD_000005）\r\n    ・アジアゲノムプロジェクトの1007名\r\n    ・大腸・直腸がん症例の617名\r\n    ・AGDD_000005のQCで除かれた1名\r\n    ・JGAD000220のQCで除かれた10名",
          "規模": "mobile element多型頻度情報",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq X/2500]",
          "ライブラリソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq DNA PCR-Free Sample Prep Kit、TruSeq Nano DNA HT Sample Prep Kit",
          "断片化の方法": "超音波断片化",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "151 bp（HiSeq X）、126 bp（HiSeq 2500）",
          "クオリティコントロール方法": "-",
          "マッピング方法": "BWA-MEM",
          "マッピングクオリティ": "-",
          "マッピングの際のリファレンス配列": "GRCh37（hs37d5）",
          "平均カバー率（Depth）": "15×以上（内、1235名：25×以上）",
          "mobile element検出方法": "MEGAnE *2",
          "mobile element数": "24,933（4880名）\r\n10,997（1235名）",
          "NBDC Dataset ID": "hum0014.v28.MEs.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "1.1 MB（txt.gz）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "hum0014.v28.MEs.v1": {
          "対象": "心房細動（ICD10：I48）：77,690症例、対照者：1,167,040名\r\n    BBJ：心房細動：9,826症例、対照者：140,446名\r\n    欧米人：心房細動：60,620症例、対照者：970,216名\r\n    FinnGen：心房細動：7,244症例、対照者：56,378名",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "ソース": "末梢血から抽出したgDNA\r\n欧米GWAS：http://csg.sph.umich.edu/willer/public/afib2018\r\nFinnGen GWAS：https://www.finngen.fi/en",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmniExpress、HumanExome、OmniExpressExome BeadChip kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software（GenomeStudio）\r\nminimac [imputation（1000 genomes Phase I v3 ）]",
          "関連解析（ソフトウェア）": "PLINK2",
          "フィルタリング": "BBJ GWAS：imputation quality（Rsq） < 0.3 または MAF < 0.001 を除外\r\nメタ解析GWAS：MAF < 1% を除外",
          "ポリジェニックリスクスコア算出方法": "Pruning and thresholding method",
          "メタ解析方法": "MANTRA、METAL",
          "マーカー数(QC後)": "BBJ GWAS：16,817,144 SNPs\r\nメタ解析GWAS：5,158,449 SNPs",
          "NBDC Dataset ID": "hum0014.v29.AF.v1\r\n（データのダウンロードは上記Dataset IDをクリックしてください）\r\nDictionary file",
          "総データ量": "BBJのGWAS集計情報：424 MB（txt）\r\nメタ解析のGWAS集計情報：78 MB（txt）\r\nポリジェニックリスクスコア：59 KB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "久保 充明",
        "所 属 機 関": "理化学研究所 統合生命医科学研究センター 疾患多様性医科学研究部門",
        "プロジェクト/研究グループ名": "オーダーメイド医療の実現プログラム",
        "科研費/助成金（Research Project Number）": {
          "14": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 難治性疾患実用化研究事業",
            "タイトル": "難治性心血管疾患におけるマルチオミックス解析による病態解明と精密医療",
            "研究課題番号": "JP20ek0109487"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in Japanese.",
          "DOI": "doi:10.1038/ejhg.2014.110",
          "データID": "hum0014.v1.freq.v1"
        },
        "2": {
          "タイトル": "A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese.",
          "DOI": "doi:10.1093/hmg/ddr268",
          "データID": "hum0014.v2.jsnp.92als.v1"
        },
        "3": {
          "タイトル": "Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk.",
          "DOI": "doi: 10.1053/j.gastro.2009.07.070",
          "データID": "hum0014.v2.jsnp.182ec.v1"
        },
        "4": {
          "タイトル": "SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations.",
          "DOI": "doi: 10.1038/ng.208",
          "データID": "T2DM (JSNP)"
        },
        "5": {
          "タイトル": "Common variants in a novel gene, FONG on chromosome 2q33.1 confer risk of osteoporosis in Japanese.",
          "DOI": "doi: 10.1371/journal.pone.0019641",
          "データID": "Osteoporosis (JSNP)"
        },
        "6": {
          "タイトル": "Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes.",
          "DOI": "doi: 10.1038/ncomms10531",
          "データID": "hum0014.v3.T2DM-1.v1\r\nhum0014.v3.T2DM-2.v1"
        },
        "7": {
          "タイトル": "Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis.",
          "DOI": "doi: 10.1038/ng.3424",
          "データID": "hum0014.v4.AD.v1"
        },
        "8": {
          "タイトル": "Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population.",
          "DOI": "doi: 10.1038/ng.2438",
          "データID": "hum0014.v4.AD.v1"
        },
        "9": {
          "タイトル": "Identification of six new genetic loci associated with atrial fibrillation in the Japanese population.",
          "DOI": "doi: 10.1038/ng.3842",
          "データID": "hum0014.v5.AF.v1"
        },
        "10": {
          "タイトル": "Genome-wide association study identifies 112 new loci for body mass index in the Japanese population.",
          "DOI": "doi:10.1038/ng.3951",
          "データID": "hum0014.v6.158k.v1\r\nJGAD000123\r\nJGAD000124"
        },
        "11": {
          "タイトル": "Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma.",
          "DOI": "doi: 10.1093/hmg/ddy053",
          "データID": "hum0014.v7.POAG.v1"
        },
        "12": {
          "タイトル": "Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.",
          "DOI": "doi:10.1038/s41588-018-0047-6",
          "データID": "hum0014.v8.58qt.v1\r\nJGAD000144-JGAD000201"
        },
        "13": {
          "タイトル": "Elucidating the genetic architecture of reproductive ageing in the Japanese population",
          "DOI": "doi: 10.1038/s41467-018-04398-z",
          "データID": "hum0014.v9.Men.v1\r\nhum0014.v9.MP.v1"
        },
        "14": {
          "タイトル": "Deep whole-genome sequencing reveals recent selection signatures linked to evolution and disease risk of Japanese.",
          "DOI": "doi: 10.1038/s41467-018-03274-0",
          "データID": "JGAD000220"
        },
        "15": {
          "タイトル": "Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.",
          "DOI": "doi: 10.1038/s41467-018-06581-8",
          "データID": "JGAD000209"
        },
        "16": {
          "タイトル": "A Variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes",
          "DOI": "doi: 10.1371/journal.pone.0208654",
          "データID": "hum0014.v12.T2DMwN.v1"
        },
        "17": {
          "タイトル": "Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population",
          "DOI": "doi: 10.1038/s41588-018-0332-4",
          "データID": "hum0014.v13.T2DMmeta.v1"
        },
        "18": {
          "タイトル": "GWAS of smoking behaviour in 165,436 Japanese people reveals seven new loci and shared genetic architecture.",
          "DOI": "doi: 10.1038/s41562-019-0557-y",
          "データID": "hum0014.v14.asi.v1\r\nhum0014.v14.cpd.v1\r\nhum0014.v14.ens.v1\r\nhum0014.v14.fcs.v1"
        },
        "19": {
          "タイトル": "Characterizing rare and low-frequency height-asssociated variants in the Japanese population",
          "DOI": "doi: 10.1038/s41467-019-12276-5",
          "データID": "JGAD000220 (fastq)\r\nJGAD000220 (reference panel)\r\nhum0014.v15.ht.v1"
        },
        "20": {
          "タイトル": "Germline pathogenic variants in 7,636 Japanese patients with prostate cancer and 12,366 controls.",
          "DOI": "doi: 10.1093/jnci/djz124",
          "データID": "JGAD000288"
        },
        "21": {
          "タイトル": "Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases",
          "DOI": "doi: 10.1038/s41588-020-0640-3",
          "データID": "hum0014.v17\r\nhum0014.v18\r\nhum0014.v21"
        },
        "22": {
          "タイトル": "GWAS of 165,084 Japanese individuals identified nine loci associated with dietary habits",
          "DOI": "doi: 10.1038/s41562-019-0805-1",
          "データID": "hum0014.v19"
        },
        "23": {
          "タイトル": "Population-specific and transethnic genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease.",
          "DOI": "doi: 10.1038/s41588-020-0705-3",
          "データID": "hum0014.v20.cad.v1"
        },
        "24": {
          "タイトル": "Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes",
          "DOI": "doi: 10.1016/j.ebiom.2020.103033",
          "データID": "JGAD000438"
        },
        "25": {
          "タイトル": "Population-based Screening for Hereditary Colorectal Cancer Variants in Japan",
          "DOI": "doi: 10.1016/j.cgh.2020.12.007",
          "データID": "JGAD000458\r\nJGAD000459"
        },
        "26": {
          "タイトル": "Genome-wide association study reveals BET1L associated with survival time in the 137,693 Japanese individuals.",
          "DOI": "",
          "データID": "hum0014.v27.surv.v1"
        },
        "27": {
          "タイトル": "Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction",
          "DOI": "doi: 10.1038/s41588-022-01284-9",
          "データID": "hum0014.v29.AF.v1"
        },
        "28": {
          "タイトル": "Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk",
          "DOI": "doi: 10.1111/cas.15522",
          "データID": "JGAD000460\r\nJGAD000721"
        },
        "29": {
          "タイトル": "Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer",
          "DOI": "doi: 10.1056/NEJMoa2211807",
          "データID": "JGAD000720\r\nJGAD000721"
        },
        "30": {
          "タイトル": "Germ line DDX41 mutations define a unique subtype of myeloid neoplasms",
          "DOI": "doi: 10.1182/blood.2022018221",
          "データID": "JGAD000399\r\nJGAD000400"
        },
        "31": {
          "タイトル": "Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis",
          "DOI": "doi: 10.1038/s41591-021-01411-9",
          "データID": "JGAD000399\r\nJGAD000400"
        }
      },
      "制限公開データの利用者一覧": {
        "Mark Daly": {
          "研究代表者": "Mark Daly",
          "所属機関": "Broad Institute of MIT and Harvard",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "岡田 随象": {
          "研究代表者": "岡田 随象",
          "所属機関": "大阪大学大学院医学系研究科・遺伝統計学",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "上辻 茂男": {
          "研究代表者": "上辻 茂男",
          "所属機関": "株式会社スタージェン　統計解析事業部",
          "研究題目": "",
          "利用データID": "ステント血栓症発症の遺伝的要因の探索のためのゲノムワイド関連研究",
          "利用期間": "JGAD000123, JGAD000124, JGAD000145, JGAD000146, JGAD000149, JGAD000151, JGAD000155, JGAD000156, JGAD000158, JGAD000159, JGAD000163, JGAD000165-JGAD000167, JGAD000170, JGAD000172-JGAD000175, JGAD000182, JGAD000187-JGAD000189, JGAD000192-JGAD000196, JGAD000200, JGAD000201"
        },
        "徳永 勝士": {
          "研究代表者": "徳永 勝士",
          "所属機関": "東京大学大学院医学系研究科人類遺伝学教室",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "角田 達彦": {
          "研究代表者": "角田 達彦",
          "所属機関": "東京医科歯科大学・難治疾患研究所・医科学数理分野",
          "研究題目": "",
          "利用データID": "オーダーメイド医療のためのシーケンス、画像データなどの解析に関する研究",
          "利用期間": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Liming Liang": {
          "研究代表者": "Liming Liang",
          "所属機関": "Harvard T.H. Chan School of Public Health, Department of Epidemiology",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000123"
        },
        "長崎 正朗": {
          "研究代表者": "長崎 正朗",
          "所属機関": "京都大学 大学院医学研究科附属ゲノム医学センター 学際融合教育研究推進センター",
          "研究題目": "",
          "利用データID": "日本人大規模全ゲノム情報を基盤とした多因子疾患関連遺伝子の同定を加速する情報解析技術の開発と応用（ゲノム情報解析技術開発）",
          "利用期間": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "小川 誠司": {
          "研究代表者": "小川 誠司",
          "所属機関": "京都大学 医学研究科",
          "研究題目": "",
          "利用データID": "造血器腫瘍における遺伝子異常の網羅的解析",
          "利用期間": "JGAD000102, JGAS000123, JGAD000220"
        },
        "河野 隆志": {
          "研究代表者": "河野 隆志",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "AYA（Adolescence and Young Adult）世代がんの個別化予防に資する遺伝要因の同定を目指す研究",
          "利用期間": "JGAD000209, JGAD000220"
        },
        "堀江 重郎": {
          "研究代表者": "堀江 重郎",
          "所属機関": "順天堂大学大学院医学研究科・遺伝子疾患先端情報学",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000123, JGAD000220"
        },
        "木下 健吾": {
          "研究代表者": "木下 健吾",
          "所属機関": "東北大学 東北メディカル・メガバンク機構",
          "研究題目": "",
          "利用データID": "日本人全ゲノムデータベースの構築",
          "利用期間": "JGAD000220"
        },
        "白石 航也": {
          "研究代表者": "白石 航也",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "ゲノム解析に基づく宿主並びに腫瘍における免疫応答ネットワーク機構の解明",
          "利用期間": "JGAD000124"
        },
        "小笠原 理": {
          "研究代表者": "小笠原 理",
          "所属機関": "国立遺伝学研究所 生命情報・DDBJセンター",
          "研究題目": "",
          "利用データID": "JGA/AGDゲノムデータを利用したヒトゲノム解析ワークフローの評価",
          "利用期間": "JGAD000123, JGAD000220"
        },
        "岡﨑 康司": {
          "研究代表者": "岡﨑 康司",
          "所属機関": "順天堂大学 大学院医学研究科 難治性疾患診断・治療学",
          "研究題目": "",
          "利用データID": "疾患コホート研究ネットワークによる疾患マーカー探索研究",
          "利用期間": "JGAD000123"
        },
        "秦 千比呂": {
          "研究代表者": "秦 千比呂",
          "所属機関": "国立遺伝学研究所 生命情報・DDBJセンター",
          "研究題目": "",
          "利用データID": "日本人乳癌患者シーケンスデータにおけるhypomorphic変異同定",
          "利用期間": "JGAD000209"
        },
        "河合 洋介": {
          "研究代表者": "河合 洋介",
          "所属機関": "東京大学医科学研究所 人癌病因遺伝子分野",
          "研究題目": "",
          "利用データID": "集団遺伝学的解析による日本人集団のなりたちの解析",
          "利用期間": "JGAD000123"
        },
        "岩田 仲生": {
          "研究代表者": "岩田 仲生",
          "所属機関": "藤田医科大学 医学部 精神神経科学",
          "研究題目": "",
          "利用データID": "遺伝子解析によるこころの健康とこころの病気に対するかかりやすさ（発症脆弱性）や薬の効きめや副作用（治療反応性）等の解明に関する研究",
          "利用期間": "JGAD000123, JGAD000124"
        },
        "Atray Dixit": {
          "研究代表者": "Atray Dixit",
          "所属機関": "Coral Genomics, Inc.",
          "研究題目": "",
          "利用データID": "Derivation and Evaluation of Functional Response Scores",
          "利用期間": "JGAD000101, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Hae Kyung Im": {
          "研究代表者": "Hae Kyung Im",
          "所属機関": "Biological Sciences Division, University of Chicago",
          "研究題目": "",
          "利用データID": "Predicted Gene Expression: High Power, Mechanism, and Direction of Effect",
          "利用期間": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Hongyu Zhao": {
          "研究代表者": "Hongyu Zhao",
          "所属機関": "Department of Biostatistics, Yale School of Public Health",
          "研究題目": "",
          "利用データID": "Leveraging multi-ethnic data and functional annotations in causal variant identification, genetic correlation estimation, and genetic risk prediction",
          "利用期間": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Charleston Chiang": {
          "研究代表者": "Charleston Chiang",
          "所属機関": "Center for Genetic Epidemiology, Keck School of Medicine, University of Southern Califolnia",
          "研究題目": "",
          "利用データID": "Investigating the evolution of complex genetic architecture in participants of Biobank Japan",
          "利用期間": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Ali Torkamani": {
          "研究代表者": "Ali Torkamani",
          "所属機関": "Scripps Research Institute",
          "研究題目": "",
          "利用データID": "Genomics Deep Learning",
          "利用期間": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "中山 一大": {
          "研究代表者": "中山 一大",
          "所属機関": "東京大学大学院 新領域創成科学研究科 先端生命科学専攻",
          "研究題目": "",
          "利用データID": "褐色脂肪組織活性に寄与するゲノム多型の探索",
          "利用期間": "JGAD000123, JGAD000124"
        },
        "藤尾 圭志": {
          "研究代表者": "藤尾 圭志",
          "所属機関": "東京大学大学院医学系研究科 アレルギー・リウマチ内科",
          "研究題目": "",
          "利用データID": "日本人免疫細胞eQTLデータと日本人大規模GWASデータの統合解析",
          "利用期間": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "菊地 正隆": {
          "研究代表者": "菊地 正隆",
          "所属機関": "東京大学 大学院新領域創成科学研究科",
          "研究題目": "日本",
          "利用データID": "日本人リファレンスパネルを用いたゲノムデータ補完",
          "利用期間": "JGAD000220"
        },
        "松田 文彦": {
          "研究代表者": "松田 文彦",
          "所属機関": "国立研究開発法人国立がん研究センター研究所 ゲノム生物学研究分野",
          "研究題目": "",
          "利用データID": "オーダーメイド医療開発プロジェクト",
          "利用期間": "JGAD000123, JGAD000220"
        },
        "野口 恵美子": {
          "研究代表者": "野口 恵美子",
          "所属機関": "筑波大学 医学医療系遺伝医学",
          "研究題目": "日本",
          "利用データID": "炎症性肺疾患の遺伝素因に関する研究",
          "利用期間": "JGAD000220"
        },
        "佐藤 憲子": {
          "研究代表者": "佐藤 憲子",
          "所属機関": "東京医科歯科大学 難治疾患研究所 分子疫学",
          "研究題目": "",
          "利用データID": "地域コホート縦断データに基づく肥満・糖尿病発症・進行の遺伝・環境リスクの解析",
          "利用期間": "JGAD000220"
        },
        "永田 安伸": {
          "研究代表者": "永田 安伸",
          "所属機関": "日本医科大学 血液内科",
          "研究題目": "",
          "利用データID": "新たな遺伝学的異常を用いた造血器腫瘍発症メカニズムの探索",
          "利用期間": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "川上 純": {
          "研究代表者": "川上 純",
          "所属機関": "長崎大学病院 リウマチ・膠原病内科",
          "研究題目": "",
          "利用データID": "免疫チェックポイント阻害薬ニボルマブが誘発する1型糖尿病、間質性肺疾患の発症に関連する原因遺伝子多型・変異の探索的研究",
          "利用期間": "JGAD000220"
        },
        "藤本 明洋": {
          "研究代表者": "藤本 明洋",
          "所属機関": "東京大学大学院 医学系研究科 人類遺伝学教室",
          "研究題目": "",
          "利用データID": "全ゲノムシークエンスデータの解析による突然変異・遺伝的多様性・転写異常の包括的解析",
          "利用期間": "JGAD000220, JGAD000410"
        },
        "朝野 仁裕": {
          "研究代表者": "朝野 仁裕",
          "所属機関": "大阪大学医学系研究科 循環器内科学",
          "研究題目": "",
          "利用データID": "遺伝性心血管疾患の感受性遺伝子解析研究",
          "利用期間": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "増子 裕典": {
          "研究代表者": "増子 裕典",
          "所属機関": "筑波大学 呼吸器内科",
          "研究題目": "",
          "利用データID": "炎症性肺疾患の遺伝素因に関する研究",
          "利用期間": "JGAD000123"
        },
        "松田 喬": {
          "研究代表者": "松田 喬",
          "所属機関": "アステラス製薬株式会社 アドバンストインフォマティクス＆アナリティクス室",
          "研究題目": "",
          "利用データID": "肝がん並びにB型肝炎発症と遺伝子多型の相関に関する検討",
          "利用期間": "JGAD000102, JGAD000123"
        },
        "二宮 利治": {
          "研究代表者": "二宮 利治",
          "所属機関": "九州大学 大学院医学研究院　衛生・公衆衛生学分野",
          "研究題目": "",
          "利用データID": "健康長寿社会の実現を目指した大規模認知症コホート研究（JPSC-AD）",
          "利用期間": "JGAD000220"
        },
        "Joshua Chiou": {
          "研究代表者": "Joshua Chiou",
          "所属機関": "Pfizer Internal Medicine Research Unit",
          "研究題目": "",
          "利用データID": "Evaluating GWAS associations from Biobank Japan to Support Confidence in Rationale for Therapeutic Targets",
          "利用期間": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Gil McVean": {
          "研究代表者": "Gil McVean",
          "所属機関": "Genomics plc",
          "研究題目": "イギリス",
          "利用データID": "Using large-scale reference panels for imputation and ancestry analysis to support target discovery and polygenic risk score models",
          "利用期間": "JGAD000220, JGAD000410"
        },
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "大規模シーケンスデータを用いた乳がん関連遺伝子における活性低下型変異の研究",
          "利用期間": "JGAD000209"
        },
        "Nuria Lopez-Bigas": {
          "研究代表者": "Nuria Lopez-Bigas",
          "所属機関": "Institute for Research in Biomedicine (IRB Barcelona)",
          "研究題目": "スペイン",
          "利用データID": "Study of the genetic basis of clonal hematopoiesis",
          "利用期間": "JGAD000399, JGAD000400"
        },
        "山崎 慶子": {
          "研究代表者": "山崎 慶子",
          "所属機関": "千葉大学大学院医学研究院 公衆衛生学",
          "研究題目": "日本",
          "利用データID": "炎症性腸疾患における分子標的薬の効果予測システムの構築",
          "利用期間": "JGAD000220"
        },
        "鬼頭 良輔": {
          "研究代表者": "鬼頭 良輔",
          "所属機関": "信州大学 医学部 耳鼻咽喉科頭頸部外科",
          "研究題目": "日本",
          "利用データID": "突発性難聴の発症・治療効果に関する遺伝子解析",
          "利用期間": "JGAD000123"
        },
        "上辻󠄀 茂男": {
          "研究代表者": "上辻󠄀 茂男",
          "所属機関": "株式会社スタージェン 統計解析事業部",
          "研究題目": "日本",
          "利用データID": "斜視の遺伝的要因の検証のためのゲノムワイド関連研究",
          "利用期間": "JGAD000123"
        },
        "由良 敬": {
          "研究代表者": "由良 敬",
          "所属機関": "お茶の水女子大学 大学院 人間文化創成科学研究科",
          "研究題目": "日本",
          "利用データID": "がん抑制遺伝子BRCA1バリアントの表現型予測に関するデータ解析研究",
          "利用期間": "JGAD000220"
        },
        "尾内 善広": {
          "研究代表者": "尾内 善広",
          "所属機関": "千葉大学大学院医学研究院 公衆衛生学",
          "研究題目": "日本",
          "利用データID": "新型コロナワクチンへの抗体応答の個人差の遺伝的背景に関する研究",
          "利用期間": "JGAD000220"
        },
        "加藤　正樹": {
          "研究代表者": "加藤　正樹",
          "所属機関": "関西医科大学",
          "研究題目": "日本",
          "利用データID": "精神疾患個別化治療アルゴリズムの構築を目的とする生物学的反応因子の探索・検証試験",
          "利用期間": "JGAD000101,JGAD000102,JGAD000123,JGAD000220"
        },
        "木村 大樹": {
          "研究代表者": "木村 大樹",
          "所属機関": "名古屋大学大学院医学系研究科",
          "研究題目": "日本",
          "利用データID": "遺伝子解析による脳とこころの病気に対するかかりやすさ（発症脆弱性）や薬の効きめや副作用（治療反応性）等の解明に関する研究",
          "利用期間": "JGAD000220"
        },
        "寺尾 知可史": {
          "研究代表者": "寺尾 知可史",
          "所属機関": "理化学研究所生命医学研究センター",
          "研究題目": "日本",
          "利用データID": "ゲノミクス情報を基盤とした個別化医療の研究",
          "利用期間": "JGAD000123,JGAD000124,JGAD000144-JGAD000201,JGAD000220"
        }
      },
      "リリース情報": {
        "hum0014.v31": {
          "Research ID": "hum0014.v31",
          "公開日": "2023/09/01",
          "内容": "JGAD000220（BBJ1,026名のWGS）の加工データ（CRAM、gVCF）\r\nJGAD000220（BBJ1,026名のWGS）の加工データ（Joint call）（aggregate VCF）\r\nJGAD000220（reference panel）の加工データ（NBDC-DDBJ imputation server 用データ）",
          "description": "JGAD000220の2003年から2007年度にバイオバンク・ジャパンに登録された1,026名の全ゲノムシークエンス解析データ（fastqファイル）に対して、特定の解析パイプラインにより加工したCRAM/gVCFファイルを提供する。利用を希望する場合は、データ利用申請書にJGAD000220（元データ）とJGAD000690（加工データ）を記載すること。\nJGAD000220の2003年から2007年度にバイオバンク・ジャパンに登録された1,026名の全ゲノムシークエンス解析データ（fastqファイル）に対して、特定の解析パイプラインにより加工したaggregate VCF、tabixファイルを提供する。Genotypeコールの際、Joint callを実施している。利用を希望する場合は、データ利用申請書にJGAD000220（元データ）とJGAD000758（加工データ）を記載すること。\nJGAS000114 reference panel（JGAD000220）に対して、特定の解析パイプラインにより加工したtbi index ファイル/bref3 ファイル/config ファイルを提供する。これらのファイルは、NBDC-DDBJ imputation serverで使用することができる。利用を希望する場合は、データ利用申請書にJGAD000220（元データ）とJGAD000679（加工データ）を記載すること。\n"
        },
        "hum0014.v30": {
          "Research ID": "hum0014.v30",
          "公開日": "2023/04/20",
          "内容": "リンパ腫1,982症例、胃がん10,366症例および対照者37,592名の遺伝性腫瘍関連27遺伝子翻訳領域のターゲットシークエンスデータ",
          "description": "Illumina社のHiSeq 2500を使用して取得した、リンパ腫1,982症例、胃がん10,366症例および対照者37,592名（BBJの非がん対象者）の遺伝性腫瘍関連27遺伝子翻訳領域のターゲットシークエンスデータを追加した（fastq）。\n"
        },
        "hum0014.v29": {
          "Research ID": "hum0014.v29",
          "公開日": "2023/04/05",
          "内容": "心房細動患者9,826症例および対照者140,446名のゲノムワイド関連解析（BBJ）\r\n心房細動患者77,690症例および対照者1,167,040名のGWASメタ解析（BBJ、欧米人、FinnGen）",
          "description": "BBJ第1コホートの心房細動患者9,826症例および対照者140,446名のGWAS集計情報を追加した（txt）。\nBBJ、欧米人、FinnGenの心房細動患者77,690症例および対照者1,167,040名のGWASメタ解析の集計情報およびポリジェニックリスクスコアを追加した（txt）。\n"
        },
        "hum0014.v28": {
          "Research ID": "hum0014.v28",
          "公開日": "2023/04/05",
          "内容": "BBJ第1コホート4,880名のmobile element多型頻度情報",
          "description": "BBJ第1コホート4,880名のmobile element多型頻度情報を追加した（txt）。\n"
        },
        "hum0014.v27": {
          "Research ID": "hum0014.v27",
          "公開日": "2022/12/31",
          "内容": "BBJ第1コホート137,693名の生存に関するゲノムワイド関連解析",
          "description": "BBJ第1コホート137,693名のGWAS集計情報を追加した（txt）。\n男女別にそれぞれCox回帰分析を用いてGWASを実施した。また、SPACoxソフトウェアを用いた関連解析も併せて実施した。\n"
        },
        "hum0014.v26": {
          "Research ID": "hum0014.v26",
          "公開日": "2022/04/01",
          "内容": "腎がん740症例および対照者5,996名の遺伝性腫瘍関連27遺伝子および腎がん関連13遺伝子翻訳領域のターゲットシークエンスデータ",
          "description": "Illumina社のHiSeq 2500を使用して取得した、腎がん740症例および対照者5,996名の遺伝性腫瘍関連27遺伝子および腎がん関連13遺伝子翻訳領域のターゲットシークエンスデータを追加した（fastq）。\n"
        },
        "hum0014.v25": {
          "Research ID": "hum0014.v25",
          "公開日": "2022/01/25",
          "内容": "心筋梗塞1,765症例、認知症199症例の全ゲノムシークエンスデータ",
          "description": "Illumina社のHiSeq X Fiveを使用して取得した、心筋梗塞1,765症例、認知症199症例の全ゲノムシークエンスデータ（fastq）、およびGEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のbam/gvcfデータを追加した。\n"
        },
        "hum0014.v24": {
          "Research ID": "hum0014.v24",
          "公開日": "2021/11/26",
          "内容": "膵がん1,005症例、大腸がん12,503症例および対照者23,705名の遺伝性腫瘍関連27遺伝子翻訳領域のターゲットシークエンスデータ",
          "description": "Illumina社のHiSeq 2500を使用して取得した、膵がん1,005症例、大腸がん12,503症例および対照者23,705名の遺伝性腫瘍関連27遺伝子翻訳領域のターゲットシークエンスデータを追加した（fastq）。\n"
        },
        "hum0014.v23": {
          "Research ID": "hum0014.v23",
          "公開日": "2021/07/13",
          "内容": "JGAD000220のWGSデータのbam/gvcfデータ",
          "description": "JGAD000220に含まれるwhole genome sequencing解析データに対し、GEnome Medical alliance Japan（GEM Japan, GEM-J）の取り組みとして、GATK Best Practicesに準拠した方法により、GRCh37の参照ゲノム配列へのマッピングおよびバリアント検知を実施した際のbam/gvcfデータを追加した。\n"
        },
        "hum0014.v22": {
          "Research ID": "hum0014.v22",
          "公開日": "2021/05/21",
          "内容": "11,234名の23遺伝子における全てのエクソン領域のターゲットシークエンス解析より得られた体細胞変異データおよびSNPアレイ解析より得られた染色体変異データ",
          "description": "2003年から2007年度にバイオバンク・ジャパンに登録されたサンプル（約20万例）から抽出された11,234名の23遺伝子における全てのエクソン領域のターゲットシークエンス解析（Illumina HiSeq 2500）より得られた体細胞変異データ、および、SNPアレイ解析（Illumina human OmniExpress、human OmniExpressExome）より得られた染色体変異データを追加した（csv、txt）。\n"
        },
        "hum0014.v21": {
          "Research ID": "hum0014.v21",
          "公開日": "2020/08/25",
          "内容": "虚血性心疾患のゲノムワイド関連解析",
          "description": "虚血性心疾患のGWAS集計情報を追加した（txt）。\n"
        },
        "hum0014.v20": {
          "Research ID": "hum0014.v20",
          "公開日": "2020/08/17",
          "内容": "冠動脈疾患のゲノムワイド関連解析",
          "description": "冠動脈疾患のGWAS集計情報およびポリジェニックリスクスコアを追加した（txt）。\nIllumina社のHumanOminiExpress、Exome、またはOmniExpressExome BeadChipを使用して、約90万個のSNVsの遺伝子型を決定し、minimac3にてimputation（reference: BBJ-CAD reference panel）を実施、plink2を用いて約2000万個の遺伝子変異についてGWASを行った。\n"
        },
        "hum0014.v19": {
          "Research ID": "hum0014.v19",
          "公開日": "2020/04/20",
          "内容": "165,084名の食習慣に関するゲノムワイド関連解析",
          "description": "2003年から2007年度にバイオバンク・ジャパンに登録した165,084名の食習慣データ（飲酒歴の有無、1週間あたりの飲酒量、コーヒー・緑茶・牛乳・ヨーグルト・チーズ・納豆・豆腐・魚・小魚・野菜および肉の摂取頻度）のGWAS結果。\nIllumina社のHumanOminiExpress、HumanExome、または、OmniExpressExome BeadChipを使用してGenotypeを決定後、minimacを用いてimputation（reference: 1000 genome phase I v3）を実施し、BOLT-LMM（for autosomes）およびProbABEL（for X chromosome）を用いて約600万個のSNVsについてGWASを行った。\n"
        },
        "hum0014.v18": {
          "Research ID": "hum0014.v18",
          "公開日": "2019/11/26",
          "内容": "乳がんのゲノムワイド関連解析",
          "description": "乳がんのGWAS集計情報を追加した（txt）。\n"
        },
        "hum0014.v17": {
          "Research ID": "hum0014.v17",
          "公開日": "2019/10/08",
          "内容": "40疾患のゲノムワイド関連解析",
          "description": "40疾患のGWAS集計情報を追加した（txt）。\nIllumina社のHumanOminiExpress、Exome、またはOmniExpressExome BeadChipを使用してGenotypeを決定後、minimac3にてimputation（reference: 1000 genomes Phase 3 v5）を実施、SAIGE（v0.29.4.2）にて8,919,992個のSNVsのGWASを行った。\n"
        },
        "hum0014.v16": {
          "Research ID": "hum0014.v16",
          "公開日": "2019/10/07",
          "内容": "遺伝性前立腺がん7,636症例と対照者12,366名の遺伝性前立腺がん原因8遺伝子翻訳領域のターゲットシークエンスデータ",
          "description": "Illumina社のHiSeq 2500を使用して取得した、遺伝性前立腺がん7,636症例と対照12,366名の遺伝性前立腺がん原因8遺伝子翻訳領域のターゲットシークエンスデータを追加した（fastq）。\n"
        },
        "hum0014.v15": {
          "Research ID": "hum0014.v15",
          "公開日": "2019/09/27",
          "内容": "バイオバンクジャパン1,037名のWGSデータと1000ゲノムプロジェクト（Phase3v5）の2,504名の全ゲノム情報を統合したgenotype imputation用のreference panel\r\n159,095名の身長のゲノムワイド関連解析",
          "description": "・バイオバンクジャパン1,037名のWGSデータと1000ゲノムプロジェクト（Phase3v5）2,504名の全ゲノム情報を統合し、genotype imputation用のreference panelを作成した。\n・Illumina社のHumanOmniExpressExomeまたはOmniExpressおよびHuman Exomeを用いてgenotypeを決定後、minimacを用いてimputation（reference panel using WGS data of the biobank Japan project (N=1,037) and 1KGP p3v5 ALL (N=2,504)）を実施し、BOLT-LMM（ver2.2）およびmach2qtlを用いて約2700万個のvariantsについてGWASを行った。\n"
        },
        "hum0014.v14": {
          "Research ID": "hum0014.v14",
          "公開日": "2019/03/26",
          "内容": "165,436名の喫煙習慣に関するゲノムワイド関連解析",
          "description": "2003年から2007年度にバイオバンク・ジャパンに登録した165,436名の喫煙習慣データ（喫煙開始年齢、喫煙本数、喫煙歴、喫煙中断歴）のGWAS結果。\nIllumina社のHumanOminiExpress、HumanExome、または、OmniExpressExome BeadChipを使用してGenotypeを決定後、minimacを用いてimputation（reference: 1000 genome phase I v3）を実施し、BOLT-LMM（v2.2）およびProbABEL（v0.4.5; for X chromosome）を用いて約600万個のSNVsについてGWASを行った。\n"
        },
        "hum0014.v13": {
          "Research ID": "hum0014.v13",
          "公開日": "2019/01/25",
          "内容": "２型糖尿病36,614症例および対照者155,150名のゲノムワイド関連解析メタ解析",
          "description": "以下の４GWASのメタ解析を行った結果を追加した（txt）。\n　・２型糖尿病9,804症例と対象者6,728名 \n　・２型糖尿病5,639症例と対象者19,407名 \n　・２型糖尿病18,688症例と対象者121,950名 \n　・２型糖尿病2,483症例と対象者7,065名 \n遺伝子型決定には、Illumina [HumanOmniExpress、HumanExome、OmniExpressExome、Human610-Quad BeadChip]を使用している。\n"
        },
        "hum0014.v12": {
          "Research ID": "hum0014.v12",
          "公開日": "2018/12/10",
          "内容": "２型糖尿病腎症2,809症例および２型糖尿病対照5,592症例のゲノムワイド関連解析メタ解析",
          "description": "以下の２GWASのメタ解析を行った結果を追加した（csv）。\n　・２型糖尿病腎症2,380症例と２型糖尿病対照（腎症非発症群）5,234症例\n　・２型糖尿病腎症429症例と２型糖尿病対照（腎症非発症群）358症例\n遺伝子型決定には、Illumina社のOmniExpressExome BeadchipもしくはHuman610-Quad BeadChipを使用している。\n"
        },
        "hum0014.v11": {
          "Research ID": "hum0014.v11",
          "公開日": "2018/10/16",
          "内容": "乳がん7,104症例と対照者23,731名の遺伝性乳がん原因11遺伝子翻訳領域のターゲットシークエンスデータ",
          "description": "Illumina社のHiSeq 2500を使用して取得した、乳がん7,104症例と対照23,731名の遺伝性乳がん原因11遺伝子翻訳領域のターゲットシークエンスデータを追加した（fastq）。\n"
        },
        "hum0014.v10": {
          "Research ID": "hum0014.v10",
          "公開日": "2018/08/13",
          "内容": "BBJ第1コホート1,026名の全ゲノムシークエンスデータ",
          "description": "Illumina社のHiSeq 2500を使用して取得した、2003年から2007年度にバイオバンク・ジャパンに登録した1,026名の全ゲノムシークエンスデータを追加した（fastq）。\n"
        },
        "hum0014.v9": {
          "Research ID": "hum0014.v9",
          "公開日": "2018/08/07",
          "内容": "初潮年齢データを有する女性67,029名および\r\n閉経年齢データを有する女性43,861名のゲノムワイド関連解析",
          "description": "Illumina社のHumanOminiExpress、HumanExome、または、OmniExpressExome BeadChipを使用して初潮年齢データを有する女性67,029名および閉経年齢データを有する女性43,861名のGenotypeを決定後、minimacを用いてimputation（reference: 1000 genome phase I v3）を実施し、mach2dat（ver. 1.0.19）を用いて約1,000万個のSNVsについてGWASを行った。\n"
        },
        "hum0014.v8": {
          "Research ID": "hum0014.v8",
          "公開日": "2018/05/01",
          "内容": "162,255名の58臨床検査値のゲノムワイド関連解析",
          "description": "2003年から2007年度にバイオバンク・ジャパンに登録した162,255名の58臨床検査値のGWASの結果（hum0014.v8.58qt.v1）および個人毎の58臨床検査値データ（JGAD000144～JGAD000201）を追加した。\nIllumina社のHumanOminiExpress-12、HumanExome、または、OmniExpressExome BeadChipを使用してGenotypeを決定後、minimacを用いてimputation（reference: 1000 genomes Phase I v3）を実施し、mach2qtl (v1.1.3)を用いて約600万個のSNVsについてGWASを行った。\n"
        },
        "hum0014.v7": {
          "Research ID": "hum0014.v7",
          "公開日": "2018/04/04",
          "内容": "開放隅角緑内障3,980症例と対照者18,815名のゲノムワイド関連解析",
          "description": "Illumina社のHumanOminiExpress、HumanExome、または、OmniExpressExome BeadChipを使用して開放隅角緑内障3,980症例と対照者18,815名のGenotypeを決定後、minimacを用いてimputation（reference: 1000 genome phase I v3）を実施し、mach2dat（ver. 1.0.19）を用いて約600万個のSNVsについてGWASを行った。\n"
        },
        "hum0014.v6": {
          "Research ID": "hum0014.v6",
          "公開日": "2017/09/08",
          "内容": "158,284名のBMIゲノムワイド関連解析\r\n182,505名のGenotypeデータ",
          "description": "2003年から2007年度にバイオバンク・ジャパンに登録した47疾患のうち158,284名のBMI-GWASの結果（hum0014.v6.158k.v1）および個人毎のBMIデータ（JGAD000124）および182,505名のGenotypeデータ（JGAD000123）を追加した。\nIllumina社のHumanOminiExpress-12、HumanExome、または、OmniExpressExome BeadChipを使用してGenotypeを決定後、minimacを用いてimputation（reference: 1000 genomes Phase I v3）を実施し、mach2qtl（v1.1.3）を用いて約600万個のSNVsについてGWASを行った。\n"
        },
        "hum0014.v5": {
          "Research ID": "hum0014.v5",
          "公開日": "2017/05/18",
          "内容": "心房細動8,180症例と対照者28,612名のゲノムワイド関連解析\r\n心房細動8,180症例のGenotypeデータ",
          "description": "2003年から2007年度にバイオバンク・ジャパンに登録した47疾患患者のうち心房細動を発症した8,180症例と心房細動を発症していない対照者28,612名のGWASの結果（hum0014.v5.AF.v1）および心房細動症例の個人毎のPhenotypeデータ（JGAD000101）およびGenotypeデータ（JGAD000102）を追加した。\nIllumina社のHumanOminiExpress-12、HumanExome、または、OmniExpressExome BeadChipを使用して、約90万個のSNVsの遺伝子型を決定後、minimacを用いてimputation（reference: 1000 genomes Phase I v3）を実施し、mach2datを用いて約500万個のSNVsについてGWASを行った。\n"
        },
        "hum0014.v4": {
          "Research ID": "hum0014.v4",
          "公開日": "2016/02/02",
          "内容": "アトピー性皮膚炎1,472症例と対照者7,966名のゲノムワイド関連解析",
          "description": "Illumina社のHumanOmniExpress-12 BeadChipを使用してアトピー性皮膚炎1,472症例と対照者7,966名の遺伝子型（606,164 SNVs）を決定後、minimacを用いてimputation（リファレンス：1000 genome phase I v3）を実施することで約770万個の変異の疾患群および対照群それぞれの頻度を推定し、mach2datアルゴリズムにより関連解析（allele dosageに対するロジスティック回帰）を行った。常染色体およびX染色体（男女別）上の変異の関連解析結果をテキストファイルにて提供する。\n"
        },
        "hum0014.v3": {
          "Research ID": "hum0014.v3",
          "公開日": "2016/01/28",
          "内容": "２型糖尿病9,817症例と対照者6,763名および２型糖尿病5,646症例と対照者19,420名のゲノムワイド関連解析",
          "description": "２型糖尿病9,817症例と対照者6,763名（552,915 SNPs）および２型糖尿病5,646症例と対照者19,420名（479,088 SNPs）の遺伝子型カウント情報およびGWASの結果を追加した。\n遺伝子型決定には、Illumina [Omni Express exome BeadchipもしくはHuman610-Quad BeadChip]を使用している。\n"
        },
        "hum0014.v2": {
          "Research ID": "hum0014.v2",
          "公開日": "2015/12/28",
          "内容": "健常者934名、35疾患各約190症例、食道がん182症例、筋萎縮性側索硬化症92症例の遺伝子型カウント情報　（JSNPのHPにおいて提供していた情報と同じものです）",
          "description": "健常者934名、35疾患各約190症例、食道がん182症例、筋萎縮性側索硬化症92症例の遺伝子型カウント情報を追加した。\n35疾患は以下の通り。\n悪性腫瘍 （肺がん、乳がん、胃がん、大腸・直腸がん、前立腺がん）\n心血管系疾患 （心不全、心筋梗塞，不安定狭心症、安定狭心症、不整脈、閉塞性動脈硬化症）\n脳血管障害 （脳梗塞、脳動脈瘤）\n呼吸器疾患 （間質性肺炎＆肺線維症、肺気腫、気管支喘息）\n慢性肝疾患 （C型慢性肝炎、肝硬変）\n眼疾患 （白内障、緑内障）\nその他 （てんかん、歯周病、尿路結石、ネフローゼ症候群、子宮筋腫、子宮内膜症、骨粗鬆症、関節リウマチ、筋萎縮性側索硬化症、花粉症、アトピー性皮膚炎、過敏性症候群（薬疹）、高脂血症、糖尿病、バセドウ病）\n遺伝子型決定には、Illumina [Human610-Quad BeadChip、HumanHap550v3 Genotyping BeadChip] 、Perlegen Sciences [high-density oligonucleotide arrays] およびHologic Japan [Invader]を使用している。\n"
        },
        "hum0014.v1": {
          "Research ID": "hum0014.v1",
          "公開日": "2014/09/30",
          "内容": "心筋梗塞1,666症例と対照健常者3,198名のゲノムワイド関連解析",
          "description": "日本人心筋梗塞1,666症例、および日本人対照健常者3,198名の約45万6千SNPsの遺伝子型カウント情報およびGWASの結果を提供する。\n遺伝子型決定には、Illumina [Human610-Quad BeadChipもしくはHumanHap550v3 Genotyping BeadChip]を使用している。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0014.v31",
      "DATA": {
        "hum0014.v1.freq.v1": {
          "Data Set ID": "hum0014.v1.freq.v1",
          "Type of Data": "GWAS for MI",
          "Criteria": "Unrestricted-access",
          "Release Date": "2014/09/30"
        },
        "hum0014.v2.jsnp.934ctrl.v1": {
          "Data Set ID": "hum0014.v2.jsnp.934ctrl.v1",
          "Type of Data": "Genotype frequencies in 934 healthy individuals\r\n (JSNP data)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2015/12/28"
        },
        "35 Dieases": {
          "Data Set ID": "35 Dieases",
          "Type of Data": "Genotype frequencies in each disease\r\n (JSNP data)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2015/12/28"
        },
        "hum0014.v2.jsnp.182ec.v1": {
          "Data Set ID": "hum0014.v2.jsnp.182ec.v1",
          "Type of Data": "Genotype frequencies in 182 esophageal cancer patients\r\n (JSNP data)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2015/12/28"
        },
        "hum0014.v2.jsnp.92als.v1": {
          "Data Set ID": "hum0014.v2.jsnp.92als.v1",
          "Type of Data": "Genotype frequencies in 92 amyotrophic lateral sclerosis (ALS) patients\r\n (JSNP data)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2015/12/28"
        },
        "hum0014.v3.T2DM-1.v1": {
          "Data Set ID": "hum0014.v3.T2DM-1.v1",
          "Type of Data": "GWAS for T2DM [1]",
          "Criteria": "Unrestricted-access",
          "Release Date": "2016/01/28"
        },
        "hum0014.v3.T2DM-2.v1": {
          "Data Set ID": "hum0014.v3.T2DM-2.v1",
          "Type of Data": "GWAS for T2DM [2]",
          "Criteria": "Unrestricted-access",
          "Release Date": "2016/01/28"
        },
        "hum0014.v4.AD.v1": {
          "Data Set ID": "hum0014.v4.AD.v1",
          "Type of Data": "GWAS for AD",
          "Criteria": "Unrestricted-access",
          "Release Date": "2016/02/02"
        },
        "hum0014.v5.AF.v1": {
          "Data Set ID": "hum0014.v5.AF.v1",
          "Type of Data": "GWAS for AF",
          "Criteria": "Unrestricted-access",
          "Release Date": "2016/05/18"
        },
        "JGAS000101": {
          "Data Set ID": "JGAS000101",
          "Type of Data": "Genotype and phenotype data for 8180 AF patients",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2016/05/18"
        },
        "hum0014.v6.158k.v1": {
          "Data Set ID": "hum0014.v6.158k.v1",
          "Type of Data": "GWAS for BMI",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/09/08"
        },
        "JGAS000114": {
          "Data Set ID": "JGAS000114",
          "Type of Data": "a reference panel from WGS data of the biobank Japan project (N=1,037) and 1KGP p3v5 ALL (N=2,504)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/09/27"
        },
        "hum0014.v7.POAG.v1": {
          "Data Set ID": "hum0014.v7.POAG.v1",
          "Type of Data": "GWAS for POAG",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/04/04"
        },
        "hum0014.v8.58qt.v1": {
          "Data Set ID": "hum0014.v8.58qt.v1",
          "Type of Data": "GWAS for 58 quantitative traits",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/05/01"
        },
        "hum0014.v9.Men.v1\r\nhum0014.v9.MP.v1": {
          "Data Set ID": "hum0014.v9.Men.v1\r\nhum0014.v9.MP.v1",
          "Type of Data": "GWAS for age at menarche and menopause",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/08/07"
        },
        "JGAS000140": {
          "Data Set ID": "JGAS000140",
          "Type of Data": "target sequencing of 11 hereditary breast cancer genes in 7,104 breast cancer patients and 23,731 controls",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/10/16"
        },
        "hum0014.v12.T2DMwN.v1": {
          "Data Set ID": "hum0014.v12.T2DMwN.v1",
          "Type of Data": "meta analysis of 2 GWASs for T2DM with diabetic nephropathy",
          "Criteria": "Unrestricted-access",
          "Release Date": "2018/12/10"
        },
        "hum0014.v13.T2DMmeta.v1": {
          "Data Set ID": "hum0014.v13.T2DMmeta.v1",
          "Type of Data": "meta analysis of 4 GWASs for T2DM",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/01/25"
        },
        "hum0014.v14.smok.v1": {
          "Data Set ID": "hum0014.v14.smok.v1",
          "Type of Data": "GWAS for smoking behaviour",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/03/26"
        },
        "hum0014.v15.ht.v1": {
          "Data Set ID": "hum0014.v15.ht.v1",
          "Type of Data": "GWAS for height",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/09/27"
        },
        "JGAS000203": {
          "Data Set ID": "JGAS000203",
          "Type of Data": "target sequencing of 8 hereditary prostate cancer genes in 7,636 prostate cancer patients and 12,366 controls",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/10/07"
        },
        "hum0014.v17": {
          "Data Set ID": "hum0014.v17",
          "Type of Data": "GWAS for 40 diseases",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/10/08"
        },
        "hum0014.v18": {
          "Data Set ID": "hum0014.v18",
          "Type of Data": "GWAS for Breast cancer",
          "Criteria": "Unrestricted-access",
          "Release Date": "2019/11/26"
        },
        "hum0014.v19": {
          "Data Set ID": "hum0014.v19",
          "Type of Data": "GWAS for dietary habits",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/04/20"
        },
        "hum0014.v20.cad.v1": {
          "Data Set ID": "hum0014.v20.cad.v1",
          "Type of Data": "GWAS for coronary artery disease",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/08/17"
        },
        "hum0014.v21": {
          "Data Set ID": "hum0014.v21",
          "Type of Data": "GWAS for coronary artery disease",
          "Criteria": "Unrestricted-access",
          "Release Date": "2020/08/25"
        },
        "JGAS000293": {
          "Data Set ID": "JGAS000293",
          "Type of Data": "target sequencing of 23 genes related to clonal hematopoiesis and SNP array in 11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/05/21"
        },
        "JGAS000114 (Data addition)": {
          "Data Set ID": "JGAS000114 (Data addition)",
          "Type of Data": "bam/gvcf data of WGS (JGAD000220)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/13"
        },
        "JGAS000327": {
          "Data Set ID": "JGAS000327",
          "Type of Data": "target sequencing of 27 cancer-predisposing genes in 1,005 pancreatic cancer patients",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/26"
        },
        "JGAS000346": {
          "Data Set ID": "JGAS000346",
          "Type of Data": "target sequencing of 27 cancer-predisposing genes in 12,503 colorectal cancer patients and 23,705 controls",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/26"
        },
        "JGAS000381": {
          "Data Set ID": "JGAS000381",
          "Type of Data": "WGS for 1,765 myocardial infarction patients and 199 dementia patients",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/01/25"
        },
        "JGAS000414": {
          "Data Set ID": "JGAS000414",
          "Type of Data": "target sequencings of 27 cancer-predisposing genes and 13 renal cell carcinoma-related genes in 740 renal cell cancer patients and 5,996 controls",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/04/01"
        },
        "hum0014.v27.surv.v1": {
          "Data Set ID": "hum0014.v27.surv.v1",
          "Type of Data": "GWAS for survival time in 137,693 individuals from BBJ 1st cohort",
          "Criteria": "Unrestricted-access",
          "Release Date": "2022/12/31"
        },
        "hum0014.v28.MEs.v1": {
          "Data Set ID": "hum0014.v28.MEs.v1",
          "Type of Data": "mobile element variations in 4,880 individuals from BBJ 1st cohort",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/04/05"
        },
        "hum0014.v29.AF.v1": {
          "Data Set ID": "hum0014.v29.AF.v1",
          "Type of Data": "GWAS for 9,826 AF patients and 140,446 controls from BBJ 1st cohort\r\nGWAS meta-analysis for 77,690 AF patients and 1,167,040 controls",
          "Criteria": "Unrestricted-access",
          "Release Date": "2023/04/05"
        },
        "JGAS000347": {
          "Data Set ID": "JGAS000347",
          "Type of Data": "target sequencing of 27 cancer-predisposing genes in 1,982 lymphoma patients",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/04/20"
        },
        "JGAS000592": {
          "Data Set ID": "JGAS000592",
          "Type of Data": "target sequencing of 27 cancer-predisposing genes in 37,592 controls",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/04/20"
        },
        "JGAD000690": {
          "Data Set ID": "JGAD000690",
          "Type of Data": "Processed data of JGAD000220 (WGS for 1,026 individuals) by JGA (CRAM, gVCF)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/08/31"
        },
        "JGAD000758": {
          "Data Set ID": "JGAD000758",
          "Type of Data": "Processed data (joint call) of JGAD000220 (WGS for 1,026 individuals) by JGA (aggregate VCF)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/08/31"
        },
        "JGAD000679": {
          "Data Set ID": "JGAD000679",
          "Type of Data": "Processed data of JGAD000220 (reference panel) by JGA (data for the use of NBDC-DDBJ imputation server)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/09/01"
        }
      },
      "SUMMARY": {
        "Aims": "Identify disease-related genes and mobile element variations in Japanese",
        "Methods": "Genomic DNA samples were genotyped by following methods: Human610-Quad BeadChip, HumanHap550v3 Genotyping BeadChip, HumanOmniExpress-12 BeadChip, HumanExome BeadChip, OmniExpressExome BeadChip (Illumina), high-density oligonucleotide arrays (Perlegen Sciences), or Invader (Hologic Japan). Genome-Wide Association Studies (GWAS) for myocardial infarction (MI) , type II diabetes mellitus (T2DM), Atopic dermatitis (AD), atrial fibrillation (AF), Body Mass Index (BMI), primary open-angle glaucoma (POAG), 58 quantitative traits, age at menarche / menopause, smoking behaviour, height, 42 diseases (among them, the samples of 4 diseases were partially overlapped with those of previous release), dietary habits, and coronary artery disease were performed using about 500-2700K variants. Meta analyses for T2DM with diabetic nephropathy and for T2DM were also performed. Whole-genome sequencing analyses for 1,026 patients, who were registered Bio Bank Japan from 2003 - 2007, 1,765 myocardial infarction patients and 199 dementia patients were performed with Illumina HiSeq 2500/X Five. Target sequencing analyses of 11 hereditary breast cancer genes in 7,104 breast cancer patients and 23,731 controls, 8 hereditary prostate cancer genes in 7,636 prostate cancer patients and 12,366 controls, 23 genes related to clonal hematopoiesis in 11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007, 27 cancer-predisposing genes in 1,009 pancreatic cancer patients, 12,606 colorectal cancer patients, 740 renal cell cancer patients, 1,982 lymphoma patients, 10,366 gastric cancer patients and 23,780 + 5,996 + 37,592 controls and 13 renal cell carcinoma-related genes in 740 renal cell cancer patients and 5,996 controls were performed with Illumina HiSeq 2500. SNP array analysis for 11,234 subjects was also performed. A new reference panel was build with WGS data of the biobank Japan project (N=1,037) and the 1KGP p3v5 ALL (N=2,504). Sex-stratified genome-wide association studies using a Cox proportional hazard model under the assumption of the additive genetic model were performed. Associations of genetic variants estimated by saddle point estimation using SPACox software were also evaluated. A mobile element variation (MEV) search tool, MEGAnE, was applied to 4,880 WGS conducted in BBJ and 24,933 MEVs were found. Genome-wide association study for atrial fibrillation was performed in 9,826 cases and 140,446 controls. A subsequent cross-ancestry meta-analysis with European GWAS (60,620 cases and 970,216 controls; http://csg.sph.umich.edu/willer/public/afib2018) and Finnish GWAS (7,244 cases and 56,378 controls; FinnGenn; https://www.finngen.fi/en) was performed (77,690 cases and 1,167,040 controls in total). Polygenic risk score was constructed based on the cross-ancestry meta-analysis of atrial fibrillation.",
        "Participants/Materials": "Participants for the Tailor-made Medical Treatment Program (BioBank Japan: BBJ)",
        "URL": "https://biobankjp.org/english/index.html"
      },
      "MOLECULAR DATA": {
        "hum0014.v1.freq.v1": {
          "Participants/Materials": "1666 MI patients and 3198 controls",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Human610-Quad BeadChip, HumanHap550v3 Genotyping BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina Human610-Quad Beadchip",
          "Genotype Call Methods (software)": "GenCall software (GenomeStudio)",
          "Filtering Methods": "sample call rate ≧ 0.98, SNP call rate ≧ 0.99, HWE P ≧ 1 x 10^-6",
          "Marker Number (after QC)": "455,781 SNPs (hg18/GRCh36)",
          "NBDC Dataset ID": "hum0014.v1.freq.v1\r\n (Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "71.3 MB (xlsx)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v2.jsnp.934ctrl.v1": {
          "Participants/Materials": "934 Japanese healthy individuals (JSNP)",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanHap550v3 Genotyping BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina HumanHap550v3 Genotyping BeadChip",
          "Genotype Call Methods (software)": "GenCall software (GenomeStudio)",
          "Filtering Methods": "sample call rate < 0.98, SNP call rate < 0.99, HWE P < 1 x 10^-6",
          "Marker Number (after QC)": "515,286 SNPs",
          "NBDC Dataset ID": "hum0014.v2.jsnp.934ctrl.v1\r\n (Click the Dataset ID to download the file) \r\nDictionary file",
          "Total Data Volume": "32.2 M (zip [xls])",
          "Comments (Policies)": "NBDC policy"
        },
        "35 Diseases": {
          "Participants/Materials": "Cancer (Lung cancer, Breast cancer, Gastric cancer, Colorectal cancer, Prostate cancer) \r\nCardiovascular diseases (Heart failure, Myocardial infarction, Unstable angina, Stable angina, Cardiac arrhythmias, Arteriosclerosis obliterans) \r\nCerebrovascular disorders (Brain infarction, Intracranial aneurysm) \r\nRespiratory tract diseases (Interstitial pneumonitis & pulmonary fibrosis, Pulmonary emphysema, Bronchial asthma) \r\nChronic liver diseases (Chronic hepatitis C, Liver cirrhosis) \r\nEye diseases (Cataract, Glaucoma) \r\nOthers (Epilepsy, Periodontal disease, Urolithiasis, Nephrotic syndrome, Uterine myoma, Endometriosis, \r\n Osteoporosis, Rheumatoid arthritis, Amyotrophic lateral sclerosis, Hay fever, Atopic dermatitis, \r\nDrug eruptions , Hyperlipidemias, Diabetes mellitus, Basedow disease ) \r\n \r\nabout 190 patients in each disease set",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Perlegen Sciences [high-density oligonucleotide arrays]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "-",
          "Genotype Call Methods (software)": "-",
          "Filtering Methods": "-",
          "Marker Number (after QC)": "About 200,000 SNPs (b129)",
          "NBDC Dataset ID": "Cancer (Lung cancer, Breast cancer, Gastric cancer, Colorectal cancer, Prostate cancer) \r\nCardiovascular diseases (Heart failure, Myocardial infarction, Unstable angina, Stable angina, Cardiac arrhythmias, Arteriosclerosis obliterans) \r\nCerebrovascular disorders (Brain infarction, Intracranial aneurysm) \r\nRespiratory tract diseases (Interstitial pneumonitis & pulmonary fibrosis, Pulmonary emphysema, Bronchial asthma) \r\nChronic liver diseases (Chronic hepatitis C, Liver cirrhosis) \r\nEye diseases (Cataract, Glaucoma) \r\nOthers (Epilepsy, Periodontal disease, Urolithiasis, Nephrotic syndrome, Uterine myoma, Endometriosis, \r\nOsteoporosis, Rheumatoid arthritis, Amyotrophic lateral sclerosis, Hay fever, Atopic dermatitis, \r\nDrug eruptions, Hyperlipidemias, Diabetes mellitus, Basedow disease) \r\n (Click the disease names to download the file) \r\nDictionary file",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v2.jsnp.182ec.v1": {
          "Participants/Materials": "182 esophageal cancer patients (JSNP)",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanHap550v3 Genotyping BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina HumanHap550v3 Genotyping BeadChip",
          "Genotype Call Methods (software)": "GenCall software (GenomeStudio)",
          "Filtering Methods": "sample call rate < 0.98, SNP call rate < 0.99, HWE P < 1 x 10^-6",
          "Marker Number (after QC)": "503,734 SNPs",
          "NBDC Dataset ID": "hum0014.v2.jsnp.182ec.v1\r\n (Click the Dataset ID to download the file) \r\nDictionary file",
          "Total Data Volume": "6.6 MB (zip [txt])",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v2.jsnp.92als.v1": {
          "Participants/Materials": "92 ALS patients (JSNP)",
          "Targets": "large-scale case-control association study",
          "Target Loci for Capture Methods": "-",
          "Platform": "Hologic Japan [Invader]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Invader assay system (Third Wave Technologies)",
          "Genotype Call Methods (software)": "ABI PRISM SDS versions 2.0 - 2.2",
          "Filtering Methods": "SNP call rate ≥ 0.95, HWE P ≥1.0 x 10^-2",
          "Marker Number (after QC)": "48,939 SNPs",
          "NBDC Dataset ID": "hum0014.v2.jsnp.92als.v1\r\n (Click the Dataset ID to download the file) \r\nDictionary file",
          "Total Data Volume": "3.2 MB (zip [txt])",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v3.T2DM-1.v1": {
          "Participants/Materials": "9817 T2DM patients\r\n6763 controls (healthy individuals and patients with Intracranial aneurysm, Esophageal cancer, Uterine cancer, Pulmonary emphysema, or Glaucoma [without T2DM])",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [OmniExpressExome Beadchip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina OmniExpressExome Beadchip kit",
          "Genotype Call Methods (software)": "GenCall software (GenomeStudio)",
          "Filtering Methods": "sample call rate < 0.98, SNP call rate < 0.99, MAF < 0.01, HWE P < 1 x 10^-6 in control",
          "Marker Number (after QC)": "552,915 SNPs (hg19)",
          "NBDC Dataset ID": "hum0014.v3.T2DM-1.v1\r\n (Click the Dataset ID to download the file) \r\nDictionary file",
          "Total Data Volume": "84.0 MB (xlsx)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v3.T2DM-2.v1": {
          "Participants/Materials": "5646 T2DM patients\r\n19,420 controls (patients with Colorectal cancer, Breast cancer, Prostate cancer, Lung cancer, Gastric cancer, \r\nArteriosclerosis obliterans, Cardiac arrhythmias, Brain infarction, Myocardial infarction, Gallbladder cancer and Cholangiocarcinoma, Pancreatic cancer, Drug eruptions, \r\nRheumatoid arthritis, Amyotrophic lateral sclerosis, Liver cancer, Liver cirrhosis, Osteoporosis, or Uterine myoma [without T2DM])",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [Human610-Quad BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina Human610-Quad Beadchip kit",
          "Genotype Call Methods (software)": "GenCall software (GenomeStudio)",
          "Filtering Methods": "sample call rate < 0.98, SNP call rate < 0.99, MAF < 0.01, HWE P < 1 x 10^-6 in control",
          "Marker Number (after QC)": "479,088 SNPs (hg18)",
          "NBDC Dataset ID": "hum0014.v3.T2DM-2.v1\r\n (Click the Dataset ID to download the file) \r\nDictionary file",
          "Total Data Volume": "72.6 MB (xlsx)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v4.AD.v1": {
          "Participants/Materials": "1472 AD patients\r\n7966 controls (healthy individuals and patients with Intracranial aneurysm, Esophageal cancer, \r\n         Uterine cancer, Pulmonary emphysema, or Glaucoma [without AD and Bronchial asthma])",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress BeadChip",
          "Genotype Call Methods (software)": "minimac [imputation (1000 genomes Phase I v3)]",
          "Association Analysis (software)": "mach2dat [GWAS]",
          "Filtering Methods": "Genotyping QC: sample call rate < 0.98, SNV call rate < 0.99, \r\n                           HWE P < 1 x 10^-6 in the control samples\r\nImputation QC: HWE P < 1 x 10^-6 or MAF < 0.01 in the reference panel\r\n                         Differences of MAF between the GWAS dataset and the reference panel > 0.16",
          "Marker Number (after QC)": "About 7,700,000 SNPs (hg19)",
          "NBDC Dataset ID": "hum0014.v4.AD.v1\r\n (Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "ADGWAS_auto.txt (525 MB)\r\nADGWAS_X_females.txt (17 MB)\r\nADGWAS_X_males.txt (15 MB)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000101 / hum0014.v5.AF.v1": {
          "Participants/Materials": "8180 atrial fibrillation patients and 28,612 controls",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "minimac [imputation (1000 genomes Phase I v3)]\r\nGenCall software（GenomeStudio）",
          "Association Analysis (software)": "mach2dat [GWAS]",
          "Filtering Methods": "Genotyping QC: sample call rate < 0.98, SNV call rate < 0.99, \r\n                           HWE P < 1 x 10^-6 in the control samples\r\nImputation QC: HWE P < 1 x 10^-6 or MAF < 0.01 in the reference panel\r\n                         Differences of MAF between the GWAS dataset and the reference panel > 0.16\r\n                         R square < 0.9",
          "Marker Number (after QC)": "About 5,000,000 SNVs",
          "Phenotype Data": "Gender, Age",
          "NBDC Dataset ID / \r\nJapanese Genotype-phenotype \r\nArchive Dataset ID": "[GWAS stats]\r\nhum0014.v5.AF.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file\r\n[Individual datasets]\r\nPhenotype: JGAD000101\r\nGenotype: JGAD000102",
          "Total Data Volume": "GWAS: 473 MB (txt)\r\nIndividual phenotype-genotype data: 1 GB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000114 / hum0014.v6.158k.v1": {
          "Participants/Materials": "182,505 individuals (158,284 individuals for BMI study)",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "minimac [imputation (1000 genomes Phase I v3)] \r\nGenCall software (GenomeStudio)",
          "Association Analysis (software)": "mach2qtl (v1.1.3)",
          "Filtering Methods": "Genotyping QC: sample call rate < 0.98, SNV call rate < 0.99, HWE P < 1 x 10^-6\r\nQC for reference panel:\r\nAfter excluding 11 closely related individuals, variants with HWE P < 1.0 x 10^-6, MAF < 0.01 were excluded.\r\nQC after imputation:\r\nVariants with imputation quality of Rsq < 0.7 were excluded.",
          "Marker Number (after QC)": "About 6,000,000 and 150,000 SNVs on autosomes and X-chromosome, respectively.",
          "NBDC Dataset ID / \r\nJapanese Genotype-phenotype \r\nArchive Dataset ID": "[GWAS]\r\nhum0014.v6.158k.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file\r\n[Individual datasets]\r\nPhenotype data (BMI): JGAD000124\r\nGenotype data: JGAD000123\r\nDetailed information on genotyping array\r\nProbe information (BLAST)",
          "Total Data Volume": "GWAS: 406 MB (zip)\r\nPhenotype data (BMI): 3.32 MB (txt.gz)\r\nGenotype data: 26.3GB (csv.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v7.POAG.v1": {
          "Participants/Materials": "3980 POAG patients (Male: 1,997, Female: 1,983)\r\n18,815 controls (Male: 7,817, Female: 10,998)",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "minimac（ver. 0.1.1） [imputation (1000 genomes Phase I v3)]",
          "Association Analysis (software)": "mach2dat（ver. 1.0.19）",
          "Filtering Methods": "Genotyping QC: sample call rate < 0.98, SNV call rate < 0.99, HWE P < 1 x 10^-6\r\nQC for reference panel: After excluding 11 closely related individuals, variants with HWE P < 1.0 x 10^-6, MAF < 0.01 were excluded. \r\nQC after imputation: Variants with imputation quality of Rsq < 0.7 were excluded. We also excluded variants with |beta| > 4 in the uploaded files.",
          "Marker Number (after QC)": "autosomes: 5,961,428 SNPs (hg19)\r\nmale X-chromosome: 147,351 SNPs (hg19)\r\nfemale X-chromosome: 147,353 SNPs (hg19)",
          "NBDC Dataset ID": "hum0014.v7.POAG.v1\r\n (Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "113 MB (txt.zip)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000114 / hum0014.v8.58qt.v1": {
          "Participants/Materials": "162,255 individuals for 58 quantitative traits",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "minimac [imputation (1000 genomes Phase I v3)] \r\nGenCall software (GenomeStudio)",
          "Association Analysis (software)": "mach2qtl (v1.1.3)",
          "Filtering Methods": "Genotyping QC: sample call rate < 0.98, SNV call rate < 0.99, HWE P < 1 x 10^-6\r\nQC for reference panel:\r\nAfter excluding 11 closely related individuals, variants with HWE P < 1.0 x 10^-6, MAF < 0.01 were excluded.\r\nQC after imputation:\r\nVariants with imputation quality of Rsq < 0.7 were excluded.",
          "Marker Number (after QC)": "5,961,600 and 147,353 SNVs on autosomes and X-chromosome, respectively.",
          "High density lipoprotein cholesterol": "JGAD000145",
          "Low density lipoprotein cholesterol": "JGAD000146",
          "Triglyceride": "JGAD000147",
          "Blood sugar": "JGAD000148",
          "Hemoglobin A1c": "JGAD000149",
          "Albumin": "JGAD000151",
          "Non-albumin protein": "JGAD000152",
          "Albumin/globulin ratio": "JGAD000153",
          "Serum creatinine": "JGAD000155",
          "Estimated glomerular filtration rate": "JGAD000156",
          "Uric acid": "JGAD000157",
          "Potassium": "JGAD000159",
          "Chlorine": "JGAD000160",
          "Calcium": "JGAD000161",
          "Phosphorus": "JGAD000162",
          "Zinc sulfate turbidity test": "JGAD000164",
          "Aspartate aminotransferase": "JGAD000165",
          "Alanine aminotransferase": "JGAD000166",
          "Alkaline phosphatase": "JGAD000167",
          "Gamma-glutamyl transferase": "JGAD000168",
          "Prothrombin time": "JGAD000170",
          "Fibrinogen": "JGAD000171",
          "Creatine kinase": "JGAD000172",
          "Lactate dehydrogenase": "JGAD000173",
          "C-reactive protein": "JGAD000174",
          "Neutrophil count": "JGAD000176",
          "Eosinophil count": "JGAD000177",
          "Basophil count": "JGAD000178",
          "Monocyte count": "JGAD000179",
          "Lymphocyte count": "JGAD000180",
          "Red blood cell count": "JGAD000181",
          "Hemoglobin": "JGAD000182",
          "Hematocrit": "JGAD000183",
          "Mean corpuscular volume": "JGAD000184",
          "Mean corpuscular hemoglobin": "JGAD000185",
          "Mean corpuscular hemoglobin concentration": "JGAD000186",
          "Platelet count": "JGAD000187",
          "Diastolic blood pressure": "JGAD000189",
          "Mean arterial pressure": "JGAD000190",
          "Pulse pressure": "JGAD000191",
          "Posterior wall thickness": "JGAD000193",
          "Left ventricular internal dimension in diastole": "JGAD000194",
          "Left ventricular internal dimension in systole": "JGAD000195",
          "Left ventricular mass": "JGAD000196",
          "Left ventricular mass index": "JGAD000197",
          "Relative wall thickness": "JGAD000198",
          "Fractional shortening": "JGAD000199",
          "Ejection fraction": "JGAD000200",
          "E/A ratio": "JGAD000201",
          "Total Data Volume": "GWAS: 123 MB (zip) on average\r\nPhenotype data (58 quantitative traits): 2.4 MB (txt.gz) on average",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v9.Men.v1 / hum0014.v9.MP.v1": {
          "Participants/Materials": "67,029 females with information on age at menarche \r\n43,861 females with information on age at menopause",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "minimac [imputation (1000 genomes Phase I v3)] \r\nGenCall software (GenomeStudio)",
          "Association Analysis (software)": "mach2qtl (v1.1.3)",
          "Filtering Methods": "Genotyping QC: sample call rate < 0.98, SNV call rate < 0.99, HWE P < 1 x 10^-6\r\nQC for reference panel: After excluding 11 closely related individuals, variants with HWE P < 1.0 x 10^-6, MAF < 0.01 were excluded. \r\nQC after imputation: Variants with imputation quality of Rsq < 0.7 were excluded. We also excluded variants with |beta| > 4 in the uploaded files.",
          "Marker Number (after QC)": "9,296,729 SNPs (hg19)",
          "NBDC Dataset ID": "menarche: hum0014.v9.Men.v1\r\nmenopause: hum0014.v9.MP.v1\r\n (Click the Dataset ID to download the file)\r\nmenarche: Dictionary file\r\nmenopause: Dictionary file",
          "Total Data Volume": "menarche: 181 MB (txt.gz)\r\nmenopause: 186 MB (txt.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000114 (JGAD000220 / JGAD000410 / JGAD000690 / JGAD000758)": {
          "Participants/Materials": "1,026 individuals",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Nano DNA Library Preparation Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "160 bp",
          "QC": "Data with bad base quality and high %GC content were removed.\r\nAlignment:\r\nData matched for the following conditions were removed.\r\n- Low mapping rate\r\n- Different insert size\r\n- Gender information mismatch between meta-data and genotype data\r\n- Suspected sex chromosome aberration\r\nGenotyping:\r\nGATK’s best practices include a variant filtering step following Variant Quality Score Recalibration (VQSR)\r\n- DP/GP (DP < 5, GQ < 20, DP > 60, GQ < 95 )\r\n- Heterozygosity (F>=0.05)\r\n- Hardy-Weinberg equilibrium (p < 10^-6）\r\n- Repeat & Low Complexity\r\nPrincipal Component Analysis (PCA):\r\nPCA was performed with individuals included in the 1000 genomes project and outliers from Japanese cluster were removed.\r\n \r\nAfter these filtering steps, variants located in the regions listed as the HighConfidenceRegion (Genome-In-A-Bottle project) were flagged.",
          "Deduplication": "Picard 2.10.6",
          "Calibration for re-alignment and base quality": "GATK 3.7",
          "Mapping Methods": "BWA mem 0.7.12",
          "Mapping Quality": "Reads with MAPQ<20 were excluded at variant calling with GATK 3.7 HaplotypeCaller",
          "Reference Genome Sequence": "GRCh37/hg19 (hs37d5)",
          "Coverage (Depth)": "31.8x",
          "Detecting Methods for Variation": "GATK 3.7 HaplotypeCaller",
          "SNV Numbers (after QC)": "76,768,387 (Autosomal Chromosomes)\r\n2,898,518 (X Chromosome)",
          "INDEL Numbers (after QC)": "10,202,908 (Autosomal Chromosomes)\r\n410,435 (X Chromosome)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000220 (fastq)\r\nJGAD000410 (bam, vcf): Whole genome sequencing analyzed data included in the JGAD000117 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. This project is an initiative of the GEnome Medical Alliance Japan (GEM Japan, GEM-J). Lean more..",
          "Dataset ID of the Processed data by JGA": "JGAD000690\r\nJGAD000758 (joint call)\r\nThe way to Process",
          "Total Data Volume": "JGAD000220: 73 TB (fastq)\r\nJGAD000410: 49 TB (bam, vcf)\r\nJGAD000690: 52.1 TB (bam, bai, vcf, document)\r\nJGAD000758: 203.8 GB (vcf_aggregate, tabix)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000140": {
          "Participants/Materials": "7,104 breast cancer patients and 23,731 controls",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "11 hereditary breast cancer genes (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, NF1, PALB2, PTEN, STK11, TP53)",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "1st PCR was performed with 2X Platinum Multiplex PCR Master Mix (Thermo Fisher Scientific) to amplify the target region, followed by the 2nd PCR with 8-bp barcode and adapter sequences added using KAPA HiFi HotStart DNA Polymerase (KAPA) *1",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000209",
          "Total Data Volume": "1 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "*1": {
          "Participants/Materials": "[GWAS-1]\r\n   - 2,380 T2DM with diabetic nephropathy patients\r\n   - 5,234 T2DM without diabetic nephropathy patients\r\n[GWAS-2]\r\n   - 429 T2DM with diabetic nephropathy patients\r\n   - 358 T2DM without diabetic nephropathy patients",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [OmniExpressExome Beadchip, Human610-Quad BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina OmniExpressExome Beadchip kit\r\nIllumina Human610-Quad Beadchip kit",
          "Genotype Call Methods (software)": "MACH and Minimac (1000 Genomes phased JPT, CHB and Han Chinese South data n = 275, March 2012)\r\nGenCall software (GenomeStudio)",
          "Association Analysis (software)": "mach2dat",
          "Filtering Methods": "sample call rate < 0.98, SNV call rate < 0.99, MAF < 0.1%, \r\nHWE P < 1 x 10-6 in control",
          "Marker Number (after QC)": "7,521,072 SNPs (hg19)",
          "NBDC Dataset ID": "hum0014.v12.T2DMw.v1\r\n (Click the Dataset ID to download the file) \r\nDictionary file",
          "Total Data Volume": "310 MB (csv.zip)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v12.T2DMwN.v1": {
          "Participants/Materials": "[GWAS-1]\r\n   - 9,804 T2DM patients (ICD-10: E11)\r\n   - 6,728 controls\r\n[GWAS-2]\r\n   - 5,639 T2DM patients (ICD-10: E11)\r\n   - 19,407 controls\r\n[GWAS-3]\r\n   - 18,688 T2DM patients (ICD-10: E11)\r\n   - 121,950 controls\r\n[GWAS-4]\r\n   - 2,483 T2DM patients (ICD-10: E11)\r\n   - 7,065 controls",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome, Human610-Quad BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome, Human610-Quad BeadChip kit",
          "Genotype Call Methods (software)": "minimac [imputation(1000 genomes Phase 3)]\r\nGenCall software (GenomeStudio)",
          "Association Analysis (software)": "mach2dat (v1.0.24)",
          "Filtering Methods": "Genotyping QC: \r\nexclusion criteria of GWAS1, GWAS3, GWAS4\r\n(i) hetero count < 5\r\n(ii) HWE P < 1.0 × 10^-6 on each chip\r\n(iii) genotype concordance rate < 0.99 with in-house WGS data\r\n(iv) SNV call rate < 0.99\r\n \r\nexclusion criteria of GWAS2\r\n(i) SNV call rate < 0.99\r\n(ii) MAF < 0.01\r\n(iii) differential missingness P < 1.0 × 10^-6\r\n(iv) HWE P < 1.0 × 10^-6\r\n \r\nImputation QC: \r\nHWE P < 1 × 10^-6 or MAF < 0.01 in the reference panel\r\nImputation quality (Rsq) < 0.3 in more than two GWAS",
          "Marker Number (after QC)": "12,557,761 SNPs (hg19)",
          "NBDC Dataset ID": "hum0014.v13.T2DMmeta.v1\r\n (Click the Dataset ID to download the file) \r\nDictionary file",
          "Total Data Volume": "257 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v13.T2DMmeta.v1": {
          "Participants/Materials": "165,436 individuals whose smoking status is available",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "minimac [imputation (1000 genomes Phase I v3)] \r\nGenCall software (GenomeStudio)",
          "Association Analysis (software)": "BOLT-LMM (v2.2)\r\nProbABEL(v0.4.5; for X chromosome)",
          "Filtering Methods": "Genotyping QC: sample call rate < 0.98, SNV call rate < 0.99, HWE P < 1 x 10^-6\r\nQC for reference panel:\r\nAfter excluding 11 closely related individuals, variants with HWE P < 1.0 x 10^-6, MAF < 0.01 were excluded.\r\nQC after imputation:\r\nVariants with imputation quality of Rsq < 0.7 and MAF < 0.01 were excluded.",
          "Marker Number (after QC)": "autosomes: 5,961,480 SNVs (hg19)\r\nmale X-chromosome (Age of smoking initiation): 163,412 SNVs (hg19)\r\nfemale X-chromosome (Age of smoking initiation): 146,130 SNVs (hg19)\r\nmale X-chromosome (Cigarettes per day): 166,111 SNVs (hg19)\r\nfemale X-chromosome (Cigarettes per day): 146,114 SNVs (hg19)\r\nmale X-chromosome (Smoking initiation [Ever vs never smokers]): 166,138 SNVs (hg19)\r\nfemale X-chromosome (Smoking initiation [Ever vs never smokers]): 146,146 SNVs (hg19)\r\nmale X-chromosome (Smoking cessation [Former vs current smokers]): 166,142 SNVs (hg19)\r\nfemale X-chromosome (Smoking cessation [Former vs current smokers]): 146,118 SNVs (hg19)",
          "NBDC Dataset ID": "hum0014.v14.asi.v1.zip (Age of smoking initiation)\r\nhum0014.v14.cpd.v1.zip (Cigarettes per day)\r\nhum0014.v14.ens.v1.zip (Smoking initiation [Ever vs never smokers])\r\nhum0014.v14.fcs.v1.zip (Smoking cessation [Former vs current smokers])\r\n (Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "1.9 GB (txt.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v14.smok.v1": {
          "Participants/Materials": "- WGS data (JGAD000220) of the biobank Japan project (N=1,037)\r\n- WGS data of 1KGP p3v5 ALL (N=2,504) (ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20130502/)",
          "Targets": "a reference panel from WGS data \r\n(variants on autosomal chromosomes and X-chromosome)",
          "Target Loci for Capture Methods": "-",
          "QC*": "We set exclusion criteria for genotypes as follows: \r\n(1) DP < 5, (2) GQ < 20, or (3) DP > 60 and GQ < 95, and regarded these genotypes as missing. \r\nVariants with call rates < 90% were excluded before variant quality score recalibration (VQSR). \r\nAfter VQSR, we excluded variants located in low-complexity regions (LCR), as defined by mdust software were excluded. \r\nFinally, we used BEAGLE to impute missing genotypes.\r\n ",
          "Deduplication*": "picard (versions 1.106)",
          "Calibration for re-alignment and base quality*": "GATK (ver.3.2-2)",
          "Mapping Methods*": "BWA-MEM (version 0.7.5a)",
          "Mapping Quality*": "MAPQ < 20 were excluded (HaplotypeCaller)",
          "Reference Genome Sequence*": "GRCh37/hg19, hs37d5",
          "Coverage (Depth)*": "aimed at 30x depth",
          "Detecting Methods for Variation*": "GATK HaplotypeCaller (version 3.2-2)",
          "Method for merging vcf files": "autosomal chromosomes: Impute2\r\nX-chromosome: Beagle (male), Impute2 (female)",
          "Variant Numbers in reference panel": "61,608,817 variants (autosomal chromosomes: 59,387,070; X-chromosome: 2,221,747)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000220",
          "Dataset ID of the Processed data by JGA": "JGAD000679\r\nThe way to Process",
          "Total Data Volume": "about 15 GB (vcf.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000114 reference panel": {
          "Participants/Materials": "159,095 individuals (Male: 86,257, Female: 72,838)",
          "Targets": "genome wide variants",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "Minimac3 [imputation reference panel using WGS data of the biobank Japan project (N=1,037) and 1KGP p3v5 ALL (N=2,504)]",
          "Association Analysis (software)": "BOLT-LMM (ver2.2), mach2qtl",
          "Filtering Methods": "Sample QCs: Exclusion criteria:\r\n1) call rate < 98%, \r\n2) closely related samples (PI_HAT > 0.175), and \r\n3) outlier from Japanese cluster determined by PCA using GCTA.\r\nQC after imputation: Variants with imputation quality of Rsq < 0.3 were excluded.",
          "Marker Number (after QC)": "autosomes: 27,211,524 variants (hg19)\r\nmale X-chromosome: 684,533 variants (hg19)\r\nfemale X-chromosome: 684,533 variants (hg19)",
          "NBDC Dataset ID": "hum0014.v15.ht.v1\r\n (Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "about 663 MB (txt.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "* ": {
          "Participants/Materials": "7,636 prostate cancer patients (ICD10：C61) and 12,366 controls",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "8 hereditary prostate cancer genes (ATM, BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, NBN, PALB2)",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "1st PCR was performed with 2X Platinum Multiplex PCR Master Mix (Thermo Fisher Scientific) to amplify the target region, followed by the 2nd PCR with 8-bp barcode and adapter sequences added using KAPA HiFi HotStart DNA Polymerase (KAPA) *1",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000288",
          "Total Data Volume": "2.2 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v15.ht.v1": {
          "Participants/Materials": "42 disease (ICD10 code) \r\nArrhythmia (I499), Bronchial asthma (J459), Atopic dermatitis (L209), \r\nGallbladder/Cholangiocarcinoma (C23, C240), Cataract (H269), \r\nCerebral aneurysm (I671), Cervical cancer (C539), \r\nChronic hepatitis B (B181), Chronic hepatitis C (B182), \r\nChronic obstructive pulmonary disease (J449), Liver cirrhosis (K746), \r\nColorectal cancer (C189, C20), Heart failure (I509, I500), \r\nDrug eruption (L270), Uterine cancer (C549), Endometriosis (N809), \r\nEpilepsy (G409), Esophageal cancer (C159), Gastric cancer (C169), \r\nGlaucoma (H409), Graves' disease (E050), Hematopoietic tumor (C81-96), \r\nLiver cancer (C220), Interstitial lung disease/Pulmonary fibrosis (J849, J841), \r\nCerebral infarction (I639), Keloid (L910), Lung cancer (C349), \r\nNephrotic syndrome (N049), Osteoporosis (M8199), Ovarian cancer (C56), \r\nPancreas cancer (C259), Periodontitis (K054), \r\nPeripheral artery disease (I709), Hay fever (J301), Prostate cancer (C61), \r\nPulmonary tuberculosis (A169), Rheumatoid arthritis (M0690), \r\nDiabetes mellitus (E14), Urolithiasis (N209), Uterine fibroids (D259), Breast cancer (C509)\r\nCoronary artery disease (I200, I209, I219)",
          "Targets": "genome wide variants",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "Minimac3 [imputation (1000 genomes Phase 3 v5)]\r\nGenCall software (GenomeStudio)",
          "Association Analysis (software)": "SAIGE(v0.29.4.2)",
          "Filtering Methods": "QC after imputation:\r\nExclusion criteria: Variants with imputation quality of Rsq < 0.7",
          "Marker Number (after QC)": "autosomes: 8,712,794 variants (hg19)\r\nX-chromosome: 207,198 variants (hg19)",
          "Bronchial asthma": "hum0014.v17.BA.v1",
          "Atopic dermatitis*": "hum0014.v17.AD.v1",
          "Gallbladder/Cholangiocarcinoma": "hum0014.v17.GCc.v1",
          "Cataract": "hum0014.v17.Cat.v1",
          "Cerebral aneurysm": "hum0014.v17.CA.v1",
          "Cervical cancer": "hum0014.v17.CeC.v1",
          "Chronic hepatitis B": "hum0014.v17.CHB.v1",
          "Chronic hepatitis C": "hum0014.v17.CHC.v1",
          "Chronic obstructive pulmonary disease": "hum0014.v17.COPD.v1",
          "Liver cirrhosis": "hum0014.v17.Cir.v1",
          "Colorectal cancer": "hum0014.v17.CC.v1",
          "Heart failure*": "hum0014.v17.HF.v1",
          "Drug eruption": "hum0014.v17.DE.v1",
          "Uterine cancer": "hum0014.v17.UC.v1",
          "Endometriosis": "hum0014.v17.EM.v1",
          "Epilepsy": "hum0014.v17.Ep.v1",
          "Esophageal cancer": "hum0014.v17.EC.v1",
          "Gastric cancer": "hum0014.v17.GC.v1",
          "Glaucoma*": "hum0014.v17.Gla.v1",
          "Graves' disease": "hum0014.v17.GD.v1",
          "Hematopoietic tumor": "hum0014.v17.HT.v1",
          "Liver cancer": "hum0014.v17.LiC.v1",
          "Interstitial lung disease/Pulmonary fibrosis": "hum0014.v17.IP.v1",
          "Cerebral infarction": "hum0014.v17.CI.v1",
          "Keloid": "hum0014.v17.Kel.v1",
          "Lung cancer": "hum0014.v17.LuC.v1",
          "Nephrotic syndrome": "hum0014.v17.NS.v1",
          "Osteoporosis": "hum0014.v17.OP.v1",
          "Ovarian cancer": "hum0014.v17.OC.v1",
          "Pancreas cancer": "hum0014.v17.PaC.v1",
          "Periodontitis": "hum0014.v17.PD.v1",
          "Peripheral artery disease": "hum0014.v17.PAD.v1",
          "Hay fever": "hum0014.v17.Hay.v1",
          "Prostate cancer": "hum0014.v17.PrC.v1",
          "Pulmonary tuberculosis": "hum0014.v17.PT.v1",
          "Rheumatoid arthritis": "hum0014.v17.RA.v1",
          "Diabetes mellitus*": "hum0014.v17.DM.v1",
          "Urolithiasis": "hum0014.v17.Uro.v1",
          "Uterine fibroids": "hum0014.v17.UF.v1",
          "Breast cancer": "hum0014.v18.BC.v1",
          "Coronary artery disease": "hum0014.v21.CAD.v1",
          "Total Data Volume": "autosomes: about 0.8-1.3 GB each\r\nX-chromosome: about 20-30 MB each",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000203": {
          "Participants/Materials": "165,084 individuals whose dietary habits status is available (13 dietary traits)",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "GenCall software（GenomeStudio）\r\nMACH\r\nminimac (v.0.1.1) [imputation (1000 genomes Phase I v3)]",
          "Association Analysis (software)": "BOLT-LMM (v2.2) for autosomes\r\nProbABEL (v0.4.5) for X chromosome",
          "Filtering Methods": "Genotyping QC: sample call rate < 0.98, SNV call rate < 0.99, MAF < 0.005\r\nQC for reference panel:\r\nVariants with HWE P < 1.0 x 10^-6, MAF < 0.01 were excluded from the reference panel.\r\nQC after imputation:\r\nVariants with imputation quality of Rsq < 0.7 and MAF < 0.01 were excluded.",
          "Marker Number (after QC)": "autosomes: 5,961,480 variants (hg19)\r\nX-chromosome: 148,568 variants for female, 170,117 variants for male (hg19)",
          "Drinks per week": "hum0014.v19.dpw.v1.zip",
          "Coffee consumption": "hum0014.v19.cafe.v1.zip",
          "Tea consumption": "hum0014.v19.tea.v1.zip",
          "Milk consumption": "hum0014.v19.milk.v1.zip",
          "Yogurt consumption": "hum0014.v19.ygt.v1.zip",
          "Cheese consumption": "hum0014.v19.cheese.v1.zip",
          "Natto consumption": "hum0014.v19.natto.v1.zip",
          "Tofu consumption": "hum0014.v19.tofu.v1.zip",
          "Fish consumption": "hum0014.v19.fish.v1.zip",
          "Small fish consumption": "hum0014.v19.sfish.v1.zip",
          "Vegetable consumption": "hum0014.v19.vege.v1.zip",
          "Meat consumption": "hum0014.v19.meat.v1.zip",
          "Total Data Volume": "6.3 GB (txt.zip)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v17 / hum0014.v18 / hum0014.v21": {
          "Participants/Materials": "25,892 coronary artery disease patients (ICD10: I20-25) and 142,336 controls",
          "Targets": "genome wide variants",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "GenCall software (GenomeStudio)\r\nminimac3 (BBJ-CAD reference panel)",
          "Association Analysis (software)": "PLINK2",
          "Filtering Methods": "QC after imputation: Variants with imputation quality of Rsq < 0.3 and MAF < 0.0002 were excluded.",
          "Marker Number (after QC)": "autosomes: 19,707,525 variants (hg19)",
          "NBDC Dataset ID": "hum0014.v20.gwas.v1 (summary statistics)\r\nhum0014.v20.prs.v1 (polygenic risk score)\r\n (Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "about 413 MB (txt.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v19": {
          "Participants/Materials": "11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "23 genes related to clonal hematopoiesis\r\nASXL1, CBL, CEBPA, DDX41, DNMT3A, ETV6, EZH2, GATA2, GNAS, GNB1, IDH1, IDH2, JAK2, KRAS, MYD88, NRAS, PPM1D, RUNX1, SF3B1, SRSF2, TET2, TP53, U2AF1",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Library was contructed as described in Momozawa, Y., et al. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population. Hum Mol Genet 25, 5027-5034 (2016).",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "QC": "We selected samples in which ≥20 depth was achieved in ≥98% regions.",
          "Mapping Methods": "bwa",
          "Mapping Quality": "≥40",
          "Reference Genome Sequence": "hg19",
          "Coverage (Depth)": "x800",
          "Detecting Methods for Variation": "Genomon pipeline",
          "Filtering Methods": "Genomon pipeline",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000399",
          "Total Data Volume": "5.3 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v20.cad.v1": {
          "Participants/Materials": "11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007",
          "Targets": "SNP array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [human OmniExpress, human OmniExpressExome]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina Infinium OmniExpress, Infinium OmniExpressExome v.1.0, or v.1.2",
          "Genotype Call Methods (software)": "GenCall software（GenomeStudio）",
          "Algorithm for detecting chromosome abnormality (software)": "Haplotype-based detection of allelic imbalances.\r\nTerao, C., et al. Chromosomal alterations among age-related haematopoietic clones in Japan. Nature (2020).",
          "Filtering Methods": "SNPs examined in all of the three versions of array",
          "Marker Numbers (after QC)": "515,355",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000400",
          "Total Data Volume": "5.3 MB (csv)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000293 (Target Capture)": {
          "Participants/Materials": "1,005 pancreatic cancer patients (ICD10: C25)\r\n12,503 colorectal cancer patients (ICD10: C18, C19, C20)\r\n740 renal cell cancer patients (ICD10: C64)\r\n1,982 lymphoma patients (ICD10: C81, C82, C83, C84, C85, C86, C88, C91)\r\n10,366 gastric cancer patients (ICD10: C16)\r\n23,705 + 5,996 + 37,592 controls",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "27 cancer-predisposing genes (APC, ATM, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDK4, CDKN2A, CDH1, CHEK2, EPCAM, HOXB13, NBN, NF1, MLH1, MSH2, MSH6, MUTYH, PALB2, PMS2, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53)",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "1st PCR was performed with 2X Platinum Multiplex PCR Master Mix (Thermo Fisher Scientific) to amplify the target region, followed by the 2nd PCR with 8-bp barcode and adapter sequences added using KAPA HiFi HotStart DNA Polymerase (KAPA) *1",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "pancreatic cancer: JGAD000438\r\ncolorectal cancer: JGAD000458\r\n23,705 controls: JGAD000459\r\nrenal cell cancer and 5,996 controls: JGAD000531\r\nlymphoma: JGAD000460\r\ngastric cancer: JGAD000720\r\n37,592 controls: JGAD000721",
          "Total Data Volume": "JGAD000438: 78 GB (fastq)\r\nJGAD000458: 956 GB (fastq)\r\nJGAD000459: 1.9 TB (fastq)\r\nJGAD000531: 961.8 GB (fastq)\r\nJGAD000460: 126 GB (fastq)\r\nJGAD000720, JGAD000721: 3.4 TB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000293 (SNP array)": {
          "Participants/Materials": "740 renal cell cancer patients (ICD10：C64)\r\n5,996 controls",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "13 renal cell carcinoma-related genes (VHL, BAP1, FH, FLCN, MET, TSC1, TSC2, MITF, SDHA, SDHB, SDHC, SDHD, CDC73)",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "1st PCR was performed with 2X Platinum Multiplex PCR Master Mix (Thermo Fisher Scientific) to amplify the target region, followed by the 2nd PCR with 8-bp barcode and adapter sequences added using KAPA HiFi HotStart DNA Polymerase (KAPA) *1",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000531",
          "Total Data Volume": "JGAD000531: 961.8 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000327 / JGAS000346 / JGAS000414 / JGAS000347 / JGAS000592": {
          "Participants/Materials": "1,765 myocardial infarction patients (ICD10: I21) and 199 dementia patients (ICD10: F00-03)",
          "Targets": "WGS",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X Five]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free Prep kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "151 bp",
          "QC": "Data with bad base quality and high %GC content were removed.\r\nAligment:\r\nData matched for the following condition were removed.\r\n- Low mapping rate\r\n- Different insert size\r\n- Gender information mismatch between meta-data and genotype data\r\n- Suspected sex chromosome aberration\r\nGenotyping:\r\nGATK’s best practices includes a variant filtering step following Variant Quality Score Recalibration (VQSR)\r\n- DP/GP (DP < 5, GQ < 20, DP > 60, GQ < 95 )\r\n- Heterozygosity (F>=0.05)\r\n- Hardy-Weinberg equilibrium (p < 10^-6）\r\n- Repeat & Low Complexity\r\nPrincipal Component Analysis (PCA):\r\nPCA was performed with individuals included in the 1000 genomes project and outliers from Japanese cluster were removed.\r\nAfter these filtering steps, variants located in the regions listed as the HighConfidenceRegion (Genome-In-A-Bottle project) were flagged.",
          "Deduplication": "Picard 2.10.6",
          "Calibration for re-alignment and base quality": "GATK 3.7",
          "Mapping Methods": "BWA mem 0.7.12",
          "Mapping Quality": "Reads with MAPQ<20 were excluded at variant calling with GATK 3.7 HaplotypeCaller",
          "Reference Genome Sequence": "GRCh37/hg19 (hs37d5)",
          "Coverage (Depth)": "myocardial infarction: 15.0x, dementia: 30.0x",
          "Detecting Methods for Variation": "GATK 3.7 HaplotypeCaller",
          "SNV Numbers (after QC)": "76,768,387 (Autosomal Chromosomes)\r\n2,898,518 (X Chromosome)",
          "INDEL Numbers (after QC)": "10,202,908 (Autosomal Chromosomes)\r\n410,435 (X Chromosome)",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000495 (fastq)\r\nJGAD000496 (bam, vcf): Whole genome sequencing analyzed data included in the JGAD000117 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J). Lean more..",
          "Total Data Volume": "188.4 TB (fastq, bam, vcf)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000414": {
          "Participants/Materials": "137,693 individuals from BBJ 1st cohort",
          "Targets": "genome wide variants",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress, HumanExome, OmniExpressExome BeadChip]",
          "Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "minimac [imputation (1000 genomes Phase I v3)]\r\nGenCall software (GenomeStudio)",
          "Association Analysis (software)": "mach2qtl (v1.1.3)\r\nSPACox",
          "Filtering Methods": "Genotyping QC: sample call rate < 0.98, SNV call rate < 0.99, HWE P < 1 x 10^-6\r\nQC for reference panel:\r\nAfter excluding 11 closely related individuals, variants with HWE P < 1.0 x 10^-6, MAF < 0.01 were excluded.\r\nQC after imputation:\r\nVariants with imputation quality of Rsq < 0.7 were excluded.",
          "Marker Number (after QC)": "6,108,833 variants (hg19)",
          "NBDC Dataset ID": "hum0014.v27.surv.v1\r\n (Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "789 MB (txt.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000381": {
          "Participants/Materials": "WGS data of 4,880 individuals from BBJ 1st cohort\r\n     - WGS data (JGAD000220) of the biobank Japan project (N=1,037)\r\n     - WGS data (JGAD000495) of 1,765 myocardial infarction patients and 199 dementia patients\r\n     - WGS data (AGDD_000005) of 225 gastric cancer patients\r\n- 1,007 individuals from Asian Genome Project\r\n- 617 colorectal cancer patients\r\n- One individual excluded from AGDD_000005 by QC\r\n- 10 individuals excluded from JGAD000220 by QC",
          "Targets": "mobile element variations",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq X/2500]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq DNA PCR-Free Sample Prep Kit, TruSeq Nano DNA HT Sample Prep Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "151 bp (HiSeq X), 126 bp (HiSeq 2500)",
          "QC": "-",
          "Mapping Methods": "BWA-MEM",
          "Mapping Quality": "-",
          "Reference Genome Sequence": "GRCh37 (hs37d5)",
          "Coverage (Depth)": "≥15× (≥25× for 1,235 individuals)",
          "Detecting Methods for mobile element": "MEGAnE *2",
          "Mobile element Number": "24,933 for 4,880 individuals\r\n10,997 for 1,235 individuals",
          "NBDC Dataset ID": "hum0014.v28.MEs.v1\r\n (Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "1.1 MB (txt.gz)",
          "Comments (Policies)": "NBDC policy"
        },
        "hum0014.v27.surv.v1": {
          "Participants/Materials": "77,690 atrial fibrillation patients and 1,167,040 controls\r\n    BBJ: 9,826 atrial fibrillation patients and 140,446 controls\r\n    European: 60,620 atrial fibrillation patients and 970,216 controls\r\n    FinnGen: 7,244 atrial fibrillation patients and 56,378 controls",
          "Targets": "genome wide SNVs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmniExpress、HumanExome、OmniExpressExome BeadChip]",
          "Source": "DNA extracted from peripheral blood cells\r\nEuropean GWAS: http://csg.sph.umich.edu/willer/public/afib2018\r\nFinnGen GWAS: https://www.finngen.fi/en",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmniExpress, HumanExome, OmniExpressExome BeadChip kit",
          "Genotype Call Methods (software)": "GenCall software (GenomeStudio), minimac [imputation (1000 genomes Phase I v3 )]",
          "Association Analysis (software)": "PLINK2",
          "Filtering Methods": "BBJ GWAS: variants with imputation quality (Rsq) < 0.3 or MAF < 0.001 were excluded\r\nmeta-analysis: variants with MAF < 1% were excluded",
          "Calculation Methods for Polygenic Risk Score": "runing and thresholding method",
          "Meta Analysis Methods": "MANTRA, METAL",
          "Marker Number (after QC)": "BBJ GWAS: 16,817,144 SNPs\r\nmeta-analysis : 5,158,449 SNPs",
          "NBDC Dataset ID": "hum0014.v29.AF.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "summary statistics of BBJ: 424 MB (txt)\r\nsummary statistics of meta analysis: 78 MB (txt)\r\npolygenic risk score: 59 KB (txt)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Michiaki Kubo",
        "Affiliation": "RIKEN Center for Integrative Medical Sciences",
        "Project / Group Name": "Tailor-made Medical Treatment Program (Bio Bank Japan: BBJ)",
        "Funds / Grants (Research Project Number)": {
          "14": {
            "Name": "Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development (AMED)",
            "Title": "Understanding pathology and implementation of precision medicine for intractable cardiovascular disease by multi-omics analysis",
            "Project Number": "JP20ek0109487"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in Japanese.",
          "DOI": "doi:10.1038/ejhg.2014.110",
          "Data Set ID": "hum0014.v1.freq.v1"
        },
        "2": {
          "Title": "A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese.",
          "DOI": "doi:10.1093/hmg/ddr268",
          "Data Set ID": "hum0014.v2.jsnp.92als.v1"
        },
        "3": {
          "Title": "Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk.",
          "DOI": "doi: 10.1053/j.gastro.2009.07.070",
          "Data Set ID": "hum0014.v2.jsnp.182ec.v1"
        },
        "4": {
          "Title": "SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations.",
          "DOI": "doi: 10.1038/ng.208",
          "Data Set ID": "T2DM (JSNP)"
        },
        "5": {
          "Title": "Common variants in a novel gene, FONG on chromosome 2q33.1 confer risk of osteoporosis in Japanese.",
          "DOI": "doi: 10.1371/journal.pone.0019641",
          "Data Set ID": "Osteoporosis (JSNP)"
        },
        "6": {
          "Title": "Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes.",
          "DOI": "doi: 10.1038/ncomms10531",
          "Data Set ID": "hum0014.v3.T2DM-1.v1\r\nhum0014.v3.T2DM-2.v1"
        },
        "7": {
          "Title": "Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis.",
          "DOI": "doi: 10.1038/ng.3424",
          "Data Set ID": "hum0014.v4.AD.v1"
        },
        "8": {
          "Title": "Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population.",
          "DOI": "doi: 10.1038/ng.2438",
          "Data Set ID": "hum0014.v4.AD.v1"
        },
        "9": {
          "Title": "Identification of six new genetic loci associated with atrial fibrillation in the Japanese population.",
          "DOI": "doi: 10.1038/ng.3842",
          "Data Set ID": "hum0014.v5.AF.v1"
        },
        "10": {
          "Title": "Genome-wide association study identifies 112 new loci for body mass index in the Japanese population.",
          "DOI": "doi:10.1038/ng.3951",
          "Data Set ID": "hum0014.v6.158k.v1\r\nJGAD000123\r\nJGAD000124"
        },
        "11": {
          "Title": "Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma.",
          "DOI": "doi: 10.1093/hmg/ddy053",
          "Data Set ID": "hum0014.v7.POAG.v1"
        },
        "12": {
          "Title": "Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.",
          "DOI": "doi:10.1038/s41588-018-0047-6",
          "Data Set ID": "hum0014.v8.58qt.v1\r\nJGAD000144-JGAD000201"
        },
        "13": {
          "Title": "Elucidating the genetic architecture of reproductive ageing in the Japanese population",
          "DOI": "doi: 10.1038/s41467-018-04398-z",
          "Data Set ID": "hum0014.v9.Men.v1\r\nhum0014.v9.MP.v1"
        },
        "14": {
          "Title": "Deep whole-genome sequencing reveals recent selection signatures linked to evolution and disease risk of Japanese.",
          "DOI": "doi: 10.1038/s41467-018-03274-0",
          "Data Set ID": "JGAD000220"
        },
        "15": {
          "Title": "Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.",
          "DOI": "doi: 10.1038/s41467-018-06581-8",
          "Data Set ID": "JGAD000209"
        },
        "16": {
          "Title": "A Variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes",
          "DOI": "doi: 10.1371/journal.pone.0208654",
          "Data Set ID": "hum0014.v12.T2DMwN.v1"
        },
        "17": {
          "Title": "Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population",
          "DOI": "doi: 10.1038/s41588-018-0332-4",
          "Data Set ID": "hum0014.v13.T2DMmeta.v1"
        },
        "18": {
          "Title": "GWAS of smoking behaviour in 165,436 Japanese people reveals seven new loci and shared genetic architecture.",
          "DOI": "doi: 10.1038/s41562-019-0557-y",
          "Data Set ID": "hum0014.v14.asi.v1\r\nhum0014.v14.cpd.v1\r\nhum0014.v14.ens.v1\r\nhum0014.v14.fcs.v1"
        },
        "19": {
          "Title": "Characterizing rare and low-frequency height-asssociated variants in the Japanese population",
          "DOI": "doi: 10.1038/s41467-019-12276-5",
          "Data Set ID": "JGAD000220 (fastq)\r\nJGAD000220 (reference panel)\r\nhum0014.v15.ht.v1"
        },
        "20": {
          "Title": "Germline pathogenic variants in 7,636 Japanese patients with prostate cancer and 12,366 controls.",
          "DOI": "doi: 10.1093/jnci/djz124",
          "Data Set ID": "JGAD000288"
        },
        "21": {
          "Title": "Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases",
          "DOI": "doi: 10.1038/s41588-020-0640-3",
          "Data Set ID": "hum0014.v17\r\nhum0014.v18\r\nhum0014.v21"
        },
        "22": {
          "Title": "GWAS of 165,084 Japanese individuals identified nine loci associated with dietary habits",
          "DOI": "doi: 10.1038/s41562-019-0805-1",
          "Data Set ID": "hum0014.v19"
        },
        "23": {
          "Title": "Population-specific and transethnic genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease.",
          "DOI": "doi: 10.1038/s41588-020-0705-3",
          "Data Set ID": "hum0014.v20.cad.v1"
        },
        "24": {
          "Title": "Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes",
          "DOI": "doi: 10.1016/j.ebiom.2020.103033",
          "Data Set ID": "JGAD000438"
        },
        "25": {
          "Title": "Population-based Screening for Hereditary Colorectal Cancer Variants in Japan",
          "DOI": "doi: 10.1016/j.cgh.2020.12.007",
          "Data Set ID": "JGAD000458\r\nJGAD000459"
        },
        "26": {
          "Title": "Genome-wide association study reveals BET1L associated with survival time in the 137,693 Japanese individuals",
          "DOI": "doi: 10.1038/s42003-023-04491-0",
          "Data Set ID": "hum0014.v27.surv.v1"
        },
        "27": {
          "Title": "Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction",
          "DOI": "doi: 10.1038/s41588-022-01284-9",
          "Data Set ID": "hum0014.v29.AF.v1"
        },
        "28": {
          "Title": "Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk",
          "DOI": "doi: 10.1111/cas.15522",
          "Data Set ID": "JGAD000460\r\nJGAD000721"
        },
        "29": {
          "Title": "Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer",
          "DOI": "doi: 10.1056/NEJMoa2211807",
          "Data Set ID": "JGAD000720\r\nJGAD000721"
        },
        "30": {
          "Title": "Germ line DDX41 mutations define a unique subtype of myeloid neoplasms",
          "DOI": "doi: 10.1182/blood.2022018221",
          "Data Set ID": "JGAD000399\r\nJGAD000400"
        },
        "31": {
          "Title": "Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis",
          "DOI": "doi: 10.1038/s41591-021-01411-9",
          "Data Set ID": "JGAD000399\r\nJGAD000400"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Mark Daly": {
          "Principal Investigator": "Mark Daly",
          "Affiliation": "Broad Institute of MIT and Harvard",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Yukinori Okada": {
          "Principal Investigator": "Yukinori Okada",
          "Affiliation": "Department of Statistical Genetics, Osaka University Graduate School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Shigeo Kamitsuji": {
          "Principal Investigator": "Shigeo Kamitsuji",
          "Affiliation": "Statistical Analysis Division, StaGen Co., Ltd.",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genome-Wide Association Study to identify genetic factors for strabismus in Japanese population",
          "Period of Data Use": "JGAD000123"
        },
        "Katsushi Tokunaga": {
          "Principal Investigator": "Katsushi Tokunaga",
          "Affiliation": "Department of Human Genetics, Graduate School of Medicine, The University of Tokyo",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Tatsuhiko Tsunoda": {
          "Principal Investigator": "Tatsuhiko Tsunoda",
          "Affiliation": "Department of Medical Science Mathematics, Medical Research Institute, Tokyo Medical and Dental University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Research on sequence, image data analysis for precision medicine",
          "Period of Data Use": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Liming Liang": {
          "Principal Investigator": "Liming Liang",
          "Affiliation": "Harvard T.H. Chan School of Public Health, Department of Epidemiology",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000123"
        },
        "Masao Nagasaki": {
          "Principal Investigator": "Masao Nagasaki",
          "Affiliation": "Center for Genomic Medicine, Graduate School of Medicine Center for the Promotion of Interdisciplinary Education and Research, Kyoto University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Development and application of bioinformatics methods to facilitate the detection of genes associated with multifactorial disorders based on large-scale whole genome sequencing data of Japanese individuals",
          "Period of Data Use": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Seishi Ogawa": {
          "Principal Investigator": "Seishi Ogawa",
          "Affiliation": "Department of Medical Science, Kyoto University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of genetic alterations in hematological malignancies",
          "Period of Data Use": "JGAD000102, JGAS000123, JGAD000220"
        },
        "Takashi Kohno": {
          "Principal Investigator": "Takashi Kohno",
          "Affiliation": "Division of Genome Biology, National Cancer Center Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Identification of genetic risk factors in AYA(Adolescence and Young Adult) cancer",
          "Period of Data Use": "JGAD000209, JGAD000220"
        },
        "Shigeo Horie": {
          "Principal Investigator": "Shigeo Horie",
          "Affiliation": "Department of Urology, Juntendo University, Graduate School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000123, JGAD000220"
        },
        "Kengo Kinoshita": {
          "Principal Investigator": "Kengo Kinoshita",
          "Affiliation": "Tohoku Medical Megabank Organization",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Construction of Japanese whole genome database",
          "Period of Data Use": "JGAD000220"
        },
        "Kouya Shiraishi": {
          "Principal Investigator": "Kouya Shiraishi",
          "Affiliation": "Division of Genome Biology, National Cancer Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Elucidation of immune-system networks between host and tumor based on genomic analysis",
          "Period of Data Use": "JGAD000124"
        },
        "Osamu Ogasawara": {
          "Principal Investigator": "Osamu Ogasawara",
          "Affiliation": "Bioinformation and DDBJ Center, National Institute of Genetics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Evaluation of human genome analysis workflow using JGA/AGD genome data.",
          "Period of Data Use": "JGAD000123, JGAD000220"
        },
        "Yasushi Okazaki": {
          "Principal Investigator": "Yasushi Okazaki",
          "Affiliation": "Diagnostics and Therapeutics of Intractable Diseases, Juntendo University Graduate School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Identification of disease biomarkers by disease cohort research network -Whole genome sequencing of epilepsy-",
          "Period of Data Use": "JGAD000123"
        },
        "Chihiro Hata": {
          "Principal Investigator": "Chihiro Hata",
          "Affiliation": "Bioinformation and DDBJ Center, National Institute of Genetics",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Identification of hypomorphic mutations in Japanese breast cancer patients",
          "Period of Data Use": "JGAD000209"
        },
        "Yosuke Kawai": {
          "Principal Investigator": "Yosuke Kawai",
          "Affiliation": "Division of Molecular Pathology, The Institute of Medical Science, The University of Tokyo",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Population Genetic Analysis of the Origin of Japanese Populations",
          "Period of Data Use": "JGAD000123"
        },
        "Nakao Iwata": {
          "Principal Investigator": "Nakao Iwata",
          "Affiliation": "Department of Psychiatry, Fujita Health University School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Research for investigating susceptibility of mental state, mental disorders, drug efficacy and side effects through genetic analysis",
          "Period of Data Use": "JGAD000123, JGAD000124"
        },
        "Atray Dixit": {
          "Principal Investigator": "Atray Dixit",
          "Affiliation": "Coral Genomics, Inc.",
          "Research Title": "Derivation and Evaluation of Functional Response Scores",
          "Data in Use (Dataset ID)": "JGAD000101, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220",
          "Period of Data Use": "2020/08/24-2021/07/21"
        },
        "Hae Kyung Im": {
          "Principal Investigator": "Hae Kyung Im",
          "Affiliation": "Biological Sciences Division, University of Chicago",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Predicted Gene Expression: High Power, Mechanism, and Direction of Effect",
          "Period of Data Use": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Hongyu Zhao": {
          "Principal Investigator": "Hongyu Zhao",
          "Affiliation": "Department of Biostatistics, Yale School of Public Health",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Leveraging multi-ethnic data and functional annotations in causal variant identification, genetic correlation estimation, and genetic risk prediction",
          "Period of Data Use": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Charleston Chiang": {
          "Principal Investigator": "Charleston Chiang",
          "Affiliation": "Center for Genetic Epidemiology, Keck School of Medicine, University of Southern Califolnia",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Investigating the evolution of complex genetic architecture in participants of Biobank Japan",
          "Period of Data Use": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Ali Torkamani": {
          "Principal Investigator": "Ali Torkamani",
          "Affiliation": "Scripps Research Institute",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Genomics Deep Learning",
          "Period of Data Use": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Kazuhiro Nakayama": {
          "Principal Investigator": "Kazuhiro Nakayama",
          "Affiliation": "Department of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Investigation of genome variation influening activity of brown adipose tissues",
          "Period of Data Use": "JGAD000123, JGAD000124"
        },
        "Keishi Fujio": {
          "Principal Investigator": "Keishi Fujio",
          "Affiliation": "Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Integrative analysis of immune-cell eQTL data and large-scaled GWAS data in Japanese",
          "Period of Data Use": "JGAD000101, JGAD000102, JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Masataka Kikuchi": {
          "Principal Investigator": "Masataka Kikuchi",
          "Affiliation": "Department of Computational Biology and Medical Sciences, Graduate School of Frontier Science, The University of Tokyo",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Imputation analysis using a Japanese reference panel",
          "Period of Data Use": "JGAD000220"
        },
        "Fumihiko Matsuda": {
          "Principal Investigator": "Fumihiko Matsuda",
          "Affiliation": "Center for Genomic Medicine, Kyoto University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Development of personalized medicine",
          "Period of Data Use": "JGAD000123, JGAD000220"
        },
        "Emiko Noguchi": {
          "Principal Investigator": "Emiko Noguchi",
          "Affiliation": "Department of Medical Genetics, Faculty of Medicine, University of Tsukuba",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Research on genetic predisposition to inflammatory lung disease",
          "Period of Data Use": "JGAD000220"
        },
        "Noriko Sato": {
          "Principal Investigator": "Noriko Sato",
          "Affiliation": "Department of Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Analysis of genetic and environmental risks of obesity and diabetes based on regional cohort longitudinal data",
          "Period of Data Use": "JGAD000220"
        },
        "Yasunobu Nagata": {
          "Principal Investigator": "Yasunobu Nagata",
          "Affiliation": "Department of hematology, Nippon Medical School",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Identification of the mechanisms for pathogenesis of hematologic tumors based on novel genetic abnormalities",
          "Period of Data Use": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Atsushi Kawakami": {
          "Principal Investigator": "Atsushi Kawakami",
          "Affiliation": "Department of Immunology and Rheumatology, Nagasaki University Hospital",
          "Research Title": "",
          "Data in Use (Dataset ID)": "An exploratory study to determine the genetic polymorphisms or mutations associated with type 1 diabetes and interstitial lung disease induced by immune checkpoint inhibitor; nivolumab",
          "Period of Data Use": "JGAD000220"
        },
        "Akihiro Fujimoto": {
          "Principal Investigator": "Akihiro Fujimoto",
          "Affiliation": "Department of Human Genetics, Graduate School of Medicine, The University of Tokyo",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Comprehensive analysis of mutations and genetic diversity by analyzing whole-genome sequence data",
          "Period of Data Use": "JGAD000220, JGAD000410"
        },
        "Yoshihiro Asano": {
          "Principal Investigator": "Yoshihiro Asano",
          "Affiliation": "Department of Cardiovascular Medicine Graduate School of Medicine, Osaka University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Sensitive gene analysis of hereditary cardiovascular disease",
          "Period of Data Use": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Hironori Masuko": {
          "Principal Investigator": "Hironori Masuko",
          "Affiliation": "Department of Pulmonary Medicine, University of Tsukuba",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Search for susceptibility genes for chronic inflammatory airway diseases",
          "Period of Data Use": "JGAD000123"
        },
        "Takashi Matsuda": {
          "Principal Investigator": "Takashi Matsuda",
          "Affiliation": "Advanced Informatics & Analytics, Astellas Pharma Inc.",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Investigation of the correlation between Liver cancer/Hepatitis B and polymorphism",
          "Period of Data Use": "JGAD000102, JGAD000123"
        },
        "Toshiharu Ninomiya": {
          "Principal Investigator": "Toshiharu Ninomiya",
          "Affiliation": "Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD)",
          "Period of Data Use": "JGAD000220"
        },
        "Joshua Chiou": {
          "Principal Investigator": "Joshua Chiou",
          "Affiliation": "Internal Medicine Research Unit, Pfizer",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Evaluating GWAS associations from Biobank Japan to Support Confidence in Rationale for Therapeutic Targets",
          "Period of Data Use": "JGAD000123, JGAD000124, JGAD000144-JGAD000201, JGAD000220"
        },
        "Gil McVean": {
          "Principal Investigator": "Gil McVean",
          "Affiliation": "Genomics plc",
          "Research Title": "United Kingdom of Great Britain and Northern Ireland",
          "Data in Use (Dataset ID)": "Using large-scale reference panels for imputation and ancestry analysis to support target discovery and polygenic risk score models",
          "Period of Data Use": "JGAD000220, JGAD000410"
        },
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Analysis of hypomorphic variants in breast cancer-associated genes by using large-scale sequencing data sets",
          "Period of Data Use": "JGAD000209"
        },
        "Nuria Lopez-Bigas": {
          "Principal Investigator": "Nuria Lopez-Bigas",
          "Affiliation": "Institute for Research in Biomedicine (IRB Barcelona)",
          "Research Title": "Spain",
          "Data in Use (Dataset ID)": "Study of the genetic basis of clonal hematopoiesis",
          "Period of Data Use": "JGAD000399, JGAD000400"
        },
        "Keiko Yamazaki": {
          "Principal Investigator": "Keiko Yamazaki",
          "Affiliation": "Department of Public Health, Graduate School of Medicine, Chiba University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Prediction of effectiveness to molecular target drugs in Japanese patients with inflammatory bowel disease",
          "Period of Data Use": "JGAD000220"
        },
        "Ryosuke Kitoh": {
          "Principal Investigator": "Ryosuke Kitoh",
          "Affiliation": "Department of Otorhinolaryngology-Head and Neck Surgery, Shinshu University School of Medicine",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genome-wide association study of the sudden sensorineural hearing loss",
          "Period of Data Use": "JGAD000123"
        },
        "Kei Yura": {
          "Principal Investigator": "Kei Yura",
          "Affiliation": "Graduate School of Humanities and Sciences, Ochanomizu University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Phenotype Prediction of Cancer Suppressor Gene BRCA1 variants",
          "Period of Data Use": "JGAD000220"
        },
        "Yoshihiro Onouchi": {
          "Principal Investigator": "Yoshihiro Onouchi",
          "Affiliation": "Department of Public Health, Graduate School of Medicine, Chiba University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "A study of the genetic background of differences in antibody response to COVID-19 vaccine",
          "Period of Data Use": "JGAD000220"
        },
        "Masaki Kato": {
          "Principal Investigator": "Masaki Kato",
          "Affiliation": "kansai medical university",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Exploratory and validation study of genetic and biological factors for the development of precision medicine algorithms for psychiatric disorders",
          "Period of Data Use": "JGAD000101,JGAD000102,JGAD000123,JGAD000220"
        },
        "Hiroki Kimura": {
          "Principal Investigator": "Hiroki Kimura",
          "Affiliation": "Department of Psychiatry, Nagoya University Graduate school of medicine",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Research on elucidation of susceptibility to brain and mental illness (vulnerability to disease onset) and efficacy and side effects of drugs (treatment responsiveness) through genetic analysis",
          "Period of Data Use": "JGAD000220"
        },
        "Chikashi Terao": {
          "Principal Investigator": "Chikashi Terao",
          "Affiliation": "Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Research on personalized medicine based on genomics information",
          "Period of Data Use": "JGAD000123,JGAD000124,JGAD000144-JGAD000201,JGAD000220"
        }
      },
      "Release Note": {
        "hum0014.v31": {
          "Research ID": "hum0014.v31",
          "Release Date": "2023/09/01",
          "Type of Data": "Processed data of JGAD000220 (WGS for 1,026 individuals) by JGA (CRAM, gVCF)\r\nProcessed data (joint call) of JGAD000220 (WGS for 1,026 individuals) by JGA (aggregate VCF)\r\nProcessed data of JGAD000220 (reference panel) by JGA (data for the use of NBDC-DDBJ imputation server)",
          "description": "The alignment results [CRAM], variant call results per sample [gVCF] processed JGAD000220 (whole genome sequencing data for a total of 1,026 patients, who were registered BioBank Japan from 2003 - 2007) in a certain workflow were provided. If you plan to use the data, please indicate both original data (JGAD000220) and processed data (JGAD000690) on the application form for data use.\nThe variant call results per dataset [aggregated VCF, tabix] processed JGAD000220 (whole genome sequencing data for a total of 1,026 patients, who were registered BioBank Japan from 2003 - 2007) in a certain workflow were provided. If you plan to use the data, please indicate both original data (JGAD000220) and processed data (JGAD000758) on the application form for data use.\nThe tbi index file, the bref3 file, and a config file processed JGAD000220 (JGAS000114 reference panel) in a certain workflow were provided. These files can be used in the NBDC-DDBJ imputation server. If you plan to use the data, please indicate both original data (JGAD000220) and processed data (JGAD000679) on the application form for data use.\n"
        },
        "hum0014.v30": {
          "Research ID": "hum0014.v30",
          "Release Date": "2023/04/20",
          "Type of Data": "target sequencings of 27 cancer-predisposing genes in 1,982 lymphoma patients, 10,366 gastric cancer patients and 37,592 controls",
          "description": "Target capture sequencing analyses of 27 cancer-predisposing genes in 1,982 lymphoma patients, 10,366 gastric cancer patients and 37,592 controls were performed. Fastq files are provided.\n"
        },
        "hum0014.v29": {
          "Research ID": "hum0014.v29",
          "Release Date": "2023/04/05",
          "Type of Data": "GWAS for 9,826 AF patients and 140,446 controls from BBJ 1st cohort\r\nGWAS meta-analysis for 77,690 AF patients and 1,167,040 controls",
          "description": "GWAS summary statistics file for 9,826 AF cases and 140,446 controls from the BBJ 1st cohort was added (txt).\nSummary statistics file of cross-ancestry meta-analysis for 77,690 AF cases and 1,167,040 controls and polygenic risk score file calculated from the meta-analysis were added (txt).\n"
        },
        "hum0014.v28": {
          "Research ID": "hum0014.v28",
          "Release Date": "2023/04/05",
          "Type of Data": "mobile element variations in 4,880 individuals from the BBJ 1st cohort",
          "description": " Files for mobile element variations in 4,880 individuals from the BBJ 1st cohort were added (txt).\n"
        },
        "hum0014.v27": {
          "Research ID": "hum0014.v27",
          "Release Date": "2022/12/31",
          "Type of Data": "GWAS for survival time in 137,693 individuals from the BBJ 1st cohort",
          "description": "GWAS analysis files for 137,693 individuals from the BBJ 1st cohort were added (txt).\nSex-stratified genome-wide association studies using a Cox proportional hazard model under the assumption of the additive genetic model were performed. Associations of genetic variants estimated by saddle point estimation using SPACox software were also evaluated.\n"
        },
        "hum0014.v26": {
          "Research ID": "hum0014.v26",
          "Release Date": "2022/04/01",
          "Type of Data": "target sequencings of 27 cancer-predisposing genes and 13 renal cell carcinoma-related genes in 740 renal cell cancer patients and 5,996 controls",
          "description": "Target capture sequencing analyses of 27 cancer-predisposing genes and 13 renal cell carcinoma-related genes in 740 renal cell cancer patients and 5,996 controls were performed. Fastq files are provided.\n"
        },
        "hum0014.v25": {
          "Research ID": "hum0014.v25",
          "Release Date": "2022/01/25",
          "Type of Data": "WGS for 1,765 myocardial infarction patients and 199 dementia patients",
          "description": "Whole genome sequensing analysis for 1,765 myocardial infarction patients and 199 dementia patients were performed. Whole genome sequencing analyzed data were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J). Fastq files, Bam files and gvcf files were provided.\n"
        },
        "hum0014.v24": {
          "Research ID": "hum0014.v24",
          "Release Date": "2021/11/26",
          "Type of Data": "target sequencing of 27 cancer-predisposing genes in 1,005 pancreatic cancer patients, 12,503 colorectal cancer patients and 23,705 controls",
          "description": "A target capture sequencing analysis of 27 cancer-predisposing genes in 1,005 pancreatic cancer patients, 12,503 colorectal cancer patients and 23,705 controls was performed. Fastq files are provided.\n"
        },
        "hum0014.v23": {
          "Research ID": "hum0014.v23",
          "Release Date": "2021/07/13",
          "Type of Data": "bam/gvcf data of WGS (JGAD000220)",
          "description": "Whole genome sequencing analyzed data included in the JGAD000220 were mapped to the GRCh37 reference genome sequence, and variant detection was carried out using the GATK (Genome Analysis Toolkit) standards. Bam files and gvcf files were added. This project is an initiative of the GEnome Medical alliance Japan (GEM Japan, GEM-J).\n"
        },
        "hum0014.v22": {
          "Research ID": "hum0014.v22",
          "Release Date": "2021/05/21",
          "Type of Data": "targeted sequencing of 23 genes related to clonal hematopoiesis and SNP-array in 11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007",
          "description": "Target capture sequencing of 23 genes related to clonal hematopoiesis and SNP-array in 11,234 subjects extracted from approximately 200,000 subjects registered in Biobank Japan between fiscal years 2003 to 2007 were performed. A list of somatic SNVs/indels detected by targeted sequencing (txt) and a table of somatic copy-number alterations detected by analysis of SNP-array data (csv) are provided.\n"
        },
        "hum0014.v21": {
          "Research ID": "hum0014.v21",
          "Release Date": "2020/08/25",
          "Type of Data": "GWAS for coronary artery disease",
          "description": "GWAS analysis files for coronary artery disease patients were added.\n"
        },
        "hum0014.v20": {
          "Research ID": "hum0014.v20",
          "Release Date": "2020/08/17",
          "Type of Data": "GWAS for coronary artery disease",
          "description": "A total of 25,892 patients with coronary artery disease and 142,336 controls were genotyped by using of Illumina HumanOminiExpress, HumanExome, or OmniExpressExome BeadChip. A genotype imputation was carried out using Minimac3 algorithm with the BBJ-CAD reference panel. Then, genome-wide association study was performed using plink2 for 20 million variants.\n"
        },
        "hum0014.v19": {
          "Research ID": "hum0014.v19",
          "Release Date": "2020/04/20",
          "Type of Data": "GWAS for dietary habits",
          "description": "A total of 165,084 participants whose dietary habits status is available were genotyped by using of Illumina HumanOminiExpress BeadChip, HumanExome, or OmniExpressExome BeadChip. A genotype imputation was carried out using Minimac algorithm with the 1000 genomes Phase I v3 release as a reference. Then, a genome-wide association study (about 6,000,000 imputed SNVs) was performed (BOLT-LMM and ProbABEL program).\n"
        },
        "hum0014.v18": {
          "Research ID": "hum0014.v18",
          "Release Date": "2019/11/26",
          "Type of Data": "GWAS for Breast cancer",
          "description": "GWAS analysis files for breast cancer patients were added.\n"
        },
        "hum0014.v17": {
          "Research ID": "hum0014.v17",
          "Release Date": "2019/10/08",
          "Type of Data": "GWAS for 40 diseases",
          "description": "A total of 212,453 patients of 40 diseases were genotyped by using of HumanOmniExpress/HumanExome/OmniExpressExome BeadChip(Illumina). A genotype imputation was carried out using Minimac3 algorithm with the 1000 genomes Phase 3 v5 release as a reference. Then, genome-wide association studies (8,919,992 imputed SNVs) were performed (SAIGE v0.29.4.2).\n"
        },
        "hum0014.v16": {
          "Research ID": "hum0014.v16",
          "Release Date": "2019/10/07",
          "Type of Data": "target sequencing of 8 hereditary prostate cancer genes in 7,636 prostate cancer patients and 12,366 controls",
          "description": "A target capture sequencing analysis of 8 hereditary prostate cancer genes in 7,636 prostate cancer patients and 12,366 controls was performed. Fastq files are provided.\n"
        },
        "hum0014.v15": {
          "Research ID": "hum0014.v15",
          "Release Date": "2019/09/27",
          "Type of Data": "reference panel by using of WGS data of the biobank Japan project (N=1,037) and 1KGP p3v5 ALL (N=2,504)\r\nGWAS for height",
          "description": "- A new reference panel was build with WGS data of the biobank Japan project (N=1,037) and the 1KGP p3v5 ALL (N=2,504) .\n- A total of 159,095 individuals were genotyped by using of Illumina HumanOminiExpress BeadChip, HumanExome, or OmniExpressExome BeadChip. A genotype imputation was carried out using Minimac algorithm with the reference panel using WGS data of the biobank Japan project (N=1,037) and 1KGP p3v5 ALL (N=2,504). Then, a genome-wide association study (about 20,000,000 imputed variants) for height was performed (BOLT-LMM [ver2.2] and mach2qtl).\n"
        },
        "hum0014.v14": {
          "Research ID": "hum0014.v14",
          "Release Date": "2019/03/26",
          "Type of Data": "GWAS for smoking behavior",
          "description": "A total of 165,436 participants whose smoking status is available were genotyped by using of Illumina HumanOminiExpress BeadChip, HumanExome, or OmniExpressExome BeadChip. A genotype imputation was carried out using Minimac algorithm with the 1000 genomes Phase I v3 release as a reference. Then, a genome-wide association study (about 6,000,000 imputed SNVs) was performed (BOLT-LMM and ProbABEL program).\n"
        },
        "hum0014.v13": {
          "Research ID": "hum0014.v13",
          "Release Date": "2019/01/25",
          "Type of Data": "meta analysis of 4 GWASs for T2DM",
          "description": "Result of meta analysis of following 4 GWASs (txt file) .\n     - 9,804 T2DM patients and 6,728 controls\n     - 5,639 T2DM patients and 19,407 controls\n     - 18,688 T2DM patients and 121,950 controls\n     - 2,483 T2DM patients and 7,065 controls\nGenotypes were determined by using of Illumina [HumanOmniExpress, HumanExome, OmniExpressExome, Human610-Quad BeadChip].\n"
        },
        "hum0014.v12": {
          "Research ID": "hum0014.v12",
          "Release Date": "2018/12/10",
          "Type of Data": "meta analysis of 2 GWASs for T2DM with diabetic nephropathy",
          "description": "Result of meta analysis of following 2 GWASs (csv file).\n     - 2,380 T2DM with diabetic nephropathy patients and 5,234 T2DM without diabetic nephropathy patients\n     - 429 T2DM with diabetic nephropathy patients and 358 T2DM without diabetic nephropathy patients\nGenotypes were determined by using of OmniExpressExome Beadchip or Human610-Quad BeadChip [Illumina].\n"
        },
        "hum0014.v11": {
          "Research ID": "hum0014.v11",
          "Release Date": "2018/10/16",
          "Type of Data": "target sequencing of 11 hereditary breast cancer genes in 7,104 breast cancer patients and 23,731 controls",
          "description": "A target capture sequencing analysis of 11 hereditary breast cancer genes in 7,104 breast cancer patients and 23,731 controls was performed. Fastq files are provided.\n"
        },
        "hum0014.v10": {
          "Research ID": "hum0014.v10",
          "Release Date": "2018/08/13",
          "Type of Data": "WGS for 1,026 individuals",
          "description": "Whole genome sequensing analysis for a total of 1,026 patients, who were registered Bio Bank Japan from 2003 - 2007 was performed. Fastq files are provided.\n"
        },
        "hum0014.v9": {
          "Research ID": "hum0014.v9",
          "Release Date": "2018/08/07",
          "Type of Data": "GWAS for age at menarche and menopause",
          "description": "A total of 67,029 females with information on age at menarche and 43,861 females with information on age at menopause were genotyped by using of Illumina HumanOminiExpress BeadChip, HumanExome, or OmniExpressExome BeadChip. A genotype imputation was carried out using Minimac algorithm with the 1000 genomes Phase I v3 release as a reference. Then, a genome-wide association study (about 10,000,000 imputed SNVs) was performed (mach2dat program).\n"
        },
        "hum0014.v8": {
          "Research ID": "hum0014.v8",
          "Release Date": "2018/05/01",
          "Type of Data": "GWAS for 58 quantitative traits",
          "description": "A total of 162,255 patients, who were registered Bio Bank Japan from 2003 - 2007 were genotyped by using of Illumina HumanOminiExpress-12 BeadChip, HumanExome, or OmniExpressExome BeadChip. A genotype imputation was carried out using Minimac algorithm with the 1000 genomes Phase I v3 release as a reference. Then, genome-wide association studies (about 6,000,000 imputed SNVs) were performed (mach2qtl program).\n"
        },
        "hum0014.v7": {
          "Research ID": "hum0014.v7",
          "Release Date": "2018/04/04",
          "Type of Data": "GWAS for POAG",
          "description": "A total of 3980 patients with primary open-angle glaucoma and 18,815 controls were genotyped by using of Illumina HumanOminiExpress BeadChip, HumanExome, or OmniExpressExome BeadChip. A genotype imputation was carried out using Minimac algorithm with the 1000 genomes Phase I v3 release as a reference. Then, a genome-wide association study (about 6,000,000 imputed SNVs) was performed (mach2dat program).\n"
        },
        "hum0014.v6": {
          "Research ID": "hum0014.v6",
          "Release Date": "2017/09/08",
          "Type of Data": "GWAS for BMI\r\nGenotype data for 182,505 individuals",
          "description": "A total of 158,284 patients, who were registered Bio Bank Japan from 2003 - 2007 were genotyped by using of Illumina HumanOminiExpress-12 BeadChip, HumanExome, or OmniExpressExome BeadChip. A genotype imputation was carried out using Minimac algorithm with the 1000 genomes Phase I v3 release as a reference. Then, a genome-wide association study (about 6,000,000 imputed SNVs) was performed (mach2qtl program).\n"
        },
        "hum0014.v5": {
          "Research ID": "hum0014.v5",
          "Release Date": "2017/05/18",
          "Type of Data": "GWAS for AF\r\nGenotype data for 8180 AFs",
          "description": "A total of 8180 patients with atrial fibrillation, who were registered Bio Bank Japan from 2003 - 2007, and 28,612 controls were genotyped by using of Illumina HumanOminiExpress-12 BeadChip, HumanExome, or OmniExpressExome BeadChip (900,000 SNVs). A genotype imputation was carried out using Minimac algorithm with the 1000 genomes Phase I v3 release as a reference. Then, a genome-wide association study (5,000,000 imputed SNVs) was performed (mach2dat program).\n"
        },
        "hum0014.v4": {
          "Research ID": "hum0014.v4",
          "Release Date": "2016/02/02",
          "Type of Data": "GWAS for AD",
          "description": "A total of 1472 patients with atopic dermatitis and 7966 controls were genotyped by using of Illumina HumanOminiExpress-12 BeadChip (606,164 SNVs). A genotype imputation was carried out using Minimac algorithm with the 1000 genomes Phase I v3 release as a reference. Then, a genome-wide association study (7,700,000 imputed SNVs) was performed using logic regression tests with imputed SNP dosage data (mach2dat program).　\n"
        },
        "hum0014.v3": {
          "Research ID": "hum0014.v3",
          "Release Date": "2016/01/28",
          "Type of Data": "GWASs for T2DM",
          "description": "GWASs for T2DM were performed using 552,915 SNPs (9817 T2DM patients vs 6763 controls) and 479,088 SNPs (5646 T2DM patients vs 19,420 controls). Allele frequencies of T2DM patients and controls were compared. \n Genotypes were determined by using of OmniExpressExome Beadchip or Human610-Quad BeadChip [Illumina], respectively.\n"
        },
        "hum0014.v2": {
          "Research ID": "hum0014.v2",
          "Release Date": "2015/12/28",
          "Type of Data": "Genotype frequencies of 934 healthy individuals, about 190 patients from each of 35 diseases, 182 esophageal cancer patients, and 92 ALS patients.",
          "description": "Genotype frequencies of 934 healthy individuals, about 190 patients from each of 35 diseases, 182 esophageal cancer patients, and 92 ALS patients.\n35 diseases:\nCancer (Lung cancer, Breast cancer, Gastric cancer, Colorectal cancer, Prostate cancer)\nCardiovascular diseases (Heart failure, Myocardial infarction, Unstable angina, Stable angina, Cardiac arrhythmias, Arteriosclerosis obliterans)\nCerebrovascular disorders (Brain infarction, Intracranial aneurysm)\nRespiratory tract diseases (Interstitial pneumonitis & pulmonary fibrosis, Pulmonary emphysema, Bronchial asthma)\nChronic liver diseases (Chronic hepatitis C, Liver cirrhosis)\nEye diseases (Cataract, Glaucoma)\nOthers (Epilepsy, Periodontal disease, Urolithiasis, Nephrotic syndrome, Uterine myoma, Endometriosis, Osteoporosis, Rheumatoid arthritis, Amyotrophic lateral sclerosis, Hay fever, Atopic dermatitis, Drug eruptions , Hyperlipidemias, Diabetes mellitus, Basedow disease)\nIllumina [Human610-Quad BeadChip, HumanHap550v3 Genotyping BeadChip], Perlegen Sciences [high-density oligonucleotide arrays], or Hologic Japan [Invader] were used for the genotyping.\n"
        },
        "hum0014.v1": {
          "Research ID": "hum0014.v1",
          "Release Date": "2014/09/30",
          "Type of Data": "GWAS for MI",
          "description": "A Genome-Wide Association Study (GWAS) for MI was performed using 455,781 SNPs (Illumina Human610-Quad BeadChip and HumanHap550v3 Genotyping BeadChip). Allele frequencies of 1666 MI patients and 3198 controls were compared.\nNote：\n"
        }
      }
    }
  },
  "hum0013.v1": {
    "ja": {
      "NBDC Research ID": "hum0013.v1",
      "データ": {
        "hum0013.v1.freq.v1": {
          "データID": "hum0013.v1.freq.v1",
          "内容": "SNP-Chipを用いて決定した遺伝子型2994名分の頻度情報",
          "制限": "非制限公開",
          "公開日": "2014/10/16"
        }
      },
      "研究内容の概要": {
        "目的": "安全性・有効性の高い薬剤開発を目的とした日本人のコントロールDNAデータベースの構築",
        "方法": "illumina HumanOmni2.5-8 BeadChipを使用し、約240万個の一塩基多型（Single Nucleotide Variants：SNVs）の遺伝子型を決定する",
        "対象": "日本人健常人2994名",
        "URL": "https://www.jstage.jst.go.jp/article/faruawpsj/46/5/46_KJ00009581938/_pdf/-char/ja"
      },
      "分子データ": {
        "hum0013.v1.freq.v1": {
          "対象": "日本人健常人 2994名",
          "規模": "genome wide SNVs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanOmni2.5-8 BeadChip]",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "HumanOmni2.5-8 v1.0 BeadChip Kit",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenomeStudio",
          "フィルタリング": "Call Rate ≧ 0.95 かつ HWE ≧ 0.001",
          "マーカー数（QC後）": "2,343,307 SNVs",
          "NBDC Data Set ID": "hum0013.v1.freq.v1\r\n（データのダウンロードは上記Data Set IDをクリックしてください）\r\nDictionary file",
          "総データ量": "68.9 MB (zip [txt])",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "末松 浩嗣",
        "所 属 機 関": "大正製薬株式会社",
        "プロジェクト/研究グループ名": "日本ファーマコジェノミクスデータサイエンスコンソーアム（JPDSC）",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects.",
          "DOI": "doi:10.2217/pgs.13.180",
          "データID": "hum0013.v1.freq.v1"
        },
        "2": {
          "タイトル": "A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.",
          "DOI": "doi:10.1038/tpj.2011.41",
          "データID": "hum0013.v1.freq.v1"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0013.v1": {
        },
        "hum0013.v1.freq.v1": {
          "Research ID": "hum0013.v1.freq.v1",
          "公開日": "2014/10/16",
          "内容": "日本人健常集団におけるGenome Wide SNVsの頻度情報"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0013.v1",
      "DATA": {
        "hum0013.v1.freq.v1": {
          "Data Set ID": "hum0013.v1.freq.v1",
          "Type of Data": "genotype counts of 2.5 million SNPs",
          "Criteria": "Unrestricted-access",
          "Release Date": "2014/10/16"
        }
      },
      "SUMMARY": {
        "Aims": "To build a Japanese control DNA database for application to genetic investigations on adverse drug reactions and facilitate in the development of drugs with high efficacy and safety.",
        "Methods": "Determine the genotype of nearly 2.5 million single nucleotide polymorphisms (SNPs) by using of illumina HumanOmni2.5-8.",
        "Participants/Materials": "2994 Japanese healthy controls",
        "URL": "https://doi.org/10.1038/jhg.2015.23"
      },
      "MOLECULAR DATA": {
        "hum0013.v1.freq.v1": {
          "Participants/Materials": "2994 Japanese healthy controls",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanOmni2.5-8 BeadChip]",
          "Source": "DNAs extracted from peripheral blood",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "HumanOmni2.5-8 v1.0 BeadChip Kit",
          "Genotype Call Methods (softwares)": "GenomeStudio",
          "Filtering Methods": "Call Rate ≧ 0.95 and HWE ≧ 0.001",
          "Marker Number (after QC)": "2,343,307 SNVs",
          "NBDC Dataset ID": "hum0013.v1.freq.v1\r\n(Click the Dataset ID to download the file)\r\nDictionary file",
          "Total Data Volume": "68.9 MB (zip [txt])",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koji Suematsu",
        "Affiliation": "PGx, Clinical Research, Taisho Pharmaceutical Co., Ltd.",
        "Project / Group Name": "The Japan PGx Data Science Consortium (JPDSC)",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects.",
          "DOI": "doi:10.2217/pgs.13.180",
          "Data Set ID": "hum0013.v1.freq.v1"
        },
        "2": {
          "Title": "A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.",
          "DOI": "doi:10.1038/tpj.2011.41",
          "Data Set ID": "hum0013.v1.freq.v1"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0013.v1": {
        },
        "hum0013.v1.freq.v1": {
          "Research ID": "hum0013.v1.freq.v1",
          "Release Date": "2014/10/16",
          "Type of Data": "genotype counts of 2.5 million SNPs"
        }
      }
    }
  },
  "hum0012.v1": {
    "ja": {
      "NBDC Research ID": "hum0012.v1",
      "データ": {
        "JGAS000012": {
          "データID": "JGAS000012",
          "内容": "ながはま0次コホートスタディにおける\r\n3712名分の遺伝子型情報",
          "制限": "制限公開（Type I）",
          "公開日": "2015/08/19"
        }
      },
      "研究内容の概要": {
        "目的": "市民の健康づくりの推進と予防医学の発展への貢献",
        "方法": "アレイによる遺伝子型データ（一般市民を対象とする多目的コホート研究）",
        "対象": "3712名",
        "URL": "http://zeroji-cohort.com/project/index.html"
      },
      "分子データ": {
        "JGAS000012": {
          "対象": "日本人健常人 3712名\r\n★対象毎に実施プラットフォームが異なります★",
          "規模": "genome wide SNPs",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina Genotyping Arrays",
          "ソース": "末梢血から抽出したgDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina Human610-Quad Beadchip Kit\r\nHumanOmni2.5-4v1 BeadChip Kit\r\nHumanOmni2.5-8v1 BeadChip Kit\r\nHumanOmni2.5S-8v1 BeadChip Kit\r\nHumanExome-12v1 BeadChip Kit\r\nHumanCoreExome-12v1 BeadChip Kits",
          "遺伝子型決定アルゴリズム（ソフトウェア）": "GenCall software (GenomeStudio)",
          "マーカー数（raw-call）\r\n※Illumina Final Report形式ファイル": "Human610-Quad: 620,901 SNPs\r\nHumanOmni2.5-4v1: 2,443,177 SNPs\r\nHumanOmni2.5-8v1: 2,379,855 SNPs\r\nHumanOmni2.5S-8v1: 2,015,318 SNPs\r\nHumanExome-12v1: 247,870 SNPs\r\nHumanCoreExome-12v1: 538,448 SNPs",
          "フィルタリング": "BLASTを用いた周辺配列アライメントによる位置の一意化。\r\nCNV用プローブ、複数個所にマップされたプローブ、および、\r\nマップされなかったプローブ情報を除去。",
          "マーカー数（フィルタ後）\r\n※ped/map形式ファイル": "Human610-Quad: 597,140 SNPs\r\nHumanOmni2.5-4v1: 2,431,379 SNPs\r\nHumanOmni2.5-8v1: 2,372,060 SNPs\r\nHumanOmni2.5S-8v1: 2,008,033 SNPs\r\nHumanExome-12v1: 246,805 SNPs\r\nHumanCoreExome-12v1: 518,247 SNPs",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000012",
          "総データ量": "5 GB（Illumina Final Report形式およびped/map形式※1）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "松田 文彦",
        "所 属 機 関": "京都大学医学研究科附属ゲノム医学センター",
        "プロジェクト/研究グループ名": "ながはま0次コホート事業",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "厚生労働科学研究費補助金\r\n難病・がん等の疾患分野の医療の実用化研究事業",
            "タイトル": "網羅的統合オミックス解析を用いた難病の原因究明と\r\n新規診断・治療法の確立",
            "研究課題番号": "11103334"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "A genome-wide association study of serum levels of prostate specific antigen in the Japanese population.",
          "DOI": "doi: 10.1136/jmedgenet-2014-102423",
          "データID": "JGAD000012"
        },
        "2": {
          "タイトル": "Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels",
          "DOI": "doi:10.1038/ncomms8754",
          "データID": "JGA0000012"
        }
      },
      "制限公開データの利用者一覧": {
        "野口恵美子": {
          "研究代表者": "野口恵美子",
          "所属機関": "筑波大学 医学医療系 遺伝医学",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000012"
        },
        "岡田 随象": {
          "研究代表者": "岡田 随象",
          "所属機関": "大阪大学大学院 医学系研究科 遺伝統計学",
          "研究題目": "",
          "利用データID": "日本人由来B細胞株DNAのゲノムデータを用いた遺伝統計解析手法の研究",
          "利用期間": "JGAD000012"
        },
        "朝野 仁裕": {
          "研究代表者": "朝野 仁裕",
          "所属機関": "大阪大学 大学院医学系研究科 循環器内科学",
          "研究題目": "",
          "利用データID": "遺伝性心血管疾患の感受性遺伝子解析研究",
          "利用期間": "JGAD000012"
        },
        "吉田 善紀": {
          "研究代表者": "吉田 善紀",
          "所属機関": "京都大学 iPS細胞研究所 増殖分化機構研究部門",
          "研究題目": "日本",
          "利用データID": "肥大型心筋症の診療実態に関する多施前向き登録研究",
          "利用期間": "JGAD000012"
        }
      },
      "リリース情報": {
        "hum0012.v1": {
          "Research ID": "hum0012.v1",
          "公開日": "2015/08/19",
          "内容": "ながはま0次コホートスタディにおける3712名分の遺伝子型情報",
          "description": "滋賀県長浜市民3712名の遺伝子について、6種のIllumina Genotypine Arrays [Human610-Quad, HumanOmni2.5-4v1, HumanOmni2.5-8v1, HumanOmni2.5S-8v1, HumanExome-12v, HumanCoreExome-12v1] を使用し決定した遺伝子型情報です。\n検体－プラットフォーム対応表はこちら。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0012.v1",
      "DATA": {
        "JGAS000012": {
          "Data Set ID": "JGAS000012",
          "Type of Data": "Genotype data of 3712 participants in Nagahama Zero-ji preventive cohort study",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/08/19"
        }
      },
      "SUMMARY": {
        "Aims": "Contribution to the promotion of the citizen’s health and the development of the preventive medicine",
        "Methods": "Genotypes were determined by using of several SNP-arrays (Multipurpose prospective cohort study about the citizen)",
        "URL": "http://zeroji-cohort.com/english/"
      },
      "MOLECULAR DATA": {
        "JGAS000012": {
          "Materials": "3712 Japanese healthy controls\r\n★Platforms used for the genotype-determination were different among samples★",
          "Targets": "genome wide SNPs",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina Genotyping Arrays",
          "Source": "gDNA extracted from peripheral blood",
          "Cell Lines": "-",
          "Reagents (Kit, Version)": "Illumina Human610-Quad Beadchip Kit\r\nHumanOmni2.5-4v1 BeadChip Kit\r\nHumanOmni2.5-8v1 BeadChip Kit\r\nHumanOmni2.5S-8v1 BeadChip Kit\r\nHumanExome-12v1 BeadChip Kit\r\nHumanCoreExome-12v1 BeadChip Kits",
          "Genotype Call Methods (softwares)": "GenCall software (GenomeStudio)",
          "Marker Numbers (without any filtering)\r\n※Illumina Final Report format files": "Human610-Quad: 620,901 SNPs\r\nHumanOmni2.5-4v1: 2,443,177 SNPs\r\nHumanOmni2.5-8v1: 2,379,855 SNPs\r\nHumanOmni2.5S-8v1: 2,015,318 SNPs\r\nHumanExome-12v1: 247,870 SNPs\r\nHumanCoreExome-12v1: 538,448 SNPs",
          "Filtering Methods": "Surrounding sequences of each probe were aligned by using of BLAST algorithm.\r\n(Probes for copy number variants, unmapped probes, and multi-mapped probes were removed.)",
          "Marker Numbers (after QC)\r\n※ped/map format files": "Human610-Quad: 597,140 SNPs\r\nHumanOmni2.5-4v1: 2,431,379 SNPs\r\nHumanOmni2.5-8v1: 2,372,060 SNPs\r\nHumanOmni2.5S-8v1: 2,008,033 SNPs\r\nHumanExome-12v1: 246,805 SNPs\r\nHumanCoreExome-12v1: 518,247 SNPs",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000012",
          "Total Data Volume": "5 GB (Illumina Final Report format or ped/map format*1)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Fumihiko Matsuda",
        "Affiliation": "Center for Genomic Medicine Kyoto University Graduate School of Medicine",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "Health and Labor Sciences Research Grants\r\n- Research Project on Applying Health Technology",
            "Title": "Investigating the cause for intractable diseases using comprehensive integrated omics analyses and the establishment of new diagnostics / treatment",
            "Project Number": "11103334"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "A genome-wide association study of serum levels of prostate specific antigen in the Japanese population.",
          "DOI": "doi: 10.1136/jmedgenet-2014-102423",
          "Data Set ID": "JGAD000012"
        },
        "2": {
          "Title": "Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels",
          "DOI": "doi:10.1038/ncomms8754",
          "Data Set ID": "JGAD000012"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Emiko Noguchi": {
          "Principal Investigator": "Emiko Noguchi",
          "Affiliation": "Department of Medical Genetics, Faculty of Medicine, University of Tsukuba",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000012"
        },
        "Yukinori Okada": {
          "Principal Investigator": "Yukinori Okada",
          "Affiliation": "Department of Statistical Genetics, Osaka University Graduate School of Medicine",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Development of statistical genetic analysis methods using the whole-genome data from B cell lines of Japanese individuals",
          "Period of Data Use": "JGAD000012"
        },
        "Yoshihiro Asano": {
          "Principal Investigator": "Yoshihiro Asano",
          "Affiliation": "Department of Cardiovascular Medicine, Graduate School of Medicine, Osaka University",
          "Research Title": "",
          "Data in Use (Dataset ID)": "Sensitive gene analysis of hereditary cardiovascular disease",
          "Period of Data Use": "JGAD000012"
        },
        "Yoshinori Yoshida": {
          "Principal Investigator": "Yoshinori Yoshida",
          "Affiliation": "Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Prospective REgistry to eVAluate the predIctors and clinicaL management of HCM",
          "Period of Data Use": "JGAD000012"
        }
      },
      "Release Note": {
        "hum0012.v1": {
          "Research ID": "hum0012.v1",
          "Release Date": "2015/08/19",
          "Type of Data": "Genotype data of 3712 participants in Nagahama Zero-ji preventive cohort study",
          "description": " Genotypes for 3712 participants living in Nagahama city were determined using Illumina SNP arrays [Human610-Quad, HumanOmni2.5-4v1, HumanOmni2.5-8v1, HumanOmni2.5S-8v1, HumanExome-12v1, HumanCoreExome-12v1]. \n The sample-platform correspondence table is here.\nNote:\n"
        }
      }
    }
  },
  "hum0011.v1": {
    "ja": {
      "NBDC Research ID": "hum0011.v1",
      "データ": {
        "JGAS000015": {
          "データID": "JGAS000015",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/10/07"
        }
      },
      "研究内容の概要": {
        "目的": "B型肝炎ウィルスのヒトゲノム内への組み込み解析研究",
        "方法": "Target enrichment systemによりHBVゲノム組み込み部位を含むヒトゲノムをキャプチャし、ライブラリとして用いた次世代シークエンス解析",
        "対象": "PLC/PRF/5細胞株1サンプル、HepG22215細胞株1サンプル、HBV感染ヒト肝がん 8症例"
      },
      "分子データ": {
        "JGAS000015": {
          "対象": "PLC/PRF/5細胞株　1サンプル、\r\nHepG22215細胞株　1サンプル、\r\nHBV感染ヒト肝がん　8症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "HBVゲノム組み込み部位を含むヒトゲノム",
          "Platform": "Roche GS FLX Titanium",
          "ライブラリソース": "HBV感染ヒト肝がん臨床組織",
          "検体情報（購入の場合）": "PLC/PRF/5細胞株（肝がん細胞、HBs抗原陽性）\r\nHepG22215細胞株（肝がん細胞、HBVが組込まれている）",
          "ライブラリ作製方法（キット名）": "カスタム",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "GS Run Processor",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "321.10 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000015",
          "総データ量": "1.84 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "山本 博幸",
        "所 属 機 関": "聖マリアンナ医科大学 消化器・肝臓内科",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（C）",
            "タイトル": "Ｂ型肝炎の肝発癌におけるＨＢｘ遺伝子の役割の網羅的解析",
            "研究課題番号": "23590964"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "DNA methylation at hepatitis B viral integrants is associated with methylation at flanking human genomic sequences.",
          "DOI": "doi: 10.1101/gr.175240.114.",
          "データID": "JGAD000015"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0011.v1": {
          "Research ID": "hum0011.v1",
          "公開日": "2015/10/07",
          "内容": "NGS （Target Capture）",
          "description": "PLC/PRF/5細胞株1サンプル、HepG22215細胞株1サンプル、HBV感染ヒト肝がん8症例のHBVゲノム組み込み部位をライブラリとした次世代シークエンス解析（Roche GS FLX Titanium）。multi-FASTA形式、 Quality value、SFF形式（454 Reads）のファイルを提供します。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0011.v1",
      "DATA": {
        "JGAS000015": {
          "Data Set ID": "JGAS000015",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/10/07"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify integrated HBV sequences in the human genome.",
        "Methods": "Target enrichment sysem-based next generation sequencer",
        "Participants/Materials": "PLC/PRF/5 cell, HepG22215 cell, and HB-HCC primary tissues"
      },
      "MOLECULAR DATA": {
        "JGAS000015": {
          "Participants/Materials": "1 PLC/PRF/5 cell\r\n1 HepG22215 cell\r\n8 HB-HCC primary tissues",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "hepatitis B viral integrants with flanking human genomic sequences",
          "Platform": "Roche GS FLX Titanium",
          "Library Source": "HB-HCC primary tissues",
          "Cell Lines": "PLC/PRF/5 cell [hepatocellular carcinoma cell line (producing HBsAg)]\r\nHepG22215 cell [hepatoblastoma cell line (contain an integrated copy of the HBV genome)]",
          "Library Construction (kit name)": "custom",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "GS Run Processor",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "321.10 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000015",
          "Total Data Volume": "1.84 GB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroyuki Yamamoto",
        "Affiliation": "St. Marianna University School of Medicine, Division of Gastroenterology and Hepatology",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (C)",
            "Title": "Sequence analysis at HBV integrants and flanking host genomes",
            "Project Number": "23590964"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "DNA methylation at hepatitis B viral integrants is associated with methylation at flanking human genomic sequences.",
          "DOI": "doi: 10.1101/gr.175240.114.",
          "Data Set ID": "JGAD000015"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0011.v1": {
          "Research ID": "hum0011.v1",
          "Release Date": "2015/10/07",
          "Type of Data": "NGS (Target Capture)",
          "description": " Exome sequense analysis using nextgenaration sequencer (Roche GS FLX Titanium) about integrated HBV sequences from 1 PLC/PRF/5 cell, 1 HepG22215 cell, 8 HB-HCC primary tissues. Multi-FASTA format files, Quality value files, and SFF format files (454 Reads) were provided.\nNote:\n"
        }
      }
    }
  },
  "hum0010.v1": {
    "ja": {
      "NBDC Research ID": "hum0010.v1",
      "データ": {
        "JGAS000008": {
          "データID": "JGAS000008",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/06/23"
        }
      },
      "研究内容の概要": {
        "目的": "脾類上皮嚢腫の発症リスクに関与する遺伝子の同定",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "脾類上皮嚢腫8症例"
      },
      "分子データ": {
        "JGAS000008": {
          "対象": "脾類上皮嚢腫：8症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon 50 Mb Kit",
          "断片化の方法": "超音波断片化（Covaris）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000008",
          "総データ量": "84 GB（16 files）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "松藤 凡",
        "所 属 機 関": "鹿児島大学大学院 医歯学総合研究科 発生発達成育学講座 小児外科学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genome-wide linkage and exome analyses identify variants of HMCN1 for splenic epidermoid cyst.",
          "DOI": "doi: 10.1186/s12881-014-0115-4",
          "データID": "JGAD000008"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0010.v1": {
          "Research ID": "hum0010.v1",
          "公開日": "2015/06/23",
          "内容": "NGS (Exome)",
          "description": "このバージョンでは、脾類上皮嚢腫8症例の末梢血から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon 50 Mb Kit（Agilent社）を用いてExon領域にしぼり、Illumina 社 HiSeq 2000にて平均長150塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0010.v1",
      "DATA": {
        "JGAS000008": {
          "Data Set ID": "JGAS000008",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/6/23"
        }
      },
      "SUMMARY": {
        "Aims": "Identification of candidate genes for splenic epidermoid cyst.",
        "Methods": "Whole exome sequence analysis using Illumina HiSeq 2000.",
        "Participants/Materials": "Patients of splenic epidermoid cyst."
      },
      "MOLECULAR DATA": {
        "JGAS000008": {
          "Participants/Materials": "8 patients of splenic epidermoid cyst",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon 50 Mb Kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "150 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000008",
          "Total Data Volume": "84 GB (16 files)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Matsufuji Hiroshi",
        "Affiliation": "Kagoshima University Graduate School of Medical and Dental Sciences",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genome-wide linkage and exome analyses identify variants of HMCN1 for splenic epidermoid cyst.",
          "DOI": "doi: 10.1186/s12881-014-0115-4",
          "Data Set ID": "JGAD000008"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0010.v1": {
          "Research ID": "hum0010.v1",
          "Release Date": "2015/06/23",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from peripheral blood cells of 8 patients of splenic epidermoid cyst were used for Exome sequencing analysis (fastq format files). Exons were captured using the SureSelect Human All Exon 50 Mb Kit and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (150 bp, Paired-end).\nNote:\n"
        }
      }
    }
  },
  "hum0009.v3": {
    "ja": {
      "NBDC Research ID": "hum0009.v3",
      "データ": {
        "DRA003802": {
          "データID": "DRA003802",
          "内容": "NGS（PBAT-seq）",
          "制限": "非制限公開",
          "公開日": "2015/08/03"
        },
        "JGAS000006": {
          "データID": "JGAS000006",
          "内容": "NGS（PBAT-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2014/12/24"
        },
        "hum0009v1.CpG.v1": {
          "データID": "hum0009v1.CpG.v1",
          "内容": "CpGサイトのメチル化率情報",
          "制限": "非制限公開",
          "公開日": "2015/01/07"
        }
      },
      "研究内容の概要": {
        "目的": "ヒト初期発生過程におけるDNAメチル化ダイナミクスの解明",
        "方法": "post-bisulfite adaptor tagging（PBAT）法によりライブラリー調製をし、Illimina社 HiSeq 2000もしくは2500を使用したメチル化解析",
        "対象": "日本人正常卵子、精子、受精卵（着床前胚）、臍帯血から抽出したゲノムDNA"
      },
      "分子データ": {
        "DRA003802（JGAS000006と同じデータセット内容です。）": {
          "対象": "11検体\r\n正常卵子、精子、受精卵（着床前胚）、臍帯血\r\n（卵子、着床前胚についてはプールしたDNAを使用）",
          "規模": "PBAT-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "それぞれの組織から抽出したDNAを使用\r\n卵子（増幅有）※1：79検体をプール\r\n卵子（増幅無）※1：123検体をプール\r\n精子：3検体\r\n受精卵（着床前胚）：80検体をプール\r\n臍帯血：5検体",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Post-bisulfite adaptor-tagging（PBAT）法※2",
          "断片化方法": "バイサルファイト処理",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "100 bp",
          "DDBJ Sequence Read Archive ID": "DRA003802",
          "総データ量": "500 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        " JGAS000006 （DRA003802[非制限公開]にアクセス制限が変更されました。DRA003802をご参照ください。）": {
          "対象": "11検体\r\n正常卵子、精子、受精卵（着床前胚）、臍帯血\r\n（卵子、着床前胚についてはプールしたDNAを使用）",
          "規模": "ゲノムワイドなメチル化シトシン同定",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "ライブラリソース": "それぞれの組織から抽出したDNAを使用\r\n卵子（増幅有）※1：79検体をプール\r\n卵子（増幅無）※1：123検体をプール\r\n精子：3検体\r\n受精卵（着床前胚）：80検体をプール\r\n臍帯血：5検体",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Post-bisulfite adaptor-tagging（PBAT）法※2",
          "断片化方法": "バイサルファイト処理",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000006",
          "総データ量": "500 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy および 民間企業における利用禁止"
        }
      },
      "提供者情報": {
        "研究代表者": "有馬 隆博",
        "所 属 機 関": "東北大学大学院 医学系研究科 環境遺伝医学総合研究センター 情報遺伝学分野",
        "プロジェクト/研究グループ名": "",
        "科研費/助成金（Research Project Number）": {
          "1": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "ヒト生殖細胞のエピゲノムダイナミクスとその制御機構",
            "研究課題番号": "26112502"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Genome-Wide Analysis of DNA Methylation Dynamics during Early Human Development",
          "DOI": "doi:10.1371/journal.pgen.1004868",
          "データID": "DRA003802（JGAS000006）"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0009.v3": {
          "Research ID": "hum0009.v3",
          "公開日": "2015/08/03",
          "内容": "NGS（PBAT-seq）",
          "description": "このバージョンでは、制限公開データ（Type I）として当初公開していたJGAD000006のアクセス制限（制限公開[Type I]）を非制限公開データ（DRA003802）に変更し、公開を開始した。データのダウンロードはDRAから。\n"
        },
        "hum0009.v2": {
          "Research ID": "hum0009.v2",
          "公開日": "2015/01/07",
          "内容": "CpGサイトのメチル化率情報",
          "description": "このバージョンでは、Bismark（v.0.9.0）のmethylation extractorを使用し、JGAD000006の各シトシンのメチル化率を算出。CpGサイトについては、両ストランドのリードを合わせてメチル化率を算出している。\n"
        },
        "hum0009.v1": {
          "Research ID": "hum0009.v1",
          "公開日": "2014/12/24",
          "内容": "NGS（PBAT-seq）",
          "description": "このバージョンでは、卵子、精子、受精卵（着床前胚）、臍帯血細胞から抽出したゲノムDNAよりpost-bisulfite adaptor tagging（PBAT）法を用いたライブラリー調製を行ない、Illumina社 HiSeq 2000もしくは2500を用いて産出したゲノムワイドメチル化データを提供する（Single-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0009.v3",
      "DATA": {
        "DRA003802": {
          "Data Set ID": "DRA003802",
          "Type of Data": "NGS (PBAT-seq)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2015/08/03"
        },
        "JGAS000006": {
          "Data Set ID": "JGAS000006",
          "Type of Data": "NGS (PBAT-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2014/12/24"
        },
        "hum0009v1.CpG.v1": {
          "Data Set ID": "hum0009v1.CpG.v1",
          "Type of Data": "methylation rate at each CpG site",
          "Criteria": "Unrestricted-access",
          "Release Date": "2015/01/07"
        }
      },
      "SUMMARY": {
        "Aims": "To generate single-base resolution DNA methylome maps of human gametes and embryos and uncover DNA methylation dynamics during early human development.",
        "Methods": "Whole genome bisulfite sequencing libraries were prepared using the post-bisulfite adaptor tagging (PBAT) method. PBAT libraries were sequenced on the HiSeq 2000 or 2500 platform (Illumina) with 100 bp single-end reads."
      },
      "MOLECULAR DATA": {
        "DRA003802": {
          "Materials": "11 samples\r\nHuman oocytes, sperm, preimplantation embryos and cord blood cells\r\n(Each DNAs from oocytes and preimplantation embryos were pooled)",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "DNAs extracted from each cell\r\nOocytes (amplified)*1: 79 samples were pooled\r\nOocytes: 123 samples were pooled\r\nSperm: 3 samples\r\nPreimplantation embryos: 80 samples were pooled\r\nCord blood cells: 5 samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Post-bisulfite Adaptor-tagging (PBAT) method*2",
          "Fragmentation Methods": "Bisulfite Treatment",
          "Spot Type": "Single-end Reads",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "DDBJ Sequence Read Archive ID": "DRA003802",
          "Total Data Volume": "500 GB",
          "Comments (Policies)": "NBDC policy"
        },
        " JGAS000006 （The access level was changed to \"Unrestricted-access\". Please have a look at DRA003802.)": {
          "Materials": "11 samples\r\nHuman oocytes, sperm, preimplantation embryos and cord blood cells\r\n(Each DNAs from oocytes and preimplantation embryos were pooled)",
          "Targets": "PBAT-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000/2500]",
          "Library Source": "DNAs extracted from each cell\r\nOocytes (amplified)*1: 79 samples were pooled\r\nOocytes: 123 samples were pooled\r\nSperm: 3 samples\r\nPreimplantation embryos: 80 samples were pooled\r\nCord blood cells: 5 samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Post-bisulfite Adaptor-tagging (PBAT) method*2",
          "Fragmentation Methods": "Bisulfite Treatment",
          "Spot Type": "Single-end Reads",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000006",
          "Total Data Volume": "500 GB",
          "Comments (Policies)": "NBDC policy & Company User Limit"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Takahiro Arima",
        "Affiliation": "Department of Informative Genetics, Environment and Genome Research Center,Tohoku University Graduate School of Medicine",
        "Funds / Grants (Research Project Number)": {
          "1": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "Epigenome Dynamics and Regulation in Germ Cells",
            "Project Number": "26112502"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Genome-Wide Analysis of DNA Methylation Dynamics during Early Human Development",
          "DOI": "doi:10.1371/journal.pgen.1004868",
          "Data Set ID": "DRA003802 (JGAS000006)"
        },
        "2": {
          "Title": " ",
          "DOI": " ",
          "Data Set ID": " "
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0009.v3": {
          "Research ID": "hum0009.v3",
          "Release Date": "2015/08/03",
          "Type of Data": "NGS (PBAT-seq)",
          "description": "The access level of JGAD000006 (Controlled-access [Type I]) was changed to \"Unrestricted-access\" (DRA003802). You can have the data through the DRA site.\n"
        },
        "hum0009.v2": {
          "Research ID": "hum0009.v2",
          "Release Date": "2015/01/07",
          "Type of Data": "methylation rate at each CpG site",
          "description": "The methylation level of each cytosine was calculated using the Bismark methylation extractor. For CpG sites, reads from both strands were combined to calculate the methylation levels.\n"
        },
        "hum0009.v1": {
          "Research ID": "hum0009.v1",
          "Release Date": "2014/12/24",
          "Type of Data": "NGS (PBAT-seq)",
          "description": "Whole genome bisulfite sequencing libraries were prepared using the post-bisulfite adaptor tagging (PBAT) method. DNAs extracted from human oocytes, sperm, preimplantation embryos, and cord blood cells were applied the method. PBAT libraries were sequenced on the HiSeq 2000/2500 platform (Illumina) with 100 bp single-end reads.\nNote:\n"
        }
      }
    }
  },
  "hum0008.v1": {
    "ja": {
      "NBDC Research ID": "hum0008.v1",
      "データ": {
        "JGAS000007": {
          "データID": "JGAS000007",
          "内容": "NGS (Exome)",
          "制限": "制限公開（Type I）",
          "公開日": "2018/01/29"
        }
      },
      "研究内容の概要": {
        "目的": "ヒルシュスプルング病の遺伝要因および発症機構の解明",
        "方法": "Illumina HiSeq 2000を使用したExome解析",
        "対象": "ヒルシュスプルング病5症例、およびその家族6例"
      },
      "分子データ": {
        "JGAS000007": {
          "対象": "ヒルシュスプルング病5症例、およびその家族6例（計11検体4セットずつ）",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Human All Exon 50 Mb Kit（Agilent社）",
          "断片化の方法": "超音波断片化（Covaris社）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000007",
          "総データ量": "113 GB (88 files)",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "松藤 凡",
        "所 属 機 関": "鹿児島大学大学院 医歯学総合研究科 発生発達成育学講座 小児外科学分野",
        "プロジェクト/研究グループ名": "-",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "-",
            "タイトル": "-",
            "研究課題番号": "-"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Identification of a novel variant of the RET proto-oncogene in a novel family with Hirschsprung's disease.",
          "DOI": "doi: 10.1007/s00383-017-4134-z",
          "データID": "JGAD000007"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0008.v1": {
          "Research ID": "hum0008.v1",
          "公開日": "2018/01/29",
          "内容": "NGS (Exome)",
          "description": "このバージョンでは、ヒルシュスプルング病5症例、患者家族6例の末梢血から抽出したDNAを用いたExome解析の結果をFastqファイルにて提供する。SureSelect Human All Exon 50 Mb Kit（Agilent社）を用いてExon領域にしぼり、Illumina 社 HiSeq 2000にて平均長100塩基のDNA断片を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0008.v1",
      "DATA": {
        "JGAS000007": {
          "Data Set ID": "JGAS000007",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/01/29"
        }
      },
      "SUMMARY": {
        "Aims": "Research for genetic causes and mechanisms of Hirschsprung's diseases.",
        "Methods": "Perform whole exome sequencing using genome DNA from patients with Hirschsprung's diseases or their families and explore candidate genes.",
        "Participants/Materials": "Patients with Hirschsprung's diseases and their families"
      },
      "MOLECULAR DATA": {
        "JGAS000007": {
          "Participants/Materials": "Patients with Hirschsprung's diseases (5 cases) and their families (6 cases)\r\n（Total 4 sets about 11 cases）",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Human All Exon 50 Mb Kit (Agilent)",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000007",
          "Total Data Volume": "113 GB (88 files)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Hiroshi Matsufuji",
        "Affiliation": "Graduate School of Medical and Dental Sciences, Kagoshima University, Graduate School of Medicine",
        "Project / Group Name": "-",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "-",
            "Project Number": "-"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Identification of a novel variant of the RET proto-oncogene in a novel family with Hirschsprung's disease.",
          "DOI": "doi: 10.1007/s00383-017-4134-z",
          "Data Set ID": "JGAD000007"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0008.v1": {
          "Research ID": "hum0008.v1",
          "Release Date": "2018/01/29",
          "Type of Data": "NGS (Exome)",
          "description": "gDNAs extracted from peripheral blood cells of 5 patients with Hirschsprung's diseases and their 6 families were used for exome sequencing analysis (fastq format files). Exons were captured using the SureSelect Human All Exon 50 Mb Kit and multiplex sequence was performed with the Illumina HiSeq 2000 sequencer (100 bp, Paired-end).\nNote:\n"
        }
      }
    }
  },
  "hum0007.v1": {
    "ja": {
      "NBDC Research ID": "hum0007.v1",
      "データ": {
        "JGAS000005": {
          "データID": "JGAS000005",
          "内容": "NGS（RNA-seq）",
          "制限": "制限公開（Type I）",
          "公開日": "2015/02/12"
        }
      },
      "研究内容の概要": {
        "目的": "Th1細胞およびTh17細胞における遺伝子発現を解析することで、自己免疫疾患の原因解明や治療方法の確立を目指す",
        "方法": "AppliedBioSystem SoLiDを使用したRNA-Seq解析",
        "対象": "健常者1名の末梢血から単離したナイーブT細胞、Th1細胞、inactive-Th17、active-Th17",
        "URL": "http://www10.showa-u.ac.jp/~biochem/Biochem/Biochem_top.html"
      },
      "分子データ": {
        "JGAS000005": {
          "対象": "健常者1名（ナイーブT細胞、Th1細胞、inactive-Th17、active-Th17）",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Applied BioSystem [5500 Genetic Analyzer]",
          "ライブラリソース": "ヒト末梢血リンパ球から調整した免疫細胞（ナイーブCD4+ T細胞、Th１細胞、活性化前CD161+Th17 細胞、活性化後CD161+Th17細胞）からRNAを抽出\r\nTh17細胞の活性化については、IL-1βとIL-23を用いたTh17誘導刺激を実施",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Applied BioSystem [SoLiD SAGE Kit]",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "35 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000005",
          "総データ量": "12.16 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "巌本 三壽",
        "所 属 機 関": "昭和大学医学部 生化学教室",
        "プロジェクト/研究グループ名": "ヒトTh17細胞サブセットに関する研究",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "該当なし\r\n ",
            "タイトル": " \r\n ",
            "研究課題番号": ""
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses.",
          "DOI": "doi:10.4049/jimmunol.179.3.1449",
          "データID": "JGAD000005"
        },
        "2": {
          "タイトル": "",
          "DOI": "",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000005"
        }
      },
      "リリース情報": {
        "hum0007.v1": {
          "Research ID": "hum0007.v1",
          "公開日": "2015/02/12",
          "内容": "NGS (RNA-seq)",
          "description": "このバージョンでは、日本人健常人1名からのナイーブT細胞、Th1細胞、活性化Th17細胞、非活性化Th17細胞から抽出したRNAを用いたRNA-seq解析の結果をcsfastaおよびqualフォーマットファイルにて提供する。AppliedBioSystems社のSOLiDキットを用い、AB5500 Genetic Analyzerにて解読した（平均長35塩基）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0007.v1",
      "DATA": {
        "JGAS000005": {
          "Data Set ID": "JGAS000005",
          "Type of Data": "NGS (RNA-seq)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2015/02/12"
        }
      },
      "SUMMARY": {
        "Aims": "To clarify the mechanism of auto-immune diseases and establish the treatment for auto-immune diseases, through analyzing the expression pattarns of Th1 cells and Th17 cells.",
        "Methods": "RNA-Seq by using of AppliedBioSystem SoLiD system",
        "URL": "http://www10.showa-u.ac.jp/~biochem/Biochem/Biochem_top.html"
      },
      "MOLECULAR DATA": {
        "JGAS000005": {
          "Participants/Materials": "One Japanese healthy individual（naïve T cells, CXCR3+Th1 cells, CD161+Th17 cells, and activated Th17 cells）",
          "Targets": "RNA-seq",
          "Target Loci for Captur Methods": "-",
          "Platform": "Applied BioSystem [5500 Genetic Analyzer]",
          "Library Source": "Total RNAs extracted from naïve T cells, CXCR3+Th1 cells, CD161+Th17 cells, and activated Th17 cells of one individual\r\nTh17cells were activated by IL-1β and IL-23",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Applied BioSystem [SoLiD SAGE Kit]",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "35 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000005",
          "Total Data Volume": "12.16 GB",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Sanju Iwamoto",
        "Affiliation": "Department of Biochemistry, Showa University School of Medicine",
        "Project / Group Name": "Research for human Th17 subset",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "-",
            "Title": "",
            "Project Number": ""
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses.",
          "DOI": "doi:10.4049/jimmunol.179.3.1449",
          "Data Set ID": "JGAD000005"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000005"
        }
      },
      "Release Note": {
        "hum0007.v1": {
          "Research ID": "hum0007.v1",
          "Release Date": "2015/02/12",
          "Type of Data": "NGS (RNA-seq)",
          "description": " Total RNAs were extracted from naïve T cells, CXCR3+Th1 cells, CD161+Th17 cells, and activated Th17 cells of one individual, and the sequences were read by using of AB5500 Genetic Analyzer (35bp). The sequences are provided as csfasta or qual format.\nNote:\n"
        }
      }
    }
  },
  "hum0006.v5": {
    "ja": {
      "NBDC Research ID": "hum0006.v5",
      "データ": {
        "JGAS000004": {
          "データID": "JGAS000004",
          "内容": "アストロサイトーマ\r\nNGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2014/01/31"
        },
        "JGAS000004 データ追加": {
          "データID": "JGAS000004 データ追加",
          "内容": "オリゴデンドログリオーマ\r\nNGS（Exome、RNA-seq）、Methylation array",
          "制限": "制限公開（Type I）",
          "公開日": "2017/06/05"
        },
        "JGAS000106": {
          "データID": "JGAS000106",
          "内容": "グリオーマ（小脳・視床・大脳）\r\nNGS（Exome、RNA-seq）、Methylation array",
          "制限": "制限公開（Type I）",
          "公開日": "2017/09/01"
        },
        "JGAS000146": {
          "データID": "JGAS000146",
          "内容": "グリオーマ\r\nNGS（Exome、RNA-seq）、Methylation array",
          "制限": "制限公開（Type I）",
          "公開日": "2019/02/13"
        },
        "JGAS000325": {
          "データID": "JGAS000325",
          "内容": "NGS（Target Capture）",
          "制限": "制限公開（Type I）",
          "公開日": "2022/08/08"
        }
      },
      "研究内容の概要": {
        "目的": "脳腫瘍のゲノム・遺伝子解析とその臨床病理学的意義の解明",
        "方法": "Illumina HiSeq 2000を使用したExome解析、RNA-seq解析、および、メチレーションアレイ解析",
        "対象": "アストロサイトーマ6症例の初発時の腫瘍組織、再発時の腫瘍組織、および、末梢血（非腫瘍組織）",
        "URL": "http://p-direct.jfcr.or.jp/program/group02/team02.html"
      },
      "分子データ": {
        "Exome": {
          "対象": "脳腫瘍：\r\nアストロサイトーマ（ICD10：C71）：6症例（23検体）\r\nオリゴデンドログリオーマ（ICD10：C71）：16症例（48検体）\r\n小脳グリオーマ（ICD10：C71）：17症例 （34検体）\r\nグリオーマ（ICD10：C71）：12症例（腫瘍組織：25検体、非腫瘍組織：12検体）\r\n                                                  初発時と再発時のペア：11症例、初発時のみ1症例",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "初発時・再発時の腫瘍組織（または同じ腫瘍の別の部位の腫瘍組織）および末梢血（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect Human All Exon v.4",
          "断片化の方法": "超音波断片化（Covaris SS）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000004（アストロサイトーマ）\r\nJGAD000106（オリゴデンドログリオーマ）\r\nJGAD000112（小脳グリオーマ）\r\nJGAD000215（初発時グレードII/IIIグリオーマとその再発時腫瘍36検体、ペア正常血液 16検体）\r\nJGAD000218（初発時グレードIVグリオーマとその再発時腫瘍16検体、ペア正常血液8検体）",
          "総データ量": "JGAD000004：375.31 GB（fastq、bam [ref: hg19]）\r\nJGAD000106：885.30 GB（fastq、bam [ref: hg19]）\r\nJGAD000112：506.99 GB（fastq、bam [ref: hg19]）\r\nJGAD000215：1.32 TB（fastq、bam [ref: hg19]）\r\nJGAD000218：552.72 GB（fastq、bam [ref: hg19]）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "RNA-seq": {
          "対象": "オリゴデンドログリオーマ（ICD10：C71）：16症例（27検体）\r\n小脳グリオーマ（ICD10：C71）：14症例（14検体）\r\n大脳グリオーマ（ICD10：C71）：8症例（8検体）\r\nグリオーマ（ICD10：C71）：23症例（31検体）\r\n　　　　初発時のみ：8症例、再発時のみ：7症例、初発時と再発時ペア：8症例",
          "規模": "RNA-seq",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "初発時・再発時の腫瘍組織（または同じ腫瘍の別の部位の腫瘍組織）および末梢血（非腫瘍組織）から抽出したRNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TruSeq Stranded Total RNA Library Prep Kit",
          "断片化の方法": "アルカリ法",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000107（オリゴデンドログリオーマ）\r\nJGAD000113（小脳グリオーマ・大脳グリオーマ）\r\nJGAD000216（初発時グレードII/IIIグリオーマとその再発時ペアを含む31検体）\r\nJGAD000219（初発時グレードIVからの再発8検体）",
          "総データ量": "JGAD000107：239.26 GB（fastq、bam）\r\nJGAD000113：363.23 GB（fastq、bam）\r\nJGAD000216：302.43 GB（fastq、bam）\r\nJGAD000219：96.94 GB（fastq、bam）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "Methylation array": {
          "対象": "オリゴデンドログリオーマ（ICD10：C71）：16症例（30検体）\r\n小脳グリオーマ（ICD10：C71）：17症例（17検体）\r\n視床グリオーマ（ICD10：C71）：14症例（14検体）\r\nグリオーマ（ICD10：C71）：93症例（113検体）\r\n　　　　　初発時のみ：69症例、再発時のみ：4症例、初発時と再発時ペア：20症例",
          "規模": "メチル化アレイ",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HumanMethylation 450 BeadChip]",
          "ソース": "初発時・再発時の腫瘍組織（または同じ腫瘍の別の部位の腫瘍組織）および末梢血（非腫瘍組織）から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "調整試薬（キット名、バージョン）": "Illumina HumanMethylation450 BeadChip kit",
          "メチル化率決定アルゴリズム（ソフトウェア）": "Genome Studio v2010.3",
          "フィルタリング": "HumanMethylation450_15017482_v1.1 （bpm）",
          "プローブ数(QC後)": "485577 methylation sites",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000108（オリゴデンドログリオーマ）\r\nJGAD000114（小脳グリオーマ・視床グリオーマ）\r\nJGAD000217（初発時グレードII/IIIグリオーマとその再発時ペアを含む113検体）",
          "総データ量": "JGAD000108：139.75 MB（txt）\r\nJGAD000114：154.82 MB（txt）\r\nJGAD000217：398.82 MB（txt）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000325": {
          "対象": "脳海綿状血管奇形（ICD10：D180）：12症例\r\n椎体血管腫（ICD10：D180）：1症例\r\n眼窩内海綿状血管奇形（ICD10：D180）：3症例\r\n　　　各症例の病変組織および末梢血、計32検体",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "6110遺伝子領域",
          "Platform": "Illumina [HiSeq 2500]",
          "ライブラリソース": "病変組織および末梢血より抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent SureSelect XT Focused Exome target enrichment kit",
          "断片化の方法": "超音波断片化（Covaris E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000436",
          "総データ量": "193.9 GB （fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "斉藤 延人",
        "所 属 機 関": "東京大学 医学部 脳神経外科",
        "プロジェクト/研究グループ名": "次世代がん研究シーズ戦略的育成プログラム/がん臨床シーズ育成グループ",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（B)",
            "タイトル": "新規血管奇形原因遺伝子による疾患発症メカニズムの解明",
            "研究課題番号": "21H03041"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma",
          "DOI": "doi:10.1126/science.1239947",
          "データID": "JGAD000004"
        },
        "2": {
          "タイトル": "Genetic and epigenetic stability of oligodendrogliomas at recurrence",
          "DOI": "doi: 10.1186/s40478-017-0422-z",
          "データID": "JGAD000106-JGAD000108"
        },
        "3": {
          "タイトル": "Distinct molecular profile of diffuse cerebellar gliomas",
          "DOI": "doi: 10.1007/s00401-017-1771-1",
          "データID": "JGAD000112-JGAD000114"
        },
        "4": {
          "タイトル": "DNA demethylation is associated with malignant progression of lower-grade gliomas",
          "DOI": "doi: 10.1038/s41598-019-38510-0",
          "データID": "JGAD000215-JGAD000219"
        },
        "5": {
          "タイトル": "Somatic GJA4 gain-of-function mutation in orbital cavernous venous malformations",
          "DOI": "doi: 10.1007/s10456-022-09846-5",
          "データID": "JGAD000436"
        }
      },
      "制限公開データの利用者一覧": {
        "浜田 道昭": {
          "研究代表者": "浜田 道昭",
          "所属機関": "早稲田大学 理工学術院",
          "研究題目": "日本",
          "利用データID": "RNA標的創薬データベースの構築",
          "利用期間": "JGAD000107JGAD000113JGAD000216JGAD000219"
        },
        "Frank Attenello": {
          "研究代表者": "Frank Attenello",
          "所属機関": "Keck School of Medicine of USC",
          "研究題目": "アメリカ合衆国",
          "利用データID": "Examining the role of a novel long noncoding RNA, linc02454, in resistance of glioblastoma to temozolomide",
          "利用期間": "JGAD000215-JGAD000219"
        }
      },
      "リリース情報": {
        "hum0006.v5": {
          "Research ID": "hum0006.v5",
          "公開日": "2022/08/08",
          "内容": "NGS （Target Capture）",
          "description": "このバージョンでは、脳海綿状血管奇形12症例、椎体血管腫1症例、眼窩内海綿状血管奇形3症例の病変組織および末梢血より抽出したDNAを用いた6110遺伝子領域のTarget Capture Sequencing解析の結果をfastqファイルにて提供する。\n"
        },
        "hum0006.v4": {
          "Research ID": "hum0006.v4",
          "公開日": "2019/02/13",
          "内容": "NGS （Exome、RNA-seq）、Methylation array",
          "description": "このバージョンでは、グリオーマ94症例（114検体）を対象とした以下の解析結果を追加した（JGAS000146）。\n・ Exome（JGAD000215、JGAD000218）： グリオーマ：12症例（腫瘍組織：25検体、非腫瘍組織：12検体）\n    腫瘍組織および末梢血（非腫瘍組織）から抽出したDNAを対象としてSureSelect Human All Exon v.4を用いてExon領域にしぼり、Illumina 社 HiSeq 2000にて平均長100塩基を解読した（Paired-end）。\n・ RNA-seq（JGAD000216、JGAD000219）： グリオーマ：23症例（31検体）\n    腫瘍組織から抽出したRNAを対象としてTruSeq Stranded Total RNA Library Prep KitによるRNAライブラリ作製後、Illumina社HiSeq 2000にて平均長100塩基を解読した（Paired-end）。\n・ Methylation array（JGAD000217）： グリオーマ：93症例（113検体）\n    腫瘍組織から抽出したDNAを対象としてIllumina社HumanMethylation 450 BeadChipにてメチル化解析を行った。\n"
        },
        "hum0006.v3": {
          "Research ID": "hum0006.v3",
          "公開日": "2017/09/01",
          "内容": "NGS （Exome、RNA-seq）、Methylation array",
          "description": "このバージョンでは、グリオーマ（小脳17症例、視床14症例、大脳8症例）を対象とした以下の解析結果を追加した（JGAS000106）。\n・ Exome： 小脳グリオーマ：17症例（34検体）\n    腫瘍組織および末梢血（非腫瘍組織）から抽出したDNAを対象としてSureSelect Human All Exon v.4を用いてExon領域にしぼり、Illumina 社 HiSeq 2000にて平均長100塩基を解読した（Paired-end）。\n・ RNA-seq： 小脳グリオーマ17症例（17検体）および大脳グリオーマ8症例（8検体）\n    腫瘍組織から抽出したRNAを対象としてTruSeq Stranded Total RNA Library Prep KitによるRNAライブラリ作製後、Illumina社HiSeq 2000にて平均長100塩基を解読した（Paired-end）。\n・ Methylation array： 小脳グリオーマ17症例（17検体）および視床グリオーマ14症例（14検体）\n    腫瘍組織から抽出したDNAを対象としてIllumina社HumanMethylation 450 BeadChipにてメチル化解析を行った。\n"
        },
        "hum0006.v2": {
          "Research ID": "hum0006.v2",
          "公開日": "2017/06/05",
          "内容": "NGS （Exome、RNA-seq）、Methylation array",
          "description": "このバージョンでは、オリゴデンドログリオーマ16症例を対象とした以下の解析結果をJGAS000004に追加した。\n・ Exome： 48検体\n    腫瘍組織および末梢血（非腫瘍組織）から抽出したDNAを対象としてSureSelect Human All Exon v.4を用いてExon領域にしぼり、Illumina 社 HiSeq 2000にて平均長100塩基を解読した（Paired-end）。\n・ RNA-seq： 27検体\n    腫瘍組織から抽出したRNAを対象としてTruSeq Stranded Total RNA Library Prep KitによるRNAライブラリ作製後、Illumina社HiSeq 2000にて平均長100塩基を解読した（Paired-end）\n・ Methylation array： 30検体\n    腫瘍組織から抽出したDNAを対象としてIllumina社HumanMethylation 450 BeadChipにてメチル化解析を行った。\n"
        },
        "hum0006.v1": {
          "Research ID": "hum0006.v1",
          "公開日": "2014/01/31",
          "内容": "NGS （Exome）",
          "description": "このバージョンでは、アストロサイトーマ6症例の初発時・再発時の腫瘍組織および末梢血（非腫瘍組織）から抽出したDNAを用いたExome解析の結果をbamファイルにて提供する。SureSelect Human All Exon v.4を用いてExon領域にしぼり、Illumina 社 HiSeq 2000にて平均長100塩基を解読した（Paired-end）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0006.v5",
      "DATA": {
        "JGAS000004": {
          "Data Set ID": "JGAS000004",
          "Type of Data": "astrocytoma\r\nNGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2014/01/31"
        },
        "JGAS000004 data addition": {
          "Data Set ID": "JGAS000004 data addition",
          "Type of Data": "oligodendroglioma\r\nNGS (Exome, RNA-seq), Methylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/06/05"
        },
        "JGAS000106": {
          "Data Set ID": "JGAS000106",
          "Type of Data": "gliomas (diffuse cerebellar glioma, cerebral glioblastoma, thalamic glioma)\r\nNGS (Exome, RNA-seq), Methylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/09/01"
        },
        "JGAS000146": {
          "Data Set ID": "JGAS000146",
          "Type of Data": "gliomas\r\nNGS (Exome, RNA-seq), Methylation array",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/02/13"
        },
        "JGAS000325": {
          "Data Set ID": "JGAS000325",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2022/08/08"
        }
      },
      "SUMMARY": {
        "Aims": "The identification of genomic/genetic alterations in brain tumors (gliomas) and analysis of their clinicopathological significance.",
        "Methods": "Exome sequencing, RNA sequencing and Methylation array were performed. Matched normal DNA was also used for Exome sequencing.",
        "Participants/Materials": "",
        "URL": "http://p-direct.jfcr.or.jp/english/"
      },
      "MOLECULAR DATA": {
        "Exome": {
          "Participants/Materials": "astrocytoma (ICD10: C71): 6 cases (23 samples) \r\noligodendroglioma (ICD10: C71): 16 cases (48 samples) \r\ndiffuse cerebellar glioma (ICD10: C71): 17 cases (34 samples) \r\nglioma (ICD10: C71): 12 cases (25 tumor samples, 12 non-tumor samples)\r\n                                   11 pairs of primary-recurrent gliomas and 1 primary glioma",
          "Targets": "Exome",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "DNAs extracted from surgical specimen of brain tumors (primary and matched recurrent samples) and paired normal peripheral blood cells.",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect Human All Exon v.4",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris SS)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000004 (astrocytoma)\r\nJGAD000106 (oligodendroglioma)\r\nJGAD000112 (diffuse cerebellar glioma)\r\nJGAD000215 (primary grade II/III gliomas and their recurrent tumors; 36 samples, matched normal blood; 16 samples)\r\nJGAD000218 (primary grade IV gliomas and their recurrent tumors; 16 samples, matched normal blood; 8 samples)",
          "Total Data Volume": "JGAD000004: 375.31 GB (fastq, bam [reference: hg19])\r\nJGAD000106: 885.30 GB (fastq, bam [reference: hg19])\r\nJGAD000112: 506.99 GB (fastq, bam [reference: hg19])\r\nJGAD000215: 1.32 TB (fastq, bam [reference: hg19])\r\nJGAD000218: 552.72 GB (fastq, bam [reference: hg19])",
          "Comments (Policies)": "NBDC policy"
        },
        "RNA-seq": {
          "Participants/Materials": "oligodendroglioma (ICD10: C71): 16 cases (27 samples)\r\ndiffuse cerebellar glioma (ICD10: C71): 14 cases (14 samples)\r\ncerebral glioblastoma (ICD10: C71): 8 cases (8 samples)\r\nglioma (ICD10: C71): 24 cases (31 samples)\r\n       8 pairs of primary-recurrent gliomas, 8 primary gliomas, and 7 recurrent gliomas",
          "Targets": "RNA-seq",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "RNAs extracted from surgical specimen of brain tumors (primary and matched recurrent samples) and paired normal peripheral blood cells.",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TruSeq Stranded Total RNA Library Prep Kit",
          "Fragmentation Methods": "Alkalization",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000107\r\nJGAD000113 (diffuse cerebellar glioma, cerebral glioblastoma)\r\nJGAD000216 (gliomas including primary grade II/III gliomas and their recurrent tumors; 31 samples)\r\nJGAD000219 (recurrent tumors of primary grade IV gliomas; 8 samples)",
          "Total Data Volume": "JGAD000107: 239.26 GB (bam, fastq）\r\nJGAD000113: 363.23 GB (bam, fastq）\r\nJGAD000216: 302.43 GB (bam, fastq）\r\nJGAD000219: 96.94 GB (bam, fastq）",
          "Comments (Policies)": "NBDC policy"
        },
        "Methylation array": {
          "Participants/Materials": "oligodendroglioma (ICD10: C71): 16 cases (30 samples)\r\ndiffuse cerebellar glioma (ICD10: C71): 17 cases (17 samples)\r\nthalamic glioma (ICD10: C71): 14 cases (14 samples)\r\nglioma (ICD10: C71): 93 cases (113 samples)\r\n20 pairs of primary-recurrent gliomas, 69 primary gliomas, and 4 recurrent gliomas",
          "Targets": "Methylation array",
          "Target Loci for Capture Methods": "-",
          "Platform": "Illumina [HumanMethylation 450 BeadChip]",
          "Library Source": "DNAs extracted from surgical specimen of brain tumors (primary and matched recurrent samples) and paired normal peripheral blood cells.",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Illumina HumanMethylation450 BeadChip kit",
          "Algorithms for Calculating Methylation-rate (software)": "Genome Studio v2010.3",
          "Filtering Methods": "HumanMethylation450_15017482_v1.1 (bpm)",
          "Probe Number (after QC)": "485577 methylation sites",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000108\r\nJGAD000114 (diffuse cerebellar glioma, thalamic glioma)\r\nJGAD000217 (gliomas including primary grade II/III tumors and their recurrent tumors; 113 samples)",
          "Total Data Volume": "JGAD000108: 139.75 MB (txt)\r\nJGAD000114: 154.82 MB (txt)\r\nJGAD000217: 398.82 MB (txt)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000325": {
          "Participants/Materials": "cerebral cavernous malformation (ICD10：D180): 12 cases\r\nvertebral hemangioma (ICD10：D180): 1 cases\r\norbital cavernous malformation (ICD10：D180): 3 cases\r\n　　vascular malformation samples, respective paired peripheral blood samples (total 32 samples)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "6110 target genes",
          "Platform": "Illumina [HiSeq 2500]",
          "Library Source": "DNAs extracted from vascular malformation samples and respective paired peripheral blood samples",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent SureSelect XT Focused Exome target enrichment kit",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris E220)",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000436",
          "Total Data Volume": "193.9 GB (fastq)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Nobuhito Saito",
        "Affiliation": "Department of Neurosurgery, The University of Tokyo",
        "Project / Group Name": "Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)",
        "Funds / Grants (Research Project Number)": {
          "2": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Analysis of novel vascular malformation causative gene",
            "Project Number": "21H03041"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma",
          "DOI": "doi:10.1126/science.1239947",
          "Data Set ID": "JGAD000004"
        },
        "2": {
          "Title": "Genetic and epigenetic stability of oligodendrogliomas at recurrence",
          "DOI": "doi: 10.1186/s40478-017-0422-z",
          "Data Set ID": "JGAD000106-JGAD000108"
        },
        "3": {
          "Title": "Distinct molecular profile of diffuse cerebellar gliomas",
          "DOI": "doi: 10.1007/s00401-017-1771-1",
          "Data Set ID": "JGAD000112-JGAD000113"
        },
        "4": {
          "Title": "DNA demethylation is associated with malignant progression of lower-grade gliomas",
          "DOI": "doi: 10.1038/s41598-019-38510-0",
          "Data Set ID": "JGAD000215-JGAD000219"
        },
        "5": {
          "Title": "Somatic GJA4 gain-of-function mutation in orbital cavernous venous malformations",
          "DOI": "doi: 10.1007/s10456-022-09846-5",
          "Data Set ID": "JGAD000436"
        }
      },
      "USERS (Controlled-Access Data)": {
        "Michiaki Hamada": {
          "Principal Investigator": "Michiaki Hamada",
          "Affiliation": "Faculty of Science and Engineering, Waseda University",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Construction of RNA-targeted Drug Discovery Database",
          "Period of Data Use": "JGAD000107JGAD000113JGAD000216JGAD000219"
        },
        "Frank Attenello": {
          "Principal Investigator": "Frank Attenello",
          "Affiliation": "Keck School of Medicine of USC",
          "Research Title": "United States of America",
          "Data in Use (Dataset ID)": "Examining the role of a novel long noncoding RNA, linc02454, in resistance of glioblastoma to temozolomide",
          "Period of Data Use": "JGAD000215-JGAD000219"
        }
      },
      "Release Note": {
        "hum0006.v5": {
          "Research ID": "hum0006.v5",
          "Release Date": "2022/08/08",
          "Type of Data": "NGS (Target Capture)",
          "description": "DNAs extracted from 12 cerebral cavernous malformations, 1 vertebral hemangioma, 3 orbital cavernous malformations and respective paired peripheral blood samples were used for the target capture sequencing analysis. Fastq files are provided. \n"
        },
        "hum0006.v4": {
          "Research ID": "hum0006.v4",
          "Release Date": "2019/02/13",
          "Type of Data": "NGS (Exome, RNA-seq), Methylation array",
          "description": " Analysis data about 94 gliomas (114 samples) were added (JGAS000146).\n• Exome (JGAD000215, JGAD000218) : glioma: 12 cases (25 tumor samples, 12 non-tumor samples)\n     DNAs extracted from gliomas and peripheral blood were used for the whole exome sequencing. Exons were narrowed down by using of SureSelect Human All Exon v.4 and read by Illumina HiSeq 2000 (paired-end: 100 bp)\n• RNA-seq (JGAD000216, JGAD000219) : glioma: 23 cases (31 samples)\n     RNAs extracted from gliomas were used for RNA-seq. RNA liberally builded using TruSeq Stranded Total RNA Library Prep Kit and read by Illumina HiSeq 2000 (paired-end: 100 bp)\n• Methylation array (JGAD000217) : glioma: 93 cases (113 samples)\n    DNAs extracted from gliomas were performed with methylation analysis using Illumina HumanMethylation 450 BeadChip.\n"
        },
        "hum0006.v3": {
          "Research ID": "hum0006.v3",
          "Release Date": "2017/09/01",
          "Type of Data": "NGS (Exome, RNA-seq), Methylation array",
          "description": " Analysis data about 39 gliomas (17 diffuse cerebellar gliomas, 14 cerebral glioblastomas, 8 thalamic gliomas) were added (JGAS000106).\n• Exome: diffuse cerebellar glioma (ICD10:C71): 17 cases (34 samples)\n     DNAs extracted from brain tumors (diffuse cerebellar gliomas, cerebral glioblastomas, thalamic gliomas) and peripheral blood were used for the whole exome sequencing. Exons were narrowed down by using of SureSelect Human All Exon v.4 and read by Illumina HiSeq 2000 (paired-end: 100 bp)\n• RNA-seq: diffuse cerebellar glioma: 14 cases (14 samples), cerebral glioblastoma: 8 cases (8 samples)\n     RNAs extracted from brain tumors (diffuse cerebellar glioma, cerebral glioblastoma) were used for RNA-seq (bam and fastq). RNA liberally builded using TruSeq Stranded Total RNA Library Prep Kit and read by Illumina HiSeq 2000 (paired-end: 100 bp)\n• Methylation array: diffuse cerebellar glioma: 17 cases (17 samples), thalamic glioma: 14 cases (14 samples)\n    DNAs extracted from brain tumors (diffuse cerebellar glioma, thalamic glioma) were performed with methylation analysis using Illumina HumanMethylation 450 BeadChip.\n"
        },
        "hum0006.v2": {
          "Research ID": "hum0006.v2",
          "Release Date": "2017/06/05",
          "Type of Data": "NGS (Exome, RNA-seq), Methylation array",
          "description": " Analysis data about 16 oligodendrogliomas were added to JGAS000004.\n• Exome: 48 samples\n     DNAs extracted from brain tumors (oligodendrogliomas) and peripheral blood were used for the whole exome sequencing. Exons were narrowed down by using of SureSelect Human All Exon v.4 and read by Illumina HiSeq 2000 (paired-end: 100 bp)\n• RNA-seq: 27 samples\n     RNAs extracted from brain tumors (oligodendrogliomas) were used for RNA-seq (bam and fastq). RNA liberally builded using TruSeq Stranded Total RNA Library Prep Kit and read by Illumina HiSeq 2000 (paired-end: 100 bp)\n• Methylation array: 30 samples\n    DNAs extracted from brain tumors (oligodendrogliomas) were performed with methylation analysis using Illumina HumanMethylation 450 BeadChip.\n"
        },
        "hum0006.v1": {
          "Research ID": "hum0006.v1",
          "Release Date": "2014/01/31",
          "Type of Data": "NGS (Exome)",
          "description": " DNAs extracted from brain tumors (6 astrocytomas) and peripheral blood were used for the whole exome sequencing (bam files). Exons were narrowed down by using of SureSelect Human All Exon v.4 and read by Illumina HiSeq 2000 (paired-end: 100 bp)\nNote:\n"
        }
      }
    }
  },
  "hum0005.v8": {
    "ja": {
      "NBDC Research ID": "hum0005.v8",
      "データ": {
        "DRA001273": {
          "データID": "DRA001273",
          "内容": "NGS (Target Capture)",
          "制限": "非制限公開",
          "公開日": "2014/01/27"
        },
        "JGAS000032": {
          "データID": "JGAS000032",
          "内容": "NGS (Target Capture)",
          "制限": "制限公開（Type I）",
          "公開日": "2017/02/24"
        },
        "DRA003791": {
          "データID": "DRA003791",
          "内容": "NGS (Target Capture)",
          "制限": "非制限公開",
          "公開日": "2017/02/24"
        },
        "JGAS000093": {
          "データID": "JGAS000093",
          "内容": "NGS (Target Capture)",
          "制限": "制限公開（Type I）",
          "公開日": "2017/06/19"
        },
        "JGAS000123": {
          "データID": "JGAS000123",
          "内容": "NGS (Target Capture)\r\n69遺伝子領域・90遺伝子領域",
          "制限": "制限公開（Type I）",
          "公開日": "2018/02/13"
        },
        "JGAS000166": {
          "データID": "JGAS000166",
          "内容": "NGS (Target Capture)\r\n69遺伝子領域・90遺伝子領域",
          "制限": "制限公開（Type I）",
          "公開日": "2019/04/18"
        },
        "JGAS000191": {
          "データID": "JGAS000191",
          "内容": "NGS (Target Capture)",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/30"
        },
        "JGAS000192": {
          "データID": "JGAS000192",
          "内容": "NGS (Target Capture)\r\n69遺伝子領域・63遺伝子領域・90遺伝子領域",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/30"
        },
        "JGAS000200": {
          "データID": "JGAS000200",
          "内容": "NGS (Target Capture)",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/30"
        },
        "JGAS000201": {
          "データID": "JGAS000201",
          "内容": "NGS (Target Capture)\r\n69遺伝子領域・63遺伝子領域・90遺伝子領域",
          "制限": "制限公開（Type I）",
          "公開日": "2021/07/30"
        },
        "JGAS000323": {
          "データID": "JGAS000323",
          "内容": "NGS (Target Capture)\r\n69遺伝子領域・63遺伝子領域・90遺伝子領域",
          "制限": "制限公開（Type I）",
          "公開日": "2021/11/19"
        },
        "JGAS000490": {
          "データID": "JGAS000490",
          "内容": "NGS (Target Capture)\r\n69遺伝子領域・63遺伝子領域",
          "制限": "制限公開（Type I）",
          "公開日": "2023/10/02"
        }
      },
      "研究内容の概要": {
        "目的": "様々な難聴および外耳・中耳・内耳奇形の原因遺伝子変異の解明と臨床診断への応用",
        "方法": "既知の難聴関連遺伝子領域の塩基配列を、Ion PGM、Ion Proton、HiSeq 2000、IonS5を用いて決定する",
        "対象": "症候群性難聴（Usher症候群）：17症例",
        "URL": "http://www.shinshu-jibi.jp/specialty/specialty01"
      },
      "分子データ": {
        "DRA001273": {
          "対象": "症候群性難聴（Usher症候群）：17症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "9遺伝子領域\r\n(MYO7A, USH1C, CDH23, PCDH15, SANS[USH1G],\r\nUSH2A, GPR98[USH2C], DFNB31[USH2D], CLRN[USH3A])",
          "Platform": "Thermo Fisher Scientific [Ion PGM]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Custom kit",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "DDBJ Sequence Read Archive ID": "DRA001273",
          "総データ量": "726.6 MB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000032、JGAS000093、JGAS000123、JGAS000166、JGAS000191、JGAS000192、JGAS000201、JGAS000323、JGAS000490": {
          "対象": "非症候群性難聴（ICD10：H90）：39症例（JGAS000032）に19症例（JGAS000093）、16症例（JGAS000123）、37症例（JGAS000166）、1症例（JGAS000191）、9症例（JGAS000192）（1症例はJGAS000032と重複）、7症例（JGAS000201）、3症例（JGAS000323）、および1410症例（JGAS000490）追加",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "69遺伝子領域\r\n(ACTG1, CABP2, CCDC50, CDH23, CEACAM16, CIB2, CLDN14, \r\nCOCH, COL11A2, COL4A6, CRYM, DFNA5, DFNB59, DIAPH1, \r\nESPN, ESRRB, EYA4, GIPC3, GJB2, GJB3, GJB6, GPSM2, GRHL2, \r\nGRXCR1, HGF, ILDR1, KARS, KCNQ4, LHFPL5, LOXHD1, LRTOMT, \r\nMARVELD2, MIRN96, MSRB3, MYH14, MYH9, MYO15A, MYO1A, \r\nMYO3A, MYO6, MYO7A, OTOA, OTOF, PCDH15, PNPT1, POU3F4, \r\nPOU4F3, PRPS1, PTPRQ, RDX, SERPINB6, SLC17A8, SLC26A4, \r\nSLC26A5, SMAC, SMPX, STRC, TECTA, TJP2, TMC1, TMIE, \r\nTMPRSS3, TPRN, TRIOBP, USH1C, USH2A, WFS1, WHRN)",
          "Platform": "Thermo Fisher Scientific [Ion PGM、Ion Proton]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Custom Panel, Ion AmpliSeq Library Kit ver 2.0",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000032\r\nJGAD000093\r\nJGAD000134\r\nJGAD000244\r\nJGAD000274\r\nJGAD000275\r\nJGAD000286\r\nJGAD000434\r\nJGAD000607",
          "総データ量": "JGAD000032：13.73 GB（fastq）\r\nJGAD000093：6 GB（fastq）\r\nJGAD000134：18 GB（fastq）\r\nJGAD000244：18 GB（fastq）\r\nJGAD000274：292 MB（fastq）\r\nJGAD000275：14.3 GB（fastq）\r\nJGAD000286：57 GB（fastq）\r\nJGAD000434：8.8 GB（fastq）\r\nJGAD000607：1.1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "DRA003791": {
          "対象": "非症候群性難聴（ICD10：H90）：5症例",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "69遺伝子領域\r\n(ACTG1, CABP2, CCDC50, CDH23, CEACAM16, CIB2, CLDN14, \r\nCOCH, COL11A2, COL4A6, CRYM, DFNA5, DFNB59, DIAPH1, \r\nESPN, ESRRB, EYA4, GIPC3, GJB2, GJB3, GJB6, GPSM2, GRHL2, \r\nGRXCR1, HGF, ILDR1, KARS, KCNQ4, LHFPL5, LOXHD1, LRTOMT, \r\nMARVELD2, MIRN96, MSRB3, MYH14, MYH9, MYO15A, MYO1A, \r\nMYO3A, MYO6, MYO7A, OTOA, OTOF, PCDH15, PNPT1, POU3F4, \r\nPOU4F3, PRPS1, PTPRQ, RDX, SERPINB6, SLC17A8, SLC26A4, \r\nSLC26A5, SMAC, SMPX, STRC, TECTA, TJP2, TMC1, TMIE, \r\nTMPRSS3, TPRN, TRIOBP, USH1C, USH2A, WFS1, WHRN)",
          "Platform": "Thermo Fisher Scientific [Ion PGM]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Custom Panel, Ion AmpliSeq Library Kit ver 2.0",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "DDBJ Sequence Read Archive ID": "DRA003791",
          "総データ量": "412.5 MB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000123、JGAS000166、JGAS000192、JGAS000201、JGAS000323": {
          "対象": "非症候群性難聴（ICD10：H90）：3症例（JGAS000123）に2症例（JGAS000166）、2症例（JGAS000192）、4症例（JGAS000201）、および1症例（JGAS000323）追加",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "90遺伝子領域\r\n(ACTG1, AIFM1, ALMS1, ATP2B2, CABP2, CACNA1D, CATSPER2, \r\nCCDC50, CDH23, CEACAM16, CIB2, CLDN14, CLRN1, COCH, \r\nCOL11A2, CRYL1, CRYM, DFNA5, DIABLO, DIAPH1, DSPP, ESPN, \r\nESSRB, EYA1, EYA4, FOXI1, GIPC3, GJB2, GJB3, GJB6, GPR98, \r\nGPSM2, GRHL2, GRXCR1, HGF, ILDR1, KCNJ10, KCNQ1, KCNQ4, \r\nLHFPL5, LOXHD1, LRTOMT, MARVELD2, MSRB3, MYH14, MYH9, \r\nMYO15A, MYO1A, MYO3A, MYO6, MYO7A, OTOA, OTOF, OTOG, \r\nOTOGL, P2RX2, PCDH15, PDZD7, PJVK, PNPT1, POU3F4, \r\nPOU4F3, PRPS1, PTPRQ, RDX, SERPINB6, SIX1, SLC17A8, \r\nSLC26A4, SLC26A5, SMPX, STRC, TECTA, TJP2, TMC1, TMIE, \r\nTMPRSS3, TPRN, TRIOBP, TSPEAR, USH1C, USH1G, USH2A, \r\nWFS1, WHRN, MIR96, MIR182, MIR183, MTRNR1, MTTS1)",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Agilent Sure Select XT",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000134\r\nJGAD000244\r\nJGAD000275\r\nJGAD000286\r\nJGAD000434",
          "総データ量": "JGAD000134：18 GB（fastq）\r\nJGAD000244：18 GB（fastq）\r\nJGAD000275：14.3 GB（fastq）\r\nJGAD000286：57 GB（fastq）\r\nJGAD000434：8.8 GB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        },
        "JGAS000192、JGAS000200、JGAS000201、JGAS000323、JGAS000490": {
          "対象": "非症候群性難聴（ICD10：H90）：17症例（JGAS000192）、7症例（JGAS000200）、15症例（JGAS000201）に11症例（JGAS000323）および1559症例（JGAS000490）追加",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "63遺伝子領域\r\n（ACTG1, CCDC50, CDH23, CEACAM16, CLDN14, COCH, \r\nCOL11A2, CRYM, DFNA5, DFNB59, DIAPH1, ESPN, ESRRB, \r\nEYA4, GIPC3, GJB2, GJB3, GJB6, GPSM2, GRHL2, GRXCR1, \r\nHGF, ILDR1, KCNQ4, LHFPL5, LOXHD1, LRTOMT, MARVELD2, \r\nMIRN96, MSRB3, MYH14, MYH9, MYO15A, MYO1A, MYO3A, \r\nMYO6, MYO7A, OTOA, OTOF, PCDH15, POU3F4, POU4F3, \r\nPRPS1, PTPRQ, RDX, SERPINB6, SLC17A8, SLC26A4, \r\nSLC26A5, SMAC, SMPX, STRC, TECTA, TJP2, TMC1, TMIE, \r\nTMPRSS3, TPRN, TRIOBP, USH1C, USH2A, WFS1, WHRN）",
          "Platform": "Thermo Fisher Scientific [Ion PGM、Ion Proton、IonS5]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "Ion AmpliSeq Custom Panel, Ion AmpliSeq Library Kit ver 2.0",
          "断片化の方法": "-",
          "ライブラリ構築方法": "Single-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "200 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000275\r\nJGAD000285\r\nJGAD000286\r\nJGAD000434\r\nJGAD000607",
          "総データ量": "JGAD000275：14.3 GB（fastq）\r\nJGAD000285：2 GB（fastq）\r\nJGAD000286：57 GB（fastq）\r\nJGAD000434：8.8 GB（fastq）\r\nJGAD000607：1.1 TB（fastq）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "宇佐美 真一",
        "所 属 機 関": "信州大学 医学部 人工聴覚器学講座",
        "科研費/助成金（Research Project Number）": {
          "10": {
            "科研費・助成金名": "日本医療研究開発機構（AMED） 難治性疾患実用化研究事業",
            "タイトル": "症候群性難聴の診療ガイドライン改定に向けた診断・治療エビデンスの創出",
            "研究課題番号": "JP21ek0109542"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1.",
          "DOI": "doi: 10.1371/journal.pone.0090688",
          "データID": "DRA001273"
        },
        "2": {
          "タイトル": "An effective screening strategy for deafness in combination with a next-generation sequencing platform: a consecutive analysis.",
          "DOI": "doi: 10.1038/jhg.2015.143",
          "データID": "JGAD000032"
        },
        "3": {
          "タイトル": "Frequency of Usher syndrome type 1 in deaf children by massively parallel DNA sequencing.",
          "DOI": "doi: 10.1038/jhg.2015.168",
          "データID": "DRA003791"
        },
        "4": {
          "タイトル": "POU4F3 mutation screening in Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis identified novel variants associated with autosomal dominant hearing loss",
          "DOI": "doi: 10.1371/journal.pone.0177636",
          "データID": "JGAD000093\r\nJGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "5": {
          "タイトル": "WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis.",
          "DOI": "doi: 10.1371/journal.pone.0193359",
          "データID": "JGAD000134（69遺伝子領域・90遺伝子領域）\r\nJGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "6": {
          "タイトル": "OTOF mutation analysis with massively parallel DNA sequencing in 2,265 Japanese sensorineural hearing loss patients.",
          "DOI": "doi: 10.1371/journal.pone.0215932",
          "データID": "JGAD000244（69遺伝子領域・90遺伝子領域）\r\nJGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "7": {
          "タイトル": "Detailed Clinical Features of Deafness Caused by a Claudin-14 Variant.",
          "DOI": "doi: 10.3390/ijms20184579",
          "データID": "JGAD000274"
        },
        "8": {
          "タイトル": "Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.",
          "DOI": "doi: 10.3390/genes10100735",
          "データID": "JGAD000275（69遺伝子領域・63遺伝子領域・90遺伝子領域）"
        },
        "9": {
          "タイトル": "Mid-Frequency Hearing Loss Is Characteristic Clinical Feature of OTOA-Associated Hearing Loss.",
          "DOI": "doi: 10.3390/genes10090715",
          "データID": "JGAD000285"
        },
        "10": {
          "タイトル": "The Prevalence and Clinical Characteristics of TECTA-Associated Autosomal Dominant Hearing Loss.",
          "DOI": "doi: 10.3390/genes10100744",
          "データID": "JGAD000286（69遺伝子領域・63遺伝子領域・90遺伝子領域）"
        },
        "11": {
          "タイトル": "Prevalence and Clinical Characteristics of Hearing Loss Caused by MYH14 Variants.",
          "DOI": "doi: 10.3390/genes12101623",
          "データID": "JGAD000434（69遺伝子領域・63遺伝子領域・90遺伝子領域）"
        },
        "12": {
          "タイトル": "Simple and efficient germline copy number variant visualization method for the Ion AmpliSeq™ custom panel.",
          "DOI": "doi: 10.1002/mgg3.399",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "13": {
          "タイトル": "The Clinical Next-Generation Sequencing Database: A Tool for the Unified Management of Clinical Information and Genetic Variants to Accelerate Variant Pathogenicity Classification.",
          "DOI": "doi: 10.1002/humu.23160",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "14": {
          "タイトル": "Frequency and clinical features of hearing loss caused by STRC deletions.",
          "DOI": "doi: 10.1038/s41598-019-40586-7",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "15": {
          "タイトル": "Diagnostic pitfalls for GJB2-related hearing loss: A novel deletion detected by Array-CGH analysis in a Japanese patient with congenital profound hearing loss.",
          "DOI": "doi: 10.1002/ccr3.1800",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "16": {
          "タイトル": "Sensorineural hearing loss and mild cardiac phenotype caused by an EYA4 mutation.",
          "DOI": "doi: 10.1038/s41439-018-0023-9",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "17": {
          "タイトル": "Frequency of the STRC-CATSPER2 deletion in STRC-associated hearing loss patients.",
          "DOI": "doi: 10.1038/s41598-021-04688-5",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "18": {
          "タイトル": "Variants in CDH23 cause a broad spectrum of hearing loss: from non-syndromic to syndromic hearing loss as well as from congenital to age-related hearing loss.",
          "DOI": "doi: 10.1007/s00439-022-02431-2",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "19": {
          "タイトル": "Genetic background in late-onset sensorineural hearing loss patients.",
          "DOI": "doi: 10.1038/s10038-021-00990-2",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "20": {
          "タイトル": "The genetic etiology of hearing loss in Japan revealed by the social health insurance-based genetic testing of 10K.",
          "DOI": "doi: 10.1007/s00439-021-02371-3",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "21": {
          "タイトル": "Detailed clinical features and genotype-phenotype correlation in an OTOF-related hearing loss cohort in Japan.",
          "DOI": "doi: 10.1007/s00439-021-02351-7",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "22": {
          "タイトル": "Prevalence and clinical features of autosomal dominant and recessive TMC1-associated hearing loss.",
          "DOI": "doi: 10.1007/s00439-021-02364-2",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "23": {
          "タイトル": "Human deafness-associated variants alter the dynamics of key molecules in hair cell stereocilia F-actin cores.",
          "DOI": "doi: 10.1007/s00439-021-02304-0",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "24": {
          "タイトル": "Identification of a Novel Copy Number Variation of EYA4 Causing Autosomal Dominant Non-syndromic Hearing Loss.",
          "DOI": "doi: 10.1097/MAO.0000000000003169",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "25": {
          "タイトル": "Novel ACTG1 mutations in patients identified by massively parallel DNA sequencing cause progressive hearing loss.",
          "DOI": "doi: 10.1038/s41598-020-63690-5",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "26": {
          "タイトル": "Clinical Characteristics and In Vitro Analysis of MYO6 Variants Causing Late-Onset Progressive Hearing Loss.",
          "DOI": "doi: 10.3390/genes11030273",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "27": {
          "タイトル": "Prevalence and clinical features of hearing loss caused by EYA4 variants.",
          "DOI": "doi: 10.1038/s41598-020-60259-0",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        },
        "28": {
          "タイトル": "Cochlear Implantation From the Perspective of Genetic Background.",
          "DOI": "doi: 10.1002/ar.24360",
          "データID": "JGAD000607（69遺伝子領域・63遺伝子領域）"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0005.v8": {
          "Research ID": "hum0005.v8",
          "公開日": "2023/10/02",
          "内容": "NGS（Target Capture：69遺伝子領域、63遺伝子領域）"
        },
        "hum0005.v7": {
          "Research ID": "hum0005.v7",
          "公開日": "2021/11/19",
          "内容": "NGS（Target Capture：69遺伝子領域、63遺伝子領域、90遺伝子領域）"
        },
        "hum0005.v6": {
          "Research ID": "hum0005.v6",
          "公開日": "2021/07/30",
          "内容": "NGS（Target Capture：69遺伝子領域、63遺伝子領域、90遺伝子領域）"
        },
        "hum0005.v5": {
          "Research ID": "hum0005.v5",
          "公開日": "2019/04/18",
          "内容": "NGS（Target Capture：69遺伝子領域、90遺伝子領域）"
        },
        "hum0005.v4": {
          "Research ID": "hum0005.v4",
          "公開日": "2018/02/13",
          "内容": "NGS（Target Capture：69遺伝子領域、90遺伝子領域）"
        },
        "hum0005.v3": {
          "Research ID": "hum0005.v3",
          "公開日": "2017/06/19",
          "内容": "NGS（Target Capture：69遺伝子領域）"
        },
        "hum0005.v2": {
          "Research ID": "hum0005.v2",
          "公開日": "2017/02/24",
          "内容": "NGS（Target Capture：69遺伝子領域）"
        },
        "hum0005.v1": {
          "Research ID": "hum0005.v1",
          "公開日": "2014/01/27",
          "内容": "NGS（Target Capture：9遺伝子領域）"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0005.v8",
      "DATA": {
        "DRA001273": {
          "Data Set ID": "DRA001273",
          "Type of Data": "NGS (Target Capture: Nine genes)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2014/01/27"
        },
        "JGAS000032": {
          "Data Set ID": "JGAS000032",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/02/24"
        },
        "DRA003791": {
          "Data Set ID": "DRA003791",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Unrestricted-access",
          "Release Date": "2017/02/24"
        },
        "JGAS000093": {
          "Data Set ID": "JGAS000093",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2017/06/19"
        },
        "JGAS000123": {
          "Data Set ID": "JGAS000123",
          "Type of Data": "NGS (Target Capture)\r\n69 genes・90 genes",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2018/02/13"
        },
        "JGAS000166": {
          "Data Set ID": "JGAS000166",
          "Type of Data": "NGS (Target Capture)\r\n69 genes・90 genes",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2019/04/18"
        },
        "JGAS000191": {
          "Data Set ID": "JGAS000191",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/30"
        },
        "JGAS000192": {
          "Data Set ID": "JGAS000192",
          "Type of Data": "NGS (Target Capture)\r\n69 genes・63 genes・90 genes",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/30"
        },
        "JGAS000200": {
          "Data Set ID": "JGAS000200",
          "Type of Data": "NGS (Target Capture)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/30"
        },
        "JGAS000201": {
          "Data Set ID": "JGAS000201",
          "Type of Data": "NGS (Target Capture)\r\n69 genes・63 genes・90 genes",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/07/30"
        },
        "JGAS000323": {
          "Data Set ID": "JGAS000323",
          "Type of Data": "NGS (Target Capture)\r\n69 genes・63 genes・90 genes",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2021/11/19"
        },
        "JGAS000490": {
          "Data Set ID": "JGAS000490",
          "Type of Data": "NGS (Target Capture)\r\n69 genes・63 genes",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2023/10/02"
        }
      },
      "SUMMARY": {
        "Aims": "To identify the causative gene mutation of hearing impairment including non-syndromic hearing loss, syndromic hearing loss, and inner, middle, outer ear malformation.",
        "Methods": "Massively Parallel DNA Sequencing was performed with an Ion Torrent Personal Genome Machine (PGM), Ion Proton or Ion S5 system using the Ion PGM 200, Proton HiQ Sequencing Kit and Ion 318 Chip or Ion P1 chip (Thermo Fisher Scientific) or 540 chip chef kit (S5) or HiSeq 2000 system (Illumina).",
        "Participants/Materials": "Usher Syndrome: 17 patients"
      },
      "MOLECULAR DATA": {
        "DRA001273": {
          "Participants/Materials": "17 usher syndrome patients",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "Nine genes\r\n(MYO7A, USH1C, CDH23, PCDH15, SANS[USH1G],\r\nUSH2A, GPR98[USH2C], DFNB31[USH2D], CLRN[USH3A])",
          "Platform": "Thermo Fisher Scientific [Ion PGM]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Custom kit",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "DDBJ Sequence Read Archive ID": "DRA001273",
          "Total Data Volume": "726.6 MB",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000032, JGAS000093, JGAS000123, JGAS000166, JGAS000191, JGAS000192, JGAS000201, JGAS000323, JGAD000490": {
          "Participants/Materials": "39 non-syndromic hearing loss patients (JGAS000032)\r\n19 non-syndromic hearing loss patients (JGAS000093)\r\n16 non-syndromic hearing loss patients (JGAS000123)\r\n37 non-syndromic hearing loss patients (JGAS000166)\r\n1 non-syndromic hearing loss patient (JGAS000191)\r\n9 non-syndromic hearing loss patients (JGAS000192) (a data from the same patient is included in JGAS000032)\r\n7 non-syndromic hearing loss patients (JGAS000201)\r\n3 non-syndromic hearing loss patients (JGAS000323)\r\n1410 non-syndromic hearing loss patients (JGAS000490)\r\n(ICD10: H90)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "69 genes\r\n（ACTG1, CCDC50, CDH23, CEACAM16, CLDN14, COCH, \r\nCOL11A2, CRYM, DFNA5, DFNB59, DIAPH1, ESPN, ESRRB, \r\nEYA4, GIPC3, GJB2, GJB3, GJB6, GPSM2, GRHL2, GRXCR1, \r\nHGF, ILDR1, KCNQ4, LHFPL5, LOXHD1, LRTOMT, MARVELD2, \r\nMIRN96, MSRB3, MYH14, MYH9, MYO15A, MYO1A, MYO3A, \r\nMYO6, MYO7A, OTOA, OTOF, PCDH15, POU3F4, POU4F3, \r\nPRPS1, PTPRQ, RDX, SERPINB6, SLC17A8, SLC26A4, \r\nSLC26A5, SMAC, SMPX, STRC, TECTA, TJP2, TMC1, TMIE, \r\nTMPRSS3, TPRN, TRIOBP, USH1C, USH2A, WFS1, WHRN）",
          "Platform": "Thermo Fisher Scientific [Ion PGM, Ion Proton]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Custom kit, Ion AmpliSeq Library Kit ver 2.0",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "DDBJ Sequence Read Archive ID": "JGAD000032\r\nJGAD000093\r\nJGAD000134\r\nJGAD000244\r\nJGAD000274\r\nJGAD000275\r\nJGAD000286\r\nJGAD000434\r\nJGAD000607",
          "Total Data Volume": "JGAD000032 : 13.73 GB (fastq)\r\nJGAD000093 : 6 GB (fastq)\r\nJGAD000134 : 18 GB (fastq)\r\nJGAD000244 : 18 GB (fastq)\r\nJGAD000274：292 MB（fastq）\r\nJGAD000275：14.3 GB（fastq）\r\nJGAD000286：57 GB（fastq）\r\nJGAD000434：8.8 GB（fastq）\r\nJGAD000607：1.1 TB（fastq）",
          "Comments (Policies)": "NBDC policy"
        },
        "DRA003791": {
          "Participants/Materials": "5 non-syndromic hearing loss patients (ICD10: H90)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "69 genes\r\n（ACTG1, CCDC50, CDH23, CEACAM16, CLDN14, COCH, \r\nCOL11A2, CRYM, DFNA5, DFNB59, DIAPH1, ESPN, ESRRB, \r\nEYA4, GIPC3, GJB2, GJB3, GJB6, GPSM2, GRHL2, GRXCR1, \r\nHGF, ILDR1, KCNQ4, LHFPL5, LOXHD1, LRTOMT, MARVELD2, \r\nMIRN96, MSRB3, MYH14, MYH9, MYO15A, MYO1A, MYO3A, \r\nMYO6, MYO7A, OTOA, OTOF, PCDH15, POU3F4, POU4F3, \r\nPRPS1, PTPRQ, RDX, SERPINB6, SLC17A8, SLC26A4, \r\nSLC26A5, SMAC, SMPX, STRC, TECTA, TJP2, TMC1, TMIE, \r\nTMPRSS3, TPRN, TRIOBP, USH1C, USH2A, WFS1, WHRN）",
          "Platform": "Thermo Fisher Scientific [Ion PGM]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Custom Panel, Ion AmpliSeq Library Kit ver 2.0",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "DDBJ Sequence Read Archive ID": "DRA003791",
          "Total Data Volume": "412.5 MB (fastq)",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000123, JGAS000166, JGAS000192, JGAS000201, JGAS000323": {
          "Participants/Materials": "3 non-syndromic hearing loss patients (JGAS000123)\r\n2 non-syndromic hearing loss patients (JGAS000166)\r\n2 non-syndromic hearing loss patients (JGAS000192)\r\n4 non-syndromic hearing loss patients (JGAS000201)\r\n1 non-syndromic hearing loss patients (JGAS000323)\r\n(ICD10: H90)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "90 genes\r\n(ACTG1, AIFM1, ALMS1, ATP2B2, CABP2, CACNA1D, CATSPER2, \r\nCCDC50, CDH23, CEACAM16, CIB2, CLDN14, CLRN1, COCH, \r\nCOL11A2, CRYL1, CRYM, DFNA5, DIABLO, DIAPH1, DSPP, ESPN, \r\nESSRB, EYA1, EYA4, FOXI1, GIPC3, GJB2, GJB3, GJB6, GPR98, \r\nGPSM2, GRHL2, GRXCR1, HGF, ILDR1, KCNJ10, KCNQ1, KCNQ4, \r\nLHFPL5, LOXHD1, LRTOMT, MARVELD2, MSRB3, MYH14, MYH9, \r\nMYO15A, MYO1A, MYO3A, MYO6, MYO7A, OTOA, OTOF, OTOG, \r\nOTOGL, P2RX2, PCDH15, PDZD7, PJVK, PNPT1, POU3F4, \r\nPOU4F3, PRPS1, PTPRQ, RDX, SERPINB6, SIX1, SLC17A8, \r\nSLC26A4, SLC26A5, SMPX, STRC, TECTA, TJP2, TMC1, TMIE, \r\nTMPRSS3, TPRN, TRIOBP, TSPEAR, USH1C, USH1G, USH2A, \r\nWFS1, WHRN, MIR96, MIR182, MIR183, MTRNR1, MTTS1)",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Agilent Sure Select XT",
          "Fragmentation Methods": "-",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "DDBJ Sequence Read Archive ID": "JGAD000134\r\nJGAD000244\r\nJGAD000275\r\nJGAD000286\r\nJGAD000434",
          "Total Data Volume": "JGAD000134 : 18 GB (fastq)\r\nJGAD000244 : 18 GB (fastq)\r\nJGAD000275：14.3 GB（fastq）\r\nJGAD000286：57 GB（fastq）\r\nJGAD000434：8.8 GB（fastq）",
          "Comments (Policies)": "NBDC policy"
        },
        "JGAS000192, JGAS000200, JGAS000201, JGAS000323, JGAD000490": {
          "Participants/Materials": "17 non-syndromic hearing loss patients (JGAS000192)\r\n7 non-syndromic hearing loss patients (JGAS000200)\r\n15 non-syndromic hearing loss patients (JGAS000201)\r\n11 non-syndromic hearing loss patients (JGAS000323)\r\n1559 non-syndromic hearing loss patients (JGAS000490)\r\n(ICD10: H90)",
          "Targets": "Target Capture",
          "Target Loci for Capture Methods": "63 genes\r\n(ACTG1, CCDC50, CDH23, CEACAM16, CLDN14, COCH, \r\nCOL11A2, CRYM, DFNA5, DFNB59, DIAPH1, ESPN, ESRRB, \r\nEYA4, GIPC3, GJB2, GJB3, GJB6, GPSM2, GRHL2, GRXCR1, \r\nHGF, ILDR1, KCNQ4, LHFPL5, LOXHD1, LRTOMT, \r\nMARVELD2, MIRN96, MSRB3, MYH14, MYH9, MYO15A, \r\nMYO1A, MYO3A, MYO6, MYO7A, OTOA, OTOF, PCDH15, \r\nPOU3F4, POU4F3, PRPS1, PTPRQ, RDX, SERPINB6, \r\nSLC17A8, SLC26A4, SLC26A5, SMAC, SMPX, STRC, \r\nTECTA, TJP2, TMC1, TMIE, TMPRSS3, TPRN, TRIOBP, \r\nUSH1C, USH2A, WFS1, WHRN)",
          "Platform": "Thermo Fisher Scientific [Ion PGM, Ion Proton, Ion S5]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "Ion AmpliSeq Custom kit, Ion AmpliSeq Library Kit ver 2.0",
          "Fragmentation Methods": "-",
          "Spot Type": "Single-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "200 bp",
          "DDBJ Sequence Read Archive ID": "JGAD000275\r\nJGAD000285\r\nJGAD000286\r\nJGAD000434\r\nJGAD000607",
          "Total Data Volume": "JGAD000275：14.3 GB（fastq）\r\nJGAD000285：2 GB（fastq）\r\nJGAD000286：57 GB（fastq）\r\nJGAD000434：8.8 GB（fastq）\r\nJGAD000607：1.1 TB（fastq）",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shin-ichi Usami",
        "Affiliation": "Department of Hearing Implant Sciences, Shinshu University School of Medicine",
        "Funds / Grants (Research Project Number)": {
          "10": {
            "Name": "Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development",
            "Title": "Development of evidence based clinical management for syndromic hearing loss.",
            "Project Number": "JP21ek0109542"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1.",
          "DOI": "doi: 10.1371/journal.pone.0090688",
          "Data Set ID": "DRA001273"
        },
        "2": {
          "Title": "An effective screening strategy for deafness in combination with a next-generation sequencing platform: a consecutive analysis.",
          "DOI": "doi: 10.1038/jhg.2015.143",
          "Data Set ID": "JGAD000032"
        },
        "3": {
          "Title": "Frequency of Usher syndrome type 1 in deaf children by massively parallel DNA sequencing.",
          "DOI": "doi: 10.1038/jhg.2015.168",
          "Data Set ID": "DRA003791"
        },
        "4": {
          "Title": "POU4F3 mutation screening in Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis identified novel variants associated with autosomal dominant hearing loss",
          "DOI": "doi: 10.1371/journal.pone.0177636",
          "Data Set ID": "JGAD000093\r\nJGAD000607 (69 genes・63 genes)"
        },
        "5": {
          "Title": "WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis.",
          "DOI": "doi: 10.1371/journal.pone.0193359",
          "Data Set ID": "JGAD000134 (69 genes・90 genes)\r\nJGAD000607 (69 genes・63 genes)"
        },
        "6": {
          "Title": "OTOF mutation analysis with massively parallel DNA sequencing in 2,265 Japanese sensorineural hearing loss patients.",
          "DOI": "doi: 10.1371/journal.pone.0215932",
          "Data Set ID": "JGAD000244 (69 genes・90 genes)\r\nJGAD000607 (69 genes・63 genes)"
        },
        "7": {
          "Title": "Detailed Clinical Features of Deafness Caused by a Claudin-14 Variant.",
          "DOI": "doi: 10.3390/ijms20184579",
          "Data Set ID": "JGAD000274"
        },
        "8": {
          "Title": "Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort.",
          "DOI": "doi: 10.3390/genes10100735",
          "Data Set ID": "JGAD000275 (69 genes・63 genes・90 genes)"
        },
        "9": {
          "Title": "Mid-Frequency Hearing Loss Is Characteristic Clinical Feature of OTOA-Associated Hearing Loss.",
          "DOI": "doi: 10.3390/genes10090715",
          "Data Set ID": "JGAD000285"
        },
        "10": {
          "Title": "The Prevalence and Clinical Characteristics of TECTA-Associated Autosomal Dominant Hearing Loss.",
          "DOI": "doi: 10.3390/genes10100744",
          "Data Set ID": "JGAD000286 (69 genes・63 genes・90 genes)"
        },
        "11": {
          "Title": "Prevalence and Clinical Characteristics of Hearing Loss Caused by MYH14 Variants.",
          "DOI": "doi: 10.3390/genes12101623",
          "Data Set ID": "JGAD000434 (69 genes・63 genes・90 genes)"
        },
        "12": {
          "Title": "Simple and efficient germline copy number variant visualization method for the Ion AmpliSeq™ custom panel.",
          "DOI": "doi: 10.1002/mgg3.399",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "13": {
          "Title": "The Clinical Next-Generation Sequencing Database: A Tool for the Unified Management of Clinical Information and Genetic Variants to Accelerate Variant Pathogenicity Classification.",
          "DOI": "doi: 10.1002/humu.23160",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "14": {
          "Title": "Frequency and clinical features of hearing loss caused by STRC deletions.",
          "DOI": "doi: 10.1038/s41598-019-40586-7",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "15": {
          "Title": "Diagnostic pitfalls for GJB2-related hearing loss: A novel deletion detected by Array-CGH analysis in a Japanese patient with congenital profound hearing loss.",
          "DOI": "doi: 10.1002/ccr3.1800",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "16": {
          "Title": "Sensorineural hearing loss and mild cardiac phenotype caused by an EYA4 mutation.",
          "DOI": "doi: 10.1038/s41439-018-0023-9",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "17": {
          "Title": "Frequency of the STRC-CATSPER2 deletion in STRC-associated hearing loss patients.",
          "DOI": "doi: 10.1038/s41598-021-04688-5",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "18": {
          "Title": "Variants in CDH23 cause a broad spectrum of hearing loss: from non-syndromic to syndromic hearing loss as well as from congenital to age-related hearing loss.",
          "DOI": "doi: 10.1007/s00439-022-02431-2",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "19": {
          "Title": "Genetic background in late-onset sensorineural hearing loss patients.",
          "DOI": "doi: 10.1038/s10038-021-00990-2",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "20": {
          "Title": "The genetic etiology of hearing loss in Japan revealed by the social health insurance-based genetic testing of 10K.",
          "DOI": "doi: 10.1007/s00439-021-02371-3",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "21": {
          "Title": "Detailed clinical features and genotype-phenotype correlation in an OTOF-related hearing loss cohort in Japan.",
          "DOI": "doi: 10.1007/s00439-021-02351-7",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "22": {
          "Title": "Prevalence and clinical features of autosomal dominant and recessive TMC1-associated hearing loss.",
          "DOI": "doi: 10.1007/s00439-021-02364-2",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "23": {
          "Title": "Human deafness-associated variants alter the dynamics of key molecules in hair cell stereocilia F-actin cores.",
          "DOI": "doi: 10.1007/s00439-021-02304-0",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "24": {
          "Title": "Identification of a Novel Copy Number Variation of EYA4 Causing Autosomal Dominant Non-syndromic Hearing Loss.",
          "DOI": "doi: 10.1097/MAO.0000000000003169",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "25": {
          "Title": "Novel ACTG1 mutations in patients identified by massively parallel DNA sequencing cause progressive hearing loss.",
          "DOI": "doi: 10.1038/s41598-020-63690-5",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "26": {
          "Title": "Clinical Characteristics and In Vitro Analysis of MYO6 Variants Causing Late-Onset Progressive Hearing Loss.",
          "DOI": "doi: 10.3390/genes11030273",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "27": {
          "Title": "Prevalence and clinical features of hearing loss caused by EYA4 variants.",
          "DOI": "doi: 10.1038/s41598-020-60259-0",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        },
        "28": {
          "Title": "Cochlear Implantation From the Perspective of Genetic Background.",
          "DOI": "doi: 10.1002/ar.24360",
          "Data Set ID": "JGAD000607 (69 genes・63 genes)"
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0005.v8": {
          "Research ID": "hum0005.v8",
          "Release Date": "2023/10/02",
          "Type of Data": "NGS (Target Capture)"
        },
        "hum0005.v7": {
          "Research ID": "hum0005.v7",
          "Release Date": "2021/11/19",
          "Type of Data": "NGS (Target Capture)"
        },
        "hum0005.v6": {
          "Research ID": "hum0005.v6",
          "Release Date": "2021/07/30",
          "Type of Data": "NGS (Target Capture)"
        },
        "hum0005.v5": {
          "Research ID": "hum0005.v5",
          "Release Date": "2019/04/18",
          "Type of Data": "NGS (Target Capture)"
        },
        "hum0005.v4": {
          "Research ID": "hum0005.v4",
          "Release Date": "2018/02/13",
          "Type of Data": "NGS (Target Capture)"
        },
        "hum0005.v3": {
          "Research ID": "hum0005.v3",
          "Release Date": "2017/06/19",
          "Type of Data": "NGS (Target Capture)"
        },
        "hum0005.v2": {
          "Research ID": "hum0005.v2",
          "Release Date": "2017/02/24",
          "Type of Data": "NGS (Target Capture)"
        },
        "hum0005.v1": {
          "Research ID": "hum0005.v1",
          "Release Date": "2014/01/27",
          "Type of Data": "NGS (Target Capture)"
        }
      }
    }
  },
  "hum0004.v1": {
    "ja": {
      "NBDC Research ID": "hum0004.v1",
      "データ": {
        "JGAS000001": {
          "データID": "JGAS000001",
          "内容": "NGS（Exome）",
          "制限": "制限公開（Type I）",
          "公開日": "2014/07/11"
        }
      },
      "研究内容の概要": {
        "目的": "アジア人に発症頻度の高いEGFR変異陽性肺腺がんの網羅的遺伝子変異プロファイルを明らかにする",
        "方法": "全エクソンシークエンシング（Illumina [Genome Analyzer IIx]）",
        "対象": "手術切除された97例の肺腫瘍組織及び非腫瘍組織から抽出したゲノムDNA",
        "URL": "https://www.ncc.go.jp/jp/epoc/division/translational_informatics/kashiwa/members/010/index.html"
      },
      "分子データ": {
        "JGAS000001": {
          "対象": "97例の肺腫瘍組織及び非腫瘍組織",
          "規模": "Exome",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [Genome Analyzer IIx]",
          "ライブラリソース": "肺腫瘍組織及び非腫瘍組織から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "SureSelect Target Enrichment System",
          "断片化の方法": "超音波断片化（Covaris社）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプタ、プライマー、リンカー）": "76 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000001",
          "総データ量": "",
          "コメント（利用にあたっての制限事項）": "NBDC policy および hum0004 policy"
        }
      },
      "提供者情報": {
        "研究代表者": "後藤 功一",
        "所 属 機 関": "国立がん研究センター東病院 呼吸器内科",
        "プロジェクト/研究グループ名": "国立がん研究センター 先端医療開発センター トランスレーショナルインフォマティクス分野",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 基盤研究（B）",
            "タイトル": "肺腺癌ゲノム解析に基づく治療標的キナーゼの探索",
            "研究課題番号": "24300345"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Identification and characterization of cancer mutations in Japanese lung adenocarcinoma without sequencing of normal tissue counterparts.",
          "DOI": "doi: 10.1371/journal.pone.0073484",
          "データID": "JGAD000001"
        },
        "2": {
          "タイトル": "Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung.",
          "DOI": "doi: 10.1111/pin.12033",
          "データID": ""
        },
        "3": {
          "タイトル": "Immunohistochemical and genetic characteristics of lung cancer mimicking organizing pneumonia.",
          "DOI": "doi: 10.1016/j.lungcan.2017.10.001",
          "データID": ""
        },
        "4": {
          "タイトル": "Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.",
          "DOI": "doi: 10.1007/s00432-018-2619-3",
          "データID": ""
        },
        "5": {
          "タイトル": "Characterization of the tumor immune-microenvironment of lung adenocarcinoma associated with usual interstitial pneumonia.",
          "DOI": "doi: 10.1016/j.lungcan.2018.11.006",
          "データID": ""
        }
      },
      "制限公開データの利用者一覧": {
        "Youping Deng": {
          "研究代表者": "Youping Deng",
          "所属機関": "Department of Complementary and Integrative Medicine, University of Hawai Manoa",
          "研究題目": "",
          "利用データID": "",
          "利用期間": "JGAD000001"
        },
        "中岡 博史": {
          "研究代表者": "中岡 博史",
          "所属機関": "公益財団法人佐々木研究所 腫瘍ゲノム研究部",
          "研究題目": "日本",
          "利用データID": "肺がん遺伝子解析研究",
          "利用期間": "JGAD000001"
        }
      },
      "リリース情報": {
        "hum0004.v1": {
          "Research ID": "hum0004.v1",
          "公開日": "2014/07/11",
          "内容": "NGS （Exome）",
          "description": " このバージョンでは、97症例の腫瘍組織/非腫瘍組織の全エクソン領域（37Mb）のシーケンスデータfastqファイルを提供する。SureSelect Target Enrichment Systemを用いてExon領域にしぼり、Illumina Genome Analyzer IIxにて配列を読んでいる（Paired-end: 2 x 76 bp）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0004.v1",
      "DATA": {
        "JGAS000001": {
          "Data Set ID": "JGAS000001",
          "Type of Data": "NGS (Exome)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2014/07/11"
        }
      },
      "SUMMARY": {
        "Aims": "Molecular epidemiological study of somatic mutation profiles of epidermal growth factor receptor: EGFR mutation-positive lung adenocarcinoma",
        "Methods": "Whole Genome Sequence (Illumina [Genome Analyzer IIx])",
        "Participants/Materials": " 97 Japanese lung adenocarcinoma patients as tumor-normal pairs.",
        "URL": "https://www.ncc.go.jp/en/epoc/division/translational_informatics/kashiwa/index.html"
      },
      "MOLECULAR DATA": {
        "JGAS000001": {
          "Participants/Materials": "97 Japanese lung adenocarcinoma patients as tumor-normal pairs",
          "Targets": "Exome",
          "Target Loci for Captur Methods": "-",
          "Platforms": "Illumina [Genome Analyzer IIx]",
          "Library Sources": "DNAs extracted from adenocarcinoma and non-adenocarcinoma",
          "Cell Lines": "-",
          "Library Construction (kit name)": "SureSelect Target Enrichment System",
          "Fragmentation Methods": "Ultrasonic fragmentation (Covaris)",
          "Spot Type": "Paired-end reads",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "76 bp x 2",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000001",
          "Total Data Volume": "",
          "Comments (Policies)": "NBDC policy & hum0004 policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Koichi Goto",
        "Affiliation": "Thoracic Oncology Division, the National Cancer Center Hospital East",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research (B)",
            "Title": "Searching for kinases related to lung cancer based on genomic analysis for lung adenocarcinoma",
            "Project Number": "24300345"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Identification and characterization of cancer mutations in Japanese lung adenocarcinoma without sequencing of normal tissue counterparts.",
          "DOI": "doi: 10.1371/journal.pone.0073484",
          "Data Set ID": "JGAD000001"
        },
        "2": {
          "Title": "Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung.",
          "DOI": "doi: 10.1111/pin.12033",
          "Data Set ID": ""
        },
        "3": {
          "Title": "Immunohistochemical and genetic characteristics of lung cancer mimicking organizing pneumonia.",
          "DOI": "doi: 10.1016/j.lungcan.2017.10.001",
          "Data Set ID": ""
        },
        "4": {
          "Title": "Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.",
          "DOI": "doi: 10.1007/s00432-018-2619-3",
          "Data Set ID": ""
        },
        "5": {
          "Title": "Characterization of the tumor immune-microenvironment of lung adenocarcinoma associated with usual interstitial pneumonia.",
          "DOI": "doi: 10.1016/j.lungcan.2018.11.006",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
        "Youping Deng": {
          "Principal Investigator": "Youping Deng",
          "Affiliation": "Department of Complementary and Integrative Medicine, University of Hawai Manoa",
          "Research Title": "",
          "Data in Use (Dataset ID)": "",
          "Period of Data Use": "JGAD000001"
        },
        "Hirofumi Nakaoka": {
          "Principal Investigator": "Hirofumi Nakaoka",
          "Affiliation": "Department of Cancer Genome Research, Sasaki Institute",
          "Research Title": "Japan",
          "Data in Use (Dataset ID)": "Genetic analysis of lung cancer",
          "Period of Data Use": "JGAD000001"
        }
      },
      "Release Note": {
        "hum0004.v1": {
          "Research ID": "hum0004.v1",
          "Release Date": "2014/07/11",
          "Type of Data": "NGS (Exome)",
          "description": "Whole exome sequencing data in FASTQ format for 97 Japanese lung adenocarcinoma patients (37 MB).Target loci were narrowed down by using of SureSelect Target Enrichment System, and read by Illumina Genome Analyzer IIx (Paired-end: 2 x 76 bp).\nNote:\n"
        }
      }
    }
  },
  "hum0003.v1": {
    "ja": {
      "NBDC Research ID": "hum0003.v1",
      "データ": {
        "DRA000908": {
          "データID": "DRA000908",
          "内容": "NGS （HLAアレルの塩基配列決定）",
          "制限": "非制限公開",
          "公開日": "2013/07/01"
        }
      },
      "研究内容の概要": {
        "目的": "HLA遺伝子(HLA-A, -C, -B, -DRB1, -DQB1および-DPB1)におけるHLAアレル完全長塩基配列(約3kb〜14kb)を決定する",
        "方法": "Long range PCRにより目的領域を増幅し、Illumina社のMiSeqにより塩基配列を解析する",
        "対象": "複数集団由来セルライン：33名"
      },
      "分子データ": {
        "DRA000908": {
          "対象": "セルライン33名分",
          "規模": "Target Capture",
          "対象領域（Target Captureの場合）": "HLA領域\r\n(HLA-A, -C, -B, -DRB1, -DQB1, -DPB1)",
          "Platform": "Illumina [MiSeq]",
          "ライブラリソース": "-",
          "検体情報（購入の場合）": "http://www.hpacultures.org.uk/products/celllines/hlatyped/search.jsp",
          "ライブラリ作製方法（キット名）": "Nextera",
          "断片化方法": "Nextera (Tagmentation)",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "250 bp x 2",
          "DDBJ Sequence Read Archive ID": "DRA000908",
          "総データ量": "1.28 GB",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "井ノ上 逸朗",
        "所 属 機 関": "国立遺伝学研究所 人類遺伝研究部門",
        "科研費/助成金（Research Project Number）": {
          "2": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究（研究領域提案型）",
            "タイトル": "ゲノム科学の総合的推進に向けた大規模ゲノム情報生産・ 高度情報解析支援",
            "研究課題番号": "221S0002"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Phase-defined complete sequencing of the HLA genes by next-generation sequencing.",
          "DOI": "doi:10.1186/1471-2164-14-355",
          "データID": "DRA00908"
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0003.v1": {
          "Research ID": "hum0003.v1",
          "公開日": "2013/07/01",
          "内容": "NGS (HLA-A, -C, -B, -DRB1, -DQB1, -DPB1)",
          "description": "このバージョンでは、6つのHLA遺伝子(HLA-A, -C, -B, DRB1, -DQB1, -DPB1)領域のLong-range PCRを行ない、Nextera DNA Preparation Kitを用いて断片化とアダプターの付加を行なった後、MiSeq (Illumina)にて配列を読んでいる（Paired-end: 2 x 250 bp）。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": null
    }
  },
  "hum0001.v1": {
    "ja": {
      "NBDC Research ID": "hum0001.v1",
      "データ": {
        "JGAS000002": {
          "データID": "JGAS000002",
          "内容": "NGS (WGS)",
          "制限": "制限公開（Type I）",
          "公開日": "2013/12/01"
        }
      },
      "研究内容の概要": {
        "目的": "脊髄小脳失調症31型（SCA31）罹患患者の DNA における疾患固有の繰返し配列を同定する。",
        "方法": "Illumina 社 HiSeq 2000 を利用して長さ100塩基のDNA断片を解読",
        "対象": "SCA31罹患患者1名"
      },
      "分子データ": {
        " JGAS000002": {
          "対象": "SCA31患者：1症例",
          "規模": "WGS",
          "対象領域（Target Captureの場合）": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "ライブラリソース": "末梢血から抽出したDNA",
          "検体情報（購入の場合）": "-",
          "ライブラリ作製方法（キット名）": "TrueSeq DNA Sample Prep Kit v2, Set A",
          "断片化の方法": "超音波断片化（Covaris社、E220）",
          "ライブラリ構築方法": "Paired-end",
          "リード長（除：バーコード、アダプター、プライマー、リンカー）": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000002",
          "総データ量": "149 GB（1,627,990,590 reads）",
          "コメント（利用にあたっての制限事項）": "NBDC policy"
        }
      },
      "提供者情報": {
        "研究代表者": "森下 真一",
        "所 属 機 関": "東京大学大学院 新領域創成科学研究科 情報生命科学専攻",
        "プロジェクト/研究グループ名": "",
        "科研費/助成金（Research Project Number）": {
          "0": {
            "科研費・助成金名": "科学研究費助成事業 新学術領域研究",
            "タイトル": "脳疾患パーソナルゲノム多様性を分析する情報学の創成",
            "研究課題番号": "22129008"
          }
        }
      },
      "関連論文": {
        "1": {
          "タイトル": "Rapid detection of expanded short tandem repeats in personal genomics using hybrid sequencing",
          "DOI": "doi: 10.1093/bioinformatics/btt647",
          "データID": "JGAD000002"
        },
        "2": {
          "タイトル": " ",
          "DOI": " ",
          "データID": " "
        }
      },
      "制限公開データの利用者一覧": {
      },
      "リリース情報": {
        "hum0001.v1": {
          "Research ID": "hum0001.v1",
          "公開日": "2013/12/01",
          "内容": "NGS (WGS)",
          "description": "このバージョンでは、脊髄小脳失調症31型（SCA31）罹患患者の DNA における疾患固有の繰返し配列を同定するため、Illumina 社 HiSeq 2000 を利用して平均長さ100塩基のDNA断片を解読した。\nNote：\n"
        }
      }
    },
    "en": {
      "NBDC Research ID": "hum0001.v1",
      "DATA": {
        "JGAS000002": {
          "Data Set ID": "JGAS000002",
          "Type of Data": "NGS (WGS)",
          "Criteria": "Controlled-access (Type I)",
          "Release Date": "2013/12/01"
        }
      },
      "SUMMARY": {
        "Aims": "To identify the short tandem repeats (STRs) with a 10-base repeat unit in spinocerebellar ataxia type 31 (SCA31).",
        "Methods": "One hundred basepair paired-end reads sequenced from one DNA sample using an Illumina HiSeq 2000 platform.",
        "Participants/Materials": "One SCA31patient"
      },
      "MOLECULAR DATA": {
        " JGAS000002": {
          "Participants/Materials": "1 SCA31 patient",
          "Targets": "WGS",
          "Target Loci for Captur Methods": "-",
          "Platform": "Illumina [HiSeq 2000]",
          "Library Source": "gDNA extracted from peripheral blood cells",
          "Cell Lines": "-",
          "Library Construction (kit name)": "TrueSeq DNA Sample Prep Kit v2, Set A",
          "Fragmentation Methods": "Covaris E220",
          "Spot Type": "Paired-end",
          "Read Length (without Barcodes, Adaptors, Primers, and Linkers)": "100 bp",
          "Japanese Genotype-phenotype Archive Dataset ID": "JGAD000002",
          "Total Data Volume": "149 GB (1,627,990,590 reads)",
          "Comments (Policies)": "NBDC policy"
        }
      },
      "DATA PROVIDER": {
        "Principal Investigator": "Shinichi Morishita",
        "Affiliation": "Dept. of Computational Biology, Graduate School of Frontier Science, The Univ. of Tokyo",
        "Project / Group Name": "",
        "Funds / Grants (Research Project Number)": {
          "0": {
            "Name": "KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas",
            "Title": "Exploring informatics for brain diseases based on personal genomics",
            "Project Number": "22129008"
          }
        }
      },
      "PUBLICATIONS": {
        "1": {
          "Title": "Rapid detection of expanded short tandem repeats in personal genomics using hybrid sequencing",
          "DOI": "doi: 10.1093/bioinformatics/btt647",
          "Data Set ID": "JGAD000002"
        },
        "2": {
          "Title": "",
          "DOI": "",
          "Data Set ID": ""
        }
      },
      "USERS (Controlled-Access Data)": {
      },
      "Release Note": {
        "hum0001.v1": {
          "Research ID": "hum0001.v1",
          "Release Date": "2013/12/01",
          "Type of Data": "NGS (WGS)",
          "description": " To identify the short tandem repeats in a spinocerebellar ataxia type 31 (SCA31) patient, DNA sample extracted from peripheral blood were used as a library for NGS (Illumina HiSeq 2000, 100 bp, paired-end). \nNote:\n"
        }
      }
    }
  }
}
